<SEC-DOCUMENT>0000917520-22-000010.txt : 20220224
<SEC-HEADER>0000917520-22-000010.hdr.sgml : 20220224
<ACCEPTANCE-DATETIME>20220224160648
ACCESSION NUMBER:		0000917520-22-000010
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		119
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220224
DATE AS OF CHANGE:		20220224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRA LIFESCIENCES HOLDINGS CORP
		CENTRAL INDEX KEY:			0000917520
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				510317849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26224
		FILM NUMBER:		22670923

	BUSINESS ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		6092750500

	MAIL ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRA LIFESCIENCES CORP
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>iart-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:79796dbd-6d84-4777-bf20-15ea797e2f25,g:15b73d14-4963-49a2-aa85-347a140ddfd4,d:172bf506156f43e6869412a665f54418--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iart="http://integralife.com/20211231" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2021-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iart-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF80L2ZyYWc6ZGYzYmRiZDI5OTc5NDY3N2IyN2FkMzZjZjhhNDEzZDgvdGFibGU6NWUyZTYzMTkyN2Q5NGFjNjk5OWFjMDNkMzJmYmY0NzEvdGFibGVyYW5nZTo1ZTJlNjMxOTI3ZDk0YWM2OTk5YWMwM2QzMmZiZjQ3MV80LTEtMS0xLTM3MzU2_a278279c-9cc9-41f7-9d8a-d70b53ac60dc">false</ix:nonNumeric><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF80L2ZyYWc6ZGYzYmRiZDI5OTc5NDY3N2IyN2FkMzZjZjhhNDEzZDgvdGFibGU6NWUyZTYzMTkyN2Q5NGFjNjk5OWFjMDNkMzJmYmY0NzEvdGFibGVyYW5nZTo1ZTJlNjMxOTI3ZDk0YWM2OTk5YWMwM2QzMmZiZjQ3MV82LTEtMS0xLTM3MzU2_047fc895-56c4-48ee-9afb-ac3e8a83552c">2021</ix:nonNumeric><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF80L2ZyYWc6ZGYzYmRiZDI5OTc5NDY3N2IyN2FkMzZjZjhhNDEzZDgvdGFibGU6NWUyZTYzMTkyN2Q5NGFjNjk5OWFjMDNkMzJmYmY0NzEvdGFibGVyYW5nZTo1ZTJlNjMxOTI3ZDk0YWM2OTk5YWMwM2QzMmZiZjQ3MV83LTEtMS0xLTM3MzU2_23f68ca7-362e-4038-946c-c74c114773a1">FY</ix:nonNumeric><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF80L2ZyYWc6ZGYzYmRiZDI5OTc5NDY3N2IyN2FkMzZjZjhhNDEzZDgvdGFibGU6NWUyZTYzMTkyN2Q5NGFjNjk5OWFjMDNkMzJmYmY0NzEvdGFibGVyYW5nZTo1ZTJlNjMxOTI3ZDk0YWM2OTk5YWMwM2QzMmZiZjQ3MV8xMC0xLTEtMS0zNzM1Ng_f6897fb0-1c2a-4b0f-a2c3-572d59a354c7">0000917520</ix:nonNumeric><ix:nonNumeric contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY0LTAtMS0xLTM3MzU2_6ec0d2c1-0137-4ab4-bbb6-a370369c6602">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI0LTAtMS0xLTQ0OTI1_bdbd4380-9fca-40b5-9280-10467d59cd85">http://integralife.com/20211231#AccountingStandardUpdate202006Member</ix:nonNumeric><ix:nonNumeric contextRef="i8fd7b7f49417402eb284796a7134d501_D20210101-20211231" name="iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI0Mzcw_c9172610-6a8d-4dac-b8b3-a0c0563d676b">P1M</ix:nonNumeric><ix:nonNumeric contextRef="i7337997e50724c52ad9348740bdd50dd_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzEtMS0xLTEtMzczNTY_b961867a-71fb-4764-b9a4-99488b80bc14">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i90fd6ad1a4554b1490ef3ec1f9cc90a8_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzItMS0xLTEtMzczNTY_eec7de4f-0eee-4729-adc8-ea5fcf54fd24">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i0fc4597fa28c4d28b01a34ea89b827b8_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzMtMS0xLTEtMzczNTY_99571667-1b63-4a3e-a336-0e78ac74db64">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i4a2a15098f6f43029cb4a63d99daaad7_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzQtMS0xLTEtMzczNTY_66809f6d-514f-4562-826f-341e9f94e75a">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="id4a31a62be1b454f97664e2f38331c1b_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzUtMS0xLTEtMzczNTY_b0f51d2c-ec0d-4bd5-8366-0719f296cb83">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i13ba3f3fdc0e466ca5971c734c60c60f_I20211231" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzYtMS0xLTEtMzczNTY_2ce8f71b-8e6d-4240-8b0a-c69b54b852ae"></ix:nonNumeric><ix:nonNumeric contextRef="ia56133e3fe074f28993f1355c3a33e00_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIyNDc_dac495da-8c41-4f99-8dc2-4cfbd78ca20b">P6Y</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzItMS0xLTEtMzczNTY_fd4c8e09-f463-4c49-b107-fff01ea79bc5">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzItMi0xLTEtMzczNTY_ccdec38d-87a2-47ae-b3cc-7020e352a786">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzItMy0xLTEtMzczNTY_cdb9c4fe-3698-4110-9b5b-8436bd2a93dd">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzMtMS0xLTEtMzczNTY_2fb32828-6cea-4c91-8dd2-1e95446b2162">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzMtMi0xLTEtMzczNTY_d32fc6f3-1fd9-4a24-be16-fb60c2997655">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ie55084e91d494776891870a81ff5cb91_I20191231" decimals="-3" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzMtMy0xLTEtMzczNTY_c0b91fa1-eae3-4b8b-a288-8dc9093ef96c">&#8212;</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iart-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45e7724895184fdf85404aad41aa5196_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ib54412ab095545838988a468e37768bb_I20220222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i488c668ed69943629b8567d269181e0c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iee25a280ce1a41fe94147173b06ec1d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if319a53d6ce443d0adc847fb824d705d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie55084e91d494776891870a81ff5cb91_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcaf1fbc6c2145ac92ae58dce7c7f40b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibca422d8af654309ab3549894c22e2d0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia653c210464848738937121e1560643c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bfd63f1146a4c15a4a961a4884d8f8e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1aef4bf54744c0c98c1b03a1df9ec4d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b92cad52f3d4933bd002cc96a643e01_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea229e31f5ee46999defcde318bf2e01_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3184ef53b5bf48b89f52d96b36d83cd8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7d6cd85315a4099a0e9a723e15cc57d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54fe101f812943a4bb6c8e21f03e6abe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57de76fda3e440858f132dfbe6b7a489_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72b41bb28dd74cab856e1fb68a9457e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfd8af4c329c447fa3829f444aa543e6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i008a1ec620f549bb9fe080a50c5507b5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide0d9f6801174af69063a55bae4f6ea4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ecb901e8b3f401a8bb8305e200e9cfd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26020eaabf34449c9314e52e2b46ced3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec381aeaa645411985794e468f533624_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82c6bb6b0f504d638356e1bbc6647d3c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fd48636569448e0af0d30413ae28c64_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib45c219279874482b251ea345021653d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6646ef2e0b7149db85eb6904dd2a2fd7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if738d2f8a6a346b78585e76bc617302c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fb5aab0b91c486f93ba0865f67d73e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife0f354f47024885b393073798c5bcb4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b2f27cba47049e49b27de743dc66104_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9e723c32e3484daf7f94702722ed89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcfb8e89af374d30815fb2d4a02f9b08_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dfb0dc7e5f246bb8a7849e9e7d24e92_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba3867d19dfa4492be95296631dd23cc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f824b4c3df84987af91c402bc76a408_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6c5aeb396884c44b182cf5d1e5128cf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f7a013d5ebd4d9cad2eddbf41dc58f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic716df195898449a87cdc08a6bad6057_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11696c20228346ddb295ad994c1d9416_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie62db310d8e24fc493ae78bec1200f60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib92542029c1c4bd08191f3e3b185049c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d0e311baee24ad7a5bd71c8891f1b7c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62b5cd28862f4322bda15977250be066_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e9517845c414b658fb2157d69d73d89_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i000ed083c92e4b89800da97c60ed285f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:SmithNephewUSDLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida04a0f98d5547f9ac6673309e068708_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a45995162b643ef92059397e2a71385_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74b70ea531614678a00a01b323481165_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6c7328c66304f0eb5f22d8ed0526940_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5208743b3814ba9b6d40074565c4081_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i602a6eef7e324d61a157d45723a03358_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b9b9c6b33494f24b03f4851071485a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i963fa8e01c224aa0a64f3cb763df2e2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic02808dda943426e93e0d648a5cde64b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefe78e2246e94ba3af3242006d2dc451_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f2cb2e9bd3545d28c0f0abacf55b9d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48bbc77d02174676af9eed39f9be47a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id648da5e33794a8d9bd7e7832d8f94cd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41401778e13647b0a2ee5fcf8f706a6a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i602ca3405d8741a38048a4535e86e784_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2a65e2f514d443397027c1f3e979693_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3295f6c4fa84b5f99c2eb43117653cf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06b3b7586a5a4a83bcf6af176544c1e7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01e4b5df061143a995961c4cc0610f5e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie167866deb594d9bad75e4138245a4e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i203bb570980f4213ae16c7f18573158d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabf661f62ecd41f38efb53c5c7fab30f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fd943aa50cb4e70b0f976a5852b32cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f2a0560d0be447492d3aa5f43a5fb1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8a2b6b9e3dc4ed2bb93554da43c0487_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6de32faeb0b247e4a9b3584e095721c3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bbd97850f3e4065b4b66bb87c2cce30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb95fbf7a7c24b6d88311032f03ec584_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6840528edb44a95a4b09018fdca6246_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>iart:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="reporting_unit"><xbrli:measure>iart:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="i8fd7b7f49417402eb284796a7134d501_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4434b0da63d4acb99529de55c3df6cc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib53b8c510bfb4f04a342d01490fff519_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id37cda7e161149dab639b5833e0cdaae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3178f6269054097bd491b98b26e7a45_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if89798fbac704337b50567a4cce07285_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife4b1f164ed2413f96ccef0da637494a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8d6853b6a2340eea65ce878ccdc9506_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ea7e387c13b48c89387b2d3d857caaa_D20190501-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="if754557c7cc244208d000f3659321df2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>iart:Customer</xbrli:measure></xbrli:unit><xbrli:context id="id3e5a63582034b89b1c34575b648c5cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb9fd4579c41462aa90ba45e8a15a748_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib12b7654fd6c486c84790834f7e43479_I20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae4f699d31404c7da2387e7912c12f8b_I20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e9d178090794fc6a66c5ddbb2103c9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">iart:CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie48f6bf8baeb442bbdf792d72242d8ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">iart:CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac4630e900f848359896b56b725b4778_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4078e47ac87f401e97eecd937cf9b64e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30fd64c1cb164ae0b2a907a07c1f841d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4207bdf79e8b43329423b675db80c712_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7337997e50724c52ad9348740bdd50dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90fd6ad1a4554b1490ef3ec1f9cc90a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fc4597fa28c4d28b01a34ea89b827b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a2a15098f6f43029cb4a63d99daaad7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4a31a62be1b454f97664e2f38331c1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13ba3f3fdc0e466ca5971c734c60c60f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb65637da52f4b90bf607fb7b60c210d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b4a664e6d9b4e52b3a3790429c82944_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ff06dcd1f9e4d58b2040d6ef14e3b3f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bb8e06d1a9b412091aa582f72d27809_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8d2e95c76ae4a789dd053d9ce02580f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3046a6eaecf24960a1993adec9143348_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb66154030084b3e8586a701e0a6bdb6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69a65713dfe64c33a00c72d8483e68a9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb4f933be6cc44ff9ddec8c3d27cbf1c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic811b1a099e24c99825ca52914fcf541_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ba7171afa8d4132b7dbe3ab5a4a60f8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if358055a698b49a2858282451967cd20_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66173391a20f4c668d46a6f1ce9e6d20_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c4278b9686c4d53aea7074968344102_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a552626ffa247e6bf4b04926eff831f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5734c3cfbd64dd99f45e59662837d44_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb8306c92f54514bfe2a9e21c1ef069_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d1799cdfeb443c297cec0ede24b319e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b76730b7e7f49afa097d63b1fb0577c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie57e505f7452456591a3ff162137393e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3269a9a9d0024d43b9f980a0524d7c42_I20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i170068c51ed94ca9bf2387c3ce7260fc_D20210104-20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ConsortiumofFocusedOrthopedistsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-04</xbrli:startDate><xbrli:endDate>2021-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53b2addcbddb44aa9a3b86029bb50420_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96bd4fb9f9f845cfb6e003e78b8a9bc7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40a2c7932fe4499294fbfb9e9cb7437f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica517bcfa6884ebc90de2aca64243203_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib985a5fa452f42faa4085adbfafaedf0_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2e483bc15a0412aa43477e358585f01_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39d90578eea04bf1b29ed35663a1802d_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i688db6d6eb2f458d8870fc231b4592c5_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f23076f31b3452e8dd0574aff2fb161_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a53bd10b62342d88e6811d75c05b920_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3b4a6c5eb0b434dba966ae4580828dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if70040a00764430ebf4558b0c9e06708_D20190729-20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-29</xbrli:startDate><xbrli:endDate>2019-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5615952a2a84ce48747f6e0a5b12e88_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71e837488c6d40d2bae9b77a42432999_D20190729-20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-29</xbrli:startDate><xbrli:endDate>2019-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4506a521f784464fab88c8e0a8d34c01_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42a7d4331e424eb9b52d2c8d7ac98fcd_D20190729-20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-29</xbrli:startDate><xbrli:endDate>2019-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bcd02ade40d4716b1746fdd3cb2430d_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8d9df81e2784a7f822f5902f3423b63_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f6f1a1544924074a1d3d7fb36a12a6d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaad07293f494ff6889330b346414a47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i318b6e50656b461a91847e56aab39040_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i051d23eceb014bb58273d6270a8f1c00_D20190909-20190909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-09</xbrli:startDate><xbrli:endDate>2019-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4878a7d091a8419aa9f27c3d38684f89_I20190909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="asset"><xbrli:measure>iart:asset</xbrli:measure></xbrli:unit><xbrli:context id="i4528a498ca614d9ea547555427227000_D20190909-20190909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-09</xbrli:startDate><xbrli:endDate>2019-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49e912b1fd87487785c228195b43bd1c_D20190909-20190909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-09</xbrli:startDate><xbrli:endDate>2019-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33224855ef3047999b2cae3d50de0f11_D20190909-20190909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:DeferredTaxAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-09</xbrli:startDate><xbrli:endDate>2019-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia442774231c74a88babc4cf70ca6a7b9_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75ac54230bc045c6acdd9a962aabc8fa_D20190104-20190104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-04</xbrli:startDate><xbrli:endDate>2019-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i085349bc37c3476aa14e6828a4112638_I20190104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a85f0f4e699490aacc709f96ed3737a_D20190104-20190104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-04</xbrli:startDate><xbrli:endDate>2019-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib718aecc355a42c295a29f73509ea5eb_D20210104-20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:SmithNephewUSDLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ConsortiumofFocusedOrthopedistsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-04</xbrli:startDate><xbrli:endDate>2021-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc245d39ae2c4b37a89f9ea473650099_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9075dc4f5594e0a9117a256577a5b6b_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57c63b69e03f47ecbb9a8c336b5343f0_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad88d8e54f1a4e9a85100c26cb3cdf36_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ab723a0be194e20ace108b34163128f_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">iart:SwinglineLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c66ebe266dc49ae8c7b140c34de1997_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee59fc6ad5d745fd93819ab6849f2abd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i501b6a51ff0140a7b9405a6883ce1ffb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ce7dfab586d445cbad7c5ae7a2d0d70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie42c1e0337854c7dbbf20f4ae06610e9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90140523e867471889b8f2498da45de1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06c53d99c8f942b598357ebec22df68a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib08f50e95c0845a09194c11c67ff0227_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthEurodollarRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b5855752106436d8e5833d80860bf2d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8815454edf87440f8ab1bc7d9bea226c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b35bf05794c4f92b13ccc87a4d842ce_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22d3d9561a884d1f8123cf11213b6e4c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04d1b0160d1340fd8ab66ecf51fa7a66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67999afc0f43421ba112b03ab3776e83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7bb504d057d4468ac3701ee85921300_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4de4ab17ca14d19958b42305fcb9dba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefe0207dab024691b9422a6871c2701c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i010dd7bd40794db0b97bdb8b4817314b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75b71a62404445ecac16c98d28a6c859_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11503d83ecb041bba066af755cc2923f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5c8f0f3fcc54d7fa864f05e7721631f_D20200204-20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-04</xbrli:startDate><xbrli:endDate>2020-02-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c7ea572f6ff408eb1c3e8b78cead270_I20201209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5fd639d6b434c4285a6fe944615d341_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i396d7f2eb0c64059b81baf2f22ba97ec_D20200204-20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-04</xbrli:startDate><xbrli:endDate>2020-02-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6851222fe6b4433adf09a9809463a04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55dda325db55443a874b0f8c37dd8b20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i532960b507734253829e73f26a86f856_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8b32770839e412698beb581305b9b06_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07286d7fc74242cca19b206f52c0f370_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i241736141ce5441cbaf9b7d07be1bd2b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedMarch272017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27e95c8600d24f1788cde97b1a748f0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedMarch272017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e368b5fda0a476a8edcda24877e2d60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bf07d7a40de4c22bd5f4ec2b7dc0864_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie632a54071064dd984a1daee5e94ea29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4f1a07697994a528de8da81d3b4a80d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0b97ff90e2648d49fb6e83da054fb38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cbba29541b0414aa84fce8d3ab05e46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i288f3609bde4438a81832109716cd5a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26217e69841f4b5f865e6ddc9b644f61_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibca66931d2494db380dd96d37d92bc88_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65c0189ffb9a4e769aae035799d3163d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bb1e3365e494ce89a0cf4822b064c93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac02b3f863ad479ab79142979d7cade1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4a132dddf0e4b05ab2279482233be48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35359b024a1d4f2a98e87757bfa30a29_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65d7dee7ffe74d79a4e2144db55b55e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i532ebca746b94440a3ce52a9b1e41c55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b86f7b9c3c848fba14945777a7f742f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i378a39326c7c47a4b12de5edfddb468f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11bfa4243b44471878dc05e0b04c5ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53695045753f4b0cb6d43100ea2c5b50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0dbe85e1e664ae9ac6dc86a82263629_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcde00d2f9ee499c9b3f5bddea1dac4b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f291ee98dcc4db0b65295c7cc02b534_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe5ea43d4f06427e8b8278ecc9d21984_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6f9c05623734f95b308753dab91e2d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i834a7d0bdde0493b82362279698dc772_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f34947eecd043ce89085543035baf6c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a00f578e1734e96abe9db9dd7e4d84d_I20171002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6c4104f081f4a0c97cc34bfa934b8de_I20171002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="chf"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:context id="i0ed96b4baeca485d88d732479d36ee6f_I20201221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie482bef356cf4e048602c1345e6faad1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9225e7f823044678109956680d2a97a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i076d006aea244c84af07364f0b1ad64a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb8fbe23f0de4b438088a04ce4c7f7cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1efb9a3c67d04590a34d8a19cd9e854a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13f31b37f3ea4d8e97eec66b802e9e49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5cde6835114b3da99ea43fe6947ed4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fa44250f8ea494f9ec6201defd7694d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0b9cf3906af44e588a43a37c9259020_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9abdd3860253449b9af0cf34bcbdeb85_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1d386cad6144838b3a92904df7a317c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5437d75eac6144cf88ae812aecc743aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4d2a0894b2040ba81435a39df496070_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0453195fa23e46d483cf46bd3e3de52a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73b0d274622045248510c3e54280fccf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2f46deba383407cb210dce486f3dcac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d35df157fe74d6e891907bc9031cca0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3f4cc639f144ce6ac3a87548c3b6c9c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a6242204a744c64a6389b0800b02769_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89d5d03c36334d73b8492d6c04b74983_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33ff7b9d006640f8938113069f4a6eff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee2b883defbc4b8f8ed1e8efbff9af9c_I20211004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib025dac64fea4558b2d30ed1bec0b8c1_I20201002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eeb4577960a4674b83a36fbcf56c4c1_D20201002-20201002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-02</xbrli:startDate><xbrli:endDate>2020-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a2aaff04d024dc4990e2909b24f4dd5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic969b2640c664168980604c5a20744f1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabd46125a80f417e9a4465bdf1807227_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i524b9ebd90024ddabb8d0282eaf6a29c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i541aa942c51c4c4399d51d31e700938e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i940998b020714fa3b0888d72a26c1945_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3776583b04954a0e9da05addfc5f9705_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccec1d91d0fd4f61b8eb3700cf25c835_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic25827b0d5bf448aa78483cc9a09b5a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08c28720b7cf47028c76c53cbd46b11c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i368c248f3bd642508bc5c82fd4f9c3f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib09607d878144ab899b3843daa56b605_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc153a66697e473287846740951f472d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f8cf8b1ba584f49b4fa0e0a794f40bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id738386e38c0494ba6b7c0a2fb112f20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4c8e8a8213441a18c7cff8f5e3e651e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6e1dd1f4bbe4812bf8b694608c2ed2c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida4c9a65c572483cbd1edbbbd8df7265_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i594ae760b6c148209383a55f5e4e67d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fecaa5319254b9986b2fe9d8c2e1da4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76c7948c2adf40bebaa47f086f3b7c41_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if753e7c4eee5471c9486881f13aa71b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9b1f400a73c4c5fbdc2fc6cd85ecbbd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd1fc1828d5040fbb20eb4d17854f200_D20210930-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="ifbeddf97b3b040cdb135d37c167dfb01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie589d17f3ce64923a38138283f3f843d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62a55cb1537d47889d076d3c8f830a02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5007bda63f4a4e2b85d809ab3472888b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8d483b000704749b5f5f0eb38c92300_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if52dea29077a4f65adb78386228ccf13_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95418fcfcff14dcbb2439d47adcad59b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97de46c1ab694e2aa2d5f857600a53fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifac5dfc2c36d4dc3a7782ef005ce490b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id92cc86da652405da37174ac4bd32ab4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i447e91e51b6c484fb722708a563e3022_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i935a17c2069e4de2b906355e2084c604_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i694c78ee7c7447a6b3c35d7312afaff3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d737f4d7da848479653a6d886df97b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f58fb0074304c0eb75e1ee30a90496f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4202a3390bb4daa9e7d55f6fbb4c9b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b3a469b84e14fa487772842b4758f1f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i244b53fa225146a8acddf34d0b484d40_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef0348bbd6a498895aa0b839af063db_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1948e2d317241c495c217c582f1fd94_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0816d77ecc2a4d5ab1a7fdecd924c086_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib93f9ad9f3ac454ab3e4579cba214ea5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb37d7988ff2469883e023d54943ceeb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if15b603d0fdf4013bb65d3fbdef4991b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75b27d98cb6b453489a1a735b29fb883_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a049fa208ff4ab2bb36343f0be21bd6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4857792c8c74e459972027dfdcb6655_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i138a2424e4fc4b28a990586217f205b5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1531f368d10d4c27aa41a904bfae834d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29855f0ec5bb4f3b88df4733138e0e6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd187ce19574cadad3a77fa3939be9c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08216cb065b9461b8fe2a96e91b1fc10_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idba5aafc495241d195d5376e3caaf972_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib65c4a4a4cb943548bc313bbe81dab81_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e6ebae6a0544329b7878caaf61f7c19_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7221c7b217944b9952cb1447ba40473_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida54b96ca0584539ae3b3b157470910b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e2ac390bcfd4e6183936c3252ad179f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i554f5b5c47644e348d9ce91db90fc9b3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cdda7c780084113bb71a011c3ec558b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8882f763c98a4445ad3da17239380121_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia478304e872e441bae733c20fd924acd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d649a29e36c49c1acac597e1b567b30_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff47d977eef64f639713c2bdfe4ec819_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c7bf1b9701f467ca31a33bccb2a8bd6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i751fe1d8d73549729e2da93079a949e7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6130dbfd55434e3ba87710002f62993d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ac68eceebd454197e37a04d780f9b2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4abb8a070bc94419b02bdf48d4701704_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75ce8d6ec8224485834914549b9bdc7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cb20ffbdee24ca9b4586a5cf126dba1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7778b95afae64e8cb2f805b44e496258_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93d465a35e4d4eabb157247c1091f1d7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i565486756b7249efbbaa382505163bde_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1252007ac54246de9abeebe0a6b2d8f2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc306b5f7a374a95bf6db9885328d885_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae5ad95d43134ec6a2a3f3e3a0aaf4f7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10c021d4850a4d869790819bbad3ae43_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62f8ee36cb1e4ac58c021879c749533b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3234077932f2438296d701e72d5ffac3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0de13c4843ae43a09d39c8eb3d4b8fe4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bbe1d90175a46fe8dfa0043b4527186_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0bcf683f0a14720a1b91832c115533e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeb0d8ccf2a044b79a58dfc3b65f8e15_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3edc297cbc6e43909b926332dfc8a2d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e32de5cf50a4cab9682cd23ec61237e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04c114db065b4f4eb88c5a3d48995ddb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd79a69fcf5a4ee1bc04e02cbd130619_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13a5de5444e140fc92fa01a15959c201_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33f5557b4fd84457a5a5e3d5dcc1d9a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4475ac8a68ef47fb85a8578399b0bf14_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i737468523a6841bf8124822271ebf871_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a37880f41f64981a5fef9ddf9b77d0c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c4b331f18ed42aba33f65f03aa1c992_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b58cefefc354ae79f2cb3074a62ea26_I20201207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia20712ff79044b74a597c82e1faea48d_I20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i538c9dcc0e144b5ca4a9c2183db495d7_D20220112-20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-12</xbrli:startDate><xbrli:endDate>2022-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i899fa5b890ff487689edae2dc21aefef_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a682151366145e6904be6c9c0346121_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eedec01832141fbb14f413eb354531d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:CertainPurchasersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c54334459e24015b6e27d3a60186407_I20200205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05515ce3d5484989bc6dd472a4eedeed_D20200205-20200205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-05</xbrli:startDate><xbrli:endDate>2020-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c6a1769495943b9b5d9b5d31e294c90_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1323b59618784a1fab24844213313e44_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ef4bd774a64465bb9beb6cfda1cdbc9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93981c800579497aaf2dd345c9d2a500_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53a14816cfaa497fba679e918c9d17fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3145669c89f4e22a4ae2186bc7b0142_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if60cbed693984bf4ac9378ff4177b4cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07b2805613624db19aac4968ce38ff27_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b897ca4831342edaea566ae6b0cdc36_D20100501-20100531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-05-01</xbrli:startDate><xbrli:endDate>2010-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26a65d8304ba448f91360ee062277da9_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i584d7e4f3e034bb6aa9b60e07b8d05fe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib73b40adb8374cff8a251fef052acd84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandOnePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13bb28aa1adf4576aeb1ec00d3e26d97_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fff9ccde2f5438e83ff62797cae4f8d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i734854acf1ee4be8bf15f1abd93bfd07_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e555d1eb8964644b65afbac50ffd7a1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:EmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia56133e3fe074f28993f1355c3a33e00_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie513c0771de143ca92523d08ff0e8443_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i929f1fd93be942479d2f584793b7dda6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cc999d233cf40bc8ec03bb79a5c46af_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0213557267b54d06b2a34a0a8ebac7d6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i805f26cc2af34805ae2b1843c1cf9841_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa6e6cac04eb43cfbe239e917800016c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d007eaff7044bccb12fab7314f2acbc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06246f5086ac4c68bca11471e51b6e0f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6371ddc8cc744adb4b34059dd3546dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59a4575819974e84b2e3ab5b22160dbf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f25d0f4a8ff400f889dcdf76cc14f18_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57f8fa208ea049e1801ad47d1e48dd52_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iece74e9f340746efb7bf12abd5b3f771_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic049e8c605994794a6b0cffa137659b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37884f7fb85845bfb78ca42534df7c4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e17b5e38d9b4e68968d4ad4b693c479_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">iart:FranceAndGermanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="renewal_option"><xbrli:measure>iart:renewal_option</xbrli:measure></xbrli:unit><xbrli:context id="i2ce740a3a7a74ecfb0d0952de3f48b37_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i362b521165e0418c9733b648915a160b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c98fd68510e48b4a3b8d493e99cff78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f1da00ed5194d3681b3dfc0e0e27e6d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7de60faccb404da8a7dddec7331da235_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c2fbe33ab9a467d8b4133eedd8f7209_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50839ea5a7cc493fb5a6e6e76650da66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i029daea7b92e41a4bc3613610fa420e9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">iart:FiveYearOptionLeasePeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaf346d6a89a4e7ea791875504218b91_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">iart:FiveYearLeasePeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f63720b3c7e46459c42a7742e5a8136_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie99f5f90e3c34fc2b03a2184dd276704_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8271de19ce8942b7a5a6ac1978cb2a0c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife5918aed5c1487692805e84f2c59330_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2d92855590d44b3b95dd1dc07dd512a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ea077a5d12f4d53afbcafb365160302_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a62d727286a47e8bee85dd137b2d0b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceSharesandRestrictedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbb8ffeeace8408783309370a8cc931b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2866d8b778aa44fe895f36a6d30cbdf5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8713e0cf33449019cc4cf84a4e3d77b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76189f48f3644d178eedea04bdbe9155_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33b0eb0c48144061a9b7a61f90a00974_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e53f5024f5b49708d10aea5ff725429_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia04c800bf5404c7b9232f7d4bc6754c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia77c775b70934877bc93a2298d93cb4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16240e1f2c9948f4bb47909f3308fa08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia65ff802a8ad4a8eadd83dd25409c85b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia068e43763f9429bac4588f20427197f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2eab101e6425464cb1a382b10930b341_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic91d4b47894f4d7a96fcbf0bd64e0b77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a23d3b6fbf04e0390ce17338efbe5ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a9425a324d94f60bb5d946be181483a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebd7836a15ac4b8b944cca235159afc0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a46fda6cf2140edb1e670f70f41e243_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aa77aab677c460cabbffe02b9267bf8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1f3f919472d407284a8f3f85a6ed4d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e801d197ed5482db7634fd855e8728f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4252807040ee4349abee84d30b8c631b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25ef1e32c9ce4449a3b9050b6a0eb0a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6092d39074b47158db64e1a12d8002f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic89e76baba8646799816d81431077940_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35e2f5b0e8cc4bb789f0d6856afb0e8d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65e3f0df348d4cdbadb7cd4bfc901932_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c75bb71571a44fa91621f994d3c6236_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d8d2300006048a5856f3014db3d9faf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia320d69e30b449ea850f977af47c941a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd2d3085810d47938abea6521730980b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19abaf1be5a54d1cad2b918f942e1949_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>iart:product</xbrli:measure></xbrli:unit><xbrli:context id="i6f756bb0be9d4f989bfa36dadc8b61d1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6343e390534664acd42ec3984442ea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98fc4020b8994f4587d792aaefced1fa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b128710253a40d3b28600e3c705fdb6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieda682a36ee340289bb7f3a9602fabce_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icabd362120ba4ad89874c966b42f3fb2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee33c44f27cc4e77b072623b9ba9c96b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24453718685347bdbc8c3364e2bc9dd1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec4766ff8b74bb2bbaa2ea51f38c98c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33ba2e9dbfa94793bdffd7e52faa2682_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53e08de3817440699e14abb26fa3b8c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f1d90d19e9e4cdaa2643ef6b865abb2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97aab3d9bc7649968f7bd24913cb99f3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if42f2680503f44fb8c7e794fb7e10a6d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3109fd420bc7439cae7cd959e1de8c73_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ef83b8d6d124777b62a31b4e2684492_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b32cebb922d4397bba7d163b3b0f280_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ef8247221b044978061dddd77b93c53_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eed1f8c5f0645c891b92ba3cda138e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i922bc66b09174c569548f8ce0a89a406_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic33aa545fd0d4f1ea1f097ae92801f2e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1119ac444814938a3b945328c7b101a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56f905190bdc42abbc8fb75b81e146e4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i785fadf198a94822ad3bd70f37b63804_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50142c614bbf430787c2956bba7a20e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i256baa22e9624220a6984e22db834aba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i019eb6b80cbd43b781098b4683f8f8ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e860ddce78e406f83a26966f4ed71d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i475c2989d2c1426fa24528e14601b247_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50cdb7226ffa49d2a639d7b8ce77fa33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i438e0780f85c42f9b797ba9e48948fd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1639642b327422bb89bec9a0b6728a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i901487c914b2405ba16f79b4bc6b4d8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bf12c9378fe4261a4675d758ca41164_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4861d0427af7477a92dde072e3da72c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8831947c0944fa381c1aca73be705ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3324aa5df4cc4aa9956ed23a488056f5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i719d426fe5474f3c937a1a2698a52f36_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i095295915bc84f77b7412b41247d7e72_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb8809409b6e47a485116299cbd2d2b2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca3471c88c14eedbaed1fb2d38b42a4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i380c1d6ae64a4d0bb857dc194834acae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied8b91f481774dfe8fc8d278e1b3b31d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72bcc06055074e33b93d370ce18fa181_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0e72938928e4ed1ad56b0e288505382_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife0647d5414a46d1b2593bedad7c330f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i172bf506156f43e6869412a665f54418_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTYw_0fee8d71-d1a9-4f38-8824-6c63f6b7cf00">10-K</ix:nonNumeric> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6YzA1MjdhZDNhMmJiNDU2MDlkMWU1YzJmOTAxMzMyM2MvdGFibGVyYW5nZTpjMDUyN2FkM2EyYmI0NTYwOWQxZTVjMmY5MDEzMzIzY18wLTAtMS0xLTM3MzU2_f3408716-7179-4e3c-a85c-00e53c362fbb">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18xMzA_ddc75e72-9cce-4ef5-afc2-2d9fcb4b7b4a"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18xMzA_ad0b90cb-a361-4d66-b42a-70f294f9cd9b">December 31</ix:nonNumeric>, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6NGNiMjJlNDMyMzBhNDQ5YTllZWI2NTUzOTM5MjU1NDAvdGFibGVyYW5nZTo0Y2IyMmU0MzIzMGE0NDlhOWVlYjY1NTM5MzkyNTU0MF8wLTAtMS0xLTM3MzU2_b89b2864-1ffd-4625-9dd0-66c1fa258ea2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMMISSION FILE NO. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU4_7bd594cf-fc5c-43c8-a15c-d625be58e238">0-26224</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU5_056ff660-acd9-41ee-9cb1-f666ecd9e9cf">INTEGRA LIFESCIENCES HOLDINGS CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM18wLTAtMS0xLTM3MzU2_1fb54de2-57e7-4a39-936c-ef618727325d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM18wLTQtMS0xLTM3MzU2_0212221d-b0c8-4363-a77e-c765b7ef40a2">51-0317849</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(STATE OR OTHER JURISDICTION OF<br/>INCORPORATION OR ORGANIZATION)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. EMPLOYER<br/>IDENTIFICATION NO.)</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM18zLTAtMS0xLTM3MzU2_ce8cf9cc-28a6-42b9-80c2-f3e1205e6ca4">1100 Campus Road</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM18zLTQtMS0xLTM3MzU2_895a2151-3717-4193-9485-44f9ae47a519">08540</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM180LTAtMS0xLTM3MzU2_86e18a63-faea-47c3-b648-4f21df7c71bb">Princeton</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM180LTItMS0xLTM3MzU2_3413b4e1-5292-47a5-bf24-ca0ad04f908b">New Jersey</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ZIP CODE)</span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">REGISTRANT&#8217;S TELEPHONE NUMBER, INCLUDING AREA CODE: (<ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU0_34c2c74b-1932-4e76-989b-d9d2aa359f11">609</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTUy_d0f27d8e-4dec-4caf-8f52-ec654761df8b">275-0500</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:37.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Njg1MWQ5YzM5YTVjNGQ5YWIxNmJhYjVkNmRmMDBkZTkvdGFibGVyYW5nZTo2ODUxZDljMzlhNWM0ZDlhYjE2YmFiNWQ2ZGYwMGRlOV8xLTAtMS0xLTM3MzU2_69f56463-94a2-4cdd-971e-f29c9dbb706e">Common Stock, Par Value $.01 Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Njg1MWQ5YzM5YTVjNGQ5YWIxNmJhYjVkNmRmMDBkZTkvdGFibGVyYW5nZTo2ODUxZDljMzlhNWM0ZDlhYjE2YmFiNWQ2ZGYwMGRlOV8xLTEtMS0xLTM3MzU2_6853a573-5a33-4b3b-b69c-c581bfe8d290">IART</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Njg1MWQ5YzM5YTVjNGQ5YWIxNmJhYjVkNmRmMDBkZTkvdGFibGVyYW5nZTo2ODUxZDljMzlhNWM0ZDlhYjE2YmFiNWQ2ZGYwMGRlOV8xLTItMS0xLTM3MzU2_0bd08706-66b4-48b8-b14b-fd94e2e40ec0">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NONE</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU1_e64436d7-e169-469b-beed-2b15a91777f1">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act. Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTUz_57121dc4-3368-40ec-a7f5-683f769ce2be">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU2_f0cee17f-a968-406f-aad8-62dca00e7dfd">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTQ5_1d50649a-e002-40df-93be-61d03f605eae">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. (Check one):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:19.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.733%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Yzg4MzczOTYwN2U0NDk1OTg5MDY0MWQ3ZTM3Y2IxMjQvdGFibGVyYW5nZTpjODgzNzM5NjA3ZTQ0OTU5ODkwNjQxZDdlMzdjYjEyNF8wLTAtMS0xLTM3MzU2_a7ae2036-02a7-4e51-80b9-a6d18cbcc389">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Yzg4MzczOTYwN2U0NDk1OTg5MDY0MWQ3ZTM3Y2IxMjQvdGFibGVyYW5nZTpjODgzNzM5NjA3ZTQ0OTU5ODkwNjQxZDdlMzdjYjEyNF8yLTMtMS0xLTM3MzU2_4b0139af-8909-45ed-a12e-a1a5f19f2241">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Yzg4MzczOTYwN2U0NDk1OTg5MDY0MWQ3ZTM3Y2IxMjQvdGFibGVyYW5nZTpjODgzNzM5NjA3ZTQ0OTU5ODkwNjQxZDdlMzdjYjEyNF80LTEtMS0xLTM3MzU2_ac7564f8-3ede-46f9-a6c6-ca9769161bb3">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check if the registrant has elected not to use the extended transition period for complying with any new revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTUw_2fbd7860-ed38-4425-978d-ada608f256bd">&#9746;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTUx_7f391515-c9ae-4433-9066-df89ced2acf2">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June 30, 2021, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates was approxim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ately $<ix:nonFraction unitRef="usd" contextRef="i45e7724895184fdf85404aad41aa5196_I20210630" decimals="-5" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18yNzA2_95af12b0-9916-45c6-8bbe-3c2518386f01">4,968.6</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">based upon the closing sales price of the registrant&#8217;s common stock on The Nasdaq Global Select Market on such date. The number of shares of the registrant&#8217;s Common Stock, $0.01 par value, outstanding as of February&#160;22, 2022 was <ix:nonFraction unitRef="shares" contextRef="ib54412ab095545838988a468e37768bb_I20220222" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18yOTIz_bb3db555-5877-4822-bcf6-600d4c081b18">83,243,031</ix:nonFraction>.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU3_5c81119f-2426-4d1e-899f-226465ed6f7e" escape="true">Certain portions of the registrant&#8217;s definitive proxy statement relating to its scheduled May&#160;13, 2022 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.717%"><tr><td style="width:1.0%"></td><td style="width:90.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_10">PART&#160;I</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_13">Item 1.      Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_19">Item 1A.   Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_19">16</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_16">Item 1B.   Unresolved Staff Comment</a></span><span style="color:#1a3cbf;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">s</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_16">15</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_22">Item 2.      Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_22">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_25">Item 3.      Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_25">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_28">Item 4.      Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_28">29</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_31">PART&#160;II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_34">Item 5.     Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_34">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_37">Item 6.     </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_37">[</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reserved]</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_37">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_40">Item 7.     Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_40">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_67">Item 7A.  Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_67">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_73">Item 8.     Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_73">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_76">Item 9.     Changes in and Disagreements with Accountants on Accounting and Financial Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_76">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_79">Item 9A.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_79">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_82">Item 9B.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_82">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_2033">Item 9C.  Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_82">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">PART&#160;III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">Item 10.   Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">Item 11.   Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matter</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">s</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">Item 13.   Certain Relationships, Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">Item 14.   Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_85">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_103">PART&#160;IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_106">Item 15.    Exhibits and Financial Statements Schedule</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_106">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_109">Item 16.    Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_109">58</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_112">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_112">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I </span></div><div id="i172bf506156f43e6869412a665f54418_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BUSINESS</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Company&#8221; and &#8220;Integra&#8221; refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries, unless the context suggests otherwise.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, headquartered in Princeton, New Jersey, is a world leader in medical technology. The Company was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra products are sold in more than 130 countries through a direct sales force as well as distributors and wholesalers. We manufacture and sell medical technologies and products in two reportable business segments: Codman Specialty Surgical ("CSS") and Tissue Technologies ("TT"). The CSS segment, which represents two-thirds of our total revenue, consists of market-leading technologies and instrumentation used for a wide range of specialties, such as neurosurgery, neurocritical care and otolaryngology. We are the world leader in neurosurgery and one of the top three providers in instruments used in precision, specialty, and general surgical procedures. Our TT segment generates about one-third of our overall revenue and focuses on three main areas: complex wound surgery, surgical reconstruction, and peripheral nerve repair.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have key manufacturing and research facilities located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, Canada, China, France, Germany, Ireland and Switzerland. We source most of our handheld surgical instruments and dural sealant products through specialized third-party vendors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vision</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aspire to continue to be a worldwide leader in neurosurgery and reconstructive surgery with a portfolio of leading businesses that delivers outstanding customer experiences through innovation, execution and teamwork to positively impact the lives of millions of patients and their families.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra is committed to delivering high quality products that positively impact the lives of millions of patients and their families. We focus on four key pillars of our strategy: 1) enabling an execution-focused culture, 2) optimizing relevant scale, 3) advancing innovation and agility, and 4) leading in customer experience. We believe that by sharpening our focus on these areas through improved planning and communication, optimization of our infrastructure, and strategically aligned acquisitions, we can build scale, increase competitiveness and achieve our long-term goals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To this end, the executive leadership team has established the following key priorities aligned to the following areas of focus:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An important part of the Company's strategy is pursuing strategic transactions and licensing agreements that increase relevant scale in the clinical areas in which Integra competes. During 2021, the Company acquired ACell Inc. ("ACell"), an innovative regenerative medicine company specializing in the manufacturing of porcine urinary bladder extracellular matrices. This acquisition not only expanded the Company&#8217;s product offering of regenerative technologies, but it also supported the Company&#8217;s long-term growth and profitability strategy as this product line has a financial profile similar to Integra&#8217;s other regenerative tissue products. All critical components of ACell have been integrated into the Company&#8217;s TT segment. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for additional details. In 2021, we continued to advance the development of pioneering neurosurgical technologies from our 2019 acquisitions, Arkis Biosciences, Inc. and Rebound Therapeutics Corporation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Portfolio Optimization and New Product Introductions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are investing in innovative product development to drive a multi-generational pipeline for our key product franchises. Our product development efforts span across our key global franchises focused on potential for significant returns on investment. In addition to new product development, we are funding studies to gather clinical evidence to support launches, ensure market access and improve reimbursement for existing products. In addition to acquisitions and organic reinvestment, we continually look to optimize our portfolio towards higher growth and higher margin businesses. As such, we may opportunistically divest businesses or discontinue products where we see limited runway for future value creation in line with our aspirations due in part to changes in the market, business fundamentals or the regulatory environment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, we completed the sale of our Extremity Orthopedics business to Smith &amp; Nephew USD Limited ("Smith &amp; Nephew"), a subsidiary of Smith &amp; Nephew plc, for approximately&#8239;$240&#8239;million in cash. This transaction enables us to increase </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">our investments in our core neurosurgery and tissue technologies businesses and fund pipeline opportunities to expand our addressable markets to strengthen our existing leadership positions in these segments and drive future growth. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Channel Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Investing in our sales channels is a core part of our strategy to create specialization and greater focus on reaching new and existing customers and addressing their needs. To support our commercial efforts in Tissue Technologies, we expanded our two-tier specialist model to increase our presence in focused segments by creating a virtual selling organization to help serve the evolving needs of our customers. In addition, we continue to build upon our leadership brands across our product franchises in both CSS and TT to engage customers through enterprise-wide contracts with leading hospitals, integrated delivery networks and global purchasing organizations in the United States. Internationally, we have increased our commercial resources significantly in key emerging markets and are making investments to support our sales organization and maximize our commercial opportunities. These investments in our international sales channel position us well for expansion and long-term growth. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We aspire to be ranked as a best-in-class provider and are committed to strengthen our relationships with all customers. We continue to invest in technologies, systems and processes to enhance the customer experience. Additionally, we launched digital tools and programs, resources and virtual product training to drive continued customer familiarity with our growing portfolio of medical technologies globally.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS SEGMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra currently manufactures and sells our products and technologies in the following two global reportable business segments: Codman Specialty Surgical and Tissue Technologies. We include financial information regarding our reportable business segments and certain geographic information under "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations", Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Codman Specialty Surgical</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Codman Specialty Surgical business consists of a broad portfolio of market-leading brands, such as Codman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, DuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, DuraSeal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CUSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Mayfield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Bactiseal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The growth in this business in the recent years has been fueled by geographic expansion and new product registrations in markets, such as China, Japan,&#8239;and&#8239;Europe, which we expect to continue in the near to long term. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also expanded our product offerings in 2021 with the launch of our new intracranial pressure ("ICP") monitoring system, CereLink&#8482; in the U.S. and Europe. It provides clinicians with advanced continuous ICP monitoring that until now, has not been available when treating patients with traumatic brain injuries</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, we are expanding into&#8239;minimally invasive surgery ("MIS") and the surgical management of intracerebral hemorrhages ("ICH"), with the 2021 clinical launch of Aurora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8239;Surgiscope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a proprietary surgical solution with integrated visualization and capabilities designed specifically for use in&#8239;deep-seated&#8239;brain lesions. We started gathering clinical evidence using this same technology for&#8239;early surgical intervention for the&#8239;treatment of ICH. We believe this technology offers the promise of transforming the standard of care in neurosurgery. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rounding out the portfolio is a catalog of surgical headlamps and surgical instrumentation, as well as after-market service. With thousands of surgical instrument products, including specialty surgical instruments, we call on the central sterile processing unit of hospitals and acute care surgical centers. Additionally, through a strong U.S. distribution model, we serve the needs of hundreds of medical offices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tissue Technologies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following the sale of the Extremity Orthopedics business in the first quarter of 2021, we rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Tissue Technologies segment consists of four unique regenerative technology areas - highly engineered bovine collagen, bovine dermis, porcine urinary bladder, and human amniotic tissue. This broad regenerative platform, which includes multiple leading brands such as Integra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Dermal Matrices, AmnioExcel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, SurgiMend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, MicroMatrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and NeuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, primarily addresses the needs of plastic, reconstructive and general surgeons focused on the treatment of acute wounds, such as burns, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">chronic wounds, including diabetic foot ulcers, and surgical tissue repair, such as hernia, tendon, peripheral nerve repair and protection. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a specialized sales organization composed of directly employed sales representatives, as well as specialty distributors, organized based upon their call point. Our wound reconstruction sales representatives call on surgeons doing procedures in limb salvage, trauma, wound reconstruction and burns, chronic wounds primarily in the inpatient wound care clinic setting. We also have a dedicated surgical reconstruction sales team focused on plastic and reconstructive surgery and hernia procedures with differentiated products. Finally, we have a distributor network focused on biologics. Outside the U.S., we have a combination of direct and indirect sales channels in international markets to sell certain product lines. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This business segment also includes private-label sales of a broad set of our regenerative and wound care technologies. Our customers are other medical technology companies that sell to end markets primarily in spine, surgical and wound care.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate new product introductions and new clinical indications will continue to contribute to the growth of the segment. In the third quarter of 2021, we filed the premarket approval application for a specific indication for SurgiMend in the use of post-mastectomy breast reconstruction, for which we hope to obtain FDA approval in 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPETITION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors for CSS are Medtronic, Inc., Stryker Corporation, Becton Dickinson and Company and Aesculap, a division of B. Braun Medical, Inc. In addition, we compete with many smaller specialized companies and larger companies that do not otherwise focus on the offerings of Codman Specialty Surgical technologies. We rely on the depth and breadth of our sales and marketing organization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our competition in TT includes Smith &amp; Nephew plc, Organogenesis Holdings Inc., MiMedx Group, Inc., LifeCell Corporation, a subsidiary of Allergan PLC, C.R. Bard, a subsidiary of Becton Dickinson and Company, and Axogen, Inc. We compete with many additional companies who partially participate in soft tissue reconstruction of complex wounds, peripheral nerve repair and surgical reconstruction.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our products also compete against medical practices that treat a condition without using a medical device or any particular product, such as medical practices that utilize autograft tissue instead of our dermal regeneration products, duraplasty products and nerve repair products. Depending on the product line, we compete based on our products' features, strength of our sales force or distributors, sophistication of our technology and cost effectiveness of our solution.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESEARCH AND DEVELOPMENT STRATEGY </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development activities focus on identifying unmet surgical needs and addressing those needs with innovative solutions and products. We apply our core competency in regenerative technology to innovate products for neurosurgical, wound applications, plastic surgery, and reconstructive surgery and we have extensive R&amp;D development programs for our core platforms of electromechanical technologies. Additionally, we conduct products and clinical studies to generate efficacy and health economic evidence.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regenerative Technologies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra was the first Company to receive a United States Food and Drug Administration ("FDA") claim for regeneration of dermal tissue and is a world leader in regenerative technology. Because regenerative technology products represent a fast-growing, high-margin opportunity for us, we allocate a large portion of our research and development budget to these projects. Our regenerative technology development program applies our expertise in bioengineering to a range of biomaterials including natural collagen and human tissues as well as synthetics such as polymers. These unique product designs are used for neurosurgical and orthopedic surgical applications, as well as dermal regeneration, including the healing of chronic and acute wounds, tendon and nerve repair. Our regenerative technology platform includes our legacy Integra</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dermal Regeneration Template ("IDRT") products and complementary technologies that we have acquired. Our collagen manufacturing capability, combined with our history of innovation, provides us with strong platform technologies for multiple indications. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we announced positive clinical and economic data on Integra</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Bilayer Wound Matrix ("IBWM") in complex lower extremity reconstruction based on two retrospective studies recently published in Plastic and Reconstructive Surgery, the official journal of the American Society of Plastic Surgeons. As surgeons look for ways to efficiently and effectively repair and close wounds, IBWM helps address the efficiency needed in operating rooms by reducing both the operating time and costs to hospitals and patients. In 2021, we completed one of the largest diabetic foot ulcers ("DFU"), randomized controlled trials of the PriMatrix</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dermal Repair Scaffold for the management of DFU. This multi-center study enrolled more than 225 patients with chronic DFU's over the course of 12-week treatments and 4-week follow-up phases. The results of this study, which was published in the Journal of Wound Care, demonstrated that PriMatrix plus standard of care ("SOC") consisting of sharp debridement, infection elimination, use of dressings and offloading was significantly more likely to achieve complete wound closure compared with SOC alone, with a median number of one application of the product. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Electromechanical Technologies and Instrumentation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Because our electromechanical products and instruments address significant needs in surgical procedures and limit uncertainty for surgeons, we continue to invest in approvals for new indications and next generation improvements to our market-leading products. We have several active programs focused on life cycle management and innovation, for capital and disposable products in our portfolio. Our product development efforts are focused on core clinical applications in CSF management, neuro-critical care monitoring, minimally invasive instruments and electrosurgery and ultrasonic medical technologies, as well as our ambition to transform the standard of care in neurosurgery with product advancements in MIS and ICH. Our lighting franchise is among the most dynamic in the industry. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company benefitted from our product launches from prior years, including our new electrosurgery generator and irrigator system, an innovative customer-centric toolkit for our Certas</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plus Programmable Valve along with additional shunt configurations. In Japan, we are experiencing strong growth as a result of the successful launch of DuraGen in mid-2019, which is the first and only collagen xenograft approved for use as a dural substitute in the country. We are focused on the development of core clinical applications in our electromechanical technologies portfolio. Also, we continue to update our CUSA Clarity platform by incorporating new ultrasonic handpiece, surgical tips and integrated electrosurgical capabilities. We continue to work with several instrument partners to bring new surgical instrument platforms to the market. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the third quarter of 2021, we launched our CereLink ICP Monitor System in the U.S. and Europe. CereLink provides enhanced accuracy, usability and advanced data presentation that provides clinicians with uncompromised, advanced continuous ICP monitoring that until now, has not been available when treating patients with traumatic brain injuries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we continued to advance the early-stage technology platforms we acquired in 2019. Through the acquisition of Arkis Biosciences, we added a platform technology, CerebroFlo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> external ventricular drainage ("EVD"), catheter with Endexo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. The CerebroFlo EVD Catheter has demonstrated an average of 99% less thrombus accumulation onto its surface, in vitro, compared to a market leading EVD catheter. In 2019, we also acquired Rebound Therapeutics, a Company that specialized in single-use medical device, known as Aurora Surgiscope, which is the only tubular retractor system designed for cranial surgery with an integrated access channel, camera and lighting. In the third quarter of 2021, we conducted a limited clinical launch of the Aurora Surgiscope for use in minimally invasive neurosurgery as well as initiated a registry called MIRROR to collect data on early surgical intervention using this same technology platform for the treatment of ICH.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESOURCES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, raw materials essential to our businesses are readily available from multiple sources. For reasons of quality assurance, availability, or cost effectiveness, certain components and raw materials are available only from a sole supplier. Our practice is to maintain sufficient inventory of components so that our production will not be significantly disrupted even if a particular component or material is not available for a period of time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our products, including but not limited to our dermal regeneration products, duraplasty products, wound care products, and nerve and tendon repair products, contain material derived from bovine tissue. We take great care to provide products that are safe and free of agents that can cause disease. In particular, the collagen used in the products that we manufacture is derived from the deep flexor tendon of cattle less than 24 months old from New Zealand, a country that has never had a reported case of bovine spongiform encephalopathy ("BSE") (otherwise known as mad cow disease), from the U.S. or from fetal bovine dermis. The World Health Organization classifies different types of cattle tissue for relative risk of BSE transmission. Deep flexor tendon and fetal bovine skin are in the lowest-risk category for BSE transmission, and therefore considered to have a negligible risk of containing the agent that causes BSE.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek patent and trademark protection for our key technology, products and product improvements, both in the U.S. and in selected foreign countries. When determined appropriate, we have enforced and plan to continue to enforce and defend our patent and trademark rights. In general, however, we do not rely solely on our patent and trademark estate to provide us with any significant competitive advantages as it relates to our existing product lines. We also rely upon trade secrets and continuing technological innovations to develop and maintain our competitive position. In an effort to protect our trade secrets, we have a policy requiring our employees, consultants and advisors to execute proprietary information and invention assignment agreements upon commencement of employment or consulting relationships with us. These agreements also provide that all confidential information developed or made known to the individual during the course of their relationship with us must be kept confidential, except in specified circumstances. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AccuDrain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, AmnioExcel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Aquasonic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Auragen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Aurora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Surgiscope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Bactiseal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, BioDFence</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, BioDOptix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  Brainet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Budde</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Buzz&#8482;,  CereLink&#8482;, CerebroFlo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> EVD Catheter with Endexo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Technology, Codman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman Accu-Flo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman Bicol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Certas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Plus, Codman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Hakim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Programmable valve, Codman Holter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman ICP Express</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman Microsensor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman VersaTru</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman VPV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Contour-Flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Cranioplastic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> CRW</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> CRW Precision&#8482;, Ctherm&#8482;, CUSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Cytal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, DirectLink</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, DuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, DuraSeal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Gentrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, HeliCote</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, HeliPlug</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, HeliTape</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> HeliMend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Helistat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Helitene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Hermetic&#8482;, Hy-Tape</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Integra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, IntegraLink</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Isocool</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Jarit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  Lead-Lok&#8482;, Licox</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, LimiTorr&#8482;, Luxtec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mayfield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, MatriStem UBM&#8482;, MediHone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">y&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  MicroFrance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, MicroMatrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Miltex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Mischler&#8482;, MoniTorr ICP&#8482;,  Natus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, NeuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, NeuraWrap&#8482;, Nicolet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  Omnigraft</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Omni-Tract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, OSV II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Padgett</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, PriMatrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Pureflow&#8482;,  Q-Snor&#8482;,  Redmond&#8482;, Revize&#8482;, Ruggles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  Signacreme</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  SurgiMend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, TCC-EZ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, TenoGlide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  TissueMend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Ultra VS&#8482;,  VersaTru</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Xtrasorb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> zRIP&#8482;, and the Integra logo are some of the material trademarks of Integra LifeSciences Corporation and its subsidiaries. MAYFIELD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is a registered trademark of SM USA, Inc., and is used by Integra under license.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEASONALITY </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues during our fourth quarter tend to be stronger than other quarters because many hospitals increase their purchases of our products during the fourth quarter to coincide with the end of their budget cycles in the U.S. In general, our first quarter usually has lower revenues than the preceding fourth quarter, the second and third quarters have higher revenues than the first quarter, and the fourth quarter revenues are the highest in the year. The main exceptions to this pattern occur because of material acquisitions as well as impacts of the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic on our business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the COVID-19 pandemic, the Company's focus remained on supporting patients, providing customers with life-saving products, and protecting the well-being of our employees. The rapid and evolving spread of the virus and subsequent variants have resulted in unprecedented challenges to the global healthcare industry. In response to the pandemic, we acted swiftly by implementing protocols to ensure continuity of our manufacturing and distribution sites around the world and to provide for the safety of our employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to have widespread and unpredictable impacts and the Company has continued to manage risks in this uncertain environment. We remain confident that the underlying markets in which the Company competes remain attractive. We also remain focused on managing the business for the long-term. The Company's adaptability and resiliency in the face of this unprecedented crisis is made possible in part by prior investments in technology infrastructure and operations, as well as our talented and committed global workforce.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital markets and worldwide economies have also been significantly impacted by the COVID-19 pandemic, and it is possible that the pandemic could cause a local and/or global economic recession. Any such economic recession could have a material adverse effect on the Company's long-term business as hospitals curtail and reduce capital as well as overall spending. The COVID-19 pandemic and local actions, such as &#8220;shelter-in-place&#8221; orders and restrictions on travel and access to our customers or temporary closures of our facilities or the facilities of our suppliers and their contract manufacturers, disruption and/or higher costs to the Company&#8217;s supply chain, staffing shortages in hospitals and labor constraints in our facilities, could further impact our sales, margins and our ability to ship our products and supply our customers. Any of these events could negatively impact the number of surgical and medical intervention procedures performed and have a material adverse effect on our business, financial condition, results of operations, or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to risk factors as it relates to the COVID-19 pandemic can be found in Item 1A. Risk Factors of this Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT REGULATION AND COMPLIANCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a manufacturer and marketer of medical devices and Human Tissue and Cell Based Products ("HCT/Ps") and therefore are subject to extensive regulation by the FDA, the Center for Medicare Services of the U.S.&#160;Department of Health and Human Services, other federal governmental agencies and, in some jurisdictions, by state and foreign governmental authorities. These regulations govern the introduction of new medical devices and HCT/Ps, the observance of certain standards with respect to the design, manufacture, testing, labeling, promotion and sales of the products, the maintenance of certain records, the ability to track devices, the reporting of potential product defects, the import and export of products, and other matters. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States Food and Drug Administration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory process for obtaining product approvals and clearances can be onerous and costly. The FDA requires, as a condition to marketing a medical device in the U.S., that we secure a Premarket Notification clearance pursuant to Section&#160;510(k) of the Federal Food, Drug and Cosmetic Act (the "FD&amp;C Act"), or an approved premarket approval ("PMA"), application (or supplemental PMA application). Obtaining these approvals and clearances can take up to several years and may involve preclinical studies and clinical trials. The FDA also may require a post-approval clinical study as a condition of approval. To perform clinical trials for significant risk devices in the U.S. on an unapproved product, we are required to obtain an Investigational Device Exemption from the FDA. The FDA also may require a filing for approval prior to marketing products that are modifications of existing products or new indications for existing products. Moreover, after clearance/approval is given, if the product is shown to be hazardous or defective, the FDA and foreign regulatory agencies have the power to withdraw the clearance or approval, as the case may be, or require us to change the device, its manufacturing process or its labeling, to supply additional proof of its safety and effectiveness or to recall, repair, replace or refund the cost of the medical device. Because we currently export medical devices manufactured in the U.S. that have not been approved by the FDA for distribution in the U.S., we are required to obtain approval/registration in the country to which we are exporting and maintain </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain records relating to exports and make these available to the FDA for inspection, if required. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Human Cells, Tissues and Cellular and Tissue-Based Products </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra, through the acquisition of Derma Sciences and BioD LLC ("BioD"), is involved with the recovery, processing, storage, transportation and distribution of donated amniotic tissue. The FDA has specific regulations governing HCT/Ps. An HCT/P is a product containing, or consisting of, human cells or tissue intended for transplantation into a human patient. Examples of HCT/Ps include bone, ligament, skin and cornea. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some HCT/Ps fall within the definition of a biological product, medical device or drug regulated under the FD&amp;C Act. These biologic, device or drug HCT/Ps must comply both with the requirements exclusively applicable to HCT/Ps and, in addition, with requirements applicable to biologics, devices or drugs, including premarket clearance or approval from the FDA. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;361 of the Public Health Service Act ("Section 361") authorizes the FDA to issue regulations to prevent the introduction, transmission or spread of communicable disease. HCT/Ps regulated as &#8220;361&#8221; HCT/Ps are subject to requirements relating to registering facilities and listing products with the FDA, screening and testing for tissue donor eligibility, and Good Tissue Practices when processing, storing, labeling, and distributing HCT/Ps, including required labeling information, stringent record keeping, and adverse event reporting. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The American Association of Tissue Banks ("AATB") has issued operating standards for tissue banking. Compliance with these standards is a requirement in order to become an AATB-accredited tissue establishment. In addition, some states have their own tissue banking regulations. We are licensed or have permits for tissue banking in California, Delaware, Illinois, Maryland, New York, Oregon, and Tennessee. In Tennessee, we are registered with the FDA Center for Biological Evaluations and Research.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Procurement of certain human organs and tissue for transplantation is subject to the restrictions of the National Organ Transplant Act, which prohibits the transfer of certain human organs, including skin and related tissue for valuable </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consideration, but permits the reasonable payment associated with the removal, transportation, implantation, processing, preservation, quality control and storage of human tissue and skin. BioD, our wholly-owned subsidiary, is a registered Tissue Bank and is involved with the recovery, storage and transportation of donated human amniotic tissue.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2015, the FDA issued an Untitled Letter (the "Untitled Letter") alleging that BioD's morselized amniotic membrane tissue-based products do not meet the criteria for regulation as HCT/Ps solely under Section 361  and that, as a result, BioD would need a biologics license to lawfully market those morselized products. Since the issuance of the Untitled Letter, BioD and the Company have made known to the FDA their disagreement with the FDA&#8217;s assertion that certain products are more than minimally manipulated. The FDA has not changed its position that certain of the BioD acquired products are not eligible for marketing solely under Section 361. In July 2020, the FDA issued the final guidance document related to human tissue titled, &#8220;Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use&#8221; (the &#8220;2020 HCT/P Final Guidance&#8221;). The 2020 HCT/P Final Guidance document supersedes the November 2017 guidance by the same title.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HCT/P Final Guidance maintains the FDA&#8217;s position that products such as the Company&#8217;s morselized amniotic membrane tissue-based products do not meet the criteria for regulation solely as HCT/Ps. In addition, in the November 2017 guidance, the FDA articulated a risk-based approach to enforcement and, while some uses for amniotic membrane tissue-based products would have as much as thirty-six months of enforcement discretion, other high risk uses could be subject to immediate enforcement action. The 2020 HCT/P Final Guidance maintained this approach and extended the discretionary enforcement period to May 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Considering the risk of enforcement action, the Company discontinued the manufacturing of all morselized amniotic membrane tissue-based products prior to May 31, 2021. We no longer distribute these products. As of December 31, 2021, the Company has not received any further notice of enforcement action from the FDA regarding its morselized amniotic membrane tissue-based products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from the now discontinued BioD morselized amniotic membrane-based products for the year ended December&#160;31, 2021 were less than 1.0% of consolidated revenues. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Device Regulations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also are required to register with the FDA as a medical device manufacturer. As such, our manufacturing sites are subject to periodic inspection by the FDA for compliance with the FDA's Quality System Regulations. These regulations require that we manufacture our products and maintain our documents in a prescribed manner with respect to design, manufacturing, testing and control activities. Further, we are required to comply with various FDA requirements and other legal requirements for labeling and promotion. If the FDA believes that a company is not in compliance with applicable regulations, it may issue a warning letter, institute proceedings to detain or seize products, issue a recall order, impose operating restrictions, enjoin future violations and assess civil penalties against that company, its officers or its employees and may recommend criminal prosecution to the U.S. Department of Justice. All Integra manufacturing facilities participate in the Medical Device Single Audit Program and are audited annually for compliance with the Quality System for US FDA, Canada, Australia, Brazil, and Japan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical device regulations also are in effect in many of the countries in which we do business outside the U.S. These laws range from comprehensive medical device approval and Quality System requirements for some or all of our medical device products to simpler requests for product data or certifications. Under the European Union Medical Device Directive, medical devices must meet the Medical Device Directive standards and receive CE Mark Certification prior to marketing in the European Union ("EU"). In addition, the EU enacted the EU Medical Device Regulation, which imposes stricter requirements on the marketing and sales of medical devices including but not limited to quality systems, labeling and clinical data. CE Mark Certification requires a comprehensive quality system program, technical documentation, clinical evaluation and data on the product, which are then reviewed by a Notified Body. A Notified Body is an organization designated by the national governments of the EU member states to make independent judgments about whether a product complies with the requirements established by each CE&#160;marking directive. The Medical Device Directive, Medical Device Regulation, ISO 9000 series and ISO 13485 are recognized international quality standards that are designed to ensure that we develop and manufacture quality medical devices. Other countries are also instituting regulations regarding medical devices or interpreting and enforcing existing regulations more strictly. Compliance with these regulations requires extensive documentation and clinical reports for our products, revisions to labeling, and other requirements such as facility inspections to comply with the registration requirements. A recognized Notified Body audits our facilities annually to verify our compliance with the ISO 13485 Quality System standard. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain countries, as well as the EU, have issued regulations that govern products that contain materials derived from animal sources. Regulatory authorities are particularly concerned with materials infected with the agent that causes BSE. These regulations affect our dermal regeneration products, duraplasty products, hernia repair products, biomaterial products for the spine, nerve and tendon repair products and certain other products, all of which contain material derived from bovine tissue. Although we take great care to provide that our products are safe and free of agents that can cause disease, products that contain materials derived from animals, including our products, may become subject to additional regulation, or even be banned in certain countries, because of concern over the potential for prion transmission. Significant new regulations, a ban of our products, or a movement away from bovine-derived products because of an outbreak of BSE could have a material, adverse effect on our current business or our ability to expand our business. See &#8220;Item&#160;1A. Risk Factors&#160;- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain of our products contain materials derived from animal sources and may become subject to additional regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of this Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Postmarket Requirements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is cleared or approved for commercial distribution, numerous regulatory requirements apply. These include the FDA Quality System Regulations which cover the procedures and documentation of the design, testing, production, control, quality assurance, labeling, packaging, sterilization, storage and shipping of medical devices; the FDA's general prohibition against promoting products for unapproved or 'off-label' uses; the Medical Device Reporting regulation, which requires that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur; and the Reports of Corrections and Removals regulation, which require manufacturers to report recalls and field corrective actions to the FDA if initiated to reduce a risk to health posed by the device or to remedy a violation of the FD&amp;C Act. Postmarket requirements are also followed globally where our products are registered and approved. These foreign jurisdictions have similar requirements to the FDA which include reporting requirements such as adverse events and recalls.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other regulations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-Bribery Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the U.S., we are subject to laws and regulations pertaining to healthcare fraud and abuse, including anti-kickback laws and physician self-referral laws that regulate the means by which companies in the health care industry may market their products to hospitals and health care professionals and may compete by discounting the prices of their products. Similar anti-bribery laws exist in many of the countries in which we sell our products outside the U.S., as well as the United States Foreign Corrupt Practices Act (which addresses the activities of U.S. companies in foreign markets). Our products also are subject to regulation regarding reimbursement, and U.S. healthcare laws apply when a customer submits a claim for a product that is reimbursed under a federally funded healthcare program. These global laws require that we exercise care in designing our sales and marketing practices, including interactions with healthcare professionals, and customer discount arrangements. See &#8220;Item&#160;1A. Risk Factors -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> We are exposed to a variety of risks relating to our international sales and operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of this Annual Report on Form 10-K for further details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Import-export</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our international operations subject us to laws regarding sanctioned countries, entities and persons, customs, and import-export. Among other things, these laws restrict, and in some cases can prevent, U.S. companies from directly or indirectly selling goods, technology or services to people or entities in certain countries. In addition, these laws require that we exercise care in our business dealings with entities in and from foreign countries. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hazardous materials</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our research, development and manufacturing processes involve the controlled use of certain hazardous materials. We are subject to country-specific, federal, state and local laws and regulations governing the use, manufacture, storage, handling and disposal of these materials and certain waste products. We believe that our environmental, health and safety procedures for handling and disposing of these materials comply with the standards prescribed by the controlling laws and regulations. However, risk of accidental releases or injury from these materials is possible. These risks are managed to minimize or eliminate associated business impacts. In the event of this type of accident, we could be held liable for damages and face a liability that could exceed our resources. We could be subject to a regulatory shutdown of a facility that could prevent the distribution and sale of products manufactured there for a significant period of time, and we could suffer a casualty loss that could require a shutdown of the facility in order to repair it, any of which could have a material, adverse effect on our business. Although we continuously strive to maintain full compliance with respect to all applicable global environmental, health and safety laws and regulations, we could incur substantial costs to fully comply with future laws and regulations, and our operations, business or assets may be negatively affected. Furthermore, global environmental, health and safety compliance is an ongoing process. Integra has compliance procedures in place for compliance with Employee Health &amp; Safety laws, driven by a centrally led organizational structure that ensures proper implementation, which is essential to our overall business objectives. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above regulations, we are, and may be, subject to regulation under country-specific federal and state laws, including, but not limited to, requirements regarding record keeping, and the maintenance of personal information, including personal health information. As a public Company, we are subject to the securities laws and regulations, including the Sarbanes-Oxley Act of 2002. We also are subject to other present and could be subject to possible future, local, state, federal and foreign regulations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third-Party Reimbursement. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers that purchase medical devices generally rely on third-party payors, including, in the U.S., the Medicare and Medicaid programs and private payors, such as indemnity insurers, employer group health insurance programs and managed care plans, to reimburse all or part of the cost of the products. As a result, demand for our products is and will continue to be dependent in part on the coverage and reimbursement policies of these payors. The manner in which reimbursement is sought and obtained varies based upon the type of payor involved and the setting in which the product is furnished and utilized. Reimbursement from Medicare, Medicaid and other third-party payors may be subject to periodic adjustments as a result of legislative, regulatory and policy changes, as well as budgetary pressures. Possible reductions in, or eliminations of, coverage or reimbursement by third-party payors, or denial of, or provision of uneconomical reimbursement for new products may affect our customers' revenue and ability to purchase our products. Any changes in the healthcare regulatory, payment or enforcement landscape relative to our customers' healthcare services have the potential to significantly affect our operations and revenue. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Privacy and Cybersecurity Laws and Regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a business with a significant global footprint, compliance with evolving regulations and standards in data privacy and cybersecurity (relating to the confidentiality and security of our information technology systems, products such as medical devices, and other services provided by us) may result in increased costs, lower revenue, new complexities in compliance, new challenges for competition, and the threat of increased regulatory enforcement activity. Our business relies on the secure electronic transmission, storage and hosting of sensitive information, including personal information, financial information, intellectual property, and other sensitive information related to our customers and workforce.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, in the U.S., the collection, maintenance, protection, use, transmission, disclosure and disposal of certain personal information and the security of medical devices are regulated at the U.S. federal and state, and industry levels. U.S. federal and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state laws protect the confidentiality of certain patient health information, including patient medical records, and restrict the use and disclosure of patient health information by health care providers. In addition, the FDA has issued guidance advising manufacturers to take cybersecurity risks into account in product design for connected medical devices and systems, to assure that appropriate safeguards are in place to reduce the risk of unauthorized access or modification to medical devices that contain software and reduce the risk of introducing threats into hospital systems that are connected to such devices. The FDA also issued guidance on post market management of cyber security in medical devices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the U.S., we are impacted by the privacy and data security requirements at the international, national and regional level, and on an industry specific basis. Legal requirements in these countries relating to the collection, storage, handling and transfer of personal data and, potentially, intellectual property continue to evolve with increasingly strict enforcement regimes. In Europe, for example, we are subject to EU General Data Protection Regulation ("GDPR") which requires member states to impose minimum restrictions on the collection, use and transfer of personal data and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR also requires companies processing personal data of individuals residing in the EU to comply with EU privacy and data protection rules.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Please refer to &#8220;Item 1A. Risk Factors - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">We are subject to requirements relating to information technology which could adversely affect our business&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of this Annual Report on Form 10-K for additional discussion of the risks accompanying compliance with data privacy and cybersecurity laws and regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations impact the ways in which we use and manage personal data, protected health information, and our information technology systems. They also impact our ability to move, store, and access data across geographic boundaries. Compliance with these requirements may require changes in business practices, complicate our operations, and add complexity and additional management and oversight needs. They also may complicate our clinical research activities, as well as product offerings that involve transmission or use of clinical data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HUMAN CAPITAL </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Workforce Demographics</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#8239;December&#160;31, 2021, we had approximately 3,800 regular full and part time employees and 900 contingent, subcontracted, and outsourced partners. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65% of our employees are located in the United States, 23% in Europe, Middle East and Africa, 4% in Latin America and Canada and 8% in Asia Pacific which includes Australia and New Zealand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify"><img src="iart-20211231_g1.jpg" alt="iart-20211231_g1.jpg" style="height:283px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diversity and Inclusion</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A diverse workforce and an inclusive culture and work environment is a business priority and a key to our long-term success.   Our commitment to diversity and inclusion ("D&amp;I") starts at the top with our Board of Directors and CEO. At all levels of the company, we focus on attracting, retaining, and developing our diverse talent.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Leadership Commitment and Accountability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive leadership team members set the D&amp;I goals for the company and advancing diversity and inclusion initiatives to build stronger teams remains a company-wide goal.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Leadership Councils, Employee Resource Groups and External Partnerships:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are accountable to our D&amp;I commitment through our leadership councils, employee resource groups, and external partnerships.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our Women&#8217;s Leadership Council, since its establishment in 2017, is an action and results-oriented advisory group comprised of fifteen of our senior women leaders across Integra. The specific charter of the Council is to work together to identify ways to continue to attract and retain female talent, advance the development of our women into leadership roles, increase the cultural awareness of the value of inclusion and diversity in our company, and create specific development forums for our high performing women at Integra. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Employee resources groups encourage a culture of awareness and inclusion, assist in the attraction and retention of diverse talent, and help colleagues develop leadership skills. Members of the executive leadership team serve as sponsors for each of Integra&#8217;s employee resource groups. Integra has five Employee Resources Groups: </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Women of Integra Networks ("WIN") with 20+ chapters globally</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">African American Affinity Group</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Veteran Employee Resource Group</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Indian American Professional Network</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Asian American and Pacific Islander Employee Resource Group</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We reinforce our commitment to diversity by partnering with other organizations focused on driving inclusion in the workplace including the CEO Action for Diversity &amp; Inclusion, the largest CEO-driven business commitment to advance D&amp;I in the workplace and Healthcare Businesswomen&#8217;s Association, an association dedicated to further the advancement and impact of women in the business of healthcare.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline">Promoting an inclusive culture through learning opportunities:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">To help drive our culture of inclusion, our colleagues participate in programs focused on how to manage bias and value differences.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:12.53pt">Members of our executive leadership, senior management team, and larger scope leaders participate in a half-day microinequities training. The content includes understanding unconscious bias and microinequities, how to identify microinequities in day-to-day decisions and actions as leaders, and ways to mitigate microinequities on an individual and organizational level.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:12.53pt">Upon joining Integra, colleagues globally participate in two programs to promote inclusion: a course that creates awareness of unconscious biases in the workplaces and tools to build-bias breaking skills and a course that examines what practicing inclusion in the workplace looks like.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline">Gender Diversity:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We believe that our company is stronger and will deliver strong operating results when we build diverse teams and leverage broad perspectives to meet the needs of our shareholders, customers, colleagues, and communities we serve. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">he breakout of our colleagues by gender as of December 31, 2021:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">48% of Integra</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">s overall population is female, 52% male. We continue to strive to ensure our diversity in our leadership roles is representative of our overall population. Through mentorship, sponsorship, recruitment efforts, and development programs we look to continue to grow our population of females in leadership roles at Integra. Currently, 42% of our executive leaders and 45% of senior leaders (non-executive vice presidents) are female.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:27pt;text-align:justify"><img src="iart-20211231_g2.jpg" alt="iart-20211231_g2.jpg" style="height:370px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In partnership with Leadership Edge, a company founded by women leaders and dedicated to growing and mentoring women, Integra sponsors the Excel Women&#8217;s Leadership Program. The program is designed to accelerate the development and advancement of high potential, mid-career female leaders into senior leadership roles. The program has assisted in further building our pipeline of women leaders with 50% of the program&#8217;s graduates being promoted into roles with increased responsibility.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Health and Safety:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra LifeSciences is committed to providing a safe environment for all employees and visitors. We rely on our environmental, health and safety management systems as well as entrusting our managers to oversee and ensure health and safety at their respective sites and foster a workplace culture to achieve that end. We implement our approach globally by our systems and support at regional and country levels from colleagues that implement proper safety protocols, identify and correct hazards, and remain safety conscious at all times. Managers are expected to enforce health and safety regulations, including compliance with applicable federal, state and local laws. Our Environmental Health and Safety ("EH&amp;S") organizational structure incorporates both workplace EH&amp;S coordinators and compliance teams. We have developed an Incident Procedure Policy and General Safety Rules that guide our colleagues to improve our workplace environment, improve safety, and reduce risk and costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we navigate the COVID-19 pandemic and its variants, we have placed a high priority on employee health, providing resources to support our workforce through this challenging time. To help limit exposure to the coronavirus, we acted to ensure employees in business-critical functions who cannot work from home are protected, including those in research and development, quality, manufacturing, distribution, and sales. Personal protective equipment, increased sanitation and social distancing guidance are provided to protect our employees. We continue to actively monitor the COVID-19 pandemic and its variants and respond based on guidance from U.S. and global health organizations, relevant governmental guidance, and evolving practices. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FINANCIAL INFORMATION ABOUT GEOGRAPHIC AREAS </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial information about our geographical areas is set forth in our financial statements Note&#160;16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act"). In accordance with the Exchange Act, we file annual, quarterly and special reports, proxy statements and other information with the Securities and Exchange Commission, ("the SEC"). Our financial information may be viewed, including the information contained in this report, and other reports we file with the SEC, on the Internet, without charge as soon as reasonably practicable after we file them with the SEC, in the &#8220;SEC Filings&#8221; page of the Investor Relations section of our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.integralife.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A copy may also be obtained for any of these reports, without charge, from our Investor Relations department, 1100 Campus Road, Princeton, NJ 08540. Alternatively, reports filed may be viewed or obtained through the SEC's website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE&#160;REGARDING FORWARD-LOOKING STATEMENTS </span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made statements in this report, including statements under &#8220;Business&#8221; and &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; that constitute forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, ("the Securities Act"), and Section&#160;21E of the Exchange Act. These forward-looking statements are subject to a number of risks, uncertainties and assumptions about us including, among other things: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the COVID-19 pandemic;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and business conditions, both nationally and in our international markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations and estimates concerning future financial performance, financing plans and the impact of competition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated trends in our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated demand for our products, particularly capital equipment;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to produce and deliver products in sufficient quantities to meet sales demands;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations concerning our ongoing restructuring, integration and manufacturing transfer and expansion activities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">existing and future regulations affecting our business, and enforcement of those regulations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain additional debt and equity financing to fund capital expenditures, working capital requirements and acquisitions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">physicians' willingness to adopt our recently launched and planned products, third-party payors' willingness to provide or continue reimbursement for any of our products and our ability to secure regulatory approval for products in development; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiatives launched by our competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property, including trade secrets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to complete acquisitions, integrate operations post-acquisition and maintain relationships with customers of acquired entities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to remediate all matters identified in FDA observations and warning letters that we received or may receive; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other risk factors described in the section entitled "Risk Factors" in this report.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements can be identified by forward-looking words such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar expressions in this report. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this report may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. </span></div><div id="i172bf506156f43e6869412a665f54418_16"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UNRESOLVED STAFF COMMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the filing of this Annual Report on Form 10-K, we had no unresolved comments from the staff of the Securities and Exchange Commission that were received not less than 180 days before the end of our 2021 fiscal year. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISK FACTORS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO COVID-19</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effects of the COVID-19 pandemic continue to significantly impact global economic conditions and have affected, and may continue to affect, our operations, supply chain, distribution, sales force, as well as the financial stability of hospitals and other customers, and have caused and could again cause a reduction in procedures, which could materially adversely affect our business, results of operations, financial condition, and stock price.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, the World Health Organization characterized the Novel Coronavirus Disease 2019 (&#8220;COVID-19&#8221;) as a pandemic. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to have widespread and unpredictable impacts on global society, economies, financial markets, and business practices and negatively impact business and healthcare activity globally. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, and in continuing efforts to control the spread of COVID-19 (including subsequent surges and variants), governments around the world, including in the U.S., have and continue to implement various preventative measures including quarantines, &#8220;shelter in place&#8221; orders, &#8220;stay at home&#8221; orders, travel restrictions, business operation restrictions, school closures, and other similar types of measures. Even as efforts to contain the pandemic have made progress, new variants of the virus are causing additional surges or outbreaks. The COVID-19 pandemic has impacted and may continue to impact our business operations, including our employees, customers, suppliers, distributors, other service providers and communities in which we operate, and there is substantial uncertainty in the nature and degree of its continued effects over time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic and related mitigation efforts, similar to many other employers in the U.S., the Company has and continues to encourage many employees to work remotely. The Company has continued to operate certain manufacturing facilities to date in compliance with federal, state and local orders regarding COVID-19. The health of the Company&#8217;s workforce is our top concern and the Company has procured equipment and implemented safety protocols in an effort to maintain the health and safety of our employees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of our network of business partners have been adversely affected by the COVID-19 pandemic. These impacts could impair our ability to move our products through distribution channels to end customers, and any such delay or shortage in the supply of materials or products may result in our inability to satisfy consumer demand for certain of our products in a timely manner or at all, which could harm our reputation, future sales and profitability. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not possible to predict with precision how future demand for our products will be impacted by the COVID-19 pandemic as the scope and duration of the pandemic and its impact on our business and the markets in which we operate remain unpredictable. The Company has implemented extensive business contingency plans across its global organization and network of third parties through which the Company conducts its business which helps limit some of the impact of the COVID-19 pandemic but does not completely prevent or avoid a negative impact on the business. In addition, COVID-19 has impacted and may further impact the global economy and capital markets, including by negatively impacting access to capital markets, foreign currency exchange rates, and interest rates, each of which may adversely impact our business and liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic will negatively affect the Company's operations and financial position will depend on future developments that remain uncertain and cannot be predicted with precision. For example, including, without limitation, the pandemic could cause: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continued fluctuations in our operational results, revenues, and cash flows which may negatively impact our stock price; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Impact on our operations and sales including but not limited to delays in orders, ability to market, sell, deliver and service our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reductions in demand for our products and services due to the impact of COVID-19 on hospitals and customers such as continued or future postponement or cancellations of procedures, hospital postponement or cancellation of capital purchases, or elimination of services;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption to manufacturing operations and distribution supply chains;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased challenges or restraints in obtaining necessary products or components from our suppliers and vendors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reduction or interruption to our manufacturing processes which could have a material adverse effect on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Local and/or global economic instability and inflation and recessions, which may result in hospitals and customers reducing capital spending and could materially affect our business, including but not limited to our future access to capital, and negatively impact the value of our stock; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continued limitations on our operations due to restrictions associated with &#8220;shelter in place&#8221; orders and travel restrictions; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Distraction of management time and focus; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased risk that insurance coverage will not provide protection for all of the COVID-19-related disruption;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continued and/or increased risks related to the health and safety of our employees (and retention issues), volatility of foreign currency exchange rates, and risk of cybersecurity attacks and breaches; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Possible liquidity constraints and credit impact;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Delays in obtaining regulatory clearances, approval to market products, quality inspections, or delays to clinical trial activity; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Delays in coverage decisions by private and public health insurers and foreign governmental health systems;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Delays in the completion of supportive clinical studies for payer coverage decisions or clinical and economic decision makers due to slowed study enrollments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Delays to acquisition plans, increased risks to the operations and financial condition of newly acquired businesses, and increased costs or delays to integration of newly acquired businesses;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of any reprioritization of capital allocations on our ability to achieve our strategic objectives over the medium and long-term; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Write downs or impairments of investments in third parties, goodwill or intangible assets from recently acquired businesses, accounts receivable, or other assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the situation surrounding the COVID-19 pandemic remains fluid, it is difficult to predict, with any certainty, the duration and extent of its impact which depends on future developments that cannot be accurately predicted at this time, such as the severity and transmission rate of the virus (including any variant strains), the extent and effectiveness of containment actions including the effectiveness of the vaccine against future variants and the availability of new antiviral medicines for the treatment of COVID-19, and the impact of these and other factors on our employees, customers, suppliers, distributors and other service providers.</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If COVID-19, or a variant strain, continues to spread and escalate domestically or internationally, or if governments impose additional measures intended to mitigate the spread and related effects of the pandemic, the risks described above could be elevated significantly. Should that occur, and the COVID-19 pandemic persist for a prolonged time, the above factors and others that are currently unknown could have a material adverse impact on our business, results of operations, financial conditions and prospects and could elevate known risks described in this Item 1A. Risk Factors. Information pertaining to the potential impact of the COVID-19 pandemic and associated economic disruptions, and the actual operational and financial impacts that we have experienced to date can be found in Management's Discussion and Analysis of Financial Position and Results of Operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATING TO OUR BUSINESS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may fluctuate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results, including components of operating results such as gross margin and cost of product sales, may fluctuate from time to time, and such fluctuations could affect our stock price. Our operating results have fluctuated in the past and can be expected to do so from time to time in the future. Some of the factors that may cause these fluctuations include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to COVID-19;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic conditions worldwide, which could affect the ability of hospitals and other customers to purchase our products and could result in a reduction in elective and non-reimbursed operative procedures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of acquisitions, our ability to integrate acquisitions, and our restructuring activities including portfolio rationalization, divestitures and product lifecycle management;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenditures for major initiatives, including acquired businesses and integrations thereof and restructuring;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of significant customer orders, which tend to increase in the fourth quarter coinciding with the end of budget cycles; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased competition for a wide range of customers across all our product lines in the markets our products are sold;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market acceptance of our existing products, as well as products in development; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">retention of current employees and recruiting of new employees in light of market competition for talent and relevant skills; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of regulatory approvals as well as changes in country-specific regulatory requirements; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the exchange rates between the U.S. dollar and foreign currencies of countries in which we do business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the variable interest rates of our debt instruments which could impact debt service requirements; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential backorders, lost sales and expenses incurred in connection with product recalls or field corrective actions; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruption of our operations and sales resulting from extreme weather conditions or natural disasters that damage our manufacturing, distribution, or infrastructure of those facilities, or the suppliers and service providers for those facilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manufacture and ship our products efficiently or in sufficient quantities to meet sales demands; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the cost or decreases in the supply of raw materials and services, including sterilization, energy, steel and honey;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of our research and development expenditures; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reimbursement for our products by third-party payors such as Medicare, Medicaid, private and public health insurers and foreign governmental health systems;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to maintain existing distribution rights to and from certain third parties;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to maintain business if or when we opt to convert such business from distributors to a direct sales model;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our commercial sales representatives to obtain sales targets in a reasonable time frame;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of changes to our sales organization, continued channel expansion, including increased specialization;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">peer-reviewed publications discussing the clinical effectiveness of the products we sell;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inspections of our manufacturing facilities for compliance with Quality System Regulations (Good Manufacturing Practices) which could result in Form 483 observations, warning letters, injunctions or other adverse findings from the FDA or from equivalent regulatory bodies, and corrective actions, procedural changes and other actions that we determine are necessary or appropriate to address the results of those inspections, any of which may affect production and our ability to supply our customers with our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulations or guidelines that impact the sales and marketing practices for products that we sell;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the increased regulatory scrutiny of certain of our products, including products which we manufacture for others, could result in removal from the market or involve field corrective actions that could affect the marketability of our products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enforcement or defense of intellectual property rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in tax laws, or their interpretations; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of goodwill and intangible asset impairment charges if future operating results of the acquired businesses are significantly less than the results anticipated at the time of the acquisitions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The industry and market segments in which we operate are highly competitive, and we may be unable to compete effectively with other companies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is intense competition among medical device companies. We compete with established medical technology companies in many of our product areas. Competition also comes from early-stage companies, universities, research institutions and other non-profit entities. In certain cases, our products compete primarily against medical practices that treat a condition without using a device or any particular product, such as the medical practices that use autograft tissue instead of our dermal regeneration products, duraplasty products and nerve repair products, or that use other technologies that cost less than our products. Many of our competitors have access to greater financial, technical, research and development, marketing, manufacturing, sales, distribution, administrative, consulting and other resources than we do. Our competitors may be more effective at developing commercial products. They may be able to gain market share by offering lower-cost products or products that enjoy better reimbursement from third-party payors and foreign governmental health systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitive position depends on our ability to achieve market acceptance for our products, develop new products, implement production and marketing plans, secure regulatory approval for products under development, demonstrate clinical and economic effectiveness, obtain and maintain reimbursement coverage and funding under third-party payors and foreign governmental health systems, obtain patent protection and produce products consistently in sufficient quantities to meet demand. We may need to develop new applications for our products to remain competitive. Technological advances by one or more of our current or future competitors or their achievement of superior reimbursement from third-party payors and foreign governmental health systems could render our present or future products obsolete or uneconomical. Our future success will depend upon our ability to compete effectively against current technology as well as to respond effectively to technological advances, changes in customers' requirements or in payor or regulatory evidence requirements. Additionally, purchasing decisions of our customers may be based on clinical evidence or comparative effectiveness studies and, because of our vast array of products, we might not be able to fund the studies necessary to gain entry or maintain our position or provide the required information to compete effectively. Other companies may have more resources available to fund such studies. For example, competitors have launched and are developing products to compete with our dural repair products, regenerative skin, neuro critical care monitors and ultrasonic tissue ablation devices, among others. In the current environment of managed care, consolidation among health care providers, increased competition, and declining reimbursement rates, we have been increasingly required to compete on the basis of price. Competitive pressures could adversely affect our profitability. Given these factors, we cannot guarantee that we will be able to compete effectively or continue our level of success in the areas in which we compete.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the healthcare industry may require us to decrease the selling price for our products, may reduce the size of the market for our products, or may eliminate a market, any of which could have a negative impact on our financial performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trends toward managed care, healthcare cost containment and other changes in government and private sector initiatives in the U.S. and other countries in which we do business are placing increased emphasis on the delivery of more cost-effective medical therapies that could adversely affect the sale and/or the prices of our products. For example:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third-party payors of hospital services and hospital outpatient services, including Medicare, Medicaid, private and public health insurers and foreign governmental health systems, annually revise their payment methodologies, which can result in stricter standards for reimbursement of hospital charges for certain medical procedures or the elimination of reimbursement;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">several foreign countries have implemented reforms of their respective healthcare sectors in an effort to reduce healthcare spending, including restricting funding to only those medical technologies and procedures with proven effectiveness, and increasing patient co-payments. Governmental health systems have revised and continue to consider revisions of healthcare budgets, which could result in stricter standards for implementing certain medical procedures, increased scrutiny of medical devices, and downward pricing pressure;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare, Medicaid, private and public health insurer and foreign governmental cutbacks could create downward pricing pressure on our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the U.S., Medicare and Medicaid coverage as well as commercial payor coverage determinations could reduce or eliminate reimbursement or coverage for certain of our wound matrix, amniotic, surgical reconstruction and advanced wound dressing products as well as other products in most regions, negatively affecting our market for these products, and future determinations could reduce or eliminate reimbursement or coverage for these products in other regions and could reduce or eliminate reimbursement or coverage for other products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there has been a consolidation among healthcare facilities and purchasers of medical devices in the U.S., some of whom prefer to limit the number of suppliers from whom they purchase medical products, and these entities may decide to stop purchasing our products or demand discounts on our prices;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the U.S., we are party to contracts with group purchasing organizations, which negotiate pricing for many member hospitals, require us to discount our prices for certain of our products and limit our ability to raise prices for certain of our products, particularly surgical instruments; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there is economic pressure to contain healthcare costs in domestic and international markets, and, regardless of the consolidation discussed above, providers generally are exploring ways to cut costs by eliminating purchases or driving reductions in the prices that they pay for medical devices, or increasing clinical or economic evidence thresholds for product formularies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there are proposed and existing laws, regulations and industry policies in domestic and international markets regulating the sales and marketing practices and the pricing and profitability of companies in the healthcare industry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">proposed laws or regulations may permit hospitals to provide financial incentives to doctors for reducing hospital costs, will award physician efficiency, and will encourage partnerships with healthcare service and goods providers to reduce prices; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there have been initiatives by third-party payors and foreign governmental health systems to challenge the prices charged for medical products that could affect our ability to sell products on a competitive basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any and all of the above factors could materially and adversely affect our levels of revenue and our profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our current strategy involves growth through acquisitions, which requires us to incur substantial costs and potential liabilities for which we may never realize the anticipated benefits, and also requires us to successfully integrate acquired businesses into our business operations in order to avoid our business being materially and adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to internally generated growth, our current strategy involves growth through acquisitions. Between January 1, 2019 and December&#160;31, 2021, we have acquired 3 businesses at a total cost of approximately $404.3 million which amount includes our acquisition of ACell, Inc. in January 2021 for $306.9&#160;million. This acquisition added products to our complex wound management product portfolio and provides additional growth opportunities for our TT segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be unable to continue to implement our growth strategy and it may ultimately be unsuccessful. A significant portion of our growth in revenues has resulted from, and is expected to continue to result from, the acquisition of businesses or products complementary to our own. We engage in evaluations of potential acquisitions and are in various stages of discussion regarding possible acquisitions, certain of which, if consummated, could be significant to us. Any new acquisition could result in material transaction expenses, increased operating, amortization and interest expenses, and possible in-process research and development charges for acquisitions that do not meet the definition of a &#8220;business,&#8221; any of which could have a material, adverse effect on our operating results. Certain businesses that we acquire may not have adequate financial, disclosure, regulatory, quality or other compliance controls at the time we acquire them and could require significant expenditures to address those controls or subject us to increased risk. As we grow by acquisition, we must manage and integrate the new businesses to bring them into our systems for financial, disclosure, compliance, regulatory and quality control, realize economies of scale, and control costs. Failure to integrate acquired businesses and operations (including acquired employees and systems), retain key customers and suppliers of any acquired business or manage the cost of providing our products or price our products appropriately could preclude realization of the full benefits that we expect from there transactions. Our failure to meet the challenges involved in integrating the business in order to realize the anticipated benefits of the acquisitions could cause an interruption of, or loss of momentum in, our activities and could materially and adversely affect our results of operations. In addition, acquisitions involve other risks, including diversion of management resources otherwise available for the running of our business and the development of our business as well as risks associated with entering markets in which our marketing teams and sales force has limited experience or where experienced distribution alliances are not available. Some acquisitions may include the need for ongoing product development to occur consistent with time sensitive milestones in order for the Company to achieve its commercial projections for the acquisition. Our future profitability will depend in part upon our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ability to develop our resources to adapt to these new products or business areas and to identify and enter into or maintain satisfactory distribution networks. As a result of our acquisitions of other healthcare businesses, we may be subject to the risk of unanticipated business uncertainties, regulatory and other compliance matters or legal liabilities relating to those acquired businesses for which the sellers of the acquired businesses may not indemnify us, for which we may not be able to obtain insurance (or adequate insurance), or for which the indemnification may not be sufficient to cover the ultimate liabilities. We may not be able to identify suitable acquisition candidates in the future, obtain acceptable financing or consummate any future acquisitions. Certain potential acquisitions are subject to antitrust and competition laws, which laws could impact our ability to pursue strategic acquisitions and could result in mandated divestitures. If we are unsuccessful in our acquisition strategy, we may be unable to meet our financial targets and our financial performance could be materially and adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks may be heightened in cases where the majority of the former businesses&#8217; operations, employees and customers are located outside the U.S. Any one or all of these factors could increase operating costs or lower anticipated financial performance. Many of these factors are also outside of our control. In addition, dispositions of certain key products, technologies and other rights, including pursuant to conditions imposed on us to obtain regulatory approvals, may affect our business operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the operations of the businesses are integrated successfully, we may not realize the full benefits of the acquisition, including the synergies, cost savings or sales or growth opportunities that we expect. These benefits may not be achieved within the anticipated time frame, or at all. Additional unanticipated costs could be incurred in the integration of the businesses. All of these factors could cause a reduction to our earnings per share, decrease or delay the expected accretive effect of the transaction, and negatively impact the price of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future financial results could be adversely affected by impairments or other charges. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to test both goodwill and indefinite-lived intangible assets for impairment on an annual basis based upon a fair value approach, rather than amortizing them over time. We are also required to test goodwill and indefinite-lived intangible assets for impairment between annual tests if an event occurs such as a significant decline in revenues or cash flows for certain products, or the discount rates used in the calculations of discounted cash flows change significantly, or circumstances change that would more likely than not reduce our enterprise fair value below its book value. If such a decline, rate change or circumstance were to materialize, we may record an impairment of these intangible assets that could be material to the financial statements. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates&#8221; of this report. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guidance on long-lived assets requires that we assess the impairment of our long-lived assets, including finite-lived intangible assets, whenever events or changes in circumstances indicate that the carrying value may not be recoverable as measured by the sum of the expected future undiscounted cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, Company decisions and other economic factors relating to our trade names may occur over time. For instance, we may discontinue certain products in the future as we continue to assess the profitability of our product lines. As a result, we may need to record impairment c</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">harges or accelerate amortization on certain trade names or technology-related intangible assets in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of a medical device business is often volatile, and the assumptions underlying our estimates made in connection with our assessments under the guidance may change as a result of that volatility or other factors outside our control and may result in impairment charges. The amount of any such impairment charges could be significant and have a material, adverse effect on our reported financial results for the period in which the charge is taken and could have an adverse effect on the market price of our securities, including the notes and the common stock into which they may be converted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lack of market acceptance for our products or market preference for technologies that compete with our products could reduce our revenues and profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market acceptance of our products depends on many factors, including our ability to convince prospective customers that our technology is an attractive alternative to other technologies, to manufacture products in sufficient quantities and at acceptable costs, and to supply and service sufficient quantities of our products directly or through our distribution alliances. For example, the use of autograft tissue is a well-established means for repairing the dermis, and it competes for acceptance in the market with our collagen-based wound care products. In addition, unfavorable payment amounts or adverse coverage determinations of third-party payors, including Medicare, Medicaid, private and public health insurers, and foreign governmental health systems, regarding our products or third-party determinations that favor a competitor&#8217;s product over ours, could harm acceptance or continued use of our products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, greater market acceptance of our wound graft products may ultimately depend on our ability to demonstrate that coverage and reimbursement are available and favorable, or because they are an attractive, cost-effective alternative to other treatment options. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If there are negative events in the healthcare industry, whether real or perceived, there could be a negative impact on the industry as a whole. The industry is subject to rapid and continuous change arising from, among other things, consolidation, technological improvements, the pressure on governments, third-party payors and providers to reduce healthcare costs, and healthcare reform legislation and initiatives domestically and internationally. In addition, our future success depends, in part, on our ability to license and develop additional products. Even if we determine that a product candidate has medical benefits, the cost of commercializing, either through internal development or payments associated with licensing arrangements, could be too high to justify development and we could ultimately face competitors with more effective products and better reimbursement status that cost less and are ready for commercial introduction before our products. If we are unable to develop additional commercially viable products, our future prospects could be materially and adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One or more of these factors could vary unpredictably, and such variations could have a material, adverse effect on our competitive position. We may not be able to adjust our contemplated plan of development to meet changing market demands.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It could be difficult to replace some of our suppliers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside vendors, some of whom are sole-source suppliers, provide key components and raw materials used in the manufacture of our products. Although we believe that alternative sources for many of these components and raw materials are available, any interruption in supply of a limited or sole-source component or raw material could harm our ability to manufacture our products until a new or alternative source of supply is identified and qualified. In addition, an uncorrected defect or supplier&#8217;s variation in a component or raw material, either unknown to us or incompatible with our manufacturing process, could harm our ability to manufacture products. We may not be able to find a sufficient alternative supplier in a reasonable time period, or on commercially reasonable terms, if at all, and our ability to produce and supply our products could be impaired. We believe that these factors are most likely to affect the following products that we sell:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our collagen-based products, such as the Integra Dermal Regeneration Template and wound matrix products, the DuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> family of products, our Absorbable Collagen Sponges, PriMatrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and SurgiMend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our products made from silicone, such as our neurosurgical shunts and drainage systems and hemodynamic shunts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">products which use many different specialty parts, electrical components, or chemicals from numerous suppliers, such as our intracranial monitors, shunts, catheters, tissue ablation, and headlights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">products which are amniotic tissue-based</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">products which are porcine tissue-based;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">products that use medical grade leptospermum honey, such as our Medihoney products; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our TCC-EZ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> total contact cast system products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of amniotic tissue-based products depends upon, among other factors, the availability of tissue from human donors. Access to donated amniotic tissue could also be adversely impacted by regulatory changes or evolving public perceptions of the donor process.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, many of our products require sterilization by third-party suppliers. To the extent these suppliers are unable to provide sterilization services, whether due to lack of capacity, regulatory requirements, environmental concerns such as those relating to ethylene oxide or otherwise, we may be unable to transition sterilization to other suppliers in a timely or cost effective manner, or at all, which could have an adverse impact on our operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our supply chain and our cost of goods also may be negatively impacted by unanticipated price increases due to factors such as inflation, including wage inflation, or to supply restrictions beyond our control or the control of our suppliers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is our policy to maintain sufficient inventory of components so that our production will not be significantly disrupted even if a particular component or material is not available for a period of time, we remain at risk that we will not be able to qualify new components or materials quickly enough to prevent a disruption if one or more of our suppliers ceases production of important components or materials.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience difficulties, delays, performance impact or unexpected costs from consolidation of facilities and transfer of manufacturing facilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we consolidated several facilities or transferred manufacturing operations from third parties to our existing internal manufacturing facilities and may further undertake similar consolidations or transfers in the future in order to improve our cost structure, achieve increased operating efficiencies, and improve our competitive standing or results of operations and/or to address unfavorable economic conditions. As part of these initiatives, we may also lose favorable tax incentives or not be able to renew leases on acceptable terms. We may further reduce staff, make changes to certain capital projects, close certain production operations and abandon leases for certain facilities that will not be used in our operations. In conjunction with any actions, we will continue to make significant investments and build the framework for our future growth. We may not realize, in full or in part, the anticipated benefits and savings from these efforts because of unforeseen difficulties, delays, implementation issues or unexpected costs. If we are unable to achieve or maintain all of the resulting savings or benefits to our business or other unforeseen events occur, our business and results of operations may be adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have significant product liability exposure and our insurance may not cover all potential claims.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to product liability and other claims if our technologies or products are alleged to have caused harm. We may not be able to obtain insurance for the potential liability on acceptable terms with adequate coverage or at reasonable costs. Any potential product liability claims could exceed the amount of our insurance coverage or may be excluded from coverage under the terms of the policy. Our insurance may not be renewed at a cost and level of coverage comparable to that then in effect.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic and political instability around the world could adversely affect the ability of hospitals, other customers, suppliers and distributors to access funds or otherwise have available liquidity, which could reduce orders for our products or interrupt our production or distribution or result in a reduction in elective and non-reimbursed operative procedures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic and political instability around the world could adversely affect the ability of hospitals and other customers to access funds to enable them to fund their operating and capital budgets. As a result, hospitals and other customers could reduce budgets or put all or part of their budgets on hold or close their operations, which could have a negative effect on our sales, particularly the sales of capital equipment such as our ultrasonic surgical aspirators, neuromonitors and stereotactic products, or result in a reduction in elective and non-reimbursed procedures. The occurrence of those economic conditions could make it more difficult for us to accurately forecast and plan our future business activities and depending on their severity, could have a material, adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our private-label product lines depend significantly on key relationships with third parties, which we could be unable to establish and maintain.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our private-label business depends in part on entering into and maintaining long-term supply agreements with third parties. The third parties with whom we have entered into agreements might terminate these agreements for a variety of reasons, including developing other sources for the products that we supply. Termination of our most important relationships could adversely affect our expectations for the growth of private-label products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR REGULATORY ENVIRONMENT </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The adoption of healthcare reform in the U.S. and initiatives sponsored by other governments may adversely affect our business, results of operations and/or financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations may be substantially affected by potential fundamental changes in the global political, economic and regulatory landscape of the healthcare industry. Government and private sector initiatives to limit the growth of healthcare costs are continuing in the U.S., and in many other countries in which we do business, causing the marketplace to put increased emphasis on the delivery of more cost-effective treatments. These initiatives include price regulation, competitive pricing, coverage and payment policies, comparative effectiveness of therapies, technology assessments and managed-care arrangements. The adoption of some or all of these initiatives could have a material, adverse effect on our financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the Patient Protection and Affordable Care Act (the &#8220;ACA&#8221;), signed into law in March 2010, includes several provisions that impact our businesses in the U.S. The ACA includes provisions that, among other things, reduce and/or limit Medicare reimbursement, require all individuals to have health insurance (with limited exceptions), and require detailed disclosure of transfers of value made to healthcare professionals. Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted, including The Budget Control Act of 2011, The American Taxpayer Relief Act of 2012 and Medicare Access and CHIP Reauthorization Act of 2015, which, among other things, have reduced payments under Medicare and Medicaid to certain healthcare providers or altered the formula by which Medicare makes annual payment adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict what impact ongoing uncertainty regarding federal and state health reform proposals, including the implementation or repeal of the ACA, judicial review and interpretation of the ACA and other healthcare laws, instability of the insurance markets, changes in the U.S. administration and policy, an expansion in government&#8217;s role in and/or additional proposals and/or changes to the U.S. health care system or its legislation will have on our customer&#8217;s purchasing decisions and/or reimbursement which could have a material adverse effect on our business. We expect that additional state and federal health care reform measures will be adopted in the future, including those initiatives affecting coverage and reimbursement for our products, any of which could limit the amounts that federal and state governments will pay for health care products and services, which could adversely affect the growth of the market for our products or demand for our products, or result in additional pricing pressures. We cannot predict the ultimate content, timing or effect of any healthcare reform legislation or the impact of potential legislation on us. We continue to monitor the implementation of such legislation and, to the extent new market or industry trends or new governmental programs evolve, we will consider implementing or implement programs in response.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to stringent domestic and foreign medical device regulations and oversight and any adverse action may adversely affect our ability to compete in the marketplace and our financial condition and business operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products, development activities and manufacturing processes are subject to extensive and rigorous regulation by numerous government agencies, including the FDA and comparable foreign agencies, as discussed in &#8220;Part 1, Item 1. Business &#8211; Government Regulation.&#8221; To varying degrees, each of these agencies monitors and enforces our compliance with laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of our medical devices. We are also subject to regulations that may apply to certain of our products that are Drug/Device Combination products or are considered to be subject to pharmaceutical regulations outside the U.S. The process of obtaining marketing approval or clearance from the FDA and comparable foreign regulatory agencies for new products, or for enhancements or modifications to existing products could be costly, time consuming and burdensome, lead to failed clinical trials or weakened clinical evidence, involve modifications, repairs or replacements of our products and result in limitations on the indicated use of our products, which may negatively impact our ability to market our products and services, result in delays or prevent full commercial realization of future products or service. Furthermore, failure to obtain timely approvals or renewals may result in significant penalties and fines. Additional regulations govern the approval, initiation, conduct, monitoring, documentation and reporting of clinical studies to regulatory agencies in the countries or regions in which they are conducted. Failure to comply, could subject us to significant enforcement actions and sanctions, including halting the study, rejection of data generated in the study, seizure of investigational devices or data, sanctions against investigators, civil or criminal penalties, and other actions. In addition, without the data from one or more clinical studies, it may not be possible for us to secure the data necessary to support certain regulatory submissions, to secure reimbursement or demonstrate other requirements. We cannot assure you that access to clinical investigators, sites and subjects, documentation and data will be available on the terms and timeframes necessary.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to extensive complex regulatory requirements by domestic and foreign government agencies and any failure to comply with our ongoing responsibilities under their applicable laws and regulations could result in a material adverse impact on our business. Failure to comply with applicable regulations could result in future product recalls, injunctions preventing the shipment of products or other enforcement actions that could have a material adverse effect on our business. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are also subject to the European Medical Device Regulation, which was adopted by the European Union (&#8220;EU&#8221;) as a common legal framework for all EU member states. The implementation for Class I products occurred on May 26, 2021 and the EUDAMED Database is scheduled for May 26, 2022. Under this regulation, companies that wish to manufacture and distribute medical devices in EU member states must meet certain quality system, and safety requirements as well as ongoing product monitoring responsibilities. Companies must also obtain a &#8220;CE&#8221; marking (i.e., a mandatory conformity marking for certain products sold within the European Economic Area) for their products. Complying with the requirements of these regulations may require us to incur significant expenditures. Various penalties exist for non-compliance with the laws implementing the European Medical Device Regulations which if incurred, could have a material adverse impact on our business, results of operations and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are subject to laws and regulations that govern the means by which companies in the healthcare industry may market their products to healthcare professionals and may compete by discounting the prices of their products, including for example, the federal Anti-Kickback Statute, the federal False Claims Act, the federal Health Insurance Portability and Accountability Act of 1996, state law equivalents to these federal laws that are meant to protect against fraud and abuse and analogous laws in foreign countries. Violations of these laws are punishable by criminal and civil sanctions, including, but not limited to, in some instances civil and criminal penalties, damages, fines, exclusion from participation in federal and state healthcare programs, including Medicare and Medicaid. Although we exercise care in structuring our sales and marketing practices and customer discount arrangements to comply with those laws and regulations, we cannot assure that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government officials charged with responsibility for enforcing those laws will not assert that our sales and marketing practices or customer discount arrangements are in violation of those laws or regulations; or</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government regulators or courts will interpret those laws or regulations in a manner consistent with our interpretation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in place policies and procedures for compliance that we believe are at least as stringent as those set forth in the AdvaMed Code of Ethics which was developed by AdvaMed, a trade association that represents the medical device industry, and which is intended to represent best practices with respect to medical device companies' interactions with healthcare providers. We regularly train our sales and marketing personnel on our policies regarding sales and marketing practices. Pursuant to the AdvaMed Code, we have certified our adoption of the AdvaMed Code. The sales and marketing practices of our industry have been the subject of increased scrutiny from federal and state government agencies, and we believe that this trend will continue. Various hospital organizations, medical societies and trade associations are establishing their own practices that may require detailed disclosures of relationships between healthcare professionals and medical device companies or ban or restrict certain marketing and sales practices such as gifts and business meals. Since these laws, regulations and ultimate enforcement continue to evolve, we cannot predict with certainty, what, if any, impact, changes to them may have on our business or our customers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the U.S. we are subject to privacy and data security regulations at the international, national and regional level, as well as on an industry specific basis. For example, in Europe, we are subject to the EU General Data Protection Regulation ("GDPR") which is related to the collection, processing, storage, transfer and use of personal data. In the U.S., we are subject to the California Consumer Privacy Act of 2018 (&#8220;CCPA&#8221;) and other similar laws in the United States, at both the federal and state level. Noncompliance with GDPR could trigger fines of up to 4% of global annual revenues. In addition, we are subject to the new China Personal Information Protection Law that went into effect November 1, 2021 which focuses on protecting personal information and cross border transfers of the information. Compliance with these requirements, either individually or in the aggregate, may require changes in business practices added complexity and additional management oversight. They also may complicate our clinical research activities, as well as product offerings that involve transmission or use of clinical data. Non-compliance may result in proceedings against us by governmental or other entities and/or significant fines which could negatively impact our reputation and adversely affect our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should we delay or fail to comply with one or more of the regulatory requirements we could have reduced sales, increased costs, delays to new product introductions, enhancements or our strategic plans, or harm to our reputation or competitiveness, which could have a material adverse effect on our business and financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of our products contain materials derived from animal sources and may become subject to additional regulation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our products are derived from bovine or porcine tissue sources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we may experience difficulties in processing and producing our bovine and porcine tissue products at scale, including problems related to yields, quality control and assurance, tissue availability, adequacy of control policies and procedures and availability of skilled personnel.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to bovine, among other products, our dermal regeneration products, duraplasty products, wound care products, bone void fillers, nerve and tendon repair products and certain other products, contain material derived from bovine tissue. In 2021, approximately 43.3% of our revenues derived from products containing material derived from bovine tissue. Products that contain materials derived from animal sources, including food, pharmaceuticals and medical devices, are subject to scrutiny in the media and by regulatory authorities. Regulatory authorities are concerned about the potential for the transmission of disease from animals to humans via those materials. This public scrutiny has been particularly acute in Japan and Western Europe with respect to products derived from animal sources, because of concern that materials infected with the agent that causes bovine spongiform encephalopathy, otherwise known as BSE or mad cow disease, may, if ingested or implanted, cause a variant of the human Creutzfeldt-Jakob Disease, an ultimately fatal disease with no known cure. The World Organization for Animal Health recognizes the U.S. as having a negligible risk for BSE, which is the highest status available.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We take care to provide that our products are safe and free of agents that can cause disease. In particular, we qualified a source of collagen from a country outside the U.S. that is considered BSE/TSE-free. The World Health Organization classifies different types of bovine tissue for relative risk of BSE transmission. Deep flexor tendon and bovine fetal skin, which are used in our products, are in the lowest-risk categories for BSE transmission and are therefore considered to have a negligible risk of containing the agent that causes BSE (an improperly folded protein known as a prion). Nevertheless, products that contain materials derived from animals, including our products, could become subject to additional regulation, or even be banned in certain countries, because of concern over the potential for the transmission of prions. Significant new regulations, or a ban of our products, could have a material, adverse effect on our current business or our ability to expand our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain countries, such as Japan, China, Taiwan and Argentina, have issued regulations that require our collagen products be sourced from countries where no cases of BSE have occurred, and the EU has requested that our dural replacement products and other products that are used in neurological tissue be sourced from a country where no cases of BSE have occurred. Currently, we source bovine fetal hides from the U.S. and purchase tendon from the U.S. and New Zealand. New Zealand has never had a case of BSE. We received approval in the U.S., the EU, Japan, Taiwan, China, Argentina as well as other countries for the use of New Zealand-sourced tendon in the manufacturing of our products. If we cannot continue to use or qualify a source of tendon from New Zealand or another country that has never had a case of BSE, we could be prohibited from selling our collagen products in certain countries.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to current and potential future requirements relating to protection of the environment, such as hazardous materials regulations, which may impose significant compliance or other costs on us. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our processes in manufacturing and research and development involve the controlled use of certain hazardous materials. In addition, we own and/or lease a number of facilities at which hazardous materials have been used in the past. Finally, we have acquired various companies that historically have used certain hazardous materials and that have owned and/or leased facilities at which hazardous materials have been used. For all of these reasons, we are subject to federal, state, foreign, and local laws and regulations governing the use, manufacture, storage, transportation, handling, treatment, remediation, and disposal of hazardous materials and certain waste products (&#8220;Environmental, Health, Safety and Transportation Laws&#8221;). Although we believe that our procedures for handling, transporting, and disposing of hazardous materials comply with the Environmental, Health, Safety and Transportation Laws, such laws may be amended in ways that increase our cost of compliance, perhaps materially.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the potential risk of accidental contamination or injury from these materials cannot be eliminated, and there is also a risk that such contamination previously has occurred in connection with one of our facilities or in connection with one of the companies we have purchased. In the event of such an accident or contamination, we could be held liable for any damages that result and any related liability could exceed the limits or fall outside the coverage of our insurance and could exceed our resources. We may not be able to maintain insurance on acceptable terms or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Our business and operations are subject to risks related to climate change.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The long-term effects of global climate change present both physical risks (from the increased frequency of extreme weather conditions or natural disasters) and transition risks (from regulatory requirements or technology changes). Such extreme weather conditions could pose physical risks to our facilities and disrupt operation of our supply chain and may impact operational costs. Concern over global climate change could result in new legal or regulatory requirements designed to mitigate the effects of climate change on the environment. If such laws or regulations are more stringent than current legal or regulatory requirements, we may experience increased compliance burdens and costs to meet the regulatory obligations and such measures may interrupt our operations or the operations of our suppliers, potentially leading to higher costs, and therefore negatively impact our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to requirements relating to information technology which could adversely affect our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to maintain reliable information technology systems and prevent disruptions, outages, or data breaches, we may suffer regulatory consequences in addition to business consequences. Our worldwide operations means that we are subject to laws and regulations, including data protection and cyber security laws and regulations, in many jurisdictions. The variety of U.S. and international privacy and cybersecurity laws and regulations impacting our operations are described in &#8220;Item 1. Business - Government Regulation - Other Factors - Data Privacy and Cybersecurity Laws and Regulations." We have programs to ensure compliance with such laws and regulations. However, there is no guarantee that we will avoid enforcement actions by governmental bodies. Enforcement actions may be costly and interrupt regular operations of our business. In addition, there has been a developing trend of civil lawsuits and class actions relating to breaches of consumer data held by large companies or incidents arising from other cyber-attacks. While Integra has not been named in any such suits, if a substantial breach or loss of data were to occur, we could become a target of such litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO TAX AND DEBT</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have additional tax liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in the U.S. and many foreign jurisdictions and are commonly audited by various tax authorities. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. Significant judgment is required in determining our worldwide provision for income taxes. Although we believe that our tax estimates are reasonable, the final determination of tax audits and any related litigation could be materially different from our historical income tax provisions and accruals. The results of an audit or litigation could have a material, adverse effect on our financial statements in the period or periods for which that determination is made.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or exposures to additional tax liabilities could negatively impact the Company's operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes, as well as taxes that are not income-based, in both the U.S. and many foreign jurisdictions. Our future effective tax rate could be unfavorably affected by numerous factors including a change in, or the interpretation of, tax rules and regulations in the jurisdictions in which we operate (including changes in legislation currently being considered), a change in our geographic earnings mix, and/or to the jurisdictions in which we operate, or a change in the measurement of our deferred taxes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our leverage and debt service obligations could adversely affect our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leverage and debt service obligations could adversely affect our business. As of December&#160;31, 2021, our total consolidated external debt was approximately $1.6 billion (See Item 7 and Note 5,5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for a discussion of our consolidated external debt). We may also incur additional indebtedness in the future. Our substantial indebtedness could have material, adverse consequences, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">making it more difficult for us to satisfy our financial obligations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our vulnerability to adverse economic, regulatory and industry conditions, and placing us at a disadvantage compared to our competitors that are less leveraged;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to compete and our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to borrow additional funds for working capital, capital expenditures, acquisitions and general corporate or other purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt service obligations will require us to use a portion of our operating cash flow to pay interest and principal on indebtedness instead of for other corporate purposes, including funding future expansion of our business, acquisitions, and ongoing capital expenditures, which could impede our growth. In addition, our ability to comply with, renegotiate or extend the Company&#8217;s debt obligations will depend on our operating and financial performance, which in turn is subject to prevailing economic conditions and financial, business and other factors beyond our control.Any disruptions in our operations, the financial markets, or the overall economy, including as a result of COVID-19, may adversely affect the availability and cost of credit to us and/or our ability to comply with our existing obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the calculation and or complete replacement of LIBOR could have an impact on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom&#8217;s Financial Conduct Authority (&#8220;FCA&#8221;), which regulates LIBOR, announced in July 2017 that it will no longer persuade or require banks to submit rates for LIBOR. On March 5, 2021, the ICE Benchmark Administration, which administers LIBOR, and the FCA announced that all LIBOR settings will either cease to be provided by any administrator, or no longer be representative immediately after December 31, 2021, for all non-U.S. dollar LIBOR settings and one-week and two-month U.S. dollar LIBOR settings, and immediately after June 30, 2023 for the remaining U.S. dollar LIBOR settings. We have multiple debt facilities which utilizes a variable rate equal to Eurodollar LIBOR rate as a component of our interest rate. This transition away from LIBOR as a common reference rate in the global financial market could have a material, adverse effect on our business. Management continues to monitor the status and discussions regarding LIBOR.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR INTELLECTUAL PROPERTY</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our intellectual property rights may not provide meaningful commercial protection for our products, potentially enabling third parties to use our technology or very similar technology and could reduce our ability to compete in the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To compete effectively, we depend, in part, on our ability to maintain the proprietary nature of our technologies and manufacturing processes, which includes the ability to obtain, protect and enforce patents on our technology and to protect our trade secrets. We own or have licensed patents that cover aspects of some of our product lines. Our patents, however, may not provide us with any significant competitive advantage. Others may challenge our patents and, as a result, our patents could be narrowed, invalidated or rendered unenforceable. Competitors may develop products similar to ours that our patents do not cover. In addition, the approval or rejection of patent applications may take several years and our current and future patent applications may not result in the issuance of patents in the U.S. or foreign countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our competitive position depends, in part, upon unpatented trade secrets, which we may be unable to protect.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitive position also depends upon unpatented trade secrets, which are difficult to protect. We cannot assure that others will not independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets, that our trade secrets will not be disclosed or that we can effectively protect our rights to unpatented trade secrets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an effort to protect our trade secrets, we require our employees, consultants and advisors to execute confidentiality and invention assignment agreements upon commencement of employment or consulting relationships with us. These agreements provide that, except in specified circumstances, all confidential information developed or made known to the individual during the course of their relationships with us must be kept confidential. We cannot assure, however, that these agreements will provide meaningful protection for our trade secrets or other proprietary information in the event of the unauthorized use or disclosure of confidential information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success will depend partly on our ability to operate without infringing or misappropriating the proprietary rights of others.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be sued for infringing the intellectual property rights of others. In addition, we may find it necessary, if threatened, to initiate a lawsuit seeking a declaration from a court that we do not infringe the proprietary rights of others or that their rights are invalid or unenforceable. If we do not prevail in any litigation, in addition to any damages we might have to pay, we would be required to stop the infringing activity (which could include a cessation of selling the products in question) or obtain a license for the proprietary rights involved. Any required license may be unavailable to us on acceptable terms, if at all. In addition, some licenses may be nonexclusive and allow our competitors to access the same technology we license.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to obtain a required license or are unable to design our products so as not to infringe on the proprietary rights of others, we may be unable to sell some of our products, and this potential inability could have a material, adverse effect on our revenues and profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be involved in lawsuits relating to our intellectual property rights and promotional practices, which may be expensive.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect or enforce our intellectual property rights, we may have to initiate or defend legal proceedings, such as infringement suits or opposition proceedings, against or by third parties. In addition, we may have to institute proceedings regarding our competitors&#8217; promotional practices or defend proceedings regarding our promotional practices. Legal proceedings are costly, and, even if we prevail, the cost of the legal proceedings could affect our profitability. In addition, litigation is time-consuming and could divert management's attention and resources away from our business. Moreover, in response to our claims against other parties, those parties could assert counterclaims against us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO GLOBAL OPERATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If any of our facilities or those of our suppliers were damaged and/or our manufacturing or business processes interrupted, we could experience lost revenues and our business could be seriously harmed.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Damage to our manufacturing, distribution, development and/or research facilities because of fire, extreme weather conditions, natural disaster, power loss, communications failure, geopolitical disruption, unauthorized entry or other events, such as a flu or other health epidemic, such as COVID-19, could significantly disrupt our operations, the operations of suppliers and critical infrastructure and delay or prevent product manufacture and shipment during the time required to repair, rebuild or replace the damaged facilities. Certain of our manufacturing facilities are located in Puerto Rico, which in the past has experienced both severe earthquakes and other natural disasters.Climate change may increase both the frequency and severity of extreme weather conditions and natural disasters and, consequently, risks to our operations and growth. Although we maintain property damage and business interruption insurance coverage on these facilities, our insurance might not cover all losses under such circumstances, and we may not be able to renew or obtain such insurance in the future on acceptable terms with adequate coverage or at reasonable costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to a variety of risks relating to our international sales and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate significant revenues outside the U.S. in multiple foreign currencies, and in U.S. dollar-denominated transactions conducted with customers who generate revenue in currencies other than the U.S. dollar. For those foreign customers who purchase our products in U.S. dollars, currency fluctuations between the U.S. dollar and the currencies in which those customers do business may have a negative impact on the demand for our products in foreign countries where the U.S. dollar has increased in value compared to the local currency.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we have operations based outside the U.S. and we generate revenues and incur operating expenses in multiple foreign currencies, we experience currency exchange risk with respect to those foreign currency-denominated revenues and expenses. Our most significant currency exchange risk relates to transactions conducted in Australian dollars, British pounds, Canadian dollars, Chinese yuan, euros, Japanese yen, and Swiss francs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the consolidated effects of exchange rate fluctuations upon our future operating results because of the number of currencies involved, the variability of currency exposure and the potential volatility of currency exchange rates. Although we address currency risk management through regular operating and financing activities, and, on a limited basis, through the use of derivative financial instruments, those actions may not prove to be fully effective. For a description of our use of derivative financial instruments, see Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations subject us to laws regarding sanctioned countries, entities and persons, customs, import-export, laws regarding transactions in foreign countries, the U.S. Foreign Corrupt Practices Act and local anti-bribery and other laws regarding interactions with healthcare professionals, and product registration requirements. Among other things, these laws restrict, and in some cases prevent, U.S. companies from directly or indirectly selling goods, technology or services to people or entities in certain countries. In addition, these laws require that we exercise care in structuring our sales and marketing practices and effecting product registrations in foreign countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom&#8217;s (&#8220;UK&#8221;) exit from the European Union on January 31, 2020, commonly referred to as Brexit, has caused, and may continue to cause uncertainty in the global political markets. It is possible that Brexit could, among other things, affect the legal and regulatory environments to which our business is subject, impose greater restrictions on imports and exports between the UK and the EU and other parties, and create economic and political uncertainty in the region.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, proposals are made to significantly change existing trade agreements and relationships between the U.S. and other countries. Owing to the complex relationships between the U.S. and such other countries, political, diplomatic, military, or other events could result in business disruptions, including increased regulatory enforcement against companies, tariffs, trade embargoes, and export restrictions. The imposition of such restrictions could increase the cost of the Company&#8217;s products and the components and raw materials that go into making them, require the Company to change its operations and the products it offers and negatively impact consumer confidence and spending, all of which, both individually and in the aggregate, could materially and adversely affect our operations and financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL RISK FACTORS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cyber-attacks or other disruptions to our information technology systems could adversely affect our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are increasingly dependent on sophisticated information technology for our infrastructure and to support business decisions. Our information systems require an ongoing commitment of significant resources to maintain, protect, and enhance existing systems and develop new systems to keep pace with continuing changes in information processing technology, evolving systems and regulatory standards, the increasing need to protect patient and customer information, and changing customer patterns. An experienced third party maintains the enterprise business system used to support our transaction processing, accounting and financial reporting, and supply chain and manufacturing processes. Any significant breakdown, intrusion, interruption, corruption, or destruction of these systems, as well as any data breaches, could have a material, adverse effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may attempt to breach our systems and may obtain data relating to patients, proprietary or sensitive information. As a result of the COVID-19 pandemic, we may face increased cybersecurity risks due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities. If we, or third parties on whom we rely, fail to maintain or protect our information systems and data integrity effectively, we could lose existing customers, have difficulty attracting new customers, suffer backlash from negative public relations, have regulatory sanctions or penalties imposed, have increases in operating expenses, incur expenses or lose revenues as a result of a data privacy breach, or suffer other adverse consequences.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have programs, processes (including ongoing improvements) and technologies in place to prevent, detect, contain, respond to and mitigate security related threats and potential incidents. Because the techniques used to obtain unauthorized access or interrupt services change frequently and can be difficult to detect, anticipating, identifying or preventing these threats or mitigating them if and when they occur, may be challenging. We are also dependent on third party vendors to supply and/or support certain aspects of our information technology systems which may contain defects in design or manufacture or other problems that could result in system disruption or unexpectedly compromise the information security of our own systems. In addition, as we grow in part through new acquisitions we may face risks due to implementation, modification, or remediation of controls, procedures, and policies relating to data privacy and cybersecurity at the acquired business. We continue to consolidate and integrate the number of systems we operate, and to upgrade and expand our information system capabilities for stable and secure business operations.</span></div><div id="i172bf506156f43e6869412a665f54418_22"></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">PROPERTIES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we lease approximately 166,991 square feet of space in Princeton, NJ, where we house our principal headquarters, sales operations, and support functions. This lease expires in 2035.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have key manufacturing and research facilities located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, Canada, China, France, Germany, Ireland and Switzerland. Our instrument procurement operations are located in Germany. Our primary distribution centers are located in Nevada, Ohio, Kentucky, Australia, Belgium, Canada, Japan and France. In addition, we lease several smaller facilities to support additional administrative, assembly, and distribution operations. Third parties own and operate the facilities in Nevada, Kentucky, Japan and Belgium. We own facilities in Biot, France, Saint Aubin Le Monial, France, Rietheim-Weilheim, Germany and Ohio and we lease all of our other facilities. We also have repair centers in Ohio, Australia, France, Japan, China and Germany, and field service presence in Canada, Dubai, India, Italy, Netherlands, Singapore, Thailand and United Kingdom. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing facilities are registered with the FDA. Our facilities are subject to FDA inspection to ensure compliance with Quality System regulations. For further information regarding the status of FDA inspections, see the "Government Regulation" and "Management's Discussion and Analysis of Financial Condition and Results of Operations - Update on Remediation Activities" sections in this Form 10-K.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_25"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">LEGAL PROCEEDINGS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to legal proceedings can be found in Note 15. Commitment and Contingencies of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K).</span></div><div id="i172bf506156f43e6869412a665f54418_28"></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">MINE SAFETY DISCLOSURES</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i172bf506156f43e6869412a665f54418_31"></div><div><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_34"></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information, Holders and Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock trades on The NASDAQ Global Select Market under the symbol &#8220;IART.&#8221; The number of stockholders of record as of February&#160;22, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was approximate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ly 777,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which includes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stockholders whose shares were held in nominee name. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales of Unregistered Securities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no sales of unregistered securities during the years ended December&#160;31, 2021, 2020 or 2019. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Registered Securities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no sales of registered securities during the years ended December&#160;31, 2021, 2020 or 2019. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2020, the Board of Directors authorized the Company to repurchase up to $225 million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2022. This stock repurchase authorization replaces the previous $225 million stock repurchase authorization, of which $125 million remained authorized at the time of its replacement, and which was otherwise set to expire on December 31, 2020. Purchases may be affected through one or more open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or a combination of the foregoing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2021, there were no repurchases of the Company&#8217;s common stock as part of the share repurchase authorization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, the Company entered into a $125.0&#160;million accelerated share repurchase ("2022 ASR") and received 1.5&#160;million shares of Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. The remaining 20% of the expected total shares is expected to settle in the first half of 2022, upon which additional shares of common stock may be delivered to the Company or, under certain circumstances, the Company may be required to make a cash payment or may elect to deliver shares of our common stock to the 2022 ASR counterparty in each case pursuant to the terms of the 2022 ASR agreement between the Company and the 2022 ASR counter party. The total number of shares to be delivered or the amount of such payment, as well as the final average price per share, will be based on the volume-weighted average price, less a discount, of the Company's common stock during the term of the transaction. As a result of this transaction, $100.0 million remains available under the $225.0 million stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> repurchase authorization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December 31, 2020, the Company repurchased 2.1&#160;million shares of Integra&#8217;s common stock as part of the previous share repurchase authorization. The Company utilized $100.0&#160;million of net proceeds from the offering of convertible notes to execute the share repurchase transactions. This included $7.6&#160;million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a $92.4&#160;million accelerated share repurchase ("2020 ASR") to complete the remaining $100.0&#160;million of share repurchase. The Company received 1.3&#160;million shares at inception of the 2020 ASR, which represented approximately 80% of the expected total shares. Upon settlement of the 2020 ASR in June 2020, the Company received an additional 0.6&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the transaction. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for further details. </span></div><div id="i172bf506156f43e6869412a665f54418_37"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">[Reserved]</span></td></tr></table></div><div id="i172bf506156f43e6869412a665f54418_40"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM&#160;7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis provides information management believes to be relevant to understanding our financial condition and results of operations. For a full understanding of financial condition and results of operations, it should be read together with the selected consolidated financial data and our financial statements with the related notes appearing elsewhere in this report. The discussion focuses on our financial results for the year ended December 31, 2021 and 2020. The comparison of fiscal 2020 to 2019 has been omitted from this Form 10-K, but can be referenced in our Form 10-K for the fiscal year ended December 31, 2020&#8212;&#8220;Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; filed on February 23, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made statements in this report which constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;). These forward-looking statements are subject to a number of risks, uncertainties and assumptions about the Company and other matters. These forward-looking statements include, but are not limited to, statements related to the Company's expectations regarding the potential impacts of the COVID-19 pandemic on our business, financial condition, and results of operations. These statements should, therefore, be considered in light of various important factors, including, but not limited to, the following: the risk that the COVID-19 pandemic could lead to further material delays and cancellations of, or reduced demand for, procedures; delayed capital spending by the Company's customers; disruption and/or higher costs to the Company&#8217;s supply chain; staffing shortages in hospitals; labor impacts in our facilities; delays in gathering clinical evidence; diversion of management and other resources to respond to the COVID-19 outbreak; the impact of global and regional economic and credit market conditions on healthcare spending; the risk that the COVID-19 virus disrupts local economies and causes economies in our key markets to enter prolonged recessions. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those set forth under the heading &#8220;Risk Factors.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra, headquartered in Princeton, New Jersey, is a world leader in medical technology. The Company was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through a combination of several global acquisitions and product development to meet the needs of its customers and impact patient care. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra manufactures and sells medical technologies and products in two reportable business segments: Codman Specialty Surgical ("CSS") and Tissue Technologies ("TT"). The CSS segment, which represents two-thirds of our total revenue, consists of market-leading technologies and instrumentation used for a wide range of specialties, such as neurosurgery, neurocritical care and otolaryngology. We are the world leader in neurosurgery and one of the top three providers in instruments used in precision, specialty, and general surgical procedures. Our TT segment generates about one-third of our overall revenue and focuses on three main areas: complex wound surgery, surgical reconstruction, and peripheral nerve repair.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have key manufacturing and research facilities located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, Canada, China, France, Germany, Ireland and Switzerland. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also source most of our handheld surgical instruments and dural sealant products through specialized third-party vendors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra is committed to delivering high quality products that positively impact the lives of millions of patients and their families. We focus on four key pillars of our strategy: 1) enabling an execution-focused culture, 2) optimizing relevant scale, 3) advancing innovation and agility, and 4) leading in customer experience. We believe that by sharpening our focus on these areas through improved planning and communication, optimization of our infrastructure, and strategically aligned tuck-in acquisitions, we can build scale, increase competitiveness and achieve our long-term goals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To this end, the executive leadership team has established the following key priorities aligned to the following areas of focus:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An important part of the Company's strategy is pursuing strategic transactions and licensing agreements that increase relevant scale in the clinical areas in which Integra competes. During 2021, the Company acquired ACell Inc. ("ACell"), an innovative regenerative medicine company specializing in the manufacturing of porcine urinary bladder extracellular matrices. This acquisition not only expanded the Company&#8217;s product offering of regenerative technologies, but it also supported the Company&#8217;s long-term growth and profitability strategy as this product line has a financial profile similar to Integra&#8217;s other regenerative tissue products. All critical components of ACell have been integrated into the Company&#8217;s TT segment. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for additional details. In 2021, we continued to advance the development of pioneering neurosurgical technologies from our 2019 acquisitions, Arkis Biosciences, Inc. and Rebound Therapeutics Corporation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Portfolio Optimization and New Product Introductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are investing in innovative product development to drive a multi-generational pipeline for our key product franchises. Our product development efforts span across our key global franchises focused on potential for significant returns on investment. In addition to new product development, we are funding studies to gather clinical evidence to support launches, ensure market access and improve reimbursement for existing products. In addition to acquisitions and organic reinvestment, we continually look to optimize our portfolio towards higher growth and higher margin businesses. As such, we may opportunistically divest businesses or discontinue products where we see limited runway for future value creation in line with our aspirations due in part to changes in the market, business fundamentals or the regulatory environment.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, we completed the sale of our Extremity Orthopedics business to Smith &amp; Nephew USD Limited ("Smith &amp; Nephew"), a subsidiary of Smith &amp; Nephew plc, for approximately&#8239;$240&#8239;million in cash. This transaction enables us to increase our investments in our core neurosurgery and tissue technologies businesses and fund pipeline opportunities to expand our addressable markets to strengthen our existing leadership positions in these segments and drive future growth. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Channel Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Investing in our sales channels is a core part of our strategy to create specialization and greater focus on reaching new and existing customers and addressing their needs. To support our commercial efforts in Tissue Technologies, we expanded our two-tier specialist model to increase our presence in focused segments by creating a virtual selling organization to help serve the evolving needs of our customers. In addition, we continue to build upon our leadership brands across our product franchises in both CSS and TT to engage customers through enterprise-wide contracts with leading hospitals, integrated delivery networks and global purchasing organizations in the United States. Internationally, we have increased our commercial resources significantly in key emerging markets and are making investments to support our sales organization and maximize our commercial opportunities. These investments in our international sales channel position us well for expansion and long-term growth. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We aspire to be ranked as a best-in-class provider and are committed to strengthen our relationships with all customers. We continue to invest in technologies, systems and processes to enhance the customer experience. Additionally, we launched digital tools and programs, resources and virtual product training to drive continued customer familiarity with our growing portfolio of medical technologies globally.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical and Product Development Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to invest in collecting clinical evidence to support the Company's existing products and new product launches, and to ensure that we obtain market access for broader and more cost-effective solutions. In each area, we continue to benefit from products launched over the past several years, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including our new electrosurgery generator and irrigator system, an innovative customer-centric toolkit for our Certas Plus Programmable Valve along with additional shunt configurations. In Japan, we are experiencing strong growth as a result of the successful launch of DuraGen in mid-2019, which is the first and only collagen xenograft approved for use as a dural substitute in the country. We are focused on the development of core clinical applications in our electromechanical technologies portfolio. Also, we continue to update our CUSA Clarity platform by incorporating new ultrasonic handpiece, surgical tips and integrated electrosurgical capabilities. We continue to work with several instrument partners to bring new surgical instrument platforms to the market. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the third quarter of 2021, our CereLink ICP Monitor System was launched in the U.S. and Europe. CereLink provides enhanced accuracy, usability and advanced data presentation that provides clinicians with uncompromised, advanced continuous ICP monitoring that until now, has not been available when treating patients with traumatic brain injuries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continued to advance the early-stage technology platforms we acquired in 2019. Through the acquisition of Arkis Biosciences, we added a platform technology, CerebroFlo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> external ventricular drainage ("EVD"), catheter with Endexo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. The CerebroFlo EVD Catheter has demonstrated an average of 99% less thrombus accumulation onto its surface, in vitro, compared to a market leading EVD catheter. In 2019, we also acquired Rebound Therapeutics, a Company that specialized in a single-use medical device, known as Aurora Surgiscope, which is the only tubular retractor system designed for cranial surgery with an integrated access channel, camera and lighting. In the third quarter of 2021, we conducted a limited clinical launch of the Aurora Surgiscope for use in minimally invasive neurosurgery as well as initiated a registry called MIRROR to collect data on early surgical intervention using this same technology platform for the treatment of ICH.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our TT segment, during 2020, we announced positive clinical and economic data on Integra</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Bilayer Wound Matrix ("IBWM") in complex lower extremity reconstruction based on two retrospective studies recently published in Plastic and Reconstructive Surgery, the official journal of the American Society of Plastic Surgeons. As surgeons look for ways to efficiently and effectively repair and close wounds, IBWM helps address the efficiency needed in operating rooms by reducing both the operating time and costs to hospitals and patients. In 2021, we completed one of the largest diabetic foot ulcers ("DFU"), randomized controlled trials of the PriMatrix</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dermal Repair Scaffold for the management of DFU. This multi-center study enrolled more than 225 patients with chronic DFU's over the course of 12-week treatments and 4-week follow-up phases. The results of this study, which was published in the Journal of Wound Care, demonstrated that PriMatrix plus standard of care ("SOC") consisting of sharp debridement, infection elimination, use of dressings and offloading was significantly more likely to achieve complete wound closure compared with SOC alone, with a median number of one application of the product. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">COVID-19 Pandemic</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During this global crisis, the Company's focus remained on supporting patients, providing customers with life-saving products, and protecting the well-being of our employees. The global COVID-19 pandemic, together with the preventative and precautionary measures taken by businesses, communities and governments, has resulted in an unprecedented challenge to the global healthcare industry. In response to the pandemic, we acted swiftly by implementing protocols to ensure continuity of our manufacturing and distribution sites around the world and to provide for the safety of our employees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to have widespread and unpredictable impacts and the Company has continued to manage the risks in this uncertain environment. We remain confident that the underlying markets in which the Company competes remain attractive. We also remain focused on managing the business for the long-term. The Company's adaptability and resiliency in the face of this unprecedented crisis is made possible in part by prior investments in technology infrastructure and operations, as well as our talented and committed global workforce.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital markets and worldwide economies have also been significantly impacted by the COVID-19 pandemic, and it is possible that it could cause a local and/or global economic recession.&#160;Any such&#160;economic recession could have a material adverse effect on the Company's long-term business as hospitals curtail and reduce capital as well as&#160;overall spending. The COVID-19 pandemic and local actions, such as &#8220;shelter-in-place&#8221; orders and restrictions on&#160;travel and access to our customers or temporary closures of our facilities or the facilities of our suppliers and their contract manufacturers, disruption and/or higher costs to the Company&#8217;s supply chain, staffing shortages in hospitals and labor constraints in our facilities, could further impact our sales and our ability to ship our products and supply our customers. Any of these events could negatively impact the number of surgical and medical intervention procedures performed and have a material adverse effect on our business, financial condition, results of operations, or cash flows.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FDA Matters</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture and distribute products derived from human tissue for which FDA has specific regulations governing human cells, tissues and cellular and tissue-based products ("HCT/Ps"). An HCT/P is a product containing or consisting of human cells or tissue intended for transplantation into a human patient. Refer to Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details around these FDA regulations and their potential effect on the Company's portfolio of morselized amniotic material-based products as well as the impact on consolidated revenues.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 7, 2019, TEI Biosciences, Inc. ("TEI") a wholly-owned subsidiary of the Company received a Warning Letter (the &#8220;Warning Letter&#8221;), dated March 6, 2019, from the FDA. The warning letter related to quality systems issues at TEI's manufacturing facility located in Boston, Massachusetts. The letter resulted from an inspection held at that facility in October and November 2018 and did not identify any new observations that were not already provided in the Form 483 that followed the inspection. The Company submitted its initial response to the FDA Warning Letter on March 28, 2019 and provides regular progress reports to the FDA as to its corrective actions and, since the conclusion of the inspection, has undertaken significant efforts to remediate the observations and continues to do so. On October 28, 2021 FDA initiated an inspection of the facility and at the conclusion of the inspection issued a Form 483 on November 12, 2021 (the "2021 Form 483"). The Company provided an initial response to the inspectional observations and will continue to provide responses to FDA. The Warning Letter and the 2021 Form 483 do not restrict the Company&#8217;s ability to manufacture or ship products or require the recall of any products, nor do they restrict our ability to seek FDA 510(k) clearance of products. The Warning Letter states that requests for Certificates to Foreign Governments would not be granted. However, due to our monthly progress reports, the FDA agreed to issue Certificates to Foreign Governments for the products manufactured at TEI due to substantial progress and the length of time it takes to resolve the Warning Letter. Additionally, premarket approval applications for Class III devices to which the Quality System regulation violations are reasonably related will not be approved until the violations have been corrected. The TEI Boston facility manufactures extracellular bovine matrix products. We cannot give any assurances that the FDA will be satisfied with our response to the Warning Letter or as to the expected date of the resolution of the matters included in the letter. Until the issues cited in the letter are resolved to the FDA&#8217;s satisfaction, the FDA may initiate additional regulatory action without further notice. Any adverse regulatory action, depending on its magnitude, may restrict us from effectively manufacturing, marketing and selling our products and could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues of products manufactured in the TEI Boston facility for the year ended December&#160;31, 2021 were approximately 4.7% of consolidated revenues.</span></div><div id="i172bf506156f43e6869412a665f54418_46"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACQUISITIONS &amp; DIVESTITURES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business to Smith &amp; Nephew. The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. The Company received an aggregate purchase price of $240.0 million from Smith &amp; Nephew and concurrently paid $41.5 million to the Consortium of Focused Orthopedists, LLC ("CFO"), effectively terminating the licensing agreement between Integra and CFO relating to the development of shoulder arthroplasty products. The Company recognized a gain of $41.8 million in connection with the sale that is presented in "Gain from the sale of business" in the consolidated statement of operations for the year ended December, 31, 2021. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ou</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r growth strategy includes the acquisition of businesses, assets or products lines to increase the breadth of our offerings and the reach of our product portfolios and drive relevant scale to our customers. As a result of several acquisitions from 2019 through 2021, our financial results for the year ended December&#160;31, 2021 may not be directly comparable to those of the corresponding prior-year perio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ds. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for a further discussion.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ACell Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, the Company acquired ACell, Inc. for an acquisition purchase price of $306.9 million plus contingent consideration obligations of up to $100 million, that may be payable upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. ACell was a privately-held company that offered a portfolio of regenerative products for complex wound management, including developing and commercializing products based on MatriStem Urinary Bladder Matrix ("UBM"), a technology platform derived from porcine urinary bladder extracellular matrix. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Arkis BioSciences Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of $30.6 million (the "Arkis Acquisition") plus contingent consideration of up to $25.5 million, that may be payable based on the successful completion of certain development and commercial milestones. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The Company estimated fair value of the contingent consideration as of December&#160;31, 2021 to be $15.1 million. The Company recorded $3.7 million in accrued expenses and other current liabilities and $11.4 million in other liabilities at December&#160;31, 2021 in the consolidated balance sheets of the Company. Arkis was a privately-held company that marketed the CerebroFlo external ventricular drainage ("EVD") catheter with Endexo technology, a permanent additive designed to reduce the potential for catheter obstruction due to clotting. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Rebound Therapeutics Corporation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (&#8220;Rebound&#8221;), developers of a single-use medical device known as the Aurora which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the &#8220;Rebound transaction&#8221;). Under the terms of the Rebound transaction, the Company made an upfront payment of $67.1 million and committed to pay up to $35.0 million of contingent development milestones upon achievement of certain regulatory milestones. The acquisition of Rebound was primarily concentrated in one single identifiable asset and thus, for accounting purposes, the Company concluded that the acquired assets did not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a $59.9 million in-process research and development ("IPR&amp;D") expense. The balance of approximately $7.2 million, which included $2.1 million of cash and cash equivalents and a net deferred tax asset of $4.2 million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carryforward. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details.</span></div><div id="i172bf506156f43e6869412a665f54418_49"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTIMIZATION AND INTEGRATION ACTIVITIES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our ongoing acquisition strategy and significant growth in recent years, we have undertaken cost-saving initiatives to consolidate manufacturing operations, distribution facilities and transfer activities, implement a common ERP system, eliminate duplicative positions, realign various sales and marketing activities, and expand and upgrade production capacity for our regenerative technology products. These efforts are expected to continue and while we expect a positive impact from ongoing restructuring, integration, and manufacturing transfer and expansion activities, such results remain uncertain. </span></div><div id="i172bf506156f43e6869412a665f54418_52"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income for the year ended December&#160;31, 2021 was $169.1 million, or $1.98 per diluted share, compared to $133.9 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or $1.57 per diluted share for the year ended December&#160;31, 2020. The increase in net income for the year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was primarily driven by higher revenues across most franchises driven by continued recovery in surgical procedure volumes from prior year COVID-19 pandemic levels. This was partially offset by higher operating expenses as costs continued to normalize after 2020 cost reduction actions. Within non-operating income and expense, the Company benefited from lower interest expense, higher other income and a gain of $41.8 million as a result of the sale of its Extremity Orthopedics business to Smith &amp; Nephew. The Company also had a net tax benefit in 2020 due to the impact of the intra-entity transfer of certain intellectual property which resulted in the recognition of a deferred tax benefit in the amount of $59.2 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Charges </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before taxes includes the following special charges:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, divestiture and integration-related charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,712)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural optimization charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU medical device regulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued product lines charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses related to debt refinancing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 pandemic related charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt non-cash interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,425&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,048&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The Company completed its sale of its Extremity Orthopedics business and recognized a gain of $41.8 million for the year ended December 31, 2021 which was partially offset by other acquisition, divestiture and integration-related charges. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Charges relate to business interruptions and costs associated with the COVID-19 pandemic which impacted the Company's operations globally, partially offset by Coronavirus government relief programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The items reported above</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are reflected in the consolidated statements of operations as follows:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,557&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from the sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,611)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,425&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,048&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Upon adoption of ASU No. 2020-06, the Company will no longer incur non-cash interest expense for the amortization of debt discount. See Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ba</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">sis of Presentation of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K), for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically define special charges as items for which the amounts and/or timing of such expenses may vary significantly from period to period, depending upon our acquisition, divestiture, integration and restructuring activities, and for which the amounts are non-cash in nature, or for which the amounts are not expected to recur at the same magnitude. We believe that given our ongoing strategy of seeking acquisitions, our continuing focus on rationalizing our existing manufacturing and distribution infrastructure and our continuing review of various product lines in relation to our current business strategy, some of the special charges discussed above could recur with similar materiality in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the separate identification of these special charges provides important supplemental information to investors regarding financial and business trends relating to our financial condition and results of operations. Investors may find this information useful in assessing comparability of our operating performance from period to period, against the business model objectives that management has established, and against other companies in our industry. We provide this information to investors so that they can analyze our operating results in the same way that management does and to use this information in their assessment of our core business and valuation of Integra. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues and Gross Margin </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues and gross margin on product revenues were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tissue Technologies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin on total revenues </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,640&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin as a percentage of total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2021, total revenues increased by $170.6 million, or 12.4%, to $1,542.4 million from $1,371.9 million during the prior year. Domestic revenues increased by $117.6 million, or 12.1%, to $1,089.5 million and were 70.6% of total revenues for the year ended December&#160;31, 2021. International revenues increased by $53.0 million or 13.3% to $452.9 million, compared to $399.9 million during 2020. The increase in revenues was primarily driven by recovery experienced from the COVID-19 pandemic across most franchises compared to the prior year. Foreign exchange fluctuations had a favorable impact of $9.8 million on revenues for the year.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the CSS segment, revenues were $1,025.2 million which was an increase of $130.4 million, or 14.6% as compared to the prior-year period as a result of the continued recovery experienced from the COVID-19 pandemic, and the launch of our new CereLink</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:112%;position:relative;top:-4.2pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> ICP monitoring system in the third quarter in U.S. and European markets. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company saw growth within our Neurosurgery portfolio increasing low double digits primarily due to sales in neuromonitoring, advanced energy and dural access and repair. Sales in our instruments portfolio increased low double digits as compared to the same period in the prior year driven by order recovery.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the TT segment, revenues were $517.2 million, which was an increase of $40.2 million, or 8.4% as compared to the prior-year period. Within TT, our Extremity Orthopedics business was divested on January 4, 2021 and the acquisition of ACell was completed on January 20, 2021. Sales in our Wound Reconstruction business, excluding the impact of the divestiture and acquisition, increased low double digits. Sales in our Private Label business increased low double digits as a result of continued recovery experienced from the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we look forward to 2022 and beyond, we continue to closely monitor local, regional, and global COVID-19 surges as well as recent variants of the virus for an impact on procedures. The reallocation of hospital resources to treat COVID-19 and staffing shortages may continue to cause a financial strain on healthcare systems and reduce procedural volumes. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Margin</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $944.6 million for the year ended December&#160;31, 2021, an increase of $93.6 million from $851.0 million for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the same period last year. Gross margin as a percentage of revenues was 61.2% in 2021 and 62.0% in 2020. The decrease in gross margin percentage was due to increased amortization associated with technology-based intangible assets and inventory step-up amortization in connection with the acquisition of ACell.</span></div><div id="i172bf506156f43e6869412a665f54418_55"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of operating expenses as a percent of total revenues:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses, which consist of research and development, selling, general and administrative, and intangible asset amortization expenses, increased by $47.7 million or 6.8% to $747.4 million in 2021, compared to $699.7 million in the prior year. The increase in operating expenses compared to the prior year reflects costs associated with higher employee related costs, increased research and development as well as increased outside spending as revenue recovered. We also benefited from reduced operating expenses from the sale of the Extremity Orthopedics business and cost synergies as a result of the acquisition of ACell.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to manage and prioritize its operating costs to increase organic investments that will drive long-term growth including the support of new product development and introductions, clinical studies, geographic expansion and targeted U.S. sales channel expansion. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development expenses for the year ended December&#160;31, 2021 increased by $15.7 million as compared to the prior year. This increase in spending resulted from additional spending on new product development, clinical studies and spending related to European Union Medical Device Regulation compliance activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the year ended December&#160;31, 2021 increased by $42.9 million as compared to the prior year driven primarily due to higher employee related costs, higher incentive and stock-based compensation, as well as increased outside spending as revenue recovered.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Asset Amortization</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense (excluding amounts reported in cost of product revenues for technology-based intangible assets) in 2021 was $16.9 million compared to $27.8 million in 2020 primarily due to a reduction in amortization expense associated with intangible assets sold in conjunction with the sale of the Extremity Orthopedics business during the current year as well as accelerated amortization expense associated with an intangible asset which was recorded in the prior year.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may discontinue certain products in the future as we continue to assess the profitability of our product lines. As our profitability assessment evolves, we may make further decisions about our trade names and incur additional impairment charges or accelerated amortization. We expect total annual amortization expense to be approximately $79.1 million in 2022, $78.4 million in 2023, $77.7 million in 2024, $77.7 million in 2025, $77.6 million in 2026 and $585.8 million thereafter. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Operating Income and Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of non-operating income and expenses:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,395)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,581)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating income and expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,850)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income for the year ended December&#160;31, 2021 decreased by $2.6 million as compared to the same period last year primarily due to the settlement of cross-currency swaps designated as net investment hedges during Q4 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the year ended December&#160;31, 2021 decreased by $21.2 million as compared to the same period last year primarily due to the elimination of the non-cash interest expense as the result of the adoption ASU 2020-06 and the expenses associated with Amended and Restated Senior Credit Agreement which occurred in the prior period. See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details in relation to the adoption of ASU 2020-06.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain from the sale of business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business and recognized a gain of $41.8 million in the first quarter of the current year.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net for the year ended December&#160;31, 2021 increased by $14.9 million primarily due to income associated with the transition services agreement with Smith &amp; Nephew, favorable impact of foreign exchange in the current year and higher income from additional cross currency swaps that were entered into during Q4 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective inco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">me tax rate was 21.2% and (43.2)% of income before income taxes in 2021 and 2020, respectively. See Note 13, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in our consolidated financial statements for a reconciliation of the United States federal statutory rate to our effective tax rate. Our effective tax rate could vary from year to year depending on, among other factors, tax law changes, the geographic and business mix and taxable earnings and losses. We consider these factors and others, including our history of generating taxable earnings, in assessing our ability to realize deferred tax assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain; the Company&#8217;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow mo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">del based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Company recorded a $59.2&#160;million deferred tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> benefit in Switzerland related to the amortizable tax basis in the transferred intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate could vary from year to year depending on, among other factors, tax law changes, the geographic and business mix and taxable earnings and losses. We consider these factors and others, including our history of generating taxable earnings, in assessing our ability to realize deferred tax assets. We estimate our worldwide effective income tax rate for 2022 to be approximately 18.4%.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company had $9.8&#160;million of valuation allowance against the remaining $190.7&#160;million of gross deferred tax assets recorded at December&#160;31, 2021. Our deferred tax asset valuation allowance decreased by $0.1 million in 2021 and remained substantially unchanged in 2020. This valuation allowance relates to deferred tax assets for which the Company does not believe it has satisfied the more likely than not threshold for realization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, we had net operating loss carryforwards of $71.7&#160;million for federal income tax purposes, $26.6&#160;million for foreign income tax purposes and $39.0&#160;million for state income tax purposes to offset future taxable income. The federal net operating loss carryforwards decreased during 2021 due to the use of net operating losses. Of the total federal net operating loss carryforwards, $67.5&#160;million expire through 2037 and $4.1&#160;million have an indefinite carryforward period. Regarding the foreign net operating loss carryforwards, $26.6 million have an indefinite carryforwa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rd period. The state net operating loss carryforwards expire in 2036.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested.&#160;Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;As such, the Company has determined the tax impact of repatriating these earnings would not be material as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GEOGRAPHIC PRODUCT REVENUES AND OPERATIONS</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:72.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates significant revenues outside the U.S., a portion of which are U.S. dollar-denominated transactions conducted with customers that generate revenue in currencies other than the U.S. dollar. As a result, currency fluctuations between the U.S. dollar and the currencies in which those customers do business could have an impact on the demand for the Company's products in foreign countries. Local economic conditions, regulatory compliance or political considerations, the effectiveness of our sales representatives and distributors, local competition and changes in local medical practice all may combine to affect our sales into markets outside the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic revenues increased by $117.6 million for the year ended December&#160;31, 2021 compared to the same period last year. European sales increased by $18.6 million for the year ended December&#160;31, 2021 compared to the same period last year. Sales to customers in Asia Pacific increased by $24.9 million for the year ended December&#160;31, 2021 compared to the same period last ye</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ar. The Rest of the World for the year ended December&#160;31, 2021 increased by $9.5 million compared to the same period last year. The increase in revenues globally was primarily driven by the continued recovery experienced from the COVID-19 pandemic across all franchises compared to the prior year due to rebound in surgical procedure volumes. Sales in China, Japan Canada, Europe and our indirect markets continue to drive international growth. The Company also benefited from the launch of the CereLink ICP Monitor which occurred during the second half of the 2021.</span></div><div id="i172bf506156f43e6869412a665f54418_61"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Working Capital</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and December&#160;31, 2020, working capital was $813.7&#160;million and $836.2&#160;million, respectively. Working capital consists of total current assets less total current liabilities as presented in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Marketable Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had cash and cash equivalents totaling approximately $513.4 million and $470.2 million&#160;at December&#160;31, 2021 and 2020, respectively, which are valued based on Level 1 measurements in the fair value hierarchy. At December&#160;31, 2021, our non-U.S. subsidiaries held approximately $245.2 million of cash and cash equivalents that are available for use outside the U.S. The Company asserts that it has the ability and intends to indefinitely reinvest the undistributed earnings from its foreign operations unless there is no material tax cost to remit the earnings into the U.S. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:73.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.309%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,073)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used (provided) by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate fluctuations on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Provided by Operating Activities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows for the year ended December&#160;31, 2021 increased by $108.6 million compared to the same period in 2020. Net income after removing the impact of the gain on sale of business and non-cash adjustments increased for the year ended December 31, 2021, by approximately $49.1 million as compared to the same period in 2020 primarily due to the continuing revenue recovery in the current year as compared to the height of the COVID-19 pandemic in the prior year. The changes in assets and liabilities, net of business acquisitions, increased cash flows from operating activities in the current year by $18.2 million compared to the decrease of $41.3 million for the same period in 2020. The improvement in 2021 working capital is attributable to a decrease in inventory of $5.4 million due to investments in building safety stock made in the prior year where inventory increased by $48.3 million as well as improved sales in 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows for the year ended December 31, 2020 decreased compared to the same period in 2019. Net income after non-cash adjustments increased by approximately $0.8 million to $245.1 million from $245.9 million. The changes in assets and liabilities, net of business acquisitions, decreased cash flows from operating activities by $41.3 million in the year ended December 31, 2020 compared to a decrease of $14.5 million for the same period in 2019. The decrease in 2020 is attributable to an increase in inventory to improve safety stock of select products. In addition, decreases were also driven by reduced payables offset by decreases in accounts receivable due to lower revenues and continued collection efforts.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Used in Investing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, we paid a net cash amount of $303.9 million in relation to the acquisition of ACell and received net proceeds of $190.5 million for the sale of the Extremity Orthopedics business. The Company also paid for $48.0 million capital expenditures to support operations improvement initiatives at a number of our manufacturing facilities and other information technology investments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, we paid $38.9 million for capital expenditures, most of which were directed to our facilities located in Mansfield, MA; Boston, MA; Memphis, TN; and Princeton, NJ and $25.0 million associated with achieving developmental milestones paid to the former shareholders of Rebound. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows (Used in) Provided by Financing </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uses of cash from financing activities for the year ended December&#160;31, 2021 were repayments of $125.5 million on the revolving portion of our Senior Credit Facility and Securitization Facility. In addition, the Company had $4.8 million in cash taxes paid in net equity settlements. These uses were offset by $6.8 million proceeds from the exercise of stock options and $25.5 million borrowings under our Senior Credit Facility and Securitization Facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of cash from financing activities for the year ended December&#160;31, 2020 were $515.3&#160;million in proceeds from the issuance of Convertible Senior Notes including the call and warrant transactions and $171.5&#160;million borrowing under our Senior Credit Facility and Securitization Facility. These were offset by repayments of $441.0&#160;million on the revolving portion of our Senior Credit Facility and Securitization Facility, $24.3&#160;million in debt issuance costs related to the Amended and Restated Senior Credit Agreement and the issuance of Convertible Senior Notes and $100.0&#160;million in purchases of treasury stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended and Restated Senior Credit Agreement, Convertible Senior Notes, Securitization and Related Hedging Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for a discussion of our Amended and Restated Senior Credit Agreement, the 2025 Notes and Securitization Facility and Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for discussion of our hedging activities. We are forecasting that sales and earnings for the next twelve months will be sufficient to remain in compliance with our financial covenants under the terms of the February 2020 Amendment and July 2020 Amendment to the Senior Credit Facility.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2020, the Board of Directors authorized the Company to repurchase up to $225&#160;million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2022. This stock repurchase authorization replaces the previous $225&#160;million stock repurchase authorization, of which $125&#160;million remained authorized at the time of its replacement, and which was otherwise set to expire on December&#160;31, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2021, there were no repurchases of the Company&#8217;s common stock as part of the share repurchase authorization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, the Company entered into a $125.0&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accelerated share repurchase ("2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASR") and received 1.5&#160;million shares of the Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. The remaining 20% of the expected total shares is expected to settle in the first half of 2022, upon which additional shares of common stock may be delivered to the Company or, under certain circumstances, the Company may be required to make a cash payment or may elect to deliver shares of our common stock to the 2022 ASR counterparty in each case pursuant to the terms of the 2022 ASR agreement between the Company and the 2022 ASR counterparty. The total number of shares to be delivered or the amount of such payment, as well as the final average price per share, will be based on the volume-weighted average price, less a discount, of the Company's common stock during the term of the transaction. As a result of this transaction, $100.0 million remains available under the $225.0 million stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> repurchase authorization</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December 31, 2020, the Company repurchased 2.1&#160;million shares of Integra&#8217;s common stock as part of the previous share repurchase authorization. The Company utilized $100.0&#160;million of net proceeds from the offering of convertible notes to execute the share repurchase transactions. This included $7.6&#160;million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a $92.4&#160;million accelerated share repurchase ("2020 ASR") to complete the remaining $100.0&#160;million of share repurchase. The Company received 1.3&#160;million shares at inception of the 2020 ASR, which represented approximately 80% of the expected total shares. Upon settlement of the 2020 ASR in June 2020, the Company received an additional 0.6&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the transaction. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for further details. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Dividend Policy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not paid any cash dividends on our common stock since our formation. Our Senior Credit Facility limits the amount of dividends that we may pay. Any future determinations to pay cash dividends on our common stock will be at the discretion of the Board and will depend upon our financial condition, results of operations, cash flows and other factors deemed relevant by the Board. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash and available borrowings under the Senior Credit Facility are sufficient to finance our operations and capital expenditures for the foreseeable future. Our future capital requirements will depend on many factors, including the growth of our business, the timing and introduction of new products and investments, strategic plans and acquisitions, among others. Additional sources of liquidity available to us include short term borrowings and the issuance of long term debt and equity securities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any off&#8211;balance sheet financing arrangements during the year-ended December&#160;31, 2021 that have or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to have cash requirements to support seasonal working capital needs and capital expenditures, to pay interest, to service debt, and to fund acquisitions. As part of our ongoing operations, we enter into contractual arrangements that obligate us to make future cash payments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary obligations include principal and interest payments on revolving portion and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan component of the Senior Credit Facility, Securitization Facility and Convertible Securities. See Note 5</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Debt</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also leases some of our manufacturing facilities and office buildings which have future minimum lease payments associated. See Note 11, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases and Related Party Leases</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a schedule of our future minimum lease payments. Amounts related to the Company's other obligations, including employment agreements and purchase obligations were not material. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has contingent consideration obligation related to prior and current year acquisitions and future pension contribution obligations. See Note 10, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retirement Benefit Plans </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Note 15, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The associated obligations are not fixed. The Company also has a liability for uncertain tax benefits including interest and penalties. See Note 12, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot make a reliable estimate of the period in which the uncertain tax benefits may be realized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Termination Benefits </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred restructuring costs of $3.4&#160;million and $4.9&#160;million in cost of goods sold, $0.5&#160;million and $1.2&#160;million in selling, general and administrative and $0.3&#160;million and $0.3&#160;million in research and development related to employee terminations associated with a future plant closure in the consolidated statement of operations for the years ended December 31, 2021 and 2020, respectively. Restructuring costs of $10.2&#160;million were included in a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ccrued expenses and other current liabilities </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $6.4&#160;million were included in other liabilities in the consolidated balance sheet for the year ended December&#160;31, 2021 and 2020, respectively. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for further details. </span></div><div id="i172bf506156f43e6869412a665f54418_64"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND THE USE OF ESTIMATES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of financial conditions and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to navigate the COVID-19 pandemic and recent variants of the virus, as well as the adverse impacts to global economic conditions, supply chain and our operations, there may be impact to future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#8217;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the following accounting policies, which form the basis for developing these estimates, are those that are most critical to the presentation of our consolidated financial statements and require the more difficult subjective and complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain. Because of this uncertainty, actual results could differ from these estimates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowances for Doubtful Accounts Receivable and Sales Returns and Allowances </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to us, we record an allowance against amounts due to reduce the net recognized receivable to the amount that we reasonably expect to collect. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. If the financial condition of customers or the length of time that receivables are past due were to change, we may change the recorded amount of allowances for doubtful accounts in the future through charges or reductions to selling, general and administrative expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a provision for estimated sales returns and allowances on revenues in the same period as the related revenues are recorded. We base these estimates on historical sales returns and allowances and other known factors. If actual returns or allowances differ from our estimates and the related provisions for sales returns and allowances, we may change the provision in the future through an increase or decrease in revenues. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on our consolidated financial statements and related disclosures. Our exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although we have historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost (determined by the first-in, first-out method) or net realizable value. At each balance sheet date, we evaluate ending inventories for excess quantities, obsolescence or shelf-life expiration. Our evaluation includes an analysis of historical sales levels by product, projections of future demand by product, the risk of technological or competitive obsolescence for our products, general market conditions, a review of the shelf-life expiration dates for our products, and the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which we do not have excess quantities in inventory. To the extent that we determine there are excess or obsolete quantities or quantities with a shelf life that is too near its expiration for us to reasonably expect that we can sell those products prior to their expiration, we adjust their carrying value to estimated net realizable value. If future demand or market conditions are lower than our projections, or if we are unable to rework excess or obsolete quantities into other products, we may record further adjustments to the carrying value of inventory through a charge to cost of product revenues in the period the revision is made. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, Business Combinations (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on the fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired in recorded as goodwill. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs and costs to restructure the acquired company are expensed as incurred.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issuance, or validity and litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition. Refer to Note 4, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and Divestitures</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for details. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K) for more information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Identifiable Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment test involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivatives </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture, and sell medical devices globally. Our earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. We address these risks through a risk management program that includes the use of derivative financial instruments and operate the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. Our derivative instruments do not subject our earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. We have not entered into derivative transactions for speculative purposes. From time to time, we may enter into derivatives that are not designated as hedging instruments in order to protect the Company from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative instruments, by considering the estimated amount we would receive to sell or transfer these instruments at the reporting date and by taking into account expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and our creditworthiness for liabilities. In certain instances, we may utilize a discounted cash flow model to measure fair value. Generally, we use inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability, and inputs that are derived principally from, or corroborated by, observable market data by correlation or other means.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we conduct operations on a global basis, our effective tax rate has and will depend upon the geographic distribution of our pre-tax earnings among locations with varying tax rates. Changes in the tax rates of the various jurisdictions in which we operate affect our profits. In addition, we maintain a reserve for uncertain tax benefits, changes to which could impact our effective tax rate in the period such changes are made. The effective tax rate can also be impacted by changes in valuation allowances of deferred tax assets, and tax law changes. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes may change period-to-period based on specific events, such as the settlement of income tax audits and changes in tax laws, as well as general factors, including the geographic mix of income before taxes, state and local taxes and the effects of the Company's global income tax strategies. We maintain strategic management and operational activities in overseas subsidiaries. See Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K), in our consolidated financial statements for disclosures related to foreign and domestic pretax income, foreign and domestic income tax expense (benefit) and the effect foreign taxes have on our overall effective tax rate. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. The amount of the accrual for which an exposure exists is measured by determining the amount that has a greater than 50 percent likelihood of being realized upon ultimate settlement of the position. Components of the reserve are classified as a long-term liability in the consolidated balance sheets. We record interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we have identified all reasonably identifiable exposures and that the reserve we have established for identifiable exposures is appropriate under the circumstances; however, it is possible that additional exposures exist and that exposures will be settled at amounts different from the amounts reserved. It is also possible that changes in facts and circumstances could cause us to either materially increase or reduce the carrying amount of our tax reserves. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their basis for income tax purposes, and the temporary differences created by the tax effects of capital loss, net operating loss and tax credit carryforwards. We record valuation allowances when it is more likely than not that some portion or all of the deferred tax assets will not be realized. We could recognize no benefit from our deferred tax assets or we could recognize some or all of the future benefit depending on the amount and timing of taxable income we generate in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to indefinitely reinvest substantially all of our foreign earnings in our foreign subsidiaries unless there is a tax&#8211;free manner under which to remit the earnings. The current analysis indicates that we have sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash.  One time or unusual items that may impact our ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary, and changes in tax laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested. Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. As such, the Company has determined the tax impact of repatriating these earnings would not be material as of December 31, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to claims and lawsuits in the ordinary course of our business, including claims by employees or former employees, and claims with respect to our products and involving commercial disputes. We accrue for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds, if applicable, and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. We consistently accrue legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost. Our financial statements do not reflect any material amounts related to possible unfavorable outcomes of claims and lawsuits to which we are currently a party because we currently believe that such claims and lawsuits are not expected, individually or in the aggregate, to result in a material, adverse effect on our financial condition. However, it is possible that these contingencies could materially affect our results of operations, financial position and cash flows in a particular period if we change our assessment of the likely outcome of these matters. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension Benefits </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions. If the actual results and events for the pension plans differ from current assumptions, the benefit obligation may be over or under valued. We recognize the underfunded status of the defined benefit pension plans as an asset or a liability in the balance sheet, with changes in the funded status recorded through other comprehensive income in the year in which those changes occur. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2021, the discount rate was prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected return on plan assets represents the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rate of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net plan assets of the pension plans are invested in common trusts as of December&#160;31, 2021. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts are valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit cost and the actuarial present value of projected pension benefit obligations for the year ended December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change of plus (minus) 25 basis points on expected rate of return on plan assets, with other assumptions held constant, would have an estimated $0.1 million favorable (unfavorable) impact on pension plan costs. As of December&#160;31, 2021, contributions expected to be paid to the plan in 2022 are $2.3 million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the corridor approach in the valuation of defined benefit pension benefit plans. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the authoritative guidance for stock-based compensation. This guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards is based on the grant date fair value on using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards on a ratable basis over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in the provision for income taxes in the consolidated statement of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued and Adopted Accounting Standards</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K), to the consolidated financial statements for recently adopted accounting pronouncements.</span></div><div id="i172bf506156f43e6869412a665f54418_67"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to various market risks, including changes in foreign currency exchange rates and interest rates that could adversely affect our results of operations and financial condition. To manage the volatility relating to these typical business exposures, we may enter into various derivative transactions when appropriate. We do not hold or issue derivative instruments for trading or other speculative purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange and Other Rate Risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to the risk that changes in foreign currency exchange rates could adversely affect our financial condition, results of operations and cash flows. We are primarily exposed to foreign currency exchange rate risk with respect to transactions and net assets denominated in Euros, British pounds, Swiss francs, Canadian dollars, Japanese yen, Mexican pesos, Brazilian reais, Australian dollars and Chinese yuan. We manage the foreign currency exposure centrally, on a combined basis, which allows us to net exposures and to take advantage of any natural offsets. To mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, we periodically enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. We temporarily record realized and unrealized gains and losses on these contracts that qualify as cash flow hedges in other comprehensive income, and then recognize them in other income or expense when the hedged item affects net earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we enter into foreign currency forward exchange contracts to manage currency exposures for transactions denominated in a currency other than an entity&#8217;s functional currency. As a result, the impact of foreign currency gains/losses recognized in earnings are partially offset by gains/losses on the related foreign currency forward exchange contracts in the same reporting period. Refer to Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information of the Notes to Consolidated Financial Statements (Part II, Item 8 of this Form 10-K).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain written policies and procedures governing our risk management activities. With respect to derivatives, changes in hedged items are generally expected to be completely offset by changes in the fair value of hedge instruments. Consequently, foreign currency exchange contracts would not subject us to material risk due to exchange rate movements, because gains and losses on these contracts offset gains and losses on the assets, liabilities or transactions being hedged.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations discussed herein have not been materially affected by inflation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We are exposed to the risk of interest rate fluctuations on the interest income earned on our cash and cash equivalents. A hypothetical 100 basis points movement in interest rates applicable to our cash and cash equivalents outstanding at December&#160;31, 2021 would increase interest income by approximately $5.1 million on an annual basis. No significant decrease in interest income would be expected as our cash balances are earning interest at rates of approximately one basis points. We are subject to foreign currency exchange risk with respect to cash balances maintained in foreign currencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Our interest rate risk relates primarily to U.S. dollar LIBOR-indexed borrowings. We use interest rate swap derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. These interest rate swaps fix the interest rate on a portion of our expected LIBOR-indexed floating-rate borrowings. The Company held the following interest rate swaps as of December&#160;31, 2021 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets (Liabilities)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,886)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,775,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43,957)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interest rate swaps were designated as cash flow hedges as of December&#160;31, 2021. The total notional amounts related to the Company&#8217;s interest rate swaps were $1.8&#160;billion and with $875.0&#160;million effective as of December&#160;31, 2021. Based on our outstanding borrowings at December&#160;31, 2021, a 100 basis points change in interest rates would have impacted interest expense on the unhedged p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ortion of the debt by $1.1 million on an annualized basis.</span></div><div id="i172bf506156f43e6869412a665f54418_73"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statements and the financial statement schedule specified by this Item, together with the report thereon of PricewaterhouseCoopers LLP, are presented following Item 15 of this report. </span></div><div id="i172bf506156f43e6869412a665f54418_76"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.783%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">CONTROLS AND PROCEDURES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure. Disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Management has designed our disclosure controls and procedures to provide reasonable assurance of achieving the desired control objectives. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Exchange Act Rule 13a-15(b), we have carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of December&#160;31, 2021. Based upon this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of December&#160;31, 2021 to provide such reasonable assurance. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) under the Securities Exchange Act of 1934, as amended. Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;). We recognize that because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies and procedures may deteriorate. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To evaluate the effectiveness of our internal control over financial reporting, management used the criteria described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). Based upon this evaluation, management concluded that our internal control over financial reporting was effective as of December&#160;31, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2021 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears herein.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended December&#160;31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div id="i172bf506156f43e6869412a665f54418_82"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">OTHER INFORMATION</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_2033"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i172bf506156f43e6869412a665f54418_85"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCORPORATION BY REFERENCE </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information called for by Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities relating to equity compensation plans, Item 10. Directors, Executive Officers and Corporate Governance, Item 11. Executive Compensation, Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters, Item 13. Certain Relationships and Related Transactions, and Director Independence and Item 14. Principal Accountant Fees and Services is incorporated herein by reference to the Company&#8217;s definitive proxy statement for its Annual Meeting of Stockholders sche</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">duled to be held on May&#160;13, 2022, w</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hich definitive proxy statement is expected to be filed with the Commission not later than 120 days after the end of the fiscal year to which this report relates. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_91"></div><div><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_94"></div><div><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_97"></div><div><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_100"></div><div><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_103"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV </span></div><div id="i172bf506156f43e6869412a665f54418_106"></div><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">EXHIBITS AND FINANCIAL STATEMENT SCHEDULE</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    (a) Documents filed as a part of this report: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    The following financial statements and financial statement schedules are filed as a part of this report: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:92.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_118">Report of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP, Florham Park, New Jersey, PCAOB ID# </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMDYvZnJhZzo4YzEzZWI1NGE4Njc0MWI5OWZkZjY4N2U3MDQyZDQxMS90YWJsZTo5YzRhN2Y1ZGE1MTg0YjY0YTE0OTc4YTNjNWJlMzc4MS90YWJsZXJhbmdlOjljNGE3ZjVkYTUxODRiNjRhMTQ5NzhhM2M1YmUzNzgxXzAtMC0xLTEtNzYwMTIvdGV4dHJlZ2lvbjo4OGJkNGQzNzFmZWE0NTg3OWNkMjEyYWEzMDdkYmU3Ml8yMTk5MDIzMjU2MDA4_29d9d56a-8169-4849-8dcc-e5dc5b10e784">238</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_118">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_118">F-1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_121">Consolidated Statements of Operations for the years ended December 31, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_121">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_121">-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_121">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_124">Consolidated Statements of Comprehensive Income for the years ended December 31, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_124">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_124">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_127">Consolidated Balance Sheets as of December 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_127">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_127">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_130">Consolidated Statements of Cash Flows for the years ended December 31, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_130">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_130">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_133">Consolidated Statements of Changes in Stockholders&#8217; Equity for the years ended December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_133">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_133">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_133">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_133"> and 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_133">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_133">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_133">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_136">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_136">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_136">8</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">2. Financial Statement Schedule.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_202">Schedule II &#8212; Valuation and Qualifying Accounts for the years ended December 31, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_202">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i172bf506156f43e6869412a665f54418_202">49</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules not listed above have been omitted, because they are not applicable or are not required, or because the required information is included in the consolidated financial statements or notes thereto. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exhibits required to be filed by Item 601 of Regulation S-K.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312514012038/d647012dex101.htm">Stock Purchase Agreement, dated as of October 25, 2013, by and between Covidien Group S.A.R.L. and Integra LifeSciences Corporation (Incorporated by Reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on January 15, 2014)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000047/iart-20200930xexx21.htm">Put Option Agreement, dated September 29, 2020, between the Company and certain of its subsidiaries and Smith &amp; Nephew USD Limited, a subsidiary of Smith+Nephew (including the Purchase and Sale Agreement attached as Appendix 1 thereto) (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000018/iart-20201231xexx21b.htm">Agreement and Plan of Merger by among Integra LifeSciences Holdings Corporation and ACell Inc. dated as of December 15, 2020 (Incorporated by reference to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312514383254/d802647dex21.htm">Stock and Asset Purchase Agreement by and among Medtronic, Inc., Medtronic Xomed Instrumentation, SAS, and Integra LifeSciences Corporation, dated as of September 12, 2014 (Incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on October 27, 2014)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312515246787/d85302dex21.htm">Separation and Distribution Agreement between Integra LifeSciences Holdings Corporation and SeaSpine Holdings Corporation, dated as of June&#160;30, 2015 (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on July 7, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312515256459/d47708dex21.htm">Agreement and Plan of Merger by and among Integra LifeSciences Corporation, Patriot S1, Inc., TEI Biosciences Inc. and Dr. Yiannis Monovoukas, dated as of June 26, 2015 (Incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on July 20, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312515256459/d47708dex22.htm">Agreement and Plan of Merger by and among Integra LifeSciences Corporation, Patriot S2, Inc., TEI Medical Inc. and Dr. Yiannis Monovoukas, dated as of June 26, 2015 (Incorporated by reference to Exhibit 2.2 to the Company's Current Report on Form 8-K filed on July 20, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312517007393/d316863dex21.htm">Agreement and Plan of Merger by and among Integra LifeSciences Holdings Corporation, Integra Derma, Inc., and Derma Sciences, Inc. dated as of January 10, 2017 (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on January 11, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312517044517/d316120dex21.htm">Binding Offer Letter by and among Integra LifeSciences Holdings Corporation and DePuy Synthes, Inc., dated as of February 14, 2017 (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on February 15, 2017</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312517170703/d395692dex21.htm">Asset Purchase Agreement accepted and countersigned by DePuy Synthes, dated May 11, 2017 (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on May 15, 2017)</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000049/iart-20170930xexx21.htm">Asset Purchase Agreement, dated September 8, 2017, between the Company and certain of its subsidiaries and Natus Medical Incorporated (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on October 26, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000066/ex3-1aform10k031406.txt">Amended and Restated Certificate of Incorporation of the Company dated February 16, 1993 (Incorporated by reference to Exhibit 3.1(a) to the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2005)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-99-001063.txt">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated May 22, 1998 (Incorporated by reference to Exhibit 3.1(b) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 1998)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv3w1wc.txt">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated May 17, 1999 (Incorporated by reference to Exhibit 3.1(c) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000107/ex_3x1xfileddecember22x2016.htm">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated December 21, 2016 (Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on December 22, 2016)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993312000849/exhibit1.htm">Amended and Restated Bylaws of the Company, effective as of May 17, 2012 (Incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed on April 13, 2012)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752018000042/ex3_1xsecondarbylawsxdec20.htm">Second Amended and Restated Bylaws of Integra LifeSciences Holdings Corporation, effective as of December 11, 2018 (Incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-k filed on December 12, 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex41.htm">Indenture, dated as of February 7, 2020, by and between Integra LifeSciences Holdings Corporation and Citibank, N.A., as trustee  (including Form of 0.50% Convertible Senior Notes due 2025) (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000051/exhibit41.htm">First Supplemental Indenture, by and between Integra LifeSciences Holdings Corporation and Citibank, N.A., as trustee (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on December 9, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312519155388/d752260dex44.htm">Integra LifeSciences Deferred Compensation Plan, effective as of May 16, 2019 (Incorporated by reference to Exhibit 4.13 to the Company's Current Form S-8 Registration Statement filed on May 23, 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20211231xexx44.htm">Description of Securities+</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000112/ex10-1form8k110105.txt">Lease Modification #2 entered into as of October 28, 2005, by and between Plainsboro Associates and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 2, 2005)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993311000711/exhibit1.htm">Lease Modification #3 entered into as of March 2, 2011, by and between Plainsboro Associates and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 3, 2011)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000017/exhibit101_leasemodificati.htm">Lease Modification #4 entered into as of April 20, 2017, by and between Plainsboro Associates and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 25, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000136231008008563/c78646exv10w1.htm">Form of Indemnification Agreement for Non-Employee Directors and Officers (effective prior to February 15, 2019) (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 24, 2008)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752019000013/iart-20181231xexx103.htm">Form of Indemnification Agreement for Non-Employee Director and Officers effective February 15, 2019. *</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-98-000200.txt">1996 Incentive Stock Option and Non-Qualified Stock Option Plan (as amended through December 27, 1997) (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 1998)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000123/ex10-3form10q110905.txt">1998 Stock Option Plan (amended and restated as of July 26, 2005) (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000123/ex10-4form10q110905.txt">1999 Stock Option Plan (amended and restated as of July 26, 2005) (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000099/ex4-1forms8081205.txt">Employee Stock Purchase Plan (as amended on May 17, 2004) (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-8 (Registration No. 333-127488) filed on August 12, 2005)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000110/ex10-1form8k102705.txt">First Amendment to Employee Stock Purchase Plan, dated October 26, 2005 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 1, 2005)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993310002081/exhibit1.htm">Second Amended and Restated 2003 Equity Incentive Plan effective May 19, 2010 (Incorporated by reference to Exhibit 10 to the Company&#8217;s Current Report on Form 8-K filed May 21, 2010)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex109.htm">Amendment to the Second Amended and Restated 2003 Equity Incentive Plan effective May 17, 2012 (Incorporated by reference to Exhibit 10.9 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000041/exhibit104amendmenttosecon.htm">Amendment to the Second Amended and Restated 2003 Equity Incentive Plan effective January 1, 2013 (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000025/exhibit101-thirdamendedand.htm">Third Amended and Restated 2003 Equity Incentive Plan effective May 22, 2015 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 29, 2015)*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000025/exhibit_10x1.htm">Fourth Amended and Restated 2003 Equity Incentive Plan, effective May 23, 2017 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 25, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7(f)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000037/iart-20200630xexx101.htm">Amendment to the Integra LifeSciences Holdings Corporation Fourth Amended and Restated 2003 Equity Incentive Plan (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7(g)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000029/ex101.htm">Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 18, 2021)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1011.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley &amp; Co. International plc. (Incorporated by reference to Exhibit 10.11 of the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993312001435/exhibit1.htm">Letter Agreement dated June 7, 2012 between Stuart M. Essig and the Company (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on June 7, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-98-000200.txt">Indemnity letter agreement dated December 27, 1997 from the Company to Stuart M. Essig (Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 1998)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-98-000200.txt">Registration Rights Provisions for Stuart M. Essig (Incorporated by reference to Exhibit B of Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 1998)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091205701000619/a2034717zex-10_2.txt">Registration Rights Provisions for Stuart M. Essig (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on January 8, 2001)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752004000031/0000917520-04-000031.txt">Registration Rights Provisions for Stuart M. Essig (Incorporated by reference to Exhibit B of Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1017.htm">Issuer Forward Repurchase Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and JPMorgan Chase Bank, National Association, New York Branch. (Incorporated by reference to Exhibit 10.17 of the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000149/ex10-3form10q110906.txt">Lease Contract, dated April 1, 2005, between the Puerto Rico Industrial Development Company and Integra CI, Inc. (executed on September 15, 2006) (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2006)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993311003262/exhibit1.htm">Amendment to Lease Contract dated as of November&#160;2, 2011, between Integra CI, Inc. and Puerto Rico Industrial Development Company (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November&#160;7, 2011)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512183626/d317931dex102.htm">Termination of Amendment to Lease Contract, dated as of April 2, 2012, between Integra CI, Inc. and Puerto Rico Industrial Development Company (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2012)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-98-000200.txt">Restricted&#160;Units&#160;Agreement&#160;dated&#160;December&#160;27,&#160;1997&#160;between&#160;the&#160;Company&#160;and&#160;Stuart&#160;M.&#160;Essig (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 1998)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091205701000619/a2034717zex-4_1.txt">Stock Option Grant and Agreement pursuant to 1999 Stock Option Plan dated December 22, 2000 between the Company and Stuart M. Essig (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on January 8, 2001)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091205701000619/a2034717zex-4_2.txt">Stock Option Grant and Agreement pursuant to 2000 Equity Incentive Plan dated December 22, 2000 between the Company and Stuart M.&#160;Essig (Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on January 8, 2001)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091205701000619/a2034717zex-4_3.txt">Restricted Units Agreement dated December 22, 2000 between the Company and Stuart M. Essig (Incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on January 8, 2001)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000137/ex10-1form8k110306.txt">Amendment 2006-1, dated as of October 30, 2006, to the Stuart M. Essig Restricted Units Agreement dated as of December 22, 2000 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 3, 2006)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w30.txt">Stock Option Grant and Agreement pursuant to 2003 Equity Incentive Plan dated July 27, 2004 between the Company and Stuart M. Essig (Incorporated by reference to Exhibit 10.30 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w31.txt">Contract Stock/Restricted Units Agreement pursuant to 2003 Equity Incentive Plan dated July 27, 2004 between the Company and Stuart M. Essig (Incorporated by reference to Exhibit 10.31 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000137/ex10-2form8k110306.txt">Amendment 2006-1, dated as of October 30, 2006, to the Stuart M. Essig Contract Stock/Restricted Units Agreement dated as of July 27, 2004 (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on November 3, 2006)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308005803/y51439exv10w25wc.htm">Amendment 2008-1, dated as of March 6, 2008, to the Stuart M. Essig Contract Stock/Restricted Units Agreement dated as of July 27, 2004 (Incorporated by reference to Exhibit 10.25(c) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2007)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312511203310/dex106.htm">Amendment 2011-1, dated as of May 17, 2011, to the Stuart M. Essig Contract Stock/Restricted Units Agreement dated as of July 24, 2004 (Incorporated by reference to Exhibit 10.6 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993311001582/exhibit2.htm">Contract Stock/Units Agreement dated as of May 17, 2011 between the Company and Stuart M.&#160;Essig (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on May 23, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312511203310/dex105.htm">Form of Amendment 2011-1 to Contract Stock/Restricted Units Agreements between the Company and Mr. Essig (Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w32.txt">Form of Stock Option Grant and Agreement between the Company and Stuart M. Essig (Incorporated by reference to Exhibit 10.32 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308009294/y65047exv10w8.htm">Form of Contract Stock/Restricted Units Agreement for Stuart M. Essig (Incorporated by reference to Exhibit 10.8 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2008)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012311017602/w80860exv10w28wxby.htm">New Form of Contract Stock/Restricted Units Agreement (for Annual Equity Awards) for Stuart M. Essig (Incorporated by reference to Exhibit 10.28(b) to the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2010)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312511203310/dex104.htm">Form of Amendment 2011-1 to Contract Stock/Restricted Units Agreement between the Company and Mr. Essig (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308009294/y65047exv10w9.htm">Form of Performance Stock Agreement for Stuart M. Essig (Incorporated by reference to Exhibit 10.9 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2008)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993309001637/exhibit3.htm">Form of Restricted Stock Agreement for Stuart M. Essig for 2009 (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed April 13, 2009)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000019/iart-exx102performancestoc.htm">Form of Performance Stock Agreement (Executive Officers) (Incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 25, 2013)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000075/exhibit10_1formofperforman.htm">Form of Performance Stock Agreement (Executive Officers) (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 29, 2016)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000075/exhibit10_2formofperforman.htm">Form of Performance Stock Agreement for Peter J. Arduini (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Report on Form 8-K filed on February 29, 2016)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752018000019/iart-20180331xexx101.htm">Form of Performance Stock Agreement (Executive Officers) (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018) *</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752018000019/iart-20180331xexx102.htm">Form of Performance Stock Agreement for Peter J. Arduini (Incorporated by reference to Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752018000019/iart-20180331xexx102.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752018000019/iart-20180331xexx102.htm"> to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000041/exhibit103-performanceince.htm">Performance Incentive Compensation Plan effective January 1, 2013 (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000004/exhibit101.htm">First Amendment, dated as of February 15, 2017, to the Performance Incentive Compensation Plan (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 17, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000025/exhibit_10x2.htm">2018 Performance Incentive Compensation Plan, effective January 1, 2018 (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on May 25, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312511203310/dex103.htm">New Form of Contract Stock/Restricted Units Agreement pursuant to 2003 Equity Incentive Plan (for 2011) Annual Equity Award for Stuart M. Essig) (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000090/ex10-1form8k72605.txt">Form of Notice of Grant of Stock Option and Stock Option Agreement (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on July 29, 2005)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w35.txt">Form of Non-Qualified Stock Option Agreement (Non-Directors) (Incorporated by reference to Exhibit 10.35 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w36.txt">Form of Incentive Stock Option Agreement (Incorporated by reference to Exhibit 10.36 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w37.txt">Form of Non-Qualified Stock Option Agreement (Directors) (Incorporated by reference to Exhibit&#160;10.37 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000022/iart-20150331xex101.htm">Form of Stock Option Agreement (Executive Officers) (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000022/iart-20150331xex102.htm">Form of Stock Option Agreement for Glenn Coleman (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000065/exhibit10-formcicfebruary2.htm">Form of Change in Control Severance Program (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 19, 2020)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex104.htm">Form of Restricted Stock Agreement for Non-Employee Directors under the 2003 Equity Incentive Plan (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000023/iart-20121231xexx1038b.htm">New Form of Restricted Stock Agreement for Non-Employee Directors under the 2003 Equity Incentive Plan (Incorporated by reference to Exhibit 10.38(b) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000136231009002762/c81593exv10w1.htm">Form of Restricted Stock Agreement for Executive Officers&#160;- Annual Vesting (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 25, 2009)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex105.htm">Form of Restricted Stock Agreement for Executive Officers - Annual Vesting (Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000023/iart-20121231xexx1038e.htm">New Form of Restricted Stock Agreement for Executive Officers - Annual Vesting (Incorporated by reference to Exhibit 10.38(e) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000136231009006565/c84477exv10w8.htm">Form of Restricted Stock Agreement for Executive Officers - Cliff Vesting (Incorporated by reference to Exhibit 10.8 to the Company&#8217;s Quarter Report on Form 10-Q for the quarter ended March&#160;31, 2009)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex106.htm">Form of Restricted Stock Agreement for Executive Officers - Cliff Vesting (Incorporated by reference to Exhibit 10.6 to the Company&#8217;s quarterly report on Form 10-Q for the quarter ended June 30, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000023/iart-20121231xexx1038h.htm">New Form of Restricted Stock Agreement for Executive Officers - Cliff Vesting (Incorporated by reference to Exhibit 10.38(h) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000104/exhibit_10x2xdecemberx5x20.htm">Davis Promotion Summary, effective December 1, 2016 (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on December 5, 2016)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752019000026/form8kfiledjune242019.htm">Coleman Promotion Summary, effective June 24, 2019(Incorporated by reference to the Current Report on Form 8-K filed on June 24, 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752019000026/form8kfiledjune242019.htm">Anderson Offer Summary, effective June 24, 2019(Incorporated by reference to the Current Report on Form 8-K filed on June 24, 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000060/exhibit102-summaryofexecut.htm">Annual Executive Physical Medical Exam Arrangement (Incorporated by reference to the Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on July 29, 2013)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308005803/y51439exv10w43wc.htm">Amended and Restated Management Incentive Compensation Plan, as of January 1, 2008 (Incorporated by reference to Exhibit 10.43(c) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2007)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308009294/y65047exv10w10.htm">Lease Agreement between 109 Morgan Lane, LLC and Integra LifeSciences Corporation, dated May 15, 2008 (Incorporated by reference to Exhibit 10.10 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2008)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000136231009006565/c84477exv10w9.htm">First Amendment to Lease Agreement between 109 Morgan Lane, LLC and Integra LifeSciences Corporation, dated March 9, 2009 (Incorporated by reference to Exhibit 10.9 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2009)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312513279558/d559455dex101.htm">Lease Agreement dated as of July 1, 2013, between 109 Morgan Lane, LLC and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on July 1, 2013)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000092963818001000/exhibit10-1.htm">Receivables Financing Agreement, dated as of December 21, 2018, by and among Integra Receivables LLC, Integra LifeSciences Sales LLC, as Servicer, PNC Bank, National Association, as Administrative Agent, PNC Capital Markets LLC, as Structuring Agent, and certain lenders and group agents that are parties thereto from time to time (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 28, 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000039/iart-20210630xexx101.htm">Amendment No. 1 to Receivables Financing Agreement and Reaffirmation of Performance Guaranty, dated as of March 29, 2019, by and among Integra Receivables LLC, Integra LifeSciences Sales LLC, as Servicer, PNC Bank, National Associations, as Administrative Agent, Committed Lender and Group Agent, Mizuho Bank, Ltd., as Committed Lender and Group Agent and PNC Capital Markets LLC, as Structuring Agent, and certain lenders and group agents that are parties thereto from time to time (Incorporated by reference to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000039/iart-20210630xexx101.htm">Amendment No. 2 to Receivables Financing Agreement and Reaffirmation of Performance Guaranty, dated as of July 17, 2020, by and among, Integra Receivables LLC, Integra LifeSciences Sales LLC, as Servicer, PNC Bank, National Associations, as Administrative Agent, Committed Lender and Group Agent, Mizuho Bank, Ltd., as Committed Lender and Group Agent and PNC Capital Markets LLC, as Structuring Agent, and certain lenders and group agents that are parties thereto from time to time (Incorporated by reference to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000039/iart-20210630xexx101.htm">Amendment No. 3 to Receivables Financing Agreement and Reaffirmation of Performance Guaranty, dated as of May 28, 2021, by and among, Integra Receivables LLC, Integra LifeSciences Sales LLC, as Servicer, PNC Bank, National Associations, as Administrative Agent, PNC Capital Markets LLC, as Structuring Agent, Committed Lender and Group Agent, and certain lenders and group agents that are parties thereto from time to time (Incorporated by reference to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000092963818001000/exhibit10-2.htm">Purchase and Sale Agreement, dated as of December 21, 2018, by and among Integra LifeSciences Sales LLC, Integra LifeSciences Corporation and Integra Receivables LLC (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 28, 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000119312520022927/d881437dex101.htm">Sixth Amended and Restated Credit Agreement, dated as of February 3, 2020, among Integra LifeSciences Holdings Corporation, the lenders party thereto, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an L/C Issuer, Citibank N.A., Morgan Stanley MUFG Loan Partners, LLC and Wells Fargo Bank, N.A., as Co-Syndication Agents, and PNC Bank, N.A., Bank of Nova Scotia, Bank of the West, BBVA USA, Capital One, National Association, Citizens Bank, N.A., DNB Capital LLC, Santander Bank, N.A., TD Bank, N.A. and Truist Bank, as Co-Documentation Agents. (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2020).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000030/amendmentno1sixtharca.htm">Amendment, dated July 14, 2020, to that Sixth Amended and Restated Credit Agreement, among Integra LifeSciences Holdings Corporation, a syndicate of lending banks, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, Citibank N.A., Morgan Stanley MUFG Loan Partners, LLC and Wells Fargo Bank, N.A. as Co-Syndication Agents, and PNC Bank, N.A., Bank of Nova Scotia, Bank of the West, BBVA USA, Capital One, National Association, Citizens Bank, N.A., DNB Capital LLC, Santander Bank, N.A., T.D. Bank, N.A. and Truist Bank, as Co-Documentation Agents (as amended, restated, modified and supplemented from time to time prior to the date hereof, the &#8220;Credit Agreement&#8221;) (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on July 20, 2020).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex101.htm">Base Call Option Transaction Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.49</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520022927/d881437dex102.htm">Ratification Agreement, dated as of February&#160;3, 2020, between Integra LifeSciences Holdings Corporation, the Subsidiary Guarantors of Integra LifeSciences Holdings Corporation and Bank of America, N.A., as Administrative Agent (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex103.htm">Base Call Option Transaction Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley &amp; Co. International plc. (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex104.htm">Base Call Option Transaction Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex105.htm">Base Warrant Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex106.htm">Base Warrant Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs&#160;&amp; Co. LLC. (Incorporated by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.54</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex107.htm">Base Warrant Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley&#160;&amp; Co. International plc. (Incorporated by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.55</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex108.htm">Base Warrant Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.8 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex109.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.9 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1010.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs &amp; Co. LLC. (Incorporated by reference to Exhibit 10.10 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.58</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1011.htm">Additional Call Option Transaction Confirmation, dated as of February&#160;5, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley&#160;&amp; Co. International plc. (Incorporated by reference to Exhibit 10.11 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.59</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1012.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.12 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1013.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.13 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.61</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1014.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs &amp; Co. LLC. (Incorporated by reference to Exhibit 10.14 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1015.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley &amp; Co. plc. (Incorporated by reference to Exhibit 10.15 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.63</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1016.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.16 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.64</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1017.htm">Issuer Forward Repurchase Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and JPMorgan Chase Bank, National Association, New York Branch. (Incorporated by reference to Exhibit 10.17 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.65</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/ex10_1xintegraemployment.htm">Employment Agreement, dated October 28, 2021, by and between Integra LifeSciences Holdings Corporation, Integra LifeSciences Corporation and Jan De Witte (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on October 28, 2021)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20211231xexx211.htm">Subsidiaries of the Company+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20211231xexx231.htm">Consent of PricewaterhouseCoopers LLP+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20211231xexx311.htm">Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20211231xexx312.htm">Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20211231xexx321.htm">Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20211231xexx322.htm">Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512003597/d276820dex991.htm">Letter, dated December 21, 2011, from the United States Food and Drug Administration to Integra LifeSciences Corporation (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on January 5, 2012)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex991.htm">Food and Drug Administration Form FDA-483, dated July 30, 2012, relating to inspection of Plainsboro, NJ manufacturing facility (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512465243/d434963dex991.htm">Letter, dated November 1, 2012, from the United States Food and Drug Administration to Integra NeuroSciences Ltd. (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on November 13, 2012)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312513065171/d487711dex991.htm">Letter, dated February&#160;13, 2013, from the United States Federal Drug Administration to Integra LifeSciences Corporation (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on February 19, 2013)</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312513381070/d606108dex991.htm">Letter, dated September 24, 2013, from the United States Federal Drug Administration to Integra LifeSciences Corporation (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on September 27, 2013)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312513459946/d637741dex991.htm">Food and Drug Administration Form FDA-483, dated November&#160;26, 2013, relating to the inspection of the A&#241;asco Facility (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on December 3, 2013)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312515014048/d854281dex991.htm">Letter, dated January 14, 2015, from the United States Food and Drug Administration to Integra LifeSciences Corporation (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on January 20, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000033/iart-20150630xex991.htm">Letter, dated May 29, 2015, from the United States Food and Drug Administration to TEI Biosciences Inc. (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000033/iart-20150630xex992.htm">Letter, dated June 30, 2015, from the United States Food and Drug Administration to Integra LifeSciences (Ireland) Limited &#160;(Incorporated by reference to Exhibit 99.2 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Definition Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Labels Linkbase Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document+#</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates a management contract or compensatory plan or arrangement.</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates this document is filed as an exhibit herewith.</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The financial information of Integra LifeSciences Holdings Corporation Annual Report on Form 10-K for the year ended December 31, 2021 filed on February 24, 2022 formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Statement of Comprehensive Income (Loss), (iii) the Consolidated Balance Sheets, (iv) Parenthetical Data to the Consolidated Balance Sheets, (v) the Consolidated Statements of Cash Flows, (vi) the Consolidated Statements of Changes in Stockholders&#8217; Equity, and (vii) Notes to Consolidated Financial Statements, is furnished electronically herewith.</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Commission File Number for Reports on Form 10-K, Form 10-Q and Form 8-K is 0-26224.</span></div><div id="i172bf506156f43e6869412a665f54418_109"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">FORM 10-K SUMMARY</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.146%"><tr><td style="width:1.0%"></td><td style="width:8.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.571%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jan De Witte</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carrie L. Anderson</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrie L. Anderson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey A. Mosebrook</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: February&#160;24, 2022 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons, on behalf of the registrant in the capacities indicated. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jan De Witte</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carrie L. Anderson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrie L. Anderson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Principal Financial Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey A. Mosebrook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Finance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stuart M. Essig, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stuart M. Essig, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Rhonda Germany Ballintyn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhonda Germany Ballintyn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Keith Bradley, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Keith Bradley, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Shaundra Clay</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shaundra Clay</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Barbara B. Hill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara B. Hill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald E. Morel, Jr., Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald E. Morel, Jr., Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Raymond G. Murphy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond G. Murphy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christian S. Schade</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christian S. Schade</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_115"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm </span></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the Board of Directors and Stockholders of Integra LifeSciences Holdings Corporation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Integra LifeSciences Holdings Corporation and its subsidiaries (the &#8220;Company&#8221;) as of December&#160;31, 2021 and 2020, and the related consolidated statements of operations, of comprehensive income, of changes in stockholders&#8217; equity and of cash flows for each of the three years in the period ended December&#160;31, 2021, including the related notes and financial statement schedule listed in the index appearing under Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company's internal control over financial reporting as of December&#160;31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2021 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Internal Control - Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2013) issued by the COSO.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Accounting Principle</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for convertible instruments in 2021 and leases in 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="text-indent:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ACell, Inc. Acquisition - Valuation of Developed Technology Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As described in Notes 2, 4 and 7 to the consolidated financial statements, in January 2021, the Company acquired ACell Inc. for an acquisition purchase price of $306.9 million plus contingent consideration of up to $100 million, which resulted in $245M of developed technology intangible assets being recorded. The estimated fair value of the developed technology acquired was determined by management using the multi-period excess earnings method of the income approach. Management&#8217;s significant assumptions used in the estimate of fair value included the estimated net cash flows, net revenues, cost of sales, selling and marketing costs, discount rates and each asset&#8217;s life cycle. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The principal considerations for our determination that performing procedures relating to the valuation of developed technology intangible assets from the acquisition of ACell Inc. is a critical audit matter are the (i) the significant judgment by management in developing the fair value of the acquired developed technology intangible assets, (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management&#8217;s assumptions related to net revenues, cost of sales, selling and marketing costs, discount rates and each asset&#8217;s life cycle; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the acquisition accounting, including controls over management&#8217;s valuation of the intangible assets and controls over the development of significant assumptions related to net revenues, cost of sales, selling and marketing costs, discount rates and each asset&#8217;s life cycle. These procedures also included, among others (i) reading the purchase agreement and (ii) testing management&#8217;s process for developing the fair value of the developed technology intangible assets. Testing management&#8217;s process included evaluating the appropriateness of the multi-period excess earnings method, testing the completeness, accuracy, and relevance of underlying data used in the method, and evaluating the reasonableness of significant assumptions used by management related to net revenues, cost of sales, selling and marketing costs, discount rates and each asset&#8217;s life cycle. Evaluating the reasonableness of management&#8217;s assumptions related to net revenues, cost of sales, selling and marketing costs and each asset&#8217;s life cycle involved considering (i) current and past performance of the products associated with the developed technology acquired, as well as the performance of the reporting unit that assumed the products associated with the developed technology acquired; (ii) the consistency with external market and industry data; and (iii) and whether the assumptions are consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company&#8217;s multi-period excess earnings method and the discount rates and each asset&#8217;s life cycle assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMTgvZnJhZzphZWM1NDdiZGJkMDI0ZGE3ODBkZjNhZGMxZTIwZTY1YS90ZXh0cmVnaW9uOmFlYzU0N2JkYmQwMjRkYTc4MGRmM2FkYzFlMjBlNjVhXzIxOTkwMjMyNjg4MzI_77ee0b54-8b5c-4f25-bdb1-c78541097b88">PricewaterhouseCoopers LLP</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMTgvZnJhZzphZWM1NDdiZGJkMDI0ZGE3ODBkZjNhZGMxZTIwZTY1YS90ZXh0cmVnaW9uOmFlYzU0N2JkYmQwMjRkYTc4MGRmM2FkYzFlMjBlNjVhXzIxOTkwMjMyNjg4MzM_150a39d3-23cf-420e-bade-6b930a947fd6">Florham Park, New Jersey</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;24, 2022 </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1989.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands, except per share amounts)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzMtMS0xLTEtMzczNTY_9c0fe8bc-b023-4b59-afdb-e50827695e67">1,542,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzMtMy0xLTEtMzczNTY_3748225b-ff59-4b8b-af34-46b1437d5152">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzMtNS0xLTEtMzczNTY_bf216d91-e173-4981-ae78-26efeea4f7c6">1,517,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzUtMS0xLTEtMzczNTY_dde5b738-1b06-45e8-bbf3-44cb90207b58">597,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzUtMy0xLTEtMzczNTY_b4157ad8-f32c-48a9-81ff-8e799bd52ed1">520,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzUtNS0xLTEtMzczNTY_5fc3d880-f342-4316-9e91-de6118903b14">564,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzYtMS0xLTEtMzczNTY_ec918f4a-b2ac-4cea-bb99-4fa5ce6c5fa4">93,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzYtMy0xLTEtMzczNTY_8b779dab-aa6f-4952-b154-19ff6eb2ff4e">77,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzYtNS0xLTEtMzczNTY_389fd93f-40c0-4a84-8abf-26f870f3f9ec">79,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentInProcess" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzctMS0xLTEtMzczNTY_57410944-18a6-4c2b-aac5-2004f92df403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentInProcess" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzctMy0xLTEtMzczNTY_33d1248e-4abb-49bb-8b2b-0e333c9aec48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ResearchAndDevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzctNS0xLTEtMzczNTY_5b586692-6731-4a03-b3b3-217fafc52f6c">64,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzgtMS0xLTEtMzczNTY_4da5f674-d183-4d10-8a41-29f77e7594d3">637,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzgtMy0xLTEtMzczNTY_c20f9d72-afeb-4f11-8e6d-deea44ea753c">594,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzgtNS0xLTEtMzczNTY_ea2432c2-9836-426f-bb73-fbbbd9d3bde2">687,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzktMS0xLTEtMzczNTY_ba7c1b39-2c16-45ad-ad16-715920b6e11c">16,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzktMy0xLTEtMzczNTY_473b981d-3c68-4d03-ad2e-e92aaecdebd3">27,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzktNS0xLTEtMzczNTY_6c920591-a5dd-45e6-855c-4f6958773744">27,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEwLTEtMS0xLTM3MzU2_a2558b2f-6ea7-436a-8ca6-6decf28fea1c">1,345,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEwLTMtMS0xLTM3MzU2_a59f2f9c-2b15-4f95-a2f6-86c58c94e065">1,220,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEwLTUtMS0xLTM3MzU2_cd45d67a-c2be-4883-8163-ea5616eab96e">1,423,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzExLTEtMS0xLTM3MzU2_45509487-d9cd-4bcd-967d-b45f438e098a">197,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzExLTMtMS0xLTM3MzU2_19c9b7f4-2fc6-4856-b9fa-5eb93581c70c">151,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzExLTUtMS0xLTM3MzU2_f9aa681a-ee82-42ea-8bee-15ab2cc7c076">93,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEyLTEtMS0xLTM3MzU2_33adeaf0-1a7e-42ef-9571-e1ab133ec548">6,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEyLTMtMS0xLTM3MzU2_21b9141b-619f-4f27-94e2-9a4d09bd77bb">9,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEyLTUtMS0xLTM3MzU2_37f6a536-4dcd-42bd-8467-903ff19fd9b1">10,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEzLTEtMS0xLTM3MzU2_5f3c8619-00cd-411b-b811-d8e228eaf8ed">50,395</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEzLTMtMS0xLTM3MzU2_2f90a9a0-61dd-4d41-bcf3-d07da0f1b417">71,581</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEzLTUtMS0xLTM3MzU2_82704e08-28b8-4e57-a0be-58e3927163f2">53,957</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTEtMS0xLTQxMDM2_079d6816-7197-41bd-a674-39ddab397d33">41,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTMtMS0xLTQxMDM2_9b4193a6-0e2e-4710-a8c1-cae6c6445515">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTUtMS0xLTQxMDM2_d078bfa6-051e-494b-8372-b584a705efbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTEtMS0xLTM3MzU2_f398d0c8-0046-472c-8c10-ae8ecf25b136">19,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTMtMS0xLTM3MzU2_eb0969b4-bcc5-48bf-9c79-1d2c6fd72f99">4,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTUtMS0xLTM3MzU2_1adc2106-19ad-44c7-b01a-fa7311740137">9,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE1LTEtMS0xLTM3MzU2_f495f8b2-c0ae-4f2d-aa59-7b6a384c5db5">214,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE1LTMtMS0xLTM3MzU2_5755b2c9-4013-49a4-bda6-f4da205fb69c">93,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE1LTUtMS0xLTM3MzU2_9e50b69f-49b6-46cb-a915-288a7fc42838">60,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE2LTEtMS0xLTM3MzU2_19e41614-e81b-48d9-a833-a848da3a92ea">45,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE2LTMtMS0xLTM3MzU2_1e078ada-35b2-4b1e-8561-9933c66c1210">40,372</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE2LTUtMS0xLTM3MzU2_045267ec-c9e9-42ed-b375-eccaf4c9e07f">9,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE3LTEtMS0xLTM3MzU2_010a1aac-f3e7-480b-b9c0-3e38bee12dd9">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE3LTMtMS0xLTM3MzU2_61d14b8f-7ea3-4bcf-9fcd-1a3a583c68c0">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE3LTUtMS0xLTM3MzU2_7ff5c49d-c69a-4fe7-9ca4-1032382fb84b">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIwLTEtMS0xLTM3MzU2_4d8cb632-b45d-427c-a276-2c475fe8d75c">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIwLTMtMS0xLTM3MzU2_b736ce50-ec1a-4ca5-af4c-213507bf8ea2">1.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIwLTUtMS0xLTM3MzU2_15ca3c33-c8d4-441d-b698-0d02eaa912da">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIxLTEtMS0xLTM3MzU2_68b6f7c9-c02e-49e8-9671-a240869bb523">1.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIxLTMtMS0xLTM3MzU2_cbadbdc5-8895-480e-b2f3-802d33625b11">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIxLTUtMS0xLTM3MzU2_6e591b03-6bd8-4cda-91d2-45e6fd943f94">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average common shares outstanding (See Note 13):</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI0LTEtMS0xLTM3MzU2_efda8698-26d2-4a5c-8263-9ad07934d49f">84,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI0LTMtMS0xLTM3MzU2_23ad5004-ce4c-44ce-b496-14b1b63d1dad">84,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI0LTUtMS0xLTM3MzU2_36ec26c1-f18f-45d1-9627-8612b6bb1ddc">85,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI1LTEtMS0xLTM3MzU2_753514ad-0bcc-4f6a-be34-dc0c2ea71bbe">85,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI1LTMtMS0xLTM3MzU2_72adb584-ff2d-4daf-8aa9-611ceedbb1bc">85,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI1LTUtMS0xLTM3MzU2_a78ab3d5-b892-48e1-ae63-6b1239af7ad9">86,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:61.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzMtMS0xLTEtMzczNTY_e059439a-058f-49b5-b9c0-882386bbc556">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzMtMy0xLTEtMzczNTY_d8ef166d-0b3b-420f-9585-223c3f51b156">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzMtNS0xLTEtMzczNTY_f7930b59-9c02-43a0-a018-ff4d7ec758da">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzUtMS0xLTEtMzczNTY_6ba8b297-d04f-431f-863e-4b70f2409285">17,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzUtMy0xLTEtMzczNTY_72ea65c3-9b9e-4104-9743-a58e27a6ddec">53,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzUtNS0xLTEtMzczNTY_5e2989aa-75fe-48c9-a08b-2893a90275c5">174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized derivative gain (loss) arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzgtMS0xLTEtMzczNTY_66fcd906-0426-4cc6-9c77-743c7ca800d6">68,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzgtMy0xLTEtMzczNTY_835515f0-b886-4a2d-8b0a-fea59f398e09">96,837</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzgtNS0xLTEtMzczNTY_782b5c7b-061b-4a8f-b24f-44ee48c79f04">13,671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Reclassification adjustments for gain (loss) included in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzktMS0xLTEtMzczNTY_a53c35b7-9ed2-45bf-bd5f-1c76adca38d6">17,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzktMy0xLTEtMzczNTY_1aa5e58b-6f8c-409f-a3fe-be91e46b9f27">24,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzktNS0xLTEtMzczNTY_4e696de2-ad25-46f7-a87e-adf9db8b13f4">14,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivatives</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEwLTEtMS0xLTM3MzU2_74a98720-1f21-4575-9459-7a26324a2191">51,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEwLTMtMS0xLTM3MzU2_a26b452b-ab2c-4a2a-8257-837865fde3eb">72,395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEwLTUtMS0xLTM3MzU2_d0e8798d-be7a-4b30-9cf3-c5a11a21357f">28,536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension plan - net gain (loss) arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEyLTEtMS0xLTM3MzU2_ab7b6818-ae0d-435b-9a05-6ba59639e8b6">6,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEyLTMtMS0xLTM3MzU2_4c390c8b-f559-4bc6-a88c-5f0c281b349f">4,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEyLTUtMS0xLTM3MzU2_3555adf3-9476-40be-841b-0f367133d074">8,973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive gain (loss), before tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE0LTEtMS0xLTM3MzU2_f9fca5e4-c387-43c9-a40b-0820e277e220">40,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE0LTMtMS0xLTM3MzU2_73cf7255-f7a4-465c-8e87-c042ef493ab6">14,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE0LTUtMS0xLTM3MzU2_976ad470-46a0-4177-ab88-73b5863330bc">37,683</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (expense) benefit related to items in other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE1LTEtMS0xLTM3MzU2_9b84ecc4-fe9d-430b-b9df-c38bb08e47e4">11,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE1LTMtMS0xLTM3MzU2_fd167fd1-32d3-482f-8402-6c84d1fefb73">16,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE1LTUtMS0xLTM3MzU2_1adabc37-199c-4d47-a56d-5a559648c74e">6,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive gain (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE2LTEtMS0xLTM3MzU2_859f77f2-b5ca-468b-a144-a67f92f8247e">28,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE2LTMtMS0xLTM3MzU2_a7b14da8-abb6-4854-afdd-7a4e93ba84aa">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE2LTUtMS0xLTM3MzU2_87053293-f5ec-4ef5-9a21-243814065065">30,959</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE4LTEtMS0xLTM3MzU2_81abfcda-6b1d-4510-b882-309f1e05fabe">197,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE4LTMtMS0xLTM3MzU2_77fccaa0-cbe7-43bd-b4a1-1ff8987a4c1d">136,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE4LTUtMS0xLTM3MzU2_a39f36cf-0406-42e3-9e65-25701ab93609">19,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands, except per share amounts)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUtMS0xLTEtMzczNTY_8ec24312-e0b6-42fa-8b70-c1a8bbdd52e0">513,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUtMy0xLTEtMzczNTY_0c875370-750d-4077-9ae8-35bcbc96ccd0">470,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzctMC0xLTEtMzczNTYvdGV4dHJlZ2lvbjpjYjI4NDVhZjI1MWY0ZTg0ODljZjlkMmIzMDk2MDM1MV81Mg_3909b1b3-082d-4b90-85b6-97185fc67148">4,735</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzctMC0xLTEtMzczNTYvdGV4dHJlZ2lvbjpjYjI4NDVhZjI1MWY0ZTg0ODljZjlkMmIzMDk2MDM1MV81OQ_bad69b84-f389-45f3-9526-95750f72cb46">6,439</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzctMS0xLTEtMzczNTY_3f0d8ab8-af77-4ced-a2d4-1ea243ae4c28">231,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzctMy0xLTEtMzczNTY_496a4ec8-116e-4104-8974-02640afeb603">225,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzgtMS0xLTEtMzczNTY_14d73a76-6678-4227-b7a4-37ceb2583aaa">317,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzgtMy0xLTEtMzczNTY_b658d75e-6724-4313-8878-468708dba80a">310,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzExLTEtMS0xLTM3MzU2_12558d2c-9bb6-4771-bd50-e93c0f656dcd">91,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzExLTMtMS0xLTM3MzU2_3b293bc1-363e-4542-8f14-52f8f30fa987">69,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzktMS0xLTEtNDE0MDk_e9b7a374-f6e7-4971-ad50-744701af0253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzktMy0xLTEtNDE0MDk_98342178-0c49-4f24-a713-0724b82c8c99">162,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzEzLTEtMS0xLTM3MzU2_08207cc8-7839-4109-9d83-7fb3c7e6a25f">1,153,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzEzLTMtMS0xLTM3MzU2_a379eed7-07d0-40ab-89c2-3fbcc4d64d96">1,237,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE0LTEtMS0xLTM3MzU2_43450ba0-f3b0-451e-ba47-4ced4c795b42">311,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE0LTMtMS0xLTM3MzU2_4f4f7e8d-fdcf-4efb-b571-8e68c6ddd1b1">287,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE1LTEtMS0xLTM3MzU2_3925339a-3cb8-43ae-87eb-2250742d1887">84,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE1LTMtMS0xLTM3MzU2_49969103-4dee-4e58-bfd0-3c838c8f6608">83,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE2LTEtMS0xLTM3MzU2_529300f0-74ed-41dd-aceb-c6d3fd52e336">1,145,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE2LTMtMS0xLTM3MzU2_2102893d-3ef5-462d-a1b2-e82c7eb88be4">989,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE3LTEtMS0xLTM3MzU2_4d31c30e-ae58-4b08-ab55-29e98d1d8a9c">1,013,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE3LTMtMS0xLTM3MzU2_5f5272a5-f441-41fd-a425-327f5eb97dbe">932,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE4LTEtMS0xLTM3MzU2_3652021b-885a-45b0-a2c9-2b12e881c88c">56,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE4LTMtMS0xLTM3MzU2_a908c16f-441f-4cf7-b612-dcb34d740392">73,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE5LTEtMS0xLTM3MzU2_c90d6740-d0b2-4fdc-bb39-3f5548df61c0">16,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE5LTMtMS0xLTM3MzU2_dbb1436d-0fad-4319-92b4-243a9789b59d">11,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzIxLTEtMS0xLTM3MzU2_93b0ffb6-3d9a-4bf0-b749-fc9ec40e68a1">3,782,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzIxLTMtMS0xLTM3MzU2_1b09c6ea-ce9f-4525-9789-925729aa2b42">3,615,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of borrowings under senior credit facility</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI0LTEtMS0xLTM3MzU2_d69fee85-a8b7-4757-a8a9-64292dedc187">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI0LTMtMS0xLTM3MzU2_c08dde1f-fd3c-468a-8501-f63e1f806a6b">33,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of borrowings under securitization facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="iart:SecuredLongTermDebtSecuritizationProgramCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI1LTEtMS0xLTM3MzU2_c2e75448-7977-4518-a408-16aafe3b4880">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="iart:SecuredLongTermDebtSecuritizationProgramCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI1LTMtMS0xLTM3MzU2_fdb257a5-8f65-47f7-8a48-4da97853586e">112,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI2LTEtMS0xLTM3MzU2_936a9a68-3a79-4667-912f-35e4b1922aeb">14,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI2LTMtMS0xLTM3MzU2_13cfdc05-90f0-4e5c-b6d4-fba5553314c1">12,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, trade</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI3LTEtMS0xLTM3MzU2_1c27b9db-48eb-427e-99b7-131d8a1e45aa">61,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI3LTMtMS0xLTM3MzU2_32721898-cc01-4983-a7ed-530ce5b40a2d">54,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI4LTEtMS0xLTM3MzU2_9abb5f57-1e01-4770-a722-fa423dc5c389">5,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI4LTMtMS0xLTM3MzU2_2661c774-8524-4645-b2e5-86edaaa1eb9f">5,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI5LTEtMS0xLTM3MzU2_5d22e686-e82c-41b8-bdbe-79a8295f5c14">92,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI5LTMtMS0xLTM3MzU2_51a6e2e4-5b67-4493-9bca-dd37cd38717c">76,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzMxLTEtMS0xLTM3MzU2_2cdc2a78-c46d-4575-be74-e775500eee19">120,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzMxLTMtMS0xLTM3MzU2_79a8d48e-f72d-4ffe-9b0c-80ef56ef119d">94,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI4LTEtMS0xLTQxNTA3_00cecc05-1339-4afe-a3eb-ee039dc01ba9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI4LTMtMS0xLTQxNTA3_7385e369-9db2-41da-8c3b-6ca9ccd8024d">11,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM0LTEtMS0xLTM3MzU2_e44930fe-1405-4c63-a62e-7c7885fd412d">340,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM0LTMtMS0xLTM3MzU2_1ee34024-8df1-417e-a841-317f1dcb7902">401,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term borrowings under senior credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:SecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM1LTEtMS0xLTM3MzU2_c1f81e34-5e4f-46c0-af51-73deb5ea4588">824,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:SecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM1LTMtMS0xLTM3MzU2_7b861e2f-2bf4-4153-bcef-6f0259e866a7">933,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term borrowings under securitization facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="iart:SecuredLongTermDebtSecuritizationProgramNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM2LTEtMS0xLTM3MzU2_4d9c8d2a-1987-46ee-9dc8-2421d1f7e5d9">112,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="iart:SecuredLongTermDebtSecuritizationProgramNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM2LTMtMS0xLTM3MzU2_6c37ba17-ed68-4740-b02c-ec46e0788970">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM3LTEtMS0xLTM3MzU2_a9a0a035-0f46-4989-8ae6-6f82c9b00af7">564,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM3LTMtMS0xLTM3MzU2_8f10e064-013a-4983-86c4-bb72d18f7409">474,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM4LTEtMS0xLTM3MzU2_3117f6f3-3d4e-4b2a-99df-487718a2ace4">90,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM4LTMtMS0xLTM3MzU2_4d4ca4b8-fdbd-4d91-b486-2543a042067f">88,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM5LTEtMS0xLTM3MzU2_85c12459-e43d-4cc2-a105-02b9ee299e96">45,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM5LTMtMS0xLTM3MzU2_40e8ed41-3224-4aac-8938-fb8a3b46ff87">16,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQwLTEtMS0xLTM3MzU2_cac8dea6-f695-4872-91dc-e0e4c375f625">120,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQwLTMtMS0xLTM3MzU2_cb738170-73ab-4df7-b576-10690c888851">186,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQyLTEtMS0xLTM3MzU2_e9a10b87-72ae-4665-87b5-b28282b29e6e">2,097,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQyLTMtMS0xLTM3MzU2_980f02e0-d5dd-4fb0-82aa-ffab1da48a79">2,100,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred Stock; <ix:nonFraction unitRef="usdPerShare" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="INF" name="us-gaap:PreferredStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTAtMS0xLTM3MzU2L3RleHRyZWdpb246MDQyN2VhMzc3MzFhNDBiYTg2ZTU3NGRhNGZkOWEwMDFfMTA5OTUxMTYyNzg1Nw_cc472a1c-9daa-4b9a-9b6f-6d74349b988e">no</ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTAtMS0xLTM3MzU2L3RleHRyZWdpb246MDQyN2VhMzc3MzFhNDBiYTg2ZTU3NGRhNGZkOWEwMDFfMzU_2d9af216-19ad-4007-b513-2361e4ea0f27"><ix:nonFraction unitRef="shares" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTAtMS0xLTM3MzU2L3RleHRyZWdpb246MDQyN2VhMzc3MzFhNDBiYTg2ZTU3NGRhNGZkOWEwMDFfMzU_6291fdff-232b-4f7f-bc94-9f7f2156d12c">15,000</ix:nonFraction></ix:nonFraction> authorized shares; <ix:nonFraction unitRef="shares" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTAtMS0xLTM3MzU2L3RleHRyZWdpb246MDQyN2VhMzc3MzFhNDBiYTg2ZTU3NGRhNGZkOWEwMDFfMTA5OTUxMTYyNzg2Ng_77d20694-4b81-481d-86a5-8472761783f1">none</ix:nonFraction> outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTEtMS0xLTM3MzU2_ec112ea9-1b9d-45d5-ba39-870f83f75110">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTMtMS0xLTM3MzU2_6dbd83e5-4cd6-4e33-8ddb-d17cad8ee8ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMTg_85a20c07-4b6d-4cb7-b013-460faabb0481"><ix:nonFraction unitRef="usdPerShare" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMTg_8c27d7c7-ef35-4fb6-be16-7f101fe50035">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMzI_750a2483-6da9-44d4-bbdb-b3d044e227d1"><ix:nonFraction unitRef="shares" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMzI_fd73301a-d407-464c-9da3-71e65337b255">240,000</ix:nonFraction></ix:nonFraction> authorized shares; <ix:nonFraction unitRef="shares" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMTA5OTUxMTYyNzkyNA_cc63f8fa-82a8-4252-9fe1-6652ff18eac8">89,600</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMTA5OTUxMTYyNzkxOQ_6d0c9520-a6fb-44e9-a740-8ce2639a5d82">89,251</ix:nonFraction> issued at December&#160;31, 2021  and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTEtMS0xLTM3MzU2_0c64c673-7ea0-4b9d-91ef-0063ea3b501b">896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTMtMS0xLTM3MzU2_e62c3ab3-01a6-4203-be2b-7a552f67ec96">893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ3LTEtMS0xLTM3MzU2_189bdc0a-9813-4723-b128-89710e42e2d5">1,264,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ3LTMtMS0xLTM3MzU2_0b21e6fa-1b48-44b2-a7dd-e272fc452dd9">1,290,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ4LTAtMS0xLTM3MzU2L3RleHRyZWdpb246OGE4MDE1NTdkYjBkNGZmOGIwNTYzMDJmNzg4MzJmODBfMTY0OTI2NzQ0MTc1Mg_e7fbe764-dbae-49d3-ab81-ea0c0f15fdf2">4,899</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ4LTAtMS0xLTM3MzU2L3RleHRyZWdpb246OGE4MDE1NTdkYjBkNGZmOGIwNTYzMDJmNzg4MzJmODBfMTA5OTUxMTYyNzg1OA_962d25ab-67c0-4517-9a70-e1ebc340aabc">4,914</ix:nonFraction> shares at December&#160;31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ4LTEtMS0xLTM3MzU2_5f656c23-08a5-4744-8ce9-69cb3977142b">234,448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ4LTMtMS0xLTM3MzU2_ac626f76-caf8-4286-acc9-691966a7849c">235,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ5LTEtMS0xLTM3MzU2_73e171c5-2ab8-4125-9e63-06d3ce9fe6e0">45,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ5LTMtMS0xLTM3MzU2_ec1010bf-7314-4107-b4ea-c3aa84924e5c">74,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUwLTEtMS0xLTM3MzU2_c8c066f2-e161-442d-b3df-f699034a8cee">698,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUwLTMtMS0xLTM3MzU2_bcd1c057-0ced-42a9-a92a-97d43a3435cf">532,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUxLTEtMS0xLTM3MzU2_a359b799-d5cd-444c-897b-5ffd43c9645e">1,684,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUxLTMtMS0xLTM3MzU2_97ae194d-f0d5-4807-a97a-4a5a815c1774">1,514,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUyLTEtMS0xLTM3MzU2_df309297-57cb-4724-bcdc-7bf0f9cdad51">3,782,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUyLTMtMS0xLTM3MzU2_49f778b1-4e47-49ab-b7a4-3b04488b9d78">3,615,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_130"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQtMS0xLTEtMzczNTY_f888343f-bf0b-46d1-939e-15440894165b">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQtMy0xLTEtMzczNTY_983a433d-d99d-4d6c-a377-b10f7762a48b">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQtNS0xLTEtMzczNTY_f2cec6f3-aa34-4524-9174-1fe4739f419c">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzctMS0xLTEtMzczNTY_ccda1c94-8e4f-479e-b573-7b959f0e438e">119,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzctMy0xLTEtMzczNTY_3e69fcb0-e55d-4fd0-9db9-3b0a2ccda35f">116,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzctNS0xLTEtMzczNTY_fbc557fd-fd53-44a0-b156-782a87dffeee">109,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash in-process research and development expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:NoncashOrPartNoncashInProcessResearchAndDevelopment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzgtMS0xLTEtMzczNTY_1751d3ac-0e35-4287-9afa-475c4a25c016">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="iart:NoncashOrPartNoncashInProcessResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzgtMy0xLTEtMzczNTY_f1b44bcb-e74e-45a3-8593-5ee9e0091576">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="iart:NoncashOrPartNoncashInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzgtNS0xLTEtMzczNTY_67e16233-889f-4140-b829-bff24414f055">64,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzktMS0xLTEtMzczNTY_d8936fd4-c175-4aec-b53f-a3adb5d77ae5">2,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzktMy0xLTEtMzczNTY_3ea1518b-e98d-4cf6-809d-960502403d91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzktNS0xLTEtMzczNTY_eb35d031-e4f6-4792-b687-e657eeef2284">5,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income tax (benefit) provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEwLTEtMS0xLTM3MzU2_8fe877df-4b44-4634-9146-36e0b441d244">2,755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEwLTMtMS0xLTM3MzU2_c87c21cf-0e76-4811-abd8-76c70483a090">64,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEwLTUtMS0xLTM3MzU2_affbb454-b7cf-4e4d-ab0b-e884c2636e8d">19,046</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEyLTEtMS0xLTM3MzU2_3b5a7ffc-6c01-44c6-8abf-95b176b3e626">36,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEyLTMtMS0xLTM3MzU2_f1732159-5ee6-4117-8d02-e19b80ab3483">19,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEyLTUtMS0xLTM3MzU2_0c1d8434-1135-4f7b-b9d4-c9be28616d62">21,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt issuance costs and expenses associated with debt refinancing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEzLTEtMS0xLTM3MzU2_bcd19e0d-8c1e-447e-aaa9-8d8a5e7b8d31">7,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEzLTMtMS0xLTM3MzU2_9ffaadfb-039e-4357-a405-46f6e512cb95">12,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEzLTUtMS0xLTM3MzU2_3e1d4166-6205-433c-8be2-90e206bbace4">5,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTEtMS0xLTM3MzU2_dbbe6f1f-a8a0-4de5-a996-1f64ffe90148">3,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="iart:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTMtMS0xLTM3MzU2_a6f49798-5160-482a-82c8-f34a1b421d62">2,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="iart:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTUtMS0xLTM3MzU2_4319b926-bd9c-4e89-b085-331183b0a76b">5,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accretion of bond issuance discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:AccretionExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE1LTEtMS0xLTM3MzU2_44e51f75-b208-4e68-a942-363b704b8980">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:AccretionExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE1LTMtMS0xLTM3MzU2_ac4175c8-755b-4d33-834d-95048dfb011c">15,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:AccretionExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE1LTUtMS0xLTM3MzU2_ab326c72-1295-45c9-9c07-795fb2ee9086">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment and construction in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE3LTEtMS0xLTM3MzU2_260a0cc6-ccf9-44ae-a406-ff9317bc2803">2,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE3LTMtMS0xLTM3MzU2_e533bf6b-a3a8-4f1f-be75-260ae0260209">7,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE3LTUtMS0xLTM3MzU2_935798c5-f6b0-461b-87b5-2cb2b75bfc08">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from the sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTEtMS0xLTQyMjMw_a35f7f4c-2f11-4b1f-87db-84989610c3a6">41,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTMtMS0xLTQyMjMw_01d830e8-84c9-4553-a00d-0def3bc869e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTUtMS0xLTQyMjMw_3fa0157b-bdf5-4686-997d-313902775846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration and others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzIwLTEtMS0xLTM3MzU2_fd019560-f330-4feb-82c7-b84febf824d4">2,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzIwLTMtMS0xLTM3MzU2_aec1ae41-be91-4834-ae4a-e6ed4ac814bb">951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzIwLTUtMS0xLTM3MzU2_b73f7965-93f4-4b4d-94d9-9c311c3e243b">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI0LTEtMS0xLTM3MzU2_2804b0ff-4b1e-4dc6-8710-a943ee1b7dc7">7,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI0LTMtMS0xLTM3MzU2_3e579710-cdb8-463c-9810-738f0475d44f">52,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI0LTUtMS0xLTM3MzU2_af8f486c-4303-403b-bb98-3575fbd940d9">9,428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI1LTEtMS0xLTM3MzU2_12829639-4811-4c1f-a757-69ca03f0f6df">5,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI1LTMtMS0xLTM3MzU2_f5d1d726-752e-43b0-928c-1429e9bbed6c">48,348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI1LTUtMS0xLTM3MzU2_3b1988a9-15ef-4ef7-8deb-78edd1930f31">43,308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI2LTEtMS0xLTM3MzU2_1dd2aa24-7993-407b-9cc1-8ae8cd9a3170">21,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI2LTMtMS0xLTM3MzU2_165caa1e-c375-4844-a634-df61774fbd23">1,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI2LTUtMS0xLTM3MzU2_64e7ed61-fcc1-4d80-a09f-2d41f821d245">13,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTEtMS0xLTM3MzU2_1fad2381-0cde-4b2b-9f18-18711b62c4a1">7,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTMtMS0xLTM3MzU2_86dced81-7f5c-4fca-8d98-758e87361cdf">13,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTUtMS0xLTM3MzU2_30398341-6c0c-4d94-a70e-931a2424d4f1">13,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI4LTEtMS0xLTM3MzU2_78ef13e2-0152-49ae-b414-4b15e1de93d5">32,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI4LTMtMS0xLTM3MzU2_414fc71c-204a-4169-b9a5-ea04c16a4494">57,512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI4LTUtMS0xLTM3MzU2_94ac4112-fd72-49aa-bbd8-65fe09ea6e4e">14,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI5LTEtMS0xLTM3MzU2_ae9fffad-652c-47ed-8c18-a8cc5d900af0">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI5LTMtMS0xLTM3MzU2_9eaad2be-2acb-4af6-b56c-8c93b96dedd2">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI5LTUtMS0xLTM3MzU2_3517bce7-357d-4ab2-a4b5-74381ee169a5">607</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMwLTEtMS0xLTM3MzU2_4f532016-ef78-4910-a35e-89bc12196959">14,110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMwLTMtMS0xLTM3MzU2_6f8a9e81-1c34-4b0f-8222-b58bd2aa6f60">2,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMwLTUtMS0xLTM3MzU2_43d4f6d6-2fb9-4cb3-93bb-c28371b35d15">2,059</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by operating activities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMzLTEtMS0xLTM3MzU2_e3906864-8864-48fb-8b42-d88afe68fdd1">312,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMzLTMtMS0xLTM3MzU2_2c418b7f-b704-456d-a4be-d570205990b9">203,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMzLTUtMS0xLTM3MzU2_0f7e9554-21a0-420c-a8d8-904e9f48edc8">231,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM3LTEtMS0xLTM3MzU2_64eb7250-27eb-43e7-896f-f6c79631427f">48,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM3LTMtMS0xLTM3MzU2_a37a70a2-35ef-4e8e-b6b1-4b7b70ac2038">38,890</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM3LTUtMS0xLTM3MzU2_066d321d-b718-4f79-bae5-2b2979f480ea">69,537</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of Extremity Orthopedics Business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTEtMS0xLTQyMjQ3_eafa5a29-5a4b-4bfb-8a2e-53b197b59e15">190,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTMtMS0xLTQyMjQ3_c6bff5cc-4f59-4750-98a6-68c71c45c552">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTUtMS0xLTQyMjQ3_8f83d456-beb0-482e-a06e-f8b325d057ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired in-process research and development and intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM4LTEtMS0xLTM3MzU2_e988eb35-ef97-4368-a2b4-88b462c3c069">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM4LTMtMS0xLTM3MzU2_8599a30a-4d59-4406-93cf-43d9de23b65a">25,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM4LTUtMS0xLTM3MzU2_ff47d17f-866e-4c2f-aa80-6b78e9341735">64,995</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from note receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM5LTEtMS0xLTM3MzU2_4ff9f547-120b-43c8-b13a-7f768d2a71df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM5LTMtMS0xLTM3MzU2_1acb459a-4c05-4ce0-bba7-8086fe9cfe8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM5LTUtMS0xLTM3MzU2_3378ab70-c59a-4105-8d67-05dfd7e4d5c2">752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:PaymentsForProceedsFromBusinessAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQwLTEtMS0xLTM3MzU2_1a303352-a026-4696-ab10-d86834c4b803">303,910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="iart:PaymentsForProceedsFromBusinessAcquisitions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQwLTMtMS0xLTM3MzU2_2e6af553-ae60-4068-99c2-ac679e9af7bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="iart:PaymentsForProceedsFromBusinessAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQwLTUtMS0xLTM3MzU2_810a4f33-4efb-4a34-8317-c0a1d97b9fc2">30,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQxLTEtMS0xLTM3MzU2_370fd887-d8c2-4902-938d-6dbfb78cbf7e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQxLTMtMS0xLTM3MzU2_28337c7d-89f7-4e31-b7ba-5d4332333c12">3,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQxLTUtMS0xLTM3MzU2_d3491c08-8022-4657-ae7b-ea7ab4e07a87">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds (payments) on swaps designated as net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQzLTEtMS0xLTM3MzU2_868a941e-689b-472b-a315-172cda85b336">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQzLTMtMS0xLTM3MzU2_9d0892b6-72aa-4e86-99e7-0d2ca278abe8">7,840</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQzLTUtMS0xLTM3MzU2_3e58eae7-fc37-4685-9420-522f4354fc0f">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQ4LTEtMS0xLTM3MzU2_45d338cc-3542-4692-a2cf-47856b5b6dd2">161,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQ4LTMtMS0xLTM3MzU2_a6d8ee26-86bf-4644-a08d-f11adc6b4e80">68,073</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQ4LTUtMS0xLTM3MzU2_27e91324-cf93-437b-b841-87f47a502b2a">162,668</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from borrowings of long-term indebtedness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUwLTEtMS0xLTM3MzU2_14ea74d0-a53e-41d4-b80b-c6bed4c089aa">25,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUwLTMtMS0xLTM3MzU2_85d5bf20-a6e2-49a1-94ad-1b2c3d6b0c1c">171,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUwLTUtMS0xLTM3MzU2_b3abc141-c538-456b-9782-7d29fa723249">236,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUxLTEtMS0xLTM3MzU2_30cb29ad-1eb4-4d11-9560-a6cf54a9f8c9">125,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUxLTMtMS0xLTM3MzU2_e27e496a-8e56-458f-9a4d-5cf21229f50d">441,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUxLTUtMS0xLTM3MzU2_c4832df0-25ba-493e-9ce2-f1ff592a1447">246,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of option hedge on convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTEtMS0xLTM3MzU2_3a0c4101-f6bd-49c5-8d73-2e81012d7474"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTEtMS0xLTM3MzU2_c461d108-586d-4a5d-8c21-ef8715664456">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTMtMS0xLTM3MzU2_507b7c88-9be6-4e3b-84af-26297927aaa3"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTMtMS0xLTM3MzU2_6d3f2d46-f990-438d-91bb-ed0b3c2c33f7">104,248</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTUtMS0xLTM3MzU2_4f066461-ac85-48c4-8458-cf2a2b0e0f78"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTUtMS0xLTM3MzU2_bea2b371-8b61-4cb5-8f14-5d4a7bf0286b">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from convertible notes issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTEtMS0xLTM3MzU2_166b3830-67ed-4665-92c3-78e03eec91d3"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTEtMS0xLTM3MzU2_17c8e849-8d4d-4dba-a4eb-272c6dbe06a6">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTMtMS0xLTM3MzU2_5dfa4074-1f3a-42ae-8c9a-3633c3ad62de"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTMtMS0xLTM3MzU2_6029a50c-5b61-4eac-86dc-ea9e1c5f024f">575,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTUtMS0xLTM3MzU2_9e228351-2326-4677-8df0-d7bd682eb617"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTUtMS0xLTM3MzU2_d78e00e4-7d58-4350-ad56-7f92b254cd14">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of stock purchase warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU0LTEtMS0xLTM3MzU2_bf9f370b-6382-41f0-a37a-7115e0ffdbb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU0LTMtMS0xLTM3MzU2_6bc66c33-4b30-4cbf-be79-af5cbfd3be99">44,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU0LTUtMS0xLTM3MzU2_351825b7-4e3e-471c-8d95-d4d07b6686aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU1LTEtMS0xLTM3MzU2_9fed3099-e366-4c70-a848-67c1600ab33e">249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU1LTMtMS0xLTM3MzU2_4ee6e8b4-d024-40cb-882f-23d140ff0c8f">24,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU1LTUtMS0xLTM3MzU2_7f397074-d876-4ae9-91c6-ee26ec1bf8ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU2LTEtMS0xLTM3MzU2_f924b014-b861-4e17-9da0-557b15eeddc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU2LTMtMS0xLTM3MzU2_586279f8-2c2e-4ae5-b58a-185af0aa1620">100,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU2LTUtMS0xLTM3MzU2_f6ea0694-5f97-4727-bf0f-9cc3f156904d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercised stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU3LTEtMS0xLTM3MzU2_d337260d-7764-4a2f-a5ea-594227bd5ddb">6,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU3LTMtMS0xLTM3MzU2_22c713a7-c3f5-4b5c-a465-f84edd0d3da0">5,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU3LTUtMS0xLTM3MzU2_520a0714-adeb-4526-96fe-08d2596e381b">6,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash taxes paid in net equity settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYyLTEtMS0xLTM3MzU2_fcd99898-63e8-4f92-9cd2-e1c90d172c49">4,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYyLTMtMS0xLTM3MzU2_c215ad86-bac9-4cb8-b222-4d6ba2217e72">5,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYyLTUtMS0xLTM3MzU2_348808a9-cc97-4596-9daa-ecd05a3f665b">6,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYzLTEtMS0xLTM3MzU2_ebad72c6-31a3-4ae4-8b7d-ce47e1a80662">98,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYzLTMtMS0xLTM3MzU2_ab548311-471d-4a46-9f3d-7f1140140625">121,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYzLTUtMS0xLTM3MzU2_9042878f-9e4e-451b-b146-e1ccb4fe0279">8,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY0LTEtMS0xLTM3MzU2_63b3552d-0d51-472c-b0f4-9114636b17b9">9,476</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY0LTMtMS0xLTM3MzU2_53e3a390-79d8-4b29-a2b9-600b8599ba39">13,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY0LTUtMS0xLTM3MzU2_686ef01f-2f13-4201-8d44-6005fb7c9a78">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY1LTEtMS0xLTM3MzU2_d7a86f15-b8d8-4842-8468-bfbd77eca720">43,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY1LTMtMS0xLTM3MzU2_9fb8662a-3c3b-4756-842f-61e104182bd1">271,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY1LTUtMS0xLTM3MzU2_afdbd88a-4f33-431a-9353-98e6939e1b9f">60,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY2LTEtMS0xLTM3MzU2_fdc6d1ac-ee29-44a4-a823-a2162ce94656">470,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55084e91d494776891870a81ff5cb91_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY2LTMtMS0xLTM3MzU2_bac33024-4905-4057-885f-bbd23f52bfb1">198,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcaf1fbc6c2145ac92ae58dce7c7f40b_I20181231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY2LTUtMS0xLTM3MzU2_ef354199-8f88-4417-a26f-5634809d4db5">138,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY3LTEtMS0xLTM3MzU2_4b97860d-cf86-4f70-a8db-f5cb1df8f379">513,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY3LTMtMS0xLTM3MzU2_0e632e56-579b-46e8-84dd-2305a76efe21">470,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55084e91d494776891870a81ff5cb91_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY3LTUtMS0xLTM3MzU2_df63376a-2cc7-40e5-82b8-0a1debb5076a">198,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.568%"><tr><td style="width:1.0%"></td><td style="width:29.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.561%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibca422d8af654309ab3549894c22e2d0_I20181231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTEtMS0xLTM3MzU2_65cc19fd-9ae3-426f-97ca-eed0f5bd2653">88,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibca422d8af654309ab3549894c22e2d0_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTMtMS0xLTM3MzU2_dcf48d65-10b2-408a-81fa-8e0a0c79dbb7">880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia653c210464848738937121e1560643c_I20181231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTUtMS0xLTM3MzU2_e2af6e4e-cf9b-4fb7-97cb-d48a356412b0">2,881</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia653c210464848738937121e1560643c_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTctMS0xLTM3MzU2_7ac329e0-c78b-4f2a-b23a-2a6c3bbef66b">120,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bfd63f1146a4c15a4a961a4884d8f8e_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTktMS0xLTM3MzU2_c09f71af-41ed-439f-bb9d-f985fad099a5">1,192,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1aef4bf54744c0c98c1b03a1df9ec4d_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTExLTEtMS0zNzM1Ng_88343575-e5a0-49cd-9f63-3bc788586c36">45,443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b92cad52f3d4933bd002cc96a643e01_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTEzLTEtMS0zNzM1Ng_8be1f9e2-aeae-4311-a1d8-cecb6f5c4c86">348,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcaf1fbc6c2145ac92ae58dce7c7f40b_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTE1LTEtMS0zNzM1Ng_de16e5d8-8e9f-4fb0-9471-72b359c2ae91">1,375,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea229e31f5ee46999defcde318bf2e01_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUxLTEzLTEtMS0zNzM1Ng_ab93450c-d2af-4482-8321-8e0773bc7df2">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUxLTE1LTEtMS0zNzM1Ng_9e9418e9-f617-43f4-8581-598d0814d5e1">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3184ef53b5bf48b89f52d96b36d83cd8_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUyLTExLTEtMS0zNzM1Ng_22fe3eaa-30c0-4b08-ab6f-7210b2b25bc2">30,959</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUyLTE1LTEtMS0zNzM1Ng_cb1269d6-b4e2-4279-8678-cd7d12672096">30,959</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7d6cd85315a4099a0e9a723e15cc57d_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUzLTEtMS0xLTM3MzU2_061b3d46-b55f-4396-a184-2d78bb592a87">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe101f812943a4bb6c8e21f03e6abe_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUzLTktMS0xLTM3MzU2_ad4b4eb2-62cd-42d7-b59f-2cc4ed3d2ef5">716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUzLTE1LTEtMS0zNzM1Ng_ef0fbea6-d142-42a8-a443-51a70e24e182">716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7d6cd85315a4099a0e9a723e15cc57d_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTEtMS0xLTM3MzU2_e6829f2e-bee4-4d2b-bcf0-acc97ac36ed3">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7d6cd85315a4099a0e9a723e15cc57d_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTMtMS0xLTM3MzU2_eb662e7a-7859-4a5f-b899-00f39047cb24">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57de76fda3e440858f132dfbe6b7a489_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTUtMS0xLTM3MzU2_3294c3f3-b05b-488e-b2c5-a2d8c99cd231">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57de76fda3e440858f132dfbe6b7a489_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTctMS0xLTM3MzU2_7d988132-ab6d-40f5-87ce-b0afc301f2e2">672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe101f812943a4bb6c8e21f03e6abe_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTktMS0xLTM3MzU2_a6620066-1dbb-4ba1-bdd9-fafa08da3435">961</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTE1LTEtMS0zNzM1Ng_d8b9db49-492c-4353-828f-e23d0626b295">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe101f812943a4bb6c8e21f03e6abe_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU1LTktMS0xLTM3MzU2_c74c2a99-f5a7-47ed-be7f-06b02d85c515">21,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU1LTE1LTEtMS0zNzM1Ng_2c28804b-2eb9-466a-b27b-42b9fd6c826a">21,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i72b41bb28dd74cab856e1fb68a9457e4_I20191231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTEtMS0xLTM3MzU2_2830735f-308a-4597-ab3e-5c92f67b361c">88,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72b41bb28dd74cab856e1fb68a9457e4_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTMtMS0xLTM3MzU2_301e4187-d676-4d2c-bc79-b39712e00572">887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idfd8af4c329c447fa3829f444aa543e6_I20191231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTUtMS0xLTM3MzU2_d739743d-f752-409e-9b4d-f744c3563bbf">2,865</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfd8af4c329c447fa3829f444aa543e6_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTctMS0xLTM3MzU2_5c851744-277e-43b2-aa85-239835a7a5a8">119,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008a1ec620f549bb9fe080a50c5507b5_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTktMS0xLTM3MzU2_8eac9f01-21c7-4e3d-9b9f-95dd4f71230d">1,213,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide0d9f6801174af69063a55bae4f6ea4_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTExLTEtMS0zNzM1Ng_4622cf17-a4ae-441b-a37b-9b506327b2d2">76,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ecb901e8b3f401a8bb8305e200e9cfd_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTEzLTEtMS0zNzM1Ng_bb0dcb9f-7d1d-47de-b3e4-c50a62fa7a83">398,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55084e91d494776891870a81ff5cb91_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTE1LTEtMS0zNzM1Ng_bb4e74b9-f6d9-4941-ae5d-4aeb308ed8a5">1,416,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26020eaabf34449c9314e52e2b46ced3_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU3LTEzLTEtMS0zNzM1Ng_3f148150-f6f5-4b6f-add5-1228da0be42b">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU3LTE1LTEtMS0zNzM1Ng_8f503c08-a5e7-4cf7-9c03-b38538754545">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec381aeaa645411985794e468f533624_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU4LTExLTEtMS0zNzM1Ng_4edd6a3b-e54f-4eef-9402-287018f0475e">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU4LTE1LTEtMS0zNzM1Ng_d6a030f8-ccf5-45b9-929c-4b30efcbaaf8">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82c6bb6b0f504d638356e1bbc6647d3c_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU5LTEtMS0xLTM3MzU2_b5679ad2-1892-4528-8f23-d0571cf6b14d">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU5LTktMS0xLTM3MzU2_58bbf1c0-ac37-45fb-a8d3-a796612ff867">694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU5LTE1LTEtMS0zNzM1Ng_9bddbc26-d4cc-4d3c-b7d8-d2ce4cbf1da8">694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82c6bb6b0f504d638356e1bbc6647d3c_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTEtMS0xLTM3MzU2_127c80e8-9112-4ac2-b8f1-70f6c560af46">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c6bb6b0f504d638356e1bbc6647d3c_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTMtMS0xLTM3MzU2_bf6f8d81-ed19-48fc-8a27-2da8741a24b9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fd48636569448e0af0d30413ae28c64_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTUtMS0xLTM3MzU2_f1cfb465-780c-41ec-bca8-2d023f5a24d2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd48636569448e0af0d30413ae28c64_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTctMS0xLTM3MzU2_c87fa215-78dc-4176-b7ef-c411c9b46ae8">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTktMS0xLTM3MzU2_9b34a920-7765-4bc8-82c3-cec8e2df1697">1,066</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTE1LTEtMS0zNzM1Ng_d97f5170-c370-48e7-842d-89dc8c0891e7">538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c6bb6b0f504d638356e1bbc6647d3c_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYxLTMtMS0xLTM3MzU2_e81c06a2-b229-40d3-b9d1-a4c71afdf6b1">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYxLTktMS0xLTM3MzU2_aa54c568-e1aa-48ad-9288-43b14a24783b">19,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYxLTE1LTEtMS0zNzM1Ng_1b857aae-7514-483a-8acf-380e9f2de0ef">19,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase and equity component of the convertible note issuance, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYyLTktMS0xLTM3MzU2_47f8c2f5-869a-48dd-87c4-6200c2961c7f">42,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYyLTE1LTEtMS0zNzM1Ng_187ec05b-660b-4abb-9217-b7bb0984e032">42,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated shares repurchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5fd48636569448e0af0d30413ae28c64_D20200101-20201231" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYzLTUtMS0xLTM3MzU2_82c0ebfd-ec7b-40fc-896a-40c237b0a95e">2,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fd48636569448e0af0d30413ae28c64_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYzLTctMS0xLTM3MzU2_be842321-469a-4992-9e5a-2c10ab883ba1">115,724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYzLTktMS0xLTM3MzU2_de868514-72d5-48a3-8cd7-4c2b2edce465">15,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYzLTE1LTEtMS0zNzM1Ng_72fe714d-3e44-43b2-a758-de5bde07dd50">100,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY0LTAtMS0xLTM3MzU2_6ec0d2c1-0137-4ab4-bbb6-a370369c6602">Adoption of Update No. 2016-13</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib45c219279874482b251ea345021653d_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY0LTEzLTEtMS0zNzM1Ng_344ec762-f0c3-4801-a776-e89956cac527">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6646ef2e0b7149db85eb6904dd2a2fd7_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY0LTE1LTEtMS0zNzM1Ng_a28bf0c6-a22d-4cf0-bafb-da38563cfa0e">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if738d2f8a6a346b78585e76bc617302c_I20201231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTEtMS0xLTM3MzU2_3073240e-e124-46c4-8db3-0654213693d6">89,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if738d2f8a6a346b78585e76bc617302c_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTMtMS0xLTM3MzU2_b7797835-e6dd-472f-bf4e-02e2cc4858a4">893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8fb5aab0b91c486f93ba0865f67d73e3_I20201231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTUtMS0xLTM3MzU2_dabfa40d-70f2-4bde-b92e-044f68eeeff6">4,914</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fb5aab0b91c486f93ba0865f67d73e3_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTctMS0xLTM3MzU2_ec722d99-ca28-4142-91d5-63c601e4f31e">235,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0f354f47024885b393073798c5bcb4_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTktMS0xLTM3MzU2_a7253357-d9b8-463e-a84c-b5b9607ec1bc">1,290,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b2f27cba47049e49b27de743dc66104_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTExLTEtMS0zNzM1Ng_1a760dba-2863-41bd-9525-c6c0827781d6">74,059</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9e723c32e3484daf7f94702722ed89_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTEzLTEtMS0zNzM1Ng_9aedf45c-37ef-4f86-9724-7bf8e46b04af">532,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTE1LTEtMS0zNzM1Ng_ce54ad35-6745-4af9-b52a-c21c42af2b0b">1,514,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcfb8e89af374d30815fb2d4a02f9b08_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzE4LTEzLTEtMS00MjY1MA_43934f63-ed74-4aa3-b354-c3dfd3ada726">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzE4LTE1LTEtMS00NDkxOQ_36d26d9b-39f0-4900-bc67-0f35d8f25860">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dfb0dc7e5f246bb8a7849e9e7d24e92_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzE5LTExLTEtMS00MjY1MA_bb15d308-03b5-4211-88d8-780d15928413">28,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzE5LTE1LTEtMS00NDkxOQ_21fbcc3b-19f9-4ee1-8fa0-a0dbcb89258f">28,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba3867d19dfa4492be95296631dd23cc_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIxLTEtMS0xLTQyNjUw_dfc89619-a845-4e09-811c-f97c32a548e9">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f824b4c3df84987af91c402bc76a408_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIxLTktMS0xLTQyNjUw_7ff6b0ed-6ce0-497a-b63b-04678f38c87f">1,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIxLTE1LTEtMS00NDkyMg_fe5a0fae-499a-4ca2-adb8-370ebb6e6e39">1,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba3867d19dfa4492be95296631dd23cc_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTEtMS0xLTQyNjUw_de1508de-4de2-4f3f-bea8-5f8333559f86">331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba3867d19dfa4492be95296631dd23cc_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTMtMS0xLTQyNjUw_b6c7decb-d736-4b07-b2ae-6b700b8afc64">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6c5aeb396884c44b182cf5d1e5128cf_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTUtMS0xLTQyNjUw_fb1e4734-bf4e-4132-9a8d-c2322887bcfd">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c5aeb396884c44b182cf5d1e5128cf_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTctMS0xLTQyNjUw_e5cf5114-9f4c-41ef-92ac-1a54ef88e6a9">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f824b4c3df84987af91c402bc76a408_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTktMS0xLTQyNjUw_8488fe9c-0284-4e10-ae96-1890c515bce8">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTE1LTEtMS00NDkyMg_3204cffe-be65-4d47-bcdd-28b9605eb1a0">895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba3867d19dfa4492be95296631dd23cc_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIzLTMtMS0xLTQyNjUw_5a61c08e-89a1-4014-8383-45b4319420be">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f824b4c3df84987af91c402bc76a408_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIzLTktMS0xLTQyNjUw_3ce940ed-1415-49bf-8145-4688f6b6d6dc">35,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIzLTE1LTEtMS00NDkyMg_2bd8c389-3b4b-4d37-a8c7-b991ec913e20">35,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI0LTAtMS0xLTQ0OTI1_bdbd4380-9fca-40b5-9280-10467d59cd85">Adoption of Update No. 2020-06</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f7a013d5ebd4d9cad2eddbf41dc58f8_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI0LTktMS0xLTQyNjUw_c0337502-9b06-410a-b485-a32f2368c82d">63,274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic716df195898449a87cdc08a6bad6057_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI0LTEzLTEtMS00MjY1MA_aaf801af-908c-4e8f-9b1f-02e571a1f6b7">2,773</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11696c20228346ddb295ad994c1d9416_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI0LTE1LTEtMS00NDkyNQ_05acf55e-1841-42c8-877b-20f903da23bb">66,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie62db310d8e24fc493ae78bec1200f60_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTEtMS0xLTQ0OTI1_17aad2a9-d20c-4a36-b3d2-a26f407df552">89,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62db310d8e24fc493ae78bec1200f60_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTMtMS0xLTQ0OTI1_57bc6673-baa3-4882-ae75-d690a1d141a9">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib92542029c1c4bd08191f3e3b185049c_I20211231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTUtMS0xLTQ0OTI1_9e8b4d6d-7f69-4731-8a88-54c14c3f3ee8">4,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92542029c1c4bd08191f3e3b185049c_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTctMS0xLTQ0OTI1_85311e9f-a592-4c31-bdd7-2f1809d6dd84">234,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0e311baee24ad7a5bd71c8891f1b7c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTktMS0xLTQ0OTI1_377a92f8-1075-4e02-a537-581661e0715d">1,264,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62b5cd28862f4322bda15977250be066_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTExLTEtMS00NDkyNQ_2315d62f-0195-44bb-8e47-1242690a52d1">45,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e9517845c414b658fb2157d69d73d89_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTEzLTEtMS00NDkyNQ_934d9b88-8838-45c0-9623-66f32de2b772">698,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTE1LTEtMS00NDkyNQ_cc035a9b-5c71-433a-b998-5adb5fa5bd4e">1,684,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_139"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzkvZnJhZzo1MjI2ODhjZjVkN2U0M2Y3YmUxY2U1MzlkMzliMThlOS90ZXh0cmVnaW9uOjUyMjY4OGNmNWQ3ZTQzZjdiZTFjZTUzOWQzOWIxOGU5XzU0NA_1d20ea41-6cc5-4e5e-83b7-87b3a08d8efa" continuedAt="i022c3b4d21bc41aea7e8c5096d52162d" escape="true">BUSINESS</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i022c3b4d21bc41aea7e8c5096d52162d">Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) was incorporated in Delaware in 1989. The Company is a worldwide leader in medical technology. The Company was founded with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care. The Company sells its products directly through various sales forces and through a variety of other distribution channels.</ix:continuation></span></div><div id="i172bf506156f43e6869412a665f54418_142"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTYw_4cdb33ad-9eea-4779-a85c-4e5c2824e47a" continuedAt="i1f82a083565d4a18839a1af6b023d883" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i1f82a083565d4a18839a1af6b023d883" continuedAt="ie3e1ed558b2945c59ed1a52986204c94"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTA2_97bb00fd-a286-4abb-b0b4-4e28b1a01cac" continuedAt="i05d3f48ba0a24617ba8dba60e04f9037" escape="true">BASIS OF PRESENTATION </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i05d3f48ba0a24617ba8dba60e04f9037">These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended.</ix:continuation> </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTc5_0534de93-61f4-49e3-b3af-1bee80d92ecf" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PRINCIPLES OF CONSOLIDATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. See Note&#160;4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of new subsidiaries included in the consolidation.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTQw_29ec2f41-8622-4f07-8fd9-86e555fca8e2" continuedAt="i93771d74fe6f4396b64852ca56f83cee" escape="true">USE OF ESTIMATES </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i93771d74fe6f4396b64852ca56f83cee" continuedAt="i511ae3de4c2841738de27d7c5e3b58a0">The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and </ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i511ae3de4c2841738de27d7c5e3b58a0">on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.</ix:continuation> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company continues to navigate the novel coronavirus ("COVID-19") pandemic and recent variants of the virus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as the adverse impacts to global economic conditions, supply chain and the operations, there may be impact to future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#8217;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTY1_cb95a8fb-48ea-445d-a9a4-45883f8a7aeb" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECLASSIFICATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts from the prior year's financial statements have been reclassified in order to conform to the current year's presentation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMDM1_93cea070-305a-4fbf-9983-7546d424736f" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CASH AND CASH EQUIVALENTS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTc2_28e9b016-2846-447a-b58d-d8d1ba118f4b" continuedAt="i99c4d6929fbf4856a7c4da3cec116a91" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie3e1ed558b2945c59ed1a52986204c94" continuedAt="i33ebf01385394dc99f4bdd9c79289176"><ix:continuation id="i99c4d6929fbf4856a7c4da3cec116a91" continuedAt="i02d0ef695d01404ebd0bc9ee609852b4"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i02d0ef695d01404ebd0bc9ee609852b4">Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered.</ix:continuation> Provision for doubtful accounts net of recoveries, associated with accounts receivable, included in selling, general and administrative expense, was recoveries of $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQ0MzE_97a8a068-e134-4e58-ad38-215091d67918">1.1</ix:nonFraction> million for the year ended December&#160;31, 2021, and charges of $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQ0MzU_d2a042c1-b339-4b6e-b853-128c853a478e">3.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQ0NDM_7dbfe249-10ae-49e3-9cae-496cfec8f36e">2.1</ix:nonFraction> million for the years ended December 31, 2020 and 2019, respectively. </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTg4_1441a030-39b7-43c2-a17c-a514320ebaed" continuedAt="ib3b4c81244e149d183b6fe6df3d45f53" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INVENTORIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTk4_d8582cc6-c5b4-4a87-9530-59910212bf44" continuedAt="i1f1e518072514cd2abd69ac77810cd62" escape="true">Inventories consisted of the following: </ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><ix:continuation id="i1f1e518072514cd2abd69ac77810cd62"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzMtMS0xLTEtMzczNTY_77e6d644-4ddd-4053-9775-06f9dc44f212">162,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzMtMy0xLTEtMzczNTY_0c2db2ab-e63b-4d95-92cb-c319095fe9b2">180,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzQtMS0xLTEtMzczNTY_f45bbdd5-d584-469a-947b-19a395fc3e37">65,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzQtMy0xLTEtMzczNTY_8a88b8c1-36f1-4765-8dcf-3b1f2a6bcd7e">53,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzUtMS0xLTEtMzczNTY_ce9ec70e-911a-4b95-bd42-a5a289724ee0">89,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzUtMy0xLTEtMzczNTY_3406df04-df53-4e7e-9b2a-0a243833a482">76,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzctMS0xLTEtMzczNTY_77921d7a-703f-48ef-8c5b-7f1ca3f20a2b">317,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzctMy0xLTEtMzczNTY_39ac32ea-0fd9-45cf-9222-b0d30006fd45">310,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i000ed083c92e4b89800da97c60ed285f_I20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NTU3Mzk_a3f7d88b-1916-4328-ac62-c718d50fcd87">52.8</ix:nonFraction>&#160;million of inventories, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib3b4c81244e149d183b6fe6df3d45f53">The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.</ix:continuation> <ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="iart:InventoryCapitalizedExpenses" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzYzNjA_0028a1c0-00cc-47f7-a65f-6024d98ecf44"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="INF" name="iart:InventoryCapitalizedExpenses" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzYzNjA_abadf78c-3970-4575-9db3-d03ebb03637d">No</ix:nonFraction></ix:nonFraction> such amounts were capitalized at December&#160;31, 2021 or 2020. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i33ebf01385394dc99f4bdd9c79289176" continuedAt="ia61e68e66c3246fe9fd7e644332c294f"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTYy_52addee0-9b18-42f1-aaec-ebb08e3ef73a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROPERTY, PLANT AND EQUIPMENT </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMDM2_7c0dd4f1-1f0f-4c3f-b66c-2e6bb7f544ea" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment balances and corresponding lives were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida04a0f98d5547f9ac6673309e068708_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzMtMS0xLTEtMzczNTY_c5764f35-8625-4647-9c4b-5ae23f2a0416">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a45995162b643ef92059397e2a71385_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzMtMy0xLTEtMzczNTY_33044212-eddd-4fbd-8f5e-b98d4457f947">1,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74b70ea531614678a00a01b323481165_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzQtMS0xLTEtMzczNTY_a5c2de09-8277-41e3-9812-21011fad967e">19,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c7328c66304f0eb5f22d8ed0526940_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzQtMy0xLTEtMzczNTY_92900b82-15e3-4162-981d-eeea5e4d7712">17,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia5208743b3814ba9b6d40074565c4081_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzQtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjozZWNhYjJlMzE4ZmI0ODVkOGQ5M2E2NjcyNmYzNTIwNF80_c988427f-833a-4e40-b15c-6ec2692d3234">5</ix:nonNumeric>-<ix:nonNumeric contextRef="i602a6eef7e324d61a157d45723a03358_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzQtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjozZWNhYjJlMzE4ZmI0ODVkOGQ5M2E2NjcyNmYzNTIwNF83_fec9b9f4-a4ca-482c-8d8e-38c068fdc2bd">40</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b9b9c6b33494f24b03f4851071485a9_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzUtMS0xLTEtMzczNTY_af2adbb7-fed9-4c10-a423-82e2779fc904">155,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i963fa8e01c224aa0a64f3cb763df2e2b_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzUtMy0xLTEtMzczNTY_001bacdd-7d4e-47aa-8cdc-f85b12dcae4d">144,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic02808dda943426e93e0d648a5cde64b_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzUtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpkY2U0MjMxOTIyY2U0ZjcxOGM0YjVjYTQ4Y2ViY2FmZV80_cc8c8244-dd3c-49d0-af1f-495dcfd0a610">1</ix:nonNumeric>-<ix:nonNumeric contextRef="iefe78e2246e94ba3af3242006d2dc451_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzUtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpkY2U0MjMxOTIyY2U0ZjcxOGM0YjVjYTQ4Y2ViY2FmZV83_32975ffb-208c-4bd6-ba5f-68b4fa3df618">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and production equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f2cb2e9bd3545d28c0f0abacf55b9d9_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzYtMS0xLTEtMzczNTY_b4743c7b-f7b3-40b2-858e-8de2b250ed4a">183,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bbc77d02174676af9eed39f9be47a3_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzYtMy0xLTEtMzczNTY_7746f9c0-20e1-4c87-b35c-2bfab1b93225">166,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id648da5e33794a8d9bd7e7832d8f94cd_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzYtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo5YzdlOTZjNTQ5MmU0M2Q3OWYyM2FiYjg3MGQyZTM4Nl80_41c7a64a-ef5e-4132-b1e6-f9da5b7e1280">3</ix:nonNumeric>-<ix:nonNumeric contextRef="i41401778e13647b0a2ee5fcf8f706a6a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzYtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo5YzdlOTZjNTQ5MmU0M2Q3OWYyM2FiYjg3MGQyZTM4Nl83_20899f22-87da-4663-8c7b-90088252b1c3">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical instrument kits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i602ca3405d8741a38048a4535e86e784_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzctMS0xLTEtMzczNTY_e9c047e5-5a1e-4909-8aa2-d21802743d37">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2a65e2f514d443397027c1f3e979693_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzctMy0xLTEtMzczNTY_fe7e1582-b890-45bc-8fcf-b7e69998874a">1,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3295f6c4fa84b5f99c2eb43117653cf_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzctNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjowMWQwNjg3MzIzZTg0MzRhYWQxYTYyN2Q2ZTQ5Yzk4NV80_08cc670a-58d6-4f9c-b1cd-478e72692e47">4</ix:nonNumeric>-<ix:nonNumeric contextRef="i06b3b7586a5a4a83bcf6af176544c1e7_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzctNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjowMWQwNjg3MzIzZTg0MzRhYWQxYTYyN2Q2ZTQ5Yzk4NV83_ee543dae-1112-41b0-ac0c-99fb7db2f998">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information systems and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e4b5df061143a995961c4cc0610f5e_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzgtMS0xLTEtMzczNTY_4e3249ee-3378-4aa8-bf16-c721116a1bbe">148,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie167866deb594d9bad75e4138245a4e7_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzgtMy0xLTEtMzczNTY_93c22ef0-5f18-46f7-b84e-3bdb26b2529f">143,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i203bb570980f4213ae16c7f18573158d_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzgtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpmNGFjNTIzYzFmMTA0NzBjOTUxZTQxNDBkNzBiMzJkY180_c48de2a6-3f95-41a5-87c8-24e9dc78791c">1</ix:nonNumeric>-<ix:nonNumeric contextRef="iabf661f62ecd41f38efb53c5c7fab30f_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzgtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpmNGFjNTIzYzFmMTA0NzBjOTUxZTQxNDBkNzBiMzJkY183_a5519e42-01e6-41aa-b74e-2de88b7bc701">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures, and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fd943aa50cb4e70b0f976a5852b32cd_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzktMS0xLTEtMzczNTY_dc8aa945-7728-4429-8b4b-f93c699862e5">20,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2a0560d0be447492d3aa5f43a5fb1f_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzktMy0xLTEtMzczNTY_cf160116-b96c-42fa-ad4f-80cfc190a81a">20,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie8a2b6b9e3dc4ed2bb93554da43c0487_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzktNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjplZWY3ZmRlODFmNzM0MjY2YmMwMWQzNjExYmJhYjAyMl80_3f4c729c-180c-43dd-92dc-da81726dc04e">1</ix:nonNumeric>-<ix:nonNumeric contextRef="i6de32faeb0b247e4a9b3584e095721c3_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzktNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjplZWY3ZmRlODFmNzM0MjY2YmMwMWQzNjExYmJhYjAyMl83_8bdf92b2-4811-4de8-9fea-5351139b6050">15</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbd97850f3e4065b4b66bb87c2cce30_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzEwLTEtMS0xLTM3MzU2_54442127-7936-45eb-b9d6-cf5001f3ab5e">94,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb95fbf7a7c24b6d88311032f03ec584_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzEwLTMtMS0xLTM3MzU2_ac7fc644-cf5e-4dad-8385-8515260aa48b">73,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzExLTEtMS0xLTM3MzU2_9d4c2904-4e21-4651-b251-91239ace80d5">626,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzExLTMtMS0xLTM3MzU2_d036db57-f4fe-424f-92e7-eb6aac2a8ad5">570,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzEyLTEtMS0xLTM3MzU2_69f67149-6c02-4ac0-99a4-0647191a9d05">314,874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzEyLTMtMS0xLTM3MzU2_eaadfcf3-758f-4d16-90df-4fd325d75249">282,849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzE0LTEtMS0xLTM3MzU2_3054a650-5238-4847-a995-37bc6c2ec5e4">311,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzE0LTMtMS0xLTM3MzU2_09450388-6482-449e-a541-cc20da7f4e40">287,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i000ed083c92e4b89800da97c60ed285f_I20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzMDk5Mzg_3d7c6d67-3e0b-47e2-9310-577380844dcc">37.9</ix:nonFraction>&#160;million of property, plant and equipment, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense associated with property, plant and equipmen</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t was $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzc1MjY_eeab0a47-165a-4549-ad9b-452fdbfe86f7">39.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzc1MzA_de3b33c7-2071-4b35-acd9-0674359b58f4">42.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzc1Mzg_4f742b04-f85a-4c94-a446-ac828f95eaf9">42.6</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company wrote-off certain construction in progress of $<ix:nonFraction unitRef="usd" contextRef="id6840528edb44a95a4b09018fdca6246_D20201001-20201231" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzc2ODQ_71942b0c-eb6e-4e33-84a1-68631cb6adc0">6.7</ix:nonFraction>&#160;million related to a manufacturing project that the Company decided to discontinue. The Company determined that the carrying amounts of these assets were not recoverable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:InterestCapitalizationPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTU1_3a890c66-e52f-40d2-921c-fdd7626b25ff" continuedAt="i809b8307f467412facbf683f914a41d4" escape="true">CAPITALIZED INTEREST</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i809b8307f467412facbf683f914a41d4">The interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings.</ix:continuation> For the years ended December&#160;31, 2021 and 2020, respectively, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:InterestCostsCapitalizedAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzg0MjU_e9dcbf97-20e7-41b7-a7fd-dab91e4e14d0">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:InterestCostsCapitalizedAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzg0MzI_97bb5228-3397-4279-9f7b-abd31a48c166">2.3</ix:nonFraction> million of interest expense into property, plant and equipment. </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTQ4_0bb1f77e-9b19-4bd2-a0be-74ef21af9085" continuedAt="i48c42262b5c6430c8c1c22b8977e0112" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, Business Combinations (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired in recorded as goodwill. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs and costs to restructure the acquired company are expensed as incurred.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia61e68e66c3246fe9fd7e644332c294f" continuedAt="i54c993ccc7754b699c52f97c2470dc92"><ix:continuation id="i48c42262b5c6430c8c1c22b8977e0112" continuedAt="i914db46873ba42e68afac3f506d5c35e"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issuance, or validity and litigation.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i914db46873ba42e68afac3f506d5c35e">If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition.</ix:continuation> Refer to Note 4, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and Divestitures</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMDAy_30afa16a-4669-47cf-8a3a-d163fb04fe37" continuedAt="ic87d9e1fafbe4dba9347d28bb4a48d8e" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i54c993ccc7754b699c52f97c2470dc92" continuedAt="i5e04ed7ae6b848dda12f3916f6949f8e"><ix:continuation id="ic87d9e1fafbe4dba9347d28bb4a48d8e"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzExNTM0_434efcda-f467-4b1a-a818-ba9a08f799c2">two</ix:nonFraction> reportable segments with <ix:nonFraction unitRef="reporting_unit" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzExNTYy_68cba0ce-409d-4a04-8f0f-5ea68c6637a5">three</ix:nonFraction> underlying reporting units. Refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on reportable segments. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">over their expected useful lives.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTI2_66f9646a-0501-4a95-a073-dbdc75e5750d" continuedAt="i01d07159a75c45768ba62b6a54951970" escape="true">LONG-LIVED ASSETS </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i01d07159a75c45768ba62b6a54951970">Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="iart:FoundationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTI3_9ccef8e5-c36e-41ff-a05a-a840ad7d3880" continuedAt="idd6d7fce02a34d12b3c2aec0a1c6f474" escape="true">INTEGRA FOUNDATION </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idd6d7fce02a34d12b3c2aec0a1c6f474">The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements.</ix:continuation> The Company contributed $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="iart:CharitableContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzE1ODQ2_e073a4e0-c5db-4b05-bba6-e3cb0bf4c085">1.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="iart:CharitableContributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzE1ODU4_422d8a20-4cc8-48b3-adb4-494de432154c">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="iart:CharitableContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzE1ODY1_a62c4b6e-c509-4ea8-82cf-de9c1331bbb6">0.3</ix:nonFraction> million to the Integra Foundation during the years ended December&#160;31, 2021, 2020 and 2019, respectively. These contributions were recorded in selling, general, and administrative expense. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i5e04ed7ae6b848dda12f3916f6949f8e" continuedAt="i0a9f4fb64a20411fb8acb21eaf705f63"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTQy_3a9b46b2-8a3e-4da0-80a0-b53194fea364" continuedAt="i048ca51ada99450684dfa753dae79ae4" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DERIVATIVES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes. From time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at the fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i048ca51ada99450684dfa753dae79ae4">The Company entered into foreign currency forward and foreign currency swap contracts that are not designated as a hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into other income, net on the consolidated financial statements.</ix:continuation> Refer to Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMTA5_ee67d622-67e2-4199-9aa6-721221fdcc18" continuedAt="iab7f7a9b20bd49c582a4a10c1a1c2040" escape="true">FOREIGN CURRENCY </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iab7f7a9b20bd49c582a4a10c1a1c2040">All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries.</ix:continuation> Foreign currency transaction net gains of less than $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzM4NDgyOTA3OTU5NDE_160105cf-76ec-42dd-b214-4daacbc2d384">0.1</ix:nonFraction>&#160;million, and net losses of $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzE5Nzgw_700d92be-a8a8-43b8-9867-ea3aab82e06b">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzE5Nzg3_d91af5d9-3db6-48e0-86df-21a19ff60bef">0.3</ix:nonFraction> million are reported in other income, net in the statements of operations, for the year ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTk0_bf3d0cad-0bcb-4732-ad84-8ee73b6cb3e9" continuedAt="i76a7173199e94259a3fe22c40ffa7d4a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INCOME TAXES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i0a9f4fb64a20411fb8acb21eaf705f63" continuedAt="ie17497a5a902436080a5e3aa8ba1ae3e"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i76a7173199e94259a3fe22c40ffa7d4a">The Company continues to indefinitely reinvest substantially all of its foreign earnings. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash.</ix:continuation> One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws. </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTE5_03469f04-1d75-45d2-9285-26396ae4962a" continuedAt="i3cdb4d4b1b1549b1a41765e498647067" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI0Mzcw_c9172610-6a8d-4dac-b8b3-a0c0563d676b">one</span> to <ix:nonNumeric contextRef="id4434b0da63d4acb99529de55c3df6cc_D20210101-20211231" name="iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI0Mzc2_de205f3c-fbf1-44ed-bbd1-ae6e2cd055b6">three months</ix:nonNumeric>. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3cdb4d4b1b1549b1a41765e498647067" continuedAt="i0bfbecc0702b492fabc2f3c99a2ce47e">Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.</ix:continuation> Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue From Contracts With Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTAw_cd9d0057-8f4c-49ad-8ed0-04d210199271" continuedAt="i52d0a358c80949a39227ff1b1f057363" escape="true">RESEARCH AND DEVELOPMENT </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i52d0a358c80949a39227ff1b1f057363">Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTMw_925b8e82-25ae-40d1-ba75-66d093470246" continuedAt="id00c065dc7a14856830b27451fe71852" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE TERMINATION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ASC Topic 420 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-time Employee Termination Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id00c065dc7a14856830b27451fe71852">The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie17497a5a902436080a5e3aa8ba1ae3e" continuedAt="i52bfd7271f284f39aa12d611cb9faf82"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred restructuring costs of $<ix:nonFraction unitRef="usd" contextRef="ib53b8c510bfb4f04a342d01490fff519_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjU4NjU_743bdaf7-4082-4051-9df8-edbafc290598">3.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id37cda7e161149dab639b5833e0cdaae_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzNDUzNjg_0ebee418-3b99-497e-a654-b725c6768e50">4.9</ix:nonFraction>&#160;million in cost of goods sold, $<ix:nonFraction unitRef="usd" contextRef="ic3178f6269054097bd491b98b26e7a45_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjU5MTE_60063ddf-02be-4852-b6e1-0ccf554d5a63">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if89798fbac704337b50567a4cce07285_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzNDUzNjk_c7818ef5-b08f-45e0-a1a4-1c12ec8de7f1">1.2</ix:nonFraction>&#160;million in selling, general and administrative and $<ix:nonFraction unitRef="usd" contextRef="ife4b1f164ed2413f96ccef0da637494a_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjU5Mjg_d1b52e0a-e2ec-47a7-8090-97ed0f05c6cc">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia8d6853b6a2340eea65ce878ccdc9506_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzNDUzNzA_02129b0e-7f6c-4b40-9f4f-2984d21920d6">0.3</ix:nonFraction>&#160;million in research and development related to employee terminations associated with a future plant closure in the consolidated statement of operations for the years ended December 31, 2021 and 2020, respectively. Restructuring costs of $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:RestructuringReserveCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjU5NzY_71eead55-4d7e-4f9c-97dd-d813774945a3">10.2</ix:nonFraction>&#160;million were included in a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ccrued expenses and other current liabilities </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI3ODY2_7da61cb7-f2b8-4b15-8b63-e5ae67a47750">6.4</ix:nonFraction>&#160;million were included in other liabilities in the consolidated balance sheet for the year ended December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTkw_b1fb048d-c588-46b3-b5b3-3e1cc7629bff" continuedAt="i88bc03430d6349a5970ae3d3d6e1d594" escape="true">STOCK-BASED COMPENSATION </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i88bc03430d6349a5970ae3d3d6e1d594">Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations.</ix:continuation> Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTIw_6a2c3d2b-c747-40e0-8930-cf0afd8051f1" continuedAt="ie34c42c6720e498d819f04d9efba3faf" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PENSION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a deferred compensation plan in which certain employees of the Company may defer the payment and taxation of up to <ix:nonFraction unitRef="number" contextRef="i1ea7e387c13b48c89387b2d3d857caaa_D20190501-20190531" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMwNDc3_c744feaf-f76b-4064-b5f4-05a5be2a1b95">75</ix:nonFraction>% of their base salary and up to <ix:nonFraction unitRef="number" contextRef="i1ea7e387c13b48c89387b2d3d857caaa_D20190501-20190531" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMwNTEx_136ca1b2-9dcb-408b-bbe7-659e67993590">100</ix:nonFraction>% of bonus amounts and other eligible cash compensation.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie34c42c6720e498d819f04d9efba3faf">This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices.</ix:continuation> </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMDE2_6b358ea9-3062-4eb6-9e7f-b5c21ff5cba2" continuedAt="ic119b4ef16da4a29848ad4fc6994567d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATION OF CREDIT RISK </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic119b4ef16da4a29848ad4fc6994567d">The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="customer" contextRef="if754557c7cc244208d000f3659321df2_D20210101-20211231" decimals="INF" name="iart:ConcentrationRiskNumberofCustomersOverBenchmark" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODQ3_25954917-4197-4cf9-bd21-ab3874f5fd1e"><ix:nonFraction unitRef="customer" contextRef="id3e5a63582034b89b1c34575b648c5cd_D20200101-20201231" decimals="INF" name="iart:ConcentrationRiskNumberofCustomersOverBenchmark" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODQ3_26bd112c-9866-43b0-b5e0-e04db44f53be"><ix:nonFraction unitRef="customer" contextRef="idb9fd4579c41462aa90ba45e8a15a748_D20190101-20191231" decimals="INF" name="iart:ConcentrationRiskNumberofCustomersOverBenchmark" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODQ3_d2bdcd70-ad05-4d05-997d-e1160da7de16">No</ix:nonFraction></ix:nonFraction></ix:nonFraction>ne of the Company's customers accounted for <ix:nonFraction unitRef="number" contextRef="idb9fd4579c41462aa90ba45e8a15a748_D20190101-20191231" decimals="INF" name="iart:ConcentrationRiskThresholdPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODkz_4797d054-1587-4323-8440-83787291e270"><ix:nonFraction unitRef="number" contextRef="if754557c7cc244208d000f3659321df2_D20210101-20211231" decimals="INF" name="iart:ConcentrationRiskThresholdPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODkz_b287d215-7490-4314-ac6b-0fa89d57c808"><ix:nonFraction unitRef="number" contextRef="id3e5a63582034b89b1c34575b648c5cd_D20200101-20201231" decimals="INF" name="iart:ConcentrationRiskThresholdPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODkz_c4a19951-f52d-4a90-831a-b910e5c89062">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% or more of the consolidated net sales during the years ended December&#160;31, 2021, 2020 and 2019.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i52bfd7271f284f39aa12d611cb9faf82" continuedAt="ifdcff547bec74f629f3ba53fc2b2119a"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMTEy_eed8e847-cf35-44a6-b81d-fb4d32e82266" continuedAt="i502e4524250446588a08ff50d4cd44c2" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU&#160;2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption was permitted. The Company adopted this guidance during the year ended December 31, 2020. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued&#160;ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under this guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The Company adopted ASU 2019-12 as of January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting.&#160;This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform.&#160;This ASU is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022.&#160;In January 2021, the FASB also issued ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform- Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which clarified certain optional expedients and exceptions to entities that are affected because of the reference rate reform. The amendments in this ASU affect the guidance in ASU 2020-04 and are effective in the same timeframe as ASU 2020-04. The Company currently has contracts that are indexed to LIBOR and are continuing to monitor this activity and evaluate the associated risk. The Company is continuing to evaluate the scope of impacted contracts and the potential impact. The Company is also monitoring the developments regarding alternative rates and may amend certain contracts to accommodate those rates if the contract does not already specify a replacement rate. While the notional value of agreements potentially indexed to LIBOR is material, the Company does not expect a material impact consolidated financial statements and related disclosures associated with this transition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years using either the modified retrospective or full retrospective method. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As detailed in Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on February 4, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="ib12b7654fd6c486c84790834f7e43479_I20200204" decimals="-5" name="us-gaap:ConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzMTE0NDE_97b5ec8a-3e5e-4ea6-a3d2-a8c0d0b2107b">575.0</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzMTE0MzM_cfe99d15-58bc-4eec-8471-313100452a79">0.5</ix:nonFraction>% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes are subject to the guidance included in ASU 2020-06. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzMTE0Mzg_7baa3e65-b3af-4b2a-8f74-a23293701952" continuedAt="i5174f05c1ba14e68bb70b57aa59005e9" escape="true">The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:</ix:nonNumeric></span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ifdcff547bec74f629f3ba53fc2b2119a" continuedAt="i95fb1ca16bc64d388dadacbb60875a62"><ix:continuation id="i502e4524250446588a08ff50d4cd44c2"><div style="margin-bottom:12pt;margin-top:12pt"><ix:continuation id="i5174f05c1ba14e68bb70b57aa59005e9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ADJUSTMENT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEET CLASSIFICATION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AMOUNT<br/>&#160;(in millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11696c20228346ddb295ad994c1d9416_I20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo2MWJhODcyZjZkNzM0MzU3YWJjNzgwZDU3ZTgzYTNmZS90YWJsZXJhbmdlOjYxYmE4NzJmNmQ3MzQzNTdhYmM3ODBkNTdlODNhM2ZlXzEtNC0xLTEtNDk3OTA_6de08de5-de42-4f52-9eb3-843fa50364dd">20.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount reclassification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e9d178090794fc6a66c5ddbb2103c9c_I20201231" decimals="-5" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo2MWJhODcyZjZkNzM0MzU3YWJjNzgwZDU3ZTgzYTNmZS90YWJsZXJhbmdlOjYxYmE4NzJmNmQ3MzQzNTdhYmM3ODBkNTdlODNhM2ZlXzItNC0xLTEtNDk3OTA_86f247ae-d92c-40d5-8edc-38bd7156323b">89.1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issuance costs reclassification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie48f6bf8baeb442bbdf792d72242d8ed_I20201231" decimals="-5" sign="-" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo2MWJhODcyZjZkNzM0MzU3YWJjNzgwZDU3ZTgzYTNmZS90YWJsZXJhbmdlOjYxYmE4NzJmNmQ3MzQzNTdhYmM3ODBkNTdlODNhM2ZlXzMtNC0xLTEtNDk3OTA_9f2202e2-a4f7-4ef9-a8f5-48b160d8c355">2.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization and equity costs reclassification, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11696c20228346ddb295ad994c1d9416_I20201231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo2MWJhODcyZjZkNzM0MzU3YWJjNzgwZDU3ZTgzYTNmZS90YWJsZXJhbmdlOjYxYmE4NzJmNmQ3MzQzNTdhYmM3ODBkNTdlODNhM2ZlXzQtNC0xLTEtNDk3OTA_3c50feb1-c15c-405a-98ef-71df9d46e677">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11696c20228346ddb295ad994c1d9416_I20201231" decimals="-5" sign="-" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo2MWJhODcyZjZkNzM0MzU3YWJjNzgwZDU3ZTgzYTNmZS90YWJsZXJhbmdlOjYxYmE4NzJmNmQ3MzQzNTdhYmM3ODBkNTdlODNhM2ZlXzUtNC0xLTEtNDk3OTA_2cb46ffb-a233-4dd0-b3ea-8ba1ffd0f8c9">63.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company made an irrevocable election under the indenture to require the principal portion of its 2025 Notes to be settled in cash and any excess in shares. Following the irrevocable notice, only the amounts settled in excess of the principal will be considered in diluted earnings per share under the &#8220;if-converted&#8221; method. Upon adoption of ASU 2020-06, the Company&#8217;s 2025 Notes were reflected entirely as a liability since the embedded conversion feature will no longer be separately presented within stockholders&#8217; equity. Additionally, from January 1, 2021, the Company is no longer incurring non-cash interest expense for the amortization of debt discount, therefore the interest expense for the 2025 Notes, which is included in the interest expense on the consolidated statements of operations and comprehensive loss, is lower as compared to the fiscal year of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which updates various codification topics by clarifying or improving disclosure requirements to align with the regulations of the U.S. Securities and Exchange Commission (the "SEC") . The ASU has been effective for the Company for annual and interim periods beginning after January 1, 2021. The Company adopted this standard on the January 1, 2021. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU 2021-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which provides guidance to clarify and reduce diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU No. 2021-04 are effective for all entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, including interim periods within those fiscal years. The amendment currently has no impact to the Company as the effect will largely depend on the terms of written call options or financings issued or modified in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for interest during the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:InterestPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQxOTI1_003392ee-8fc1-4ec7-ad57-fcdbae675d81">43.2</ix:nonFraction> million (net of $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQxOTM2_ad5a6c96-8dee-4bf9-b938-b2d0a79f01ee">1.2</ix:nonFraction> million that was capitalized into construction in progress), $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQxOTky_e96b8b6e-96c5-4e5d-aec6-2a2a6443e82c">47.3</ix:nonFraction> million (net of $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMDAz_fd0b3354-dc57-4f80-bf77-26d85e7e5519">2.3</ix:nonFraction> million that was capitalized into construction in progress) and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:InterestPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMDYy_785e82c0-d8f6-4805-96ce-3d66c0abc668">48.9</ix:nonFraction> million (net of $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMDcz_740209f4-b200-4e17-8d56-16da8a9252c1">3.1</ix:nonFraction> million that was capitalized into construction in progress), respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for income taxes, net of refunds, for the years ended December&#160;31, 2021, 2020 and 2019</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMjI1_fb914b44-4cf2-4ef9-a557-c1f180660e1d">49.5</ix:nonFraction> million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMjI5_bdad9694-4f28-4c66-ae96-11a25f948e1a">29.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMjM2_9ce689e5-f1c6-4ac6-aabc-7d91db868ea8">16.2</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NON-CASH INVESTING AND FINANCING ACTIVITIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment purchases included in liabilities at December&#160;31, 2021, 2020 and 2019 were $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMzc5_7758fa3b-d6da-49c1-84d5-8cde9bdca6e0">4.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMzgz_d07b7b17-29e1-4a32-82ca-d12c4a31ff63">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMzkw_5442bb67-c661-44fe-bd88-67350edbe841">11.0</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company achieved its final developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="iac4630e900f848359896b56b725b4778_I20211231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjYzMzQ_c6fcab54-efa2-4173-bc25-33db8e2e2260">5.0</ix:nonFraction>&#160;million obligation to be paid to former shareholders of Rebound Therapeutics Corporation ("Rebound"). The Company recorded $<ix:nonFraction unitRef="usd" contextRef="iac4630e900f848359896b56b725b4778_I20211231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjY0MjA_c6fcab54-efa2-4173-bc25-33db8e2e2260">5.0</ix:nonFraction>&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The remaining obligation was included in accrued liabilities at December 31, 2021 in the consolidated balance sheets. The milestone is expected to be fully paid during the first quarter of 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="i4078e47ac87f401e97eecd937cf9b64e_I20201231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI3NDg3NzkxNTcxNTM_2b0b637a-0eda-4a9a-b695-885135b93f25">20.0</ix:nonFraction>&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i4078e47ac87f401e97eecd937cf9b64e_I20201231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI3NDg3NzkxNTcyMzk_ba9ad83a-4377-4f55-9233-b18cb7ed9960">20.0</ix:nonFraction>&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i95fb1ca16bc64d388dadacbb60875a62">During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="i30fd64c1cb164ae0b2a907a07c1f841d_I20191231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyNTAw_0ae7e097-f2b8-4579-ac6e-ddd47d3b6742">5.0</ix:nonFraction>&#160;million obligation to be paid to former shareholders of Rebound. In addition, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i4207bdf79e8b43329423b675db80c712_D20190101-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentInProcess" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyNjMx_17293a9d-fb84-4c90-9eec-e40cc1c0bdf5">5.0</ix:nonFraction>&#160;million as in-process research and development expense in the consolidated statements of operations. The obligation was included in accrued liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.</ix:continuation></span></div><div id="i172bf506156f43e6869412a665f54418_148"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;<ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzUwOTk_2843883d-20c9-4052-bb4f-633fe99ddb33" continuedAt="i19ae3ed413af40bdbcb7301fd905b9ca" escape="true">REVENUES FROM CONTRACTS WITH CUSTOMERS</ix:nonNumeric></span></div><ix:continuation id="i19ae3ed413af40bdbcb7301fd905b9ca" continuedAt="if09e321226f745c5b7ac56bd60421949"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Summary of Accounting Policies on Revenue Recognition</span></div><ix:continuation id="i0bfbecc0702b492fabc2f3c99a2ce47e" continuedAt="id5687737943c4c32bbd91d1f4a5b3e98"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzE3NDg_5b074aa8-941a-418b-9232-b5288eed0136">ninety days</ix:nonNumeric>. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="if09e321226f745c5b7ac56bd60421949" continuedAt="ia04f0104e54740b184e3cf011e9bc186"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzUxMDA_b41d6198-64c9-4e3f-8b1d-78f00b78e542" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2021:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:79.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.222%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, January 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzMtNS0xLTEtMzczNTY_86d270f8-c85b-49d9-ba52-433141a55aa0">7,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to trade receivable of contract asset included<br/>&#160;&#160;&#160;&#160;&#160;in beginning of the year contract asset </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzQtNS0xLTEtMzczNTY_00189cf1-8ce4-4cc1-9e1b-13d499ad61aa">7,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzUtNS0xLTEtMzczNTY_51a89de8-1a74-44e8-ad51-03e7db8ba591">11,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzYtNS0xLTEtMzczNTY_34f7e2b7-d5d9-4ae8-831f-dacc4b682025">11,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, January 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzktNS0xLTEtMzczNTY_371b8950-ad75-4c15-abd5-019ed0cbb147">11,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzEwLTUtMS0xLTM3MzU2_16384958-4f55-4366-b18d-537c452a7385">5,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzExLTUtMS0xLTM3MzU2_e504c4bd-ab47-4e29-9680-5c445bdb86da">5,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="iart:ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzEzLTUtMS0xLTM3MzU2_df52c561-384e-4069-881f-353a74db4bfc">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzE0LTUtMS0xLTM3MzU2_306fea43-5394-4fe8-aa18-5e2e8fe8e82b">11,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the short-term portion of the contract liability of $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMwMjU_7c1ba207-e366-4406-9097-b52145684cfd">5.3</ix:nonFraction> million and the long-term portion of $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMwNjY_74e8c788-f9d2-4b97-8f9e-0a57df338bab">6.7</ix:nonFraction> million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company is expected to recognize revenue of approximately $<ix:nonFraction unitRef="usd" contextRef="i7337997e50724c52ad9348740bdd50dd_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMyNzA_9e8b2891-394b-4ffe-9ad1-9573de9571f0">5.3</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="i90fd6ad1a4554b1490ef3ec1f9cc90a8_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMyODA_ea086335-7a77-4999-bbb5-57e7fc24c37f">2.9</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="i0fc4597fa28c4d28b01a34ea89b827b8_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMyOTA_13e3479a-fc39-4db6-8000-356f7122f0d6">1.8</ix:nonFraction> million in 2024, $<ix:nonFraction unitRef="usd" contextRef="i4a2a15098f6f43029cb4a63d99daaad7_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMzMDA_fd157981-72e7-4e30-8a2f-11062184fadc">0.9</ix:nonFraction> million in 2025, $<ix:nonFraction unitRef="usd" contextRef="id4a31a62be1b454f97664e2f38331c1b_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMzMTA_ec21a3b1-32f0-4de1-8b20-589a5e4ed52a">0.6</ix:nonFraction> million in 2026, and $<ix:nonFraction unitRef="usd" contextRef="i13ba3f3fdc0e466ca5971c734c60c60f_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMzMjQ_4a686769-95c9-41b7-a401-09cbc9aa690f">0.4</ix:nonFraction> million thereafter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:continuation id="id5687737943c4c32bbd91d1f4a5b3e98" continuedAt="id7f6a14772b84f53b06cc177233a0121">Shipping and Handling Fees</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id7f6a14772b84f53b06cc177233a0121">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</ix:continuation> </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ExtendedProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzUwOTc_9fcdc379-7b7a-4128-9c8b-432c444df6ba" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="iart:RevenueProductWarrantyPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzQwMzg_07a115a1-f109-4cc2-be54-45cc97273115">two years</ix:nonNumeric> from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzUwOTQ_58d3ed7e-c3bb-47c5-946f-9e5f1a83d65c" continuedAt="ied80384dd0c8414b8d3c2c047b51eb23" escape="true">Taxes Collected from Customers</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ied80384dd0c8414b8d3c2c047b51eb23">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia04f0104e54740b184e3cf011e9bc186"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregated Revenue</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzUwOTg_4d85a405-bbd7-42d1-843e-b1b0c00362ed" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2021, 2020 and 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb65637da52f4b90bf607fb7b60c210d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzItNC0xLTEtMzczNTY_2571b91e-62b1-469f-b721-879de390cae7">802,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b4a664e6d9b4e52b3a3790429c82944_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzItNS0xLTEtMzczNTY_1feb81c1-d9bc-47ab-ae6e-14df2a51f689">716,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ff06dcd1f9e4d58b2040d6ef14e3b3f_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzItNi0xLTEtMzczNTY_0a3fcde8-f8f2-4f39-aeda-f2c566fd9170">767,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb8e06d1a9b412091aa582f72d27809_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzMtNC0xLTEtMzczNTY_0f42cc1f-7466-4a7d-9edb-f4232e7ce693">222,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8d2e95c76ae4a789dd053d9ce02580f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzMtNS0xLTEtMzczNTY_0182b383-28d1-422c-8feb-59c120efb8ff">178,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3046a6eaecf24960a1993adec9143348_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzMtNi0xLTEtMzczNTY_f9446999-6305-47c7-8321-a39ce58a4811">228,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzQtNC0xLTEtMzczNTY_199abfcd-df98-420a-a9c0-6e40eb3c0fdf">1,025,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb66154030084b3e8586a701e0a6bdb6_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzQtNS0xLTEtMzczNTY_799ad5da-5f5d-4dd4-b24c-81feeafaf643">894,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69a65713dfe64c33a00c72d8483e68a9_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzQtNi0xLTEtMzczNTY_e6fe47cc-f8cd-433c-92cb-7bd920ba5cbf">996,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb4f933be6cc44ff9ddec8c3d27cbf1c_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzYtNC0xLTEtMzczNTY_db0aa00c-72a2-4e6a-acd1-540b8efb66fe">392,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic811b1a099e24c99825ca52914fcf541_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzYtNS0xLTEtMzczNTY_129d7243-b50a-47c2-8218-e5e69a2d8db4">293,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ba7171afa8d4132b7dbe3ab5a4a60f8_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzYtNi0xLTEtMzczNTY_b185fcf3-10c9-48a2-acd0-a29e9849c1e5">322,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extremity Orthopedics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if358055a698b49a2858282451967cd20_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzctNC0xLTEtMzczNTY_ac5f15b6-36cf-49a6-941d-9bf5f6023a52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66173391a20f4c668d46a6f1ce9e6d20_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzctNS0xLTEtMzczNTY_dadac0a4-538d-47b6-b0f9-9cda99294b4f">78,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c4278b9686c4d53aea7074968344102_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzctNi0xLTEtMzczNTY_fd6a9d02-c870-43ac-85c1-2b773d3daf12">90,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a552626ffa247e6bf4b04926eff831f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzgtNC0xLTEtMzczNTY_6f9d6492-1adf-47a7-94e3-2b69aa77978e">124,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5734c3cfbd64dd99f45e59662837d44_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzgtNS0xLTEtMzczNTY_25959353-ef5d-47b9-8b85-372a06e9ee02">105,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb8306c92f54514bfe2a9e21c1ef069_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzgtNi0xLTEtMzczNTY_b4858ebe-64bc-48df-9461-61112ac630fd">108,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total  Tissue Technologies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d1799cdfeb443c297cec0ede24b319e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzktNC0xLTEtMzczNTY_472a9267-eeba-4561-8b2c-7c6abade5407">517,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b76730b7e7f49afa097d63b1fb0577c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzktNS0xLTEtMzczNTY_f06e2d6e-93e0-4934-bea0-1e1154ec1715">477,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie57e505f7452456591a3ff162137393e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzktNi0xLTEtMzczNTY_fcdf3635-1dcd-4a22-bfe1-94a65b989b9c">521,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzEwLTQtMS0xLTM3MzU2_c5bc1051-1564-4975-9009-144b19df8ef7">1,542,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzEwLTUtMS0xLTM3MzU2_137b1592-a396-4834-a27b-479b8634ad32">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzEwLTYtMS0xLTM3MzU2_adab5b16-828f-424f-8197-cf2c584385ce">1,517,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. Acquisitions and Divestitures, for details.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period amounts were reclassified between categories within the Codman Specialty Surgical segment to conform to the current period presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographical Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of revenues based on the location of the customer.</span></div></ix:continuation><div id="i172bf506156f43e6869412a665f54418_154"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;<ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzg5ODg_129e0886-5a50-4d2a-a52d-2b2041034378" continuedAt="ic4a7dda56652417284b1f65f12460546" escape="true">ACQUISITIONS AND DIVESTITURES</ix:nonNumeric></span></div><ix:continuation id="ic4a7dda56652417284b1f65f12460546" continuedAt="ia43a79a1306d42d1be4c000af30dca00"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of Extremity Orthopedics Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, the Company completed the sale of its Extremity Orthopedics business to Smith &amp; Nephew USD Limited ("Smith &amp; Nephew"). The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. The Company received an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i3269a9a9d0024d43b9f980a0524d7c42_I20210104" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE0NjM_7b5f530d-8bb3-458a-9c62-176383c43e87">240.0</ix:nonFraction>&#160;million from Smith &amp; Nephew and concurrently paid $<ix:nonFraction unitRef="usd" contextRef="i170068c51ed94ca9bf2387c3ce7260fc_D20210104-20210104" decimals="-5" name="iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE0Nzk_98bcaecf-dd25-4553-8adb-76cea545da19">41.5</ix:nonFraction>&#160;million to the Consortium of Focused Orthopedists, LLC ("CFO") effectively terminating the licensing agreement between Integra and CFO relating to the development of shoulder arthroplasty products. </span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia43a79a1306d42d1be4c000af30dca00" continuedAt="i1b018143d6ef4fcaa37623b3a33c6c81"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1ODk_3a971ad8-efa2-4574-bc9a-0d224108247b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities divested consisted of the following as of December 31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.111%"><tr><td style="width:1.0%"></td><td style="width:68.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzAtMS0xLTEtNDM0NDI_c44693c9-81d6-4771-b936-6b52f8161cdc">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset - operating leases and Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="iart:DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzEtMS0xLTEtNDM0NDI_fdcaa91c-568a-4959-b4e9-9c512ed8624e">3,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzItMS0xLTEtNDM0NDI_f531553f-fe46-4143-a330-5026be7399fb">6,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzMtMS0xLTEtNDM0NDI_337ae867-61d8-4ec5-b6a7-e66b670316bb">13,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzQtMS0xLTEtNDM0NDI_224cacec-2f03-4a59-8af6-d775f6e10b6b">37,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzUtMS0xLTEtNDM0NDI_bba39d76-2d7e-4b9d-b5d9-fa9c8c285497">47,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzYtMS0xLTEtNDM0NDI_e460ac55-1443-41bc-b86d-e3a3cf069bf7">52,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzctMS0xLTEtNDUwMDY_80296521-9d33-4762-8276-20d6087e14a1">162,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzktMS0xLTEtNDM0NDY_20c11f4e-fae2-4cff-b980-62d2b7e12d90">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzEwLTEtMS0xLTQzNDQ2_41eef76e-7950-496d-86ad-9f5cf7346928">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzExLTEtMS0xLTQzNDQ2_4ce1e6aa-8735-4c21-87d7-eaebe064f370">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzEyLTEtMS0xLTQzNDQ2_ec7d762c-8041-4d19-95c4-d6c8da3b2db1">3,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzEzLTEtMS0xLTQzNDQ2_212a464d-fee2-46ec-975a-a3c7d4a16c49">5,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzE0LTEtMS0xLTQ1MDA2_e915a22a-2fb1-44cf-af17-4492c3ac9574">11,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The divestiture does not represent a strategic shift that will have a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the Extremity Orthopedics business to the Company's Tissue Technologies reporting unit. In connection with the sale, the Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i96bd4fb9f9f845cfb6e003e78b8a9bc7_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE0OTQ_2a63aef2-c160-461f-99c6-ad2d38d7f7fc">41.8</ix:nonFraction>&#160;million that is presented in Gain from the sale of business in the consolidated statement of operations for the year ended December&#160;31, 2021. The Company finalized the net working capital and paid an additional $<ix:nonFraction unitRef="usd" contextRef="i40a2c7932fe4499294fbfb9e9cb7437f_I20211231" decimals="-5" name="iart:NetWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzEwOTk1MTE2NTExMjc_53247a32-b4c6-436e-9791-47266939fb23">1.3</ix:nonFraction>&#160;million to Smith &amp; Nephew as of December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also entered into a transition services agreement with Smit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h &amp; Nephew which requires the Company to provide certain services on behalf</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of Smith &amp; Nephew for the duration of the period subsequent to the sale of the business as defined in the agreement. The Company recognized a payable due to Smith &amp; Nephew of $<ix:nonFraction unitRef="usd" contextRef="i40a2c7932fe4499294fbfb9e9cb7437f_I20211231" decimals="-5" name="iart:DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzEwOTk1MTE2Mzg4NzM_241d5363-0304-40fb-831b-55d7450c374f">9.1</ix:nonFraction> million as of December&#160;31, 2021, included in the consolidated balance sheet within accrued expenses and other current liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACell, Inc. Acquisition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 20, 2021, the Company acquired ACell, Inc. (the "ACell Acquisition") for an acquisition purchase price of $<ix:nonFraction unitRef="usd" contextRef="ica517bcfa6884ebc90de2aca64243203_D20210120-20210120" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1MjM_df213957-f782-4ad9-8a72-2c72501e0839">306.9</ix:nonFraction>&#160;million plus contingent considerations of up to $<ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1Mzk_70772615-e4bd-4e2d-9b58-bf8a41b696fc">100</ix:nonFraction>&#160;million, that may be payable upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. The final working capital adjustments of $<ix:nonFraction unitRef="usd" contextRef="ia2e483bc15a0412aa43477e358585f01_I20210630" decimals="-5" name="iart:BusinessCombinationWorkingCapitalAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1NTM_99a4e64d-70f3-49a4-a6a5-e879fbe6c96b">1.3</ix:nonFraction>&#160;million was finalized and paid as of June 30, 2021. ACell was a privately-held company that offered a portfolio of regenerative products for complex wound management, including developing and commercializing products based on MatriStem Urinary Bladder Matrix, a technology platform derived from porcine urinary bladder extracellular matrix.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACell Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination are recognized at their fair values as of the acquisition date. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i1b018143d6ef4fcaa37623b3a33c6c81" continuedAt="ib332815419b24268b7a18c7e4843dec3"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1OTA_d2221786-6134-4835-8de7-0d2b03b250a0" continuedAt="ibf1d54bf467a4f0eb614ab4d18f3ad22" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzItMS0xLTEtNDM1MjQ_2ef3e386-6fea-4742-bfe1-6d1eb4cd3eb3">2,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzMtMS0xLTEtNDM1MjQ_b94fd32f-2e20-4675-a518-7d5f22c0b9c0">16,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzQtMS0xLTEtNDM1MjQ_6d7155fa-60cf-4fcc-8654-193bcda1f523">18,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzUtMS0xLTEtNDM1MjQ_213d5661-2c72-44c0-9f0b-1317f8528ee3">1,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzYtMS0xLTEtNDQ5Mzg_0b46f608-ff48-4504-9f10-a26070548948">38,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzctMS0xLTEtNDM1MjQ_6f3b6ea4-6c61-479a-9291-1beba20bf6df">13,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzgtMS0xLTEtNDM1MjQ_7c8144a4-9557-44db-8471-4f86b809157c">245,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39d90578eea04bf1b29ed35663a1802d_D20210120-20210120" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzgtMy0xLTEtNDM1MjQvdGV4dHJlZ2lvbjphNmVlNTc0MGViZmU0MTA3YWM1YTc3NzRiMTkyNzNkMF8xMDk5NTExNjI3Nzk0_518c8df4-00a3-4b9b-88da-0b0ba69ba61a">13</ix:nonNumeric>-<ix:nonNumeric contextRef="i688db6d6eb2f458d8870fc231b4592c5_D20210120-20210120" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzgtMy0xLTEtNDM1MjQvdGV4dHJlZ2lvbjphNmVlNTc0MGViZmU0MTA3YWM1YTc3NzRiMTkyNzNkMF8xMDk5NTExNjI3Nzk4_44429b56-995b-4f20-a80f-62b1a7269f54">14</ix:nonNumeric> years</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzktMS0xLTEtNDM1MjQ_d78a7e74-5e04-46c5-899a-8509165dbebe">94,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzEwLTEtMS0xLTQzNTI0_870a3ee9-8f9a-4977-bede-78325cb9d0b1">9,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzExLTEtMS0xLTQzNTI0_303d63f7-6281-416a-9fb7-e118b89f0add">7,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzEyLTEtMS0xLTQzNTI0_c0068d36-7acc-4b66-b7bf-23a69d73337e">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzEzLTEtMS0xLTQ0OTM4_7e1be7ed-d81e-4cb1-b856-be8caffbe066">408,780</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzE2LTEtMS0xLTQzNTI0_df435661-737b-4b47-ad35-6b3eec5e5b23">718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzE3LTEtMS0xLTQzNTI0_67a4873e-f229-4c8b-9eec-1e04bdef9bbc">5,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzE4LTEtMS0xLTQzNTI0_094b8a65-3d03-408c-b180-6c1fc002182c">1,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzE5LTEtMS0xLTQ0OTM4_87841a79-c6f2-408d-9ace-d10d9a4d48f5">8,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzIwLTEtMS0xLTQzNTI0_f8cacef0-2881-4ab8-83c5-84a6762515cc">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzIxLTEtMS0xLTQzNTI0_01275e66-1988-4d33-8664-659b83dfccc3">7,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzIyLTEtMS0xLTQzNTI0_673bca51-8c1b-47b0-a08c-71c72b6943b8">61,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzIzLTEtMS0xLTQzNTI0_4e7ed25d-4413-47dd-a16b-89b378adf01a">23,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzI0LTEtMS0xLTQ0OTM4_e948dca1-4bab-413f-9296-db025d122448">101,842</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzI2LTEtMS0xLTQ0OTM4_8b3d9ac8-0675-4eb1-8af1-5c7a759d163e">306,938</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the developed technology acquired was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used a discount rate of <ix:nonFraction unitRef="number" contextRef="i5f23076f31b3452e8dd0574aff2fb161_I20211231" decimals="3" name="iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzUzMDE_617ad910-d0b6-4acd-af39-92e6bc8a1809">8.5</ix:nonFraction>% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated goodwill related to the ACell acquisition to the Tissue Technologies segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected synergies of the combined company and assembled workforce. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition, the Company is required to make payments to the former shareholders of ACell up to $<ix:nonFraction unitRef="usd" contextRef="i5f23076f31b3452e8dd0574aff2fb161_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1NzU_cc6d27af-cd96-4901-a76d-ae0c2779a203">100</ix:nonFraction>&#160;million based on the achievement of certain revenue-based performance milestones in 2022, 2023, and 2025. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Company used iterations of the Monte Carlo simulation to calculate the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $<ix:nonFraction unitRef="usd" contextRef="i5f23076f31b3452e8dd0574aff2fb161_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzEwOTk1MTE2NDc3NTE_3c1b4f70-3da2-429d-ac53-21092928ec34">23.9</ix:nonFraction> million at the acquisition date. The estimated fair value as of December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i5f23076f31b3452e8dd0574aff2fb161_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzEwOTk1MTE2NDM2NTE_125e90a6-de74-4cd0-81c3-3240027ca90c">21.8</ix:nonFraction> million. This amount is included in other liabilities at December&#160;31, 2021 in the consolidated balance sheets of the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ib332815419b24268b7a18c7e4843dec3" continuedAt="i9c0400ba4a76425195140a13ceb391bd"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the acquisition date fair value of contingent consideration obligations using a Monte Carlo simulation, as well as significant unobservable inputs, reflecting the Company&#8217;s assessment of the assumptions market participants would use to value these liabilities. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resultant most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligations is revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Tax Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro Forma Results (unaudited)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma revenues for the year ended December 31, 2021 and 2020 were $<ix:nonFraction unitRef="usd" contextRef="i9a53bd10b62342d88e6811d75c05b920_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQzOTgwNDY1MzA2NTY_9235bd8d-987a-4c4b-888b-6fb8c6cfd9db">1,547.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ie3b4a6c5eb0b434dba966ae4580828dd_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQzOTgwNDY1MzA2NzQ_da36eb33-3789-404c-a1ff-b74c95186d3c">1,466.8</ix:nonFraction>&#160;million, respectively. Pro forma net income and earnings per share are not presented for this acquisition as they are not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Arkis BioSciences Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of $<ix:nonFraction unitRef="usd" contextRef="if70040a00764430ebf4558b0c9e06708_D20190729-20190729" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzE1NA_3d68dbed-7bc3-4218-9778-8a24c68a5c85">30.6</ix:nonFraction> million (the "Arkis Acquisition") plus contingent consideration of up to $<ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIyMg_c39c2a0e-99b3-4f9d-bb3e-a79a33fe2f7e">25.5</ix:nonFraction> million, that may be payable based on the successful completion of certain development and commercial milestones. The contingent consideration had an acquisition date fair value of $<ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzM5OA_f8b6b965-db47-4d4f-a003-72ab3e6ddf35">13.1</ix:nonFraction> million. Arkis was a privately-held company that marketed the CerebroFlo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> external ventricular drainage (EVD) catheter with Endexo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arkis Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. </span></div><ix:continuation id="ibf1d54bf467a4f0eb614ab4d18f3ad22"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzItMS0xLTEtMzczNTY_4dd2a403-705d-4819-8df1-ec4069bc5c28">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzMtMS0xLTEtMzczNTY_149b5aca-5077-40ab-ba08-8175381e0fc2">751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzQtMS0xLTEtMzczNTY_ea3ae3e4-4d71-418f-8661-aa1b93f3e074">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzUtMS0xLTEtMzczNTY_ccb9a7d2-7049-4d40-b90e-d0e8f438fed7">1,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CerebroFlo developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5615952a2a84ce48747f6e0a5b12e88_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzctMS0xLTEtMzczNTY_5042c153-4e2c-440e-a0a3-367d75c43b5c">20,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i71e837488c6d40d2bae9b77a42432999_D20190729-20190729" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzctMi0xLTEtMzczNTY_2f787416-0849-4fc1-b449-bc463ba90fa7">15</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling technology license</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4506a521f784464fab88c8e0a8d34c01_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzgtMS0xLTEtMzczNTY_a6cce117-0a40-4645-8916-3ff686542150">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i42a7d4331e424eb9b52d2c8d7ac98fcd_D20190729-20190729" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzgtMi0xLTEtMzczNTY_db52cd2d-075e-4063-9cc2-d9a9a26a3a3c">14</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzktMS0xLTEtMzczNTY_1f0e961a-7491-4ca2-b324-2485c523c8b2">27,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzEwLTEtMS0xLTM3MzU2_4e1ca378-a110-4c10-8559-5605d49b67a8">52,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzEyLTEtMS0xLTM3MzU2_bac8cf7e-3ea1-45ca-8769-e6868fba52f1">2,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzEzLTEtMS0xLTM3MzU2_f04a7e1a-6038-4f20-a000-53d73a3bc06f">13,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzE0LTEtMS0xLTM3MzU2_6806da9d-b90f-4f93-b3de-ac3b26076b45">5,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired   </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzE1LTEtMS0xLTM3MzU2_78c7f83b-447c-43a4-bc2d-8326b403f3d8">30,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the intangible assets was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each asset (including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, and working capital/contributory asset charges), the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i9c0400ba4a76425195140a13ceb391bd" continuedAt="idb9a06a5c4f34bfb8586db52cfcdd6a9"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used a discount rate of <ix:nonFraction unitRef="number" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="INF" name="iart:AcquiredFinitelivedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzE5MzY_77d9d7fa-976d-4523-9341-094b818cbb20">14.5</ix:nonFraction>% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated goodwill related to the Arkis Acquisition to the Codman Specialty Surgical segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. One of the key factors that contributes to the recognition of goodwill, and a driver for the Company's acquisition of Arkis, is the planned expansion of the Endexo technology with the existing products within the Codman Specialty Surgical segment. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level&#160;3 measurement as defined using the fair value concepts in ASC 820. The resultant probability-weighted cash flows are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation is revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent consideration obligations may result from changes in discount periods and rates, changes in the timing and amount of revenue estimates and changes in probability assumptions with respect to the likelihood of achieving the various contingent payment obligations. Adverse changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition, the Company is required to pay the former shareholders of Arkis up to $<ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQ0NDA_b1442790-f565-4461-8109-7b611271dfeb">25.5</ix:nonFraction> million based on the timing of certain development milestones of $<ix:nonFraction unitRef="usd" contextRef="i4bcd02ade40d4716b1746fdd3cb2430d_I20190729" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQ1MDA_8229cd8c-50eb-43f8-aaef-12a394380577">10</ix:nonFraction> million and commercial sales milestones of $<ix:nonFraction unitRef="usd" contextRef="ib8d9df81e2784a7f822f5902f3423b63_I20190729" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQ1Mzk_cc328d7a-6bbf-4893-be3d-adf19a96ac05">15.5</ix:nonFraction> million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $<ix:nonFraction unitRef="usd" contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzEwOTk1MTE2NDc3NTk_3004bb67-4640-42c5-87a9-63e843f68c82">13.1</ix:nonFraction> million at the acquisition date. The estimated the fair value as of December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i5f6f1a1544924074a1d3d7fb36a12a6d_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQzOTgwNDY1MzA3OTM_e0019327-3093-461b-b406-af209553779f">15.1</ix:nonFraction>&#160;million. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="ieaad07293f494ff6889330b346414a47_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQzOTgwNDY1MzA4MjU_0a377810-d8e9-43c3-8382-d39c1a85e802">3.7</ix:nonFraction>&#160;million in accrued expenses and other current liabilities and $<ix:nonFraction unitRef="usd" contextRef="i318b6e50656b461a91847e56aab39040_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQzOTgwNDY1MzA4NDU_22c5fda1-9124-4fef-87c0-ce84b9a3e3c4">11.4</ix:nonFraction>&#160;million in other liabilities at December&#160;31, 2021 in the consolidated balance sheets of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Tax Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma results are not presented for this acquisition as they are not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Rebound Therapeutics Corporation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (&#8220;Rebound&#8221;), developers of a single-use medical device known as the Aurora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Surgiscope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System ("Aurora") which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the &#8220;Rebound transaction&#8221;). Under the terms of the Rebound transaction, the Company made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i051d23eceb014bb58273d6270a8f1c00_D20190909-20190909" decimals="-5" name="us-gaap:AssetAcquisitionConsiderationTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzU5MDg_b1ee8538-bb5f-45a2-8350-613c85cf59fb">67.1</ix:nonFraction> million and are committed to pay up to $<ix:nonFraction unitRef="usd" contextRef="i051d23eceb014bb58273d6270a8f1c00_D20190909-20190909" decimals="INF" name="iart:AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzU5NTA_ae4a2df4-78ea-44da-94e7-8d819e909088">35.0</ix:nonFraction> million of contingent development milestones upon achievement of certain regulatory milestones.&#160;The acquisition of Rebound was primarily concentrated in <ix:nonFraction unitRef="asset" contextRef="i4878a7d091a8419aa9f27c3d38684f89_I20190909" decimals="INF" name="iart:AssetAcquisitionNumberOfAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzYxMDY_7b02536d-d802-44c5-99a3-218fca1301cb">one</ix:nonFraction> single identifiable asset and thus, for accounting purposes, the Company has concluded that the acquired assets do not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a $<ix:nonFraction unitRef="usd" contextRef="i4528a498ca614d9ea547555427227000_D20190909-20190909" decimals="-5" name="us-gaap:AssetAcquisitionConsiderationTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzYzNDQ_827e79c7-768e-48b0-afd4-debc22a30284">59.9</ix:nonFraction> million IPR&amp;D expense. The balance of approximately $<ix:nonFraction unitRef="usd" contextRef="i051d23eceb014bb58273d6270a8f1c00_D20190909-20190909" decimals="-5" name="iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzYzOTk_42d897d2-76de-4556-84c4-dc71a91a02e0">7.2</ix:nonFraction> million, which included $<ix:nonFraction unitRef="usd" contextRef="i49e912b1fd87487785c228195b43bd1c_D20190909-20190909" decimals="-5" name="iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzY0MjY_46fa401a-e91b-4d59-97c3-dd1d0b3d7691">2.1</ix:nonFraction> million of cash and cash equivalents and a net deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="i33224855ef3047999b2cae3d50de0f11_D20190909-20190909" decimals="-5" name="iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzY0OTg_08a77297-0257-4703-994c-dc594f951f9e">4.2</ix:nonFraction> million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carry forward. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="i30fd64c1cb164ae0b2a907a07c1f841d_I20191231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzY3NjI_cc670ee6-939a-4679-b9d1-6135d540b811">5.0</ix:nonFraction> million obligation to be paid to former shareholders of Rebound. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="ia442774231c74a88babc4cf70ca6a7b9_D20191001-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzY4NTE_320bd504-6bd0-421b-9249-0c072e69a9b0">5.0</ix:nonFraction> million as IPR&amp;D expense in the consolidated statements of operations. The obligation was included in accrued expenses and other current liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="i4078e47ac87f401e97eecd937cf9b64e_I20201231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzcyMjQ_2b0b637a-0eda-4a9a-b695-885135b93f25">20.0</ix:nonFraction>&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i4078e47ac87f401e97eecd937cf9b64e_I20201231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzczMDk_ba9ad83a-4377-4f55-9233-b18cb7ed9960">20.0</ix:nonFraction>&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="idb9a06a5c4f34bfb8586db52cfcdd6a9"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company achieved its final developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="iac4630e900f848359896b56b725b4778_I20211231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQ5NDc4MDIzNDMyODI_c6fcab54-efa2-4173-bc25-33db8e2e2260">5.0</ix:nonFraction>&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="iac4630e900f848359896b56b725b4778_I20211231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQ5NDc4MDIzNDMzMDU_c6fcab54-efa2-4173-bc25-33db8e2e2260">5.0</ix:nonFraction>&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The remaining obligation was included in accrued expenses and other current liabilities at December 31, 2021 in the consolidated balance sheets. The milestone is expected to be fully paid during the first quarter of 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Integrated Shoulder Collaboration, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2019, the Company entered into a licensing agreement with Integrated Shoulder Collaboration, Inc ("ISC"). Under the terms of the agreement, the Company paid ISC $<ix:nonFraction unitRef="usd" contextRef="i75ac54230bc045c6acdd9a962aabc8fa_D20190104-20190104" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzc2NzI_f3c4a2bb-1183-4a6e-a5dd-6bed6cf70865">1.7</ix:nonFraction> million for the exclusive, worldwide license to commercialize its short stem and stemless shoulder system. A patent related to short stem and stemless shoulder systems was issued to ISC during the first quarter of 2019. ISC is eligible to receive royalties on sales of the short stem and stemless shoulder system. The Company has the option to acquire ISC at a date <ix:nonNumeric contextRef="i75ac54230bc045c6acdd9a962aabc8fa_D20190104-20190104" name="iart:AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzgwNDE_b2ff49d4-89a8-418d-9997-21e162824e63">four years</ix:nonNumeric> subsequent to the first commercial sale, which becomes mandatory upon the achievement of a certain sales thresholds of the short stem and stemless shoulder system, for an amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="i75ac54230bc045c6acdd9a962aabc8fa_D20190104-20190104" decimals="INF" name="iart:AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzgyMzc_b23dfdcd-fadc-489b-bf8c-16933e63b882">80.0</ix:nonFraction> million. The transaction was accounted for as an asset acquisition as the Company concluded that it acquired primarily <ix:nonFraction unitRef="asset" contextRef="i085349bc37c3476aa14e6828a4112638_I20190104" decimals="INF" name="iart:AssetAcquisitionNumberOfAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzgzNTk_14eea5a5-285a-413b-8f68-5b5e50e5155b">one</ix:nonFraction> asset. The total upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i1a85f0f4e699490aacc709f96ed3737a_D20190104-20190104" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzgzOTg_5063f700-f144-4658-b002-4a29a3f8faf6">1.7</ix:nonFraction> million was expensed as a component of research and development expense and the future milestone and option payments will be recorded if the corresponding events become probable. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the Company's Extremity Orthopedic business, on January 4, 2021 the Company paid $<ix:nonFraction unitRef="usd" contextRef="ib718aecc355a42c295a29f73509ea5eb_D20210104-20210104" decimals="-5" name="iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzg2OTM_6f2f4a12-6969-49aa-8cf7-27a942995daa">41.5</ix:nonFraction>&#160;million to CFO pursuant to the terms of certain agreements between the Company and CFO relating to the sale of shares of ISC effectively terminating our licensing agreement with ISC.</span></div></ix:continuation><div id="i172bf506156f43e6869412a665f54418_157"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzEwNjIy_d5c7a0aa-741f-43fd-a248-200f21e0c40d" continuedAt="i5d28345d639d46099d0b1390515adf25" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="i5d28345d639d46099d0b1390515adf25" continuedAt="iaedd621862ed4ba1a6634e15c40c6bb1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment to the Sixth Amended and Restated Senior Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February&#160;3, 2025. The Company continues to have the aggregate principal amount of up to approximately $<ix:nonFraction unitRef="usd" contextRef="icc245d39ae2c4b37a89f9ea473650099_I20200203" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzUwNA_61ea5eb6-5525-419b-a2b7-a692347686ea">2.2</ix:nonFraction> billion available to it through the following facilities: (i) a $<ix:nonFraction unitRef="usd" contextRef="if9075dc4f5594e0a9117a256577a5b6b_I20200203" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU2MQ_aacbc8cb-85c4-48d2-b503-f886d9a09fc9">877.5</ix:nonFraction> million Term Loan facility, and (ii) a $<ix:nonFraction unitRef="usd" contextRef="i57c63b69e03f47ecbb9a8c336b5343f0_I20200203" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU5NQ_e806e3e8-f0bd-4fe3-930f-9ad6a137faa0">1.3</ix:nonFraction> billion revolving credit facility, which includes a $<ix:nonFraction unitRef="usd" contextRef="iad88d8e54f1a4e9a85100c26cb3cdf36_I20200203" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjQ2NDg_1e5b698d-d957-480b-916a-a6567a6083e9">60</ix:nonFraction>&#160;million sublimit for the issuance of standby letters of credit and a $<ix:nonFraction unitRef="usd" contextRef="i1ab723a0be194e20ace108b34163128f_I20200203" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjQ2MTk_ea7b345c-7e63-4c81-88ee-7a0319c39bc9">60</ix:nonFraction>&#160;million sublimit for swingline loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 14, 2020, the Company entered into an amendment (the "July 2020 Amendment") to the February 2020 Amendment of the Senior Credit Facility to increase financial flexibility through June 30, 2021, in light of the unprecedented impact and uncertainty of the COVID-19 pandemic on the global economy. The July 2020 amendment did not increase the Company&#8217;s total indebtedness.</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzEwNjQ5_940d4722-3faa-4818-834f-91511dc34fec" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the July 2020 amendment, the Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"></td><td style="width:75.155%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of July 2020 Amendment through June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c66ebe266dc49ae8c7b140c34de1997_I20211231" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZToxZTA2ZDY1YTNhZDM0MzJhOGJhOTAwMjllOWY2NWRkNi90YWJsZXJhbmdlOjFlMDZkNjVhM2FkMzQzMmE4YmE5MDAyOWU5ZjY1ZGQ2XzMtMi0xLTEtMzczNTYvdGV4dHJlZ2lvbjo2NzU3MzNhMjU0Yjg0NDg0YmRmNDMxYjM5YThjMWRhMl80_f3eedb67-33aa-4e65-ac76-e32929ad4716">5.50</ix:nonFraction> to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021 through June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee59fc6ad5d745fd93819ab6849f2abd_I20211231" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZToxZTA2ZDY1YTNhZDM0MzJhOGJhOTAwMjllOWY2NWRkNi90YWJsZXJhbmdlOjFlMDZkNjVhM2FkMzQzMmE4YmE5MDAyOWU5ZjY1ZGQ2XzQtMi0xLTEtMzczNTYvdGV4dHJlZ2lvbjpiZjNkZTcxYjdmNTM0N2Q5YjNkODk0MDU1N2U5MWU1NV80_8d589744-809b-4023-8ea2-8646573ba4fb">5.00</ix:nonFraction> to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022 through June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i501b6a51ff0140a7b9405a6883ce1ffb_I20211231" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZToxZTA2ZDY1YTNhZDM0MzJhOGJhOTAwMjllOWY2NWRkNi90YWJsZXJhbmdlOjFlMDZkNjVhM2FkMzQzMmE4YmE5MDAyOWU5ZjY1ZGQ2XzUtMi0xLTEtMzczNTYvdGV4dHJlZ2lvbjo5OWIwYTkxZmUwNWE0Y2NhODI4MDViMmJiN2Y5NDcxNF80_53d85020-c02a-4c42-9975-061fbc79d0c5">4.50</ix:nonFraction> to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ce7dfab586d445cbad7c5ae7a2d0d70_I20211231" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZToxZTA2ZDY1YTNhZDM0MzJhOGJhOTAwMjllOWY2NWRkNi90YWJsZXJhbmdlOjFlMDZkNjVhM2FkMzQzMmE4YmE5MDAyOWU5ZjY1ZGQ2XzYtMi0xLTEtMzczNTYvdGV4dHJlZ2lvbjo5Mjc3NzJhMDVlMTE0YTE0YTg2YTA4ZWM4MGU1ZTU5Zl80_b87204bc-d097-4a3a-bed5-7b9306db1ed7">4.00</ix:nonFraction> to 1.00</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Senior Credit Facility bear interest, at the Company&#8217;s option, at a rate equal to the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from <ix:nonFraction unitRef="number" contextRef="ie42c1e0337854c7dbbf20f4ae06610e9_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzE1NTU_89ac6004-d40f-4623-95ac-4f4d4221e829">1.00</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i90140523e867471889b8f2498da45de1_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzE1NjE_7c2edce1-af82-413f-9b18-ad92e169319b">2.25</ix:nonFraction>%), or </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the highest of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus <ix:nonFraction unitRef="number" contextRef="i06c53d99c8f942b598357ebec22df68a_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzE2OTc_bbeadd09-4e65-4950-9900-58346295454f">0.50</ix:nonFraction>%</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the prime lending rate of Bank of America, N.A. or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the one-month Eurodollar Rate plus <ix:nonFraction unitRef="number" contextRef="ib08f50e95c0845a09194c11c67ff0227_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzE3ODY_95e566ee-dfd7-4026-b532-e60a580bef6e">1.00</ix:nonFraction>% </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable rates are based on the Company&#8217;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iaedd621862ed4ba1a6634e15c40c6bb1" continuedAt="ic85ef28a5db441448230e4e23018e989"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;consolidated EBITDA (as defined by the July 2020 amendment), for the period of four consecutive fiscal quarters ending on such date).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay an annual commitment fee (ranging from&#160;<ix:nonFraction unitRef="number" contextRef="i1b5855752106436d8e5833d80860bf2d_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzIyMzI_41efb433-8508-4452-95d0-679ca6cfb70a">0.15</ix:nonFraction>%&#160;to&#160;<ix:nonFraction unitRef="number" contextRef="i8815454edf87440f8ab1bc7d9bea226c_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzIyMzg_30b323e9-0d0c-406c-ab8d-0f88cce49725">0.30</ix:nonFraction>%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#8217;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at December&#160;31, 2021, the Company was in compliance with all such covenants. In connection with the February 2020 Amendment, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="icc245d39ae2c4b37a89f9ea473650099_I20200203" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzI3OTc_e3f6d92c-dc22-4675-8a56-3d021a8e5d5f">4.6</ix:nonFraction>&#160;million of financing costs in connection with modification </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Senior Credit Facility and wrote off $<ix:nonFraction unitRef="usd" contextRef="i7b35bf05794c4f92b13ccc87a4d842ce_D20200101-20200331" decimals="-5" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzI4OTY_c1e4dee3-8aea-4904-b8de-b54b0e0bbaf6">1.2</ix:nonFraction>&#160;million of previously capitalized financing costs during the first quarter of 2020. In connection with the July 2020 amendment, the Company expensed $<ix:nonFraction unitRef="usd" contextRef="i22d3d9561a884d1f8123cf11213b6e4c_D20200701-20200930" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMwNDE_facbddc4-e2b6-47d8-ab78-cc5e460d31e2">3.3</ix:nonFraction>&#160;million of incremental financing costs in connection with the modification of the Senior Credit Facility during the third quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, there was</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i04d1b0160d1340fd8ab66ecf51fa7a66_I20211231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMxOTk_0356f09a-6f10-4c24-b5c2-d58f127a7f85">31.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i67999afc0f43421ba112b03ab3776e83_I20201231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMyMDY_02f955be-1726-4cfa-b8dd-3e287fcabdc1">97.5</ix:nonFraction> million, respectively, outstanding under the revolving portion of the Senior Credit Facility at weighted average interest rates of <ix:nonFraction unitRef="number" contextRef="i04d1b0160d1340fd8ab66ecf51fa7a66_I20211231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMzMzI_80a0136d-2fe9-4353-aaeb-fe5d75e38149">1.4</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i67999afc0f43421ba112b03ab3776e83_I20201231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMzMzk_35b00c7d-e0c6-446d-b763-04a8c6f1676a">1.5</ix:nonFraction>%, respectively. At December&#160;31, 2021 and 2020, there was $<ix:nonFraction unitRef="usd" contextRef="if7bb504d057d4468ac3701ee85921300_I20211231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMzODE_e8691d1c-a8af-40e5-929c-2f87a3f9a0c4">843.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia4de4ab17ca14d19958b42305fcb9dba_I20201231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjU0MzQ_1258868d-b5b0-4e36-8296-e48d64258671">877.5</ix:nonFraction>&#160;million, respectively, outstanding, under the Term Loan component of the Senior Credit Facility at weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="if7bb504d057d4468ac3701ee85921300_I20211231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzM1MDk_29fb5970-5864-42e3-882c-dc9b36f64081">1.4</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ia4de4ab17ca14d19958b42305fcb9dba_I20201231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzM1MTY_4f38072f-978a-4e4b-b088-5dcf0fcf636c">1.5</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. At December&#160;31, 2021 and 2020, there was $<ix:nonFraction unitRef="usd" contextRef="if7bb504d057d4468ac3701ee85921300_I20211231" decimals="-5" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzM1NDE_d3377200-750b-45e9-8dee-e19fb1f41a06">45.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia4de4ab17ca14d19958b42305fcb9dba_I20201231" decimals="-5" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzIxOTkwMjMyNzQxMTQ_dbb3daa2-c0d5-4201-820e-15f47fc2787a">33.8</ix:nonFraction>&#160;million, respectively, of the Term Loan component of the Senior Credit Facility was classified as current on the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding borrowings of the Senior Credit Facility's revolving credit and Term Loan components at December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $<ix:nonFraction unitRef="usd" contextRef="iefe0207dab024691b9422a6871c2701c_I20211231" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzM4NzI_4d2f8d24-ef39-4f90-937c-a39f08c0c286">31.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i010dd7bd40794db0b97bdb8b4817314b_I20211231" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzM4Nzk_e4e32807-713c-4acb-9eb0-c29e0094aabf">838.4</ix:nonFraction> million, re</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">spectively. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit outstanding as of December&#160;31, 2021 and 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> totaled $<ix:nonFraction unitRef="usd" contextRef="i75b71a62404445ecac16c98d28a6c859_I20211231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQ0NzM_b92fdd6c-93a9-4084-aa19-b1656e06a996"><ix:nonFraction unitRef="usd" contextRef="i11503d83ecb041bba066af755cc2923f_I20201231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQ0NzM_f6e352ac-9730-4ef3-8a50-93cf2794a04f">1.6</ix:nonFraction></ix:nonFraction> million. Ther</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e were <ix:nonFraction unitRef="usd" contextRef="i75b71a62404445ecac16c98d28a6c859_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQ1MjU_d45f7208-9347-49c6-a19d-8c231a9980d9">no</ix:nonFraction> amounts drawn as of December&#160;31, 2021.</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzEwNjI2_17ef076f-0a21-4bf7-aafc-da3e1a0b58f0" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZTpmYzc4YTVmMGYyODg0MGQ1YjMyMTg4MGY3MDg1ZjlmNi90YWJsZXJhbmdlOmZjNzhhNWYwZjI4ODQwZDViMzIxODgwZjcwODVmOWY2XzQtMS0xLTEtMzczNTY_299ae5e8-ee3f-4063-b805-392c3f6e858d">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZTpmYzc4YTVmMGYyODg0MGQ1YjMyMTg4MGY3MDg1ZjlmNi90YWJsZXJhbmdlOmZjNzhhNWYwZjI4ODQwZDViMzIxODgwZjcwODVmOWY2XzUtMS0xLTEtMzczNTY_fb2034af-0b27-4f12-bd95-7bc6bad59028">61,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZTpmYzc4YTVmMGYyODg0MGQ1YjMyMTg4MGY3MDg1ZjlmNi90YWJsZXJhbmdlOmZjNzhhNWYwZjI4ODQwZDViMzIxODgwZjcwODVmOWY2XzYtMS0xLTEtMzczNTY_9a916dfc-4a9f-486b-9c86-0c13245691fa">67,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZTpmYzc4YTVmMGYyODg0MGQ1YjMyMTg4MGY3MDg1ZjlmNi90YWJsZXJhbmdlOmZjNzhhNWYwZjI4ODQwZDViMzIxODgwZjcwODVmOWY2XzctMS0xLTEtMzczNTY_5af60b85-c081-4fa7-b825-2032cd4131c0">669,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZTpmYzc4YTVmMGYyODg0MGQ1YjMyMTg4MGY3MDg1ZjlmNi90YWJsZXJhbmdlOmZjNzhhNWYwZjI4ODQwZDViMzIxODgwZjcwODVmOWY2XzktMS0xLTEtMzczNTY_3a423731-b00f-4ed4-bc51-e1fad2d3b829">843,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="iart:InterestPaymentsYearOne" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1Mjg0NDQ_35a6ee43-9267-49b5-aa07-10ad85392ac9">11.0</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="iart:InterestPaymentsYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1Mjg0ODg_03272980-91fa-4aff-9167-ed1688f27947">10.3</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="iart:InterestPaymentsYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1Mjg0OTc_0b0dd0a2-d065-44b0-82c1-070d7e760e07">9.4</ix:nonFraction> million in 2024, and $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="iart:InterestPaymentsYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1Mjg1MDg_75b73dcd-ff0b-4db1-ac80-066cf0a24162">0.9</ix:nonFraction> million in 2025. Interest is calculated on the term loan portion of the Senior Credit Facility based on LIBOR plus the spread paid by the Company. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQ4MzM_c19238bc-49d3-42c7-b395-df684ab5089b">575.0</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQ4NzA_441aa1a3-9754-4146-bafa-148e9b09dc3a">0.5</ix:nonFraction>% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzUwMDQ_4196a897-429c-41aa-86aa-fdf1889d3f24">0.5</ix:nonFraction>% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $<ix:nonFraction unitRef="usd" contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204" decimals="-5" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzUyMzU_0e54740a-cf97-48fc-ae90-7ca2c4b7a020">104.5</ix:nonFraction>&#160;million. The effective interest rate implicit in the liability component was <ix:nonFraction unitRef="number" contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU0MTg_d887304d-4377-4047-b208-7ccdab29faa5">4.2</ix:nonFraction>%. In connection with this offering, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU0ODA_d3c399df-6dd8-424a-a60a-3f6f6b975103">13.2</ix:nonFraction>&#160;million of financing fees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of <ix:nonFraction unitRef="number" contextRef="if5c8f0f3fcc54d7fa864f05e7721631f_D20200204-20200204" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU4ODQ_d1793d3c-d610-4831-99c6-f3a60d057b3e">13.5739</ix:nonFraction> shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU5OTA_8c91fd92-bad2-47ef-86cb-d70728095023">73.67</ix:nonFraction> per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least <ix:nonFraction unitRef="number" contextRef="if5c8f0f3fcc54d7fa864f05e7721631f_D20200204-20200204" decimals="INF" name="iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzYxMzg_f2ae3b5f-e0af-4500-8e38-a4ef4aae108d">130</ix:nonFraction>% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to <ix:nonFraction unitRef="number" contextRef="if5c8f0f3fcc54d7fa864f05e7721631f_D20200204-20200204" decimals="INF" name="iart:DebtInstrumentMaximumAverageConversionValueOfNotes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzYyODc_f1a25a46-c3aa-478f-bfcf-8b8580875a64">98</ix:nonFraction>% of the average conversion </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ic85ef28a5db441448230e4e23018e989"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of December&#160;31, 2021, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#8217;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#8217;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $<ix:nonFraction unitRef="usd" contextRef="i9c7ea572f6ff408eb1c3e8b78cead270_I20201209" decimals="INF" name="iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzcyNjg_0e0cf28f-e9eb-481d-8e71-3360fe149ba0">1,000</ix:nonFraction>. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at <ix:nonFraction unitRef="number" contextRef="if5c8f0f3fcc54d7fa864f05e7721631f_D20200204-20200204" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzczOTY_2c6d742f-55d1-4493-b9a9-99df4f92b8db">100</ix:nonFraction>% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#8220;hedge participants&#8221;). The cost of the call transactions was $<ix:nonFraction unitRef="usd" contextRef="ia5fd639d6b434c4285a6fe944615d341_D20210101-20211231" decimals="-5" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzgwNjg_63d192af-4755-484d-b839-5998afa8411b">104.2</ix:nonFraction>&#160;million for the 2025 Notes. The Company received $<ix:nonFraction unitRef="usd" contextRef="ia5fd639d6b434c4285a6fe944615d341_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzgxMTI_9b8b6bf5-3421-4e30-a17f-988b982acfc7">44.5</ix:nonFraction>&#160;million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $<ix:nonFraction unitRef="usdPerShare" contextRef="i396d7f2eb0c64059b81baf2f22ba97ec_D20200204-20200204" decimals="2" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzg0NjA_7395f90c-b360-44b6-98b1-353661e1d7d3">73.67</ix:nonFraction>, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $<ix:nonFraction unitRef="usdPerShare" contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzg2MDg_c7412e2b-cd84-4b8e-abd4-e6747aff73e6">113.34</ix:nonFraction> for the 2025 Notes, subject to customary anti-dilution adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the carrying amount of the liability component was $<ix:nonFraction unitRef="usd" contextRef="if6851222fe6b4433adf09a9809463a04_I20201231" decimals="-5" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjM1NTM_91569140-768f-47cc-959d-7bfe18a2983c">485.9</ix:nonFraction>&#160;million, the remaining unamortized discount was $<ix:nonFraction unitRef="usd" contextRef="if6851222fe6b4433adf09a9809463a04_I20201231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjM1MTk_f925168d-75e6-48f8-8f27-34162e24584a">89.1</ix:nonFraction>&#160;million, and the principal amount outstanding was $<ix:nonFraction unitRef="usd" contextRef="if6851222fe6b4433adf09a9809463a04_I20201231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjM0ODk_a8f0499f-a853-4d27-8708-2de56a01ee03">575.0</ix:nonFraction>&#160;million. On January 1, 2021, the Company adopted ASU 2020-06 using the modified retrospective method. See Note 2, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details. At December&#160;31, 2021, the carrying amount of the liability was $<ix:nonFraction unitRef="usd" contextRef="i55dda325db55443a874b0f8c37dd8b20_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjM4Mjg_207824f8-4304-4779-8f32-c1624dfcb078">575.0</ix:nonFraction>&#160;million. The fair value of the 2025 Notes at December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i55dda325db55443a874b0f8c37dd8b20_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjQ0Njg_52c0e045-0c3f-4589-92ec-fa433839c712">640.5</ix:nonFraction>&#160;million. Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the adoption of ASU 2020-06, the Company recognized only cash interest related to the contractual interest coupon of $<ix:nonFraction unitRef="usd" contextRef="i532960b507734253829e73f26a86f856_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjQzOTM_a203cc63-747d-4d37-9603-3076e4687e96">2.9</ix:nonFraction>&#160;million on the 2025 Notes for the year ended December&#160;31, 2021. Prior to the adoption, during the year ended December 31, 2020, the Company recognized cash interest of $<ix:nonFraction unitRef="usd" contextRef="ic8b32770839e412698beb581305b9b06_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzg3OTg_f561720d-0321-4e17-b996-2cebb564b2bc">2.6</ix:nonFraction>&#160;million and amortization of the discount on the liability component of $<ix:nonFraction unitRef="usd" contextRef="i532960b507734253829e73f26a86f856_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzg4NjQ_0c623f49-928f-4d5b-926d-77c5fb1b1c83">15.4</ix:nonFraction>&#160;million for a total interest charge of $<ix:nonFraction unitRef="usd" contextRef="i532960b507734253829e73f26a86f856_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzg4OTg_044100c1-5af6-4fea-b39b-ddd2cce96bcd">18.0</ix:nonFraction>&#160;million on the 2025 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securitization Facility</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#8220;SPE&#8221;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="INF" name="iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzk2NTU_5af4d022-3f34-494b-a937-dce86f7d3197">150.0</ix:nonFraction> million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of December&#160;31, 2021, the Company was in compliance with the covenants and none of the termination events had occurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company&#8217;s total indebtedness.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At both December&#160;31, 2021 and 2020, the Company&#160;had $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="iart:SecuredLongTermDebtSecuritizationProgram" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjE4NzE_246b82df-80b7-4c6c-9d45-5e99bc58ef39"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-5" name="iart:SecuredLongTermDebtSecuritizationProgram" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjE4NzE_df81d523-f27e-4deb-9a29-b00784c53cac">112.5</ix:nonFraction></ix:nonFraction>&#160;million, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="3" name="iart:DebtWeightedAverageInterestRateFromSecuritization" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjE5MTM_d198d351-53ea-4244-9eee-9832574c091d">1.1</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="3" name="iart:DebtWeightedAverageInterestRateFromSecuritization" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjE4OTY_a7802aa4-9960-40b5-afc0-1fe0ecd93e31">1.3</ix:nonFraction>%, respectively. The fair value of the outstanding borrowing of the Securitization Facility at December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i07286d7fc74242cca19b206f52c0f370_I20211231" decimals="-5" name="iart:SecuritizationFacilityFairValueOfAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzEwNjE4_5be9cf01-84a6-4321-8a81-eb80cb5a6337">111.8</ix:nonFraction> million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;<ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzEwODY4_4e6b0cf4-b9b6-4475-8b38-c118deb45d7b" continuedAt="i776a15f9e81e44318301d128b8798fb3" escape="true">DERIVATIVE INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="i776a15f9e81e44318301d128b8798fb3" continuedAt="i916e1002240b455ab72d86270f0d1368"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzEwODY1_bd6dd51b-684a-4c4a-af51-7241d1bafea0" continuedAt="i2d7daa9980414a0aa9b3d1bd332c16d0" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241736141ce5441cbaf9b7d07be1bd2b_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzUtMi0xLTEtMzczNTY_e0b66806-a8dc-4a04-9315-32d8b7e7ece0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e95c8600d24f1788cde97b1a748f0c_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzUtNC0xLTEtMzczNTY_c34fc688-b79c-477d-aee1-c2c3d0b81b0a">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 27, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i241736141ce5441cbaf9b7d07be1bd2b_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzUtMTItMS0xLTM3MzU2_3b4b65bb-4f40-4645-a9c0-8fd94df5224f">1.971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241736141ce5441cbaf9b7d07be1bd2b_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzUtMTQtMS0xLTM3MzU2_2425c11c-51c5-4b91-810a-1db2f02c1fde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27e95c8600d24f1788cde97b1a748f0c_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzUtMTYtMS0xLTM3MzU2_e51b455f-9efa-41c0-943c-dd88618b7775">929</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e368b5fda0a476a8edcda24877e2d60_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzYtMi0xLTEtMzczNTY_a36dfd00-13db-4e3b-963f-7e24a3fb7060">300,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf07d7a40de4c22bd5f4ec2b7dc0864_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzYtNC0xLTEtMzczNTY_e492ef84-772b-4f53-a404-ccb46c4ea68a">300,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e368b5fda0a476a8edcda24877e2d60_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzYtMTItMS0xLTM3MzU2_874dade9-28f5-4c46-b9d4-5cdee47a1fe6">2.201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e368b5fda0a476a8edcda24877e2d60_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzYtMTQtMS0xLTM3MzU2_3cc7af1e-e2cd-424a-abe7-e2e82fa2e5cd">5,268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bf07d7a40de4c22bd5f4ec2b7dc0864_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzYtMTYtMS0xLTM3MzU2_a8e3fe28-2128-43af-b87b-877ce49155c6">12,557</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie632a54071064dd984a1daee5e94ea29_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzctMi0xLTEtMzczNTY_5085b0b5-6bce-42df-a3f6-0e4df722de6a">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f1a07697994a528de8da81d3b4a80d_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzctNC0xLTEtMzczNTY_6f41c71e-8c25-4580-b540-272342bf0a28">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie632a54071064dd984a1daee5e94ea29_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzctMTItMS0xLTM3MzU2_aa034975-f57f-4831-b967-1fff89c66f06">2.423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie632a54071064dd984a1daee5e94ea29_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzctMTQtMS0xLTM3MzU2_884232de-a541-4908-b7d4-aff48beddd12">5,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4f1a07697994a528de8da81d3b4a80d_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzctMTYtMS0xLTM3MzU2_0c090207-c327-4854-ab42-b43ae1e511ca">11,502</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b97ff90e2648d49fb6e83da054fb38_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzgtMi0xLTEtMzczNTY_51c5bf56-7a72-492d-aa45-e5fb26680bdd">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cbba29541b0414aa84fce8d3ab05e46_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzgtNC0xLTEtMzczNTY_f87f1199-7df5-45bb-b8d1-83cc8aca4b05">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia0b97ff90e2648d49fb6e83da054fb38_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzgtMTItMS0xLTM3MzU2_3056af4f-af78-47ba-a5f4-f3d2312437b9">2.313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b97ff90e2648d49fb6e83da054fb38_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzgtMTQtMS0xLTM3MzU2_06f09fbd-2307-45f9-b5e9-ee6480a0679d">7,421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cbba29541b0414aa84fce8d3ab05e46_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzgtMTYtMS0xLTM3MzU2_b1159d67-585b-4c8a-b6a0-de3fb76ed0fc">16,243</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i288f3609bde4438a81832109716cd5a9_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzktMi0xLTEtMzczNTY_59e57f71-036c-4320-b8c3-c7a81c8b1146">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26217e69841f4b5f865e6ddc9b644f61_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzktNC0xLTEtMzczNTY_91facb86-1329-44dd-a920-1975950384a2">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i288f3609bde4438a81832109716cd5a9_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzktMTItMS0xLTM3MzU2_0cac479d-42db-4903-8304-8b512ad84bac">3.220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i288f3609bde4438a81832109716cd5a9_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzktMTQtMS0xLTM3MzU2_3d2e327d-5700-44ca-a3f2-0c88c49132d3">5,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26217e69841f4b5f865e6ddc9b644f61_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzktMTYtMS0xLTM3MzU2_69139604-5248-4327-9512-ca4961c0c632">9,836</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibca66931d2494db380dd96d37d92bc88_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEwLTItMS0xLTM3MzU2_c67699e3-4035-4cbd-b981-490fdf1d61b3">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65c0189ffb9a4e769aae035799d3163d_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEwLTQtMS0xLTM3MzU2_ff373fdf-eace-43a8-a5eb-905d219d74a7">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibca66931d2494db380dd96d37d92bc88_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEwLTEyLTEtMS0zNzM1Ng_751c1999-3124-47d4-8a9c-b1f0db26170f">3.199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibca66931d2494db380dd96d37d92bc88_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEwLTE0LTEtMS0zNzM1Ng_b31b791a-431b-4247-b137-9828a85d5206">5,464</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65c0189ffb9a4e769aae035799d3163d_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEwLTE2LTEtMS0zNzM1Ng_a5549887-257a-4588-b405-7795982dd4fe">9,826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bb1e3365e494ce89a0cf4822b064c93_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzExLTItMS0xLTM3MzU2_aead0392-f1d9-44ff-b381-818c4e8073a9">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac02b3f863ad479ab79142979d7cade1_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzExLTQtMS0xLTM3MzU2_7fb3c49b-0420-438f-bab7-a87966875b67">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6bb1e3365e494ce89a0cf4822b064c93_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzExLTEyLTEtMS0zNzM1Ng_8a7ae308-8549-45da-bdd1-e6cb883dec35">3.209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bb1e3365e494ce89a0cf4822b064c93_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzExLTE0LTEtMS0zNzM1Ng_cf1f60e3-2892-4e01-b455-cdc27d501b3b">5,494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac02b3f863ad479ab79142979d7cade1_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzExLTE2LTEtMS0zNzM1Ng_83261388-32cd-4fa6-af52-25a259c06e43">9,783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a132dddf0e4b05ab2279482233be48_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEyLTItMS0xLTM3MzU2_df0a1e73-d14b-427f-b8dd-293f17a96a5c">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35359b024a1d4f2a98e87757bfa30a29_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEyLTQtMS0xLTM3MzU2_3401b294-19cd-485f-8447-3cfa8e64d20c">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic4a132dddf0e4b05ab2279482233be48_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEyLTEyLTEtMS0zNzM1Ng_7cfa2c26-00c9-4edc-8b0b-547abb3d3a8d">2.885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4a132dddf0e4b05ab2279482233be48_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEyLTE0LTEtMS0zNzM1Ng_45bd28a7-6cce-4385-91bf-942f2dd6937d">6,886</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35359b024a1d4f2a98e87757bfa30a29_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEyLTE2LTEtMS0zNzM1Ng_51b7bb3f-5568-4ec7-ae7e-f39deb98217e">10,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d7dee7ffe74d79a4e2144db55b55e0_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEzLTItMS0xLTM3MzU2_51f73e36-f47a-4788-bc10-9e4c4150b44a">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i532ebca746b94440a3ce52a9b1e41c55_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEzLTQtMS0xLTM3MzU2_5a4dec90-1f60-4061-87f2-1adcd363f3db">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i65d7dee7ffe74d79a4e2144db55b55e0_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEzLTEyLTEtMS0zNzM1Ng_f00ceb3c-533c-4275-b72a-c83829440d41">2.867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65d7dee7ffe74d79a4e2144db55b55e0_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEzLTE0LTEtMS0zNzM1Ng_0364c3a5-03ef-418a-b650-a09bf3ff3316">6,764</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i532ebca746b94440a3ce52a9b1e41c55_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEzLTE2LTEtMS0zNzM1Ng_fee6171b-4e24-4a85-8dae-37df87bc7cd9">10,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b86f7b9c3c848fba14945777a7f742f_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE0LTItMS0xLTM3MzU2_6a37999e-69e3-4864-b586-43d975c55a27">575,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378a39326c7c47a4b12de5edfddb468f_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE0LTQtMS0xLTM3MzU2_0bb0d2c4-d22c-4496-a4bd-94c27ec9d5b2">575,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b86f7b9c3c848fba14945777a7f742f_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE0LTEyLTEtMS0zNzM1Ng_0d2a04d8-39b0-44e1-af31-5eca66886e6d">1.415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b86f7b9c3c848fba14945777a7f742f_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE0LTE0LTEtMS0zNzM1Ng_5df4b70e-5025-4425-b661-f9f6548b3058">3,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i378a39326c7c47a4b12de5edfddb468f_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE0LTE2LTEtMS0zNzM1Ng_1afa089e-2f7f-4bcf-8fef-98a8c6fc5dc1">1,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id11bfa4243b44471878dc05e0b04c5ae_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE1LTItMS0xLTM3MzU2_e2000f5e-78e3-454f-911b-48ac2c9fcd57">125,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53695045753f4b0cb6d43100ea2c5b50_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE1LTQtMS0xLTM3MzU2_df270fa8-dcc5-4f12-bd49-981c3974779e">125,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id11bfa4243b44471878dc05e0b04c5ae_I20211231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE1LTEyLTEtMS0zNzM1Ng_5a13cbc0-1c9e-45d5-a3cd-0ae8f42d3c0d">1.404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id11bfa4243b44471878dc05e0b04c5ae_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE1LTE0LTEtMS0zNzM1Ng_3ee3882b-2983-4a1f-87ba-2fa2269ea5af">821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53695045753f4b0cb6d43100ea2c5b50_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE1LTE2LTEtMS0zNzM1Ng_90790828-035a-4e35-aadc-d5f215c070f3">348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0dbe85e1e664ae9ac6dc86a82263629_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzIxLTItMS0xLTM3MzU2_78889731-5842-444f-818f-1408285ad65a">1,775,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcde00d2f9ee499c9b3f5bddea1dac4b_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzIxLTQtMS0xLTM3MzU2_2733d85f-af4c-4bed-b36a-93507e4035f3">1,875,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0dbe85e1e664ae9ac6dc86a82263629_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzIxLTE0LTEtMS0zNzM1Ng_897de309-182a-4b46-9e6d-c1bb0e592f80">43,957</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcde00d2f9ee499c9b3f5bddea1dac4b_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzIxLTE2LTEtMS0zNzM1Ng_8f50f048-4d52-4282-a066-5b97e063720a">93,769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (&#8220;AOCL&#8221;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax. Those amounts are subsequently reclassified to earnings from AOCL as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company entered into foreign currency forward contracts, with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i9f291ee98dcc4db0b65295c7cc02b534_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIzOTk_d46f6b29-7ba5-476e-a24b-0497317222cb">9.7</ix:nonFraction>&#160;million, to mitigate the foreign exchange risk related to certain intercompany loans denominated in Canadian Dollar ("CAD") and intercompany receivables denominated in Japanese Yen ("JPY"). The contracts are not designated as hedging instruments. The Company subsequently settled its foreign currency forward contracts associated with the intercompany receivables denominated in JPY during the first quarter of 2021. The Company recognized a $<ix:nonFraction unitRef="usd" contextRef="ibe5ea43d4f06427e8b8278ecc9d21984_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzI2NjU_361fa52e-742f-4e12-ba32-854f8a1d9a9c">0.2</ix:nonFraction>&#160;million loss from the change in fair value of the contracts, which was included in other income, net in the consolidated statement of operations as of December 31, 2021 and 2020, respectively. The fair value of the foreign currency forward contracts denominated in CAD was $<ix:nonFraction unitRef="usd" contextRef="ia6f9c05623734f95b308753dab91e2d1_I20211231" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjIwMzA_0854c042-6286-4adf-bca9-bc35a4094a31">0.2</ix:nonFraction>&#160;million as of December 31, 2021. The fair value of the foreign currency forward contracts was $<ix:nonFraction unitRef="usd" contextRef="i9f291ee98dcc4db0b65295c7cc02b534_I20201231" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNzMxNTE_3a314fcf-a9b1-4467-b4db-4c71720d5cc7">0.2</ix:nonFraction>&#160;million as of December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional of $<ix:nonFraction unitRef="usd" contextRef="i834a7d0bdde0493b82362279698dc772_I20210630" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNjkyMTI_2e5fa22b-e76b-4218-81ef-f57ecf72da55">7.3</ix:nonFraction>&#160;million to mitigate the risk from fluctuations in foreign currency exchange rates associated with certain intercompany loan denominated in </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i916e1002240b455ab72d86270f0d1368" continuedAt="ie04eb841b3fa45c5af196534396fcb5a"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japanese Yen ("JPY"). In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The change in fair value of the foreign currency swap was $<ix:nonFraction unitRef="usd" contextRef="i3f34947eecd043ce89085543035baf6c_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNzM2MDc_4157f266-1d99-48bd-85c6-78794fbd606a">0.6</ix:nonFraction>&#160;million as of December 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Company&#8217;s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Currency Rate Swaps</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2017, the Company entered into cross currency swap agreements to convert a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i3a00f578e1734e96abe9db9dd7e4d84d_I20171002" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzM0Nzc_c1637001-a97b-4bc3-ac04-b42adaf86698">300.0</ix:nonFraction> million equivalent to <ix:nonFraction unitRef="chf" contextRef="ie6c4104f081f4a0c97cc34bfa934b8de_I20171002" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzM0OTQ_abda9aec-2cf6-4e35-9735-a97d5eaf96a2">291.2</ix:nonFraction> million of Swiss Francs ("CHF") denominated intercompany loans into U.S. dollars. The CHF- denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i0ed96b4baeca485d88d732479d36ee6f_I20201221" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzM4MzU_8534a01e-b5ee-49bf-a616-bf43b48644f1">471.6</ix:nonFraction>&#160;million equivalent to <ix:nonFraction unitRef="chf" contextRef="i0ed96b4baeca485d88d732479d36ee6f_I20201221" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzM4NTI_f4aec9e1-dd55-41a6-af6c-9087f6b53ad8">420.1</ix:nonFraction> million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF <ix:nonFraction unitRef="chf" contextRef="ie482bef356cf4e048602c1345e6faad1_D20210101-20211231" decimals="-5" name="iart:IntercompanyLoanQuarterlyPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNjkyMjY_3b641047-fb7c-465f-bf3d-57e85aca7c2c">5.8</ix:nonFraction>&#160;million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.</span></div><ix:continuation id="i2d7daa9980414a0aa9b3d1bd332c16d0" continuedAt="i58c49c381521494298d0fdb29e2a791b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.897%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset (Liability)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 4, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic9225e7f823044678109956680d2a97a_I20211231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEyLTYtMS0xLTM3MzU2_ba0938c2-6447-4dda-8e51-56e5671c4436">1.85</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="ic9225e7f823044678109956680d2a97a_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEyLTktMS0xLTQ4MzYz_6b0b0e6c-5ab1-4bdf-8ac4-4dacbb59653f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i076d006aea244c84af07364f0b1ad64a_I20201231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEyLTktMS0xLTM3MzU2_c84d49b9-4d80-4866-919e-6a0f16b2bed7">48,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8fbe23f0de4b438088a04ce4c7f7cc_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEyLTEyLTEtMS00ODM2OQ_e6ccca84-4ad2-4405-bb1d-cacdddc7f4f3">&#8212;</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1efb9a3c67d04590a34d8a19cd9e854a_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEyLTExLTEtMS0zNzM1Ng_99ccb576-bea7-48b6-9793-783da882c59f">4,335</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13f31b37f3ea4d8e97eec66b802e9e49_I20211231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEzLTYtMS0xLTM3MzU2_5da507cf-1bd8-4c9b-a444-8d2188a96486">4.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13f31b37f3ea4d8e97eec66b802e9e49_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEzLTktMS0xLTQ4MzYz_662ee8d6-2b24-41ce-a533-6026cf51e34b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5cde6835114b3da99ea43fe6947ed4_I20201231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEzLTktMS0xLTM3MzU2_8289311f-9165-4464-87c2-216762254f5e">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2fa44250f8ea494f9ec6201defd7694d_I20211231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE1LTYtMS0xLTM3MzU2_bb8b7501-6468-4071-a4df-2a675cff64f2">1.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i2fa44250f8ea494f9ec6201defd7694d_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE1LTktMS0xLTQ4MzYz_901e3634-71a9-49cf-a218-f22c4b7528cf">145,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="ie0b9cf3906af44e588a43a37c9259020_I20201231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE1LTktMS0xLTM3MzU2_3bcc1d2a-e138-44cd-9b1d-b49a0a5af6b7">145,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9abdd3860253449b9af0cf34bcbdeb85_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE1LTEyLTEtMS00ODM2OQ_3b97d49b-301d-4e1b-98d6-198d269631ab">8,283</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1d386cad6144838b3a92904df7a317c_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE1LTExLTEtMS0zNzM1Ng_118c9c08-d36c-4035-adb9-95b95f432abd">11,262</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5437d75eac6144cf88ae812aecc743aa_I20211231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE2LTYtMS0xLTM3MzU2_f8d7a69a-a97a-424b-ab96-08eba4fa9619">4.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5437d75eac6144cf88ae812aecc743aa_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE2LTktMS0xLTQ4MzYz_66552b1b-a046-4b5b-a4f0-bca6a6dfbcfb">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d2a0894b2040ba81435a39df496070_I20201231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE2LTktMS0xLTM3MzU2_bd0a1f8e-72f6-4f57-8e12-fc67651599c7">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0453195fa23e46d483cf46bd3e3de52a_I20211231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE4LTYtMS0xLTM3MzU2_3705da48-a1d1-4758-87e7-5b2c9c2014e2">3.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i0453195fa23e46d483cf46bd3e3de52a_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE4LTktMS0xLTQ4MzYz_40ea1ff0-9808-4e85-aa4b-4a6fa3433f1c">397,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i73b0d274622045248510c3e54280fccf_I20201231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE4LTktMS0xLTM3MzU2_83e75309-738e-4a94-be7c-0cc5e1f50ea4">420,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2f46deba383407cb210dce486f3dcac_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE4LTEyLTEtMS00ODM2OQ_897d0ba8-cd36-4f11-b691-a0d104ad84dc">41</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d35df157fe74d6e891907bc9031cca0_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE4LTExLTEtMS0zNzM1Ng_f4c31747-dcdf-4f0a-8880-315a7f11031d">7,843</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie3f4cc639f144ce6ac3a87548c3b6c9c_I20211231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE5LTYtMS0xLTM3MzU2_09eedb1a-942a-4d92-b843-2114341f733c">3.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f4cc639f144ce6ac3a87548c3b6c9c_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE5LTktMS0xLTQ4MzYz_94ea616b-070f-4af9-888d-b97082d4165f">445,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6242204a744c64a6389b0800b02769_I20201231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE5LTktMS0xLTM3MzU2_aa11db4d-9a57-47be-a26b-2d05a9ca1c57">471,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89d5d03c36334d73b8492d6c04b74983_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzIxLTEyLTEtMS00OTgzMg_2e995f82-020b-4f22-b701-aa4df4d1d7b4">8,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33ff7b9d006640f8938113069f4a6eff_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzIxLTExLTEtMS0zNzM1Ng_e8881bd3-e749-4a7a-b1ac-8b99c45c9116">23,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 4, 2021 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="iee2b883defbc4b8f8ed1e8efbff9af9c_I20211004" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNjkyMzk_b4e4eba2-5904-4032-9089-330e1baf46a6">50.0</ix:nonFraction>&#160;million. The gain recorded by the Company upon the settlement of the swap was not material for the period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2020 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="ib025dac64fea4558b2d30ed1bec0b8c1_I20201002" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQ5MDA_a126d978-e5ca-40cc-ad61-0379a4cd9e88">33.3</ix:nonFraction>&#160;million. As a result of the settlement, the Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i4eeb4577960a4674b83a36fbcf56c4c1_D20201002-20201002" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQ5NjY_68614cf9-8658-4d96-8e7e-f2d6069534aa">0.3</ix:nonFraction>&#160;million in other income, net in the consolidated statement of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the years ended December&#160;31, 2021 and 2020, the Company recorded a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gain of $<ix:nonFraction unitRef="usd" contextRef="i2a2aaff04d024dc4990e2909b24f4dd5_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNzMxNzk_4005b58c-480c-4656-b2a0-fdb88a339609">23.8</ix:nonFraction>&#160;million and loss of $<ix:nonFraction unitRef="usd" contextRef="ic969b2640c664168980604c5a20744f1_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjMzODk_1b1f3c87-672e-4a81-9bab-1f605eacfb92">21.7</ix:nonFraction>&#160;million, respectively, in other income, net related to change in fair value related to the foreign currency rate tran</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">slation to offset the gains or losses recognized on the intercompany loans.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie04eb841b3fa45c5af196534396fcb5a" continuedAt="idf30286922654cde8e2045008a06e1b3"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company reco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rded a gain of $<ix:nonFraction unitRef="usd" contextRef="ie482bef356cf4e048602c1345e6faad1_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzYxMDU_077722b3-3bb2-4c61-be0b-bb30bb9d9be3">24.3</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a loss of $<ix:nonFraction unitRef="usd" contextRef="iabd46125a80f417e9a4465bdf1807227_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzYxMjI_b3af56f8-5adf-474e-815d-7417feaf321f">17.1</ix:nonFraction> million, respectively, in AOCL related to change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company reco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rded gains of $<ix:nonFraction unitRef="usd" contextRef="ie482bef356cf4e048602c1345e6faad1_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzYyNzA_40fcfe83-b97a-4251-b8d7-a532bb5e2987">9.1</ix:nonFraction> million an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d $<ix:nonFraction unitRef="usd" contextRef="iabd46125a80f417e9a4465bdf1807227_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzYyNzc_26565113-40ae-4d8c-825b-a20a3a18fa8a">5.8</ix:nonFraction> million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated loss that is expected to be reclassified to other income, net from AOCL as of December&#160;31, 2021 within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i524b9ebd90024ddabb8d0282eaf6a29c_I20211231" decimals="-5" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzY1NzA_c53d9399-fe47-445b-a097-03ffc3310c4c">3.4</ix:nonFraction> million. As of December&#160;31, 2021, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign currency on foreign subsidiaries.</span></div><ix:continuation id="i58c49c381521494298d0fdb29e2a791b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i541aa942c51c4c4399d51d31e700938e_I20211231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzMtNi0xLTEtMzczNTY_6d9251e1-0d73-4743-9467-130f0d8fec95">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i541aa942c51c4c4399d51d31e700938e_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzMtOS0xLTEtMzczNTY_f1861f0b-487c-437b-b64c-10f8e3fb01c2">44,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i940998b020714fa3b0888d72a26c1945_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzMtMTEtMS0xLTM3MzU2_e4d22ece-4feb-48fd-9a0e-4b71e18af574">&#8212;</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3776583b04954a0e9da05addfc5f9705_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzMtMTItMS0xLTQ4NzA2_ffa942e6-1232-403d-a646-e50dd1c0f914">1,884</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iccec1d91d0fd4f61b8eb3700cf25c835_I20211231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzQtNi0xLTEtMzczNTY_ceaf87f9-eef6-456e-84b9-cfcc061a6014">3.01</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccec1d91d0fd4f61b8eb3700cf25c835_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzQtOS0xLTEtMzczNTY_855ddc65-2a1e-4636-986c-3a8e05a31d87">52,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic25827b0d5bf448aa78483cc9a09b5a7_I20211231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzYtNi0xLTEtMzczNTY_3a80fb89-d2c5-48be-bbda-3badaf06277a">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic25827b0d5bf448aa78483cc9a09b5a7_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzYtOS0xLTEtMzczNTY_1699aea4-89ea-4f49-8ea3-6d6fe35d4186">51,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08c28720b7cf47028c76c53cbd46b11c_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzYtMTEtMS0xLTM3MzU2_9ba8b1d3-d488-40e1-a754-fd4bea5e22a6">2,503</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i368c248f3bd642508bc5c82fd4f9c3f2_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzYtMTItMS0xLTQ4NzA5_d5ef1cb1-3076-42da-99eb-aca5d0b24f0d">450</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib09607d878144ab899b3843daa56b605_I20211231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzctNi0xLTEtMzczNTY_a2e566e5-3898-47c8-9424-fad319f74a0d">2.57</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09607d878144ab899b3843daa56b605_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzctOS0xLTEtMzczNTY_df2f33b0-e9fa-42be-a510-ee6e91167d7b">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc153a66697e473287846740951f472d_I20211231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzktNi0xLTEtMzczNTY_9538be5b-ec2b-4dbd-9c97-019e5195c124">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibc153a66697e473287846740951f472d_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzktOS0xLTEtMzczNTY_7622fff8-dffe-482b-8bf4-37c6e5e427c5">38,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f8cf8b1ba584f49b4fa0e0a794f40bb_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzktMTEtMS0xLTM3MzU2_a100b61a-2278-4ac7-911c-0a5d36357b12">2,147</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id738386e38c0494ba6b7c0a2fb112f20_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzktMTItMS0xLTQ4NzEy_f66f5c45-e488-4265-92ff-c8de6d1cc18b">92</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic4c8e8a8213441a18c7cff8f5e3e651e_I20211231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzEwLTYtMS0xLTM3MzU2_4fc6db18-d452-43a6-ba6a-439cf43030ae">2.19</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c8e8a8213441a18c7cff8f5e3e651e_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzEwLTktMS0xLTM3MzU2_ff6eb176-28a3-42be-8c00-06d3ab2bb2d0">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic6e1dd1f4bbe4812bf8b694608c2ed2c_I20211231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE4LTYtMS0xLTM3MzU2_4fc205a6-d364-4286-8a11-bb51f0cfed38">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="ic6e1dd1f4bbe4812bf8b694608c2ed2c_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE4LTktMS0xLTM3MzU2_df9ddc09-582d-4657-8077-9559fb303180">222,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida4c9a65c572483cbd1edbbbd8df7265_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE4LTExLTEtMS0zNzM1Ng_56883040-e564-4cfb-8ede-0c92e606b2dd">792</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i594ae760b6c148209383a55f5e4e67d2_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE4LTEyLTEtMS00ODcxNQ_62f2d1f7-134c-4e32-b4c3-60f407d4950b">3,794</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2fecaa5319254b9986b2fe9d8c2e1da4_I20211231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE5LTYtMS0xLTM3MzU2_dea076c8-9e2d-4d6f-8735-1f24e5b09594">1.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fecaa5319254b9986b2fe9d8c2e1da4_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE5LTktMS0xLTM3MzU2_1936134e-a1f5-423f-ade9-cc71631a9407">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76c7948c2adf40bebaa47f086f3b7c41_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzIxLTExLTEtMS0zNzM1Ng_b48d1015-8cd1-41bf-9172-9205657c7ce0">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if753e7c4eee5471c9486881f13aa71b7_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzIxLTEyLTEtMS00ODcxNg_c7883e74-11a1-48a4-802b-f0d0caff2cf2">6,036</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2021, in accordance with the termination date, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="id9b1f400a73c4c5fbdc2fc6cd85ecbbd_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjM5NDQ_ff6c90c6-e81a-4ea6-bd2a-2306faacdae3">52</ix:nonFraction>&#160;million equivalent to <ix:nonFraction unitRef="eur" contextRef="id9b1f400a73c4c5fbdc2fc6cd85ecbbd_I20210930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjM5NTc_7b87da03-44a3-483a-a8cb-a2062394d760">44.9</ix:nonFraction>&#160;million Euros. As a result of the settlement, the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="idd1fc1828d5040fbb20eb4d17854f200_D20210930-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjM5NzE_a21b2df2-1d39-476b-b84d-119ec2428581">0.1</ix:nonFraction> million in AOCL.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="if753e7c4eee5471c9486881f13aa71b7_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzc2NTg_c2d9a74f-289a-4745-9325-b6a1160ca2f1">167.5</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="gbp" contextRef="if753e7c4eee5471c9486881f13aa71b7_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzc2NjU_07bb4989-1867-4dd6-abf7-a2f2cc47b10b">128.3</ix:nonFraction>&#160;million Pound Sterling respectively as a result of an intra-entity transfer of certain intellectual property rights to a subsidiary. The original settlement date was September 30, 2025. As a result of the settlement, the Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="ifbeddf97b3b040cdb135d37c167dfb01_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzc5MDg_65b31e22-e04b-492b-8f44-4b296c640e48">7.8</ix:nonFraction>&#160;million in AOCL.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded as unrealized gains or losses in AOCL. For the year ended December&#160;31, 2021 and 2020, the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="ie589d17f3ce64923a38138283f3f843d_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzg1ODI_892358b0-9e21-4781-a503-b4575738e7c6">16.5</ix:nonFraction> million and a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> loss of $<ix:nonFraction unitRef="usd" contextRef="ifbeddf97b3b040cdb135d37c167dfb01_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzg1OTk_5fcb4ba0-bd80-4c1a-ac72-3a9f0fa0ce9d">14.9</ix:nonFraction> million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company recorded a gain of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ie589d17f3ce64923a38138283f3f843d_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzg3NTI_6d2a5df6-7391-4d91-aaf7-365b9ed82e04">6.5</ix:nonFraction> million an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d $<ix:nonFraction unitRef="usd" contextRef="ifbeddf97b3b040cdb135d37c167dfb01_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzg3NTk_4e1a8a56-449e-4703-9553-afced8fb8d55">7.6</ix:nonFraction> million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="idf30286922654cde8e2045008a06e1b3" continuedAt="ia640618e6d8e4a539f60ac9771d7a346"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to interest income from AOCL as of December&#160;31, 2021 within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i76c7948c2adf40bebaa47f086f3b7c41_I20211231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzkwNDc_69401c9e-4f98-47e4-a90b-8c9207b2a96a">5.1</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#8217;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#8217;s credit ratings from any credit rating agency.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk. </span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia640618e6d8e4a539f60ac9771d7a346" continuedAt="ie74eef4b84ee4fc3959cb5334d5d816f"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzEwODgx_96bdaafe-2816-4618-96d9-a88b95bef99f" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Location on Balance Sheet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a55cb1537d47889d076d3c8f830a02_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzctMS0xLTEtMzczNTY_55b122e4-9327-407c-b7ad-f7eae7092df8">4,900</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5007bda63f4a4e2b85d809ab3472888b_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzctMy0xLTEtMzczNTY_695b24c0-6030-4ed8-9332-3f65743cba7c">7,623</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8d483b000704749b5f5f0eb38c92300_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzktMS0xLTEtMzczNTY_0df3be9b-1415-48ab-883d-5b7f4b242314">5,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52dea29077a4f65adb78386228ccf13_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzktMy0xLTEtMzczNTY_ff8b42c3-2b4b-46b5-b392-2e98283e0ba0">5,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95418fcfcff14dcbb2439d47adcad59b_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzEyLTEtMS0xLTM3MzU2_e4eaf613-d295-444f-9a4d-67799bced2da">4,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97de46c1ab694e2aa2d5f857600a53fe_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzEyLTMtMS0xLTM3MzU2_a175407f-3400-48e2-a53d-95920891a6ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac5dfc2c36d4dc3a7782ef005ce490b_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzE1LTEtMS0xLTM3MzU2_a3c5fbbf-7e76-410d-856c-afdc30ee5b55">2,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id92cc86da652405da37174ac4bd32ab4_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzE1LTMtMS0xLTM3MzU2_ea2cc5c8-f655-4abf-b2a8-773cdd33ec9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i447e91e51b6c484fb722708a563e3022_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzE2LTEtMS0xLTM3MzU2_03fafd98-b316-430f-8ce0-614ebcd43484">16,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i935a17c2069e4de2b906355e2084c604_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzE2LTMtMS0xLTM3MzU2_148ac80a-2cbe-4b27-bb06-7b2d9fbabb37">12,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i694c78ee7c7447a6b3c35d7312afaff3_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzIxLTEtMS0xLTM3MzU2_2068b310-f98e-4ec6-ace8-cf8165d18cf5">18,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d737f4d7da848479653a6d886df97b1_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzIxLTMtMS0xLTM3MzU2_da77c636-6419-4ecb-943a-2951382888a9">22,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f58fb0074304c0eb75e1ee30a90496f_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzIyLTEtMS0xLTM3MzU2_57a11a50-54aa-4b97-8205-40a69b466729">8,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4202a3390bb4daa9e7d55f6fbb4c9b6_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzIyLTMtMS0xLTM3MzU2_cb2662ed-bcdf-41d2-996b-32560c4a3db0">4,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3a469b84e14fa487772842b4758f1f_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI0LTEtMS0xLTM3MzU2_29d482fa-8816-4342-84d4-0c22ad5e94cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244b53fa225146a8acddf34d0b484d40_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI0LTMtMS0xLTM3MzU2_d10d2cbc-ac7f-46a9-8a75-46369a169f52">1,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icef0348bbd6a498895aa0b839af063db_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI3LTEtMS0xLTM3MzU2_34f66bff-f128-4128-8dae-b8ed4febccc0">30,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1948e2d317241c495c217c582f1fd94_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI3LTMtMS0xLTM3MzU2_fa8fc8eb-aa1f-4e1d-bd03-76b42b2b2d99">71,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0816d77ecc2a4d5ab1a7fdecd924c086_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI4LTEtMS0xLTM3MzU2_3aeab5b2-019d-41cb-b64a-54533843f1a0">4,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93f9ad9f3ac454ab3e4579cba214ea5_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI4LTMtMS0xLTM3MzU2_d3a1b200-0b83-4229-b067-ea3579c54ded">26,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb37d7988ff2469883e023d54943ceeb_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzMwLTEtMS0xLTM3MzU2_2a5befb2-19d8-470f-9a89-3bb755cfaefd">3,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if15b603d0fdf4013bb65d3fbdef4991b_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzMwLTMtMS0xLTM3MzU2_1af344f2-d923-40b6-ba6c-fdd343427e74">9,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i447e91e51b6c484fb722708a563e3022_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzMxLTEtMS0xLTM3MzU2_8a5d5f38-6559-432e-9cb5-1076b9673d24">64,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i935a17c2069e4de2b906355e2084c604_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzMxLTMtMS0xLTM3MzU2_00649f72-6b31-44ce-be0b-af3e2c68d9f1">136,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">At December 31, 2021 and 2020, the total notional amounts related to the Company&#8217;s interest rate swaps were $<ix:nonFraction unitRef="usd" contextRef="i75b27d98cb6b453489a1a735b29fb883_I20211231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjY0Nzk_1e50f928-7c90-4b48-974d-3e11acffcaa4">1.8</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i3a049fa208ff4ab2bb36343f0be21bd6_I20201231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNjkyNjg_2af7da7e-d86e-4366-9ea7-1d0493b84702">1.9</ix:nonFraction>&#160;billion, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie74eef4b84ee4fc3959cb5334d5d816f"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzEwODUw_d812b32a-c6f1-4bd0-a34c-7d5dbe8cfa71" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statement of operations during the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:23.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain&#160;(Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>End of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4857792c8c74e459972027dfdcb6655_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzQtMS0xLTEtMzczNTY_0c2fc227-728a-4cbe-83f1-2cb57ac057a4">93,769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i138a2424e4fc4b28a990586217f205b5_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzQtMy0xLTEtMzczNTY_29cafc7e-bc17-44a2-8b7e-916441510d29">27,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i138a2424e4fc4b28a990586217f205b5_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzQtNS0xLTEtMzczNTY_0499fcbc-c83e-4d5b-9ce6-dd6a9beef9bf">22,411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1531f368d10d4c27aa41a904bfae834d_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzQtNy0xLTEtMzczNTY_54cef86f-01f8-4e73-b854-8e0f58328a27">43,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29855f0ec5bb4f3b88df4733138e0e6a_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzUtMS0xLTEtMzczNTY_7303d984-739d-4511-b8ed-a936957d62e9">1,073</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd187ce19574cadad3a77fa3939be9c_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzUtMy0xLTEtMzczNTY_77b51ae4-b5ba-4ba9-b000-e5c07a38c644">24,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd187ce19574cadad3a77fa3939be9c_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzUtNS0xLTEtMzczNTY_915ca4cd-e817-4fbd-8cb7-417665109e49">32,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08216cb065b9461b8fe2a96e91b1fc10_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzUtNy0xLTEtMzczNTY_d046e7e1-e8a0-44fb-adca-891f14ca53de">9,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idba5aafc495241d195d5376e3caaf972_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzctMS0xLTEtMzczNTY_21178a92-1d1f-4447-adb7-da9797b39448">12,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65c4a4a4cb943548bc313bbe81dab81_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzctMy0xLTEtMzczNTY_c84e0f50-eff1-4051-a8a7-5f2f6eb79fcf">16,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65c4a4a4cb943548bc313bbe81dab81_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzctNS0xLTEtMzczNTY_0e461f99-538f-4ea7-96c8-2fea6fa097c3">6,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e6ebae6a0544329b7878caaf61f7c19_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzctNy0xLTEtMzczNTY_d7bcafef-f777-4a3b-b9c4-0c8c0e1a2223">2,321</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7221c7b217944b9952cb1447ba40473_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzgtMS0xLTEtMzczNTY_55aba98a-5e91-4df8-b6af-04717b0a5ac1">107,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida54b96ca0584539ae3b3b157470910b_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzgtMy0xLTEtMzczNTY_7193510f-7471-4200-949d-6827186050d5">68,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida54b96ca0584539ae3b3b157470910b_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzgtNS0xLTEtMzczNTY_b8c2b259-916b-4a28-81b9-f71321883f89">17,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e2ac390bcfd4e6183936c3252ad179f_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzgtNy0xLTEtMzczNTY_605e91a9-3103-4e36-9ac7-fe4fec989468">55,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i554f5b5c47644e348d9ce91db90fc9b3_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzExLTEtMS0xLTM3MzU2_a11597d2-562d-477f-ad3e-a866b1061cfb">45,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cdda7c780084113bb71a011c3ec558b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzExLTMtMS0xLTM3MzU2_1296be7c-a82d-46ea-8a0d-297a8bb72746">64,778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cdda7c780084113bb71a011c3ec558b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzExLTUtMS0xLTM3MzU2_6d360278-85c4-4756-8325-26aacefadcaa">16,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4857792c8c74e459972027dfdcb6655_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzExLTctMS0xLTM3MzU2_6ce7f7d2-648f-4952-ab27-115bc5a189f6">93,769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8882f763c98a4445ad3da17239380121_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzEyLTEtMS0xLTM3MzU2_ee369e23-7d13-466c-8eea-02a4eedaa715">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia478304e872e441bae733c20fd924acd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzEyLTMtMS0xLTM3MzU2_91b2de7c-a8c6-4907-8ccd-c0388827e5f6">17,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia478304e872e441bae733c20fd924acd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzEyLTUtMS0xLTM3MzU2_ec0cad9f-0474-4fc0-b9ca-8f0ec909b110">15,897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29855f0ec5bb4f3b88df4733138e0e6a_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzEyLTctMS0xLTM3MzU2_53410e9c-3bab-4537-90b4-4f21d729d50c">1,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d649a29e36c49c1acac597e1b567b30_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE0LTEtMS0xLTM3MzU2_6151940c-012c-4253-81f2-7fbda54cfffc">10,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff47d977eef64f639713c2bdfe4ec819_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE0LTMtMS0xLTM3MzU2_93cf49a1-d38a-4beb-9a32-15716a4f755b">14,911</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff47d977eef64f639713c2bdfe4ec819_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE0LTUtMS0xLTM3MzU2_cec3fad3-d60c-42ce-a7ef-f89c1ae8c789">7,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idba5aafc495241d195d5376e3caaf972_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE0LTctMS0xLTM3MzU2_460e657f-0343-49ef-acc9-ebfefd916cbf">12,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7bf1b9701f467ca31a33bccb2a8bd6_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE1LTEtMS0xLTM3MzU2_4f8ff734-c91e-48b4-8edc-2475ec7a674f">34,739</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i751fe1d8d73549729e2da93079a949e7_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE1LTMtMS0xLTM3MzU2_2f7a5446-a4e3-4480-8923-41e83c80680f">96,836</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i751fe1d8d73549729e2da93079a949e7_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE1LTUtMS0xLTM3MzU2_0cc54d4f-9b80-4888-8415-010d3fa9f84f">24,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7221c7b217944b9952cb1447ba40473_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE1LTctMS0xLTM3MzU2_6d93a48c-bcf1-4f3f-8c22-efccff50048e">107,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i172bf506156f43e6869412a665f54418_163"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYxNjg_88228a30-ac02-4dc4-8985-086f7f66da16" continuedAt="i62c42b63de19409babc8f42f5dc3eb76" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS </ix:nonNumeric></span></div><ix:continuation id="i62c42b63de19409babc8f42f5dc3eb76" continuedAt="ibafab56e92684edc89bef7c3d0441d1f"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment by either performing a qualitative evaluation or a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The qualitative evaluation is an assessment of factors including reporting unit specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of a reporting unit is less than its carrying amount, including goodwill. The Company may elect to bypass the qualitative assessment for its&#160;<ix:nonFraction unitRef="reporting_unit" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU0Ng_aa2be0ea-6abb-4f61-bc3e-8b7204b94618">three</ix:nonFraction>&#160;reporting units and perform a quantitative test. The assumptions used in evaluating goodwill for impairment are subject to change and are tracked against historical results by management. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative test estimates the fair value of the <ix:nonFraction unitRef="reporting_unit" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzc5Mg_aa2be0ea-6abb-4f61-bc3e-8b7204b94618">three</ix:nonFraction> reporting units using a discounted cash flow model, which incorporates significant estimates and assumptions made by management which, by their nature, are characterized by uncertainty. Inputs used to fair value the Company's reporting units are considered inputs of the fair value hierarchy. For Level 3 measurements, significant increases or decreases in long-term growth rates or discount rates in isolation or in combination could result in a significantly lower or higher fair value measurement. The key assumptions impacting the valuation included the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The reporting unit's financial projections, which are based on management's assessment of regional and macroeconomic variables, industry trends and market opportunities, and the Company's strategic objectives and future growth plans.</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The projected terminal value for the reporting unit, which represents the present value of projected cash flows beyond the last period in the discounted cash flow analysis. The terminal value reflects the Company's assumptions related to long-term growth rates and profitability, which are based on several factors, including local and macroeconomic variables, market opportunities, and future growth plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The discount rate used to measure the present value of the projected future cash flows is set using a weighted-average cost of capital method that considers market and industry data as well as the Company's specific risk factors that are likely to be considered by a market participant. The weighted-average cost of capital is the Company's estimate of the overall after-tax rate of return required by equity and debt holders of a business enterprise. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ibafab56e92684edc89bef7c3d0441d1f" continuedAt="i624da374691d406bbbcb3d9c0f425ee3"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company elected to perform a qualitative analysis for its <ix:nonFraction unitRef="reporting_unit" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzgyNDYzMzcyMzAyMjc_7f66ff31-a0aa-4b1c-bfda-e5c57884761f">three</ix:nonFraction> reporting units. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYxNzQ_f33d5d00-7eb0-458b-b993-445402d2a5e7" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill in 2021 and 2020 were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty Surgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6130dbfd55434e3ba87710002f62993d_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzUtMS0xLTEtMzczNTY_5f8396d5-a517-4dbd-abf3-b7692fc63cf0">653,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7ac68eceebd454197e37a04d780f9b2_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzUtMy0xLTEtMzczNTY_44b03d46-369c-4e0d-93cd-f747db5437f5">300,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55084e91d494776891870a81ff5cb91_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzUtNS0xLTEtMzczNTY_d7b7770b-9d3c-469b-9490-b6d84648118c">954,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb66154030084b3e8586a701e0a6bdb6_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzYtMS0xLTEtMzczNTY_0b209991-7d30-43e7-8c59-f2450dd61f98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b76730b7e7f49afa097d63b1fb0577c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GoodwillTransfers" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzYtMy0xLTEtMzczNTY_2291c7ef-93b6-4dd2-b115-a6d4bdb8b1cc">47,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GoodwillTransfers" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzYtNS0xLTEtMzczNTY_1e9b7666-c50a-4b1f-b9c3-1fb1a4a1da3e">47,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb66154030084b3e8586a701e0a6bdb6_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzctMS0xLTEtMzczNTY_a742e006-f8f7-46ec-aea1-0465dc9c48af">18,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b76730b7e7f49afa097d63b1fb0577c_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzctMy0xLTEtMzczNTY_924cbf2b-5586-4f70-8447-fa76a92462dd">7,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzctNS0xLTEtMzczNTY_1439c424-6bbc-4916-881a-334aecd3d403">25,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abb8a070bc94419b02bdf48d4701704_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzgtMS0xLTEtMzczNTY_5c934099-ad54-4829-a846-824784daf904">671,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75ce8d6ec8224485834914549b9bdc7c_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzgtMy0xLTEtMzczNTY_000ce99f-c112-4d57-b94d-7cc6c07b4a15">260,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzgtNS0xLTEtMzczNTY_279141a6-3978-46be-bf94-c07f35711834">932,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACell Acquisition </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzktMS0xLTEtNDkxMDc_8f49396d-6003-4f04-a47a-2190e22132f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d1799cdfeb443c297cec0ede24b319e_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzktMy0xLTEtNDkxMTQ_78b99c40-2254-4289-9d8a-13c4f65514b1">94,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzgtNS0xLTEtNDk4NTk_3800c9af-1960-4203-9b31-223003ffb24d">94,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzktMS0xLTEtMzczNTY_9bad5037-c765-4964-a0e3-3a7ea1f2d26c">8,547</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d1799cdfeb443c297cec0ede24b319e_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzktMy0xLTEtMzczNTY_83c9bf95-8f17-49d4-a8d5-1ac3e05feb49">4,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzktNS0xLTEtMzczNTY_6cea4c75-ef94-4905-8ef4-f2ca6e359a83">13,056</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb20ffbdee24ca9b4586a5cf126dba1_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzExLTEtMS0xLTM3MzU2_c2d190ec-7195-4bf9-9859-10342b242745">663,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7778b95afae64e8cb2f805b44e496258_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzExLTMtMS0xLTM3MzU2_d720bddb-f90e-47f0-85cd-14261bdcae1c">350,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzExLTUtMS0xLTM3MzU2_560c88d0-c9a4-4830-9223-2d60122d0f42">1,013,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Intangible Assets</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYxNzM_51f10330-1473-4f8b-aa73-525e5bebdf9b" escape="true"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYxNzc_1a3783d2-5ab4-48cd-b973-b5e0dc1c0ccc" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:47.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i93d465a35e4d4eabb157247c1091f1d7_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzQtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpiN2MzNGE0ZmFhNTA0YzBiOGY0ODBmMDkwZDUxOTczY180_1a7aa786-91eb-4cf1-b0df-f49fdcc578da">18</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565486756b7249efbbaa382505163bde_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzQtMy0xLTEtMzczNTY_a7c822bd-e082-40dc-b64b-60e0fd4f0356">1,132,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i565486756b7249efbbaa382505163bde_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzQtNS0xLTEtMzczNTY_89d87988-aaa3-45b7-93ef-e0b1c807af50">307,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565486756b7249efbbaa382505163bde_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzQtNy0xLTEtMzczNTY_e79bf7d0-1a25-46c9-967b-5e0790759d47">825,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1252007ac54246de9abeebe0a6b2d8f2_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzUtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo3Y2IzMzVjYTE2YTU0ZjAyYmM0NjNlNzYxM2YzY2VmNF80_35abb41a-8880-4080-88da-d71fbaa55351">12</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc306b5f7a374a95bf6db9885328d885_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzUtMy0xLTEtMzczNTY_3a7de71f-ee52-486d-9802-9c5ead9658e7">211,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc306b5f7a374a95bf6db9885328d885_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzUtNS0xLTEtMzczNTY_7a0b0a95-afe7-48de-9b61-ce4fd5098e7e">142,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc306b5f7a374a95bf6db9885328d885_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzUtNy0xLTEtMzczNTY_142422f2-e706-4dad-bfb6-be7fd211ca3c">68,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae5ad95d43134ec6a2a3f3e3a0aaf4f7_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzYtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo2NjY4ZjlkMDc3Mjk0NWU3YjYyOWI1ZDRlYjY0Y2U3MF80_6057f23b-2563-4de2-867e-e1fa11d1e22f">28</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c021d4850a4d869790819bbad3ae43_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzYtMy0xLTEtMzczNTY_14e08198-be08-4716-a253-1a283d081cc8">98,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c021d4850a4d869790819bbad3ae43_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzYtNS0xLTEtMzczNTY_0350c842-44b9-420e-ab23-827e0400e595">31,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c021d4850a4d869790819bbad3ae43_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzYtNy0xLTEtMzczNTY_adb273d2-83c7-429c-862a-02c6b47af1fe">66,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f8ee36cb1e4ac58c021879c749533b_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzctMy0xLTEtMzczNTY_9d2608d0-d7ca-42c7-96d0-33d3bdc91539">167,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f8ee36cb1e4ac58c021879c749533b_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzctNy0xLTEtMzczNTY_af1741c2-b7b2-4a4b-8505-d7d088440e6c">167,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3234077932f2438296d701e72d5ffac3_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzgtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpjN2YyYzc1NzViYTQ0OThkODgzOWQ3NGZlNDBlMDU3MF80_1bf2987a-2930-42d9-baad-657a227cc279">30</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0de13c4843ae43a09d39c8eb3d4b8fe4_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzgtMy0xLTEtMzczNTY_ff56a1a5-1f13-4ebb-bb30-c1a0f72133e0">30,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0de13c4843ae43a09d39c8eb3d4b8fe4_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzgtNS0xLTEtMzczNTY_096f5061-2569-4c80-b53c-fe193db3c069">16,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0de13c4843ae43a09d39c8eb3d4b8fe4_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzgtNy0xLTEtMzczNTY_dfb0dedd-6ddd-47f3-82b2-1426902495d1">14,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bbe1d90175a46fe8dfa0043b4527186_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzktMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpiNDQ5OWMzZGQ3NGM0N2M3YThmYTQ2MThhOTlhMTJiZF80_e3a36ed8-4510-46c4-8d4b-4c907f3e332b">11</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0bcf683f0a14720a1b91832c115533e_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzktMy0xLTEtMzczNTY_751d1944-9c8a-400a-9d04-59df3a76e742">6,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0bcf683f0a14720a1b91832c115533e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzktNS0xLTEtMzczNTY_7c4120be-2a4c-40c7-815e-9429f86591e6">3,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0bcf683f0a14720a1b91832c115533e_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzktNy0xLTEtMzczNTY_b689b213-d246-4df6-9558-2a3cfda3715f">2,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzEwLTMtMS0xLTM3MzU2_bc6751de-357f-4458-a990-4b76954a0990">1,646,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzEwLTUtMS0xLTM3MzU2_878254f7-61b0-4375-8cf0-46e9cc438d52">501,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzEwLTctMS0xLTM3MzU2_e84d46a9-fe04-4458-820a-d54a46739917">1,145,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:47.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaeb0d8ccf2a044b79a58dfc3b65f8e15_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzQtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjphMzU4ZjQ2MTlhMGY0MDU0OWZkOGE4Y2UwZjY4OTY2MF80_94ee8fa5-f4b6-4b57-93a6-2c7e78588058">19</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3edc297cbc6e43909b926332dfc8a2d9_I20201231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzQtMy0xLTEtMzczNTY_3a64f3d0-7f09-4947-9f03-05bbbd555be7">896,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3edc297cbc6e43909b926332dfc8a2d9_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzQtNS0xLTEtMzczNTY_b05530d7-0a86-4066-9ef4-d4f42329215c">248,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3edc297cbc6e43909b926332dfc8a2d9_I20201231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzQtNy0xLTEtMzczNTY_5ae93963-b9c3-47ba-ad4a-bd88d403a983">648,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e32de5cf50a4cab9682cd23ec61237e_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzUtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjoxNWZmMWI0OGU3MzI0YjVlYTBkOGMxMzM1NjhkNDU4NF80_45da6ad3-1bee-4151-8d1b-cf9da0f59b6d">12</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04c114db065b4f4eb88c5a3d48995ddb_I20201231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzUtMy0xLTEtMzczNTY_2165eb54-631a-4875-b0d5-7c83b877bb16">213,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04c114db065b4f4eb88c5a3d48995ddb_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzUtNS0xLTEtMzczNTY_2a0a3e1a-aefe-49f2-9f9b-17f548260dd3">132,838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04c114db065b4f4eb88c5a3d48995ddb_I20201231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzUtNy0xLTEtMzczNTY_f39bb4f2-9095-4501-bd27-d10f340822b2">80,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idd79a69fcf5a4ee1bc04e02cbd130619_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzYtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo2OTZmZTkxOTRmZTA0NGVhYWE1YWUzNzJjNDQzYjBmOV80_0ff3f617-95e1-461b-a768-6d364ff31ef2">28</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13a5de5444e140fc92fa01a15959c201_I20201231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzYtMy0xLTEtMzczNTY_30e8499f-6d1f-47ce-a9f6-9a7381758353">104,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13a5de5444e140fc92fa01a15959c201_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzYtNS0xLTEtMzczNTY_9c4c1822-086b-4713-9140-a8810e57e1e8">31,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13a5de5444e140fc92fa01a15959c201_I20201231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzYtNy0xLTEtMzczNTY_128a238d-533d-4864-9c82-cad3ad937d72">72,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33f5557b4fd84457a5a5e3d5dcc1d9a9_I20201231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzctMy0xLTEtMzczNTY_d243d4e9-48d7-47b1-97af-09e26e335990">170,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33f5557b4fd84457a5a5e3d5dcc1d9a9_I20201231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzctNy0xLTEtMzczNTY_eb33f410-b46e-486f-8547-1ba0a3f9d563">170,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4475ac8a68ef47fb85a8578399b0bf14_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzgtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo5YTgxNDQ2Y2I5OWI0OTEwYjZiZDI5NmI3NTBiZjNhN180_8ea7662e-3119-4bc6-aa3c-d4af9640acb7">27</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737468523a6841bf8124822271ebf871_I20201231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzgtMy0xLTEtMzczNTY_1a8a0fed-e2ad-4e7c-89c4-93ad452f460f">30,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i737468523a6841bf8124822271ebf871_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzgtNS0xLTEtMzczNTY_00d05006-c7e0-4f31-a9f6-d26b0d4f242d">15,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737468523a6841bf8124822271ebf871_I20201231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzgtNy0xLTEtMzczNTY_83578b67-d1cb-4548-885d-d35622542a88">15,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3a37880f41f64981a5fef9ddf9b77d0c_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzktMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjozNmI4MGFlN2JlZTQ0YzEyYjlmZDgxNzk5YjZmOTVkNF80_12f7b4c4-2397-42de-9583-6903fe360b74">4</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4b331f18ed42aba33f65f03aa1c992_I20201231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzktMy0xLTEtMzczNTY_fac4b537-8e7e-407e-94f7-2e9a2943e0f4">6,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4b331f18ed42aba33f65f03aa1c992_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzktNS0xLTEtMzczNTY_2261223f-dc43-4945-b8b8-32859738b6c9">3,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4b331f18ed42aba33f65f03aa1c992_I20201231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzktNy0xLTEtMzczNTY_5180a54e-dc63-498c-ada1-7de8e6f14e21">2,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzEwLTMtMS0xLTM3MzU2_309e06dd-f57d-43e2-8cc4-cd0fe24961da">1,421,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzEwLTUtMS0xLTM3MzU2_041f3fd5-24ed-41ef-9ec2-618460e635d7">431,651</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzEwLTctMS0xLTM3MzU2_3bd6aae3-ab6e-4606-931e-12e655e771bd">989,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Prior period amounts were reclassified as it relates to All Other within this table to conform to the current period presentation</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:3pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i000ed083c92e4b89800da97c60ed285f_I20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzMzOTc_8e8aa8e4-868c-4aed-8033-6b117d493fad">13.3</ix:nonFraction> million of Intangible assets, net were presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the Company's identifiable intangible assets at December 31, 2021 as compared to the year ended December 31, 2020, was primarily driven from intangible assets acquired in conjunction with the ACell Acquisition. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i624da374691d406bbbcb3d9c0f425ee3"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets with Indefinite Lives</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company elected to perform a qualitative analysis for its intangible asset with indefinite lives. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense (including amounts reported in cost of product revenues) for the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU3MjQ_f1dc22e2-f720-4fe6-b17c-40f3ec17e3fa">83.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU3MzY_dc686007-4c0d-4cc5-90ec-22c2de86b71b">74.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU3NTI_75cfb68a-ff9d-4644-9f7e-3890fa27a4e1">72.8</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual amortization expense is expected to approximate $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU4MzQ_5f10bb2d-4c37-4a9a-83ad-6c2cae883948">79.1</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU4NTM_b670e67f-9f4e-49cf-bc68-ce57cce0da9e">78.4</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU4NzI_2836dbf6-842f-4b5f-ad6e-ecc2d9236a48">77.7</ix:nonFraction> million in 2024, $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU4OTE_f1998acf-358b-43c6-905b-25fd555d9a1b">77.7</ix:nonFraction> million in 2025, $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU5MDk_9a9226bf-328c-4d04-ac8f-9943a121d7cc">77.6</ix:nonFraction> million in 2026 and $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU5MzA_f4281911-0142-4dd9-9672-4fc167b450dc">585.8</ix:nonFraction> million thereafter. Amortization of product technology based intangible assets totaled $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYwMjE_192a8a66-090b-42a2-b679-a9b7cbba31ef">66.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYwMzQ_faa85584-631e-4025-b6b5-0d4c4ebe4515">46.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYwNTA_8d1ea1c5-008a-493b-accb-e3af7248c8d8">45.8</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively, and is presented by the Company within cost of goods sold.</span></div></ix:continuation><div id="i172bf506156f43e6869412a665f54418_166"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;<ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:TreasuryStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzE1NzU_307275d1-c67e-435c-bb1b-95da3d2acafc" continuedAt="id9c9042b130b4d66863097bb51cb764f" escape="true">TREASURY STOCK</ix:nonNumeric></span></div><ix:continuation id="id9c9042b130b4d66863097bb51cb764f" continuedAt="if6d0e593eea34e4c822f5a513c3fc62f"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, there were <ix:nonFraction unitRef="shares" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzUx_65c8802a-917a-4f12-84db-7af5ad72afd3"><ix:nonFraction unitRef="shares" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzUx_ce2755c1-182e-4cd3-be2a-dfb1ad9b0928">4.9</ix:nonFraction></ix:nonFraction> million shares of treasury stock outstanding with a cost of $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzEzMA_fe6df185-95a0-4f36-96bb-2c5bdbe4c03f">234.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzE0Ng_fb1756b0-5306-479b-b1a1-84f7f8ab0b72">235.1</ix:nonFraction> million, respectively, at a weighted average cost per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzE5OQ_bbe1f20b-98a4-43f4-93a4-e11ea0103a39"><ix:nonFraction unitRef="usdPerShare" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzE5OQ_ce0ec6cf-24ef-45c5-aa91-d1754e9f5f77">47.86</ix:nonFraction></ix:nonFraction>.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 7, 2020, the Board of Directors authorized the Company to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i1b58cefefc354ae79f2cb3074a62ea26_I20201207" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzMxMQ_d1ec5efb-7b3b-47ff-8bd5-a85aeecc23fe">225</ix:nonFraction>&#160;million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2022. The price and timing of any future purchases under the share repurchase program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price, and such repurchases may be discontinued at any time.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="if6d0e593eea34e4c822f5a513c3fc62f" continuedAt="i5b635c0bfcda4aeebd7b0612bf3f9ec1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2021, there were no repurchases of the Company&#8217;s common stock as part of the share repurchase authorization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 12, 2022, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="ia20712ff79044b74a597c82e1faea48d_I20220112" decimals="-5" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzU0OTc1NTgxNDY5ODc_6c5e1b97-0892-4595-af44-db88e4fbcadb">125.0</ix:nonFraction>&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">accelerated share repurchase ("2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ASR") and received <ix:nonFraction unitRef="shares" contextRef="ia20712ff79044b74a597c82e1faea48d_I20220112" decimals="-5" name="iart:AcceleratedShareRepurchasesSharesReceivedAtInception" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzU0OTc1NTgxNDY5OTE_d0315985-fefe-4192-add2-2b790fca185e">1.5</ix:nonFraction>&#160;million shares of Company common stock at inception of the 2022 ASR, which represented approximately <ix:nonFraction unitRef="number" contextRef="i538c9dcc0e144b5ca4a9c2183db495d7_D20220112-20220112" decimals="2" name="iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzIxOTkwMjMyNjM2ODI_5d9e78a5-f64a-47a2-bb83-8e1a6e377e10">80</ix:nonFraction>% of the expected total shares under the 2022 ASR. The remaining <ix:nonFraction unitRef="number" contextRef="i899fa5b890ff487689edae2dc21aefef_D20220101-20220630" decimals="2" name="iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzIxOTkwMjMyNjM2ODc_976cdac1-1916-415d-9c52-095e69cc9170">20</ix:nonFraction>% of the expected total shares is expected to settle in the first half of 2022, upon which additional shares of common stock may be delivered to the Company or, under certain circumstances, the Company may be required to make a cash payment or may elect to deliver shares of our common stock to the 2022 ASR counterparty in each case pursuant to the terms of the 2022 ASR agreement between the Company and the 2022 ASR counterparty. The total number of shares to be delivered or the amount of such payment, as well as the final average price per share, will be based on the volume-weighted average price, less a discount, of the Company's common stock during the term of the transaction. As a result of this transaction, $<ix:nonFraction unitRef="usd" contextRef="ia20712ff79044b74a597c82e1faea48d_I20220112" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzIxOTkwMjMyNjM2Njg_d22c6797-8873-4c6c-bd68-c1632d6be106">100</ix:nonFraction>&#160;million remains available under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$<ix:nonFraction unitRef="usd" contextRef="i1b58cefefc354ae79f2cb3074a62ea26_I20201207" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzgyNDYzMzcyMTY5NDE_d1ec5efb-7b3b-47ff-8bd5-a85aeecc23fe">225</ix:nonFraction>&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> repurchase authorization</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5b635c0bfcda4aeebd7b0612bf3f9ec1">During the twelve months ended December 31, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzc2OQ_08336461-93c0-4ef7-8c39-d5e07e2f2ac1">2.1</ix:nonFraction>&#160;million shares of Integra&#8217;s common stock as part of the previous share repurchase authorization. The Company utilized $<ix:nonFraction unitRef="usd" contextRef="i7a682151366145e6904be6c9c0346121_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzg4Mg_2ae19489-633f-4e2b-9982-e8d07711572a">100.0</ix:nonFraction>&#160;million of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included $<ix:nonFraction unitRef="usd" contextRef="i1eedec01832141fbb14f413eb354531d_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzEwMTE_51a8175e-ffef-4982-8658-470eabdae438">7.6</ix:nonFraction>&#160;million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i9c54334459e24015b6e27d3a60186407_I20200205" decimals="-5" sign="-" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzExNjA_341d5e94-e761-4e00-b125-199eb47c9bea">92.4</ix:nonFraction>&#160;million accelerated share repurchase ("2020 ASR") to complete the remaining $<ix:nonFraction unitRef="usd" contextRef="i9c54334459e24015b6e27d3a60186407_I20200205" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzEyMjY_f3cb3b0e-b75c-4edb-ba9e-38d24511dce0">100.0</ix:nonFraction>&#160;million of share repurchase. The Company received <ix:nonFraction unitRef="shares" contextRef="i05515ce3d5484989bc6dd472a4eedeed_D20200205-20200205" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzEyNzE_c6fe67e6-487d-449a-987c-c0e07be87319">1.3</ix:nonFraction>&#160;million shares at inception of the 2020 ASR, which represented approximately <ix:nonFraction unitRef="number" contextRef="i05515ce3d5484989bc6dd472a4eedeed_D20200205-20200205" decimals="2" name="iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzEzMzg_72d4ae56-34a0-4c65-9a4e-b4c2c1cb0a9c">80</ix:nonFraction>% of the expected total shares. Upon settlement of the 2020 ASR in June 2020, the Company received an additional <ix:nonFraction unitRef="shares" contextRef="i8c6a1769495943b9b5d9b5d31e294c90_D20200601-20200630" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzE0NDc_93249434-adbc-4fc0-9ffb-271c221510e9">0.6</ix:nonFraction>&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the transaction.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i172bf506156f43e6869412a665f54418_169"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYzMjU_afb59530-38cb-4aef-ac2c-1922760b7143" continuedAt="ie7ddffd6156f419aa0c8618fc33fc1a4" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="ie7ddffd6156f419aa0c8618fc33fc1a4" continuedAt="ib97c45b2599047a4ba508ae7ecbf53d4"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYzNjQ_f7c2443c-f7ac-452a-beab-e55dd688785b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53b8c510bfb4f04a342d01490fff519_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzMtMS0xLTEtMzczNTY_7c5cb7c3-da89-4420-87b3-0037b2c2921c">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37cda7e161149dab639b5833e0cdaae_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzMtMy0xLTEtMzczNTY_6e782c1c-eeee-475a-92c5-148559797172">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1323b59618784a1fab24844213313e44_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzMtNS0xLTEtMzczNTY_60d7e77e-8b8e-4c9c-bee8-2099e5936cad">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4b1f164ed2413f96ccef0da637494a_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzQtMS0xLTEtMzczNTY_3aecf8ed-ba40-47b9-9a1e-0f9ebcf87b64">1,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d6853b6a2340eea65ce878ccdc9506_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzQtMy0xLTEtMzczNTY_e0170670-d2aa-4323-ac16-b20496b57dbf">1,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef4bd774a64465bb9beb6cfda1cdbc9_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzQtNS0xLTEtMzczNTY_644c6f2e-0986-4c46-b25c-963a45ac8c79">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3178f6269054097bd491b98b26e7a45_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzUtMS0xLTEtMzczNTY_cdde56e5-9104-4be2-b47f-3a156987ac11">34,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89798fbac704337b50567a4cce07285_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzUtMy0xLTEtMzczNTY_4fd0cae4-0732-40dc-b18f-48a87029fe1d">17,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93981c800579497aaf2dd345c9d2a500_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzUtNS0xLTEtMzczNTY_d005f0b2-2e41-43f1-9a14-4359200d2ec3">19,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzYtMS0xLTEtMzczNTY_c82389ef-8edd-452a-bd4e-e60d77eaf47e">36,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzYtMy0xLTEtMzczNTY_729ae8bb-576b-4017-815a-9f3654285a79">19,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzYtNS0xLTEtMzczNTY_705b8619-4890-4b82-b53e-da3043c7cc6a">21,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated tax benefit related to stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzctMS0xLTEtMzczNTY_4197a312-bbfc-4555-91df-7da5bdd6e3ad">13,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzctMy0xLTEtMzczNTY_05161b9c-a937-49a1-9060-0e6232cfa47b">6,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzctNS0xLTEtMzczNTY_a8ca20ab-d722-44ca-bbce-ba20eac36abe">9,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect on net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzgtMS0xLTEtMzczNTY_6b46e5dd-2bec-478c-99e3-3bf7542dd9c9">22,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzgtMy0xLTEtMzczNTY_5062af9a-72fb-4549-8b0a-718fba23c2b8">13,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzgtNS0xLTEtMzczNTY_8e930c15-b887-4394-a951-65702c4ea650">11,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE STOCK PURCHASE PLAN </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan. Under the ESPP, a total of <ix:nonFraction unitRef="shares" contextRef="i53a14816cfaa497fba679e918c9d17fd_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzUyMQ_7aa4289f-0826-46e7-9e4a-d4567beb6b00">3.0</ix:nonFraction> million shares of common stock are reserved for issuance. These shares will be made available either from the Company&#8217;s authorized but unissued shares of common stock or from shares of common stock reacquired by the Company as treasury stock. At December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="i53a14816cfaa497fba679e918c9d17fd_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzc2Ng_2e56548c-0efe-4e72-b212-22868cc73d53">2.0</ix:nonFraction> million shares remain available for purchase under the ESPP. During the years ended December&#160;31, 2021, 2020 and 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="ib3145669c89f4e22a4ae2186bc7b0142_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzg3OQ_ba0ee556-ed3d-461f-b222-f0abc20485a2">16,948</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="if60cbed693984bf4ac9378ff4177b4cb_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzg5MA_e3c6cf71-cd4b-4c0a-8cfc-b29fb9f907a3">18,284</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i07b2805613624db19aac4968ce38ff27_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzkwNA_2d1125a6-af55-4eab-ac2c-d1c3cd375664">12,531</ix:nonFraction> shares under the ESPP for $<ix:nonFraction unitRef="usd" contextRef="ib3145669c89f4e22a4ae2186bc7b0142_D20210101-20211231" decimals="-5" name="iart:EmployeeStockPurchasePlanProceeds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzkzMw_3cb353da-be13-4ef4-9deb-8aaae1678abc">1.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="if60cbed693984bf4ac9378ff4177b4cb_D20200101-20201231" decimals="-5" name="iart:EmployeeStockPurchasePlanProceeds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzkzNw_38c2ad53-d704-4a8f-a233-620d0e0d5851">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i07b2805613624db19aac4968ce38ff27_D20190101-20191231" decimals="-5" name="iart:EmployeeStockPurchasePlanProceeds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzk0NA_e586267a-8a31-47d6-b0f6-3f25f90c2ef9">0.7</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EQUITY AWARD PLANS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the &#8220;2003 Plan&#8221;). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2010 and May 2017, the stockholders of the Company approved amendments to the 2003 Plan to increase by <ix:nonFraction unitRef="shares" contextRef="i2b897ca4831342edaea566ae6b0cdc36_D20100501-20100531" decimals="INF" name="iart:IncreaseInAuthorizedShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzE0NTU_2898fd81-b850-471a-8f5d-6ced140bf37d">3.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i26a65d8304ba448f91360ee062277da9_D20170501-20170531" decimals="INF" name="iart:IncreaseInAuthorizedShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzE0NjI_2c6b108c-0c41-4f3b-8834-639ecbcd1603">1.7</ix:nonFraction> million, respectively, the number of shares of common stock that may be issued under the 2003 Plan. The Company has reserved <ix:nonFraction unitRef="shares" contextRef="i584d7e4f3e034bb6aa9b60e07b8d05fe_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzE1ODI_961704fc-bb2a-4bac-b0a9-f6de1a7273d6"><ix:nonFraction unitRef="shares" contextRef="ib73b40adb8374cff8a251fef052acd84_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzE1ODI_c4527e86-7f84-4faf-8dcf-b1efd32ff6f0">4.0</ix:nonFraction></ix:nonFraction> million shares under each of the 2000 Plan and the 2001 Plan, and <ix:nonFraction unitRef="shares" contextRef="i13bb28aa1adf4576aeb1ec00d3e26d97_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzE2NDM_48dc8246-8614-49fd-a12e-ee715c66e1b6">14.7</ix:nonFraction> million shares under the 2003 Plan. The Plans permit the Company to grant incentive and non-qualified stock options, stock appreciation rights, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ib97c45b2599047a4ba508ae7ecbf53d4" continuedAt="i04f2ac0a10b5471bb63cd52481726b43"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restricted stock, contract stock, performance stock, or dividend equivalent rights to designated directors, officers, employees and associates of the Company. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options issued under the 2003 Plan became exercisable over specified periods, generally within <ix:nonNumeric contextRef="i5fff9ccde2f5438e83ff62797cae4f8d_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIwMzk_c3cf52a8-42d2-40e5-87ad-0f1821a1fc7b">four years</ix:nonNumeric> from the date of grant for officers and employees, and within <ix:nonNumeric contextRef="i734854acf1ee4be8bf15f1abd93bfd07_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIxMDQ_b925a4e7-1998-490f-9ce2-37a868d86985">one year</ix:nonNumeric> from the date of the grant for members of the Board of Directors. The awards generally expire <ix:nonNumeric contextRef="i0e555d1eb8964644b65afbac50ffd7a1_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIyMDE_33347a51-9fcc-4a3d-a596-ca549d9b4a99">eight years</ix:nonNumeric> from the grant date for employees and from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIyNDc_dac495da-8c41-4f99-8dc2-4cfbd78ca20b">six</span> to <ix:nonNumeric contextRef="ie513c0771de143ca92523d08ff0e8443_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIyNTM_f520770a-81f6-412f-9f00-7ff402db1ad2">ten years</ix:nonNumeric> for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in control provisions within their grant agreements. Restricted stock issued under the 2003 Plan vests ratably over specified periods, generally <ix:nonNumeric contextRef="i929f1fd93be942479d2f584793b7dda6_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIzOTA_f91ae07e-abe3-40d7-8ff8-c44744cd4d21">three years</ix:nonNumeric> after the date of grant. The vesting of performance stock issued under the 2003 Plan is subject to service and performance conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values stock option grants using the binomial distribution model. Management believes that the binomial distribution model is preferable to the Black-Scholes model because it is a more flexible model that gives consideration to the impact of non-transferability and vesting provisions in valuing employee stock options. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the value of stock options granted, the Company considered that it has never paid cash dividends and does not currently intend to pay cash dividends, and thus has assumed a <ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzI5NTQ_4d1c0744-011b-4e85-917b-7a64546c4c83">0</ix:nonFraction>% dividend yield. Expected volatilities are based on the historical volatility of the Company&#8217;s stock price. The expected life of stock options is estimated based on historical data on exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock options granted. The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected life of the options. The Company accounts for forfeitures as they occur. </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYzNDA_1c1e95c2-6cef-417e-84d9-fa3bc06e6f1c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used in the calculation of fair value:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzItMS0xLTEtMzczNTY_66d759b3-229b-4d38-abec-fbbdd326213c">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzItMy0xLTEtMzczNTY_adc3e527-8e62-4834-8dc6-6f5a333fa813">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzItNS0xLTEtMzczNTY_ac2d89ea-ff38-4e96-8096-1406c9bf7afd">0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzMtMS0xLTEtMzczNTY_d02beb4e-2ae9-418f-946a-7e1172d18880">29</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzMtMy0xLTEtMzczNTY_17d3ea95-2a80-451e-a2dd-9193924d237e">27</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzMtNS0xLTEtMzczNTY_b41e74d4-bba2-4fe1-91c1-cb3467e8ef0d">28</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzQtMS0xLTEtMzczNTY_85ec7db5-ba43-4a73-9920-ff71c95a7160">1.30</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzQtMy0xLTEtMzczNTY_33454038-17a6-4e45-8022-e02b6a6dd320">0.89</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzQtNS0xLTEtMzczNTY_e0fe0e9a-2f37-4968-93fe-f6c6672667f2">2.51</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of option from grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzUtMS0xLTEtMzczNTY_36b59b59-9f1a-4fcb-ba98-941942fcb330">7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzUtMy0xLTEtMzczNTY_07c9ab79-56c2-4d3e-b66c-84a3e225a0e4">7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzUtNS0xLTEtMzczNTY_5c752401-149e-4273-b5cb-7bc06b52dd9f">7</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzYtMS0xLTEtMzczNTY_cd3a72d9-afe5-4c98-9ee2-3fc1f4827f49">22.59</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzYtMy0xLTEtMzczNTY_e0153bc7-ba2f-4000-b49b-85cac6861da2">13.03</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzYtNS0xLTEtMzczNTY_6c7d6a5f-b338-4411-89d5-bfc7a18cb215">18.74</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYzNTQ_9ee567bd-1dbf-4558-b09e-1a1a1a900e52" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock option activity. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Contractual Term in Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzQtMS0xLTEtMzczNTY_48b9a9e3-9045-4cfb-bdf3-2f559e02fa94">1,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzQtMy0xLTEtMzczNTY_b3034a4d-e777-4211-96a2-2ea130b0e4aa">39.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzQtNS0xLTEtMzczNTY_5b01a3da-c320-499f-87df-5484b3b0259f">4.41</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzQtNy0xLTEtMzczNTY_1f4a266f-7c29-4862-8989-92f829e45ad1">34,560</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzYtMS0xLTEtMzczNTY_e6b4bd86-495a-4e50-8be7-d6eb01f36c66">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzYtMy0xLTEtMzczNTY_971743bd-79b0-4151-a43b-f578c2749c22">68.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzctMS0xLTEtMzczNTY_22273745-9594-4ea0-bcb7-c7843b03bfb2">230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzctMy0xLTEtMzczNTY_2d297079-2e5f-49ac-9ac5-41d63e55cf07">24.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzgtMS0xLTEtMzczNTY_eb31f589-7ed2-4ee0-96ed-295797c5712d">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzgtMy0xLTEtMzczNTY_9db94a40-a2e4-44ec-9f88-0d6fc5097c6f">51.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzktMS0xLTEtMzczNTY_870e3fec-c8fa-4ddc-9c6c-b7f2caf22477">1,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzktMy0xLTEtMzczNTY_a4034bd4-a47e-4db3-89ae-32fd66309d28">45.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzktNS0xLTEtMzczNTY_88c96466-fac9-4f1a-8b78-5dd3bee0ef7b">4.30</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzktNy0xLTEtMzczNTY_d1c11bb8-740d-4dfd-b8ce-8aee0b30bffb">26,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzExLTEtMS0xLTM3MzU2_fdcb1eef-3bcc-450f-87e1-7ce14b61cac6">858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzExLTMtMS0xLTM3MzU2_d3d89f22-3920-42ae-a076-909ef69a4168">41.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzExLTUtMS0xLTM3MzU2_0aed848c-8287-4f4e-a39e-034c35939074">3.38</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzExLTctMS0xLTM3MzU2_cbf3798f-929d-4992-bd02-9ae1856d0348">22,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i5fff9ccde2f5438e83ff62797cae4f8d_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM2OTk_b07743d6-4d60-4765-951c-eaeb195a054e">5.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i8cc999d233cf40bc8ec03bb79a5c46af_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM3MTE_dccfbb73-efb4-4c42-9762-2b44e09fe3b0">3.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0213557267b54d06b2a34a0a8ebac7d6_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM3MjY_565ad3bf-18a4-4877-885a-0d6130e8651d">3.0</ix:nonFraction> million in expense related to stock options during the years ended December 31, 2021, 2020 and 2019, respectively. The intrinsic value of options exercised for the years ended December&#160;31, 2021, 2020 and 2019 were $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM5MTg_5e47205e-a6c5-4850-8168-2382907b0436">11.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM5MjI_d0fdac1d-4c77-41e8-8aef-1474b4528e5d">8.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM5Mjk_94e32496-a5e1-4d51-a896-9c5ddd735243">14.6</ix:nonFraction> million, respectively. Cash received from option exercises and employee stock purchase plan was $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQwMjA_35ff3a7d-1150-485c-a153-0cbf4998344a">6.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQwMjQ_b0e4ff5c-ae24-4d5a-af83-cdead32fdd38">5.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQwMzE_23fd3b3d-d533-43a0-a9e5-05b68b7a1dee">6.9</ix:nonFraction> million, for the years ended December 31, 2021, 2020 and 2019, respectively. The realized tax benefit from options exercised w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ere $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQxNTA_b48617d5-1338-4ad6-b35e-15c78e82b625">2.2</ix:nonFraction> mi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">llion, $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQxNjI_d8068f41-a094-4661-9de6-016d29d3c62a">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQxNzc_75dbf1f7-8f6b-4dc9-8f37-60a1370f87a8">3.0</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, there was approximately $<ix:nonFraction unitRef="usd" contextRef="i805f26cc2af34805ae2b1843c1cf9841_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQyODQ_a2980bb3-8b94-4a31-bb1c-94ba3e19aaab">2.9</ix:nonFraction> million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="i5fff9ccde2f5438e83ff62797cae4f8d_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ0NjE_91ffc288-dc6a-4f48-951f-b85a57814b0e">two years</ix:nonNumeric>. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i04f2ac0a10b5471bb63cd52481726b43"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards of Restricted Stock, Performance Stock and Contract Stock </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYzMjc_1276cfd9-f7b5-4c8f-b58c-f1d1762c0895" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock and Contract  Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa6e6cac04eb43cfbe239e917800016c_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzYtMS0xLTEtMzczNTY_b7403fc2-3e2b-4b12-9315-71f6f3e045b5">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa6e6cac04eb43cfbe239e917800016c_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzYtMy0xLTEtMzczNTY_38e8c193-9ff6-4281-ba65-1ca58651dd5b">50.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d007eaff7044bccb12fab7314f2acbc_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzYtNS0xLTEtMzczNTY_6303f880-ee44-40c8-969f-3cc23f588c19">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0d007eaff7044bccb12fab7314f2acbc_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzYtNy0xLTEtMzczNTY_4c3f89f5-27ce-45ac-a634-3d3302f900c7">47.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzktMS0xLTEtMzczNTY_711ea3ae-43db-45c3-a710-d586954444cd">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzktMy0xLTEtMzczNTY_b0466a9c-3d49-42d7-9ed7-b561d369ed2e">68.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzktNS0xLTEtMzczNTY_2dacbaf6-7e0c-4fd6-b8ea-4d8329b8d310">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzktNy0xLTEtMzczNTY_30508e19-9ef9-4a36-8bf7-afac58157c11">67.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for performance achievement related to award target</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231" decimals="-3" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEwLTUtMS0xLTM3MzU2_68d4df7e-188b-43f4-bce8-7a345dedd6ec">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231" decimals="2" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEwLTctMS0xLTM3MzU2_27dcb95b-cd90-48d2-b354-514a753a2209">58.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzExLTEtMS0xLTM3MzU2_be57339f-911a-47dd-a2d1-69bf3abe66f2">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzExLTMtMS0xLTM3MzU2_fb53f29e-ceb9-4481-87d9-fdf1c0eb3f38">54.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzExLTUtMS0xLTM3MzU2_f14e7e1d-6335-45a6-b085-6080f265f2d2">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzExLTctMS0xLTM3MzU2_431b57b5-dd5b-4815-9bfe-e1ab28b9f7f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEzLTEtMS0xLTM3MzU2_8198e67b-0195-491a-b625-21c4b58e1f92">214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEzLTMtMS0xLTM3MzU2_b966d9cb-d5dc-42b5-8715-9a5bac7321b8">51.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEzLTUtMS0xLTM3MzU2_23d3a1a9-a02d-4a5a-8bf7-0bc29af15d4c">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEzLTctMS0xLTM3MzU2_4f46a5f2-29cc-438b-a5c0-4e5f0233df58">67.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested but not released</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231" decimals="-3" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE0LTEtMS0xLTM3MzU2_a0907ddd-bd26-41e7-aeca-663f15bab75b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231" decimals="2" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE0LTMtMS0xLTM3MzU2_519eafa5-fa2d-4c8d-8d65-88fe61301b46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231" decimals="-3" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE0LTUtMS0xLTM3MzU2_611f5254-35cf-4df8-9794-2837286682c1">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231" decimals="2" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE0LTctMS0xLTM3MzU2_78f73fb7-f381-44a8-948e-b03028fdcb5f">58.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i06246f5086ac4c68bca11471e51b6e0f_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE1LTEtMS0xLTM3MzU2_ad0ada23-c535-4c97-af03-08f200f60726">422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i06246f5086ac4c68bca11471e51b6e0f_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE1LTMtMS0xLTM3MzU2_23f95b7f-ea4e-4d41-85a4-e30080ec9ca3">58.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6371ddc8cc744adb4b34059dd3546dd_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE1LTUtMS0xLTM3MzU2_08bc936e-1a14-4cba-bca7-7faa5c80f5ea">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id6371ddc8cc744adb4b34059dd3546dd_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE1LTctMS0xLTM3MzU2_619a94a8-4e64-4702-90fb-2281f4eb3e62">70.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i59a4575819974e84b2e3ab5b22160dbf_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ2OTI_045b704f-0c36-4bd8-8e2d-137ade22f022">31.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i1f25d0f4a8ff400f889dcdf76cc14f18_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ2OTY_14132d8c-4250-4356-82e2-1d7d6a9d0e93">16.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i57f8fa208ea049e1801ad47d1e48dd52_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ3MDM_6aa7be55-bc77-48a0-8d33-0551fcdb0901">18.1</ix:nonFraction> million in expense related to such awards during the years ended December 31, 2021, 2020 and 2019, respectively. The total fair market value of shares vested and released in 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i59a4575819974e84b2e3ab5b22160dbf_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ4ODQ_b8451d6b-d3d5-432f-ad95-ee4fe2488e7b">15.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i1f25d0f4a8ff400f889dcdf76cc14f18_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ4ODg_611e3f27-5bfb-4bf4-905d-5d6685f8b59c">17.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i57f8fa208ea049e1801ad47d1e48dd52_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ4OTU_b8cd1d9a-f2da-47e8-8cb0-810fa8493d44">21.1</ix:nonFraction> million, respectively. Vested awards include shares that have been fully earned but had not been delivered as of December&#160;31, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock awards have performance features associated with them. Performance stock, restricted stock and contract stock awards generally have requisite service periods of <ix:nonNumeric contextRef="i59a4575819974e84b2e3ab5b22160dbf_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzUxODc_e7abb608-abf7-49d8-a2eb-a78b9454602c">three years</ix:nonNumeric>. The fair value of these awards is being expensed on a straight-line basis over the vesting period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, there was approximately $<ix:nonFraction unitRef="usd" contextRef="iece74e9f340746efb7bf12abd5b3f771_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzUzMzg_185d24e4-6da3-41d5-b3a5-4451326437e6">21.1</ix:nonFraction> million of total unrecognized compensation costs related to unvested restricted stock, performance stock and contract stock awards. These costs are expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="i59a4575819974e84b2e3ab5b22160dbf_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzU1NTU_9ad3f96a-ed50-42eb-9623-340e8ef9f48f">two years</ix:nonNumeric>. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, there were approximately <ix:nonFraction unitRef="shares" contextRef="ic049e8c605994794a6b0cffa137659b4_I20211231" decimals="-5" name="iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzU2MDg_f495c5b5-ca23-4f5e-bb34-a2540b2d9896">0.5</ix:nonFraction> million vested Restricted Units and <ix:nonFraction unitRef="shares" contextRef="i37884f7fb85845bfb78ca42534df7c4c_I20211231" decimals="-5" name="iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzU2Mzk_b3beb6d0-bac5-4f35-9ee6-a55c48d21e8b">0.1</ix:nonFraction> million vested performance share units held by various employees for which the related shares have not yet been issued. The final determination of the number of shares to be issued is made by the Company's Compensation Committee of the Board of Directors which is contingent upon achieving certain revenue and organic revenue growth performance metric.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, there were approximately <ix:nonFraction unitRef="shares" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYwNDM_7e64f551-7d01-43ee-ba91-248bf47820e6">3.5</ix:nonFraction> million shares available for grant under the 2003 Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized into inventory, share based compensation costs of $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYxNjQ_5def35e0-ed39-404e-9788-116ca6f643e8">0.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYxNjg_3c818830-d94a-43ca-8b14-3db563f386d9">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYxNzU_58d5aaef-8220-484c-bc33-f8976edc0f5e">0.3</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively. Such share-based compensation was recognized as cost of goods sold when related inventory was sold.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxNzM_4038e6a0-8f63-408a-884c-65d1d89d2f6e" continuedAt="i89508e3251da4d0e919e13be0f92e2c4" escape="true">RETIREMENT BENEFIT PLANS</ix:nonNumeric></span></div><ix:continuation id="i89508e3251da4d0e919e13be0f92e2c4" continuedAt="i33097735edff4e80b2d42374547803ce"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED BENEFIT PLANS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various defined benefit plans which covers certain employees in France, Japan, Germany and Switzerland. </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxNjQ_8420b162-9c93-4887-b8d8-aa333b2f4291" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the years ended December&#160;31, 2021 and 2020 included the following (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzItMS0xLTEtMzczNTY_6d8b2316-a7b6-4ea6-8262-5e32efcd3dd9">2,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzItMy0xLTEtMzczNTY_37b4bba2-5d98-40b5-904b-38ace921d6f2">4,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzMtMS0xLTEtMzczNTY_4de5dddd-e25f-4718-9011-d68be97c54c8">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzMtMy0xLTEtMzczNTY_56926161-0efd-4384-94b1-96ce8d10b611">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzQtMS0xLTEtMzczNTY_4c2c36eb-e471-4026-9064-c08db2dba5f5">893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzQtMy0xLTEtMzczNTY_4cd4d949-75c4-4d36-9776-3daf05d48369">652</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzUtMS0xLTEtMzczNTY_4d08339f-773b-464d-a861-40b447a562a0">281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzUtMy0xLTEtMzczNTY_4b8d4719-20c8-48ba-bd5f-e2a2dad05037">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzYtMS0xLTEtMzczNTY_6a12ac8d-a4bd-4182-a1b3-f78dc9396084">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzYtMy0xLTEtMzczNTY_f48a3d71-8761-4d66-95a5-12cb4674b997">787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzctMS0xLTEtMzczNTY_152c8321-05a7-48e7-bdd9-86cc9f43285f">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzctMy0xLTEtMzczNTY_888193cb-2f01-4697-885f-851a1027821e">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net period benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzgtMS0xLTEtMzczNTY_639efd13-8a1c-45f9-a735-b5c31cd37fa5">1,904</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzgtMy0xLTEtMzczNTY_ec6b1f1e-2dc6-477e-8a01-159e0edd340e">4,007</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxNzk_43b29962-eed8-46dc-8ddf-5068de42a62b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.958%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzItMS0xLTEtMzczNTY_41de272c-94e2-4827-88c7-4d067eebd40e">0.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzItMy0xLTEtMzczNTY_e2b10280-a368-4547-84a5-ded2726d835f">0.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzMtMS0xLTEtMzczNTY_42e9ccdd-89c3-4d5a-a634-3e7ffaa14886">3.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzMtMy0xLTEtMzczNTY_2b6d607e-2f2c-4469-8e43-d14145a744da">2.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzQtMS0xLTEtMzczNTY_15dfa699-fe87-4a1c-921b-fb6d6a2985de">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzQtMy0xLTEtMzczNTY_4ab646c1-f63f-46af-902d-72b73a44b172">2.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzUtMS0xLTEtMzczNTY_23844d1b-c0b8-45fe-b5d8-de13645f2dd1">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzUtMy0xLTEtMzczNTY_4d0641ba-8314-46c2-b1fa-d5d8f3232738">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2021 and 2020, the discount rates were prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities. The expected returns on plan assets represent the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rates of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i33097735edff4e80b2d42374547803ce" continuedAt="id22a580d39ce495e98b63efc71df0e9a"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxNTY_faad234c-ce44-40ac-b4f2-40402de8d9c2" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2021 and 2020 and a reconciliation of the funded status at December&#160;31, 2021 and 2020, respectively (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"></td><td style="width:64.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.287%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzMtMS0xLTEtMzczNTY_b0410ea6-1901-454c-bc01-8e5d506550a9">72,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55084e91d494776891870a81ff5cb91_I20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzMtMy0xLTEtMzczNTY_35ce51d3-a13f-48c5-b431-32ce11add3a8">66,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzQtMS0xLTEtMzczNTY_02d0f3a4-842b-4bc0-8489-f4f102a1910c">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzQtMy0xLTEtMzczNTY_f9721f15-4a4c-4cc8-935f-70c485fce0ba">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzUtMS0xLTEtMzczNTY_229e805a-4422-417c-a279-df60edfe795c">2,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzUtMy0xLTEtMzczNTY_19c510fc-6f06-416f-a96c-26722ea2cd0d">4,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzYtMS0xLTEtMzczNTY_ee1c7a16-e666-49c0-b337-84292dc83d1f">5,044</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzYtMy0xLTEtMzczNTY_0d5fefae-7978-4cb3-afa5-8df1c9a52ea6">3,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzctMS0xLTEtMzczNTY_3acdc652-49a6-4d4f-854e-57fc84234692">586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAmendments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzctMy0xLTEtMzczNTY_b3da136d-9550-4f79-a257-5a05a1bf5fdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzgtMS0xLTEtMzczNTY_a461a8e9-877d-4029-9c99-9dfcd4b46ac4">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzgtMy0xLTEtMzczNTY_51020d14-9a7a-4e0d-9f38-6148771f70a7">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzktMS0xLTEtMzczNTY_4701c040-4ec1-4d91-a8c8-7e435747fef0">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzktMy0xLTEtMzczNTY_7b56318f-0c49-47ca-b5f8-55ca8036493e">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:DefinedBenefitPlanBenefitObligationPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEwLTEtMS0xLTM3MzU2_30cab794-5453-4330-80e1-5307ab2b057f">373</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="iart:DefinedBenefitPlanBenefitObligationPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEwLTMtMS0xLTM3MzU2_3690e41f-cb77-4130-87f9-d8cd8f2d8bf9">388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEyLTEtMS0xLTM3MzU2_ab392dc0-4e8b-4842-9c2a-a5cc962cd299">2,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEyLTMtMS0xLTM3MzU2_6d8931e2-e44a-4666-a710-441ae85a40a4">1,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plans transferred in</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEzLTEtMS0xLTM3MzU2_b929de93-4626-4c07-b1a0-2331cba11698">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEzLTMtMS0xLTM3MzU2_9186d355-cb39-4f68-b7e1-abd8a5dcde85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzE0LTEtMS0xLTM3MzU2_3ee51a03-672c-4d2f-9f81-03d1c0fff09e">2,657</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzE0LTMtMS0xLTM3MzU2_eff1c0f5-d282-424e-9b05-364cb676ee78">6,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected benefit obligations, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzE1LTEtMS0xLTM3MzU2_032bca28-032f-49c3-ba95-df8a4bd44211">65,184</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzE1LTMtMS0xLTM3MzU2_57861116-940e-4b46-b6ac-78e4242095d5">72,869</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIwLTEtMS0xLTM3MzU2_5ee73708-a682-4706-8290-6e379cb7cae5">37,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55084e91d494776891870a81ff5cb91_I20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIwLTMtMS0xLTM3MzU2_9d8e5dfd-0ab0-4e4b-b7ad-f5f21b1f5af9">30,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIxLTEtMS0xLTM3MzU2_da94d519-3413-492e-ab72-7d72700e8d23">3,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIxLTMtMS0xLTM3MzU2_9fab21d1-0b71-4353-a3a8-33218eaf0ffb">2,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIyLTEtMS0xLTM3MzU2_19987742-8b47-4574-8e00-aa2e47d40b1f">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIyLTMtMS0xLTM3MzU2_3e3a6e29-4eab-4171-898d-0ba5f8cbb258">2,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIzLTEtMS0xLTM3MzU2_e327e637-bd52-4837-bd67-b561cc462d6d">917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIzLTMtMS0xLTM3MzU2_7b527125-ac88-40ca-b7b2-39fbca62ab15">883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI0LTEtMS0xLTM3MzU2_7d3c3418-16a1-4132-9f66-c98029c8d722">633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI0LTMtMS0xLTM3MzU2_72800c4a-4ce0-4e7f-b2ef-1695460189ed">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI1LTEtMS0xLTM3MzU2_a9dab49d-c717-4e45-b28c-c6f188478679">2,128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI1LTMtMS0xLTM3MzU2_683adbb4-8dbc-4a44-8ec0-7ec4924fd29b">1,537</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:DefinedBenefitPlanPlanAssetsPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI2LTEtMS0xLTM3MzU2_feded5d4-27c3-4da6-b261-231a6ff17afe">373</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="iart:DefinedBenefitPlanPlanAssetsPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI2LTMtMS0xLTM3MzU2_8aa8be52-08a7-4626-be87-2e7dfacc1d21">388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI4LTEtMS0xLTM3MzU2_9426ef33-5ea1-4861-9822-c8afc4c53365">1,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI4LTMtMS0xLTM3MzU2_6b0679f0-6653-4eb4-84a5-5e849966c9f9">2,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan assets at fair value, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI5LTEtMS0xLTM3MzU2_1fc3e0f1-73c5-4eab-8cbb-80fe8a5a7242">39,914</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI5LTMtMS0xLTM3MzU2_db6fe0ba-2820-4d56-95d4-83bc1f5c9c41">37,825</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfNetFundedStatusTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxOTc_ff098dbe-3da2-4a8d-881e-267f79ab9cef" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"></td><td style="width:65.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.116%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.117%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation Of Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzMtMS0xLTEtMzczNTY_e9586315-250f-4247-9057-418c7fd4473f">39,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzMtMy0xLTEtMzczNTY_ec9e15a4-119a-4df1-bf19-aa4c5a6c26b2">37,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzQtMS0xLTEtMzczNTY_6cf5a94b-1f95-40d2-b8c2-ed0e5562b56e">65,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzQtMy0xLTEtMzczNTY_774ab3f1-bc7e-4966-9460-09a4b11c60cd">72,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzUtMS0xLTEtMzczNTY_8a04bc5b-3e90-4cea-bffa-3a4bf5aa1b29">25,270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzUtMy0xLTEtMzczNTY_fc49679e-5471-47d9-8710-b92810bea61e">35,044</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unfunded benefit obligations are included in other liabilities in the consolidated balance sheets at December&#160;31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the periods ended December&#160;31, 2021 and 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had a net gain of $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzIwOTM_7b12505f-39c0-43c4-a5e3-79e6e03f5a74">7.0</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzIxMTQ_53de050a-38d9-4795-aaee-7f479040d84a">4.6</ix:nonFraction> million, respectively, recognized within accumulated other comprehensive loss that has not been recognized as a component of net periodic benefit cost. The gain recognized during the period ended December 31, 2021, is primarily attributed to a change in the discount rate used to estimate the projected benefit obligation for defined benefit plans which cover certain employees in Switzerland. The combined accumulated benefit obligations for the defined benefit plans was $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzI1ODI_54a55294-3b90-48ef-a0af-6d1e523a8b33">60.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzI1ODk_0c7cc28f-4116-47ec-845d-22be8d0a85ea">61.5</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized gains and losses are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses is determined by using a 10% corridor of the greater of the market value of assets or the accumulated benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="id22a580d39ce495e98b63efc71df0e9a"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior service costs/benefits for the pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net plan assets of the pension plans are invested in common trusts. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts is valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefit plans in France and Germany had <ix:nonFraction unitRef="usd" contextRef="i4e17b5e38d9b4e68968d4ad4b693c479_I20211231" decimals="INF" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzM4MTU_d9d981c5-76a7-4583-8055-0ccad8dc77e2">no</ix:nonFraction> assets at December&#160;31, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, <ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="INF" name="us-gaap:DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzM4NDM_40da5ca5-9b87-479d-81ba-c35ed05499ff">no</ix:nonFraction> plan assets are expected to be returned to the Company in the next twelve months.</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxOTE_3fc62f17-1bde-445d-bbf8-9b69f6ded7fe" escape="true"><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is the summary of expected future benefit payments (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzItMS0xLTEtMzczNTY_b9c064f2-1e95-4252-8eb6-e47c018947bc">1,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzMtMS0xLTEtMzczNTY_6cc366c5-19a5-4812-86c0-21aa4bdb1195">1,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzQtMS0xLTEtMzczNTY_cc5d6d6e-a056-43bd-b049-52f8e6088293">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzUtMS0xLTEtMzczNTY_29d6ad2b-f3b4-4e60-9375-335f6be5f575">2,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzYtMS0xLTEtMzczNTY_631dfb53-cdfd-46ac-a79f-a56c201fbd03">2,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next five years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzctMS0xLTEtMzczNTY_bc769601-3cce-4773-b75a-aaf0ec474909">10,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, contributions expected to be paid to the plan in 2022 is $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzQwODQ_0ea7b409-105d-450b-8121-98d4f207c377">2.3</ix:nonFraction> million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED CONTRIBUTION PLANS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various defined contribution savings plans that cover substantially all employees in the United States, Belgium, Canada, France, Japan, Netherlands, the U.K. and Puerto Rico. The Company matches a certain percentage of each employee&#8217;s contributions as per the provisions of the plans. Total contributions by the Company to the plans were $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzQ0NzY_a9aa1041-34f4-4bf4-bcc0-957641681cbf">8.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzQ0ODA_81b06179-67af-4188-aac3-28e369a91cfe">6.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzQ0ODc_5e633bc4-192f-4226-bef8-a61a7e7aa551">8.6</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFERRED COMPENSATION PLAN</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to <ix:nonFraction unitRef="number" contextRef="i1ea7e387c13b48c89387b2d3d857caaa_D20190501-20190531" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzIxOTkwMjMyNjE1MDA_e5db4015-492d-4902-ac98-2fd247f85689">75</ix:nonFraction>% of their base salary and up to <ix:nonFraction unitRef="number" contextRef="i1ea7e387c13b48c89387b2d3d857caaa_D20190501-20190531" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzIxOTkwMjMyNjE1MDU_079c6c91-89a7-498c-8675-d85bea875407">100</ix:nonFraction>% of bonus amounts and other eligible cash compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, employees participating in the Company's deferred compensation plan began to defer their compensation. This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at December&#160;31, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUwNDI_45af244f-b87d-4600-8b62-0f25726f0f78">3.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzc2OTY1ODEzOTk4ODY_d3195190-f6c0-4586-8075-7cb2afc9f42e">2.0</ix:nonFraction> million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.</span></div></ix:continuation><div id="i172bf506156f43e6869412a665f54418_175"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0Njg_32ac3c15-05ac-41eb-b1c4-3ff6475e5f7a" continuedAt="iafa9e2bf328e4fdf965476ca22475fba" escape="true">LEASES AND RELATED PARTY LEASES</ix:nonNumeric></span></div><ix:continuation id="iafa9e2bf328e4fdf965476ca22475fba" continuedAt="i0110ce96acf4421fbdf33516611d0f29"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of December&#160;31, 2021. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most facility leases include <ix:nonFraction unitRef="renewal_option" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="iart:LesseeOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzUxMw_66df436a-510f-4b99-ba4f-792d98eaff65">one</ix:nonFraction> or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expense for the year ended December&#160;31, 2021 and December 31, 2020, was $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzEyNzA_8030a8e2-eb86-4b7f-bb23-da7815ce592c">20.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzQ5NDc4MDIzMjc1NTc_17a7c1ee-95bf-4bca-8690-3857483addf0">19.7</ix:nonFraction> million, respectively, which includes $<ix:nonFraction unitRef="usd" contextRef="i2ce740a3a7a74ecfb0d0952de3f48b37_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzEzMTA_a187e438-29e6-41bc-8950-a38addf66c4f"><ix:nonFraction unitRef="usd" contextRef="i362b521165e0418c9733b648915a160b_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzEzMTA_dd8a7c99-29c3-4c4c-828b-1f0010c74b3a">0.3</ix:nonFraction></ix:nonFraction> million, in related party operating lease expense.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i0110ce96acf4421fbdf33516611d0f29" continuedAt="i49f2a89957a04836a4c78dcb90bea131"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="iart:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0NjE_eee7df72-58f5-4e7d-a92f-505e40f45eac" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases at December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.946%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.086%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except lease term and discount rate)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzMtNS0xLTEtMzczNTY_9cd6570c-9ba9-41fa-a26f-29d1fa3c864b">84,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzMtNy0xLTEtMzczNTY_3d7266a8-8d62-4f3a-832a-ba51be2bab6c">83,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzUtNS0xLTEtMzczNTY_65a394cc-f5e9-44b6-b917-110e41d0ff43">14,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzUtNy0xLTEtMzczNTY_c411430e-83a3-491f-ad84-dde5bf6bdd1e">12,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzYtNS0xLTEtMzczNTY_716e2b7c-5908-4f3a-a78e-269b9b8fb974">90,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzYtNy0xLTEtMzczNTY_32958cf2-e52d-4f22-a183-a12ececf5ac1">88,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzctNS0xLTEtMzczNTY_a93a8adf-9e52-4cf2-9163-e4434937fec5">105,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzctNy0xLTEtMzczNTY_352dbd68-dee0-4865-8989-c8b7fa5c42ce">100,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2c98fd68510e48b4a3b8d493e99cff78_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzExLTUtMS0xLTM3MzU2_dd5fe1e5-33ed-4bed-9cb3-2c85cfe4deb9">10.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7f1da00ed5194d3681b3dfc0e0e27e6d_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzExLTctMS0xLTM3MzU2_e8ef1825-19a7-46be-aa86-e6ce7b9d814e">11.6</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7de60faccb404da8a7dddec7331da235_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzEyLTUtMS0xLTM3MzU2_213ce30d-f44c-4fea-be60-a6333d6f7309">2.1</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2c2fbe33ab9a467d8b4133eedd8f7209_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzEyLTctMS0xLTM3MzU2_7eab9b78-4b7f-4b5a-b90b-76a5b7f12b35">2.3</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c98fd68510e48b4a3b8d493e99cff78_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzE1LTUtMS0xLTM3MzU2_215d4feb-01f3-41f7-ab64-3d2a17e1788d">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f1da00ed5194d3681b3dfc0e0e27e6d_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzE1LTctMS0xLTM3MzU2_e7247112-c1f9-4f38-8eaf-429d97cf1ee0">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7de60faccb404da8a7dddec7331da235_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzE2LTUtMS0xLTM3MzU2_916060dc-e124-4c0c-b717-14098475a71e">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c2fbe33ab9a467d8b4133eedd8f7209_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzE2LTctMS0xLTM3MzU2_cc8e5b64-1e52-4937-8299-9bf7a2b7967c">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="iart:CashFlowLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0NjM_e44ba1e7-67d4-4a2d-9b8f-30f2fac2404e" escape="true"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZToyMDdkZjJhMDUyNTk0MTdhOTI5ZDhiYjMwNmVmMjU4NC90YWJsZXJhbmdlOjIwN2RmMmEwNTI1OTQxN2E5MjlkOGJiMzA2ZWYyNTg0XzMtMS0xLTEtMzczNTY_99491b89-df6d-4cf7-92f9-7334c6a2b92d">15,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZToyMDdkZjJhMDUyNTk0MTdhOTI5ZDhiYjMwNmVmMjU4NC90YWJsZXJhbmdlOjIwN2RmMmEwNTI1OTQxN2E5MjlkOGJiMzA2ZWYyNTg0XzMtMy0xLTEtMzczNTY_a60cd722-c40f-467e-9c23-bbba359dcaeb">15,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZToyMDdkZjJhMDUyNTk0MTdhOTI5ZDhiYjMwNmVmMjU4NC90YWJsZXJhbmdlOjIwN2RmMmEwNTI1OTQxN2E5MjlkOGJiMzA2ZWYyNTg0XzYtMS0xLTEtMzczNTY_328d19b1-35fe-4507-b8da-3b18475788d5">12,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZToyMDdkZjJhMDUyNTk0MTdhOTI5ZDhiYjMwNmVmMjU4NC90YWJsZXJhbmdlOjIwN2RmMmEwNTI1OTQxN2E5MjlkOGJiMzA2ZWYyNTg0XzYtMy0xLTEtMzczNTY_f88bcee9-2c2b-4c0e-b78b-80fe8d469a45">6,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0NTg_51809715-d958-48c8-939a-067e913cc8a6" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzItMS0xLTEtMzczNTY_608e3e88-cf37-43f9-92ad-b76029186587">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzItMy0xLTEtMzczNTY_db71280e-9101-463a-a61a-fa267f19da0b">17,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzItNS0xLTEtMzczNTY_a19185db-ab0e-45ba-94db-cabd1969ac15">17,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzMtMS0xLTEtMzczNTY_c7f3c0b4-9142-4a7d-820c-164ae24fa6ea">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzMtMy0xLTEtMzczNTY_271c7e31-f48f-4cad-9297-10a324c5a8ac">14,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzMtNS0xLTEtMzczNTY_1f1b3ee0-5507-4780-9c36-d77e676ce6ec">14,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzQtMS0xLTEtMzczNTY_05f72bd8-bac1-4e08-9bdb-f06ab82d35a9">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzQtMy0xLTEtMzczNTY_3bd7a9a5-f859-46d7-96cd-7f10d2220240">12,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzQtNS0xLTEtMzczNTY_fec90e81-5b32-4d77-82a6-0611bf3789d5">13,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzUtMS0xLTEtMzczNTY_34c3c342-cb36-4267-bed8-66eba6a2559e">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzUtMy0xLTEtMzczNTY_01adf3c8-ea70-47b3-9edf-4945478c9c67">11,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzUtNS0xLTEtMzczNTY_80218fa7-d830-4ef5-9714-e5dc41747381">11,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzYtMS0xLTEtMzczNTY_29e6673f-6f89-4637-b48a-ab3e36b5ded5">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzYtMy0xLTEtMzczNTY_ef744d26-6a93-4a5f-9503-daf925b66a14">9,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzYtNS0xLTEtMzczNTY_1a35ec1e-af22-41b7-b205-d28bc682c578">10,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzctMS0xLTEtMzczNTY_e3d8d266-36af-4e60-b84d-2403e007e870">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzctMy0xLTEtMzczNTY_ea5aa00c-cba6-4eae-855a-006b369bd5ad">67,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzctNS0xLTEtMzczNTY_9bf30c38-3b02-41c5-a491-2319f5ff0313">68,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzgtMS0xLTEtMzczNTY_8a40813f-387a-40ce-8f52-21e05bfb256a">2,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzgtMy0xLTEtMzczNTY_a36d06b9-ffe1-4c71-87ea-589e22ab655c">134,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzgtNS0xLTEtMzczNTY_f7910ec7-8a2e-4f0c-b17e-d12e572e77e5">136,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzktNS0xLTEtMzczNTY_e9adef51-6a0f-46b1-9e1b-43c5b4d06894">31,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzEwLTUtMS0xLTM3MzU2_0127fc51-d4f8-4ff0-8d6a-3c0d1d30b35f">105,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzExLTUtMS0xLTM3MzU2_65a394cc-f5e9-44b6-b917-110e41d0ff43">14,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzEyLTUtMS0xLTM3MzU2_716e2b7c-5908-4f3a-a78e-269b9b8fb974">90,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="INF" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzE2NDk_c45cf51e-fdfa-46de-873d-b59e654f64ac">no</ix:nonFraction> future minimum lease payments under finance leases at December&#160;31, 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i49f2a89957a04836a4c78dcb90bea131"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leases </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is <ix:nonFraction unitRef="number" contextRef="i2ce740a3a7a74ecfb0d0952de3f48b37_D20210101-20211231" decimals="2" name="iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzE4NDE_97629ea4-603a-41cf-b8ed-0e5ae998103e">50</ix:nonFraction>% owned by a corporation whose stockholders are trusts, whose beneficiaries include family members of the Company&#8217;s principal stockholder and former director. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $<ix:nonFraction unitRef="usd" contextRef="i2ce740a3a7a74ecfb0d0952de3f48b37_D20210101-20211231" decimals="-5" name="iart:AnnualRateOfLeaseAgreement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzIwNzg_06d16f84-23ac-445c-abac-cdf3475e380f">0.3</ix:nonFraction> million per year. The current lease agreement also provides (i) a <ix:nonNumeric contextRef="i029daea7b92e41a4bc3613610fa420e9_D20210101-20211231" name="iart:OptionToExtendLeaseYears" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzIxMzk_b8071a61-7561-4c3a-9f16-ea30825b5322">5</ix:nonNumeric>-year renewal option for the Company to extend the lease from <ix:nonNumeric contextRef="i029daea7b92e41a4bc3613610fa420e9_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseOptionToExtend" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0NjU_b03004f0-ea88-4342-a829-c076b27704d0">November 1, 2029 through October 31, 2034</ix:nonNumeric> at the fair market rental rate of the premises, and (ii) another <ix:nonNumeric contextRef="ifaf346d6a89a4e7ea791875504218b91_D20210101-20211231" name="iart:OptionToExtendLeaseYears" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzIzMTA_70477d97-68f2-4ca9-87b3-a41c1d79698a">5</ix:nonNumeric>-year renewal option to extend the lease from <ix:nonNumeric contextRef="ifaf346d6a89a4e7ea791875504218b91_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseOptionToExtend" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0NTM_685880a0-1459-4397-a35f-e22f7efa5843">November 1, 2034 through October 31, 2039</ix:nonNumeric> at the fair market rental rate of the premises.</span></div></ix:continuation><div id="i172bf506156f43e6869412a665f54418_178"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxMTY_43bb4d0c-7a13-40c7-805b-ae5fdf00aede" continuedAt="i60b180c812dd4e329ec2a2ff97d12a16" escape="true">INCOME TAXES </ix:nonNumeric></span></div><ix:continuation id="i60b180c812dd4e329ec2a2ff97d12a16" continuedAt="idda276474b0a416c9ab1ca8685b28e4a"><div style="margin-bottom:12pt;margin-top:12pt"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxMTM_8d91baa1-38da-45bc-887f-4325a0ceb4fd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (Loss) before income taxes consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzMtMS0xLTEtMzczNTY_35c7ed79-2b99-4f79-9809-f8c13cd20274">91,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzMtMy0xLTEtMzczNTY_d63af452-8f72-4aab-a2e1-87df4325d2c3">15,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzMtNS0xLTEtMzczNTY_bc056967-e0df-411f-8819-07551bc8c034">38,359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzQtMS0xLTEtMzczNTY_e051f771-fad6-4cb6-9473-7e26b248101b">123,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzQtMy0xLTEtMzczNTY_a00c208c-c041-4747-b346-b92a698dca10">78,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzQtNS0xLTEtMzczNTY_0c1cec06-cc37-4795-8ba8-a52fc677ec08">98,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzUtMS0xLTEtMzczNTY_b3ba4dff-4c0b-466c-bb58-e3d0fc9011b3">214,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzUtMy0xLTEtMzczNTY_ab6ff5fa-ffe7-4ac3-89e0-5f4af1ef6e66">93,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzUtNS0xLTEtMzczNTY_4c2afbc0-644c-4970-a2d0-a496320de0d0">60,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxMjI_a24c6336-2bfc-4381-9e76-a0f17c7c2d81" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. Federal statutory rate to the Company&#8217;s effective tax rate is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzItMS0xLTEtMzczNTY_14676916-bef7-4d30-8d54-8296c3fbbb6e">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzItMy0xLTEtMzczNTY_9921b66c-573a-4d90-be31-3f98870e90f1">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzItNS0xLTEtMzczNTY_5e724ca2-28e4-48d5-919d-0866c7410df3">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in income taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzQtMS0xLTEtMzczNTY_b5a146d1-db61-4756-b840-133d90e4ff6e">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzQtMy0xLTEtMzczNTY_32950df1-aac6-4bad-b1e9-2663e38d6224">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzQtNS0xLTEtMzczNTY_333b266d-7b61-4fde-ac87-6096a9e52d57">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzUtMS0xLTEtMzczNTY_4894ac8d-a575-4d39-8eec-34ce8cc3b226">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzUtMy0xLTEtMzczNTY_8b2a2b39-f683-4536-b11e-60fa729c0450">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzUtNS0xLTEtMzczNTY_d4e79543-f737-459c-8250-2c99401c5739">20.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Excess tax benefits from stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzctMS0xLTEtMzczNTY_a1285a49-5e9f-4907-af80-87ebd4a9fc5d">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzctMy0xLTEtMzczNTY_e806b442-d671-4afc-abd0-72c78fd31f4c">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzctNS0xLTEtMzczNTY_d3df3321-d3ed-46f2-ada0-8dbc30f5f9dc">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible meals and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzktMS0xLTEtMzczNTY_1010ea50-6f78-4030-8a3d-f459677b8672">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzktMy0xLTEtMzczNTY_b8689606-6311-43de-997c-b698e1813d8e">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzktNS0xLTEtMzczNTY_d6833f4a-e9f4-45ed-a8da-35f6c118ee05">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intercompany profit in inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzExLTEtMS0xLTM3MzU2_d3c830fe-3367-40b1-9928-1d1c3b1a5161">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzExLTMtMS0xLTM3MzU2_4b601d16-edba-4150-94d9-b8f10ef0ef1a">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzExLTUtMS0xLTM3MzU2_96d498ee-bdd1-440a-a217-b6f13b8de233">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible facilitative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzEyLTEtMS0xLTM3MzU2_029fa61c-0bda-40fc-a410-bda0d59648ad">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzEyLTMtMS0xLTM3MzU2_6860656a-bd84-442e-bd61-b0833f60adc5">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzEyLTUtMS0xLTM3MzU2_a648054a-48e5-487c-a916-d25953560d5f">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE1LTEtMS0xLTM3MzU2_a0f434d8-2087-4236-b346-932bac60a3c7">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE1LTMtMS0xLTM3MzU2_bf7878ec-dfd1-4788-b161-6792e29a2546">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE1LTUtMS0xLTM3MzU2_dad8f424-c9da-4f9c-973e-ad8018acfb64">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE2LTEtMS0xLTM3MzU2_dfd1ec65-e6aa-4527-85ab-a0383c5f5f4c">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE2LTMtMS0xLTM3MzU2_fb1d50fb-32ca-41fb-ac08-368bff89d872">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE2LTUtMS0xLTM3MzU2_c621fc9e-7037-4872-9c6b-9996cec70970">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE3LTEtMS0xLTM3MzU2_42b9f4e8-9985-4561-83e3-d785996b9f38">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE3LTMtMS0xLTM3MzU2_1ce6d155-4121-468b-8465-749e3b77227d">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE3LTUtMS0xLTM3MzU2_3cc1b81d-9052-4f08-9664-e811072d43df">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE4LTEtMS0xLTM3MzU2_aa042fed-ef05-4dda-b5b8-c8c0f7b18d3a">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE4LTMtMS0xLTM3MzU2_2f97baf5-d2aa-4c05-aa2f-a5b084bb5041">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE4LTUtMS0xLTM3MzU2_814abd89-2cf7-456d-8c6b-c33181002268">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;Fair market value step up on intra-entity transfer of intellectual property</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTEtMS0xLTM3MzU2_a6b7b0fe-b969-4b73-9357-c2416ed97da7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTMtMS0xLTM3MzU2_233b4dca-598d-4bb8-8a71-b5a5ed4d708e">63.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTUtMS0xLTM3MzU2_a7a4ccc1-2fa6-4fd8-a939-490378151228">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain from sale of business - book to tax differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTEtMS0xLTM3MzU2_6dfa80dd-0ee7-4636-a412-d1d4f8cbb693">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTMtMS0xLTM3MzU2_7eb2adc0-dedf-40fc-ad3c-a10b871ca884">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTUtMS0xLTM3MzU2_27cde1e5-e1a7-4d90-8118-6aceb834692e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Swiss tax holiday</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTEtMS0xLTc1MTM5_5b42e400-17ec-476b-b6d5-536f767b4a2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTMtMS0xLTc1MTM5_d4b1a2a3-0971-451f-b577-e036ae411cc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTUtMS0xLTc1MTM5_0b773980-fcb8-46db-a7f1-cf3a6e8d954b">15.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible R&amp;D expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTEtMS0xLTc1MTAz_8eaadfe9-9a0c-4d40-a591-771826ca192b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTMtMS0xLTc1MTAz_a8148e32-6c4e-4b7f-92fa-f0f501c733bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTUtMS0xLTc1MTAz_98d02698-b08b-42f7-9c6d-4a3e877b8031">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTEtMS0xLTgxMTc3_edadd873-c22f-4fc4-8e3d-d0ca17ccfd22">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTMtMS0xLTgxMTc3_e097c55f-98a0-473d-aaf4-bcc31e17790b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTUtMS0xLTgxMTc3_2b3a4ed3-6008-40e4-8fbd-17eb57acd818">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI2LTEtMS0xLTM3MzU2_be9350c5-d2b9-4f3f-9921-dad070f84498">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI2LTMtMS0xLTM3MzU2_90cf8f42-aceb-455b-8415-d768dd6ad60f">43.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI2LTUtMS0xLTM3MzU2_15db1ca8-db4e-4cff-889e-b9860b57d880">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective tax rate was <ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzExOTI_be9350c5-d2b9-4f3f-9921-dad070f84498">21.2</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzEwOTk1MTE2MzUxNDM_90cf8f42-aceb-455b-8415-d768dd6ad60f">43.2</ix:nonFraction>)% of income before income taxes for the years ended December&#160;31, 2021 and December&#160;31, 2020, respectively. In 2021, the Company's higher effective tax rate was driven in part by an $<ix:nonFraction unitRef="usd" contextRef="i9f63720b3c7e46459c42a7742e5a8136_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxOTI_275b2caf-7f39-44f2-97b2-245205bf2cf5">8.5</ix:nonFraction>&#160;million income tax expense for nondeductible goodwill related to the sale of the Extremity Orthopedics business, offset by a $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxMjA_1182778a-9b8e-4f67-ac66-5329824de8f3">3.1</ix:nonFraction>&#160;million income tax benefit related to excess tax benefits from stock compensation. In 2020, the Company&#8217;s lower worldwide effective tax rate was primarily driven by an $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="iart:EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzEzOTg_6873cfc0-d8bb-4e69-8ef4-1d96adf50afc">59.2</ix:nonFraction>&#160;million income tax benefit on an intra-entity transfer of certain intellectual property, substantially completed during the fourth quarter in 2020. Excluding this transaction, the effective worldwide tax rate for 2020 was <ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" name="iart:EffectiveWorldwideIncomeTaxRateReconciliationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzE2MTQ_88c7da12-9e78-481b-8bfb-d227bdf856c2">20.2</ix:nonFraction>%.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="idda276474b0a416c9ab1ca8685b28e4a" continuedAt="i17385344f7124fa7b8b68a52840ccf20"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain, the Company&#8217;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow model based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Co</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">mpany recorded a $<ix:nonFraction unitRef="usd" contextRef="ie99f5f90e3c34fc2b03a2184dd276704_D20201201-20201231" decimals="-5" name="iart:EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzIxODI_483a4688-0811-4661-b8a9-6bea405a5d14">59.2</ix:nonFraction>&#160;million deferred tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in Switzerland related to the amortizable tax basis in the transferred intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, the Company&#8217;s foreign operations generated a $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzIzNTk_f62ae358-6067-4979-9ebf-96d641338cbc">63.6</ix:nonFraction>&#160;million increase in income tax expense when compared to the same period in 2020, because of the intra-entity transfer of certain intellectual property in 2020, geographic and business mix of taxable earnings and losses, among other factors. The 2021 foreign effective tax rate is <ix:nonFraction unitRef="number" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="3" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzI2MjY_784c390b-758f-49a8-bdc0-fb6670b608f3">15.2</ix:nonFraction>%, compared to (<ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" sign="-" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzI2NDI_bede2a8c-3821-4458-b318-5c47e98188b0">57.1</ix:nonFraction>)% in 2020. The Company&#8217;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above for 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2020, the Company&#8217;s foreign operations generated a $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxMzQ_3cad3aa0-00c4-4034-b230-1f20b824a980">48.2</ix:nonFraction>&#160;million decrease in income tax expense when compared to the same period in 2019 due to the intra-entity transfer of certain intellectual property, geographic and business mix of taxable earnings and losses, among other factors. The 2020 foreign effective tax rate is (<ix:nonFraction unitRef="number" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="3" sign="-" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxNDk_57981524-e278-4d08-8ec1-d9b38277f037">57.1</ix:nonFraction>)%, compared to <ix:nonFraction unitRef="number" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="3" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxNTg_aa321a46-5118-4de5-a0d6-a966db3d114a">3.5</ix:nonFraction>% in 2019.  The Company&#8217;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above for 2020. During 2019, the Company finalized negotiations related to tax holidays in Switzerland, on a federal, cantonal, and communal level. The Company received a federal tax credit in Switzerland of $<ix:nonFraction unitRef="usd" contextRef="i8271de19ce8942b7a5a6ac1978cb2a0c_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM0NDA_d93675a1-a8c9-4f86-874b-de9cddfa808d">12.1</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i8271de19ce8942b7a5a6ac1978cb2a0c_D20190101-20191231" decimals="2" name="iart:EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM0NDQ_7d9bab9d-bbd9-4118-92b7-67df719b08ca">0.14</ix:nonFraction> per share), which may be used over a seven-year period, ending in 2024. The Company also received a reduction in its rate for the cantonal and communal level taxes during the third quarter of 2019, pursuant to tax reform in Switzerland. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate.  Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation.  The current U.S. administration has proposed tax reform which, if enacted, may increase the Company&#8217;s U.S. federal income tax liability.  Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing (BEPS) project begun by the Organization for Economic Cooperation and Development (OECD).  The OECD recently finalized major reform of the international tax system with respect to implementing a global minimum tax rate.  Such changes in U.S. and Non-U.S. jurisdictions could have an adverse effect on the Company&#8217;s effective tax rate.</span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxMjY_f1d47847-d39c-4243-bb54-f48da0182a5c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzQtMS0xLTEtMzczNTY_87169bfe-b056-4a16-b9cb-82cf7e2ead16">31,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzQtMy0xLTEtMzczNTY_44393a8a-512a-4f85-8025-fafe238b4245">6,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzQtNS0xLTEtMzczNTY_b698bc18-5a69-4884-8b3e-a57dcdc281fc">14,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzUtMS0xLTEtMzczNTY_ab5ad3f5-c65e-4597-b566-0f4d2b2f8db1">11,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzUtMy0xLTEtMzczNTY_953ae68f-6655-4624-993a-b47dd22aa69e">5,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzUtNS0xLTEtMzczNTY_f528a3f5-5e8d-435f-923b-44557c5fd236">3,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzYtMS0xLTEtMzczNTY_3b2cfacb-0242-48af-9296-46fe5e6394d5">5,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzYtMy0xLTEtMzczNTY_53765d78-3b02-456c-be8b-db340994b8a2">12,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzYtNS0xLTEtMzczNTY_a802175a-be88-45a2-9526-aeeb8e15caa8">10,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzctMS0xLTEtMzczNTY_b31214ac-a10e-4646-aec6-1bb48e5e3dc0">48,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzctMy0xLTEtMzczNTY_631f6fd1-4449-40e9-8dc5-94482de2d80a">23,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzctNS0xLTEtMzczNTY_f77e7c62-3ca7-4577-9643-75eb40cdd339">28,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzktMS0xLTEtMzczNTY_dee731fb-b26d-4a00-9f72-50d6588577bf">12,830</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzktMy0xLTEtMzczNTY_41a3cce0-d01a-4897-aaab-7f187819c072">5,079</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzktNS0xLTEtMzczNTY_1fb8a160-a399-4f7f-8d5f-2aac7c44fe96">10,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEwLTEtMS0xLTM3MzU2_8620c218-3910-4d95-99dc-b1d129d80df9">3,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEwLTMtMS0xLTM3MzU2_9942bf63-a773-4b2a-b440-50a0d6f3b9f9">1,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEwLTUtMS0xLTM3MzU2_298fcbb9-e05c-4d88-be79-e82788beff52">666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzExLTEtMS0xLTM3MzU2_4c61f859-b808-4371-a19f-8bd0c6c4e3f9">13,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzExLTMtMS0xLTM3MzU2_8515b8d3-7f68-4fdc-9b29-b9d9ceb9cdbd">57,299</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzExLTUtMS0xLTM3MzU2_6ec8be21-7a0a-4dd5-beae-6e2625208b3e">7,491</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEyLTEtMS0xLTM3MzU2_aec6c7b0-f088-4822-ab7d-041080e6583d">2,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEyLTMtMS0xLTM3MzU2_cd378069-d29c-4f2b-93c4-74887b63abaa">64,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEyLTUtMS0xLTM3MzU2_5c25e8ab-dbff-4166-a07c-c47b8d89b360">19,046</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEzLTEtMS0xLTM3MzU2_8b77e489-be22-4e56-bbdf-a9f31f3a284c">45,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEzLTMtMS0xLTM3MzU2_4b28a226-a0e9-4036-95e5-69977b1e88d2">40,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEzLTUtMS0xLTM3MzU2_469deec7-73fb-43b5-9eef-20d056440d10">9,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i17385344f7124fa7b8b68a52840ccf20" continuedAt="ifd36ca7162dd420db37d829c9cf00898"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxNTI_be7d32f3-d82f-4e2f-b788-f6332e732839" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzQtMS0xLTEtMzczNTY_2c041977-c8bb-4ba1-9dd9-8f99b3180f32">2,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzQtMy0xLTEtMzczNTY_a6add4ae-bbaf-4fbb-817d-97482be7c5bb">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzUtMS0xLTEtMzczNTY_d733f411-9290-405c-9112-6cbfce57e1c3">31,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzUtMy0xLTEtMzczNTY_0e86d4da-9f08-4f5e-893b-b575dc47bb3f">47,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzYtMS0xLTEtMzczNTY_4aeb5cdb-2c68-421f-91f0-733989bbe58d">13,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzYtMy0xLTEtMzczNTY_645eaa93-7027-4b69-a0a9-53de49ce5f2a">18,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued vacation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzctMS0xLTEtMzczNTY_d3d54c73-1fdd-41cc-9521-cd0ca783c76b">3,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzctMy0xLTEtMzczNTY_f528c82f-a8a6-4ddf-bba4-60afcb916ee8">3,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzgtMS0xLTEtMzczNTY_eb7d077f-4411-41f3-a0ba-c7d3484fe4ea">7,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzgtMy0xLTEtMzczNTY_d3916078-1d5c-4e39-8a9c-27002d357494">4,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzktMS0xLTEtMzczNTY_33493d58-5535-4f3b-b87b-c05c0f98f386">13,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzktMy0xLTEtMzczNTY_8bbc4f4f-ef67-4ba7-8c89-2144d65ad7bb">6,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsDeferredIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEwLTEtMS0xLTM3MzU2_e2bbe36e-2bd6-4891-96e6-162c49ac6f3b">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsDeferredIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEwLTMtMS0xLTM3MzU2_d782fcd6-0de9-45ca-a5a6-e9631a866482">1,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzExLTEtMS0xLTM3MzU2_eff9bb71-7c2d-4cd4-928b-20bd95d177c6">26,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzExLTMtMS0xLTM3MzU2_9e079787-7be2-46e6-abba-9857cec3687f">29,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization of research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEyLTEtMS0xLTM3MzU2_a3e357dc-a8b5-489a-a430-2ee7d3f8e6f5">36,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEyLTMtMS0xLTM3MzU2_b2bd38e0-3158-4e1f-a4a1-875683c307f4">13,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEzLTEtMS0xLTM3MzU2_ff4a3864-e68c-43a0-a2df-604567e64090">12,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEzLTMtMS0xLTM3MzU2_606d2f58-f9c5-4009-bfe9-480c4f4e24cb">23,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE0LTEtMS0xLTM3MzU2_667375c9-2a45-4078-a057-e1c8c480310d">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE0LTMtMS0xLTM3MzU2_036ec9bc-e360-4d6f-9a87-2daf5c777677">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="iart:DeferredTaxAssetsLeasesAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE2LTEtMS0xLTM3MzU2_4d6a2ae2-1934-4a06-a462-fb4974ff32c0">41,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="iart:DeferredTaxAssetsLeasesAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE2LTMtMS0xLTM3MzU2_98fe4b3e-cf9c-4a8c-9a8c-d2cb86ad6c7c">23,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE3LTEtMS0xLTM3MzU2_d047c773-00e9-4989-80df-3d78ef3f32d4">190,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE3LTMtMS0xLTM3MzU2_85afa55f-0009-45be-9946-08c2fd4c6442">173,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE4LTEtMS0xLTM3MzU2_a5368bba-97f6-4bd8-9723-fec4072b26af">9,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE4LTMtMS0xLTM3MzU2_bb8ff0b0-6aea-4a19-803c-c9715d89f50e">9,897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets after valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE5LTEtMS0xLTM3MzU2_0a544ee0-9dcd-44e2-9433-9844a7759dfc">180,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE5LTMtMS0xLTM3MzU2_d7915431-49de-4e1f-952c-8ce066ac39dd">163,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIxLTEtMS0xLTM3MzU2_e18e649a-62f2-424b-a927-e968fa53ca7b">152,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIxLTMtMS0xLTM3MzU2_6598bfeb-e9dd-4615-8985-c1c8bc203b58">90,274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="iart:DeferredTaxLiabilitiesLeasesAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIyLTEtMS0xLTM3MzU2_b05c6207-6b48-4d73-a886-c7f1e6187269">17,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="iart:DeferredTaxLiabilitiesLeasesAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIyLTMtMS0xLTM3MzU2_781e99ae-bcbb-4627-94c0-a26042ea3d37">15,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIzLTEtMS0xLTM3MzU2_4c0cf4a0-6b9d-4da1-b66d-ab901e712a2b">169,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIzLTMtMS0xLTM3MzU2_f3fb9fe6-523b-428d-9d79-306cf13e8046">105,859</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzI1LTEtMS0xLTM3MzU2_c4ea30de-501d-437b-8cdf-36a6eea1ad83">11,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzI1LTMtMS0xLTM3MzU2_ebe5a005-afb7-45a7-89fb-93df5a8c1f66">57,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company had net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ife5918aed5c1487692805e84f2c59330_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzQxNjY_32782cb9-3200-4ee1-816e-112035dd4d9f">71.7</ix:nonFraction> million for federal income tax purposes, $<ix:nonFraction unitRef="usd" contextRef="ia2d92855590d44b3b95dd1dc07dd512a_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzQyMDI_49d3628a-d82e-41da-aa09-0b3eb8dd7fac">26.6</ix:nonFraction> million for foreign income tax purposes and $<ix:nonFraction unitRef="usd" contextRef="i1ea077a5d12f4d53afbcafb365160302_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzQyNDE_8306283a-8e47-465a-9acf-c6917e179d76">39.0</ix:nonFraction> million for state income tax purposes to offset future taxable income. The majority of the federal net operating loss carryforwards expire through 2037, while $<ix:nonFraction unitRef="usd" contextRef="ife5918aed5c1487692805e84f2c59330_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzQzOTM_274f5ef4-c24d-4393-9eba-270293408c23">4.1</ix:nonFraction> million have an indefinite carry forward period. For foreign net operating loss carryforwards, the remaining $<ix:nonFraction unitRef="usd" contextRef="ia2d92855590d44b3b95dd1dc07dd512a_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzQ1MzM_470e9cd2-22bb-4b4c-99f2-65a8c38cc04b">26.6</ix:nonFraction> million have an indefinite carry forward period. The state net operating loss carryforwards expire through 2036. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance relates to deferred tax assets for certain items that will be deductible for income tax purposes under very limited circumstances and for which the Company believes it will not satisfy the more likely than not threshold for realization of the associated tax benefit. In the event that the Company determines that it would be able to realize more or less than the recorded amount of net deferred tax assets, an adjustment to the deferred tax asset valuation allowance would be recorded in the period such a determination is made. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s valuation allowance decreased by less than $<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzUyNTk_07019501-9e46-4cfd-b4d3-3a821a309af7">0.1</ix:nonFraction> million, increased by less than $<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxNjQ_529cef39-2544-416e-8738-72984e1bf8a2">0.1</ix:nonFraction>&#160;million and increased by $<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxNzg_4e5e8674-008c-4362-a620-436855d9796a">2.9</ix:nonFraction>&#160;million at December 31, 2021, 2020 and 2019, respectively. The 2021 and 2020 valuation allowance primarily remained unchanged from the prior period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost.&#160;Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;The Company will repatriate foreign earnings when there is no need for reinvestment overseas and no material tax cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans. As such, the Company has determined the tax impact of repatriating these earnings would <ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ForeignEarningsRepatriated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzU5NDc_a56a9b88-5c22-4540-aebd-02fa04683a64">no</ix:nonFraction>t be material as of December&#160;31, 2021. The Company does not anticipate the need to repatriate earnings from foreign subsidiaries as a result of the impact of the COVID-19 pandemic.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ifd36ca7162dd420db37d829c9cf00898" continuedAt="i3f532b1367944752b628d4eba28433c0"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxMjg_7e18b207-b4d5-4042-b16a-c1bef71a24f3" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzMtMS0xLTEtMzczNTY_bce6b9db-1aed-4bbe-aa60-4c4a243b3e33">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55084e91d494776891870a81ff5cb91_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzMtMy0xLTEtMzczNTY_62ee925c-e3a6-4879-93fd-e2e29eeaeade">676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcaf1fbc6c2145ac92ae58dce7c7f40b_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzMtNS0xLTEtMzczNTY_ed3f4874-d6f5-4dd8-9b3d-589f5827b6d4">676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzUtMS0xLTEtMzczNTY_bb41b188-b9c7-4435-ae58-c16f7f2bbaed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzUtMy0xLTEtMzczNTY_0b97f7d5-86a4-420f-9509-b2ec0c1b0e4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzUtNS0xLTEtMzczNTY_20df087a-7d5c-4f3c-9d43-afd9d1c6235d">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prior years' tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzYtMS0xLTEtMzczNTY_dfefb418-9d11-4be5-b323-5e6f3c236a40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzYtMy0xLTEtMzczNTY_12bd5510-9838-4036-ab6c-80abb98c1cf8">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzYtNS0xLTEtMzczNTY_ea847c0f-a292-4eed-af66-0d5cd96d6980">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="iart:UnrecognizedTaxBenefitsReductionsResultingFromOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzExLTEtMS0xLTM3MzU2_f399efd7-4aa7-4f18-a62c-2b2c2fc2c953">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="iart:UnrecognizedTaxBenefitsReductionsResultingFromOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzExLTMtMS0xLTM3MzU2_e039b985-68ac-443d-b9a1-7616d27a9cdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="iart:UnrecognizedTaxBenefitsReductionsResultingFromOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzExLTUtMS0xLTM3MzU2_3f92a18b-b643-4a0a-bf09-4f78999dc962">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzEyLTEtMS0xLTM3MzU2_3b3fb66e-4cf8-40c8-9b5e-f0469e02ae7f">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzEyLTMtMS0xLTM3MzU2_e9f1b78b-893f-41dc-a492-4174286ff450">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55084e91d494776891870a81ff5cb91_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzEyLTUtMS0xLTM3MzU2_8c0e82f8-33ef-4056-8283-731c2e235911">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $<ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzYwODM_ef290dd6-1cae-4e35-80c5-64f9bf43f8ae">0.7</ix:nonFraction> million of the balance at December&#160;31, 2021 relates to uncertain tax positions that, if recognized, would affect the annual effective tax rate. There are <ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="INF" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzYyMTc_823af604-74d3-4fa0-b436-589949052810">no</ix:nonFraction> amounts within the balance of uncertain tax positions at December&#160;31, 2021 related to tax positions for which it is reasonably possible that the amounts could be reduced during the twelve months following December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties relating to uncertain tax positions in income tax expense. The Company recognized a minimal benefit for the years ended December&#160;31, 2021, 2020 and 2019. The Company had minimal interest and penalties accrued for the years ended December 31, 2021 and 2020 and 2019. </span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f532b1367944752b628d4eba28433c0">The Company files Federal income tax returns, as well as multiple state, local and foreign jurisdiction tax returns. The Company is no longer subject to examinations of its U.S. consolidated Federal income tax returns by the IRS through fiscal year 2017. All significant state and local matters have been concluded through fiscal 2015. All significant foreign matters have been settled through fiscal 2012.</ix:continuation> </span></div><div id="i172bf506156f43e6869412a665f54418_184"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90ZXh0cmVnaW9uOjUxMDg4ZGE5ZGZlNTQ3ZWY5YWY3NTAyMTBhOTU4NWUxXzcwMQ_5486ee29-a9d7-41ca-9f1d-735787e9e9bb" continuedAt="ib7b66ae8cef84aea89048b950de16b48" escape="true">NET INCOME PER SHARE</ix:nonNumeric></span></div><ix:continuation id="ib7b66ae8cef84aea89048b950de16b48" continuedAt="i4b72945312e643e5b2588a5b66ab8f8e"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90ZXh0cmVnaW9uOjUxMDg4ZGE5ZGZlNTQ3ZWY5YWY3NTAyMTBhOTU4NWUxXzcwMA_e8bfc570-b01c-4975-ac5b-173268aad7c2" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzQtMS0xLTEtMzczNTY_65468cf4-dd35-4218-a5e9-2d0f7a7d7121">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzQtMy0xLTEtMzczNTY_bf2afda1-fa9e-40ac-ad64-f2b61249170f">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzQtNS0xLTEtMzczNTY_4bec1973-aa6f-4f25-b842-f1852aac9e73">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzYtMS0xLTEtMzczNTY_75a86537-18dc-42ba-af53-749d6a579505">84,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzYtMy0xLTEtMzczNTY_1e98e3fb-9af3-48db-8395-2fe2da4ea616">84,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzYtNS0xLTEtMzczNTY_765ddf45-3463-485d-bf11-e753346d3963">85,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzgtMS0xLTEtMzczNTY_e3a44300-e647-4c1a-8f2e-002c5e9701b6">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzgtMy0xLTEtMzczNTY_d1d14dec-d77e-4408-9313-1b951ed91a0d">1.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzgtNS0xLTEtMzczNTY_9c6c951e-1aa9-46aa-bef3-296f613af9a7">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzExLTEtMS0xLTM3MzU2_74b5bd5c-7ea0-4c84-99b4-7c1c75f17883">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzExLTMtMS0xLTM3MzU2_823e03b2-2997-42aa-931a-f574f84fec50">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzExLTUtMS0xLTM3MzU2_286290ce-5973-4385-9d30-dabb77f7e142">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzEzLTEtMS0xLTM3MzU2_b1adc263-d1c0-4b21-b46f-556384c916d6">84,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzEzLTMtMS0xLTM3MzU2_0fe40724-a228-4123-a8c1-5c0a145b848a">84,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzEzLTUtMS0xLTM3MzU2_2c4f324c-b8bc-4df7-857b-ed3afd08b480">85,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE3LTEtMS0xLTM3MzU2_95cec570-8ec0-4a79-9424-311ddbbe6f62">787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE3LTMtMS0xLTM3MzU2_3865d4a5-84b1-4e3f-bb53-5b6c859f8c78">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE3LTUtMS0xLTM3MzU2_757cc7bf-afde-4477-9afc-d1cc776452ee">857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE4LTEtMS0xLTM3MzU2_519a8ecd-9a28-4abe-827c-c5478d1655cf">85,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE4LTMtMS0xLTM3MzU2_1251cb81-b6d1-4815-837b-04d70d4e6e62">85,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE4LTUtMS0xLTM3MzU2_00a170ef-07cc-4863-9d80-7c36eae47d33">86,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE5LTEtMS0xLTM3MzU2_bf5fcabb-3bc7-44c1-a924-fd19a833100a">1.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE5LTMtMS0xLTM3MzU2_26ab4b20-afd5-4c2b-b428-77aae77ab934">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE5LTUtMS0xLTM3MzU2_ad4d5e65-b277-4cf2-bcb7-866f4881ecf2">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock of approximately <ix:nonFraction unitRef="shares" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90ZXh0cmVnaW9uOjUxMDg4ZGE5ZGZlNTQ3ZWY5YWY3NTAyMTBhOTU4NWUxXzExNw_08faa078-40bb-4371-88bd-08152c9349a6">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90ZXh0cmVnaW9uOjUxMDg4ZGE5ZGZlNTQ3ZWY5YWY3NTAyMTBhOTU4NWUxXzEzMg_a066107e-f883-46f2-9294-24b345ba04cb">0.3</ix:nonFraction> million shares at December&#160;31, 2021, and 2020 that are issuable through exercise of dilutive securities, respectively, and were not included in the computation of diluted net income per share because their effect would have been anti-dilutive. </span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4b72945312e643e5b2588a5b66ab8f8e">Performance Shares and Restricted Units that entitle the holders to approximately <ix:nonFraction unitRef="shares" contextRef="i0a62d727286a47e8bee85dd137b2d0b4_I20211231" decimals="-5" name="iart:AdditionalEPSShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90ZXh0cmVnaW9uOjUxMDg4ZGE5ZGZlNTQ3ZWY5YWY3NTAyMTBhOTU4NWUxXzQ0NQ_a05b51ce-e689-4f57-a706-3b3fd048132c">0.5</ix:nonFraction> million shares of common stock are included in the basic and diluted weighted average shares outstanding calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><div id="i172bf506156f43e6869412a665f54418_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90ZXh0cmVnaW9uOjQyNGFjNjIxOGM3NjQyOTU4ZDQ4MDBiMmUwYTVkMGI2XzM1NQ_d54650e8-c48b-49b9-b5ff-7e9cabb0b7f1" continuedAt="i22da1b96e73d4906a2a21ba852e1bcd1" escape="true">ACCUMULATED OTHER COMPREHENSIVE LOSS</ix:nonNumeric></span></div><ix:continuation id="i22da1b96e73d4906a2a21ba852e1bcd1"><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90ZXh0cmVnaW9uOjQyNGFjNjIxOGM3NjQyOTU4ZDQ4MDBiMmUwYTVkMGI2XzM0Nw_68c2081c-b0f8-4435-bf36-ed2110b074b3" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive loss by component between December&#160;31, 2021 and 2020 are presented in the table below, net of tax:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbb8ffeeace8408783309370a8cc931b_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzItMi0xLTEtMzczNTY_e3efe9a5-6640-46e0-b970-4a4d0aa09b13">82,249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2866d8b778aa44fe895f36a6d30cbdf5_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzItNC0xLTEtMzczNTY_cff16c86-0633-4ee2-af00-128767f19403">5,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8713e0cf33449019cc4cf84a4e3d77b_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzItNi0xLTEtMzczNTY_96e86918-5dd7-4671-8827-7b5143dc1a02">13,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b2f27cba47049e49b27de743dc66104_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzItOC0xLTEtMzczNTY_bc86e0f0-0509-45fa-b7b5-e748ab377aaf">74,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76189f48f3644d178eedea04bdbe9155_D20210101-20211231" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzMtMi0xLTEtMzczNTY_0ca48089-c0f7-45be-8e6b-c104824c8c26">52,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b0eb0c48144061a9b7a61f90a00974_D20210101-20211231" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzMtNC0xLTEtMzczNTY_6b70b45f-bc16-457f-a9e0-42638fe46cb8">6,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e53f5024f5b49708d10aea5ff725429_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzMtNi0xLTEtMzczNTY_77fb0b45-2d85-442f-a051-8e0f8927a1f2">17,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzMtOC0xLTEtMzczNTY_034be5d5-f574-4e4b-9742-91a60fd14e2e">41,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76189f48f3644d178eedea04bdbe9155_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzQtMi0xLTEtMzczNTY_b8a6d654-d4ec-4afc-93ab-a5f4ea4ff387">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b0eb0c48144061a9b7a61f90a00974_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzQtNC0xLTEtMzczNTY_6205cf39-bac3-48a9-87d3-76d236eaf262">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e53f5024f5b49708d10aea5ff725429_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzQtNi0xLTEtMzczNTY_ca980151-9fd2-4752-b9b6-45b058569f8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzQtOC0xLTEtMzczNTY_47c07a3f-56e2-4b6e-9fe4-177e48116d50">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76189f48f3644d178eedea04bdbe9155_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzYtMi0xLTEtMzczNTY_63ce014a-eaf7-4c6f-9fa7-7cd64e47f6c8">39,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b0eb0c48144061a9b7a61f90a00974_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzYtNC0xLTEtMzczNTY_9c59be9d-6e80-42b4-9d79-52cbc64cfbe4">6,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e53f5024f5b49708d10aea5ff725429_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzYtNi0xLTEtMzczNTY_1a04dc82-c045-4960-87a8-87fe412051e7">17,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzYtOC0xLTEtMzczNTY_fcf24b54-3006-44fb-9266-77198cc40c3d">28,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia04c800bf5404c7b9232f7d4bc6754c6_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzctMi0xLTEtMzczNTY_ff3e7591-cb01-420a-8289-8ceb73e18271">42,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia77c775b70934877bc93a2298d93cb4c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzctNC0xLTEtMzczNTY_00a9fd89-510f-4a56-abfb-9e65ed9f352a">1,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16240e1f2c9948f4bb47909f3308fa08_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzctNi0xLTEtMzczNTY_2f5bf876-0479-4cc9-9df2-ec89a0ef9594">4,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62b5cd28862f4322bda15977250be066_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzctOC0xLTEtMzczNTY_833f03c9-8d16-43a3-8b0d-616e30e4d7bf">45,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2021, the Company reclassified a gain of $<ix:nonFraction unitRef="usd" contextRef="ia65ff802a8ad4a8eadd83dd25409c85b_D20210101-20211231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90ZXh0cmVnaW9uOjQyNGFjNjIxOGM3NjQyOTU4ZDQ4MDBiMmUwYTVkMGI2XzIzNQ_9dc5a1a7-17be-4c7a-8b25-20e2a35e726d">25.3</ix:nonFraction> million and a loss of $<ix:nonFraction unitRef="usd" contextRef="ia068e43763f9429bac4588f20427197f_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90ZXh0cmVnaW9uOjQyNGFjNjIxOGM3NjQyOTU4ZDQ4MDBiMmUwYTVkMGI2XzI0Mg_da0207c4-1de6-45cc-8bf8-b7f18328d585">12.2</ix:nonFraction>&#160;million from accumulated other comprehensive loss to other income, net and interest income, respectively.</span></div></ix:continuation><div id="i172bf506156f43e6869412a665f54418_190"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzIwNjI_34fb49fb-3662-40a1-a079-d98b445432df" continuedAt="i7e41095313fe424591016daf7bf82b0b" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i7e41095313fe424591016daf7bf82b0b" continuedAt="i4427837cf2944a68b3004ee2892de424"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of contingent consideration during the twelve-month period ended December&#160;31, 2021 and 2020 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period. </span></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzIwNTU_95df60d1-fc0a-4663-b7c2-17f44593fa4a" continuedAt="i197541b3d54b48b49b3927b01c4cfed8" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2021 and 2020 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.527%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis <br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.<br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eab101e6425464cb1a382b10930b341_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzMtMi0xLTEtNDM4ODI_d8cf0b7b-dae9-425b-8699-cc88f1d29a15">3,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic91d4b47894f4d7a96fcbf0bd64e0b77_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzMtNC0xLTEtNDM4ODk_6c72b651-a2b8-45cf-93c3-d37c03c8b716">11,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a23d3b6fbf04e0390ce17338efbe5ad_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzMtOC0xLTEtNDM4OTU_43c62385-6429-46a2-b1b0-c4d8b145ea26">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a9425a324d94f60bb5d946be181483a_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzMtMTEtMS0xLTQzOTAx_d553a668-ee31-4de4-8664-b697ddec51b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additiions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd7836a15ac4b8b944cca235159afc0_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzQtMTEtMS0xLTQzOTAx_2f7bebf4-369b-4537-b986-89ad1b0ccd0f">23,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a46fda6cf2140edb1e670f70f41e243_D20210101-20211231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzUtMi0xLTEtNDM4ODI_ba5a737c-7067-48d4-ae99-7955888ea871">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa77aab677c460cabbffe02b9267bf8_D20210101-20211231" decimals="-3" sign="-" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzUtNC0xLTEtNDM4ODk_b677848a-e2f5-4b0d-bb1a-3d70d6bdd92c">276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a46fda6cf2140edb1e670f70f41e243_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzYtMi0xLTEtNDM4ODI_601c8fb5-9fff-4fe1-a9cc-3dfb1494a967">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa77aab677c460cabbffe02b9267bf8_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzYtNC0xLTEtNDM4ODk_448a600d-4d2b-48c5-84c7-37c089e0861b">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd7836a15ac4b8b944cca235159afc0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzYtMTEtMS0xLTQzOTAx_f72f1289-5b74-44ca-9c0a-f48a4a45cad3">2,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1f3f919472d407284a8f3f85a6ed4d4_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzctMi0xLTEtNDQ5MzU_c7615139-04c1-4101-8f03-79bfb361da04">3,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e801d197ed5482db7634fd855e8728f_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzctNC0xLTEtNDQ5MzU_564042a6-1f7b-493b-984a-e4c7533d6fbd">11,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252807040ee4349abee84d30b8c631b_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzctOC0xLTEtNDQ5MzU_8ec2fbc1-b093-43d6-a9a6-769bd04a769f">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25ef1e32c9ce4449a3b9050b6a0eb0a9_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzctMTEtMS0xLTQ0OTM1_56b1592a-343f-4b37-8c3a-13b6f1911acc">21,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><ix:continuation id="i4427837cf2944a68b3004ee2892de424" continuedAt="i18a616301d6040b8a8cd1024cf839de1"><ix:continuation id="i197541b3d54b48b49b3927b01c4cfed8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Arkis <br/>(See Note 4)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6092d39074b47158db64e1a12d8002f_I20191231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzItMi0xLTEtMzczNTY_0f469275-f440-45b7-98a9-a13297f3b181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89e76baba8646799816d81431077940_I20191231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzItNC0xLTEtMzczNTY_b5acd348-398f-4edd-a0b7-0e002a3d98d9">14,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e2f5b0e8cc4bb789f0d6856afb0e8d_I20191231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzItNi0xLTEtMzczNTY_34a07c7d-b8a0-43f9-8d5a-72d6966a6e56">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e3f0df348d4cdbadb7cd4bfc901932_D20200101-20201231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzMtMi0xLTEtMzczNTY_6b1094c7-0a53-48a4-bf31-4a059927daca">3,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c75bb71571a44fa91621f994d3c6236_D20200101-20201231" decimals="-3" sign="-" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzMtNC0xLTEtMzczNTY_df8c6afe-6c3a-48ef-b4fe-8c789a49e210">3,415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d8d2300006048a5856f3014db3d9faf_D20200101-20201231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzMtNi0xLTEtMzczNTY_8b4f89e3-f719-4e16-84d3-26c214bf550c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e3f0df348d4cdbadb7cd4bfc901932_D20200101-20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzQtMi0xLTEtMzczNTY_85fbeba3-9390-47b8-9ef7-85009ee264ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c75bb71571a44fa91621f994d3c6236_D20200101-20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzQtNC0xLTEtMzczNTY_f39c9b98-fd1b-4aad-9893-3e05c28f7e84">951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d8d2300006048a5856f3014db3d9faf_D20200101-20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzQtNi0xLTEtMzczNTY_deed83cf-084c-4656-9a96-d9199db208a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eab101e6425464cb1a382b10930b341_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzUtMi0xLTEtMzczNTY_4a8a0fe2-4ec0-41c3-aa45-cf9b9c504095">3,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic91d4b47894f4d7a96fcbf0bd64e0b77_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzUtNC0xLTEtMzczNTY_2a459a89-7545-4e64-a9c5-067923961153">11,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a23d3b6fbf04e0390ce17338efbe5ad_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzUtNi0xLTEtMzczNTY_6ecc3f98-7232-4b40-8c05-0bf9f7d2ff8a">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derma Sciences</span></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i18a616301d6040b8a8cd1024cf839de1">The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences")&#160;related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $<ix:nonFraction unitRef="usd" contextRef="ia320d69e30b449ea850f977af47c941a_D20210101-20211231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzI3NDg3NzkwNzE5Nzk_15c0de68-24d8-4ad3-95c8-3f59bafd5bed">33.3</ix:nonFraction> million related to the aforementioned contingent liabilities. One contingent milestone remains which relates to net sales of Medihoney&#8482; products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $<ix:nonFraction unitRef="usd" contextRef="ia320d69e30b449ea850f977af47c941a_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzI3NDg3NzkwNzIyNjY_0f2de039-4d0a-4119-bf4d-93d60042af44">3.0</ix:nonFraction> million. The estimated fair value as of December&#160;31, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ifd2d3085810d47938abea6521730980b_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzI3NDg3NzkwNzIzMTg_46bd7396-235f-47c9-adb2-5dbd0be94b42"><ix:nonFraction unitRef="usd" contextRef="i19abaf1be5a54d1cad2b918f942e1949_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzI3NDg3NzkwNzIzMTg_aafa0d93-9606-435b-ae5c-a13188b96a76">0.2</ix:nonFraction></ix:nonFraction> million.</ix:continuation> </span></div><div id="i172bf506156f43e6869412a665f54418_193"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90ZXh0cmVnaW9uOmU2YWQ3MDZhOTExNjRiNzc4ZTQ0MTczZWU3NWVjNTUxXzIxNjY_8af69fc9-cbcc-42d5-bc89-912d2fba4b7a" continuedAt="i9870cbfbe7c04e07af4280a01574e59c" escape="true">SEGMENT AND GEOGRAPHIC INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i9870cbfbe7c04e07af4280a01574e59c" continuedAt="ib89cb32dad4f4a64924349cebd57f7f6"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company internally manages&#160;<ix:nonFraction unitRef="segment" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90ZXh0cmVnaW9uOmU2YWQ3MDZhOTExNjRiNzc4ZTQ0MTczZWU3NWVjNTUxXzgw_72f1f5f2-4664-4fc4-a780-a6474a7d8d94">two</ix:nonFraction>&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;<ix:nonFraction unitRef="segment" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90ZXh0cmVnaW9uOmU2YWQ3MDZhOTExNjRiNzc4ZTQ0MTczZWU3NWVjNTUxXzE5NQ_aa87322a-cd41-4728-836c-2b29f7c68809">two</ix:nonFraction>&#160;reportable segments and their activities are described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than <ix:nonFraction unitRef="product" contextRef="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231" decimals="INF" name="iart:SegmentReportingInformationNumberOfProductsOffered" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90ZXh0cmVnaW9uOmU2YWQ3MDZhOTExNjRiNzc4ZTQ0MTczZWU3NWVjNTUxXzY0NA_03310bcf-4de5-4e81-ad85-4852beb6734b">40,000</ix:nonFraction> instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Tissue Technologies segment includes such offerings as skin and wound repair, plastics &amp; surgical reconstruction products, bone grafts, and nerve and tendon repair products. In conjunction with the sale of the Extremity Orthopedics business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. <ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90ZXh0cmVnaW9uOmU2YWQ3MDZhOTExNjRiNzc4ZTQ0MTczZWU3NWVjNTUxXzIxNTY_17358ea8-3f98-48fd-bdcd-594c1ddff6c9" continuedAt="i58421a4d57e34be9817c32fe2467094d" escape="true">Net sales and profit by reportable segment for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ib89cb32dad4f4a64924349cebd57f7f6"><div style="margin-bottom:12pt;margin-top:12pt"><ix:continuation id="i58421a4d57e34be9817c32fe2467094d" continuedAt="i0d3726dbbf624568a9615dfd4dfd591c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:58.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzQtMS0xLTEtMzczNTY_14eacba5-a6ad-4e01-bf65-a438b3982fe5">1,025,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb66154030084b3e8586a701e0a6bdb6_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzQtMy0xLTEtMzczNTY_d597fe1e-a250-44e6-81a7-ae18429b537f">894,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69a65713dfe64c33a00c72d8483e68a9_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzQtNS0xLTEtMzczNTY_752481ca-d497-43cd-9711-2af5c55fb26e">996,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d1799cdfeb443c297cec0ede24b319e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzUtMS0xLTEtMzczNTY_1556bb2b-2de5-4255-a817-4acfd7785e20">517,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b76730b7e7f49afa097d63b1fb0577c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzUtMy0xLTEtMzczNTY_bf613354-6e36-4215-902e-1cc9d0cdb61a">477,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie57e505f7452456591a3ff162137393e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzUtNS0xLTEtMzczNTY_a7893160-02cf-40f0-ad6c-1cbc425659af">521,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzYtMS0xLTEtMzczNTY_538301cd-0de4-4aac-bdb1-677969fa9f03">1,542,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzYtMy0xLTEtMzczNTY_efb537e7-3c7c-4857-9034-0aae3a9e224f">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzYtNS0xLTEtMzczNTY_2ead1a5c-c517-4d86-8043-7107fb329198">1,517,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f756bb0be9d4f989bfa36dadc8b61d1_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzgtMS0xLTEtMzczNTY_01070e39-f338-4cfd-8b35-57edaae1544e">439,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6343e390534664acd42ec3984442ea_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzgtMy0xLTEtMzczNTY_e3220c93-ba5e-430a-9336-9ad893250752">356,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98fc4020b8994f4587d792aaefced1fa_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzgtNS0xLTEtMzczNTY_041fa4ad-1c76-4ba2-871d-b95395745556">395,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b128710253a40d3b28600e3c705fdb6_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzktMS0xLTEtMzczNTY_ba3b56ee-239a-4c19-b389-53d58cc91ff4">228,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda682a36ee340289bb7f3a9602fabce_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzktMy0xLTEtMzczNTY_919acb3e-4186-4182-a365-1da284f336a5">159,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icabd362120ba4ad89874c966b42f3fb2_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzktNS0xLTEtMzczNTY_6a19e3e5-7135-4f54-8efd-a85d3fc0be9b">144,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee33c44f27cc4e77b072623b9ba9c96b_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEwLTEtMS0xLTM3MzU2_0e217adb-4de1-4b35-b31e-86d4306dced5">667,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24453718685347bdbc8c3364e2bc9dd1_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEwLTMtMS0xLTM3MzU2_03647c4c-b68d-460b-9ac9-8ec6775dabc7">516,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec4766ff8b74bb2bbaa2ea51f38c98c_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEwLTUtMS0xLTM3MzU2_b396b87a-4268-4c4d-ae97-fac5bf9528c4">539,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzExLTEtMS0xLTM3MzU2_eca76822-0eca-4b6b-a08d-61c3c46b3e35">16,914</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzExLTMtMS0xLTM3MzU2_40f64fc3-d866-4cbf-a8c3-0fdd683ec05e">27,757</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzExLTUtMS0xLTM3MzU2_62969d95-7a44-4afb-b5dc-919842e7544e">27,028</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33ba2e9dbfa94793bdffd7e52faa2682_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEyLTEtMS0xLTM3MzU2_d14ae12c-d767-4252-808d-7eedd7e1e899">453,526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53e08de3817440699e14abb26fa3b8c1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEyLTMtMS0xLTM3MzU2_2275c075-89e0-405e-bb1d-9c864abaa193">337,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f1d90d19e9e4cdaa2643ef6b865abb2_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEyLTUtMS0xLTM3MzU2_1a909308-92e2-43f5-83c9-e66405b74957">418,869</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEzLTEtMS0xLTM3MzU2_67111ea7-a825-4ca4-a87a-eb78e873f825">197,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEzLTMtMS0xLTM3MzU2_6c20e9ec-8a84-4021-8ffd-b25146d2c116">151,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEzLTUtMS0xLTM3MzU2_d6b89124-7260-40b4-b01b-7315f60ca40b">93,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenue to geographic areas based on the location of the customer. <ix:continuation id="i0d3726dbbf624568a9615dfd4dfd591c" continuedAt="i26cc5c4c17e0434dbb06fec3d7800da2">Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: </ix:continuation></span></div><ix:continuation id="i26cc5c4c17e0434dbb06fec3d7800da2"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:34.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97aab3d9bc7649968f7bd24913cb99f3_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzMtMS0xLTEtMzczNTY_93438cb5-5dc0-4f0e-adbe-bf5060184278">1,089,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42f2680503f44fb8c7e794fb7e10a6d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzMtMy0xLTEtMzczNTY_e24d9978-5f09-4515-b687-e6fe1b709d86">191,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3109fd420bc7439cae7cd959e1de8c73_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzMtNS0xLTEtMzczNTY_926d99db-5064-41c8-a302-bbb4ecc4ad09">182,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef83b8d6d124777b62a31b4e2684492_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzMtNy0xLTEtMzczNTY_dd737352-7445-45d8-8631-ab991c651084">79,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzMtOS0xLTEtMzczNTY_8377477f-907a-4a9d-a0ec-ebdf26589e4c">1,542,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b32cebb922d4397bba7d163b3b0f280_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzQtMS0xLTEtMzczNTY_514ff98e-d616-4bc5-8260-9039dee04dfa">971,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef8247221b044978061dddd77b93c53_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzQtMy0xLTEtMzczNTY_412461d2-9db1-429f-b1be-f84bb35a59a4">172,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eed1f8c5f0645c891b92ba3cda138e1_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzQtNS0xLTEtMzczNTY_f3a28cb9-b338-4755-9ab1-0e766d4bbf9a">157,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i922bc66b09174c569548f8ce0a89a406_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzQtNy0xLTEtMzczNTY_09b3491f-333f-4437-ab0f-b46178e68a90">70,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzQtOS0xLTEtMzczNTY_f3c126c6-10c7-4438-adcb-4d0a616eecc8">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33aa545fd0d4f1ea1f097ae92801f2e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzUtMS0xLTEtMzczNTY_504ee94c-765b-4dca-848c-26e66cf44dcb">1,077,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1119ac444814938a3b945328c7b101a_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzUtMy0xLTEtMzczNTY_eb21fab9-6e71-4a3c-831b-c3d58957d84f">197,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f905190bdc42abbc8fb75b81e146e4_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzUtNS0xLTEtMzczNTY_8efb3985-b163-457b-b029-7e51241724f1">157,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fadf198a94822ad3bd70f37b63804_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzUtNy0xLTEtMzczNTY_605644ff-1cbe-46fd-91cf-dce425d0aba1">85,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzUtOS0xLTEtMzczNTY_8b23fc62-8f72-4eca-b934-d412a9fe0dbf">1,517,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50142c614bbf430787c2956bba7a20e7_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzctMS0xLTEtMzczNTY_46c5e675-d46d-4b1a-a41a-c92c2d0899bf">339,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i256baa22e9624220a6984e22db834aba_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzctMy0xLTEtMzczNTY_d1908551-bb65-460c-b852-93f2caf55f57">55,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019eb6b80cbd43b781098b4683f8f8ce_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzctNS0xLTEtMzczNTY_c31b240c-843b-4d4a-94b9-911a976f9779">11,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e860ddce78e406f83a26966f4ed71d7_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzctNy0xLTEtMzczNTY_4917c2c6-fd29-4681-a9d6-5706618fe725">6,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzctOS0xLTEtMzczNTY_1c4b5cbb-593a-4727-9dbf-1dc14b3599cf">412,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i475c2989d2c1426fa24528e14601b247_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzgtMS0xLTEtMzczNTY_73b96997-6459-42a1-bdf6-942ab8449777">324,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50cdb7226ffa49d2a639d7b8ce77fa33_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzgtMy0xLTEtMzczNTY_8104dd93-d894-4719-bdd3-793e50b011cf">38,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i438e0780f85c42f9b797ba9e48948fd1_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzgtNS0xLTEtMzczNTY_675a7428-0fcf-4271-a5ca-def1953b81b5">13,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1639642b327422bb89bec9a0b6728a6_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzgtNy0xLTEtMzczNTY_e19d926d-7910-43b4-8636-c0e30539eb56">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzgtOS0xLTEtMzczNTY_17ceecc5-1bc9-4170-b55f-5e6af7a100a0">382,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes long-lived assets in Puerto Rico.</span></div></ix:continuation></ix:continuation><div id="i172bf506156f43e6869412a665f54418_202"></div><ix:nonNumeric contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90ZXh0cmVnaW9uOjBiYzk1NWZkNDMwNTQyYjc5ZTRiZWUxN2U3MTY2YWJiXzYxMw_80a2e951-7bec-4865-9557-ea94d853fb68" escape="true"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II &#8212; VALUATION AND QUALIFYING ACCOUNTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901487c914b2405ba16f79b4bc6b4d8e_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzQtMS0xLTEtMzczNTY_d9e4db43-69df-4b84-a72f-de16df1b860c">6,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bf12c9378fe4261a4675d758ca41164_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzQtMy0xLTEtMzczNTY_959288d5-c4ff-4cfd-8d04-0501cffa5ceb">1,059</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf12c9378fe4261a4675d758ca41164_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzQtNS0xLTEtMzczNTY_9101228e-1783-442f-80b5-3a0adbc56502">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bf12c9378fe4261a4675d758ca41164_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzQtNy0xLTEtMzczNTY_fa131e9d-1443-4637-b764-7cc5f43ae937">986</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4861d0427af7477a92dde072e3da72c3_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzQtOS0xLTEtMzczNTY_ed95cfdb-9f47-45b0-bbba-47e3cb28e64f">4,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8831947c0944fa381c1aca73be705ae_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzUtMS0xLTEtMzczNTY_f3db07e5-0482-496b-badd-866604a2e001">13,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3324aa5df4cc4aa9956ed23a488056f5_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzUtMy0xLTEtMzczNTY_48dc3a5e-4f71-406a-b866-dfc3b732d316">1,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3324aa5df4cc4aa9956ed23a488056f5_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzUtNS0xLTEtMzczNTY_7c18ff5d-c1d9-41a8-b295-0a2c5d928be8">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3324aa5df4cc4aa9956ed23a488056f5_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzUtNy0xLTEtMzczNTY_070b5871-24fd-4eee-a3eb-d34953cdcebe">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i719d426fe5474f3c937a1a2698a52f36_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzUtOS0xLTEtMzczNTY_04fe87a7-e34e-40a9-8da0-dbb1e522e506">15,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095295915bc84f77b7412b41247d7e72_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzctMS0xLTEtMzczNTY_51e3dc4c-0fa5-470c-a84c-f2afb86ba73c">4,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8809409b6e47a485116299cbd2d2b2_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzctMy0xLTEtMzczNTY_26660ecd-112d-4648-b711-3841fffc8669">3,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8809409b6e47a485116299cbd2d2b2_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzctNS0xLTEtMzczNTY_fe733034-9d1c-468f-a4e8-615a55e2a30d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8809409b6e47a485116299cbd2d2b2_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzctNy0xLTEtMzczNTY_a15f6b6c-ed42-4c60-a4f0-bfd53247cd82">1,499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901487c914b2405ba16f79b4bc6b4d8e_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzctOS0xLTEtMzczNTY_c22e50fe-04ac-4a12-965f-21dbb6d0e316">6,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca3471c88c14eedbaed1fb2d38b42a4_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzgtMS0xLTEtMzczNTY_64891a00-24f7-4bf1-9cb8-808c799b86fb">12,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380c1d6ae64a4d0bb857dc194834acae_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzgtMy0xLTEtMzczNTY_170fece5-210f-47fe-bd34-320552f70885">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380c1d6ae64a4d0bb857dc194834acae_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzgtNS0xLTEtMzczNTY_7d0e4a7d-a198-41e2-b340-afb223599455">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380c1d6ae64a4d0bb857dc194834acae_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzgtNy0xLTEtMzczNTY_bb6cd40d-2cb1-49f3-8e75-e519d6cdf6c3">139</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8831947c0944fa381c1aca73be705ae_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzgtOS0xLTEtMzczNTY_611074e9-bdb5-48c5-a790-1fcf6189202e">13,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8b91f481774dfe8fc8d278e1b3b31d_I20181231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzEwLTEtMS0xLTM3MzU2_6bc66128-7dfd-43d7-bb89-d9263bba6f72">3,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72bcc06055074e33b93d370ce18fa181_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzEwLTMtMS0xLTM3MzU2_34b09898-c0d1-4153-a1f0-7af001082edb">2,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72bcc06055074e33b93d370ce18fa181_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzEwLTUtMS0xLTM3MzU2_878b711c-1403-4cb0-9be1-04ded74157a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72bcc06055074e33b93d370ce18fa181_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzEwLTctMS0xLTM3MzU2_9a2e858a-465b-4c65-b726-d73b4f7301b6">1,542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095295915bc84f77b7412b41247d7e72_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzEwLTktMS0xLTM3MzU2_d85cc081-b944-4412-8903-5db35f9b4872">4,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e72938928e4ed1ad56b0e288505382_I20181231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzExLTEtMS0xLTM3MzU2_80fca608-87ca-45ab-8fb7-6de136f0ee93">6,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0647d5414a46d1b2593bedad7c330f_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzExLTMtMS0xLTM3MzU2_1747d21c-bc72-47cb-85c1-1715a2f171b6">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0647d5414a46d1b2593bedad7c330f_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzExLTUtMS0xLTM3MzU2_e2f3b9e4-e802-4676-b407-452824b428df">1,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife0647d5414a46d1b2593bedad7c330f_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzExLTctMS0xLTM3MzU2_c7d52df5-03fb-4f17-bd16-1307510b77a3">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca3471c88c14eedbaed1fb2d38b42a4_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzExLTktMS0xLTM3MzU2_565f750e-4724-483f-aeb4-66d0ae3c3d18">12,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The above amount primarily relates to amounts acquired through the acquisition of Arkis and a charge recorded in 2019 to valuation allowance related to the non-deductibility of executive compensation.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The above amount primarily relates to amounts acquired through the acquisition of ACell.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Deduction primarily relates to a decrease to the allowance for doubtful accounts as a result of collections in the period and accounts written off during the year, net of recoveries.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-49</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>2
<FILENAME>iart-20211231xexx44.htm
<DESCRIPTION>EX-4.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8cd880518b574c3093218c518d2be893_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 4.4</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of the Company&#8217;s Common Stock Registered</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Under Section 12 of the Exchange Act </font></div><div style="margin-bottom:8pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the common stock of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;). The description does not purport to be complete and is subject to and qualified in its entirety by reference to the Company&#8217;s amended and restated certificate of incorporation and its amended and restated by-laws, each of which are filed as exhibits to this Annual Report on Form 10-K, and to the provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;).</font></div><div style="margin-bottom:8pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Matters</font></div><div style="margin-bottom:8pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Authorized Shares</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s authorized capital stock consists of 255,000,000 shares of stock, of which 240,000,000 shares are designated as common stock, par value $0.01 per share, and 15,000,000 shares are designated as preferred stock, no par value. As of December 31, 2021, we had 89,599,803 shares of common stock outstanding, 4,898,914 shares were designated as treasury stock, and no shares of preferred stock outstanding.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of common stock are entitled to receive dividends out of assets legally available therefor at such times and in such amounts as the board of directors may from time to time determine. However, our senior credit facility limits the amount of dividends that we may pay. Any future determinations to pay cash dividends on our common stock will be at the discretion of our board of directors and will depend upon our financial condition, results of operations, cash flows and other factors that our board of directors deems relevant.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Rights</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each stockholder is entitled to one vote in person or by proxy for each share of the capital stock having voting power held by such stockholder. Stockholders do not have cumulative voting rights. The Company&#8217;s board of directors is not classified and each director is elected annually. The voting standard for the election of directors is a majority of votes cast in uncontested elections. In contested elections where the number of nominees exceeds the number of directors to be elected, the vote standard is a plurality of the votes cast. Holders of a majority of the outstanding shares of common stock entitled to vote in any election of directors may elect all of the directors standing for election. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preemptive or Similar Rights</font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is not entitled to preemptive rights and is not subject to conversion or redemption.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Right to Receive Liquidation Distributions</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the occurrence of a liquidation, dissolution or winding-up, the holders of shares of common stock would be entitled to share ratably in the distribution of all of our assets remaining available for distribution after satisfaction of all its liabilities and the payment of the liquidation preference of any outstanding preferred stock.</font></div><div style="margin-bottom:8pt;margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Exchange</font></div><div style="margin-bottom:8pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the Nasdaq Global Select Market under the symbol &#8220;IART&#8221;. </font></div><div style="margin-bottom:8pt;margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred Stock </font></div><div style="margin-bottom:8pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors has the authority to issue up to 15,000,000 shares of Preferred Stock from time to time in one or more series and with such rights and preferences as determined by the Board with respect to each series. The issuance of </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preferred stock could have the effect of decreasing the market price of our common stock and could adversely affect the voting and other rights of holders of common stock. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Takeover Effects of Delaware Law </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the provisions of Section&#160;203 of the DGCL. Under Section&#160;203, we would generally be prohibited from engaging in any business combination with any interested stockholder for a period of three years following the time that this stockholder became an interested stockholder unless&#58; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to this time, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon consummation of the transaction that resulted in the stockholder&#8217;s becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding shares owned by persons who are directors and also officers, and by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at or subsequent to such time, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8260;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">% of the outstanding voting stock that is not owned by the interested stockholder.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Section&#160;203, a &#8220;business combination&#8221; includes&#58; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any merger or consolidation involving the corporation and the interested stockholder&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder, subject to limited exceptions&#59; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, Section&#160;203 defines an interested stockholder as an entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by such entity or person. </font></div><div style="margin-bottom:8pt;margin-top:6pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>iart-20211231xexx211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i39c53676021448ae811930956ed28b75_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 21.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiaries of Integra LifeSciences Holdings Corporation</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:56.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name of Subsidiary</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">State or Country of Incorporation or Organization</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ACell, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Arkis Biosciences Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ascension Orthopedics Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BIMECO, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BioD, LLC</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BioDlogics, LLC</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BioRecovery, LLC</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">CardioDyne, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cathtec Incorporated</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Caveangle Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Confluent Surgical, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derma First Aid Products, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derma Sciences Canada, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derma Sciences Europe Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derma Sciences, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EndoSolutions, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fiber Imaging Technologies, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">GMS, Gesellschaft f&#252;r medizinische Sondentechnik mbH</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ILS Financing (Ireland) Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ILS Financing Corporation</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ILS Services Switzerland Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ILS Surgical Investments, LLC</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">INS Sweden AB</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Burlington MA, Inc. (formerly known as Integra Radionics, Inc.)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Canada ULC (formerly known as Canada Microsurgical ULC)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra CI, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cayman Islands</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Euro Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra France Holdings SAS</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra German Holdings GmbH</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra GmbH</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Japan K.K.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences (Canada) Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences (Ireland) Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences (Shanghai) Co., Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Austria GmbH</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Brazil Ltda.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Corporation</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Enterprises, LLLP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Financing (Cyprus) Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cyprus</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Italy S.r.l.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Middle East FZ-LLC</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dubai</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Production Corporation</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Sales LLC (f&#47;k&#47;a Integra Healthcare Products LLC)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Services (France) SAS</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Shared Services (Ireland) Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Singapore Pte. Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Spain, S.L.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Switzerland S&#225;rl</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LS (Benelux) NV</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LS Mexico, S. DE R. L. DE C.V.</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:56.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Luxtec, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra ME GmbH</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra MicroFrance SAS</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra NeuroSciences (International), Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra NeuroSciences Holdings (UK) Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra NeuroSciences Holdings B.V.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra NeuroSciences Implants (France) SAS </font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra NeuroSciences Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Neurosciences Pty Ltd. (AUS)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Neurosciences Pty Ltd. (NZ)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Receivables LLC</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Sales, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Selector LLC</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Switzerland Holdings Sarl</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra York PA, Inc. (formerly known as Miltex, Inc.)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IsoTis NV</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IsoTis T.E. Facility B.V.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">J. Jamner Surgical Instruments, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jarit GmbH</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">LXU Healthcare, Inc. - Medical Specialty Products</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedEfficiency, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minnesota Scientific, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minnesota</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nantong Derma Medical Products Co., Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Newdeal SAS</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Newdeal, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Texas</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Precise Dental Holding Corp.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Precise Dental Internacional, S.A. de C.V.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Precise Dental Products, Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Precision Dental International, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rebound Therapeutics Corporation</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spembly Cryosurgery Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spembly Medical Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tarsus Medical Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TEI Biosciences (UK) Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TEI Biosciences Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TEI Medical Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGX Medical Systems, LLC</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>iart-20211231xexx231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i75af419647fd41ee8978c229a7444320_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 23.1 </font></div><div style="margin-bottom:24pt;margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We hereby consent to the incorporation by reference in the Registration Statements on Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">S-8 (Nos.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">333-231709, 333-221210, 333-216212, 333-170210, 333-155263, 333-127488, 333-109042, 333-73512, 333-46024, 333-82233, 333-58235, 333-06577, and  333-261744) of Integra LifeSciences Holdings Corporation of our report dated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> February&#160;24, 2022 relating to the financial statements, financial statement schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Florham Park, New Jersey</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;24, 2022 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>iart-20211231xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i30aa3f96cc4043888490318aec38a043_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jan De Witte, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Integra LifeSciences Holdings Corporation&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13 a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:4.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>iart-20211231xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i333da62bd7f34e96a4b2c358ef999645_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Carrie L. Anderson, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Integra LifeSciences Holdings Corporation&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13 a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:4.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.128%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carrie L. Anderson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrie L. Anderson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>iart-20211231xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie552038bb5a447a88e19771d5bc5efae_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jan De Witte, President and Chief Executive Officer of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;), hereby certify that, to my knowledge&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2021 (the &#8220;Report&#8221;) fully complies with the requirement of Section&#160;13(a) or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:4.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>iart-20211231xexx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2e28731556f14872b7e630bea97f60a7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Carrie L. Anderson, Executive Vice President and Chief Financial Officer of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;), hereby certify that, to my knowledge&#58; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2021 (the &#8220;Report&#8221;) fully complies with the requirement of Section&#160;13(a) or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:4.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carrie L. Anderson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrie L. Anderson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>iart-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:79796dbd-6d84-4777-bf20-15ea797e2f25,g:15b73d14-4963-49a2-aa85-347a140ddfd4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iart="http://integralife.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://integralife.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://integralife.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://integralife.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1003005 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
        <link:definition>1006008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESS" roleURI="http://integralife.com/role/BUSINESS">
        <link:definition>2101101 - Disclosure - BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2304301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>2405401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails">
        <link:definition>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails">
        <link:definition>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details">
        <link:definition>2408404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERS" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS">
        <link:definition>2109103 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSTables" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables">
        <link:definition>2310302 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails">
        <link:definition>2411405 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails">
        <link:definition>2412406 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1">
        <link:definition>2412406 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails">
        <link:definition>2413407 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails">
        <link:definition>2414408 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURES" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURES">
        <link:definition>2115104 - Disclosure - ACQUISITIONS AND DIVESTITURES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESTables" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables">
        <link:definition>2316303 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails">
        <link:definition>2417409 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails">
        <link:definition>2418410 - Disclosure - ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails">
        <link:definition>2419411 - Disclosure - ACQUISITIONS AND DIVESTITURES (Business Acquisition, Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails">
        <link:definition>2420412 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails">
        <link:definition>2421413 - Disclosure - ACQUISITIONS AND DIVESTITURES (Asset Acquisition, Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://integralife.com/role/DEBT">
        <link:definition>2122105 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://integralife.com/role/DEBTTables">
        <link:definition>2323304 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://integralife.com/role/DEBTNarrativeDetails">
        <link:definition>2424414 - Disclosure - DEBT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTMaximumTotalLeverageRatioTableDetails" roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails">
        <link:definition>2425415 - Disclosure - DEBT (Maximum Total Leverage Ratio Table) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofDebtMaturityDetails" roleURI="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails">
        <link:definition>2426416 - Disclosure - DEBT (Schedule of Debt Maturity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTS" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTS">
        <link:definition>2127106 - Disclosure - DERIVATIVE INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSTables" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables">
        <link:definition>2328305 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails">
        <link:definition>2429417 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSNarrativeDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails">
        <link:definition>2430418 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails">
        <link:definition>2431419 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails">
        <link:definition>2432420 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails">
        <link:definition>2433421 - Disclosure - DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails">
        <link:definition>2434422 - Disclosure - DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>2135107 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>2336306 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails">
        <link:definition>2437423 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails">
        <link:definition>2438424 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails">
        <link:definition>2439425 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TREASURYSTOCK" roleURI="http://integralife.com/role/TREASURYSTOCK">
        <link:definition>2140108 - Disclosure - TREASURY STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TREASURYSTOCKNarrativeDetails" roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails">
        <link:definition>2441426 - Disclosure - TREASURY STOCK - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>2142109 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>2343307 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails">
        <link:definition>2444427 - Disclosure - STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONNarrativeDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>2445428 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails">
        <link:definition>2446429 - Disclosure - STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails">
        <link:definition>2447430 - Disclosure - STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails">
        <link:definition>2448431 - Disclosure - STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANS" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANS">
        <link:definition>2149110 - Disclosure - RETIREMENT BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSTables" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSTables">
        <link:definition>2350308 - Disclosure - RETIREMENT BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails">
        <link:definition>2451432 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails">
        <link:definition>2452433 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails">
        <link:definition>2453434 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails">
        <link:definition>2454435 - Disclosure - RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSNarrativeDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails">
        <link:definition>2455436 - Disclosure - RETIREMENT BENEFIT PLANS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails">
        <link:definition>2456437 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASES" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES">
        <link:definition>2157111 - Disclosure - LEASES AND RELATED PARTY LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESTables" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables">
        <link:definition>2358309 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESNarrativeDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails">
        <link:definition>2459438 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails">
        <link:definition>2460439 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails">
        <link:definition>2461440 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails">
        <link:definition>2462441 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://integralife.com/role/INCOMETAXES">
        <link:definition>2163112 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://integralife.com/role/INCOMETAXESTables">
        <link:definition>2364310 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails">
        <link:definition>2465442 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails">
        <link:definition>2466443 - Disclosure - INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>2467444 - Disclosure - INCOME TAXES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>2468445 - Disclosure - INCOME TAXES (Schedule of Provision for Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>2469446 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails">
        <link:definition>2470447 - Disclosure - INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARE" roleURI="http://integralife.com/role/NETINCOMEPERSHARE">
        <link:definition>2171113 - Disclosure - NET INCOME PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARETables" roleURI="http://integralife.com/role/NETINCOMEPERSHARETables">
        <link:definition>2372311 - Disclosure - NET INCOME PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails">
        <link:definition>2473448 - Disclosure - NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARENarrativeDetails" roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails">
        <link:definition>2474449 - Disclosure - NET INCOME PER SHARE (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSS" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS">
        <link:definition>2175114 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables">
        <link:definition>2376312 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2477450 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails">
        <link:definition>2478451 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2179115 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESTables" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables">
        <link:definition>2380313 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails">
        <link:definition>2481452 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESNarrativeDetails" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails">
        <link:definition>2482453 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATION" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION">
        <link:definition>2183116 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONTables" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables">
        <link:definition>2384314 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails">
        <link:definition>2485454 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails">
        <link:definition>2486455 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails">
        <link:definition>2487456 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS">
        <link:definition>2188117 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails">
        <link:definition>2489457 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="iart_NoncashLeaseExpense" abstract="false" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TwoThousandPlanMember" abstract="true" name="TwoThousandPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_TrademarksBrandNamesMember" abstract="true" name="TrademarksBrandNamesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestPaymentsYearThree" abstract="false" name="InterestPaymentsYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtCovenantPeriodDomain" abstract="true" name="DebtCovenantPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractTwoMember" abstract="true" name="CrossCurrencyInterestRateContractTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_SegmentReportingInformationNumberOfProductsOffered" abstract="false" name="SegmentReportingInformationNumberOfProductsOffered" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" abstract="false" name="DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_RegenerativeSkinAndWoundMember" abstract="true" name="RegenerativeSkinAndWoundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" abstract="false" name="UnrecognizedTaxBenefitsReductionsResultingFromOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_ACellIncMember" abstract="true" name="ACellIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ConsortiumofFocusedOrthopedistsLLCMember" abstract="true" name="ConsortiumofFocusedOrthopedistsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche3Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AccumulatedOtherComprehensiveIncomeLossRollForward" abstract="true" name="AccumulatedOtherComprehensiveIncomeLossRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" abstract="false" name="SecuredLongTermDebtSecuritizationProgramNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CharitableContributions" abstract="false" name="CharitableContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SupplierRelationShipsMember" abstract="true" name="SupplierRelationShipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" abstract="true" name="CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche1Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" abstract="false" name="BusinessCombinationIntangibleAssetAcquiredDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_InformationSystemsandHardwareMember" abstract="true" name="InformationSystemsandHardwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_PaymentsForOptionIndexToIssuersEquity" abstract="false" name="PaymentsForOptionIndexToIssuersEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" abstract="false" name="AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" abstract="false" name="AcquiredFinitelivedIntangibleAssetsDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche2Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtWeightedAverageInterestRateFromSecuritization" abstract="false" name="DebtWeightedAverageInterestRateFromSecuritization" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_ACellMember" abstract="true" name="ACellMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TwoThousandOnePlanMember" abstract="true" name="TwoThousandOnePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtInstrumentCovenantMaximumLeverageRatio" abstract="false" name="DebtInstrumentCovenantMaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractFourMember" abstract="true" name="CrossCurrencyInterestRateContractFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DirectorsandCertainExecutiveOfficersMember" abstract="true" name="DirectorsandCertainExecutiveOfficersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_TissueTechnologiesMember" abstract="true" name="TissueTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_PaymentsForProceedsFromBusinessAcquisitions" abstract="false" name="PaymentsForProceedsFromBusinessAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_IntercompanyLoanQuarterlyPayment" abstract="false" name="IntercompanyLoanQuarterlyPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_PrivateLabelMember" abstract="true" name="PrivateLabelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_MilestonePaymentTwoMember" abstract="true" name="MilestonePaymentTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" abstract="true" name="AccruedExpensesAndOtherCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" abstract="false" name="NoncashOrPartNoncashInProcessResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AdditionalEPSShares" abstract="false" name="AdditionalEPSShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_DermaSciencesMember" abstract="true" name="DermaSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" abstract="true" name="TwoThousandTwentyFiveSeniorConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ExtremityOrthopedicsMember" abstract="true" name="ExtremityOrthopedicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" abstract="false" name="ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_RestrictedStockPerformanceStockAndContractStockMember" abstract="true" name="RestrictedStockPerformanceStockAndContractStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" abstract="false" name="PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_DeferredTaxAssetsLeasesAndOther" abstract="false" name="DeferredTaxAssetsLeasesAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CertainPurchasersMember" abstract="true" name="CertainPurchasersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CashFlowLesseeTableTextBlock" abstract="false" name="CashFlowLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" abstract="false" name="AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" abstract="false" name="TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CompletedTechnologyMember" abstract="true" name="CompletedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ChangeInContractWithCustomerAssetRollForward" abstract="true" name="ChangeInContractWithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" abstract="false" name="AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_EmployeeMember" abstract="true" name="EmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InventoryCapitalizedExpenses" abstract="false" name="InventoryCapitalizedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_AcceleratedShareRepurchasesSharesReceivedAtInception" abstract="false" name="AcceleratedShareRepurchasesSharesReceivedAtInception" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_FiveYearOptionLeasePeriodOneMember" abstract="true" name="FiveYearOptionLeasePeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestPaymentsYearOne" abstract="false" name="InterestPaymentsYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ScheduleOfAssetAcquisitionLineItems" abstract="true" name="ScheduleOfAssetAcquisitionLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_DebtCovenantPeriodAxis" abstract="true" name="DebtCovenantPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_PerformanceSharesandRestrictedUnitsMember" abstract="true" name="PerformanceSharesandRestrictedUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestPaymentsYearFour" abstract="false" name="InterestPaymentsYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractThreeMember" abstract="true" name="CrossCurrencyInterestRateContractThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" abstract="false" name="AssetAcquisitionDevelopmentMilestonePaymentToBePaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_SeniorCreditFacilityMember" abstract="true" name="SeniorCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" abstract="false" name="EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_SurgicalInstrumentKitsMember" abstract="true" name="SurgicalInstrumentKitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember182018Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember182018Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationWorkingCapitalAdjustment" abstract="false" name="BusinessCombinationWorkingCapitalAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ConcentrationRiskThresholdPercentage" abstract="false" name="ConcentrationRiskThresholdPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_ChangeInContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_FranceAndGermanyMember" abstract="true" name="FranceAndGermanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" abstract="false" name="ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" abstract="false" name="AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AnnualRateOfLeaseAgreement" abstract="false" name="AnnualRateOfLeaseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" abstract="true" name="UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" abstract="false" name="DefinedBenefitPlanBenefitObligationPremiumsPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" abstract="false" name="AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ArkisBioSciencesInc.Member" abstract="true" name="ArkisBioSciencesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_OneMonthEurodollarRateMember" abstract="true" name="OneMonthEurodollarRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtCovenantPeriod3Member" abstract="true" name="DebtCovenantPeriod3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" abstract="false" name="ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche3Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_PerformanceStockandContractStockMember" abstract="true" name="PerformanceStockandContractStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DeferredTaxAssetMember" abstract="true" name="DeferredTaxAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_SmithNephewUSDLimitedMember" abstract="true" name="SmithNephewUSDLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_ConcentrationRiskNumberofCustomersOverBenchmark" abstract="false" name="ConcentrationRiskNumberofCustomersOverBenchmark" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" abstract="false" name="ContractWithCustomerAssetNetOfReclassifiedToReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RevenueProductWarrantyPeriod" abstract="false" name="RevenueProductWarrantyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" abstract="false" name="GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" abstract="false" name="RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_FoundationPolicyTextBlock" abstract="false" name="FoundationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateSwapContractThreeMember" abstract="true" name="CrossCurrencyInterestRateSwapContractThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" abstract="false" name="FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" abstract="false" name="EffectiveWorldwideIncomeTaxRateReconciliationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_RelatedPartiesMember" abstract="true" name="RelatedPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_NeurosurgeryMember" abstract="true" name="NeurosurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" abstract="false" name="DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtCovenantPeriod1Member" abstract="true" name="DebtCovenantPeriod1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AccountingStandardUpdate202006Member" abstract="true" name="AccountingStandardUpdate202006Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" abstract="false" name="DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" abstract="false" name="PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_IncomeTaxTable" abstract="true" name="IncomeTaxTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_FiveYearLeasePeriodTwoMember" abstract="true" name="FiveYearLeasePeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtCovenantPeriod2Member" abstract="true" name="DebtCovenantPeriod2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_ReboundTherapeuticsCorporationMember" abstract="true" name="ReboundTherapeuticsCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractOneMember" abstract="true" name="CrossCurrencyInterestRateContractOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ScheduleOfAssetAcquisitionTable" abstract="true" name="ScheduleOfAssetAcquisitionTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" abstract="false" name="DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CodmanSpecialtySurgicalMember" abstract="true" name="CodmanSpecialtySurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_OneMonthUSDLIBORMember" abstract="true" name="OneMonthUSDLIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DeferredTaxLiabilitiesLeasesAndOther" abstract="false" name="DeferredTaxLiabilitiesLeasesAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember182018Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember182018Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_OptionToExtendLeaseYears" abstract="false" name="OptionToExtendLeaseYears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_AllOtherMember" abstract="true" name="AllOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" abstract="false" name="AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" abstract="true" name="CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" abstract="false" name="CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateSwapContractOneMember" abstract="true" name="CrossCurrencyInterestRateSwapContractOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EmployeeStockPurchasePlanProceeds" abstract="false" name="EmployeeStockPurchasePlanProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SecuredLongTermDebtSecuritizationProgram" abstract="false" name="SecuredLongTermDebtSecuritizationProgram" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ThirdPartiesMember" abstract="true" name="ThirdPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_SwinglineLoanMember" abstract="true" name="SwinglineLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AssetAcquisitionNumberOfAssetsAcquired" abstract="false" name="AssetAcquisitionNumberOfAssetsAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_SecuritizationFacilityFairValueOfAmountOutstanding" abstract="false" name="SecuritizationFacilityFairValueOfAmountOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_IncreaseInAuthorizedShares" abstract="false" name="IncreaseInAuthorizedShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_MilestonePaymentOneMember" abstract="true" name="MilestonePaymentOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestPaymentsYearTwo" abstract="false" name="InterestPaymentsYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_IntegratedShoulderCollaborationInc.Member" abstract="true" name="IntegratedShoulderCollaborationInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_TwoThousandThreePlanMember" abstract="true" name="TwoThousandThreePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_IncomeTaxLineItems" abstract="true" name="IncomeTaxLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_SecuredLongTermDebtSecuritizationProgramCurrent" abstract="false" name="SecuredLongTermDebtSecuritizationProgramCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_NetWorkingCapital" abstract="false" name="NetWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iart_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedMarch272017Member" abstract="true" name="InterestRateSwapDesignatedMarch272017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ContingentConsiderationLiabilityMember" abstract="true" name="ContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" abstract="false" name="DefinedBenefitPlanPlanAssetsPremiumsPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" abstract="false" name="DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_DebtInstrumentMaximumAverageConversionValueOfNotes" abstract="false" name="DebtInstrumentMaximumAverageConversionValueOfNotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateSwapContractTwoMember" abstract="true" name="CrossCurrencyInterestRateSwapContractTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtCovenantPeriod4Member" abstract="true" name="DebtCovenantPeriod4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>iart-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:79796dbd-6d84-4777-bf20-15ea797e2f25,g:15b73d14-4963-49a2-aa85-347a140ddfd4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_33648d82-d7ae-403f-a1a1-b85a9b53f37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6be1aa99-52d8-4cd4-96c5-b1bd36f1dd53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_33648d82-d7ae-403f-a1a1-b85a9b53f37f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6be1aa99-52d8-4cd4-96c5-b1bd36f1dd53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3ca59d18-bcc0-4667-880b-b6897cf11c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_33648d82-d7ae-403f-a1a1-b85a9b53f37f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3ca59d18-bcc0-4667-880b-b6897cf11c41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_522d041a-f6f4-4888-b116-f068baf61604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9599c40a-c51e-4f83-8b06-73e233e8bd12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_522d041a-f6f4-4888-b116-f068baf61604" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9599c40a-c51e-4f83-8b06-73e233e8bd12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d99d93f8-1803-4f2c-b933-ad484f9f2613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_522d041a-f6f4-4888-b116-f068baf61604" xlink:to="loc_us-gaap_CostsAndExpenses_d99d93f8-1803-4f2c-b933-ad484f9f2613" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_407985e0-eccb-4873-a72b-c89028278f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bbe860de-6547-49ac-9f56-92aeaf88f41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_407985e0-eccb-4873-a72b-c89028278f87" xlink:to="loc_us-gaap_OperatingIncomeLoss_bbe860de-6547-49ac-9f56-92aeaf88f41c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_49bb3025-25dc-4ad9-b2de-c672d1affc33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_407985e0-eccb-4873-a72b-c89028278f87" xlink:to="loc_us-gaap_InvestmentIncomeInterest_49bb3025-25dc-4ad9-b2de-c672d1affc33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_baa3760a-dc85-4b80-ad3e-8b10bfc9963b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_407985e0-eccb-4873-a72b-c89028278f87" xlink:to="loc_us-gaap_InterestExpense_baa3760a-dc85-4b80-ad3e-8b10bfc9963b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_e7cd67c2-953b-4528-bb14-b10f659576c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_407985e0-eccb-4873-a72b-c89028278f87" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_e7cd67c2-953b-4528-bb14-b10f659576c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e1778dab-8a07-4b76-9c0a-6f1589cef742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_407985e0-eccb-4873-a72b-c89028278f87" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e1778dab-8a07-4b76-9c0a-6f1589cef742" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_24b68875-485c-402f-ba3c-1e4aca63e92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_213aab99-c8e1-4bfc-ae62-7975e9746789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_24b68875-485c-402f-ba3c-1e4aca63e92f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_213aab99-c8e1-4bfc-ae62-7975e9746789" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_c16a1477-accd-45d3-9350-84b5f378c913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_24b68875-485c-402f-ba3c-1e4aca63e92f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_c16a1477-accd-45d3-9350-84b5f378c913" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_4f53fe8d-4cd2-466c-a98d-6bd1eafa6232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_24b68875-485c-402f-ba3c-1e4aca63e92f" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_4f53fe8d-4cd2-466c-a98d-6bd1eafa6232" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d4065a26-c45e-4399-b189-d9dca0bec761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_24b68875-485c-402f-ba3c-1e4aca63e92f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d4065a26-c45e-4399-b189-d9dca0bec761" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3ca80722-5804-4a0a-a15e-9bf02b18c731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_24b68875-485c-402f-ba3c-1e4aca63e92f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3ca80722-5804-4a0a-a15e-9bf02b18c731" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c931b30e-267f-4e77-9a86-2fb6978ab262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_a7df1d2f-e70f-405c-955e-999adb885eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c931b30e-267f-4e77-9a86-2fb6978ab262" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_a7df1d2f-e70f-405c-955e-999adb885eb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_601c335b-54c1-45f1-a914-53630da962e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c931b30e-267f-4e77-9a86-2fb6978ab262" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_601c335b-54c1-45f1-a914-53630da962e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1a94bf6b-4141-4d68-966b-ac9ed2652c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b2f041c1-42f3-40a5-b89b-af0408189878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1a94bf6b-4141-4d68-966b-ac9ed2652c17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b2f041c1-42f3-40a5-b89b-af0408189878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_13a39730-3311-4af1-9e04-c942ff3ad55b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1a94bf6b-4141-4d68-966b-ac9ed2652c17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_13a39730-3311-4af1-9e04-c942ff3ad55b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_214c52c7-3004-4845-b002-084418554a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1dc4643b-d138-4923-949a-9c870377431d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_214c52c7-3004-4845-b002-084418554a4b" xlink:to="loc_us-gaap_NetIncomeLoss_1dc4643b-d138-4923-949a-9c870377431d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4734275a-7c35-4a1e-b036-0f1194284640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_214c52c7-3004-4845-b002-084418554a4b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4734275a-7c35-4a1e-b036-0f1194284640" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_17ef5f1f-dc5a-44e0-aa3d-3d433fc6cf13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_713234ee-5cba-42d2-abfd-212b08b836c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_17ef5f1f-dc5a-44e0-aa3d-3d433fc6cf13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_713234ee-5cba-42d2-abfd-212b08b836c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_72345896-4f56-44d7-9641-96b015456797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_17ef5f1f-dc5a-44e0-aa3d-3d433fc6cf13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_72345896-4f56-44d7-9641-96b015456797" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_a76b6250-06cf-47cb-bb6d-a14a78f888f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_17ef5f1f-dc5a-44e0-aa3d-3d433fc6cf13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_a76b6250-06cf-47cb-bb6d-a14a78f888f1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_68909668-2aff-4ea1-bcd8-558e408cc26f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7a277a3f-d4c9-48b1-a339-ea458f7d23da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_68909668-2aff-4ea1-bcd8-558e408cc26f" xlink:to="loc_us-gaap_LiabilitiesCurrent_7a277a3f-d4c9-48b1-a339-ea458f7d23da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_19029426-bc6c-42f7-963f-f29d635eb451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_68909668-2aff-4ea1-bcd8-558e408cc26f" xlink:to="loc_us-gaap_SecuredLongTermDebt_19029426-bc6c-42f7-963f-f29d635eb451" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_4e1b8fa2-9662-4b2f-bfc8-bff21c1f6fe3" xlink:href="iart-20211231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_68909668-2aff-4ea1-bcd8-558e408cc26f" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_4e1b8fa2-9662-4b2f-bfc8-bff21c1f6fe3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_1d93377d-5719-40a4-b044-c28be9c65974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_68909668-2aff-4ea1-bcd8-558e408cc26f" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_1d93377d-5719-40a4-b044-c28be9c65974" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fd6066ad-ed87-44ec-b657-00a26da3e55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_68909668-2aff-4ea1-bcd8-558e408cc26f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fd6066ad-ed87-44ec-b657-00a26da3e55f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f129296b-a3dd-4315-aa22-0af543f519e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_68909668-2aff-4ea1-bcd8-558e408cc26f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f129296b-a3dd-4315-aa22-0af543f519e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5017868d-5282-420f-8b98-30e8d9b4a800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_68909668-2aff-4ea1-bcd8-558e408cc26f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5017868d-5282-420f-8b98-30e8d9b4a800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ef27c3b3-2749-4be2-8c66-6a000523c282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_557e12c3-0ed6-4dba-81d8-d626378e5c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ef27c3b3-2749-4be2-8c66-6a000523c282" xlink:to="loc_us-gaap_Liabilities_557e12c3-0ed6-4dba-81d8-d626378e5c11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9493e041-ce96-4b74-a951-3fa374868d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ef27c3b3-2749-4be2-8c66-6a000523c282" xlink:to="loc_us-gaap_StockholdersEquity_9493e041-ce96-4b74-a951-3fa374868d03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0495db04-541e-4965-ad29-fcaf88fde878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cb06b203-5a5a-40d2-bc3a-6578863f3dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0495db04-541e-4965-ad29-fcaf88fde878" xlink:to="loc_us-gaap_AssetsCurrent_cb06b203-5a5a-40d2-bc3a-6578863f3dac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_aaea0b01-32dd-4d93-b6c0-5c8e946bb95f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0495db04-541e-4965-ad29-fcaf88fde878" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_aaea0b01-32dd-4d93-b6c0-5c8e946bb95f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3cc3887a-f164-4544-b684-babadd94c794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0495db04-541e-4965-ad29-fcaf88fde878" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3cc3887a-f164-4544-b684-babadd94c794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_47214279-5bbd-43d7-9178-e7a39e1f1564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0495db04-541e-4965-ad29-fcaf88fde878" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_47214279-5bbd-43d7-9178-e7a39e1f1564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_92c5e870-1c84-4a43-9015-341241be1891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0495db04-541e-4965-ad29-fcaf88fde878" xlink:to="loc_us-gaap_Goodwill_92c5e870-1c84-4a43-9015-341241be1891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_0cdce0cc-24df-4749-8823-c044898907a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0495db04-541e-4965-ad29-fcaf88fde878" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_0cdce0cc-24df-4749-8823-c044898907a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_39635557-f9b9-4d41-8e8c-4382d2043056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0495db04-541e-4965-ad29-fcaf88fde878" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_39635557-f9b9-4d41-8e8c-4382d2043056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9ded5cd4-10de-4ad1-afca-5b7ed8746fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6b9b5bd4-608e-4ff6-a6d5-9c9e9b279e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9ded5cd4-10de-4ad1-afca-5b7ed8746fe3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6b9b5bd4-608e-4ff6-a6d5-9c9e9b279e1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_68d49620-2d24-4bce-ac7f-fc542de46f43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9ded5cd4-10de-4ad1-afca-5b7ed8746fe3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_68d49620-2d24-4bce-ac7f-fc542de46f43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_89850c80-08b0-401b-ab0c-b39ab76fe905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9ded5cd4-10de-4ad1-afca-5b7ed8746fe3" xlink:to="loc_us-gaap_InventoryNet_89850c80-08b0-401b-ab0c-b39ab76fe905" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_6e0f2db6-8612-48c5-bc40-fc8b6b876df8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9ded5cd4-10de-4ad1-afca-5b7ed8746fe3" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_6e0f2db6-8612-48c5-bc40-fc8b6b876df8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e7d498ff-e464-4911-ba74-005e0782eb70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9ded5cd4-10de-4ad1-afca-5b7ed8746fe3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e7d498ff-e464-4911-ba74-005e0782eb70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_54ed37e5-16ef-48f5-b5a0-90e9caa5e4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2c8e97be-c361-4b19-b194-f94cec2c830b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_54ed37e5-16ef-48f5-b5a0-90e9caa5e4b4" xlink:to="loc_us-gaap_PreferredStockValue_2c8e97be-c361-4b19-b194-f94cec2c830b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7516f3d1-f842-4d2a-98e4-d8a3e2c30759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_54ed37e5-16ef-48f5-b5a0-90e9caa5e4b4" xlink:to="loc_us-gaap_CommonStockValue_7516f3d1-f842-4d2a-98e4-d8a3e2c30759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_6497e01f-c910-4ca8-bfa6-49f1e1e99200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_54ed37e5-16ef-48f5-b5a0-90e9caa5e4b4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_6497e01f-c910-4ca8-bfa6-49f1e1e99200" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_cc4f8c10-353e-4213-816d-8602522e0681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_54ed37e5-16ef-48f5-b5a0-90e9caa5e4b4" xlink:to="loc_us-gaap_TreasuryStockValue_cc4f8c10-353e-4213-816d-8602522e0681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6b5f0830-1cf0-41bb-8fa7-af14559388aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_54ed37e5-16ef-48f5-b5a0-90e9caa5e4b4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6b5f0830-1cf0-41bb-8fa7-af14559388aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b2c394b7-b83d-4ccc-a0e0-b82b2849f1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_54ed37e5-16ef-48f5-b5a0-90e9caa5e4b4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b2c394b7-b83d-4ccc-a0e0-b82b2849f1a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6a759839-4b52-4b5b-8ddd-408852f6a2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_9d2ccb80-8b2c-40e4-94f1-87ff52ead331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6a759839-4b52-4b5b-8ddd-408852f6a2f6" xlink:to="loc_us-gaap_SecuredDebtCurrent_9d2ccb80-8b2c-40e4-94f1-87ff52ead331" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_b8e43f97-42d3-4f4f-8b9d-da83ee36aa57" xlink:href="iart-20211231.xsd#iart_SecuredLongTermDebtSecuritizationProgramCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6a759839-4b52-4b5b-8ddd-408852f6a2f6" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_b8e43f97-42d3-4f4f-8b9d-da83ee36aa57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_298af3c7-e01e-48f4-a321-f8ab70a6a4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6a759839-4b52-4b5b-8ddd-408852f6a2f6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_298af3c7-e01e-48f4-a321-f8ab70a6a4df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_2e87ce8b-bca5-4579-99ef-b591e73af98a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6a759839-4b52-4b5b-8ddd-408852f6a2f6" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_2e87ce8b-bca5-4579-99ef-b591e73af98a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_91d7c82c-91e9-49ec-8cbd-756dd1e9ea43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6a759839-4b52-4b5b-8ddd-408852f6a2f6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_91d7c82c-91e9-49ec-8cbd-756dd1e9ea43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e0c984f4-a8d6-44a5-bd00-5e27f8c3e3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6a759839-4b52-4b5b-8ddd-408852f6a2f6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e0c984f4-a8d6-44a5-bd00-5e27f8c3e3c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_151ffbf8-186d-4519-9d36-06a0a7c860c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6a759839-4b52-4b5b-8ddd-408852f6a2f6" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_151ffbf8-186d-4519-9d36-06a0a7c860c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e06bced3-a7da-4b6b-92ef-b6e3d6340503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6a759839-4b52-4b5b-8ddd-408852f6a2f6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_e06bced3-a7da-4b6b-92ef-b6e3d6340503" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_188a8947-98fd-4ec5-8623-5731eff9f946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_a115686d-fc7c-4833-998b-d4f2039f1f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_188a8947-98fd-4ec5-8623-5731eff9f946" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_a115686d-fc7c-4833-998b-d4f2039f1f12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_2775e30a-d14e-40db-b8ae-50056a7f80a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_188a8947-98fd-4ec5-8623-5731eff9f946" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_2775e30a-d14e-40db-b8ae-50056a7f80a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_9643f625-bd7b-4cf3-845b-e3f5b0cd8ac6" xlink:href="iart-20211231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_188a8947-98fd-4ec5-8623-5731eff9f946" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_9643f625-bd7b-4cf3-845b-e3f5b0cd8ac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_fa05351d-e2c0-47f5-940b-44c2456ea47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_188a8947-98fd-4ec5-8623-5731eff9f946" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_fa05351d-e2c0-47f5-940b-44c2456ea47d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_a203e361-4cb2-41d3-9d6e-23d508ccba60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_188a8947-98fd-4ec5-8623-5731eff9f946" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_a203e361-4cb2-41d3-9d6e-23d508ccba60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_26e8a6fb-aa19-48ec-b546-c135c55ed49b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_188a8947-98fd-4ec5-8623-5731eff9f946" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_26e8a6fb-aa19-48ec-b546-c135c55ed49b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2705f1b9-cf95-4cb9-83ea-3c986ddde5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_188a8947-98fd-4ec5-8623-5731eff9f946" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2705f1b9-cf95-4cb9-83ea-3c986ddde5ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_072a2606-55ee-49b2-a024-a103121b7895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_188a8947-98fd-4ec5-8623-5731eff9f946" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_072a2606-55ee-49b2-a024-a103121b7895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2703d370-a0fc-4c41-bd05-e220504e0579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_188a8947-98fd-4ec5-8623-5731eff9f946" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2703d370-a0fc-4c41-bd05-e220504e0579" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_db600ffc-9102-4369-8972-f2dba9767c63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_NetIncomeLoss_db600ffc-9102-4369-8972-f2dba9767c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_a7ab05b4-4154-4e2c-b00d-23975db3fea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_a7ab05b4-4154-4e2c-b00d-23975db3fea8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_0b3f0722-e2f1-4c01-a073-31077341014c" xlink:href="iart-20211231.xsd#iart_NoncashOrPartNoncashInProcessResearchAndDevelopment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_0b3f0722-e2f1-4c01-a073-31077341014c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_5ca259d8-38e1-411b-b472-5d8521cfb607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_5ca259d8-38e1-411b-b472-5d8521cfb607" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5f009df8-2eaa-4c96-ba60-caf10705bf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5f009df8-2eaa-4c96-ba60-caf10705bf3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b8cc6d29-dbcc-463a-81bd-8ee1f0e20dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_ShareBasedCompensation_b8cc6d29-dbcc-463a-81bd-8ee1f0e20dfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_2aabd24c-4f80-4422-abca-5b33ee4cdd12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_2aabd24c-4f80-4422-abca-5b33ee4cdd12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_07f5050b-84f8-4f71-982d-8d8d4fbdb797" xlink:href="iart-20211231.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_07f5050b-84f8-4f71-982d-8d8d4fbdb797" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense_492f609b-1423-4bc5-bea6-7a602a23b430" xlink:href="iart-20211231.xsd#iart_NoncashLeaseExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_iart_NoncashLeaseExpense_492f609b-1423-4bc5-bea6-7a602a23b430" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_cbc5ac15-7880-4924-9cf9-b8d31761c397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_AccretionExpense_cbc5ac15-7880-4924-9cf9-b8d31761c397" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_332740a2-ef39-4a33-9935-f445c4623364" xlink:href="iart-20211231.xsd#iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_332740a2-ef39-4a33-9935-f445c4623364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2d75f398-aa40-488f-af67-e400f6886eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2d75f398-aa40-488f-af67-e400f6886eba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f82adf6b-5cb0-4e2d-9468-c510d6dc1c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f82adf6b-5cb0-4e2d-9468-c510d6dc1c90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_ca7fd224-7d1e-45b1-92c1-35cc9f610c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_ca7fd224-7d1e-45b1-92c1-35cc9f610c8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_97f226a0-d4d4-42b4-ac17-6340fbf6eab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_97f226a0-d4d4-42b4-ac17-6340fbf6eab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_057cee34-267b-442c-bd42-cb6f7f83bd0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_057cee34-267b-442c-bd42-cb6f7f83bd0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_41752303-efcf-4b40-aa17-d876a0b6a41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_41752303-efcf-4b40-aa17-d876a0b6a41e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_47e9fd69-2a22-4b44-adbd-7c8cd1f6e8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_47e9fd69-2a22-4b44-adbd-7c8cd1f6e8ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_fc8de2aa-7c78-4662-8417-cdc9a02a34c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c1b2b7d-232e-434a-a737-abd93aee2a1f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_fc8de2aa-7c78-4662-8417-cdc9a02a34c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_165ffc7b-c3cd-4ecf-babc-c67d40f9a6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d1d38f58-938b-4074-817f-56c77bd7048f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_165ffc7b-c3cd-4ecf-babc-c67d40f9a6e2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d1d38f58-938b-4074-817f-56c77bd7048f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_19ad2741-c199-4146-8c7c-0463debaf213" xlink:href="iart-20211231.xsd#iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_165ffc7b-c3cd-4ecf-babc-c67d40f9a6e2" xlink:to="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_19ad2741-c199-4146-8c7c-0463debaf213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_645836f6-24d0-4afb-a2b2-6a839fcbb333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_165ffc7b-c3cd-4ecf-babc-c67d40f9a6e2" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_645836f6-24d0-4afb-a2b2-6a839fcbb333" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_d77c7f54-f9e8-49bb-b546-5bd5458f0be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_165ffc7b-c3cd-4ecf-babc-c67d40f9a6e2" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_d77c7f54-f9e8-49bb-b546-5bd5458f0be1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_bcc2fe72-1fc5-4cc4-a34b-352eb0e4494a" xlink:href="iart-20211231.xsd#iart_PaymentsForProceedsFromBusinessAcquisitions"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_165ffc7b-c3cd-4ecf-babc-c67d40f9a6e2" xlink:to="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_bcc2fe72-1fc5-4cc4-a34b-352eb0e4494a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_9091e8b4-e458-4f0a-9fbb-385af69c8a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_165ffc7b-c3cd-4ecf-babc-c67d40f9a6e2" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_9091e8b4-e458-4f0a-9fbb-385af69c8a3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_32f94560-3ef7-432d-becf-15f4c5a23b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_165ffc7b-c3cd-4ecf-babc-c67d40f9a6e2" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_32f94560-3ef7-432d-becf-15f4c5a23b86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1d799941-7244-4193-8b6b-460cd54a50c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9320e7c-433f-4610-88b0-b2cb0f509629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1d799941-7244-4193-8b6b-460cd54a50c8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9320e7c-433f-4610-88b0-b2cb0f509629" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b83b1bdc-2d40-4943-ab96-976e39b80ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1d799941-7244-4193-8b6b-460cd54a50c8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b83b1bdc-2d40-4943-ab96-976e39b80ed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d29b262-8db2-401a-b3df-2da027c22c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1d799941-7244-4193-8b6b-460cd54a50c8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d29b262-8db2-401a-b3df-2da027c22c7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c2eaeeaf-c0fb-458c-81df-15ebf46352c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1d799941-7244-4193-8b6b-460cd54a50c8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c2eaeeaf-c0fb-458c-81df-15ebf46352c0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_69300dc8-58df-40dc-a293-08937ecbb13f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_61a4557f-1f79-4139-9043-f6f6977bdd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_69300dc8-58df-40dc-a293-08937ecbb13f" xlink:to="loc_us-gaap_InventoryFinishedGoods_61a4557f-1f79-4139-9043-f6f6977bdd5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_bfa04785-ed43-41a1-9651-7f682c8bc901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_69300dc8-58df-40dc-a293-08937ecbb13f" xlink:to="loc_us-gaap_InventoryWorkInProcess_bfa04785-ed43-41a1-9651-7f682c8bc901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_31bce85f-5377-4b4c-93c5-37699c00ade6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_69300dc8-58df-40dc-a293-08937ecbb13f" xlink:to="loc_us-gaap_InventoryRawMaterials_31bce85f-5377-4b4c-93c5-37699c00ade6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e1525ca8-4d63-48a4-ba7f-3f06c69456b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2a55aad4-fa38-4422-8dea-28931da83c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e1525ca8-4d63-48a4-ba7f-3f06c69456b6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2a55aad4-fa38-4422-8dea-28931da83c9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5976ba14-1c85-422f-9a3d-07a8b4807ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e1525ca8-4d63-48a4-ba7f-3f06c69456b6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5976ba14-1c85-422f-9a3d-07a8b4807ce5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_924d0083-5073-4c45-b228-52a1eb8c8a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_92fc9876-0e73-45be-a494-ed1a8b06d9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_924d0083-5073-4c45-b228-52a1eb8c8a6b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_92fc9876-0e73-45be-a494-ed1a8b06d9fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_a9e36a32-0ef1-4992-89a0-2bc95d2c99f4" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_924d0083-5073-4c45-b228-52a1eb8c8a6b" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_a9e36a32-0ef1-4992-89a0-2bc95d2c99f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_7edafe7f-49f9-4879-81fc-c1dffddd3a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_924d0083-5073-4c45-b228-52a1eb8c8a6b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_7edafe7f-49f9-4879-81fc-c1dffddd3a08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_77fb47eb-f167-42d9-8498-b35fab8d136a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_924d0083-5073-4c45-b228-52a1eb8c8a6b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_77fb47eb-f167-42d9-8498-b35fab8d136a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_491c26a5-e04a-4f58-8e05-00351838df22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_924d0083-5073-4c45-b228-52a1eb8c8a6b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_491c26a5-e04a-4f58-8e05-00351838df22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_e9c3ac47-68c2-40aa-9dc0-13654015f412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_924d0083-5073-4c45-b228-52a1eb8c8a6b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_e9c3ac47-68c2-40aa-9dc0-13654015f412" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_0d66af46-abf0-40e3-80c3-2362c50fa20b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_924d0083-5073-4c45-b228-52a1eb8c8a6b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_0d66af46-abf0-40e3-80c3-2362c50fa20b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_b4793c00-8741-4682-aac1-079de39c1e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_04cc34e9-14d9-48dc-9fd1-bd79d9158101" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_b4793c00-8741-4682-aac1-079de39c1e1b" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_04cc34e9-14d9-48dc-9fd1-bd79d9158101" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_24a76855-85fb-4fd7-930c-94715cc4352e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_b4793c00-8741-4682-aac1-079de39c1e1b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_24a76855-85fb-4fd7-930c-94715cc4352e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_4d2439bc-56dd-4383-8055-680f8f4c9791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_b4793c00-8741-4682-aac1-079de39c1e1b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_4d2439bc-56dd-4383-8055-680f8f4c9791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_299c5d40-9999-4fca-906a-42ceb7163bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_b4793c00-8741-4682-aac1-079de39c1e1b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_299c5d40-9999-4fca-906a-42ceb7163bf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_6fb8d5ad-6c7c-4d70-a762-6798c28f0615" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_b4793c00-8741-4682-aac1-079de39c1e1b" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_6fb8d5ad-6c7c-4d70-a762-6798c28f0615" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9377693b-a15f-4407-99b1-59b515989b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_3f4b6333-b702-4f71-9602-7303d4d34783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9377693b-a15f-4407-99b1-59b515989b8e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_3f4b6333-b702-4f71-9602-7303d4d34783" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_f5ead8da-15c1-4db6-9a3e-e442f9858108" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9377693b-a15f-4407-99b1-59b515989b8e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_f5ead8da-15c1-4db6-9a3e-e442f9858108" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_c5ea8129-367d-4f33-ab74-0fd8cde65538" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9377693b-a15f-4407-99b1-59b515989b8e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_c5ea8129-367d-4f33-ab74-0fd8cde65538" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_599b585d-f048-423f-9be5-fe5362ab27f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0db95ab0-2aa2-4797-b370-9bf1df2e2e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_599b585d-f048-423f-9be5-fe5362ab27f6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0db95ab0-2aa2-4797-b370-9bf1df2e2e69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_330eb902-6eec-40d1-9411-27b9d9fb1899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_599b585d-f048-423f-9be5-fe5362ab27f6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_330eb902-6eec-40d1-9411-27b9d9fb1899" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5e3298c3-601f-4908-8032-ba95528e754e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_599b585d-f048-423f-9be5-fe5362ab27f6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5e3298c3-601f-4908-8032-ba95528e754e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5e66a38c-029b-4344-b714-4267e724ec08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_599b585d-f048-423f-9be5-fe5362ab27f6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5e66a38c-029b-4344-b714-4267e724ec08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_f23b3428-fac6-488c-a7d9-07b7d5ec163d" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_fe0496f1-dbe6-49a6-aed8-d43ed85a2b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_f23b3428-fac6-488c-a7d9-07b7d5ec163d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_fe0496f1-dbe6-49a6-aed8-d43ed85a2b60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c8c0298e-94b0-4b03-a54d-5aac96cb67a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_f23b3428-fac6-488c-a7d9-07b7d5ec163d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c8c0298e-94b0-4b03-a54d-5aac96cb67a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_3adc5cd3-8122-492f-8611-994af125d584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_f23b3428-fac6-488c-a7d9-07b7d5ec163d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_3adc5cd3-8122-492f-8611-994af125d584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_b7293eef-8470-49ba-ba38-f15920622ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_f23b3428-fac6-488c-a7d9-07b7d5ec163d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_b7293eef-8470-49ba-ba38-f15920622ed0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_99a248a8-5da2-48e7-a373-4c1908ef486b" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_f23b3428-fac6-488c-a7d9-07b7d5ec163d" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_99a248a8-5da2-48e7-a373-4c1908ef486b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_3e612ff7-c5ce-4de6-b2d3-d68e5f093bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_f23b3428-fac6-488c-a7d9-07b7d5ec163d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_3e612ff7-c5ce-4de6-b2d3-d68e5f093bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_06f50efb-eb28-44d4-b40f-145f73090079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_f23b3428-fac6-488c-a7d9-07b7d5ec163d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_06f50efb-eb28-44d4-b40f-145f73090079" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1f42bf0a-8d95-4fc7-b47e-5ecc10e9011b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_f23b3428-fac6-488c-a7d9-07b7d5ec163d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1f42bf0a-8d95-4fc7-b47e-5ecc10e9011b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_641be8e1-29aa-4a26-88a5-5f3d21ab9ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_f23b3428-fac6-488c-a7d9-07b7d5ec163d" xlink:to="loc_us-gaap_Goodwill_641be8e1-29aa-4a26-88a5-5f3d21ab9ec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_81f988ba-621a-49f7-98f1-77ba04149bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_970765fa-f14b-4d54-a852-54672fb3d721" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_81f988ba-621a-49f7-98f1-77ba04149bad" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_970765fa-f14b-4d54-a852-54672fb3d721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_636feb67-7174-4889-8cd7-9894c86fd1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_81f988ba-621a-49f7-98f1-77ba04149bad" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_636feb67-7174-4889-8cd7-9894c86fd1a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9a11bce-8d6b-49f7-8c9c-7b08a7db64b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_4c7d65c7-70f5-474b-90b9-6daf15d2ac3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9a11bce-8d6b-49f7-8c9c-7b08a7db64b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_4c7d65c7-70f5-474b-90b9-6daf15d2ac3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3d36d6e4-39dc-42d1-bb04-296d9d66a79d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9a11bce-8d6b-49f7-8c9c-7b08a7db64b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3d36d6e4-39dc-42d1-bb04-296d9d66a79d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_57e307de-b4bc-42c6-9cdc-665a42cd1743" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9a11bce-8d6b-49f7-8c9c-7b08a7db64b3" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_57e307de-b4bc-42c6-9cdc-665a42cd1743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d052e8d2-51c1-4614-a14d-8f0f5857ed37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9a11bce-8d6b-49f7-8c9c-7b08a7db64b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d052e8d2-51c1-4614-a14d-8f0f5857ed37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_0cf4b76e-d7ac-4539-b958-22809c2bae5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9a11bce-8d6b-49f7-8c9c-7b08a7db64b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_0cf4b76e-d7ac-4539-b958-22809c2bae5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_42a6f624-6a1c-498a-a955-f77524c05521" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9a11bce-8d6b-49f7-8c9c-7b08a7db64b3" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_42a6f624-6a1c-498a-a955-f77524c05521" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DEBTScheduleofDebtMaturityDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7141ccc1-a6e0-4f13-b879-67dc627baf7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8f887ede-228a-4525-b7fa-42f0aa160b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7141ccc1-a6e0-4f13-b879-67dc627baf7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8f887ede-228a-4525-b7fa-42f0aa160b19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ca7f0519-f761-49e0-838f-df7ae70909fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7141ccc1-a6e0-4f13-b879-67dc627baf7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ca7f0519-f761-49e0-838f-df7ae70909fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5acd40d7-b0b3-42de-9412-302b92855e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7141ccc1-a6e0-4f13-b879-67dc627baf7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5acd40d7-b0b3-42de-9412-302b92855e3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_701aba0b-8101-4ef9-8ea0-0b36a3e5abe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7141ccc1-a6e0-4f13-b879-67dc627baf7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_701aba0b-8101-4ef9-8ea0-0b36a3e5abe3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_960cdfc5-323d-4234-9d97-500976fdb79e" xlink:href="iart-20211231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_20865bc6-1d52-4ef4-be92-98d6f85afef4" xlink:href="iart-20211231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_960cdfc5-323d-4234-9d97-500976fdb79e" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_20865bc6-1d52-4ef4-be92-98d6f85afef4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d119eb5c-6293-4a45-b3d7-c592a86e0ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_960cdfc5-323d-4234-9d97-500976fdb79e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d119eb5c-6293-4a45-b3d7-c592a86e0ae0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_80e1eb01-7afd-4137-8f4c-0bbdbd113fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_42b9330f-da24-4229-bf8e-980a66ae618e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_80e1eb01-7afd-4137-8f4c-0bbdbd113fcd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_42b9330f-da24-4229-bf8e-980a66ae618e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d6318818-11c3-49f3-bec6-46669f34a0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_80e1eb01-7afd-4137-8f4c-0bbdbd113fcd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d6318818-11c3-49f3-bec6-46669f34a0eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40cbbcdd-d047-4bc0-88d7-450b7182afef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_243568b8-8157-456a-88d2-2525d0ad562c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40cbbcdd-d047-4bc0-88d7-450b7182afef" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_243568b8-8157-456a-88d2-2525d0ad562c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a72d364a-f4ed-4f4d-9929-a7f62312b2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40cbbcdd-d047-4bc0-88d7-450b7182afef" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a72d364a-f4ed-4f4d-9929-a7f62312b2ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e6a531ea-b0cc-40e3-a591-da7e2337c132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40cbbcdd-d047-4bc0-88d7-450b7182afef" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e6a531ea-b0cc-40e3-a591-da7e2337c132" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_03c3ca3f-b270-4d3d-9178-a91ebe825e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40cbbcdd-d047-4bc0-88d7-450b7182afef" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_03c3ca3f-b270-4d3d-9178-a91ebe825e93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_df6f35dc-71f1-47ca-a77c-030eaa62c177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40cbbcdd-d047-4bc0-88d7-450b7182afef" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_df6f35dc-71f1-47ca-a77c-030eaa62c177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_db661b22-cf84-4b1c-afe7-753e29b0a72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40cbbcdd-d047-4bc0-88d7-450b7182afef" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_db661b22-cf84-4b1c-afe7-753e29b0a72b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8f4098c9-0d58-40a5-aa29-f10b0756a115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4abc408a-0f64-4ce6-9a4f-d38780f38ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8f4098c9-0d58-40a5-aa29-f10b0756a115" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4abc408a-0f64-4ce6-9a4f-d38780f38ca7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3d1e4f6a-02ce-4769-95bd-1625e6730491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8f4098c9-0d58-40a5-aa29-f10b0756a115" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3d1e4f6a-02ce-4769-95bd-1625e6730491" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_33acd509-0645-43f8-9734-0503eac76b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d023a484-fde3-4fba-afd7-7eb936251ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_33acd509-0645-43f8-9734-0503eac76b0b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d023a484-fde3-4fba-afd7-7eb936251ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f66060cf-fe47-46da-9995-0d8f19c90e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_33acd509-0645-43f8-9734-0503eac76b0b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f66060cf-fe47-46da-9995-0d8f19c90e4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_746c0bf0-7182-442d-9175-5117ba99509b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_67e97f09-cd31-4c27-9ccb-268ad5309803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_746c0bf0-7182-442d-9175-5117ba99509b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_67e97f09-cd31-4c27-9ccb-268ad5309803" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8b817d84-c954-4518-8d58-68a573d0e4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_746c0bf0-7182-442d-9175-5117ba99509b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8b817d84-c954-4518-8d58-68a573d0e4d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_abdbb319-4e87-421b-a41f-e53672760cca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_746c0bf0-7182-442d-9175-5117ba99509b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_abdbb319-4e87-421b-a41f-e53672760cca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9e73bf35-33d5-4d9c-93e2-9bb6adee8e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_746c0bf0-7182-442d-9175-5117ba99509b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9e73bf35-33d5-4d9c-93e2-9bb6adee8e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_53f23f38-cd38-4668-8961-c8f845353008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_746c0bf0-7182-442d-9175-5117ba99509b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_53f23f38-cd38-4668-8961-c8f845353008" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ed142e13-6e5c-46a2-8de5-d836ede32005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_746c0bf0-7182-442d-9175-5117ba99509b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ed142e13-6e5c-46a2-8de5-d836ede32005" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3ed3e903-811e-413d-b1e1-f14516abe0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_16eaa7a8-f206-4e48-bff0-421b13871e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3ed3e903-811e-413d-b1e1-f14516abe0d8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_16eaa7a8-f206-4e48-bff0-421b13871e43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d0019705-4c0b-404e-bd8a-115739352940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3ed3e903-811e-413d-b1e1-f14516abe0d8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d0019705-4c0b-404e-bd8a-115739352940" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b3018b94-c253-469a-bdf4-03b909641f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b3018b94-c253-469a-bdf4-03b909641f6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dd0f935e-41db-4d10-b374-1ee19d6d5de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dd0f935e-41db-4d10-b374-1ee19d6d5de5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_875a9c47-cd52-4f19-a2c8-62740454d057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_875a9c47-cd52-4f19-a2c8-62740454d057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_ccb642ff-7719-4f24-a8b3-974bd33997a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_ccb642ff-7719-4f24-a8b3-974bd33997a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_f941fba5-45e1-4c64-890f-cb89522a1764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_f941fba5-45e1-4c64-890f-cb89522a1764" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_b333126c-b099-49b6-a47f-e9e2a8e08eb5" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_b333126c-b099-49b6-a47f-e9e2a8e08eb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_90b449f8-b3d2-4a16-bfbd-a34348f9a577" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_90b449f8-b3d2-4a16-bfbd-a34348f9a577" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_82d59a94-c6cc-447f-95d6-b199731ba23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_82d59a94-c6cc-447f-95d6-b199731ba23d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_c7822ea1-8cd7-4cae-9c01-1017e0ee055c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_c7822ea1-8cd7-4cae-9c01-1017e0ee055c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_686c277f-5906-4522-bf8e-22a35c24c518" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_686c277f-5906-4522-bf8e-22a35c24c518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_2ed97fc9-1dc6-42c4-ba57-1874f5bd9996" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_2ed97fc9-1dc6-42c4-ba57-1874f5bd9996" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_f8cd8381-c0c2-4d8c-b8bf-7bc53e165dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_f8cd8381-c0c2-4d8c-b8bf-7bc53e165dbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_1e19973a-8e33-4bee-8752-868d50d1b3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_1e19973a-8e33-4bee-8752-868d50d1b3fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_f00082e4-a8a5-426f-b936-122100099ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_f00082e4-a8a5-426f-b936-122100099ec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_08bc5aaa-e7d5-4197-9e33-205bbdfe82f4" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_08bc5aaa-e7d5-4197-9e33-205bbdfe82f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_60e3ec34-f16e-4bfe-930b-452a1ab6c060" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2d3cef6-afe8-454f-a49a-8651b40839dd" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_60e3ec34-f16e-4bfe-930b-452a1ab6c060" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_269429bc-7a43-49f2-8ad2-29e731fc2704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c78a66ed-e2bb-4502-8659-16b71327330f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_269429bc-7a43-49f2-8ad2-29e731fc2704" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c78a66ed-e2bb-4502-8659-16b71327330f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fae29b76-a743-4f65-9bb1-663cd444b96b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_269429bc-7a43-49f2-8ad2-29e731fc2704" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fae29b76-a743-4f65-9bb1-663cd444b96b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_65f168ba-595b-4633-b9a7-79d56f0aeddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_269429bc-7a43-49f2-8ad2-29e731fc2704" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_65f168ba-595b-4633-b9a7-79d56f0aeddd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3358b6d8-70b4-4226-9ecc-69b53d1249fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_af13b00e-774f-48fc-a15c-ccc59489cfed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3358b6d8-70b4-4226-9ecc-69b53d1249fa" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_af13b00e-774f-48fc-a15c-ccc59489cfed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c65eb711-d622-4a25-b615-a07c64586a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3358b6d8-70b4-4226-9ecc-69b53d1249fa" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c65eb711-d622-4a25-b615-a07c64586a0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b4595ef8-3b7e-4c6a-9297-7e2cd04cdbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8c0df375-5cc4-49d3-b860-9ecbc39dadcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b4595ef8-3b7e-4c6a-9297-7e2cd04cdbf3" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8c0df375-5cc4-49d3-b860-9ecbc39dadcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2db084a6-1b18-4405-907b-c23e257aae07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b4595ef8-3b7e-4c6a-9297-7e2cd04cdbf3" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2db084a6-1b18-4405-907b-c23e257aae07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a5b68511-54e4-4f14-89b9-51f4fc1637fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b4595ef8-3b7e-4c6a-9297-7e2cd04cdbf3" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a5b68511-54e4-4f14-89b9-51f4fc1637fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_ae96682e-6f8a-41c3-ad1e-ea1524e042e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_12507fd1-f8c7-4f99-9b7b-a021a5755dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_ae96682e-6f8a-41c3-ad1e-ea1524e042e3" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_12507fd1-f8c7-4f99-9b7b-a021a5755dc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fb89f89a-cb82-420a-86a2-cfc5bf3ab7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_ae96682e-6f8a-41c3-ad1e-ea1524e042e3" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fb89f89a-cb82-420a-86a2-cfc5bf3ab7a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c0a48b1e-e414-4eb4-99a0-f92e46fee3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e53fb28a-1ee8-4e10-86af-d511f261ad36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c0a48b1e-e414-4eb4-99a0-f92e46fee3fc" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_e53fb28a-1ee8-4e10-86af-d511f261ad36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a0f16100-a7fe-4351-bb2f-a73aab31a3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c0a48b1e-e414-4eb4-99a0-f92e46fee3fc" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a0f16100-a7fe-4351-bb2f-a73aab31a3e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_1df3fb5f-133d-4044-bea5-1b551e4e0d11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_1df3fb5f-133d-4044-bea5-1b551e4e0d11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_e6cda2fd-9b85-432a-b14a-6545e7bd3ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_e6cda2fd-9b85-432a-b14a-6545e7bd3ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_25aaff7d-97e0-4efa-831a-bc751ef3e256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_25aaff7d-97e0-4efa-831a-bc751ef3e256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_1e0b900c-1ed9-44be-abaa-088f980109f7" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_1e0b900c-1ed9-44be-abaa-088f980109f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_7444f9fd-6333-4b28-8aa9-aaf2594fc08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_7444f9fd-6333-4b28-8aa9-aaf2594fc08b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ddd3f593-92ec-495a-8bb5-b1a7156bedcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ddd3f593-92ec-495a-8bb5-b1a7156bedcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_d35f8d74-0f8f-4117-9fe1-4df277b79821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_d35f8d74-0f8f-4117-9fe1-4df277b79821" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_39f456e4-97d5-4525-a996-42adc7d4631a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_39f456e4-97d5-4525-a996-42adc7d4631a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_68fd891e-1031-46a7-99ff-b81e2122184d" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_68fd891e-1031-46a7-99ff-b81e2122184d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_b8986a26-9e04-45aa-90df-d72a53bcec89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_b8986a26-9e04-45aa-90df-d72a53bcec89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_4085be14-b6c6-4963-a39e-9e4b86aa297f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_4085be14-b6c6-4963-a39e-9e4b86aa297f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsLeasesAndOther_c878dd5e-27e0-4839-8062-e500c637ae74" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetsLeasesAndOther"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d1ec3afb-a31f-4cb0-bd24-d6fb0590d165" xlink:to="loc_iart_DeferredTaxAssetsLeasesAndOther_c878dd5e-27e0-4839-8062-e500c637ae74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1edf173b-ee18-4efb-a97c-f38b7f35697f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_0f45f4e2-2390-47f6-aef8-d1d9e0d2b93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_1edf173b-ee18-4efb-a97c-f38b7f35697f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_0f45f4e2-2390-47f6-aef8-d1d9e0d2b93a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_5441dfcf-0e9d-462c-978f-c11ee39c62d7" xlink:href="iart-20211231.xsd#iart_DeferredTaxLiabilitiesLeasesAndOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_1edf173b-ee18-4efb-a97c-f38b7f35697f" xlink:to="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_5441dfcf-0e9d-462c-978f-c11ee39c62d7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_df9a0932-b4d3-45e4-8f31-a8460fd2e2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2d049f30-fc64-49b4-976b-4a29828c7c05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_df9a0932-b4d3-45e4-8f31-a8460fd2e2db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2d049f30-fc64-49b4-976b-4a29828c7c05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_826627b4-3097-48bb-bc92-94ff33adc7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_df9a0932-b4d3-45e4-8f31-a8460fd2e2db" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_826627b4-3097-48bb-bc92-94ff33adc7c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_44b1c92b-7021-462c-b857-0f1377999511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_1e1540da-e938-43b3-a6e9-0a31d250f9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_44b1c92b-7021-462c-b857-0f1377999511" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_1e1540da-e938-43b3-a6e9-0a31d250f9d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_3806214a-1ce6-4074-bdd1-de7bea1fa66b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_44b1c92b-7021-462c-b857-0f1377999511" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_3806214a-1ce6-4074-bdd1-de7bea1fa66b" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>iart-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:79796dbd-6d84-4777-bf20-15ea797e2f25,g:15b73d14-4963-49a2-aa85-347a140ddfd4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended" id="i1d2f8ef78cc64bf3998cbd71af6efded_CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3d5547fb-0350-480b-a17a-a921f66499d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3d5547fb-0350-480b-a17a-a921f66499d6" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_f71beb7a-1987-40fe-bcbc-8f712486f126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_SharesIssued_f71beb7a-1987-40fe-bcbc-8f712486f126" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0ce0fb9d-58ff-40b0-8eea-3765eaa5af28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockholdersEquity_0ce0fb9d-58ff-40b0-8eea-3765eaa5af28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_24e33a79-4109-48c6-a6a4-1a658ade6557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_TreasuryStockShares_24e33a79-4109-48c6-a6a4-1a658ade6557" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_921e7f64-5529-41d4-9ad4-d0dff43cdd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_NetIncomeLoss_921e7f64-5529-41d4-9ad4-d0dff43cdd36" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_86e957a5-42f0-42c1-8b06-59ba68dfda88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_86e957a5-42f0-42c1-8b06-59ba68dfda88" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a42a708b-35e3-40ef-b97b-364a9575c37a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a42a708b-35e3-40ef-b97b-364a9575c37a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0e6096cd-1078-4501-9348-2feb1015c3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0e6096cd-1078-4501-9348-2feb1015c3d3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4968836b-f8de-4369-95c4-914f79b8d07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4968836b-f8de-4369-95c4-914f79b8d07b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9d2a2ab7-594d-4d08-9128-0f92a9f57e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9d2a2ab7-594d-4d08-9128-0f92a9f57e2d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_77fc5c75-99ab-419c-802b-6cc2f0293853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_77fc5c75-99ab-419c-802b-6cc2f0293853" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2699a76b-ac41-4117-a202-89af9349e8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2699a76b-ac41-4117-a202-89af9349e8c7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0bb6c049-d2ff-43cc-b9df-a7d74f3937a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0bb6c049-d2ff-43cc-b9df-a7d74f3937a0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_1220fc9e-0917-4dad-8d78-5e9f5d05f7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_1220fc9e-0917-4dad-8d78-5e9f5d05f7e5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_35c7ee93-6858-4736-9081-6fce60e02ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6af29a17-239d-4a48-b73f-7af1bbaf8340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_87d43314-a4c6-40b7-89cd-f45a2a4d5622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_7d40f4b5-c6cb-4f41-a8fe-db9851a8bbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_7d40f4b5-c6cb-4f41-a8fe-db9851a8bbe0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_187aad63-a861-4f14-b4a8-d7daeec4ca1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3d5547fb-0350-480b-a17a-a921f66499d6" xlink:to="loc_us-gaap_StatementTable_187aad63-a861-4f14-b4a8-d7daeec4ca1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_54ed4f7b-91d5-4397-b5b8-606163fe854f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_187aad63-a861-4f14-b4a8-d7daeec4ca1a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_54ed4f7b-91d5-4397-b5b8-606163fe854f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_54ed4f7b-91d5-4397-b5b8-606163fe854f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_54ed4f7b-91d5-4397-b5b8-606163fe854f" xlink:to="loc_us-gaap_EquityComponentDomain_54ed4f7b-91d5-4397-b5b8-606163fe854f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_54ed4f7b-91d5-4397-b5b8-606163fe854f" xlink:to="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_90ad2b15-48b6-4389-b84c-f7653b9a1263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:to="loc_us-gaap_CommonStockMember_90ad2b15-48b6-4389-b84c-f7653b9a1263" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_889d8311-6427-4b91-9e36-307d39c87e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:to="loc_us-gaap_TreasuryStockMember_889d8311-6427-4b91-9e36-307d39c87e8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_cd8f2c25-2209-4bf3-8ca0-e2d85b77d25e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_cd8f2c25-2209-4bf3-8ca0-e2d85b77d25e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4c18ca1a-564d-4804-9678-9c4b5561eae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4c18ca1a-564d-4804-9678-9c4b5561eae3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4a6b2e2d-3c45-403e-a4cf-7971505d41ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:to="loc_us-gaap_RetainedEarningsMember_4a6b2e2d-3c45-403e-a4cf-7971505d41ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c0a69d9e-e4e5-4ba6-baf3-1a8b5a5d8aec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_187aad63-a861-4f14-b4a8-d7daeec4ca1a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c0a69d9e-e4e5-4ba6-baf3-1a8b5a5d8aec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c0a69d9e-e4e5-4ba6-baf3-1a8b5a5d8aec_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c0a69d9e-e4e5-4ba6-baf3-1a8b5a5d8aec" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c0a69d9e-e4e5-4ba6-baf3-1a8b5a5d8aec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_055ac216-af36-42c7-921d-fcc7bcbd0f90" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c0a69d9e-e4e5-4ba6-baf3-1a8b5a5d8aec" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_055ac216-af36-42c7-921d-fcc7bcbd0f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f7de5148-0f8c-47a5-bad0-b9aeddb03cd4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_055ac216-af36-42c7-921d-fcc7bcbd0f90" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f7de5148-0f8c-47a5-bad0-b9aeddb03cd4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended" id="i664119b8d16b494798d611a3fc95b6e5_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:href="iart-20211231.xsd#iart_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_6acf1081-63fc-4ed4-9be9-6a12b88e1b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_6acf1081-63fc-4ed4-9be9-6a12b88e1b37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a4d57e46-8a55-4152-9490-0fb316dab4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a4d57e46-8a55-4152-9490-0fb316dab4f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InventoryCapitalizedExpenses_9bb164bf-b703-4939-a8f8-85138969be6d" xlink:href="iart-20211231.xsd#iart_InventoryCapitalizedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_InventoryCapitalizedExpenses_9bb164bf-b703-4939-a8f8-85138969be6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_b4fc456e-1777-4a62-92e4-a7005e8c7f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_b4fc456e-1777-4a62-92e4-a7005e8c7f0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_88ba5eea-39ad-4b40-9a95-1613693c1bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_Depreciation_88ba5eea-39ad-4b40-9a95-1613693c1bbe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2ce08981-916a-41a0-9225-160e208b1751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2ce08981-916a-41a0-9225-160e208b1751" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalizedAdjustment_4875a8c8-27fa-48cb-a4b8-74f5ead3a745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalizedAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_InterestCostsCapitalizedAdjustment_4875a8c8-27fa-48cb-a4b8-74f5ead3a745" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_80ac552d-6a16-4e83-8693-45f48eca7421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_NumberOfReportableSegments_80ac552d-6a16-4e83-8693-45f48eca7421" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_37ec13c8-fcd1-4f06-8f10-1e8e414b852e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_NumberOfReportingUnits_37ec13c8-fcd1-4f06-8f10-1e8e414b852e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CharitableContributions_c18165b1-df5d-4693-a488-650341e274cb" xlink:href="iart-20211231.xsd#iart_CharitableContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_CharitableContributions_c18165b1-df5d-4693-a488-650341e274cb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_3e4d1fef-fd36-440d-9268-1dd76275f65c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_3e4d1fef-fd36-440d-9268-1dd76275f65c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_10806c14-f859-4e7c-b2e0-534e81606acd" xlink:href="iart-20211231.xsd#iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_10806c14-f859-4e7c-b2e0-534e81606acd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_faa51c5e-efd7-4fb4-a048-ee702b8b8c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_RestructuringCharges_faa51c5e-efd7-4fb4-a048-ee702b8b8c1d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_0a072726-6a05-43ea-8d3e-a1ee3ff541f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_RestructuringReserveCurrent_0a072726-6a05-43ea-8d3e-a1ee3ff541f9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_704ef05b-41d4-470c-9326-685cc122b11f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_704ef05b-41d4-470c-9326-685cc122b11f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_b57a16ef-1d8d-4ebf-ba32-257efe983f84" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_b57a16ef-1d8d-4ebf-ba32-257efe983f84" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_5e7d6295-3f58-4c97-afb0-5fdbc126edbb" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_5e7d6295-3f58-4c97-afb0-5fdbc126edbb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskThresholdPercentage_fc52ded4-bb58-4719-9d39-ee9dd5cad361" xlink:href="iart-20211231.xsd#iart_ConcentrationRiskThresholdPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_ConcentrationRiskThresholdPercentage_fc52ded4-bb58-4719-9d39-ee9dd5cad361" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_72d1e7e0-173d-404b-87d6-3885cc18cd56" xlink:href="iart-20211231.xsd#iart_ConcentrationRiskNumberofCustomersOverBenchmark"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_72d1e7e0-173d-404b-87d6-3885cc18cd56" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_c2fc7ab7-2278-4dee-b3e8-168e77045573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_ConvertibleDebt_c2fc7ab7-2278-4dee-b3e8-168e77045573" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eccfd623-260b-417e-ba72-498a18d5abd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eccfd623-260b-417e-ba72-498a18d5abd3" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_6839d3a0-de7b-4ce1-a2aa-ea07516aa195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_InterestPaid_6839d3a0-de7b-4ce1-a2aa-ea07516aa195" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_7f378934-499c-4141-a5c2-130625e5fa66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_InterestPaidCapitalized_7f378934-499c-4141-a5c2-130625e5fa66" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_ae7bc935-69d1-4810-ab82-e77f1556ff0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_IncomeTaxesPaid_ae7bc935-69d1-4810-ab82-e77f1556ff0a" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d6d4bdf0-7f94-45d2-8625-ea43fbc12b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d6d4bdf0-7f94-45d2-8625-ea43fbc12b32" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_e86cb8b8-4243-4a11-8ea4-93d0e948b7f1" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_e86cb8b8-4243-4a11-8ea4-93d0e948b7f1" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_1c5fbcab-7762-40e9-9685-4d114dae7262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_1c5fbcab-7762-40e9-9685-4d114dae7262" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5d11ed7f-c8c2-4a8d-ba83-7f826498170c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5d11ed7f-c8c2-4a8d-ba83-7f826498170c" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:href="iart-20211231.xsd#iart_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d385e5a8-5b4d-4ed3-8366-225abd14f180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d385e5a8-5b4d-4ed3-8366-225abd14f180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d385e5a8-5b4d-4ed3-8366-225abd14f180_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d385e5a8-5b4d-4ed3-8366-225abd14f180" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d385e5a8-5b4d-4ed3-8366-225abd14f180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_20e2ab30-50c8-4168-a080-8accc6a3cec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d385e5a8-5b4d-4ed3-8366-225abd14f180" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_20e2ab30-50c8-4168-a080-8accc6a3cec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_39025f9b-09ac-4dc7-9923-909cb9c73b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_20e2ab30-50c8-4168-a080-8accc6a3cec6" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_39025f9b-09ac-4dc7-9923-909cb9c73b21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_54422b89-ef6a-42ca-81c7-fab4bdb900fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_54422b89-ef6a-42ca-81c7-fab4bdb900fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_54422b89-ef6a-42ca-81c7-fab4bdb900fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_54422b89-ef6a-42ca-81c7-fab4bdb900fe" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_54422b89-ef6a-42ca-81c7-fab4bdb900fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1d6ef0a-086f-4028-b814-7fc95c762eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_54422b89-ef6a-42ca-81c7-fab4bdb900fe" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1d6ef0a-086f-4028-b814-7fc95c762eda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_a17aea2c-50eb-4dea-a35c-6ce2c51fdca0" xlink:href="iart-20211231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1d6ef0a-086f-4028-b814-7fc95c762eda" xlink:to="loc_iart_SmithNephewUSDLimitedMember_a17aea2c-50eb-4dea-a35c-6ce2c51fdca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b383a047-60ad-4e34-9f3c-ce51ed2336ca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_srt_RangeAxis_b383a047-60ad-4e34-9f3c-ce51ed2336ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b383a047-60ad-4e34-9f3c-ce51ed2336ca_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b383a047-60ad-4e34-9f3c-ce51ed2336ca" xlink:to="loc_srt_RangeMember_b383a047-60ad-4e34-9f3c-ce51ed2336ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f542bffb-e13a-4674-9d12-ea96e7b093e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b383a047-60ad-4e34-9f3c-ce51ed2336ca" xlink:to="loc_srt_RangeMember_f542bffb-e13a-4674-9d12-ea96e7b093e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_31bce8bd-ef11-43cc-9143-d7d9e992b4d2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f542bffb-e13a-4674-9d12-ea96e7b093e7" xlink:to="loc_srt_MinimumMember_31bce8bd-ef11-43cc-9143-d7d9e992b4d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c5d70b5b-7ef4-4e4f-affd-16d43c6586e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f542bffb-e13a-4674-9d12-ea96e7b093e7" xlink:to="loc_srt_MaximumMember_c5d70b5b-7ef4-4e4f-affd-16d43c6586e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c899d1e9-75b5-4513-a593-97ff37998877" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c899d1e9-75b5-4513-a593-97ff37998877" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c899d1e9-75b5-4513-a593-97ff37998877_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c899d1e9-75b5-4513-a593-97ff37998877" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c899d1e9-75b5-4513-a593-97ff37998877_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_69432c0c-132d-4b74-a095-6594579e53db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c899d1e9-75b5-4513-a593-97ff37998877" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_69432c0c-132d-4b74-a095-6594579e53db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_155b6584-66f7-4026-9fd8-c97c68929a40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_69432c0c-132d-4b74-a095-6594579e53db" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_155b6584-66f7-4026-9fd8-c97c68929a40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4d8edbeb-6f16-4d3c-9011-1ff0a94d19f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4d8edbeb-6f16-4d3c-9011-1ff0a94d19f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4d8edbeb-6f16-4d3c-9011-1ff0a94d19f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4d8edbeb-6f16-4d3c-9011-1ff0a94d19f2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4d8edbeb-6f16-4d3c-9011-1ff0a94d19f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86ab1e4e-05d7-4df1-bca1-334f0e4e4169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4d8edbeb-6f16-4d3c-9011-1ff0a94d19f2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86ab1e4e-05d7-4df1-bca1-334f0e4e4169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_bb4fd31d-8daa-499a-9b65-5b3757c60f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86ab1e4e-05d7-4df1-bca1-334f0e4e4169" xlink:to="loc_us-gaap_SalesRevenueNetMember_bb4fd31d-8daa-499a-9b65-5b3757c60f97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_148e04c4-6ee2-4449-92f6-35e662adedb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_AssetAcquisitionAxis_148e04c4-6ee2-4449-92f6-35e662adedb1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_148e04c4-6ee2-4449-92f6-35e662adedb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_148e04c4-6ee2-4449-92f6-35e662adedb1" xlink:to="loc_us-gaap_AssetAcquisitionDomain_148e04c4-6ee2-4449-92f6-35e662adedb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_c11fd286-3b47-48a6-94d9-73851ab5a5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_148e04c4-6ee2-4449-92f6-35e662adedb1" xlink:to="loc_us-gaap_AssetAcquisitionDomain_c11fd286-3b47-48a6-94d9-73851ab5a5fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember_c9fb6179-ff17-4013-954f-2297470ee929" xlink:href="iart-20211231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_c11fd286-3b47-48a6-94d9-73851ab5a5fc" xlink:to="loc_iart_ReboundTherapeuticsCorporationMember_c9fb6179-ff17-4013-954f-2297470ee929" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ab584fd9-f092-45c6-808c-cf3a1c6f4a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ab584fd9-f092-45c6-808c-cf3a1c6f4a67" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ab584fd9-f092-45c6-808c-cf3a1c6f4a67_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ab584fd9-f092-45c6-808c-cf3a1c6f4a67" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ab584fd9-f092-45c6-808c-cf3a1c6f4a67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eed03509-3afd-4a97-b36b-ca7a289bea26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ab584fd9-f092-45c6-808c-cf3a1c6f4a67" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eed03509-3afd-4a97-b36b-ca7a289bea26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_7f6dfdad-596a-4d1f-b382-d10db4fac3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed03509-3afd-4a97-b36b-ca7a289bea26" xlink:to="loc_us-gaap_ConvertibleDebtMember_7f6dfdad-596a-4d1f-b382-d10db4fac3ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9e6e9fed-2994-452b-9846-8a1dcbeb314e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_DebtInstrumentAxis_9e6e9fed-2994-452b-9846-8a1dcbeb314e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9e6e9fed-2994-452b-9846-8a1dcbeb314e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9e6e9fed-2994-452b-9846-8a1dcbeb314e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9e6e9fed-2994-452b-9846-8a1dcbeb314e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95e8cf2d-8e99-4e72-b922-0d6e52de28fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9e6e9fed-2994-452b-9846-8a1dcbeb314e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95e8cf2d-8e99-4e72-b922-0d6e52de28fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_928a315a-6e5a-440a-a0d4-4eec3447df87" xlink:href="iart-20211231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95e8cf2d-8e99-4e72-b922-0d6e52de28fd" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_928a315a-6e5a-440a-a0d4-4eec3447df87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fd53138a-9e37-43ec-91b3-8df5a7d5eee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fd53138a-9e37-43ec-91b3-8df5a7d5eee0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fd53138a-9e37-43ec-91b3-8df5a7d5eee0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fd53138a-9e37-43ec-91b3-8df5a7d5eee0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fd53138a-9e37-43ec-91b3-8df5a7d5eee0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d3d85654-6784-44d8-be57-8ea2f68ae48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fd53138a-9e37-43ec-91b3-8df5a7d5eee0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d3d85654-6784-44d8-be57-8ea2f68ae48a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4798d30e-28e9-479d-b4b3-3b7d04c5f0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d3d85654-6784-44d8-be57-8ea2f68ae48a" xlink:to="loc_us-gaap_CostOfSalesMember_4798d30e-28e9-479d-b4b3-3b7d04c5f0cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4c590a02-7d79-4863-99ed-35d0b30ef152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d3d85654-6784-44d8-be57-8ea2f68ae48a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4c590a02-7d79-4863-99ed-35d0b30ef152" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8ce1a030-3cd5-459f-96fe-9e8e53b2e506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d3d85654-6784-44d8-be57-8ea2f68ae48a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8ce1a030-3cd5-459f-96fe-9e8e53b2e506" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_f158ab61-0576-4e9c-bc98-193b62eb1562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_f158ab61-0576-4e9c-bc98-193b62eb1562" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f158ab61-0576-4e9c-bc98-193b62eb1562_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f158ab61-0576-4e9c-bc98-193b62eb1562" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f158ab61-0576-4e9c-bc98-193b62eb1562_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e22c3de7-a265-4a67-9e41-92be8618c03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f158ab61-0576-4e9c-bc98-193b62eb1562" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e22c3de7-a265-4a67-9e41-92be8618c03c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_4334b89c-efe9-45e9-b37a-c501df2da029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_e22c3de7-a265-4a67-9e41-92be8618c03c" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_4334b89c-efe9-45e9-b37a-c501df2da029" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="extended" id="ibea092e8e8dd43888dc672612f7e600a_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a577dcae-7d4e-4d7f-ac01-1e1bf77d3757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a577dcae-7d4e-4d7f-ac01-1e1bf77d3757" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d14f39d1-f310-4e77-8e06-616e1b7d42fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d14f39d1-f310-4e77-8e06-616e1b7d42fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0d4773a4-f1e4-43e8-9177-a48a169eae5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0d4773a4-f1e4-43e8-9177-a48a169eae5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bb3fc4ac-166b-47b6-8c93-8d9cb937d5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bb3fc4ac-166b-47b6-8c93-8d9cb937d5d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ecaf6187-fb8e-434a-b515-066e6440f25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ecaf6187-fb8e-434a-b515-066e6440f25b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88c9e143-5b65-4a5d-b303-f9a42dc8d272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ecaf6187-fb8e-434a-b515-066e6440f25b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88c9e143-5b65-4a5d-b303-f9a42dc8d272" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_88c9e143-5b65-4a5d-b303-f9a42dc8d272_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88c9e143-5b65-4a5d-b303-f9a42dc8d272" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_88c9e143-5b65-4a5d-b303-f9a42dc8d272_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88c9e143-5b65-4a5d-b303-f9a42dc8d272" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_4f4cbf65-f23a-400b-8fe9-47a906ef38c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_LandMember_4f4cbf65-f23a-400b-8fe9-47a906ef38c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_2dfa3bee-52d0-48c5-bc34-5445ff4317ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_2dfa3bee-52d0-48c5-bc34-5445ff4317ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3ea12625-a3be-4369-b9f4-8710fe790de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3ea12625-a3be-4369-b9f4-8710fe790de2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_4372dbc5-3769-4e8f-8c98-0138bf9b4370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_4372dbc5-3769-4e8f-8c98-0138bf9b4370" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInstrumentKitsMember_e229e0d9-5630-4892-8e3e-761653e04c9e" xlink:href="iart-20211231.xsd#iart_SurgicalInstrumentKitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_iart_SurgicalInstrumentKitsMember_e229e0d9-5630-4892-8e3e-761653e04c9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InformationSystemsandHardwareMember_2549e324-66b1-4136-92d8-f35d0872d236" xlink:href="iart-20211231.xsd#iart_InformationSystemsandHardwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_iart_InformationSystemsandHardwareMember_2549e324-66b1-4136-92d8-f35d0872d236" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_0933b5a1-bd10-4153-a7d2-e3fa7c182ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_0933b5a1-bd10-4153-a7d2-e3fa7c182ef3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_2448c3ab-65eb-45d2-a1c6-13a7a5af0925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_ConstructionInProgressMember_2448c3ab-65eb-45d2-a1c6-13a7a5af0925" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c3b05f0f-f625-4891-bc9e-df96ad3996b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ecaf6187-fb8e-434a-b515-066e6440f25b" xlink:to="loc_srt_RangeAxis_c3b05f0f-f625-4891-bc9e-df96ad3996b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c3b05f0f-f625-4891-bc9e-df96ad3996b6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c3b05f0f-f625-4891-bc9e-df96ad3996b6" xlink:to="loc_srt_RangeMember_c3b05f0f-f625-4891-bc9e-df96ad3996b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_550c7f03-ea6f-40b1-9abf-b87cdf614b48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c3b05f0f-f625-4891-bc9e-df96ad3996b6" xlink:to="loc_srt_RangeMember_550c7f03-ea6f-40b1-9abf-b87cdf614b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4a76f1f9-8752-4436-a446-b75719a26176" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_550c7f03-ea6f-40b1-9abf-b87cdf614b48" xlink:to="loc_srt_MinimumMember_4a76f1f9-8752-4436-a446-b75719a26176" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c67a52d1-5c86-4714-9023-ba4e8a6f9ea9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_550c7f03-ea6f-40b1-9abf-b87cdf614b48" xlink:to="loc_srt_MaximumMember_c67a52d1-5c86-4714-9023-ba4e8a6f9ea9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details" xlink:type="extended" id="i1be260af0848429e8febd3a4a1fad8bc_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_786b25e7-1f1b-44bb-b742-75627f82ebf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_786b25e7-1f1b-44bb-b742-75627f82ebf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_66852fa3-4e69-462d-b6fc-eb794e73fa6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_66852fa3-4e69-462d-b6fc-eb794e73fa6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_26e3db5a-99f4-4adf-b5af-91e489b405be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_26e3db5a-99f4-4adf-b5af-91e489b405be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_f8e124b8-5636-4b23-8d19-c323493331d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:to="loc_us-gaap_AdditionalPaidInCapital_f8e124b8-5636-4b23-8d19-c323493331d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f7855fd0-7d0f-4096-896c-8206f206a6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f7855fd0-7d0f-4096-896c-8206f206a6fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_b2101f0c-9a3b-4ef5-a506-ad18ece708f2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f7855fd0-7d0f-4096-896c-8206f206a6fc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_b2101f0c-9a3b-4ef5-a506-ad18ece708f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b2101f0c-9a3b-4ef5-a506-ad18ece708f2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_b2101f0c-9a3b-4ef5-a506-ad18ece708f2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b2101f0c-9a3b-4ef5-a506-ad18ece708f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f2f77ffe-1593-48f1-920f-2811a9d891c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_b2101f0c-9a3b-4ef5-a506-ad18ece708f2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f2f77ffe-1593-48f1-920f-2811a9d891c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2200d491-0c3a-4333-96d6-e378394ba2d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f2f77ffe-1593-48f1-920f-2811a9d891c8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2200d491-0c3a-4333-96d6-e378394ba2d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_54cccc61-e5e2-46b5-8318-e1b6263771aa" xlink:href="iart-20211231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2200d491-0c3a-4333-96d6-e378394ba2d0" xlink:to="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_54cccc61-e5e2-46b5-8318-e1b6263771aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_dd8231a9-7da4-45c0-9dcf-bd327c97039d" xlink:href="iart-20211231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2200d491-0c3a-4333-96d6-e378394ba2d0" xlink:to="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_dd8231a9-7da4-45c0-9dcf-bd327c97039d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="extended" id="iad88edd172c84808ad9d56cc017607eb_REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_62b79624-d2e5-4685-8faa-fe6353891f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_be058cd4-9245-4467-81df-43f0cc64b579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_62b79624-d2e5-4685-8faa-fe6353891f04" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_be058cd4-9245-4467-81df-43f0cc64b579" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_39d0c70c-4cf3-4b5c-93cf-49622a31c42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_62b79624-d2e5-4685-8faa-fe6353891f04" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_39d0c70c-4cf3-4b5c-93cf-49622a31c42d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ecb13356-474f-4864-b2a1-6e2537bb1b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_39d0c70c-4cf3-4b5c-93cf-49622a31c42d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ecb13356-474f-4864-b2a1-6e2537bb1b1d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="iart-20211231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended" id="i29b9337d4c9d4e1babc1263ea5aa4ff9_REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_62b79624-d2e5-4685-8faa-fe6353891f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_be058cd4-9245-4467-81df-43f0cc64b579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_62b79624-d2e5-4685-8faa-fe6353891f04" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_be058cd4-9245-4467-81df-43f0cc64b579" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_39d0c70c-4cf3-4b5c-93cf-49622a31c42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_62b79624-d2e5-4685-8faa-fe6353891f04" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_39d0c70c-4cf3-4b5c-93cf-49622a31c42d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="extended" id="i2460d6f6c5d14f158e0d3c48a7855463_REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3834c336-b6b6-417b-abcd-a8e27f1280fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ba150f1e-c731-42bb-ac18-ed7506d34ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3834c336-b6b6-417b-abcd-a8e27f1280fc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ba150f1e-c731-42bb-ac18-ed7506d34ef6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fcd4adb7-ac04-4a98-b584-a813937d678c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3834c336-b6b6-417b-abcd-a8e27f1280fc" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fcd4adb7-ac04-4a98-b584-a813937d678c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_45b684b5-3503-4d07-b305-664fac580134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fcd4adb7-ac04-4a98-b584-a813937d678c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_45b684b5-3503-4d07-b305-664fac580134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_45b684b5-3503-4d07-b305-664fac580134_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_45b684b5-3503-4d07-b305-664fac580134" xlink:to="loc_us-gaap_SegmentDomain_45b684b5-3503-4d07-b305-664fac580134_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d3f903be-a3b5-4405-9480-7135e9e6afbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_45b684b5-3503-4d07-b305-664fac580134" xlink:to="loc_us-gaap_SegmentDomain_d3f903be-a3b5-4405-9480-7135e9e6afbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_9edeef74-fa22-4cd0-840d-4b02560a1d10" xlink:href="iart-20211231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d3f903be-a3b5-4405-9480-7135e9e6afbc" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_9edeef74-fa22-4cd0-840d-4b02560a1d10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_5c1a487b-e821-46bc-9a78-f92fa5c4bf59" xlink:href="iart-20211231.xsd#iart_TissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d3f903be-a3b5-4405-9480-7135e9e6afbc" xlink:to="loc_iart_TissueTechnologiesMember_5c1a487b-e821-46bc-9a78-f92fa5c4bf59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4d788c36-ac9a-485b-94ca-a3ab4f1f8dc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fcd4adb7-ac04-4a98-b584-a813937d678c" xlink:to="loc_srt_ProductOrServiceAxis_4d788c36-ac9a-485b-94ca-a3ab4f1f8dc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4d788c36-ac9a-485b-94ca-a3ab4f1f8dc8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4d788c36-ac9a-485b-94ca-a3ab4f1f8dc8" xlink:to="loc_srt_ProductsAndServicesDomain_4d788c36-ac9a-485b-94ca-a3ab4f1f8dc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4d788c36-ac9a-485b-94ca-a3ab4f1f8dc8" xlink:to="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember_15c5ad6e-18c7-4198-a46a-d9026e17d672" xlink:href="iart-20211231.xsd#iart_NeurosurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:to="loc_iart_NeurosurgeryMember_15c5ad6e-18c7-4198-a46a-d9026e17d672" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember_495fafa2-5b23-4fa5-bc61-55d8d6b96f7d" xlink:href="iart-20211231.xsd#iart_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:to="loc_iart_InstrumentsMember_495fafa2-5b23-4fa5-bc61-55d8d6b96f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember_1f89dbd1-2075-49c1-9fc6-e2dfe72c64a9" xlink:href="iart-20211231.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:to="loc_iart_RegenerativeSkinAndWoundMember_1f89dbd1-2075-49c1-9fc6-e2dfe72c64a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_e52353e9-63c6-4988-9b2f-3186839cef68" xlink:href="iart-20211231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:to="loc_iart_ExtremityOrthopedicsMember_e52353e9-63c6-4988-9b2f-3186839cef68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember_e3ce46a8-731f-4997-abff-28f34ff65119" xlink:href="iart-20211231.xsd#iart_PrivateLabelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:to="loc_iart_PrivateLabelMember_e3ce46a8-731f-4997-abff-28f34ff65119" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="extended" id="i66709d1ee8b94ad9b97acef4309e3e8d_ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_58ac41a6-8335-4db9-ae77-a1c6bc4d5c63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_58ac41a6-8335-4db9-ae77-a1c6bc4d5c63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_760336fc-bfb3-441d-9bd7-d74eec29d444" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_760336fc-bfb3-441d-9bd7-d74eec29d444" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_725171fe-fa28-42a3-a76b-41b4fb05c7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_725171fe-fa28-42a3-a76b-41b4fb05c7da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NetWorkingCapital_4c4440b1-f74d-4ff0-ba55-55575764ab7e" xlink:href="iart-20211231.xsd#iart_NetWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_iart_NetWorkingCapital_4c4440b1-f74d-4ff0-ba55-55575764ab7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_47c4dbdd-d49b-456b-ba38-de5bf0bb9552" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_47c4dbdd-d49b-456b-ba38-de5bf0bb9552" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a87c3539-80d6-4a47-9223-6037c775ce48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:to="loc_srt_CounterpartyNameAxis_a87c3539-80d6-4a47-9223-6037c775ce48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a87c3539-80d6-4a47-9223-6037c775ce48_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_a87c3539-80d6-4a47-9223-6037c775ce48" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a87c3539-80d6-4a47-9223-6037c775ce48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c417921c-0ed8-4994-b181-cda607199208" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_a87c3539-80d6-4a47-9223-6037c775ce48" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c417921c-0ed8-4994-b181-cda607199208" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_cc6d876e-98da-49be-9d96-bb70c954e2c1" xlink:href="iart-20211231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c417921c-0ed8-4994-b181-cda607199208" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_cc6d876e-98da-49be-9d96-bb70c954e2c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8eda7235-a398-4e39-b446-5011ca9b9b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8eda7235-a398-4e39-b446-5011ca9b9b03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8eda7235-a398-4e39-b446-5011ca9b9b03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8eda7235-a398-4e39-b446-5011ca9b9b03" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8eda7235-a398-4e39-b446-5011ca9b9b03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_43d79a60-79ec-47dc-8e9e-5ef0c78701ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8eda7235-a398-4e39-b446-5011ca9b9b03" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_43d79a60-79ec-47dc-8e9e-5ef0c78701ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e125e250-95cc-4537-86d9-7a02b55d0819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_43d79a60-79ec-47dc-8e9e-5ef0c78701ac" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e125e250-95cc-4537-86d9-7a02b55d0819" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98c90a8b-409c-474c-9aab-aec6338e245e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98c90a8b-409c-474c-9aab-aec6338e245e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98c90a8b-409c-474c-9aab-aec6338e245e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98c90a8b-409c-474c-9aab-aec6338e245e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98c90a8b-409c-474c-9aab-aec6338e245e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_330794c6-e244-4110-b310-28d55634a0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98c90a8b-409c-474c-9aab-aec6338e245e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_330794c6-e244-4110-b310-28d55634a0da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_65435027-33da-410e-987f-289e5b8347dd" xlink:href="iart-20211231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_330794c6-e244-4110-b310-28d55634a0da" xlink:to="loc_iart_ExtremityOrthopedicsMember_65435027-33da-410e-987f-289e5b8347dd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="extended" id="ie5a021c52aa742049127b9d9556a9f07_ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_ddf27e10-0d67-4de2-84ef-12e5ec004473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_ddf27e10-0d67-4de2-84ef-12e5ec004473" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_859c3b4a-10c4-4694-9409-d6f05364d084" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_859c3b4a-10c4-4694-9409-d6f05364d084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_3d84db39-8a19-4f6f-aa45-aca9c17ddc66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_3d84db39-8a19-4f6f-aa45-aca9c17ddc66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_a88f09bb-3d03-4286-b379-9d5a6ad2f47a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_a88f09bb-3d03-4286-b379-9d5a6ad2f47a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_07f447fc-b86b-473a-8e25-82fcf9b7280d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_07f447fc-b86b-473a-8e25-82fcf9b7280d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_fcf30115-b719-4f31-be7c-040faae150f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_fcf30115-b719-4f31-be7c-040faae150f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b10147ab-9e63-42db-b6a3-60de5a0fefa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b10147ab-9e63-42db-b6a3-60de5a0fefa2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d821d5ee-bb56-4abe-ac4e-e15b3a844371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d821d5ee-bb56-4abe-ac4e-e15b3a844371" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_f15b9ee2-5ccc-41c8-a072-f65996f31d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_f15b9ee2-5ccc-41c8-a072-f65996f31d82" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_a56b40b3-f5c4-4dc3-81da-f7a2f6895d69" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_a56b40b3-f5c4-4dc3-81da-f7a2f6895d69" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_44f0836f-5d07-4e5f-8053-ffa38cca521f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_44f0836f-5d07-4e5f-8053-ffa38cca521f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_be77deaf-9e14-47f5-891d-25d3db4151fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_be77deaf-9e14-47f5-891d-25d3db4151fe" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_2fc23544-807e-4314-b70c-a3a4e2ea0c0b" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_2fc23544-807e-4314-b70c-a3a4e2ea0c0b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_4eca7a7d-d75c-4a1c-8b0f-5396fe265654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_4eca7a7d-d75c-4a1c-8b0f-5396fe265654" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2a6283d8-ad68-4bdb-aa0d-fef34889b71a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2a6283d8-ad68-4bdb-aa0d-fef34889b71a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a618fb93-8318-43e9-bcf3-bc1cf445014c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2a6283d8-ad68-4bdb-aa0d-fef34889b71a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a618fb93-8318-43e9-bcf3-bc1cf445014c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a618fb93-8318-43e9-bcf3-bc1cf445014c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a618fb93-8318-43e9-bcf3-bc1cf445014c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a618fb93-8318-43e9-bcf3-bc1cf445014c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1ef640b4-4311-4fe5-9351-86017894037d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a618fb93-8318-43e9-bcf3-bc1cf445014c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1ef640b4-4311-4fe5-9351-86017894037d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0f0c4e21-f2f2-4622-9b05-60e7f062cb19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1ef640b4-4311-4fe5-9351-86017894037d" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0f0c4e21-f2f2-4622-9b05-60e7f062cb19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_515253fc-7f89-4270-82b2-142237c56663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2a6283d8-ad68-4bdb-aa0d-fef34889b71a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_515253fc-7f89-4270-82b2-142237c56663" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_515253fc-7f89-4270-82b2-142237c56663_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_515253fc-7f89-4270-82b2-142237c56663" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_515253fc-7f89-4270-82b2-142237c56663_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_54a8d55a-7ce3-4800-80a4-d7027689835e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_515253fc-7f89-4270-82b2-142237c56663" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_54a8d55a-7ce3-4800-80a4-d7027689835e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_40a80f02-a5d0-4af7-a85a-514b939e82f3" xlink:href="iart-20211231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_54a8d55a-7ce3-4800-80a4-d7027689835e" xlink:to="loc_iart_ExtremityOrthopedicsMember_40a80f02-a5d0-4af7-a85a-514b939e82f3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails" xlink:type="extended" id="i357461e6537c472ca1f08d0f606fe914_ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_82dda9ff-37d6-41c9-8d1b-e8852a9deb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_82dda9ff-37d6-41c9-8d1b-e8852a9deb6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_402888b1-44ac-47a2-aa4f-dc4846f3cf58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_402888b1-44ac-47a2-aa4f-dc4846f3cf58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationWorkingCapitalAdjustment_0e41c677-cd40-4591-a8e3-6966146ad57e" xlink:href="iart-20211231.xsd#iart_BusinessCombinationWorkingCapitalAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_iart_BusinessCombinationWorkingCapitalAdjustment_0e41c677-cd40-4591-a8e3-6966146ad57e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dffbf46c-0b86-4b1a-bc42-c7cbae60faf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_Goodwill_dffbf46c-0b86-4b1a-bc42-c7cbae60faf9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_26ebd525-8b89-4157-8a39-eff0ff22b2f6" xlink:href="iart-20211231.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_26ebd525-8b89-4157-8a39-eff0ff22b2f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_3bb524cd-707c-4a7d-ba0c-060b6f1b7e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_3bb524cd-707c-4a7d-ba0c-060b6f1b7e8a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fe3dd04b-9691-4645-b407-a933beccec1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fe3dd04b-9691-4645-b407-a933beccec1a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f866ec42-4e05-46af-96b7-1898533dca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_Revenues_f866ec42-4e05-46af-96b7-1898533dca0c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8281a8f4-735a-4aef-92e9-9dd39a23a5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8281a8f4-735a-4aef-92e9-9dd39a23a5c2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_8fa6d34c-0fca-4318-9893-f68b7f10abd6" xlink:href="iart-20211231.xsd#iart_AcquiredFinitelivedIntangibleAssetsDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_8fa6d34c-0fca-4318-9893-f68b7f10abd6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_65ab3b3b-f980-4f53-8e19-795013327f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_65ab3b3b-f980-4f53-8e19-795013327f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65ab3b3b-f980-4f53-8e19-795013327f83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_65ab3b3b-f980-4f53-8e19-795013327f83" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65ab3b3b-f980-4f53-8e19-795013327f83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af7731e8-6387-4f48-8a0d-6d34c87a1a58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_65ab3b3b-f980-4f53-8e19-795013327f83" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af7731e8-6387-4f48-8a0d-6d34c87a1a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_0ecef4e1-c4df-48a2-9c05-d5f3f207274f" xlink:href="iart-20211231.xsd#iart_ACellIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af7731e8-6387-4f48-8a0d-6d34c87a1a58" xlink:to="loc_iart_ACellIncMember_0ecef4e1-c4df-48a2-9c05-d5f3f207274f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_f4a6d679-61ad-465a-882f-709ea102466a" xlink:href="iart-20211231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af7731e8-6387-4f48-8a0d-6d34c87a1a58" xlink:to="loc_iart_ArkisBioSciencesInc.Member_f4a6d679-61ad-465a-882f-709ea102466a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_19e9c590-648d-411e-923d-53c521041180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_19e9c590-648d-411e-923d-53c521041180" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_19e9c590-648d-411e-923d-53c521041180_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_19e9c590-648d-411e-923d-53c521041180" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_19e9c590-648d-411e-923d-53c521041180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_614c6ac5-5dad-4e6f-88e2-255882598fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_19e9c590-648d-411e-923d-53c521041180" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_614c6ac5-5dad-4e6f-88e2-255882598fe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember_c21cf4e0-6a78-479d-a04e-61529a5bb297" xlink:href="iart-20211231.xsd#iart_MilestonePaymentOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_614c6ac5-5dad-4e6f-88e2-255882598fe9" xlink:to="loc_iart_MilestonePaymentOneMember_c21cf4e0-6a78-479d-a04e-61529a5bb297" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember_d73bfcd8-b1ad-4053-a839-153c0e1b9f0a" xlink:href="iart-20211231.xsd#iart_MilestonePaymentTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_614c6ac5-5dad-4e6f-88e2-255882598fe9" xlink:to="loc_iart_MilestonePaymentTwoMember_d73bfcd8-b1ad-4053-a839-153c0e1b9f0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e41faee2-fe0f-445e-bdd1-36d005f5515e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e41faee2-fe0f-445e-bdd1-36d005f5515e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e41faee2-fe0f-445e-bdd1-36d005f5515e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e41faee2-fe0f-445e-bdd1-36d005f5515e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e41faee2-fe0f-445e-bdd1-36d005f5515e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b965bfc4-433c-4df1-b46a-9a3e6fdf6da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e41faee2-fe0f-445e-bdd1-36d005f5515e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b965bfc4-433c-4df1-b46a-9a3e6fdf6da0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_3b0156cf-d20a-4a00-9938-3546454b4d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b965bfc4-433c-4df1-b46a-9a3e6fdf6da0" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_3b0156cf-d20a-4a00-9938-3546454b4d73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_de0fafbd-beee-4114-929a-318855014f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b965bfc4-433c-4df1-b46a-9a3e6fdf6da0" xlink:to="loc_us-gaap_OtherLiabilitiesMember_de0fafbd-beee-4114-929a-318855014f64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a952889d-01aa-4023-965d-2da05c9a98ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:to="loc_srt_StatementScenarioAxis_a952889d-01aa-4023-965d-2da05c9a98ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a952889d-01aa-4023-965d-2da05c9a98ed_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a952889d-01aa-4023-965d-2da05c9a98ed" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a952889d-01aa-4023-965d-2da05c9a98ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_88173592-0469-492f-8b7a-a138192651c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a952889d-01aa-4023-965d-2da05c9a98ed" xlink:to="loc_srt_ScenarioUnspecifiedDomain_88173592-0469-492f-8b7a-a138192651c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_7a5bbef8-25cb-49dd-8506-3f13c962814a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_88173592-0469-492f-8b7a-a138192651c0" xlink:to="loc_srt_ProFormaMember_7a5bbef8-25cb-49dd-8506-3f13c962814a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="extended" id="i07e2af9491cf45649b8b5b8157248cc0_ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6515d6b9-e4e5-4c74-96ff-58bfa047e507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6515d6b9-e4e5-4c74-96ff-58bfa047e507" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_95c46a8a-56af-43a5-b5b4-4e002666814e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_95c46a8a-56af-43a5-b5b4-4e002666814e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9248fb4a-cf6a-40dd-bcf6-2f40a5bd38ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9248fb4a-cf6a-40dd-bcf6-2f40a5bd38ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_70adcb3b-597d-47ce-8fad-40e56844d7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_70adcb3b-597d-47ce-8fad-40e56844d7cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_636776e9-c2c0-4619-8f2e-f0b68433ca2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_636776e9-c2c0-4619-8f2e-f0b68433ca2b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_d2e6227e-a13d-4efc-b77f-0e4274ad48fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_d2e6227e-a13d-4efc-b77f-0e4274ad48fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9cc15591-4325-4b5a-8a38-fe26f777abbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9cc15591-4325-4b5a-8a38-fe26f777abbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e323568f-74ed-45cf-9e58-da7ecf0b49d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e323568f-74ed-45cf-9e58-da7ecf0b49d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e882a74f-c5a9-477f-b220-1b4a4f21f983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_Goodwill_e882a74f-c5a9-477f-b220-1b4a4f21f983" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_d58fd8d1-55d5-4edd-8512-6319cbd1331c" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_d58fd8d1-55d5-4edd-8512-6319cbd1331c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e254cb41-91bb-4759-85fa-a01d44460243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e254cb41-91bb-4759-85fa-a01d44460243" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_429dc1aa-282b-4832-942b-b1d74c1f40c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_429dc1aa-282b-4832-942b-b1d74c1f40c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_9f84956d-7a59-4c8e-9ff2-eaa7bb8e985d" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_9f84956d-7a59-4c8e-9ff2-eaa7bb8e985d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_21cdc005-2111-42ef-9334-d405d51f6548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_21cdc005-2111-42ef-9334-d405d51f6548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_0a480bd5-ff4d-4d42-b52e-1067380a7f44" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_0a480bd5-ff4d-4d42-b52e-1067380a7f44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_76cc1867-3ee1-440b-b1ac-bc363491df2b" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_76cc1867-3ee1-440b-b1ac-bc363491df2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_8dec58aa-7169-4ba8-b0dc-feef65cbd642" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_8dec58aa-7169-4ba8-b0dc-feef65cbd642" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3422b26e-d840-4b32-9bad-72625a120111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3422b26e-d840-4b32-9bad-72625a120111" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ceb268d1-2b66-4bc6-b6dd-68285be8c333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ceb268d1-2b66-4bc6-b6dd-68285be8c333" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_1447fc4e-d118-4cb9-a4e7-c490ecbb16e8" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_1447fc4e-d118-4cb9-a4e7-c490ecbb16e8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d9db1638-5769-45b6-b175-ac44298e0869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d9db1638-5769-45b6-b175-ac44298e0869" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_ec8b1e28-67a9-44c8-a763-d3eed480e84c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_ec8b1e28-67a9-44c8-a763-d3eed480e84c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_eb1ab5dd-ad4d-4278-9dfc-40d43b2e2aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_eb1ab5dd-ad4d-4278-9dfc-40d43b2e2aaf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_adf0fc29-776d-432f-b927-c0def896e99e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_adf0fc29-776d-432f-b927-c0def896e99e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_529b9640-2fec-4d9a-9ddb-fea718c82144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_529b9640-2fec-4d9a-9ddb-fea718c82144" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_14b48248-6678-4afc-abf0-6a940972a6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_14b48248-6678-4afc-abf0-6a940972a6ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14b48248-6678-4afc-abf0-6a940972a6ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14b48248-6678-4afc-abf0-6a940972a6ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14b48248-6678-4afc-abf0-6a940972a6ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a91e2ed-06de-498d-929b-80a2051b9bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14b48248-6678-4afc-abf0-6a940972a6ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a91e2ed-06de-498d-929b-80a2051b9bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_84af2de4-a449-4a75-b700-faa608c0b775" xlink:href="iart-20211231.xsd#iart_ACellIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a91e2ed-06de-498d-929b-80a2051b9bf1" xlink:to="loc_iart_ACellIncMember_84af2de4-a449-4a75-b700-faa608c0b775" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_6953e409-e1e0-45d7-9532-e6e156d7b31a" xlink:href="iart-20211231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a91e2ed-06de-498d-929b-80a2051b9bf1" xlink:to="loc_iart_ArkisBioSciencesInc.Member_6953e409-e1e0-45d7-9532-e6e156d7b31a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_34b595f2-e97b-4867-9dd7-d0627e18706f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:to="loc_srt_RangeAxis_34b595f2-e97b-4867-9dd7-d0627e18706f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_34b595f2-e97b-4867-9dd7-d0627e18706f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_34b595f2-e97b-4867-9dd7-d0627e18706f" xlink:to="loc_srt_RangeMember_34b595f2-e97b-4867-9dd7-d0627e18706f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f81aaac2-0ab6-4d8f-b036-62684feaa96d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_34b595f2-e97b-4867-9dd7-d0627e18706f" xlink:to="loc_srt_RangeMember_f81aaac2-0ab6-4d8f-b036-62684feaa96d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f495d060-7843-4de0-b81a-99c813d5e0d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f81aaac2-0ab6-4d8f-b036-62684feaa96d" xlink:to="loc_srt_MinimumMember_f495d060-7843-4de0-b81a-99c813d5e0d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bb552f9c-d008-4d35-a62b-7603b829eb5d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f81aaac2-0ab6-4d8f-b036-62684feaa96d" xlink:to="loc_srt_MaximumMember_bb552f9c-d008-4d35-a62b-7603b829eb5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d064524c-72f2-434d-b00c-b81262e5eac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d064524c-72f2-434d-b00c-b81262e5eac5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d064524c-72f2-434d-b00c-b81262e5eac5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d064524c-72f2-434d-b00c-b81262e5eac5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d064524c-72f2-434d-b00c-b81262e5eac5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9970660-ca93-4e4b-a5db-8b096aa567a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d064524c-72f2-434d-b00c-b81262e5eac5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9970660-ca93-4e4b-a5db-8b096aa567a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_0a218abb-9a05-4a1d-a2a0-9429504c01e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9970660-ca93-4e4b-a5db-8b096aa567a1" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_0a218abb-9a05-4a1d-a2a0-9429504c01e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_1d5d8dd7-2cb0-47c2-a8df-00219a82ba00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9970660-ca93-4e4b-a5db-8b096aa567a1" xlink:to="loc_us-gaap_LicensingAgreementsMember_1d5d8dd7-2cb0-47c2-a8df-00219a82ba00" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails" xlink:type="extended" id="i16ed1d1b18744d6ca1cc31ed59809080_ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:href="iart-20211231.xsd#iart_ScheduleOfAssetAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_fcfcb568-7f5f-429e-9569-1b75228d4775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_fcfcb568-7f5f-429e-9569-1b75228d4775" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_8dcdd760-c7b5-409d-b953-87693d0ba266" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_8dcdd760-c7b5-409d-b953-87693d0ba266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionNumberOfAssetsAcquired_bfd08dbc-4aa7-4303-85a4-ba9ef4614f0f" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionNumberOfAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionNumberOfAssetsAcquired_bfd08dbc-4aa7-4303-85a4-ba9ef4614f0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_4182c42d-b64a-4be1-92da-cd9bb220e8d5" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_4182c42d-b64a-4be1-92da-cd9bb220e8d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_ef0bf95d-8231-47ab-9aec-97712b2d7b6b" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_ef0bf95d-8231-47ab-9aec-97712b2d7b6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_acd7cc52-dd0e-4d16-827e-9d3eee793149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_acd7cc52-dd0e-4d16-827e-9d3eee793149" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d7841896-b958-4b71-936c-be9abeb7625e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d7841896-b958-4b71-936c-be9abeb7625e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_e72de53d-f966-460a-9d28-9fa2e8b8740b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_e72de53d-f966-460a-9d28-9fa2e8b8740b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_b97a7cc8-12e2-4d08-9669-18740d11c62f" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_b97a7cc8-12e2-4d08-9669-18740d11c62f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_95ffbcbb-dd6c-4af1-8bc5-900e15b8f7dd" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_95ffbcbb-dd6c-4af1-8bc5-900e15b8f7dd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_79c5ff25-b1e7-4e62-8c08-8c69d46dba19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_79c5ff25-b1e7-4e62-8c08-8c69d46dba19" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_cbb2994d-5733-4809-8dc3-f7889c277d30" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_cbb2994d-5733-4809-8dc3-f7889c277d30" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:href="iart-20211231.xsd#iart_ScheduleOfAssetAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_d2062d6d-d8dd-4134-b9dc-5acb2d764ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_AssetAcquisitionAxis_d2062d6d-d8dd-4134-b9dc-5acb2d764ab4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_d2062d6d-d8dd-4134-b9dc-5acb2d764ab4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_d2062d6d-d8dd-4134-b9dc-5acb2d764ab4" xlink:to="loc_us-gaap_AssetAcquisitionDomain_d2062d6d-d8dd-4134-b9dc-5acb2d764ab4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_f451774f-01ba-4661-804d-7feaa3405a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_d2062d6d-d8dd-4134-b9dc-5acb2d764ab4" xlink:to="loc_us-gaap_AssetAcquisitionDomain_f451774f-01ba-4661-804d-7feaa3405a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember_173e8f9a-7f68-4ee9-9f3f-1bff5cdfd578" xlink:href="iart-20211231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_f451774f-01ba-4661-804d-7feaa3405a01" xlink:to="loc_iart_ReboundTherapeuticsCorporationMember_173e8f9a-7f68-4ee9-9f3f-1bff5cdfd578" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntegratedShoulderCollaborationInc.Member_3504ea9e-9554-45b8-9541-bcb715ed746b" xlink:href="iart-20211231.xsd#iart_IntegratedShoulderCollaborationInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_f451774f-01ba-4661-804d-7feaa3405a01" xlink:to="loc_iart_IntegratedShoulderCollaborationInc.Member_3504ea9e-9554-45b8-9541-bcb715ed746b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9a1b7690-72f2-44a9-8678-7638091bdfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9a1b7690-72f2-44a9-8678-7638091bdfa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9a1b7690-72f2-44a9-8678-7638091bdfa4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9a1b7690-72f2-44a9-8678-7638091bdfa4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9a1b7690-72f2-44a9-8678-7638091bdfa4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_82eea153-ef60-4f3f-8841-df775a5dd099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9a1b7690-72f2-44a9-8678-7638091bdfa4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_82eea153-ef60-4f3f-8841-df775a5dd099" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1f7646cd-54ce-4f32-973b-c2bf9595fbed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_82eea153-ef60-4f3f-8841-df775a5dd099" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1f7646cd-54ce-4f32-973b-c2bf9595fbed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f27b617d-ded4-4020-b00a-0e6c7c15a466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f27b617d-ded4-4020-b00a-0e6c7c15a466" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f27b617d-ded4-4020-b00a-0e6c7c15a466_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f27b617d-ded4-4020-b00a-0e6c7c15a466" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f27b617d-ded4-4020-b00a-0e6c7c15a466_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9995559d-c34f-42f6-8bd2-d7178a703984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f27b617d-ded4-4020-b00a-0e6c7c15a466" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9995559d-c34f-42f6-8bd2-d7178a703984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_5aa16eac-510e-4e30-8f71-cf24758e9464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9995559d-c34f-42f6-8bd2-d7178a703984" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_5aa16eac-510e-4e30-8f71-cf24758e9464" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetMember_b5641953-4927-41b3-9a4b-0475a06a88d7" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9995559d-c34f-42f6-8bd2-d7178a703984" xlink:to="loc_iart_DeferredTaxAssetMember_b5641953-4927-41b3-9a4b-0475a06a88d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c8abf523-2a81-4cdc-83e7-9dad81796f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c8abf523-2a81-4cdc-83e7-9dad81796f4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c8abf523-2a81-4cdc-83e7-9dad81796f4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c8abf523-2a81-4cdc-83e7-9dad81796f4e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c8abf523-2a81-4cdc-83e7-9dad81796f4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35d1f821-b246-4a15-92c0-f18524de48b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c8abf523-2a81-4cdc-83e7-9dad81796f4e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35d1f821-b246-4a15-92c0-f18524de48b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_6719bf98-f9f9-4f80-9685-e38f9c425e79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35d1f821-b246-4a15-92c0-f18524de48b3" xlink:to="loc_us-gaap_LicensingAgreementsMember_6719bf98-f9f9-4f80-9685-e38f9c425e79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6b83e5b4-81a8-4872-bd7c-aaec74126563" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_srt_CounterpartyNameAxis_6b83e5b4-81a8-4872-bd7c-aaec74126563" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b83e5b4-81a8-4872-bd7c-aaec74126563_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_6b83e5b4-81a8-4872-bd7c-aaec74126563" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b83e5b4-81a8-4872-bd7c-aaec74126563_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18e7ae7c-16eb-486c-9e60-938229c94c0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_6b83e5b4-81a8-4872-bd7c-aaec74126563" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18e7ae7c-16eb-486c-9e60-938229c94c0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_ec952eff-5846-45a7-845b-8133e6b07412" xlink:href="iart-20211231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18e7ae7c-16eb-486c-9e60-938229c94c0c" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_ec952eff-5846-45a7-845b-8133e6b07412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_22bba6dc-a12c-42e6-a595-0c525755665e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_22bba6dc-a12c-42e6-a595-0c525755665e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_22bba6dc-a12c-42e6-a595-0c525755665e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_22bba6dc-a12c-42e6-a595-0c525755665e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_22bba6dc-a12c-42e6-a595-0c525755665e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a1cc8d8c-7e9f-4565-9a3e-9a2757d3a717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_22bba6dc-a12c-42e6-a595-0c525755665e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a1cc8d8c-7e9f-4565-9a3e-9a2757d3a717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_32e3b6ef-fcfb-4bcc-8869-9b28a575acfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_a1cc8d8c-7e9f-4565-9a3e-9a2757d3a717" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_32e3b6ef-fcfb-4bcc-8869-9b28a575acfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0b0d69ed-1765-466c-aa5e-fe9e59e44c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0b0d69ed-1765-466c-aa5e-fe9e59e44c5a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0b0d69ed-1765-466c-aa5e-fe9e59e44c5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0b0d69ed-1765-466c-aa5e-fe9e59e44c5a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0b0d69ed-1765-466c-aa5e-fe9e59e44c5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a7b7b582-b24a-4446-959a-8f10acae8f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0b0d69ed-1765-466c-aa5e-fe9e59e44c5a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a7b7b582-b24a-4446-959a-8f10acae8f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_ed550b4b-ed3d-43d7-87e3-3bd34aeb1f2f" xlink:href="iart-20211231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a7b7b582-b24a-4446-959a-8f10acae8f0c" xlink:to="loc_iart_SmithNephewUSDLimitedMember_ed550b4b-ed3d-43d7-87e3-3bd34aeb1f2f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="extended" id="iaf45a5550b8c497287f1fde1066c327e_DEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f2d2c356-b4ae-42e8-b517-d2214f470e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f2d2c356-b4ae-42e8-b517-d2214f470e46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_47271a0b-51e7-41f5-8542-0347ffe39cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_47271a0b-51e7-41f5-8542-0347ffe39cb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_48087ae1-9562-4650-9abf-349342dae4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_48087ae1-9562-4650-9abf-349342dae4c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_8d024dc8-15b1-44e9-9200-b0e65899aaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_8d024dc8-15b1-44e9-9200-b0e65899aaa9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_462707d2-b701-4f2f-bb6d-ed29268a8f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_462707d2-b701-4f2f-bb6d-ed29268a8f2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_5ea6469b-686c-40e7-a26e-af694fb8f0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_5ea6469b-686c-40e7-a26e-af694fb8f0da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_92392aa7-1637-44d0-9d9b-3a47faf98f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_LineOfCredit_92392aa7-1637-44d0-9d9b-3a47faf98f79" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_1d1f2a1c-f29d-4e84-992e-69260f822ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_1d1f2a1c-f29d-4e84-992e-69260f822ab3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_1c924b84-83ad-4ad3-bcca-76441608f920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_SecuredDebtCurrent_1c924b84-83ad-4ad3-bcca-76441608f920" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_7e2cc076-c331-46d1-96d6-59fabcba33cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_7e2cc076-c331-46d1-96d6-59fabcba33cb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_94d8c058-84b3-4718-8081-ae71ae8879ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_94d8c058-84b3-4718-8081-ae71ae8879ef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearOne_b0b1d605-cbbe-4892-a7d1-10a4380ded36" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_InterestPaymentsYearOne_b0b1d605-cbbe-4892-a7d1-10a4380ded36" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearTwo_723723c4-1e68-406d-9374-e13ec382b8bd" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_InterestPaymentsYearTwo_723723c4-1e68-406d-9374-e13ec382b8bd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearThree_c3b6fd32-a079-4a07-9a5e-018e506a4343" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_InterestPaymentsYearThree_c3b6fd32-a079-4a07-9a5e-018e506a4343" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearFour_e1d796e3-2546-4594-949b-38e168448c2c" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_InterestPaymentsYearFour_e1d796e3-2546-4594-949b-38e168448c2c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4a47d676-5af1-4f90-8b92-01076bc4849d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4a47d676-5af1-4f90-8b92-01076bc4849d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a703257c-4a1c-4989-b745-d4954073b654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a703257c-4a1c-4989-b745-d4954073b654" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_4da03e60-eca3-4150-99cf-ec88240b2723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_4da03e60-eca3-4150-99cf-ec88240b2723" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_092704a6-1057-48ba-b644-98dc33abfcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_092704a6-1057-48ba-b644-98dc33abfcbb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ff3264ed-2311-4e80-8eac-27c94d6388f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ff3264ed-2311-4e80-8eac-27c94d6388f8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_091e9fcb-21b5-44a4-9839-f42be751fcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_091e9fcb-21b5-44a4-9839-f42be751fcb1" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_665fcd12-257a-4a13-a60d-29df1f08847b" xlink:href="iart-20211231.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_665fcd12-257a-4a13-a60d-29df1f08847b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_72190682-8e50-4a31-9cab-c01776d16145" xlink:href="iart-20211231.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_72190682-8e50-4a31-9cab-c01776d16145" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_67726b9f-9f7d-4ef6-9ea3-f789a43caf6b" xlink:href="iart-20211231.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_67726b9f-9f7d-4ef6-9ea3-f789a43caf6b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_47c971f8-21cf-496a-b7bf-dad294f874b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_47c971f8-21cf-496a-b7bf-dad294f874b1" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_9ceffb90-65c7-4359-a331-2bb6783e40ec" xlink:href="iart-20211231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_9ceffb90-65c7-4359-a331-2bb6783e40ec" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_b3358a1b-a535-428d-8ce3-8f047b1f2597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_b3358a1b-a535-428d-8ce3-8f047b1f2597" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_f857b9ae-ec8b-49a0-a815-775e4ecd5b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_f857b9ae-ec8b-49a0-a815-775e4ecd5b86" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5df82749-20b0-430e-b332-79c09c222036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5df82749-20b0-430e-b332-79c09c222036" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_1e72a744-92be-4037-ac25-322afa13aa68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_1e72a744-92be-4037-ac25-322afa13aa68" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_f7455c62-d10f-4c29-b22a-4ad39d7d595a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_f7455c62-d10f-4c29-b22a-4ad39d7d595a" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_843af695-a3b5-42b2-bd5a-2ae82990dfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentFairValue_843af695-a3b5-42b2-bd5a-2ae82990dfa0" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_f1f57756-d511-4d11-b0ce-e0d795ae7e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_f1f57756-d511-4d11-b0ce-e0d795ae7e26" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_06cc14ac-12b9-4036-bd94-b16b78f8172f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_06cc14ac-12b9-4036-bd94-b16b78f8172f" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_e6fef4d3-6ac6-443b-acfe-88d4787b4f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_InterestExpenseDebt_e6fef4d3-6ac6-443b-acfe-88d4787b4f93" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_ad92563e-269a-4568-95a9-abc60e76d892" xlink:href="iart-20211231.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_ad92563e-269a-4568-95a9-abc60e76d892" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgram_3ad13c32-8404-462c-8120-745fd69e7e26" xlink:href="iart-20211231.xsd#iart_SecuredLongTermDebtSecuritizationProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgram_3ad13c32-8404-462c-8120-745fd69e7e26" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_5c908b87-5f0f-42ad-89cf-8546106deca4" xlink:href="iart-20211231.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_5c908b87-5f0f-42ad-89cf-8546106deca4" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_86c60cef-d88f-4fc0-a580-3f8d53e82eb2" xlink:href="iart-20211231.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_86c60cef-d88f-4fc0-a580-3f8d53e82eb2" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c207b500-367b-4822-8e45-8b60eaa31359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_DebtInstrumentAxis_c207b500-367b-4822-8e45-8b60eaa31359" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c207b500-367b-4822-8e45-8b60eaa31359_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c207b500-367b-4822-8e45-8b60eaa31359" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c207b500-367b-4822-8e45-8b60eaa31359_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8c8e1b5a-ba9d-4409-a6ef-c8e0fccafae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c207b500-367b-4822-8e45-8b60eaa31359" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8c8e1b5a-ba9d-4409-a6ef-c8e0fccafae3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_3646b2be-2ebe-4520-94eb-eff2c7c89286" xlink:href="iart-20211231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c8e1b5a-ba9d-4409-a6ef-c8e0fccafae3" xlink:to="loc_iart_SeniorCreditFacilityMember_3646b2be-2ebe-4520-94eb-eff2c7c89286" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember_c7d9454b-f3db-4049-a703-74cd698d07ac" xlink:href="iart-20211231.xsd#iart_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c8e1b5a-ba9d-4409-a6ef-c8e0fccafae3" xlink:to="loc_iart_TermLoanFacilityMember_c7d9454b-f3db-4049-a703-74cd698d07ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_c5155ed0-c006-4007-b3be-b9bec286a3cd" xlink:href="iart-20211231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c8e1b5a-ba9d-4409-a6ef-c8e0fccafae3" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_c5155ed0-c006-4007-b3be-b9bec286a3cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b093a6f6-d189-4144-9019-95e2a420c4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_CreditFacilityAxis_b093a6f6-d189-4144-9019-95e2a420c4c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b093a6f6-d189-4144-9019-95e2a420c4c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b093a6f6-d189-4144-9019-95e2a420c4c1" xlink:to="loc_us-gaap_CreditFacilityDomain_b093a6f6-d189-4144-9019-95e2a420c4c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b093a6f6-d189-4144-9019-95e2a420c4c1" xlink:to="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_6db2315f-1e94-47a0-8e40-d137a19dd9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:to="loc_us-gaap_SecuredDebtMember_6db2315f-1e94-47a0-8e40-d137a19dd9ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_27416574-eb0a-4c76-8268-4f27e664f8be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_27416574-eb0a-4c76-8268-4f27e664f8be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_c0162bff-0d29-42dc-ae98-fbc389a89352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_c0162bff-0d29-42dc-ae98-fbc389a89352" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember_89b3ab5a-8e36-4522-9579-3848c94f77ce" xlink:href="iart-20211231.xsd#iart_SwinglineLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:to="loc_iart_SwinglineLoanMember_89b3ab5a-8e36-4522-9579-3848c94f77ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_09a9c7eb-36a2-4f80-b031-4ff97ca42ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_VariableRateAxis_09a9c7eb-36a2-4f80-b031-4ff97ca42ed6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_09a9c7eb-36a2-4f80-b031-4ff97ca42ed6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_09a9c7eb-36a2-4f80-b031-4ff97ca42ed6" xlink:to="loc_us-gaap_VariableRateDomain_09a9c7eb-36a2-4f80-b031-4ff97ca42ed6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_adaa4893-9662-4196-aa5a-5d9404c61b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_09a9c7eb-36a2-4f80-b031-4ff97ca42ed6" xlink:to="loc_us-gaap_VariableRateDomain_adaa4893-9662-4196-aa5a-5d9404c61b26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_b7c9bd6a-0ddc-49e4-b26f-29341734c59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_adaa4893-9662-4196-aa5a-5d9404c61b26" xlink:to="loc_us-gaap_EurodollarMember_b7c9bd6a-0ddc-49e4-b26f-29341734c59a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_13c956e2-510d-4496-8df5-96761a553705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_adaa4893-9662-4196-aa5a-5d9404c61b26" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_13c956e2-510d-4496-8df5-96761a553705" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthEurodollarRateMember_75940773-f716-4c08-9cfd-c7e07d482a2b" xlink:href="iart-20211231.xsd#iart_OneMonthEurodollarRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_adaa4893-9662-4196-aa5a-5d9404c61b26" xlink:to="loc_iart_OneMonthEurodollarRateMember_75940773-f716-4c08-9cfd-c7e07d482a2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fd04ee33-ff2b-4222-aa86-45234c2ed08d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_srt_RangeAxis_fd04ee33-ff2b-4222-aa86-45234c2ed08d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd04ee33-ff2b-4222-aa86-45234c2ed08d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fd04ee33-ff2b-4222-aa86-45234c2ed08d" xlink:to="loc_srt_RangeMember_fd04ee33-ff2b-4222-aa86-45234c2ed08d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8f341c60-d888-4822-ad9c-ff5a661fe817" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fd04ee33-ff2b-4222-aa86-45234c2ed08d" xlink:to="loc_srt_RangeMember_8f341c60-d888-4822-ad9c-ff5a661fe817" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_576e98fd-bd98-4c1a-94f9-4c91361a9efa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8f341c60-d888-4822-ad9c-ff5a661fe817" xlink:to="loc_srt_MinimumMember_576e98fd-bd98-4c1a-94f9-4c91361a9efa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_479cf736-7d47-4f49-9c4a-c5c60f8065cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8f341c60-d888-4822-ad9c-ff5a661fe817" xlink:to="loc_srt_MaximumMember_479cf736-7d47-4f49-9c4a-c5c60f8065cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7ace7db5-6bbb-4512-a309-3532d88be20e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7ace7db5-6bbb-4512-a309-3532d88be20e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7ace7db5-6bbb-4512-a309-3532d88be20e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7ace7db5-6bbb-4512-a309-3532d88be20e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7ace7db5-6bbb-4512-a309-3532d88be20e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_491a3d20-2612-4d76-84ea-6223ed03b921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7ace7db5-6bbb-4512-a309-3532d88be20e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_491a3d20-2612-4d76-84ea-6223ed03b921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b4c4881c-a774-48c1-b382-a00c578bd2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_491a3d20-2612-4d76-84ea-6223ed03b921" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b4c4881c-a774-48c1-b382-a00c578bd2f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a8d58fca-703e-4318-9d76-3b68e88796e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a8d58fca-703e-4318-9d76-3b68e88796e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a8d58fca-703e-4318-9d76-3b68e88796e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a8d58fca-703e-4318-9d76-3b68e88796e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a8d58fca-703e-4318-9d76-3b68e88796e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86d67c25-d720-42f1-af7e-140ca1e5b19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a8d58fca-703e-4318-9d76-3b68e88796e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86d67c25-d720-42f1-af7e-140ca1e5b19e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_ab3591e2-138e-4469-9302-c344284e3bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86d67c25-d720-42f1-af7e-140ca1e5b19e" xlink:to="loc_us-gaap_ConvertibleDebtMember_ab3591e2-138e-4469-9302-c344284e3bc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cf6e08ab-568a-4f00-8426-849d24eab17d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cf6e08ab-568a-4f00-8426-849d24eab17d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_cf6e08ab-568a-4f00-8426-849d24eab17d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cf6e08ab-568a-4f00-8426-849d24eab17d" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_cf6e08ab-568a-4f00-8426-849d24eab17d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_2923b4aa-c2cf-42fe-b228-cb020b780452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cf6e08ab-568a-4f00-8426-849d24eab17d" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_2923b4aa-c2cf-42fe-b228-cb020b780452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_833b2b38-085b-4853-9461-225081fbbfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_2923b4aa-c2cf-42fe-b228-cb020b780452" xlink:to="loc_us-gaap_CallOptionMember_833b2b38-085b-4853-9461-225081fbbfd5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DEBTMaximumTotalLeverageRatioTableDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="extended" id="icf886ffadbae4820a5852481f9e056df_DEBTMaximumTotalLeverageRatioTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0736530f-829c-4207-b466-d3b4359a463a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_66acef6b-0ca0-4ee9-8a22-10a4db9439d0" xlink:href="iart-20211231.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0736530f-829c-4207-b466-d3b4359a463a" xlink:to="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_66acef6b-0ca0-4ee9-8a22-10a4db9439d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a93e6266-9a89-40be-9b21-02f5ff26f748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0736530f-829c-4207-b466-d3b4359a463a" xlink:to="loc_us-gaap_DebtInstrumentTable_a93e6266-9a89-40be-9b21-02f5ff26f748" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_74a8c48a-d0a3-4d17-a2c3-e39853602951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a93e6266-9a89-40be-9b21-02f5ff26f748" xlink:to="loc_us-gaap_DebtInstrumentAxis_74a8c48a-d0a3-4d17-a2c3-e39853602951" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_74a8c48a-d0a3-4d17-a2c3-e39853602951_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_74a8c48a-d0a3-4d17-a2c3-e39853602951" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_74a8c48a-d0a3-4d17-a2c3-e39853602951_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6077aa6f-5c11-44df-807c-c6fd6d40f5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_74a8c48a-d0a3-4d17-a2c3-e39853602951" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6077aa6f-5c11-44df-807c-c6fd6d40f5c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_717acc50-6646-478f-a979-9d0229a7f872" xlink:href="iart-20211231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6077aa6f-5c11-44df-807c-c6fd6d40f5c5" xlink:to="loc_iart_SeniorCreditFacilityMember_717acc50-6646-478f-a979-9d0229a7f872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis_86577815-caaf-4391-afc2-425b09736968" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a93e6266-9a89-40be-9b21-02f5ff26f748" xlink:to="loc_iart_DebtCovenantPeriodAxis_86577815-caaf-4391-afc2-425b09736968" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_86577815-caaf-4391-afc2-425b09736968_default" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iart_DebtCovenantPeriodAxis_86577815-caaf-4391-afc2-425b09736968" xlink:to="loc_iart_DebtCovenantPeriodDomain_86577815-caaf-4391-afc2-425b09736968_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iart_DebtCovenantPeriodAxis_86577815-caaf-4391-afc2-425b09736968" xlink:to="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod1Member_99fa67d8-448d-4ec8-81b7-b1d25888dc55" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:to="loc_iart_DebtCovenantPeriod1Member_99fa67d8-448d-4ec8-81b7-b1d25888dc55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod2Member_8570d43a-994b-4480-80ff-a38855c7b957" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:to="loc_iart_DebtCovenantPeriod2Member_8570d43a-994b-4480-80ff-a38855c7b957" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member_76f673ff-86f9-4153-8622-c9f2cd11d367" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:to="loc_iart_DebtCovenantPeriod3Member_76f673ff-86f9-4153-8622-c9f2cd11d367" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod4Member_ee9b4f81-a954-45d1-a481-70f9ea80a6e6" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:to="loc_iart_DebtCovenantPeriod4Member_ee9b4f81-a954-45d1-a481-70f9ea80a6e6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="extended" id="ic78c6d7030c64d6399929f80b4029847_DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_42a87839-d2a1-4dfd-98aa-af6f53eabda9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f0fe9948-7845-48fe-a3b7-f13e54ccd00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_42a87839-d2a1-4dfd-98aa-af6f53eabda9" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f0fe9948-7845-48fe-a3b7-f13e54ccd00e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_3622484b-ff21-4bf7-b8fc-bff93d716632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_42a87839-d2a1-4dfd-98aa-af6f53eabda9" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_3622484b-ff21-4bf7-b8fc-bff93d716632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_0aea4bda-2895-4479-87d7-aa7e8887a36a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_42a87839-d2a1-4dfd-98aa-af6f53eabda9" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_0aea4bda-2895-4479-87d7-aa7e8887a36a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_42a87839-d2a1-4dfd-98aa-af6f53eabda9" xlink:to="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fc7696a8-7f1a-4ea8-9dfc-fe064028f77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fc7696a8-7f1a-4ea8-9dfc-fe064028f77c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fc7696a8-7f1a-4ea8-9dfc-fe064028f77c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fc7696a8-7f1a-4ea8-9dfc-fe064028f77c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fc7696a8-7f1a-4ea8-9dfc-fe064028f77c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2c27dd80-3a01-4f63-86f4-3d1410cab9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fc7696a8-7f1a-4ea8-9dfc-fe064028f77c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2c27dd80-3a01-4f63-86f4-3d1410cab9cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_edabf002-8d9f-48c0-82af-69817cbe99fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2c27dd80-3a01-4f63-86f4-3d1410cab9cd" xlink:to="loc_us-gaap_CashFlowHedgingMember_edabf002-8d9f-48c0-82af-69817cbe99fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_bf47d98b-1542-4bf5-bb90-b1d2915af03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:to="loc_us-gaap_HedgingDesignationAxis_bf47d98b-1542-4bf5-bb90-b1d2915af03c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bf47d98b-1542-4bf5-bb90-b1d2915af03c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_bf47d98b-1542-4bf5-bb90-b1d2915af03c" xlink:to="loc_us-gaap_HedgingDesignationDomain_bf47d98b-1542-4bf5-bb90-b1d2915af03c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_39e5feaa-d54e-4b30-9875-2cdcc0e65c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_bf47d98b-1542-4bf5-bb90-b1d2915af03c" xlink:to="loc_us-gaap_HedgingDesignationDomain_39e5feaa-d54e-4b30-9875-2cdcc0e65c9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_989f510d-3852-4690-b1e2-002551bee8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_39e5feaa-d54e-4b30-9875-2cdcc0e65c9b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_989f510d-3852-4690-b1e2-002551bee8dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9115e4eb-2e71-49aa-9f5c-6f4e2eaaf4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:to="loc_us-gaap_VariableRateAxis_9115e4eb-2e71-49aa-9f5c-6f4e2eaaf4ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9115e4eb-2e71-49aa-9f5c-6f4e2eaaf4ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_9115e4eb-2e71-49aa-9f5c-6f4e2eaaf4ac" xlink:to="loc_us-gaap_VariableRateDomain_9115e4eb-2e71-49aa-9f5c-6f4e2eaaf4ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_21e22cf4-b772-4261-8d41-ba24df6de0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_9115e4eb-2e71-49aa-9f5c-6f4e2eaaf4ac" xlink:to="loc_us-gaap_VariableRateDomain_21e22cf4-b772-4261-8d41-ba24df6de0de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthUSDLIBORMember_4bc5a4c0-1fc5-4092-829e-ef0077fc6956" xlink:href="iart-20211231.xsd#iart_OneMonthUSDLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_21e22cf4-b772-4261-8d41-ba24df6de0de" xlink:to="loc_iart_OneMonthUSDLIBORMember_4bc5a4c0-1fc5-4092-829e-ef0077fc6956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_401bce25-7bc0-4699-852f-29de6486bdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_401bce25-7bc0-4699-852f-29de6486bdb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_401bce25-7bc0-4699-852f-29de6486bdb3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_401bce25-7bc0-4699-852f-29de6486bdb3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_401bce25-7bc0-4699-852f-29de6486bdb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_401bce25-7bc0-4699-852f-29de6486bdb3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedMarch272017Member_26a281f8-a992-47d8-8a54-d497e5601f04" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedMarch272017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedMarch272017Member_26a281f8-a992-47d8-8a54-d497e5601f04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_0b115f70-2472-4bab-8de8-11cc19625679" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_0b115f70-2472-4bab-8de8-11cc19625679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_d66a4377-237c-48eb-88c2-3dfb4f755ef9" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_d66a4377-237c-48eb-88c2-3dfb4f755ef9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_d5c7ff1d-3bc0-49b8-be74-32b6f7d32cde" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_d5c7ff1d-3bc0-49b8-be74-32b6f7d32cde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_8690e5a8-3f01-4f54-a9a1-d65f5ad76539" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_8690e5a8-3f01-4f54-a9a1-d65f5ad76539" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_c93f5584-f9cc-4873-a916-bd60c30c571f" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_c93f5584-f9cc-4873-a916-bd60c30c571f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_2de6b036-9ade-40fd-814a-b657f09fd88d" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_2de6b036-9ade-40fd-814a-b657f09fd88d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_f5fde828-9985-4ea7-a07a-190d7e4e0f98" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_f5fde828-9985-4ea7-a07a-190d7e4e0f98" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_f5e4a1e6-f11d-4382-8f6b-4170174d182b" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_f5e4a1e6-f11d-4382-8f6b-4170174d182b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_57b8ad61-3be1-450e-a964-ef9acddcb3e6" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_57b8ad61-3be1-450e-a964-ef9acddcb3e6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_14e26098-5430-4f22-afed-c1ad909446ef" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_14e26098-5430-4f22-afed-c1ad909446ef" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="extended" id="i9dfd65270eb945179da3da38c6056897_DERIVATIVEINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2aa16871-63ab-48bb-926d-6bf115541205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2aa16871-63ab-48bb-926d-6bf115541205" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_54d59c31-c1b0-4ff0-94b9-c47a02e11903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_54d59c31-c1b0-4ff0-94b9-c47a02e11903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e5d13b8-e052-43d7-97ee-4e21955ec2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e5d13b8-e052-43d7-97ee-4e21955ec2ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntercompanyLoanQuarterlyPayment_2a9487dd-3565-4027-93e8-f2204ef99061" xlink:href="iart-20211231.xsd#iart_IntercompanyLoanQuarterlyPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_iart_IntercompanyLoanQuarterlyPayment_2a9487dd-3565-4027-93e8-f2204ef99061" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_d758a52d-491c-459c-8974-1363639b5472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_d758a52d-491c-459c-8974-1363639b5472" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a5a92a2b-05dc-4ab0-bcaf-e7c70229564c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a5a92a2b-05dc-4ab0-bcaf-e7c70229564c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_1a783d61-fbdf-4181-bd6e-60eaf07a7265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_1a783d61-fbdf-4181-bd6e-60eaf07a7265" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_fd88accc-88be-4e00-a413-f8402f76aae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_fd88accc-88be-4e00-a413-f8402f76aae3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ab7ed51b-57fd-4081-a542-1a919af24406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ab7ed51b-57fd-4081-a542-1a919af24406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ab7ed51b-57fd-4081-a542-1a919af24406_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ab7ed51b-57fd-4081-a542-1a919af24406" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ab7ed51b-57fd-4081-a542-1a919af24406_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5abaa87d-84f8-4737-a860-3b91656f3829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ab7ed51b-57fd-4081-a542-1a919af24406" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5abaa87d-84f8-4737-a860-3b91656f3829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f419f3bb-9fd8-425f-87f1-5cd8c393f4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5abaa87d-84f8-4737-a860-3b91656f3829" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f419f3bb-9fd8-425f-87f1-5cd8c393f4ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_d1c20354-31b6-47b2-b007-3ff4f17a0e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5abaa87d-84f8-4737-a860-3b91656f3829" xlink:to="loc_us-gaap_CurrencySwapMember_d1c20354-31b6-47b2-b007-3ff4f17a0e15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_a4f1cc05-5d92-487f-b8f8-1ce9b55d839c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5abaa87d-84f8-4737-a860-3b91656f3829" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_a4f1cc05-5d92-487f-b8f8-1ce9b55d839c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_60d98f37-9502-41cb-8453-dcc08fdc97fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:to="loc_us-gaap_PositionAxis_60d98f37-9502-41cb-8453-dcc08fdc97fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_60d98f37-9502-41cb-8453-dcc08fdc97fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_60d98f37-9502-41cb-8453-dcc08fdc97fc" xlink:to="loc_us-gaap_PositionDomain_60d98f37-9502-41cb-8453-dcc08fdc97fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_c9db24c2-c459-4b32-9d3c-6fb9ee0146cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_60d98f37-9502-41cb-8453-dcc08fdc97fc" xlink:to="loc_us-gaap_PositionDomain_c9db24c2-c459-4b32-9d3c-6fb9ee0146cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_75920bd4-3385-4100-9cf5-2efe744af308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_c9db24c2-c459-4b32-9d3c-6fb9ee0146cf" xlink:to="loc_us-gaap_ShortMember_75920bd4-3385-4100-9cf5-2efe744af308" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_03b1e7ce-0884-492e-93b5-6734349c67f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_c9db24c2-c459-4b32-9d3c-6fb9ee0146cf" xlink:to="loc_us-gaap_LongMember_03b1e7ce-0884-492e-93b5-6734349c67f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0acdbb18-42c4-46e1-8322-cf40520c1ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0acdbb18-42c4-46e1-8322-cf40520c1ee1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0acdbb18-42c4-46e1-8322-cf40520c1ee1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0acdbb18-42c4-46e1-8322-cf40520c1ee1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0acdbb18-42c4-46e1-8322-cf40520c1ee1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4ab3d07e-513e-4afe-83c6-f542a7605df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0acdbb18-42c4-46e1-8322-cf40520c1ee1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4ab3d07e-513e-4afe-83c6-f542a7605df3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_408d6d28-28f7-4c41-8782-2858f1c9feb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4ab3d07e-513e-4afe-83c6-f542a7605df3" xlink:to="loc_us-gaap_CashFlowHedgingMember_408d6d28-28f7-4c41-8782-2858f1c9feb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_922fa33e-585b-48f9-9992-0eafa4f786ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4ab3d07e-513e-4afe-83c6-f542a7605df3" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_922fa33e-585b-48f9-9992-0eafa4f786ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2e7bd765-dc47-4f79-986f-8cbda624d507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:to="loc_us-gaap_HedgingDesignationAxis_2e7bd765-dc47-4f79-986f-8cbda624d507" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2e7bd765-dc47-4f79-986f-8cbda624d507_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_2e7bd765-dc47-4f79-986f-8cbda624d507" xlink:to="loc_us-gaap_HedgingDesignationDomain_2e7bd765-dc47-4f79-986f-8cbda624d507_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_19739dcb-b7bc-4e3b-8ae2-7b4f19bb2606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_2e7bd765-dc47-4f79-986f-8cbda624d507" xlink:to="loc_us-gaap_HedgingDesignationDomain_19739dcb-b7bc-4e3b-8ae2-7b4f19bb2606" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_444b2f66-cd1a-4883-9b17-99d6d8bf6af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_19739dcb-b7bc-4e3b-8ae2-7b4f19bb2606" xlink:to="loc_us-gaap_NondesignatedMember_444b2f66-cd1a-4883-9b17-99d6d8bf6af8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_99c621fd-5b1a-46ea-9da7-169d2d48c983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_19739dcb-b7bc-4e3b-8ae2-7b4f19bb2606" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_99c621fd-5b1a-46ea-9da7-169d2d48c983" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="extended" id="i35f61868b8b441b49d02a52fd839cf4b_DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4c0b0832-f256-4e1a-938a-b8bbff091dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_d19fda4d-9b84-45a9-9adb-08e6f7522a02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4c0b0832-f256-4e1a-938a-b8bbff091dc1" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_d19fda4d-9b84-45a9-9adb-08e6f7522a02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_37fdc9ef-78ed-4f49-a3a6-e3fe996f40bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4c0b0832-f256-4e1a-938a-b8bbff091dc1" xlink:to="loc_us-gaap_DerivativeNotionalAmount_37fdc9ef-78ed-4f49-a3a6-e3fe996f40bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_71df10af-a9bd-4d94-91a9-7b57895bbf28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4c0b0832-f256-4e1a-938a-b8bbff091dc1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_71df10af-a9bd-4d94-91a9-7b57895bbf28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_4c0b0832-f256-4e1a-938a-b8bbff091dc1" xlink:to="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6bd51b6b-803e-4fef-bc33-fecbb085940c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6bd51b6b-803e-4fef-bc33-fecbb085940c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6bd51b6b-803e-4fef-bc33-fecbb085940c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6bd51b6b-803e-4fef-bc33-fecbb085940c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6bd51b6b-803e-4fef-bc33-fecbb085940c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b438dbb8-5e97-43b8-8720-77ae06a51ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6bd51b6b-803e-4fef-bc33-fecbb085940c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b438dbb8-5e97-43b8-8720-77ae06a51ba4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_b94e5198-c850-4de0-afed-0a14f66d96bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b438dbb8-5e97-43b8-8720-77ae06a51ba4" xlink:to="loc_us-gaap_CashFlowHedgingMember_b94e5198-c850-4de0-afed-0a14f66d96bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ef56e679-c426-4c41-95f0-53f82476f2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:to="loc_us-gaap_HedgingDesignationAxis_ef56e679-c426-4c41-95f0-53f82476f2d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ef56e679-c426-4c41-95f0-53f82476f2d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_ef56e679-c426-4c41-95f0-53f82476f2d1" xlink:to="loc_us-gaap_HedgingDesignationDomain_ef56e679-c426-4c41-95f0-53f82476f2d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b6e492c8-6d17-4757-8848-6a061f89a0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_ef56e679-c426-4c41-95f0-53f82476f2d1" xlink:to="loc_us-gaap_HedgingDesignationDomain_b6e492c8-6d17-4757-8848-6a061f89a0fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3e766727-9c20-46d9-a09a-bc2a0313b9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b6e492c8-6d17-4757-8848-6a061f89a0fe" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3e766727-9c20-46d9-a09a-bc2a0313b9de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c541dbd9-a6dd-447e-9aed-021ad2af2fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c541dbd9-a6dd-447e-9aed-021ad2af2fca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c541dbd9-a6dd-447e-9aed-021ad2af2fca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c541dbd9-a6dd-447e-9aed-021ad2af2fca" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c541dbd9-a6dd-447e-9aed-021ad2af2fca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c541dbd9-a6dd-447e-9aed-021ad2af2fca" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractOneMember_eaae25dc-2535-429e-a763-da7d3fa384fa" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateSwapContractOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractOneMember_eaae25dc-2535-429e-a763-da7d3fa384fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember_89fa6f4c-b331-4e89-a050-dfc6ae919e72" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateSwapContractTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember_89fa6f4c-b331-4e89-a050-dfc6ae919e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember_8b85b945-f573-4e00-bf83-f1a0e95e3fdf" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateSwapContractThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember_8b85b945-f573-4e00-bf83-f1a0e95e3fdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_d1bc7f04-843f-4e22-9659-9242b4d47e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_d1bc7f04-843f-4e22-9659-9242b4d47e75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_5c8aac7c-5822-4413-915b-1ce7e6831117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:to="loc_us-gaap_PositionAxis_5c8aac7c-5822-4413-915b-1ce7e6831117" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_5c8aac7c-5822-4413-915b-1ce7e6831117_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_5c8aac7c-5822-4413-915b-1ce7e6831117" xlink:to="loc_us-gaap_PositionDomain_5c8aac7c-5822-4413-915b-1ce7e6831117_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_c44b26be-a9cd-4229-b209-86e0ae2c5b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_5c8aac7c-5822-4413-915b-1ce7e6831117" xlink:to="loc_us-gaap_PositionDomain_c44b26be-a9cd-4229-b209-86e0ae2c5b7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_b4c871fb-43ae-4cd3-acb9-a36aa260926d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_c44b26be-a9cd-4229-b209-86e0ae2c5b7a" xlink:to="loc_us-gaap_LongMember_b4c871fb-43ae-4cd3-acb9-a36aa260926d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_a9e5185d-ac76-4086-acd3-4132b5c0dd08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_c44b26be-a9cd-4229-b209-86e0ae2c5b7a" xlink:to="loc_us-gaap_ShortMember_a9e5185d-ac76-4086-acd3-4132b5c0dd08" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="extended" id="i3b2a5627901d418abf860b243af7bd59_DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5846cd71-a2c5-47fd-9b62-6762e5d393a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_d5aedc92-2488-4d7d-91bd-d7d5e168693f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5846cd71-a2c5-47fd-9b62-6762e5d393a7" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_d5aedc92-2488-4d7d-91bd-d7d5e168693f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_35f3cd4c-cb4f-465d-91df-05959e638d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5846cd71-a2c5-47fd-9b62-6762e5d393a7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_35f3cd4c-cb4f-465d-91df-05959e638d44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_a9751031-3f65-4fd7-a26a-4857d1c79858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5846cd71-a2c5-47fd-9b62-6762e5d393a7" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_a9751031-3f65-4fd7-a26a-4857d1c79858" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5846cd71-a2c5-47fd-9b62-6762e5d393a7" xlink:to="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06ab946c-a583-4fa2-a578-5c37780380c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06ab946c-a583-4fa2-a578-5c37780380c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_06ab946c-a583-4fa2-a578-5c37780380c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06ab946c-a583-4fa2-a578-5c37780380c7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_06ab946c-a583-4fa2-a578-5c37780380c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ea427c18-7981-4ced-8cde-d40b66188cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06ab946c-a583-4fa2-a578-5c37780380c7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ea427c18-7981-4ced-8cde-d40b66188cec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6de0d536-571e-44a7-92fa-fb2ec6c152cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ea427c18-7981-4ced-8cde-d40b66188cec" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6de0d536-571e-44a7-92fa-fb2ec6c152cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_71f24ad6-50f3-4474-b0af-f90a9ef3309c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:to="loc_us-gaap_HedgingDesignationAxis_71f24ad6-50f3-4474-b0af-f90a9ef3309c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_71f24ad6-50f3-4474-b0af-f90a9ef3309c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_71f24ad6-50f3-4474-b0af-f90a9ef3309c" xlink:to="loc_us-gaap_HedgingDesignationDomain_71f24ad6-50f3-4474-b0af-f90a9ef3309c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_24345d88-cc85-4590-8196-0922f07fb9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_71f24ad6-50f3-4474-b0af-f90a9ef3309c" xlink:to="loc_us-gaap_HedgingDesignationDomain_24345d88-cc85-4590-8196-0922f07fb9b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3d6c3a9c-3e29-4e4c-95e0-6d488a53d4da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_24345d88-cc85-4590-8196-0922f07fb9b9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3d6c3a9c-3e29-4e4c-95e0-6d488a53d4da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9cacabfa-815f-4305-bfa4-002e46f85a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9cacabfa-815f-4305-bfa4-002e46f85a9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9cacabfa-815f-4305-bfa4-002e46f85a9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9cacabfa-815f-4305-bfa4-002e46f85a9d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9cacabfa-815f-4305-bfa4-002e46f85a9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9cacabfa-815f-4305-bfa4-002e46f85a9d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember_587a3604-265a-4a9a-9da6-45a5a0961a37" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:to="loc_iart_CrossCurrencyInterestRateContractOneMember_587a3604-265a-4a9a-9da6-45a5a0961a37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember_ba165690-e6b4-4b56-9669-9d88bcc93f2b" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:to="loc_iart_CrossCurrencyInterestRateContractTwoMember_ba165690-e6b4-4b56-9669-9d88bcc93f2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember_3b966e95-6e53-4b1c-a7bd-9d9dbf5aa71d" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:to="loc_iart_CrossCurrencyInterestRateContractThreeMember_3b966e95-6e53-4b1c-a7bd-9d9dbf5aa71d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFourMember_dc0f3c05-18ee-4e6e-b30d-42c737a3c8eb" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:to="loc_iart_CrossCurrencyInterestRateContractFourMember_dc0f3c05-18ee-4e6e-b30d-42c737a3c8eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_aece10e0-96a8-4625-91eb-68b6cfcdb979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_aece10e0-96a8-4625-91eb-68b6cfcdb979" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_d533283e-4452-4ec3-bfe0-4762da039efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:to="loc_us-gaap_PositionAxis_d533283e-4452-4ec3-bfe0-4762da039efc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_d533283e-4452-4ec3-bfe0-4762da039efc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_d533283e-4452-4ec3-bfe0-4762da039efc" xlink:to="loc_us-gaap_PositionDomain_d533283e-4452-4ec3-bfe0-4762da039efc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_702019c8-b14b-475a-ab75-dcba9708535d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_d533283e-4452-4ec3-bfe0-4762da039efc" xlink:to="loc_us-gaap_PositionDomain_702019c8-b14b-475a-ab75-dcba9708535d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_36b77486-3af8-46c8-a94a-2b903ae4a7df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_702019c8-b14b-475a-ab75-dcba9708535d" xlink:to="loc_us-gaap_LongMember_36b77486-3af8-46c8-a94a-2b903ae4a7df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_ccd7f1bd-d387-4aa5-a21e-ea60d8b9bef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_702019c8-b14b-475a-ab75-dcba9708535d" xlink:to="loc_us-gaap_ShortMember_ccd7f1bd-d387-4aa5-a21e-ea60d8b9bef0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="extended" id="icf4d041f75a44972b874fc1f01dea111_DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_e03374d1-215d-49d4-ba5a-5a08a09ee8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_69214762-f2e6-4636-aa65-692251693fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e03374d1-215d-49d4-ba5a-5a08a09ee8b5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_69214762-f2e6-4636-aa65-692251693fe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_36429d5a-0347-4da2-80f0-b9e60f2fdf78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e03374d1-215d-49d4-ba5a-5a08a09ee8b5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_36429d5a-0347-4da2-80f0-b9e60f2fdf78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e7de1355-da13-46bf-a510-c4f448815e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e03374d1-215d-49d4-ba5a-5a08a09ee8b5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e7de1355-da13-46bf-a510-c4f448815e63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e03374d1-215d-49d4-ba5a-5a08a09ee8b5" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_9cec6e34-45ae-4701-852c-5c9fb241cbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:to="loc_us-gaap_HedgingDesignationAxis_9cec6e34-45ae-4701-852c-5c9fb241cbc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9cec6e34-45ae-4701-852c-5c9fb241cbc3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_9cec6e34-45ae-4701-852c-5c9fb241cbc3" xlink:to="loc_us-gaap_HedgingDesignationDomain_9cec6e34-45ae-4701-852c-5c9fb241cbc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_332fc61b-6d6d-4fdf-babe-f6407a31eceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_9cec6e34-45ae-4701-852c-5c9fb241cbc3" xlink:to="loc_us-gaap_HedgingDesignationDomain_332fc61b-6d6d-4fdf-babe-f6407a31eceb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_19d696b9-5cb8-44aa-b7d0-ce1720805fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_332fc61b-6d6d-4fdf-babe-f6407a31eceb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_19d696b9-5cb8-44aa-b7d0-ce1720805fb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4d916e13-4a3a-4258-81cf-6e3de1d74f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4d916e13-4a3a-4258-81cf-6e3de1d74f72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4d916e13-4a3a-4258-81cf-6e3de1d74f72_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4d916e13-4a3a-4258-81cf-6e3de1d74f72" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4d916e13-4a3a-4258-81cf-6e3de1d74f72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3a1e36d2-1b7e-4c38-a1cd-e29c7bcc81a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4d916e13-4a3a-4258-81cf-6e3de1d74f72" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3a1e36d2-1b7e-4c38-a1cd-e29c7bcc81a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b8263177-2816-4d1b-85af-250097fba625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3a1e36d2-1b7e-4c38-a1cd-e29c7bcc81a0" xlink:to="loc_us-gaap_InterestRateSwapMember_b8263177-2816-4d1b-85af-250097fba625" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_58e484fa-db8f-421d-9ea6-6916a409cbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3a1e36d2-1b7e-4c38-a1cd-e29c7bcc81a0" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_58e484fa-db8f-421d-9ea6-6916a409cbe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_636e6058-0b0e-4f2a-9db1-64b6203d4aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_636e6058-0b0e-4f2a-9db1-64b6203d4aa4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_636e6058-0b0e-4f2a-9db1-64b6203d4aa4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_636e6058-0b0e-4f2a-9db1-64b6203d4aa4" xlink:to="loc_us-gaap_HedgingRelationshipDomain_636e6058-0b0e-4f2a-9db1-64b6203d4aa4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e448490f-768f-4872-8436-31161af33800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_636e6058-0b0e-4f2a-9db1-64b6203d4aa4" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e448490f-768f-4872-8436-31161af33800" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_39a704c8-3451-46c7-918b-2ba7705b36e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e448490f-768f-4872-8436-31161af33800" xlink:to="loc_us-gaap_CashFlowHedgingMember_39a704c8-3451-46c7-918b-2ba7705b36e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_79ff52cf-5034-4474-8834-f88b54e3e84d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e448490f-768f-4872-8436-31161af33800" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_79ff52cf-5034-4474-8834-f88b54e3e84d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3bd88a38-f437-414b-9f7d-b1699838fa93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3bd88a38-f437-414b-9f7d-b1699838fa93" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3bd88a38-f437-414b-9f7d-b1699838fa93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bd88a38-f437-414b-9f7d-b1699838fa93" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3bd88a38-f437-414b-9f7d-b1699838fa93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bd88a38-f437-414b-9f7d-b1699838fa93" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_7bfe0d5b-7deb-44d9-a3f7-90faff6d9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_7bfe0d5b-7deb-44d9-a3f7-90faff6d9ab0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_b2b3ed1e-f074-4b0c-8e44-b03d08c8f196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:to="loc_us-gaap_OtherAssetsMember_b2b3ed1e-f074-4b0c-8e44-b03d08c8f196" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_08c2fbbf-1ce1-4461-a690-c41a13f85291" xlink:href="iart-20211231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_08c2fbbf-1ce1-4461-a690-c41a13f85291" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_d738cd16-cc4c-4187-9d81-e3d1c6472e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:to="loc_us-gaap_OtherLiabilitiesMember_d738cd16-cc4c-4187-9d81-e3d1c6472e80" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="extended" id="id471410146de4b60b91ff02cd5b8a016_DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e88e3544-6d76-486e-8e86-a972c15c5bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e88e3544-6d76-486e-8e86-a972c15c5bca" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_87fb8894-51ae-473e-9d0e-273b3ac5b7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:to="loc_us-gaap_StockholdersEquity_87fb8894-51ae-473e-9d0e-273b3ac5b7d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_35db3d81-1304-41f8-b30e-5bb8db0dbde9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_35db3d81-1304-41f8-b30e-5bb8db0dbde9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6ce871d8-aa5a-4325-9884-3dcfc1ac3cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6ce871d8-aa5a-4325-9884-3dcfc1ac3cbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1c6c89dd-10d9-43a5-ae32-73013c06911a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e88e3544-6d76-486e-8e86-a972c15c5bca" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_57c0827c-b793-47f0-bf11-f61248f2ce22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_HedgingDesignationAxis_57c0827c-b793-47f0-bf11-f61248f2ce22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_57c0827c-b793-47f0-bf11-f61248f2ce22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_57c0827c-b793-47f0-bf11-f61248f2ce22" xlink:to="loc_us-gaap_HedgingDesignationDomain_57c0827c-b793-47f0-bf11-f61248f2ce22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2210ebcb-6c8b-46a3-af6d-24cf951acc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_57c0827c-b793-47f0-bf11-f61248f2ce22" xlink:to="loc_us-gaap_HedgingDesignationDomain_2210ebcb-6c8b-46a3-af6d-24cf951acc3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_efa74e6f-0fee-462c-ba8c-60a6606bbfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2210ebcb-6c8b-46a3-af6d-24cf951acc3d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_efa74e6f-0fee-462c-ba8c-60a6606bbfe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6bee9eb8-24e0-449d-87a1-4f80f695198c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6bee9eb8-24e0-449d-87a1-4f80f695198c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6bee9eb8-24e0-449d-87a1-4f80f695198c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6bee9eb8-24e0-449d-87a1-4f80f695198c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6bee9eb8-24e0-449d-87a1-4f80f695198c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_34625aab-22ec-4874-ab45-9b3759bb5e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6bee9eb8-24e0-449d-87a1-4f80f695198c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_34625aab-22ec-4874-ab45-9b3759bb5e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_52e4509b-7a0f-4161-958c-5817edc76e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_34625aab-22ec-4874-ab45-9b3759bb5e24" xlink:to="loc_us-gaap_InterestRateSwapMember_52e4509b-7a0f-4161-958c-5817edc76e24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_e9695e63-1c63-4ea4-bf2a-8f4f49861271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_34625aab-22ec-4874-ab45-9b3759bb5e24" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_e9695e63-1c63-4ea4-bf2a-8f4f49861271" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a9a4d7f0-d522-433b-81f9-79215a209d66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a9a4d7f0-d522-433b-81f9-79215a209d66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a9a4d7f0-d522-433b-81f9-79215a209d66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a9a4d7f0-d522-433b-81f9-79215a209d66" xlink:to="loc_us-gaap_EquityComponentDomain_a9a4d7f0-d522-433b-81f9-79215a209d66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_367da541-f3dc-46be-b139-f272d0a0247d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a9a4d7f0-d522-433b-81f9-79215a209d66" xlink:to="loc_us-gaap_EquityComponentDomain_367da541-f3dc-46be-b139-f272d0a0247d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8d48eed0-53bc-4959-98aa-2685c883436d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_367da541-f3dc-46be-b139-f272d0a0247d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8d48eed0-53bc-4959-98aa-2685c883436d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ba5ebe8c-c08b-4f21-85ce-88a50c0dee51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ba5ebe8c-c08b-4f21-85ce-88a50c0dee51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ba5ebe8c-c08b-4f21-85ce-88a50c0dee51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ba5ebe8c-c08b-4f21-85ce-88a50c0dee51" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ba5ebe8c-c08b-4f21-85ce-88a50c0dee51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_12173f2b-be80-4c55-9662-2fad866b3bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ba5ebe8c-c08b-4f21-85ce-88a50c0dee51" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_12173f2b-be80-4c55-9662-2fad866b3bc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_7b964ce3-d186-4256-849c-d7a0afddbe0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12173f2b-be80-4c55-9662-2fad866b3bc7" xlink:to="loc_us-gaap_InterestExpenseMember_7b964ce3-d186-4256-849c-d7a0afddbe0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b3622825-6572-49be-9ace-3175a96bd595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12173f2b-be80-4c55-9662-2fad866b3bc7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b3622825-6572-49be-9ace-3175a96bd595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_008c4589-f6c7-4814-b17a-5152906f6d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12173f2b-be80-4c55-9662-2fad866b3bc7" xlink:to="loc_us-gaap_InterestIncomeMember_008c4589-f6c7-4814-b17a-5152906f6d9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d83a1946-0994-4d2c-8cea-188ea52596cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d83a1946-0994-4d2c-8cea-188ea52596cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d83a1946-0994-4d2c-8cea-188ea52596cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d83a1946-0994-4d2c-8cea-188ea52596cd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d83a1946-0994-4d2c-8cea-188ea52596cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_59ee2834-077f-4329-a652-31287d3ecd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d83a1946-0994-4d2c-8cea-188ea52596cd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_59ee2834-077f-4329-a652-31287d3ecd7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_a3d440f1-3b95-48f5-ab6f-758373dddcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_59ee2834-077f-4329-a652-31287d3ecd7a" xlink:to="loc_us-gaap_CashFlowHedgingMember_a3d440f1-3b95-48f5-ab6f-758373dddcc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d4d3ba19-face-4d65-8fb7-c5017cf3fc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_59ee2834-077f-4329-a652-31287d3ecd7a" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d4d3ba19-face-4d65-8fb7-c5017cf3fc49" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended" id="i3b472957a7144e4e9f18b15c4fd1665b_GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_72e1de3e-7c28-4f3c-bd22-405461c62692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_NumberOfReportingUnits_72e1de3e-7c28-4f3c-bd22-405461c62692" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_7aa13484-126c-4b68-b4b2-b7940e0168e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_7aa13484-126c-4b68-b4b2-b7940e0168e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_06a8ec2e-eb5c-4da6-b3d3-bf4e909ef32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_AdjustmentForAmortization_06a8ec2e-eb5c-4da6-b3d3-bf4e909ef32b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_9131b590-6a59-4375-a88d-544c2fab1542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_9131b590-6a59-4375-a88d-544c2fab1542" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_85d06b5f-bd47-41d6-a58a-35f8a099b61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_85d06b5f-bd47-41d6-a58a-35f8a099b61c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6fe423e6-06b7-4ac4-922a-60400ec9ff54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6fe423e6-06b7-4ac4-922a-60400ec9ff54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_58a0b73d-c19d-4486-8e97-fec40c15828f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_58a0b73d-c19d-4486-8e97-fec40c15828f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e574ed79-93c9-4de3-bcf8-7a0669419528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e574ed79-93c9-4de3-bcf8-7a0669419528" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ade5a74d-8961-41e7-b516-d0c27bd32937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ade5a74d-8961-41e7-b516-d0c27bd32937" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_8e966335-14f7-443e-a89f-b1d83daa8a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_8e966335-14f7-443e-a89f-b1d83daa8a45" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_68bd36d2-1aa0-41d6-b9bf-4c6cf944a329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_68bd36d2-1aa0-41d6-b9bf-4c6cf944a329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68bd36d2-1aa0-41d6-b9bf-4c6cf944a329_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_68bd36d2-1aa0-41d6-b9bf-4c6cf944a329" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68bd36d2-1aa0-41d6-b9bf-4c6cf944a329_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54cdc3f8-ef32-4d65-aafe-9abc6b631add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_68bd36d2-1aa0-41d6-b9bf-4c6cf944a329" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54cdc3f8-ef32-4d65-aafe-9abc6b631add" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6962581c-a1ce-420b-bad3-37e565642ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54cdc3f8-ef32-4d65-aafe-9abc6b631add" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6962581c-a1ce-420b-bad3-37e565642ef0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c2d6ba73-1f39-498e-b7ff-06f8ae734259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c2d6ba73-1f39-498e-b7ff-06f8ae734259" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2d6ba73-1f39-498e-b7ff-06f8ae734259_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c2d6ba73-1f39-498e-b7ff-06f8ae734259" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2d6ba73-1f39-498e-b7ff-06f8ae734259_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a251530-bd3b-4155-8cb3-fd373fd23b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c2d6ba73-1f39-498e-b7ff-06f8ae734259" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a251530-bd3b-4155-8cb3-fd373fd23b2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_6ff49158-8189-4e84-a49a-737cfbcacf68" xlink:href="iart-20211231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a251530-bd3b-4155-8cb3-fd373fd23b2e" xlink:to="loc_iart_SmithNephewUSDLimitedMember_6ff49158-8189-4e84-a49a-737cfbcacf68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_f1898cf0-cee7-43e1-b5e1-f45ed0b03305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_f1898cf0-cee7-43e1-b5e1-f45ed0b03305" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f1898cf0-cee7-43e1-b5e1-f45ed0b03305_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f1898cf0-cee7-43e1-b5e1-f45ed0b03305" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f1898cf0-cee7-43e1-b5e1-f45ed0b03305_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1be05867-d12c-4677-a614-7ea17e91fa10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f1898cf0-cee7-43e1-b5e1-f45ed0b03305" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1be05867-d12c-4677-a614-7ea17e91fa10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8becb3ef-d849-4f11-8000-b178691f20b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1be05867-d12c-4677-a614-7ea17e91fa10" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8becb3ef-d849-4f11-8000-b178691f20b2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="extended" id="ibb8ed257ad5543609ac1a89a833023b8_GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_18a63387-6399-4a79-ab54-6ad8c3b4ab10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_18a63387-6399-4a79-ab54-6ad8c3b4ab10" xlink:to="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec515a6f-a753-4f8f-8c25-5545076fb77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:to="loc_us-gaap_Goodwill_ec515a6f-a753-4f8f-8c25-5545076fb77d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_ab484176-624f-43c8-a490-73d7f3a1d26e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:to="loc_us-gaap_GoodwillTransfers_ab484176-624f-43c8-a490-73d7f3a1d26e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_cc7a2c30-9dd1-419c-b1f1-f26391384f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_cc7a2c30-9dd1-419c-b1f1-f26391384f3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e754b99e-b77a-4ce8-b9e1-eab67929150a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e754b99e-b77a-4ce8-b9e1-eab67929150a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_eaaa8517-a8ff-460e-b8d4-68bc2946f048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_236be894-f31f-4b0c-8961-ffd524998c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_18a63387-6399-4a79-ab54-6ad8c3b4ab10" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_236be894-f31f-4b0c-8961-ffd524998c2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dfdaf0e2-9064-441c-b873-bfde395fc5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_236be894-f31f-4b0c-8961-ffd524998c2a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dfdaf0e2-9064-441c-b873-bfde395fc5e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dfdaf0e2-9064-441c-b873-bfde395fc5e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dfdaf0e2-9064-441c-b873-bfde395fc5e9" xlink:to="loc_us-gaap_SegmentDomain_dfdaf0e2-9064-441c-b873-bfde395fc5e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5609abde-3566-4d17-a766-4123e1a12fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dfdaf0e2-9064-441c-b873-bfde395fc5e9" xlink:to="loc_us-gaap_SegmentDomain_5609abde-3566-4d17-a766-4123e1a12fc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_ee474edc-8f4a-489f-bfd7-74c7c5edb64e" xlink:href="iart-20211231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5609abde-3566-4d17-a766-4123e1a12fc4" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_ee474edc-8f4a-489f-bfd7-74c7c5edb64e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_c08e6d6a-1efe-46d0-855d-bab9d121b104" xlink:href="iart-20211231.xsd#iart_TissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5609abde-3566-4d17-a766-4123e1a12fc4" xlink:to="loc_iart_TissueTechnologiesMember_c08e6d6a-1efe-46d0-855d-bab9d121b104" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="i5db17417117a429499b72061d7bb3956_GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1cee9af2-06c1-48ca-b889-53bb574023e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1cee9af2-06c1-48ca-b889-53bb574023e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_418a7412-64a0-4c1e-beb0-a3d0776beead" xlink:href="iart-20211231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_418a7412-64a0-4c1e-beb0-a3d0776beead" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8291e1b6-e41c-46ac-9464-ce2ab683fbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8291e1b6-e41c-46ac-9464-ce2ab683fbcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_703e1457-8e39-439b-a3fb-479d963b8682" xlink:href="iart-20211231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:to="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_703e1457-8e39-439b-a3fb-479d963b8682" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_c67b7221-25c9-45c5-8ebb-f73ad61570ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_c67b7221-25c9-45c5-8ebb-f73ad61570ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_762aea1b-b4ec-4910-8ffe-bc76a330a8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_c67b7221-25c9-45c5-8ebb-f73ad61570ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_762aea1b-b4ec-4910-8ffe-bc76a330a8d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_762aea1b-b4ec-4910-8ffe-bc76a330a8d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_762aea1b-b4ec-4910-8ffe-bc76a330a8d1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_762aea1b-b4ec-4910-8ffe-bc76a330a8d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_762aea1b-b4ec-4910-8ffe-bc76a330a8d1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember_f12e79f5-c579-47f9-bef5-e689d8464337" xlink:href="iart-20211231.xsd#iart_CompletedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:to="loc_iart_CompletedTechnologyMember_f12e79f5-c579-47f9-bef5-e689d8464337" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e792f1e0-2a36-4992-81ed-3da25ff5531e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e792f1e0-2a36-4992-81ed-3da25ff5531e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember_49646614-a184-4195-8d15-88024d515486" xlink:href="iart-20211231.xsd#iart_TrademarksBrandNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:to="loc_iart_TrademarksBrandNamesMember_49646614-a184-4195-8d15-88024d515486" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember_4fe15c6b-f740-4424-852c-ddb9e7273d97" xlink:href="iart-20211231.xsd#iart_SupplierRelationShipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:to="loc_iart_SupplierRelationShipsMember_4fe15c6b-f740-4424-852c-ddb9e7273d97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember_54760677-f076-427e-a823-2187f46c1cfd" xlink:href="iart-20211231.xsd#iart_AllOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:to="loc_iart_AllOtherMember_54760677-f076-427e-a823-2187f46c1cfd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ac1f429c-4e20-477c-8ba4-c7b5d7368cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_c67b7221-25c9-45c5-8ebb-f73ad61570ff" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ac1f429c-4e20-477c-8ba4-c7b5d7368cb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ac1f429c-4e20-477c-8ba4-c7b5d7368cb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ac1f429c-4e20-477c-8ba4-c7b5d7368cb7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ac1f429c-4e20-477c-8ba4-c7b5d7368cb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae017087-c2c8-4f27-ba3e-47105dba6cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ac1f429c-4e20-477c-8ba4-c7b5d7368cb7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae017087-c2c8-4f27-ba3e-47105dba6cfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_0d56bb16-3d55-4673-a476-10a4214bfe6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae017087-c2c8-4f27-ba3e-47105dba6cfb" xlink:to="loc_us-gaap_TradeNamesMember_0d56bb16-3d55-4673-a476-10a4214bfe6a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#TREASURYSTOCKNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="extended" id="if2e20a98393143739a812ed6d7227809_TREASURYSTOCKNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_b3482f19-0dc8-4b51-8bb8-da33b170a791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_TreasuryStockCommonShares_b3482f19-0dc8-4b51-8bb8-da33b170a791" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_4446780a-70d6-45b8-a3d9-70da65825059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_TreasuryStockCommonValue_4446780a-70d6-45b8-a3d9-70da65825059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_afaa3311-eab5-446b-9d47-59407ca59054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_afaa3311-eab5-446b-9d47-59407ca59054" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_259be3ae-d8c6-4226-a2d5-d29c66195024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_259be3ae-d8c6-4226-a2d5-d29c66195024" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_c78e209a-68b0-4c37-bd5e-89752019dc94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_c78e209a-68b0-4c37-bd5e-89752019dc94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_828227dd-ae07-4637-ac31-1264d4b5ad0a" xlink:href="iart-20211231.xsd#iart_AcceleratedShareRepurchasesSharesReceivedAtInception"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_828227dd-ae07-4637-ac31-1264d4b5ad0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_7efc3e38-ee26-4b62-9d3a-0d3430c307ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_7efc3e38-ee26-4b62-9d3a-0d3430c307ef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_f571a3b2-94c7-456f-a997-b7bebfb9e4a0" xlink:href="iart-20211231.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_f571a3b2-94c7-456f-a997-b7bebfb9e4a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_e2988644-241f-48c1-9b53-2d18bbe2b11e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_e2988644-241f-48c1-9b53-2d18bbe2b11e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_6ff27881-9971-4fe3-92b2-454b7d576489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_6ff27881-9971-4fe3-92b2-454b7d576489" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_0f29bcc7-e529-4ada-aee1-4b8256c55245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_0f29bcc7-e529-4ada-aee1-4b8256c55245" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_61150baf-8b13-457d-a0dc-763930b8f736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_61150baf-8b13-457d-a0dc-763930b8f736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_61150baf-8b13-457d-a0dc-763930b8f736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_61150baf-8b13-457d-a0dc-763930b8f736" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_61150baf-8b13-457d-a0dc-763930b8f736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a0b2d8d0-bd13-4c84-8ebb-b55211bd3a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_61150baf-8b13-457d-a0dc-763930b8f736" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a0b2d8d0-bd13-4c84-8ebb-b55211bd3a7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_d333aa2c-dab9-4415-8532-ae7420d4a0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a0b2d8d0-bd13-4c84-8ebb-b55211bd3a7b" xlink:to="loc_us-gaap_ConvertibleDebtMember_d333aa2c-dab9-4415-8532-ae7420d4a0aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_804f4031-8d7b-4d53-8589-dee68829d359" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:to="loc_srt_CounterpartyNameAxis_804f4031-8d7b-4d53-8589-dee68829d359" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_804f4031-8d7b-4d53-8589-dee68829d359_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_804f4031-8d7b-4d53-8589-dee68829d359" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_804f4031-8d7b-4d53-8589-dee68829d359_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_581494c6-76f8-4c85-931d-b8ea9483d7bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_804f4031-8d7b-4d53-8589-dee68829d359" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_581494c6-76f8-4c85-931d-b8ea9483d7bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CertainPurchasersMember_8062ab31-de48-4e60-9f95-f9ad0016f69c" xlink:href="iart-20211231.xsd#iart_CertainPurchasersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_581494c6-76f8-4c85-931d-b8ea9483d7bf" xlink:to="loc_iart_CertainPurchasersMember_8062ab31-de48-4e60-9f95-f9ad0016f69c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0bf753e6-f764-43c5-a767-dc6b05ec8e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0bf753e6-f764-43c5-a767-dc6b05ec8e59" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0bf753e6-f764-43c5-a767-dc6b05ec8e59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0bf753e6-f764-43c5-a767-dc6b05ec8e59" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0bf753e6-f764-43c5-a767-dc6b05ec8e59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5179f009-d4e6-44fa-95d7-ddc275dc1c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0bf753e6-f764-43c5-a767-dc6b05ec8e59" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5179f009-d4e6-44fa-95d7-ddc275dc1c7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_bd468bff-0c58-4ef3-8f4b-56d5a234ca4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5179f009-d4e6-44fa-95d7-ddc275dc1c7e" xlink:to="loc_us-gaap_SubsequentEventMember_bd468bff-0c58-4ef3-8f4b-56d5a234ca4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_524fa6a2-45f1-442a-a5dd-a1fc4bc4f863" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:to="loc_srt_StatementScenarioAxis_524fa6a2-45f1-442a-a5dd-a1fc4bc4f863" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_524fa6a2-45f1-442a-a5dd-a1fc4bc4f863_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_524fa6a2-45f1-442a-a5dd-a1fc4bc4f863" xlink:to="loc_srt_ScenarioUnspecifiedDomain_524fa6a2-45f1-442a-a5dd-a1fc4bc4f863_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4c7d03f0-1c3b-4449-b93e-1541a9ecb669" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_524fa6a2-45f1-442a-a5dd-a1fc4bc4f863" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4c7d03f0-1c3b-4449-b93e-1541a9ecb669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c65949ea-6324-4b84-b5ba-d1392bca2110" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_4c7d03f0-1c3b-4449-b93e-1541a9ecb669" xlink:to="loc_srt_ScenarioForecastMember_c65949ea-6324-4b84-b5ba-d1392bca2110" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="extended" id="ibce2f7ba8b5b471abed04c9a20ce0775_STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7410dcf5-db1f-4561-a91e-c6d874bf3091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_fd083a21-e05f-4fea-958c-460ec68b191c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7410dcf5-db1f-4561-a91e-c6d874bf3091" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_fd083a21-e05f-4fea-958c-460ec68b191c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b2ca29ea-7852-460b-8c75-c35331d1da72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7410dcf5-db1f-4561-a91e-c6d874bf3091" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b2ca29ea-7852-460b-8c75-c35331d1da72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_7f4f9c8f-17c2-4f8b-a7d5-20310ae13534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7410dcf5-db1f-4561-a91e-c6d874bf3091" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_7f4f9c8f-17c2-4f8b-a7d5-20310ae13534" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_db3fe3e9-3dcf-4d78-aa14-99d01c76320c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7410dcf5-db1f-4561-a91e-c6d874bf3091" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_db3fe3e9-3dcf-4d78-aa14-99d01c76320c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_eacf1053-cf62-49dc-91ed-0a27f04fefe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_db3fe3e9-3dcf-4d78-aa14-99d01c76320c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_eacf1053-cf62-49dc-91ed-0a27f04fefe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_eacf1053-cf62-49dc-91ed-0a27f04fefe0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_eacf1053-cf62-49dc-91ed-0a27f04fefe0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_eacf1053-cf62-49dc-91ed-0a27f04fefe0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_02e62bbc-7e79-4311-9045-005a86a93e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_eacf1053-cf62-49dc-91ed-0a27f04fefe0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_02e62bbc-7e79-4311-9045-005a86a93e89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3ecf2d27-e01d-4e94-ae13-71034c88d710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_02e62bbc-7e79-4311-9045-005a86a93e89" xlink:to="loc_us-gaap_CostOfSalesMember_3ecf2d27-e01d-4e94-ae13-71034c88d710" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f15a4d00-371d-45a8-92fe-91bff27b8362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_02e62bbc-7e79-4311-9045-005a86a93e89" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f15a4d00-371d-45a8-92fe-91bff27b8362" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_be8c8f71-a488-4745-a7b4-5182a5d2f000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_02e62bbc-7e79-4311-9045-005a86a93e89" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_be8c8f71-a488-4745-a7b4-5182a5d2f000" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="i3ad546e17dba4206a429dfec1d298859_STOCKBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e1efaed5-6a13-41ae-9057-7b4c3ca98907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e1efaed5-6a13-41ae-9057-7b4c3ca98907" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_44d3d86a-983d-4fc9-8c01-d2d93c0f10e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_44d3d86a-983d-4fc9-8c01-d2d93c0f10e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5189217d-1f6b-4a13-800b-44475ad46bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5189217d-1f6b-4a13-800b-44475ad46bcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeStockPurchasePlanProceeds_2bf91ba4-610b-4268-b8d7-b5dc6c9dcd66" xlink:href="iart-20211231.xsd#iart_EmployeeStockPurchasePlanProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_iart_EmployeeStockPurchasePlanProceeds_2bf91ba4-610b-4268-b8d7-b5dc6c9dcd66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncreaseInAuthorizedShares_8654eda3-8847-42bd-a66e-4e25e63f4095" xlink:href="iart-20211231.xsd#iart_IncreaseInAuthorizedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_iart_IncreaseInAuthorizedShares_8654eda3-8847-42bd-a66e-4e25e63f4095" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_634dff11-a6a2-4f70-b6d9-17cb5db2574e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_634dff11-a6a2-4f70-b6d9-17cb5db2574e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_a927c61d-bdb2-4ecf-9aa5-a9ea5e41aef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_a927c61d-bdb2-4ecf-9aa5-a9ea5e41aef4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b01001d4-7712-40fb-b8ac-64c634a4934d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b01001d4-7712-40fb-b8ac-64c634a4934d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_51945e8f-00b9-4630-a7f0-99c014ae5e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_51945e8f-00b9-4630-a7f0-99c014ae5e3a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9b40806a-5a73-4684-9707-b04716a64113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9b40806a-5a73-4684-9707-b04716a64113" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0fecddd1-9283-4568-8c2f-c61e92afa648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0fecddd1-9283-4568-8c2f-c61e92afa648" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_459328cf-eeea-4244-b17b-3c0224bc8099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_459328cf-eeea-4244-b17b-3c0224bc8099" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e670baf7-d84f-45e2-910b-33d150e924bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e670baf7-d84f-45e2-910b-33d150e924bf" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6244ef3b-66f9-4318-8f14-4d254d0d6394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6244ef3b-66f9-4318-8f14-4d254d0d6394" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a751660b-7aa6-479b-9610-b068daca9066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a751660b-7aa6-479b-9610-b068daca9066" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_ace25ad4-6197-4921-89aa-d43a93fce14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_ace25ad4-6197-4921-89aa-d43a93fce14a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_1434541e-177b-46f6-ad4b-7c18a7e3fcbd" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_1434541e-177b-46f6-ad4b-7c18a7e3fcbd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_95afe36b-d9a8-45e3-9f7d-87c5b2b2705c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_95afe36b-d9a8-45e3-9f7d-87c5b2b2705c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_92262024-b0f3-44c8-8317-6da2eef5c123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:to="loc_us-gaap_AwardTypeAxis_92262024-b0f3-44c8-8317-6da2eef5c123" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_92262024-b0f3-44c8-8317-6da2eef5c123_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_92262024-b0f3-44c8-8317-6da2eef5c123" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_92262024-b0f3-44c8-8317-6da2eef5c123_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_92262024-b0f3-44c8-8317-6da2eef5c123" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_639ed39d-1477-4684-8727-f027937ce367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:to="loc_us-gaap_EmployeeStockMember_639ed39d-1477-4684-8727-f027937ce367" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_81846f3c-c082-491a-8686-e74256b6cba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:to="loc_us-gaap_EmployeeStockOptionMember_81846f3c-c082-491a-8686-e74256b6cba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_277ea7e1-6f03-40e6-92ac-0a86270a9765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_277ea7e1-6f03-40e6-92ac-0a86270a9765" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_174cb2c7-c3ff-464a-9a63-366cd53b9e53" xlink:href="iart-20211231.xsd#iart_RestrictedStockPerformanceStockAndContractStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:to="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_174cb2c7-c3ff-464a-9a63-366cd53b9e53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_19cdeeeb-0e26-4a5d-a5af-9eb751c7acdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:to="loc_us-gaap_PerformanceSharesMember_19cdeeeb-0e26-4a5d-a5af-9eb751c7acdb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_83f74b22-9b83-4a9c-b3de-597598b7697f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:to="loc_us-gaap_PlanNameAxis_83f74b22-9b83-4a9c-b3de-597598b7697f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_83f74b22-9b83-4a9c-b3de-597598b7697f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_83f74b22-9b83-4a9c-b3de-597598b7697f" xlink:to="loc_us-gaap_PlanNameDomain_83f74b22-9b83-4a9c-b3de-597598b7697f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d4ce16fa-1d68-454b-946e-6009544483e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_83f74b22-9b83-4a9c-b3de-597598b7697f" xlink:to="loc_us-gaap_PlanNameDomain_d4ce16fa-1d68-454b-946e-6009544483e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandThreePlanMember_a8cc0e89-1de7-40e6-8fab-841561d95ef5" xlink:href="iart-20211231.xsd#iart_TwoThousandThreePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d4ce16fa-1d68-454b-946e-6009544483e0" xlink:to="loc_iart_TwoThousandThreePlanMember_a8cc0e89-1de7-40e6-8fab-841561d95ef5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanMember_13a2a84c-2282-4ec0-8316-c2d94c7b3321" xlink:href="iart-20211231.xsd#iart_TwoThousandPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d4ce16fa-1d68-454b-946e-6009544483e0" xlink:to="loc_iart_TwoThousandPlanMember_13a2a84c-2282-4ec0-8316-c2d94c7b3321" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandOnePlanMember_6ebd999c-cad8-4d1f-b215-ee708b593c5b" xlink:href="iart-20211231.xsd#iart_TwoThousandOnePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d4ce16fa-1d68-454b-946e-6009544483e0" xlink:to="loc_iart_TwoThousandOnePlanMember_6ebd999c-cad8-4d1f-b215-ee708b593c5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_b751ce77-d43b-486d-88c9-b543fa300c63" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:to="loc_srt_TitleOfIndividualAxis_b751ce77-d43b-486d-88c9-b543fa300c63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b751ce77-d43b-486d-88c9-b543fa300c63_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_b751ce77-d43b-486d-88c9-b543fa300c63" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b751ce77-d43b-486d-88c9-b543fa300c63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d3bc95-2279-47c1-9827-adf963dda92b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_b751ce77-d43b-486d-88c9-b543fa300c63" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d3bc95-2279-47c1-9827-adf963dda92b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_258c8626-0bb0-421a-aa41-617bccd3eb05" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d3bc95-2279-47c1-9827-adf963dda92b" xlink:to="loc_srt_DirectorMember_258c8626-0bb0-421a-aa41-617bccd3eb05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember_2145f49c-a131-4605-b144-e0b398c2a236" xlink:href="iart-20211231.xsd#iart_EmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d3bc95-2279-47c1-9827-adf963dda92b" xlink:to="loc_iart_EmployeeMember_2145f49c-a131-4605-b144-e0b398c2a236" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember_b95a3494-ede0-4d96-813e-10deb0582c6d" xlink:href="iart-20211231.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d3bc95-2279-47c1-9827-adf963dda92b" xlink:to="loc_iart_DirectorsandCertainExecutiveOfficersMember_b95a3494-ede0-4d96-813e-10deb0582c6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_62ef7245-10b5-4ef4-aad7-490ed8ad16b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:to="loc_srt_RangeAxis_62ef7245-10b5-4ef4-aad7-490ed8ad16b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_62ef7245-10b5-4ef4-aad7-490ed8ad16b3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_62ef7245-10b5-4ef4-aad7-490ed8ad16b3" xlink:to="loc_srt_RangeMember_62ef7245-10b5-4ef4-aad7-490ed8ad16b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0295a113-8c40-4ffc-bb11-f55ffe1dd847" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_62ef7245-10b5-4ef4-aad7-490ed8ad16b3" xlink:to="loc_srt_RangeMember_0295a113-8c40-4ffc-bb11-f55ffe1dd847" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_da2c8580-c88e-42bc-9e38-01fe79f272cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0295a113-8c40-4ffc-bb11-f55ffe1dd847" xlink:to="loc_srt_MinimumMember_da2c8580-c88e-42bc-9e38-01fe79f272cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fb8f199e-9a79-49f9-976c-0725f079f95a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0295a113-8c40-4ffc-bb11-f55ffe1dd847" xlink:to="loc_srt_MaximumMember_fb8f199e-9a79-49f9-976c-0725f079f95a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="extended" id="i6f3f8204889a46678198656db343e5d1_STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13aaa747-abd0-44f3-8da3-d25de870d09d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13aaa747-abd0-44f3-8da3-d25de870d09d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72f54b5f-8818-4177-a4f9-c416450d4d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72f54b5f-8818-4177-a4f9-c416450d4d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_59416f8c-9148-4e18-aef9-d8c74ef59192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_59416f8c-9148-4e18-aef9-d8c74ef59192" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_79f8469d-bac2-4fb9-9ba3-0d09c05430a7" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_79f8469d-bac2-4fb9-9ba3-0d09c05430a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a8942dfc-ac60-435a-b7c3-606446a969aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a8942dfc-ac60-435a-b7c3-606446a969aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_06269bf5-741b-4932-accc-4f73dc4d9160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_06269bf5-741b-4932-accc-4f73dc4d9160" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_e7f947cf-c652-40dc-8b82-8b9298e7f7e1" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_e7f947cf-c652-40dc-8b82-8b9298e7f7e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b291e64-c2df-4639-adb4-6ec77db433d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13aaa747-abd0-44f3-8da3-d25de870d09d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fc31359d-1d18-4ef8-84bf-a0e687a6c9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fc31359d-1d18-4ef8-84bf-a0e687a6c9ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3fee7071-93ee-42c7-a474-14850c296695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3fee7071-93ee-42c7-a474-14850c296695" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_1017349e-dbc0-431f-9dab-7e8ed0bbf6e7" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_1017349e-dbc0-431f-9dab-7e8ed0bbf6e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5839de83-2543-495e-98d6-3290275ff758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5839de83-2543-495e-98d6-3290275ff758" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f07d591f-1c90-4dd7-a6ca-54d34d6427ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f07d591f-1c90-4dd7-a6ca-54d34d6427ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_7e9b6ee0-c421-4596-83a9-38f43439a000" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_7e9b6ee0-c421-4596-83a9-38f43439a000" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1c6a607e-edf6-44ca-994d-49e7c4030c59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7a466bb8-ab6e-49d0-b147-a52247be433f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13aaa747-abd0-44f3-8da3-d25de870d09d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7a466bb8-ab6e-49d0-b147-a52247be433f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d90612fe-f7c2-440a-b0d3-afebddc634d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7a466bb8-ab6e-49d0-b147-a52247be433f" xlink:to="loc_us-gaap_AwardTypeAxis_d90612fe-f7c2-440a-b0d3-afebddc634d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d90612fe-f7c2-440a-b0d3-afebddc634d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d90612fe-f7c2-440a-b0d3-afebddc634d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d90612fe-f7c2-440a-b0d3-afebddc634d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a890bcf-1684-4f62-9483-8a156a23a709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d90612fe-f7c2-440a-b0d3-afebddc634d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a890bcf-1684-4f62-9483-8a156a23a709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_eda36762-4684-4f15-9b27-80746076762a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a890bcf-1684-4f62-9483-8a156a23a709" xlink:to="loc_us-gaap_RestrictedStockMember_eda36762-4684-4f15-9b27-80746076762a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockandContractStockMember_dc0aafe6-76fd-4a51-b9ef-eba6267f2fee" xlink:href="iart-20211231.xsd#iart_PerformanceStockandContractStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a890bcf-1684-4f62-9483-8a156a23a709" xlink:to="loc_iart_PerformanceStockandContractStockMember_dc0aafe6-76fd-4a51-b9ef-eba6267f2fee" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="extended" id="idfb1d73671944c84a6f083035b3e821f_RETIREMENTBENEFITPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_77c98254-8246-4b0d-98ac-12e49f135bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_77c98254-8246-4b0d-98ac-12e49f135bf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_edad8e94-89d0-4727-bbed-b3db325b5beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_edad8e94-89d0-4727-bbed-b3db325b5beb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b7500f93-3aa1-4ea9-b84b-ef7bb62a6f36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b7500f93-3aa1-4ea9-b84b-ef7bb62a6f36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_945e5942-3e0d-4e0e-86e2-0d37563e68bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_945e5942-3e0d-4e0e-86e2-0d37563e68bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_60b99bdd-ec4e-4aae-98bd-27df7dbc310e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_60b99bdd-ec4e-4aae-98bd-27df7dbc310e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_0284633b-6a8b-4a46-9a80-7ac93d738d42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_0284633b-6a8b-4a46-9a80-7ac93d738d42" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_3525ac7f-36bc-4b39-b5b0-fdca6d1f3898" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_3525ac7f-36bc-4b39-b5b0-fdca6d1f3898" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_87229f72-c47c-41bd-96eb-5b3cfd35ba3f" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_87229f72-c47c-41bd-96eb-5b3cfd35ba3f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_e435aab6-15aa-4d3d-89c5-3e61636b3768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_e435aab6-15aa-4d3d-89c5-3e61636b3768" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2cc42653-2d62-4deb-8f62-1dc761312695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2cc42653-2d62-4deb-8f62-1dc761312695" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_a2862808-9d44-4e30-bb9f-9c9d24339e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2cc42653-2d62-4deb-8f62-1dc761312695" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_a2862808-9d44-4e30-bb9f-9c9d24339e01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_a2862808-9d44-4e30-bb9f-9c9d24339e01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a2862808-9d44-4e30-bb9f-9c9d24339e01" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_a2862808-9d44-4e30-bb9f-9c9d24339e01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_e550094d-54bc-4384-a643-624c6fbd6e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a2862808-9d44-4e30-bb9f-9c9d24339e01" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_e550094d-54bc-4384-a643-624c6fbd6e64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_e89d8548-efcd-4198-89b5-7c123024830a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e550094d-54bc-4384-a643-624c6fbd6e64" xlink:to="loc_us-gaap_ForeignPlanMember_e89d8548-efcd-4198-89b5-7c123024830a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FranceAndGermanyMember_596580cd-a6e7-439c-842b-6adec6098514" xlink:href="iart-20211231.xsd#iart_FranceAndGermanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_e89d8548-efcd-4198-89b5-7c123024830a" xlink:to="loc_iart_FranceAndGermanyMember_596580cd-a6e7-439c-842b-6adec6098514" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#LEASESANDRELATEDPARTYLEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="extended" id="i1d8f696228cb4422a23c44ed83e653eb_LEASESANDRELATEDPARTYLEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_12e2fe7a-1f9a-4a5b-affb-45350634fb15" xlink:href="iart-20211231.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_12e2fe7a-1f9a-4a5b-affb-45350634fb15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_1361c7c3-1e2b-4fdd-89bc-2600af9e6034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_us-gaap_OperatingLeaseExpense_1361c7c3-1e2b-4fdd-89bc-2600af9e6034" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1cad3d99-8c18-40d3-b831-c1767ca70324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1cad3d99-8c18-40d3-b831-c1767ca70324" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_24b8e0b3-cb0c-4835-8beb-bb02f00d98f0" xlink:href="iart-20211231.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_24b8e0b3-cb0c-4835-8beb-bb02f00d98f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement_e29b4d77-212b-4ba5-bcf7-dcf9e49b4046" xlink:href="iart-20211231.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_iart_AnnualRateOfLeaseAgreement_e29b4d77-212b-4ba5-bcf7-dcf9e49b4046" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OptionToExtendLeaseYears_81ad0b2a-4daf-433c-b3eb-f88f4e1b8c63" xlink:href="iart-20211231.xsd#iart_OptionToExtendLeaseYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_iart_OptionToExtendLeaseYears_81ad0b2a-4daf-433c-b3eb-f88f4e1b8c63" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_612ecf8d-4c60-4bac-8e7f-8d11ffaaec4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_612ecf8d-4c60-4bac-8e7f-8d11ffaaec4e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b02b8914-b093-482e-85d9-2c42220ec09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b02b8914-b093-482e-85d9-2c42220ec09c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0fef6f1b-6051-4bab-9382-5458f9d427af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b02b8914-b093-482e-85d9-2c42220ec09c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0fef6f1b-6051-4bab-9382-5458f9d427af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0fef6f1b-6051-4bab-9382-5458f9d427af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0fef6f1b-6051-4bab-9382-5458f9d427af" xlink:to="loc_us-gaap_RelatedPartyDomain_0fef6f1b-6051-4bab-9382-5458f9d427af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c151eada-f6aa-4f23-bc24-17b876fbf773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0fef6f1b-6051-4bab-9382-5458f9d427af" xlink:to="loc_us-gaap_RelatedPartyDomain_c151eada-f6aa-4f23-bc24-17b876fbf773" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_caaa8dbe-d70e-4b86-9601-97364f620660" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c151eada-f6aa-4f23-bc24-17b876fbf773" xlink:to="loc_srt_AffiliatedEntityMember_caaa8dbe-d70e-4b86-9601-97364f620660" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_8ef23681-f361-492c-8de6-4975429faf70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b02b8914-b093-482e-85d9-2c42220ec09c" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_8ef23681-f361-492c-8de6-4975429faf70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_8ef23681-f361-492c-8de6-4975429faf70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_8ef23681-f361-492c-8de6-4975429faf70" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_8ef23681-f361-492c-8de6-4975429faf70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_57274069-6ace-4841-812c-fd4196103693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_8ef23681-f361-492c-8de6-4975429faf70" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_57274069-6ace-4841-812c-fd4196103693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember_9319450e-d3e6-4a90-924b-24e08b1d8087" xlink:href="iart-20211231.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_57274069-6ace-4841-812c-fd4196103693" xlink:to="loc_iart_FiveYearOptionLeasePeriodOneMember_9319450e-d3e6-4a90-924b-24e08b1d8087" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearLeasePeriodTwoMember_91e1e6a9-2745-4ac3-b59b-38f9c183dfe9" xlink:href="iart-20211231.xsd#iart_FiveYearLeasePeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_57274069-6ace-4841-812c-fd4196103693" xlink:to="loc_iart_FiveYearLeasePeriodTwoMember_91e1e6a9-2745-4ac3-b59b-38f9c183dfe9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i0a743a469ea54b9aa54fcbec5d5beb71_LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_64559a7f-a192-464b-9607-8f443b9a0d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_64559a7f-a192-464b-9607-8f443b9a0d43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_97bf7e8f-cdc2-468b-87c0-33fff56bca06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_97bf7e8f-cdc2-468b-87c0-33fff56bca06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bb3f63cf-932a-45f9-bc97-e7a34fdd157f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bb3f63cf-932a-45f9-bc97-e7a34fdd157f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e12dafd1-f003-4267-93dc-d299346cede8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseLiability_e12dafd1-f003-4267-93dc-d299346cede8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1b9cf755-cff3-4b17-b59f-d2216a423244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1b9cf755-cff3-4b17-b59f-d2216a423244" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ca95fa5f-e039-4852-8c03-20a997a3d50d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ca95fa5f-e039-4852-8c03-20a997a3d50d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2d3b36ce-770a-4e34-88ff-cb7fe3704f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2d3b36ce-770a-4e34-88ff-cb7fe3704f1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bf2dc9bd-02e6-4eb3-b0cc-033a54f65be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d3b36ce-770a-4e34-88ff-cb7fe3704f1a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bf2dc9bd-02e6-4eb3-b0cc-033a54f65be8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bf2dc9bd-02e6-4eb3-b0cc-033a54f65be8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bf2dc9bd-02e6-4eb3-b0cc-033a54f65be8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bf2dc9bd-02e6-4eb3-b0cc-033a54f65be8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5570aa2-46b8-4bba-ad19-2fa9fefb6c62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bf2dc9bd-02e6-4eb3-b0cc-033a54f65be8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5570aa2-46b8-4bba-ad19-2fa9fefb6c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_98a9456c-5f3f-4775-bd2f-3b0c5093d15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5570aa2-46b8-4bba-ad19-2fa9fefb6c62" xlink:to="loc_us-gaap_BuildingMember_98a9456c-5f3f-4775-bd2f-3b0c5093d15a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_117a4c72-83b1-485d-a93e-5982242684bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5570aa2-46b8-4bba-ad19-2fa9fefb6c62" xlink:to="loc_us-gaap_VehiclesMember_117a4c72-83b1-485d-a93e-5982242684bb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="extended" id="ife42a132d2814fb8b333445f05de78a7_LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8df8cb52-1d70-45f6-b9da-92ec0a21464e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8df8cb52-1d70-45f6-b9da-92ec0a21464e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fc5499a5-655c-4476-af22-2d7473d965d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fc5499a5-655c-4476-af22-2d7473d965d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e79eaffe-ffdf-4795-a08f-072b4b67b180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e79eaffe-ffdf-4795-a08f-072b4b67b180" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ae20dff-275b-4b3a-8fa2-5c3232962767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ae20dff-275b-4b3a-8fa2-5c3232962767" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4c405f8d-e7f6-41f3-b5bf-ef5a552e3de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4c405f8d-e7f6-41f3-b5bf-ef5a552e3de4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_edbaa790-210f-4134-98f1-2f90812aaf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_edbaa790-210f-4134-98f1-2f90812aaf7c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75c30d74-e24f-4fc7-b180-591b038a22bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75c30d74-e24f-4fc7-b180-591b038a22bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_48dbe9da-d1dd-4308-b2fa-4f7d6f3b5b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_48dbe9da-d1dd-4308-b2fa-4f7d6f3b5b45" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_32aec346-cd31-4619-955f-0d3092efb9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_OperatingLeaseLiability_32aec346-cd31-4619-955f-0d3092efb9ad" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_21bcc93d-6870-41f7-8b74-b265abc838b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_21bcc93d-6870-41f7-8b74-b265abc838b9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_106a7e12-be37-45c2-b07c-3a62b5adb72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_106a7e12-be37-45c2-b07c-3a62b5adb72f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_1528e9bd-022a-4230-824a-39bc054c3a79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_1528e9bd-022a-4230-824a-39bc054c3a79" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_39f41d1b-b243-42fb-93bc-631c9225c45d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_1528e9bd-022a-4230-824a-39bc054c3a79" xlink:to="loc_srt_CounterpartyNameAxis_39f41d1b-b243-42fb-93bc-631c9225c45d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_39f41d1b-b243-42fb-93bc-631c9225c45d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_39f41d1b-b243-42fb-93bc-631c9225c45d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_39f41d1b-b243-42fb-93bc-631c9225c45d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6bd66d5a-08c9-49fd-bea4-0feaefc95895" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_39f41d1b-b243-42fb-93bc-631c9225c45d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6bd66d5a-08c9-49fd-bea4-0feaefc95895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember_ab5a0222-d75c-4cbb-9565-5259bac8c5a5" xlink:href="iart-20211231.xsd#iart_RelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6bd66d5a-08c9-49fd-bea4-0feaefc95895" xlink:to="loc_iart_RelatedPartiesMember_ab5a0222-d75c-4cbb-9565-5259bac8c5a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember_0a4e5151-0b63-4bf2-aa94-496a13a3189b" xlink:href="iart-20211231.xsd#iart_ThirdPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6bd66d5a-08c9-49fd-bea4-0feaefc95895" xlink:to="loc_iart_ThirdPartiesMember_0a4e5151-0b63-4bf2-aa94-496a13a3189b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended" id="ie1b024fd80034358a84a46f556a417fe_INCOMETAXESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:href="iart-20211231.xsd#iart_IncomeTaxLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_67070de8-8abe-4aed-a1e2-31a247cf8ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_67070de8-8abe-4aed-a1e2-31a247cf8ffc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_6288e483-5b02-4e49-9327-0be539f42f43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_6288e483-5b02-4e49-9327-0be539f42f43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_ce917829-9c59-4a6d-a69f-61a51ff41210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_ce917829-9c59-4a6d-a69f-61a51ff41210" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_352e0331-6eb4-40d5-9b60-a0e65125fb8d" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_352e0331-6eb4-40d5-9b60-a0e65125fb8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_a305e559-adb9-4138-a174-ae6031688243" xlink:href="iart-20211231.xsd#iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_a305e559-adb9-4138-a174-ae6031688243" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_d637d323-e4df-411c-b151-86eefdd0ff9a" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_d637d323-e4df-411c-b151-86eefdd0ff9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e28b0823-e513-4190-95b1-0c8f21621227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e28b0823-e513-4190-95b1-0c8f21621227" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_ec96bf92-88ee-4b35-ba86-dcff335b38c8" xlink:href="iart-20211231.xsd#iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_ec96bf92-88ee-4b35-ba86-dcff335b38c8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_69490c46-ed47-499a-93ac-b63a2f08481d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_69490c46-ed47-499a-93ac-b63a2f08481d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_d231b635-1493-453d-a879-a99eea4a8615" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_d231b635-1493-453d-a879-a99eea4a8615" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_c2968408-d491-4e2c-86bd-d2d87871d978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_OperatingLossCarryforwards_c2968408-d491-4e2c-86bd-d2d87871d978" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_3b669bbb-7f4e-4558-ae43-09e6825add17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_3b669bbb-7f4e-4558-ae43-09e6825add17" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_64b7fcef-12a3-4377-afb4-36ccc3f7b77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_64b7fcef-12a3-4377-afb4-36ccc3f7b77a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated_5cf8f6d2-a3d6-4a01-900c-9545636f9522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_ForeignEarningsRepatriated_5cf8f6d2-a3d6-4a01-900c-9545636f9522" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4b17999e-3bb7-40eb-a326-6297d0629339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4b17999e-3bb7-40eb-a326-6297d0629339" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_095b7858-dbfb-4738-bdbb-42da7eddaed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_095b7858-dbfb-4738-bdbb-42da7eddaed1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_eee7b95c-bcff-4329-add5-b8040d677fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_eee7b95c-bcff-4329-add5-b8040d677fef" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_1110abfc-9e61-43a6-a031-abab53768a26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_1110abfc-9e61-43a6-a031-abab53768a26" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:href="iart-20211231.xsd#iart_IncomeTaxTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_e08d8242-96c1-411d-a1f7-cc2db594d642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_e08d8242-96c1-411d-a1f7-cc2db594d642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e08d8242-96c1-411d-a1f7-cc2db594d642_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e08d8242-96c1-411d-a1f7-cc2db594d642" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e08d8242-96c1-411d-a1f7-cc2db594d642_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ad90eb38-a7b1-407a-8af6-dd8b66485e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e08d8242-96c1-411d-a1f7-cc2db594d642" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ad90eb38-a7b1-407a-8af6-dd8b66485e04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_9c2a616a-a8c0-4668-b94f-e9fbc9892e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ad90eb38-a7b1-407a-8af6-dd8b66485e04" xlink:to="loc_us-gaap_ForeignCountryMember_9c2a616a-a8c0-4668-b94f-e9fbc9892e56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_96198006-eb75-4053-ba90-86ed8007b8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ad90eb38-a7b1-407a-8af6-dd8b66485e04" xlink:to="loc_us-gaap_DomesticCountryMember_96198006-eb75-4053-ba90-86ed8007b8e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_75b72fe6-865a-40fe-b401-8fb0b68485b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ad90eb38-a7b1-407a-8af6-dd8b66485e04" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_75b72fe6-865a-40fe-b401-8fb0b68485b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_abf07ce0-2fae-40fb-bfec-45941b0a4f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_abf07ce0-2fae-40fb-bfec-45941b0a4f45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_abf07ce0-2fae-40fb-bfec-45941b0a4f45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_abf07ce0-2fae-40fb-bfec-45941b0a4f45" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_abf07ce0-2fae-40fb-bfec-45941b0a4f45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_e1a07320-a232-433c-ba4c-a86fa2cd9a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_abf07ce0-2fae-40fb-bfec-45941b0a4f45" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_e1a07320-a232-433c-ba4c-a86fa2cd9a8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_3e485752-3026-4d27-a4b3-956d088fa1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_e1a07320-a232-433c-ba4c-a86fa2cd9a8b" xlink:to="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_3e485752-3026-4d27-a4b3-956d088fa1e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_794c859a-7328-44a8-a51f-e801920099f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_794c859a-7328-44a8-a51f-e801920099f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_794c859a-7328-44a8-a51f-e801920099f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_794c859a-7328-44a8-a51f-e801920099f7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_794c859a-7328-44a8-a51f-e801920099f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5aabc56-23c8-4d2c-9001-4b5439a5aa5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_794c859a-7328-44a8-a51f-e801920099f7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5aabc56-23c8-4d2c-9001-4b5439a5aa5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_2e8ac293-cae7-496a-88f9-ae289ef35482" xlink:href="iart-20211231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5aabc56-23c8-4d2c-9001-4b5439a5aa5f" xlink:to="loc_iart_ExtremityOrthopedicsMember_2e8ac293-cae7-496a-88f9-ae289ef35482" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#NETINCOMEPERSHARENarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="extended" id="i8c27efaa7a384cb2a4fd84437f7eb1de_NETINCOMEPERSHARENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_dea6b10d-adb5-41d1-89b3-3f30211950ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67f3cdbe-4af9-4c42-ac4a-0cdd16e62fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_dea6b10d-adb5-41d1-89b3-3f30211950ee" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67f3cdbe-4af9-4c42-ac4a-0cdd16e62fcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AdditionalEPSShares_d3c9fbbd-fd6b-4d16-afc2-03f0ba8770af" xlink:href="iart-20211231.xsd#iart_AdditionalEPSShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_dea6b10d-adb5-41d1-89b3-3f30211950ee" xlink:to="loc_iart_AdditionalEPSShares_d3c9fbbd-fd6b-4d16-afc2-03f0ba8770af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0342c37d-d99f-4797-87c5-fedf3c409107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_dea6b10d-adb5-41d1-89b3-3f30211950ee" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0342c37d-d99f-4797-87c5-fedf3c409107" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ee9b01d5-77b6-43fe-b6a6-b7a0e09f74d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0342c37d-d99f-4797-87c5-fedf3c409107" xlink:to="loc_us-gaap_AwardTypeAxis_ee9b01d5-77b6-43fe-b6a6-b7a0e09f74d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee9b01d5-77b6-43fe-b6a6-b7a0e09f74d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ee9b01d5-77b6-43fe-b6a6-b7a0e09f74d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee9b01d5-77b6-43fe-b6a6-b7a0e09f74d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63737067-2ce8-477d-9276-4778ea48c2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ee9b01d5-77b6-43fe-b6a6-b7a0e09f74d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63737067-2ce8-477d-9276-4778ea48c2b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceSharesandRestrictedUnitsMember_3e11b2a8-5f80-4d73-886a-2106ce554244" xlink:href="iart-20211231.xsd#iart_PerformanceSharesandRestrictedUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63737067-2ce8-477d-9276-4778ea48c2b8" xlink:to="loc_iart_PerformanceSharesandRestrictedUnitsMember_3e11b2a8-5f80-4d73-886a-2106ce554244" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i47feab61a2e24ebab6a99da8eef6808a_ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c54f66c8-26c5-4144-a9c6-421dae5a9b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:href="iart-20211231.xsd#iart_AccumulatedOtherComprehensiveIncomeLossRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c54f66c8-26c5-4144-a9c6-421dae5a9b0b" xlink:to="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_26ca1294-6434-406d-bce3-917703a296a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:to="loc_us-gaap_StockholdersEquity_26ca1294-6434-406d-bce3-917703a296a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_473a1b07-31dc-4059-9b99-df7445679e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_473a1b07-31dc-4059-9b99-df7445679e66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_cfd4ea7d-ee0c-44f1-98e7-0977a6a241fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_cfd4ea7d-ee0c-44f1-98e7-0977a6a241fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_241b54c8-78be-42e6-9142-52c16f3e14a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_241b54c8-78be-42e6-9142-52c16f3e14a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_76023a61-14ab-4406-b728-713a5dd66420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_18e87bae-151a-4068-afcf-7d2e3af09897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c54f66c8-26c5-4144-a9c6-421dae5a9b0b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_18e87bae-151a-4068-afcf-7d2e3af09897" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ac1bab2f-78be-4608-b678-86323ec563a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_18e87bae-151a-4068-afcf-7d2e3af09897" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ac1bab2f-78be-4608-b678-86323ec563a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ac1bab2f-78be-4608-b678-86323ec563a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ac1bab2f-78be-4608-b678-86323ec563a7" xlink:to="loc_us-gaap_EquityComponentDomain_ac1bab2f-78be-4608-b678-86323ec563a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c0ef355-fd22-4ad0-93bd-b33933f4e39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ac1bab2f-78be-4608-b678-86323ec563a7" xlink:to="loc_us-gaap_EquityComponentDomain_2c0ef355-fd22-4ad0-93bd-b33933f4e39a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba73a887-0fe1-44eb-b854-ab52a0a94535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2c0ef355-fd22-4ad0-93bd-b33933f4e39a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba73a887-0fe1-44eb-b854-ab52a0a94535" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5aa038b8-9335-4bcb-8bb8-a7b072949014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba73a887-0fe1-44eb-b854-ab52a0a94535" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5aa038b8-9335-4bcb-8bb8-a7b072949014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_065036d7-6162-4db4-82a0-fe7bba06b1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba73a887-0fe1-44eb-b854-ab52a0a94535" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_065036d7-6162-4db4-82a0-fe7bba06b1e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dc9d7b99-c2b4-4597-bda8-7722137d5837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba73a887-0fe1-44eb-b854-ab52a0a94535" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dc9d7b99-c2b4-4597-bda8-7722137d5837" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" xlink:type="extended" id="iff63cb932dd745b0b61be929751df4fa_ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8e652cb3-c77b-4e7b-929f-57261395176d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_d6298ebe-da4a-46fc-9bb9-719c9dda0385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8e652cb3-c77b-4e7b-929f-57261395176d" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_d6298ebe-da4a-46fc-9bb9-719c9dda0385" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8c75768c-f54b-4c2a-896c-4ab8a7747c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8e652cb3-c77b-4e7b-929f-57261395176d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8c75768c-f54b-4c2a-896c-4ab8a7747c1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a221f19c-96ce-4e1f-a021-053ab1140496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8c75768c-f54b-4c2a-896c-4ab8a7747c1d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a221f19c-96ce-4e1f-a021-053ab1140496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a221f19c-96ce-4e1f-a021-053ab1140496_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a221f19c-96ce-4e1f-a021-053ab1140496" xlink:to="loc_us-gaap_EquityComponentDomain_a221f19c-96ce-4e1f-a021-053ab1140496_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a53d3a1e-4d1c-4529-b1c9-3eb7ccc9b6af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a221f19c-96ce-4e1f-a021-053ab1140496" xlink:to="loc_us-gaap_EquityComponentDomain_a53d3a1e-4d1c-4529-b1c9-3eb7ccc9b6af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_be0ec04f-b4cb-4545-9d35-658b24570b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a53d3a1e-4d1c-4529-b1c9-3eb7ccc9b6af" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_be0ec04f-b4cb-4545-9d35-658b24570b87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1cb01090-a805-4167-ba0c-c70d6a5bd596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8c75768c-f54b-4c2a-896c-4ab8a7747c1d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1cb01090-a805-4167-ba0c-c70d6a5bd596" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1cb01090-a805-4167-ba0c-c70d6a5bd596_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1cb01090-a805-4167-ba0c-c70d6a5bd596" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1cb01090-a805-4167-ba0c-c70d6a5bd596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5ed5c7ee-edf1-4b6d-9a55-7d2f9ce97949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1cb01090-a805-4167-ba0c-c70d6a5bd596" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5ed5c7ee-edf1-4b6d-9a55-7d2f9ce97949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_90e287e5-3296-4030-8f17-5b37de2af1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5ed5c7ee-edf1-4b6d-9a55-7d2f9ce97949" xlink:to="loc_us-gaap_OtherExpenseMember_90e287e5-3296-4030-8f17-5b37de2af1dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_7fe26567-f2ad-4ba9-bb72-21d6e0ce6336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5ed5c7ee-edf1-4b6d-9a55-7d2f9ce97949" xlink:to="loc_us-gaap_InterestIncomeMember_7fe26567-f2ad-4ba9-bb72-21d6e0ce6336" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="extended" id="i19120eea906d4f1a8ce4d859d0c6c0a9_COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4f5bf5f0-ba01-45d0-8ff6-99fa61e27aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4f5bf5f0-ba01-45d0-8ff6-99fa61e27aa5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b508b4e5-d776-4b30-a7a8-af6c22d50180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b508b4e5-d776-4b30-a7a8-af6c22d50180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0d786029-4cb9-4100-a5f7-443458b78473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0d786029-4cb9-4100-a5f7-443458b78473" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_7bad0388-4d3a-44c3-bbd9-c23c2a2cc2cd" xlink:href="iart-20211231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:to="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_7bad0388-4d3a-44c3-bbd9-c23c2a2cc2cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_36160772-1a73-4e5e-9b13-ea66753af880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_36160772-1a73-4e5e-9b13-ea66753af880" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b32c0c53-4069-4787-b392-3005644fd558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4f5bf5f0-ba01-45d0-8ff6-99fa61e27aa5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7410e0ed-2ea6-4343-a253-559b2cb930c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7410e0ed-2ea6-4343-a253-559b2cb930c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7410e0ed-2ea6-4343-a253-559b2cb930c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7410e0ed-2ea6-4343-a253-559b2cb930c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7410e0ed-2ea6-4343-a253-559b2cb930c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2322a-82b3-4118-9e73-f74acd93510c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7410e0ed-2ea6-4343-a253-559b2cb930c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2322a-82b3-4118-9e73-f74acd93510c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_41c6b3d8-7753-4df8-9567-054a12cf52d1" xlink:href="iart-20211231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2322a-82b3-4118-9e73-f74acd93510c" xlink:to="loc_iart_ArkisBioSciencesInc.Member_41c6b3d8-7753-4df8-9567-054a12cf52d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_2a956a9d-5e60-4e15-b1d7-d8d388e272e1" xlink:href="iart-20211231.xsd#iart_DermaSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2322a-82b3-4118-9e73-f74acd93510c" xlink:to="loc_iart_DermaSciencesMember_2a956a9d-5e60-4e15-b1d7-d8d388e272e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember_0b282fe4-3944-4b50-87be-ab2bde4b88c6" xlink:href="iart-20211231.xsd#iart_ACellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2322a-82b3-4118-9e73-f74acd93510c" xlink:to="loc_iart_ACellMember_0b282fe4-3944-4b50-87be-ab2bde4b88c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_f84baae3-055d-461f-9322-05e9eb1b3662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_f84baae3-055d-461f-9322-05e9eb1b3662" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f84baae3-055d-461f-9322-05e9eb1b3662_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f84baae3-055d-461f-9322-05e9eb1b3662" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f84baae3-055d-461f-9322-05e9eb1b3662_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_cbbb3e37-a994-44e2-8ce4-8ddd75bc5cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f84baae3-055d-461f-9322-05e9eb1b3662" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_cbbb3e37-a994-44e2-8ce4-8ddd75bc5cd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_91a25011-e475-4a2c-bffd-37d8d42f56ef" xlink:href="iart-20211231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_cbbb3e37-a994-44e2-8ce4-8ddd75bc5cd7" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_91a25011-e475-4a2c-bffd-37d8d42f56ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_da7fbdfe-a162-4c0b-abd9-044290abce60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_da7fbdfe-a162-4c0b-abd9-044290abce60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_da7fbdfe-a162-4c0b-abd9-044290abce60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_da7fbdfe-a162-4c0b-abd9-044290abce60" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_da7fbdfe-a162-4c0b-abd9-044290abce60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_68d4965d-654e-4902-b51f-ef770fc8bc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_da7fbdfe-a162-4c0b-abd9-044290abce60" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_68d4965d-654e-4902-b51f-ef770fc8bc99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6e5655f2-5862-4f6c-9261-72a707695d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_68d4965d-654e-4902-b51f-ef770fc8bc99" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6e5655f2-5862-4f6c-9261-72a707695d2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8c8ddf8e-6a73-4889-b4b8-16b6c90a62df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8c8ddf8e-6a73-4889-b4b8-16b6c90a62df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8c8ddf8e-6a73-4889-b4b8-16b6c90a62df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8c8ddf8e-6a73-4889-b4b8-16b6c90a62df" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8c8ddf8e-6a73-4889-b4b8-16b6c90a62df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_370cdf1d-ac76-4e43-b6cc-af2d4c554528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8c8ddf8e-6a73-4889-b4b8-16b6c90a62df" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_370cdf1d-ac76-4e43-b6cc-af2d4c554528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_af8caeff-0770-4117-876c-ef02fe265d6c" xlink:href="iart-20211231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_370cdf1d-ac76-4e43-b6cc-af2d4c554528" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_af8caeff-0770-4117-876c-ef02fe265d6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2fcb304a-a659-4fa0-ab5b-2806e74a1013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_370cdf1d-ac76-4e43-b6cc-af2d4c554528" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2fcb304a-a659-4fa0-ab5b-2806e74a1013" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#COMMITMENTSANDCONTINGENCIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="extended" id="idb4aed94330c4db6be8eac0c3e253222_COMMITMENTSANDCONTINGENCIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_506df61e-961b-4a73-be44-afe3bf4d393f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_dd81e0ec-af25-4d43-b7c2-fc5d823341cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_506df61e-961b-4a73-be44-afe3bf4d393f" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_dd81e0ec-af25-4d43-b7c2-fc5d823341cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_32114fa3-f0af-40e4-b579-d26bc7fb2b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_506df61e-961b-4a73-be44-afe3bf4d393f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_32114fa3-f0af-40e4-b579-d26bc7fb2b23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c1b3c4d5-23b4-452a-abcd-114e1f585ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_506df61e-961b-4a73-be44-afe3bf4d393f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c1b3c4d5-23b4-452a-abcd-114e1f585ab1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5abed335-39b1-48cb-8d43-1e5fad169323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_506df61e-961b-4a73-be44-afe3bf4d393f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5abed335-39b1-48cb-8d43-1e5fad169323" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c766443c-27e1-4197-805e-d8eca81bd1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5abed335-39b1-48cb-8d43-1e5fad169323" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c766443c-27e1-4197-805e-d8eca81bd1bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c766443c-27e1-4197-805e-d8eca81bd1bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c766443c-27e1-4197-805e-d8eca81bd1bb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c766443c-27e1-4197-805e-d8eca81bd1bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da127e00-7ec8-45e5-81fc-1e1699081de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c766443c-27e1-4197-805e-d8eca81bd1bb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da127e00-7ec8-45e5-81fc-1e1699081de2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_7af2c019-b50e-4e32-8bb3-47ac5e96c167" xlink:href="iart-20211231.xsd#iart_DermaSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da127e00-7ec8-45e5-81fc-1e1699081de2" xlink:to="loc_iart_DermaSciencesMember_7af2c019-b50e-4e32-8bb3-47ac5e96c167" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98734c09-0ea5-4c22-8fd9-8df728c4a587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5abed335-39b1-48cb-8d43-1e5fad169323" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98734c09-0ea5-4c22-8fd9-8df728c4a587" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98734c09-0ea5-4c22-8fd9-8df728c4a587_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98734c09-0ea5-4c22-8fd9-8df728c4a587" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98734c09-0ea5-4c22-8fd9-8df728c4a587_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_60c6775b-0051-4e4a-ab99-e26d5ea6218b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98734c09-0ea5-4c22-8fd9-8df728c4a587" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_60c6775b-0051-4e4a-ab99-e26d5ea6218b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9747bd92-a819-4fd0-b399-982859d9b5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_60c6775b-0051-4e4a-ab99-e26d5ea6218b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9747bd92-a819-4fd0-b399-982859d9b5bb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="extended" id="i7fb9476d054f44ebbfd73dc10af19398_SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3f0aa3d6-9b42-44af-9d2d-4ad4d9d2713b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_15c2664c-7257-4d10-ac2e-48b0769d9ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3f0aa3d6-9b42-44af-9d2d-4ad4d9d2713b" xlink:to="loc_us-gaap_NumberOfReportableSegments_15c2664c-7257-4d10-ac2e-48b0769d9ac1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered_8f4f6406-5a76-4b57-b98a-209b6518468c" xlink:href="iart-20211231.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3f0aa3d6-9b42-44af-9d2d-4ad4d9d2713b" xlink:to="loc_iart_SegmentReportingInformationNumberOfProductsOffered_8f4f6406-5a76-4b57-b98a-209b6518468c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f8f8b2b-f742-4605-bb6a-35e114e1845e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3f0aa3d6-9b42-44af-9d2d-4ad4d9d2713b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f8f8b2b-f742-4605-bb6a-35e114e1845e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a5c1159c-f30b-404a-b0d1-f0381672972d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f8f8b2b-f742-4605-bb6a-35e114e1845e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a5c1159c-f30b-404a-b0d1-f0381672972d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a5c1159c-f30b-404a-b0d1-f0381672972d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a5c1159c-f30b-404a-b0d1-f0381672972d" xlink:to="loc_us-gaap_SegmentDomain_a5c1159c-f30b-404a-b0d1-f0381672972d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4254f56a-a143-46ad-9b85-eb67df3836cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a5c1159c-f30b-404a-b0d1-f0381672972d" xlink:to="loc_us-gaap_SegmentDomain_4254f56a-a143-46ad-9b85-eb67df3836cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_cab901b3-38a7-4680-aa1c-fab7d8026a0f" xlink:href="iart-20211231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4254f56a-a143-46ad-9b85-eb67df3836cb" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_cab901b3-38a7-4680-aa1c-fab7d8026a0f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="extended" id="i2f20d81bca654b01a32a32f7abf42147_SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_757931b9-acdc-4637-a8a8-ed2fd9605a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_0f7157fa-4334-4651-a5ad-4ce30bf33ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_757931b9-acdc-4637-a8a8-ed2fd9605a0c" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_0f7157fa-4334-4651-a5ad-4ce30bf33ad0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2cabed17-9cc9-49ec-9ce4-4330189ab94f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_0f7157fa-4334-4651-a5ad-4ce30bf33ad0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2cabed17-9cc9-49ec-9ce4-4330189ab94f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_45d548cc-3875-430a-8d80-8be99c96d377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_757931b9-acdc-4637-a8a8-ed2fd9605a0c" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_45d548cc-3875-430a-8d80-8be99c96d377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_43e26fb9-5f48-4a9d-9e7b-9f7470bbdc44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_45d548cc-3875-430a-8d80-8be99c96d377" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_43e26fb9-5f48-4a9d-9e7b-9f7470bbdc44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a48e296f-513a-4293-91ce-0c125c3f79e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_45d548cc-3875-430a-8d80-8be99c96d377" xlink:to="loc_us-gaap_OperatingIncomeLoss_a48e296f-513a-4293-91ce-0c125c3f79e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3d9df4-83fc-49ad-b5b0-9a922b74453c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_757931b9-acdc-4637-a8a8-ed2fd9605a0c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3d9df4-83fc-49ad-b5b0-9a922b74453c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_954015e7-348e-4055-91f6-2a8d28767684" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3d9df4-83fc-49ad-b5b0-9a922b74453c" xlink:to="loc_srt_ConsolidationItemsAxis_954015e7-348e-4055-91f6-2a8d28767684" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_954015e7-348e-4055-91f6-2a8d28767684_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_954015e7-348e-4055-91f6-2a8d28767684" xlink:to="loc_srt_ConsolidationItemsDomain_954015e7-348e-4055-91f6-2a8d28767684_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_01906a0d-6907-418c-ab71-03e748414ddb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_954015e7-348e-4055-91f6-2a8d28767684" xlink:to="loc_srt_ConsolidationItemsDomain_01906a0d-6907-418c-ab71-03e748414ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7e757983-a2eb-4ca9-a7bc-175f82e73333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_01906a0d-6907-418c-ab71-03e748414ddb" xlink:to="loc_us-gaap_OperatingSegmentsMember_7e757983-a2eb-4ca9-a7bc-175f82e73333" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f18858c0-1593-48d9-90ab-351ebf2dc2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_01906a0d-6907-418c-ab71-03e748414ddb" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f18858c0-1593-48d9-90ab-351ebf2dc2b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7a295b0e-cc2a-4579-9e2d-22dbb2c4955c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3d9df4-83fc-49ad-b5b0-9a922b74453c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7a295b0e-cc2a-4579-9e2d-22dbb2c4955c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7a295b0e-cc2a-4579-9e2d-22dbb2c4955c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7a295b0e-cc2a-4579-9e2d-22dbb2c4955c" xlink:to="loc_us-gaap_SegmentDomain_7a295b0e-cc2a-4579-9e2d-22dbb2c4955c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0b6d6b4b-e38f-4996-bb00-7db2042d81ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7a295b0e-cc2a-4579-9e2d-22dbb2c4955c" xlink:to="loc_us-gaap_SegmentDomain_0b6d6b4b-e38f-4996-bb00-7db2042d81ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_ec7c5a37-32c9-4096-811b-f678af235d91" xlink:href="iart-20211231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0b6d6b4b-e38f-4996-bb00-7db2042d81ad" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_ec7c5a37-32c9-4096-811b-f678af235d91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_7ff3ee1b-3d59-487d-936b-c1a890273ba1" xlink:href="iart-20211231.xsd#iart_TissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0b6d6b4b-e38f-4996-bb00-7db2042d81ad" xlink:to="loc_iart_TissueTechnologiesMember_7ff3ee1b-3d59-487d-936b-c1a890273ba1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="extended" id="ie7f53fc933c44825900f4b653c2dcfee_SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_77800914-968e-46cc-9c72-5c260c3d3a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_78ca6045-9683-497d-80f8-dc1973c33b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77800914-968e-46cc-9c72-5c260c3d3a5a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_78ca6045-9683-497d-80f8-dc1973c33b0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_e4639ad5-ce1c-4636-9023-3cda2e239d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77800914-968e-46cc-9c72-5c260c3d3a5a" xlink:to="loc_us-gaap_NoncurrentAssets_e4639ad5-ce1c-4636-9023-3cda2e239d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e288af6e-b68d-48a7-bba1-4adac4fc1dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77800914-968e-46cc-9c72-5c260c3d3a5a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e288af6e-b68d-48a7-bba1-4adac4fc1dc4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a8c3bedf-86ea-4fb6-b122-e6c8a5e57902" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e288af6e-b68d-48a7-bba1-4adac4fc1dc4" xlink:to="loc_srt_StatementGeographicalAxis_a8c3bedf-86ea-4fb6-b122-e6c8a5e57902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a8c3bedf-86ea-4fb6-b122-e6c8a5e57902_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a8c3bedf-86ea-4fb6-b122-e6c8a5e57902" xlink:to="loc_srt_SegmentGeographicalDomain_a8c3bedf-86ea-4fb6-b122-e6c8a5e57902_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a8c3bedf-86ea-4fb6-b122-e6c8a5e57902" xlink:to="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_67df4598-b7c4-4d6f-b4b6-38dbea7d8e76" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:to="loc_country_US_67df4598-b7c4-4d6f-b4b6-38dbea7d8e76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_3be41048-4d14-4e13-866b-41b5835057b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:to="loc_srt_EuropeMember_3be41048-4d14-4e13-866b-41b5835057b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_891cffe9-eee4-4287-bb0b-6584b7581330" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:to="loc_srt_AsiaPacificMember_891cffe9-eee4-4287-bb0b-6584b7581330" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember_4d20f554-f6a8-4c8e-b8cf-a57121bef474" xlink:href="iart-20211231.xsd#iart_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:to="loc_iart_RestOfWorldMember_4d20f554-f6a8-4c8e-b8cf-a57121bef474" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended" id="i7484921337ed4e948241ba9ccfe40198_SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_fcdb164f-ae24-4612-ab98-7cb19be4809d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_fcdb164f-ae24-4612-ab98-7cb19be4809d" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_30f56b2f-ce10-4396-9228-51e7b73582dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_30f56b2f-ce10-4396-9228-51e7b73582dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f448789d-0e1b-49a2-a192-2342944ba728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f448789d-0e1b-49a2-a192-2342944ba728" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_7021ee87-722b-43dc-9dbd-4d8693c656b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_7021ee87-722b-43dc-9dbd-4d8693c656b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d20d9022-bfce-44a9-a46f-b7cb7a9fa790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d20d9022-bfce-44a9-a46f-b7cb7a9fa790" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_6ad54f5f-631c-48a7-b028-094f56d7ee8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6b3f82b0-e9c6-49f7-a1e1-c9788bc90ba8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_fcdb164f-ae24-4612-ab98-7cb19be4809d" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6b3f82b0-e9c6-49f7-a1e1-c9788bc90ba8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e9498b3b-1c6c-461d-adaf-92d2b5676f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6b3f82b0-e9c6-49f7-a1e1-c9788bc90ba8" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e9498b3b-1c6c-461d-adaf-92d2b5676f3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_e9498b3b-1c6c-461d-adaf-92d2b5676f3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e9498b3b-1c6c-461d-adaf-92d2b5676f3a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_e9498b3b-1c6c-461d-adaf-92d2b5676f3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_719cd63f-0c01-4f14-84d4-a3d9616960c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e9498b3b-1c6c-461d-adaf-92d2b5676f3a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_719cd63f-0c01-4f14-84d4-a3d9616960c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_bf3cedd3-422a-44f9-a94a-4491460cbaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_719cd63f-0c01-4f14-84d4-a3d9616960c8" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_bf3cedd3-422a-44f9-a94a-4491460cbaaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_64d9fdba-d683-4569-b849-2c66dd822287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_719cd63f-0c01-4f14-84d4-a3d9616960c8" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_64d9fdba-d683-4569-b849-2c66dd822287" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccountingStandardUpdate202006Member_fc8bb380-ea1a-43e6-a35f-27c39f06f2c8" xlink:href="iart-20211231.xsd#iart_AccountingStandardUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_iart_AccountingStandardUpdate202006Member_fc8bb380-ea1a-43e6-a35f-27c39f06f2c8" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>iart-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:79796dbd-6d84-4777-bf20-15ea797e2f25,g:15b73d14-4963-49a2-aa85-347a140ddfd4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_fbbe72c6-c90f-47b4-8650-e311e7a0801c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b62eab10-1da3-4f94-ac6b-98252f994519_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c703c052-0844-4bb4-a525-c7958d832c0b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_3c4e65a6-afc7-4838-ba14-19efc9667388_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_b74e9038-14e3-4637-a8ad-07122b3647e5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_354fe25c-34bf-4d8f-94dd-4dd4e05b691c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_label_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_3c75b1df-a17f-4bb2-a00e-bee13eb9b711_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to provision</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_082391f0-c45c-4120-b760-a7b47358ed86_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ed6a99a0-23ae-4e1f-9752-c0ad2e22c7e1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_31abcc1e-dbce-444f-a8f0-be1b58db8e26_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_638fd6c0-a77d-48aa-ba88-553a668e06f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_4d0d29dd-43e5-41c6-b6a6-6b2ad85fbb59_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for extended lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_860687a8-7a12-4ede-ae89-ad1eff8aaabc_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_f87da7c1-058d-4f3e-a9ba-1265368f8f44_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Contract Assets and Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_96349243-369c-4737-b597-6a811611bf38_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1ad66352-6bff-4879-b3b3-727339079649_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_33579b65-3c4e-41e6-9531-cc08f84be515_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_35eb02c2-098a-496f-a92d-5298e59c5f7d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive gain (loss), before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1374594-58a1-448c-9b32-bb9956560ec1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation, Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_e87e8372-87b2-4eb7-9319-29daf2d3cff3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FiveYearLeasePeriodTwoMember_cca0ceb9-95bb-477c-ba8e-06b535adce72_terseLabel_en-US" xlink:label="lab_iart_FiveYearLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease From November 1, 2034 Through October 31, 2039</link:label>
    <link:label id="lab_iart_FiveYearLeasePeriodTwoMember_label_en-US" xlink:label="lab_iart_FiveYearLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Lease Period Two [Member]</link:label>
    <link:label id="lab_iart_FiveYearLeasePeriodTwoMember_documentation_en-US" xlink:label="lab_iart_FiveYearLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Lease Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearLeasePeriodTwoMember" xlink:href="iart-20211231.xsd#iart_FiveYearLeasePeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FiveYearLeasePeriodTwoMember" xlink:to="lab_iart_FiveYearLeasePeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_84629855-c59a-41eb-a083-b51eba4bcf46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for purchase (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_49f958a7-c447-4fda-bded-b5e4dee1b328_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_75d32837-64d7-41e1-a173-92565c4f1fc2_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PerformanceSharesandRestrictedUnitsMember_b3b61cbc-a105-440f-8fc9-7c7f1a2efee7_terseLabel_en-US" xlink:label="lab_iart_PerformanceSharesandRestrictedUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares and Restricted Units</link:label>
    <link:label id="lab_iart_PerformanceSharesandRestrictedUnitsMember_label_en-US" xlink:label="lab_iart_PerformanceSharesandRestrictedUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares and Restricted Units [Member]</link:label>
    <link:label id="lab_iart_PerformanceSharesandRestrictedUnitsMember_documentation_en-US" xlink:label="lab_iart_PerformanceSharesandRestrictedUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares and Restricted Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceSharesandRestrictedUnitsMember" xlink:href="iart-20211231.xsd#iart_PerformanceSharesandRestrictedUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PerformanceSharesandRestrictedUnitsMember" xlink:to="lab_iart_PerformanceSharesandRestrictedUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f042b0e1-fdbc-4138-bf99-512e0eb348cb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ed3cf0bd-a9c9-4946-b6cc-7bf9daba7e14_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TissueTechnologiesMember_ac53edaf-b907-4d73-abf2-bcc12204efb8_terseLabel_en-US" xlink:label="lab_iart_TissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tissue Technologies</link:label>
    <link:label id="lab_iart_TissueTechnologiesMember_label_en-US" xlink:label="lab_iart_TissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tissue Technologies [Member]</link:label>
    <link:label id="lab_iart_TissueTechnologiesMember_documentation_en-US" xlink:label="lab_iart_TissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tissue Technologies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember" xlink:href="iart-20211231.xsd#iart_TissueTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TissueTechnologiesMember" xlink:to="lab_iart_TissueTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_cccf80d2-6c78-4aa6-93e1-0aa669af810e_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_abd72120-ea0a-4d7a-810e-6e6d1233aec3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value, options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4f333d7b-cbb8-41de-ac51-2cdb6f46f80a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_5d150884-29fa-47a7-907e-eef7e534214f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_076ab846-dc73-4753-82f8-1808cb0510b3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_aac5d8d6-a0cf-4b4c-b84e-d5b0753c086c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_0c4d903b-0323-4e0c-818e-a792e4d89be2_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_487c05fc-ba31-406e-9cbe-6fb72fbe2028_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_11fbbc0c-b58f-4c88-8141-8892a42c16e3_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4a46793f-88e3-4b10-b81b-2565697199a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amount under share repurchase</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_9b2919a9-ed23-49f3-8ba6-b9ef5c9f3d51_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of construction in progress</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_1104d97e-6f16-4692-b2b0-d5c46be82013_terseLabel_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers from long-term to current portion</link:label>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_label_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</link:label>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_documentation_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:href="iart-20211231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:to="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_a919cde0-fb46-4642-b964-0b0ceb8e3900_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years' tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EmployeeMember_98685b69-b83e-4f31-8b79-9df11a7f3294_terseLabel_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee</link:label>
    <link:label id="lab_iart_EmployeeMember_label_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee [Member]</link:label>
    <link:label id="lab_iart_EmployeeMember_documentation_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember" xlink:href="iart-20211231.xsd#iart_EmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EmployeeMember" xlink:to="lab_iart_EmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_643111ea-a30e-45bf-b332-415d7a23572c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e5212b2e-750b-46b3-b03f-e9d2695d4d36_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares excluded from computation as their effect would be antidilutive (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_7290acd3-7983-49dd-a219-29d1e254f4a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_3ba8440a-c649-463c-9801-d9a48d57135c_terseLabel_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization facility, outstanding borrowings, maximum limit</link:label>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_label_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</link:label>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_documentation_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:href="iart-20211231.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:to="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_30b5801d-7920-426e-b124-e2066c78be95_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7ceaf407-ab18-445a-8424-7c7bc910ef55_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of revenue included in beginning of year contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_9c078730-0061-436f-9828-deab8672d601_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_4df037ed-dca7-4109-847b-ef2c43b16486_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets after valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember_26e38cf7-80ee-4836-85f8-6d413b787085_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Two</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Two [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateSwapContractTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:to="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_23c9defc-e2b0-44ad-8972-1bf521728051_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_76a48c9c-05fe-4324-9161-4a5b06104024_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_9eab5c86-3534-4a32-8c58-9e34c97fa684_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AdditionalEPSShares_98eb60fc-b65c-4075-b2cf-976a3bdb9cbd_terseLabel_en-US" xlink:label="lab_iart_AdditionalEPSShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional EPS shares (in shares)</link:label>
    <link:label id="lab_iart_AdditionalEPSShares_label_en-US" xlink:label="lab_iart_AdditionalEPSShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional EPS Shares</link:label>
    <link:label id="lab_iart_AdditionalEPSShares_documentation_en-US" xlink:label="lab_iart_AdditionalEPSShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares included in the basic and diluted calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AdditionalEPSShares" xlink:href="iart-20211231.xsd#iart_AdditionalEPSShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AdditionalEPSShares" xlink:to="lab_iart_AdditionalEPSShares" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InformationSystemsandHardwareMember_863611e4-61a3-4ff5-a273-6d9aab8c4bc2_terseLabel_en-US" xlink:label="lab_iart_InformationSystemsandHardwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information systems and hardware</link:label>
    <link:label id="lab_iart_InformationSystemsandHardwareMember_label_en-US" xlink:label="lab_iart_InformationSystemsandHardwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Systems and Hardware [Member]</link:label>
    <link:label id="lab_iart_InformationSystemsandHardwareMember_documentation_en-US" xlink:label="lab_iart_InformationSystemsandHardwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Systems and Hardware [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InformationSystemsandHardwareMember" xlink:href="iart-20211231.xsd#iart_InformationSystemsandHardwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InformationSystemsandHardwareMember" xlink:to="lab_iart_InformationSystemsandHardwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_e5bae37a-efa9-4b5b-8922-4264c9da218a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_f4115d26-2e3a-443c-8ac6-ed8e0303103d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_06e54da9-e08a-420e-a6d3-03d98dc3c037_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Collected from Customers</link:label>
    <link:label id="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_52c36be7-b17c-4ab9-bfb4-481963d845c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ce8391f8-3b9f-4a17-9e15-2493a3c477be_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e722fd7a-7650-40d2-b4b2-e22a7671580a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4a9ba014-8ee5-4f67-a66b-fd84b0437453_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized actuarial losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c068c562-4bb8-47a4-9a78-1d76817252b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2134ceb5-7a71-45c5-a1d6-c1ebda470b7a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_046da165-f66a-4f44-9678-1a45d4aea3f3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_817013b2-91c0-4295-abf3-a66db73dc784_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_e013f61f-181a-40e2-8950-c94dfc8a7fc9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock; no par value; 15,000 authorized shares; none outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f6949062-6871-48f5-af0d-105e88ad5871_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_036714c5-8a0f-4561-bc8b-d61d60059380_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsYearOne_676a7a18-730f-4942-91b0-35b3c9c8b583_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, year one</link:label>
    <link:label id="lab_iart_InterestPaymentsYearOne_label_en-US" xlink:label="lab_iart_InterestPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year One</link:label>
    <link:label id="lab_iart_InterestPaymentsYearOne_documentation_en-US" xlink:label="lab_iart_InterestPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearOne" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsYearOne" xlink:to="lab_iart_InterestPaymentsYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_17db43ba-785e-4e14-b134-e4ff916256e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SurgicalInstrumentKitsMember_9182f2cb-fafd-401d-8d02-e3d6bbf709cb_terseLabel_en-US" xlink:label="lab_iart_SurgicalInstrumentKitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical instrument kits</link:label>
    <link:label id="lab_iart_SurgicalInstrumentKitsMember_label_en-US" xlink:label="lab_iart_SurgicalInstrumentKitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Instrument Kits [Member]</link:label>
    <link:label id="lab_iart_SurgicalInstrumentKitsMember_documentation_en-US" xlink:label="lab_iart_SurgicalInstrumentKitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Instrument Kits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInstrumentKitsMember" xlink:href="iart-20211231.xsd#iart_SurgicalInstrumentKitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SurgicalInstrumentKitsMember" xlink:to="lab_iart_SurgicalInstrumentKitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_910a2570-ccf7-4f90-a526-565d8a7b12f6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandThreePlanMember_0deb7f56-3f72-4370-b43d-510fb78f79ce_terseLabel_en-US" xlink:label="lab_iart_TwoThousandThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2003 Plan</link:label>
    <link:label id="lab_iart_TwoThousandThreePlanMember_label_en-US" xlink:label="lab_iart_TwoThousandThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Three Plan [Member]</link:label>
    <link:label id="lab_iart_TwoThousandThreePlanMember_documentation_en-US" xlink:label="lab_iart_TwoThousandThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand three Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandThreePlanMember" xlink:href="iart-20211231.xsd#iart_TwoThousandThreePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandThreePlanMember" xlink:to="lab_iart_TwoThousandThreePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_028816bf-06a9-4c77-a22e-0a50f0104c5d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8e751e4a-f2ab-47f3-90fa-2f6f13643f08_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment purchases included in liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e3dbb43f-6e74-42aa-b3ed-304b6665eb1c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ff827583-75db-46e6-9af2-45072a3575f5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_94218ea0-c6ba-4012-928b-01bee3ec2e10_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_b7980c3b-7f2a-4cab-82c2-7f706cb4ad67_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_c665b856-56dd-483e-aca9-31e2718955c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate on debt</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_91290e43-dd61-49a5-94f9-f363f92505a9_negatedTerseLabel_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_label_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reductions Resulting From Other</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_documentation_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reductions Resulting From Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:href="iart-20211231.xsd#iart_UnrecognizedTaxBenefitsReductionsResultingFromOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:to="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_4c316590-b821-4863-8fb0-436b033d2c45_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aab464ab-960b-4a44-80fe-ed33bcedb48e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_e6b5d250-847e-4845-8aaf-a62b4c95cdb2_terseLabel_en-US" xlink:label="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective foreign income tax rate</link:label>
    <link:label id="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_label_en-US" xlink:label="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Foreign Income Tax Rate Reconciliation, Continuing Operations</link:label>
    <link:label id="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_documentation_en-US" xlink:label="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Foreign Income Tax Rate Reconciliation, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:href="iart-20211231.xsd#iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:to="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_ba179f10-9bbf-4207-80d0-c3eee25d07d8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_b4a3b8a6-1cdc-47d5-8b44-32de648596a0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_8c5f15a7-2a16-4b3f-89d1-2c1d72618306_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Interest Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_b49ff69b-6179-40f3-95de-2ece434a0eaf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_fc830fc8-6a65-459b-8448-3f07728ea12c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_463386f3-19dc-44a6-bc59-99fa41a3a4cd_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ThirdPartiesMember_55f927d3-2266-4fe9-8638-4c01b2e0d262_verboseLabel_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties</link:label>
    <link:label id="lab_iart_ThirdPartiesMember_label_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties [Member]</link:label>
    <link:label id="lab_iart_ThirdPartiesMember_documentation_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember" xlink:href="iart-20211231.xsd#iart_ThirdPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ThirdPartiesMember" xlink:to="lab_iart_ThirdPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_23b88c2c-2e15-484e-97aa-c822127c1751_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance, period increase (decrease)</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_7a84c984-94c0-4548-b701-03906f2a9ab2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_691ec7f2-d07d-4077-a2f7-e5625b6aa986_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES FROM CONTRACTS WITH CUSTOMERS</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DermaSciencesMember_135c3563-8a22-4395-bdfc-59d2f7f2be7d_terseLabel_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences</link:label>
    <link:label id="lab_iart_DermaSciencesMember_label_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences [Member]</link:label>
    <link:label id="lab_iart_DermaSciencesMember_documentation_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember" xlink:href="iart-20211231.xsd#iart_DermaSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DermaSciencesMember" xlink:to="lab_iart_DermaSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_445903e4-f247-49f6-9de6-135fed44bc50_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5565f8f6-f880-49bd-aa25-55604338419b_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_11d8d496-6b2f-42d0-b083-9b11032454ae_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0af16aac-1f98-4a2b-8165-7199694c7135_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8c5c69c7-53f9-410d-9876-ac5bde2d68e8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_6c106570-406e-4646-829a-4e8f86401c4e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_f9ece411-3b42-40a5-936e-66e11d86d4af_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_a182d3cd-0957-4a92-9355-82873ae892fa_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_55e77c5a-48c1-437f-b813-3f330acb5788_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_2202b6f5-f7e4-4f31-9563-94333a6b8e88_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining net assets acquired</link:label>
    <link:label id="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Assets Acquired And Liabilities Assumed, Net</link:label>
    <link:label id="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Assets Acquired And Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_10310755-e0c7-4c23-9282-ca93cf7514d5_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_8721b3d0-e438-402e-a478-6df53c98bc3b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange loss</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Unrealized Currency Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_74224503-25b9-4774-8f83-4785efb75361_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and production equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_a52d3a69-ef3f-485e-87b4-e736f4c0244e_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_93c82151-f420-4b3c-af91-fcbd85c91eb5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total derivatives designated as hedges &#8212; Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_f4874a7c-9be1-44a4-877d-15cfaf76780e_negatedLabel_en-US" xlink:label="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment and construction in-progress</link:label>
    <link:label id="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_label_en-US" xlink:label="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress</link:label>
    <link:label id="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_documentation_en-US" xlink:label="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:href="iart-20211231.xsd#iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:to="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_0f18eef5-73cb-4eb4-90e2-16a16bc03eb9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized derivative gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_663a936f-7679-47d4-9bfd-e46e6a88bf58_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recorded in AOCL, change in fair value</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_06f6f9c1-4d3a-40a1-b52c-b482a32b4d72_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_352c8fa4-97ad-4f9e-ab33-08c3fc88ddd4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan, fair value of assets</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember_0c5d5d5a-add5-4ec8-8313-992abd6ebabc_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Three</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Three [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateSwapContractThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:to="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c81c8692-6e75-453e-8cc7-4f5d683154ad_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_23c5171c-f80e-4441-ac5b-f50e7c3b42e9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_cca45857-ac03-4d45-88f9-b482dd4c2503_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Funded Status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_baa60188-83a6-40e2-b442-808a989d2530_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_4153768f-f94f-4107-9cb2-a28abb06d085_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_e8ecceb2-31a8-42ef-baa5-375be8a26224_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_b90ea6a4-ca1a-4908-93cb-a6380a756ecc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings of long-term indebtedness</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_79f2a3b6-3576-41f9-a6ef-e5c9ace156da_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_14266a2c-8d64-449c-aa4e-251b83ce0961_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Repayment</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e3e4d774-0e34-46e3-b4cf-982fc36c398e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_3735f192-3928-45e9-b122-c5479c0efa26_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_77ccf399-7bd5-4817-beff-e9fc91bd7751_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smaller Reporting Company</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_5c77ebc1-a177-40fc-a730-ce8a01ee3dea_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_e99395db-7752-4238-92e1-c1c70cc5ca38_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, capitalized into construction in progress</link:label>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Capitalized, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidCapitalized" xlink:to="lab_us-gaap_InterestPaidCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_95aa7fc9-eec9-49df-8bbd-adfa9df7635b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_f30d1346-af38-4708-b430-53c6920ba2ab_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetsLeasesAndOther_887472de-94c8-42ac-aeb1-aa351b29b9a9_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases and Other</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsLeasesAndOther_label_en-US" xlink:label="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leases And Other</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsLeasesAndOther_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leases And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsLeasesAndOther" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetsLeasesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetsLeasesAndOther" xlink:to="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_ac6449bb-ffa6-44e8-913f-f3186dad96c8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan amendments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_8874e83d-1de4-433f-9672-6e64eac984b7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c2a5f6d0-cd78-42c2-9f7d-c9081c650e78_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_c9b169f3-8173-4876-b77b-602413c055d5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_d2b3d23f-3c5a-4f1e-86d5-77956b288f5b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions from acquisition of ACell</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_aeecac1b-82ab-47e9-8e57-9a289259ff62_netLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_368e3e10-9a98-42dc-890c-579cde276a76_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_72236a55-d61b-4120-ba8b-6f88a442445d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds (payments) on swaps designated as net investment hedges</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandPlanMember_f953d1f9-a69b-4a4d-9ac7-eed32f377611_terseLabel_en-US" xlink:label="lab_iart_TwoThousandPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2000 Plan</link:label>
    <link:label id="lab_iart_TwoThousandPlanMember_label_en-US" xlink:label="lab_iart_TwoThousandPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Plan [Member]</link:label>
    <link:label id="lab_iart_TwoThousandPlanMember_documentation_en-US" xlink:label="lab_iart_TwoThousandPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanMember" xlink:href="iart-20211231.xsd#iart_TwoThousandPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandPlanMember" xlink:to="lab_iart_TwoThousandPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_fd292791-32d7-42fa-9c5f-b7b06ce8be5d_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_f93f2d5c-51e1-4f21-9949-434c29c489d1_terseLabel_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty period (up to)</link:label>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_label_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product Warranty Period</link:label>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_documentation_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product Warranty Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueProductWarrantyPeriod" xlink:href="iart-20211231.xsd#iart_RevenueProductWarrantyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RevenueProductWarrantyPeriod" xlink:to="lab_iart_RevenueProductWarrantyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsYearFour_3b9039b3-a12f-4e7c-9be1-03c4c3762337_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, year four</link:label>
    <link:label id="lab_iart_InterestPaymentsYearFour_label_en-US" xlink:label="lab_iart_InterestPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Four</link:label>
    <link:label id="lab_iart_InterestPaymentsYearFour_documentation_en-US" xlink:label="lab_iart_InterestPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearFour" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsYearFour" xlink:to="lab_iart_InterestPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_79803574-606e-4b5b-91fb-330995e61bfa_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IncomeTaxTable_0521caab-d377-46f0-968d-3375f34bd2da_terseLabel_en-US" xlink:label="lab_iart_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:label id="lab_iart_IncomeTaxTable_label_en-US" xlink:label="lab_iart_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:label id="lab_iart_IncomeTaxTable_documentation_en-US" xlink:label="lab_iart_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxTable" xlink:href="iart-20211231.xsd#iart_IncomeTaxTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IncomeTaxTable" xlink:to="lab_iart_IncomeTaxTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_103a45aa-78a0-4191-bb47-d86a1c72b9b9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_3f6b05fc-a366-4160-ba99-d953c5468bad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_74ae903d-9f74-4654-ad53-816ca59d1b1f_terseLabel_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers</link:label>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_label_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers [Member]</link:label>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_documentation_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember" xlink:href="iart-20211231.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DirectorsandCertainExecutiveOfficersMember" xlink:to="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_5c6a664a-0eab-4347-83a6-474702276485_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_163173c1-d19c-4445-805e-a10e31e6c912_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration and others</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_154a3d08-3828-46a5-aaae-edbd7c8fc253_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_75fe4703-956c-4843-89ed-f837f1062439_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_22aa7b8d-1602-413b-a840-e616bd35aebe_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesTable_fa5273c8-cb2b-42d8-8a41-973b1f36c515_terseLabel_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:href="iart-20211231.xsd#iart_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_884174d8-8e74-44eb-834d-df55f544e8df_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible meals and entertainment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_ee269032-e91a-4c7c-af55-0cf7e85a65d7_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_9ba68dc1-39b5-42dc-8417-5793fab3b1d4_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_2825589d-55f5-4db7-9178-d924051665bb_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_5735e3dd-1c6b-4986-a9dd-1ee8ec9b73b3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_3d410311-b4eb-4b86-9a21-4923bfaddd52_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_c4a40454-44ed-4c9c-8587-816f4e321901_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liability - operating leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Current Portion of Lease Liability, Operating Leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Current Portion of Lease Liability, Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2471627c-5505-466d-85b0-659928bc81aa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IncomeTaxLineItems_ae998568-1fcc-42b9-ab26-1f6dc072ec69_terseLabel_en-US" xlink:label="lab_iart_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_iart_IncomeTaxLineItems_label_en-US" xlink:label="lab_iart_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_iart_IncomeTaxLineItems_documentation_en-US" xlink:label="lab_iart_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxLineItems" xlink:href="iart-20211231.xsd#iart_IncomeTaxLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IncomeTaxLineItems" xlink:to="lab_iart_IncomeTaxLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4f19dddd-f74a-4ccd-9797-bd244562cbc9_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amounts reclassified from accumulated other comprehensive income, net</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_924cf141-01a6-4bca-9798-7e66e5676510_verboseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) reclassified from AOCL</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_d9f7906d-ddd4-431f-8b7b-e00fb9b04d0c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedMarch272017Member_0e401225-af4f-407e-9edf-a70592288aac_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedMarch272017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated March 27, 2017</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedMarch272017Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedMarch272017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated March 27, 2017 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedMarch272017Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedMarch272017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated March 27, 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedMarch272017Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedMarch272017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedMarch272017Member" xlink:to="lab_iart_InterestRateSwapDesignatedMarch272017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_be00bdc2-3cd3-4c2a-b460-0b5a5cd41041_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ExtremityOrthopedicsMember_e7840caa-224c-4f87-ab0c-9beec18fca22_terseLabel_en-US" xlink:label="lab_iart_ExtremityOrthopedicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extremity Orthopedics</link:label>
    <link:label id="lab_iart_ExtremityOrthopedicsMember_label_en-US" xlink:label="lab_iart_ExtremityOrthopedicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extremity Orthopedics [Member]</link:label>
    <link:label id="lab_iart_ExtremityOrthopedicsMember_documentation_en-US" xlink:label="lab_iart_ExtremityOrthopedicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extremity Orthopedics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember" xlink:href="iart-20211231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ExtremityOrthopedicsMember" xlink:to="lab_iart_ExtremityOrthopedicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ac8a5766-80cf-48ae-98ee-d0f4b150c275_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Exercisable at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_716790c8-7ce6-454a-b43c-7186c941dcf9_negatedTerseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Premiums Paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Premiums Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanBenefitObligationPremiumsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:to="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_0909fb89-2638-4c79-955d-dbe288dec8e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_eeedaf7a-c78e-4b75-945b-56d85e6ba7f3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fdfbe7e2-605a-427d-9c2d-c25caacd2f78_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Contractual Term in Years, Outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_30654573-8b57-4cea-843e-617e0bc0599f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_a6ee86c1-67c6-478e-a129-fba450f652c0_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_c55f9da7-c314-47ed-b899-294a91c1ad0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss recorded, settlement of derivative</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_d3ffd8a8-57db-4d2d-802c-8b8f44034b89_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_148d3571-f362-4243-ac91-22b94b698b85_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_ac3e0196-7624-4322-a065-5c7621a08880_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_52616bb3-1254-461c-b8c9-be3d70e77c05_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_40645eff-bfe3-4f01-842e-a8bdcafee2b1_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CallOptionMember_d3f2bf3f-3442-4ddf-b739-9332a6d4e065_terseLabel_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option</link:label>
    <link:label id="lab_us-gaap_CallOptionMember_label_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CallOptionMember" xlink:to="lab_us-gaap_CallOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_2dafd467-3176-4c12-be65-3e90cc809943_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.01 par value; 240,000 authorized shares; 89,600 and 89,251 issued at December&#160;31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1656ad00-13aa-4b50-9597-cdee913d7c72_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8f099a1e-c166-4295-b9aa-2006d60f0a76_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for cost recognition, in years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_49c17b88-e5bb-44bc-9852-e403dabc3cf9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_553a06c7-61b5-4b51-8e54-b182fbf2d466_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_39080fd9-bfda-411b-8421-c4c4b79b15a4_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_a3e1a66c-4c65-4fb8-81d7-67a4b53c1cf5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES AND RELATED PARTY LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ef636637-4d62-49d6-b47c-fb97ea0e7827_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_2bbd2873-1dfd-436b-aaca-5a7b0fa9e857_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8f85addb-a33b-40df-9b69-5f480379439e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Weighted-Average Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_ab099b8a-1fba-4aa9-a2c4-2aee0adb7ab6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_017818c5-2ca2-4c10-8c60-03a41037c491_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Restricted Stock, Performance Stock, and Contract Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4362f589-369f-4e91-92eb-4dfb9260a42c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_78c94ef2-716d-47cb-a5fd-aa95ac28c85a_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_6dc9ce5a-1a3d-475e-8fe6-d357da0614b0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetMember_6a61a90f-0dcd-4985-bf4d-40a2727d4413_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset</link:label>
    <link:label id="lab_iart_DeferredTaxAssetMember_label_en-US" xlink:label="lab_iart_DeferredTaxAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Member]</link:label>
    <link:label id="lab_iart_DeferredTaxAssetMember_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetMember" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetMember" xlink:to="lab_iart_DeferredTaxAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsYearThree_d7a3fcae-9534-443b-9e52-d8a75f207404_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, year three</link:label>
    <link:label id="lab_iart_InterestPaymentsYearThree_label_en-US" xlink:label="lab_iart_InterestPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Three</link:label>
    <link:label id="lab_iart_InterestPaymentsYearThree_documentation_en-US" xlink:label="lab_iart_InterestPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearThree" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsYearThree" xlink:to="lab_iart_InterestPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NeurosurgeryMember_3ef34f5d-552a-48ba-85b6-fab8d5a7680f_terseLabel_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery</link:label>
    <link:label id="lab_iart_NeurosurgeryMember_label_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery [Member]</link:label>
    <link:label id="lab_iart_NeurosurgeryMember_documentation_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember" xlink:href="iart-20211231.xsd#iart_NeurosurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NeurosurgeryMember" xlink:to="lab_iart_NeurosurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_6ec21fc9-9171-44b5-9e53-1c16ab9b79c2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_4fdfb817-daea-4f9a-a242-f70fcf8eb585_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Interest</link:label>
    <link:label id="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Capitalization, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCapitalizationPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:to="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ec164ce9-d480-4ac5-b412-ffe0d7191038_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_eadb756c-1a97-4e04-b451-ae37cb7940df_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f2481cd0-c065-4e73-9a4a-435fcdf497d5_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30b01702-b910-4bfd-8a20-ddf7ebd6b909_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3e36365-f4b5-48a1-9a60-0c02a8a4cbce_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7c9cf737-cf42-4923-8bf6-1e38078f2a5c_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_dbd6a804-0391-4b73-9408-8e2c1cc8c7bb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_b7707f6b-bf75-4f8d-841e-c9158f3b0c40_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrecorded benefit reasonably possible to be recognized (less than)</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_9329e269-48e2-40f4-8d7c-220d89d4f1a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_c451e110-fe69-4769-bcea-b4d93c0fc834_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_8072e639-d40b-4dc8-9668-69dc00efd530_terseLabel_en-US" xlink:label="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective worldwide tax rate</link:label>
    <link:label id="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_label_en-US" xlink:label="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Worldwide Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_documentation_en-US" xlink:label="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Worldwide Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:href="iart-20211231.xsd#iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:to="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_c1cfc74f-b437-4df6-b3c0-185bf5a66013_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_8cc05ead-7180-45f4-9fd2-642c66a41ea6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_467b1751-f0bc-426b-b2ca-dd967e1781be_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_a2ebec25-3e73-4c2a-8380-d205d9aad63d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_b738e5ab-5b59-4a2c-a4c3-bc4d8c01e198_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - operating leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability, Operating Leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability, Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_e2133edd-81f5-495e-b327-42b2b3b39b7d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recorded, net investment hedge, change in fair value</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_562e4daa-2dce-40d2-945a-45c86b02369a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_ba6f709b-4dad-40bb-8cf7-14f78f7d8236_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT AND GEOGRAPHIC INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_965c76a4-3b95-4bc6-a639-a5e125694ed7_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain (loss)</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9e2b1a8e-3680-4414-b7b2-bf5137b3a77d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_ea2a0343-b3d9-4c0b-a3be-bdc56217aed1_terseLabel_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wound Reconstruction and Care</link:label>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_label_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regenerative Skin And Wound [Member]</link:label>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_documentation_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regenerative Skin And Wound [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember" xlink:href="iart-20211231.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RegenerativeSkinAndWoundMember" xlink:to="lab_iart_RegenerativeSkinAndWoundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_785e6fba-07d9-4954-8cb9-5ca6f20f50b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_27347deb-26fd-434e-9ce6-48d25622729a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_89b08a97-b6aa-408d-8765-b81bdc7dc7a4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_290408b4-8c6c-45f9-8fd7-f4b3672524c9_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_721c7c4b-a2a0-42f9-b935-0c9beaf36d99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_0ed90bd7-d444-4dec-8f8f-195bf0bdf190_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Next five years</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember_1c634c34-31bd-4d8f-90c2-d915a5c69be1_terseLabel_en-US" xlink:label="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consortium of Focused Orthopedists, LLC</link:label>
    <link:label id="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember_label_en-US" xlink:label="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consortium of Focused Orthopedists, LLC [Member]</link:label>
    <link:label id="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember_documentation_en-US" xlink:label="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consortium of Focused Orthopedists, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:href="iart-20211231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:to="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_dc7bc957-1599-4c85-bf27-7e093bf808bf_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap One</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract One [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractOneMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_51ace512-8db3-436d-9afc-ce62aa0aa97d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_02cb25a4-9dee-43d7-bbfe-25df5c60b3cd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to assets held for sale</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RelatedPartiesMember_05ac5d38-a007-459f-9122-033f6f3270a7_terseLabel_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_iart_RelatedPartiesMember_label_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties [Member]</link:label>
    <link:label id="lab_iart_RelatedPartiesMember_documentation_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember" xlink:href="iart-20211231.xsd#iart_RelatedPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RelatedPartiesMember" xlink:to="lab_iart_RelatedPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_3d3fa69e-b8fe-4583-a39c-d8f4593becb8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_f9766050-69a7-4684-8a5d-45127a9bacf1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from stock compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c3ddf54f-1550-4b19-bdf8-03a014db4ef9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_e6125713-6d3a-441b-8340-ab08d723bbfd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d4d4f909-6667-4b62-8dd0-cba32b72c314_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1e59b721-db9e-416d-b825-76f3642ade2a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in income taxes resulting from:</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e9ec63b-43dd-4fe1-9cae-37d52e7eaf5f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_03905adb-680e-44c3-aa1a-a770e92288db_verboseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_b98e83ad-f765-4070-b3f3-eeafe5918af1_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7280671e-d862-46d4-ae6c-14855014544a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_fef6f860-3aca-42d0-b589-ba8e8e1d68f2_negatedLabel_en-US" xlink:label="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in-process research and development and intangibles</link:label>
    <link:label id="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_label_en-US" xlink:label="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire In Process Research And Development And Intangible Assets</link:label>
    <link:label id="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_documentation_en-US" xlink:label="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire In Process Research And Development And Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:href="iart-20211231.xsd#iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:to="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2072c736-3b3b-43d2-9e3c-8ee468b86f25_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_c172d1a8-c957-430e-ad49-0f6847e38597_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e973ca47-ef76-4dca-9714-466795689d00_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8121fdbe-97d8-407f-807b-8ee817784df7_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f53757e9-cbfa-4972-9d5f-c8368e3f1e81_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7d50001b-721f-4fcc-8f59-2d97f5ba0ffe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c08c680d-ec1c-4b45-9206-d257084cbb7a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_d823f4b3-2542-4072-8aa2-5afdfab308d3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_MilestonePaymentTwoMember_62e3c67d-c958-4678-b0ad-631e851a9c06_terseLabel_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two</link:label>
    <link:label id="lab_iart_MilestonePaymentTwoMember_label_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two [Member]</link:label>
    <link:label id="lab_iart_MilestonePaymentTwoMember_documentation_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember" xlink:href="iart-20211231.xsd#iart_MilestonePaymentTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_MilestonePaymentTwoMember" xlink:to="lab_iart_MilestonePaymentTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_ee8ed88b-9f98-425f-8454-25024df3d803_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_bb65ac92-fc19-4a6f-86bf-f1f12cd47a77_terseLabel_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_label_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fa5599e7-9b7b-4a63-b8f6-d80f4170e57d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_c779a625-e449-4fd4-87d9-360f4c57dcda_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_68718791-9aa1-4b38-a82a-5c97f2c53730_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_d94406cf-5192-4767-b831-f34fd07d680b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_89d423d2-a11f-4121-9ff1-a6ad505daa09_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_2f7b6f9d-ffc6-4767-a4c1-9c53301e7e67_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_a055ab0d-4ea8-4cfd-b66a-f2a81d538450_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_262a8798-2195-4b40-b352-f6c29510662b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0beac6d9-56ad-40d4-b94c-f7a2fd6f5097_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_04af1b41-13b4-4b2a-a07e-b443b0e5a196_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_69f42a75-2af1-4bd7-b215-d382f2fc1330_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future minimum lease payments, finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_630a3945-e5fe-403c-87c4-f60074bb9af6_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_df8ad89d-16de-4b6f-b715-73ec295b8f04_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_511dd5eb-edba-488b-aae4-ddb653c9c397_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net period benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b1ac4409-6ba4-45d2-9c35-c0d7a72488a1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total estimated tax benefit related to stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_8882f859-743b-48d0-860b-9cc5877f0549_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0f9f29b2-e4d7-4e9f-bd72-cc919992d445_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_b85b097f-22ca-4ddd-9a00-9a8fbdc2d5a2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_c323ce9d-b238-49dd-a998-d0a085a7c871_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7dcfc5d4-159f-47de-8a24-075f537b0dc3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_b01eb5f1-4431-4198-ae3d-c85ea0898a92_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_e7c6e9ad-5622-44e8-95c4-fbb7155b0e3d_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_d2d2b0e4-e212-4af4-91b5-81ade589ddbf_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_87cd9bf4-3370-44e8-bb43-408a07c841f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ConcentrationRiskThresholdPercentage_f73acc7e-09b1-4fee-8037-a8e150e1248c_terseLabel_en-US" xlink:label="lab_iart_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, threshold percentage</link:label>
    <link:label id="lab_iart_ConcentrationRiskThresholdPercentage_label_en-US" xlink:label="lab_iart_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Threshold Percentage</link:label>
    <link:label id="lab_iart_ConcentrationRiskThresholdPercentage_documentation_en-US" xlink:label="lab_iart_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Threshold Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskThresholdPercentage" xlink:href="iart-20211231.xsd#iart_ConcentrationRiskThresholdPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ConcentrationRiskThresholdPercentage" xlink:to="lab_iart_ConcentrationRiskThresholdPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_5640e3bf-d463-46bb-b4bb-94c3367d8a8c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RestrictedStockPerformanceStockAndContractStockMember_38b4cff9-3e8a-4a63-b6e9-de7c6dcb9fa5_terseLabel_en-US" xlink:label="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Performance Stock and Contract Stock</link:label>
    <link:label id="lab_iart_RestrictedStockPerformanceStockAndContractStockMember_label_en-US" xlink:label="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Performance Stock, And Contract Stock [Member]</link:label>
    <link:label id="lab_iart_RestrictedStockPerformanceStockAndContractStockMember_documentation_en-US" xlink:label="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock, performance stock and contract stock member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:href="iart-20211231.xsd#iart_RestrictedStockPerformanceStockAndContractStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:to="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_79df1fac-f446-40e0-af63-98de143726bb_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings under senior credit facility</link:label>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredLongTermDebt" xlink:to="lab_us-gaap_SecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_26008aac-f4a9-4d1a-8715-7c20acea7e03_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_0f4b537c-a734-40b1-9821-1684f771b339_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_0f9b62ab-b2bd-45c5-8df9-8ada81e06a7b_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebt_f687204d-0159-47f7-b65d-265deae1489d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebt" xlink:to="lab_us-gaap_ConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_208f0868-da8c-4efa-b47e-d14be5633b1c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SwinglineLoanMember_fb45acba-bd74-46c2-9648-0e2b3f6424bc_terseLabel_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan</link:label>
    <link:label id="lab_iart_SwinglineLoanMember_label_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan [Member]</link:label>
    <link:label id="lab_iart_SwinglineLoanMember_documentation_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember" xlink:href="iart-20211231.xsd#iart_SwinglineLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SwinglineLoanMember" xlink:to="lab_iart_SwinglineLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_68636273-721a-40c9-a9f5-ee50d85967aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f863ed1f-fa9e-445f-a1df-05d75a9166f2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d8a03a03-a0a8-4273-bc3b-fde59a62454d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f235e1fc-38da-4b46-a1f4-68dc0bab9c62_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_1b8a9053-65cb-418d-b49e-a63761ddd1bd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net of allowances of $4,735 and $6,439</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_389a4f4d-f2d9-4027-9df2-ed55aad6e336_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_5994e4b9-1806-4691-bf02-f3327933a4e8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory related items</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4296ebe-6711-41e5-bf16-784b9aa7987c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4ad1df6f-ee20-4213-8dd9-8cd83cb3f5d3_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_dde5b7a8-af92-49e3-8161-d8de6eb99df3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b6f3ba44-3dda-4c00-8bfe-2ddfeab488a6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ba131749-6310-4afd-a44e-a21f61e7a385_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f17b72ac-125b-42c9-aac3-201a2adf161a_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7083f597-f314-4495-aebe-e71d26402c0b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellations (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a1348c46-3a96-4c3e-98da-af456e653ad2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCL into Earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_fedd1640-1065-4821-9415-00bc41341407_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap Three</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Three [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractThreeMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_7f7c04a3-7034-43e6-8ee6-54ff848c3efb_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, net of revenue recognized on contracts during the period</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_label_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:href="iart-20211231.xsd#iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:to="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_fd1248b6-a3e4-4a82-adb4-f43532d3b376_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_0af7673d-17fa-4ba1-b74f-3bab2a5bcec9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_fe455f82-31d7-4404-a4eb-d7bd7ce9edb5_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated shares repurchased, amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_48f6e745-b9cd-4b10-a77f-23d05ad4a7fd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_6bc3773a-0104-49c1-85e1-8030cdbe61d5_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_78f01364-f0d9-4a82-a713-6713feab5e1c_terseLabel_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, shares received at inception</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_label_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases. Shares Received at Inception</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_documentation_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases. Shares Received at Inception</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:href="iart-20211231.xsd#iart_AcceleratedShareRepurchasesSharesReceivedAtInception"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:to="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_c8c6ae11-db9b-4cab-8851-5acbffbbd7b8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_55f79ec5-491e-4e1d-923b-83b35f12d434_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_963e3762-5a1c-4ef9-9160-8d70e175f126_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_064c0c30-2417-4758-96df-379fd469180b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_8b665761-268a-478a-b7e4-ed09182cf979_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liability - operating leases</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Lease Liability, Current</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_29f9902f-91a0-4afd-96d3-0895ef3bd12b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_062b8922-3797-40be-8f52-265df0ca8838_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_edf89ab2-517f-487e-bda3-9c7150c1287b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4bf6e4fb-429f-409d-ad6c-559dc2011839_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2b8c10b2-1e5b-4717-943d-c9fa5ec9cd02_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_1a7ae9d0-a47c-43cc-abd3-ec48855f84aa_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_dc31ff4d-a449-4963-881a-cc1a02bd9eb5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized incremental financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_b5ccb0d4-b4a4-40cc-93cd-17a1742c61f3_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFourMember_ae3742ae-bb7f-447a-8921-93a3ae062c8b_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap Four</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFourMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Four [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFourMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFourMember" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractFourMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_c7842f82-c7b2-423d-9cc4-316f5801f5d3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligations expected to be satisfied</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_e7756aea-54bb-4bc6-8343-926479d95e76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Employee Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_32daf176-59be-4c00-8653-a4b8fc92f367_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5fb8e25f-4a06-40ed-a898-710fefb93458_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_627ae82b-0ecc-4c57-9fbd-a80dc2334008_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair market value step up on intra-entity transfer of intellectual property</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_29d911e8-d7eb-4f5c-8ed9-bd8522716150_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_59ffbdb0-4441-4851-89fa-36366033209a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_18ee1898-c9a2-484f-8454-5321bce81e15_terseLabel_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical</link:label>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_label_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical [Member]</link:label>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_documentation_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember" xlink:href="iart-20211231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CodmanSpecialtySurgicalMember" xlink:to="lab_iart_CodmanSpecialtySurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_b112c69b-8721-4a38-a41e-2976de2c5589_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash interest</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_0a3282c7-128d-4bbc-b29c-d89350050d46_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_c223ff91-6b3a-4741-8a59-2f97411ba67a_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_4dc76aff-ccd4-491f-a298-a7fb4eb2b784_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of stock purchase warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_c35ea0f3-52fd-4a99-8f74-e77bcf5537f7_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from warrant transactions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_0d88641f-0e02-4519-af4a-25c8d188d1fa_totalLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_eaacad30-7633-4418-8228-8369adb33e7f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8e391df4-234d-4d66-82b2-61797b17d0c4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_3c17ca75-7ad1-498a-bea4-e9bf375743f2_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum future purchase price, if circumstances met (not to exceed)</link:label>
    <link:label id="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_label_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met</link:label>
    <link:label id="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:to="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_dc9d0332-d60a-41ef-96f4-92ad2fadcff4_terseLabel_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets obtained in exchange for lease liabilities:</link:label>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="iart-20211231.xsd#iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_f2a9bfb6-41d8-44fc-94b4-28125970468f_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c062d042-4480-4b19-b05d-81d376509c06_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic And Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3dcca4e5-da43-41ea-b09f-0096051650b9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive gain (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a2d21f35-676f-4a93-96bb-b290aefa4987_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_3511ea2b-fef4-4522-91d5-b91225c14aa3_terseLabel_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, percentage of expected total repurchased</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_label_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_documentation_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:href="iart-20211231.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:to="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a9139e11-4e72-4fdc-a5eb-7cf3b6f7654b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e4e45c9c-1134-49ca-b7c9-a784b9b7e2f2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_ede6cd76-bb3d-4b06-b99e-f53ae140990e_negatedTerseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany profit in inventory</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_6d6dc0f9-dfda-4030-aca1-9a6fc2bc827a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_675988ee-7557-4b85-af55-f6543772756e_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_71d073ed-351a-4d36-8b8f-c7279e36510b_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_66808fbe-5214-403c-b037-653fb3be5e78_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_aacc784f-f111-4a4a-ba88-b855c1116ddf_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_c066489b-213c-4fce-b98d-842e6550557e_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combination settlement for debt conversion, minimum settled in cash per principal amount</link:label>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_label_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</link:label>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_documentation_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:href="iart-20211231.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:to="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_b7d2ef15-be4a-4def-8dff-82dc61ce746f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_2099cca7-4dc9-46a7-b4b8-12a4127fce86_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e407f090-1e7b-4327-b866-f933d99b5ec8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_b1abfaf0-d920-425f-98e6-70978f2a7900_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1f19a62b-954f-4ca3-8af1-86a3e45fb9ca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_99ecdcf5-7d1a-4cd9-a5e8-a6b14b3b8ab3_terseLabel_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products offered (more than)</link:label>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_label_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Number Of Products Offered</link:label>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_documentation_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products sold by a segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:href="iart-20211231.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:to="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2c5f0d5c-1b99-410c-802d-48381f3f82d3_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ACellMember_65a0eee4-3053-4b61-be60-d3e5351c379c_terseLabel_en-US" xlink:label="lab_iart_ACellMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell</link:label>
    <link:label id="lab_iart_ACellMember_label_en-US" xlink:label="lab_iart_ACellMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell [Member]</link:label>
    <link:label id="lab_iart_ACellMember_documentation_en-US" xlink:label="lab_iart_ACellMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember" xlink:href="iart-20211231.xsd#iart_ACellMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ACellMember" xlink:to="lab_iart_ACellMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_0ac6beee-6143-45c0-a621-8cc830228d6d_terseLabel_en-US" xlink:label="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:label id="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_label_en-US" xlink:label="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:label id="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_documentation_en-US" xlink:label="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:href="iart-20211231.xsd#iart_AccumulatedOtherComprehensiveIncomeLossRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_83cbfb83-5ccb-4f78-9e79-edd59a789a43_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_3a52eacf-ff7f-421e-aec1-d501bed4a639_negatedLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested but not released (in shares)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:to="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_ea9f35d0-6303-4b7a-8c1c-fedd443f921f_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_bf6fc06e-cc9a-4bfb-b397-f702717fb9f4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_45f2f83d-c57a-4111-86e0-13482ea9fe5c_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_06e616f2-b00c-467e-bced-34ccba958257_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_74d75a42-a106-4e53-a786-c1688b0764b2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7fedd4c1-22cc-4b40-aa50-94a2259ccef5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0fb02fd3-0f9b-49e1-98fa-776e55ae8251_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND DIVESTITURES</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_79fcad40-2307-4ec5-8efb-cbc93c6e9644_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_6a666362-73b5-4fec-aa5f-0b92a1b1000a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation, foreign income tax rate differential, increase (decrease), amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TrademarksBrandNamesMember_fa21127d-6bb0-4dfe-bf2b-509fcca841cb_terseLabel_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks/brand names</link:label>
    <link:label id="lab_iart_TrademarksBrandNamesMember_label_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks Brand Names [Member]</link:label>
    <link:label id="lab_iart_TrademarksBrandNamesMember_documentation_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks Brand Names.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember" xlink:href="iart-20211231.xsd#iart_TrademarksBrandNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TrademarksBrandNamesMember" xlink:to="lab_iart_TrademarksBrandNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_fc155cb7-30a3-4d30-8b4e-cd0dbfcc4181_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax credit (in dollars per share)</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Per Share</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f220852-fe43-4752-a8d7-8c48056ba6f0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CompletedTechnologyMember_7865e556-7741-4ec2-966c-cdd427ff6559_terseLabel_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed technology</link:label>
    <link:label id="lab_iart_CompletedTechnologyMember_label_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed Technology [Member]</link:label>
    <link:label id="lab_iart_CompletedTechnologyMember_documentation_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember" xlink:href="iart-20211231.xsd#iart_CompletedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CompletedTechnologyMember" xlink:to="lab_iart_CompletedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_119340c7-355b-44e3-b57d-7686d6ab742c_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 4,899 and 4,914 shares at December&#160;31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e3ae3edc-2afc-48c7-a1be-d1c550ec4eb5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding (See Note 13):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_a281d43d-ba6a-4c73-a980-f16bb165ee0a_terseLabel_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification</link:label>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_label_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification [Member]</link:label>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_documentation_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:href="iart-20211231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:to="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0c5b83d9-f885-4003-b673-4e7b25133b38_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_471dc806-ea5b-42cd-9df6-c1becc1a4062_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_23951941-f96c-4dbc-968f-91b464a06866_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets expected to be returned next twelve months</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Expected to be Returned to Employer, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_OneMonthUSDLIBORMember_6d0ea201-b448-4de5-9240-e490a5de1117_terseLabel_en-US" xlink:label="lab_iart_OneMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1-month USD LIBOR Loan</link:label>
    <link:label id="lab_iart_OneMonthUSDLIBORMember_label_en-US" xlink:label="lab_iart_OneMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month USD LIBOR [Member]</link:label>
    <link:label id="lab_iart_OneMonthUSDLIBORMember_documentation_en-US" xlink:label="lab_iart_OneMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month USD LIBOR [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthUSDLIBORMember" xlink:href="iart-20211231.xsd#iart_OneMonthUSDLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_OneMonthUSDLIBORMember" xlink:to="lab_iart_OneMonthUSDLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_338e56ec-b609-43aa-80a6-2efe47c6cd05_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs incurred</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractOneMember_3d0f47f3-ecfa-4630-a008-98902967001d_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract One</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractOneMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract One [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractOneMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateSwapContractOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:to="lab_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_d02019ad-7769-4638-ac9b-5bb27409b0f3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_cb291175-8274-4eb4-a5ce-926211f8fd3b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_34c727c3-548b-461f-9618-d6ba0140c3d0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_a25a28d4-2a77-49ee-8343-01baf427c93d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_f859b5c1-e0ef-4fcc-bb3e-69e88bc8ac70_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_d2d624cc-2d96-4726-9a76-efcede933c71_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_e7866eb3-8f0c-4f9b-b45e-9fe2898ebb7d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible notes issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_ccfa8247-036d-4e80-857b-74eecf398e52_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from offering of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_65a6f73f-631f-4ebc-a3c0-1c6079a37273_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_6224e623-e281-4650-bad0-3362032532e9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_1d4e95e5-5894-4156-8e59-b9b88bc2fef1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_db5fe9e5-01c4-408f-878a-102bd30eacdf_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_76d3d249-015d-4eca-a6ba-f7272d1292f7_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment, intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_a6a27444-5635-4abd-b593-22243ddbc88d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_beff70f6-51ce-4834-9248-3b49a4480272_terseLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested but not released (in dollars per share)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_9982fe1a-5fc2-4417-8248-3abd52571954_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f8180e0f-1438-482e-83b2-7425aaf036a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_651f262e-d110-42d8-9fc8-bd3986af8ce7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c78990ef-9b52-4187-99db-5dca9655da73_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_074a153b-bfe0-41d2-b64a-e815eb028616_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment Balances and Corresponding Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_72dae175-2d9e-4cfd-b4bc-1e52cb5347d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_8d566242-cc8a-4c07-88e8-b37191851e2b_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark_b5e991bb-606b-4dda-a5f3-554b25bef7be_terseLabel_en-US" xlink:label="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, number of customers over benchmark</link:label>
    <link:label id="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark_label_en-US" xlink:label="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers Over Benchmark</link:label>
    <link:label id="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark_documentation_en-US" xlink:label="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers Over Benchmark</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:href="iart-20211231.xsd#iart_ConcentrationRiskNumberofCustomersOverBenchmark"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:to="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FoundationPolicyTextBlock_ddc4611e-abd1-4132-8db7-be4041cae257_terseLabel_en-US" xlink:label="lab_iart_FoundationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integra Foundation</link:label>
    <link:label id="lab_iart_FoundationPolicyTextBlock_label_en-US" xlink:label="lab_iart_FoundationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foundation [Policy Text Block]</link:label>
    <link:label id="lab_iart_FoundationPolicyTextBlock_documentation_en-US" xlink:label="lab_iart_FoundationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foundation [Policy Text Block].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FoundationPolicyTextBlock" xlink:href="iart-20211231.xsd#iart_FoundationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FoundationPolicyTextBlock" xlink:to="lab_iart_FoundationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_5a780e4a-2c21-468a-95df-17cc2e2ea40e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Net Sales</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_951948da-231a-4bdc-a403-847288e92859_terseLabel_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_label_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Table Text Block]</link:label>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_documentation_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeTableTextBlock" xlink:href="iart-20211231.xsd#iart_CashFlowLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CashFlowLesseeTableTextBlock" xlink:to="lab_iart_CashFlowLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_94a39c22-3d1c-4ad3-a6f3-518ca8715502_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible R&amp;D expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_566e116d-ec89-4a3e-9dc0-3a4820e1f18a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_fa162dc0-6560-4193-884a-fd425c599158_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_d884c8dc-48d8-4b0a-9c87-86829f434627_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit, transfer intra-entity intellectual property, amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationWorkingCapitalAdjustment_cf9b3d43-29d7-4b5e-b03d-107a00b644e0_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital adjustment</link:label>
    <link:label id="lab_iart_BusinessCombinationWorkingCapitalAdjustment_label_en-US" xlink:label="lab_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Working Capital Adjustment</link:label>
    <link:label id="lab_iart_BusinessCombinationWorkingCapitalAdjustment_documentation_en-US" xlink:label="lab_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Working Capital Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:href="iart-20211231.xsd#iart_BusinessCombinationWorkingCapitalAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:to="lab_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_9c7a3020-7910-4716-b868-b20837cdf86c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_92b9eb9a-32a4-4aba-beb3-d4653e7853ca_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_94390d0b-4f30-4ec4-bb02-4cedbf9dfa17_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_0fa717ce-1236-4a95-b5ac-2ab3cfeccfe9_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_967b4c2a-49f8-4d0e-895b-9af9af5ab80d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_1dec5ce7-13ea-415d-ae83-0db8aceb6fb2_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase From Foreign Currency Translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase From Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:href="iart-20211231.xsd#iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:to="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_9c29400f-7e9c-4d79-9bff-97555b378862_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_971c1cbf-6795-4114-b839-6280e6d95529_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6cc02598-f29d-44b8-84d9-650e8d072a41_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_72ccb085-b4d9-4e69-9d18-a24efe111ebb_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_76363319-5937-4c28-87c3-c52fb89dd34c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_2798094b-aebe-4c62-8b51-45d27a6b2ab8_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_528169e3-61f3-4fe3-881e-d4030cef7fdf_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6ebf8146-5e95-41fc-b935-515a4b73d24e_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets at fair value, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0acd7dff-999c-47fb-a20f-0c408d7d0f59_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets at fair value, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4e7f32fe-7fe6-4f90-8778-b71a42411806_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3fdb8032-61b4-4202-ad7a-dcf239acdfdf_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plans, assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8e98369e-ae62-43ff-b8bd-9b3898d1f47d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SwissFederalTaxAdministrationFTAMember_6e40ae31-a037-4925-aa78-e32457d76e11_terseLabel_en-US" xlink:label="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_us-gaap_SwissFederalTaxAdministrationFTAMember_label_en-US" xlink:label="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss Federal Tax Administration (FTA) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:to="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_3c57de4b-ebd4-4de7-afd2-da9e5be9ad7c_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible executive compensation</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_46f8030a-1586-43e4-ae6d-501e36aa9e84_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7e95b45e-4268-41fa-85e8-750ba084e795_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems_2b347f25-b416-4713-981e-43f4cc921d4c_terseLabel_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="iart-20211231.xsd#iart_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_72793af4-535f-4979-8fa7-e3815cabc95c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions expected to be paid to plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_5ae718cd-5987-4502-a98d-663b0cd000f2_totalLabel_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill</link:label>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_documentation_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:href="iart-20211231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:to="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_c59c4cbd-837c-4d0c-aed8-66a5de19cc6a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental financing cost expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_f8783b92-822f-4231-9baa-2095e1e6725d_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase program, receipt (payment)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Settlement (Payment) or Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_d3dac797-342a-4dd8-8aa7-c5e39d058de7_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_label_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt Covenant Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriodDomain" xlink:to="lab_iart_DebtCovenantPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_418b12f2-9f62-41fc-b969-ffe2f1690ee8_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_33ab8194-26e0-476f-a759-632563a10d7d_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum selling price of the company's common stock of the conversion price</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_label_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_documentation_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:href="iart-20211231.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:to="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_b4ccf1ed-f7ad-4019-9fa1-6e04ceba2f96_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_1909a615-876f-4c8a-b952-c6c0250e10d5_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_ab69f97d-f2bb-4654-946c-cafb6ee17c82_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States (Includes long-lived assets in Puerto Rico)</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_1d31b141-249f-4a20-bba3-28e25a50f6f0_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_bec0938c-b1e6-4419-b1d1-a92bc5900e72_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_55f50b48-19d1-464f-8344-93dfa40c8276_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_c8e83561-02a2-418a-b81e-72f4709020af_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_419ad63c-d20b-4769-8fe7-64208b7513d3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_c3f94de3-db7a-4dfe-9156-1054357a1749_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4fc5490b-28ff-419b-be5e-b83c5054a322_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Shipping and Handling Fees</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_d5980271-8733-48d0-9cd3-65eecdca305b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a0ebf4bc-22e1-4eae-8026-a488f6ac974c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a5e2dfdb-5f9d-46aa-85f6-e8326603dfac_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares for diluted earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1b712386-53df-470a-adc9-7c9f32b6502a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_0fb0b6b4-a5e1-4dcf-ad6c-570a432da6a1_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_5a261df8-97d6-4d34-bed5-9288fe08ef52_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from note receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c5ace30b-0516-4e5f-9701-aadfbb2e00cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_880f76b8-6f3b-4c48-8ae2-2eaebc91a989_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_20fb27d0-09c6-4725-ba47-8b6a26959666_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a6be5303-4db5-4d85-b7a6-df05efcbde70_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_35303efc-52e7-4b06-8744-440d3059e058_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rates available to the company at its option</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_93c19b09-0a74-493f-b15b-19b73c96e8af_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_560ad34e-e57a-4cb0-adaa-fb66a96b8877_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase and equity component of the convertible note issuance, net</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_3aafca0f-5ea2-48af-ada1-4a77d6399151_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_3e5b1545-e6aa-484a-b805-81c2ccf69148_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_791bcd22-c43a-47f1-8d3e-8e25da75d675_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a909a873-613f-427c-8e9a-2a51609edcfc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6dd15ec1-e35e-4d5b-858b-09e99c405e4a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_37ee2ef9-6bb1-4f8f-b106-8d908ed34beb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_4798e6d4-e732-434e-b9fb-2be9ffab944e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_83c326a1-50e5-4be3-a248-6281ce62cfb0_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ef89ba26-9605-4a32-a65a-5cabcd2436fb_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_ee9874e9-b9af-416e-bca2-5aec1345e92b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_9b9f8fed-ff0a-4eec-b1b0-0e3be7c0187f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_0665ec4f-5b95-4820-a248-56bcdb416a06_terseLabel_en-US" xlink:label="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets, discount rate</link:label>
    <link:label id="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_label_en-US" xlink:label="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Discount Rate</link:label>
    <link:label id="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_documentation_en-US" xlink:label="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:href="iart-20211231.xsd#iart_AcquiredFinitelivedIntangibleAssetsDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:to="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d7a071fd-a1f8-40f8-8e4e-46becab619d8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_be2a7ecb-8225-4f91-832e-aef699fee05a_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles Of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_1148996e-9898-44fa-93bf-6fbd5077fc89_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0acb6736-b0db-4647-b6fd-e94ba8e6ff57_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life of option from grant date</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_73000083-0d7e-4e09-b4c3-4e8332675e86_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_b25ed2ae-180b-443d-ab8d-df448f198682_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1d5575d1-aa59-4bb8-a728-26a08a1afc2d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash taxes paid in net equity settlement</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_7c079138-6498-4c4c-a557-404dee7c9a8b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Forward Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_d44e545e-e3ae-45af-9f24-e17a106df824_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, trade</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0bd1882b-6525-4ff3-adb6-15f2b7fe329f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_166f5676-b12c-4baf-85d5-0d7f26167838_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Benefit Obligations and Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PrivateLabelMember_4cae9af9-ae1e-49f0-8ed2-60cf7873ed64_terseLabel_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label</link:label>
    <link:label id="lab_iart_PrivateLabelMember_label_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label [Member]</link:label>
    <link:label id="lab_iart_PrivateLabelMember_documentation_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember" xlink:href="iart-20211231.xsd#iart_PrivateLabelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PrivateLabelMember" xlink:to="lab_iart_PrivateLabelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_a43f6df6-7f3e-43e2-9564-78ea9ba7ffb0_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AllOtherMember_57783029-2585-4319-ba3a-93e037035907_terseLabel_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other</link:label>
    <link:label id="lab_iart_AllOtherMember_label_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:label id="lab_iart_AllOtherMember_documentation_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember" xlink:href="iart-20211231.xsd#iart_AllOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AllOtherMember" xlink:to="lab_iart_AllOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_043b5304-5548-4070-890d-e91e2945454c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_667e9365-4b8e-4fef-b070-e87556debd95_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred to trade receivable of contract asset included in beginning of the year contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Reclassified to Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:to="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_b6314d66-bd7e-49e3-ad91-e9924e2cdf0e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3a055309-f1c9-40cf-8470-7695dbec46ca_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_89e3384e-360b-45d8-96cd-0967b71db38a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9352b2ac-cac5-4afe-a9d2-af5f8d9bf74a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation costs related to unvested awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_d1087501-2def-485d-921a-c032e9186e91_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_d6fea7be-ba5d-4859-b673-2f841a416e57_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Accounts Receivable And Allowances For Doubtful Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_2b8868dd-b6c0-4bd7-a8b1-bfbdacd61eec_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_3c8dd567-599e-46bd-9e83-f45c55edba05_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_abdf02ca-cf11-43f5-9d4c-7e6af60eaf6e_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_a0e7f1b9-7b3f-4a7f-9a74-ab1ba038c032_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f2175d7c-64c1-4979-bb92-4a7e37ef6300_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_caa3423a-a1b2-4ffc-9b3f-73f99a3fc776_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_0b76bc6f-555e-4334-9d99-5bc0ffba2ae2_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_05c18c24-8f72-4d16-88bb-dfc2593cb6cb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_50269d4a-17bd-4a4b-8d3f-abf0dd333cd1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_a37a94ba-65eb-42f2-b3f1-7c6efd0e93dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Fair Value in Balance Sheet for Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dca289eb-827c-48cc-86bf-7e4e85276cfd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_9052cd30-2496-499a-bf2d-1ad3911a7d23_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax (benefit) provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_18251e65-198c-4cb3-8cbb-da13f5dae77f_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NetWorkingCapital_19df0c8d-f3d9-4b9e-8089-5854402e8ffe_terseLabel_en-US" xlink:label="lab_iart_NetWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net working capital</link:label>
    <link:label id="lab_iart_NetWorkingCapital_label_en-US" xlink:label="lab_iart_NetWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Working Capital</link:label>
    <link:label id="lab_iart_NetWorkingCapital_documentation_en-US" xlink:label="lab_iart_NetWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NetWorkingCapital" xlink:href="iart-20211231.xsd#iart_NetWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NetWorkingCapital" xlink:to="lab_iart_NetWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_7d5d9608-8377-4ef6-b540-f6b6ef5bf460_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_1a3afa2a-dcf7-437b-8610-3061eb217e00_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_06e438cf-140d-4d92-a18a-2e5e2b65b1f2_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_505eca68-d76a-4edf-b480-d3608d36bb17_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_69cd88ba-8a98-470d-a880-276b1ff4e74a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_55ef0411-91d0-431e-8402-2fc9cec0748f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction gain (loss)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_5ebd9bf2-c18e-4387-97b1-138d1d30f1c4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ReboundTherapeuticsCorporationMember_3d0880d1-4bc6-483a-9110-d87751c47679_terseLabel_en-US" xlink:label="lab_iart_ReboundTherapeuticsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebound</link:label>
    <link:label id="lab_iart_ReboundTherapeuticsCorporationMember_label_en-US" xlink:label="lab_iart_ReboundTherapeuticsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebound Therapeutics Corporation [Member]</link:label>
    <link:label id="lab_iart_ReboundTherapeuticsCorporationMember_documentation_en-US" xlink:label="lab_iart_ReboundTherapeuticsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebound Therapeutics Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember" xlink:href="iart-20211231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ReboundTherapeuticsCorporationMember" xlink:to="lab_iart_ReboundTherapeuticsCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3220c026-3ca9-4644-954a-f21361634fb1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_869df324-212f-4a5d-a043-2bdcf86ee9f6_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_1c54dafc-a93f-4cfa-b9a2-d94d26394a9f_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c38ce665-6ec3-46d6-a2aa-837d2555f89f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_9f2dd153-3079-423d-b4d7-f762c0c7b95e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_143354eb-fbfe-4937-8076-bb7360d532cc_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_a5a0a845-4478-4e5b-ae05-73f15301ed2f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4fd59057-7553-4bd6-8df3-f23039bcdd8b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_079b8dcd-96c5-4b23-b0bb-5436e709a050_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_f7d6e263-912f-4340-95eb-45d5e8b09ffe_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f5a1d5d4-25e0-42fe-b798-504b58b30385_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandOnePlanMember_4c2f0003-35de-43b5-890e-a771ffcd7ab6_terseLabel_en-US" xlink:label="lab_iart_TwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2001 Plan</link:label>
    <link:label id="lab_iart_TwoThousandOnePlanMember_label_en-US" xlink:label="lab_iart_TwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand One Plan [Member]</link:label>
    <link:label id="lab_iart_TwoThousandOnePlanMember_documentation_en-US" xlink:label="lab_iart_TwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand One Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandOnePlanMember" xlink:href="iart-20211231.xsd#iart_TwoThousandOnePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandOnePlanMember" xlink:to="lab_iart_TwoThousandOnePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_a17af2ad-216a-4ce4-a1c7-cf2fd5f661ff_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Termination Benefits</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_1028bf27-20b3-452d-8ab3-7d9303fc4368_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_f5a53d3f-2cda-497e-9010-2b39836f41c8_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_d0c50e9e-b4ea-4d7c-890a-a65d007605d0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_da6d87f8-4e0d-4c92-94d2-b0f1e19aee8e_terseLabel_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liability</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:href="iart-20211231.xsd#iart_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:to="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_10aff842-6a19-483c-b75d-1701bc697149_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_328bc7f1-ae61-4d11-8d51-b0cd66cb8a51_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_4e5721cd-48b8-4019-9cc8-da9a97490a9f_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_690b9414-fcf6-4c93-add4-1fc65c3f3bed_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global intangible low-taxed income ("GILTI")</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Global Intangible Low-Taxed Income, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Global Intangible Low-Taxed Income, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_c8ed2712-40ad-4185-b98c-df65fc5dcf2f_terseLabel_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="iart-20211231.xsd#iart_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fc23ccb0-b33a-4eeb-bb21-a0d8447bc3ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_ab3bc30e-10ca-4618-a739-f6326670f553_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - operating leases</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Lease Liability, Noncurrent</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Lease Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_f044d8b9-2fba-4b41-b566-9994d857869f_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_label_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriodAxis" xlink:to="lab_iart_DebtCovenantPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_2584f695-4ba6-4f4f-a11e-a86676821e14_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price received</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_96642a17-a30a-4db5-a175-7bde22f55066_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_da3e3520-d029-4b29-87f2-da27fe95f391_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_c2df16a1-ee30-4886-a5b2-90071a9d1893_terseLabel_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of renewal options (or more)</link:label>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:href="iart-20211231.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_ebd4a5b5-e60d-44d3-883d-f5e43805ce92_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_78552572-13ee-45ff-b1c8-bdd785b8a7c7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InventoryCapitalizedExpenses_35c0ec3b-1ac5-44e4-be63-58361d09c696_terseLabel_en-US" xlink:label="lab_iart_InventoryCapitalizedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, capitalized expenses</link:label>
    <link:label id="lab_iart_InventoryCapitalizedExpenses_label_en-US" xlink:label="lab_iart_InventoryCapitalizedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Capitalized Expenses</link:label>
    <link:label id="lab_iart_InventoryCapitalizedExpenses_documentation_en-US" xlink:label="lab_iart_InventoryCapitalizedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Capitalized Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InventoryCapitalizedExpenses" xlink:href="iart-20211231.xsd#iart_InventoryCapitalizedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InventoryCapitalizedExpenses" xlink:to="lab_iart_InventoryCapitalizedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7842d598-ba36-482e-befa-2fa66e418d42_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9978477a-9133-43e6-b8f4-4ccb28706165_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_6fafb00d-6379-4722-a66c-5f4e0c274ed5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9301ca6a-5fe1-4ec5-ac61-a4ff2156b5ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_70e85875-ab10-491d-8581-e94c783800b2_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_795c67a3-ac5d-4797-80cb-c01b2c97a72e_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0ddf8953-c399-4b27-b8bf-c24e6755487d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_8ac01ecb-6178-4739-98f5-5afe00ea724f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3f4bdf33-c75e-4033-aaf9-c91ef2f0e3d1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_36a7f636-e1f1-45a7-ae49-647d29bf6141_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4b92e31c-ca05-4a34-bcba-3e961b46638a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignEarningsRepatriated_0f9c2275-2bbd-4c32-b9b7-4e691bd7242e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignEarningsRepatriated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax impact of repatriating foreign earnings</link:label>
    <link:label id="lab_us-gaap_ForeignEarningsRepatriated_label_en-US" xlink:label="lab_us-gaap_ForeignEarningsRepatriated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Earnings Repatriated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignEarningsRepatriated" xlink:to="lab_us-gaap_ForeignEarningsRepatriated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_1b668444-442b-49db-ad1f-7a602962e850_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_655a63a8-2417-42be-a744-2d78583f478c_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased facilities</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4e7938e5-4f50-4cfb-9701-6e235c292e65_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_57f990b6-fc5f-4cdc-b16c-e093e31d778c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_896aae9b-e832-455a-a3dd-7ea9507319e8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_2232eb77-9c7b-45d0-a810-6fe2577c1d81_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_179fa921-44a0-4469-9654-5a53ce92885f_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_c18de63f-0e9e-4859-9a04-ec2f4d55279a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3c72531e-3551-49ac-b5bb-4a6e08747025_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_59a3220c-b2f6-4a33-a5a4-1888736f9a54_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_795bfa27-f973-4699-be08-d9baa3026e04_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InstrumentsMember_788e6530-71ee-45f0-b873-5150518767d8_terseLabel_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_iart_InstrumentsMember_label_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:label id="lab_iart_InstrumentsMember_documentation_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember" xlink:href="iart-20211231.xsd#iart_InstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InstrumentsMember" xlink:to="lab_iart_InstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5f86f450-7f6b-4ed7-be79-8cc98eae5a60_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyPolicy_765cf79e-60e0-4363-bc13-c5ca9473ba2c_terseLabel_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtendedProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtendedProductWarrantyPolicy" xlink:to="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_ac3b79a2-a6c3-47d9-bf42-6cb01fa416fc_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_71924076-dc24-4262-a2cf-3c7de61dd829_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_6cea3c51-cef2-4cbf-9d58-88145ec88893_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_a257b64a-6854-476b-a9d7-3adca38da6c7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RestOfWorldMember_9802615d-4ab8-4004-a264-47186435557a_terseLabel_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of the World</link:label>
    <link:label id="lab_iart_RestOfWorldMember_label_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World [Member]</link:label>
    <link:label id="lab_iart_RestOfWorldMember_documentation_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from rest of the world.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember" xlink:href="iart-20211231.xsd#iart_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RestOfWorldMember" xlink:to="lab_iart_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_21fa059f-09f4-4694-8ad6-09ae94483b2f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_c7a54489-4e7a-4134-9e56-ff4bf06c633a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_12ed5307-5610-443c-a130-fbc0dc01ed5c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_374a7220-5e02-474c-ad39-8657bc1b05c1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from option exercises and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_9fcd18fd-4623-433d-b740-81635ecd52c5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant And Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_735b5e56-3dd8-4596-8de3-c744c234c47d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_906fc119-e146-4be5-a596-f0c537551599_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense related to sale of business</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3ab8002b-126e-4aee-8a85-719b4f8accd2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_730b3401-aede-4aa4-93c4-8534dfcfce8e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_99216460-bc04-4053-a623-13ff7ecb9a9d_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_817e53b4-f35e-4d28-b372-572bdb846803_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5b1552f5-1e84-4c13-8c90-f0c5be35a980_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_7d6d3c80-a446-4e1c-9b7a-d198fad8bb04_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit, transfer intra-entity intellectual property, amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_6c02740a-9c9f-4e06-8a45-49ace38a3b34_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_977afed3-6a92-4ec9-97f9-1e9989545a8e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_7ac40ba5-20d0-4b0d-b475-d1e61a29f99f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest crediting rate for cash balance plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_OptionToExtendLeaseYears_e9fb00c6-c975-410d-a702-1d41332bd824_terseLabel_en-US" xlink:label="lab_iart_OptionToExtendLeaseYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend lease, years</link:label>
    <link:label id="lab_iart_OptionToExtendLeaseYears_label_en-US" xlink:label="lab_iart_OptionToExtendLeaseYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option To Extend Lease, Years</link:label>
    <link:label id="lab_iart_OptionToExtendLeaseYears_documentation_en-US" xlink:label="lab_iart_OptionToExtendLeaseYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend lease, years.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OptionToExtendLeaseYears" xlink:href="iart-20211231.xsd#iart_OptionToExtendLeaseYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_OptionToExtendLeaseYears" xlink:to="lab_iart_OptionToExtendLeaseYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_79007388-90ba-4269-b916-778bcde33250_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3233b8aa-19d3-4580-8f22-a0fbe187d4aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_524f3a77-bf7d-4964-880d-93382c2d6bd3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_323bd16e-588c-40d4-a1e0-5ca72983bd4f_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_234e45aa-ce3c-4fa1-b032-e5368c3ae9c8_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible facilitative costs</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_563b4606-5728-413e-a941-763b52a9e7ae_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9aefd2ba-dbef-4a1c-8ca4-3aeeec9ba916_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f294df50-9f49-4750-aed2-50b992866934_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e691eeda-8533-4950-a5bd-180ce3428af6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2285ac16-52d1-4582-a37f-f892029eabc1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_bd76b2bd-6c7b-40d8-a37a-fec76423e58e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized share-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_cf83c6f4-cf6b-4af6-8455-ba408c1a4171_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension plan - net gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8877db64-2146-43e0-aada-fcfb86e27142_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_5719086b-cee1-452a-a21d-a0bb6f651c0a_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap Two</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Two [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractTwoMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_13b096dc-69a6-473f-93f9-972699c3f214_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) estimated to be reclassified to earnings during next twelve months</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PaymentsForProceedsFromBusinessAcquisitions_ce90e1cd-db19-4b68-8ee4-e0bdfabb77bc_negatedTerseLabel_en-US" xlink:label="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_iart_PaymentsForProceedsFromBusinessAcquisitions_label_en-US" xlink:label="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Business Acquisitions</link:label>
    <link:label id="lab_iart_PaymentsForProceedsFromBusinessAcquisitions_documentation_en-US" xlink:label="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:href="iart-20211231.xsd#iart_PaymentsForProceedsFromBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:to="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_edd37128-644a-4b25-8548-3103d5de606f_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_11b36e3f-0f8f-42c8-aff6-6c45bd39038b_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_6be46421-7d45-4d03-b876-efa1984cc1f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from the sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2225dd5f-733f-401c-9886-c8453c2dc4ec_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_56464c6a-3987-4986-b40e-441e9943431a_terseLabel_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis</link:label>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_label_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis BioSciences Inc. [Member]</link:label>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_documentation_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis BioSciences Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member" xlink:href="iart-20211231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ArkisBioSciencesInc.Member" xlink:to="lab_iart_ArkisBioSciencesInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ed6d937b-a7f4-4f90-a26c-8b479a88720a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ece9fd2c-4dbb-4215-ad5d-f13d67ccbaee_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_056d897d-e425-45c8-bbe7-071ed1505820_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_be5603f9-2cbb-4b9b-ad8a-95a493b61c3e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_9ad7a16b-e064-4dc2-9ca8-e3c0def4342b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_e56faa87-decd-4e55-aa0c-aa82f5105d6f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total contributions made</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_bcd89d56-fb76-4855-816c-9bc033002bfe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsYearTwo_c57918c5-d119-4050-af8c-8326943016ba_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, year two</link:label>
    <link:label id="lab_iart_InterestPaymentsYearTwo_label_en-US" xlink:label="lab_iart_InterestPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Two</link:label>
    <link:label id="lab_iart_InterestPaymentsYearTwo_documentation_en-US" xlink:label="lab_iart_InterestPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearTwo" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsYearTwo" xlink:to="lab_iart_InterestPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionNumberOfAssetsAcquired_9ec1e7b7-3e53-4549-b15c-17247fa2ace0_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of assets acquired</link:label>
    <link:label id="lab_iart_AssetAcquisitionNumberOfAssetsAcquired_label_en-US" xlink:label="lab_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Number Of Assets Acquired</link:label>
    <link:label id="lab_iart_AssetAcquisitionNumberOfAssetsAcquired_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Number Of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionNumberOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:to="lab_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2d6d1653-31c4-4126-9ca3-c035b8eaf496_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_db7528cf-7895-44ab-8a27-092ed9346df0_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_f8ab10a3-006c-4dda-a689-bb3bc7a027b2_negatedLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Premiums Paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Premiums Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanPlanAssetsPremiumsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:to="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_7f5219d7-460a-49f0-95ec-019cb66a2c83_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_23f297df-d92c-4010-9cb2-b8ab08bad544_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_485c648a-dc8f-4ebd-8940-2b3b74c18a9e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from stock compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_b3643a5f-6334-4f98-950b-68ad918f4dd7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_606ce36c-2528-4cb8-9f0e-bd3c355ae391_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of business combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_8aa33f06-44da-4cb5-b647-082b845080ad_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_f2f48d5f-260f-43cf-b306-beef517db7a4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_8b3dd438-cf15-4795-a2a0-ddf7d2605a71_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6a3b87c8-296e-4db4-a08b-8dfd6c809f37_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Uncertain Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_16f06297-c8d2-4957-a941-aad2ed403914_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_4c71f3e2-15cf-4a78-96bd-69629adef947_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TREASURY STOCK</link:label>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_label_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockTextBlock" xlink:to="lab_us-gaap_TreasuryStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IncreaseInAuthorizedShares_8e467fef-4834-4269-8847-efc41eccf61e_terseLabel_en-US" xlink:label="lab_iart_IncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in authorized shares (in shares)</link:label>
    <link:label id="lab_iart_IncreaseInAuthorizedShares_label_en-US" xlink:label="lab_iart_IncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Authorized Shares</link:label>
    <link:label id="lab_iart_IncreaseInAuthorizedShares_documentation_en-US" xlink:label="lab_iart_IncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase in the number of authorized shares under the Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncreaseInAuthorizedShares" xlink:href="iart-20211231.xsd#iart_IncreaseInAuthorizedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IncreaseInAuthorizedShares" xlink:to="lab_iart_IncreaseInAuthorizedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1765c398-9a72-4788-af68-6c5d2190ffc2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_fbdf2db6-e2d7-43ad-b8e9-0e5e68415d01_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_014b5544-d999-4909-a603-8466da6195e0_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_c70516ab-ef07-4eb0-a95e-82ea47fdf46a_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term portion of contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_68f1bdd4-ef7c-49a3-8202-f5758ff6e05c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_79443184-40e1-4255-868c-75d9b5683b8f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_a623ddf4-8753-4301-99fb-946f36f9e66e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgram_a1968d9d-1cc2-4f82-a1c5-90573cec78a5_terseLabel_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured long-term debt, securitization program</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgram_label_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgram_documentation_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgram" xlink:href="iart-20211231.xsd#iart_SecuredLongTermDebtSecuritizationProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuredLongTermDebtSecuritizationProgram" xlink:to="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_9fc4870a-4b51-4883-81de-7076883b788e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_51e61ca3-46cd-4b36-8908-3528fa4883a0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit realized from stock options exercised</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_08d7c7f2-baca-4477-a14a-96aaee4f90f3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_66c45714-41c7-4f79-80f1-2f7c1545bf69_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_a46f6043-b2be-451f-878e-7ab6ec1eec0d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d839c96a-f62a-4cf7-b8a1-0631f9ab2b06_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_3f86fc94-8faf-467f-9826-ebacd2181d9b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_bb4d5a1c-b831-454a-ab42-fbae9081ed9a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, average cost per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_3b6b3207-fc9d-4048-b415-277a4be77efd_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_52b4d7ac-eeff-4c30-a5c5-831d1e1e52ca_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_4c2da9c5-b73d-4f7f-9642-02bb6ad0270e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Profit</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_7cbddf9b-7bc9-430e-8629-60bb474e3383_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_9de33053-c50d-4072-8e22-0126dfc0a8af_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_ef479e86-5f52-4ff6-a6e8-b1fb09787bea_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_96733eab-16fd-4ecd-947d-e7fe3aa2a9a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt proceeds, classified as equity at time of offering</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a759888f-4847-4a1c-a69f-81856374e713_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_82ef3812-abac-4d81-8494-a9a767858316_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e56a535b-6bbb-4201-82b9-cac0c38f5a9e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_0b33730d-6c96-4c98-b937-2214b63c45b2_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_830cc572-50d5-4457-b1cb-029dc504800d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7166d44d-a75a-4e1b-8602-a08df7a6c218_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_32352102-daba-4444-b9b7-9d34cff10423_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_da4bfb41-9024-40be-8c8f-8f830482479d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_92120047-b0df-48d7-88e8-02ed464b161f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_0467e499-8300-4ed2-81b4-4495339c2b68_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CertainPurchasersMember_c3599dd9-7135-4da3-a736-c2f15c22c6f1_terseLabel_en-US" xlink:label="lab_iart_CertainPurchasersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Purchasers</link:label>
    <link:label id="lab_iart_CertainPurchasersMember_label_en-US" xlink:label="lab_iart_CertainPurchasersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Purchasers [Member]</link:label>
    <link:label id="lab_iart_CertainPurchasersMember_documentation_en-US" xlink:label="lab_iart_CertainPurchasersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Purchasers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CertainPurchasersMember" xlink:href="iart-20211231.xsd#iart_CertainPurchasersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CertainPurchasersMember" xlink:to="lab_iart_CertainPurchasersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_aa87c4c1-561b-42d4-a10a-59953c504fd6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_37444793-b787-4cd1-bdf0-fa2837782f45_terseLabel_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of days from shipment to issue a credit on returned goods</link:label>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_label_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Policy, Issue Of Credit, Number Of Days From Shipment</link:label>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_documentation_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Policy, Issue of Credit, Number of Days from Shipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:href="iart-20211231.xsd#iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:to="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_7e4497f3-854d-49de-864c-025d876360ee_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_173e8c2d-0941-4af4-96a5-2610df9dcd7a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_18d6ad22-16f4-451f-b72d-6c38f5076d3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ec389fb7-7598-4cb1-ae6e-5ad35046d43f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_7f0bade0-36b6-4465-926d-371da9e86afe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionLineItems_e8550656-e991-4868-bf23-70addab2a511_terseLabel_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Asset Acquisition [Line Items]</link:label>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionLineItems_label_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Asset Acquisition [Line Items]</link:label>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionLineItems_documentation_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule Of Asset Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionLineItems" xlink:href="iart-20211231.xsd#iart_ScheduleOfAssetAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems" xlink:to="lab_iart_ScheduleOfAssetAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_f99f320f-2d14-4738-ab0a-27f7b952eb77_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_932bb031-5cce-40cb-a988-43ca074bede8_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_a1b435ab-fd25-4545-9c3c-7788b5e358c5_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset-operating leases and Other assets</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Right of Use Asset Operating Leases and Other Assets</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Right of Use Asset Operating Leases and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_bb04f23a-f62f-4683-afbe-b6918a210ed1_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_MilestonePaymentOneMember_e2296fe7-57d1-4e57-80a5-89f516c05769_terseLabel_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One</link:label>
    <link:label id="lab_iart_MilestonePaymentOneMember_label_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One [Member]</link:label>
    <link:label id="lab_iart_MilestonePaymentOneMember_documentation_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember" xlink:href="iart-20211231.xsd#iart_MilestonePaymentOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_MilestonePaymentOneMember" xlink:to="lab_iart_MilestonePaymentOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_4a099ac4-7893-49ee-bf09-87191cec43aa_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_9768ab4d-ad69-4247-aa44-5127d39abf20_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell Acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d7d5d458-6175-4bc8-9a32-54bc591af69a_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_610d726e-37be-4002-b1f1-c6378a731ac4_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_c0985898-3858-4af8-9eee-b0dfad66018b_terseLabel_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings under securitization facility</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_label_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Noncurrent</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_documentation_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:href="iart-20211231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:to="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f01aacba-8d6e-4a09-bbba-9f4d6b6c13c0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_12e9831b-9465-48f9-8a6e-e1fa5b5b9e6d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_b182e6e7-010c-4da2-8462-82b980b6bc95_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_fea7f014-c6ec-41c3-9054-e6b41a51a5ed_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_e1e44128-f912-4408-8d9f-eca47d23387c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_eb9123a9-5813-4e5a-b146-788e8b50c06a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_b57759c3-3443-443c-b919-9ea866a995ac_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalization of research and development expenses</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_label_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:to="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_19b78e09-415e-447f-8329-cf1d01e819b8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_afa8b2e2-1246-4cad-bb1b-e7735bd03952_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_86f226d3-7981-45f1-8da3-43e29537749d_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_32b15b14-4ee6-4135-b545-7450da867fb4_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_8c650bc1-46fb-477d-89ed-9baa41009e69_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of borrowings under senior credit facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_162f84ec-2101-417e-9135-4c9e9fbad381_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan component of senior credit facility, classified as current</link:label>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_label_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtCurrent" xlink:to="lab_us-gaap_SecuredDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_7ea81954-9609-4435-84d9-d1bab85b5bef_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_2cce19e5-65ff-484e-b490-20d8a446bc1f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss tax holiday</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Holiday, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_59539271-10fb-41c2-afb0-cf259fe43b15_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_f26a30bd-9a15-48c5-80a0-bf5c25b7441b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_f950288a-fff4-44fa-94bb-5ec8cd0cff3c_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period, Treasury Stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_2014b5c2-103c-47d3-b567-88d54138fc4c_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period, Treasury Stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_0c2b74bd-c6e5-4644-a1a3-e783acc5334b_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defer payment and taxation, base salary, percentage (up to)</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:to="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c55ae166-7663-48b1-9144-25d0db89e207_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockNoParValue_bc750197-3575-4233-9334-ed563222b849_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockNoParValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, No Par Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNoParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNoParValue" xlink:to="lab_us-gaap_PreferredStockNoParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ee4fa774-63f2-43a2-9984-a997239760e7_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SupplierRelationShipsMember_645366c4-a4ec-4759-972c-bf668f1ba329_terseLabel_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier relationships</link:label>
    <link:label id="lab_iart_SupplierRelationShipsMember_label_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Relation Ships [Member]</link:label>
    <link:label id="lab_iart_SupplierRelationShipsMember_documentation_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Relation Ships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember" xlink:href="iart-20211231.xsd#iart_SupplierRelationShipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SupplierRelationShipsMember" xlink:to="lab_iart_SupplierRelationShipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_17cc20c9-4a85-4b56-9555-84f5e2e19dc0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_6a3b0a14-a90e-46c1-8ce8-0ed55b188490_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_74d2cc14-100c-4ce2-813f-f2bfb9872dba_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_902d0d19-bcd8-48aa-b00b-3ab7b838f235_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_645ea06f-df0d-45ab-8550-336a940b7b4e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_877df027-ab7b-44e4-8477-40ab0f9a8058_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_8ebeb345-0c73-4f03-b6d2-8ed093c8b94f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liability - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_6062bce8-a381-42eb-b797-cccdd93ad8d3_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_cbdad18c-e40a-4613-88bd-a9bc86c3538a_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_ea5496c8-6a83-4253-85de-1fa9b95e15f2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_aa113b51-c201-4e36-a687-16e86ef419e8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_f9a52015-4e65-496b-b78d-9d9d41916c11_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a02134c4-efb8-45b9-a64c-40837db0232e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4c4c458e-04ef-4f2a-8551-d0349c67e5f0_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6c33b1c2-9d53-4c89-991b-8d1437fa74e8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_5911da99-5e45-459e-abde-ad755da411d7_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_32221b5b-d978-4e8b-8f75-df8b86daf747_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_785be248-e20b-461b-8022-7fee90243117_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_f0704d6f-6f90-4002-8c3f-1eec1112e66e_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in other income</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_4b7675da-81b8-4a3f-bf2b-d6876a17da56_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_5c9d879b-4e67-4dae-a3a3-02f7f4fe561c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impact on Statement of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_653a8aec-8ed8-4cc2-9dd3-5e5b692893be_netLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_73818a80-8b93-462d-9ee7-2628a92fe6b9_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_e74c54bd-c04c-465a-abe2-4834a7a92119_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_ba4f29c3-855e-4fb3-9fdf-5b2830ec0d77_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_85cda4bf-f74e-43a3-93de-24cc34b4f6b7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ab70f91b-005e-4537-96ce-f2062f34aee2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_7341cd7e-99ee-4ef8-a2f2-93aa0eb8cc9e_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of business - book to tax differences</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_efa065f2-5d1b-47dd-90b1-ffa041ee6f4b_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_ef843913-2f49-4ff6-8a26-e4e1a0ed2ab9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Asset (Liability)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_17b46fa5-d7b0-45ec-ac8c-7d02a03f5f95_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_9d5c3a98-6e5a-4ba1-8232-4ff23b520ab1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_4b22eaa6-1bf1-45be-a7b1-f7bf17e66890_netLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_a0e8b897-c2a6-47b8-8ada-9d0ce8171e48_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3bb657de-236a-4cf5-a333-d41b736029f8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0835cafe-21ab-45e8-89f8-9c90ecbe7d57_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_eb0f6834-0bcd-40a5-8888-f664e9a26353_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_a3f6a383-dfc9-47c8-9ff8-ea1bfc7172d2_terseLabel_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Asset</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_label_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Asset [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerAssetRollForward" xlink:href="iart-20211231.xsd#iart_ChangeInContractWithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward" xlink:to="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_ec91924c-3797-427e-b262-5314f8627c54_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_c7fea66c-65e7-49bb-8f98-d97e7602c2e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_72655f5c-bc84-4518-b2aa-7688b6aa4df3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FranceAndGermanyMember_62cace0e-cf73-48ca-be9c-44d379447299_terseLabel_en-US" xlink:label="lab_iart_FranceAndGermanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">France and Germany</link:label>
    <link:label id="lab_iart_FranceAndGermanyMember_label_en-US" xlink:label="lab_iart_FranceAndGermanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">France and Germany [Member]</link:label>
    <link:label id="lab_iart_FranceAndGermanyMember_documentation_en-US" xlink:label="lab_iart_FranceAndGermanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">France and Germany [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FranceAndGermanyMember" xlink:href="iart-20211231.xsd#iart_FranceAndGermanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FranceAndGermanyMember" xlink:to="lab_iart_FranceAndGermanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_88d64ee9-d3a1-4c99-81c1-83f3e4cb247c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_4aa92290-a221-43ff-9754-8fc0d35d4f2c_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, net of transferred to trade receivables on contracts during the period</link:label>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_label_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Net Of Reclassified To Receivable</link:label>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Net Of Reclassified To Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:href="iart-20211231.xsd#iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:to="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_53cf1f44-b020-4267-aa9c-c0f1a06646f4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_a8f14082-d5fc-4692-a698-2f015bc126ad_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar Rate</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_0549af51-cb96-4644-adbc-b6c7ffd6c765_terseLabel_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual rate of lease agreement</link:label>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_label_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Rate Of Lease Agreement</link:label>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_documentation_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual rate of lease agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement" xlink:href="iart-20211231.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AnnualRateOfLeaseAgreement" xlink:to="lab_iart_AnnualRateOfLeaseAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_368ee3d7-050f-4dc7-ae9c-3046f62d45a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_396b1b18-f11c-403d-b3ae-dd4ca7a8248d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_d9c52efe-4a5c-4ca3-890d-97b827c497bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Uncertain Tax Benefits Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeMember_a83a722e-3874-4ebd-9556-529824994095_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeMember_d34e1f9c-e890-4770-99ad-850546190217_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeMember_label_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeMember" xlink:to="lab_us-gaap_InterestIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_a705a94f-1499-4a7b-a272-26937f2a9f15_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_0a981c63-e98a-4217-bf60-c9612b95a3fb_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE LOSS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_59610f5d-2415-46f1-95c6-651f560f6c82_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_64cb7500-bcd9-41bd-ac9c-600869f02d98_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enabling technology license</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3c84be1d-b24d-4039-9472-0c70df48534a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e2b682b2-e6e6-41b8-b6df-3da81fdb5509_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_44e40c43-e1de-477f-8a3d-900c3c7f5ed0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8de21754-86e4-4078-aaf3-147eb09fd73f_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_d5736fd5-ee87-432a-a6d6-8fa9d2858a49_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_bb1fe8e2-2199-432c-862b-b36dbb9cb800_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_752922aa-f635-4341-81cf-a0d451c88fb3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EmployeeStockPurchasePlanProceeds_63e2a7b6-8b96-4c56-a625-e94fd20e7905_terseLabel_en-US" xlink:label="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP proceeds received</link:label>
    <link:label id="lab_iart_EmployeeStockPurchasePlanProceeds_label_en-US" xlink:label="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Proceeds</link:label>
    <link:label id="lab_iart_EmployeeStockPurchasePlanProceeds_documentation_en-US" xlink:label="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received from employees in connection with the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeStockPurchasePlanProceeds" xlink:href="iart-20211231.xsd#iart_EmployeeStockPurchasePlanProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EmployeeStockPurchasePlanProceeds" xlink:to="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_98053a6c-2b5a-4796-853d-443fa29c5cf9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4fcf4e87-da68-4f31-8542-881e713c2025_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_caaec315-71b7-41f2-9102-1cca57cc1e9b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_99fb2cc0-b5db-4ed9-ac60-b6974165bba0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, fair value of amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_7494190b-7694-470b-81f0-08dd8f95cc4d_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_5c8c5098-4a88-4e27-99d8-aad04e36d0c9_verboseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_09ece4d0-e9a9-4db4-ac1f-97e6ee8343a7_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Extremity Orthopedics business, payment for terminating license agreement</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d97f50f6-40f9-4ec8-817d-cb1135aa5c70_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e73c9c89-4f34-44b9-8030-1748505e5e64_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalizedAdjustment_142e76cb-7afa-438d-9da2-e18de221e2fb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalizedAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense capitalized into property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalizedAdjustment_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalizedAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalizedAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalizedAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalizedAdjustment" xlink:to="lab_us-gaap_InterestCostsCapitalizedAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_606b05ee-323d-4d1a-b5bd-85ca662eb805_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_OneMonthEurodollarRateMember_8fdb9d36-c1e7-4ee5-9c04-e08b1bf69b51_terseLabel_en-US" xlink:label="lab_iart_OneMonthEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-Month Eurodollar Rate</link:label>
    <link:label id="lab_iart_OneMonthEurodollarRateMember_label_en-US" xlink:label="lab_iart_OneMonthEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Eurodollar Rate [Member]</link:label>
    <link:label id="lab_iart_OneMonthEurodollarRateMember_documentation_en-US" xlink:label="lab_iart_OneMonthEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Eurodollar Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthEurodollarRateMember" xlink:href="iart-20211231.xsd#iart_OneMonthEurodollarRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_OneMonthEurodollarRateMember" xlink:to="lab_iart_OneMonthEurodollarRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_565b4dfd-8ad2-4647-b741-305d2f0339ad_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercised stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionExpense_238a5f47-cc55-4a2b-af45-777ef9bc176e_terseLabel_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of bond issuance discount</link:label>
    <link:label id="lab_us-gaap_AccretionExpense_label_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionExpense" xlink:to="lab_us-gaap_AccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_f873477e-7cc9-499c-8db1-b0ca79e1ea76_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_04495136-861a-4ba1-9812-c61bf76945d1_terseLabel_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases:</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_label_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases During Period [Abstract]</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_documentation_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases During Period [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:href="iart-20211231.xsd#iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:to="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d5d53c8-7c61-415d-b85f-b8e3c3983f32_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_45d01a75-512e-403b-8473-506f713862f4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_cd17c7f1-cd3a-41fc-84e3-34f0d4700261_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b7dd4563-3778-4d5c-8caf-55eab4e29001_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_6524cced-d7a7-4d1d-b13f-848d5db125f1_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development milestone payment, to be paid</link:label>
    <link:label id="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_label_en-US" xlink:label="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Development Milestone Payment To Be Paid</link:label>
    <link:label id="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Development Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:to="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_48a41ea4-75c6-4316-a28c-fcf1c8e92f20_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_5a268cf3-a0b5-4fdb-a80c-a416d3467019_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_f8873252-85c2-4d83-b997-1d7c863e510c_terseLabel_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes</link:label>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_label_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Five Senior Convertible Notes [Member]</link:label>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_documentation_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Five Senior Convertible Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:href="iart-20211231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:to="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_bbfdeb06-c09c-4535-8f0c-bc63dd083891_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_8a7fc080-c0a3-4a4b-995b-008490e99d4a_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_acff471a-0190-4138-9b72-00fde9cb204f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Sales and Profit, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0329960d-706f-480a-aaab-82be2f15106f_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Geographic Revenue, by Area</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_f077cc53-9f9b-4532-b2fa-e87765086eef_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_38a0e4ab-ac82-4f78-a47e-3638fedf9134_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e5de8572-5b89-4633-a9aa-3e7938b0d227_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_cc4cdca8-4b3c-439a-8ce1-bce756456cbe_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_af61ed50-fbb4-4b38-8432-7d1f8bb5e989_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_32752977-251c-4071-9a98-94a57a3da781_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TermLoanFacilityMember_21694d7e-c1fc-466c-976f-ba8fa859f137_terseLabel_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_iart_TermLoanFacilityMember_label_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_iart_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember" xlink:href="iart-20211231.xsd#iart_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TermLoanFacilityMember" xlink:to="lab_iart_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4c153385-bbed-4356-a312-8364b0a7bc7c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_73156f09-a4af-478f-a5f6-68dbcc841a27_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_4c563f39-da98-41e0-a554-8420b2489148_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_d668c290-ef58-403b-9ce8-4367d9bd7a7f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Funded Status</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Funded Status [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_563b01cb-07d3-47b5-aeb2-04be7051ce85_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_bf542ef4-f0e3-4df1-bee6-a2922bdeadf5_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term convertible securities</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_1bdde618-aee7-4333-bf2a-d0c6da8bcb4a_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a5c3d831-0e50-4753-812a-8d7b4f0da21f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_0489aff6-7dd6-4ba4-afa1-e3a904d6967e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent_be67de12-9389-4f2e-878f-eea69a3abb1d_terseLabel_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of borrowings under securitization facility</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent_label_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Current</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent_documentation_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:href="iart-20211231.xsd#iart_SecuredLongTermDebtSecuritizationProgramCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:to="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_e0646925-532d-490c-9866-bd62cf96a287_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contributions carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Charitable Contribution Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_6ec1cd5a-f7e5-4364-bc37-85a81db047a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_877c7638-2f50-48b1-be0a-653870106914_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_84c2ca68-0243-43ab-aed6-1f75b4a05eca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_37da20eb-cfe6-48cc-b51a-d66ae37a3859_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_8641cb4c-bbd6-4671-bdf0-7d53f23b8532_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_52f348d6-276f-4791-98b1-7b734abe2f35_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_56b44090-0af8-4e14-9d0d-3b8c5a0fe941_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum undiscounted payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_321f77e2-d524-452a-88c6-b10c9787a218_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5966fb7f-1acf-466d-98c2-be6a691e5ca1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_584e2700-cb0a-4764-9fb5-12ceb58110a9_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_2fb467b6-9afc-4a59-92fd-541347085ca0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_5a170be4-ff06-47bf-b19f-681372939573_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NoncashLeaseExpense_436dc987-fa2c-41c9-b34d-0a7bdcb6e678_terseLabel_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_iart_NoncashLeaseExpense_label_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:label id="lab_iart_NoncashLeaseExpense_documentation_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense" xlink:href="iart-20211231.xsd#iart_NoncashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NoncashLeaseExpense" xlink:to="lab_iart_NoncashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_7f7c64f0-8191-46f5-bf83-e5b45f48ea2c_terseLabel_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill</link:label>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_documentation_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:href="iart-20211231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenseMember_f662c1c1-7651-4bff-bb26-d00ebb326b9c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenseMember" xlink:to="lab_us-gaap_OtherExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_2865563e-e556-470b-9f69-7a44bd55c48d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax credit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_c2d192c9-91d9-4327-a902-d36b647eaf13_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RETIREMENT BENEFIT PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_0063ae43-e0d6-443d-9601-2b2675354e74_verboseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial strike price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9a2fc30-bb1d-45e1-b176-f2904c9d2797_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_fe0e7c94-a88f-4163-995c-e28b6d20d070_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_7f7bc458-6a8f-4dbd-bf83-2a317a222172_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_765bddcf-a11d-4d01-8cb0-533559177d21_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_548a387e-6192-47b1-a56c-0ab6e85b2b0f_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_fdc6be3c-30fa-462a-96a9-d206d73bd771_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_6fb4038c-40ce-4842-8fcc-26bbde1405a5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (expense) benefit related to items in other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_03ceddd7-c89d-4b7b-baad-b8ea9ce8a951_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_3e9e39f2-dd60-4077-b0a1-a68fedd5ceee_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_d47ed89c-9501-4bac-87bd-973398fbadf3_terseLabel_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security facility, weighted average interest rate</link:label>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_label_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate, From Securitization</link:label>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_documentation_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate, From Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:href="iart-20211231.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:to="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_2c682796-d59b-475f-8812-8ef0f3626c9e_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_1db56f8d-5680-4a77-8836-e2beb9f43111_terseLabel_en-US" xlink:label="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing period for products shipped with no alternative use and right of payment for performance</link:label>
    <link:label id="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_label_en-US" xlink:label="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period</link:label>
    <link:label id="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_documentation_en-US" xlink:label="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:href="iart-20211231.xsd#iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:to="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_605bb90f-6ddd-4346-b762-da933ab19ca6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_9464c189-3a74-44c6-aea2-8cd6bcece0b7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_d9550934-60e4-4448-ab3f-51fba93eab3e_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_17f8fd6e-3a31-4264-a595-08f654201571_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transitional supply agreement, payable</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transitional Supply Agreement, Payable</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transitional Supply Agreement, Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_fe65883c-1715-4b59-8945-d7a9755864b3_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_566a1f0a-9645-44a8-a44f-3f8025ce8ea7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligations expected to be satisfied, expected timing</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_e1270db5-9a14-48c4-9c40-5435d25c7f61_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:to="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_a33af6bc-6988-42ba-88b0-2b6bfa9d0877_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_360e46d6-b0ba-4f1d-baba-a949869a5c7d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_2e3b4359-03c4-4b5c-92d8-53ccfd961b69_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures, and office equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_4a8a74e4-bd87-4c4a-a95e-45b71be683c2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_96ed6413-8a03-4d74-85c8-65aa16127dcf_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:to="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_38301bf1-14a0-4f36-9336-db6aed6ce618_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_55b29b97-a5bd-42fb-af56-f529647feb0c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_c0f196f1-069f-4670-8c70-9aa02cede1dd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plans transferred in</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a23563e3-518c-451a-9aae-82c3730eeef5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a94de756-0ead-4106-a211-f138eb18130f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_53c9dd23-8d0c-407a-ad78-cfb65a3ebf08_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8f7678bc-9718-42d2-830d-e7cbd0c95b8a_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_03fd7ca5-7227-411e-af5b-2302e960e630_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_85a2eeca-45ca-43f5-bac3-5d3a76ab7265_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued vacation</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_label_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:to="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_120b5cf0-ab14-4ac5-a80d-d7c838784227_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_2d4ef631-3227-46b4-af81-5d6358d88cbc_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_241fad43-242c-4a1e-9fc4-bd85820a9f81_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum average conversion value of notes</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_label_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Average Conversion Value Of Notes</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_documentation_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Average Conversion Value Of Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:href="iart-20211231.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:to="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_ca094cec-ef25-4d6d-995d-56996f9e3d89_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_0904cb8f-21f9-4b5f-b5a6-327d61d88759_terseLabel_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification</link:label>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_label_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification [Member]</link:label>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_documentation_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:href="iart-20211231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:to="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2f1048e4-77ac-47b2-8a83-7a1e97bf4680_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1aaa953b-f3f5-4da7-8add-f2db25200c01_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_856dd852-0b2b-457c-a2ac-608cb3a5bde9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_6ac3ae8f-0300-47e8-bbcd-9beea725ebb2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_189a07f2-a3fa-4ac0-9c3b-d56e618bd795_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, End of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_26144b85-cdee-4da0-8dae-7aaab13a9c62_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_55c2186b-ae00-4b1e-8bbd-8d7cb7807726_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_6a12fe7b-201f-43ce-a7dd-9225895ce33b_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_277e630a-6f07-4346-9d33-4b7f21d58c4b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_e2204d26-8348-45be-8f38-2a301e255ff9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d7f19f67-606a-4399-910f-281e7c6a2d30_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ff40dfe7-cece-4577-a792-60e0b4d94e24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_7397cbf0-eb01-45e7-b1ad-f0ba2998993f_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to acquire, period subsequent to first commercial sale</link:label>
    <link:label id="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_label_en-US" xlink:label="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met</link:label>
    <link:label id="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:to="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_de6493ae-eb42-405a-844c-1e2910bff786_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Doubtful accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_97364d97-cc3f-4d0c-947a-7dad4c59bb29_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net effect on net income</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d9e88a99-9ae5-4ba8-8dd9-206c0bcf4170_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ACellIncMember_28100d06-27a9-4b43-bdbe-62896d233b65_terseLabel_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc.</link:label>
    <link:label id="lab_iart_ACellIncMember_label_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc. [Member]</link:label>
    <link:label id="lab_iart_ACellIncMember_documentation_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember" xlink:href="iart-20211231.xsd#iart_ACellIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ACellIncMember" xlink:to="lab_iart_ACellIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a82a774-fc23-4396-a79b-f5044ff1757c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_74d95ed7-0b2d-40cf-9aa9-d52c3766011d_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_f345876c-dd2a-465a-8f71-a1304d0d8ae1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_7acf63ff-11af-4386-9f4c-30719c5a5a78_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, Beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_b262c412-26e4-4b57-9e58-28b00f4aca61_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, End of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_ca73a1cc-64eb-48e7-9c9e-06a2d218a97e_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_9f67550a-a931-45b8-8706-1f2f94875ae4_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_a36681e8-0516-425a-8470-540edac367c9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of Extremity Orthopedics Business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_289f3b9b-572a-462d-8b72-fe54c086af4f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_1a2ddf1c-cf5e-43f8-b248-e25baf07f449_terseLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for performance achievement related to award target (in shares)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:to="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1499688e-5c65-4096-ad94-07ee85baae9c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_cacc7599-83b7-44d0-8c6f-a241f6e92fb1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_085e5a96-8a6e-4362-be98-693fbb0bec4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c2b16bee-fc7c-48dd-880f-8065738b9cb2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_3338d683-4b13-4a1d-ac46-aff82ecc5498_negatedLabel_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of option hedge on convertible notes</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_7d6b24d9-bbae-4c54-86d1-50bb904821cf_verboseLabel_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of call transactions</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_label_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Option Index To Issuers Equity</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_documentation_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Options Indexed to Issuer's Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity" xlink:href="iart-20211231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PaymentsForOptionIndexToIssuersEquity" xlink:to="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_e7b9080a-ba3b-4544-9861-2f14537c8781_terseLabel_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director</link:label>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_label_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</link:label>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_documentation_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:href="iart-20211231.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:to="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_6ed0e51f-d334-48b2-b18f-8157d75d3b06_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_75d0602a-982d-4d89-bab3-b6acf8f42740_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_e3eee775-f178-4f0b-9f5c-7168e8d651c8_terseLabel_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization facility, fair value of amount outstanding</link:label>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization Facility, Fair Value Of Amount Outstanding</link:label>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_documentation_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization Facility, Fair Value Of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:href="iart-20211231.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:to="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_f2463624-aace-4a3a-ac05-1049737e2c2b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProFormaMember_7e32b66e-190b-4cae-b99c-1ebe522c3073_terseLabel_en-US" xlink:label="lab_srt_ProFormaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma</link:label>
    <link:label id="lab_srt_ProFormaMember_label_en-US" xlink:label="lab_srt_ProFormaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProFormaMember" xlink:to="lab_srt_ProFormaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_efcd93ae-7d28-446c-a909-2722a75d2768_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligations, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_5ea03e8a-97d3-465e-8357-998a0127fc0f_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligations, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_ce99796d-467b-4146-a987-12f225e2c84f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_fb50beb4-1448-4cae-a7f6-74357a629c3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Maximum Leverage Ratios</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_900e6d67-10c0-4781-8790-da2bddd50934_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_19d216a7-47ba-445e-bf73-817abb3b422a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c39e52f9-0860-424a-a66d-859874b08413_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AuditInformationAbstract_label_en-US" xlink:label="lab_iart_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_iart_AuditInformationAbstract_documentation_en-US" xlink:label="lab_iart_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AuditInformationAbstract" xlink:href="iart-20211231.xsd#iart_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AuditInformationAbstract" xlink:to="lab_iart_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_bbbc2e76-4815-41ba-ba45-bc64b5020d84_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c0a5b625-8871-4ae7-88ac-dc76dcece4ba_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant strike price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_f1c13c0f-c661-4c3e-9b89-8d04ca9767c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_e7793f3d-13c5-4b41-8fad-6fe2bacde380_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_8c257b20-1626-48c1-ba99-75860ac7bcfb_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_3b04833a-b326-4711-9bfb-7aedc4dc6273_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b483a51c-902f-46f8-880f-2fd16ea59bc9_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_e7618f7b-77c6-41eb-bde4-dda84bb48a80_netLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense recognized</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_ab99300c-797a-4439-8ece-11a337009bf0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Contractual Term in Years, Exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_1c78531d-cdb0-47e7-87f4-9e196d85e4ec_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod4Member_7b534945-f8c4-4cfb-b87a-cdf36aab5f29_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 30, 2023 and the last day of each fiscal quarter thereafter</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod4Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 4 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod4Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod4Member" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod4Member" xlink:to="lab_iart_DebtCovenantPeriod4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_4ff8ac21-e8dd-4dca-8f4e-ac2825c4b115_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of product technology</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_b97cbfc0-37f0-4e7b-8869-c870251c0938_terseLabel_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability</link:label>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_label_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_documentation_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember" xlink:href="iart-20211231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContingentConsiderationLiabilityMember" xlink:to="lab_iart_ContingentConsiderationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_45b89344-7b90-4e8c-98b2-54ac756f56fe_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_label_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_documentation_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:href="iart-20211231.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:to="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_e3939bdc-1659-427a-a7b7-02cf2cc807ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income (Loss) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_af5e51e0-d3d5-4efc-bb7a-06000ae26f5d_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_6a31909c-8eb8-46f8-8bd0-7fdeaca05d68_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6b1c01e4-e807-44e1-83af-f11ee313cea8_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80165636-9fb2-49f3-8ff8-926dff4f1d53_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_21eded34-9f88-40ac-b182-e82dafdb600f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_dbd55668-bcd3-4a4c-91b2-64bc0b4dfcb9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_914c869a-8bb8-43f8-abc9-a6c20b233cba_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_9d4a3de9-db2f-4a9b-bbe5-b6aae287df14_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1bfef170-ec9f-45d8-8130-f0ca69ece85d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_e88700dc-fe2c-4047-9a9c-ea1656960a7f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IntercompanyLoanQuarterlyPayment_a74e4a5b-6a50-46a6-99a5-cebb575ebfe8_terseLabel_en-US" xlink:label="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany loan, quarterly payment</link:label>
    <link:label id="lab_iart_IntercompanyLoanQuarterlyPayment_label_en-US" xlink:label="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Loan, Quarterly Payment</link:label>
    <link:label id="lab_iart_IntercompanyLoanQuarterlyPayment_documentation_en-US" xlink:label="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Loan, Quarterly Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntercompanyLoanQuarterlyPayment" xlink:href="iart-20211231.xsd#iart_IntercompanyLoanQuarterlyPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IntercompanyLoanQuarterlyPayment" xlink:to="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_5761784d-544b-40bf-adea-d8a623352cfb_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_aa20d0cc-5810-4bae-9fe2-af64c10890d8_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent development milestone payments commitment (up to)</link:label>
    <link:label id="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_label_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Maximum Contingent Development Milestone Payments, If Circumstances Met</link:label>
    <link:label id="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Maximum Contingent Development Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:to="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_37310e48-ae1c-4cc3-9f0c-9198ab5ed55f_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_6d955ff1-5d0b-4e1a-a91b-1aae5e29ac05_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requisite service periods of performance stock, restricted stock and contract stock awards, in years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod1Member_b052c85c-2fe2-4b5f-8f71-905877130e17_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Execution of July 2020 Amendment through June 30, 2021</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod1Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 1 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod1Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod1Member" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod1Member" xlink:to="lab_iart_DebtCovenantPeriod1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_60b4e832-9c0b-474a-9660-8245ead65eb1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Major Classes of Assets and Liabilities Held For Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_49e43fe2-da8d-4e47-b7bb-b666b1a38b2e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IntegratedShoulderCollaborationInc.Member_837c3ea2-0feb-471d-9ac6-f8af0c12e346_terseLabel_en-US" xlink:label="lab_iart_IntegratedShoulderCollaborationInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ISC</link:label>
    <link:label id="lab_iart_IntegratedShoulderCollaborationInc.Member_label_en-US" xlink:label="lab_iart_IntegratedShoulderCollaborationInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Shoulder Collaboration, Inc. [Member]</link:label>
    <link:label id="lab_iart_IntegratedShoulderCollaborationInc.Member_documentation_en-US" xlink:label="lab_iart_IntegratedShoulderCollaborationInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Shoulder Collaboration, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntegratedShoulderCollaborationInc.Member" xlink:href="iart-20211231.xsd#iart_IntegratedShoulderCollaborationInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IntegratedShoulderCollaborationInc.Member" xlink:to="lab_iart_IntegratedShoulderCollaborationInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_07378d8b-ac9f-443d-a003-1f301498bc09_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_642afb7a-cf9f-43a5-9c9d-6c5626b97707_terseLabel_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease From November 1, 2029 Through October 31, 2034</link:label>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_label_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease Period One [Member]</link:label>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_documentation_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember" xlink:href="iart-20211231.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FiveYearOptionLeasePeriodOneMember" xlink:to="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_ba0453c1-ef0e-490e-85c5-b16adfd3fecb_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_90b51d70-7e52-4682-a508-a215da2ff804_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxLiabilitiesLeasesAndOther_cf471c96-2e27-4df2-8d83-b94a36e026d2_negatedLabel_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases and Other</link:label>
    <link:label id="lab_iart_DeferredTaxLiabilitiesLeasesAndOther_label_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leases And Other</link:label>
    <link:label id="lab_iart_DeferredTaxLiabilitiesLeasesAndOther_documentation_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leases And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:href="iart-20211231.xsd#iart_DeferredTaxLiabilitiesLeasesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:to="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_eb13797b-710d-4e7b-97e1-f9da25314b3f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, before tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_43a1a1ff-41ab-43f3-bd3e-0292d8b2a4ff_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_21456b2e-2c0b-4773-b80f-65d8b73abdb4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Projected Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_0e18b388-a471-4e1d-ab9a-d4c71089ea63_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_6cc4d897-a48c-43dc-b5f7-c88b02e9cf32_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d610e4d8-8120-47fe-88e4-76db42753b18_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0974bbd6-938c-4ff0-92e2-ca3a7958f34f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CharitableContributions_55f37faf-3474-4373-8a52-50a52db4f978_terseLabel_en-US" xlink:label="lab_iart_CharitableContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions to Integra Foundation</link:label>
    <link:label id="lab_iart_CharitableContributions_label_en-US" xlink:label="lab_iart_CharitableContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contributions</link:label>
    <link:label id="lab_iart_CharitableContributions_documentation_en-US" xlink:label="lab_iart_CharitableContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CharitableContributions" xlink:href="iart-20211231.xsd#iart_CharitableContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CharitableContributions" xlink:to="lab_iart_CharitableContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_156ae0c9-6773-4377-82ec-aaaff491bceb_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_c7030b51-c4dc-4621-b409-9741d45e660a_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and fixed assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_16c744ef-3064-48fd-83d3-fa7c62553f69_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b045351a-a872-43bb-8a37-a9adc5ac0a79_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_6d7da26d-47a2-45c9-a55d-101a02927bc1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_b6408cb6-a78c-45da-ab73-41a85a056e96_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 30, 2022 through June 30, 2023</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 3 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod3Member" xlink:to="lab_iart_DebtCovenantPeriod3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_fe664a73-0613-4d87-b6d5-b155af0904cb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_e68a9645-a833-4863-a927-95ade5532044_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_f404f0fa-5c53-4302-a795-5954675f5f8d_terseLabel_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities [Member]</link:label>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:href="iart-20211231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:to="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e18de5b3-2558-46cd-9243-ee68680a499c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_b0e384cb-a4a7-414a-8259-00e90713426f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_b9de4b5f-ade2-4510-a6f7-658feea09700_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_label_en-US" xlink:label="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Intangible Asset Acquired, Discount Rate</link:label>
    <link:label id="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_documentation_en-US" xlink:label="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Intangible Asset Acquired, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:href="iart-20211231.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:to="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_32469779-17dc-419d-85a7-cb019ef31535_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_c7da5c07-0ab0-4ed0-a520-b462931e4ec9_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_0196fc32-d31c-4f77-b4e6-ca73b5a86fc9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_5d63e938-f3a2-4934-afe2-e7e5c5f63ff0_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overnight Federal Funds Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionTable_a310bf53-6710-4591-b74f-8ff0c8f75080_terseLabel_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Asset Acquisition [Table]</link:label>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionTable_label_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Asset Acquisition [Table]</link:label>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionTable_documentation_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Asset Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionTable" xlink:href="iart-20211231.xsd#iart_ScheduleOfAssetAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable" xlink:to="lab_iart_ScheduleOfAssetAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_057b9255-880c-4403-9edd-9ef105df285b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_2ded7ade-fd4b-4423-bf6b-0bc70c477fce_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_d6880969-6320-4ded-ad79-3870163f33ce_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued bonus</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_c107ed6a-428b-4b9a-a950-3cdb6cbf2abe_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_d5cf7a5e-494d-40be-85ad-a09a12949282_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a69a3f66-3c8b-46f1-89dd-75cee8fe9fec_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_84d5dc7b-ef7e-4dde-8963-86eefb44e513_terseLabel_en-US" xlink:label="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash in-process research and development expense</link:label>
    <link:label id="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash, In Process Research And Development</link:label>
    <link:label id="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_documentation_en-US" xlink:label="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash, In Process Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:href="iart-20211231.xsd#iart_NoncashOrPartNoncashInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:to="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_11c2c969-db01-4a69-9154-d7b83f2bc077_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset - operating leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Asset, Operating Leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Asset, Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PerformanceStockandContractStockMember_fc6647a6-9344-402e-8146-dc8651f6ac9d_terseLabel_en-US" xlink:label="lab_iart_PerformanceStockandContractStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock and Contract Stock Awards</link:label>
    <link:label id="lab_iart_PerformanceStockandContractStockMember_label_en-US" xlink:label="lab_iart_PerformanceStockandContractStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock and Contract Stock [Member]</link:label>
    <link:label id="lab_iart_PerformanceStockandContractStockMember_documentation_en-US" xlink:label="lab_iart_PerformanceStockandContractStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock and Contract Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockandContractStockMember" xlink:href="iart-20211231.xsd#iart_PerformanceStockandContractStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PerformanceStockandContractStockMember" xlink:to="lab_iart_PerformanceStockandContractStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_11525e19-44e3-4adc-9da4-7eea4d063ff1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total derivatives designated as hedges &#8212; Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_e36fccf0-f563-45e6-a3f4-13514dfc1710_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized within accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_10a9aae7-a638-4d76-8b8b-fa0e2a743439_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_fd72e57d-1541-44f7-8df2-103e1e0584f1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reclassification adjustments for gain (loss) included in net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_db481bb3-a29f-4dc0-af85-a24a865e8cf1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_5b2cb97a-9296-4333-8844-0d9cdb2672d8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_9cf89447-ca5e-4820-845d-dc5cf910a98e_terseLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested but not issued (in shares)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested But Not Issued In Period</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested But Not Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:to="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_61c4d630-995a-4334-92aa-bf2ec8188303_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e39d5cf2-5292-4467-856b-ed619f4208b6_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously capitalized financing costs, written-off</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod2Member_8a4ad02e-1842-4bda-866c-113e2bd83b4f_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 30, 2021 through June 30, 2022</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod2Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 2 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod2Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod2Member" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod2Member" xlink:to="lab_iart_DebtCovenantPeriod2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_1de328f0-1501-4717-9e14-a017792c2c09_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_819904a4-ce4a-4f88-b12c-b30da1aaf2c3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SmithNephewUSDLimitedMember_c8afec5a-a6cc-49e8-b39e-71853c9d228c_terseLabel_en-US" xlink:label="lab_iart_SmithNephewUSDLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smith &amp; Nephew USD Limited</link:label>
    <link:label id="lab_iart_SmithNephewUSDLimitedMember_label_en-US" xlink:label="lab_iart_SmithNephewUSDLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smith &amp; Nephew USD Limited [Member]</link:label>
    <link:label id="lab_iart_SmithNephewUSDLimitedMember_documentation_en-US" xlink:label="lab_iart_SmithNephewUSDLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smith &amp; Nephew USD Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember" xlink:href="iart-20211231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SmithNephewUSDLimitedMember" xlink:to="lab_iart_SmithNephewUSDLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CashFlowLesseeAbstract_36df8cb4-dce7-4f23-ada1-b16f905749ba_terseLabel_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_iart_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_iart_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeAbstract" xlink:href="iart-20211231.xsd#iart_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CashFlowLesseeAbstract" xlink:to="lab_iart_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_42454866-13c7-4259-af60-8e59b1ab1ff3_terseLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for performance achievement related to award target (in dollars per share)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:to="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_be976bc4-cf47-4214-9d7e-3c7da3b13f1e_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CerebroFlo developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_5f4cf57c-81bc-47e0-b1b1-506b3310d5ac_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_51f6e503-a136-4d71-8558-e3858bbc540f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_81f319f9-45fd-4b07-b394-3bac7bb10e67_terseLabel_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs and expenses associated with debt refinancing</link:label>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_label_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs And Debt Refinanced Fees</link:label>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_documentation_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs And Debt Refinanced Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:href="iart-20211231.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:to="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SeniorCreditFacilityMember_baad1a0f-e2cd-422c-b8b6-d94e3a908332_terseLabel_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility</link:label>
    <link:label id="lab_iart_SeniorCreditFacilityMember_label_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility [Member]</link:label>
    <link:label id="lab_iart_SeniorCreditFacilityMember_documentation_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember" xlink:href="iart-20211231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SeniorCreditFacilityMember" xlink:to="lab_iart_SeniorCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AccountingStandardUpdate202006Member_label_en-US" xlink:label="lab_iart_AccountingStandardUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standard Update 2020-06 [Member]</link:label>
    <link:label id="lab_iart_AccountingStandardUpdate202006Member_documentation_en-US" xlink:label="lab_iart_AccountingStandardUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standard Update 2020-06</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccountingStandardUpdate202006Member" xlink:href="iart-20211231.xsd#iart_AccountingStandardUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AccountingStandardUpdate202006Member" xlink:to="lab_iart_AccountingStandardUpdate202006Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>iart-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:79796dbd-6d84-4777-bf20-15ea797e2f25,g:15b73d14-4963-49a2-aa85-347a140ddfd4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20211231.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b5c0e618-1636-44fa-ad4b-b3b6ad8f9457" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_DocumentType_b5c0e618-1636-44fa-ad4b-b3b6ad8f9457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_9ba84000-7281-4645-a9ce-230955565a3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_DocumentAnnualReport_9ba84000-7281-4645-a9ce-230955565a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5237de7d-c96c-40bd-8b55-efe0239e70f9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_DocumentPeriodEndDate_5237de7d-c96c-40bd-8b55-efe0239e70f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_cb102fe5-7ca4-4214-92ad-ddb8c488e4c0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_CurrentFiscalYearEndDate_cb102fe5-7ca4-4214-92ad-ddb8c488e4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_7e4fbfd5-d4ee-4421-833d-8a926f93471c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_DocumentTransitionReport_7e4fbfd5-d4ee-4421-833d-8a926f93471c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b13ae459-d176-496b-9c65-7496d82d761c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityFileNumber_b13ae459-d176-496b-9c65-7496d82d761c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cd464243-1103-4e55-a7e6-262a9e6f0b20" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityRegistrantName_cd464243-1103-4e55-a7e6-262a9e6f0b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ed17de73-815a-4b43-88ab-86fe84e91960" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ed17de73-815a-4b43-88ab-86fe84e91960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2900d080-c15b-4025-a9ab-cbb754db6c8e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityTaxIdentificationNumber_2900d080-c15b-4025-a9ab-cbb754db6c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bd9a70bc-6c72-4172-b327-066750fccbbf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityAddressAddressLine1_bd9a70bc-6c72-4172-b327-066750fccbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_891ac1b8-9db1-4622-af95-4a477ab328b3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityAddressPostalZipCode_891ac1b8-9db1-4622-af95-4a477ab328b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ede960c9-a65d-4351-b965-1265abd5276f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityAddressCityOrTown_ede960c9-a65d-4351-b965-1265abd5276f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5e130f55-261a-41f6-99c8-15615f090d2c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityAddressStateOrProvince_5e130f55-261a-41f6-99c8-15615f090d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_757d2380-e86f-4498-9841-b014961d2e7c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_CityAreaCode_757d2380-e86f-4498-9841-b014961d2e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_eea0ec12-0576-49b9-9808-eb5138f2cc6b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_LocalPhoneNumber_eea0ec12-0576-49b9-9808-eb5138f2cc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0f376d93-6fea-42cb-b3e0-4297463cba97" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_Security12bTitle_0f376d93-6fea-42cb-b3e0-4297463cba97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_13892c32-0fcb-4fdc-a894-f38e6a4f44a2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_TradingSymbol_13892c32-0fcb-4fdc-a894-f38e6a4f44a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3f8d6fe2-bdd7-457a-a700-f2a4a469d69d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_SecurityExchangeName_3f8d6fe2-bdd7-457a-a700-f2a4a469d69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_65e769a1-7064-4662-ac03-53f5c08a0043" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_65e769a1-7064-4662-ac03-53f5c08a0043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_a95dff48-cb79-468c-be6a-829b707fc0d1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityVoluntaryFilers_a95dff48-cb79-468c-be6a-829b707fc0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_498f07fe-6e9b-404c-8f28-cf010221e2f5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityCurrentReportingStatus_498f07fe-6e9b-404c-8f28-cf010221e2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_6390fb80-e122-4c7b-82b2-68b556eaa399" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityInteractiveDataCurrent_6390fb80-e122-4c7b-82b2-68b556eaa399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2b9c4016-a254-44ff-827b-11da1732d777" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityFilerCategory_2b9c4016-a254-44ff-827b-11da1732d777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_4c3b1a7d-6fc8-4300-9d88-320f2853d7f9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntitySmallBusiness_4c3b1a7d-6fc8-4300-9d88-320f2853d7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_77563b8c-f1bd-442d-b248-a7b73dcd2d23" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityEmergingGrowthCompany_77563b8c-f1bd-442d-b248-a7b73dcd2d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_e429ee74-894c-4c05-b119-f5509f032d6c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_IcfrAuditorAttestationFlag_e429ee74-894c-4c05-b119-f5509f032d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_0b4facbf-6459-4253-89c6-8ebb026876dd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityShellCompany_0b4facbf-6459-4253-89c6-8ebb026876dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_c8aef21b-7bde-4849-a253-6d33f3053c01" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityPublicFloat_c8aef21b-7bde-4849-a253-6d33f3053c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c317a8bf-2ac2-4dca-8b67-2d3721ecc8f1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c317a8bf-2ac2-4dca-8b67-2d3721ecc8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_28a5fb17-7bfc-402c-b1c6-480b1abfe03d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_28a5fb17-7bfc-402c-b1c6-480b1abfe03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e0a11247-550c-41cb-a6a2-52b0f45b94cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_AmendmentFlag_e0a11247-550c-41cb-a6a2-52b0f45b94cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ebff58c1-3105-4842-99e1-2900d89b6b1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_DocumentFiscalYearFocus_ebff58c1-3105-4842-99e1-2900d89b6b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3bbdd55a-fde4-45ba-8909-f90662426cf8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3bbdd55a-fde4-45ba-8909-f90662426cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_eda4123e-2bf9-4c24-8edd-f9d5f2482071" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da404bfd-5b39-4505-b242-93686b012343" xlink:to="loc_dei_EntityCentralIndexKey_eda4123e-2bf9-4c24-8edd-f9d5f2482071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/AuditInformation" xlink:type="simple" xlink:href="iart-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://integralife.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_AuditInformationAbstract_0d4ccf3c-76dc-4f6c-8b2c-f7138e8ea62b" xlink:href="iart-20211231.xsd#iart_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_78b5f491-3d95-43a2-a3b4-6b038340a279" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AuditInformationAbstract_0d4ccf3c-76dc-4f6c-8b2c-f7138e8ea62b" xlink:to="loc_dei_AuditorName_78b5f491-3d95-43a2-a3b4-6b038340a279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_2ca36b0b-c4b7-471b-98cf-da4fe2ab9afc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AuditInformationAbstract_0d4ccf3c-76dc-4f6c-8b2c-f7138e8ea62b" xlink:to="loc_dei_AuditorLocation_2ca36b0b-c4b7-471b-98cf-da4fe2ab9afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_0e56483e-dfbc-4d1d-938d-4789cb14a11e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AuditInformationAbstract_0d4ccf3c-76dc-4f6c-8b2c-f7138e8ea62b" xlink:to="loc_dei_AuditorFirmId_0e56483e-dfbc-4d1d-938d-4789cb14a11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2581b3d9-6806-42ee-b05e-f42fd233aad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2581b3d9-6806-42ee-b05e-f42fd233aad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_56d77475-fe67-4ca1-98b4-0e427ca817b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_56d77475-fe67-4ca1-98b4-0e427ca817b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_268504dc-6e5a-4bae-9dc6-295393ef76a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_56d77475-fe67-4ca1-98b4-0e427ca817b1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_268504dc-6e5a-4bae-9dc6-295393ef76a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ded3d17c-1463-4e80-a35e-f47eca459efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_56d77475-fe67-4ca1-98b4-0e427ca817b1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ded3d17c-1463-4e80-a35e-f47eca459efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_ba5fa3da-08f4-4201-ab37-5d38db8f7ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_56d77475-fe67-4ca1-98b4-0e427ca817b1" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_ba5fa3da-08f4-4201-ab37-5d38db8f7ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7431b6c2-a19c-4a7c-b371-935564d57387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_56d77475-fe67-4ca1-98b4-0e427ca817b1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7431b6c2-a19c-4a7c-b371-935564d57387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fda35456-42cd-4371-a50c-c97a38b7f3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_56d77475-fe67-4ca1-98b4-0e427ca817b1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fda35456-42cd-4371-a50c-c97a38b7f3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7ecd8c76-2cf0-4dff-b8ad-e94df6aff8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_56d77475-fe67-4ca1-98b4-0e427ca817b1" xlink:to="loc_us-gaap_CostsAndExpenses_7ecd8c76-2cf0-4dff-b8ad-e94df6aff8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_650b3eb0-0277-4a7f-87b2-717f71d97efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_OperatingIncomeLoss_650b3eb0-0277-4a7f-87b2-717f71d97efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_e86a54da-38d0-49bd-a325-73af706539bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_InvestmentIncomeInterest_e86a54da-38d0-49bd-a325-73af706539bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_abb10329-28a4-4691-8f5c-4fb2e6f74c13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_InterestExpense_abb10329-28a4-4691-8f5c-4fb2e6f74c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_73d7fe69-6d3b-49a9-8401-8d2830c3cc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_73d7fe69-6d3b-49a9-8401-8d2830c3cc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0ca9db91-367e-4d69-9708-993fa72af797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0ca9db91-367e-4d69-9708-993fa72af797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e646a3f1-b99e-4a04-897a-0b9bdb812bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e646a3f1-b99e-4a04-897a-0b9bdb812bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d05f0441-f64b-41a8-afdd-a0c7e4293cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d05f0441-f64b-41a8-afdd-a0c7e4293cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dcf8d990-78bb-4e30-96f8-5e5d1f27c5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_NetIncomeLoss_dcf8d990-78bb-4e30-96f8-5e5d1f27c5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_913b0851-28aa-48d4-ad88-3cae3f6a22f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_EarningsPerShareAbstract_913b0851-28aa-48d4-ad88-3cae3f6a22f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_640656ee-5bdb-41a7-a1e7-bc427732baf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_913b0851-28aa-48d4-ad88-3cae3f6a22f8" xlink:to="loc_us-gaap_EarningsPerShareBasic_640656ee-5bdb-41a7-a1e7-bc427732baf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8c01902a-8bc7-478e-be18-f2510467f84c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_913b0851-28aa-48d4-ad88-3cae3f6a22f8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8c01902a-8bc7-478e-be18-f2510467f84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bffb9d9-91e1-492a-9f4e-7e0c09a175d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9de841a4-fd8e-49eb-b7e8-eedf886ee582" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bffb9d9-91e1-492a-9f4e-7e0c09a175d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_48e60eda-85e5-4ebf-ba4d-2ca3e47e59f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bffb9d9-91e1-492a-9f4e-7e0c09a175d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_48e60eda-85e5-4ebf-ba4d-2ca3e47e59f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ac410046-e708-4c69-be84-93dcb5b1f940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bffb9d9-91e1-492a-9f4e-7e0c09a175d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ac410046-e708-4c69-be84-93dcb5b1f940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c2df0b59-5572-463a-8505-66c6eec31b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a48fd264-bfde-4fa9-9426-b7a8668e7080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c2df0b59-5572-463a-8505-66c6eec31b05" xlink:to="loc_us-gaap_NetIncomeLoss_a48fd264-bfde-4fa9-9426-b7a8668e7080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_f4d46693-cb68-481c-b03f-91fb8b11c3da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c2df0b59-5572-463a-8505-66c6eec31b05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_f4d46693-cb68-481c-b03f-91fb8b11c3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_92ff2400-f7aa-4683-a12d-4a65a2df96d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_f4d46693-cb68-481c-b03f-91fb8b11c3da" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_92ff2400-f7aa-4683-a12d-4a65a2df96d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_bed5345a-afe2-46a1-9b9f-5c9f1e5964b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_f4d46693-cb68-481c-b03f-91fb8b11c3da" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_bed5345a-afe2-46a1-9b9f-5c9f1e5964b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b67f0574-5229-4c0a-b98b-0e36a855ba62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_bed5345a-afe2-46a1-9b9f-5c9f1e5964b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b67f0574-5229-4c0a-b98b-0e36a855ba62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5e4d2547-0227-4353-99ee-d5b0261146ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_bed5345a-afe2-46a1-9b9f-5c9f1e5964b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5e4d2547-0227-4353-99ee-d5b0261146ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_df9d584d-2d13-4439-84d2-2deb3f4d3a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_bed5345a-afe2-46a1-9b9f-5c9f1e5964b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_df9d584d-2d13-4439-84d2-2deb3f4d3a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_704364f2-b0ac-4fd9-88d4-d3f5ccb3268c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_f4d46693-cb68-481c-b03f-91fb8b11c3da" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_704364f2-b0ac-4fd9-88d4-d3f5ccb3268c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_c5044dd8-d093-4a4f-bac6-affea7f22176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c2df0b59-5572-463a-8505-66c6eec31b05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_c5044dd8-d093-4a4f-bac6-affea7f22176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_6e2a51c0-847f-453d-9d23-b704426e86b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_c5044dd8-d093-4a4f-bac6-affea7f22176" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_6e2a51c0-847f-453d-9d23-b704426e86b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_32489f36-3ed4-4189-b1b6-ed859d1610d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c2df0b59-5572-463a-8505-66c6eec31b05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_32489f36-3ed4-4189-b1b6-ed859d1610d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0b7fa4de-1bb0-4d6b-9378-ab5649cd10fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c2df0b59-5572-463a-8505-66c6eec31b05" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0b7fa4de-1bb0-4d6b-9378-ab5649cd10fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7f0506d6-a203-4cce-bf50-c4606fd64352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_686bd040-4ed2-470e-86f7-212225352d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7f0506d6-a203-4cce-bf50-c4606fd64352" xlink:to="loc_us-gaap_AssetsAbstract_686bd040-4ed2-470e-86f7-212225352d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_9d362e57-86db-4dc4-a90e-c58620a899cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_686bd040-4ed2-470e-86f7-212225352d01" xlink:to="loc_us-gaap_AssetsCurrentAbstract_9d362e57-86db-4dc4-a90e-c58620a899cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3d97a73c-53b2-4af2-bcfa-73cbbf2c3139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d362e57-86db-4dc4-a90e-c58620a899cf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3d97a73c-53b2-4af2-bcfa-73cbbf2c3139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1c0d6622-1eaa-4e2b-a13b-e9c4bb47182e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d362e57-86db-4dc4-a90e-c58620a899cf" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1c0d6622-1eaa-4e2b-a13b-e9c4bb47182e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_854d7f5f-2623-457f-b529-b85e3cf3e8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d362e57-86db-4dc4-a90e-c58620a899cf" xlink:to="loc_us-gaap_InventoryNet_854d7f5f-2623-457f-b529-b85e3cf3e8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_457473f6-17ce-4d04-915f-9decebca6801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d362e57-86db-4dc4-a90e-c58620a899cf" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_457473f6-17ce-4d04-915f-9decebca6801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_39efcda6-fbee-4d26-aec1-d799f89d877d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d362e57-86db-4dc4-a90e-c58620a899cf" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_39efcda6-fbee-4d26-aec1-d799f89d877d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_23a393af-bab7-4352-ae54-9fff5ccd7fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d362e57-86db-4dc4-a90e-c58620a899cf" xlink:to="loc_us-gaap_AssetsCurrent_23a393af-bab7-4352-ae54-9fff5ccd7fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_280de2ca-c209-4d1b-9d11-132ad8f3e052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_686bd040-4ed2-470e-86f7-212225352d01" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_280de2ca-c209-4d1b-9d11-132ad8f3e052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7d4c839e-d4e6-4538-9725-1273bcb78ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_686bd040-4ed2-470e-86f7-212225352d01" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7d4c839e-d4e6-4538-9725-1273bcb78ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e04c8784-a081-4a16-aff8-409b916173ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_686bd040-4ed2-470e-86f7-212225352d01" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e04c8784-a081-4a16-aff8-409b916173ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3b3b5f81-813a-4a89-8462-caacd852323e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_686bd040-4ed2-470e-86f7-212225352d01" xlink:to="loc_us-gaap_Goodwill_3b3b5f81-813a-4a89-8462-caacd852323e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ae42c1ae-a671-4586-88c6-fcc07750ccb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_686bd040-4ed2-470e-86f7-212225352d01" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ae42c1ae-a671-4586-88c6-fcc07750ccb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9b9ea6d6-c72c-48b1-99ca-07a12d02e6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_686bd040-4ed2-470e-86f7-212225352d01" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9b9ea6d6-c72c-48b1-99ca-07a12d02e6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fb456b9c-7dbf-4185-acf5-a9d287ce8641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_686bd040-4ed2-470e-86f7-212225352d01" xlink:to="loc_us-gaap_Assets_fb456b9c-7dbf-4185-acf5-a9d287ce8641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7f0506d6-a203-4cce-bf50-c4606fd64352" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_0142920f-4a73-4c30-b5d7-125211d4b124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:to="loc_us-gaap_SecuredDebtCurrent_0142920f-4a73-4c30-b5d7-125211d4b124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_acf34ed2-0335-4a72-8596-135f2185e7ab" xlink:href="iart-20211231.xsd#iart_SecuredLongTermDebtSecuritizationProgramCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_acf34ed2-0335-4a72-8596-135f2185e7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c1c03b4f-949a-4edf-8a0f-2c10b4a4df37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c1c03b4f-949a-4edf-8a0f-2c10b4a4df37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_92d4e820-a519-46b2-b478-55c867a5116b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_92d4e820-a519-46b2-b478-55c867a5116b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_be8b12b0-6947-4c26-90dc-1d7ef17f1739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_be8b12b0-6947-4c26-90dc-1d7ef17f1739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_76e9ce06-0ac4-4925-afea-de58b5157488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_76e9ce06-0ac4-4925-afea-de58b5157488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d3188861-11f8-426a-a55e-16324fbcbebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d3188861-11f8-426a-a55e-16324fbcbebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0411f01e-0d4c-4d75-8b9f-4901d5085022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0411f01e-0d4c-4d75-8b9f-4901d5085022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cac41d9a-3bc3-4792-8955-4e8e50c7e01e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_206722a2-358b-4077-8fe2-e4179cb9fb54" xlink:to="loc_us-gaap_LiabilitiesCurrent_cac41d9a-3bc3-4792-8955-4e8e50c7e01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_cf8f3416-21de-46b1-bd0e-da0f0a4f031d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:to="loc_us-gaap_SecuredLongTermDebt_cf8f3416-21de-46b1-bd0e-da0f0a4f031d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_d982a342-d943-4876-817d-828c5015d4c5" xlink:href="iart-20211231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_d982a342-d943-4876-817d-828c5015d4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_e6fd0dc7-f88c-4253-bf8f-70f7d8439207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_e6fd0dc7-f88c-4253-bf8f-70f7d8439207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fdf66135-f68f-4ac8-9f87-898c6c7293ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fdf66135-f68f-4ac8-9f87-898c6c7293ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_cc70ff23-6b2e-434f-ae52-cd39717b0e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_cc70ff23-6b2e-434f-ae52-cd39717b0e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bced251d-557d-4d62-841f-557e3e18157d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bced251d-557d-4d62-841f-557e3e18157d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f0a71e0f-04b2-4896-90e5-2ac5226ed4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:to="loc_us-gaap_Liabilities_f0a71e0f-04b2-4896-90e5-2ac5226ed4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c754f1ee-2ebb-47db-b3c6-75f339ad58c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c754f1ee-2ebb-47db-b3c6-75f339ad58c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_97bfd803-4258-49a7-a045-218a6280d555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c754f1ee-2ebb-47db-b3c6-75f339ad58c3" xlink:to="loc_us-gaap_PreferredStockValue_97bfd803-4258-49a7-a045-218a6280d555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f918e486-bc87-4edd-a79a-79ade27e866a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c754f1ee-2ebb-47db-b3c6-75f339ad58c3" xlink:to="loc_us-gaap_CommonStockValue_f918e486-bc87-4edd-a79a-79ade27e866a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_14e40526-3185-45b9-87d9-89da9e0a8c02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c754f1ee-2ebb-47db-b3c6-75f339ad58c3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_14e40526-3185-45b9-87d9-89da9e0a8c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_044c83f9-3af8-4548-8563-cd9441570cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c754f1ee-2ebb-47db-b3c6-75f339ad58c3" xlink:to="loc_us-gaap_TreasuryStockValue_044c83f9-3af8-4548-8563-cd9441570cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4acd3bf8-ad39-456d-b7fe-053b8cac5fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c754f1ee-2ebb-47db-b3c6-75f339ad58c3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4acd3bf8-ad39-456d-b7fe-053b8cac5fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c852f4f6-979b-4705-83ac-1214d220c518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c754f1ee-2ebb-47db-b3c6-75f339ad58c3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c852f4f6-979b-4705-83ac-1214d220c518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c07c4fd5-4bf1-471a-af55-7e6aa5702e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c754f1ee-2ebb-47db-b3c6-75f339ad58c3" xlink:to="loc_us-gaap_StockholdersEquity_c07c4fd5-4bf1-471a-af55-7e6aa5702e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_595cdb9a-cc7e-49bf-bd3f-ed02b9b7a9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b038384d-a69b-41f8-97f7-e0b90c15484c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_595cdb9a-cc7e-49bf-bd3f-ed02b9b7a9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ead7312c-7870-4546-9b94-014ea1e91bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1209693e-56b6-4ff7-be25-b817e178d379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ead7312c-7870-4546-9b94-014ea1e91bff" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1209693e-56b6-4ff7-be25-b817e178d379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNoParValue_44d9e92d-8ae8-4b4f-84df-70129f97175b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNoParValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ead7312c-7870-4546-9b94-014ea1e91bff" xlink:to="loc_us-gaap_PreferredStockNoParValue_44d9e92d-8ae8-4b4f-84df-70129f97175b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_3094e8dd-e1a2-4985-aa10-4f56275dfb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ead7312c-7870-4546-9b94-014ea1e91bff" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_3094e8dd-e1a2-4985-aa10-4f56275dfb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_fd560741-3209-46ee-b3b3-0ac20ce3f7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ead7312c-7870-4546-9b94-014ea1e91bff" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_fd560741-3209-46ee-b3b3-0ac20ce3f7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5f4317b7-5293-460c-b497-9b3fb53dcd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ead7312c-7870-4546-9b94-014ea1e91bff" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5f4317b7-5293-460c-b497-9b3fb53dcd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9e788dd6-a913-4533-a8b9-93d6707f1b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ead7312c-7870-4546-9b94-014ea1e91bff" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9e788dd6-a913-4533-a8b9-93d6707f1b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4318c1e6-8f14-4d43-ae6a-f3f57a66d447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ead7312c-7870-4546-9b94-014ea1e91bff" xlink:to="loc_us-gaap_CommonStockSharesIssued_4318c1e6-8f14-4d43-ae6a-f3f57a66d447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_5fceff25-9ab3-4833-a279-d03e29dacba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ead7312c-7870-4546-9b94-014ea1e91bff" xlink:to="loc_us-gaap_TreasuryStockShares_5fceff25-9ab3-4833-a279-d03e29dacba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_73b4c92d-7712-47e3-b1da-168296b695d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95783fd3-2b64-42a4-b97c-1c9df201003a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73b4c92d-7712-47e3-b1da-168296b695d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95783fd3-2b64-42a4-b97c-1c9df201003a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_388202f0-dd9a-4ec9-919b-7e0f297b41ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95783fd3-2b64-42a4-b97c-1c9df201003a" xlink:to="loc_us-gaap_NetIncomeLoss_388202f0-dd9a-4ec9-919b-7e0f297b41ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95783fd3-2b64-42a4-b97c-1c9df201003a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_56e638f3-1eac-43b1-ae30-1a78aabced47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_56e638f3-1eac-43b1-ae30-1a78aabced47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_126d57d5-a7a4-4770-94bd-51aea7ea2280" xlink:href="iart-20211231.xsd#iart_NoncashOrPartNoncashInProcessResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_126d57d5-a7a4-4770-94bd-51aea7ea2280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_008d7027-e2b3-41fc-aa44-7570a682188e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_008d7027-e2b3-41fc-aa44-7570a682188e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cf710b77-255b-4ce9-8dfc-05ab4c1c8055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cf710b77-255b-4ce9-8dfc-05ab4c1c8055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cbe5c6c0-112e-474d-90bb-620ffb871dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_us-gaap_ShareBasedCompensation_cbe5c6c0-112e-474d-90bb-620ffb871dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_deb228d2-26d9-4b10-bc72-c60608387401" xlink:href="iart-20211231.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_deb228d2-26d9-4b10-bc72-c60608387401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense_33a1e130-6594-47b8-a804-8cba77d974a7" xlink:href="iart-20211231.xsd#iart_NoncashLeaseExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_iart_NoncashLeaseExpense_33a1e130-6594-47b8-a804-8cba77d974a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_25f394e3-d38b-476b-b5b5-8fbea7fc68b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_us-gaap_AccretionExpense_25f394e3-d38b-476b-b5b5-8fbea7fc68b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_7b362e28-9020-4ca8-94b5-0a26037200eb" xlink:href="iart-20211231.xsd#iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_7b362e28-9020-4ca8-94b5-0a26037200eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_ea4e8c45-5838-4d7b-82aa-080f3b40dd29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_ea4e8c45-5838-4d7b-82aa-080f3b40dd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1405381b-dc56-4846-bdad-3aad801d74d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a948c-7f2a-496c-a59d-f966f76abf1a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1405381b-dc56-4846-bdad-3aad801d74d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_90a074f1-2bab-4fa2-9f11-22e508d30505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95783fd3-2b64-42a4-b97c-1c9df201003a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_90a074f1-2bab-4fa2-9f11-22e508d30505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_52c8b0e2-78d4-47d6-91dd-5bcf51717d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_90a074f1-2bab-4fa2-9f11-22e508d30505" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_52c8b0e2-78d4-47d6-91dd-5bcf51717d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_03c753bf-4857-4728-af6f-afee89acd1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_90a074f1-2bab-4fa2-9f11-22e508d30505" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_03c753bf-4857-4728-af6f-afee89acd1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e3d3c554-446a-46a2-8556-e1b607d7913c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_90a074f1-2bab-4fa2-9f11-22e508d30505" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e3d3c554-446a-46a2-8556-e1b607d7913c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8860818b-ea88-4bfc-ac71-03fd10b431ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_90a074f1-2bab-4fa2-9f11-22e508d30505" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8860818b-ea88-4bfc-ac71-03fd10b431ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_05a74612-3cbd-4105-921d-f7a63a81265e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_90a074f1-2bab-4fa2-9f11-22e508d30505" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_05a74612-3cbd-4105-921d-f7a63a81265e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_7b751adb-a7c1-4fbb-916a-469e40065726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_90a074f1-2bab-4fa2-9f11-22e508d30505" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_7b751adb-a7c1-4fbb-916a-469e40065726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_9103f938-16e8-45ff-ab47-2f37b1f345b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_90a074f1-2bab-4fa2-9f11-22e508d30505" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_9103f938-16e8-45ff-ab47-2f37b1f345b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38b7ba1a-20d4-43d2-8a97-17a6352a36bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95783fd3-2b64-42a4-b97c-1c9df201003a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38b7ba1a-20d4-43d2-8a97-17a6352a36bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e03dcc9e-6f40-490f-98a0-53d5170b1cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73b4c92d-7712-47e3-b1da-168296b695d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e03dcc9e-6f40-490f-98a0-53d5170b1cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c1facd13-7ce8-4ba5-8e4b-b74f0368cfcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e03dcc9e-6f40-490f-98a0-53d5170b1cfe" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c1facd13-7ce8-4ba5-8e4b-b74f0368cfcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8cd1b2c0-8d82-4cb2-b94d-f3b149c8b7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e03dcc9e-6f40-490f-98a0-53d5170b1cfe" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8cd1b2c0-8d82-4cb2-b94d-f3b149c8b7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_cd4fd9d1-0e23-4f25-a23b-08513342c037" xlink:href="iart-20211231.xsd#iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e03dcc9e-6f40-490f-98a0-53d5170b1cfe" xlink:to="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_cd4fd9d1-0e23-4f25-a23b-08513342c037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_849ebf9b-b56f-4ff9-9e58-f0a7aefb3419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e03dcc9e-6f40-490f-98a0-53d5170b1cfe" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_849ebf9b-b56f-4ff9-9e58-f0a7aefb3419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_5bc1fa74-58b0-41f7-bd45-b8a6520e2d0d" xlink:href="iart-20211231.xsd#iart_PaymentsForProceedsFromBusinessAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e03dcc9e-6f40-490f-98a0-53d5170b1cfe" xlink:to="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_5bc1fa74-58b0-41f7-bd45-b8a6520e2d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_24b32a4f-6020-45da-a2a6-e59fe3b7a6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e03dcc9e-6f40-490f-98a0-53d5170b1cfe" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_24b32a4f-6020-45da-a2a6-e59fe3b7a6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_ade12f5e-4efc-433a-873c-d1ea17353e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e03dcc9e-6f40-490f-98a0-53d5170b1cfe" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_ade12f5e-4efc-433a-873c-d1ea17353e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6e1b213b-2174-4e2d-8b3d-a29682bdb6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e03dcc9e-6f40-490f-98a0-53d5170b1cfe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6e1b213b-2174-4e2d-8b3d-a29682bdb6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73b4c92d-7712-47e3-b1da-168296b695d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_393e36d0-2c9c-406f-a123-8cc201367e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_393e36d0-2c9c-406f-a123-8cc201367e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_c51ceb7d-ccb6-4f05-adc5-37733e458bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_c51ceb7d-ccb6-4f05-adc5-37733e458bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_55215773-cf88-4927-b9ad-73f4a94e2a77" xlink:href="iart-20211231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_55215773-cf88-4927-b9ad-73f4a94e2a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_83745e7a-ea37-45bb-b079-72947245ae6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_83745e7a-ea37-45bb-b079-72947245ae6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_029ecbd8-9e8f-4cab-9b50-f485563046e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_029ecbd8-9e8f-4cab-9b50-f485563046e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e904d7b3-0bd1-44fe-9c52-ddf87b394997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e904d7b3-0bd1-44fe-9c52-ddf87b394997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_843b5ec0-4e25-4101-9306-0937bbc00ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_843b5ec0-4e25-4101-9306-0937bbc00ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ce479553-def7-4ead-bfde-9f35ac093ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ce479553-def7-4ead-bfde-9f35ac093ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d28e7a5a-cd93-4b15-8cb0-d1ddca257f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d28e7a5a-cd93-4b15-8cb0-d1ddca257f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d3092d2-6bc9-4bb2-9c0e-818caffd8d02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b343819-7768-4d90-8571-e5b8a2beecb7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d3092d2-6bc9-4bb2-9c0e-818caffd8d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91411a19-a1c6-4d35-82b4-c4eec8d0ff56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73b4c92d-7712-47e3-b1da-168296b695d2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91411a19-a1c6-4d35-82b4-c4eec8d0ff56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8bf1790b-7a47-4490-93a1-22879cf55489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73b4c92d-7712-47e3-b1da-168296b695d2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8bf1790b-7a47-4490-93a1-22879cf55489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0aa32faf-189b-49e2-ae0b-76fe88dbe998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73b4c92d-7712-47e3-b1da-168296b695d2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0aa32faf-189b-49e2-ae0b-76fe88dbe998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dea39289-c168-4542-820c-9b84efa4876f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73b4c92d-7712-47e3-b1da-168296b695d2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dea39289-c168-4542-820c-9b84efa4876f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="iart-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1cd01dea-d5b7-46ca-a07d-308580ed7a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_187aad63-a861-4f14-b4a8-d7daeec4ca1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1cd01dea-d5b7-46ca-a07d-308580ed7a82" xlink:to="loc_us-gaap_StatementTable_187aad63-a861-4f14-b4a8-d7daeec4ca1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_54ed4f7b-91d5-4397-b5b8-606163fe854f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_187aad63-a861-4f14-b4a8-d7daeec4ca1a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_54ed4f7b-91d5-4397-b5b8-606163fe854f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_54ed4f7b-91d5-4397-b5b8-606163fe854f" xlink:to="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_90ad2b15-48b6-4389-b84c-f7653b9a1263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:to="loc_us-gaap_CommonStockMember_90ad2b15-48b6-4389-b84c-f7653b9a1263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_889d8311-6427-4b91-9e36-307d39c87e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:to="loc_us-gaap_TreasuryStockMember_889d8311-6427-4b91-9e36-307d39c87e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_cd8f2c25-2209-4bf3-8ca0-e2d85b77d25e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_cd8f2c25-2209-4bf3-8ca0-e2d85b77d25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4c18ca1a-564d-4804-9678-9c4b5561eae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4c18ca1a-564d-4804-9678-9c4b5561eae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4a6b2e2d-3c45-403e-a4cf-7971505d41ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_393f1871-b6b2-4366-9486-a8d16561a75b" xlink:to="loc_us-gaap_RetainedEarningsMember_4a6b2e2d-3c45-403e-a4cf-7971505d41ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c0a69d9e-e4e5-4ba6-baf3-1a8b5a5d8aec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_187aad63-a861-4f14-b4a8-d7daeec4ca1a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c0a69d9e-e4e5-4ba6-baf3-1a8b5a5d8aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_055ac216-af36-42c7-921d-fcc7bcbd0f90" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c0a69d9e-e4e5-4ba6-baf3-1a8b5a5d8aec" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_055ac216-af36-42c7-921d-fcc7bcbd0f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f7de5148-0f8c-47a5-bad0-b9aeddb03cd4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_055ac216-af36-42c7-921d-fcc7bcbd0f90" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f7de5148-0f8c-47a5-bad0-b9aeddb03cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3d5547fb-0350-480b-a17a-a921f66499d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_187aad63-a861-4f14-b4a8-d7daeec4ca1a" xlink:to="loc_us-gaap_StatementLineItems_3d5547fb-0350-480b-a17a-a921f66499d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3d5547fb-0350-480b-a17a-a921f66499d6" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_f71beb7a-1987-40fe-bcbc-8f712486f126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_SharesIssued_f71beb7a-1987-40fe-bcbc-8f712486f126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0ce0fb9d-58ff-40b0-8eea-3765eaa5af28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockholdersEquity_0ce0fb9d-58ff-40b0-8eea-3765eaa5af28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_24e33a79-4109-48c6-a6a4-1a658ade6557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_TreasuryStockShares_24e33a79-4109-48c6-a6a4-1a658ade6557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_921e7f64-5529-41d4-9ad4-d0dff43cdd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_NetIncomeLoss_921e7f64-5529-41d4-9ad4-d0dff43cdd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_86e957a5-42f0-42c1-8b06-59ba68dfda88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_86e957a5-42f0-42c1-8b06-59ba68dfda88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a42a708b-35e3-40ef-b97b-364a9575c37a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a42a708b-35e3-40ef-b97b-364a9575c37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0e6096cd-1078-4501-9348-2feb1015c3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0e6096cd-1078-4501-9348-2feb1015c3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4968836b-f8de-4369-95c4-914f79b8d07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4968836b-f8de-4369-95c4-914f79b8d07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9d2a2ab7-594d-4d08-9128-0f92a9f57e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9d2a2ab7-594d-4d08-9128-0f92a9f57e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_77fc5c75-99ab-419c-802b-6cc2f0293853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_77fc5c75-99ab-419c-802b-6cc2f0293853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2699a76b-ac41-4117-a202-89af9349e8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2699a76b-ac41-4117-a202-89af9349e8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0bb6c049-d2ff-43cc-b9df-a7d74f3937a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0bb6c049-d2ff-43cc-b9df-a7d74f3937a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_1220fc9e-0917-4dad-8d78-5e9f5d05f7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_1220fc9e-0917-4dad-8d78-5e9f5d05f7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_35c7ee93-6858-4736-9081-6fce60e02ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_SharesIssued_35c7ee93-6858-4736-9081-6fce60e02ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6af29a17-239d-4a48-b73f-7af1bbaf8340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_StockholdersEquity_6af29a17-239d-4a48-b73f-7af1bbaf8340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_87d43314-a4c6-40b7-89cd-f45a2a4d5622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_TreasuryStockShares_87d43314-a4c6-40b7-89cd-f45a2a4d5622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_7d40f4b5-c6cb-4f41-a8fe-db9851a8bbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07ebf3f-2bfe-4b28-b33c-fbe2cb6cddd3" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_7d40f4b5-c6cb-4f41-a8fe-db9851a8bbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/BUSINESS" xlink:type="simple" xlink:href="iart-20211231.xsd#BUSINESS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/BUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_589665d1-84e7-4770-ba18-149b61df32e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_01119042-2800-41de-ae54-60ce4d32cf0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_589665d1-84e7-4770-ba18-149b61df32e6" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_01119042-2800-41de-ae54-60ce4d32cf0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f5636f74-694d-4f14-afe9-fb50ba19ccdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c366b9e1-0300-4466-b72a-4ce47268c103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f5636f74-694d-4f14-afe9-fb50ba19ccdb" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c366b9e1-0300-4466-b72a-4ce47268c103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2b9737ad-0fc4-4bcc-88be-7d5ea7a56db8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2b9737ad-0fc4-4bcc-88be-7d5ea7a56db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_8b9767af-73b7-4f87-a98f-2f49d56533e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_8b9767af-73b7-4f87-a98f-2f49d56533e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_0edb5d1b-0553-4dbd-bb57-188331127029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_UseOfEstimates_0edb5d1b-0553-4dbd-bb57-188331127029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_0a40338b-1b49-4189-8421-2a83b14196d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_0a40338b-1b49-4189-8421-2a83b14196d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b132f17c-82f0-418c-9708-6b350a4545bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b132f17c-82f0-418c-9708-6b350a4545bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_d29a4301-e74c-4f2d-be35-30c49ebf5c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_d29a4301-e74c-4f2d-be35-30c49ebf5c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_f1cebb54-f04e-4bb0-b0d8-9c36a0552c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_f1cebb54-f04e-4bb0-b0d8-9c36a0552c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3aea9136-86bb-4017-b5eb-c6dca4d6d61b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3aea9136-86bb-4017-b5eb-c6dca4d6d61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_0bf6b7c3-8a6c-4766-a7ae-96e2a9cda6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCapitalizationPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_0bf6b7c3-8a6c-4766-a7ae-96e2a9cda6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_c413aeaa-2885-4fff-bdf7-a43b60729660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_c413aeaa-2885-4fff-bdf7-a43b60729660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_ed51f69c-1598-4e62-9aa4-096a9cb473e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_ed51f69c-1598-4e62-9aa4-096a9cb473e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_e48fcb7d-6725-4fad-b3c7-5639463e1bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_e48fcb7d-6725-4fad-b3c7-5639463e1bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FoundationPolicyTextBlock_c065875f-7c6d-40ec-b974-c83d17298255" xlink:href="iart-20211231.xsd#iart_FoundationPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_iart_FoundationPolicyTextBlock_c065875f-7c6d-40ec-b974-c83d17298255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_ac80549f-14f1-46ff-80f4-14f395a63025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_ac80549f-14f1-46ff-80f4-14f395a63025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_df33e101-836f-4995-a902-3d1d52d465dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_df33e101-836f-4995-a902-3d1d52d465dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_17506d85-6786-4e54-9632-90c5ff2a9a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_17506d85-6786-4e54-9632-90c5ff2a9a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_913f11f0-cc9f-4cfc-92d9-a6b4cc20f39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_913f11f0-cc9f-4cfc-92d9-a6b4cc20f39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_7433f003-6f71-4026-8eac-07a946d9d59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_7433f003-6f71-4026-8eac-07a946d9d59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0cae65cd-e748-4c07-a0cc-e9f3da807bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0cae65cd-e748-4c07-a0cc-e9f3da807bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_e34acf8b-0c34-4563-a248-7268a46b7138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_e34acf8b-0c34-4563-a248-7268a46b7138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_0f2251f2-5385-4a14-8f98-33bbce9352ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_0f2251f2-5385-4a14-8f98-33bbce9352ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_9d0314bd-0553-428c-93e4-1cb8ee50194e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_9d0314bd-0553-428c-93e4-1cb8ee50194e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_61db4e09-b8f1-43f4-ac5c-8f10931437ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_61db4e09-b8f1-43f4-ac5c-8f10931437ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_039885b9-b887-49a1-8c8c-f09e1601936a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_039885b9-b887-49a1-8c8c-f09e1601936a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyPolicy_0680a34a-9a43-4394-a444-9d3c124fd43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtendedProductWarrantyPolicy"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_ExtendedProductWarrantyPolicy_0680a34a-9a43-4394-a444-9d3c124fd43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_fb75fdea-7a38-45ae-95b7-fdb292629e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_873071cc-18d4-435e-a0b2-66761c169c8e" xlink:to="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_fb75fdea-7a38-45ae-95b7-fdb292629e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_98fac49d-15b9-43fc-b63e-1d087ae5e657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_48620f81-8215-46fa-90e6-a81739b8536d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_98fac49d-15b9-43fc-b63e-1d087ae5e657" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_48620f81-8215-46fa-90e6-a81739b8536d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7ba0e2f2-6334-4c87-9130-41c47d32f24d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_98fac49d-15b9-43fc-b63e-1d087ae5e657" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7ba0e2f2-6334-4c87-9130-41c47d32f24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_78935251-6263-4329-af31-8eb5bc2ef432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_98fac49d-15b9-43fc-b63e-1d087ae5e657" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_78935251-6263-4329-af31-8eb5bc2ef432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0642728c-86cf-4e1a-8d86-19e3c8adcb30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:href="iart-20211231.xsd#iart_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0642728c-86cf-4e1a-8d86-19e3c8adcb30" xlink:to="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d385e5a8-5b4d-4ed3-8366-225abd14f180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d385e5a8-5b4d-4ed3-8366-225abd14f180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_20e2ab30-50c8-4168-a080-8accc6a3cec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d385e5a8-5b4d-4ed3-8366-225abd14f180" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_20e2ab30-50c8-4168-a080-8accc6a3cec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_39025f9b-09ac-4dc7-9923-909cb9c73b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_20e2ab30-50c8-4168-a080-8accc6a3cec6" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_39025f9b-09ac-4dc7-9923-909cb9c73b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_54422b89-ef6a-42ca-81c7-fab4bdb900fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_54422b89-ef6a-42ca-81c7-fab4bdb900fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1d6ef0a-086f-4028-b814-7fc95c762eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_54422b89-ef6a-42ca-81c7-fab4bdb900fe" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1d6ef0a-086f-4028-b814-7fc95c762eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_a17aea2c-50eb-4dea-a35c-6ce2c51fdca0" xlink:href="iart-20211231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1d6ef0a-086f-4028-b814-7fc95c762eda" xlink:to="loc_iart_SmithNephewUSDLimitedMember_a17aea2c-50eb-4dea-a35c-6ce2c51fdca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b383a047-60ad-4e34-9f3c-ce51ed2336ca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_srt_RangeAxis_b383a047-60ad-4e34-9f3c-ce51ed2336ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f542bffb-e13a-4674-9d12-ea96e7b093e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b383a047-60ad-4e34-9f3c-ce51ed2336ca" xlink:to="loc_srt_RangeMember_f542bffb-e13a-4674-9d12-ea96e7b093e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_31bce8bd-ef11-43cc-9143-d7d9e992b4d2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f542bffb-e13a-4674-9d12-ea96e7b093e7" xlink:to="loc_srt_MinimumMember_31bce8bd-ef11-43cc-9143-d7d9e992b4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c5d70b5b-7ef4-4e4f-affd-16d43c6586e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f542bffb-e13a-4674-9d12-ea96e7b093e7" xlink:to="loc_srt_MaximumMember_c5d70b5b-7ef4-4e4f-affd-16d43c6586e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c899d1e9-75b5-4513-a593-97ff37998877" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c899d1e9-75b5-4513-a593-97ff37998877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_69432c0c-132d-4b74-a095-6594579e53db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c899d1e9-75b5-4513-a593-97ff37998877" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_69432c0c-132d-4b74-a095-6594579e53db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_155b6584-66f7-4026-9fd8-c97c68929a40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_69432c0c-132d-4b74-a095-6594579e53db" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_155b6584-66f7-4026-9fd8-c97c68929a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4d8edbeb-6f16-4d3c-9011-1ff0a94d19f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4d8edbeb-6f16-4d3c-9011-1ff0a94d19f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86ab1e4e-05d7-4df1-bca1-334f0e4e4169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4d8edbeb-6f16-4d3c-9011-1ff0a94d19f2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86ab1e4e-05d7-4df1-bca1-334f0e4e4169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_bb4fd31d-8daa-499a-9b65-5b3757c60f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86ab1e4e-05d7-4df1-bca1-334f0e4e4169" xlink:to="loc_us-gaap_SalesRevenueNetMember_bb4fd31d-8daa-499a-9b65-5b3757c60f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_148e04c4-6ee2-4449-92f6-35e662adedb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_AssetAcquisitionAxis_148e04c4-6ee2-4449-92f6-35e662adedb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_c11fd286-3b47-48a6-94d9-73851ab5a5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_148e04c4-6ee2-4449-92f6-35e662adedb1" xlink:to="loc_us-gaap_AssetAcquisitionDomain_c11fd286-3b47-48a6-94d9-73851ab5a5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember_c9fb6179-ff17-4013-954f-2297470ee929" xlink:href="iart-20211231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_c11fd286-3b47-48a6-94d9-73851ab5a5fc" xlink:to="loc_iart_ReboundTherapeuticsCorporationMember_c9fb6179-ff17-4013-954f-2297470ee929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ab584fd9-f092-45c6-808c-cf3a1c6f4a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ab584fd9-f092-45c6-808c-cf3a1c6f4a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eed03509-3afd-4a97-b36b-ca7a289bea26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ab584fd9-f092-45c6-808c-cf3a1c6f4a67" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eed03509-3afd-4a97-b36b-ca7a289bea26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_7f6dfdad-596a-4d1f-b382-d10db4fac3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed03509-3afd-4a97-b36b-ca7a289bea26" xlink:to="loc_us-gaap_ConvertibleDebtMember_7f6dfdad-596a-4d1f-b382-d10db4fac3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9e6e9fed-2994-452b-9846-8a1dcbeb314e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_DebtInstrumentAxis_9e6e9fed-2994-452b-9846-8a1dcbeb314e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95e8cf2d-8e99-4e72-b922-0d6e52de28fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9e6e9fed-2994-452b-9846-8a1dcbeb314e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95e8cf2d-8e99-4e72-b922-0d6e52de28fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_928a315a-6e5a-440a-a0d4-4eec3447df87" xlink:href="iart-20211231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95e8cf2d-8e99-4e72-b922-0d6e52de28fd" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_928a315a-6e5a-440a-a0d4-4eec3447df87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fd53138a-9e37-43ec-91b3-8df5a7d5eee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fd53138a-9e37-43ec-91b3-8df5a7d5eee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d3d85654-6784-44d8-be57-8ea2f68ae48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fd53138a-9e37-43ec-91b3-8df5a7d5eee0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d3d85654-6784-44d8-be57-8ea2f68ae48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4798d30e-28e9-479d-b4b3-3b7d04c5f0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d3d85654-6784-44d8-be57-8ea2f68ae48a" xlink:to="loc_us-gaap_CostOfSalesMember_4798d30e-28e9-479d-b4b3-3b7d04c5f0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4c590a02-7d79-4863-99ed-35d0b30ef152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d3d85654-6784-44d8-be57-8ea2f68ae48a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4c590a02-7d79-4863-99ed-35d0b30ef152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8ce1a030-3cd5-459f-96fe-9e8e53b2e506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d3d85654-6784-44d8-be57-8ea2f68ae48a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8ce1a030-3cd5-459f-96fe-9e8e53b2e506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_f158ab61-0576-4e9c-bc98-193b62eb1562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_f158ab61-0576-4e9c-bc98-193b62eb1562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e22c3de7-a265-4a67-9e41-92be8618c03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f158ab61-0576-4e9c-bc98-193b62eb1562" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e22c3de7-a265-4a67-9e41-92be8618c03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_4334b89c-efe9-45e9-b37a-c501df2da029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_e22c3de7-a265-4a67-9e41-92be8618c03c" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_4334b89c-efe9-45e9-b37a-c501df2da029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:href="iart-20211231.xsd#iart_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_fd021d07-3f0c-44cd-a08c-5da8a0a034f4" xlink:to="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_6acf1081-63fc-4ed4-9be9-6a12b88e1b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_6acf1081-63fc-4ed4-9be9-6a12b88e1b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a4d57e46-8a55-4152-9490-0fb316dab4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a4d57e46-8a55-4152-9490-0fb316dab4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InventoryCapitalizedExpenses_9bb164bf-b703-4939-a8f8-85138969be6d" xlink:href="iart-20211231.xsd#iart_InventoryCapitalizedExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_InventoryCapitalizedExpenses_9bb164bf-b703-4939-a8f8-85138969be6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_b4fc456e-1777-4a62-92e4-a7005e8c7f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_b4fc456e-1777-4a62-92e4-a7005e8c7f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_88ba5eea-39ad-4b40-9a95-1613693c1bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_Depreciation_88ba5eea-39ad-4b40-9a95-1613693c1bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2ce08981-916a-41a0-9225-160e208b1751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2ce08981-916a-41a0-9225-160e208b1751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalizedAdjustment_4875a8c8-27fa-48cb-a4b8-74f5ead3a745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalizedAdjustment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_InterestCostsCapitalizedAdjustment_4875a8c8-27fa-48cb-a4b8-74f5ead3a745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_80ac552d-6a16-4e83-8693-45f48eca7421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_NumberOfReportableSegments_80ac552d-6a16-4e83-8693-45f48eca7421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_37ec13c8-fcd1-4f06-8f10-1e8e414b852e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_NumberOfReportingUnits_37ec13c8-fcd1-4f06-8f10-1e8e414b852e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CharitableContributions_c18165b1-df5d-4693-a488-650341e274cb" xlink:href="iart-20211231.xsd#iart_CharitableContributions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_CharitableContributions_c18165b1-df5d-4693-a488-650341e274cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_3e4d1fef-fd36-440d-9268-1dd76275f65c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_3e4d1fef-fd36-440d-9268-1dd76275f65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_10806c14-f859-4e7c-b2e0-534e81606acd" xlink:href="iart-20211231.xsd#iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_10806c14-f859-4e7c-b2e0-534e81606acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_faa51c5e-efd7-4fb4-a048-ee702b8b8c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_RestructuringCharges_faa51c5e-efd7-4fb4-a048-ee702b8b8c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_0a072726-6a05-43ea-8d3e-a1ee3ff541f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_RestructuringReserveCurrent_0a072726-6a05-43ea-8d3e-a1ee3ff541f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_704ef05b-41d4-470c-9326-685cc122b11f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_704ef05b-41d4-470c-9326-685cc122b11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_b57a16ef-1d8d-4ebf-ba32-257efe983f84" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_b57a16ef-1d8d-4ebf-ba32-257efe983f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_5e7d6295-3f58-4c97-afb0-5fdbc126edbb" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_5e7d6295-3f58-4c97-afb0-5fdbc126edbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskThresholdPercentage_fc52ded4-bb58-4719-9d39-ee9dd5cad361" xlink:href="iart-20211231.xsd#iart_ConcentrationRiskThresholdPercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_ConcentrationRiskThresholdPercentage_fc52ded4-bb58-4719-9d39-ee9dd5cad361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_72d1e7e0-173d-404b-87d6-3885cc18cd56" xlink:href="iart-20211231.xsd#iart_ConcentrationRiskNumberofCustomersOverBenchmark"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_72d1e7e0-173d-404b-87d6-3885cc18cd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_c2fc7ab7-2278-4dee-b3e8-168e77045573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_ConvertibleDebt_c2fc7ab7-2278-4dee-b3e8-168e77045573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eccfd623-260b-417e-ba72-498a18d5abd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eccfd623-260b-417e-ba72-498a18d5abd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_6839d3a0-de7b-4ce1-a2aa-ea07516aa195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_InterestPaid_6839d3a0-de7b-4ce1-a2aa-ea07516aa195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_7f378934-499c-4141-a5c2-130625e5fa66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_InterestPaidCapitalized_7f378934-499c-4141-a5c2-130625e5fa66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_ae7bc935-69d1-4810-ab82-e77f1556ff0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_IncomeTaxesPaid_ae7bc935-69d1-4810-ab82-e77f1556ff0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d6d4bdf0-7f94-45d2-8625-ea43fbc12b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d6d4bdf0-7f94-45d2-8625-ea43fbc12b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_e86cb8b8-4243-4a11-8ea4-93d0e948b7f1" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_e86cb8b8-4243-4a11-8ea4-93d0e948b7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_1c5fbcab-7762-40e9-9685-4d114dae7262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_1c5fbcab-7762-40e9-9685-4d114dae7262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5d11ed7f-c8c2-4a8d-ba83-7f826498170c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_56a1c699-6b14-40bb-b4c3-daa77a099114" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5d11ed7f-c8c2-4a8d-ba83-7f826498170c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_79a9d8db-8255-4189-8ad4-f26a16634ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_fe65579e-14e4-45b5-9bec-fb524f59c23b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_79a9d8db-8255-4189-8ad4-f26a16634ca9" xlink:to="loc_us-gaap_InventoryFinishedGoods_fe65579e-14e4-45b5-9bec-fb524f59c23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_cb905225-2cb9-4cef-ab2e-defeb8f16b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_79a9d8db-8255-4189-8ad4-f26a16634ca9" xlink:to="loc_us-gaap_InventoryWorkInProcess_cb905225-2cb9-4cef-ab2e-defeb8f16b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_427c6502-47cb-4e0e-8477-0ec044654e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_79a9d8db-8255-4189-8ad4-f26a16634ca9" xlink:to="loc_us-gaap_InventoryRawMaterials_427c6502-47cb-4e0e-8477-0ec044654e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d98a3319-8b96-4fec-be56-a99bb79da54c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_79a9d8db-8255-4189-8ad4-f26a16634ca9" xlink:to="loc_us-gaap_InventoryNet_d98a3319-8b96-4fec-be56-a99bb79da54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4312a1d4-c506-44f3-a243-f6e991909528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ecaf6187-fb8e-434a-b515-066e6440f25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4312a1d4-c506-44f3-a243-f6e991909528" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ecaf6187-fb8e-434a-b515-066e6440f25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88c9e143-5b65-4a5d-b303-f9a42dc8d272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ecaf6187-fb8e-434a-b515-066e6440f25b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88c9e143-5b65-4a5d-b303-f9a42dc8d272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88c9e143-5b65-4a5d-b303-f9a42dc8d272" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_4f4cbf65-f23a-400b-8fe9-47a906ef38c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_LandMember_4f4cbf65-f23a-400b-8fe9-47a906ef38c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_2dfa3bee-52d0-48c5-bc34-5445ff4317ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_2dfa3bee-52d0-48c5-bc34-5445ff4317ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3ea12625-a3be-4369-b9f4-8710fe790de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3ea12625-a3be-4369-b9f4-8710fe790de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_4372dbc5-3769-4e8f-8c98-0138bf9b4370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_4372dbc5-3769-4e8f-8c98-0138bf9b4370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInstrumentKitsMember_e229e0d9-5630-4892-8e3e-761653e04c9e" xlink:href="iart-20211231.xsd#iart_SurgicalInstrumentKitsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_iart_SurgicalInstrumentKitsMember_e229e0d9-5630-4892-8e3e-761653e04c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InformationSystemsandHardwareMember_2549e324-66b1-4136-92d8-f35d0872d236" xlink:href="iart-20211231.xsd#iart_InformationSystemsandHardwareMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_iart_InformationSystemsandHardwareMember_2549e324-66b1-4136-92d8-f35d0872d236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_0933b5a1-bd10-4153-a7d2-e3fa7c182ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_0933b5a1-bd10-4153-a7d2-e3fa7c182ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_2448c3ab-65eb-45d2-a1c6-13a7a5af0925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_738c3085-4b50-4270-b6d6-16ddb24eb92b" xlink:to="loc_us-gaap_ConstructionInProgressMember_2448c3ab-65eb-45d2-a1c6-13a7a5af0925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c3b05f0f-f625-4891-bc9e-df96ad3996b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ecaf6187-fb8e-434a-b515-066e6440f25b" xlink:to="loc_srt_RangeAxis_c3b05f0f-f625-4891-bc9e-df96ad3996b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_550c7f03-ea6f-40b1-9abf-b87cdf614b48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c3b05f0f-f625-4891-bc9e-df96ad3996b6" xlink:to="loc_srt_RangeMember_550c7f03-ea6f-40b1-9abf-b87cdf614b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4a76f1f9-8752-4436-a446-b75719a26176" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_550c7f03-ea6f-40b1-9abf-b87cdf614b48" xlink:to="loc_srt_MinimumMember_4a76f1f9-8752-4436-a446-b75719a26176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c67a52d1-5c86-4714-9023-ba4e8a6f9ea9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_550c7f03-ea6f-40b1-9abf-b87cdf614b48" xlink:to="loc_srt_MaximumMember_c67a52d1-5c86-4714-9023-ba4e8a6f9ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ecaf6187-fb8e-434a-b515-066e6440f25b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a577dcae-7d4e-4d7f-ac01-1e1bf77d3757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a577dcae-7d4e-4d7f-ac01-1e1bf77d3757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d14f39d1-f310-4e77-8e06-616e1b7d42fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d14f39d1-f310-4e77-8e06-616e1b7d42fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0d4773a4-f1e4-43e8-9177-a48a169eae5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0d4773a4-f1e4-43e8-9177-a48a169eae5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bb3fc4ac-166b-47b6-8c93-8d9cb937d5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3efa0f1-126b-4825-96bc-90f78c6b1711" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bb3fc4ac-166b-47b6-8c93-8d9cb937d5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details" xlink:type="simple" xlink:href="iart-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_98ed7ae0-40e1-4307-b42a-643e221937b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f7855fd0-7d0f-4096-896c-8206f206a6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_98ed7ae0-40e1-4307-b42a-643e221937b9" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f7855fd0-7d0f-4096-896c-8206f206a6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_b2101f0c-9a3b-4ef5-a506-ad18ece708f2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f7855fd0-7d0f-4096-896c-8206f206a6fc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_b2101f0c-9a3b-4ef5-a506-ad18ece708f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f2f77ffe-1593-48f1-920f-2811a9d891c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_b2101f0c-9a3b-4ef5-a506-ad18ece708f2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f2f77ffe-1593-48f1-920f-2811a9d891c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2200d491-0c3a-4333-96d6-e378394ba2d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f2f77ffe-1593-48f1-920f-2811a9d891c8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2200d491-0c3a-4333-96d6-e378394ba2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_54cccc61-e5e2-46b5-8318-e1b6263771aa" xlink:href="iart-20211231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2200d491-0c3a-4333-96d6-e378394ba2d0" xlink:to="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_54cccc61-e5e2-46b5-8318-e1b6263771aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_dd8231a9-7da4-45c0-9dcf-bd327c97039d" xlink:href="iart-20211231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2200d491-0c3a-4333-96d6-e378394ba2d0" xlink:to="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_dd8231a9-7da4-45c0-9dcf-bd327c97039d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f7855fd0-7d0f-4096-896c-8206f206a6fc" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_786b25e7-1f1b-44bb-b742-75627f82ebf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_786b25e7-1f1b-44bb-b742-75627f82ebf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_66852fa3-4e69-462d-b6fc-eb794e73fa6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_66852fa3-4e69-462d-b6fc-eb794e73fa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_26e3db5a-99f4-4adf-b5af-91e489b405be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_26e3db5a-99f4-4adf-b5af-91e489b405be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_f8e124b8-5636-4b23-8d19-c323493331d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5ea4095-a9dd-4c62-91f8-36c0610fae41" xlink:to="loc_us-gaap_AdditionalPaidInCapital_f8e124b8-5636-4b23-8d19-c323493331d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="simple" xlink:href="iart-20211231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fbf70015-5df4-4ca6-88e0-652ac9af4f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_48e4720b-43a8-406b-afed-06495ca0c97b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fbf70015-5df4-4ca6-88e0-652ac9af4f5a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_48e4720b-43a8-406b-afed-06495ca0c97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="simple" xlink:href="iart-20211231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f0d61537-ae8f-4bfa-935f-c29685f794f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_51072b13-1d3c-4e2c-a03a-f007b7058228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f0d61537-ae8f-4bfa-935f-c29685f794f0" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_51072b13-1d3c-4e2c-a03a-f007b7058228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_602126e2-b2bf-4c8c-a101-82f4f8856033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f0d61537-ae8f-4bfa-935f-c29685f794f0" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_602126e2-b2bf-4c8c-a101-82f4f8856033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_81d49f8b-e8de-4a4c-9282-edb9e2dbde68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_6e0dd184-1dcd-474b-b542-a59ad141c2ac" xlink:href="iart-20211231.xsd#iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_81d49f8b-e8de-4a4c-9282-edb9e2dbde68" xlink:to="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_6e0dd184-1dcd-474b-b542-a59ad141c2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e64b2815-4a4f-4178-9def-475a0c39261f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_81d49f8b-e8de-4a4c-9282-edb9e2dbde68" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e64b2815-4a4f-4178-9def-475a0c39261f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_651c6854-1fb3-4340-bf7c-3d8f68d3adec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_81d49f8b-e8de-4a4c-9282-edb9e2dbde68" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_651c6854-1fb3-4340-bf7c-3d8f68d3adec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueProductWarrantyPeriod_a1b2bae5-b98d-4d6e-9d09-e86b2143aff6" xlink:href="iart-20211231.xsd#iart_RevenueProductWarrantyPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_81d49f8b-e8de-4a4c-9282-edb9e2dbde68" xlink:to="loc_iart_RevenueProductWarrantyPeriod_a1b2bae5-b98d-4d6e-9d09-e86b2143aff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_609b65e3-97b4-492a-b81b-13e5b3f9fd75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_47c611ef-330b-4e05-9ec3-1b4a98477283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_609b65e3-97b4-492a-b81b-13e5b3f9fd75" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_47c611ef-330b-4e05-9ec3-1b4a98477283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_39d0c70c-4cf3-4b5c-93cf-49622a31c42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_609b65e3-97b4-492a-b81b-13e5b3f9fd75" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_39d0c70c-4cf3-4b5c-93cf-49622a31c42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ecb13356-474f-4864-b2a1-6e2537bb1b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_39d0c70c-4cf3-4b5c-93cf-49622a31c42d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ecb13356-474f-4864-b2a1-6e2537bb1b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_62b79624-d2e5-4685-8faa-fe6353891f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_39d0c70c-4cf3-4b5c-93cf-49622a31c42d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_62b79624-d2e5-4685-8faa-fe6353891f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_be058cd4-9245-4467-81df-43f0cc64b579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_62b79624-d2e5-4685-8faa-fe6353891f04" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_be058cd4-9245-4467-81df-43f0cc64b579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="iart-20211231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_049433c1-8e77-48c0-9f99-e7488dde0f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerAssetRollForward_7e5761d2-ec66-4802-b965-e48f9e583689" xlink:href="iart-20211231.xsd#iart_ChangeInContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_049433c1-8e77-48c0-9f99-e7488dde0f48" xlink:to="loc_iart_ChangeInContractWithCustomerAssetRollForward_7e5761d2-ec66-4802-b965-e48f9e583689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_48dba0cb-057c-4fc9-b475-acb241ba0c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_7e5761d2-ec66-4802-b965-e48f9e583689" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_48dba0cb-057c-4fc9-b475-acb241ba0c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_86d5124c-e91f-435f-8917-1db048886631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_7e5761d2-ec66-4802-b965-e48f9e583689" xlink:to="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_86d5124c-e91f-435f-8917-1db048886631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_f55792c9-2e25-4d73-8359-bb1978c4b79f" xlink:href="iart-20211231.xsd#iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_7e5761d2-ec66-4802-b965-e48f9e583689" xlink:to="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_f55792c9-2e25-4d73-8359-bb1978c4b79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_c3edba32-411c-4bf5-a915-678d52b8ea6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_7e5761d2-ec66-4802-b965-e48f9e583689" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_c3edba32-411c-4bf5-a915-678d52b8ea6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_a9280b6a-7462-47f7-ba44-672881e2274d" xlink:href="iart-20211231.xsd#iart_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_049433c1-8e77-48c0-9f99-e7488dde0f48" xlink:to="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_a9280b6a-7462-47f7-ba44-672881e2274d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_f2cc3e9a-dbfd-4378-8609-fc88e0e25c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_a9280b6a-7462-47f7-ba44-672881e2274d" xlink:to="loc_us-gaap_ContractWithCustomerLiability_f2cc3e9a-dbfd-4378-8609-fc88e0e25c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_6597b010-61b4-44e2-93ba-2a6d4fd29c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_a9280b6a-7462-47f7-ba44-672881e2274d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_6597b010-61b4-44e2-93ba-2a6d4fd29c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_d30496f8-b770-4307-b5e6-1401801c0f4a" xlink:href="iart-20211231.xsd#iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_a9280b6a-7462-47f7-ba44-672881e2274d" xlink:to="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_d30496f8-b770-4307-b5e6-1401801c0f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_b7177e99-a5e7-432c-b14e-403504d0dd37" xlink:href="iart-20211231.xsd#iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_a9280b6a-7462-47f7-ba44-672881e2274d" xlink:to="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_b7177e99-a5e7-432c-b14e-403504d0dd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_90e201ef-2caa-43af-8b6a-313b92236837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_a9280b6a-7462-47f7-ba44-672881e2274d" xlink:to="loc_us-gaap_ContractWithCustomerLiability_90e201ef-2caa-43af-8b6a-313b92236837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7fe7ad0-927e-49d7-af66-119d103e0ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fcd4adb7-ac04-4a98-b584-a813937d678c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7fe7ad0-927e-49d7-af66-119d103e0ba1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fcd4adb7-ac04-4a98-b584-a813937d678c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_45b684b5-3503-4d07-b305-664fac580134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fcd4adb7-ac04-4a98-b584-a813937d678c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_45b684b5-3503-4d07-b305-664fac580134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d3f903be-a3b5-4405-9480-7135e9e6afbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_45b684b5-3503-4d07-b305-664fac580134" xlink:to="loc_us-gaap_SegmentDomain_d3f903be-a3b5-4405-9480-7135e9e6afbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_9edeef74-fa22-4cd0-840d-4b02560a1d10" xlink:href="iart-20211231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d3f903be-a3b5-4405-9480-7135e9e6afbc" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_9edeef74-fa22-4cd0-840d-4b02560a1d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_5c1a487b-e821-46bc-9a78-f92fa5c4bf59" xlink:href="iart-20211231.xsd#iart_TissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d3f903be-a3b5-4405-9480-7135e9e6afbc" xlink:to="loc_iart_TissueTechnologiesMember_5c1a487b-e821-46bc-9a78-f92fa5c4bf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4d788c36-ac9a-485b-94ca-a3ab4f1f8dc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fcd4adb7-ac04-4a98-b584-a813937d678c" xlink:to="loc_srt_ProductOrServiceAxis_4d788c36-ac9a-485b-94ca-a3ab4f1f8dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4d788c36-ac9a-485b-94ca-a3ab4f1f8dc8" xlink:to="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember_15c5ad6e-18c7-4198-a46a-d9026e17d672" xlink:href="iart-20211231.xsd#iart_NeurosurgeryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:to="loc_iart_NeurosurgeryMember_15c5ad6e-18c7-4198-a46a-d9026e17d672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember_495fafa2-5b23-4fa5-bc61-55d8d6b96f7d" xlink:href="iart-20211231.xsd#iart_InstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:to="loc_iart_InstrumentsMember_495fafa2-5b23-4fa5-bc61-55d8d6b96f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember_1f89dbd1-2075-49c1-9fc6-e2dfe72c64a9" xlink:href="iart-20211231.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:to="loc_iart_RegenerativeSkinAndWoundMember_1f89dbd1-2075-49c1-9fc6-e2dfe72c64a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_e52353e9-63c6-4988-9b2f-3186839cef68" xlink:href="iart-20211231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:to="loc_iart_ExtremityOrthopedicsMember_e52353e9-63c6-4988-9b2f-3186839cef68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember_e3ce46a8-731f-4997-abff-28f34ff65119" xlink:href="iart-20211231.xsd#iart_PrivateLabelMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_864cc45b-337a-4f0b-a641-e2d511a0302c" xlink:to="loc_iart_PrivateLabelMember_e3ce46a8-731f-4997-abff-28f34ff65119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3834c336-b6b6-417b-abcd-a8e27f1280fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fcd4adb7-ac04-4a98-b584-a813937d678c" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_3834c336-b6b6-417b-abcd-a8e27f1280fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ba150f1e-c731-42bb-ac18-ed7506d34ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3834c336-b6b6-417b-abcd-a8e27f1280fc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ba150f1e-c731-42bb-ac18-ed7506d34ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURES" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e20d7479-0baa-4e7b-971a-97ff196663e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_dd0fb811-c43c-4ad4-b321-b0a5a0243a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e20d7479-0baa-4e7b-971a-97ff196663e4" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_dd0fb811-c43c-4ad4-b321-b0a5a0243a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_199550e5-e951-43a5-be8f-7200c16afc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_92c9f77e-addf-484c-bc9f-660432d2f3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_199550e5-e951-43a5-be8f-7200c16afc3a" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_92c9f77e-addf-484c-bc9f-660432d2f3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_9bf55750-c442-470f-ab52-b77a155ee779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_199550e5-e951-43a5-be8f-7200c16afc3a" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_9bf55750-c442-470f-ab52-b77a155ee779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a78f7b26-a7d8-4b29-8ce9-e253c7feb2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a78f7b26-a7d8-4b29-8ce9-e253c7feb2b4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a87c3539-80d6-4a47-9223-6037c775ce48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:to="loc_srt_CounterpartyNameAxis_a87c3539-80d6-4a47-9223-6037c775ce48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c417921c-0ed8-4994-b181-cda607199208" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a87c3539-80d6-4a47-9223-6037c775ce48" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c417921c-0ed8-4994-b181-cda607199208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_cc6d876e-98da-49be-9d96-bb70c954e2c1" xlink:href="iart-20211231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c417921c-0ed8-4994-b181-cda607199208" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_cc6d876e-98da-49be-9d96-bb70c954e2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8eda7235-a398-4e39-b446-5011ca9b9b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8eda7235-a398-4e39-b446-5011ca9b9b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_43d79a60-79ec-47dc-8e9e-5ef0c78701ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8eda7235-a398-4e39-b446-5011ca9b9b03" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_43d79a60-79ec-47dc-8e9e-5ef0c78701ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e125e250-95cc-4537-86d9-7a02b55d0819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_43d79a60-79ec-47dc-8e9e-5ef0c78701ac" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e125e250-95cc-4537-86d9-7a02b55d0819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98c90a8b-409c-474c-9aab-aec6338e245e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98c90a8b-409c-474c-9aab-aec6338e245e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_330794c6-e244-4110-b310-28d55634a0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98c90a8b-409c-474c-9aab-aec6338e245e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_330794c6-e244-4110-b310-28d55634a0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_65435027-33da-410e-987f-289e5b8347dd" xlink:href="iart-20211231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_330794c6-e244-4110-b310-28d55634a0da" xlink:to="loc_iart_ExtremityOrthopedicsMember_65435027-33da-410e-987f-289e5b8347dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_29edfb80-d9d2-433c-b019-90f5c429694d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_58ac41a6-8335-4db9-ae77-a1c6bc4d5c63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_58ac41a6-8335-4db9-ae77-a1c6bc4d5c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_760336fc-bfb3-441d-9bd7-d74eec29d444" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_760336fc-bfb3-441d-9bd7-d74eec29d444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_725171fe-fa28-42a3-a76b-41b4fb05c7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_725171fe-fa28-42a3-a76b-41b4fb05c7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NetWorkingCapital_4c4440b1-f74d-4ff0-ba55-55575764ab7e" xlink:href="iart-20211231.xsd#iart_NetWorkingCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_iart_NetWorkingCapital_4c4440b1-f74d-4ff0-ba55-55575764ab7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_47c4dbdd-d49b-456b-ba38-de5bf0bb9552" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e00e9253-d652-44a7-9b92-3094f839f484" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_47c4dbdd-d49b-456b-ba38-de5bf0bb9552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9374a8b4-2c3e-496a-ae8d-c073b9a10e61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2a6283d8-ad68-4bdb-aa0d-fef34889b71a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9374a8b4-2c3e-496a-ae8d-c073b9a10e61" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2a6283d8-ad68-4bdb-aa0d-fef34889b71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a618fb93-8318-43e9-bcf3-bc1cf445014c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2a6283d8-ad68-4bdb-aa0d-fef34889b71a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a618fb93-8318-43e9-bcf3-bc1cf445014c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1ef640b4-4311-4fe5-9351-86017894037d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a618fb93-8318-43e9-bcf3-bc1cf445014c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1ef640b4-4311-4fe5-9351-86017894037d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0f0c4e21-f2f2-4622-9b05-60e7f062cb19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1ef640b4-4311-4fe5-9351-86017894037d" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0f0c4e21-f2f2-4622-9b05-60e7f062cb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_515253fc-7f89-4270-82b2-142237c56663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2a6283d8-ad68-4bdb-aa0d-fef34889b71a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_515253fc-7f89-4270-82b2-142237c56663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_54a8d55a-7ce3-4800-80a4-d7027689835e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_515253fc-7f89-4270-82b2-142237c56663" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_54a8d55a-7ce3-4800-80a4-d7027689835e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_40a80f02-a5d0-4af7-a85a-514b939e82f3" xlink:href="iart-20211231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_54a8d55a-7ce3-4800-80a4-d7027689835e" xlink:to="loc_iart_ExtremityOrthopedicsMember_40a80f02-a5d0-4af7-a85a-514b939e82f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2a6283d8-ad68-4bdb-aa0d-fef34889b71a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_ddf27e10-0d67-4de2-84ef-12e5ec004473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_ddf27e10-0d67-4de2-84ef-12e5ec004473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_859c3b4a-10c4-4694-9409-d6f05364d084" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_859c3b4a-10c4-4694-9409-d6f05364d084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_3d84db39-8a19-4f6f-aa45-aca9c17ddc66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_3d84db39-8a19-4f6f-aa45-aca9c17ddc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_a88f09bb-3d03-4286-b379-9d5a6ad2f47a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_a88f09bb-3d03-4286-b379-9d5a6ad2f47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_07f447fc-b86b-473a-8e25-82fcf9b7280d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_07f447fc-b86b-473a-8e25-82fcf9b7280d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_fcf30115-b719-4f31-be7c-040faae150f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_fcf30115-b719-4f31-be7c-040faae150f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b10147ab-9e63-42db-b6a3-60de5a0fefa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b10147ab-9e63-42db-b6a3-60de5a0fefa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d821d5ee-bb56-4abe-ac4e-e15b3a844371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d821d5ee-bb56-4abe-ac4e-e15b3a844371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_f15b9ee2-5ccc-41c8-a072-f65996f31d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_f15b9ee2-5ccc-41c8-a072-f65996f31d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_a56b40b3-f5c4-4dc3-81da-f7a2f6895d69" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_a56b40b3-f5c4-4dc3-81da-f7a2f6895d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_44f0836f-5d07-4e5f-8053-ffa38cca521f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_44f0836f-5d07-4e5f-8053-ffa38cca521f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_be77deaf-9e14-47f5-891d-25d3db4151fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_be77deaf-9e14-47f5-891d-25d3db4151fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_2fc23544-807e-4314-b70c-a3a4e2ea0c0b" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_2fc23544-807e-4314-b70c-a3a4e2ea0c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_4eca7a7d-d75c-4a1c-8b0f-5396fe265654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c30bce53-bb97-47fb-8c4d-f074416c9894" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_4eca7a7d-d75c-4a1c-8b0f-5396fe265654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f5e1a3fd-fc0a-4235-a3eb-ee4aaf1f719f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f5e1a3fd-fc0a-4235-a3eb-ee4aaf1f719f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_65ab3b3b-f980-4f53-8e19-795013327f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_65ab3b3b-f980-4f53-8e19-795013327f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af7731e8-6387-4f48-8a0d-6d34c87a1a58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_65ab3b3b-f980-4f53-8e19-795013327f83" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af7731e8-6387-4f48-8a0d-6d34c87a1a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_0ecef4e1-c4df-48a2-9c05-d5f3f207274f" xlink:href="iart-20211231.xsd#iart_ACellIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af7731e8-6387-4f48-8a0d-6d34c87a1a58" xlink:to="loc_iart_ACellIncMember_0ecef4e1-c4df-48a2-9c05-d5f3f207274f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_f4a6d679-61ad-465a-882f-709ea102466a" xlink:href="iart-20211231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af7731e8-6387-4f48-8a0d-6d34c87a1a58" xlink:to="loc_iart_ArkisBioSciencesInc.Member_f4a6d679-61ad-465a-882f-709ea102466a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_19e9c590-648d-411e-923d-53c521041180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_19e9c590-648d-411e-923d-53c521041180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_614c6ac5-5dad-4e6f-88e2-255882598fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_19e9c590-648d-411e-923d-53c521041180" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_614c6ac5-5dad-4e6f-88e2-255882598fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember_c21cf4e0-6a78-479d-a04e-61529a5bb297" xlink:href="iart-20211231.xsd#iart_MilestonePaymentOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_614c6ac5-5dad-4e6f-88e2-255882598fe9" xlink:to="loc_iart_MilestonePaymentOneMember_c21cf4e0-6a78-479d-a04e-61529a5bb297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember_d73bfcd8-b1ad-4053-a839-153c0e1b9f0a" xlink:href="iart-20211231.xsd#iart_MilestonePaymentTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_614c6ac5-5dad-4e6f-88e2-255882598fe9" xlink:to="loc_iart_MilestonePaymentTwoMember_d73bfcd8-b1ad-4053-a839-153c0e1b9f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e41faee2-fe0f-445e-bdd1-36d005f5515e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e41faee2-fe0f-445e-bdd1-36d005f5515e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b965bfc4-433c-4df1-b46a-9a3e6fdf6da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e41faee2-fe0f-445e-bdd1-36d005f5515e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b965bfc4-433c-4df1-b46a-9a3e6fdf6da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_3b0156cf-d20a-4a00-9938-3546454b4d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b965bfc4-433c-4df1-b46a-9a3e6fdf6da0" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_3b0156cf-d20a-4a00-9938-3546454b4d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_de0fafbd-beee-4114-929a-318855014f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b965bfc4-433c-4df1-b46a-9a3e6fdf6da0" xlink:to="loc_us-gaap_OtherLiabilitiesMember_de0fafbd-beee-4114-929a-318855014f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a952889d-01aa-4023-965d-2da05c9a98ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:to="loc_srt_StatementScenarioAxis_a952889d-01aa-4023-965d-2da05c9a98ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_88173592-0469-492f-8b7a-a138192651c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a952889d-01aa-4023-965d-2da05c9a98ed" xlink:to="loc_srt_ScenarioUnspecifiedDomain_88173592-0469-492f-8b7a-a138192651c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_7a5bbef8-25cb-49dd-8506-3f13c962814a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_88173592-0469-492f-8b7a-a138192651c0" xlink:to="loc_srt_ProFormaMember_7a5bbef8-25cb-49dd-8506-3f13c962814a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24bee3a0-95d2-473e-8a9e-e0ecb3b1d7c1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_82dda9ff-37d6-41c9-8d1b-e8852a9deb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_82dda9ff-37d6-41c9-8d1b-e8852a9deb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_402888b1-44ac-47a2-aa4f-dc4846f3cf58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_402888b1-44ac-47a2-aa4f-dc4846f3cf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationWorkingCapitalAdjustment_0e41c677-cd40-4591-a8e3-6966146ad57e" xlink:href="iart-20211231.xsd#iart_BusinessCombinationWorkingCapitalAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_iart_BusinessCombinationWorkingCapitalAdjustment_0e41c677-cd40-4591-a8e3-6966146ad57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dffbf46c-0b86-4b1a-bc42-c7cbae60faf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_Goodwill_dffbf46c-0b86-4b1a-bc42-c7cbae60faf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_26ebd525-8b89-4157-8a39-eff0ff22b2f6" xlink:href="iart-20211231.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_26ebd525-8b89-4157-8a39-eff0ff22b2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_3bb524cd-707c-4a7d-ba0c-060b6f1b7e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_3bb524cd-707c-4a7d-ba0c-060b6f1b7e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fe3dd04b-9691-4645-b407-a933beccec1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fe3dd04b-9691-4645-b407-a933beccec1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f866ec42-4e05-46af-96b7-1898533dca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_Revenues_f866ec42-4e05-46af-96b7-1898533dca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8281a8f4-735a-4aef-92e9-9dd39a23a5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8281a8f4-735a-4aef-92e9-9dd39a23a5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_8fa6d34c-0fca-4318-9893-f68b7f10abd6" xlink:href="iart-20211231.xsd#iart_AcquiredFinitelivedIntangibleAssetsDiscountRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_92a79ea8-03f3-4071-90df-796eefe43740" xlink:to="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_8fa6d34c-0fca-4318-9893-f68b7f10abd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5032670f-55d9-4b07-814a-3306d9887a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5032670f-55d9-4b07-814a-3306d9887a4e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_14b48248-6678-4afc-abf0-6a940972a6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_14b48248-6678-4afc-abf0-6a940972a6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a91e2ed-06de-498d-929b-80a2051b9bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14b48248-6678-4afc-abf0-6a940972a6ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a91e2ed-06de-498d-929b-80a2051b9bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_84af2de4-a449-4a75-b700-faa608c0b775" xlink:href="iart-20211231.xsd#iart_ACellIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a91e2ed-06de-498d-929b-80a2051b9bf1" xlink:to="loc_iart_ACellIncMember_84af2de4-a449-4a75-b700-faa608c0b775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_6953e409-e1e0-45d7-9532-e6e156d7b31a" xlink:href="iart-20211231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a91e2ed-06de-498d-929b-80a2051b9bf1" xlink:to="loc_iart_ArkisBioSciencesInc.Member_6953e409-e1e0-45d7-9532-e6e156d7b31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_34b595f2-e97b-4867-9dd7-d0627e18706f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:to="loc_srt_RangeAxis_34b595f2-e97b-4867-9dd7-d0627e18706f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f81aaac2-0ab6-4d8f-b036-62684feaa96d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_34b595f2-e97b-4867-9dd7-d0627e18706f" xlink:to="loc_srt_RangeMember_f81aaac2-0ab6-4d8f-b036-62684feaa96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f495d060-7843-4de0-b81a-99c813d5e0d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f81aaac2-0ab6-4d8f-b036-62684feaa96d" xlink:to="loc_srt_MinimumMember_f495d060-7843-4de0-b81a-99c813d5e0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bb552f9c-d008-4d35-a62b-7603b829eb5d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f81aaac2-0ab6-4d8f-b036-62684feaa96d" xlink:to="loc_srt_MaximumMember_bb552f9c-d008-4d35-a62b-7603b829eb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d064524c-72f2-434d-b00c-b81262e5eac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d064524c-72f2-434d-b00c-b81262e5eac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9970660-ca93-4e4b-a5db-8b096aa567a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d064524c-72f2-434d-b00c-b81262e5eac5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9970660-ca93-4e4b-a5db-8b096aa567a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_0a218abb-9a05-4a1d-a2a0-9429504c01e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9970660-ca93-4e4b-a5db-8b096aa567a1" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_0a218abb-9a05-4a1d-a2a0-9429504c01e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_1d5d8dd7-2cb0-47c2-a8df-00219a82ba00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9970660-ca93-4e4b-a5db-8b096aa567a1" xlink:to="loc_us-gaap_LicensingAgreementsMember_1d5d8dd7-2cb0-47c2-a8df-00219a82ba00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc1ecb63-8c18-456d-9774-6e545d3025b3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6515d6b9-e4e5-4c74-96ff-58bfa047e507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6515d6b9-e4e5-4c74-96ff-58bfa047e507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_95c46a8a-56af-43a5-b5b4-4e002666814e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_95c46a8a-56af-43a5-b5b4-4e002666814e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9248fb4a-cf6a-40dd-bcf6-2f40a5bd38ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9248fb4a-cf6a-40dd-bcf6-2f40a5bd38ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_70adcb3b-597d-47ce-8fad-40e56844d7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_70adcb3b-597d-47ce-8fad-40e56844d7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_636776e9-c2c0-4619-8f2e-f0b68433ca2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_636776e9-c2c0-4619-8f2e-f0b68433ca2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_d2e6227e-a13d-4efc-b77f-0e4274ad48fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_33956a52-fa46-4757-9fe5-ff0aa409bc43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_d2e6227e-a13d-4efc-b77f-0e4274ad48fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9cc15591-4325-4b5a-8a38-fe26f777abbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9cc15591-4325-4b5a-8a38-fe26f777abbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e323568f-74ed-45cf-9e58-da7ecf0b49d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e323568f-74ed-45cf-9e58-da7ecf0b49d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e882a74f-c5a9-477f-b220-1b4a4f21f983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_Goodwill_e882a74f-c5a9-477f-b220-1b4a4f21f983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_d58fd8d1-55d5-4edd-8512-6319cbd1331c" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_d58fd8d1-55d5-4edd-8512-6319cbd1331c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e254cb41-91bb-4759-85fa-a01d44460243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e254cb41-91bb-4759-85fa-a01d44460243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_429dc1aa-282b-4832-942b-b1d74c1f40c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_429dc1aa-282b-4832-942b-b1d74c1f40c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_9f84956d-7a59-4c8e-9ff2-eaa7bb8e985d" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_9f84956d-7a59-4c8e-9ff2-eaa7bb8e985d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_21cdc005-2111-42ef-9334-d405d51f6548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_21cdc005-2111-42ef-9334-d405d51f6548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_0a480bd5-ff4d-4d42-b52e-1067380a7f44" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_0a480bd5-ff4d-4d42-b52e-1067380a7f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_76cc1867-3ee1-440b-b1ac-bc363491df2b" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_76cc1867-3ee1-440b-b1ac-bc363491df2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_8dec58aa-7169-4ba8-b0dc-feef65cbd642" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_8dec58aa-7169-4ba8-b0dc-feef65cbd642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3422b26e-d840-4b32-9bad-72625a120111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d140275a-f97d-40b0-826a-573450b6a001" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3422b26e-d840-4b32-9bad-72625a120111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ceb268d1-2b66-4bc6-b6dd-68285be8c333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ceb268d1-2b66-4bc6-b6dd-68285be8c333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_1447fc4e-d118-4cb9-a4e7-c490ecbb16e8" xlink:href="iart-20211231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_1447fc4e-d118-4cb9-a4e7-c490ecbb16e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d9db1638-5769-45b6-b175-ac44298e0869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d9db1638-5769-45b6-b175-ac44298e0869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_ec8b1e28-67a9-44c8-a763-d3eed480e84c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_ec8b1e28-67a9-44c8-a763-d3eed480e84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_eb1ab5dd-ad4d-4278-9dfc-40d43b2e2aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_eb1ab5dd-ad4d-4278-9dfc-40d43b2e2aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_adf0fc29-776d-432f-b927-c0def896e99e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_adf0fc29-776d-432f-b927-c0def896e99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_529b9640-2fec-4d9a-9ddb-fea718c82144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4a9dc558-b059-4bf8-be9f-d626d8bf7f61" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_529b9640-2fec-4d9a-9ddb-fea718c82144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_639ef590-06cb-485e-9c27-74bd0bf08850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:href="iart-20211231.xsd#iart_ScheduleOfAssetAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_639ef590-06cb-485e-9c27-74bd0bf08850" xlink:to="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_d2062d6d-d8dd-4134-b9dc-5acb2d764ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_AssetAcquisitionAxis_d2062d6d-d8dd-4134-b9dc-5acb2d764ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_f451774f-01ba-4661-804d-7feaa3405a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_d2062d6d-d8dd-4134-b9dc-5acb2d764ab4" xlink:to="loc_us-gaap_AssetAcquisitionDomain_f451774f-01ba-4661-804d-7feaa3405a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember_173e8f9a-7f68-4ee9-9f3f-1bff5cdfd578" xlink:href="iart-20211231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_f451774f-01ba-4661-804d-7feaa3405a01" xlink:to="loc_iart_ReboundTherapeuticsCorporationMember_173e8f9a-7f68-4ee9-9f3f-1bff5cdfd578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntegratedShoulderCollaborationInc.Member_3504ea9e-9554-45b8-9541-bcb715ed746b" xlink:href="iart-20211231.xsd#iart_IntegratedShoulderCollaborationInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_f451774f-01ba-4661-804d-7feaa3405a01" xlink:to="loc_iart_IntegratedShoulderCollaborationInc.Member_3504ea9e-9554-45b8-9541-bcb715ed746b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9a1b7690-72f2-44a9-8678-7638091bdfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9a1b7690-72f2-44a9-8678-7638091bdfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_82eea153-ef60-4f3f-8841-df775a5dd099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9a1b7690-72f2-44a9-8678-7638091bdfa4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_82eea153-ef60-4f3f-8841-df775a5dd099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1f7646cd-54ce-4f32-973b-c2bf9595fbed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_82eea153-ef60-4f3f-8841-df775a5dd099" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1f7646cd-54ce-4f32-973b-c2bf9595fbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f27b617d-ded4-4020-b00a-0e6c7c15a466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f27b617d-ded4-4020-b00a-0e6c7c15a466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9995559d-c34f-42f6-8bd2-d7178a703984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f27b617d-ded4-4020-b00a-0e6c7c15a466" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9995559d-c34f-42f6-8bd2-d7178a703984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_5aa16eac-510e-4e30-8f71-cf24758e9464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9995559d-c34f-42f6-8bd2-d7178a703984" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_5aa16eac-510e-4e30-8f71-cf24758e9464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetMember_b5641953-4927-41b3-9a4b-0475a06a88d7" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9995559d-c34f-42f6-8bd2-d7178a703984" xlink:to="loc_iart_DeferredTaxAssetMember_b5641953-4927-41b3-9a4b-0475a06a88d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c8abf523-2a81-4cdc-83e7-9dad81796f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c8abf523-2a81-4cdc-83e7-9dad81796f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35d1f821-b246-4a15-92c0-f18524de48b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c8abf523-2a81-4cdc-83e7-9dad81796f4e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35d1f821-b246-4a15-92c0-f18524de48b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_6719bf98-f9f9-4f80-9685-e38f9c425e79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35d1f821-b246-4a15-92c0-f18524de48b3" xlink:to="loc_us-gaap_LicensingAgreementsMember_6719bf98-f9f9-4f80-9685-e38f9c425e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6b83e5b4-81a8-4872-bd7c-aaec74126563" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_srt_CounterpartyNameAxis_6b83e5b4-81a8-4872-bd7c-aaec74126563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18e7ae7c-16eb-486c-9e60-938229c94c0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_6b83e5b4-81a8-4872-bd7c-aaec74126563" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18e7ae7c-16eb-486c-9e60-938229c94c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_ec952eff-5846-45a7-845b-8133e6b07412" xlink:href="iart-20211231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18e7ae7c-16eb-486c-9e60-938229c94c0c" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_ec952eff-5846-45a7-845b-8133e6b07412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_22bba6dc-a12c-42e6-a595-0c525755665e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_22bba6dc-a12c-42e6-a595-0c525755665e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a1cc8d8c-7e9f-4565-9a3e-9a2757d3a717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_22bba6dc-a12c-42e6-a595-0c525755665e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a1cc8d8c-7e9f-4565-9a3e-9a2757d3a717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_32e3b6ef-fcfb-4bcc-8869-9b28a575acfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_a1cc8d8c-7e9f-4565-9a3e-9a2757d3a717" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_32e3b6ef-fcfb-4bcc-8869-9b28a575acfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0b0d69ed-1765-466c-aa5e-fe9e59e44c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0b0d69ed-1765-466c-aa5e-fe9e59e44c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a7b7b582-b24a-4446-959a-8f10acae8f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0b0d69ed-1765-466c-aa5e-fe9e59e44c5a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a7b7b582-b24a-4446-959a-8f10acae8f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_ed550b4b-ed3d-43d7-87e3-3bd34aeb1f2f" xlink:href="iart-20211231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a7b7b582-b24a-4446-959a-8f10acae8f0c" xlink:to="loc_iart_SmithNephewUSDLimitedMember_ed550b4b-ed3d-43d7-87e3-3bd34aeb1f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:href="iart-20211231.xsd#iart_ScheduleOfAssetAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_455c363e-0c2a-47d2-bb54-98c86480d38a" xlink:to="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_fcfcb568-7f5f-429e-9569-1b75228d4775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_fcfcb568-7f5f-429e-9569-1b75228d4775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_8dcdd760-c7b5-409d-b953-87693d0ba266" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_8dcdd760-c7b5-409d-b953-87693d0ba266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionNumberOfAssetsAcquired_bfd08dbc-4aa7-4303-85a4-ba9ef4614f0f" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionNumberOfAssetsAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionNumberOfAssetsAcquired_bfd08dbc-4aa7-4303-85a4-ba9ef4614f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_4182c42d-b64a-4be1-92da-cd9bb220e8d5" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_4182c42d-b64a-4be1-92da-cd9bb220e8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_ef0bf95d-8231-47ab-9aec-97712b2d7b6b" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_ef0bf95d-8231-47ab-9aec-97712b2d7b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_acd7cc52-dd0e-4d16-827e-9d3eee793149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_acd7cc52-dd0e-4d16-827e-9d3eee793149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d7841896-b958-4b71-936c-be9abeb7625e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d7841896-b958-4b71-936c-be9abeb7625e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_e72de53d-f966-460a-9d28-9fa2e8b8740b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_e72de53d-f966-460a-9d28-9fa2e8b8740b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_b97a7cc8-12e2-4d08-9669-18740d11c62f" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_b97a7cc8-12e2-4d08-9669-18740d11c62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_95ffbcbb-dd6c-4af1-8bc5-900e15b8f7dd" xlink:href="iart-20211231.xsd#iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_95ffbcbb-dd6c-4af1-8bc5-900e15b8f7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_79c5ff25-b1e7-4e62-8c08-8c69d46dba19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_79c5ff25-b1e7-4e62-8c08-8c69d46dba19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_cbb2994d-5733-4809-8dc3-f7889c277d30" xlink:href="iart-20211231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_27112abc-50ed-4465-837e-45e55ad04d2c" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_cbb2994d-5733-4809-8dc3-f7889c277d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBT" xlink:type="simple" xlink:href="iart-20211231.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_953a0416-e30b-4947-bb27-ba6ff32531bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7791e58f-a12e-48a1-aad5-196fd67f06c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_953a0416-e30b-4947-bb27-ba6ff32531bc" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7791e58f-a12e-48a1-aad5-196fd67f06c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTTables" xlink:type="simple" xlink:href="iart-20211231.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f08e9fbd-76fe-4ef7-bd3b-8f483a1cce51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_b60e5736-a2b2-4240-8b24-27c12953616f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f08e9fbd-76fe-4ef7-bd3b-8f483a1cce51" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_b60e5736-a2b2-4240-8b24-27c12953616f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fdc9ed14-a8c0-4612-a071-1bbafcf1558b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f08e9fbd-76fe-4ef7-bd3b-8f483a1cce51" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fdc9ed14-a8c0-4612-a071-1bbafcf1558b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0f08d8a0-e598-410e-8282-fc79045d93aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0f08d8a0-e598-410e-8282-fc79045d93aa" xlink:to="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c207b500-367b-4822-8e45-8b60eaa31359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_DebtInstrumentAxis_c207b500-367b-4822-8e45-8b60eaa31359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8c8e1b5a-ba9d-4409-a6ef-c8e0fccafae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c207b500-367b-4822-8e45-8b60eaa31359" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8c8e1b5a-ba9d-4409-a6ef-c8e0fccafae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_3646b2be-2ebe-4520-94eb-eff2c7c89286" xlink:href="iart-20211231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c8e1b5a-ba9d-4409-a6ef-c8e0fccafae3" xlink:to="loc_iart_SeniorCreditFacilityMember_3646b2be-2ebe-4520-94eb-eff2c7c89286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember_c7d9454b-f3db-4049-a703-74cd698d07ac" xlink:href="iart-20211231.xsd#iart_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c8e1b5a-ba9d-4409-a6ef-c8e0fccafae3" xlink:to="loc_iart_TermLoanFacilityMember_c7d9454b-f3db-4049-a703-74cd698d07ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_c5155ed0-c006-4007-b3be-b9bec286a3cd" xlink:href="iart-20211231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c8e1b5a-ba9d-4409-a6ef-c8e0fccafae3" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_c5155ed0-c006-4007-b3be-b9bec286a3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b093a6f6-d189-4144-9019-95e2a420c4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_CreditFacilityAxis_b093a6f6-d189-4144-9019-95e2a420c4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b093a6f6-d189-4144-9019-95e2a420c4c1" xlink:to="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_6db2315f-1e94-47a0-8e40-d137a19dd9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:to="loc_us-gaap_SecuredDebtMember_6db2315f-1e94-47a0-8e40-d137a19dd9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_27416574-eb0a-4c76-8268-4f27e664f8be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_27416574-eb0a-4c76-8268-4f27e664f8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_c0162bff-0d29-42dc-ae98-fbc389a89352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_c0162bff-0d29-42dc-ae98-fbc389a89352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember_89b3ab5a-8e36-4522-9579-3848c94f77ce" xlink:href="iart-20211231.xsd#iart_SwinglineLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0e6cb38c-f019-43e9-9182-dfa4f23aa7bf" xlink:to="loc_iart_SwinglineLoanMember_89b3ab5a-8e36-4522-9579-3848c94f77ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_09a9c7eb-36a2-4f80-b031-4ff97ca42ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_VariableRateAxis_09a9c7eb-36a2-4f80-b031-4ff97ca42ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_adaa4893-9662-4196-aa5a-5d9404c61b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_09a9c7eb-36a2-4f80-b031-4ff97ca42ed6" xlink:to="loc_us-gaap_VariableRateDomain_adaa4893-9662-4196-aa5a-5d9404c61b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_b7c9bd6a-0ddc-49e4-b26f-29341734c59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_adaa4893-9662-4196-aa5a-5d9404c61b26" xlink:to="loc_us-gaap_EurodollarMember_b7c9bd6a-0ddc-49e4-b26f-29341734c59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_13c956e2-510d-4496-8df5-96761a553705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_adaa4893-9662-4196-aa5a-5d9404c61b26" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_13c956e2-510d-4496-8df5-96761a553705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthEurodollarRateMember_75940773-f716-4c08-9cfd-c7e07d482a2b" xlink:href="iart-20211231.xsd#iart_OneMonthEurodollarRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_adaa4893-9662-4196-aa5a-5d9404c61b26" xlink:to="loc_iart_OneMonthEurodollarRateMember_75940773-f716-4c08-9cfd-c7e07d482a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fd04ee33-ff2b-4222-aa86-45234c2ed08d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_srt_RangeAxis_fd04ee33-ff2b-4222-aa86-45234c2ed08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8f341c60-d888-4822-ad9c-ff5a661fe817" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fd04ee33-ff2b-4222-aa86-45234c2ed08d" xlink:to="loc_srt_RangeMember_8f341c60-d888-4822-ad9c-ff5a661fe817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_576e98fd-bd98-4c1a-94f9-4c91361a9efa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8f341c60-d888-4822-ad9c-ff5a661fe817" xlink:to="loc_srt_MinimumMember_576e98fd-bd98-4c1a-94f9-4c91361a9efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_479cf736-7d47-4f49-9c4a-c5c60f8065cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8f341c60-d888-4822-ad9c-ff5a661fe817" xlink:to="loc_srt_MaximumMember_479cf736-7d47-4f49-9c4a-c5c60f8065cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7ace7db5-6bbb-4512-a309-3532d88be20e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7ace7db5-6bbb-4512-a309-3532d88be20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_491a3d20-2612-4d76-84ea-6223ed03b921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7ace7db5-6bbb-4512-a309-3532d88be20e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_491a3d20-2612-4d76-84ea-6223ed03b921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b4c4881c-a774-48c1-b382-a00c578bd2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_491a3d20-2612-4d76-84ea-6223ed03b921" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b4c4881c-a774-48c1-b382-a00c578bd2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a8d58fca-703e-4318-9d76-3b68e88796e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a8d58fca-703e-4318-9d76-3b68e88796e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86d67c25-d720-42f1-af7e-140ca1e5b19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a8d58fca-703e-4318-9d76-3b68e88796e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86d67c25-d720-42f1-af7e-140ca1e5b19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_ab3591e2-138e-4469-9302-c344284e3bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86d67c25-d720-42f1-af7e-140ca1e5b19e" xlink:to="loc_us-gaap_ConvertibleDebtMember_ab3591e2-138e-4469-9302-c344284e3bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cf6e08ab-568a-4f00-8426-849d24eab17d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cf6e08ab-568a-4f00-8426-849d24eab17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_2923b4aa-c2cf-42fe-b228-cb020b780452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cf6e08ab-568a-4f00-8426-849d24eab17d" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_2923b4aa-c2cf-42fe-b228-cb020b780452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_833b2b38-085b-4853-9461-225081fbbfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_2923b4aa-c2cf-42fe-b228-cb020b780452" xlink:to="loc_us-gaap_CallOptionMember_833b2b38-085b-4853-9461-225081fbbfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4b34707-3779-4c1e-bf28-9f74589702e1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f2d2c356-b4ae-42e8-b517-d2214f470e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f2d2c356-b4ae-42e8-b517-d2214f470e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_47271a0b-51e7-41f5-8542-0347ffe39cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_47271a0b-51e7-41f5-8542-0347ffe39cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_48087ae1-9562-4650-9abf-349342dae4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_48087ae1-9562-4650-9abf-349342dae4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_8d024dc8-15b1-44e9-9200-b0e65899aaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_8d024dc8-15b1-44e9-9200-b0e65899aaa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_462707d2-b701-4f2f-bb6d-ed29268a8f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_462707d2-b701-4f2f-bb6d-ed29268a8f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_5ea6469b-686c-40e7-a26e-af694fb8f0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_5ea6469b-686c-40e7-a26e-af694fb8f0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_92392aa7-1637-44d0-9d9b-3a47faf98f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_LineOfCredit_92392aa7-1637-44d0-9d9b-3a47faf98f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_1d1f2a1c-f29d-4e84-992e-69260f822ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_1d1f2a1c-f29d-4e84-992e-69260f822ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_1c924b84-83ad-4ad3-bcca-76441608f920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_SecuredDebtCurrent_1c924b84-83ad-4ad3-bcca-76441608f920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_7e2cc076-c331-46d1-96d6-59fabcba33cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_7e2cc076-c331-46d1-96d6-59fabcba33cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_94d8c058-84b3-4718-8081-ae71ae8879ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_94d8c058-84b3-4718-8081-ae71ae8879ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearOne_b0b1d605-cbbe-4892-a7d1-10a4380ded36" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearOne"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_InterestPaymentsYearOne_b0b1d605-cbbe-4892-a7d1-10a4380ded36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearTwo_723723c4-1e68-406d-9374-e13ec382b8bd" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearTwo"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_InterestPaymentsYearTwo_723723c4-1e68-406d-9374-e13ec382b8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearThree_c3b6fd32-a079-4a07-9a5e-018e506a4343" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearThree"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_InterestPaymentsYearThree_c3b6fd32-a079-4a07-9a5e-018e506a4343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearFour_e1d796e3-2546-4594-949b-38e168448c2c" xlink:href="iart-20211231.xsd#iart_InterestPaymentsYearFour"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_InterestPaymentsYearFour_e1d796e3-2546-4594-949b-38e168448c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4a47d676-5af1-4f90-8b92-01076bc4849d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4a47d676-5af1-4f90-8b92-01076bc4849d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a703257c-4a1c-4989-b745-d4954073b654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a703257c-4a1c-4989-b745-d4954073b654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_4da03e60-eca3-4150-99cf-ec88240b2723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_4da03e60-eca3-4150-99cf-ec88240b2723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_092704a6-1057-48ba-b644-98dc33abfcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_092704a6-1057-48ba-b644-98dc33abfcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ff3264ed-2311-4e80-8eac-27c94d6388f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ff3264ed-2311-4e80-8eac-27c94d6388f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_091e9fcb-21b5-44a4-9839-f42be751fcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_091e9fcb-21b5-44a4-9839-f42be751fcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_665fcd12-257a-4a13-a60d-29df1f08847b" xlink:href="iart-20211231.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_665fcd12-257a-4a13-a60d-29df1f08847b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_72190682-8e50-4a31-9cab-c01776d16145" xlink:href="iart-20211231.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_72190682-8e50-4a31-9cab-c01776d16145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_67726b9f-9f7d-4ef6-9ea3-f789a43caf6b" xlink:href="iart-20211231.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_67726b9f-9f7d-4ef6-9ea3-f789a43caf6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_47c971f8-21cf-496a-b7bf-dad294f874b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_47c971f8-21cf-496a-b7bf-dad294f874b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_9ceffb90-65c7-4359-a331-2bb6783e40ec" xlink:href="iart-20211231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_9ceffb90-65c7-4359-a331-2bb6783e40ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_b3358a1b-a535-428d-8ce3-8f047b1f2597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_b3358a1b-a535-428d-8ce3-8f047b1f2597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_f857b9ae-ec8b-49a0-a815-775e4ecd5b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_f857b9ae-ec8b-49a0-a815-775e4ecd5b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5df82749-20b0-430e-b332-79c09c222036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5df82749-20b0-430e-b332-79c09c222036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_1e72a744-92be-4037-ac25-322afa13aa68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_1e72a744-92be-4037-ac25-322afa13aa68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_f7455c62-d10f-4c29-b22a-4ad39d7d595a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_f7455c62-d10f-4c29-b22a-4ad39d7d595a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_843af695-a3b5-42b2-bd5a-2ae82990dfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_DebtInstrumentFairValue_843af695-a3b5-42b2-bd5a-2ae82990dfa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_f1f57756-d511-4d11-b0ce-e0d795ae7e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_f1f57756-d511-4d11-b0ce-e0d795ae7e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_06cc14ac-12b9-4036-bd94-b16b78f8172f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_06cc14ac-12b9-4036-bd94-b16b78f8172f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_e6fef4d3-6ac6-443b-acfe-88d4787b4f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_us-gaap_InterestExpenseDebt_e6fef4d3-6ac6-443b-acfe-88d4787b4f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_ad92563e-269a-4568-95a9-abc60e76d892" xlink:href="iart-20211231.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_ad92563e-269a-4568-95a9-abc60e76d892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgram_3ad13c32-8404-462c-8120-745fd69e7e26" xlink:href="iart-20211231.xsd#iart_SecuredLongTermDebtSecuritizationProgram"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgram_3ad13c32-8404-462c-8120-745fd69e7e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_5c908b87-5f0f-42ad-89cf-8546106deca4" xlink:href="iart-20211231.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_5c908b87-5f0f-42ad-89cf-8546106deca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_86c60cef-d88f-4fc0-a580-3f8d53e82eb2" xlink:href="iart-20211231.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a613a3b9-a14a-4375-b0f0-a5bf9dcf8836" xlink:to="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_86c60cef-d88f-4fc0-a580-3f8d53e82eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DEBTMaximumTotalLeverageRatioTableDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2a76e2a2-c44f-4911-bddf-67e761bca567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a93e6266-9a89-40be-9b21-02f5ff26f748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2a76e2a2-c44f-4911-bddf-67e761bca567" xlink:to="loc_us-gaap_DebtInstrumentTable_a93e6266-9a89-40be-9b21-02f5ff26f748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_74a8c48a-d0a3-4d17-a2c3-e39853602951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a93e6266-9a89-40be-9b21-02f5ff26f748" xlink:to="loc_us-gaap_DebtInstrumentAxis_74a8c48a-d0a3-4d17-a2c3-e39853602951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6077aa6f-5c11-44df-807c-c6fd6d40f5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_74a8c48a-d0a3-4d17-a2c3-e39853602951" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6077aa6f-5c11-44df-807c-c6fd6d40f5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_717acc50-6646-478f-a979-9d0229a7f872" xlink:href="iart-20211231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6077aa6f-5c11-44df-807c-c6fd6d40f5c5" xlink:to="loc_iart_SeniorCreditFacilityMember_717acc50-6646-478f-a979-9d0229a7f872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis_86577815-caaf-4391-afc2-425b09736968" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a93e6266-9a89-40be-9b21-02f5ff26f748" xlink:to="loc_iart_DebtCovenantPeriodAxis_86577815-caaf-4391-afc2-425b09736968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodAxis_86577815-caaf-4391-afc2-425b09736968" xlink:to="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod1Member_99fa67d8-448d-4ec8-81b7-b1d25888dc55" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:to="loc_iart_DebtCovenantPeriod1Member_99fa67d8-448d-4ec8-81b7-b1d25888dc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod2Member_8570d43a-994b-4480-80ff-a38855c7b957" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:to="loc_iart_DebtCovenantPeriod2Member_8570d43a-994b-4480-80ff-a38855c7b957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member_76f673ff-86f9-4153-8622-c9f2cd11d367" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:to="loc_iart_DebtCovenantPeriod3Member_76f673ff-86f9-4153-8622-c9f2cd11d367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod4Member_ee9b4f81-a954-45d1-a481-70f9ea80a6e6" xlink:href="iart-20211231.xsd#iart_DebtCovenantPeriod4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_64daa432-db8c-4f55-98ec-ee40aaf37e7d" xlink:to="loc_iart_DebtCovenantPeriod4Member_ee9b4f81-a954-45d1-a481-70f9ea80a6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0736530f-829c-4207-b466-d3b4359a463a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a93e6266-9a89-40be-9b21-02f5ff26f748" xlink:to="loc_us-gaap_DebtInstrumentLineItems_0736530f-829c-4207-b466-d3b4359a463a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_66acef6b-0ca0-4ee9-8a22-10a4db9439d0" xlink:href="iart-20211231.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0736530f-829c-4207-b466-d3b4359a463a" xlink:to="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_66acef6b-0ca0-4ee9-8a22-10a4db9439d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DEBTScheduleofDebtMaturityDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c12b33b2-44cd-4de8-a3eb-b662b361c511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_cd93bdd0-e52d-4d73-a99e-9e69f6744dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c12b33b2-44cd-4de8-a3eb-b662b361c511" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_cd93bdd0-e52d-4d73-a99e-9e69f6744dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b3eb1a5d-a559-4ef2-8e60-094275ee359d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c12b33b2-44cd-4de8-a3eb-b662b361c511" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b3eb1a5d-a559-4ef2-8e60-094275ee359d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0cf5d552-044f-4f84-83bc-386661b389ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c12b33b2-44cd-4de8-a3eb-b662b361c511" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0cf5d552-044f-4f84-83bc-386661b389ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_03031549-2b6f-49ee-b3a9-afbd0af2a849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c12b33b2-44cd-4de8-a3eb-b662b361c511" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_03031549-2b6f-49ee-b3a9-afbd0af2a849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6b9b4b60-2f3b-40bb-b1f7-c825751641cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c12b33b2-44cd-4de8-a3eb-b662b361c511" xlink:to="loc_us-gaap_LongTermDebt_6b9b4b60-2f3b-40bb-b1f7-c825751641cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d8c1a7ea-6d4f-467f-a3ec-85cfa1f78f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ae310e2f-7e7d-4df0-8e0e-886645c3f7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d8c1a7ea-6d4f-467f-a3ec-85cfa1f78f49" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ae310e2f-7e7d-4df0-8e0e-886645c3f7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ad5ed86-9e8c-4d2b-851b-f6b99c1b9b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_4a32c6e3-a952-45c2-adc9-f5fa2b5a9be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ad5ed86-9e8c-4d2b-851b-f6b99c1b9b9a" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_4a32c6e3-a952-45c2-adc9-f5fa2b5a9be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_b44af30d-bfbd-49f1-b37d-f7622ebb05c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ad5ed86-9e8c-4d2b-851b-f6b99c1b9b9a" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_b44af30d-bfbd-49f1-b37d-f7622ebb05c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_97535a9d-4462-4bf8-9f9e-a05db0d79549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ad5ed86-9e8c-4d2b-851b-f6b99c1b9b9a" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_97535a9d-4462-4bf8-9f9e-a05db0d79549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d7078b8f-acf8-4e0b-95d2-8044cb6e9a77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d7078b8f-acf8-4e0b-95d2-8044cb6e9a77" xlink:to="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fc7696a8-7f1a-4ea8-9dfc-fe064028f77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fc7696a8-7f1a-4ea8-9dfc-fe064028f77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2c27dd80-3a01-4f63-86f4-3d1410cab9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fc7696a8-7f1a-4ea8-9dfc-fe064028f77c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2c27dd80-3a01-4f63-86f4-3d1410cab9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_edabf002-8d9f-48c0-82af-69817cbe99fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2c27dd80-3a01-4f63-86f4-3d1410cab9cd" xlink:to="loc_us-gaap_CashFlowHedgingMember_edabf002-8d9f-48c0-82af-69817cbe99fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_bf47d98b-1542-4bf5-bb90-b1d2915af03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:to="loc_us-gaap_HedgingDesignationAxis_bf47d98b-1542-4bf5-bb90-b1d2915af03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_39e5feaa-d54e-4b30-9875-2cdcc0e65c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_bf47d98b-1542-4bf5-bb90-b1d2915af03c" xlink:to="loc_us-gaap_HedgingDesignationDomain_39e5feaa-d54e-4b30-9875-2cdcc0e65c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_989f510d-3852-4690-b1e2-002551bee8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_39e5feaa-d54e-4b30-9875-2cdcc0e65c9b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_989f510d-3852-4690-b1e2-002551bee8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9115e4eb-2e71-49aa-9f5c-6f4e2eaaf4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:to="loc_us-gaap_VariableRateAxis_9115e4eb-2e71-49aa-9f5c-6f4e2eaaf4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_21e22cf4-b772-4261-8d41-ba24df6de0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_9115e4eb-2e71-49aa-9f5c-6f4e2eaaf4ac" xlink:to="loc_us-gaap_VariableRateDomain_21e22cf4-b772-4261-8d41-ba24df6de0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthUSDLIBORMember_4bc5a4c0-1fc5-4092-829e-ef0077fc6956" xlink:href="iart-20211231.xsd#iart_OneMonthUSDLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_21e22cf4-b772-4261-8d41-ba24df6de0de" xlink:to="loc_iart_OneMonthUSDLIBORMember_4bc5a4c0-1fc5-4092-829e-ef0077fc6956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_401bce25-7bc0-4699-852f-29de6486bdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_401bce25-7bc0-4699-852f-29de6486bdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_401bce25-7bc0-4699-852f-29de6486bdb3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedMarch272017Member_26a281f8-a992-47d8-8a54-d497e5601f04" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedMarch272017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedMarch272017Member_26a281f8-a992-47d8-8a54-d497e5601f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_0b115f70-2472-4bab-8de8-11cc19625679" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_0b115f70-2472-4bab-8de8-11cc19625679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_d66a4377-237c-48eb-88c2-3dfb4f755ef9" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_d66a4377-237c-48eb-88c2-3dfb4f755ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_d5c7ff1d-3bc0-49b8-be74-32b6f7d32cde" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_d5c7ff1d-3bc0-49b8-be74-32b6f7d32cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_8690e5a8-3f01-4f54-a9a1-d65f5ad76539" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_8690e5a8-3f01-4f54-a9a1-d65f5ad76539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_c93f5584-f9cc-4873-a916-bd60c30c571f" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_c93f5584-f9cc-4873-a916-bd60c30c571f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_2de6b036-9ade-40fd-814a-b657f09fd88d" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_2de6b036-9ade-40fd-814a-b657f09fd88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_f5fde828-9985-4ea7-a07a-190d7e4e0f98" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_f5fde828-9985-4ea7-a07a-190d7e4e0f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_f5e4a1e6-f11d-4382-8f6b-4170174d182b" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_f5e4a1e6-f11d-4382-8f6b-4170174d182b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_57b8ad61-3be1-450e-a964-ef9acddcb3e6" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_57b8ad61-3be1-450e-a964-ef9acddcb3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_14e26098-5430-4f22-afed-c1ad909446ef" xlink:href="iart-20211231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7213f9ff-7e9e-4d0d-b6e9-30ba289f2e6c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_14e26098-5430-4f22-afed-c1ad909446ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_42a87839-d2a1-4dfd-98aa-af6f53eabda9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_869004f5-5846-403f-b7e2-df2ab49d0395" xlink:to="loc_us-gaap_DerivativeLineItems_42a87839-d2a1-4dfd-98aa-af6f53eabda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f0fe9948-7845-48fe-a3b7-f13e54ccd00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_42a87839-d2a1-4dfd-98aa-af6f53eabda9" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f0fe9948-7845-48fe-a3b7-f13e54ccd00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_3622484b-ff21-4bf7-b8fc-bff93d716632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_42a87839-d2a1-4dfd-98aa-af6f53eabda9" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_3622484b-ff21-4bf7-b8fc-bff93d716632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_0aea4bda-2895-4479-87d7-aa7e8887a36a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_42a87839-d2a1-4dfd-98aa-af6f53eabda9" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_0aea4bda-2895-4479-87d7-aa7e8887a36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_83e91720-eed0-4c29-813f-bcc568a85583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_83e91720-eed0-4c29-813f-bcc568a85583" xlink:to="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ab7ed51b-57fd-4081-a542-1a919af24406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ab7ed51b-57fd-4081-a542-1a919af24406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5abaa87d-84f8-4737-a860-3b91656f3829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ab7ed51b-57fd-4081-a542-1a919af24406" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5abaa87d-84f8-4737-a860-3b91656f3829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f419f3bb-9fd8-425f-87f1-5cd8c393f4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5abaa87d-84f8-4737-a860-3b91656f3829" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f419f3bb-9fd8-425f-87f1-5cd8c393f4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_d1c20354-31b6-47b2-b007-3ff4f17a0e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5abaa87d-84f8-4737-a860-3b91656f3829" xlink:to="loc_us-gaap_CurrencySwapMember_d1c20354-31b6-47b2-b007-3ff4f17a0e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_a4f1cc05-5d92-487f-b8f8-1ce9b55d839c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5abaa87d-84f8-4737-a860-3b91656f3829" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_a4f1cc05-5d92-487f-b8f8-1ce9b55d839c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_60d98f37-9502-41cb-8453-dcc08fdc97fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:to="loc_us-gaap_PositionAxis_60d98f37-9502-41cb-8453-dcc08fdc97fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_c9db24c2-c459-4b32-9d3c-6fb9ee0146cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_60d98f37-9502-41cb-8453-dcc08fdc97fc" xlink:to="loc_us-gaap_PositionDomain_c9db24c2-c459-4b32-9d3c-6fb9ee0146cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_75920bd4-3385-4100-9cf5-2efe744af308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_c9db24c2-c459-4b32-9d3c-6fb9ee0146cf" xlink:to="loc_us-gaap_ShortMember_75920bd4-3385-4100-9cf5-2efe744af308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_03b1e7ce-0884-492e-93b5-6734349c67f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_c9db24c2-c459-4b32-9d3c-6fb9ee0146cf" xlink:to="loc_us-gaap_LongMember_03b1e7ce-0884-492e-93b5-6734349c67f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0acdbb18-42c4-46e1-8322-cf40520c1ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0acdbb18-42c4-46e1-8322-cf40520c1ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4ab3d07e-513e-4afe-83c6-f542a7605df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0acdbb18-42c4-46e1-8322-cf40520c1ee1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4ab3d07e-513e-4afe-83c6-f542a7605df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_408d6d28-28f7-4c41-8782-2858f1c9feb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4ab3d07e-513e-4afe-83c6-f542a7605df3" xlink:to="loc_us-gaap_CashFlowHedgingMember_408d6d28-28f7-4c41-8782-2858f1c9feb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_922fa33e-585b-48f9-9992-0eafa4f786ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4ab3d07e-513e-4afe-83c6-f542a7605df3" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_922fa33e-585b-48f9-9992-0eafa4f786ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2e7bd765-dc47-4f79-986f-8cbda624d507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:to="loc_us-gaap_HedgingDesignationAxis_2e7bd765-dc47-4f79-986f-8cbda624d507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_19739dcb-b7bc-4e3b-8ae2-7b4f19bb2606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_2e7bd765-dc47-4f79-986f-8cbda624d507" xlink:to="loc_us-gaap_HedgingDesignationDomain_19739dcb-b7bc-4e3b-8ae2-7b4f19bb2606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_444b2f66-cd1a-4883-9b17-99d6d8bf6af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_19739dcb-b7bc-4e3b-8ae2-7b4f19bb2606" xlink:to="loc_us-gaap_NondesignatedMember_444b2f66-cd1a-4883-9b17-99d6d8bf6af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_99c621fd-5b1a-46ea-9da7-169d2d48c983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_19739dcb-b7bc-4e3b-8ae2-7b4f19bb2606" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_99c621fd-5b1a-46ea-9da7-169d2d48c983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f92f8e83-6332-4936-8bd7-e5d165fa8a8c" xlink:to="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2aa16871-63ab-48bb-926d-6bf115541205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2aa16871-63ab-48bb-926d-6bf115541205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_54d59c31-c1b0-4ff0-94b9-c47a02e11903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_54d59c31-c1b0-4ff0-94b9-c47a02e11903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e5d13b8-e052-43d7-97ee-4e21955ec2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e5d13b8-e052-43d7-97ee-4e21955ec2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntercompanyLoanQuarterlyPayment_2a9487dd-3565-4027-93e8-f2204ef99061" xlink:href="iart-20211231.xsd#iart_IntercompanyLoanQuarterlyPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_iart_IntercompanyLoanQuarterlyPayment_2a9487dd-3565-4027-93e8-f2204ef99061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_d758a52d-491c-459c-8974-1363639b5472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_d758a52d-491c-459c-8974-1363639b5472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a5a92a2b-05dc-4ab0-bcaf-e7c70229564c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a5a92a2b-05dc-4ab0-bcaf-e7c70229564c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_1a783d61-fbdf-4181-bd6e-60eaf07a7265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_1a783d61-fbdf-4181-bd6e-60eaf07a7265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_fd88accc-88be-4e00-a413-f8402f76aae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_298e3184-ff03-408f-ab99-540a31c5c281" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_fd88accc-88be-4e00-a413-f8402f76aae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4437c453-be15-4739-bc30-5a3a8076dbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4437c453-be15-4739-bc30-5a3a8076dbfb" xlink:to="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6bd51b6b-803e-4fef-bc33-fecbb085940c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6bd51b6b-803e-4fef-bc33-fecbb085940c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b438dbb8-5e97-43b8-8720-77ae06a51ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6bd51b6b-803e-4fef-bc33-fecbb085940c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b438dbb8-5e97-43b8-8720-77ae06a51ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_b94e5198-c850-4de0-afed-0a14f66d96bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b438dbb8-5e97-43b8-8720-77ae06a51ba4" xlink:to="loc_us-gaap_CashFlowHedgingMember_b94e5198-c850-4de0-afed-0a14f66d96bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ef56e679-c426-4c41-95f0-53f82476f2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:to="loc_us-gaap_HedgingDesignationAxis_ef56e679-c426-4c41-95f0-53f82476f2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b6e492c8-6d17-4757-8848-6a061f89a0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_ef56e679-c426-4c41-95f0-53f82476f2d1" xlink:to="loc_us-gaap_HedgingDesignationDomain_b6e492c8-6d17-4757-8848-6a061f89a0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3e766727-9c20-46d9-a09a-bc2a0313b9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b6e492c8-6d17-4757-8848-6a061f89a0fe" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3e766727-9c20-46d9-a09a-bc2a0313b9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c541dbd9-a6dd-447e-9aed-021ad2af2fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c541dbd9-a6dd-447e-9aed-021ad2af2fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c541dbd9-a6dd-447e-9aed-021ad2af2fca" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractOneMember_eaae25dc-2535-429e-a763-da7d3fa384fa" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateSwapContractOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractOneMember_eaae25dc-2535-429e-a763-da7d3fa384fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember_89fa6f4c-b331-4e89-a050-dfc6ae919e72" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateSwapContractTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember_89fa6f4c-b331-4e89-a050-dfc6ae919e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember_8b85b945-f573-4e00-bf83-f1a0e95e3fdf" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateSwapContractThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember_8b85b945-f573-4e00-bf83-f1a0e95e3fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_d1bc7f04-843f-4e22-9659-9242b4d47e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_76ffd077-9512-481c-bd89-92884881f2cc" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_d1bc7f04-843f-4e22-9659-9242b4d47e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_5c8aac7c-5822-4413-915b-1ce7e6831117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:to="loc_us-gaap_PositionAxis_5c8aac7c-5822-4413-915b-1ce7e6831117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_c44b26be-a9cd-4229-b209-86e0ae2c5b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_5c8aac7c-5822-4413-915b-1ce7e6831117" xlink:to="loc_us-gaap_PositionDomain_c44b26be-a9cd-4229-b209-86e0ae2c5b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_b4c871fb-43ae-4cd3-acb9-a36aa260926d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_c44b26be-a9cd-4229-b209-86e0ae2c5b7a" xlink:to="loc_us-gaap_LongMember_b4c871fb-43ae-4cd3-acb9-a36aa260926d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_a9e5185d-ac76-4086-acd3-4132b5c0dd08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_c44b26be-a9cd-4229-b209-86e0ae2c5b7a" xlink:to="loc_us-gaap_ShortMember_a9e5185d-ac76-4086-acd3-4132b5c0dd08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4c0b0832-f256-4e1a-938a-b8bbff091dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cb7739c2-660c-4f53-bf0c-f650933415e3" xlink:to="loc_us-gaap_DerivativeLineItems_4c0b0832-f256-4e1a-938a-b8bbff091dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_d19fda4d-9b84-45a9-9adb-08e6f7522a02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4c0b0832-f256-4e1a-938a-b8bbff091dc1" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_d19fda4d-9b84-45a9-9adb-08e6f7522a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_37fdc9ef-78ed-4f49-a3a6-e3fe996f40bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4c0b0832-f256-4e1a-938a-b8bbff091dc1" xlink:to="loc_us-gaap_DerivativeNotionalAmount_37fdc9ef-78ed-4f49-a3a6-e3fe996f40bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_71df10af-a9bd-4d94-91a9-7b57895bbf28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4c0b0832-f256-4e1a-938a-b8bbff091dc1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_71df10af-a9bd-4d94-91a9-7b57895bbf28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7e118106-c36a-4432-afeb-4e0380d5ca0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7e118106-c36a-4432-afeb-4e0380d5ca0b" xlink:to="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06ab946c-a583-4fa2-a578-5c37780380c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06ab946c-a583-4fa2-a578-5c37780380c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ea427c18-7981-4ced-8cde-d40b66188cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06ab946c-a583-4fa2-a578-5c37780380c7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ea427c18-7981-4ced-8cde-d40b66188cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6de0d536-571e-44a7-92fa-fb2ec6c152cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ea427c18-7981-4ced-8cde-d40b66188cec" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6de0d536-571e-44a7-92fa-fb2ec6c152cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_71f24ad6-50f3-4474-b0af-f90a9ef3309c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:to="loc_us-gaap_HedgingDesignationAxis_71f24ad6-50f3-4474-b0af-f90a9ef3309c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_24345d88-cc85-4590-8196-0922f07fb9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_71f24ad6-50f3-4474-b0af-f90a9ef3309c" xlink:to="loc_us-gaap_HedgingDesignationDomain_24345d88-cc85-4590-8196-0922f07fb9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3d6c3a9c-3e29-4e4c-95e0-6d488a53d4da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_24345d88-cc85-4590-8196-0922f07fb9b9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3d6c3a9c-3e29-4e4c-95e0-6d488a53d4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9cacabfa-815f-4305-bfa4-002e46f85a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9cacabfa-815f-4305-bfa4-002e46f85a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9cacabfa-815f-4305-bfa4-002e46f85a9d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember_587a3604-265a-4a9a-9da6-45a5a0961a37" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:to="loc_iart_CrossCurrencyInterestRateContractOneMember_587a3604-265a-4a9a-9da6-45a5a0961a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember_ba165690-e6b4-4b56-9669-9d88bcc93f2b" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:to="loc_iart_CrossCurrencyInterestRateContractTwoMember_ba165690-e6b4-4b56-9669-9d88bcc93f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember_3b966e95-6e53-4b1c-a7bd-9d9dbf5aa71d" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:to="loc_iart_CrossCurrencyInterestRateContractThreeMember_3b966e95-6e53-4b1c-a7bd-9d9dbf5aa71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFourMember_dc0f3c05-18ee-4e6e-b30d-42c737a3c8eb" xlink:href="iart-20211231.xsd#iart_CrossCurrencyInterestRateContractFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:to="loc_iart_CrossCurrencyInterestRateContractFourMember_dc0f3c05-18ee-4e6e-b30d-42c737a3c8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_aece10e0-96a8-4625-91eb-68b6cfcdb979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a98469c3-83de-49eb-b0f7-740ac0a8ad00" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_aece10e0-96a8-4625-91eb-68b6cfcdb979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_d533283e-4452-4ec3-bfe0-4762da039efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:to="loc_us-gaap_PositionAxis_d533283e-4452-4ec3-bfe0-4762da039efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_702019c8-b14b-475a-ab75-dcba9708535d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_d533283e-4452-4ec3-bfe0-4762da039efc" xlink:to="loc_us-gaap_PositionDomain_702019c8-b14b-475a-ab75-dcba9708535d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_36b77486-3af8-46c8-a94a-2b903ae4a7df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_702019c8-b14b-475a-ab75-dcba9708535d" xlink:to="loc_us-gaap_LongMember_36b77486-3af8-46c8-a94a-2b903ae4a7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_ccd7f1bd-d387-4aa5-a21e-ea60d8b9bef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_702019c8-b14b-475a-ab75-dcba9708535d" xlink:to="loc_us-gaap_ShortMember_ccd7f1bd-d387-4aa5-a21e-ea60d8b9bef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5846cd71-a2c5-47fd-9b62-6762e5d393a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_96ae518d-d904-4648-b3fd-8ddf5e767e8e" xlink:to="loc_us-gaap_DerivativeLineItems_5846cd71-a2c5-47fd-9b62-6762e5d393a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_d5aedc92-2488-4d7d-91bd-d7d5e168693f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5846cd71-a2c5-47fd-9b62-6762e5d393a7" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_d5aedc92-2488-4d7d-91bd-d7d5e168693f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_35f3cd4c-cb4f-465d-91df-05959e638d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5846cd71-a2c5-47fd-9b62-6762e5d393a7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_35f3cd4c-cb4f-465d-91df-05959e638d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_a9751031-3f65-4fd7-a26a-4857d1c79858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5846cd71-a2c5-47fd-9b62-6762e5d393a7" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_a9751031-3f65-4fd7-a26a-4857d1c79858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4732c635-2e64-4055-b994-8c311f29470f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4732c635-2e64-4055-b994-8c311f29470f" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_9cec6e34-45ae-4701-852c-5c9fb241cbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:to="loc_us-gaap_HedgingDesignationAxis_9cec6e34-45ae-4701-852c-5c9fb241cbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_332fc61b-6d6d-4fdf-babe-f6407a31eceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_9cec6e34-45ae-4701-852c-5c9fb241cbc3" xlink:to="loc_us-gaap_HedgingDesignationDomain_332fc61b-6d6d-4fdf-babe-f6407a31eceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_19d696b9-5cb8-44aa-b7d0-ce1720805fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_332fc61b-6d6d-4fdf-babe-f6407a31eceb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_19d696b9-5cb8-44aa-b7d0-ce1720805fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4d916e13-4a3a-4258-81cf-6e3de1d74f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4d916e13-4a3a-4258-81cf-6e3de1d74f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3a1e36d2-1b7e-4c38-a1cd-e29c7bcc81a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4d916e13-4a3a-4258-81cf-6e3de1d74f72" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3a1e36d2-1b7e-4c38-a1cd-e29c7bcc81a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b8263177-2816-4d1b-85af-250097fba625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3a1e36d2-1b7e-4c38-a1cd-e29c7bcc81a0" xlink:to="loc_us-gaap_InterestRateSwapMember_b8263177-2816-4d1b-85af-250097fba625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_58e484fa-db8f-421d-9ea6-6916a409cbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3a1e36d2-1b7e-4c38-a1cd-e29c7bcc81a0" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_58e484fa-db8f-421d-9ea6-6916a409cbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_636e6058-0b0e-4f2a-9db1-64b6203d4aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_636e6058-0b0e-4f2a-9db1-64b6203d4aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e448490f-768f-4872-8436-31161af33800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_636e6058-0b0e-4f2a-9db1-64b6203d4aa4" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e448490f-768f-4872-8436-31161af33800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_39a704c8-3451-46c7-918b-2ba7705b36e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e448490f-768f-4872-8436-31161af33800" xlink:to="loc_us-gaap_CashFlowHedgingMember_39a704c8-3451-46c7-918b-2ba7705b36e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_79ff52cf-5034-4474-8834-f88b54e3e84d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e448490f-768f-4872-8436-31161af33800" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_79ff52cf-5034-4474-8834-f88b54e3e84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3bd88a38-f437-414b-9f7d-b1699838fa93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3bd88a38-f437-414b-9f7d-b1699838fa93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bd88a38-f437-414b-9f7d-b1699838fa93" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_7bfe0d5b-7deb-44d9-a3f7-90faff6d9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_7bfe0d5b-7deb-44d9-a3f7-90faff6d9ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_b2b3ed1e-f074-4b0c-8e44-b03d08c8f196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:to="loc_us-gaap_OtherAssetsMember_b2b3ed1e-f074-4b0c-8e44-b03d08c8f196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_08c2fbbf-1ce1-4461-a690-c41a13f85291" xlink:href="iart-20211231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_08c2fbbf-1ce1-4461-a690-c41a13f85291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_d738cd16-cc4c-4187-9d81-e3d1c6472e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ccea7563-5296-4420-a27c-a6943b043796" xlink:to="loc_us-gaap_OtherLiabilitiesMember_d738cd16-cc4c-4187-9d81-e3d1c6472e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_e03374d1-215d-49d4-ba5a-5a08a09ee8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6c484c1c-45aa-47e8-9fcb-63abf112a4d6" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_e03374d1-215d-49d4-ba5a-5a08a09ee8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_69214762-f2e6-4636-aa65-692251693fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e03374d1-215d-49d4-ba5a-5a08a09ee8b5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_69214762-f2e6-4636-aa65-692251693fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_36429d5a-0347-4da2-80f0-b9e60f2fdf78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e03374d1-215d-49d4-ba5a-5a08a09ee8b5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_36429d5a-0347-4da2-80f0-b9e60f2fdf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e7de1355-da13-46bf-a510-c4f448815e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e03374d1-215d-49d4-ba5a-5a08a09ee8b5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e7de1355-da13-46bf-a510-c4f448815e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_476f9c91-9ecf-4aa2-9cdd-c2d71d649b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_476f9c91-9ecf-4aa2-9cdd-c2d71d649b1d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_57c0827c-b793-47f0-bf11-f61248f2ce22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_HedgingDesignationAxis_57c0827c-b793-47f0-bf11-f61248f2ce22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2210ebcb-6c8b-46a3-af6d-24cf951acc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_57c0827c-b793-47f0-bf11-f61248f2ce22" xlink:to="loc_us-gaap_HedgingDesignationDomain_2210ebcb-6c8b-46a3-af6d-24cf951acc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_efa74e6f-0fee-462c-ba8c-60a6606bbfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2210ebcb-6c8b-46a3-af6d-24cf951acc3d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_efa74e6f-0fee-462c-ba8c-60a6606bbfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6bee9eb8-24e0-449d-87a1-4f80f695198c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6bee9eb8-24e0-449d-87a1-4f80f695198c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_34625aab-22ec-4874-ab45-9b3759bb5e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6bee9eb8-24e0-449d-87a1-4f80f695198c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_34625aab-22ec-4874-ab45-9b3759bb5e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_52e4509b-7a0f-4161-958c-5817edc76e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_34625aab-22ec-4874-ab45-9b3759bb5e24" xlink:to="loc_us-gaap_InterestRateSwapMember_52e4509b-7a0f-4161-958c-5817edc76e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_e9695e63-1c63-4ea4-bf2a-8f4f49861271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_34625aab-22ec-4874-ab45-9b3759bb5e24" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_e9695e63-1c63-4ea4-bf2a-8f4f49861271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a9a4d7f0-d522-433b-81f9-79215a209d66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a9a4d7f0-d522-433b-81f9-79215a209d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_367da541-f3dc-46be-b139-f272d0a0247d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a9a4d7f0-d522-433b-81f9-79215a209d66" xlink:to="loc_us-gaap_EquityComponentDomain_367da541-f3dc-46be-b139-f272d0a0247d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8d48eed0-53bc-4959-98aa-2685c883436d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_367da541-f3dc-46be-b139-f272d0a0247d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8d48eed0-53bc-4959-98aa-2685c883436d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ba5ebe8c-c08b-4f21-85ce-88a50c0dee51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ba5ebe8c-c08b-4f21-85ce-88a50c0dee51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_12173f2b-be80-4c55-9662-2fad866b3bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ba5ebe8c-c08b-4f21-85ce-88a50c0dee51" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_12173f2b-be80-4c55-9662-2fad866b3bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_7b964ce3-d186-4256-849c-d7a0afddbe0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12173f2b-be80-4c55-9662-2fad866b3bc7" xlink:to="loc_us-gaap_InterestExpenseMember_7b964ce3-d186-4256-849c-d7a0afddbe0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b3622825-6572-49be-9ace-3175a96bd595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12173f2b-be80-4c55-9662-2fad866b3bc7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b3622825-6572-49be-9ace-3175a96bd595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_008c4589-f6c7-4814-b17a-5152906f6d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12173f2b-be80-4c55-9662-2fad866b3bc7" xlink:to="loc_us-gaap_InterestIncomeMember_008c4589-f6c7-4814-b17a-5152906f6d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d83a1946-0994-4d2c-8cea-188ea52596cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d83a1946-0994-4d2c-8cea-188ea52596cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_59ee2834-077f-4329-a652-31287d3ecd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d83a1946-0994-4d2c-8cea-188ea52596cd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_59ee2834-077f-4329-a652-31287d3ecd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_a3d440f1-3b95-48f5-ab6f-758373dddcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_59ee2834-077f-4329-a652-31287d3ecd7a" xlink:to="loc_us-gaap_CashFlowHedgingMember_a3d440f1-3b95-48f5-ab6f-758373dddcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d4d3ba19-face-4d65-8fb7-c5017cf3fc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_59ee2834-077f-4329-a652-31287d3ecd7a" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d4d3ba19-face-4d65-8fb7-c5017cf3fc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e88e3544-6d76-486e-8e86-a972c15c5bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1704bfb0-5d30-43e0-9429-1a4b2c5557f8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e88e3544-6d76-486e-8e86-a972c15c5bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e88e3544-6d76-486e-8e86-a972c15c5bca" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_87fb8894-51ae-473e-9d0e-273b3ac5b7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:to="loc_us-gaap_StockholdersEquity_87fb8894-51ae-473e-9d0e-273b3ac5b7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_35db3d81-1304-41f8-b30e-5bb8db0dbde9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_35db3d81-1304-41f8-b30e-5bb8db0dbde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6ce871d8-aa5a-4325-9884-3dcfc1ac3cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6ce871d8-aa5a-4325-9884-3dcfc1ac3cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1c6c89dd-10d9-43a5-ae32-73013c06911a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd9f288-277c-46b6-9347-7c8d4747ccef" xlink:to="loc_us-gaap_StockholdersEquity_1c6c89dd-10d9-43a5-ae32-73013c06911a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="iart-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fd610477-17ed-429a-9618-107bfe31f5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8380ceb4-a799-4658-b186-22ccc794f690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fd610477-17ed-429a-9618-107bfe31f5b6" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8380ceb4-a799-4658-b186-22ccc794f690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="iart-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c84c2daf-2f37-4242-8b1c-beba3aceeda2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_7367f7bf-0551-46b1-a79c-c1b15e35b963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c84c2daf-2f37-4242-8b1c-beba3aceeda2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_7367f7bf-0551-46b1-a79c-c1b15e35b963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_55ee55c6-40cd-4297-b96b-e7b278f475af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c84c2daf-2f37-4242-8b1c-beba3aceeda2" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_55ee55c6-40cd-4297-b96b-e7b278f475af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c26b64ad-285b-4bb0-833e-ba9376ff0588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c84c2daf-2f37-4242-8b1c-beba3aceeda2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c26b64ad-285b-4bb0-833e-ba9376ff0588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cab4569c-66c4-4aed-9c4f-a1ea72196de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cab4569c-66c4-4aed-9c4f-a1ea72196de6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_68bd36d2-1aa0-41d6-b9bf-4c6cf944a329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_68bd36d2-1aa0-41d6-b9bf-4c6cf944a329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54cdc3f8-ef32-4d65-aafe-9abc6b631add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_68bd36d2-1aa0-41d6-b9bf-4c6cf944a329" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54cdc3f8-ef32-4d65-aafe-9abc6b631add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6962581c-a1ce-420b-bad3-37e565642ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54cdc3f8-ef32-4d65-aafe-9abc6b631add" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6962581c-a1ce-420b-bad3-37e565642ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c2d6ba73-1f39-498e-b7ff-06f8ae734259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c2d6ba73-1f39-498e-b7ff-06f8ae734259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a251530-bd3b-4155-8cb3-fd373fd23b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c2d6ba73-1f39-498e-b7ff-06f8ae734259" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a251530-bd3b-4155-8cb3-fd373fd23b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_6ff49158-8189-4e84-a49a-737cfbcacf68" xlink:href="iart-20211231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a251530-bd3b-4155-8cb3-fd373fd23b2e" xlink:to="loc_iart_SmithNephewUSDLimitedMember_6ff49158-8189-4e84-a49a-737cfbcacf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_f1898cf0-cee7-43e1-b5e1-f45ed0b03305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_f1898cf0-cee7-43e1-b5e1-f45ed0b03305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1be05867-d12c-4677-a614-7ea17e91fa10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f1898cf0-cee7-43e1-b5e1-f45ed0b03305" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1be05867-d12c-4677-a614-7ea17e91fa10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8becb3ef-d849-4f11-8000-b178691f20b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1be05867-d12c-4677-a614-7ea17e91fa10" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8becb3ef-d849-4f11-8000-b178691f20b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ad0b44b0-cafe-4b0c-af5d-8ac1dd062701" xlink:to="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_72e1de3e-7c28-4f3c-bd22-405461c62692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_NumberOfReportingUnits_72e1de3e-7c28-4f3c-bd22-405461c62692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_7aa13484-126c-4b68-b4b2-b7940e0168e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_7aa13484-126c-4b68-b4b2-b7940e0168e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_06a8ec2e-eb5c-4da6-b3d3-bf4e909ef32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_AdjustmentForAmortization_06a8ec2e-eb5c-4da6-b3d3-bf4e909ef32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_9131b590-6a59-4375-a88d-544c2fab1542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_9131b590-6a59-4375-a88d-544c2fab1542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_85d06b5f-bd47-41d6-a58a-35f8a099b61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_85d06b5f-bd47-41d6-a58a-35f8a099b61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6fe423e6-06b7-4ac4-922a-60400ec9ff54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6fe423e6-06b7-4ac4-922a-60400ec9ff54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_58a0b73d-c19d-4486-8e97-fec40c15828f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_58a0b73d-c19d-4486-8e97-fec40c15828f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e574ed79-93c9-4de3-bcf8-7a0669419528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e574ed79-93c9-4de3-bcf8-7a0669419528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ade5a74d-8961-41e7-b516-d0c27bd32937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ade5a74d-8961-41e7-b516-d0c27bd32937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_8e966335-14f7-443e-a89f-b1d83daa8a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0b87f87d-74a5-4619-bb3b-82fc62c43273" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_8e966335-14f7-443e-a89f-b1d83daa8a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_31402ff6-4df5-4723-add2-3a5226de8ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_236be894-f31f-4b0c-8961-ffd524998c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_31402ff6-4df5-4723-add2-3a5226de8ca2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_236be894-f31f-4b0c-8961-ffd524998c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dfdaf0e2-9064-441c-b873-bfde395fc5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_236be894-f31f-4b0c-8961-ffd524998c2a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dfdaf0e2-9064-441c-b873-bfde395fc5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5609abde-3566-4d17-a766-4123e1a12fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dfdaf0e2-9064-441c-b873-bfde395fc5e9" xlink:to="loc_us-gaap_SegmentDomain_5609abde-3566-4d17-a766-4123e1a12fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_ee474edc-8f4a-489f-bfd7-74c7c5edb64e" xlink:href="iart-20211231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5609abde-3566-4d17-a766-4123e1a12fc4" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_ee474edc-8f4a-489f-bfd7-74c7c5edb64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_c08e6d6a-1efe-46d0-855d-bab9d121b104" xlink:href="iart-20211231.xsd#iart_TissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5609abde-3566-4d17-a766-4123e1a12fc4" xlink:to="loc_iart_TissueTechnologiesMember_c08e6d6a-1efe-46d0-855d-bab9d121b104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_18a63387-6399-4a79-ab54-6ad8c3b4ab10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_236be894-f31f-4b0c-8961-ffd524998c2a" xlink:to="loc_us-gaap_GoodwillLineItems_18a63387-6399-4a79-ab54-6ad8c3b4ab10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_18a63387-6399-4a79-ab54-6ad8c3b4ab10" xlink:to="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec515a6f-a753-4f8f-8c25-5545076fb77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:to="loc_us-gaap_Goodwill_ec515a6f-a753-4f8f-8c25-5545076fb77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_ab484176-624f-43c8-a490-73d7f3a1d26e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:to="loc_us-gaap_GoodwillTransfers_ab484176-624f-43c8-a490-73d7f3a1d26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_cc7a2c30-9dd1-419c-b1f1-f26391384f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_cc7a2c30-9dd1-419c-b1f1-f26391384f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e754b99e-b77a-4ce8-b9e1-eab67929150a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e754b99e-b77a-4ce8-b9e1-eab67929150a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_eaaa8517-a8ff-460e-b8d4-68bc2946f048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dbdfb46f-ad8f-4164-8064-fd503fa7c9bc" xlink:to="loc_us-gaap_Goodwill_eaaa8517-a8ff-460e-b8d4-68bc2946f048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da3f77c9-ad9f-4d95-a2f1-0b3b769a5a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_c67b7221-25c9-45c5-8ebb-f73ad61570ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da3f77c9-ad9f-4d95-a2f1-0b3b769a5a9c" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_c67b7221-25c9-45c5-8ebb-f73ad61570ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_762aea1b-b4ec-4910-8ffe-bc76a330a8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_c67b7221-25c9-45c5-8ebb-f73ad61570ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_762aea1b-b4ec-4910-8ffe-bc76a330a8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_762aea1b-b4ec-4910-8ffe-bc76a330a8d1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember_f12e79f5-c579-47f9-bef5-e689d8464337" xlink:href="iart-20211231.xsd#iart_CompletedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:to="loc_iart_CompletedTechnologyMember_f12e79f5-c579-47f9-bef5-e689d8464337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e792f1e0-2a36-4992-81ed-3da25ff5531e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e792f1e0-2a36-4992-81ed-3da25ff5531e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember_49646614-a184-4195-8d15-88024d515486" xlink:href="iart-20211231.xsd#iart_TrademarksBrandNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:to="loc_iart_TrademarksBrandNamesMember_49646614-a184-4195-8d15-88024d515486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember_4fe15c6b-f740-4424-852c-ddb9e7273d97" xlink:href="iart-20211231.xsd#iart_SupplierRelationShipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:to="loc_iart_SupplierRelationShipsMember_4fe15c6b-f740-4424-852c-ddb9e7273d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember_54760677-f076-427e-a823-2187f46c1cfd" xlink:href="iart-20211231.xsd#iart_AllOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75811bb1-1ba4-4850-93dc-3dd0a1d02f5a" xlink:to="loc_iart_AllOtherMember_54760677-f076-427e-a823-2187f46c1cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ac1f429c-4e20-477c-8ba4-c7b5d7368cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_c67b7221-25c9-45c5-8ebb-f73ad61570ff" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ac1f429c-4e20-477c-8ba4-c7b5d7368cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae017087-c2c8-4f27-ba3e-47105dba6cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ac1f429c-4e20-477c-8ba4-c7b5d7368cb7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae017087-c2c8-4f27-ba3e-47105dba6cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_0d56bb16-3d55-4673-a476-10a4214bfe6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae017087-c2c8-4f27-ba3e-47105dba6cfb" xlink:to="loc_us-gaap_TradeNamesMember_0d56bb16-3d55-4673-a476-10a4214bfe6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_c67b7221-25c9-45c5-8ebb-f73ad61570ff" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1cee9af2-06c1-48ca-b889-53bb574023e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1cee9af2-06c1-48ca-b889-53bb574023e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_418a7412-64a0-4c1e-beb0-a3d0776beead" xlink:href="iart-20211231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_418a7412-64a0-4c1e-beb0-a3d0776beead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8291e1b6-e41c-46ac-9464-ce2ab683fbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8291e1b6-e41c-46ac-9464-ce2ab683fbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_703e1457-8e39-439b-a3fb-479d963b8682" xlink:href="iart-20211231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_a3496868-1be8-4365-9c6f-698bb8a5760a" xlink:to="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_703e1457-8e39-439b-a3fb-479d963b8682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCK" xlink:type="simple" xlink:href="iart-20211231.xsd#TREASURYSTOCK"/>
  <link:presentationLink xlink:role="http://integralife.com/role/TREASURYSTOCK" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a6cc1286-ee67-47ad-8d23-5e0ec34b7ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock_8e500248-6c5b-4630-b4db-0c4f00f12fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a6cc1286-ee67-47ad-8d23-5e0ec34b7ce8" xlink:to="loc_us-gaap_TreasuryStockTextBlock_8e500248-6c5b-4630-b4db-0c4f00f12fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#TREASURYSTOCKNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5faf25ad-5708-4c72-9eb0-24b3a244391d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5faf25ad-5708-4c72-9eb0-24b3a244391d" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_61150baf-8b13-457d-a0dc-763930b8f736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_61150baf-8b13-457d-a0dc-763930b8f736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a0b2d8d0-bd13-4c84-8ebb-b55211bd3a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_61150baf-8b13-457d-a0dc-763930b8f736" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a0b2d8d0-bd13-4c84-8ebb-b55211bd3a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_d333aa2c-dab9-4415-8532-ae7420d4a0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a0b2d8d0-bd13-4c84-8ebb-b55211bd3a7b" xlink:to="loc_us-gaap_ConvertibleDebtMember_d333aa2c-dab9-4415-8532-ae7420d4a0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_804f4031-8d7b-4d53-8589-dee68829d359" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:to="loc_srt_CounterpartyNameAxis_804f4031-8d7b-4d53-8589-dee68829d359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_581494c6-76f8-4c85-931d-b8ea9483d7bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_804f4031-8d7b-4d53-8589-dee68829d359" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_581494c6-76f8-4c85-931d-b8ea9483d7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CertainPurchasersMember_8062ab31-de48-4e60-9f95-f9ad0016f69c" xlink:href="iart-20211231.xsd#iart_CertainPurchasersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_581494c6-76f8-4c85-931d-b8ea9483d7bf" xlink:to="loc_iart_CertainPurchasersMember_8062ab31-de48-4e60-9f95-f9ad0016f69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0bf753e6-f764-43c5-a767-dc6b05ec8e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0bf753e6-f764-43c5-a767-dc6b05ec8e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5179f009-d4e6-44fa-95d7-ddc275dc1c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0bf753e6-f764-43c5-a767-dc6b05ec8e59" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5179f009-d4e6-44fa-95d7-ddc275dc1c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_bd468bff-0c58-4ef3-8f4b-56d5a234ca4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5179f009-d4e6-44fa-95d7-ddc275dc1c7e" xlink:to="loc_us-gaap_SubsequentEventMember_bd468bff-0c58-4ef3-8f4b-56d5a234ca4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_524fa6a2-45f1-442a-a5dd-a1fc4bc4f863" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:to="loc_srt_StatementScenarioAxis_524fa6a2-45f1-442a-a5dd-a1fc4bc4f863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4c7d03f0-1c3b-4449-b93e-1541a9ecb669" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_524fa6a2-45f1-442a-a5dd-a1fc4bc4f863" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4c7d03f0-1c3b-4449-b93e-1541a9ecb669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c65949ea-6324-4b84-b5ba-d1392bca2110" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_4c7d03f0-1c3b-4449-b93e-1541a9ecb669" xlink:to="loc_srt_ScenarioForecastMember_c65949ea-6324-4b84-b5ba-d1392bca2110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44275a8c-4717-4e33-8f74-0751e07c4542" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_b3482f19-0dc8-4b51-8bb8-da33b170a791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_TreasuryStockCommonShares_b3482f19-0dc8-4b51-8bb8-da33b170a791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_4446780a-70d6-45b8-a3d9-70da65825059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_TreasuryStockCommonValue_4446780a-70d6-45b8-a3d9-70da65825059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_afaa3311-eab5-446b-9d47-59407ca59054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_afaa3311-eab5-446b-9d47-59407ca59054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_259be3ae-d8c6-4226-a2d5-d29c66195024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_259be3ae-d8c6-4226-a2d5-d29c66195024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_c78e209a-68b0-4c37-bd5e-89752019dc94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_c78e209a-68b0-4c37-bd5e-89752019dc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_828227dd-ae07-4637-ac31-1264d4b5ad0a" xlink:href="iart-20211231.xsd#iart_AcceleratedShareRepurchasesSharesReceivedAtInception"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_828227dd-ae07-4637-ac31-1264d4b5ad0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_7efc3e38-ee26-4b62-9d3a-0d3430c307ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_7efc3e38-ee26-4b62-9d3a-0d3430c307ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_f571a3b2-94c7-456f-a997-b7bebfb9e4a0" xlink:href="iart-20211231.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_f571a3b2-94c7-456f-a997-b7bebfb9e4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_e2988644-241f-48c1-9b53-2d18bbe2b11e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_e2988644-241f-48c1-9b53-2d18bbe2b11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_6ff27881-9971-4fe3-92b2-454b7d576489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_6ff27881-9971-4fe3-92b2-454b7d576489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_0f29bcc7-e529-4ada-aee1-4b8256c55245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ed77d66f-dcac-4174-b34f-e945f955bd40" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_0f29bcc7-e529-4ada-aee1-4b8256c55245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c89ba837-9377-41ba-ba0c-29b9372b615b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d6dd077f-9265-4b40-b011-4035f009f740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c89ba837-9377-41ba-ba0c-29b9372b615b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d6dd077f-9265-4b40-b011-4035f009f740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3da7ba24-c175-4544-aaac-ead6bee8752b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_92d5d4ff-80c6-40e2-9dae-c7773e6b3d81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3da7ba24-c175-4544-aaac-ead6bee8752b" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_92d5d4ff-80c6-40e2-9dae-c7773e6b3d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_464d2bab-c431-4c92-ade7-e4e515f04c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3da7ba24-c175-4544-aaac-ead6bee8752b" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_464d2bab-c431-4c92-ade7-e4e515f04c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_86e1dd9b-ac20-4154-8582-bc65a8a15c13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3da7ba24-c175-4544-aaac-ead6bee8752b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_86e1dd9b-ac20-4154-8582-bc65a8a15c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_2b546b34-54f7-4c67-98d6-2ab2bf7e9597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3da7ba24-c175-4544-aaac-ead6bee8752b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_2b546b34-54f7-4c67-98d6-2ab2bf7e9597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c964d3d1-58e9-48d3-8ea0-836f9af56d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_db3fe3e9-3dcf-4d78-aa14-99d01c76320c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c964d3d1-58e9-48d3-8ea0-836f9af56d6e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_db3fe3e9-3dcf-4d78-aa14-99d01c76320c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_eacf1053-cf62-49dc-91ed-0a27f04fefe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_db3fe3e9-3dcf-4d78-aa14-99d01c76320c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_eacf1053-cf62-49dc-91ed-0a27f04fefe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_02e62bbc-7e79-4311-9045-005a86a93e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_eacf1053-cf62-49dc-91ed-0a27f04fefe0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_02e62bbc-7e79-4311-9045-005a86a93e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3ecf2d27-e01d-4e94-ae13-71034c88d710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_02e62bbc-7e79-4311-9045-005a86a93e89" xlink:to="loc_us-gaap_CostOfSalesMember_3ecf2d27-e01d-4e94-ae13-71034c88d710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f15a4d00-371d-45a8-92fe-91bff27b8362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_02e62bbc-7e79-4311-9045-005a86a93e89" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f15a4d00-371d-45a8-92fe-91bff27b8362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_be8c8f71-a488-4745-a7b4-5182a5d2f000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_02e62bbc-7e79-4311-9045-005a86a93e89" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_be8c8f71-a488-4745-a7b4-5182a5d2f000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7410dcf5-db1f-4561-a91e-c6d874bf3091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_db3fe3e9-3dcf-4d78-aa14-99d01c76320c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7410dcf5-db1f-4561-a91e-c6d874bf3091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_fd083a21-e05f-4fea-958c-460ec68b191c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7410dcf5-db1f-4561-a91e-c6d874bf3091" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_fd083a21-e05f-4fea-958c-460ec68b191c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b2ca29ea-7852-460b-8c75-c35331d1da72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7410dcf5-db1f-4561-a91e-c6d874bf3091" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b2ca29ea-7852-460b-8c75-c35331d1da72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_7f4f9c8f-17c2-4f8b-a7d5-20310ae13534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7410dcf5-db1f-4561-a91e-c6d874bf3091" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_7f4f9c8f-17c2-4f8b-a7d5-20310ae13534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e0d4f91-fe33-4464-91f3-ceefa5663a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e0d4f91-fe33-4464-91f3-ceefa5663a1f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_92262024-b0f3-44c8-8317-6da2eef5c123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:to="loc_us-gaap_AwardTypeAxis_92262024-b0f3-44c8-8317-6da2eef5c123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_92262024-b0f3-44c8-8317-6da2eef5c123" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_639ed39d-1477-4684-8727-f027937ce367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:to="loc_us-gaap_EmployeeStockMember_639ed39d-1477-4684-8727-f027937ce367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_81846f3c-c082-491a-8686-e74256b6cba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:to="loc_us-gaap_EmployeeStockOptionMember_81846f3c-c082-491a-8686-e74256b6cba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_277ea7e1-6f03-40e6-92ac-0a86270a9765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_277ea7e1-6f03-40e6-92ac-0a86270a9765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_174cb2c7-c3ff-464a-9a63-366cd53b9e53" xlink:href="iart-20211231.xsd#iart_RestrictedStockPerformanceStockAndContractStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:to="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_174cb2c7-c3ff-464a-9a63-366cd53b9e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_19cdeeeb-0e26-4a5d-a5af-9eb751c7acdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4df8d3d-6d28-47ac-97ce-82f30afcb0da" xlink:to="loc_us-gaap_PerformanceSharesMember_19cdeeeb-0e26-4a5d-a5af-9eb751c7acdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_83f74b22-9b83-4a9c-b3de-597598b7697f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:to="loc_us-gaap_PlanNameAxis_83f74b22-9b83-4a9c-b3de-597598b7697f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d4ce16fa-1d68-454b-946e-6009544483e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_83f74b22-9b83-4a9c-b3de-597598b7697f" xlink:to="loc_us-gaap_PlanNameDomain_d4ce16fa-1d68-454b-946e-6009544483e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandThreePlanMember_a8cc0e89-1de7-40e6-8fab-841561d95ef5" xlink:href="iart-20211231.xsd#iart_TwoThousandThreePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d4ce16fa-1d68-454b-946e-6009544483e0" xlink:to="loc_iart_TwoThousandThreePlanMember_a8cc0e89-1de7-40e6-8fab-841561d95ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanMember_13a2a84c-2282-4ec0-8316-c2d94c7b3321" xlink:href="iart-20211231.xsd#iart_TwoThousandPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d4ce16fa-1d68-454b-946e-6009544483e0" xlink:to="loc_iart_TwoThousandPlanMember_13a2a84c-2282-4ec0-8316-c2d94c7b3321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandOnePlanMember_6ebd999c-cad8-4d1f-b215-ee708b593c5b" xlink:href="iart-20211231.xsd#iart_TwoThousandOnePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d4ce16fa-1d68-454b-946e-6009544483e0" xlink:to="loc_iart_TwoThousandOnePlanMember_6ebd999c-cad8-4d1f-b215-ee708b593c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_b751ce77-d43b-486d-88c9-b543fa300c63" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:to="loc_srt_TitleOfIndividualAxis_b751ce77-d43b-486d-88c9-b543fa300c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d3bc95-2279-47c1-9827-adf963dda92b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_b751ce77-d43b-486d-88c9-b543fa300c63" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d3bc95-2279-47c1-9827-adf963dda92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_258c8626-0bb0-421a-aa41-617bccd3eb05" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d3bc95-2279-47c1-9827-adf963dda92b" xlink:to="loc_srt_DirectorMember_258c8626-0bb0-421a-aa41-617bccd3eb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember_2145f49c-a131-4605-b144-e0b398c2a236" xlink:href="iart-20211231.xsd#iart_EmployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d3bc95-2279-47c1-9827-adf963dda92b" xlink:to="loc_iart_EmployeeMember_2145f49c-a131-4605-b144-e0b398c2a236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember_b95a3494-ede0-4d96-813e-10deb0582c6d" xlink:href="iart-20211231.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d3bc95-2279-47c1-9827-adf963dda92b" xlink:to="loc_iart_DirectorsandCertainExecutiveOfficersMember_b95a3494-ede0-4d96-813e-10deb0582c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_62ef7245-10b5-4ef4-aad7-490ed8ad16b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:to="loc_srt_RangeAxis_62ef7245-10b5-4ef4-aad7-490ed8ad16b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0295a113-8c40-4ffc-bb11-f55ffe1dd847" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_62ef7245-10b5-4ef4-aad7-490ed8ad16b3" xlink:to="loc_srt_RangeMember_0295a113-8c40-4ffc-bb11-f55ffe1dd847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_da2c8580-c88e-42bc-9e38-01fe79f272cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0295a113-8c40-4ffc-bb11-f55ffe1dd847" xlink:to="loc_srt_MinimumMember_da2c8580-c88e-42bc-9e38-01fe79f272cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fb8f199e-9a79-49f9-976c-0725f079f95a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0295a113-8c40-4ffc-bb11-f55ffe1dd847" xlink:to="loc_srt_MaximumMember_fb8f199e-9a79-49f9-976c-0725f079f95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f31e0ea6-adae-44a6-9074-b51224307ac6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e1efaed5-6a13-41ae-9057-7b4c3ca98907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e1efaed5-6a13-41ae-9057-7b4c3ca98907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_44d3d86a-983d-4fc9-8c01-d2d93c0f10e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_44d3d86a-983d-4fc9-8c01-d2d93c0f10e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5189217d-1f6b-4a13-800b-44475ad46bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5189217d-1f6b-4a13-800b-44475ad46bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeStockPurchasePlanProceeds_2bf91ba4-610b-4268-b8d7-b5dc6c9dcd66" xlink:href="iart-20211231.xsd#iart_EmployeeStockPurchasePlanProceeds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_iart_EmployeeStockPurchasePlanProceeds_2bf91ba4-610b-4268-b8d7-b5dc6c9dcd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncreaseInAuthorizedShares_8654eda3-8847-42bd-a66e-4e25e63f4095" xlink:href="iart-20211231.xsd#iart_IncreaseInAuthorizedShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_iart_IncreaseInAuthorizedShares_8654eda3-8847-42bd-a66e-4e25e63f4095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_634dff11-a6a2-4f70-b6d9-17cb5db2574e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_634dff11-a6a2-4f70-b6d9-17cb5db2574e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_a927c61d-bdb2-4ecf-9aa5-a9ea5e41aef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_a927c61d-bdb2-4ecf-9aa5-a9ea5e41aef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b01001d4-7712-40fb-b8ac-64c634a4934d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b01001d4-7712-40fb-b8ac-64c634a4934d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_51945e8f-00b9-4630-a7f0-99c014ae5e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_51945e8f-00b9-4630-a7f0-99c014ae5e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9b40806a-5a73-4684-9707-b04716a64113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9b40806a-5a73-4684-9707-b04716a64113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0fecddd1-9283-4568-8c2f-c61e92afa648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0fecddd1-9283-4568-8c2f-c61e92afa648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_459328cf-eeea-4244-b17b-3c0224bc8099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_459328cf-eeea-4244-b17b-3c0224bc8099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e670baf7-d84f-45e2-910b-33d150e924bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e670baf7-d84f-45e2-910b-33d150e924bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6244ef3b-66f9-4318-8f14-4d254d0d6394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6244ef3b-66f9-4318-8f14-4d254d0d6394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a751660b-7aa6-479b-9610-b068daca9066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a751660b-7aa6-479b-9610-b068daca9066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_ace25ad4-6197-4921-89aa-d43a93fce14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_ace25ad4-6197-4921-89aa-d43a93fce14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_1434541e-177b-46f6-ad4b-7c18a7e3fcbd" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_1434541e-177b-46f6-ad4b-7c18a7e3fcbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_95afe36b-d9a8-45e3-9f7d-87c5b2b2705c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d58445c-09e3-404d-b76f-9ff7048f20f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_95afe36b-d9a8-45e3-9f7d-87c5b2b2705c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4768cbcb-da92-4ae4-982c-71e0e8705af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a1a395ca-4e81-4b9d-920c-d887a37b8d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4768cbcb-da92-4ae4-982c-71e0e8705af7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a1a395ca-4e81-4b9d-920c-d887a37b8d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_cc4f366c-ec15-4008-849a-76dee1f01c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4768cbcb-da92-4ae4-982c-71e0e8705af7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_cc4f366c-ec15-4008-849a-76dee1f01c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7a9d3f14-7f24-488c-92aa-5cb73b916b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4768cbcb-da92-4ae4-982c-71e0e8705af7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7a9d3f14-7f24-488c-92aa-5cb73b916b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ff59e4cb-34c7-40ad-8f3f-13f53f2ca6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4768cbcb-da92-4ae4-982c-71e0e8705af7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ff59e4cb-34c7-40ad-8f3f-13f53f2ca6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e699857c-8304-4089-958b-e777f9bcd664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4768cbcb-da92-4ae4-982c-71e0e8705af7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e699857c-8304-4089-958b-e777f9bcd664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c0876c1-837f-4539-9390-a6738da033b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74141c7f-e71b-455d-af08-1e93f81185ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c0876c1-837f-4539-9390-a6738da033b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74141c7f-e71b-455d-af08-1e93f81185ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a8ea6433-72ef-46a7-88b0-783713c5dd38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74141c7f-e71b-455d-af08-1e93f81185ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a8ea6433-72ef-46a7-88b0-783713c5dd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_a740c268-dd40-44ea-b7a3-c76bbec44dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74141c7f-e71b-455d-af08-1e93f81185ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_a740c268-dd40-44ea-b7a3-c76bbec44dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9c95a95c-02e2-4eb7-ac82-cf72b68bf856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74141c7f-e71b-455d-af08-1e93f81185ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9c95a95c-02e2-4eb7-ac82-cf72b68bf856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1de91282-8ca3-44f7-bf4f-70227f43014b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74141c7f-e71b-455d-af08-1e93f81185ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1de91282-8ca3-44f7-bf4f-70227f43014b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_775eee20-a564-45b5-8852-d06261b26da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74141c7f-e71b-455d-af08-1e93f81185ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_775eee20-a564-45b5-8852-d06261b26da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a644b4e3-f55a-4009-a289-646dcb8b5317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c0876c1-837f-4539-9390-a6738da033b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a644b4e3-f55a-4009-a289-646dcb8b5317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b21d44a9-c9cb-46d3-8b26-143e2bc0b7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c0876c1-837f-4539-9390-a6738da033b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b21d44a9-c9cb-46d3-8b26-143e2bc0b7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_645aacc5-cb0b-4ca7-ab5a-60e694e0578d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b21d44a9-c9cb-46d3-8b26-143e2bc0b7ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_645aacc5-cb0b-4ca7-ab5a-60e694e0578d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_69a37448-53b7-47ab-a581-cbfbfecec749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b21d44a9-c9cb-46d3-8b26-143e2bc0b7ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_69a37448-53b7-47ab-a581-cbfbfecec749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5f7eeaa1-4635-4b51-8406-f9383d40292f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b21d44a9-c9cb-46d3-8b26-143e2bc0b7ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5f7eeaa1-4635-4b51-8406-f9383d40292f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f6e3b91c-b342-4059-a1b3-950c3e452ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b21d44a9-c9cb-46d3-8b26-143e2bc0b7ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f6e3b91c-b342-4059-a1b3-950c3e452ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ce2f0f5c-3dda-4a76-af6f-3dd8f01e7d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b21d44a9-c9cb-46d3-8b26-143e2bc0b7ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ce2f0f5c-3dda-4a76-af6f-3dd8f01e7d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d2e9fb20-43b8-480f-9554-a3c0fda68a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c0876c1-837f-4539-9390-a6738da033b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d2e9fb20-43b8-480f-9554-a3c0fda68a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_85ef0ac9-21b4-4c6b-bf0e-36e8e95edcbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c0876c1-837f-4539-9390-a6738da033b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_85ef0ac9-21b4-4c6b-bf0e-36e8e95edcbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_908ce91c-345f-41e2-8c7d-ca3faa268420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c0876c1-837f-4539-9390-a6738da033b4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_908ce91c-345f-41e2-8c7d-ca3faa268420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_0eaf51b6-0cfb-48d2-b5f8-1ffffd44665e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c0876c1-837f-4539-9390-a6738da033b4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_0eaf51b6-0cfb-48d2-b5f8-1ffffd44665e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_13333524-624f-4b33-800d-b98b35adc4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c0876c1-837f-4539-9390-a6738da033b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_13333524-624f-4b33-800d-b98b35adc4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_56237b8e-4e08-4f32-afae-aabe977db78e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c0876c1-837f-4539-9390-a6738da033b4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_56237b8e-4e08-4f32-afae-aabe977db78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0fab5d23-f5d6-4f32-aa35-6b87bd747c97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7a466bb8-ab6e-49d0-b147-a52247be433f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0fab5d23-f5d6-4f32-aa35-6b87bd747c97" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7a466bb8-ab6e-49d0-b147-a52247be433f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d90612fe-f7c2-440a-b0d3-afebddc634d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7a466bb8-ab6e-49d0-b147-a52247be433f" xlink:to="loc_us-gaap_AwardTypeAxis_d90612fe-f7c2-440a-b0d3-afebddc634d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a890bcf-1684-4f62-9483-8a156a23a709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d90612fe-f7c2-440a-b0d3-afebddc634d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a890bcf-1684-4f62-9483-8a156a23a709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_eda36762-4684-4f15-9b27-80746076762a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a890bcf-1684-4f62-9483-8a156a23a709" xlink:to="loc_us-gaap_RestrictedStockMember_eda36762-4684-4f15-9b27-80746076762a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockandContractStockMember_dc0aafe6-76fd-4a51-b9ef-eba6267f2fee" xlink:href="iart-20211231.xsd#iart_PerformanceStockandContractStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a890bcf-1684-4f62-9483-8a156a23a709" xlink:to="loc_iart_PerformanceStockandContractStockMember_dc0aafe6-76fd-4a51-b9ef-eba6267f2fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13aaa747-abd0-44f3-8da3-d25de870d09d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7a466bb8-ab6e-49d0-b147-a52247be433f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13aaa747-abd0-44f3-8da3-d25de870d09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13aaa747-abd0-44f3-8da3-d25de870d09d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72f54b5f-8818-4177-a4f9-c416450d4d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72f54b5f-8818-4177-a4f9-c416450d4d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_59416f8c-9148-4e18-aef9-d8c74ef59192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_59416f8c-9148-4e18-aef9-d8c74ef59192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_79f8469d-bac2-4fb9-9ba3-0d09c05430a7" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_79f8469d-bac2-4fb9-9ba3-0d09c05430a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a8942dfc-ac60-435a-b7c3-606446a969aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a8942dfc-ac60-435a-b7c3-606446a969aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_06269bf5-741b-4932-accc-4f73dc4d9160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_06269bf5-741b-4932-accc-4f73dc4d9160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_e7f947cf-c652-40dc-8b82-8b9298e7f7e1" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_e7f947cf-c652-40dc-8b82-8b9298e7f7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b291e64-c2df-4639-adb4-6ec77db433d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da660128-0f0b-4bf5-83c1-81e83faae8a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b291e64-c2df-4639-adb4-6ec77db433d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13aaa747-abd0-44f3-8da3-d25de870d09d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fc31359d-1d18-4ef8-84bf-a0e687a6c9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fc31359d-1d18-4ef8-84bf-a0e687a6c9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3fee7071-93ee-42c7-a474-14850c296695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3fee7071-93ee-42c7-a474-14850c296695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_1017349e-dbc0-431f-9dab-7e8ed0bbf6e7" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_1017349e-dbc0-431f-9dab-7e8ed0bbf6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5839de83-2543-495e-98d6-3290275ff758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5839de83-2543-495e-98d6-3290275ff758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f07d591f-1c90-4dd7-a6ca-54d34d6427ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f07d591f-1c90-4dd7-a6ca-54d34d6427ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_7e9b6ee0-c421-4596-83a9-38f43439a000" xlink:href="iart-20211231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_7e9b6ee0-c421-4596-83a9-38f43439a000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1c6a607e-edf6-44ca-994d-49e7c4030c59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81399eb1-27f2-412d-9cf5-cd6fa3ecdf22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1c6a607e-edf6-44ca-994d-49e7c4030c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANS" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66c84b20-8e82-4923-8a75-daae7bff762c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_3e19992e-9fbd-4216-a7c6-9ef2a22508de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66c84b20-8e82-4923-8a75-daae7bff762c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_3e19992e-9fbd-4216-a7c6-9ef2a22508de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSTables" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cf4f6506-80dd-4dd3-833e-31aa306a3bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_8e3b4d57-42c7-4c72-a742-355f820f367a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cf4f6506-80dd-4dd3-833e-31aa306a3bdf" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_8e3b4d57-42c7-4c72-a742-355f820f367a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_c7566df4-5006-409d-b683-a4e4442f86b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cf4f6506-80dd-4dd3-833e-31aa306a3bdf" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_c7566df4-5006-409d-b683-a4e4442f86b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_dbb23809-8c28-4c49-9bcf-16446f93a797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cf4f6506-80dd-4dd3-833e-31aa306a3bdf" xlink:to="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_dbb23809-8c28-4c49-9bcf-16446f93a797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_1624eb78-418d-45ed-ad2e-6a8fd0bce8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cf4f6506-80dd-4dd3-833e-31aa306a3bdf" xlink:to="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_1624eb78-418d-45ed-ad2e-6a8fd0bce8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_ad5ad788-6f9f-4469-b4f2-e43898902dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cf4f6506-80dd-4dd3-833e-31aa306a3bdf" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_ad5ad788-6f9f-4469-b4f2-e43898902dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66c4e35b-23d9-4966-b23f-13e131b1a8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_682d8a72-4302-4c94-89c1-8c4ae4f2e499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66c4e35b-23d9-4966-b23f-13e131b1a8fa" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_682d8a72-4302-4c94-89c1-8c4ae4f2e499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a5b6a9f8-8468-46e8-90bf-6fb909747e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66c4e35b-23d9-4966-b23f-13e131b1a8fa" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a5b6a9f8-8468-46e8-90bf-6fb909747e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_de2aea90-111c-4410-8a62-b07641506ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66c4e35b-23d9-4966-b23f-13e131b1a8fa" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_de2aea90-111c-4410-8a62-b07641506ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_938f0e43-ef1d-4998-bc8e-0e52cee58f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66c4e35b-23d9-4966-b23f-13e131b1a8fa" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_938f0e43-ef1d-4998-bc8e-0e52cee58f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_c07c05d7-0ddf-4627-9f31-02cd19088782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66c4e35b-23d9-4966-b23f-13e131b1a8fa" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_c07c05d7-0ddf-4627-9f31-02cd19088782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_5af3d96b-18fb-4830-9b5f-bfbdbb1c49ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66c4e35b-23d9-4966-b23f-13e131b1a8fa" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_5af3d96b-18fb-4830-9b5f-bfbdbb1c49ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3db12c09-b9f5-4fe0-94da-05c389db5d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66c4e35b-23d9-4966-b23f-13e131b1a8fa" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3db12c09-b9f5-4fe0-94da-05c389db5d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_80dcb072-8111-47b4-862b-b009693c669a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_be8fca04-ce6e-4866-9b81-e93160d289a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_80dcb072-8111-47b4-862b-b009693c669a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_be8fca04-ce6e-4866-9b81-e93160d289a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_f15c2e3e-40ea-43bb-83db-165dab76b333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_80dcb072-8111-47b4-862b-b009693c669a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_f15c2e3e-40ea-43bb-83db-165dab76b333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_d2f352e4-fb36-4220-87cb-92a65f8c0f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_80dcb072-8111-47b4-862b-b009693c669a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_d2f352e4-fb36-4220-87cb-92a65f8c0f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_9fc65397-6041-4f62-9364-d67ffc933198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_80dcb072-8111-47b4-862b-b009693c669a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_9fc65397-6041-4f62-9364-d67ffc933198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6fa87b6c-6cdc-443c-baa1-8398cbe7e0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6fa87b6c-6cdc-443c-baa1-8398cbe7e0bc" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8e1a41da-3a33-42e4-9adc-e43258fc3aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8e1a41da-3a33-42e4-9adc-e43258fc3aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_43164d15-f6ce-43c5-9de3-f351ae0e4a49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_43164d15-f6ce-43c5-9de3-f351ae0e4a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_c65fc38a-93e3-432b-b734-89a18ef5b098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_c65fc38a-93e3-432b-b734-89a18ef5b098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_72336af9-2d48-4c4e-b08d-e9448fa5b3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_72336af9-2d48-4c4e-b08d-e9448fa5b3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_4914bef9-c3be-4307-bb1f-504dfb56905b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_4914bef9-c3be-4307-bb1f-504dfb56905b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d8a93c15-3149-4e49-9b14-b4bf3fc4677b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d8a93c15-3149-4e49-9b14-b4bf3fc4677b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_cb24c642-bfd7-435c-8c43-868082b20529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_cb24c642-bfd7-435c-8c43-868082b20529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_1444d04b-53f2-4fdd-a063-68eb79660eb8" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanBenefitObligationPremiumsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_1444d04b-53f2-4fdd-a063-68eb79660eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2657ffc5-2ec1-4fb0-b150-067fef402758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2657ffc5-2ec1-4fb0-b150-067fef402758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_d255ad1c-be56-4de4-805b-7b7d6e832457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_d255ad1c-be56-4de4-805b-7b7d6e832457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_84d73513-edef-4ab9-a65b-af62034d3435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_84d73513-edef-4ab9-a65b-af62034d3435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7cbe5eb6-2d36-440c-a537-213c14cd2e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5bf39f3b-1e13-4599-8359-3fad72e2cab0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7cbe5eb6-2d36-440c-a537-213c14cd2e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6fa87b6c-6cdc-443c-baa1-8398cbe7e0bc" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_309ff3bf-0f7f-4c97-8315-8b3a6fc3ce87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_309ff3bf-0f7f-4c97-8315-8b3a6fc3ce87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_34828827-6efb-413b-bb3c-5ff4e24c25f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_34828827-6efb-413b-bb3c-5ff4e24c25f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_982520b0-972d-4d4f-96cb-fad758789033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_982520b0-972d-4d4f-96cb-fad758789033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_9bf82496-57af-406c-8253-a56f35513ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_9bf82496-57af-406c-8253-a56f35513ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_9586d5c3-6427-47e6-bf33-8b248a763903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_9586d5c3-6427-47e6-bf33-8b248a763903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_01e7aa97-d1e1-471c-b289-2e5ec6b77b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_01e7aa97-d1e1-471c-b289-2e5ec6b77b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_fb24fbde-8540-468c-a4fc-ae972c63d503" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanPlanAssetsPremiumsPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:to="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_fb24fbde-8540-468c-a4fc-ae972c63d503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_3764cf2a-e3f8-4154-8626-e549036468fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_3764cf2a-e3f8-4154-8626-e549036468fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_38906a67-7c2e-4e0c-bf79-433987921bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_41266e71-eed8-4ae3-99b8-bda63dcc119b" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_38906a67-7c2e-4e0c-bf79-433987921bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b554d83f-330b-42a0-8951-846ec044d41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_aa1680da-dad6-4200-8273-880e9c9a2488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b554d83f-330b-42a0-8951-846ec044d41c" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_aa1680da-dad6-4200-8273-880e9c9a2488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f585954b-1efd-4667-a877-dfd2a754f613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_aa1680da-dad6-4200-8273-880e9c9a2488" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f585954b-1efd-4667-a877-dfd2a754f613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8da62669-12ee-4c69-bc7a-9093e512303a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_aa1680da-dad6-4200-8273-880e9c9a2488" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8da62669-12ee-4c69-bc7a-9093e512303a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_73f689f1-40dd-4393-8b0d-e2ae4e91a77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_aa1680da-dad6-4200-8273-880e9c9a2488" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_73f689f1-40dd-4393-8b0d-e2ae4e91a77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b4f30d9d-0e5b-4b3d-b2ac-95de9647a1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2cc42653-2d62-4deb-8f62-1dc761312695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b4f30d9d-0e5b-4b3d-b2ac-95de9647a1ec" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2cc42653-2d62-4deb-8f62-1dc761312695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_a2862808-9d44-4e30-bb9f-9c9d24339e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2cc42653-2d62-4deb-8f62-1dc761312695" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_a2862808-9d44-4e30-bb9f-9c9d24339e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_e550094d-54bc-4384-a643-624c6fbd6e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a2862808-9d44-4e30-bb9f-9c9d24339e01" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_e550094d-54bc-4384-a643-624c6fbd6e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_e89d8548-efcd-4198-89b5-7c123024830a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e550094d-54bc-4384-a643-624c6fbd6e64" xlink:to="loc_us-gaap_ForeignPlanMember_e89d8548-efcd-4198-89b5-7c123024830a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FranceAndGermanyMember_596580cd-a6e7-439c-842b-6adec6098514" xlink:href="iart-20211231.xsd#iart_FranceAndGermanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_e89d8548-efcd-4198-89b5-7c123024830a" xlink:to="loc_iart_FranceAndGermanyMember_596580cd-a6e7-439c-842b-6adec6098514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2cc42653-2d62-4deb-8f62-1dc761312695" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_77c98254-8246-4b0d-98ac-12e49f135bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_77c98254-8246-4b0d-98ac-12e49f135bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_edad8e94-89d0-4727-bbed-b3db325b5beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_edad8e94-89d0-4727-bbed-b3db325b5beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b7500f93-3aa1-4ea9-b84b-ef7bb62a6f36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b7500f93-3aa1-4ea9-b84b-ef7bb62a6f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_945e5942-3e0d-4e0e-86e2-0d37563e68bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_945e5942-3e0d-4e0e-86e2-0d37563e68bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_60b99bdd-ec4e-4aae-98bd-27df7dbc310e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_60b99bdd-ec4e-4aae-98bd-27df7dbc310e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_0284633b-6a8b-4a46-9a80-7ac93d738d42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_0284633b-6a8b-4a46-9a80-7ac93d738d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_3525ac7f-36bc-4b39-b5b0-fdca6d1f3898" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_3525ac7f-36bc-4b39-b5b0-fdca6d1f3898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_87229f72-c47c-41bd-96eb-5b3cfd35ba3f" xlink:href="iart-20211231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_87229f72-c47c-41bd-96eb-5b3cfd35ba3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_e435aab6-15aa-4d3d-89c5-3e61636b3768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1866fc9c-9254-4869-a117-1aeec917b2dc" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_e435aab6-15aa-4d3d-89c5-3e61636b3768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_99ba8be3-80ff-45fa-8693-26b4dc8e93be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_d9adc4aa-c3c2-43ba-aaaf-ae9faffff3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_99ba8be3-80ff-45fa-8693-26b4dc8e93be" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_d9adc4aa-c3c2-43ba-aaaf-ae9faffff3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_ed5862a5-b2b0-4141-ab5b-510556f7d756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_99ba8be3-80ff-45fa-8693-26b4dc8e93be" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_ed5862a5-b2b0-4141-ab5b-510556f7d756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_4415560a-019f-4cd9-8741-eab7150f6920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_99ba8be3-80ff-45fa-8693-26b4dc8e93be" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_4415560a-019f-4cd9-8741-eab7150f6920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_d4387398-12cd-466d-b677-82d84182ce13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_99ba8be3-80ff-45fa-8693-26b4dc8e93be" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_d4387398-12cd-466d-b677-82d84182ce13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_94f906f2-1cc1-4923-b545-c1d728d937ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_99ba8be3-80ff-45fa-8693-26b4dc8e93be" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_94f906f2-1cc1-4923-b545-c1d728d937ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_f6054768-a4e6-4a5c-bfcb-ee291b8a430c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_99ba8be3-80ff-45fa-8693-26b4dc8e93be" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_f6054768-a4e6-4a5c-bfcb-ee291b8a430c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="simple" xlink:href="iart-20211231.xsd#LEASESANDRELATEDPARTYLEASES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8f5a3d16-c7fc-4122-bd73-9742f44a2f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_de58ed28-8aef-4f77-92b4-66baa0d0a292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8f5a3d16-c7fc-4122-bd73-9742f44a2f08" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_de58ed28-8aef-4f77-92b4-66baa0d0a292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="simple" xlink:href="iart-20211231.xsd#LEASESANDRELATEDPARTYLEASESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a7e27049-518a-49c0-b92b-d535a2d26b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock_5e91f411-2e11-4b90-994b-5484cef30f09" xlink:href="iart-20211231.xsd#iart_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a7e27049-518a-49c0-b92b-d535a2d26b3a" xlink:to="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock_5e91f411-2e11-4b90-994b-5484cef30f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeTableTextBlock_93109d7a-2231-499a-af1b-23cd56edd7e6" xlink:href="iart-20211231.xsd#iart_CashFlowLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a7e27049-518a-49c0-b92b-d535a2d26b3a" xlink:to="loc_iart_CashFlowLesseeTableTextBlock_93109d7a-2231-499a-af1b-23cd56edd7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c908b545-8aa0-46d2-99ea-4a841c208577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a7e27049-518a-49c0-b92b-d535a2d26b3a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c908b545-8aa0-46d2-99ea-4a841c208577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#LEASESANDRELATEDPARTYLEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f6741ec8-e91c-45ab-b695-e17ec1dd0031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b02b8914-b093-482e-85d9-2c42220ec09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f6741ec8-e91c-45ab-b695-e17ec1dd0031" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b02b8914-b093-482e-85d9-2c42220ec09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0fef6f1b-6051-4bab-9382-5458f9d427af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b02b8914-b093-482e-85d9-2c42220ec09c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0fef6f1b-6051-4bab-9382-5458f9d427af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c151eada-f6aa-4f23-bc24-17b876fbf773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0fef6f1b-6051-4bab-9382-5458f9d427af" xlink:to="loc_us-gaap_RelatedPartyDomain_c151eada-f6aa-4f23-bc24-17b876fbf773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_caaa8dbe-d70e-4b86-9601-97364f620660" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c151eada-f6aa-4f23-bc24-17b876fbf773" xlink:to="loc_srt_AffiliatedEntityMember_caaa8dbe-d70e-4b86-9601-97364f620660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_8ef23681-f361-492c-8de6-4975429faf70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b02b8914-b093-482e-85d9-2c42220ec09c" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_8ef23681-f361-492c-8de6-4975429faf70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_57274069-6ace-4841-812c-fd4196103693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_8ef23681-f361-492c-8de6-4975429faf70" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_57274069-6ace-4841-812c-fd4196103693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember_9319450e-d3e6-4a90-924b-24e08b1d8087" xlink:href="iart-20211231.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_57274069-6ace-4841-812c-fd4196103693" xlink:to="loc_iart_FiveYearOptionLeasePeriodOneMember_9319450e-d3e6-4a90-924b-24e08b1d8087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearLeasePeriodTwoMember_91e1e6a9-2745-4ac3-b59b-38f9c183dfe9" xlink:href="iart-20211231.xsd#iart_FiveYearLeasePeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_57274069-6ace-4841-812c-fd4196103693" xlink:to="loc_iart_FiveYearLeasePeriodTwoMember_91e1e6a9-2745-4ac3-b59b-38f9c183dfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b02b8914-b093-482e-85d9-2c42220ec09c" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_12e2fe7a-1f9a-4a5b-affb-45350634fb15" xlink:href="iart-20211231.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_12e2fe7a-1f9a-4a5b-affb-45350634fb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_1361c7c3-1e2b-4fdd-89bc-2600af9e6034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_us-gaap_OperatingLeaseExpense_1361c7c3-1e2b-4fdd-89bc-2600af9e6034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1cad3d99-8c18-40d3-b831-c1767ca70324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1cad3d99-8c18-40d3-b831-c1767ca70324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_24b8e0b3-cb0c-4835-8beb-bb02f00d98f0" xlink:href="iart-20211231.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_24b8e0b3-cb0c-4835-8beb-bb02f00d98f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement_e29b4d77-212b-4ba5-bcf7-dcf9e49b4046" xlink:href="iart-20211231.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_iart_AnnualRateOfLeaseAgreement_e29b4d77-212b-4ba5-bcf7-dcf9e49b4046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OptionToExtendLeaseYears_81ad0b2a-4daf-433c-b3eb-f88f4e1b8c63" xlink:href="iart-20211231.xsd#iart_OptionToExtendLeaseYears"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_iart_OptionToExtendLeaseYears_81ad0b2a-4daf-433c-b3eb-f88f4e1b8c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_612ecf8d-4c60-4bac-8e7f-8d11ffaaec4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_2f0a7e05-7bc1-4b23-9a61-1213ea996710" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_612ecf8d-4c60-4bac-8e7f-8d11ffaaec4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_51d2e2cb-7251-4a0b-ad9d-0cdafefd6cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2d3b36ce-770a-4e34-88ff-cb7fe3704f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_51d2e2cb-7251-4a0b-ad9d-0cdafefd6cce" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2d3b36ce-770a-4e34-88ff-cb7fe3704f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bf2dc9bd-02e6-4eb3-b0cc-033a54f65be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d3b36ce-770a-4e34-88ff-cb7fe3704f1a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bf2dc9bd-02e6-4eb3-b0cc-033a54f65be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5570aa2-46b8-4bba-ad19-2fa9fefb6c62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bf2dc9bd-02e6-4eb3-b0cc-033a54f65be8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5570aa2-46b8-4bba-ad19-2fa9fefb6c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_98a9456c-5f3f-4775-bd2f-3b0c5093d15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5570aa2-46b8-4bba-ad19-2fa9fefb6c62" xlink:to="loc_us-gaap_BuildingMember_98a9456c-5f3f-4775-bd2f-3b0c5093d15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_117a4c72-83b1-485d-a93e-5982242684bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5570aa2-46b8-4bba-ad19-2fa9fefb6c62" xlink:to="loc_us-gaap_VehiclesMember_117a4c72-83b1-485d-a93e-5982242684bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d3b36ce-770a-4e34-88ff-cb7fe3704f1a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_64559a7f-a192-464b-9607-8f443b9a0d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_64559a7f-a192-464b-9607-8f443b9a0d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_97bf7e8f-cdc2-468b-87c0-33fff56bca06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_97bf7e8f-cdc2-468b-87c0-33fff56bca06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bb3f63cf-932a-45f9-bc97-e7a34fdd157f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bb3f63cf-932a-45f9-bc97-e7a34fdd157f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e12dafd1-f003-4267-93dc-d299346cede8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseLiability_e12dafd1-f003-4267-93dc-d299346cede8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1b9cf755-cff3-4b17-b59f-d2216a423244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1b9cf755-cff3-4b17-b59f-d2216a423244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ca95fa5f-e039-4852-8c03-20a997a3d50d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_227c56ea-96e4-458e-8694-76b63af81e4a" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ca95fa5f-e039-4852-8c03-20a997a3d50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_19329b9a-a7a2-46c2-8b82-b74aa10c9751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeAbstract_15e66e09-1c05-473a-ad1b-a53661cbc0d9" xlink:href="iart-20211231.xsd#iart_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_19329b9a-a7a2-46c2-8b82-b74aa10c9751" xlink:to="loc_iart_CashFlowLesseeAbstract_15e66e09-1c05-473a-ad1b-a53661cbc0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_78d28fd4-ccf0-4056-9e38-85dabb209e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_CashFlowLesseeAbstract_15e66e09-1c05-473a-ad1b-a53661cbc0d9" xlink:to="loc_us-gaap_OperatingLeasePayments_78d28fd4-ccf0-4056-9e38-85dabb209e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_e61723f8-20ab-4244-9f4d-47e4b8fcafc6" xlink:href="iart-20211231.xsd#iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_19329b9a-a7a2-46c2-8b82-b74aa10c9751" xlink:to="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_e61723f8-20ab-4244-9f4d-47e4b8fcafc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_67489452-a364-42dc-a473-798a600ffc77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_e61723f8-20ab-4244-9f4d-47e4b8fcafc6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_67489452-a364-42dc-a473-798a600ffc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_edacca05-1717-40bc-92ac-5f2fb7081f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_1528e9bd-022a-4230-824a-39bc054c3a79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_edacca05-1717-40bc-92ac-5f2fb7081f0f" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_1528e9bd-022a-4230-824a-39bc054c3a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_39f41d1b-b243-42fb-93bc-631c9225c45d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_1528e9bd-022a-4230-824a-39bc054c3a79" xlink:to="loc_srt_CounterpartyNameAxis_39f41d1b-b243-42fb-93bc-631c9225c45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6bd66d5a-08c9-49fd-bea4-0feaefc95895" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_39f41d1b-b243-42fb-93bc-631c9225c45d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6bd66d5a-08c9-49fd-bea4-0feaefc95895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember_ab5a0222-d75c-4cbb-9565-5259bac8c5a5" xlink:href="iart-20211231.xsd#iart_RelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6bd66d5a-08c9-49fd-bea4-0feaefc95895" xlink:to="loc_iart_RelatedPartiesMember_ab5a0222-d75c-4cbb-9565-5259bac8c5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember_0a4e5151-0b63-4bf2-aa94-496a13a3189b" xlink:href="iart-20211231.xsd#iart_ThirdPartiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6bd66d5a-08c9-49fd-bea4-0feaefc95895" xlink:to="loc_iart_ThirdPartiesMember_0a4e5151-0b63-4bf2-aa94-496a13a3189b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_1528e9bd-022a-4230-824a-39bc054c3a79" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8df8cb52-1d70-45f6-b9da-92ec0a21464e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8df8cb52-1d70-45f6-b9da-92ec0a21464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fc5499a5-655c-4476-af22-2d7473d965d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fc5499a5-655c-4476-af22-2d7473d965d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e79eaffe-ffdf-4795-a08f-072b4b67b180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e79eaffe-ffdf-4795-a08f-072b4b67b180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ae20dff-275b-4b3a-8fa2-5c3232962767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ae20dff-275b-4b3a-8fa2-5c3232962767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4c405f8d-e7f6-41f3-b5bf-ef5a552e3de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4c405f8d-e7f6-41f3-b5bf-ef5a552e3de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_edbaa790-210f-4134-98f1-2f90812aaf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_edbaa790-210f-4134-98f1-2f90812aaf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75c30d74-e24f-4fc7-b180-591b038a22bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75c30d74-e24f-4fc7-b180-591b038a22bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_48dbe9da-d1dd-4308-b2fa-4f7d6f3b5b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_48dbe9da-d1dd-4308-b2fa-4f7d6f3b5b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_32aec346-cd31-4619-955f-0d3092efb9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_OperatingLeaseLiability_32aec346-cd31-4619-955f-0d3092efb9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_21bcc93d-6870-41f7-8b74-b265abc838b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_21bcc93d-6870-41f7-8b74-b265abc838b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_106a7e12-be37-45c2-b07c-3a62b5adb72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abffbd1f-02da-4b69-bea2-a9f52193fa2c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_106a7e12-be37-45c2-b07c-3a62b5adb72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXES" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_695ccc8a-2ffe-40aa-a944-7ac6a1e231ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_36a1fb81-9f9d-4c60-816e-f97565b54c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_695ccc8a-2ffe-40aa-a944-7ac6a1e231ce" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_36a1fb81-9f9d-4c60-816e-f97565b54c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b8ae9629-dd04-4d27-85b9-7bbb7b371ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1d6afc08-1bd1-42b9-be60-b6c31fce3ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b8ae9629-dd04-4d27-85b9-7bbb7b371ce4" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1d6afc08-1bd1-42b9-be60-b6c31fce3ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_654172c6-9524-4e01-abb3-4684a752dde2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b8ae9629-dd04-4d27-85b9-7bbb7b371ce4" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_654172c6-9524-4e01-abb3-4684a752dde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_124b8306-a650-4c70-8f3d-0630d853575c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b8ae9629-dd04-4d27-85b9-7bbb7b371ce4" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_124b8306-a650-4c70-8f3d-0630d853575c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c1db2556-bdd2-4e83-b2be-ec98bb5df2be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b8ae9629-dd04-4d27-85b9-7bbb7b371ce4" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c1db2556-bdd2-4e83-b2be-ec98bb5df2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_de89769e-8762-4d57-9c86-9f06dd2dbc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b8ae9629-dd04-4d27-85b9-7bbb7b371ce4" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_de89769e-8762-4d57-9c86-9f06dd2dbc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_23d54a47-4452-4b61-8000-d511b1c57129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1a95996a-0c09-4ae7-afca-689f6d7c1b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23d54a47-4452-4b61-8000-d511b1c57129" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1a95996a-0c09-4ae7-afca-689f6d7c1b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1e957667-9e72-403e-bcf6-dcc53ea8d304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23d54a47-4452-4b61-8000-d511b1c57129" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1e957667-9e72-403e-bcf6-dcc53ea8d304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13652e77-41a0-44f4-b2dc-632e5a702f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23d54a47-4452-4b61-8000-d511b1c57129" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13652e77-41a0-44f4-b2dc-632e5a702f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b3430a36-4f86-4b49-98b8-d836f33c01ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ab20a202-d8fe-4bd6-a9a2-28326ae75ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b3430a36-4f86-4b49-98b8-d836f33c01ee" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ab20a202-d8fe-4bd6-a9a2-28326ae75ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b3430a36-4f86-4b49-98b8-d836f33c01ee" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_61731b8e-c600-4a93-bb6d-98e0f510092f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_61731b8e-c600-4a93-bb6d-98e0f510092f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f6e31da4-9493-4f62-ab24-650daeabc9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f6e31da4-9493-4f62-ab24-650daeabc9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_1f03c0a0-bcfb-41c2-8814-c564653a704a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_1f03c0a0-bcfb-41c2-8814-c564653a704a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_0f5f0390-a9f9-41c4-975d-39f6bd681589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_0f5f0390-a9f9-41c4-975d-39f6bd681589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_474b0c66-5c73-4b05-94bc-98ae97b8ca0a" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_474b0c66-5c73-4b05-94bc-98ae97b8ca0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_d0d280fc-6f85-426c-8236-d2da966b497e" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_d0d280fc-6f85-426c-8236-d2da966b497e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_76f3e66c-5658-4195-9c08-f803e665d55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_76f3e66c-5658-4195-9c08-f803e665d55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_6cffaf15-60b4-4ce4-aca3-a96c82e368be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_6cffaf15-60b4-4ce4-aca3-a96c82e368be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_761c416f-aa20-46be-85c1-2cd8da686c37" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_761c416f-aa20-46be-85c1-2cd8da686c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_204139e7-2ec0-41c7-aaae-957788a8bfec" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_204139e7-2ec0-41c7-aaae-957788a8bfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_bf3cbe8c-6d7a-4103-9ec8-fd7ada13c825" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_bf3cbe8c-6d7a-4103-9ec8-fd7ada13c825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_594b44b9-cd2c-4698-ae66-fdc6fc9e226a" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_594b44b9-cd2c-4698-ae66-fdc6fc9e226a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_448dba45-7547-4880-97f7-96d87ad6c8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_448dba45-7547-4880-97f7-96d87ad6c8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_b4faef1d-2fcb-4740-a611-4256db548c27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_b4faef1d-2fcb-4740-a611-4256db548c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_3a65b8a9-28a1-4a3e-8b06-8198e94379d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_121870c1-95a5-436c-a4e2-41e880870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_3a65b8a9-28a1-4a3e-8b06-8198e94379d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_885d42be-c958-499d-8857-d0876cb29acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b3430a36-4f86-4b49-98b8-d836f33c01ee" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_885d42be-c958-499d-8857-d0876cb29acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_decee320-3528-426d-ac63-cec485855034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:href="iart-20211231.xsd#iart_IncomeTaxTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_decee320-3528-426d-ac63-cec485855034" xlink:to="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_e08d8242-96c1-411d-a1f7-cc2db594d642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_e08d8242-96c1-411d-a1f7-cc2db594d642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ad90eb38-a7b1-407a-8af6-dd8b66485e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e08d8242-96c1-411d-a1f7-cc2db594d642" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ad90eb38-a7b1-407a-8af6-dd8b66485e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_9c2a616a-a8c0-4668-b94f-e9fbc9892e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ad90eb38-a7b1-407a-8af6-dd8b66485e04" xlink:to="loc_us-gaap_ForeignCountryMember_9c2a616a-a8c0-4668-b94f-e9fbc9892e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_96198006-eb75-4053-ba90-86ed8007b8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ad90eb38-a7b1-407a-8af6-dd8b66485e04" xlink:to="loc_us-gaap_DomesticCountryMember_96198006-eb75-4053-ba90-86ed8007b8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_75b72fe6-865a-40fe-b401-8fb0b68485b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ad90eb38-a7b1-407a-8af6-dd8b66485e04" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_75b72fe6-865a-40fe-b401-8fb0b68485b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_abf07ce0-2fae-40fb-bfec-45941b0a4f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_abf07ce0-2fae-40fb-bfec-45941b0a4f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_e1a07320-a232-433c-ba4c-a86fa2cd9a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_abf07ce0-2fae-40fb-bfec-45941b0a4f45" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_e1a07320-a232-433c-ba4c-a86fa2cd9a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_3e485752-3026-4d27-a4b3-956d088fa1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_e1a07320-a232-433c-ba4c-a86fa2cd9a8b" xlink:to="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_3e485752-3026-4d27-a4b3-956d088fa1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_794c859a-7328-44a8-a51f-e801920099f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_794c859a-7328-44a8-a51f-e801920099f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5aabc56-23c8-4d2c-9001-4b5439a5aa5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_794c859a-7328-44a8-a51f-e801920099f7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5aabc56-23c8-4d2c-9001-4b5439a5aa5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_2e8ac293-cae7-496a-88f9-ae289ef35482" xlink:href="iart-20211231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5aabc56-23c8-4d2c-9001-4b5439a5aa5f" xlink:to="loc_iart_ExtremityOrthopedicsMember_2e8ac293-cae7-496a-88f9-ae289ef35482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:href="iart-20211231.xsd#iart_IncomeTaxLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_c295bacc-8424-464c-a8f4-b53cb029f09a" xlink:to="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_67070de8-8abe-4aed-a1e2-31a247cf8ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_67070de8-8abe-4aed-a1e2-31a247cf8ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_6288e483-5b02-4e49-9327-0be539f42f43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_6288e483-5b02-4e49-9327-0be539f42f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_ce917829-9c59-4a6d-a69f-61a51ff41210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_ce917829-9c59-4a6d-a69f-61a51ff41210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_352e0331-6eb4-40d5-9b60-a0e65125fb8d" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_352e0331-6eb4-40d5-9b60-a0e65125fb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_a305e559-adb9-4138-a174-ae6031688243" xlink:href="iart-20211231.xsd#iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_a305e559-adb9-4138-a174-ae6031688243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_d637d323-e4df-411c-b151-86eefdd0ff9a" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_d637d323-e4df-411c-b151-86eefdd0ff9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e28b0823-e513-4190-95b1-0c8f21621227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e28b0823-e513-4190-95b1-0c8f21621227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_ec96bf92-88ee-4b35-ba86-dcff335b38c8" xlink:href="iart-20211231.xsd#iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_ec96bf92-88ee-4b35-ba86-dcff335b38c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_69490c46-ed47-499a-93ac-b63a2f08481d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_69490c46-ed47-499a-93ac-b63a2f08481d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_d231b635-1493-453d-a879-a99eea4a8615" xlink:href="iart-20211231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_d231b635-1493-453d-a879-a99eea4a8615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_c2968408-d491-4e2c-86bd-d2d87871d978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_OperatingLossCarryforwards_c2968408-d491-4e2c-86bd-d2d87871d978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_3b669bbb-7f4e-4558-ae43-09e6825add17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_3b669bbb-7f4e-4558-ae43-09e6825add17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_64b7fcef-12a3-4377-afb4-36ccc3f7b77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_64b7fcef-12a3-4377-afb4-36ccc3f7b77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated_5cf8f6d2-a3d6-4a01-900c-9545636f9522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_ForeignEarningsRepatriated_5cf8f6d2-a3d6-4a01-900c-9545636f9522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4b17999e-3bb7-40eb-a326-6297d0629339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4b17999e-3bb7-40eb-a326-6297d0629339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_095b7858-dbfb-4738-bdbb-42da7eddaed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_095b7858-dbfb-4738-bdbb-42da7eddaed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_eee7b95c-bcff-4329-add5-b8040d677fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_eee7b95c-bcff-4329-add5-b8040d677fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_1110abfc-9e61-43a6-a031-abab53768a26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_cd4836e6-883a-45c2-ad6e-e0f2a0ff19e2" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_1110abfc-9e61-43a6-a031-abab53768a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cda64137-3b55-49e3-9368-cbdaf1981749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ec805857-d30b-4ea1-934b-c90b971c58c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cda64137-3b55-49e3-9368-cbdaf1981749" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ec805857-d30b-4ea1-934b-c90b971c58c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_74804255-b3c6-4981-adde-62018502d091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ec805857-d30b-4ea1-934b-c90b971c58c2" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_74804255-b3c6-4981-adde-62018502d091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3f56d45a-05d0-404c-9c4c-bbdb618f968c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ec805857-d30b-4ea1-934b-c90b971c58c2" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3f56d45a-05d0-404c-9c4c-bbdb618f968c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_55560d80-2ef5-43ff-91d2-9f3d6cd7304d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ec805857-d30b-4ea1-934b-c90b971c58c2" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_55560d80-2ef5-43ff-91d2-9f3d6cd7304d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_26587017-dfc4-4490-ac85-79844af65c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ec805857-d30b-4ea1-934b-c90b971c58c2" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_26587017-dfc4-4490-ac85-79844af65c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1553a616-f21f-44c5-a05d-3ff2271726b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cda64137-3b55-49e3-9368-cbdaf1981749" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1553a616-f21f-44c5-a05d-3ff2271726b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7d6608e5-1ba4-42db-bfa1-954b121f1074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1553a616-f21f-44c5-a05d-3ff2271726b5" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7d6608e5-1ba4-42db-bfa1-954b121f1074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b3a41a1d-88ec-421a-b2c3-88ccaa239bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1553a616-f21f-44c5-a05d-3ff2271726b5" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b3a41a1d-88ec-421a-b2c3-88ccaa239bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_d30134fc-9442-4c01-924d-e183c311d9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1553a616-f21f-44c5-a05d-3ff2271726b5" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_d30134fc-9442-4c01-924d-e183c311d9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a44f2c8c-f912-4e1d-81f8-65d0a4949e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1553a616-f21f-44c5-a05d-3ff2271726b5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a44f2c8c-f912-4e1d-81f8-65d0a4949e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7a3626ba-05f5-438c-867c-e40fafd484d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cda64137-3b55-49e3-9368-cbdaf1981749" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7a3626ba-05f5-438c-867c-e40fafd484d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0e211092-9f9a-4490-814b-dd0933162c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0e211092-9f9a-4490-814b-dd0933162c30" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_50cc77a1-f195-4740-b7d6-776f7d154863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_50cc77a1-f195-4740-b7d6-776f7d154863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_cef82d22-2b02-4ff8-a373-b3a067e4adec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_cef82d22-2b02-4ff8-a373-b3a067e4adec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f53c7baf-b5aa-4e00-889b-40b05b81c7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f53c7baf-b5aa-4e00-889b-40b05b81c7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_b6960ae6-e94e-467d-a884-d84a5ae006ff" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_b6960ae6-e94e-467d-a884-d84a5ae006ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_d0b91dbe-af6e-4a55-89e4-1604214590b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_d0b91dbe-af6e-4a55-89e4-1604214590b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_19c0374f-a9bb-4bc4-adb8-fc73d34664f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_19c0374f-a9bb-4bc4-adb8-fc73d34664f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_ecb8b881-be20-4d94-8183-5c480606e6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_ecb8b881-be20-4d94-8183-5c480606e6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4ef800a6-107f-4f02-adbb-24df889d84a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4ef800a6-107f-4f02-adbb-24df889d84a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_0b86d1ab-e833-4b0f-8874-5898daff0b66" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_0b86d1ab-e833-4b0f-8874-5898daff0b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_3d551cdf-3abd-4382-a983-f27d80425f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_3d551cdf-3abd-4382-a983-f27d80425f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_fae6ed38-52eb-40b0-a84c-2c01989672c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_fae6ed38-52eb-40b0-a84c-2c01989672c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsLeasesAndOther_8e0c7e64-ad60-41a4-a4f4-1ae4c4809e8a" xlink:href="iart-20211231.xsd#iart_DeferredTaxAssetsLeasesAndOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_iart_DeferredTaxAssetsLeasesAndOther_8e0c7e64-ad60-41a4-a4f4-1ae4c4809e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_db95704c-c7fb-4b13-ad49-ce047600945d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_db95704c-c7fb-4b13-ad49-ce047600945d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2f2b95de-1cb4-49f9-9448-a97a9de1a84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2f2b95de-1cb4-49f9-9448-a97a9de1a84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_39659ff6-3d56-4ebe-beab-bfb94d05471b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_6f38a372-af39-4927-a635-5fb560b94aeb" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_39659ff6-3d56-4ebe-beab-bfb94d05471b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3309d31d-ffd6-43ab-bda7-39e53af66f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0e211092-9f9a-4490-814b-dd0933162c30" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3309d31d-ffd6-43ab-bda7-39e53af66f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_e615fbfa-76cf-4b31-9ca6-3ccd0225a584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3309d31d-ffd6-43ab-bda7-39e53af66f18" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_e615fbfa-76cf-4b31-9ca6-3ccd0225a584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_c7594bb0-d80b-4a1e-bae7-eb0eae4adf0e" xlink:href="iart-20211231.xsd#iart_DeferredTaxLiabilitiesLeasesAndOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3309d31d-ffd6-43ab-bda7-39e53af66f18" xlink:to="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_c7594bb0-d80b-4a1e-bae7-eb0eae4adf0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_bbc07700-f040-4c6a-8f7d-02a860b9d76e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3309d31d-ffd6-43ab-bda7-39e53af66f18" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_bbc07700-f040-4c6a-8f7d-02a860b9d76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_78f06d20-0548-42cb-9b93-ceaaa3c2448f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0e211092-9f9a-4490-814b-dd0933162c30" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_78f06d20-0548-42cb-9b93-ceaaa3c2448f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c6aa2b47-4408-4010-ac28-8dd71e9e7b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0bda6e02-53a8-4a33-b520-120bb1936f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c6aa2b47-4408-4010-ac28-8dd71e9e7b54" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0bda6e02-53a8-4a33-b520-120bb1936f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1b2703d1-a258-46ff-a985-e24ad1515b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0bda6e02-53a8-4a33-b520-120bb1936f6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1b2703d1-a258-46ff-a985-e24ad1515b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_59ed6a88-2130-406e-9518-425d54e3131e" xlink:href="iart-20211231.xsd#iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0bda6e02-53a8-4a33-b520-120bb1936f6e" xlink:to="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_59ed6a88-2130-406e-9518-425d54e3131e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_a216f74e-85f8-44af-bf45-525c8c99a1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_59ed6a88-2130-406e-9518-425d54e3131e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_a216f74e-85f8-44af-bf45-525c8c99a1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_3b6eb33b-26b4-4851-b09a-2857b6ca5a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_59ed6a88-2130-406e-9518-425d54e3131e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_3b6eb33b-26b4-4851-b09a-2857b6ca5a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_3a83d763-0f2b-40a4-bfb7-362732a43955" xlink:href="iart-20211231.xsd#iart_UnrecognizedTaxBenefitsReductionsResultingFromOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0bda6e02-53a8-4a33-b520-120bb1936f6e" xlink:to="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_3a83d763-0f2b-40a4-bfb7-362732a43955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8c026e4a-9978-41e0-9bb9-f5b0b2fed4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0bda6e02-53a8-4a33-b520-120bb1936f6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8c026e4a-9978-41e0-9bb9-f5b0b2fed4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="iart-20211231.xsd#NETINCOMEPERSHARE"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9a8d990d-b06b-4e11-a7fd-b3fde5fc206b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_05d48ee5-31ab-458b-bc49-334e1dcfa219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9a8d990d-b06b-4e11-a7fd-b3fde5fc206b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_05d48ee5-31ab-458b-bc49-334e1dcfa219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="iart-20211231.xsd#NETINCOMEPERSHARETables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0418058e-ed3c-42a6-ad17-d33c098cb4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_34b2d55b-b781-4a5d-89cd-126ca28dfb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0418058e-ed3c-42a6-ad17-d33c098cb4db" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_34b2d55b-b781-4a5d-89cd-126ca28dfb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e2bdf965-7a88-4317-8775-48bb7b8f249a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_c953c26c-6cab-46c8-b9a7-c56f9b69024e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e2bdf965-7a88-4317-8775-48bb7b8f249a" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_c953c26c-6cab-46c8-b9a7-c56f9b69024e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c076f798-1f3a-4834-a1ed-4c8a422196f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_c953c26c-6cab-46c8-b9a7-c56f9b69024e" xlink:to="loc_us-gaap_NetIncomeLoss_c076f798-1f3a-4834-a1ed-4c8a422196f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c36aa766-6aea-42cb-a93f-90ba9edc7bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_c953c26c-6cab-46c8-b9a7-c56f9b69024e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c36aa766-6aea-42cb-a93f-90ba9edc7bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c61aa89e-82fd-42d4-9eee-78a74d94c739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_c953c26c-6cab-46c8-b9a7-c56f9b69024e" xlink:to="loc_us-gaap_EarningsPerShareBasic_c61aa89e-82fd-42d4-9eee-78a74d94c739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_65f0500d-3998-4da8-b256-83717e620f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e2bdf965-7a88-4317-8775-48bb7b8f249a" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_65f0500d-3998-4da8-b256-83717e620f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3214390b-946f-4ed6-8379-3873660549a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_65f0500d-3998-4da8-b256-83717e620f9a" xlink:to="loc_us-gaap_NetIncomeLoss_3214390b-946f-4ed6-8379-3873660549a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_be13a2fb-f8fc-415b-8851-81eb5b82743a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_65f0500d-3998-4da8-b256-83717e620f9a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_be13a2fb-f8fc-415b-8851-81eb5b82743a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_279c013a-6fe0-4cd6-9a82-6b11756480a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_65f0500d-3998-4da8-b256-83717e620f9a" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_279c013a-6fe0-4cd6-9a82-6b11756480a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_94d2293c-a4a8-4018-9cc3-4aacf60c129b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_279c013a-6fe0-4cd6-9a82-6b11756480a1" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_94d2293c-a4a8-4018-9cc3-4aacf60c129b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ecc4ba92-7b90-4095-95a9-65c91f009954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_279c013a-6fe0-4cd6-9a82-6b11756480a1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ecc4ba92-7b90-4095-95a9-65c91f009954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7a0f2064-7ea5-4de7-94c2-a227766f8928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_65f0500d-3998-4da8-b256-83717e620f9a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7a0f2064-7ea5-4de7-94c2-a227766f8928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#NETINCOMEPERSHARENarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2c11efd5-c12d-45ab-834c-b6aba5314011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0342c37d-d99f-4797-87c5-fedf3c409107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2c11efd5-c12d-45ab-834c-b6aba5314011" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0342c37d-d99f-4797-87c5-fedf3c409107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ee9b01d5-77b6-43fe-b6a6-b7a0e09f74d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0342c37d-d99f-4797-87c5-fedf3c409107" xlink:to="loc_us-gaap_AwardTypeAxis_ee9b01d5-77b6-43fe-b6a6-b7a0e09f74d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63737067-2ce8-477d-9276-4778ea48c2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ee9b01d5-77b6-43fe-b6a6-b7a0e09f74d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63737067-2ce8-477d-9276-4778ea48c2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceSharesandRestrictedUnitsMember_3e11b2a8-5f80-4d73-886a-2106ce554244" xlink:href="iart-20211231.xsd#iart_PerformanceSharesandRestrictedUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63737067-2ce8-477d-9276-4778ea48c2b8" xlink:to="loc_iart_PerformanceSharesandRestrictedUnitsMember_3e11b2a8-5f80-4d73-886a-2106ce554244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_dea6b10d-adb5-41d1-89b3-3f30211950ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0342c37d-d99f-4797-87c5-fedf3c409107" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_dea6b10d-adb5-41d1-89b3-3f30211950ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67f3cdbe-4af9-4c42-ac4a-0cdd16e62fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_dea6b10d-adb5-41d1-89b3-3f30211950ee" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67f3cdbe-4af9-4c42-ac4a-0cdd16e62fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AdditionalEPSShares_d3c9fbbd-fd6b-4d16-afc2-03f0ba8770af" xlink:href="iart-20211231.xsd#iart_AdditionalEPSShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_dea6b10d-adb5-41d1-89b3-3f30211950ee" xlink:to="loc_iart_AdditionalEPSShares_d3c9fbbd-fd6b-4d16-afc2-03f0ba8770af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="iart-20211231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_374ffa7f-b57f-4a0b-8bb1-f153e7e2a4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_61fae7cf-7c58-4ed7-b47a-1e303259878e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_374ffa7f-b57f-4a0b-8bb1-f153e7e2a4c8" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_61fae7cf-7c58-4ed7-b47a-1e303259878e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="simple" xlink:href="iart-20211231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_62274590-6244-4b0a-b4eb-5c23e264ab88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b792ed1f-6d56-4bd1-8bc8-db73323226db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_62274590-6244-4b0a-b4eb-5c23e264ab88" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b792ed1f-6d56-4bd1-8bc8-db73323226db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_a98973ef-c901-422c-934d-14ad0b474451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_18e87bae-151a-4068-afcf-7d2e3af09897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_a98973ef-c901-422c-934d-14ad0b474451" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_18e87bae-151a-4068-afcf-7d2e3af09897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ac1bab2f-78be-4608-b678-86323ec563a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_18e87bae-151a-4068-afcf-7d2e3af09897" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ac1bab2f-78be-4608-b678-86323ec563a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c0ef355-fd22-4ad0-93bd-b33933f4e39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ac1bab2f-78be-4608-b678-86323ec563a7" xlink:to="loc_us-gaap_EquityComponentDomain_2c0ef355-fd22-4ad0-93bd-b33933f4e39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba73a887-0fe1-44eb-b854-ab52a0a94535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2c0ef355-fd22-4ad0-93bd-b33933f4e39a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba73a887-0fe1-44eb-b854-ab52a0a94535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5aa038b8-9335-4bcb-8bb8-a7b072949014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba73a887-0fe1-44eb-b854-ab52a0a94535" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5aa038b8-9335-4bcb-8bb8-a7b072949014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_065036d7-6162-4db4-82a0-fe7bba06b1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba73a887-0fe1-44eb-b854-ab52a0a94535" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_065036d7-6162-4db4-82a0-fe7bba06b1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dc9d7b99-c2b4-4597-bda8-7722137d5837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba73a887-0fe1-44eb-b854-ab52a0a94535" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dc9d7b99-c2b4-4597-bda8-7722137d5837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c54f66c8-26c5-4144-a9c6-421dae5a9b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_18e87bae-151a-4068-afcf-7d2e3af09897" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c54f66c8-26c5-4144-a9c6-421dae5a9b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:href="iart-20211231.xsd#iart_AccumulatedOtherComprehensiveIncomeLossRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c54f66c8-26c5-4144-a9c6-421dae5a9b0b" xlink:to="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_26ca1294-6434-406d-bce3-917703a296a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:to="loc_us-gaap_StockholdersEquity_26ca1294-6434-406d-bce3-917703a296a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_473a1b07-31dc-4059-9b99-df7445679e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_473a1b07-31dc-4059-9b99-df7445679e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_cfd4ea7d-ee0c-44f1-98e7-0977a6a241fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_cfd4ea7d-ee0c-44f1-98e7-0977a6a241fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_241b54c8-78be-42e6-9142-52c16f3e14a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_241b54c8-78be-42e6-9142-52c16f3e14a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_76023a61-14ab-4406-b728-713a5dd66420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_3f912e5d-ff81-4aff-bdc1-40cd88b1d472" xlink:to="loc_us-gaap_StockholdersEquity_76023a61-14ab-4406-b728-713a5dd66420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_f88164ba-c5cf-4748-8258-3909b3e86a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8c75768c-f54b-4c2a-896c-4ab8a7747c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f88164ba-c5cf-4748-8258-3909b3e86a7e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8c75768c-f54b-4c2a-896c-4ab8a7747c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a221f19c-96ce-4e1f-a021-053ab1140496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8c75768c-f54b-4c2a-896c-4ab8a7747c1d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a221f19c-96ce-4e1f-a021-053ab1140496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a53d3a1e-4d1c-4529-b1c9-3eb7ccc9b6af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a221f19c-96ce-4e1f-a021-053ab1140496" xlink:to="loc_us-gaap_EquityComponentDomain_a53d3a1e-4d1c-4529-b1c9-3eb7ccc9b6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_be0ec04f-b4cb-4545-9d35-658b24570b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a53d3a1e-4d1c-4529-b1c9-3eb7ccc9b6af" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_be0ec04f-b4cb-4545-9d35-658b24570b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1cb01090-a805-4167-ba0c-c70d6a5bd596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8c75768c-f54b-4c2a-896c-4ab8a7747c1d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1cb01090-a805-4167-ba0c-c70d6a5bd596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5ed5c7ee-edf1-4b6d-9a55-7d2f9ce97949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1cb01090-a805-4167-ba0c-c70d6a5bd596" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5ed5c7ee-edf1-4b6d-9a55-7d2f9ce97949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_90e287e5-3296-4030-8f17-5b37de2af1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5ed5c7ee-edf1-4b6d-9a55-7d2f9ce97949" xlink:to="loc_us-gaap_OtherExpenseMember_90e287e5-3296-4030-8f17-5b37de2af1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_7fe26567-f2ad-4ba9-bb72-21d6e0ce6336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5ed5c7ee-edf1-4b6d-9a55-7d2f9ce97949" xlink:to="loc_us-gaap_InterestIncomeMember_7fe26567-f2ad-4ba9-bb72-21d6e0ce6336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8e652cb3-c77b-4e7b-929f-57261395176d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8c75768c-f54b-4c2a-896c-4ab8a7747c1d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8e652cb3-c77b-4e7b-929f-57261395176d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_d6298ebe-da4a-46fc-9bb9-719c9dda0385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8e652cb3-c77b-4e7b-929f-57261395176d" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_d6298ebe-da4a-46fc-9bb9-719c9dda0385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="iart-20211231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cc531bc0-b18e-4b01-93de-b4f512d59fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_eeb07b35-072c-4bbc-8f74-7e4e881b574e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cc531bc0-b18e-4b01-93de-b4f512d59fdc" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_eeb07b35-072c-4bbc-8f74-7e4e881b574e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="simple" xlink:href="iart-20211231.xsd#COMMITMENTSANDCONTINGENCIESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75d4723d-b180-4b6b-800e-f804736c2874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_16bdbbcc-9eb0-4926-b817-5611e1362984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75d4723d-b180-4b6b-800e-f804736c2874" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_16bdbbcc-9eb0-4926-b817-5611e1362984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2fbcebbf-eaa5-4e4a-a552-e9f313a9e7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2fbcebbf-eaa5-4e4a-a552-e9f313a9e7d3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7410e0ed-2ea6-4343-a253-559b2cb930c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7410e0ed-2ea6-4343-a253-559b2cb930c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2322a-82b3-4118-9e73-f74acd93510c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7410e0ed-2ea6-4343-a253-559b2cb930c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2322a-82b3-4118-9e73-f74acd93510c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_41c6b3d8-7753-4df8-9567-054a12cf52d1" xlink:href="iart-20211231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2322a-82b3-4118-9e73-f74acd93510c" xlink:to="loc_iart_ArkisBioSciencesInc.Member_41c6b3d8-7753-4df8-9567-054a12cf52d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_2a956a9d-5e60-4e15-b1d7-d8d388e272e1" xlink:href="iart-20211231.xsd#iart_DermaSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2322a-82b3-4118-9e73-f74acd93510c" xlink:to="loc_iart_DermaSciencesMember_2a956a9d-5e60-4e15-b1d7-d8d388e272e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember_0b282fe4-3944-4b50-87be-ab2bde4b88c6" xlink:href="iart-20211231.xsd#iart_ACellMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2322a-82b3-4118-9e73-f74acd93510c" xlink:to="loc_iart_ACellMember_0b282fe4-3944-4b50-87be-ab2bde4b88c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_f84baae3-055d-461f-9322-05e9eb1b3662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_f84baae3-055d-461f-9322-05e9eb1b3662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_cbbb3e37-a994-44e2-8ce4-8ddd75bc5cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f84baae3-055d-461f-9322-05e9eb1b3662" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_cbbb3e37-a994-44e2-8ce4-8ddd75bc5cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_91a25011-e475-4a2c-bffd-37d8d42f56ef" xlink:href="iart-20211231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_cbbb3e37-a994-44e2-8ce4-8ddd75bc5cd7" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_91a25011-e475-4a2c-bffd-37d8d42f56ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_da7fbdfe-a162-4c0b-abd9-044290abce60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_da7fbdfe-a162-4c0b-abd9-044290abce60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_68d4965d-654e-4902-b51f-ef770fc8bc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_da7fbdfe-a162-4c0b-abd9-044290abce60" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_68d4965d-654e-4902-b51f-ef770fc8bc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6e5655f2-5862-4f6c-9261-72a707695d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_68d4965d-654e-4902-b51f-ef770fc8bc99" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6e5655f2-5862-4f6c-9261-72a707695d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8c8ddf8e-6a73-4889-b4b8-16b6c90a62df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8c8ddf8e-6a73-4889-b4b8-16b6c90a62df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_370cdf1d-ac76-4e43-b6cc-af2d4c554528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8c8ddf8e-6a73-4889-b4b8-16b6c90a62df" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_370cdf1d-ac76-4e43-b6cc-af2d4c554528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_af8caeff-0770-4117-876c-ef02fe265d6c" xlink:href="iart-20211231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_370cdf1d-ac76-4e43-b6cc-af2d4c554528" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_af8caeff-0770-4117-876c-ef02fe265d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2fcb304a-a659-4fa0-ab5b-2806e74a1013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_370cdf1d-ac76-4e43-b6cc-af2d4c554528" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2fcb304a-a659-4fa0-ab5b-2806e74a1013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4f5bf5f0-ba01-45d0-8ff6-99fa61e27aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36e63f65-6953-474d-bf2f-c4602527c256" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4f5bf5f0-ba01-45d0-8ff6-99fa61e27aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4f5bf5f0-ba01-45d0-8ff6-99fa61e27aa5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b508b4e5-d776-4b30-a7a8-af6c22d50180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b508b4e5-d776-4b30-a7a8-af6c22d50180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0d786029-4cb9-4100-a5f7-443458b78473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0d786029-4cb9-4100-a5f7-443458b78473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_7bad0388-4d3a-44c3-bbd9-c23c2a2cc2cd" xlink:href="iart-20211231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:to="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_7bad0388-4d3a-44c3-bbd9-c23c2a2cc2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_36160772-1a73-4e5e-9b13-ea66753af880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_36160772-1a73-4e5e-9b13-ea66753af880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b32c0c53-4069-4787-b392-3005644fd558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8f8bcc1-d5e7-4efc-8695-1e1987e788d5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b32c0c53-4069-4787-b392-3005644fd558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#COMMITMENTSANDCONTINGENCIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_091e4b64-6f87-4fac-ab97-d5ba329a08c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5abed335-39b1-48cb-8d43-1e5fad169323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_091e4b64-6f87-4fac-ab97-d5ba329a08c5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5abed335-39b1-48cb-8d43-1e5fad169323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c766443c-27e1-4197-805e-d8eca81bd1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5abed335-39b1-48cb-8d43-1e5fad169323" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c766443c-27e1-4197-805e-d8eca81bd1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da127e00-7ec8-45e5-81fc-1e1699081de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c766443c-27e1-4197-805e-d8eca81bd1bb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da127e00-7ec8-45e5-81fc-1e1699081de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_7af2c019-b50e-4e32-8bb3-47ac5e96c167" xlink:href="iart-20211231.xsd#iart_DermaSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da127e00-7ec8-45e5-81fc-1e1699081de2" xlink:to="loc_iart_DermaSciencesMember_7af2c019-b50e-4e32-8bb3-47ac5e96c167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98734c09-0ea5-4c22-8fd9-8df728c4a587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5abed335-39b1-48cb-8d43-1e5fad169323" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98734c09-0ea5-4c22-8fd9-8df728c4a587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_60c6775b-0051-4e4a-ab99-e26d5ea6218b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98734c09-0ea5-4c22-8fd9-8df728c4a587" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_60c6775b-0051-4e4a-ab99-e26d5ea6218b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9747bd92-a819-4fd0-b399-982859d9b5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_60c6775b-0051-4e4a-ab99-e26d5ea6218b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9747bd92-a819-4fd0-b399-982859d9b5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_506df61e-961b-4a73-be44-afe3bf4d393f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5abed335-39b1-48cb-8d43-1e5fad169323" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_506df61e-961b-4a73-be44-afe3bf4d393f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_dd81e0ec-af25-4d43-b7c2-fc5d823341cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_506df61e-961b-4a73-be44-afe3bf4d393f" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_dd81e0ec-af25-4d43-b7c2-fc5d823341cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_32114fa3-f0af-40e4-b579-d26bc7fb2b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_506df61e-961b-4a73-be44-afe3bf4d393f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_32114fa3-f0af-40e4-b579-d26bc7fb2b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c1b3c4d5-23b4-452a-abcd-114e1f585ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_506df61e-961b-4a73-be44-afe3bf4d393f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c1b3c4d5-23b4-452a-abcd-114e1f585ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="simple" xlink:href="iart-20211231.xsd#SEGMENTANDGEOGRAPHICINFORMATION"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9e06e564-1a89-4a91-8bc8-86bc78751d54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_2085dcda-98ca-4122-935a-48289529d9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9e06e564-1a89-4a91-8bc8-86bc78751d54" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_2085dcda-98ca-4122-935a-48289529d9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="simple" xlink:href="iart-20211231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_85cbf0c2-eae4-4418-9b68-11b5509eb5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_48d29900-639c-433e-af9e-e1c10f042981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_85cbf0c2-eae4-4418-9b68-11b5509eb5b5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_48d29900-639c-433e-af9e-e1c10f042981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_73deb2d2-a897-4b34-a39c-bcb9c1ee0846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_85cbf0c2-eae4-4418-9b68-11b5509eb5b5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_73deb2d2-a897-4b34-a39c-bcb9c1ee0846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b3ab6387-4c31-4f19-b386-55ffc761a7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f8f8b2b-f742-4605-bb6a-35e114e1845e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b3ab6387-4c31-4f19-b386-55ffc761a7d3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f8f8b2b-f742-4605-bb6a-35e114e1845e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a5c1159c-f30b-404a-b0d1-f0381672972d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f8f8b2b-f742-4605-bb6a-35e114e1845e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a5c1159c-f30b-404a-b0d1-f0381672972d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4254f56a-a143-46ad-9b85-eb67df3836cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a5c1159c-f30b-404a-b0d1-f0381672972d" xlink:to="loc_us-gaap_SegmentDomain_4254f56a-a143-46ad-9b85-eb67df3836cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_cab901b3-38a7-4680-aa1c-fab7d8026a0f" xlink:href="iart-20211231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4254f56a-a143-46ad-9b85-eb67df3836cb" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_cab901b3-38a7-4680-aa1c-fab7d8026a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3f0aa3d6-9b42-44af-9d2d-4ad4d9d2713b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f8f8b2b-f742-4605-bb6a-35e114e1845e" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_3f0aa3d6-9b42-44af-9d2d-4ad4d9d2713b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_15c2664c-7257-4d10-ac2e-48b0769d9ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3f0aa3d6-9b42-44af-9d2d-4ad4d9d2713b" xlink:to="loc_us-gaap_NumberOfReportableSegments_15c2664c-7257-4d10-ac2e-48b0769d9ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered_8f4f6406-5a76-4b57-b98a-209b6518468c" xlink:href="iart-20211231.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3f0aa3d6-9b42-44af-9d2d-4ad4d9d2713b" xlink:to="loc_iart_SegmentReportingInformationNumberOfProductsOffered_8f4f6406-5a76-4b57-b98a-209b6518468c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6593e49f-f007-42eb-911e-fe5307b0d4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3d9df4-83fc-49ad-b5b0-9a922b74453c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6593e49f-f007-42eb-911e-fe5307b0d4fc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3d9df4-83fc-49ad-b5b0-9a922b74453c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_954015e7-348e-4055-91f6-2a8d28767684" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3d9df4-83fc-49ad-b5b0-9a922b74453c" xlink:to="loc_srt_ConsolidationItemsAxis_954015e7-348e-4055-91f6-2a8d28767684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_01906a0d-6907-418c-ab71-03e748414ddb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_954015e7-348e-4055-91f6-2a8d28767684" xlink:to="loc_srt_ConsolidationItemsDomain_01906a0d-6907-418c-ab71-03e748414ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7e757983-a2eb-4ca9-a7bc-175f82e73333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_01906a0d-6907-418c-ab71-03e748414ddb" xlink:to="loc_us-gaap_OperatingSegmentsMember_7e757983-a2eb-4ca9-a7bc-175f82e73333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f18858c0-1593-48d9-90ab-351ebf2dc2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_01906a0d-6907-418c-ab71-03e748414ddb" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f18858c0-1593-48d9-90ab-351ebf2dc2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7a295b0e-cc2a-4579-9e2d-22dbb2c4955c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3d9df4-83fc-49ad-b5b0-9a922b74453c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7a295b0e-cc2a-4579-9e2d-22dbb2c4955c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0b6d6b4b-e38f-4996-bb00-7db2042d81ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7a295b0e-cc2a-4579-9e2d-22dbb2c4955c" xlink:to="loc_us-gaap_SegmentDomain_0b6d6b4b-e38f-4996-bb00-7db2042d81ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_ec7c5a37-32c9-4096-811b-f678af235d91" xlink:href="iart-20211231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0b6d6b4b-e38f-4996-bb00-7db2042d81ad" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_ec7c5a37-32c9-4096-811b-f678af235d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_7ff3ee1b-3d59-487d-936b-c1a890273ba1" xlink:href="iart-20211231.xsd#iart_TissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0b6d6b4b-e38f-4996-bb00-7db2042d81ad" xlink:to="loc_iart_TissueTechnologiesMember_7ff3ee1b-3d59-487d-936b-c1a890273ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_757931b9-acdc-4637-a8a8-ed2fd9605a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3d9df4-83fc-49ad-b5b0-9a922b74453c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_757931b9-acdc-4637-a8a8-ed2fd9605a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_0f7157fa-4334-4651-a5ad-4ce30bf33ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_757931b9-acdc-4637-a8a8-ed2fd9605a0c" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_0f7157fa-4334-4651-a5ad-4ce30bf33ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2cabed17-9cc9-49ec-9ce4-4330189ab94f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_0f7157fa-4334-4651-a5ad-4ce30bf33ad0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2cabed17-9cc9-49ec-9ce4-4330189ab94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_45d548cc-3875-430a-8d80-8be99c96d377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_757931b9-acdc-4637-a8a8-ed2fd9605a0c" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_45d548cc-3875-430a-8d80-8be99c96d377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_43e26fb9-5f48-4a9d-9e7b-9f7470bbdc44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_45d548cc-3875-430a-8d80-8be99c96d377" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_43e26fb9-5f48-4a9d-9e7b-9f7470bbdc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a48e296f-513a-4293-91ce-0c125c3f79e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_45d548cc-3875-430a-8d80-8be99c96d377" xlink:to="loc_us-gaap_OperatingIncomeLoss_a48e296f-513a-4293-91ce-0c125c3f79e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c9f0cf3a-45b4-469f-a0e3-0d5fbd102ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e288af6e-b68d-48a7-bba1-4adac4fc1dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c9f0cf3a-45b4-469f-a0e3-0d5fbd102ae6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e288af6e-b68d-48a7-bba1-4adac4fc1dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a8c3bedf-86ea-4fb6-b122-e6c8a5e57902" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e288af6e-b68d-48a7-bba1-4adac4fc1dc4" xlink:to="loc_srt_StatementGeographicalAxis_a8c3bedf-86ea-4fb6-b122-e6c8a5e57902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a8c3bedf-86ea-4fb6-b122-e6c8a5e57902" xlink:to="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_67df4598-b7c4-4d6f-b4b6-38dbea7d8e76" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:to="loc_country_US_67df4598-b7c4-4d6f-b4b6-38dbea7d8e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_3be41048-4d14-4e13-866b-41b5835057b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:to="loc_srt_EuropeMember_3be41048-4d14-4e13-866b-41b5835057b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_891cffe9-eee4-4287-bb0b-6584b7581330" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:to="loc_srt_AsiaPacificMember_891cffe9-eee4-4287-bb0b-6584b7581330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember_4d20f554-f6a8-4c8e-b8cf-a57121bef474" xlink:href="iart-20211231.xsd#iart_RestOfWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a3531a1f-bedf-46bd-af1e-c093fdb1ac3a" xlink:to="loc_iart_RestOfWorldMember_4d20f554-f6a8-4c8e-b8cf-a57121bef474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_77800914-968e-46cc-9c72-5c260c3d3a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e288af6e-b68d-48a7-bba1-4adac4fc1dc4" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_77800914-968e-46cc-9c72-5c260c3d3a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_78ca6045-9683-497d-80f8-dc1973c33b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77800914-968e-46cc-9c72-5c260c3d3a5a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_78ca6045-9683-497d-80f8-dc1973c33b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_e4639ad5-ce1c-4636-9023-3cda2e239d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77800914-968e-46cc-9c72-5c260c3d3a5a" xlink:to="loc_us-gaap_NoncurrentAssets_e4639ad5-ce1c-4636-9023-3cda2e239d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="iart-20211231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_9687aade-46fa-49da-b6ca-612d88885211" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_bda32602-a8a0-4446-8615-a226a79686c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_9687aade-46fa-49da-b6ca-612d88885211" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_bda32602-a8a0-4446-8615-a226a79686c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="iart-20211231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_0d3887ad-6128-4c4f-83e5-ba19f37fe6d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6b3f82b0-e9c6-49f7-a1e1-c9788bc90ba8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_0d3887ad-6128-4c4f-83e5-ba19f37fe6d7" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6b3f82b0-e9c6-49f7-a1e1-c9788bc90ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e9498b3b-1c6c-461d-adaf-92d2b5676f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6b3f82b0-e9c6-49f7-a1e1-c9788bc90ba8" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e9498b3b-1c6c-461d-adaf-92d2b5676f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_719cd63f-0c01-4f14-84d4-a3d9616960c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e9498b3b-1c6c-461d-adaf-92d2b5676f3a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_719cd63f-0c01-4f14-84d4-a3d9616960c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_bf3cedd3-422a-44f9-a94a-4491460cbaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_719cd63f-0c01-4f14-84d4-a3d9616960c8" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_bf3cedd3-422a-44f9-a94a-4491460cbaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_64d9fdba-d683-4569-b849-2c66dd822287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_719cd63f-0c01-4f14-84d4-a3d9616960c8" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_64d9fdba-d683-4569-b849-2c66dd822287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_fcdb164f-ae24-4612-ab98-7cb19be4809d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6b3f82b0-e9c6-49f7-a1e1-c9788bc90ba8" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_fcdb164f-ae24-4612-ab98-7cb19be4809d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_fcdb164f-ae24-4612-ab98-7cb19be4809d" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_30f56b2f-ce10-4396-9228-51e7b73582dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_30f56b2f-ce10-4396-9228-51e7b73582dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f448789d-0e1b-49a2-a192-2342944ba728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f448789d-0e1b-49a2-a192-2342944ba728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_7021ee87-722b-43dc-9dbd-4d8693c656b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_7021ee87-722b-43dc-9dbd-4d8693c656b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d20d9022-bfce-44a9-a46f-b7cb7a9fa790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d20d9022-bfce-44a9-a46f-b7cb7a9fa790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_6ad54f5f-631c-48a7-b028-094f56d7ee8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_08be7335-d235-474a-a7f9-84a8111557f6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_6ad54f5f-631c-48a7-b028-094f56d7ee8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>iart-20211231_g1.jpg
<TEXT>
begin 644 iart-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MPW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\
MY^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)
M_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P *
M T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/
M_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=
MS10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\*
MT?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_
M +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11
M_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\
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M_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\
MOXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_
M  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?
MG4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\
M$5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_
MPH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G
M4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\
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MB?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\
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MPW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\
MY^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)
M_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P *
M T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/
M_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=
MS10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\*
MT?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_
M +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11
M_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\
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M_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\
MOXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_
M  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?
MG4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\
M$5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_
MPH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G
M4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\
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MB?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\
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MPW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\
MY^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)
M_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P *
M T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/
M_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=
MS10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\*
MT?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_
M +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11
M_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\
MGYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_
M !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#
M?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#G
MYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_
M ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#
M1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^
M_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-
M% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1
M_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\
MOXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_
M  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?
MG4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\
M$5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_
MPH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G
M4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\
MQ%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'
M_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,17)?$[P1;_  ZET^33
M[B\WW/F;F>097;MZ%0/[QKV:O,_VBO\ F#_]MO\ VG0!I_ #_D3;K_K];_T"
M.NYKAO@!_P B;=?]?K?^@1UW- !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %>9_M%?\P?_ +;?^TZ],KS/]HK_ )@__;;_ -IT :?P
M _Y$VZ_Z_6_] CKN:X;X ?\ (FW7_7ZW_H$==S0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7F?[17_,'_P"VW_M.O3*\S_:*_P"8
M/_VV_P#:= &G\ /^1-NO^OUO_0(Z[FN&^ '_ ")MU_U^M_Z!'7<T %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YG^T5_S!_\ MM_[
M3KTRO,_VBO\ F#_]MO\ VG0!I_ #_D3;K_K];_T".NYKAO@!_P B;=?]?K?^
M@1UW- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>9
M_M%?\P?_ +;?^TZ],KS/]HK_ )@__;;_ -IT :?P _Y$VZ_Z_6_] CKN:X;X
M ?\ (FW7_7ZW_H$==S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7F?[17_,'_P"VW_M.O3*\S_:*_P"8/_VV_P#:= &G\ /^1-NO
M^OUO_0(Z[FN&^ '_ ")MU_U^M_Z!'7<T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5YG^T5_S!_\ MM_[3KTRO,_VBO\ F#_]MO\
MVG0!I_ #_D3;K_K];_T".NYKAO@!_P B;=?]?K?^@1UW- !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 45#?7\&F6DEQ<S0V\$8R\DKA$0>Y/ K@?%?[6/P]\'NR7'B:QNI5&=EE
MNNL]L;HP5!]B17E9IGV6Y;#VF8XB%)=YRC'\VCJPV"Q&(?+0@Y/R3?Y'HE%?
M-OBK_@I#HEF2NB^'=2U XQONYDME!^B[R?TKS3Q)_P %!/'6L#;9)H^DJ,\P
M6QD<_4R%A^0%?E><?2 X,P#<88B5:2Z4X-_^32Y8OY2/I<+P-F]?5P4%_>:7
MX*[_  /MVJNJZY9:% )+Z\M;.,G >>58U/XDBOSQ\0_M+>/O%#-]K\5:P _5
M;>;[,I_X#'M%<;?ZE<:K<--=7$US,QRSRN78GW)K\WS3Z5&"C=9=@)R[.<U'
M\(J?Y_,^APWAG6?^\5TO\*;_ !=OR/T8UK]HCP+H /VGQ9H.Y>"L5VDS#\$)
M-<IK'[<OPXTM/W>L7-\W]VWL9<_FZJ/UKX,HKX?'?2AXBJ:87#48+S4Y/[^:
M*_ ]BCX;X"/\6I.7I9?H_P S[.OO^"C7@^$G[/I'B.;W:*% ?_(A_E6'>?\
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MJ0C6Q]N-WXUV&A_\'$/@>X>/^TOA[XKM%8?O#;7=O<%3[!BF?QQ7Y-45RU.
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MV!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %>9_M%?\P?\ [;?^TZ],KS/]HK_F#_\ ;;_VG0!I
M_ #_ )$VZ_Z_6_\ 0(Z[FN&^ '_(FW7_ %^M_P"@1UW- !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M .!PUIXK][+STC]W7YMKR-KQK\1M>^(U^MUKFK7NIS+G9Y\A98\]0J_=4>P
MK%HH R:_ <5BJ^)JNOB9N<Y;RDVV_5O5GW%.G"G%0II)+HE9!16C8>%KR^Y\
MORE]9./TZULV7@FW@YF=YF]/NK_C^M>?4Q=*&[^XZ(T92.7CB:9]JJS,>@ R
M:T+3PE>W76,0KZN<?IUKKK:SBLTVQ1I&O^R,9J2N&IF,G\"-XX==3!M/ L:<
MS3-)[*-HK3M="L[/_5V\><YRPW$?B:MT5QSQ%27Q,VC3BMD &****Q+"BBB@
M HHHH **** ([S_CSF_W#_*O/Z] O/\ CSF_W#_*O/Z];+=I'+B>@5\6_ME?
M\E]U3_KC;_\ HI:^TJ^+?VRO^2^ZI_UQM_\ T4M?W)]!3_DOL7_V!U/_ $]A
MS\-\=/\ D04O^OT?_2*AY;6IX9_U\O\ NBLNM3PS_KY?]T5_K)3^(_DVI\)L
M4445U'*%%%% !1110 4444 -DB65<,JL/0C-59]"MYNBF,^JFKE%)I/<:DUL
M8\_AEU_U<BM[$8JC<:?-:_?C8#UZBNFHJ'370M5'U.3HKI+C2;>Y^]&%;U7@
MUGW/AIAS%)N]F_QK-TVC15$S+I4=HG5E8JRG((."#3Y[26U/[R-E]R./SJ.L
MS0^G?V:?^"N/QF_9Q^Q67]O?\)=X=M,K_9>N#[1\I[+/_KEQ_"-Y4<?*1Q7Z
M+_LQ_P#!:KX0_'2UL[/Q%>R?#WQ%<,L36NJ$M9NY Y2Z4>6$R<9E\L^U?B71
M7RN;<&Y9C[R<.2?\T=/O6S^Z_F>U@<^Q>&T4N:/9Z_=U7Y']-]C?0ZG90W-M
M-%<6]PBRQ2Q.'21&&0RD<$$$$$=:EK^?#]F']OGXH_LCWZ'PEXDN#I6[,FC7
M^;K3INO_ "R)^0G.2T91C@9..*_3/]D[_@N+\-_C5]GTOQU'_P *[U^3Y?-N
M9?-TJ=N>D^ 8N!G$H51D#>QK\KSK@7,,%>I27M8=X[KUCO\ =<^RR_B3"XCW
M9^Y+SV^3_P ['VY14.GZC;ZO8PW5K/#=6UPH>*6)P\<BGH58<$'U%35\3MHS
MZ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\S_:*
M_P"8/_VV_P#:=>F5YG^T5_S!_P#MM_[3H T_@!_R)MU_U^M_Z!'7<UPWP _Y
M$VZ_Z_6_] CKN: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BF7-
MS'96\DTTB0PPJ7=W;:J*!DDD\  =Z^4?VE?^"G&D^#?M&D> XHM;U12T4FHS
M*19VQ&!E!P93UYX7@'+@XH ^DOB)\4_#OPET-M2\2:Q9:19\[6G?YI2,9"(,
MLYY'"@FOD[XE_P#!2#4/'HN[3P5;MI%C&YB^VW"AKN48^\J\K&#V^\W&<@\#
MY#^(?Q*UWXK^)IM8\0ZG=:IJ$Y),DS9$8R3M1>B*,G"J !Z57\):W_8NK*S'
M$,OR2>P]?PKX#Q.R_-\9PYB*>1UI4Z\5S+DTE)+5P3W3DKV<6GS65[-GN<.5
M\+2S"G+&P4H-V=]E?9]M'O?2UST[6-:O/$&I37E_=7%Y=SMNDFGD,DCGU)/)
MJK0#N&117^8-2<YS<ZC;;W;W;\S^CHQ25H[!4EM:2WDFV*-I&]%'2M#POI5O
MJMPZS,VY!N" XW#O766UK'9Q[(HUC7T48KS\1C%3?*EJ=%.BY*YSNG>"'E&Z
MZD\O_83EOSZ?SK<L-&MM-_U42AO[QY;\ZM45Y=3$5*GQ,ZHTXQV"BBBL#0**
M** "BBB@ HHHH **** "BBB@ HHHH CO/^/.;_</\J\_KT"\_P"/.;_</\J\
M_KULMVD<N)Z!7Q;^V5_R7W5/^N-O_P"BEK[2KXM_;*_Y+[JG_7&W_P#12U_<
MGT%/^2^Q?_8'4_\ 3V'/PWQT_P"1!2_Z_1_](J'EM:GAG_7R_P"Z*RZU/#/^
MOE_W17^LE/XC^3:GPFQ11174<H4444 %%%% !1110 4444 %%%% !1110 C*
M'7:P# ]015*[T"&XY7]VWMT_*KU%)Q3W&I-;'.W>C36A^[YB^J\U5KK*JWFD
MPWF2R[6_O+UK*5+L:QJ]SG:*NWNAS6OS+^\3U'4?A5*LFFMS5-/8]H_94_;]
M^)W['FI+_P (GKTDFC,P:;1-0S<:=,-VXXC)!C8G.6B*,>Y-?JA^QA_P6(^'
M'[3=K9Z3XBN+?P'XRD&QK._GQ97; #F&X8!?FSQ&^U\\#?C<?Q'HKY?/.$L!
MF2<IQY9_S1W^?1_/7LT>SE^=8G".T7>/9[?+L?TZ45^'O[&?_!7SXE?LMRV.
MDZM=2>-_!D 6'^SM1E)N;.('_EWG^\N!P$?<@   7J/UF_91_;>^'O[9'A;[
M?X/U@-?6Z@WNDW8$.H6!/]^/)W+_ +:%D/3=D$#\9SWA/'98^>HN:G_,MOGV
M^>G9L^]RW.L/C/=B[2[/?Y=SURBBBOF#UPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *\S_:*_Y@_P#VV_\ :=>F5YG^T5_S!_\ MM_[3H T_@!_
MR)MU_P!?K?\ H$==S7#? #_D3;K_ *_6_P#0(Z[F@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***;+*L,;.[*J*"S,QP !W- #J\Y^/_[4OA+]G/1VEUR^$VI2
M1^9;:7;$/=W()P#MSA5Z_,Q ^4XR1BO#?VK?^"E5GX1-UH/P]DAU'5(V,<VK
ML!):VQ&,^4"")3U&X_(,<;\\?#>O>(+_ ,4ZM-?ZE>76H7URQ>6XN)6DDD)[
MEF))H ]5_:4_;4\6?M&7,UI-,=(\-^9NATJV?Y2!T,KX!D/?G"@\A17CU%%
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MN'^5>?UZV6[2.7$] KXM_;*_Y+[JG_7&W_\ 12U]I5\6_ME?\E]U3_KC;_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KS/]HK_F#_ /;;_P!IUZ97F?[1
M7_,'_P"VW_M.@#3^ '_(FW7_ %^M_P"@1UW-<-\ /^1-NO\ K];_ - CKN:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBO-/VD/VI_#?[-?AWS]4E%YJUQ&7L]+AD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O,_P!HK_F#_P#;;_VG7IE>9_M%?\P?_MM_[3H
MT_@!_P B;=?]?K?^@1UW-<-\ /\ D3;K_K];_P! CKN: "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***^8_VX/V[1\$KFX\)^%_WOBK8INKF2/,>FJZ!EP",/(593W4 \Y/
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M[97_ "7W5/\ KC;_ /HI:_N3Z"G_ "7V+_[ ZG_I[#GX;XZ?\B"E_P!?H_\
MI%0\MK4\,_Z^7_=%9=:GAG_7R_[HK_62G\1_)M3X38HHHKJ.4**** "BBB@
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M=^]3>TOT?9_GTZI?IF4YQ2QL+;36Z_5>7Y'84445\N>P%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %>9_M%?\P?\ [;?^TZ],KS/]HK_F#_\ ;;_VG0!I_ #_ )$VZ_Z_6_\
M0(Z[FN&^ '_(FW7_ %^M_P"@1UW- !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ,4\+U<JJ\T?>I2>C[>3\_S^]+]-R?.(8V%GI-;K]5Y?D=C1117R9[04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7F?[17_,'_ .VW_M.O3*\S_:*_Y@__ &V_]IT :?P _P"1-NO^
MOUO_ $".NYKAO@!_R)MU_P!?K?\ H$==S0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7D]>@>"M<_M?20KMF:WPCY[CL?\ /I7\?_27X#_A\4X./:%:WW0F_P#TAO\
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MTBC+[2ZL B#DG!R2 .^/HC]K;X?-^T-\8_!/@G39E:32()[S5[E1N^P02&(
MGT9O+.%/)+*>G->7?MR?&+3X/#\/PI\(;;70-#58KYH6XFE0Y$6>X5OF8G[S
M]>5Y /D[Q6NEIXFU!=%:\;1UN'%FUWM\]HLG87V@#<1@G Q1X8UDZ)JT<O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>9_M%?\P?_
M +;?^TZ],KS/]HK_ )@__;;_ -IT :?P _Y$VZ_Z_6_] CKN:X;X ?\ (FW7
M_7ZW_H$==S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW&58=^G8X(/!P:U*_GN47%\LMS]/4DU=!1114C"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7F?[17_ #!_^VW_ +3KTRO,_P!HK_F#_P#;
M;_VG0!I_ #_D3;K_ *_6_P#0(Z[FN&^ '_(FW7_7ZW_H$==S0 4444 %%%%
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M6N8EQ^4=?9X3Z._&M97J484_\52/_MKD>35X]R>'PS<O2+_6Q\4U\6_ME?\
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MU*&]'R-\W]T\&MHS3,90:+%%%%42%%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS/]HK_F#_\ ;;_VG7IE
M>9_M%?\ ,'_[;?\ M.@#3^ '_(FW7_7ZW_H$==S7#? #_D3;K_K];_T".NYH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^RODOH=R?B.XKHC.YSR@T344459 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN445_0M.G&G!0@K):)+9+LC^;*E2=2;J5&VV[MO5MOJPHHHJR HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#YQ_P""A'_!.?PS^W+X*\TM%HOCC2H&72=85.&ZD6]P ,O"3GI\
MR$EESEE?\._BS\*-?^!WQ$U7PKXHT^72]<T6<P7-NY!P>H96'#*P(96&0001
MP:_I2KY;_P""EW_!-_2OVV_ @U+21:Z7\0M%B/\ 9U\PVQWR=?LLY'\)/W7P
M2A]BP/Z!P;Q=+ S6$Q;_ '+V?\K_ /D>ZZ;KK?YG/LC6)BZ]!>^M_/\ X/\
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M0 4444 %>9_M%?\ ,'_[;?\ M.O3*\S_ &BO^8/_ -MO_:= &G\ /^1-NO\
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M^4\3B*N(JRKUI.4I.[;W;84445L8A1110 4444 %%%% !1110 4444 %%%%
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MA%Q T9Z,,4^B@#E9$,4C*WWE.#3:O:_;^3?ENT@W?C5&N22L['7%W5S]>/\
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MI/A%XC\;? K_ ((E37GB*UUCP_XS\.>"]3ABBO(VBO-/*-<1VC%6&Y"L7DL
M1\H &.,4G_!"+X4Z1X(_8%T7Q!9VT*ZMXSOKV\U&X"CS)/)N9;:)"W7:JQ9"
M] 9'/5C0!\N?MF_MF^"?VTOVN?V6=;\'W%['+IOBB*VU/3+^#R+[2Y3J-EA)
M4!*\@$@JS*<$9R"!^N%?F+_P5?\ A3X>\&_\%*OV<?$6E:7:V&K^*O$5F=6G
MA7;]N:'4+,1NX'!<*Y!;&2 H).!C].J /F?_ (+":IKFD?\ !.CXD2Z"UQ'<
MM;VT5R\#$2+:O=PK/C'\)B+ANVPO7%_\$A/ 7P;\=_L0^&?[!T'PKJVKPP^7
MXE^TV4-Q>+?DGS/.W@M@_P &>-FW'%?86MZ+9^)=&N].U"UM[[3[^%[>YMIX
MQ)%/&X*LC*>&4@D$'@@U^>GQW_X(HZU\+?&-UX[_ &;?&^J>"=>C+2IHDMV\
M<,G.XQ17 .0AQ@1S!U.>7 H ^R? OP*\!_LA>%?&6K^"O":Z3;WXDUG4-/TE
M&/VN2&(X6&$ML1BJX"(%4D].<U^6-Y_P4*L9_P#@K9:_%[_A _'OV.'1S9?V
M";)?[5/^AO%N$>[&W+;NO3)K[._X)1?\%!_%'[44OBKX?_$JP6Q^)'@%BM[(
ML(@-[&LAAD\R)?E2:.0!7"@*=ZX Y%>9ZA_RL6V/_8N'_P!-DE 'UU^S#^V!
MI?[2?P6U;QQ)X>\2^"=,T6ZGM[F+Q#;"WF"0PQS/. I.8]KXSZHP[5X'??\
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MUO"%MYVI-)VB7/XGC_&OYOJ2Y8MG]/4X\TDCI54(H4<!1@"EHHKR3U@HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>VR&,NV/M"\X%>W?L16TEE^Q?\(89HY(9H?!6C(Z.I5D86,(((/((/:O4**
M/S[_ &>M%O(/^"_?QDO)+.Z2TD\+*$G:)A&_[G2NC8P>A_*JO_!5;0K[4?\
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MNAVF&V3YYGS@X(0-C(QNP.]?M)I&E6^@Z3:V-I&L-K9PI!#&H"K&B@*H '
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT:TZ,MXMK[G8_9J-15*<:BZI/[PHHHK T"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KS/\ :*_Y@_\ VV_]IUZ97F?[17_,'_[;?^TZ -/X ?\ (FW7
M_7ZW_H$==S7#? #_ )$VZ_Z_6_\ 0(Z[F@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M![1?._\ MW5?>[+YGP''N9_4LCKS3]Z2Y%ZRT?W*[^1]D4445_4!_* 4444
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ME#V.;XB']Z__ (%[WZGZQDM3GP-*7E;[M/T"BBBOG3U HHHH **** "BBB@
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M  D[#_XU73_%#P]#:? WQ%I.EVD%K!'H5S:6EM!&(XXE%NR)&BJ,*H&  !@
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M6^#?[.^CW#)<^-]9CU35S&?F@M%8Q(Q'=0/M,A'K;J>:Y']N/2;7_@G_ /\
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M=S^,+6X\67&L1V?BG4K+2[:2/5$2)GD$<<L6U-V.JJAR.-HXJO\ !76/VO\
M]J7Q_P"&_BI9ZYX:\!?"_4]5M;F#PE=HAO+G1C*N]R3;N2\D))!:1"2<J$&S
M/-_\''O_ ";Q\/O^QBD_])GK]%HHE@B6.-52- %55& H'0 4 ?&/_!0?]KCX
M@? S]M[]GGP?X7UQ=-\.^.-:M[37+4V-O-]NBDO[:%EWR(SI\CN 8V4_-G/
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M:A\6?A[\/[R^ G?2++P]%>_801GRF>6.3+#/(#-@CAB*X/\ X-R/^37?'/\
MV-)_])(* /T.HHHH **** "O,_VBO^8/_P!MO_:=>F5YG^T5_P P?_MM_P"T
MZ -/X ?\B;=?]?K?^@1UW-<-\ /^1-NO^OUO_0(Z[F@ HHHH **** "BBB@
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M$8Q]&!!)R#7N7_!4;QGINC?L[+H]Q) VI:S?P_9(2?W@$9WO(!Z 84G_ *:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\)_X*;>"E\??L$?%*Q:/S1;Z*^I
M;=Q7!M'2Z!R/3R<XZ'&#Q7NU<O\ '#P^OBWX*^,-*95D74]$O;0J3@,)('7'
MZUV9?6='%4ZJ^S*+^YIF&*I^THSAW37WH_FSHHHK^J#\:.FT^3S;*%O]D5-5
M71&W:9%^(_6K5=<=CDEN%%%%,04444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% &/XG7$T3>JD5EUK>)QQ"?]X?RK)KFJ?$=-/X3Z@_X(W>(%T#_@HE
MX#\Q<I?+?6A/=2UE.5_\> 'T)K]U*_ 7_@E]J']F_M^?"^3=MW:OY6=VW[\4
MB?\ LW3OTK]^J_#O$RG;,:<N\%^$I'Z+PC+_ &62_O?H@HHHK\Y/J@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *_-'_ (<U?$__ *#W@/\ \#;O
M_P"1J_2ZBOG\]X9P6;\GUQ-\E[6=M[7_ "1]'P_Q5C\F]I]2:7/:]U?X;V_-
MGYH_\.:OB?\ ]![P'_X&W?\ \C5TWP6_X).?$7X<_&/PGXAOM:\%2V6@ZS9Z
MC<)!=W+2O'#.DC! ;< L0IP"0,]Q7Z$45X='PYR:G.-2,97337O=CWZWB=GE
M6G*E.4;233]U;/0*^0/^"JO[ GCG]M74_AGJG@/6O#.D:IX!N[RY/]LR31QR
M&8VK(RF.*7)5K;E64 ANO&#]?T5]X?GI\-_\*>_;Z_Z*M\%__ 1__E?7T_\
MLP:!\2M"^#UM9?%S5_#GB#Q@)IOM%WHT12TEA+'RUPT<?S!>#\@'UY)]%HH
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M*#P?H,TVH333M>ZGJ4Z!)=1N6"J7*CA$"JJJF3M Y+$LQ_.6]_9R\0?M(_\
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MRG&,[>041N=I5O ?#_[,7[:GC_P[;_#WQE\4?">B^#XT6UO_ !#I1,VL7]J
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MV6T\PLS 1;8W4J&=RH/EF,$J&9217WA10!\:> OAS^V?\3/'>@7/C7QM\.O
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M%% !3[>XDM+B.:)FCDB8.C*<%2.013**-M4&^C/:A_P4/^,0'_(X?^4JR_\
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M3_4****^Z/@0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7F?[17_,'_ .VW_M.O3*\S_:*_Y@__
M &V_]IT :?P _P"1-NO^OUO_ $".NYKAO@!_R)MU_P!?K?\ H$==S0 4444
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M10 4444 9GB8_P"CQ_[U8U;'B<_NH?J:QZYJGQ'33^$]6_84A6?]M7X2JPW
M>,-*;\1=Q$?J*_H>K^?+_@G9;_:OVZ/A2N[;CQ):/G']UPW]*_H-K\4\3I?[
M917]U_F?H/"*_<3?G^@4445^9GUP4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>9_M%?\P?_ +;?^TZ],KS/]HK_ )@__;;_ -IT :?P _Y$VZ_Z_6_]
M CKN:X;X ?\ (FW7_7ZW_H$==S0 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***_/W_ (>S^//^@!X1_P"_-Q_\>H _0*BOS]_X
M>S^//^@!X1_[\W'_ ,>KH/A-_P %.O&GC[XJ>&=!NM#\+PVNM:M:V$SQ13B1
M$EF1&*YE(W ,<9!&: /N*BBOSQ_X+B^.=:\(?&7]FZ+2=8U32XKW6[W[0EI=
MR0+/MGTP+O"D;L;FQGIN/J: /T.HHJ.[NXK"UDFGDCAAA4O))(P544<DDG@
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M9&<AHE8N",'J.QKIZ "BL'QS\5/"_P ,+5)O$OB30?#L,GW)-3U"*T5OH9&
M-7_#?BK2_&6E1W^CZE8:K8R<)<6=PD\3_1E)!_.@"_16;XE\9Z/X,AMI-8U;
M3=)CO)UM;=KRY2!9Y6^[&A8C<YP<*.3BLO6OC1X.\-^-;3PUJ/BSPSI_B/4-
MHM=*N=4@BO;G=@+LA9@[9R,8!SF@#IJ*^8/&?[%?A?Q%_P %*/#_ ,6I_B-)
M:>*-/T\?9_"OFQ>;<QI#+"77+^8(B&)90A!(8YY./I^@ HKD%_:#\ OXJ705
M\;^$&UQG\L:<-9M_M1;IM\K?OS[8KKR<"@ HKB7_ &F/AO'X@_LEOB!X)75
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M - CKN:X;X ?\B;=?]?K?^@1UW- !1110 4444 %%%% !1110 4444 %%%%
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MA84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'_#-/[$/C36H)_(U;5K?^P]+(;:_VBY!CW*?[R1^;(/^N=?)O[%__!(?Q_\
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M?;7B3]JGX=^$_@O_ ,+"OO&&AQ^#V@%Q%J2W*M'."NY40#YFD((Q&!OSQC-
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M?_1*T >T4444 %%%% !1110 5YG^T5_S!_\ MM_[3KTRO,_VBO\ F#_]MO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7IE>9_M%?\P?_MM_[3H T_@!_P B;=?]?K?^@1UW-<-\ /\ D3;K_K];_P!
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MWKGZ!A9>[8****Y3J"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445A_$OXD:+\(/
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M444 %%%% !1110 4444 %%%% !1110!'>S_9K623^ZO'UKE\UM^))]EFJ?\
M/1OT'^16)7/5>MCHI+2X5^XW_!%SX1_\*L_8,\.W4L#07OBZZN-<G##DAW\J
M$].AAAB8?[WO7XG>!?"%Y\0O&VCZ!IZA]0UR^@T^V4G :6618T'_ 'TPK^DK
MP-X.L?AWX*TC0-+@CMM-T2SAL;6)!M6.*) B@#V %?EOB9CN3"TL(MY-M^D5
M^K?X'V7".'YJTZ[Z*WW_ /#?B:M%%%?C)]\%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445^6OV^X_Y[3?]]FOR'Q6\5EP7]5OA?;^WY_M
M\G+R<G]R5[\_E:W6Y]5PSPR\W]I:IR<G+TO>]_-;6/U*HK\M?M]Q_P ]IO\
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M?]?K?^@1UW- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!CK_@J/\,OVS/$,?AZS_M#PSXXMP[G0=:A$<[.BD2>0X)60J-V1\K[=Q*
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M6/\ @B#J4U__ ,$WO!*3-N6UN=2ACSV7[=.V/S8UY7^T/_P57TS]KOX ^+O
M_P $_ WC+QEK7B70[RRU&YNK 6MCH=I);NMQ++)O.9%C8[5^Z6(^9CA']/\
M^"'$31?\$X_"&Y67=>ZBPR,9'VR7F@#ZYK\KO^"K^L^,?#__  5]^$-[\/\
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M90><*HR!R8^H .;_ .#BZPATK]FKX;VMK#';VUMK[1111J%2-%M7"J .
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MTQ1_%#\A_I7YKBHZ*1^HX66KB:%%%%<1VA1110 4444 %%%% !1110 4444
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M^9T_#;XJ_%;Q!\;OB#JGBKQ5JEQK&O:Q,9KJZF/+'H%4#A450%5% 55
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M-\A XRS[F/NQKL:**_EVK4E4FZD]6W=^K/V&$5&*C'9!1116904444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 V>
M".Z@>*5%DCD4JZ,-RL#P01W!I401H%4!548  X I:* "BBB@!L42PKM155<E
ML*,<DY)_$DG\:=110 4444 %%%% #3$IE63:OF*"H;'(!QD9]\#\A3J** "F
MQPI$[LJ*K2-N<@8+G &3ZG  ^@%.HH **** "BBB@ IHA19FD"*)&4*S8^8@
M9P"?09/YFG44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F?[1
M7_,'_P"VW_M.O3*\S_:*_P"8/_VV_P#:= &G\ /^1-NO^OUO_0(Z[FN&^ '_
M ")MU_U^M_Z!'7<T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;2ZMH(KH26A&!;3P2%0RJ,J&!/R[5*\;CW/B7_@KI\'_ -GOX>WVF? _X?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KS/]HK_F#_\ ;;_VG7IE>9_M%?\ ,'_[
M;?\ M.@#3^ '_(FW7_7ZW_H$==S7#? #_D3;K_K];_T".NYH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *\S_:*_Y@_P#VV_\ :=>F5YG^T5_S!_\ MM_[3H T_@!_R)MU_P!?K?\
MH$==S7#? #_D3;K_ *_6_P#0(Z[F@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%;QBEL8RDWN%%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,_VBO^8/
M_P!MO_:=>F5YG^T5_P P?_MM_P"TZ -/X ?\B;=?]?K?^@1UW-<-\ /^1-NO
M^OUO_0(Z[F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\RYQFE7,,7/%U=Y/1=ET7R7^9^MX'!PPM"-&'3\7U84445YIUA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YG^T5_S!_P#MM_[3
MKTRO,_VBO^8/_P!MO_:= &G\ /\ D3;K_K];_P! CKN:X;X ?\B;=?\ 7ZW_
M *!'7<T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7Y2_\ !1_]E5OV>/C(^I:7;+'X5\4.]S9"*,K'9RYS);]P,$[E' VM
M@#Y37ZM5PO[2'P&TO]I#X1:IX7U153[4OFV=SMRUE<J#Y<H^A.".ZLP[U\KQ
MAP['-\ Z4?XD=8/S[>CV];/H?7\%\2RR;,%5E_#EI->7?UCOZ774_%6BMKXB
M> =4^%GCC5/#NM6YM=4T>X:VN(^VX?Q*>ZL,,#W!![UBU_+]2G*$G":LUHUV
M:/ZNIU(U(*<'=-7375/9A106VC)X ZFO/O'GQF2S+6NCLLDJDJ]P1E%_W?4^
M_3Z]:^JX/X)S?B;&?4LJI\S^U)Z0@N\I=/):M]$SYSBKC#*^'L)];S*IRK[,
M5K*3[177S>B75HZ7QGX_L?!D \XF:Y<92!#\Q]S_ '1[_D#7C_BGQA?>+[P2
MWDGRI]R-.$C^@_J>:SKBXDNIWDD=I))&+,S')8GJ2:97]\>&_@_E'"=-5TO;
M8IK6I);=U!:\J[OXGU=K)?Q1Q]XIYIQ--T7^ZPR>E-/?SF_M/\%T5]644Z*)
MIY J*68]A6UINA+;8>;#R=AV%?KT8MGY=*213TW0VNBKR92/T[M6U#"MO&%1
M0JCL*=171&*1SRDV%%%%42%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !2,H<88!AZ$4M% %6?1;>?_EGM/JO%59?#"G_ %<K#V89
MK4HJ>1,I3:,&7P[<)]W8_P!#_C4+Z7<1]89/P&:Z2BI]DBO:LY5XFC^\K+]1
M3:ZRFF-3_"OY5/L2O;'*T5U!M8C_ ,LX_P#OD4?9(O\ GE'_ -\BCV(>V.7H
M W'BNI%M&IXC3_OFGA=O04>Q#VQRZ6DLGW8Y&^BFIH]%N9/^6>/J0*Z*BG[)
M"]JS%B\-2M]Z1%^G-6H?#D*?>9Y/T%:%%4J<42ZDF0P6,-L/W<:K[XYJ:BBK
M("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7F?[17_,'_ .VW_M.O3*\S_:*_Y@__ &V_]IT :?P _P"1-NO^
MOUO_ $".NYKAO@!_R)MU_P!?K?\ H$==S0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "O,_VBO^8/\ ]MO_ &G7IE>9
M_M%?\P?_ +;?^TZ -/X ?\B;=?\ 7ZW_ *!'7<UPWP _Y$VZ_P"OUO\ T".N
MYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F
M?[17_,'_ .VW_M.O3*\S_:*_Y@__ &V_]IT :?P _P"1-NO^OUO_ $".NYKA
MO@!_R)MU_P!?K?\ H$==S0 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9^L:O]D7RX_]8>I_
MNT[6-6^QKY<?,A_\=K"9B[9/)/4UE4J6T1K3IWU8A.3117OW_!/K]@W7/VY?
MBR-/CDFTOPII)6;6]55 3#'VBBSPTS]!G(498@@!6\_&8RCA:,L17ERQBKM_
MU^".VA0G6J*E35VSLO\ @EW_ ,$XKK]M'Q^=8\0QW5G\.]!E'VZ5,QOJDHP1
M:Q-V'(+L.0O PQ!7]N/#WAZP\(Z#9Z7I=G:Z=ING0);6MK;1"*&VB0!51%7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O,_P!HK_F#_P#;;_VG7IE>9_M%?\P?_MM_[3H T_@!_P B;=?]
M?K?^@1UW-<-\ /\ D3;K_K];_P! CKN: "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F
M?[17_,'_ .VW_M.O3*\S_:*_Y@__ &V_]IT :?P _P"1-NO^OUO_ $".NYKA
MO@!_R)MU_P!?K?\ H$==S0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XO\ MF?L)>!_
MVW/!D>G^)K:2SU>Q5O[,UJT 6[L6/;)&)(B>3&W!Z@JV&'M%%=&%Q5;#556H
M2<9+9HSK4858.G45T^A_//\ M=_L5>./V,?'DFD^*M.D;3YI&73=8@1C8ZF@
MYRC]G QNC;#+Z$$$^1U_29\9?@OX9_: ^'FH>%?%VDV^L:+J2[9(91RC?PR(
MPY1UZAE((-?CM_P4!_X)%^+?V3I-0\3>%Q<^*OAY"/->Z&#>Z2O<7$8QN0?\
M]4&W'W@G&?V[A?C>CCDL/C+0J].BEZ=GY?=V7Y[G'#U3#7JT/>A^*_X'G]Y\
M>5>TW6GLL(WSQ^G=?I5&BOOU)K8^8:3W.IM[A+J(/&VY33ZY>VNY+.3=&VT_
MSK:T_7([OY7_ '<GOT-;QJ)[F$J;6Q>HHHK0S"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BFS3K;Q[I&"KZF
ML74=>:Y!2+,<?<_Q&IE)(J,6R]J.M1V>57]Y)TQV7ZUBW%S)=2;I&+-_*H\T
M5SRDV=$8I!171?"KX2>)/C?XWL_#?A/1[S7-:OFQ%;6RC.,@%F8D*BC(RS$*
M,\D5^P7_  3Y_P""/WAG]EK[/XF\:_8?%WCQ&26!P&:PT9AS^X5@"\F?^6CC
M(VC:$^8M\[GW$F$RJG>L[S>T5N_\EYOY7/6RW*:^-E:GI'JWLO\ -^1\_?\
M!-C_ ((PW'B6XT_QU\8]-FM=,4"XL/"]PICENC_"]V.&1!U\G@M\N_"[D;]2
M]/TZWTBQAM;2WAM;6W4)%#$@2.-1T"J. !Z"IJ*_ \ZSS%9G7]MB'IT2V2\O
MU>[/TK+\NHX.GR4EZOJPHHHKQSN"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS/]HK_
M )@__;;_ -IUZ97F?[17_,'_ .VW_M.@#3^ '_(FW7_7ZW_H$==S7#? #_D3
M;K_K];_T".NYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D=%E1E90RL,$$9!%
M+10!^>__  4%_P"")VD_$^.\\6?""ULM!\1L?-N- W+;Z?J'7)A_A@D/'R\1
MG_8Y)_*GQSX$UGX9^++[0O$&F7FCZQILIAN;2ZB,<D3#U![>A'!'(R*_I>KR
M/]K/]B3P!^V9X2_L_P 8:4&U"VC9-/U>U/EWVG$_W'_B7/)1PR'KC."/T7AO
MCZMA$L/C[SI]']I?YK\?-['RN:\-4Z]ZN&]V7;H_\G^!_//17TG^V]_P3 ^(
M/[%][<:C-;MXF\$AP(=?LH2$B!( %S'DF!LD#))0D@!B3@?-E?LN"QU#%TE7
MPTE*+ZK^M'Y/4^#Q&'JT)^SJJS+UAKLEI\K_ +Q/<\BMBUOH[U<QMGU'<5S-
M.CD:)PRL58="*[HU&MSEE33.JHK(L?$9&%G'_ Q_45JPS+.FY&#+ZBMHR3V,
M91:W'44451(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M56^U>&R&,[G_ +H_K0W;<:3>Q:K/O]?CMQMBQ(__ (Z*S;W6)KTXSL3^ZM5:
MQE4[&L:?<DN;N2[DW2,6/\JCHK1\)>$=4\?>);+1M$T^\U;5M2E$-K9VD32S
M3N>BJJ\DUA*22YI;&T8WT1G5]%?L1?\ !-'X@?MM7XO-/C7P[X/B9EGU^_B8
MPNRL 8X$&#-(,G@$(-I#.IP#]@_L'?\ !#*WT-K'Q5\:/*O;M<30>%H) T$+
M Y'VJ53B0_\ 3-#L]6<$K7Z0Z7I=KHFG06=E;V]G9VJ"*&"",1QQ(!@*JC@
M#L*_,N(O$&G1OA\LM*76?V5Z=WY[>I]?E7#,ZEJN+T7;J_7M^?H>8_LG?L9^
M!?V,_!$FC^#=.9)KS8U_J5T5DOM190=IED ' RQ"@!5W-@#)SZM117X_B,15
MKU'6K2<I/=O=GW-*E"G%0IJR71!1116)H%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ+]FG_@D+\9?VC8H;Y]%7P;H4F"+[7]UL\@W 'RX,&5CC+ LJH0.&Z9_0_\
M9>_X(J?"7X#V\-YXDMI/B)X@4*S7&J)ML86'7R[525P>/]:9#QP1R*^5S;C+
M+,!>+GSS_ECK][V7WW\CVL%D.+Q.JCRQ[O3\-V?EE^R]^P5\4/VO+Y/^$1\.
MS'2=^V76;[-MIL/4']Z0=Y!&"L8=AW%?I;^R=_P0R^'?P9N(-6\>71^(FN1G
M<MM-#Y&DP'C_ )8Y)F(Y&9&V$'_5@C-?;UE90Z;:1V]O#%;P0J%2.- J(/0
M< 5+7Y7G/'F88V\*+]E#M'=^LM_NL?98#AO"X?WJGOR\]ODO\[D.GZ=;Z18P
MVMI;PVMK;J$BAB0)'&HZ!5'  ]!4U%%?$[ZL^@"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O,_VBO^8/_P!MO_:=>F5YG^T5_P P
M?_MM_P"TZ -/X ?\B;=?]?K?^@1UW-<-\ /^1-NO^OUO_0(Z[F@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRM#;R>$/"=C;ZK#%Y3:O=#[5J$N<;B9GR5W8R53:OHH'%>P45^?9IQ/F6/\
M=Q%5\O\ *M%]RW^=SZC!Y/A,-K2AKW>K_P"!\@HHHKP#T@HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,_VBO^8/\
M]MO_ &G7IE>9_M%?\P?_ +;?^TZ -/X ?\B;=?\ 7ZW_ *!'7<UPWP _Y$VZ
M_P"OUO\ T".NYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** *^J:7:ZWI\MI>VUO>6LZ[9(9XQ)'
M(/0J>"/K7@_Q4_X)<? ?XN12_;OAWHFEW$BX%QHJG3'0_P!X+ 50G_>4U] 4
M5U87'8C#2YL/-Q?DVOR,:V'I55:K%2]5<_/+XL?\&]'@G77DF\&>.?$/AV1B
M6$&I6T>I0@\_*I4PNJ_=&6+D8/7/'SM\2/\ @@C\9O"1:30[[PCXKAP2J6]\
MUK<<8ZK,BH,]L.>G.*_9:BOIL)QWG%#1U%-?WDG^*L_Q/(K\-X&IJH\OH_\
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MP^7X:C_"@E\M?OW"BBBO,.P**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS/]HK_F#_ /;;_P!I
MUZ97F?[17_,'_P"VW_M.@#3^ '_(FW7_ %^M_P"@1UW-<-\ /^1-NO\ K];_
M - CKN: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M\S_:*_Y@_P#VV_\ :=>F5YG^T5_S!_\ MM_[3H T_@!_R)MU_P!?K?\ H$==
MS7#? #_D3;K_ *_6_P#0(Z[F@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "O,_VBO^8/\ ]MO_ &G7IE>9_M%?\P?_ +;?^TZ -/X
M?\B;=?\ 7ZW_ *!'7<UPWP _Y$VZ_P"OUO\ T".NYH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KS/]HK_F#_ /;;_P!IUZ97F?[1
M7_,'_P"VW_M.@#3^ '_(FW7_ %^M_P"@1UW-<-\ /^1-NO\ K];_ - CKN:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\S_:*_Y@
M_P#VV_\ :=>F5YG^T5_S!_\ MM_[3H T_@!_R)MU_P!?K?\ H$==S7#? #_D
M3;K_ *_6_P#0(Z[F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "O,_VBO^8/\ ]MO_ &G7IE>9_M%?\P?_ +;?^TZ -/X ?\B;=?\
M7ZW_ *!'7<UPWP _Y$VZ_P"OUO\ T".NYH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\
M"_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/
M_OVG_P 71_PO_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO
M_1_^?;4_^_:?_%T =S17#?\ "_\ 1_\ GVU/_OVG_P 71_PO_1_^?;4_^_:?
M_%T =S7F?[17_,'_ .VW_M.M/_A?^C_\^VI_]^T_^+KDOBCXZM?B ^GK8P7B
1M;>9N$B#+;MN,;2?[IH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>iart-20211231_g2.jpg
<TEXT>
begin 644 iart-20211231_g2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 2%![X# 2(  A$! Q$!_\0
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>?_ ! _Y#,/
M_7NO_H35Z!7G_P 0/^0S#_U[K_Z$U &U\/\ _D#3?]?#?^@K735S/P__ .0-
M-_U\-_Z"M=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7G_Q _Y#,/\ U[K_ .A-7H%>?_$#_D,P_P#7NO\ Z$U &U\/_P#D#3?]
M?#?^@K735S/P_P#^0--_U\-_Z"M=-0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9.L:R^FWVG0+&KBZ
MDV,2?N\J./SK6KF?%7_(9T#_ *^/_9DKIJ "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH HZUJ#:7ID]TB!VC PK=#D@?UJ;3[HWEC;W#*%,L:N5
M';(S6?XN_P"1=O/HO_H0JSH/_(%L?^N"?R% %^BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *R=)UE]1U#4+9HU1;5]H8'D\D<_E6M7,^&/^0]KO
M_7;_ -F:@#IJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)NM9>
MWU^TT\1J4F0L7SR/O?X5K5S.I?\ (\:9_P!<3_)Z .FHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "LKQ%K#Z)8K<)&LA,@3:QQU!/\ 2M6N:\??
M\@6/_KNO\FH Z13N4'U%+38_]6OTIU !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 9/AW67UJUEE>-8RDA3"G/8'^M:U<SX"_Y!MS_U\'_T$5TU
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9,.LO+XBGTXQJ$CC
MWA\\GA?\:UJYFT_Y'R]_Z]Q_)*Z:@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** ,G6M9?2[K3XEC5Q<R;"6/3D#^M:U<SXN_P"0EH?_ %\?^S)7
M34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!1UK4&TO3)[I$#M
M&!A6Z') _K4VGW1O+&WN&4*98U<J.V1FL_Q=_P B[>?1?_0A5G0?^0+8_P#7
M!/Y"@"_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9.DZR^HZAJ
M%LT:HMJ^T,#R>2.?RK6KF?#'_(>UW_KM_P"S-0!TU%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5DW&LO#XBM=.$:E)HRY?/(X;_ .)K6KF;_P#Y
M'S3?^O<_RDH Z:BBB@ HHHH **** "BBB@ HHHH *\_^('_(9A_Z]U_]":O0
M*\_^('_(9A_Z]U_]":@#:^'_ /R!IO\ KX;_ -!6NFKF?A__ ,@:;_KX;_T%
M:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH YGQ5_R&= _Z^/_ &9*Z:N9\5?\AG0/^OC_ -F2NFH
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M** "BBB@ HHHH **** "N:\??\@6/_KNO\FKI:YKQ]_R!8_^NZ_R:@#HX_\
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M#,/_ %[K_P"A-0!M?#__ ) TW_7PW_H*UTU<S\/_ /D#3?\ 7PW_ *"M=-0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 <SXJ_Y#.@?]?'_LR5TU<SXJ_P"0SH'_ %\?^S)734 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!C^+O\ D7;SZ+_Z$*LZ#_R!
M;'_K@G\A5;Q=_P B[>?1?_0A5G0?^0+8_P#7!/Y"@"_1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %<SX8_Y#VN_]=O_ &9JZ:N9\,?\A[7?^NW_
M +,U '34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,ZE_R/&F?
M]<3_ ">NFKF=2_Y'C3/^N)_D] '34444 %%%% !1110 4444 %%%% !1110
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M\A0!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9\,?\A[7?\
MKM_[,U=-7,^&/^0]KO\ UV_]F:@#IJ*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KF;_ /Y'S3?^O<_RDKIJYF__ .1\TW_KW/\ *2@#IJ*** "B
MBB@ HHHH **** "BBB@ KS_X@?\ (9A_Z]U_]":O0*\_^('_ "&8?^O=?_0F
MH VOA_\ \@:;_KX;_P!!6NFKF?A__P @:;_KX;_T%:Z:@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y
MGQ5_R&= _P"OC_V9*Z:N9\5?\AG0/^OC_P!F2NFH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#'\7?\B[>?1?_ $(59T'_ ) MC_UP3^0JMXN_
MY%V\^B_^A"K.@_\ (%L?^N"?R% %^BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110!S/B[_D):'_U\?^S)735S/B[_ )"6A_\
M7Q_[,E=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/XN_P"1
M=O/HO_H0JSH/_(%L?^N"?R%5O%W_ "+MY]%_]"%6=!_Y MC_ -<$_D* +]%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/AC_D/:[_UV_\ 9FKI
MJYGPQ_R'M=_Z[?\ LS4 =-1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<S?_P#(^:;_ ->Y_E)735S-_P#\CYIO_7N?Y24 =-1110 4444 %%%%
M !1110 4444 %>?_ ! _Y#,/_7NO_H35Z!7G_P 0/^0S#_U[K_Z$U &U\/\
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M_7!/Y"JWB[_D7;SZ+_Z$*LZ#_P @6Q_ZX)_(4 7Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KF?#'_ "'M=_Z[?^S-735S/AC_ )#VN_\ 7;_V
M9J .FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9O_ /D?--_Z
M]S_*2NFKF;__ )'S3?\ KW/\I* .FHHHH **** "BBB@ HHHH **** "O/\
MX@?\AF'_ *]U_P#0FKT"O/\ X@?\AF'_ *]U_P#0FH VOA__ ,@:;_KX;_T%
M:Z:N9^'_ /R!IO\ KX;_ -!6NFH **** "BBB@ HHHH **** "BBB@ HHHH
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MGPY_YX:W_P" B?\ QRC^R<?_ ,^9?<'U[#?\_$?0M%?/7_#<GPY_YX:W_P"
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M:G<2PZQY=Q)N3;:H3C+'G]Y[T?V3C_\ GS+[@^O8;_GXCZ>HKYZ_X;D^'/\
MSPUO_P !$_\ CE'_  W)\.?^>&M_^ B?_'*/[)Q__/F7W!]>PW_/Q'T+17SU
M_P -R?#G_GAK?_@(G_QRC_AN3X<_\\-;_P# 1/\ XY1_9./_ .?,ON#Z]AO^
M?B/H6BOGK_AN3X<_\\-;_P# 1/\ XY1_PW)\.?\ GAK?_@(G_P <H_LG'_\
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MEJG_ (#K_P#%T?VUEW_/^/WA_8>9_P#/B7W'L%%>/_\ #4O@S_GEJG_@.O\
M\71_PU+X,_YY:I_X#K_\71_;67?\_P"/WA_8>9_\^)?<>P45X_\ \-2^#/\
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M^$]/U34[B6/4?+N)-R;8%)QECS\WO1_;67?\_P"/WA_8>9_\^)?<>\T5X_\
M\-2^#/\ GEJG_@.O_P 71_PU+X,_YY:I_P" Z_\ Q=']M9=_S_C]X?V'F?\
MSXE]Q[!17C__  U+X,_YY:I_X#K_ /%T?\-2^#/^>6J?^ Z__%T?VUEW_/\
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M^@K734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'E'[1_\ R3G6O^P5??\ HFOS3K]+/VC_ /DG.M?]
M@J^_]$U^:=?I7"G\"KZK\CY+.OXD/0****^Y/G HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KVZX_U\G^\?YUXC7MUQ_K
MY/\ >/\ .OYS\8-L!_W$_P#<9^\^%F^-_P"X?_MXRBBBOYP/WP**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *]P_96_P"1HO\ _=3_ - EKP^O
M</V5O^1HO_\ =3_T"6OI>'/^1K1^?_I+/E^)O^136_[=_P#2D?5%%%%?N9^!
M!1110 4444 %%%% !1110 5Y_P#$#_D,P_\ 7NO_ *$U>@5Y_P#$#_D,P_\
M7NO_ *$U &U\/_\ D#3?]?#?^@K735S/P_\ ^0--_P!?#?\ H*UTU !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!Y1^T?_R3G6O^P5??^B:_-.OTL_:/_P"2<ZU_V"K[_P!$U^:=?I7"
MG\"KZK\CY+.OXD/0****^Y/G HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KVZX_U\G^\?YUXC7MUQ_KY/]X_SK^<_&#;
M?]Q/_<9^\^%F^-_[A_\ MXRBBBOYP/WP**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&<;OP^K* "BODO\ 88O[F]\4?%_[1<33[=5AV^:Y;&7N<XS]!^5'P/O[F?\
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M!5]_Z)K\TZ_2N%/X%7U7Y'R6=?Q(>@4445]R?.!1110 4444 %%%% !1110
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M\W/$4H0C-O25K=;WVL3&E.4G%+5;_(\QHHHKI,@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "O;KC_7R?[Q_G7B->W7'^OD_P!X_P Z_G/Q
M@VP'_<3_ -QG[SX6;XW_ +A_^WC****_G _? HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **\QO/CIIT'BY=$@L);J,W*VIO%D 7<6"D@8Y )]:]
M-9@JEF(  R2>U=N(P6(PB@Z\.7F5UZ'#AL=A\8YJA/FY79^O]=A:*\TN/C1]
MNOKB#PYX>O\ Q$D!VO<0Y6/.>Q"MQ]<9K3\&_%:Q\5:M)I-Q97&CZN@)^R70
MP6P,D \<@<X('%=-3*L;3INK*GHM7JKI>:O=?-'-3S? U:BI0J:MV6CLWV3M
M9_)G<45S'C'QU!X3ELK2.TGU/5+TD6]C;?>8#J2>P_\ K^AJMX3^(B>(-8N=
M'OM-N-%UB!/--K<$,&7CE6&,]1V_KCG6!Q$J/UA1]W?IMM>V]K];6.AX_#1K
M_5W/WMNN]KVOM>W2]SL**QO%WBBT\'Z#<ZI>'*1#"1YP9'/W5'N?Y9/:G^%=
M2OM8T&TO=1LET^ZG7>;=6+;5/W<Y YQ@X[9K'V%3V/MVO=O;Y_UN;_6*?MOJ
MZ?O6O\MM?7I\S6HHHKG.@**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]P
M_96_Y&B__P!U/_0):\/KW#]E;_D:+_\ W4_] EKZ7AS_ )&M'Y_^DL^7XF_Y
M%-;_ +=_]*1]44445^YGX$%%%% !1110 4444 %%%% !7G_Q _Y#,/\ U[K_
M .A-7H%>?_$#_D,P_P#7NO\ Z$U &U\/_P#D#3?]?#?^@K735S/P_P#^0--_
MU\-_Z"M=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R9^U/
M,WQ8^.'PW^$UNQDLO/&JZJJ]-F&X/H1$DW_?Q:^K[BXCM;>2>9UBAC4N[L<!
M5 R23Z8KX"^%D/Q2^+WQ;\;?%;P ='A,MW)I\4VM9.V'"%$0;3\RQK$">/O>
MYH [S]J2)O@S^T)\//BI:)Y6GSL+#4O+&!M3Y6S[M"[ ?]<A7V''(DT:21L'
MC8!E93D$'H17Q5\<OAK^T%X\^'>HP>*Y?"VH:5IZG4C%8!A<;HD8YC^09;:6
M&.^<5[;^Q_\ $3_A8GP+T.2:7S-0TD'2KK)R<Q ",GUS&8SGUS0!Y=^P?_R-
M'QA_["L/_H=S1\"O^3XOBU_UYS?^CK>C]@__ )&CXP_]A6'_ -#N:/@5_P G
MQ?%K_KSF_P#1UO0!]=U\I?\ !1G_ ))#X?\ ^P['_P"D\]?5M?*7_!1G_DD/
MA_\ [#L?_I//0!/H?[=O@S3]$T^UD\+>,G>"WCB9H].A*DJH!(_?].*^A_ ?
MC.S^(7A#3/$5A;W5K9ZA&9(X;Z,1S( Q4AE!(!R#T)JUX3_Y%;1O^O*'_P!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*LBLK*&5A@J1D$>E>.? /]G;_A0VL>*9+'Q"VHZ-K,RRPZ:UIY?V3:S[1O\
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M'R6=?Q(>@4445]R?.!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVF&218HBOS.FU2-Q)()Z@#C&3G8\4^%?@AXTU^\UK6/BWJU[J-V^^65X3^
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M^XS]Y\+-\;_W#_\ ;QE%%%?S@?O@4444 %%%% !1110 4444 %%%% !1110
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M117W)\X%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %>W7'^OD_WC_.O$:]NN/]?)_O'^=?SGXP;8#_ +B?^XS]Y\+-\;_W
M#_\ ;QE%%%?S@?O@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5[A^RM_R-%__ +J?^@2UX?7N'[*W_(T7_P#NI_Z!+7TO#G_(UH_/_P!)9\OQ
M-_R*:W_;O_I2/JBBBBOW,_ @HHHH **** "BBB@ HHHH *\_^('_ "&8?^O=
M?_0FKT"O/_B!_P AF'_KW7_T)J -KX?_ /(&F_Z^&_\ 05KIJYGX?_\ (&F_
MZ^&_]!6NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /*/VC_\ DG.M?]@J^_\ 1-?FG7Z6?M'_ /).
M=:_[!5]_Z)K\TZ_2N%/X%7U7Y'R6=?Q(>@4445]R?.!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7MUQ_KY/]X_SKQ&O;
MKC_7R?[Q_G7\Y^,&V _[B?\ N,_>?"S?&_\ </\ ]O&4445_.!^^!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJO8^,?\ AW[J'_0Z6W_@O;_XY1_P[]U#_H=+;_P7M_\ '*^SJ*[_ /6#,?\
MGY^"_P CF_LO"?R_B_\ ,^,?^'?NH?\ 0Z6W_@O;_P".4?\ #OW4/^ATMO\
MP7M_\<K[.HH_U@S'_GY^"_R#^R\)_+^+_P SXQ_X=^ZA_P!#I;?^"]O_ (Y1
M_P ._=0_Z'2V_P#!>W_QROLZBC_6#,?^?GX+_(/[+PG\OXO_ #/C'_AW[J'_
M $.EM_X+V_\ CE'_  []U#_H=+;_ ,%[?_'*^SJ*/]8,Q_Y^?@O\@_LO"?R_
MB_\ ,^,?^'?NH?\ 0Z6W_@O;_P".4?\ #OW4/^ATMO\ P7M_\<K[.HH_U@S'
M_GY^"_R#^R\)_+^+_P SXQ_X=^ZA_P!#I;?^"]O_ (Y1_P ._=0_Z'2V_P#!
M>W_QROLZBC_6#,?^?GX+_(/[+PG\OXO_ #/C'_AW[J'_ $.EM_X+V_\ CE'_
M  []U#_H=+;_ ,%[?_'*^SJ*/]8,Q_Y^?@O\@_LO"?R_B_\ ,^,?^'?NH?\
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M;?\ @O;_ ..5]G44?ZP9C_S\_!?Y!_9>$_E_%_YGQC_P[]U#_H=+;_P7M_\
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M7:]M[]V?-7_#(MY_T,L'_@&W_P 71_PR+>?]#+!_X!M_\77TK17S/^K.5_\
M/K_R:7^9]#_K3FW_ #]_\EC_ )'S5_PR+>?]#+!_X!M_\71_PR+>?]#+!_X!
MM_\ %U]*T4?ZLY7_ ,^O_)I?YA_K3FW_ #]_\EC_ )'S5_PR+>?]#+!_X!M_
M\71_PR+>?]#+!_X!M_\ %U]*T4?ZLY7_ ,^O_)I?YA_K3FW_ #]_\EC_ )'S
M5_PR+>?]#+!_X!M_\71_PR+>?]#+!_X!M_\ %U]*T4?ZLY7_ ,^O_)I?YA_K
M3FW_ #]_\EC_ )'S5_PR+>?]#+!_X!M_\71_PR+>?]#+!_X!M_\ %U]*T4?Z
MLY7_ ,^O_)I?YA_K3FW_ #]_\EC_ )'S5_PR+>?]#+!_X!M_\71_PR+>?]#+
M!_X!M_\ %U]*T4?ZLY7_ ,^O_)I?YA_K3FW_ #]_\EC_ )'S5_PR+>?]#+!_
MX!M_\71_PR+>?]#+!_X!M_\ %U]*T4?ZLY7_ ,^O_)I?YA_K3FW_ #]_\EC_
M )'RQ%^R]=2ZY-IO_"00AHX]_F?93@].,;O>M+_AD6\_Z&6#_P  V_\ BZ]O
MM/\ D?+W_KW'\DKIJ/\ 5G*_^?7_ )-+_,/]:<V_Y^_^2Q_R/FK_ (9%O/\
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M=W)'][VKZGKF?#'_ "'M=_Z[?^S-1_JSE?\ SZ_\FE_F'^M.;?\ /W_R6/\
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M*T4?ZLY7_P ^O_)I?YA_K3FW_/W_ ,EC_D?-7_#(MY_T,L'_ (!M_P#%T?\
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M/:[_ -=O_9FKIJYGPQ_R'M=_Z[?^S-0!TU%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5S.I?\CQIG_7$_R>NFKF=2_Y'C3/^N)_D] '34444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7->/O^0+'_UW7^35TM<UX^_Y
M L?_ %W7^34 =''_ *M?I3J;'_JU^E.H **** "BBB@ HHHH **** "BBB@
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MO_\ D?--_P"O<_RDH Z:BBB@ HHHH **** "BBB@ HHHH *\_P#B!_R&8?\
MKW7_ -":O0*\_P#B!_R&8?\ KW7_ -":@#:^'_\ R!IO^OAO_05KIJYGX?\
M_(&F_P"OAO\ T%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH YGQ5_P AG0/^OC_V9*Z:N9\5?\AG
M0/\ KX_]F2NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\7
M?\B[>?1?_0A5G0?^0+8_]<$_D*K>+O\ D7;SZ+_Z$*LZ#_R!;'_K@G\A0!?H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9\,?\A[7?^NW_ +,U
M=-7,^&/^0]KO_7;_ -F:@#IJ*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KF=2_Y'C3/^N)_D]=-7,ZE_P CQIG_ %Q/\GH Z:BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *YKQ]_R!8_\ KNO\FKI:YKQ]_P @6/\
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M=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/XN_Y%V\^B_\
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M'_(9A_Z]U_\ 0FH VOA__P @:;_KX;_T%:Z:N9^'_P#R!IO^OAO_ $%:Z:@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH YGQ5_R&= _Z^/\ V9*Z:N9\5?\ (9T#_KX_]F2NFH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\7?\ (NWGT7_T(59T'_D"
MV/\ UP3^0JMXN_Y%V\^B_P#H0JSH/_(%L?\ K@G\A0!?HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S
M/BK_ )#.@?\ 7Q_[,E=-7,^*O^0SH'_7Q_[,E=-0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% &/XN_Y%V\^B_^A"K.@_\ (%L?^N"?R%5O%W_(
MNWGT7_T(59T'_D"V/_7!/Y"@"_1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %<SX8_Y#VN_]=O\ V9JZ:N9\,?\ (>UW_KM_[,U '34444 %%%%
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F?%7_(9T#_KX_\
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M]!%=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ',VG_(^7O\
MU[C^25TU<S:?\CY>_P#7N/Y)734 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!S/B[_ )"6A_\ 7Q_[,E=-7,^+O^0EH?\ U\?^S)734 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!C^+O^1=O/HO_H0JSH/_ "!;
M'_K@G\A5;Q=_R+MY]%_]"%6=!_Y MC_UP3^0H OT444 %%%% !1110 4444
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M:[_UV_\ 9FKIJYGPQ_R'M=_Z[?\ LS4 =-1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<SJ7_(\:9_UQ/\ )ZZ:N9U+_D>-,_ZXG^3T =-1110
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MO^OAO_05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#F?%7_(9T#_ *^/_9DKIJYGQ5_R&= _Z^/_
M &9*Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,?Q=_R+MY]
M%_\ 0A5G0?\ D"V/_7!/Y"JWB[_D7;SZ+_Z$*LZ#_P @6Q_ZX)_(4 7Z***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?#'_ "'M=_Z[?^S-735S
M/AC_ )#VN_\ 7;_V9J .FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "N9U+_D>-,_ZXG^3UTU<SJ7_(\:9_UQ/\GH Z:BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *YKQ]_P @6/\ Z[K_ ":NEKFO'W_(%C_Z[K_)
MJ .CC_U:_2G4V/\ U:_2G4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?^O@_P#H(KIJYGP%_P @VY_Z^#_Z"*Z:@ HHHH **** "BBB@ HHHH ****
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M HHHH **** "BBB@ HHHH *\_P#B!_R&8?\ KW7_ -":O0*\_P#B!_R&8?\
MKW7_ -":@#:^'_\ R!IO^OAO_05KIJYGX?\ _(&F_P"OAO\ T%:Z:@ HHHH
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M^0H OT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,^&/^0]KO\
MUV_]F:NFKF?#'_(>UW_KM_[,U '34444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7,W__ "/FF_\ 7N?Y25TU<S?_ /(^:;_U[G^4E '34444 %%%
M% !1110 4444 %%%% !7G_Q _P"0S#_U[K_Z$U>@5Y_\0/\ D,P_]>Z_^A-0
M!M?#_P#Y TW_ %\-_P"@K735S/P__P"0--_U\-_Z"M=-0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"#&'_XJC_A9GA#_H:]$_\ !C#_ /%5^4-%'^JE+_GZ_N#^VI_R+[S]7O\
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MH_U4I?\ /U_<']M3_D7WGZO?\+,\(?\ 0UZ)_P"#&'_XJC_A9GA#_H:]$_\
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MJE+_ )^O[@_MJ?\ (OO/U>_X69X0_P"AKT3_ ,&,/_Q5'_"S/"'_ $->B?\
M@QA_^*K\H:*/]5*7_/U_<']M3_D7WGZO?\+,\(?]#7HG_@QA_P#BJ/\ A9GA
M#_H:]$_\&,/_ ,57Y0T4?ZJ4O^?K^X/[:G_(OO/U>_X69X0_Z&O1/_!C#_\
M%5SNH_$3PHWC+391XGT<QK$07%_%@??[[J_,.BC_ %4I?\_7]P?VU/\ D7WG
MZO?\+,\(?]#7HG_@QA_^*H_X69X0_P"AKT3_ ,&,/_Q5?E#11_JI2_Y^O[@_
MMJ?\B^\_5[_A9GA#_H:]$_\ !C#_ /%4?\+,\(?]#7HG_@QA_P#BJ_*&BC_5
M2E_S]?W!_;4_Y%]Y^KW_  LSPA_T->B?^#&'_P"*H_X69X0_Z&O1/_!C#_\
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M (JORAHH_P!5*7_/U_<']M3_ )%]Y^KW_"S/"'_0UZ)_X,8?_BJ/^%F>$/\
MH:]$_P#!C#_\57Y0T4?ZJ4O^?K^X/[:G_(OO/U>_X69X0_Z&O1/_  8P_P#Q
M5'_"S/"'_0UZ)_X,8?\ XJORAHH_U4I?\_7]P?VU/^1?>?J]_P +,\(?]#7H
MG_@QA_\ BJ/^%F>$/^AKT3_P8P__ !5?E#11_JI2_P"?K^X/[:G_ "+[S]7O
M^%F>$/\ H:]$_P#!C#_\51_PLSPA_P!#7HG_ (,8?_BJ_*&BC_52E_S]?W!_
M;4_Y%]Y^GG@CXB>%+?3[E9?$^CQDSD@/?Q#L/]JNB_X69X0_Z&O1/_!C#_\
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M^I-'_G^_N7^9]_?\)MX=_P"@_I?_ (&1_P#Q5'_";>'?^@_I?_@9'_\ %5\
MT4?ZY5O^?*^]_P"0?ZDT?^?[^Y?YGW]_PFWAW_H/Z7_X&1__ !5'_";>'?\
MH/Z7_P"!D?\ \57P#11_KE6_Y\K[W_D'^I-'_G^_N7^9]_?\)MX=_P"@_I?_
M (&1_P#Q5'_";>'?^@_I?_@9'_\ %5\ T4?ZY5O^?*^]_P"0?ZDT?^?[^Y?Y
MGW]_PFWAW_H/Z7_X&1__ !5'_";>'?\ H/Z7_P"!D?\ \57P#11_KE6_Y\K[
MW_D'^I-'_G^_N7^9]_?\)MX=_P"@_I?_ (&1_P#Q5'_";>'?^@_I?_@9'_\
M%5\ T4?ZY5O^?*^]_P"0?ZDT?^?[^Y?YGVWXI\7Z%-J&C-'K6G.$GRQ6[C..
M5Z\UT?\ PFWAW_H/Z7_X&1__ !5? -%'^N5;_GROO?\ D'^I-'_G^_N7^9]_
M?\)MX=_Z#^E_^!D?_P 51_PFWAW_ *#^E_\ @9'_ /%5\ T4?ZY5O^?*^]_Y
M!_J31_Y_O[E_F??W_";>'?\ H/Z7_P"!D?\ \51_PFWAW_H/Z7_X&1__ !5?
M -%'^N5;_GROO?\ D'^I-'_G^_N7^9]_?\)MX=_Z#^E_^!D?_P 51_PFWAW_
M *#^E_\ @9'_ /%5\ T4?ZY5O^?*^]_Y!_J31_Y_O[E_F??W_";>'?\ H/Z7
M_P"!D?\ \51_PFWAW_H/Z7_X&1__ !5? -%'^N5;_GROO?\ D'^I-'_G^_N7
M^9]_?\)MX=_Z#^E_^!D?_P 51_PFWAW_ *#^E_\ @9'_ /%5\ T4?ZY5O^?*
M^]_Y!_J31_Y_O[E_F??W_";>'?\ H/Z7_P"!D?\ \51_PFWAW_H/Z7_X&1__
M !5? -%'^N5;_GROO?\ D'^I-'_G^_N7^9]_?\)MX=_Z#^E_^!D?_P 51_PF
MWAW_ *#^E_\ @9'_ /%5\ T4?ZY5O^?*^]_Y!_J31_Y_O[E_F??W_";>'?\
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MH_URK?\ /E?>_P#(/]2:/_/]_<O\S[^_X3;P[_T']+_\#(__ (JC_A-O#O\
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M_P"?*^]_Y!_J31_Y_O[E_F??W_";>'?^@_I?_@9'_P#%4?\ ";>'?^@_I?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"-V6.2T<D;CIT:@#Z"HKRO\ :6^+TWP4^%5[K]DL$FK231VEC'<J6C:5SDY
M()PBNW7L*L0_%&X\$_ BT\;^.UCAOH].CO+RWLTV9EDP4A16;AB65>3USVH
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MFZU4^&'[0'CG2_C+%\,/BCI&GVVK7D)FL-2TPD1S85F&0200P1\,-N&7!'/
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MBD<X 8<Y0<_6@#VZBOES_A;'QU^+,$GB#X<^%],T;PFI)L3KC 76I*#]X L
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M9Z!K'[;*Q6:PR:2=;W@(!L,Z)N;'8_OE/UK3\-^+/$+?MM7,;WETV_6;FS:
MNQ4VH#JJ[>FT(JM^ /O6E;'UK)T4E:'.[W^[I;U_ BGAJ=[3;?O<JM^9\Q5U
MC?##7HOAV/&T\,-MH+W'V6&2:4+).^<'RTZL 0W(_NMZ&O2(?A#'\3/VCO%V
ME6;K8^&[#5+JXU"\7"1VT"RMN /0$D%1^?0&N>^/WQ6@^(?B*VT[1(_L?@_0
MX_L>DV: A=B@ RD>K8&,] !WSGK6*E6J0IT5T4I>2>R]7^6IC[%4X2G4]%YO
MOZ(\LHHHKU3B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH WO O_ "-%I_NR_P#HIJ]-KS+P+_R-%I_NR_\ HIJ]-K^3
M_%G_ )'='_KTO_2YG],>&7_(HJ_]?'_Z3 ****_%#]="BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBN%^+/BR?0=%BTW3<OK6JM]FM43[RYX9A^>![D'M75AL//%5HT8;O\
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M0ZIXJ^ -QX#\7:\VKZU>6CI<ZORP\\R&5& ."51M@ XR$[=@#3_9[D67X%^
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MD="JGG&*\QTNZ_:DU#1X_"=SI&AZ6WEK;OXMDN$>58\8\S"RMF3&>1'^ /-
M%#]DM0G[2GQV50%4:I<  # '^F35RGBF'QSJG[=7BB+P;>:18:_%81BVDUH.
MT A^S0%@NU&.X[B>G=J]-_99^ /B;X+_ !(\>2ZLKW6DWB0QV6JRSQL]Z0S,
M[E Q93D_Q>O4]:U/C]\ /$>O>.](^)?PYO[?3O&NF)Y<D%R L=X@! ^;INVL
MR$-PRD<KMY ,;Q1\._VDO&'AO5-"U+Q'X#DT_4;:2UG5$G5BCJ5.#Y'!P>#6
MQ;_#74_A%^QEXF\+:Q>6U[?6>B:FSR698Q#>)9 JE@"?O=P.2:HKX_\ VF;Z
M/[$GPT\.V%UG:VH37Z- N?X@@G+?S]QVKTSQ-X7\5^(?V?\ 6M U66UU3QC?
M:%<6LK6N(X9;EXF "DA0!D@9( [\4 <-^PI:PV_[.ND211)')/=W4DK*H!=A
M*R@GU.U5'T KT'XZ?!ZP^.'P_N?#=[<M92>:MS:7:KN\B=00K%<C<,,RD>C'
MO6)^RKX!USX:?!71]!\1V8L-6@FN'EMQ*DNT/*S+\R$J>".AK7^-*?$B/1].
MO/AK)I\NI6MSONM.U)5V7D)4C8&.-I#8/#+]>Q / ?\ A:7QC_99M+&V\?Z5
M;>,_!,+I;+K=B^9XDZ*&8XY Z"11D\;Z[[]K[7+/Q-^R?J^KZ?+Y]AJ$>GW5
MO)@C=&]Q"RG!Z<$5QOC[1?C[^T%X?_X0[6?"&C>"-#N)HVO]0>]2<L(V# *J
M2,<;@#P.2 -P&:])^.GP?U'5OV99_ 'A&U.H7EK;6-K:0R2I$TJPRQ9)9B%!
MVH2<D9- '3?LX1K'\!? 0150?V/;MA1CDH"3^))->)>'!Y?_  42\4[?EWZ.
MA;'?_1K;K^0_*OH+X,^'+_PA\)_"6B:K"+?4K#3(+>XA#JX214 8;E)!P>X.
M*\MT?X3>*+3]LK6_'<NG*OA:ZTM8(K[[1&29!#"FWR]V\<HW.W''6@#B?BE_
MRD ^''_8*7^5Y5[_ (*,_P#)(?#_ /V'8_\ TGGKH_'GPB\5:W^U]X)\<6>G
M++X8T[3Q#=7OVB-3&X%Q\NPMO/\ K$Y (Y]JYS_@HS_R2'P__P!AV/\ ])YZ
M /IWP]&L.@:8B*J(MK$JJHP  @P *^4O 4:1_P#!0KQP-.Q]G_LS-QLZ9,-J
M7Z?]-,9]\U8TN/\ :.^%.@P>'O#NF:3X]T;RD73-6NY$2>WC*_*DBM*GW1TS
MN X^8C KN?V8O@#JWPSFUWQ9XQO(]2\<>(7+W4D9#"W0L79-PX)9L%L# VJ!
MP,D ]\HHHH **** /*/VC_\ DG.M?]@J^_\ 1-?FG7Z6?M'_ /).=:_[!5]_
MZ)K\TZ_2N%/X%7U7Y'R6=?Q(>@4445]R?.!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-K>SZORL<F7XFH\12I1J:WFI0TM",;\NEKK9)=[GI5%%%?&GVH4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5[A^RM_P C1?\ ^ZG_ *!+7A]>X?LK?\C1?_[J?^@2U]+PY_R-
M:/S_ /26?+\3?\BFM_V[_P"E(^J****_<S\""BBB@ HHHH **** "BBB@ KS
M_P"('_(9A_Z]U_\ 0FKT"O/_ (@?\AF'_KW7_P!":@#:^'__ "!IO^OAO_05
MKIJYGX?_ /(&F_Z^&_\ 05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "O$_VK_@EK?QV\!Z7HN@W>GV=W:ZDMX[:C(Z1E!%(A
M *(YSEQV]>:]LHH K:;;-9Z?:V[$,T42QDCH2 !5FBB@ HHHH **** /*/VC
M_P#DG.M?]@J^_P#1-?FG7Z6?M'_\DYUK_L%7W_HFOS3K]*X4_@5?5?D?)9U_
M$AZ!1117W)\X%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#>\"_\C1:?[LO_HIJ]-KS+P+_ ,C1:?[LO_HIJ]-K^3_%
MG_D=T?\ KTO_ $N9_3'AE_R**O\ U\?_ *3 ****_%#]="BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!OEKY@?:N_&-V.<4ZBB@ HHHH @N+&VO)(7GMXIWA;?&TB!BC>
MJD]#]*GHHIW;5F*R3ND,DB28 .BN <@,,\T^BBD,**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "O</V5O^1HO_P#=3_T"6O#Z]P_96_Y&B_\ ]U/_ $"6OI>'/^1K1^?_
M *2SY?B;_D4UO^W?_2D?5%%%%?N9^!!1110 4444 %%%% !1110 5Y_\0/\
MD,P_]>Z_^A-7H%>?_$#_ )#,/_7NO_H34 ;7P_\ ^0--_P!?#?\ H*UTU<S\
M/_\ D#3?]?#?^@K734 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'E'[1_\ R3G6O^P5??\ HFOS3K]+
M/VC_ /DG.M?]@J^_]$U^:=?I7"G\"KZK\CY+.OXD/0****^Y/G HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#>\"_\C1:?[LO_ **:O3:\R\"_\C1:?[LO_HIJ
M]-K^3_%G_D=T?^O2_P#2YG],>&7_ "**O_7Q_P#I, HHHK\4/UT**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *]P_96_Y&B_\ ]U/_ $"6O#Z]P_96_P"1HO\ _=3_ - EKZ7AS_D:T?G_
M .DL^7XF_P"136_[=_\ 2D?5%%%%?N9^!!1110 4444 %%%% !1110 5Y_\
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M3_G]'_P)?YA]6K_R/[F>545ZK_PRW\4_^A0N?^_\/_Q='_#+?Q3_ .A0N?\
MO_#_ /%T?7\)_P _H_\ @2_S#ZM7_D?W,\JHKU7_ (9;^*?_ $*%S_W_ (?_
M (NC_AEOXI_]"A<_]_X?_BZ/K^$_Y_1_\"7^8?5J_P#(_N9Y517JO_#+?Q3_
M .A0N?\ O_#_ /%T?\,M_%/_ *%"Y_[_ ,/_ ,71]?PG_/Z/_@2_S#ZM7_D?
MW,\JHKU7_AEOXI_]"A<_]_X?_BZK6_[-?Q+NYIH8?"MP\D)VR+Y\/RGG_;]C
M1]?PG_/Z/_@2_P P^K5_Y']S/,Z*]5_X9;^*?_0H7/\ W_A_^+H_X9;^*?\
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M;^*?_0H7/_?^'_XNC_AEOXI_]"A<_P#?^'_XNCZ_A/\ G]'_ ,"7^8?5J_\
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M545ZK_PRW\4_^A0N?^_\/_Q='_#+?Q3_ .A0N?\ O_#_ /%T?7\)_P _H_\
M@2_S#ZM7_D?W,\JHKU7_ (9;^*?_ $*%S_W_ (?_ (NC_AEOXI_]"A<_]_X?
M_BZ/K^$_Y_1_\"7^8?5J_P#(_N9Y517JO_#+?Q3_ .A0N?\ O_#_ /%T?\,M
M_%/_ *%"Y_[_ ,/_ ,71]?PG_/Z/_@2_S#ZM7_D?W,\JHKU7_AEOXI_]"A<_
M]_X?_BZKWW[-/Q+TV$2W/A6XBC)VAC/">?P?VH^OX3_G]'_P)?YA]6K_ ,C^
MYGF5%>J#]EOXI'D>$+G_ +_P_P#Q=+_PRW\4_P#H4+G_ +_P_P#Q='U_"?\
M/Z/_ ($O\P^K5_Y']S/*J*]5_P"&6_BG_P!"A<_]_P"'_P"+H_X9;^*?_0H7
M/_?^'_XNCZ_A/^?T?_ E_F'U:O\ R/[F>545ZK_PRW\4_P#H4+G_ +_P_P#Q
M='_#+?Q3_P"A0N?^_P##_P#%T?7\)_S^C_X$O\P^K5_Y']S/*J*]5_X9;^*?
M_0H7/_?^'_XNC_AEOXI_]"A<_P#?^'_XNCZ_A/\ G]'_ ,"7^8?5J_\ (_N9
MY517JO\ PRW\4_\ H4+G_O\ P_\ Q='_  RW\4_^A0N?^_\ #_\ %T?7\)_S
M^C_X$O\ ,/JU?^1_<SRJBO5?^&6_BG_T*%S_ -_X?_BZ/^&6_BG_ -"A<_\
M?^'_ .+H^OX3_G]'_P "7^8?5J_\C^YGE5%>J_\ #+?Q3_Z%"Y_[_P /_P 7
M1_PRW\4_^A0N?^_\/_Q='U_"?\_H_P#@2_S#ZM7_ )']S/*J*]5_X9;^*?\
MT*%S_P!_X?\ XNC_ (9;^*?_ $*%S_W_ (?_ (NCZ_A/^?T?_ E_F'U:O_(_
MN9Y517JO_#+?Q3_Z%"Y_[_P__%T?\,M_%/\ Z%"Y_P"_\/\ \71]?PG_ #^C
M_P"!+_,/JU?^1_<SRJBO3+']FOXEZC&SVWA6XE16VDB>$<^G+U9_X9;^*?\
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M;^*?_0H7/_?^'_XNC_AEOXI_]"A<_P#?^'_XNCZ_A/\ G]'_ ,"7^8?5J_\
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M^!+_ #."HKO?^%$^//\ H79_^_L7_P 51_PHGQY_T+L__?V+_P"*H_L[&_\
M/B7_ ("_\@_M/ _\_P"'_@2_S."HKO?^%$^//^A=G_[^Q?\ Q5'_  HGQY_T
M+L__ ']B_P#BJ/[.QO\ SXE_X"_\@_M/ _\ /^'_ ($O\S@J*[BZ^"?C>RMW
MFGT":.)?O,98^.<?WJ=#\#_'-Q"DL?A^9HW 96\V/D'_ (%1_9V-_P"?$O\
MP%_Y!_:>!_Y_P_\  E_F<+17>_\ "B?'G_0NS_\ ?V+_ .*H_P"%$^//^A=G
M_P"_L7_Q5']G8W_GQ+_P%_Y!_:>!_P"?\/\ P)?YG!45WO\ PHGQY_T+L_\
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M]"[/_P!_8O\ XJJUO\&?&EW--##H4SR0G;(OF1_*>?\ :]C1_9V-_P"?$O\
MP%_Y!_:>!_Y_P_\  E_F<717>_\ "B?'G_0NS_\ ?V+_ .*H_P"%$^//^A=G
M_P"_L7_Q5']G8W_GQ+_P%_Y!_:>!_P"?\/\ P)?YG!45WO\ PHGQY_T+L_\
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M4445^SGX>%%%% !1110 4444 %%%% !7G_Q _P"0S#_U[K_Z$U>@5Y_\0/\
MD,P_]>Z_^A-0!M?#_P#Y TW_ %\-_P"@K735S/P__P"0--_U\-_Z"M=-0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P!<3_)ZZ:N9U+_D>-,_ZXG^3T =-1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<UX^_P"0+'_UW7^35TM<UX^_Y L?_7=?Y-0!T<?^K7Z4ZFQ_
MZM?I3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YGP%_R#;G_
M *^#_P"@BNFKF? 7_(-N?^O@_P#H(KIJ "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH YFT_Y'R]_P"O<?R2NFKF;3_D?+W_ *]Q_)*Z:@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** .9\7?\ (2T/_KX_]F2NFKF?
M%W_(2T/_ *^/_9DKIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH Q_%W_(NWGT7_T(59T'_D"V/_7!/Y"JWB[_ )%V\^B_^A"K.@_\@6Q_ZX)_
M(4 7Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?#'_(>UW_KM
M_P"S-735S/AC_D/:[_UV_P#9FH Z:BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *YF__ .1\TW_KW/\ *2NFKF;_ /Y'S3?^O<_RDH Z:BBB@ HH
MHH **** "BBB@ HHHH *\_\ B!_R&8?^O=?_ $)J] KS_P"('_(9A_Z]U_\
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MBB@ HHHH **** "N9\,?\A[7?^NW_LS5TU<SX8_Y#VN_]=O_ &9J .FHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "N9U+_D>-,_ZXG^3UTU<SJ7
M_(\:9_UQ/\GH Z:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YK
MQ]_R!8_^NZ_R:NEKFO'W_(%C_P"NZ_R:@#HX_P#5K]*=38_]6OTIU !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 <SX"_Y!MS_U\'_T$5TU<SX"
M_P"0;<_]?!_]!%=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M',VG_(^7O_7N/Y)735S-I_R/E[_U[C^25TU !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 <SXN_Y"6A_P#7Q_[,E=-7,^+O^0EH?_7Q_P"S)734
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^+O^1=O/HO_ *$*
MLZ#_ ,@6Q_ZX)_(56\7?\B[>?1?_ $(59T'_ ) MC_UP3^0H OT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7,^&/\ D/:[_P!=O_9FKIJYGPQ_
MR'M=_P"NW_LS4 =-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<
MS?\ _(^:;_U[G^4E=-7,W_\ R/FF_P#7N?Y24 =-1110 4444 %%%% !1110
M 4444 %>?_$#_D,P_P#7NO\ Z$U>@5Y_\0/^0S#_ ->Z_P#H34 ;7P__ .0-
M-_U\-_Z"M=-7,_#_ /Y TW_7PW_H*UTU !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S/BK_ )#.@?\
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MHH **** "BBB@ HHHH **** .9\!?\@VY_Z^#_Z"*Z:N9\!?\@VY_P"O@_\
MH(KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YFT_P"1\O?^
MO<?R2NFKF;3_ )'R]_Z]Q_)*Z:@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** .9\7?\A+0_^OC_ -F2NFKF?%W_ "$M#_Z^/_9DKIJ "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH Q_%W_ "+MY]%_]"%6=!_Y MC_
M -<$_D*K>+O^1=O/HO\ Z$*LZ#_R!;'_ *X)_(4 7Z*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KF?#'_(>UW_KM_[,U=-7,^&/^0]KO_7;_P!F
M:@#IJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF;__ )'S3?\
MKW/\I*Z:N9O_ /D?--_Z]S_*2@#IJ*** "BBB@ HHHH **** "BBB@ KS_X@
M?\AF'_KW7_T)J] KS_X@?\AF'_KW7_T)J -KX?\ _(&F_P"OAO\ T%:Z:N9^
M'_\ R!IO^OAO_05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#F?%7_(9T#_KX_\ 9DKIJYGQ5_R&
M= _Z^/\ V9*Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,?Q
M=_R+MY]%_P#0A5G0?^0+8_\ 7!/Y"JWB[_D7;SZ+_P"A"K.@_P#(%L?^N"?R
M% %^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGPQ_R'M=_P"N
MW_LS5TU<SX8_Y#VN_P#7;_V9J .FHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N9U+_ )'C3/\ KB?Y/735S.I?\CQIG_7$_P GH Z:BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *YKQ]_R!8_^NZ_R:NEKFO'W_(%
MC_Z[K_)J .CC_P!6OTIU-C_U:_2G4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!S/@+_D&W/\ U\'_ -!%=-7,^ O^0;<_]?!_]!%=-0 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 5S-_\ \CYIO_7N?Y25TU<S?_\
M(^:;_P!>Y_E)0!TU%%% !1110 4444 %%%% !1110 5Y_P#$#_D,P_\ 7NO_
M *$U>@5Y_P#$#_D,P_\ 7NO_ *$U &U\/_\ D#3?]?#?^@K735S/P_\ ^0--
M_P!?#?\ H*UTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!S/BK_D,Z!_U\?^S)735S/BK_ )#.@?\
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M34 =''_JU^E.IL?^K7Z4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH *YGPQ_R'M=_P"NW_LS5TU<SX8_Y#VN_P#7;_V9J .FHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N9O\ _D?--_Z]S_*2NFKF;_\ Y'S3?^O<
M_P I* .FHHHH **** "BBB@ HHHH **** "O/_B!_P AF'_KW7_T)J] KS_X
M@?\ (9A_Z]U_]":@#:^'_P#R!IO^OAO_ $%:Z:N9^'__ "!IO^OAO_05KIJ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#F?%7_(9T#_ *^/_9DKIJYGQ5_R&= _Z^/_ &9*Z:@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,?Q=_R+MY]%_\ 0A5G0?\
MD"V/_7!/Y"JWB[_D7;SZ+_Z$*LZ#_P @6Q_ZX)_(4 7Z*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KF?#'_ "'M=_Z[?^S-735S/AC_ )#VN_\
M7;_V9J .FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9U+_D>-
M,_ZXG^3UTU<SJ7_(\:9_UQ/\GH Z:BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *YKQ]_P @6/\ Z[K_ ":NEKFO'W_(%C_Z[K_)J .CC_U:_2G4
MV/\ U:_2G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S/@+_D
M&W/_ %\'_P!!%=-7,^ O^0;<_P#7P?\ T$5TU !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 <S:?\CY>_\ 7N/Y)735S-I_R/E[_P!>X_DE=-0
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M@ HHHH **** "BBB@ HHHH YGQ=_R$M#_P"OC_V9*Z:N9\7?\A+0_P#KX_\
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MZ+_Z$*LZ#_R!;'_K@G\A0!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N9\,?\A[7?^NW_ +,U=-7,^&/^0]KO_7;_ -F:@#IJ*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KF=2_Y'C3/^N)_D]=-7,ZE_P CQIG_
M %Q/\GH Z:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YKQ]_R!
M8_\ KNO\FKI:YKQ]_P @6/\ Z[K_ ":@#HX_]6OTIU-C_P!6OTIU !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 <SX"_P"0;<_]?!_]!%=-7,^
MO^0;<_\ 7P?_ $$5TU !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 <S:?\ (^7O_7N/Y)735S-I_P CY>_]>X_DE=-0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% ',^+O^0EH?_7Q_P"S)735S/B[_D):'_U\?^S)
M734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^+O^1=O/HO\
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M %\-_P"@K735S/P__P"0--_U\-_Z"M=-0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <SXJ_Y#.@?]?'
M_LR5TU<SXJ_Y#.@?]?'_ +,E=-0 4444 %%%% !1110 4444 %%%% !1110
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MW/\ *2NFKF;_ /Y'S3?^O<_RDH Z:BBB@ HHHH **** "BBB@ HHHH *\_\
MB!_R&8?^O=?_ $)J] KS_P"('_(9A_Z]U_\ 0FH VOA__P @:;_KX;_T%:Z:
MN9^'_P#R!IO^OAO_ $%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH YGQ5_R&= _Z^/\ V9*Z:N9\
M5?\ (9T#_KX_]F2NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#'\7?\ (NWGT7_T(59T'_D"V/\ UP3^0JMXN_Y%V\^B_P#H0JSH/_(%L?\
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M4 %%%% !1110 4444 %%%% !1110 4444 %<S?\ _(^:;_U[G^4E=-7,W_\
MR/FF_P#7N?Y24 =-1110 4444 %%%% !1110 4444 %>?_$#_D,P_P#7NO\
MZ$U>@5Y_\0/^0S#_ ->Z_P#H34 ;7P__ .0--_U\-_Z"M=-7,_#_ /Y TW_7
MPW_H*UTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!S/BK_ )#.@?\ 7Q_[,E=-7,^*O^0SH'_7Q_[,
ME=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/XN_Y%V\^B_^
MA"K.@_\ (%L?^N"?R%5O%W_(NWGT7_T(59T'_D"V/_7!/Y"@"_1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<SX8_Y#VN_]=O\ V9JZ:N9\,?\
M(>UW_KM_[,U '34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,Z
ME_R/&F?]<3_)ZZ:N9U+_ )'C3/\ KB?Y/0!TU%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5S7C[_D"Q_P#7=?Y-72US7C[_ ) L?_7=?Y-0!T<?
M^K7Z4ZFQ_P"K7Z4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M.9\!?\@VY_Z^#_Z"*Z:N9\!?\@VY_P"O@_\ H(KIJ "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH YFT_P"1\O?^O<?R2NFKF;3_ )'R]_Z]Q_)*
MZ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .9\7?\A+0_^OC_
M -F2NFKF?%W_ "$M#_Z^/_9DKIJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH Q_%W_ "+MY]%_]"%6=!_Y MC_ -<$_D*K>+O^1=O/HO\ Z$*L
MZ#_R!;'_ *X)_(4 7Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKF?#'_(>UW_KM_[,U=-7,^&/^0]KO_7;_P!F:@#IJ*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KF;__ )'S3?\ KW/\I*Z:N9O_ /D?--_Z]S_*
M2@#IJ*** "BBB@ HHHH **** "BBB@ KS_X@?\AF'_KW7_T)J] KS_X@?\AF
M'_KW7_T)J -KX?\ _(&F_P"OAO\ T%:Z:N9^'_\ R!IO^OAO_05KIJ "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#RK]HQVC^'FL.C%772[XAE."#Y/6OS=_MG4/^?ZY_P"_S?XU^D'[
M1_\ R3G6O^P5??\ HFOS3K](X52=&K==5^1\GG3?M(>A<_MG4/\ G^N?^_S?
MXT?VSJ'_ #_7/_?YO\:IT5]SRQ['SG,^Y<_MG4/^?ZY_[_-_C1_;.H?\_P!<
M_P#?YO\ &J=%'+'L',^Y<_MG4/\ G^N?^_S?XT?VSJ'_ #_7/_?YO\:IT4<L
M>P<S[ES^V=0_Y_KG_O\ -_C1_;.H?\_US_W^;_&J=%'+'L',^Y<_MG4/^?ZY
M_P"_S?XT?VSJ'_/]<_\ ?YO\:IT4<L>P<S[ES^V=0_Y_KG_O\W^-']LZA_S_
M %S_ -_F_P :IT4<L>P<S[ES^V=0_P"?ZY_[_-_C1_;.H?\ /]<_]_F_QJG1
M1RQ[!S/N7/[9U#_G^N?^_P W^-']LZA_S_7/_?YO\:IT4<L>P<S[EMM8OV&#
M>W!'H96_QI1K%^HP+ZY _P"NK?XU3HHY8]@YGW+G]LZA_P _US_W^;_&C^V=
M0_Y_KG_O\W^-4Z*.6/8.9]RY_;.H?\_US_W^;_&C^V=0_P"?ZY_[_-_C5.BC
MECV#F?<N?VSJ'_/]<_\ ?YO\:/[9U#_G^N?^_P W^-4Z*.6/8.9]RY_;.H?\
M_P!<_P#?YO\ &C^V=0_Y_KG_ +_-_C5.BCECV#F?<N?VSJ'_ #_7/_?YO\:/
M[9U#_G^N?^_S?XU3HHY8]@YGW+G]LZA_S_7/_?YO\:/[9U#_ )_KG_O\W^-4
MZ*.6/8.9]RY_;.H?\_US_P!_F_QH_MG4/^?ZY_[_ #?XU3HHY8]@YGW+G]LZ
MA_S_ %S_ -_F_P :/[9U#_G^N?\ O\W^-4Z*.6/8.9]RY_;.H?\ /]<_]_F_
MQI!JU\I)%[< GK^];_&JE%'+'L',^Y<_MG4/^?ZY_P"_S?XT?VSJ'_/]<_\
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M_C1_;.H?\_US_P!_F_QJG11RQ[!S/N7/[9U#_G^N?^_S?XT?VSJ'_/\ 7/\
MW^;_ !JG11RQ[!S/N7/[9U#_ )_KG_O\W^-']LZA_P _US_W^;_&J=%'+'L'
M,^Y<_MG4/^?ZY_[_ #?XT?VSJ'_/]<_]_F_QJG11RQ[!S/N7/[9U#_G^N?\
MO\W^-']LZA_S_7/_ '^;_&J=%'+'L',^Y<_MG4/^?ZY_[_-_C1_;.H?\_P!<
M_P#?YO\ &J=%'+'L',^Y<_MG4/\ G^N?^_S?XT?VSJ'_ #_7/_?YO\:IT4<L
M>P<S[EM=6OEX6]N%^DK?XTO]LZA_S_7/_?YO\:IT4<L>P<S[ES^V=0_Y_KG_
M +_-_C1_;.H?\_US_P!_F_QJG11RQ[!S/N7/[9U#_G^N?^_S?XT?VSJ'_/\
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MARQ[%G^T[S_G[G_[^-_C1_:=Y_S]S_\ ?QO\:K44<TNX<L>Q9_M.\_Y^Y_\
MOXW^-']IWG_/W/\ ]_&_QJM11S2[ARQ[%G^T[S_G[G_[^-_C1_:=Y_S]S_\
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MHYI=PY8]BS_:=Y_S]S_]_&_QH_M.\_Y^Y_\ OXW^-5J*.:7<.6/8L_VG>?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%O OQ,\/^!=3-[_;>MB(V[0P!H5\R1HX][9!&64C@''?%>DT %%%% !1110
M4444 >4?M'_\DYUK_L%7W_HFOS3K]+/VC_\ DG.M?]@J^_\ 1-?FG7Z5PI_
MJ^J_(^2SK^)#T"BBBON3YP**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **?'"\N[8C/M7<VT9P/4^U,I %%7-+
MT>_URX:WTZQN=0G52YBM86D8*.K84$X&1S5.BZO8?F%%%%,04444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5ZIX0_Y%?3O]U_\ T:]>
M5UZIX0_Y%?3O]U__ $:]?BWBQ_R(Z7_7V/\ Z1,_6_#/_D<5/^O<O_2H&O11
M17\FG]-!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%-219
M%W(P9?53D4Z@ HJ"UOK:^$AMKB*X$;%'\IPVUAU!QT/M4]-IQ=F)-25T%%%%
M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %>X?LK?\ (T7_ /NI_P"@2UX?7N'[*W_(
MT7_^ZG_H$M?2\.?\C6C\_P#TEGR_$W_(IK?]N_\ I2/JBBBBOW,_ @HHHH *
M*** "BBB@ HHHH *\_\ B!_R&8?^O=?_ $)J] KS_P"('_(9A_Z]U_\ 0FH
MVOA__P @:;_KX;_T%:Z:N9^'_P#R!IO^OAO_ $%:Z:@ HHHH **** "BBB@
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MCNLD5EC\P#:V 0K#I_RT8]Z /9=/_;,L=,URQL/'7@;Q'\/X+Z39;W^K6["
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML*UR+16Z6Z!1117&=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>X?LK?\ (T7_ /NI
M_P"@2UX?7N'[*W_(T7_^ZG_H$M?2\.?\C6C\_P#TEGR_$W_(IK?]N_\ I2/J
MBBBBOW,_ @HHHH **** "BBB@ HHHH *\_\ B!_R&8?^O=?_ $)J] KS_P"(
M'_(9A_Z]U_\ 0FH VOA__P @:;_KX;_T%:Z:N9^'_P#R!IO^OAO_ $%:Z:@
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MRO\ ?[WXG!>/-2M_B1\2O#NFZ%(MX+%]\]U%RBC>I8@]P O7U.!7NA8*"2<
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M>B^#XY$TFP2U,GWWR7=OJS$G'MTK;KS\=B*==TXTK\L(J*;W>K=[:VW[L]+
M8:IAXU)5;<TY.32V5TE:^E]M[+4****\T],**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *]4\(?\BOIW^Z_P#Z->O*Z]4\(?\ (KZ=_NO_ .C7K\6\6/\ D1TO^OL?
M_2)GZWX9_P#(XJ?]>Y?^E0->BBBOY-/Z:"BBB@ HHHH **** "BBB@ HHHH
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M]>Z_^A-7H%>?_$#_ )#,/_7NO_H34 ;7P_\ ^0--_P!?#?\ H*UTU<S\/_\
MD#3?]?#?^@K734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% 'E'[1_\ R3G6O^P5??\ HFOS3K]+/VC_
M /DG.M?]@J^_]$U^:=?I7"G\"KZK\CY+.OXD/0****^Y/G HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ KU3PA_P BOIW^Z_\ Z->O*Z]4\(?\BOIW^Z__ *->OQ;Q8_Y$=+_K['_T
MB9^M^&?_ ".*G_7N7_I4#7HHHK^33^F@HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKW#]E;_D:+__ '4_] EKP^O</V5O^1HO_P#=3_T"6OI>'/\ D:T?G_Z2SY?B
M;_D4UO\ MW_TI'U11117[F?@04444 %%%% !1110 4444 %>?_$#_D,P_P#7
MNO\ Z$U>@5Y_\0/^0S#_ ->Z_P#H34 ;7P__ .0--_U\-_Z"M=-7,_#_ /Y
MTW_7PW_H*UTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!Y;^T-:S7O@+5+>WBDGN)M,O8XXHE+.[&+
M 4 <DD\8%?GE_P *S\8?]"IK?_@NF_\ B:_3GQ5_R&= _P"OC_V9*Z:OH<LS
MB>60E",.:[ON>7C,!'&24G*UC\H/^%9^,/\ H5-;_P#!=-_\31_PK/QA_P!"
MIK?_ (+IO_B:_5^BO:_UKJ_\^E]YY_\ 8L/YW]Q^4'_"L_&'_0J:W_X+IO\
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MM_\ @NF_^)K]7Z*/]:ZO_/I?>']BP_G?W'Y0?\*S\8?]"IK?_@NF_P#B:/\
MA6?C#_H5-;_\%TW_ ,37ZOT4?ZUU?^?2^\/[%A_._N/R@_X5GXP_Z%36_P#P
M73?_ !-,;X=^*UE6(^&-8$C#(0V$N3^&VOUBKF=2_P"1XTS_ *XG^3T?ZUU?
M^?2^\/[%A_._N/S&_P"%9^,/^A4UO_P73?\ Q-'_  K/QA_T*FM_^"Z;_P")
MK]7Z*/\ 6NK_ ,^E]X?V+#^=_<?E!_PK/QA_T*FM_P#@NF_^)H_X5GXP_P"A
M4UO_ ,%TW_Q-?J_11_K75_Y]+[P_L6'\[^X_*#_A6?C#_H5-;_\ !=-_\31_
MPK/QA_T*FM_^"Z;_ .)K]7Z*/]:ZO_/I?>']BP_G?W'Y0?\ "L_&'_0J:W_X
M+IO_ (FC_A6?C#_H5-;_ /!=-_\ $U^K]%'^M=7_ )]+[P_L6'\[^X_*#_A6
M?C#_ *%36_\ P73?_$T?\*S\8?\ 0J:W_P""Z;_XFOU?HH_UKJ_\^E]X?V+#
M^=_<?E!_PK/QA_T*FM_^"Z;_ .)H_P"%9^,/^A4UO_P73?\ Q-?J_11_K75_
MY]+[P_L6'\[^X_*#_A6?C#_H5-;_ /!=-_\ $T?\*S\8?]"IK?\ X+IO_B:_
M5^BC_6NK_P ^E]X?V+#^=_<?E!_PK/QA_P!"IK?_ (+IO_B:/^%9^,/^A4UO
M_P %TW_Q-?J_11_K75_Y]+[P_L6'\[^X_*#_ (5GXP_Z%36__!=-_P#$TR;X
M=^*[==TOAC68USC<^GR@?^@U^L5<UX^_Y L?_7=?Y-1_K75_Y]+[P_L6'\[^
MX_,7_A6GB_\ Z%36_P#P73?_ !-'_"L_&'_0J:W_ ."Z;_XFOU=C_P!6OTIU
M'^M=7_GTOO#^Q8?SO[C\H/\ A6?C#_H5-;_\%TW_ ,31_P *S\8?]"IK?_@N
MF_\ B:_5^BC_ %KJ_P#/I?>']BP_G?W'Y0?\*S\8?]"IK?\ X+IO_B:/^%9^
M,/\ H5-;_P#!=-_\37ZOT4?ZUU?^?2^\/[%A_._N/R@_X5GXP_Z%36__  73
M?_$T?\*S\8?]"IK?_@NF_P#B:_5^BC_6NK_SZ7WA_8L/YW]Q^4'_  K/QA_T
M*FM_^"Z;_P")H_X5GXP_Z%36_P#P73?_ !-?J_11_K75_P"?2^\/[%A_._N/
MR@_X5GXP_P"A4UO_ ,%TW_Q-'_"L_&'_ $*FM_\ @NF_^)K]7Z*/]:ZO_/I?
M>']BP_G?W'Y0?\*S\8?]"IK?_@NF_P#B:/\ A6?C#_H5-;_\%TW_ ,37ZOT4
M?ZUU?^?2^\/[%A_._N/R@_X5GXP_Z%36_P#P73?_ !-'_"L_&'_0J:W_ ."Z
M;_XFOU?HH_UKJ_\ /I?>']BP_G?W'Y0?\*S\8?\ 0J:W_P""Z;_XFC_A6?C#
M_H5-;_\ !=-_\37ZOT4?ZUU?^?2^\/[%A_._N/R=A^'?BNX4M%X8UB0 X)2P
ME/\ [+3_ /A6?C#_ *%36_\ P73?_$U^G/@+_D&W/_7P?_01734?ZUU?^?2^
M\/[%A_._N/R@_P"%9^,/^A4UO_P73?\ Q-'_  K/QA_T*FM_^"Z;_P")K]7Z
M*/\ 6NK_ ,^E]X?V+#^=_<?E!_PK/QA_T*FM_P#@NF_^)H_X5GXP_P"A4UO_
M ,%TW_Q-?J_11_K75_Y]+[P_L6'\[^X_*#_A6?C#_H5-;_\ !=-_\31_PK/Q
MA_T*FM_^"Z;_ .)K]7Z*/]:ZO_/I?>']BP_G?W'Y0?\ "L_&'_0J:W_X+IO_
M (FO3/"O@7Q+#X;L(Y/#VJHZJ^5:RE!'[QSTVU^B=%?(<48A\3X*.#J+D49*
M5UKLFK?B?4\.U/\ 5W%RQ=/WVXN-GINT[_@? /\ PA/B+_H :I_X!R?_ !-'
M_"$^(O\ H :I_P" <G_Q-??U%?EW^IM'_G\_N7^9^C?Z[5O^?"^]_P"1\ _\
M(3XB_P"@!JG_ (!R?_$T?\(3XB_Z &J?^ <G_P 37W]11_J;1_Y_/[E_F'^N
MU;_GPOO?^1\ _P#"$^(O^@!JG_@')_\ $T?\(3XB_P"@!JG_ (!R?_$U]_44
M?ZFT?^?S^Y?YA_KM6_Y\+[W_ )'P#_PA/B+_ * &J?\ @')_\31_PA/B+_H
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MZBC_ %-H_P#/Y_<O\P_UVK?\^%][_P CX!_X0GQ%_P! #5/_  #D_P#B:/\
MA"?$7_0 U3_P#D_^)K[^HH_U-H_\_G]R_P P_P!=JW_/A?>_\CX!_P"$)\1?
M] #5/_ .3_XFC_A"?$7_ $ -4_\  .3_ .)K[^HH_P!3:/\ S^?W+_,/]=JW
M_/A?>_\ (^ ?^$)\1?\ 0 U3_P  Y/\ XFC_ (0GQ%_T -4_\ Y/_B:^_J*/
M]3:/_/Y_<O\ ,/\ 7:M_SX7WO_(^ ?\ A"?$7_0 U3_P#D_^)H_X0GQ%_P!
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MH_\ /Y_<O\P_UVK?\^%][_R/@'_A"?$7_0 U3_P#D_\ B:/^$)\1?] #5/\
MP#D_^)K[^HH_U-H_\_G]R_S#_7:M_P ^%][_ ,CX!_X0GQ%_T -4_P# .3_X
MFC_A"?$7_0 U3_P#D_\ B:^_J*/]3:/_ #^?W+_,/]=JW_/A?>_\CX!_X0GQ
M%_T -4_\ Y/_ (FC_A"?$7_0 U3_ , Y/_B:^_J*/]3:/_/Y_<O\P_UVK?\
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MJ?\ @')_\37W]11_J;1_Y_/[E_F'^NU;_GPOO?\ D? /_"$^(O\ H :I_P"
M<G_Q-'_"$^(O^@!JG_@')_\ $U]_44?ZFT?^?S^Y?YA_KM6_Y\+[W_D? /\
MPA/B+_H :I_X!R?_ !-'_"$^(O\ H :I_P" <G_Q-??U%'^IM'_G\_N7^8?Z
M[5O^?"^]_P"1\ _\(3XB_P"@!JG_ (!R?_$T?\(3XB_Z &J?^ <G_P 37W]1
M1_J;1_Y_/[E_F'^NU;_GPOO?^1\ _P#"$^(O^@!JG_@')_\ $T?\(3XB_P"@
M!JG_ (!R?_$U]_44?ZFT?^?S^Y?YA_KM6_Y\+[W_ )'P#_PA/B+_ * &J?\
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M"^]_Y'P#_P (3XB_Z &J?^ <G_Q-'_"$^(O^@!JG_@')_P#$U]_44?ZFT?\
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M@HHHH **** "BBB@ HHHH *\_P#B!_R&8?\ KW7_ -":O0*\_P#B!_R&8?\
MKW7_ -":@#:^'_\ R!IO^OAO_05KIJYGX?\ _(&F_P"OAO\ T%:Z:@ HHHH
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M^0H OT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,^&/^0]KO\
MUV_]F:NFKF?#'_(>UW_KM_[,U '34444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7,W__ "/FF_\ 7N?Y25TU<S?_ /(^:;_U[G^4E '34444 %%%
M% !1110 4444 %%%% !7G_Q _P"0S#_U[K_Z$U>@5Y_\0/\ D,P_]>Z_^A-0
M!M?#_P#Y TW_ %\-_P"@K735S/P__P"0--_U\-_Z"M=-0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <
MSXJ_Y#.@?]?'_LR5TU<SXJ_Y#.@?]?'_ +,E=-0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% &/XN_Y%V\^B_\ H0JSH/\ R!;'_K@G\A5;Q=_R
M+MY]%_\ 0A5G0?\ D"V/_7!/Y"@"_1110 4444 %%%% !1110 4444 %%%%
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M0 4444 <SXN_Y"6A_P#7Q_[,E=-7,^+O^0EH?_7Q_P"S)734 %%%% !1110
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M"_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<SX8_Y#VN_]=O\
MV9JZ:N9\,?\ (>UW_KM_[,U '34444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7,ZE_R/&F?]<3_)ZZ:N9U+_ )'C3/\ KB?Y/0!TU%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5S7C[_D"Q_P#7=?Y-72US7C[_ ) L
M?_7=?Y-0!T<?^K7Z4ZFQ_P"K7Z4Z@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** .9\!?\@VY_Z^#_Z"*Z:N9\!?\@VY_P"O@_\ H(KIJ "BBB@
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M734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S/B[_ )"6A_\
M7Q_[,E=-7,^+O^0EH?\ U\?^S)734 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!C^+O^1=O/HO_H0JSH/_ "!;'_K@G\A5;Q=_R+MY]%_]"%6=
M!_Y MC_UP3^0H OT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,
M^&/^0]KO_7;_ -F:NFKF?#'_ "'M=_Z[?^S-0!TU%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5S-_\ \CYIO_7N?Y25TU<S?_\ (^:;_P!>Y_E)
M0!TU%%% !1110 4444 %%%% !1110 5Y_P#$#_D,P_\ 7NO_ *$U>@5Y_P#$
M#_D,P_\ 7NO_ *$U &U\/_\ D#3?]?#?^@K735S/P_\ ^0--_P!?#?\ H*UT
MU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 QHDD92R*Q7E21G'TI]%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 -=%D4JZAE/4,,BE50J@*  . !2T4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4Q8DC9F5%5FY) P3]:?10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !3#$C2!RBEQP&QR/QI]% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %,DC29<.BN.N&&:?10 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R.)(00B*@ZX48
MI]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,\I!(7"*'/!;
M'/YT^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &/$DA4LBL
M5Y!89Q3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :Z+(I5
MU#*>H89%*JA5 4  < "EHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ IBQ)&S,J*K-R2!@GZT^B@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "F&)&D#E%+C@-CD?C3Z* "BBB@ HHHH **** "BBB@ HHHH *\
M_P#B!_R&8?\ KW7_ -":O0*\_P#B!_R&8?\ KW7_ -":@#:^'_\ R!IO^OAO
M_05KIJYGX?\ _(&F_P"OAO\ T%:Z:@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT5\GR_\ !/\ T-O#YN5\6:Y_PF_E^;_:[7"^4;G'7;MW[,_[6[OGM6]^Q?\
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MYLKD=]R+T+8^@/"_AG3?!GAW3]#TBV6TTVPA6""%>RCU/<GJ3W))H U:***
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MSQ9;M"+@-;>&-,EY%G:<CS?]Y@6 /?<[=&7 !]*T444 %%%% !1110 4444
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ME X]6...F3XRGD_:L^,:^#;&1S\-O"5PL^MW43834;L$A8%(ZJ""./\ ;/\
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M:L49X) X##J"0>OM5FN-^$?PPTOX/^ ]-\,Z4NZ.W7=/<$8:XF.-\K>Y/;L
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M64MC (;@D9SUKL_@'^T)?>-/V;==\4ZFRW?B#PQ:W0NV(V_:##"98W(']Y<
MX[JW% 'T517Q%X5^"$'Q&_9UOOBGK.O:S/\ $&>TO=5@U5;YT\AHFDV1JH.
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M^!EOI3JVM0W-Q+=K'S(MJ#&<MCHI5;C_ ,>H ^G**** "BBB@ HHHH ****
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M=/CI\8O"?A+X3^(+R?6]/NGO-/F@L[>"X25KF21&1 H!Y&3R>@ )H X7Q_\
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M\1^"_$C?&SXQ7&D6TGA^R:TT3P_HCNP>>0, "S]6.YNF[CYN G-'X=^(M/\
M@WO^(_Q-6\U'XE^.6+V>CZ=;&>[@M>-D,<>1MX"9R1P%7J&K2\.Q/^UE\9#X
MBN49_A?X.N#%ID+C]WJEZ,$RD=U'!Y[;1_$XJWXBD2T_;V\-OJ958IO#;1Z:
M\O"^9F;(4G^+'F?]]>] 'JWPI^/'AGXO7.HV.EK?Z;K.G8-UI&KVWV>ZB4X^
M8ID@C)QP3@XSU&?1J^8TV7W[?3/I1WBU\,[=5:'D!B3M#X[X:#@^@KZ<H **
M** "BBB@ HHHH **** "OG']N+XF2^$/A;'X:TUF;6O%,OV&../[_D#'FD ?
MWLI'COYA]*^CJ^+?![_\-+?MD7WB$_Z3X3\% +:GJDCQLPB((_O2^9*#_=0
MT ?2GP*^&L7PE^%>@>&U51=00"2\=>=]P_S2'/<!B0/917S]^Q3)]N^,7QNO
M9!F=]25MW^]<7)/Z@?E7U_7Q/\+/$%I^S_\ M>>/M!\27,>EZ3XD=[FTO+D[
M(B7E,L.7/ 7#RID_Q+B@#Z6_:%A2?X%^/ED4,HT2[8 ^HB8@_F!7AG[/GPW3
MXP?L5?\ "*75P;07DUR+:X*[A$Z7!D1L9&1O'(]":ZS]L+XRZ!X>^#>L:+9Z
MK:WVN:[$+.VM+699',;D;W(4G"[,X/<D"N^_9O\  EQ\-_@EX4T*]5H[Z.V,
M]S&XPR22NTK(1ZJ7V_\  : /'=7^#WQA^(/@W2/ OCG4O#&E^#-+,)O]6L99
M6NKR" ?*/F 4< $L0O(![8./#XBT;XN>,KCXB^(Y5TSX,?#]OL^CP2J2E_=*
M0HEV=6 .S [_ "+C[]=O^T/XLU/XF>+K+X*>#[@Q7NH*)_$>H1\BPL>"4/\
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M\S %8B1CJ ,DOD?57B#Q!I_A70[[6-5N4L].L86GGGD/"(HR3[GVZD\5\\_
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ME(W#KU!QDXQDUT?P_P#AOX<^%OA]=%\,:7'I=@',C*A9VD<]6=V)9CP.2>@
M' KI:* "BBB@ HHHH **** "BBB@ KB/B1\%?!?Q<BB7Q5H,&IRPJ4BN=S13
MQC.<"1"&QGG&<>U=O10!X3H'[$_PET'4$NSX?EU)XVWI'J%W)+&#[ID*P]F!
M%>XVMK#96\5O;Q)!!$H2.*)0JHH&  !P !VJ6B@#S/XH?LY^ ?C!>)?>(M$$
MFIJH07]K*T$Q4= Q4X8#MN!QVQ4?PQ_9K^'WPCOSJ'A_1 -4P5%_>2M/,@/!
M"ECA..,J 2"0:]0HH JZG8_VEIMW9BXGM#<0O%]HMF"RQ;E(W(2#AAG(.#R*
MYGX6_"GP_P#!_P ,_P!A^'H)$MVF:>:>X??-/(W5G; R< #IT KL** .;\?_
M  Z\._%#P^^B^)M,CU33V<2!')5HW&0'1E(96Y(R#T)'0FN;^&?[//@7X2ZA
M/J/A_2635)D\IK^[G>>8)_<4L3M' Z 9P,YP*](HH **** "BBB@ HHHH **
M** "BBB@".XA2Z@DAD7='(I1ESC((P17)_#'X3>&O@_H=QI/A>RDLK*XN#=2
M)).\I:0JJDY8G'"+Q[5V%% ',^/OAOX:^*&AG2/$^DPZK9;MZ+)E7C;^\CJ0
MRGW!'I7F'AW]BGX3>'=52_70)=1DC8/'#J%T\T*D'/*9PP]FR*]UHH ;'&L4
M:HBA$4855&  .PKA]#^#F@:'\2M8\=@W=_XBU*,0F>]E$BVT8P-D*X&P8 '<
MX'7DY[JB@"&\LX-0LY[6ZACN;:=&BEAE4,DB,,,K \$$$@BO'=*_8]^%6C^(
M(M6A\-F1X9?/AM+BZEEMHWSG<(V8@]N#D<#BO:** "BBB@ HHHH **** "BB
MB@ IDT*7$3Q2HLD;J59'&0P/!!'<4^B@#P?7/V(_A)KFH&[&@SZ<S'<\5C>2
M1Q,?]TDA?HN!7?\ PV^"7@GX1Q2KX6T&#3IIAB6Z9FEG<>AD<EL<9V@X]J[F
MB@"OJ&GVVJV-Q97MO%=V=PC136\Z!TD0C!5E/!!'8UX7??L._".^U0W@T*ZM
MD9MS6L%_*L)]>-V0/8$>V*]\HH Q_"?A#1? NAV^C:!IMOI6F0?<M[=<#)ZD
MGJS'N3DGN:Y_XA?![0/BAK'A^]\0&[NH=$N/M4&GB4"UEDXPTJ8^?&..>A(Z
M$Y[BB@ KR;QY^RU\-_B-XBEUS5M#9=2G_P"/F6RN9+<7(_Z:*C $],G )P,F
MO6:* ,OPSX8TKP;H5GHVB6,.FZ7:)LAMH!A5'7ZDDY))Y)))YK4HHH ****
M"BBB@ HHHH **** .:\??#CPW\4-";2/$^E0ZK8[MZK)D/&V,;D<$,K8/4&O
M-?#7[&/PF\,ZHFH1^'&OYXY/,B74+J2:-#V&PMM8?[P->WT4 (JA%"J J@8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5Y_\0/\ D,P_]>Z_^A-7H%>?_$#_ )#,/_7NO_H34 ;7
MP_\ ^0--_P!?#?\ H*UTU<S\/_\ D#3?]?#?^@K734 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5Y_P#$#_D,P_\ 7NO_ *$U>@5Y
M_P#$#_D,P_\ 7NO_ *$U &U\/_\ D#3?]?#?^@K735S/P_\ ^0--_P!?#?\
MH*UTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>?
M_$#_ )#,/_7NO_H35Z!7G_Q _P"0S#_U[K_Z$U &U\/_ /D#3?\ 7PW_ *"M
M=-7,_#__ ) TW_7PW_H*UTU !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5Y_P#$#_D,P_\ 7NO_ *$U>@5Y_P#$#_D,P_\ 7NO_
M *$U &U\/_\ D#3?]?#?^@K735S/P_\ ^0--_P!?#?\ H*UTU !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#7Q;I4=J^D:%- ]ZTLX210EP)#M7'/RT =?^T1\=K;X$^$K6^&GMJVKZA/\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O/\
MX@?\AF'_ *]U_P#0FKT"O/\ X@?\AF'_ *]U_P#0FH VOA__ ,@:;_KX;_T%
M:Z:N9^'_ /R!IO\ KX;_ -!6NFH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KS_X@?\AF'_KW7_T)J] KS_X@?\AF'_KW7_T)J -K
MX?\ _(&F_P"OAO\ T%:Z:N9^'_\ R!IO^OAO_05KIJ "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *\_P#B!_R&8?\ KW7_ -":O0*\
M_P#B!_R&8?\ KW7_ -":@#:^'_\ R!IO^OAO_05KIJYGX?\ _(&F_P"OAO\
MT%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW_Y"3_"BB@ _X3#5_P#G[_\ (2?X4?\ "8:O_P _?_D)/\*** #_ (3#5_\
MG[_\A)_A1_PF&K_\_?\ Y"3_  HHH /^$PU?_G[_ /(2?X4?\)AJ_P#S]_\
MD)/\*** #_A,-7_Y^_\ R$G^%'_"8:O_ ,_?_D)/\*** #_A,-7_ .?O_P A
M)_A1_P )AJ__ #]_^0D_PHHH /\ A,-7_P"?O_R$G^%'_"8:O_S]_P#D)/\
M"BB@ _X3#5_^?O\ \A)_A1_PF&K_ //W_P"0D_PHHH /^$PU?_G[_P#(2?X4
M?\)AJ_\ S]_^0D_PHHH /^$PU?\ Y^__ "$G^%'_  F&K_\ /W_Y"3_"BB@
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M^0D_PHHH /\ A,-7_P"?O_R$G^%'_"8:O_S]_P#D)/\ "BB@ _X3#5_^?O\
M\A)_A1_PF&K_ //W_P"0D_PHHH /^$PU?_G[_P#(2?X4?\)AJ_\ S]_^0D_P
MHHH /^$PU?\ Y^__ "$G^%'_  F&K_\ /W_Y"3_"BB@ _P"$PU?_ )^__(2?
MX4?\)AJ__/W_ .0D_P *** #_A,-7_Y^_P#R$G^%'_"8:O\ \_?_ )"3_"BB
M@ _X3#5_^?O_ ,A)_A1_PF&K_P#/W_Y"3_"BB@ _X3#5_P#G[_\ (2?X4?\
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M?_G[_P#(2?X4?\)AJ_\ S]_^0D_PHHH /^$PU?\ Y^__ "$G^%'_  F&K_\
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MPU?_ )^__(2?X4?\)AJ__/W_ .0D_P *** #_A,-7_Y^_P#R$G^%'_"8:O\
M\_?_ )"3_"BB@ _X3#5_^?O_ ,A)_A1_PF&K_P#/W_Y"3_"BB@ _X3#5_P#G
M[_\ (2?X4?\ "8:O_P _?_D)/\*** #_ (3#5_\ G[_\A)_A1_PF&K_\_?\
MY"3_  HHH /^$PU?_G[_ /(2?X4?\)AJ_P#S]_\ D)/\*** #_A,-7_Y^_\
MR$G^%'_"8:O_ ,_?_D)/\*** #_A,-7_ .?O_P A)_A1_P )AJ__ #]_^0D_
MPHHH /\ A,-7_P"?O_R$G^%'_"8:O_S]_P#D)/\ "BB@ _X3#5_^?O\ \A)_
MA1_PF&K_ //W_P"0D_PHHH /^$PU?_G[_P#(2?X4?\)AJ_\ S]_^0D_PHHH
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M1_PF&K_\_?\ Y"3_  HHH /^$PU?_G[_ /(2?X4?\)AJ_P#S]_\ D)/\***
M#_A,-7_Y^_\ R$G^%'_"8:O_ ,_?_D)/\*** #_A,-7_ .?O_P A)_A1_P )
MAJ__ #]_^0D_PHHH /\ A,-7_P"?O_R$G^%'_"8:O_S]_P#D)/\ "BB@ _X3
M#5_^?O\ \A)_A1_PF&K_ //W_P"0D_PHHH /^$PU?_G[_P#(2?X4?\)AJ_\
MS]_^0D_PHHH /^$PU?\ Y^__ "$G^%'_  F&K_\ /W_Y"3_"BB@ _P"$PU?_
M )^__(2?X4?\)AJ__/W_ .0D_P *** #_A,-7_Y^_P#R$G^%'_"8:O\ \_?_
M )"3_"BB@ _X3#5_^?O_ ,A)_A1_PF&K_P#/W_Y"3_"BB@ _X3#5_P#G[_\
M(2?X4?\ "8:O_P _?_D)/\*** #_ (3#5_\ G[_\A)_A1_PF&K_\_?\ Y"3_
J  HHH /^$PU?_G[_ /(2?X57:XN?$%YNNI]TBI@-L X!Z8&/4T44 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474995064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 22, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-26224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTEGRA LIFESCIENCES HOLDINGS CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0317849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1100 Campus Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">275-0500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $.01 Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IART<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Smaller Reporting Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,968.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,243,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Certain portions of the registrant&#8217;s definitive proxy statement relating to its scheduled May&#160;13, 2022 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000917520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471923672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Florham Park, New Jersey<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787475045352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">$ 1,542,448<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
<td class="nump">$ 1,517,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">597,808<span></span>
</td>
<td class="nump">520,834<span></span>
</td>
<td class="nump">564,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">93,051<span></span>
</td>
<td class="nump">77,381<span></span>
</td>
<td class="nump">79,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">64,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">637,445<span></span>
</td>
<td class="nump">594,526<span></span>
</td>
<td class="nump">687,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="nump">16,914<span></span>
</td>
<td class="nump">27,757<span></span>
</td>
<td class="nump">27,028<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">1,345,218<span></span>
</td>
<td class="nump">1,220,498<span></span>
</td>
<td class="nump">1,423,797<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">197,230<span></span>
</td>
<td class="nump">151,370<span></span>
</td>
<td class="nump">93,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">6,737<span></span>
</td>
<td class="nump">9,297<span></span>
</td>
<td class="nump">10,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(50,395)<span></span>
</td>
<td class="num">(71,581)<span></span>
</td>
<td class="num">(53,957)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of business</a></td>
<td class="nump">41,798<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">19,307<span></span>
</td>
<td class="nump">4,434<span></span>
</td>
<td class="nump">9,522<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">214,677<span></span>
</td>
<td class="nump">93,520<span></span>
</td>
<td class="nump">60,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">45,602<span></span>
</td>
<td class="num">(40,372)<span></span>
</td>
<td class="nump">9,903<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.98<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding (See Note 13):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">84,698<span></span>
</td>
<td class="nump">84,650<span></span>
</td>
<td class="nump">85,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">85,485<span></span>
</td>
<td class="nump">85,228<span></span>
</td>
<td class="nump">86,494<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472049496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in foreign currency translation adjustments</a></td>
<td class="num">(17,362)<span></span>
</td>
<td class="nump">53,363<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized gain (loss) on derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Unrealized derivative gain (loss) arising during period</a></td>
<td class="nump">68,192<span></span>
</td>
<td class="num">(96,837)<span></span>
</td>
<td class="num">(13,671)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Less: Reclassification adjustments for gain (loss) included in net income</a></td>
<td class="nump">17,024<span></span>
</td>
<td class="num">(24,442)<span></span>
</td>
<td class="nump">14,865<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="nump">51,168<span></span>
</td>
<td class="num">(72,395)<span></span>
</td>
<td class="num">(28,536)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Defined benefit pension plan - net gain (loss) arising during period</a></td>
<td class="nump">6,998<span></span>
</td>
<td class="nump">4,604<span></span>
</td>
<td class="num">(8,973)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), before tax</a></td>
<td class="nump">40,804<span></span>
</td>
<td class="num">(14,428)<span></span>
</td>
<td class="num">(37,683)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax (expense) benefit related to items in other comprehensive loss</a></td>
<td class="num">(11,900)<span></span>
</td>
<td class="nump">16,771<span></span>
</td>
<td class="nump">6,724<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="nump">28,904<span></span>
</td>
<td class="nump">2,343<span></span>
</td>
<td class="num">(30,959)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income, net of tax</a></td>
<td class="nump">$ 197,979<span></span>
</td>
<td class="nump">$ 136,235<span></span>
</td>
<td class="nump">$ 19,242<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787476255656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 513,448<span></span>
</td>
<td class="nump">$ 470,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable, net of allowances of $4,735 and $6,439</a></td>
<td class="nump">231,831<span></span>
</td>
<td class="nump">225,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">317,386<span></span>
</td>
<td class="nump">310,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">91,051<span></span>
</td>
<td class="nump">69,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">162,105<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,153,716<span></span>
</td>
<td class="nump">1,237,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">311,703<span></span>
</td>
<td class="nump">287,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset - operating leases</a></td>
<td class="nump">84,543<span></span>
</td>
<td class="nump">83,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,145,573<span></span>
</td>
<td class="nump">989,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,013,458<span></span>
</td>
<td class="nump">932,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">56,950<span></span>
</td>
<td class="nump">73,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">16,440<span></span>
</td>
<td class="nump">11,277<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,782,383<span></span>
</td>
<td class="nump">3,615,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Current portion of borrowings under senior credit facility</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">33,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgramCurrent', window );">Current portion of borrowings under securitization facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liability - operating leases</a></td>
<td class="nump">14,775<span></span>
</td>
<td class="nump">12,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable, trade</a></td>
<td class="nump">61,837<span></span>
</td>
<td class="nump">54,608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">5,295<span></span>
</td>
<td class="nump">5,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">92,656<span></span>
</td>
<td class="nump">76,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">120,458<span></span>
</td>
<td class="nump">94,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,751<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">340,021<span></span>
</td>
<td class="nump">401,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredLongTermDebt', window );">Long-term borrowings under senior credit facility</a></td>
<td class="nump">824,257<span></span>
</td>
<td class="nump">933,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent', window );">Long-term borrowings under securitization facility</a></td>
<td class="nump">112,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="nump">564,426<span></span>
</td>
<td class="nump">474,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability - operating leases</a></td>
<td class="nump">90,329<span></span>
</td>
<td class="nump">88,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">45,788<span></span>
</td>
<td class="nump">16,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">120,258<span></span>
</td>
<td class="nump">186,727<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,097,579<span></span>
</td>
<td class="nump">2,100,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock; no par value; 15,000 authorized shares; none outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.01 par value; 240,000 authorized shares; 89,600 and 89,251 issued at December&#160;31, 2021 and 2020, respectively</a></td>
<td class="nump">896<span></span>
</td>
<td class="nump">893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,264,943<span></span>
</td>
<td class="nump">1,290,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 4,899 and 4,914 shares at December&#160;31, 2021 and 2020, respectively</a></td>
<td class="num">(234,448)<span></span>
</td>
<td class="num">(235,141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(45,155)<span></span>
</td>
<td class="num">(74,059)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">698,568<span></span>
</td>
<td class="nump">532,265<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,684,804<span></span>
</td>
<td class="nump">1,514,867<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 3,782,383<span></span>
</td>
<td class="nump">$ 3,615,136<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgramCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgramCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgramNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474796552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Trade accounts receivable, allowances</a></td>
<td class="nump">$ 4,735<span></span>
</td>
<td class="nump">$ 6,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNoParValue', window );">Preferred Stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, authorized shares (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized shares (in shares)</a></td>
<td class="nump">240,000,000<span></span>
</td>
<td class="nump">240,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">89,600,000<span></span>
</td>
<td class="nump">89,251,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, at cost; shares (in shares)</a></td>
<td class="nump">4,899,000<span></span>
</td>
<td class="nump">4,914,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787476024232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">119,836<span></span>
</td>
<td class="nump">116,031<span></span>
</td>
<td class="nump">109,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment', window );">Non-cash in-process research and development expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="nump">64,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Non-cash impairment charges</a></td>
<td class="nump">2,754<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) provision</a></td>
<td class="num">(2,755)<span></span>
</td>
<td class="num">(64,138)<span></span>
</td>
<td class="num">(19,046)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">36,210<span></span>
</td>
<td class="nump">19,590<span></span>
</td>
<td class="nump">21,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees', window );">Amortization of debt issuance costs and expenses associated with debt refinancing</a></td>
<td class="nump">7,030<span></span>
</td>
<td class="nump">12,076<span></span>
</td>
<td class="nump">5,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">3,834<span></span>
</td>
<td class="nump">2,955<span></span>
</td>
<td class="nump">5,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion of bond issuance discount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,415<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress', window );">Loss on disposal of property and equipment and construction in-progress</a></td>
<td class="nump">2,240<span></span>
</td>
<td class="nump">7,855<span></span>
</td>
<td class="nump">1,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from the sale of business</a></td>
<td class="num">(41,798)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration and others</a></td>
<td class="num">(2,162)<span></span>
</td>
<td class="nump">951<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">7,265<span></span>
</td>
<td class="nump">52,105<span></span>
</td>
<td class="num">(9,428)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">5,374<span></span>
</td>
<td class="num">(48,348)<span></span>
</td>
<td class="num">(43,308)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(21,143)<span></span>
</td>
<td class="nump">1,632<span></span>
</td>
<td class="nump">13,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other non-current assets</a></td>
<td class="nump">7,875<span></span>
</td>
<td class="nump">13,735<span></span>
</td>
<td class="nump">13,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other current liabilities</a></td>
<td class="nump">32,874<span></span>
</td>
<td class="num">(57,512)<span></span>
</td>
<td class="nump">14,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">28<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(607)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="num">(14,110)<span></span>
</td>
<td class="num">(2,889)<span></span>
</td>
<td class="num">(2,059)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">312,427<span></span>
</td>
<td class="nump">203,832<span></span>
</td>
<td class="nump">231,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(48,022)<span></span>
</td>
<td class="num">(38,890)<span></span>
</td>
<td class="num">(69,537)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of Extremity Orthopedics Business</a></td>
<td class="nump">190,468<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets', window );">Acquired in-process research and development and intangibles</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(25,000)<span></span>
</td>
<td class="num">(64,995)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from note receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsForProceedsFromBusinessAcquisitions', window );">Cash paid for business acquisitions, net of cash acquired</a></td>
<td class="num">(303,910)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,509)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sales of property and equipment</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3,657<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities', window );">Net proceeds (payments) on swaps designated as net investment hedges</a></td>
<td class="nump">76<span></span>
</td>
<td class="num">(7,840)<span></span>
</td>
<td class="nump">1,584<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(161,443)<span></span>
</td>
<td class="num">(68,073)<span></span>
</td>
<td class="num">(162,668)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from borrowings of long-term indebtedness</a></td>
<td class="nump">25,500<span></span>
</td>
<td class="nump">171,500<span></span>
</td>
<td class="nump">236,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Payments on debt</a></td>
<td class="num">(125,500)<span></span>
</td>
<td class="num">(441,000)<span></span>
</td>
<td class="num">(246,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Purchase of option hedge on convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(104,248)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible notes issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">575,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of stock purchase warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">44,563<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="num">(249)<span></span>
</td>
<td class="num">(24,347)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercised stock options</a></td>
<td class="nump">6,824<span></span>
</td>
<td class="nump">5,232<span></span>
</td>
<td class="nump">6,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash taxes paid in net equity settlement</a></td>
<td class="num">(4,801)<span></span>
</td>
<td class="num">(5,075)<span></span>
</td>
<td class="num">(6,514)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(98,226)<span></span>
</td>
<td class="nump">121,625<span></span>
</td>
<td class="num">(8,766)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(9,476)<span></span>
</td>
<td class="nump">13,871<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">43,282<span></span>
</td>
<td class="nump">271,255<span></span>
</td>
<td class="nump">60,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">470,166<span></span>
</td>
<td class="nump">198,911<span></span>
</td>
<td class="nump">138,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 513,448<span></span>
</td>
<td class="nump">$ 470,166<span></span>
</td>
<td class="nump">$ 198,911<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Debt Issuance Costs And Debt Refinanced Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Or Part Noncash, In Process Research And Development</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_NoncashOrPartNoncashInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForOptionIndexToIssuersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Options Indexed to Issuer's Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForOptionIndexToIssuersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForProceedsFromBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For (Proceeds From) Business Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForProceedsFromBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire In Process Research And Development And Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787469275992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Beginning of Period (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,044,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period at Dec. 31, 2018</a></td>
<td class="nump">$ 1,375,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 880<span></span>
</td>
<td class="num">$ (120,615)<span></span>
</td>
<td class="nump">$ 1,192,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (45,443)<span></span>
</td>
<td class="nump">$ 348,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, Beginning of Period, Treasury Stock (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,881,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">50,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(30,959)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,959)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">674,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</a></td>
<td class="num">(282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 672<span></span>
</td>
<td class="num">(961)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">21,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, End of Period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,735,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period at Dec. 31, 2019</a></td>
<td class="nump">$ 1,416,736<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
<td class="nump">$ 887<span></span>
</td>
<td class="num">$ (119,943)<span></span>
</td>
<td class="nump">1,213,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,402)<span></span>
</td>
<td class="nump">398,574<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, End of Period, Treasury Stock (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,865,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">2,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</a></td>
<td class="num">(538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 526<span></span>
</td>
<td class="num">(1,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">19,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Share repurchase and equity component of the convertible note issuance, net</a></td>
<td class="nump">$ 42,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Accelerated shares repurchased (in shares)</a></td>
<td class="num">(2,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,060,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Accelerated shares repurchased</a></td>
<td class="num">$ (100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (115,724)<span></span>
</td>
<td class="nump">15,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, End of Period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period at Dec. 31, 2020</a></td>
<td class="nump">$ 1,514,867<span></span>
</td>
<td class="num">$ (66,047)<span></span>
</td>
<td class="nump">$ 893<span></span>
</td>
<td class="num">$ (235,141)<span></span>
</td>
<td class="nump">1,290,908<span></span>
</td>
<td class="num">$ (63,274)<span></span>
</td>
<td class="num">(74,059)<span></span>
</td>
<td class="nump">532,266<span></span>
</td>
<td class="num">$ (2,773)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, End of Period, Treasury Stock (in shares) at Dec. 31, 2020</a></td>
<td class="num">(4,914,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,914,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standard Update 2020-06 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">28,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">1,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</a></td>
<td class="nump">895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 693<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">35,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, End of Period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period at Dec. 31, 2021</a></td>
<td class="nump">$ 1,684,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 896<span></span>
</td>
<td class="num">$ (234,448)<span></span>
</td>
<td class="nump">$ 1,264,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (45,155)<span></span>
</td>
<td class="nump">$ 698,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, End of Period, Treasury Stock (in shares) at Dec. 31, 2021</a></td>
<td class="num">(4,899,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,899,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472039896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">BUSINESS</a></td>
<td class="text">BUSINESSIntegra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) was incorporated in Delaware in 1989. The Company is a worldwide leader in medical technology. The Company was founded with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care. The Company sells its products directly through various sales forces and through a variety of other distribution channels.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471887816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BASIS OF PRESENTATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PRINCIPLES OF CONSOLIDATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. See Note&#160;4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of new subsidiaries included in the consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">USE OF ESTIMATES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company continues to navigate the novel coronavirus ("COVID-19") pandemic and recent variants of the virus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as the adverse impacts to global economic conditions, supply chain and the operations, there may be impact to future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#8217;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECLASSIFICATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts from the prior year's financial statements have been reclassified in order to conform to the current year's presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CASH AND CASH EQUIVALENTS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. Provision for doubtful accounts net of recoveries, associated with accounts receivable, included in selling, general and administrative expense, was recoveries of $1.1 million for the year ended December&#160;31, 2021, and charges of $3.6 million, and $2.1 million for the years ended December 31, 2020 and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INVENTORIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $52.8&#160;million of inventories, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program. No such amounts were capitalized at December&#160;31, 2021 or 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROPERTY, PLANT AND EQUIPMENT </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment balances and corresponding lives were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and production equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical instrument kits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information systems and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures, and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314,874)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282,849)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $37.9&#160;million of property, plant and equipment, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense associated with property, plant and equipmen</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t was $39.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, $42.1 million, and $42.6 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company wrote-off certain construction in progress of $6.7&#160;million related to a manufacturing project that the Company decided to discontinue. The Company determined that the carrying amounts of these assets were not recoverable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CAPITALIZED INTEREST</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended December&#160;31, 2021 and 2020, respectively, the Company capitalized $1.2 million and $2.3 million of interest expense into property, plant and equipment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, Business Combinations (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired in recorded as goodwill. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs and costs to restructure the acquired company are expensed as incurred.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issuance, or validity and litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition. Refer to Note 4, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and Divestitures</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two reportable segments with three underlying reporting units. Refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on reportable segments. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">over their expected useful lives.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LONG-LIVED ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INTEGRA FOUNDATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements. The Company contributed $1.2 million, $0.8 million and $0.3 million to the Integra Foundation during the years ended December&#160;31, 2021, 2020 and 2019, respectively. These contributions were recorded in selling, general, and administrative expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DERIVATIVES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes. From time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at the fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into foreign currency forward and foreign currency swap contracts that are not designated as a hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into other income, net on the consolidated financial statements. Refer to Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FOREIGN CURRENCY </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries. Foreign currency transaction net gains of less than $0.1&#160;million, and net losses of $1.6 million and $0.3 million are reported in other income, net in the statements of operations, for the year ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INCOME TAXES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to indefinitely reinvest substantially all of its foreign earnings. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash. One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI0Mzcw_c9172610-6a8d-4dac-b8b3-a0c0563d676b">one</span> to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue From Contracts With Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RESEARCH AND DEVELOPMENT </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE TERMINATION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ASC Topic 420 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-time Employee Termination Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred restructuring costs of $3.4&#160;million and $4.9&#160;million in cost of goods sold, $0.5&#160;million and $1.2&#160;million in selling, general and administrative and $0.3&#160;million and $0.3&#160;million in research and development related to employee terminations associated with a future plant closure in the consolidated statement of operations for the years ended December 31, 2021 and 2020, respectively. Restructuring costs of $10.2&#160;million were included in a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ccrued expenses and other current liabilities </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $6.4&#160;million were included in other liabilities in the consolidated balance sheet for the year ended December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">STOCK-BASED COMPENSATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PENSION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a deferred compensation plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATION OF CREDIT RISK </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the Company's customers accounted for 10% or more of the consolidated net sales during the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU&#160;2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption was permitted. The Company adopted this guidance during the year ended December 31, 2020. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued&#160;ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under this guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The Company adopted ASU 2019-12 as of January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting.&#160;This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform.&#160;This ASU is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022.&#160;In January 2021, the FASB also issued ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform- Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which clarified certain optional expedients and exceptions to entities that are affected because of the reference rate reform. The amendments in this ASU affect the guidance in ASU 2020-04 and are effective in the same timeframe as ASU 2020-04. The Company currently has contracts that are indexed to LIBOR and are continuing to monitor this activity and evaluate the associated risk. The Company is continuing to evaluate the scope of impacted contracts and the potential impact. The Company is also monitoring the developments regarding alternative rates and may amend certain contracts to accommodate those rates if the contract does not already specify a replacement rate. While the notional value of agreements potentially indexed to LIBOR is material, the Company does not expect a material impact consolidated financial statements and related disclosures associated with this transition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years using either the modified retrospective or full retrospective method. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As detailed in Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes are subject to the guidance included in ASU 2020-06. The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ADJUSTMENT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEET CLASSIFICATION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AMOUNT<br/>&#160;(in millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount reclassification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issuance costs reclassification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization and equity costs reclassification, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company made an irrevocable election under the indenture to require the principal portion of its 2025 Notes to be settled in cash and any excess in shares. Following the irrevocable notice, only the amounts settled in excess of the principal will be considered in diluted earnings per share under the &#8220;if-converted&#8221; method. Upon adoption of ASU 2020-06, the Company&#8217;s 2025 Notes were reflected entirely as a liability since the embedded conversion feature will no longer be separately presented within stockholders&#8217; equity. Additionally, from January 1, 2021, the Company is no longer incurring non-cash interest expense for the amortization of debt discount, therefore the interest expense for the 2025 Notes, which is included in the interest expense on the consolidated statements of operations and comprehensive loss, is lower as compared to the fiscal year of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which updates various codification topics by clarifying or improving disclosure requirements to align with the regulations of the U.S. Securities and Exchange Commission (the "SEC") . The ASU has been effective for the Company for annual and interim periods beginning after January 1, 2021. The Company adopted this standard on the January 1, 2021. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU 2021-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which provides guidance to clarify and reduce diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU No. 2021-04 are effective for all entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, including interim periods within those fiscal years. The amendment currently has no impact to the Company as the effect will largely depend on the terms of written call options or financings issued or modified in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for interest during the years ended December&#160;31, 2021, 2020 and 2019 was $43.2 million (net of $1.2 million that was capitalized into construction in progress), $47.3 million (net of $2.3 million that was capitalized into construction in progress) and $48.9 million (net of $3.1 million that was capitalized into construction in progress), respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for income taxes, net of refunds, for the years ended December&#160;31, 2021, 2020 and 2019</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $49.5 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$29.8 million and $16.2 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NON-CASH INVESTING AND FINANCING ACTIVITIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment purchases included in liabilities at December&#160;31, 2021, 2020 and 2019 were $4.7 million, $1.6 million and $11.0 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company achieved its final developmental milestone which triggered a $5.0&#160;million obligation to be paid to former shareholders of Rebound Therapeutics Corporation ("Rebound"). The Company recorded $5.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The remaining obligation was included in accrued liabilities at December 31, 2021 in the consolidated balance sheets. The milestone is expected to be fully paid during the first quarter of 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $20.0&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $20.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.</span></div>During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $5.0&#160;million obligation to be paid to former shareholders of Rebound. In addition, the Company recorded $5.0&#160;million as in-process research and development expense in the consolidated statements of operations. The obligation was included in accrued liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472039896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUES FROM CONTRACTS WITH CUSTOMERS</a></td>
<td class="text">REVENUES FROM CONTRACTS WITH CUSTOMERS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Summary of Accounting Policies on Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2021:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:79.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.222%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, January 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to trade receivable of contract asset included<br/>&#160;&#160;&#160;&#160;&#160;in beginning of the year contract asset </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, January 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,946&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the short-term portion of the contract liability of $5.3 million and the long-term portion of $6.7 million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company is expected to recognize revenue of approximately $5.3 million in 2022, $2.9 million in 2023, $1.8 million in 2024, $0.9 million in 2025, $0.6 million in 2026, and $0.4 million thereafter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Shipping and Handling Fees</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes Collected from Customers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregated Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2021, 2020 and 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extremity Orthopedics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total  Tissue Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. Acquisitions and Divestitures, for details.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period amounts were reclassified between categories within the Codman Specialty Surgical segment to conform to the current period presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographical Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of revenues based on the location of the customer.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472181784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">ACQUISITIONS AND DIVESTITURES</a></td>
<td class="text">ACQUISITIONS AND DIVESTITURES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of Extremity Orthopedics Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, the Company completed the sale of its Extremity Orthopedics business to Smith &amp; Nephew USD Limited ("Smith &amp; Nephew"). The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. The Company received an aggregate purchase price of $240.0&#160;million from Smith &amp; Nephew and concurrently paid $41.5&#160;million to the Consortium of Focused Orthopedists, LLC ("CFO") effectively terminating the licensing agreement between Integra and CFO relating to the development of shoulder arthroplasty products. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities divested consisted of the following as of December 31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.111%"><tr><td style="width:1.0%"/><td style="width:68.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset - operating leases and Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,751&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The divestiture does not represent a strategic shift that will have a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the Extremity Orthopedics business to the Company's Tissue Technologies reporting unit. In connection with the sale, the Company recognized a gain of $41.8&#160;million that is presented in Gain from the sale of business in the consolidated statement of operations for the year ended December&#160;31, 2021. The Company finalized the net working capital and paid an additional $1.3&#160;million to Smith &amp; Nephew as of December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also entered into a transition services agreement with Smit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h &amp; Nephew which requires the Company to provide certain services on behalf</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of Smith &amp; Nephew for the duration of the period subsequent to the sale of the business as defined in the agreement. The Company recognized a payable due to Smith &amp; Nephew of $9.1 million as of December&#160;31, 2021, included in the consolidated balance sheet within accrued expenses and other current liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACell, Inc. Acquisition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 20, 2021, the Company acquired ACell, Inc. (the "ACell Acquisition") for an acquisition purchase price of $306.9&#160;million plus contingent considerations of up to $100&#160;million, that may be payable upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. The final working capital adjustments of $1.3&#160;million was finalized and paid as of June 30, 2021. ACell was a privately-held company that offered a portfolio of regenerative products for complex wound management, including developing and commercializing products based on MatriStem Urinary Bladder Matrix, a technology platform derived from porcine urinary bladder extracellular matrix.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACell Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination are recognized at their fair values as of the acquisition date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13-14 years</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">408,780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101,842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">306,938</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the developed technology acquired was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used a discount rate of 8.5% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated goodwill related to the ACell acquisition to the Tissue Technologies segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected synergies of the combined company and assembled workforce. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition, the Company is required to make payments to the former shareholders of ACell up to $100&#160;million based on the achievement of certain revenue-based performance milestones in 2022, 2023, and 2025. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Company used iterations of the Monte Carlo simulation to calculate the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $23.9 million at the acquisition date. The estimated fair value as of December&#160;31, 2021 was $21.8 million. This amount is included in other liabilities at December&#160;31, 2021 in the consolidated balance sheets of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the acquisition date fair value of contingent consideration obligations using a Monte Carlo simulation, as well as significant unobservable inputs, reflecting the Company&#8217;s assessment of the assumptions market participants would use to value these liabilities. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resultant most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligations is revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Tax Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro Forma Results (unaudited)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma revenues for the year ended December 31, 2021 and 2020 were $1,547.0&#160;million and $1,466.8&#160;million, respectively. Pro forma net income and earnings per share are not presented for this acquisition as they are not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Arkis BioSciences Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of $30.6 million (the "Arkis Acquisition") plus contingent consideration of up to $25.5 million, that may be payable based on the successful completion of certain development and commercial milestones. The contingent consideration had an acquisition date fair value of $13.1 million. Arkis was a privately-held company that marketed the CerebroFlo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> external ventricular drainage (EVD) catheter with Endexo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arkis Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CerebroFlo developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling technology license</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired   </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the intangible assets was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each asset (including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, and working capital/contributory asset charges), the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used a discount rate of 14.5% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated goodwill related to the Arkis Acquisition to the Codman Specialty Surgical segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. One of the key factors that contributes to the recognition of goodwill, and a driver for the Company's acquisition of Arkis, is the planned expansion of the Endexo technology with the existing products within the Codman Specialty Surgical segment. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level&#160;3 measurement as defined using the fair value concepts in ASC 820. The resultant probability-weighted cash flows are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation is revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent consideration obligations may result from changes in discount periods and rates, changes in the timing and amount of revenue estimates and changes in probability assumptions with respect to the likelihood of achieving the various contingent payment obligations. Adverse changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition, the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10 million and commercial sales milestones of $15.5 million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated the fair value as of December&#160;31, 2021 was $15.1&#160;million. The Company recorded $3.7&#160;million in accrued expenses and other current liabilities and $11.4&#160;million in other liabilities at December&#160;31, 2021 in the consolidated balance sheets of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Tax Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma results are not presented for this acquisition as they are not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Rebound Therapeutics Corporation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (&#8220;Rebound&#8221;), developers of a single-use medical device known as the Aurora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Surgiscope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System ("Aurora") which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the &#8220;Rebound transaction&#8221;). Under the terms of the Rebound transaction, the Company made an upfront payment of $67.1 million and are committed to pay up to $35.0 million of contingent development milestones upon achievement of certain regulatory milestones.&#160;The acquisition of Rebound was primarily concentrated in one single identifiable asset and thus, for accounting purposes, the Company has concluded that the acquired assets do not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a $59.9 million IPR&amp;D expense. The balance of approximately $7.2 million, which included $2.1 million of cash and cash equivalents and a net deferred tax asset of $4.2 million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carry forward. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $5.0 million obligation to be paid to former shareholders of Rebound. The Company recorded $5.0 million as IPR&amp;D expense in the consolidated statements of operations. The obligation was included in accrued expenses and other current liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $20.0&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $20.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company achieved its final developmental milestone which triggered a $5.0&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $5.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The remaining obligation was included in accrued expenses and other current liabilities at December 31, 2021 in the consolidated balance sheets. The milestone is expected to be fully paid during the first quarter of 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Integrated Shoulder Collaboration, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2019, the Company entered into a licensing agreement with Integrated Shoulder Collaboration, Inc ("ISC"). Under the terms of the agreement, the Company paid ISC $1.7 million for the exclusive, worldwide license to commercialize its short stem and stemless shoulder system. A patent related to short stem and stemless shoulder systems was issued to ISC during the first quarter of 2019. ISC is eligible to receive royalties on sales of the short stem and stemless shoulder system. The Company has the option to acquire ISC at a date four years subsequent to the first commercial sale, which becomes mandatory upon the achievement of a certain sales thresholds of the short stem and stemless shoulder system, for an amount not to exceed $80.0 million. The transaction was accounted for as an asset acquisition as the Company concluded that it acquired primarily one asset. The total upfront payment of $1.7 million was expensed as a component of research and development expense and the future milestone and option payments will be recorded if the corresponding events become probable. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the Company's Extremity Orthopedic business, on January 4, 2021 the Company paid $41.5&#160;million to CFO pursuant to the terms of certain agreements between the Company and CFO relating to the sale of shares of ISC effectively terminating our licensing agreement with ISC.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471672632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment to the Sixth Amended and Restated Senior Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February&#160;3, 2025. The Company continues to have the aggregate principal amount of up to approximately $2.2 billion available to it through the following facilities: (i) a $877.5 million Term Loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60&#160;million sublimit for the issuance of standby letters of credit and a $60&#160;million sublimit for swingline loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 14, 2020, the Company entered into an amendment (the "July 2020 Amendment") to the February 2020 Amendment of the Senior Credit Facility to increase financial flexibility through June 30, 2021, in light of the unprecedented impact and uncertainty of the COVID-19 pandemic on the global economy. The July 2020 amendment did not increase the Company&#8217;s total indebtedness.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the July 2020 amendment, the Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"/><td style="width:75.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of July 2020 Amendment through June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021 through June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022 through June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00 to 1.00</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Senior Credit Facility bear interest, at the Company&#8217;s option, at a rate equal to the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from 1.00% to 2.25%), or </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the highest of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50%</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the prime lending rate of Bank of America, N.A. or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the one-month Eurodollar Rate plus 1.00% </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable rates are based on the Company&#8217;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;consolidated EBITDA (as defined by the July 2020 amendment), for the period of four consecutive fiscal quarters ending on such date).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay an annual commitment fee (ranging from&#160;0.15%&#160;to&#160;0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#8217;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at December&#160;31, 2021, the Company was in compliance with all such covenants. In connection with the February 2020 Amendment, the Company capitalized $4.6&#160;million of financing costs in connection with modification </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Senior Credit Facility and wrote off $1.2&#160;million of previously capitalized financing costs during the first quarter of 2020. In connection with the July 2020 amendment, the Company expensed $3.3&#160;million of incremental financing costs in connection with the modification of the Senior Credit Facility during the third quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, there was</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $31.3 million and $97.5 million, respectively, outstanding under the revolving portion of the Senior Credit Facility at weighted average interest rates of 1.4% and 1.5%, respectively. At December&#160;31, 2021 and 2020, there was $843.8 million and $877.5&#160;million, respectively, outstanding, under the Term Loan component of the Senior Credit Facility at weighted average interest rate of 1.4% and 1.5%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. At December&#160;31, 2021 and 2020, there was $45.0 million and $33.8&#160;million, respectively, of the Term Loan component of the Senior Credit Facility was classified as current on the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding borrowings of the Senior Credit Facility's revolving credit and Term Loan components at December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $31.0 million and $838.4 million, re</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">spectively. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit outstanding as of December&#160;31, 2021 and 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> totaled $1.6 million. Ther</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e were no amounts drawn as of December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $11.0 million in 2022, $10.3 million in 2023, $9.4 million in 2024, and $0.9 million in 2025. Interest is calculated on the term loan portion of the Senior Credit Facility based on LIBOR plus the spread paid by the Company. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $104.5&#160;million. The effective interest rate implicit in the liability component was 4.2%. In connection with this offering, the Company capitalized $13.2&#160;million of financing fees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of December&#160;31, 2021, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#8217;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#8217;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#8220;hedge participants&#8221;). The cost of the call transactions was $104.2&#160;million for the 2025 Notes. The Company received $44.5&#160;million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the carrying amount of the liability component was $485.9&#160;million, the remaining unamortized discount was $89.1&#160;million, and the principal amount outstanding was $575.0&#160;million. On January 1, 2021, the Company adopted ASU 2020-06 using the modified retrospective method. See Note 2, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details. At December&#160;31, 2021, the carrying amount of the liability was $575.0&#160;million. The fair value of the 2025 Notes at December&#160;31, 2021 was $640.5&#160;million. Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the adoption of ASU 2020-06, the Company recognized only cash interest related to the contractual interest coupon of $2.9&#160;million on the 2025 Notes for the year ended December&#160;31, 2021. Prior to the adoption, during the year ended December 31, 2020, the Company recognized cash interest of $2.6&#160;million and amortization of the discount on the liability component of $15.4&#160;million for a total interest charge of $18.0&#160;million on the 2025 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securitization Facility</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#8220;SPE&#8221;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of December&#160;31, 2021, the Company was in compliance with the covenants and none of the termination events had occurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company&#8217;s total indebtedness.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At both December&#160;31, 2021 and 2020, the Company&#160;had $112.5&#160;million, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 1.1% and 1.3%, respectively. The fair value of the outstanding borrowing of the Securitization Facility at December&#160;31, 2021 was $111.8 million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471854168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text">DERIVATIVE INSTRUMENTS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 27, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(929)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,557)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11,502)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,512)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,775,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,875,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43,957)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (&#8220;AOCL&#8221;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax. Those amounts are subsequently reclassified to earnings from AOCL as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company entered into foreign currency forward contracts, with a notional amount of $9.7&#160;million, to mitigate the foreign exchange risk related to certain intercompany loans denominated in Canadian Dollar ("CAD") and intercompany receivables denominated in Japanese Yen ("JPY"). The contracts are not designated as hedging instruments. The Company subsequently settled its foreign currency forward contracts associated with the intercompany receivables denominated in JPY during the first quarter of 2021. The Company recognized a $0.2&#160;million loss from the change in fair value of the contracts, which was included in other income, net in the consolidated statement of operations as of December 31, 2021 and 2020, respectively. The fair value of the foreign currency forward contracts denominated in CAD was $0.2&#160;million as of December 31, 2021. The fair value of the foreign currency forward contracts was $0.2&#160;million as of December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional of $7.3&#160;million to mitigate the risk from fluctuations in foreign currency exchange rates associated with certain intercompany loan denominated in </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japanese Yen ("JPY"). In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The change in fair value of the foreign currency swap was $0.6&#160;million as of December 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Company&#8217;s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Currency Rate Swaps</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2017, the Company entered into cross currency swap agreements to convert a notional amount of $300.0 million equivalent to 291.2 million of Swiss Francs ("CHF") denominated intercompany loans into U.S. dollars. The CHF- denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6&#160;million equivalent to 420.1 million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF 5.8&#160;million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.897%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset (Liability)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 4, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.85%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,335)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,283)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,262)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,843)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,242)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,441)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 4, 2021 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $50.0&#160;million. The gain recorded by the Company upon the settlement of the swap was not material for the period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2020 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $33.3&#160;million. As a result of the settlement, the Company recorded a loss of $0.3&#160;million in other income, net in the consolidated statement of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the years ended December&#160;31, 2021 and 2020, the Company recorded a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gain of $23.8&#160;million and loss of $21.7&#160;million, respectively, in other income, net related to change in fair value related to the foreign currency rate tran</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">slation to offset the gains or losses recognized on the intercompany loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company reco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rded a gain of $24.3 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a loss of $17.1 million, respectively, in AOCL related to change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company reco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rded gains of $9.1 million an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d $5.8 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated loss that is expected to be reclassified to other income, net from AOCL as of December&#160;31, 2021 within the next twelve months is $3.4 million. As of December&#160;31, 2021, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign currency on foreign subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,884)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(792)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,794)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,036)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2021, in accordance with the termination date, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $52&#160;million equivalent to 44.9&#160;million Euros. As a result of the settlement, the Company recorded a gain of $0.1 million in AOCL.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $167.5&#160;million and 128.3&#160;million Pound Sterling respectively as a result of an intra-entity transfer of certain intellectual property rights to a subsidiary. The original settlement date was September 30, 2025. As a result of the settlement, the Company recorded a loss of $7.8&#160;million in AOCL.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded as unrealized gains or losses in AOCL. For the year ended December&#160;31, 2021 and 2020, the Company recorded a gain of $16.5 million and a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> loss of $14.9 million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company recorded a gain of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6.5 million an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d $7.6 million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to interest income from AOCL as of December&#160;31, 2021 within the next twelve months is $5.1 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#8217;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#8217;s credit ratings from any credit rating agency.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Location on Balance Sheet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,497&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,920&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">At December 31, 2021 and 2020, the total notional amounts related to the Company&#8217;s interest rate swaps were $1.8&#160;billion and $1.9&#160;billion, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statement of operations during the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.436%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.861%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.981%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain&#160;(Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>End of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,965)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,911)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,739)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,836)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,442)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107,133)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472181784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment by either performing a qualitative evaluation or a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The qualitative evaluation is an assessment of factors including reporting unit specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of a reporting unit is less than its carrying amount, including goodwill. The Company may elect to bypass the qualitative assessment for its&#160;three&#160;reporting units and perform a quantitative test. The assumptions used in evaluating goodwill for impairment are subject to change and are tracked against historical results by management. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative test estimates the fair value of the three reporting units using a discounted cash flow model, which incorporates significant estimates and assumptions made by management which, by their nature, are characterized by uncertainty. Inputs used to fair value the Company's reporting units are considered inputs of the fair value hierarchy. For Level 3 measurements, significant increases or decreases in long-term growth rates or discount rates in isolation or in combination could result in a significantly lower or higher fair value measurement. The key assumptions impacting the valuation included the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The reporting unit's financial projections, which are based on management's assessment of regional and macroeconomic variables, industry trends and market opportunities, and the Company's strategic objectives and future growth plans.</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The projected terminal value for the reporting unit, which represents the present value of projected cash flows beyond the last period in the discounted cash flow analysis. The terminal value reflects the Company's assumptions related to long-term growth rates and profitability, which are based on several factors, including local and macroeconomic variables, market opportunities, and future growth plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The discount rate used to measure the present value of the projected future cash flows is set using a weighted-average cost of capital method that considers market and industry data as well as the Company's specific risk factors that are likely to be considered by a market participant. The weighted-average cost of capital is the Company's estimate of the overall after-tax rate of return required by equity and debt holders of a business enterprise. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company elected to perform a qualitative analysis for its three reporting units. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill in 2021 and 2020 were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">954,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,546)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,546)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671,975&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932,367&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACell Acquisition </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,509)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,056)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,428&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013,458&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646,892&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501,319)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431,651)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Prior period amounts were reclassified as it relates to All Other within this table to conform to the current period presentation</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $13.3 million of Intangible assets, net were presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the Company's identifiable intangible assets at December 31, 2021 as compared to the year ended December 31, 2020, was primarily driven from intangible assets acquired in conjunction with the ACell Acquisition. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets with Indefinite Lives</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company elected to perform a qualitative analysis for its intangible asset with indefinite lives. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense (including amounts reported in cost of product revenues) for the years ended December&#160;31, 2021, 2020 and 2019 was $83.3 million, $74.5 million and $72.8 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual amortization expense is expected to approximate $79.1 million in 2022, $78.4 million in 2023, $77.7 million in 2024, $77.7 million in 2025, $77.6 million in 2026 and $585.8 million thereafter. Amortization of product technology based intangible assets totaled $66.5 million, $46.7 million and $45.8 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively, and is presented by the Company within cost of goods sold.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471669624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TREASURY STOCK<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">TREASURY STOCK</a></td>
<td class="text">TREASURY STOCK<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, there were 4.9 million shares of treasury stock outstanding with a cost of $234.4 million and $235.1 million, respectively, at a weighted average cost per share of $47.86.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 7, 2020, the Board of Directors authorized the Company to repurchase up to $225&#160;million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2022. The price and timing of any future purchases under the share repurchase program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price, and such repurchases may be discontinued at any time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2021, there were no repurchases of the Company&#8217;s common stock as part of the share repurchase authorization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 12, 2022, the Company entered into a $125.0&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">accelerated share repurchase ("2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ASR") and received 1.5&#160;million shares of Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. The remaining 20% of the expected total shares is expected to settle in the first half of 2022, upon which additional shares of common stock may be delivered to the Company or, under certain circumstances, the Company may be required to make a cash payment or may elect to deliver shares of our common stock to the 2022 ASR counterparty in each case pursuant to the terms of the 2022 ASR agreement between the Company and the 2022 ASR counterparty. The total number of shares to be delivered or the amount of such payment, as well as the final average price per share, will be based on the volume-weighted average price, less a discount, of the Company's common stock during the term of the transaction. As a result of this transaction, $100&#160;million remains available under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$225&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> repurchase authorization</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div>During the twelve months ended December 31, 2020, the Company repurchased 2.1&#160;million shares of Integra&#8217;s common stock as part of the previous share repurchase authorization. The Company utilized $100.0&#160;million of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included $7.6&#160;million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a $92.4&#160;million accelerated share repurchase ("2020 ASR") to complete the remaining $100.0&#160;million of share repurchase. The Company received 1.3&#160;million shares at inception of the 2020 ASR, which represented approximately 80% of the expected total shares. Upon settlement of the 2020 ASR in June 2020, the Company received an additional 0.6&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the transaction.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208821<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471672632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated tax benefit related to stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect on net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE STOCK PURCHASE PLAN </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan. Under the ESPP, a total of 3.0 million shares of common stock are reserved for issuance. These shares will be made available either from the Company&#8217;s authorized but unissued shares of common stock or from shares of common stock reacquired by the Company as treasury stock. At December&#160;31, 2021, 2.0 million shares remain available for purchase under the ESPP. During the years ended December&#160;31, 2021, 2020 and 2019, the Company issued 16,948 shares, 18,284 shares and 12,531 shares under the ESPP for $1.1 million, $1.1 million and $0.7 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EQUITY AWARD PLANS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the &#8220;2003 Plan&#8221;). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2010 and May 2017, the stockholders of the Company approved amendments to the 2003 Plan to increase by 3.5 million and 1.7 million, respectively, the number of shares of common stock that may be issued under the 2003 Plan. The Company has reserved 4.0 million shares under each of the 2000 Plan and the 2001 Plan, and 14.7 million shares under the 2003 Plan. The Plans permit the Company to grant incentive and non-qualified stock options, stock appreciation rights, </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restricted stock, contract stock, performance stock, or dividend equivalent rights to designated directors, officers, employees and associates of the Company. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options issued under the 2003 Plan became exercisable over specified periods, generally within four years from the date of grant for officers and employees, and within one year from the date of the grant for members of the Board of Directors. The awards generally expire eight years from the grant date for employees and from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIyNDc_dac495da-8c41-4f99-8dc2-4cfbd78ca20b">six</span> to ten years for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in control provisions within their grant agreements. Restricted stock issued under the 2003 Plan vests ratably over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the 2003 Plan is subject to service and performance conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values stock option grants using the binomial distribution model. Management believes that the binomial distribution model is preferable to the Black-Scholes model because it is a more flexible model that gives consideration to the impact of non-transferability and vesting provisions in valuing employee stock options. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the value of stock options granted, the Company considered that it has never paid cash dividends and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield. Expected volatilities are based on the historical volatility of the Company&#8217;s stock price. The expected life of stock options is estimated based on historical data on exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock options granted. The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected life of the options. The Company accounts for forfeitures as they occur. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used in the calculation of fair value:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.51%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of option from grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13.03</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.74</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock option activity. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Contractual Term in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.41</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34,560</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.07&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,242&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $5.0 million, $3.2 million and $3.0 million in expense related to stock options during the years ended December 31, 2021, 2020 and 2019, respectively. The intrinsic value of options exercised for the years ended December&#160;31, 2021, 2020 and 2019 were $11.1 million, $8.7 million and $14.6 million, respectively. Cash received from option exercises and employee stock purchase plan was $6.8 million, $5.2 million and $6.9 million, for the years ended December 31, 2021, 2020 and 2019, respectively. The realized tax benefit from options exercised w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ere $2.2 mi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">llion, $1.7 million and $3.0 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, there was approximately $2.9 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately two years. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards of Restricted Stock, Performance Stock and Contract Stock </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock and Contract  Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for performance achievement related to award target</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested but not released</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.78&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.74&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $31.2 million, $16.4 million and $18.1 million in expense related to such awards during the years ended December 31, 2021, 2020 and 2019, respectively. The total fair market value of shares vested and released in 2021, 2020 and 2019 was $15.7 million, $17.3 million and $21.1 million, respectively. Vested awards include shares that have been fully earned but had not been delivered as of December&#160;31, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock awards have performance features associated with them. Performance stock, restricted stock and contract stock awards generally have requisite service periods of three years. The fair value of these awards is being expensed on a straight-line basis over the vesting period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, there was approximately $21.1 million of total unrecognized compensation costs related to unvested restricted stock, performance stock and contract stock awards. These costs are expected to be recognized over a weighted-average period of approximately two years. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, there were approximately 0.5 million vested Restricted Units and 0.1 million vested performance share units held by various employees for which the related shares have not yet been issued. The final determination of the number of shares to be issued is made by the Company's Compensation Committee of the Board of Directors which is contingent upon achieving certain revenue and organic revenue growth performance metric.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, there were approximately 3.5 million shares available for grant under the 2003 Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized into inventory, share based compensation costs of $0.5 million, $0.4 million and $0.3 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively. Such share-based compensation was recognized as cost of goods sold when related inventory was sold.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471852616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">RETIREMENT BENEFIT PLANS</a></td>
<td class="text">RETIREMENT BENEFIT PLANS<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED BENEFIT PLANS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various defined benefit plans which covers certain employees in France, Japan, Germany and Switzerland. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the years ended December&#160;31, 2021 and 2020 included the following (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.957%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net period benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,904</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,007</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2021 and 2020, the discount rates were prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities. The expected returns on plan assets represent the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rates of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2021 and 2020 and a reconciliation of the funded status at December&#160;31, 2021 and 2020, respectively (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:64.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.287%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,044)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plans transferred in</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,657)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected benefit obligations, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,184</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan assets at fair value, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:65.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.117%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation Of Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unfunded benefit obligations are included in other liabilities in the consolidated balance sheets at December&#160;31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the periods ended December&#160;31, 2021 and 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had a net gain of $7.0 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $4.6 million, respectively, recognized within accumulated other comprehensive loss that has not been recognized as a component of net periodic benefit cost. The gain recognized during the period ended December 31, 2021, is primarily attributed to a change in the discount rate used to estimate the projected benefit obligation for defined benefit plans which cover certain employees in Switzerland. The combined accumulated benefit obligations for the defined benefit plans was $60.3 million and $61.5 million as of December&#160;31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized gains and losses are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses is determined by using a 10% corridor of the greater of the market value of assets or the accumulated benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior service costs/benefits for the pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net plan assets of the pension plans are invested in common trusts. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts is valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefit plans in France and Germany had no assets at December&#160;31, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, no plan assets are expected to be returned to the Company in the next twelve months.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is the summary of expected future benefit payments (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next five years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, contributions expected to be paid to the plan in 2022 is $2.3 million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED CONTRIBUTION PLANS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various defined contribution savings plans that cover substantially all employees in the United States, Belgium, Canada, France, Japan, Netherlands, the U.K. and Puerto Rico. The Company matches a certain percentage of each employee&#8217;s contributions as per the provisions of the plans. Total contributions by the Company to the plans were $8.8 million, $6.7 million and $8.6 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFERRED COMPENSATION PLAN</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, employees participating in the Company's deferred compensation plan began to defer their compensation. This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at December&#160;31, 2021 and 2020 was $3.8 million and $2.0 million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472180088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES AND RELATED PARTY LEASES</a></td>
<td class="text">LEASES AND RELATED PARTY LEASES<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of December&#160;31, 2021. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expense for the year ended December&#160;31, 2021 and December 31, 2020, was $20.3 million and $19.7 million, respectively, which includes $0.3 million, in related party operating lease expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases at December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.086%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except lease term and discount rate)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,457&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no future minimum lease payments under finance leases at December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leases </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is 50% owned by a corporation whose stockholders are trusts, whose beneficiaries include family members of the Company&#8217;s principal stockholder and former director. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787473313352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES <div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (Loss) before income taxes consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,359)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. Federal statutory rate to the Company&#8217;s effective tax rate is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in income taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Excess tax benefits from stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible meals and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intercompany profit in inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible facilitative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;Fair market value step up on intra-entity transfer of intellectual property</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain from sale of business - book to tax differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Swiss tax holiday</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible R&amp;D expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective tax rate was 21.2% and (43.2)% of income before income taxes for the years ended December&#160;31, 2021 and December&#160;31, 2020, respectively. In 2021, the Company's higher effective tax rate was driven in part by an $8.5&#160;million income tax expense for nondeductible goodwill related to the sale of the Extremity Orthopedics business, offset by a $3.1&#160;million income tax benefit related to excess tax benefits from stock compensation. In 2020, the Company&#8217;s lower worldwide effective tax rate was primarily driven by an $59.2&#160;million income tax benefit on an intra-entity transfer of certain intellectual property, substantially completed during the fourth quarter in 2020. Excluding this transaction, the effective worldwide tax rate for 2020 was 20.2%.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain, the Company&#8217;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow model based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Co</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">mpany recorded a $59.2&#160;million deferred tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in Switzerland related to the amortizable tax basis in the transferred intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, the Company&#8217;s foreign operations generated a $63.6&#160;million increase in income tax expense when compared to the same period in 2020, because of the intra-entity transfer of certain intellectual property in 2020, geographic and business mix of taxable earnings and losses, among other factors. The 2021 foreign effective tax rate is 15.2%, compared to (57.1)% in 2020. The Company&#8217;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above for 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2020, the Company&#8217;s foreign operations generated a $48.2&#160;million decrease in income tax expense when compared to the same period in 2019 due to the intra-entity transfer of certain intellectual property, geographic and business mix of taxable earnings and losses, among other factors. The 2020 foreign effective tax rate is (57.1)%, compared to 3.5% in 2019.  The Company&#8217;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above for 2020. During 2019, the Company finalized negotiations related to tax holidays in Switzerland, on a federal, cantonal, and communal level. The Company received a federal tax credit in Switzerland of $12.1 million ($0.14 per share), which may be used over a seven-year period, ending in 2024. The Company also received a reduction in its rate for the cantonal and communal level taxes during the third quarter of 2019, pursuant to tax reform in Switzerland. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate.  Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation.  The current U.S. administration has proposed tax reform which, if enacted, may increase the Company&#8217;s U.S. federal income tax liability.  Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing (BEPS) project begun by the Organization for Economic Cooperation and Development (OECD).  The OECD recently finalized major reform of the international tax system with respect to implementing a global minimum tax rate.  Such changes in U.S. and Non-U.S. jurisdictions could have an adverse effect on the Company&#8217;s effective tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,830)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,299)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,755)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,046)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,372)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued vacation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization of research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,737&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,256&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets after valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,658)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169,808)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,859)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company had net operating loss carryforwards of $71.7 million for federal income tax purposes, $26.6 million for foreign income tax purposes and $39.0 million for state income tax purposes to offset future taxable income. The majority of the federal net operating loss carryforwards expire through 2037, while $4.1 million have an indefinite carry forward period. For foreign net operating loss carryforwards, the remaining $26.6 million have an indefinite carry forward period. The state net operating loss carryforwards expire through 2036. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance relates to deferred tax assets for certain items that will be deductible for income tax purposes under very limited circumstances and for which the Company believes it will not satisfy the more likely than not threshold for realization of the associated tax benefit. In the event that the Company determines that it would be able to realize more or less than the recorded amount of net deferred tax assets, an adjustment to the deferred tax asset valuation allowance would be recorded in the period such a determination is made. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s valuation allowance decreased by less than $0.1 million, increased by less than $0.1&#160;million and increased by $2.9&#160;million at December 31, 2021, 2020 and 2019, respectively. The 2021 and 2020 valuation allowance primarily remained unchanged from the prior period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost.&#160;Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;The Company will repatriate foreign earnings when there is no need for reinvestment overseas and no material tax cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans. As such, the Company has determined the tax impact of repatriating these earnings would not be material as of December&#160;31, 2021. The Company does not anticipate the need to repatriate earnings from foreign subsidiaries as a result of the impact of the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prior years' tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $0.7 million of the balance at December&#160;31, 2021 relates to uncertain tax positions that, if recognized, would affect the annual effective tax rate. There are no amounts within the balance of uncertain tax positions at December&#160;31, 2021 related to tax positions for which it is reasonably possible that the amounts could be reduced during the twelve months following December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties relating to uncertain tax positions in income tax expense. The Company recognized a minimal benefit for the years ended December&#160;31, 2021, 2020 and 2019. The Company had minimal interest and penalties accrued for the years ended December 31, 2021 and 2020 and 2019. </span></div>The Company files Federal income tax returns, as well as multiple state, local and foreign jurisdiction tax returns. The Company is no longer subject to examinations of its U.S. consolidated Federal income tax returns by the IRS through fiscal year 2017. All significant state and local matters have been concluded through fiscal 2015. All significant foreign matters have been settled through fiscal 2012.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471735944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME PER SHARE</a></td>
<td class="text">NET INCOME PER SHARE<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,485&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock of approximately 0.1 million and 0.3 million shares at December&#160;31, 2021, and 2020 that are issuable through exercise of dilutive securities, respectively, and were not included in the computation of diluted net income per share because their effect would have been anti-dilutive. </span></div>Performance Shares and Restricted Units that entitle the holders to approximately 0.5 million shares of common stock are included in the basic and diluted weighted average shares outstanding calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787473311960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE LOSS</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE LOSS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive loss by component between December&#160;31, 2021 and 2020 are presented in the table below, net of tax:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,249)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,059)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,362)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,268&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,362)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,981)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,893&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,067)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,155)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2021, the Company reclassified a gain of $25.3 million and a loss of $12.2&#160;million from accumulated other comprehensive loss to other income, net and interest income, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471684024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of contingent consideration during the twelve-month period ended December&#160;31, 2021 and 2020 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2021 and 2020 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.527%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis <br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.<br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additiions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,691&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,800&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.074%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Arkis <br/>(See Note 4)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,746&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derma Sciences</span>The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences")&#160;related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3 million related to the aforementioned contingent liabilities. One contingent milestone remains which relates to net sales of Medihoney&#8482; products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0 million. The estimated fair value as of December&#160;31, 2021 and 2020 was $0.2 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471674040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND GEOGRAPHIC INFORMATION</a></td>
<td class="text">SEGMENT AND GEOGRAPHIC INFORMATION<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company internally manages&#160;two&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;two&#160;reportable segments and their activities are described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Tissue Technologies segment includes such offerings as skin and wound repair, plastics &amp; surgical reconstruction products, bone grafts, and nerve and tendon repair products. In conjunction with the sale of the Extremity Orthopedics business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,914)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,757)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,028)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(453,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.289%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes long-lived assets in Puerto Rico.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787471766712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II &#8212; VALUATION AND QUALIFYING ACCOUNTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.679%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(986)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,542)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The above amount primarily relates to amounts acquired through the acquisition of Arkis and a charge recorded in 2019 to valuation allowance related to the non-deductibility of executive compensation.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The above amount primarily relates to amounts acquired through the acquisition of ACell.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Deduction primarily relates to a decrease to the allowance for doubtful accounts as a result of collections in the period and accounts written off during the year, net of recoveries.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787470209032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis Of Presentation</a></td>
<td class="text">BASIS OF PRESENTATION These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles Of Consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PRINCIPLES OF CONSOLIDATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. See Note&#160;4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of new subsidiaries included in the consolidation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text">USE OF ESTIMATES The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECLASSIFICATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts from the prior year's financial statements have been reclassified in order to conform to the current year's presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash And Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CASH AND CASH EQUIVALENTS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Trade Accounts Receivable And Allowances For Doubtful Accounts Receivable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.</span></div>Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INVENTORIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $52.8&#160;million of inventories, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. </span></div>The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant And Equipment</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROPERTY, PLANT AND EQUIPMENT </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCapitalizationPolicyPolicyTextBlock', window );">Capitalized Interest</a></td>
<td class="text">CAPITALIZED INTERESTThe interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Acquisitions</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, Business Combinations (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired in recorded as goodwill. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs and costs to restructure the acquired company are expensed as incurred.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issuance, or validity and litigation.</span></div>If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill And Other Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two reportable segments with three underlying reporting units. Refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on reportable segments. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">over their expected useful lives.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text">LONG-LIVED ASSETS Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_FoundationPolicyTextBlock', window );">Integra Foundation</a></td>
<td class="text">INTEGRA FOUNDATION The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DERIVATIVES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes. From time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at the fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes.</span></div>The Company entered into foreign currency forward and foreign currency swap contracts that are not designated as a hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into other income, net on the consolidated financial statements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text">FOREIGN CURRENCY All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INCOME TAXES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. </span></div>The Company continues to indefinitely reinvest substantially all of its foreign earnings. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI0Mzcw_c9172610-6a8d-4dac-b8b3-a0c0563d676b">one</span> to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.</span></div>Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div>Shipping and Handling FeesThe Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research And Development</a></td>
<td class="text">RESEARCH AND DEVELOPMENT Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Employee Termination Benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE TERMINATION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ASC Topic 420 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-time Employee Termination Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div>The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">STOCK-BASED COMPENSATION Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Pension Benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PENSION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a deferred compensation plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.</span></div>This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATION OF CREDIT RISK </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. </span></div>The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU&#160;2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption was permitted. The Company adopted this guidance during the year ended December 31, 2020. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued&#160;ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under this guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The Company adopted ASU 2019-12 as of January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting.&#160;This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform.&#160;This ASU is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022.&#160;In January 2021, the FASB also issued ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform- Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which clarified certain optional expedients and exceptions to entities that are affected because of the reference rate reform. The amendments in this ASU affect the guidance in ASU 2020-04 and are effective in the same timeframe as ASU 2020-04. The Company currently has contracts that are indexed to LIBOR and are continuing to monitor this activity and evaluate the associated risk. The Company is continuing to evaluate the scope of impacted contracts and the potential impact. The Company is also monitoring the developments regarding alternative rates and may amend certain contracts to accommodate those rates if the contract does not already specify a replacement rate. While the notional value of agreements potentially indexed to LIBOR is material, the Company does not expect a material impact consolidated financial statements and related disclosures associated with this transition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years using either the modified retrospective or full retrospective method. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As detailed in Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes are subject to the guidance included in ASU 2020-06. The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ADJUSTMENT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEET CLASSIFICATION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AMOUNT<br/>&#160;(in millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount reclassification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issuance costs reclassification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization and equity costs reclassification, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company made an irrevocable election under the indenture to require the principal portion of its 2025 Notes to be settled in cash and any excess in shares. Following the irrevocable notice, only the amounts settled in excess of the principal will be considered in diluted earnings per share under the &#8220;if-converted&#8221; method. Upon adoption of ASU 2020-06, the Company&#8217;s 2025 Notes were reflected entirely as a liability since the embedded conversion feature will no longer be separately presented within stockholders&#8217; equity. Additionally, from January 1, 2021, the Company is no longer incurring non-cash interest expense for the amortization of debt discount, therefore the interest expense for the 2025 Notes, which is included in the interest expense on the consolidated statements of operations and comprehensive loss, is lower as compared to the fiscal year of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which updates various codification topics by clarifying or improving disclosure requirements to align with the regulations of the U.S. Securities and Exchange Commission (the "SEC") . The ASU has been effective for the Company for annual and interim periods beginning after January 1, 2021. The Company adopted this standard on the January 1, 2021. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU 2021-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which provides guidance to clarify and reduce diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU No. 2021-04 are effective for all entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, including interim periods within those fiscal years. The amendment currently has no impact to the Company as the effect will largely depend on the terms of written call options or financings issued or modified in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition and Shipping and Handling Fees</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI0Mzcw_c9172610-6a8d-4dac-b8b3-a0c0563d676b">one</span> to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.</span></div>Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div>Shipping and Handling FeesThe Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyPolicy', window );">Product Warranties</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock', window );">Taxes Collected from Customers</a></td>
<td class="text">Taxes Collected from CustomersThe Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_FoundationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foundation [Policy Text Block].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_FoundationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCapitalizationPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for interest capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCapitalizationPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for election to exclude from measurement of transaction price tax assessed by governmental authority that are both imposed on and concurrent with specific revenue-producing transaction, and collected from customer. Includes, but is not limited to, sales, use, value-added and excise tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 32<br> -Paragraph 2A<br> -URI http://asc.fasb.org/extlink&amp;oid=123355311&amp;loc=SL82860478-203043<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787562286248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text">Inventories consisted of the following: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment Balances and Corresponding Lives</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment balances and corresponding lives were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and production equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical instrument kits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information systems and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures, and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314,874)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282,849)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of Impact on Statement of Operations</a></td>
<td class="text">The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ADJUSTMENT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEET CLASSIFICATION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AMOUNT<br/>&#160;(in millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount reclassification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issuance costs reclassification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization and equity costs reclassification, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474992952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Changes in Contract Assets and Contract Liabilities</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2021:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:79.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.222%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, January 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to trade receivable of contract asset included<br/>&#160;&#160;&#160;&#160;&#160;in beginning of the year contract asset </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, January 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,946&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2021, 2020 and 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extremity Orthopedics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total  Tissue Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. Acquisitions and Divestitures, for details.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787473386568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Major Classes of Assets and Liabilities Held For Sale</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities divested consisted of the following as of December 31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.111%"><tr><td style="width:1.0%"/><td style="width:68.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset - operating leases and Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,751&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13-14 years</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">408,780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101,842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">306,938</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CerebroFlo developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling technology license</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired   </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787475121576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Maximum Leverage Ratios</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the July 2020 amendment, the Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"/><td style="width:75.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of July 2020 Amendment through June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021 through June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022 through June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00 to 1.00</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Contractual Repayments of Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787562304232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 27, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(929)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,557)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11,502)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,512)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,775,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,875,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43,957)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.897%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset (Liability)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 4, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.85%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,335)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,283)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,262)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,843)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,242)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,441)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,884)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(792)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,794)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,036)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Summary of Fair Value in Balance Sheet for Derivatives Designated as Hedging Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Location on Balance Sheet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,497&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,920&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">At December 31, 2021 and 2020, the total notional amounts related to the Company&#8217;s interest rate swaps were $1.8&#160;billion and $1.9&#160;billion, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statement of operations during the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.436%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.861%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.981%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain&#160;(Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>End of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,965)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,911)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,739)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,836)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,442)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107,133)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474102280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill in 2021 and 2020 were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">954,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,546)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,546)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671,975&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932,367&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACell Acquisition </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,509)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,056)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,428&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013,458&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Components of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646,892&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501,319)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431,651)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Prior period amounts were reclassified as it relates to All Other within this table to conform to the current period presentation</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Components of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646,892&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501,319)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431,651)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Prior period amounts were reclassified as it relates to All Other within this table to conform to the current period presentation</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474128728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary Of Employee Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated tax benefit related to stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect on net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary Of Weighted-Average Assumptions</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used in the calculation of fair value:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.51%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of option from grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13.03</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.74</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary Of Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock option activity. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Contractual Term in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.41</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34,560</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.07&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,242&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary Of Restricted Stock, Performance Stock, and Contract Stock Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock and Contract  Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for performance achievement related to award target</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested but not released</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.78&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.74&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787476214984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Net Periodic Benefit Costs</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the years ended December&#160;31, 2021 and 2020 included the following (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.957%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net period benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,904</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,007</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Weighted Average Assumptions Used</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Benefit Obligations and Plan Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2021 and 2020 and a reconciliation of the funded status at December&#160;31, 2021 and 2020, respectively (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:64.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.287%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,044)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plans transferred in</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,657)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected benefit obligations, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,184</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan assets at fair value, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock', window );">Schedule of Funded Status</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:65.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.117%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation Of Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is the summary of expected future benefit payments (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next five years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetFundedStatusTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474106728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental Balance Sheet Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases at December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.086%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except lease term and discount rate)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CashFlowLesseeTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,457&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CashFlowLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CashFlowLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472335240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) Before Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (Loss) before income taxes consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,359)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. Federal statutory rate to the Company&#8217;s effective tax rate is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in income taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Excess tax benefits from stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible meals and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intercompany profit in inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible facilitative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;Fair market value step up on intra-entity transfer of intellectual property</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain from sale of business - book to tax differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Swiss tax holiday</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible R&amp;D expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,830)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,299)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,755)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,046)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,372)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued vacation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization of research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,737&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,256&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets after valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,658)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169,808)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,859)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Uncertain Tax Benefits Reconciliation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prior years' tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472208568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic And Diluted Net Income Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,485&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472182616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive loss by component between December&#160;31, 2021 and 2020 are presented in the table below, net of tax:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,249)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,059)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,362)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,268&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,362)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,981)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,893&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,067)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,155)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787477139992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Contingent Consideration</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2021 and 2020 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.527%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis <br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.<br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additiions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,691&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,800&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.074%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Arkis <br/>(See Note 4)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,746&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787476186104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Net Sales and Profit, by Segment</a></td>
<td class="text">Net sales and profit by reportable segment for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,914)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,757)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,028)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(453,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: <div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.289%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes long-lived assets in Puerto Rico.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Geographic Revenue, by Area</a></td>
<td class="text">Net sales and profit by reportable segment for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,914)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,757)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,028)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(453,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: <div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.289%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes long-lived assets in Puerto Rico.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787465424408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2019</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>reporting_unit </div>
<div>Segment </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,100,000)<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_InventoryCapitalizedExpenses', window );">Inventory, capitalized expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,400,000<span></span>
</td>
<td class="nump">42,100,000<span></span>
</td>
<td class="nump">42,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Write off of construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalizedAdjustment', window );">Interest expense capitalized into property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CharitableContributions', window );">Contributions to Integra Foundation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign currency transaction gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="num">(1,600,000)<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring reserve, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage', window );">Defer payment and taxation, base salary, percentage (up to)</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage', window );">Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,200,000<span></span>
</td>
<td class="nump">47,300,000<span></span>
</td>
<td class="nump">48,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Interest paid, capitalized into construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,500,000<span></span>
</td>
<td class="nump">29,800,000<span></span>
</td>
<td class="nump">16,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment purchases included in liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">64,916,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">989,436,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,145,573,000<span></span>
</td>
<td class="nump">989,436,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember', window );">2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid', window );">Development milestone payment, to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue, Net | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ConcentrationRiskThresholdPercentage', window );">Concentration risk, threshold percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ConcentrationRiskNumberofCustomersOverBenchmark', window );">Concentration risk, number of customers over benchmark | Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod', window );">Manufacturing period for products shipped with no alternative use and right of payment for performance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod', window );">Manufacturing period for products shipped with no alternative use and right of payment for performance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Smith &amp; Nephew USD Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Development Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CharitableContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Charitable contributions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CharitableContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ConcentrationRiskNumberofCustomersOverBenchmark">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Number of Customers Over Benchmark</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ConcentrationRiskNumberofCustomersOverBenchmark</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ConcentrationRiskThresholdPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Threshold Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ConcentrationRiskThresholdPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InventoryCapitalizedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory, Capitalized Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InventoryCapitalizedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalizedAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest costs capitalized disclosed as an adjusting item to interest costs incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalizedAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest capitalized, classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph 210-10-S99-1(SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787469823416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 162,528<span></span>
</td>
<td class="nump">$ 180,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">65,323<span></span>
</td>
<td class="nump">53,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">89,535<span></span>
</td>
<td class="nump">76,480<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories, net</a></td>
<td class="nump">$ 317,386<span></span>
</td>
<td class="nump">$ 310,117<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787468047800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 626,577<span></span>
</td>
<td class="nump">$ 570,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(314,874)<span></span>
</td>
<td class="num">(282,849)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">311,703<span></span>
</td>
<td class="nump">287,529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">1,541<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and building improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 19,032<span></span>
</td>
<td class="nump">17,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and building improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and building improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 155,495<span></span>
</td>
<td class="nump">144,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and production equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 183,270<span></span>
</td>
<td class="nump">166,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and production equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and production equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_SurgicalInstrumentKitsMember', window );">Surgical instrument kits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 2,791<span></span>
</td>
<td class="nump">1,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_SurgicalInstrumentKitsMember', window );">Surgical instrument kits | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_SurgicalInstrumentKitsMember', window );">Surgical instrument kits | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember', window );">Information systems and hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 148,706<span></span>
</td>
<td class="nump">143,770<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember', window );">Information systems and hardware | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember', window );">Information systems and hardware | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 20,921<span></span>
</td>
<td class="nump">20,843<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and office equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and office equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 94,850<span></span>
</td>
<td class="nump">$ 73,890<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_SurgicalInstrumentKitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_SurgicalInstrumentKitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787469520472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">$ 45,788<span></span>
</td>
<td class="nump">$ 16,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="nump">564,426<span></span>
</td>
<td class="nump">474,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">$ 698,568<span></span>
</td>
<td class="nump">532,265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,600)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63,300)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember', window );">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember', window );">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,500)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787473357272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment', window );">Number of days from shipment to issue a credit on returned goods</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Short-term portion of contract liability</a></td>
<td class="nump">$ 5,295<span></span>
</td>
<td class="nump">$ 5,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long-term portion of contract liability</a></td>
<td class="nump">$ 6,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_RevenueProductWarrantyPeriod', window );">Product warranty period (up to)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Return Policy, Issue of Credit, Number of Days from Shipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RevenueProductWarrantyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, Product Warranty Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RevenueProductWarrantyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787470203640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 5.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 2.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787475072952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Contract Asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset, Beginning of period</a></td>
<td class="nump">$ 7,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable', window );">Transferred to trade receivable of contract asset included in beginning of the year contract asset</a></td>
<td class="num">(7,430)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable', window );">Contract asset, net of transferred to trade receivables on contracts during the period</a></td>
<td class="nump">11,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset, End of Period</a></td>
<td class="nump">11,412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ChangeInContractWithCustomerLiabilityRollForward', window );"><strong>Contract Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability, Beginning of Period</a></td>
<td class="nump">11,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Recognition of revenue included in beginning of year contract liability</a></td>
<td class="num">(5,164)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation', window );">Contract liability, net of revenue recognized on contracts during the period</a></td>
<td class="nump">5,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability, End of Period</a></td>
<td class="nump">$ 11,946<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ChangeInContractWithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change In Contract With Customer, Asset [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ChangeInContractWithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ChangeInContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change In Contract With Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ChangeInContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Net Of Reclassified To Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Increase From Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787467977528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,542,448<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
<td class="nump">$ 1,517,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,025,232<span></span>
</td>
<td class="nump">894,831<span></span>
</td>
<td class="nump">996,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Neurosurgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">802,959<span></span>
</td>
<td class="nump">716,339<span></span>
</td>
<td class="nump">767,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">222,273<span></span>
</td>
<td class="nump">178,492<span></span>
</td>
<td class="nump">228,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">517,216<span></span>
</td>
<td class="nump">477,037<span></span>
</td>
<td class="nump">521,351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Wound Reconstruction and Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">392,463<span></span>
</td>
<td class="nump">293,038<span></span>
</td>
<td class="nump">322,739<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Extremity Orthopedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">78,316<span></span>
</td>
<td class="nump">90,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Private Label</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 124,753<span></span>
</td>
<td class="nump">$ 105,683<span></span>
</td>
<td class="nump">$ 108,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_NeurosurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_NeurosurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_RegenerativeSkinAndWoundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_RegenerativeSkinAndWoundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_ExtremityOrthopedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_ExtremityOrthopedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_PrivateLabelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_PrivateLabelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787475025000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 04, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,798<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Extremity Orthopedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Aggregate purchase price received</a></td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_NetWorkingCapital', window );">Net working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable', window );">Transitional supply agreement, payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember', window );">Consortium of Focused Orthopedists, LLC | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Extremity Orthopedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination', window );">Sale of Extremity Orthopedics business, payment for terminating license agreement</a></td>
<td class="nump">$ 41,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Transitional Supply Agreement, Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_NetWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Working Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_NetWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787476183912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details) - Disposal Group, Disposed of by Sale, Not Discontinued Operations - Extremity Orthopedics<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets', window );">Right of use asset-operating leases and Other assets</a></td>
<td class="nump">3,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">6,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">13,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">37,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="nump">47,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="nump">52,845<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held for sale</a></td>
<td class="nump">162,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent', window );">Current portion of lease liability - operating leases</a></td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities', window );">Accrued compensation</a></td>
<td class="nump">1,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">3,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent', window );">Lease liability - operating leases</a></td>
<td class="nump">5,669<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held for sale</a></td>
<td class="nump">$ 11,751<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Lease Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Right of Use Asset Operating Leases and Other Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787469466488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES (Business Acquisition, Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th"><div>Jul. 29, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,013,458,000<span></span>
</td>
<td class="nump">$ 932,367,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 954,280,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="nump">$ 306,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationWorkingCapitalAdjustment', window );">Working capital adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">94,147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration, fair value</a></td>
<td class="nump">$ 23,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc. | Pro Forma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,547,000,000<span></span>
</td>
<td class="nump">$ 1,466,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,153,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,100,000<span></span>
</td>
<td class="nump">15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate', window );">Acquired intangible assets, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Milestone Payment One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Milestone Payment Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquired Finite-lived Intangible Assets, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcquiredFinitelivedIntangibleAssetsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Intangible Asset Acquired, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationWorkingCapitalAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Working Capital Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationWorkingCapitalAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ProFormaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ProFormaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787468951256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th"><div>Jul. 29, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,013,458<span></span>
</td>
<td class="nump">$ 932,367<span></span>
</td>
<td class="nump">$ 954,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 2,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Trade accounts receivable, net</a></td>
<td class="nump">16,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories, net</a></td>
<td class="nump">18,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaids expenses and other current assets</a></td>
<td class="nump">1,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Total current assets</a></td>
<td class="nump">38,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">13,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">94,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases', window );">Right of use asset - operating leases</a></td>
<td class="nump">9,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">7,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="nump">408,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued expenses</a></td>
<td class="nump">5,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases', window );">Current portion of lease liability - operating leases</a></td>
<td class="nump">1,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">8,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liability</a></td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases', window );">Lease liability - operating leases</a></td>
<td class="nump">7,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="nump">61,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration, fair value</a></td>
<td class="nump">23,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">101,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">$ 306,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc. | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc. | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,100<span></span>
</td>
<td class="nump">$ 15,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | CerebroFlo developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Enabling technology license</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Current Portion of Lease Liability, Operating Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability, Operating Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Asset, Operating Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787465528840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES (Asset Acquisition, Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 09, 2019 </div>
<div>USD ($) </div>
<div>asset</div>
</th>
<th class="th">
<div>Jan. 04, 2019 </div>
<div>USD ($) </div>
<div>asset</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">IPR&amp;D expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 64,916,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,145,573,000<span></span>
</td>
<td class="nump">989,436,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember', window );">Consortium of Focused Orthopedists, LLC | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Smith &amp; Nephew USD Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination', window );">Sale of Extremity Orthopedics business, payment for terminating license agreement</a></td>
<td class="nump">$ 41,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet', window );">Contingent development milestone payments commitment (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionNumberOfAssetsAcquired', window );">Number of assets acquired | asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet', window );">Remaining net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid', window );">Development milestone payment, to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">IPR&amp;D expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet', window );">Remaining net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound | Deferred Tax Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet', window );">Remaining net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound | IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=iart_IntegratedShoulderCollaborationInc.Member', window );">ISC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=iart_IntegratedShoulderCollaborationInc.Member', window );">ISC | Enabling technology license</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionNumberOfAssetsAcquired', window );">Number of assets acquired | asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Upfront payment, intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet', window );">Option to acquire, period subsequent to first commercial sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet', window );">Maximum future purchase price, if circumstances met (not to exceed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Assets Acquired And Liabilities Assumed, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Development Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Maximum Contingent Development Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionNumberOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Number Of Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionNumberOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ScheduleOfAssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule Of Asset Acquisition [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ScheduleOfAssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6829253&amp;loc=SL6831962-166255<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=iart_DeferredTaxAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=iart_DeferredTaxAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=iart_IntegratedShoulderCollaborationInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=iart_IntegratedShoulderCollaborationInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787463340440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 03, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Term loan component of senior credit facility, classified as current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="nump">$ 33,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_InterestPaymentsYearOne', window );">Interest payments, year one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_InterestPaymentsYearTwo', window );">Interest payments, year two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_InterestPaymentsYearThree', window );">Interest payments, year three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_InterestPaymentsYearFour', window );">Interest payments, year four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Cost of call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">104,248,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from warrant transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">44,563,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">564,426,000<span></span>
</td>
<td class="nump">474,834,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit', window );">Securitization facility, outstanding borrowings, maximum limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgram', window );">Secured long-term debt, securitization program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,500,000<span></span>
</td>
<td class="nump">$ 112,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtWeightedAverageInterestRateFromSecuritization', window );">Security facility, weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SecuritizationFacilityFairValueOfAmountOutstanding', window );">Securitization facility, fair value of amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,300,000<span></span>
</td>
<td class="nump">$ 97,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate on debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of credit facility, fair value of amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember', window );">Swingline Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Capitalized incremental financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Previously capitalized financing costs, written-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Incremental financing cost expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Eurodollar Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Eurodollar Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Overnight Federal Funds Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | One-Month Eurodollar Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember', window );">Term Loan Facility | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 877,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 843,800,000<span></span>
</td>
<td class="nump">$ 877,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate on debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Term loan component of senior credit facility, classified as current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="nump">$ 33,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember', window );">Term Loan Facility | Secured Debt | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of credit facility, fair value of amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">838,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember', window );">2025 Notes | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Capitalized incremental financing costs</a></td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes, aggregate principal amount</a></td>
<td class="nump">$ 575,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575,000,000<span></span>
</td>
<td class="nump">575,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Convertible notes, interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Debt proceeds, classified as equity at time of offering</a></td>
<td class="nump">$ 104,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate</a></td>
<td class="nump">13.5739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod', window );">Maximum selling price of the company's common stock of the conversion price</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentMaximumAverageConversionValueOfNotes', window );">Maximum average conversion value of notes</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount', window );">Combination settlement for debt conversion, minimum settled in cash per principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 113.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">640,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Cash interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember', window );">2025 Notes | Convertible Debt | Call Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Cost of call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from warrant transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Initial strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentMaximumAverageConversionValueOfNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Average Conversion Value Of Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentMaximumAverageConversionValueOfNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtWeightedAverageInterestRateFromSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt, Weighted Average Interest Rate, From Securitization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtWeightedAverageInterestRateFromSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForOptionIndexToIssuersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Options Indexed to Issuer's Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForOptionIndexToIssuersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuritizationFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securitization Facility, Fair Value Of Amount Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuritizationFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityStrikePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iart_OneMonthEurodollarRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iart_OneMonthEurodollarRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787473865256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Maximum Total Leverage Ratio Table) (Details) - Senior Credit Facility<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Execution of July 2020 Amendment through June 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt Instrument, Covenant, Maximum Leverage Ratio</a></td>
<td class="nump">5.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">September 30, 2021 through June 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt Instrument, Covenant, Maximum Leverage Ratio</a></td>
<td class="nump">5.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">September 30, 2022 through June 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt Instrument, Covenant, Maximum Leverage Ratio</a></td>
<td class="nump">4.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">September 30, 2023 and the last day of each fiscal quarter thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt Instrument, Covenant, Maximum Leverage Ratio</a></td>
<td class="nump">4.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentCovenantMaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maximum Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentCovenantMaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474429048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Schedule of Debt Maturity) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 45,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">61,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">67,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">669,375<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Principal Repayment</a></td>
<td class="nump">$ 843,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787465270888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details) - Cash Flow Hedging - Designated as Hedging Instrument - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 1,775,000,000<span></span>
</td>
<td class="nump">$ 1,875,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">(43,957,000)<span></span>
</td>
<td class="num">(93,769,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated March 27, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.971%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(929,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 13, 2017 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.201%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (5,268,000)<span></span>
</td>
<td class="num">(12,557,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 13, 2017 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.423%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (5,520,000)<span></span>
</td>
<td class="num">(11,502,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 13, 2017 Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.313%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (7,421,000)<span></span>
</td>
<td class="num">(16,243,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated October 10, 2018 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.22%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (5,512,000)<span></span>
</td>
<td class="num">(9,836,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated October 10, 2018 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.199%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (5,464,000)<span></span>
</td>
<td class="num">(9,826,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated October 10, 2018 Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.209%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (5,494,000)<span></span>
</td>
<td class="num">(9,783,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 18, 2018 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.885%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (6,886,000)<span></span>
</td>
<td class="num">(10,407,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 18, 2018 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.867%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (6,764,000)<span></span>
</td>
<td class="num">(10,431,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 15, 2020 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 575,000,000<span></span>
</td>
<td class="nump">575,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.415%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 3,552,000<span></span>
</td>
<td class="num">(1,907,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 15, 2020 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="nump">125,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.404%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 821,000<span></span>
</td>
<td class="num">$ (348,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iart_OneMonthUSDLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iart_OneMonthUSDLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedMarch272017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedMarch272017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787462797688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Narrative) (Details)<br> &#8364; in Millions, &#163; in Millions, SFr in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,192,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (96,837,000)<span></span>
</td>
<td class="num">$ (13,671,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,497,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,920,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,192,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(96,836,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,775,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,875,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Currency Forward Contract | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) recognized in other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) recognized in other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IntercompanyLoanQuarterlyPayment', window );">Intercompany loan, quarterly payment | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 5.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Gain (loss) estimated to be reclassified to earnings during next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) recognized in other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives', window );">Loss recorded, settlement of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 44.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Net Investment Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 128.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) recognized in other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives', window );">Loss recorded, settlement of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Gain (loss) estimated to be reclassified to earnings during next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded, net investment hedge, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 291.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IntercompanyLoanQuarterlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intercompany Loan, Quarterly Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IntercompanyLoanQuarterlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of foreign currency derivatives and nonderivative instruments designated as fair value hedging instruments which were recognized in earnings, net of offsets by the gain (loss) on the hedged item to the extent that the fair value hedge was determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787462896232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)<br> SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 291,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 1,775,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,875,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">(43,957,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,769,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,335,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract One | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">1.85%<span></span>
</td>
<td class="nump">1.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 48,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract One | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">4.46%<span></span>
</td>
<td class="nump">4.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (8,283,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,262,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Two | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">1.95%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 145,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Two | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">4.52%<span></span>
</td>
<td class="nump">4.52%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 41,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,843,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Three | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 397,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 420,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Three | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">3.98%<span></span>
</td>
<td class="nump">3.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 445,821,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471,640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (8,242,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,441,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787462691144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)<br> &#8364; in Thousands, SFr in Thousands, &#163; in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 291,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="nump">&#8364; 44,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,884,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap One | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 44,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap One | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.01%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 2,503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(450,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Two | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 51,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Two | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 2,147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Three | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 38,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Three | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (792,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,794,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Four | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 222,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Four | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,500,000<span></span>
</td>
<td class="nump">&#163; 128.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 3,858,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,036,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787463080072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)<br> &#8364; in Millions, &#163; in Millions, SFr in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="nump">&#8364; 44.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">$ 16,497,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,920,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">64,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">1,775,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,875,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">4,373,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">18,187,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,033,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">30,143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,736,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,623,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">8,283,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,335,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">4,859,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,728,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,500,000<span></span>
</td>
<td class="nump">&#163; 128.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">5,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,297,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">2,104,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,884,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">$ 3,366,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,449,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787462894008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,514,867<span></span>
</td>
<td class="nump">$ 1,416,736<span></span>
</td>
<td class="nump">$ 1,375,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,192<span></span>
</td>
<td class="num">(96,837)<span></span>
</td>
<td class="num">(13,671)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,684,804<span></span>
</td>
<td class="nump">1,514,867<span></span>
</td>
<td class="nump">1,416,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,059)<span></span>
</td>
<td class="num">(76,402)<span></span>
</td>
<td class="num">(45,443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,155)<span></span>
</td>
<td class="num">(74,059)<span></span>
</td>
<td class="num">(76,402)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,300<span></span>
</td>
<td class="num">(17,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,192<span></span>
</td>
<td class="num">(96,836)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCL into Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,024<span></span>
</td>
<td class="num">(24,442)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(107,133)<span></span>
</td>
<td class="num">(34,739)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,965)<span></span>
</td>
<td class="num">(107,133)<span></span>
</td>
<td class="num">(34,739)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Interest expense | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,769)<span></span>
</td>
<td class="num">(45,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,402<span></span>
</td>
<td class="num">(64,778)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCL into Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,411)<span></span>
</td>
<td class="num">(16,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,956)<span></span>
</td>
<td class="num">(93,769)<span></span>
</td>
<td class="num">(45,145)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Other income, net | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,275<span></span>
</td>
<td class="num">(17,147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCL into Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,890<span></span>
</td>
<td class="num">(15,897)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,688)<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Interest income | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,291)<span></span>
</td>
<td class="nump">10,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,515<span></span>
</td>
<td class="num">(14,911)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCL into Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">7,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,321)<span></span>
</td>
<td class="num">$ (12,291)<span></span>
</td>
<td class="nump">$ 10,229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787476202424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 83.3<span></span>
</td>
<td class="nump">$ 74.5<span></span>
</td>
<td class="nump">$ 72.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Expected annual amortization expense, 2022</a></td>
<td class="nump">79.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Expected annual amortization expense, 2023</a></td>
<td class="nump">78.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Expected annual amortization expense, 2024</a></td>
<td class="nump">77.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Expected annual amortization expense, 2025</a></td>
<td class="nump">77.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Expected annual amortization expense, 2026</a></td>
<td class="nump">77.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Expected annual amortization expense, thereafter</a></td>
<td class="nump">585.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of product technology</a></td>
<td class="nump">$ 66.5<span></span>
</td>
<td class="nump">46.7<span></span>
</td>
<td class="nump">$ 45.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember', window );">Smith &amp; Nephew USD Limited | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787468046520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of period</a></td>
<td class="nump">$ 932,367<span></span>
</td>
<td class="nump">$ 954,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,546)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(13,056)<span></span>
</td>
<td class="nump">25,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">ACell Acquisition</a></td>
<td class="nump">94,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of period</a></td>
<td class="nump">1,013,458<span></span>
</td>
<td class="nump">932,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of period</a></td>
<td class="nump">671,975<span></span>
</td>
<td class="nump">653,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(8,547)<span></span>
</td>
<td class="nump">18,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">ACell Acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of period</a></td>
<td class="nump">663,428<span></span>
</td>
<td class="nump">671,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of period</a></td>
<td class="nump">260,392<span></span>
</td>
<td class="nump">300,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,546)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(4,509)<span></span>
</td>
<td class="nump">7,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">ACell Acquisition</a></td>
<td class="nump">94,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of period</a></td>
<td class="nump">$ 350,030<span></span>
</td>
<td class="nump">$ 260,392<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787465503304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 1,646,892<span></span>
</td>
<td class="nump">$ 1,421,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(501,319)<span></span>
</td>
<td class="num">(431,651)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">1,145,573<span></span>
</td>
<td class="nump">989,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Codman trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">167,758<span></span>
</td>
<td class="nump">170,226<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 167,758<span></span>
</td>
<td class="nump">$ 170,226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember', window );">Completed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">19 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 1,132,954<span></span>
</td>
<td class="nump">$ 896,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(307,013)<span></span>
</td>
<td class="num">(248,088)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 825,941<span></span>
</td>
<td class="nump">$ 648,390<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 211,344<span></span>
</td>
<td class="nump">$ 213,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(142,755)<span></span>
</td>
<td class="num">(132,838)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 68,589<span></span>
</td>
<td class="nump">$ 80,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember', window );">Trademarks/brand names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">28 years<span></span>
</td>
<td class="text">28 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 98,367<span></span>
</td>
<td class="nump">$ 104,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(31,468)<span></span>
</td>
<td class="num">(31,767)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 66,899<span></span>
</td>
<td class="nump">$ 72,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember', window );">Supplier relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">27 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 30,211<span></span>
</td>
<td class="nump">$ 30,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(16,192)<span></span>
</td>
<td class="num">(15,203)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 14,019<span></span>
</td>
<td class="nump">$ 15,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember', window );">All other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 6,258<span></span>
</td>
<td class="nump">$ 6,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3,891)<span></span>
</td>
<td class="num">(3,755)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 2,367<span></span>
</td>
<td class="nump">$ 2,938<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787469374632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TREASURY STOCK - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 12, 2022</div></th>
<th class="th"><div>Feb. 05, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 07, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 234,400,000<span></span>
</td>
<td class="nump">$ 235,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock, average cost per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47.86<span></span>
</td>
<td class="nump">$ 47.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase program, receipt (payment)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (92,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Accelerated shares repurchased, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased', window );">Accelerated share repurchases, percentage of expected total repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining amount under share repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from offering of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 575,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased', window );">Accelerated share repurchases, percentage of expected total repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase program, receipt (payment)</a></td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesSharesReceivedAtInception', window );">Accelerated share repurchases, shares received at inception</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased', window );">Accelerated share repurchases, percentage of expected total repurchased</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining amount under share repurchase</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from offering of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Certain Purchasers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from offering of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcceleratedShareRepurchasesSharesReceivedAtInception">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases. Shares Received at Inception</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcceleratedShareRepurchasesSharesReceivedAtInception</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_CertainPurchasersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_CertainPurchasersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787470139304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 36,210<span></span>
</td>
<td class="nump">$ 19,591<span></span>
</td>
<td class="nump">$ 21,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Total estimated tax benefit related to stock-based compensation expense</a></td>
<td class="nump">13,804<span></span>
</td>
<td class="nump">6,221<span></span>
</td>
<td class="nump">9,420<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Net effect on net income</a></td>
<td class="nump">22,406<span></span>
</td>
<td class="nump">13,370<span></span>
</td>
<td class="nump">11,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">344<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">1,644<span></span>
</td>
<td class="nump">1,471<span></span>
</td>
<td class="nump">1,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 34,096<span></span>
</td>
<td class="nump">$ 17,776<span></span>
</td>
<td class="nump">$ 19,153<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787468849992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2010</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,210<span></span>
</td>
<td class="nump">$ 19,591<span></span>
</td>
<td class="nump">$ 21,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value, options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,100<span></span>
</td>
<td class="nump">8,700<span></span>
</td>
<td class="nump">14,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Cash received from option exercises and employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Tax benefit realized from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized share-based compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iart_TwoThousandThreePlanMember', window );">2003 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncreaseInAuthorizedShares', window );">Increase in authorized shares (in shares)</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iart_TwoThousandPlanMember', window );">2000 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iart_TwoThousandOnePlanMember', window );">2001 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,948<span></span>
</td>
<td class="nump">18,284<span></span>
</td>
<td class="nump">12,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EmployeeStockPurchasePlanProceeds', window );">ESPP proceeds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation costs related to unvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for cost recognition, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Directors and Certain Executive Officers | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Directors and Certain Executive Officers | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod', window );">Vested but not issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iart_RestrictedStockPerformanceStockAndContractStockMember', window );">Restricted Stock, Performance Stock and Contract Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,200<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="nump">18,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation costs related to unvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for cost recognition, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,700<span></span>
</td>
<td class="nump">$ 17,300<span></span>
</td>
<td class="nump">$ 21,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Requisite service periods of performance stock, restricted stock and contract stock awards, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod', window );">Vested but not issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EmployeeStockPurchasePlanProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds received from employees in connection with the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EmployeeStockPurchasePlanProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IncreaseInAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in the number of authorized shares under the Plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IncreaseInAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested But Not Issued In Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iart_TwoThousandThreePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iart_TwoThousandThreePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iart_TwoThousandPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iart_TwoThousandPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iart_TwoThousandOnePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iart_TwoThousandOnePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iart_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iart_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iart_DirectorsandCertainExecutiveOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iart_DirectorsandCertainExecutiveOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iart_RestrictedStockPerformanceStockAndContractStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iart_RestrictedStockPerformanceStockAndContractStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472050184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">0.89%<span></span>
</td>
<td class="nump">2.51%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of option from grant date</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of options granted (in dollars per share)</a></td>
<td class="nump">$ 22.59<span></span>
</td>
<td class="nump">$ 13.03<span></span>
</td>
<td class="nump">$ 18.74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787467951384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">1,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited or Expired (in shares)</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of year (in shares)</a></td>
<td class="nump">1,225<span></span>
</td>
<td class="nump">1,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of year (in shares)</a></td>
<td class="nump">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)</a></td>
<td class="nump">$ 39.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted (in dollars per share)</a></td>
<td class="nump">68.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised (in dollars per share)</a></td>
<td class="nump">24.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)</a></td>
<td class="nump">51.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)</a></td>
<td class="nump">45.11<span></span>
</td>
<td class="nump">$ 39.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable at end of year (in dollars per share)</a></td>
<td class="nump">$ 41.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Contractual Term in Years, Outstanding at end of year</a></td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">4 years 4 months 28 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Contractual Term in Years, Exercisable at end of year</a></td>
<td class="text">3 years 4 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding</a></td>
<td class="nump">$ 26,970<span></span>
</td>
<td class="nump">$ 34,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable at end of year</a></td>
<td class="nump">$ 22,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787468758136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of year (in shares) | shares</a></td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancellations (in shares) | shares</a></td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares) | shares</a></td>
<td class="num">(214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod', window );">Vested but not released (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of year (in shares) | shares</a></td>
<td class="nump">422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 50.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">68.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancellations (in dollars per share) | $ / shares</a></td>
<td class="nump">54.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share) | $ / shares</a></td>
<td class="nump">51.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue', window );">Vested but not released (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 58.78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iart_PerformanceStockandContractStockMember', window );">Performance Stock and Contract Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of year (in shares) | shares</a></td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares', window );">Adjustments for performance achievement related to award target (in shares) | shares</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancellations (in shares) | shares</a></td>
<td class="num">(152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares) | shares</a></td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod', window );">Vested but not released (in shares) | shares</a></td>
<td class="num">(289)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of year (in shares) | shares</a></td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 47.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">67.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue', window );">Adjustments for performance achievement related to award target (in dollars per share) | $ / shares</a></td>
<td class="nump">58.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancellations (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share) | $ / shares</a></td>
<td class="nump">67.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue', window );">Vested but not released (in dollars per share) | $ / shares</a></td>
<td class="nump">58.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 70.74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iart_PerformanceStockandContractStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iart_PerformanceStockandContractStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787473704024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 2,741<span></span>
</td>
<td class="nump">$ 4,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(893)<span></span>
</td>
<td class="num">(652)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost (credit)</a></td>
<td class="num">(281)<span></span>
</td>
<td class="num">(274)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial losses</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="nump">51<span></span>
</td>
<td class="num">(102)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net period benefit cost</a></td>
<td class="nump">$ 1,904<span></span>
</td>
<td class="nump">$ 4,007<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474974536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">0.37%<span></span>
</td>
<td class="nump">0.34%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">3.59%<span></span>
</td>
<td class="nump">2.04%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.14%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Interest crediting rate for cash balance plans</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787468765608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change In Projected Benefit Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations, beginning of year</a></td>
<td class="nump">$ 72,869<span></span>
</td>
<td class="nump">$ 66,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">2,741<span></span>
</td>
<td class="nump">4,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(5,044)<span></span>
</td>
<td class="num">(3,347)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Plan amendments</a></td>
<td class="num">(586)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Plan settlements</a></td>
<td class="num">(655)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Employee contribution</a></td>
<td class="nump">917<span></span>
</td>
<td class="nump">883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid', window );">Premiums paid</a></td>
<td class="num">(373)<span></span>
</td>
<td class="num">(388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefit payment</a></td>
<td class="num">(2,128)<span></span>
</td>
<td class="num">(1,537)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation', window );">Plans transferred in</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Effect of foreign currency exchange rates</a></td>
<td class="num">(2,657)<span></span>
</td>
<td class="nump">6,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations, end of year</a></td>
<td class="nump">65,184<span></span>
</td>
<td class="nump">72,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change In Plan Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Plan assets at fair value, beginning of year</a></td>
<td class="nump">37,825<span></span>
</td>
<td class="nump">30,770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">3,371<span></span>
</td>
<td class="nump">2,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">2,254<span></span>
</td>
<td class="nump">2,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Employee contributions</a></td>
<td class="nump">917<span></span>
</td>
<td class="nump">883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Plan settlements</a></td>
<td class="num">(633)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(2,128)<span></span>
</td>
<td class="num">(1,537)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid', window );">Premiums paid</a></td>
<td class="num">(373)<span></span>
</td>
<td class="num">(388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Effect of foreign currency exchange rates</a></td>
<td class="num">(1,319)<span></span>
</td>
<td class="nump">2,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Plan assets at fair value, end of year</a></td>
<td class="nump">$ 39,914<span></span>
</td>
<td class="nump">$ 37,825<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Premiums Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanBenefitObligationPremiumsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Premiums Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanPlanAssetsPremiumsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in benefit obligation of defined benefit plan from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787473401000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract', window );"><strong>Reconciliation Of Funded Status</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 39,914<span></span>
</td>
<td class="nump">$ 37,825<span></span>
</td>
<td class="nump">$ 30,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligations</a></td>
<td class="nump">65,184<span></span>
</td>
<td class="nump">72,869<span></span>
</td>
<td class="nump">$ 66,972<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Unfunded benefit obligations</a></td>
<td class="nump">$ 25,270<span></span>
</td>
<td class="nump">$ 35,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474134440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax', window );">Gain (loss) recognized within accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,300,000<span></span>
</td>
<td class="nump">61,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Benefit plans, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,914,000<span></span>
</td>
<td class="nump">37,825,000<span></span>
</td>
<td class="nump">$ 30,770,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount', window );">Plan assets expected to be returned next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Contributions expected to be paid to plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total contributions made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="nump">6,700,000<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage', window );">Defer payment and taxation, base salary, percentage (up to)</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage', window );">Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan, fair value of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=iart_FranceAndGermanyMember', window );">France and Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Benefit plans, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of defined benefit plan asset expected to be returned to employer within one year or operating cycle, if longer, following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (t)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=iart_FranceAndGermanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=iart_FranceAndGermanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787469236472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 1,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2023</a></td>
<td class="nump">1,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2024</a></td>
<td class="nump">1,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2025</a></td>
<td class="nump">2,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2026</a></td>
<td class="nump">2,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Next five years</a></td>
<td class="nump">$ 10,395<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787462653352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options (or more) | renewal_option</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 20,300,000<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Future minimum lease payments, finance leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector', window );">Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AnnualRateOfLeaseAgreement', window );">Annual rate of lease agreement</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Five Year Option Lease From November 1, 2029 Through October 31, 2034</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_OptionToExtendLeaseYears', window );">Option to extend lease, years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Period for extended lease</a></td>
<td class="text">November 1, 2029 through October 31, 2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Five Year Option Lease From November 1, 2034 Through October 31, 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_OptionToExtendLeaseYears', window );">Option to extend lease, years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Period for extended lease</a></td>
<td class="text">November 1, 2034 through October 31, 2039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AnnualRateOfLeaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual rate of lease agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AnnualRateOfLeaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_OptionToExtendLeaseYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Option to extend lease, years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_OptionToExtendLeaseYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=iart_FiveYearOptionLeasePeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=iart_FiveYearOptionLeasePeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=iart_FiveYearLeasePeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=iart_FiveYearLeasePeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787465393112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="nump">$ 84,543<span></span>
</td>
<td class="nump">$ 83,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">14,775<span></span>
</td>
<td class="nump">12,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current lease liabilities</a></td>
<td class="nump">90,329<span></span>
</td>
<td class="nump">88,118<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 105,104<span></span>
</td>
<td class="nump">$ 100,936<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Leased facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">10 years 4 months 24 days<span></span>
</td>
<td class="text">11 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Leased vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787477188136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 15,077<span></span>
</td>
<td class="nump">$ 15,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>ROU assets obtained in exchange for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">$ 12,610<span></span>
</td>
<td class="nump">$ 6,027<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787476156456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 17,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">14,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">13,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">11,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">10,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">68,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">136,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="nump">31,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">105,104<span></span>
</td>
<td class="nump">$ 100,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Current lease liabilities</a></td>
<td class="nump">14,775<span></span>
</td>
<td class="nump">12,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">90,329<span></span>
</td>
<td class="nump">$ 88,118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_RelatedPartiesMember', window );">Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">2,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_ThirdPartiesMember', window );">Third Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">17,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">14,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">12,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">11,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">9,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">67,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">$ 134,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ThirdPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ThirdPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787472292488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Income Before Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States operations</a></td>
<td class="nump">$ 91,150<span></span>
</td>
<td class="nump">$ 15,082<span></span>
</td>
<td class="num">$ (38,359)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign operations</a></td>
<td class="nump">123,527<span></span>
</td>
<td class="nump">78,438<span></span>
</td>
<td class="nump">98,463<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">$ 214,677<span></span>
</td>
<td class="nump">$ 93,520<span></span>
</td>
<td class="nump">$ 60,104<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787462779944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Increase (decrease) in income taxes resulting from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign operations</a></td>
<td class="num">(4.00%)<span></span>
</td>
<td class="num">(7.90%)<span></span>
</td>
<td class="num">(20.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Excess tax benefits from stock compensation</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(5.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Nondeductible meals and entertainment</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent', window );">Intercompany profit in inventory</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent', window );">Nondeductible facilitative costs</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credit</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
<td class="num">(2.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Return to provision</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(2.30%)<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent', window );">Global intangible low-taxed income ("GILTI")</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent', window );">Nondeductible executive compensation</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent', window );">Fair market value step up on intra-entity transfer of intellectual property</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(63.30%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent', window );">Gain from sale of business - book to tax differences</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays', window );">Swiss tax holiday</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(15.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment', window );">Nondeductible R&amp;D expense</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">22.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">21.20%<span></span>
</td>
<td class="num">(43.20%)<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Global Intangible Low-Taxed Income, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income exempt from income tax because of a tax holiday.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787462728840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.20%<span></span>
</td>
<td class="num">(43.20%)<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Excess tax benefits from stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount', window );">Income tax benefit, transfer intra-entity intellectual property, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent', window );">Effective worldwide tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Effective income tax rate reconciliation, foreign income tax rate differential, increase (decrease), amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,600,000<span></span>
</td>
<td class="num">$ (48,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations', window );">Effective foreign income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.20%<span></span>
</td>
<td class="num">(57.10%)<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease', window );">Valuation allowance, period increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100,000)<span></span>
</td>
<td class="num">$ (100,000)<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignEarningsRepatriated', window );">Tax impact of repatriating foreign earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Amount of unrecorded benefit reasonably possible to be recognized (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Penalties and interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Penalties and interest accrued</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember', window );">Extremity Orthopedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness', window );">Tax expense related to sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority | Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount', window );">Deferred income tax benefit, transfer intra-entity intellectual property, amount</a></td>
<td class="nump">$ 59,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign', window );">Federal tax credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare', window );">Federal tax credit (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Foreign Income Tax Rate Reconciliation, Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Worldwide Income Tax Rate Reconciliation, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IncomeTaxLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IncomeTaxLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignEarningsRepatriated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign earnings repatriated from subsidiaries outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignEarningsRepatriated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787468939864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Provision for Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 31,938<span></span>
</td>
<td class="nump">$ 6,184<span></span>
</td>
<td class="nump">$ 14,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">11,377<span></span>
</td>
<td class="nump">5,029<span></span>
</td>
<td class="nump">3,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">5,042<span></span>
</td>
<td class="nump">12,553<span></span>
</td>
<td class="nump">10,905<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">48,357<span></span>
</td>
<td class="nump">23,766<span></span>
</td>
<td class="nump">28,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(12,830)<span></span>
</td>
<td class="num">(5,079)<span></span>
</td>
<td class="num">(10,889)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(3,688)<span></span>
</td>
<td class="num">(1,760)<span></span>
</td>
<td class="num">(666)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">13,763<span></span>
</td>
<td class="num">(57,299)<span></span>
</td>
<td class="num">(7,491)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(2,755)<span></span>
</td>
<td class="num">(64,138)<span></span>
</td>
<td class="num">(19,046)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 45,602<span></span>
</td>
<td class="num">$ (40,372)<span></span>
</td>
<td class="nump">$ 9,903<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787470294520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Doubtful accounts</a></td>
<td class="nump">$ 2,029<span></span>
</td>
<td class="nump">$ 2,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory related items</a></td>
<td class="nump">31,841<span></span>
</td>
<td class="nump">47,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">13,319<span></span>
</td>
<td class="nump">18,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation', window );">Accrued vacation</a></td>
<td class="nump">3,042<span></span>
</td>
<td class="nump">3,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses', window );">Accrued bonus</a></td>
<td class="nump">7,415<span></span>
</td>
<td class="nump">4,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">13,955<span></span>
</td>
<td class="nump">6,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">1,742<span></span>
</td>
<td class="nump">1,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">26,198<span></span>
</td>
<td class="nump">29,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment', window );">Capitalization of research and development expenses</a></td>
<td class="nump">36,770<span></span>
</td>
<td class="nump">13,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses', window );">Unrealized foreign exchange loss</a></td>
<td class="nump">12,849<span></span>
</td>
<td class="nump">23,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards', window );">Charitable contributions carryforward</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DeferredTaxAssetsLeasesAndOther', window );">Leases and Other</a></td>
<td class="nump">41,371<span></span>
</td>
<td class="nump">23,205<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">190,737<span></span>
</td>
<td class="nump">173,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(9,767)<span></span>
</td>
<td class="num">(9,897)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets after valuation allowance</a></td>
<td class="nump">180,970<span></span>
</td>
<td class="nump">163,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangible and fixed assets</a></td>
<td class="num">(152,150)<span></span>
</td>
<td class="num">(90,274)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DeferredTaxLiabilitiesLeasesAndOther', window );">Leases and Other</a></td>
<td class="num">(17,658)<span></span>
</td>
<td class="num">(15,585)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(169,808)<span></span>
</td>
<td class="num">(105,859)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total net deferred tax assets</a></td>
<td class="nump">$ 11,162<span></span>
</td>
<td class="nump">$ 57,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxAssetsLeasesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leases And Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxAssetsLeasesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxLiabilitiesLeasesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Leases And Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxLiabilitiesLeasesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474131032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Uncertain Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance, beginning of year</a></td>
<td class="nump">$ 702<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract', window );"><strong>Gross increases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Current year tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Prior years' tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther', window );">Other</a></td>
<td class="num">(26)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance, end of year</a></td>
<td class="nump">$ 676<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increases During Period [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Reductions Resulting From Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_UnrecognizedTaxBenefitsReductionsResultingFromOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787475225496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - Basic (in shares)</a></td>
<td class="nump">84,698<span></span>
</td>
<td class="nump">84,650<span></span>
</td>
<td class="nump">85,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common share (in dollars per share)</a></td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - Basic (in shares)</a></td>
<td class="nump">84,698<span></span>
</td>
<td class="nump">84,650<span></span>
</td>
<td class="nump">85,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and restricted stock (in shares)</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="nump">857<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares for diluted earnings per share (in shares)</a></td>
<td class="nump">85,485<span></span>
</td>
<td class="nump">85,228<span></span>
</td>
<td class="nump">86,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in dollars per share)</a></td>
<td class="nump">$ 1.98<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787469182872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Narrative) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares excluded from computation as their effect would be antidilutive (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iart_PerformanceSharesandRestrictedUnitsMember', window );">Performance Shares and Restricted Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AdditionalEPSShares', window );">Additional EPS shares (in shares)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AdditionalEPSShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the basic and diluted calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AdditionalEPSShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iart_PerformanceSharesandRestrictedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iart_PerformanceSharesandRestrictedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787462869480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="nump">$ 1,514,867<span></span>
</td>
<td class="nump">$ 1,416,736<span></span>
</td>
<td class="nump">$ 1,375,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="nump">41,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">13,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="nump">28,904<span></span>
</td>
<td class="nump">2,343<span></span>
</td>
<td class="num">(30,959)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="nump">1,684,804<span></span>
</td>
<td class="nump">1,514,867<span></span>
</td>
<td class="nump">1,416,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(74,059)<span></span>
</td>
<td class="num">(76,402)<span></span>
</td>
<td class="num">(45,443)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="nump">28,904<span></span>
</td>
<td class="nump">2,343<span></span>
</td>
<td class="num">(30,959)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">(45,155)<span></span>
</td>
<td class="num">(74,059)<span></span>
</td>
<td class="num">$ (76,402)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(82,249)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="nump">52,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">13,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="nump">39,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">(42,981)<span></span>
</td>
<td class="num">(82,249)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Pension Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(5,105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="nump">6,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="nump">6,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="nump">1,893<span></span>
</td>
<td class="num">(5,105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="nump">13,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="num">(17,362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="num">(17,362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">$ (4,067)<span></span>
</td>
<td class="nump">$ 13,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AccumulatedOtherComprehensiveIncomeLossRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787475033960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Gain (loss) reclassified from AOCL</a></td>
<td class="nump">$ 13,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Gain (loss) reclassified from AOCL</a></td>
<td class="nump">13,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives | Other Income, Net</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Gain (loss) reclassified from AOCL</a></td>
<td class="nump">25,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives | Interest Income</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Gain (loss) reclassified from AOCL</a></td>
<td class="num">$ (12,200)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787470157272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) - Contingent Consideration Liability - Level 3 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">$ 3,415<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">3,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">3,691<span></span>
</td>
<td class="nump">3,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">11,746<span></span>
</td>
<td class="nump">14,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="num">(276)<span></span>
</td>
<td class="num">(3,415)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="num">(62)<span></span>
</td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">11,408<span></span>
</td>
<td class="nump">11,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Derma Sciences | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellMember', window );">ACell | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions from acquisition of ACell</a></td>
<td class="nump">23,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="num">(2,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">$ 21,800<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787474190088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Narrative (Details) - Derma Sciences - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment for contingent consideration</a></td>
<td class="nump">$ 33.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh', window );">Maximum undiscounted payment</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any change recognized during the period in the high-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787477201144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>Segment </div>
<div>product</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SegmentReportingInformationNumberOfProductsOffered', window );">Number of products offered (more than) | product</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SegmentReportingInformationNumberOfProductsOffered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of products sold by a segment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SegmentReportingInformationNumberOfProductsOffered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787473777768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,542,448<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
<td class="nump">$ 1,517,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="num">(16,914)<span></span>
</td>
<td class="num">(27,757)<span></span>
</td>
<td class="num">(27,028)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">197,230<span></span>
</td>
<td class="nump">151,370<span></span>
</td>
<td class="nump">93,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,025,232<span></span>
</td>
<td class="nump">894,831<span></span>
</td>
<td class="nump">996,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">517,216<span></span>
</td>
<td class="nump">477,037<span></span>
</td>
<td class="nump">521,351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">667,670<span></span>
</td>
<td class="nump">516,287<span></span>
</td>
<td class="nump">539,657<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">439,471<span></span>
</td>
<td class="nump">356,657<span></span>
</td>
<td class="nump">395,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">228,199<span></span>
</td>
<td class="nump">159,630<span></span>
</td>
<td class="nump">144,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="num">$ (453,526)<span></span>
</td>
<td class="num">$ (337,160)<span></span>
</td>
<td class="num">$ (418,869)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787462839656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">$ 1,542,448<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
<td class="nump">$ 1,517,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">412,686<span></span>
</td>
<td class="nump">382,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States (Includes long-lived assets in Puerto Rico)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">1,089,526<span></span>
</td>
<td class="nump">971,975<span></span>
</td>
<td class="nump">1,077,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">339,535<span></span>
</td>
<td class="nump">324,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">191,327<span></span>
</td>
<td class="nump">172,689<span></span>
</td>
<td class="nump">197,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">55,026<span></span>
</td>
<td class="nump">38,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">182,034<span></span>
</td>
<td class="nump">157,174<span></span>
</td>
<td class="nump">157,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">11,289<span></span>
</td>
<td class="nump">13,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iart_RestOfWorldMember', window );">Rest of the World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">79,561<span></span>
</td>
<td class="nump">70,030<span></span>
</td>
<td class="nump">$ 85,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">$ 6,836<span></span>
</td>
<td class="nump">$ 5,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iart_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iart_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139787473774504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Period</a></td>
<td class="nump">$ 6,439<span></span>
</td>
<td class="nump">$ 4,303<span></span>
</td>
<td class="nump">$ 3,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="num">(1,059)<span></span>
</td>
<td class="nump">3,635<span></span>
</td>
<td class="nump">2,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Other</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(986)<span></span>
</td>
<td class="num">(1,499)<span></span>
</td>
<td class="num">(1,542)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">4,735<span></span>
</td>
<td class="nump">6,439<span></span>
</td>
<td class="nump">4,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Deferred tax assets valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Period</a></td>
<td class="nump">13,825<span></span>
</td>
<td class="nump">12,069<span></span>
</td>
<td class="nump">6,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">1,444<span></span>
</td>
<td class="nump">1,617<span></span>
</td>
<td class="nump">3,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Other</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">$ 15,258<span></span>
</td>
<td class="nump">$ 13,825<span></span>
</td>
<td class="nump">$ 12,069<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>iart-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iart="http://integralife.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="iart-20211231.xsd" xlink:type="simple"/>
    <context id="i37632302c2864aada6356f5aeb73834f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45e7724895184fdf85404aad41aa5196_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib54412ab095545838988a468e37768bb_I20220222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2022-02-22</instant>
        </period>
    </context>
    <context id="i488c668ed69943629b8567d269181e0c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iee25a280ce1a41fe94147173b06ec1d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if319a53d6ce443d0adc847fb824d705d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie55084e91d494776891870a81ff5cb91_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifcaf1fbc6c2145ac92ae58dce7c7f40b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibca422d8af654309ab3549894c22e2d0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia653c210464848738937121e1560643c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3bfd63f1146a4c15a4a961a4884d8f8e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic1aef4bf54744c0c98c1b03a1df9ec4d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6b92cad52f3d4933bd002cc96a643e01_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iea229e31f5ee46999defcde318bf2e01_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3184ef53b5bf48b89f52d96b36d83cd8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if7d6cd85315a4099a0e9a723e15cc57d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i54fe101f812943a4bb6c8e21f03e6abe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i57de76fda3e440858f132dfbe6b7a489_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i72b41bb28dd74cab856e1fb68a9457e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idfd8af4c329c447fa3829f444aa543e6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i008a1ec620f549bb9fe080a50c5507b5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ide0d9f6801174af69063a55bae4f6ea4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2ecb901e8b3f401a8bb8305e200e9cfd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i26020eaabf34449c9314e52e2b46ced3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iec381aeaa645411985794e468f533624_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i82c6bb6b0f504d638356e1bbc6647d3c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5fd48636569448e0af0d30413ae28c64_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib45c219279874482b251ea345021653d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6646ef2e0b7149db85eb6904dd2a2fd7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if738d2f8a6a346b78585e76bc617302c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8fb5aab0b91c486f93ba0865f67d73e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife0f354f47024885b393073798c5bcb4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9b2f27cba47049e49b27de743dc66104_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f9e723c32e3484daf7f94702722ed89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifcfb8e89af374d30815fb2d4a02f9b08_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3dfb0dc7e5f246bb8a7849e9e7d24e92_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iba3867d19dfa4492be95296631dd23cc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f824b4c3df84987af91c402bc76a408_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if6c5aeb396884c44b182cf5d1e5128cf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7f7a013d5ebd4d9cad2eddbf41dc58f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic716df195898449a87cdc08a6bad6057_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11696c20228346ddb295ad994c1d9416_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie62db310d8e24fc493ae78bec1200f60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib92542029c1c4bd08191f3e3b185049c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2d0e311baee24ad7a5bd71c8891f1b7c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i62b5cd28862f4322bda15977250be066_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e9517845c414b658fb2157d69d73d89_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i000ed083c92e4b89800da97c60ed285f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:SmithNephewUSDLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida04a0f98d5547f9ac6673309e068708_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a45995162b643ef92059397e2a71385_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i74b70ea531614678a00a01b323481165_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6c7328c66304f0eb5f22d8ed0526940_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia5208743b3814ba9b6d40074565c4081_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i602a6eef7e324d61a157d45723a03358_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b9b9c6b33494f24b03f4851071485a9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i963fa8e01c224aa0a64f3cb763df2e2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic02808dda943426e93e0d648a5cde64b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iefe78e2246e94ba3af3242006d2dc451_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9f2cb2e9bd3545d28c0f0abacf55b9d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48bbc77d02174676af9eed39f9be47a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id648da5e33794a8d9bd7e7832d8f94cd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i41401778e13647b0a2ee5fcf8f706a6a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i602ca3405d8741a38048a4535e86e784_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2a65e2f514d443397027c1f3e979693_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3295f6c4fa84b5f99c2eb43117653cf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i06b3b7586a5a4a83bcf6af176544c1e7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i01e4b5df061143a995961c4cc0610f5e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie167866deb594d9bad75e4138245a4e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i203bb570980f4213ae16c7f18573158d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iabf661f62ecd41f38efb53c5c7fab30f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7fd943aa50cb4e70b0f976a5852b32cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f2a0560d0be447492d3aa5f43a5fb1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8a2b6b9e3dc4ed2bb93554da43c0487_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6de32faeb0b247e4a9b3584e095721c3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9bbd97850f3e4065b4b66bb87c2cce30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icb95fbf7a7c24b6d88311032f03ec584_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6840528edb44a95a4b09018fdca6246_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8fd7b7f49417402eb284796a7134d501_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id4434b0da63d4acb99529de55c3df6cc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib53b8c510bfb4f04a342d01490fff519_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id37cda7e161149dab639b5833e0cdaae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic3178f6269054097bd491b98b26e7a45_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if89798fbac704337b50567a4cce07285_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife4b1f164ed2413f96ccef0da637494a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia8d6853b6a2340eea65ce878ccdc9506_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1ea7e387c13b48c89387b2d3d857caaa_D20190501-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="if754557c7cc244208d000f3659321df2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3e5a63582034b89b1c34575b648c5cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb9fd4579c41462aa90ba45e8a15a748_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib12b7654fd6c486c84790834f7e43479_I20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-04</instant>
        </period>
    </context>
    <context id="iae4f699d31404c7da2387e7912c12f8b_I20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-04</instant>
        </period>
    </context>
    <context id="i9e9d178090794fc6a66c5ddbb2103c9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">iart:CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie48f6bf8baeb442bbdf792d72242d8ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">iart:CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac4630e900f848359896b56b725b4778_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4078e47ac87f401e97eecd937cf9b64e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30fd64c1cb164ae0b2a907a07c1f841d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4207bdf79e8b43329423b675db80c712_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7337997e50724c52ad9348740bdd50dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i90fd6ad1a4554b1490ef3ec1f9cc90a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0fc4597fa28c4d28b01a34ea89b827b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a2a15098f6f43029cb4a63d99daaad7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id4a31a62be1b454f97664e2f38331c1b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13ba3f3fdc0e466ca5971c734c60c60f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieb65637da52f4b90bf607fb7b60c210d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0b4a664e6d9b4e52b3a3790429c82944_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0ff06dcd1f9e4d58b2040d6ef14e3b3f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1bb8e06d1a9b412091aa582f72d27809_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic8d2e95c76ae4a789dd053d9ce02580f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3046a6eaecf24960a1993adec9143348_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icb66154030084b3e8586a701e0a6bdb6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69a65713dfe64c33a00c72d8483e68a9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idb4f933be6cc44ff9ddec8c3d27cbf1c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic811b1a099e24c99825ca52914fcf541_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0ba7171afa8d4132b7dbe3ab5a4a60f8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if358055a698b49a2858282451967cd20_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66173391a20f4c668d46a6f1ce9e6d20_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c4278b9686c4d53aea7074968344102_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8a552626ffa247e6bf4b04926eff831f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic5734c3cfbd64dd99f45e59662837d44_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ideb8306c92f54514bfe2a9e21c1ef069_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4d1799cdfeb443c297cec0ede24b319e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1b76730b7e7f49afa097d63b1fb0577c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie57e505f7452456591a3ff162137393e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3269a9a9d0024d43b9f980a0524d7c42_I20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-04</instant>
        </period>
    </context>
    <context id="i170068c51ed94ca9bf2387c3ce7260fc_D20210104-20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ConsortiumofFocusedOrthopedistsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2021-01-04</endDate>
        </period>
    </context>
    <context id="i53b2addcbddb44aa9a3b86029bb50420_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96bd4fb9f9f845cfb6e003e78b8a9bc7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i40a2c7932fe4499294fbfb9e9cb7437f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica517bcfa6884ebc90de2aca64243203_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="ib985a5fa452f42faa4085adbfafaedf0_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="ia2e483bc15a0412aa43477e358585f01_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i39d90578eea04bf1b29ed35663a1802d_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i688db6d6eb2f458d8870fc231b4592c5_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i5f23076f31b3452e8dd0574aff2fb161_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a53bd10b62342d88e6811d75c05b920_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3b4a6c5eb0b434dba966ae4580828dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if70040a00764430ebf4558b0c9e06708_D20190729-20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-29</startDate>
            <endDate>2019-07-29</endDate>
        </period>
    </context>
    <context id="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="ic5615952a2a84ce48747f6e0a5b12e88_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i71e837488c6d40d2bae9b77a42432999_D20190729-20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-29</startDate>
            <endDate>2019-07-29</endDate>
        </period>
    </context>
    <context id="i4506a521f784464fab88c8e0a8d34c01_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i42a7d4331e424eb9b52d2c8d7ac98fcd_D20190729-20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-29</startDate>
            <endDate>2019-07-29</endDate>
        </period>
    </context>
    <context id="i4bcd02ade40d4716b1746fdd3cb2430d_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="ib8d9df81e2784a7f822f5902f3423b63_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i5f6f1a1544924074a1d3d7fb36a12a6d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieaad07293f494ff6889330b346414a47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i318b6e50656b461a91847e56aab39040_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i051d23eceb014bb58273d6270a8f1c00_D20190909-20190909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-09</startDate>
            <endDate>2019-09-09</endDate>
        </period>
    </context>
    <context id="i4878a7d091a8419aa9f27c3d38684f89_I20190909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-09</instant>
        </period>
    </context>
    <context id="i4528a498ca614d9ea547555427227000_D20190909-20190909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-09</startDate>
            <endDate>2019-09-09</endDate>
        </period>
    </context>
    <context id="i49e912b1fd87487785c228195b43bd1c_D20190909-20190909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-09</startDate>
            <endDate>2019-09-09</endDate>
        </period>
    </context>
    <context id="i33224855ef3047999b2cae3d50de0f11_D20190909-20190909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:DeferredTaxAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-09</startDate>
            <endDate>2019-09-09</endDate>
        </period>
    </context>
    <context id="ia442774231c74a88babc4cf70ca6a7b9_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i75ac54230bc045c6acdd9a962aabc8fa_D20190104-20190104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-04</startDate>
            <endDate>2019-01-04</endDate>
        </period>
    </context>
    <context id="i085349bc37c3476aa14e6828a4112638_I20190104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-04</instant>
        </period>
    </context>
    <context id="i1a85f0f4e699490aacc709f96ed3737a_D20190104-20190104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-04</startDate>
            <endDate>2019-01-04</endDate>
        </period>
    </context>
    <context id="ib718aecc355a42c295a29f73509ea5eb_D20210104-20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ConsortiumofFocusedOrthopedistsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:SmithNephewUSDLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2021-01-04</endDate>
        </period>
    </context>
    <context id="icc245d39ae2c4b37a89f9ea473650099_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="if9075dc4f5594e0a9117a256577a5b6b_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="i57c63b69e03f47ecbb9a8c336b5343f0_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="iad88d8e54f1a4e9a85100c26cb3cdf36_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="i1ab723a0be194e20ace108b34163128f_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">iart:SwinglineLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="i6c66ebe266dc49ae8c7b140c34de1997_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee59fc6ad5d745fd93819ab6849f2abd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i501b6a51ff0140a7b9405a6883ce1ffb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ce7dfab586d445cbad7c5ae7a2d0d70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie42c1e0337854c7dbbf20f4ae06610e9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i90140523e867471889b8f2498da45de1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i06c53d99c8f942b598357ebec22df68a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib08f50e95c0845a09194c11c67ff0227_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthEurodollarRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1b5855752106436d8e5833d80860bf2d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8815454edf87440f8ab1bc7d9bea226c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b35bf05794c4f92b13ccc87a4d842ce_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i22d3d9561a884d1f8123cf11213b6e4c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i04d1b0160d1340fd8ab66ecf51fa7a66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67999afc0f43421ba112b03ab3776e83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if7bb504d057d4468ac3701ee85921300_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4de4ab17ca14d19958b42305fcb9dba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iefe0207dab024691b9422a6871c2701c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i010dd7bd40794db0b97bdb8b4817314b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i75b71a62404445ecac16c98d28a6c859_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i11503d83ecb041bba066af755cc2923f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5c8f0f3fcc54d7fa864f05e7721631f_D20200204-20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-04</startDate>
            <endDate>2020-02-04</endDate>
        </period>
    </context>
    <context id="i9c7ea572f6ff408eb1c3e8b78cead270_I20201209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-09</instant>
        </period>
    </context>
    <context id="ia5fd639d6b434c4285a6fe944615d341_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i396d7f2eb0c64059b81baf2f22ba97ec_D20200204-20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-04</startDate>
            <endDate>2020-02-04</endDate>
        </period>
    </context>
    <context id="if6851222fe6b4433adf09a9809463a04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i55dda325db55443a874b0f8c37dd8b20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i532960b507734253829e73f26a86f856_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic8b32770839e412698beb581305b9b06_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07286d7fc74242cca19b206f52c0f370_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i241736141ce5441cbaf9b7d07be1bd2b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedMarch272017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27e95c8600d24f1788cde97b1a748f0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedMarch272017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e368b5fda0a476a8edcda24877e2d60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8bf07d7a40de4c22bd5f4ec2b7dc0864_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie632a54071064dd984a1daee5e94ea29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4f1a07697994a528de8da81d3b4a80d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0b97ff90e2648d49fb6e83da054fb38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4cbba29541b0414aa84fce8d3ab05e46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i288f3609bde4438a81832109716cd5a9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i26217e69841f4b5f865e6ddc9b644f61_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibca66931d2494db380dd96d37d92bc88_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65c0189ffb9a4e769aae035799d3163d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6bb1e3365e494ce89a0cf4822b064c93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac02b3f863ad479ab79142979d7cade1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4a132dddf0e4b05ab2279482233be48_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i35359b024a1d4f2a98e87757bfa30a29_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i65d7dee7ffe74d79a4e2144db55b55e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i532ebca746b94440a3ce52a9b1e41c55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b86f7b9c3c848fba14945777a7f742f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i378a39326c7c47a4b12de5edfddb468f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id11bfa4243b44471878dc05e0b04c5ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53695045753f4b0cb6d43100ea2c5b50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0dbe85e1e664ae9ac6dc86a82263629_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibcde00d2f9ee499c9b3f5bddea1dac4b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9f291ee98dcc4db0b65295c7cc02b534_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe5ea43d4f06427e8b8278ecc9d21984_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia6f9c05623734f95b308753dab91e2d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i834a7d0bdde0493b82362279698dc772_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3f34947eecd043ce89085543035baf6c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a00f578e1734e96abe9db9dd7e4d84d_I20171002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-02</instant>
        </period>
    </context>
    <context id="ie6c4104f081f4a0c97cc34bfa934b8de_I20171002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-02</instant>
        </period>
    </context>
    <context id="i0ed96b4baeca485d88d732479d36ee6f_I20201221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-21</instant>
        </period>
    </context>
    <context id="ie482bef356cf4e048602c1345e6faad1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic9225e7f823044678109956680d2a97a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i076d006aea244c84af07364f0b1ad64a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icb8fbe23f0de4b438088a04ce4c7f7cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1efb9a3c67d04590a34d8a19cd9e854a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i13f31b37f3ea4d8e97eec66b802e9e49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e5cde6835114b3da99ea43fe6947ed4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2fa44250f8ea494f9ec6201defd7694d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie0b9cf3906af44e588a43a37c9259020_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9abdd3860253449b9af0cf34bcbdeb85_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1d386cad6144838b3a92904df7a317c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5437d75eac6144cf88ae812aecc743aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4d2a0894b2040ba81435a39df496070_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0453195fa23e46d483cf46bd3e3de52a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73b0d274622045248510c3e54280fccf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2f46deba383407cb210dce486f3dcac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d35df157fe74d6e891907bc9031cca0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3f4cc639f144ce6ac3a87548c3b6c9c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a6242204a744c64a6389b0800b02769_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89d5d03c36334d73b8492d6c04b74983_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33ff7b9d006640f8938113069f4a6eff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee2b883defbc4b8f8ed1e8efbff9af9c_I20211004">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-04</instant>
        </period>
    </context>
    <context id="ib025dac64fea4558b2d30ed1bec0b8c1_I20201002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-02</instant>
        </period>
    </context>
    <context id="i4eeb4577960a4674b83a36fbcf56c4c1_D20201002-20201002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-02</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="i2a2aaff04d024dc4990e2909b24f4dd5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic969b2640c664168980604c5a20744f1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iabd46125a80f417e9a4465bdf1807227_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i524b9ebd90024ddabb8d0282eaf6a29c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i541aa942c51c4c4399d51d31e700938e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i940998b020714fa3b0888d72a26c1945_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3776583b04954a0e9da05addfc5f9705_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iccec1d91d0fd4f61b8eb3700cf25c835_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic25827b0d5bf448aa78483cc9a09b5a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i08c28720b7cf47028c76c53cbd46b11c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i368c248f3bd642508bc5c82fd4f9c3f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib09607d878144ab899b3843daa56b605_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc153a66697e473287846740951f472d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f8cf8b1ba584f49b4fa0e0a794f40bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id738386e38c0494ba6b7c0a2fb112f20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4c8e8a8213441a18c7cff8f5e3e651e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6e1dd1f4bbe4812bf8b694608c2ed2c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida4c9a65c572483cbd1edbbbd8df7265_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i594ae760b6c148209383a55f5e4e67d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2fecaa5319254b9986b2fe9d8c2e1da4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76c7948c2adf40bebaa47f086f3b7c41_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if753e7c4eee5471c9486881f13aa71b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id9b1f400a73c4c5fbdc2fc6cd85ecbbd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idd1fc1828d5040fbb20eb4d17854f200_D20210930-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifbeddf97b3b040cdb135d37c167dfb01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie589d17f3ce64923a38138283f3f843d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i62a55cb1537d47889d076d3c8f830a02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5007bda63f4a4e2b85d809ab3472888b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8d483b000704749b5f5f0eb38c92300_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if52dea29077a4f65adb78386228ccf13_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95418fcfcff14dcbb2439d47adcad59b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97de46c1ab694e2aa2d5f857600a53fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifac5dfc2c36d4dc3a7782ef005ce490b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id92cc86da652405da37174ac4bd32ab4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i447e91e51b6c484fb722708a563e3022_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i935a17c2069e4de2b906355e2084c604_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i694c78ee7c7447a6b3c35d7312afaff3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d737f4d7da848479653a6d886df97b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f58fb0074304c0eb75e1ee30a90496f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie4202a3390bb4daa9e7d55f6fbb4c9b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b3a469b84e14fa487772842b4758f1f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i244b53fa225146a8acddf34d0b484d40_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icef0348bbd6a498895aa0b839af063db_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1948e2d317241c495c217c582f1fd94_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0816d77ecc2a4d5ab1a7fdecd924c086_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib93f9ad9f3ac454ab3e4579cba214ea5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb37d7988ff2469883e023d54943ceeb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if15b603d0fdf4013bb65d3fbdef4991b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75b27d98cb6b453489a1a735b29fb883_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a049fa208ff4ab2bb36343f0be21bd6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if4857792c8c74e459972027dfdcb6655_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i138a2424e4fc4b28a990586217f205b5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1531f368d10d4c27aa41a904bfae834d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29855f0ec5bb4f3b88df4733138e0e6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6cd187ce19574cadad3a77fa3939be9c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i08216cb065b9461b8fe2a96e91b1fc10_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idba5aafc495241d195d5376e3caaf972_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib65c4a4a4cb943548bc313bbe81dab81_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5e6ebae6a0544329b7878caaf61f7c19_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7221c7b217944b9952cb1447ba40473_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida54b96ca0584539ae3b3b157470910b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2e2ac390bcfd4e6183936c3252ad179f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i554f5b5c47644e348d9ce91db90fc9b3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6cdda7c780084113bb71a011c3ec558b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8882f763c98a4445ad3da17239380121_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia478304e872e441bae733c20fd924acd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d649a29e36c49c1acac597e1b567b30_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iff47d977eef64f639713c2bdfe4ec819_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3c7bf1b9701f467ca31a33bccb2a8bd6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i751fe1d8d73549729e2da93079a949e7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6130dbfd55434e3ba87710002f62993d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7ac68eceebd454197e37a04d780f9b2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4abb8a070bc94419b02bdf48d4701704_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75ce8d6ec8224485834914549b9bdc7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2cb20ffbdee24ca9b4586a5cf126dba1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7778b95afae64e8cb2f805b44e496258_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93d465a35e4d4eabb157247c1091f1d7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i565486756b7249efbbaa382505163bde_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1252007ac54246de9abeebe0a6b2d8f2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icc306b5f7a374a95bf6db9885328d885_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae5ad95d43134ec6a2a3f3e3a0aaf4f7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i10c021d4850a4d869790819bbad3ae43_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i62f8ee36cb1e4ac58c021879c749533b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3234077932f2438296d701e72d5ffac3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0de13c4843ae43a09d39c8eb3d4b8fe4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9bbe1d90175a46fe8dfa0043b4527186_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic0bcf683f0a14720a1b91832c115533e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaeb0d8ccf2a044b79a58dfc3b65f8e15_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3edc297cbc6e43909b926332dfc8a2d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e32de5cf50a4cab9682cd23ec61237e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i04c114db065b4f4eb88c5a3d48995ddb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd79a69fcf5a4ee1bc04e02cbd130619_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i13a5de5444e140fc92fa01a15959c201_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i33f5557b4fd84457a5a5e3d5dcc1d9a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4475ac8a68ef47fb85a8578399b0bf14_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i737468523a6841bf8124822271ebf871_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a37880f41f64981a5fef9ddf9b77d0c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7c4b331f18ed42aba33f65f03aa1c992_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b58cefefc354ae79f2cb3074a62ea26_I20201207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2020-12-07</instant>
        </period>
    </context>
    <context id="ia20712ff79044b74a597c82e1faea48d_I20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-12</instant>
        </period>
    </context>
    <context id="i538c9dcc0e144b5ca4a9c2183db495d7_D20220112-20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-12</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="i899fa5b890ff487689edae2dc21aefef_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7a682151366145e6904be6c9c0346121_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1eedec01832141fbb14f413eb354531d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:CertainPurchasersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c54334459e24015b6e27d3a60186407_I20200205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2020-02-05</instant>
        </period>
    </context>
    <context id="i05515ce3d5484989bc6dd472a4eedeed_D20200205-20200205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-02-05</startDate>
            <endDate>2020-02-05</endDate>
        </period>
    </context>
    <context id="i8c6a1769495943b9b5d9b5d31e294c90_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1323b59618784a1fab24844213313e44_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4ef4bd774a64465bb9beb6cfda1cdbc9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i93981c800579497aaf2dd345c9d2a500_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i53a14816cfaa497fba679e918c9d17fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib3145669c89f4e22a4ae2186bc7b0142_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if60cbed693984bf4ac9378ff4177b4cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07b2805613624db19aac4968ce38ff27_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2b897ca4831342edaea566ae6b0cdc36_D20100501-20100531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-05-01</startDate>
            <endDate>2010-05-31</endDate>
        </period>
    </context>
    <context id="i26a65d8304ba448f91360ee062277da9_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="i584d7e4f3e034bb6aa9b60e07b8d05fe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib73b40adb8374cff8a251fef052acd84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13bb28aa1adf4576aeb1ec00d3e26d97_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5fff9ccde2f5438e83ff62797cae4f8d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i734854acf1ee4be8bf15f1abd93bfd07_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0e555d1eb8964644b65afbac50ffd7a1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia56133e3fe074f28993f1355c3a33e00_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie513c0771de143ca92523d08ff0e8443_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i929f1fd93be942479d2f584793b7dda6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8cc999d233cf40bc8ec03bb79a5c46af_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0213557267b54d06b2a34a0a8ebac7d6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i805f26cc2af34805ae2b1843c1cf9841_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa6e6cac04eb43cfbe239e917800016c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d007eaff7044bccb12fab7314f2acbc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2996160eb8934409898d8d620fe2717d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i06246f5086ac4c68bca11471e51b6e0f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id6371ddc8cc744adb4b34059dd3546dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59a4575819974e84b2e3ab5b22160dbf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1f25d0f4a8ff400f889dcdf76cc14f18_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i57f8fa208ea049e1801ad47d1e48dd52_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iece74e9f340746efb7bf12abd5b3f771_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic049e8c605994794a6b0cffa137659b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i37884f7fb85845bfb78ca42534df7c4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e17b5e38d9b4e68968d4ad4b693c479_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">iart:FranceAndGermanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ce740a3a7a74ecfb0d0952de3f48b37_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i362b521165e0418c9733b648915a160b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2c98fd68510e48b4a3b8d493e99cff78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f1da00ed5194d3681b3dfc0e0e27e6d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7de60faccb404da8a7dddec7331da235_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c2fbe33ab9a467d8b4133eedd8f7209_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50839ea5a7cc493fb5a6e6e76650da66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i029daea7b92e41a4bc3613610fa420e9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">iart:FiveYearOptionLeasePeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifaf346d6a89a4e7ea791875504218b91_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">iart:FiveYearLeasePeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9f63720b3c7e46459c42a7742e5a8136_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie99f5f90e3c34fc2b03a2184dd276704_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8271de19ce8942b7a5a6ac1978cb2a0c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ife5918aed5c1487692805e84f2c59330_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2d92855590d44b3b95dd1dc07dd512a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ea077a5d12f4d53afbcafb365160302_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a62d727286a47e8bee85dd137b2d0b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceSharesandRestrictedUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibbb8ffeeace8408783309370a8cc931b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2866d8b778aa44fe895f36a6d30cbdf5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8713e0cf33449019cc4cf84a4e3d77b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76189f48f3644d178eedea04bdbe9155_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i33b0eb0c48144061a9b7a61f90a00974_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6e53f5024f5b49708d10aea5ff725429_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia04c800bf5404c7b9232f7d4bc6754c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia77c775b70934877bc93a2298d93cb4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16240e1f2c9948f4bb47909f3308fa08_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia65ff802a8ad4a8eadd83dd25409c85b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia068e43763f9429bac4588f20427197f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2eab101e6425464cb1a382b10930b341_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic91d4b47894f4d7a96fcbf0bd64e0b77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a23d3b6fbf04e0390ce17338efbe5ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a9425a324d94f60bb5d946be181483a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iebd7836a15ac4b8b944cca235159afc0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2a46fda6cf2140edb1e670f70f41e243_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6aa77aab677c460cabbffe02b9267bf8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if1f3f919472d407284a8f3f85a6ed4d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e801d197ed5482db7634fd855e8728f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4252807040ee4349abee84d30b8c631b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25ef1e32c9ce4449a3b9050b6a0eb0a9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie6092d39074b47158db64e1a12d8002f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic89e76baba8646799816d81431077940_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i35e2f5b0e8cc4bb789f0d6856afb0e8d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i65e3f0df348d4cdbadb7cd4bfc901932_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c75bb71571a44fa91621f994d3c6236_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d8d2300006048a5856f3014db3d9faf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia320d69e30b449ea850f977af47c941a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifd2d3085810d47938abea6521730980b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i19abaf1be5a54d1cad2b918f942e1949_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f756bb0be9d4f989bfa36dadc8b61d1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d6343e390534664acd42ec3984442ea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98fc4020b8994f4587d792aaefced1fa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5b128710253a40d3b28600e3c705fdb6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieda682a36ee340289bb7f3a9602fabce_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icabd362120ba4ad89874c966b42f3fb2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iee33c44f27cc4e77b072623b9ba9c96b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i24453718685347bdbc8c3364e2bc9dd1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ec4766ff8b74bb2bbaa2ea51f38c98c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i33ba2e9dbfa94793bdffd7e52faa2682_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i53e08de3817440699e14abb26fa3b8c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9f1d90d19e9e4cdaa2643ef6b865abb2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i97aab3d9bc7649968f7bd24913cb99f3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if42f2680503f44fb8c7e794fb7e10a6d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3109fd420bc7439cae7cd959e1de8c73_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8ef83b8d6d124777b62a31b4e2684492_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b32cebb922d4397bba7d163b3b0f280_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4ef8247221b044978061dddd77b93c53_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4eed1f8c5f0645c891b92ba3cda138e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i922bc66b09174c569548f8ce0a89a406_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic33aa545fd0d4f1ea1f097ae92801f2e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie1119ac444814938a3b945328c7b101a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i56f905190bdc42abbc8fb75b81e146e4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i785fadf198a94822ad3bd70f37b63804_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i50142c614bbf430787c2956bba7a20e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i256baa22e9624220a6984e22db834aba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i019eb6b80cbd43b781098b4683f8f8ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e860ddce78e406f83a26966f4ed71d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i475c2989d2c1426fa24528e14601b247_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50cdb7226ffa49d2a639d7b8ce77fa33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i438e0780f85c42f9b797ba9e48948fd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1639642b327422bb89bec9a0b6728a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i901487c914b2405ba16f79b4bc6b4d8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6bf12c9378fe4261a4675d758ca41164_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4861d0427af7477a92dde072e3da72c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8831947c0944fa381c1aca73be705ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3324aa5df4cc4aa9956ed23a488056f5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i719d426fe5474f3c937a1a2698a52f36_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i095295915bc84f77b7412b41247d7e72_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifb8809409b6e47a485116299cbd2d2b2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ca3471c88c14eedbaed1fb2d38b42a4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i380c1d6ae64a4d0bb857dc194834acae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ied8b91f481774dfe8fc8d278e1b3b31d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i72bcc06055074e33b93d370ce18fa181_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id0e72938928e4ed1ad56b0e288505382_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ife0647d5414a46d1b2593bedad7c330f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>iart:Segment</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>iart:reporting_unit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="customer">
        <measure>iart:Customer</measure>
    </unit>
    <unit id="asset">
        <measure>iart:asset</measure>
    </unit>
    <unit id="chf">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="renewal_option">
        <measure>iart:renewal_option</measure>
    </unit>
    <unit id="product">
        <measure>iart:product</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF80L2ZyYWc6ZGYzYmRiZDI5OTc5NDY3N2IyN2FkMzZjZjhhNDEzZDgvdGFibGU6NWUyZTYzMTkyN2Q5NGFjNjk5OWFjMDNkMzJmYmY0NzEvdGFibGVyYW5nZTo1ZTJlNjMxOTI3ZDk0YWM2OTk5YWMwM2QzMmZiZjQ3MV80LTEtMS0xLTM3MzU2_a278279c-9cc9-41f7-9d8a-d70b53ac60dc">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF80L2ZyYWc6ZGYzYmRiZDI5OTc5NDY3N2IyN2FkMzZjZjhhNDEzZDgvdGFibGU6NWUyZTYzMTkyN2Q5NGFjNjk5OWFjMDNkMzJmYmY0NzEvdGFibGVyYW5nZTo1ZTJlNjMxOTI3ZDk0YWM2OTk5YWMwM2QzMmZiZjQ3MV82LTEtMS0xLTM3MzU2_047fc895-56c4-48ee-9afb-ac3e8a83552c">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF80L2ZyYWc6ZGYzYmRiZDI5OTc5NDY3N2IyN2FkMzZjZjhhNDEzZDgvdGFibGU6NWUyZTYzMTkyN2Q5NGFjNjk5OWFjMDNkMzJmYmY0NzEvdGFibGVyYW5nZTo1ZTJlNjMxOTI3ZDk0YWM2OTk5YWMwM2QzMmZiZjQ3MV83LTEtMS0xLTM3MzU2_23f68ca7-362e-4038-946c-c74c114773a1">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF80L2ZyYWc6ZGYzYmRiZDI5OTc5NDY3N2IyN2FkMzZjZjhhNDEzZDgvdGFibGU6NWUyZTYzMTkyN2Q5NGFjNjk5OWFjMDNkMzJmYmY0NzEvdGFibGVyYW5nZTo1ZTJlNjMxOTI3ZDk0YWM2OTk5YWMwM2QzMmZiZjQ3MV8xMC0xLTEtMS0zNzM1Ng_f6897fb0-1c2a-4b0f-a2c3-572d59a354c7">0000917520</dei:EntityCentralIndexKey>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY0LTAtMS0xLTM3MzU2_6ec0d2c1-0137-4ab4-bbb6-a370369c6602">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI0LTAtMS0xLTQ0OTI1_bdbd4380-9fca-40b5-9280-10467d59cd85">http://integralife.com/20211231#AccountingStandardUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod
      contextRef="i8fd7b7f49417402eb284796a7134d501_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI0Mzcw_c9172610-6a8d-4dac-b8b3-a0c0563d676b">P1M</iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i7337997e50724c52ad9348740bdd50dd_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzEtMS0xLTEtMzczNTY_b961867a-71fb-4764-b9a4-99488b80bc14">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i90fd6ad1a4554b1490ef3ec1f9cc90a8_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzItMS0xLTEtMzczNTY_eec7de4f-0eee-4729-adc8-ea5fcf54fd24">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i0fc4597fa28c4d28b01a34ea89b827b8_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzMtMS0xLTEtMzczNTY_99571667-1b63-4a3e-a336-0e78ac74db64">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i4a2a15098f6f43029cb4a63d99daaad7_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzQtMS0xLTEtMzczNTY_66809f6d-514f-4562-826f-341e9f94e75a">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="id4a31a62be1b454f97664e2f38331c1b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzUtMS0xLTEtMzczNTY_b0f51d2c-ec0d-4bd5-8366-0719f296cb83">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i13ba3f3fdc0e466ca5971c734c60c60f_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTEvZnJhZzoxYzU5NWQ3NzgwMDQ0ZDVmOTAzYzE3NjE5OWEyYzdlNC90YWJsZTo5YWIzOTcwZDQ5Mjk0M2I2OGJhNGQ0ZGQzNGVhNWE1Mi90YWJsZXJhbmdlOjlhYjM5NzBkNDkyOTQzYjY4YmE0ZDRkZDM0ZWE1YTUyXzYtMS0xLTEtMzczNTY_2ce8f71b-8e6d-4240-8b0a-c69b54b852ae"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ia56133e3fe074f28993f1355c3a33e00_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIyNDc_dac495da-8c41-4f99-8dc2-4cfbd78ca20b">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzItMS0xLTEtMzczNTY_fd4c8e09-f463-4c49-b107-fff01ea79bc5"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzItMi0xLTEtMzczNTY_ccdec38d-87a2-47ae-b3cc-7020e352a786"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzItMy0xLTEtMzczNTY_cdb9c4fe-3698-4110-9b5b-8436bd2a93dd"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzMtMS0xLTEtMzczNTY_2fb32828-6cea-4c91-8dd2-1e95446b2162"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzMtMi0xLTEtMzczNTY_d32fc6f3-1fd9-4a24-be16-fb60c2997655"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="ie55084e91d494776891870a81ff5cb91_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODEvZnJhZzo1YjlmN2E3MDQ1NTE0ODE4OTEzNGYzOWMxMmYyNzhkZi90YWJsZTo0YjFjZWRhMzgwZjA0NWM2YTM5YjIwZGUyYWIwOTVjYy90YWJsZXJhbmdlOjRiMWNlZGEzODBmMDQ1YzZhMzliMjBkZTJhYjA5NWNjXzMtMy0xLTEtMzczNTY_c0b91fa1-eae3-4b8b-a288-8dc9093ef96c"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <dei:DocumentType
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTYw_0fee8d71-d1a9-4f38-8824-6c63f6b7cf00">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6YzA1MjdhZDNhMmJiNDU2MDlkMWU1YzJmOTAxMzMyM2MvdGFibGVyYW5nZTpjMDUyN2FkM2EyYmI0NTYwOWQxZTVjMmY5MDEzMzIzY18wLTAtMS0xLTM3MzU2_f3408716-7179-4e3c-a85c-00e53c362fbb">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18xMzA_ddc75e72-9cce-4ef5-afc2-2d9fcb4b7b4a">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18xMzA_ad0b90cb-a361-4d66-b42a-70f294f9cd9b">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6NGNiMjJlNDMyMzBhNDQ5YTllZWI2NTUzOTM5MjU1NDAvdGFibGVyYW5nZTo0Y2IyMmU0MzIzMGE0NDlhOWVlYjY1NTM5MzkyNTU0MF8wLTAtMS0xLTM3MzU2_b89b2864-1ffd-4625-9dd0-66c1fa258ea2">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU4_7bd594cf-fc5c-43c8-a15c-d625be58e238">0-26224</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU5_056ff660-acd9-41ee-9cb1-f666ecd9e9cf">INTEGRA LIFESCIENCES HOLDINGS CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM18wLTAtMS0xLTM3MzU2_1fb54de2-57e7-4a39-936c-ef618727325d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM18wLTQtMS0xLTM3MzU2_0212221d-b0c8-4363-a77e-c765b7ef40a2">51-0317849</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM18zLTAtMS0xLTM3MzU2_ce8cf9cc-28a6-42b9-80c2-f3e1205e6ca4">1100 Campus Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM18zLTQtMS0xLTM3MzU2_895a2151-3717-4193-9485-44f9ae47a519">08540</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM180LTAtMS0xLTM3MzU2_86e18a63-faea-47c3-b648-4f21df7c71bb">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6ZGY4YWQyMzQwN2RjNDk5Njg1NzJhNzBiNzk4ODBiMjMvdGFibGVyYW5nZTpkZjhhZDIzNDA3ZGM0OTk2ODU3MmE3MGI3OTg4MGIyM180LTItMS0xLTM3MzU2_3413b4e1-5292-47a5-bf24-ca0ad04f908b">NJ</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU0_34c2c74b-1932-4e76-989b-d9d2aa359f11">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTUy_d0f27d8e-4dec-4caf-8f52-ec654761df8b">275-0500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Njg1MWQ5YzM5YTVjNGQ5YWIxNmJhYjVkNmRmMDBkZTkvdGFibGVyYW5nZTo2ODUxZDljMzlhNWM0ZDlhYjE2YmFiNWQ2ZGYwMGRlOV8xLTAtMS0xLTM3MzU2_69f56463-94a2-4cdd-971e-f29c9dbb706e">Common Stock, Par Value $.01 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Njg1MWQ5YzM5YTVjNGQ5YWIxNmJhYjVkNmRmMDBkZTkvdGFibGVyYW5nZTo2ODUxZDljMzlhNWM0ZDlhYjE2YmFiNWQ2ZGYwMGRlOV8xLTEtMS0xLTM3MzU2_6853a573-5a33-4b3b-b69c-c581bfe8d290">IART</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Njg1MWQ5YzM5YTVjNGQ5YWIxNmJhYjVkNmRmMDBkZTkvdGFibGVyYW5nZTo2ODUxZDljMzlhNWM0ZDlhYjE2YmFiNWQ2ZGYwMGRlOV8xLTItMS0xLTM3MzU2_0bd08706-66b4-48b8-b14b-fd94e2e40ec0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU1_e64436d7-e169-469b-beed-2b15a91777f1">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTUz_57121dc4-3368-40ec-a7f5-683f769ce2be">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU2_f0cee17f-a968-406f-aad8-62dca00e7dfd">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTQ5_1d50649a-e002-40df-93be-61d03f605eae">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Yzg4MzczOTYwN2U0NDk1OTg5MDY0MWQ3ZTM3Y2IxMjQvdGFibGVyYW5nZTpjODgzNzM5NjA3ZTQ0OTU5ODkwNjQxZDdlMzdjYjEyNF8wLTAtMS0xLTM3MzU2_a7ae2036-02a7-4e51-80b9-a6d18cbcc389">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Yzg4MzczOTYwN2U0NDk1OTg5MDY0MWQ3ZTM3Y2IxMjQvdGFibGVyYW5nZTpjODgzNzM5NjA3ZTQ0OTU5ODkwNjQxZDdlMzdjYjEyNF8yLTMtMS0xLTM3MzU2_4b0139af-8909-45ed-a12e-a1a5f19f2241">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGFibGU6Yzg4MzczOTYwN2U0NDk1OTg5MDY0MWQ3ZTM3Y2IxMjQvdGFibGVyYW5nZTpjODgzNzM5NjA3ZTQ0OTU5ODkwNjQxZDdlMzdjYjEyNF80LTEtMS0xLTM3MzU2_ac7564f8-3ede-46f9-a6c6-ca9769161bb3">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTUw_2fbd7860-ed38-4425-978d-ada608f256bd">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTUx_7f391515-c9ae-4433-9066-df89ced2acf2">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i45e7724895184fdf85404aad41aa5196_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18yNzA2_95af12b0-9916-45c6-8bbe-3c2518386f01"
      unitRef="usd">4968600000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib54412ab095545838988a468e37768bb_I20220222"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18yOTIz_bb3db555-5877-4822-bcf6-600d4c081b18"
      unitRef="shares">83243031</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xL2ZyYWc6MjA5ZjgxODAwNjI5NDQ1MDgyMTU4NTMwNmQwZWQyNGMvdGV4dHJlZ2lvbjoyMDlmODE4MDA2Mjk0NDUwODIxNTg1MzA2ZDBlZDI0Y18zMTU3_5c81119f-2426-4d1e-899f-226465ed6f7e">Certain portions of the registrant&#x2019;s definitive proxy statement relating to its scheduled May&#160;13, 2022 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMDYvZnJhZzo4YzEzZWI1NGE4Njc0MWI5OWZkZjY4N2U3MDQyZDQxMS90YWJsZTo5YzRhN2Y1ZGE1MTg0YjY0YTE0OTc4YTNjNWJlMzc4MS90YWJsZXJhbmdlOjljNGE3ZjVkYTUxODRiNjRhMTQ5NzhhM2M1YmUzNzgxXzAtMC0xLTEtNzYwMTIvdGV4dHJlZ2lvbjo4OGJkNGQzNzFmZWE0NTg3OWNkMjEyYWEzMDdkYmU3Ml8yMTk5MDIzMjU2MDA4_29d9d56a-8169-4849-8dcc-e5dc5b10e784">238</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMTgvZnJhZzphZWM1NDdiZGJkMDI0ZGE3ODBkZjNhZGMxZTIwZTY1YS90ZXh0cmVnaW9uOmFlYzU0N2JkYmQwMjRkYTc4MGRmM2FkYzFlMjBlNjVhXzIxOTkwMjMyNjg4MzI_77ee0b54-8b5c-4f25-bdb1-c78541097b88">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMTgvZnJhZzphZWM1NDdiZGJkMDI0ZGE3ODBkZjNhZGMxZTIwZTY1YS90ZXh0cmVnaW9uOmFlYzU0N2JkYmQwMjRkYTc4MGRmM2FkYzFlMjBlNjVhXzIxOTkwMjMyNjg4MzM_150a39d3-23cf-420e-bade-6b930a947fd6">Florham Park, New Jersey</dei:AuditorLocation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzMtMS0xLTEtMzczNTY_9c0fe8bc-b023-4b59-afdb-e50827695e67"
      unitRef="usd">1542448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzMtMy0xLTEtMzczNTY_3748225b-ff59-4b8b-af34-46b1437d5152"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzMtNS0xLTEtMzczNTY_bf216d91-e173-4981-ae78-26efeea4f7c6"
      unitRef="usd">1517557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzUtMS0xLTEtMzczNTY_dde5b738-1b06-45e8-bbf3-44cb90207b58"
      unitRef="usd">597808000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzUtMy0xLTEtMzczNTY_b4157ad8-f32c-48a9-81ff-8e799bd52ed1"
      unitRef="usd">520834000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzUtNS0xLTEtMzczNTY_5fc3d880-f342-4316-9e91-de6118903b14"
      unitRef="usd">564681000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzYtMS0xLTEtMzczNTY_ec918f4a-b2ac-4cea-bb99-4fa5ce6c5fa4"
      unitRef="usd">93051000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzYtMy0xLTEtMzczNTY_8b779dab-aa6f-4952-b154-19ff6eb2ff4e"
      unitRef="usd">77381000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzYtNS0xLTEtMzczNTY_389fd93f-40c0-4a84-8abf-26f870f3f9ec"
      unitRef="usd">79573000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzctMS0xLTEtMzczNTY_57410944-18a6-4c2b-aac5-2004f92df403"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzctMy0xLTEtMzczNTY_33d1248e-4abb-49bb-8b2b-0e333c9aec48"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzctNS0xLTEtMzczNTY_5b586692-6731-4a03-b3b3-217fafc52f6c"
      unitRef="usd">64916000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzgtMS0xLTEtMzczNTY_4da5f674-d183-4d10-8a41-29f77e7594d3"
      unitRef="usd">637445000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzgtMy0xLTEtMzczNTY_c20f9d72-afeb-4f11-8e6d-deea44ea753c"
      unitRef="usd">594526000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzgtNS0xLTEtMzczNTY_ea2432c2-9836-426f-bb73-fbbbd9d3bde2"
      unitRef="usd">687599000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzktMS0xLTEtMzczNTY_ba7c1b39-2c16-45ad-ad16-715920b6e11c"
      unitRef="usd">16914000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzktMy0xLTEtMzczNTY_473b981d-3c68-4d03-ad2e-e92aaecdebd3"
      unitRef="usd">27757000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzktNS0xLTEtMzczNTY_6c920591-a5dd-45e6-855c-4f6958773744"
      unitRef="usd">27028000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:CostsAndExpenses
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEwLTEtMS0xLTM3MzU2_a2558b2f-6ea7-436a-8ca6-6decf28fea1c"
      unitRef="usd">1345218000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEwLTMtMS0xLTM3MzU2_a59f2f9c-2b15-4f95-a2f6-86c58c94e065"
      unitRef="usd">1220498000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEwLTUtMS0xLTM3MzU2_cd45d67a-c2be-4883-8163-ea5616eab96e"
      unitRef="usd">1423797000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzExLTEtMS0xLTM3MzU2_45509487-d9cd-4bcd-967d-b45f438e098a"
      unitRef="usd">197230000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzExLTMtMS0xLTM3MzU2_19c9b7f4-2fc6-4856-b9fa-5eb93581c70c"
      unitRef="usd">151370000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzExLTUtMS0xLTM3MzU2_f9aa681a-ee82-42ea-8bee-15ab2cc7c076"
      unitRef="usd">93760000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEyLTEtMS0xLTM3MzU2_33adeaf0-1a7e-42ef-9571-e1ab133ec548"
      unitRef="usd">6737000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEyLTMtMS0xLTM3MzU2_21b9141b-619f-4f27-94e2-9a4d09bd77bb"
      unitRef="usd">9297000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEyLTUtMS0xLTM3MzU2_37f6a536-4dcd-42bd-8467-903ff19fd9b1"
      unitRef="usd">10779000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEzLTEtMS0xLTM3MzU2_5f3c8619-00cd-411b-b811-d8e228eaf8ed"
      unitRef="usd">50395000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEzLTMtMS0xLTM3MzU2_2f90a9a0-61dd-4d41-bcf3-d07da0f1b417"
      unitRef="usd">71581000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzEzLTUtMS0xLTM3MzU2_82704e08-28b8-4e57-a0be-58e3927163f2"
      unitRef="usd">53957000</us-gaap:InterestExpense>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTEtMS0xLTQxMDM2_079d6816-7197-41bd-a674-39ddab397d33"
      unitRef="usd">41798000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTMtMS0xLTQxMDM2_9b4193a6-0e2e-4710-a8c1-cae6c6445515"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTUtMS0xLTQxMDM2_d078bfa6-051e-494b-8372-b584a705efbe"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTEtMS0xLTM3MzU2_f398d0c8-0046-472c-8c10-ae8ecf25b136"
      unitRef="usd">19307000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTMtMS0xLTM3MzU2_eb0969b4-bcc5-48bf-9c79-1d2c6fd72f99"
      unitRef="usd">4434000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE0LTUtMS0xLTM3MzU2_1adc2106-19ad-44c7-b01a-fa7311740137"
      unitRef="usd">9522000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE1LTEtMS0xLTM3MzU2_f495f8b2-c0ae-4f2d-aa59-7b6a384c5db5"
      unitRef="usd">214677000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE1LTMtMS0xLTM3MzU2_5755b2c9-4013-49a4-bda6-f4da205fb69c"
      unitRef="usd">93520000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE1LTUtMS0xLTM3MzU2_9e50b69f-49b6-46cb-a915-288a7fc42838"
      unitRef="usd">60104000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE2LTEtMS0xLTM3MzU2_19e41614-e81b-48d9-a833-a848da3a92ea"
      unitRef="usd">45602000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE2LTMtMS0xLTM3MzU2_1e078ada-35b2-4b1e-8561-9933c66c1210"
      unitRef="usd">-40372000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE2LTUtMS0xLTM3MzU2_045267ec-c9e9-42ed-b375-eccaf4c9e07f"
      unitRef="usd">9903000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE3LTEtMS0xLTM3MzU2_010a1aac-f3e7-480b-b9c0-3e38bee12dd9"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE3LTMtMS0xLTM3MzU2_61d14b8f-7ea3-4bcf-9fcd-1a3a583c68c0"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzE3LTUtMS0xLTM3MzU2_7ff5c49d-c69a-4fe7-9ca4-1032382fb84b"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIwLTEtMS0xLTM3MzU2_4d8cb632-b45d-427c-a276-2c475fe8d75c"
      unitRef="usdPerShare">2.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIwLTMtMS0xLTM3MzU2_b736ce50-ec1a-4ca5-af4c-213507bf8ea2"
      unitRef="usdPerShare">1.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIwLTUtMS0xLTM3MzU2_15ca3c33-c8d4-441d-b698-0d02eaa912da"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIxLTEtMS0xLTM3MzU2_68b6f7c9-c02e-49e8-9671-a240869bb523"
      unitRef="usdPerShare">1.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIxLTMtMS0xLTM3MzU2_cbadbdc5-8895-480e-b2f3-802d33625b11"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzIxLTUtMS0xLTM3MzU2_6e591b03-6bd8-4cda-91d2-45e6fd943f94"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI0LTEtMS0xLTM3MzU2_efda8698-26d2-4a5c-8263-9ad07934d49f"
      unitRef="shares">84698000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI0LTMtMS0xLTM3MzU2_23ad5004-ce4c-44ce-b496-14b1b63d1dad"
      unitRef="shares">84650000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI0LTUtMS0xLTM3MzU2_36ec26c1-f18f-45d1-9627-8612b6bb1ddc"
      unitRef="shares">85637000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI1LTEtMS0xLTM3MzU2_753514ad-0bcc-4f6a-be34-dc0c2ea71bbe"
      unitRef="shares">85485000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI1LTMtMS0xLTM3MzU2_72adb584-ff2d-4daf-8aa9-611ceedbb1bc"
      unitRef="shares">85228000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjEvZnJhZzpmNzQ0MmVkN2JjNTA0ZjNhYWM5MzFiZjc3OTUxYjEzNS90YWJsZTo5N2I1M2I2MjU1NDQ0MmU5OWQ2NTg3Y2FlNjAzZmQyMy90YWJsZXJhbmdlOjk3YjUzYjYyNTU0NDQyZTk5ZDY1ODdjYWU2MDNmZDIzXzI1LTUtMS0xLTM3MzU2_a78ab3d5-b892-48e1-ae63-6b1239af7ad9"
      unitRef="shares">86494000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzMtMS0xLTEtMzczNTY_e059439a-058f-49b5-b9c0-882386bbc556"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzMtMy0xLTEtMzczNTY_d8ef166d-0b3b-420f-9585-223c3f51b156"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzMtNS0xLTEtMzczNTY_f7930b59-9c02-43a0-a018-ff4d7ec758da"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzUtMS0xLTEtMzczNTY_6ba8b297-d04f-431f-863e-4b70f2409285"
      unitRef="usd">-17362000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzUtMy0xLTEtMzczNTY_72ea65c3-9b9e-4104-9743-a58e27a6ddec"
      unitRef="usd">53363000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzUtNS0xLTEtMzczNTY_5e2989aa-75fe-48c9-a08b-2893a90275c5"
      unitRef="usd">-174000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzgtMS0xLTEtMzczNTY_66fcd906-0426-4cc6-9c77-743c7ca800d6"
      unitRef="usd">68192000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzgtMy0xLTEtMzczNTY_835515f0-b886-4a2d-8b0a-fea59f398e09"
      unitRef="usd">-96837000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzgtNS0xLTEtMzczNTY_782b5c7b-061b-4a8f-b24f-44ee48c79f04"
      unitRef="usd">-13671000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzktMS0xLTEtMzczNTY_a53c35b7-9ed2-45bf-bd5f-1c76adca38d6"
      unitRef="usd">17024000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzktMy0xLTEtMzczNTY_1aa5e58b-6f8c-409f-a3fe-be91e46b9f27"
      unitRef="usd">-24442000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzktNS0xLTEtMzczNTY_4e696de2-ad25-46f7-a87e-adf9db8b13f4"
      unitRef="usd">14865000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEwLTEtMS0xLTM3MzU2_74a98720-1f21-4575-9459-7a26324a2191"
      unitRef="usd">51168000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEwLTMtMS0xLTM3MzU2_a26b452b-ab2c-4a2a-8257-837865fde3eb"
      unitRef="usd">-72395000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEwLTUtMS0xLTM3MzU2_d0e8798d-be7a-4b30-9cf3-c5a11a21357f"
      unitRef="usd">-28536000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEyLTEtMS0xLTM3MzU2_ab7b6818-ae0d-435b-9a05-6ba59639e8b6"
      unitRef="usd">6998000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEyLTMtMS0xLTM3MzU2_4c390c8b-f559-4bc6-a88c-5f0c281b349f"
      unitRef="usd">4604000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzEyLTUtMS0xLTM3MzU2_3555adf3-9476-40be-841b-0f367133d074"
      unitRef="usd">-8973000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE0LTEtMS0xLTM3MzU2_f9fca5e4-c387-43c9-a40b-0820e277e220"
      unitRef="usd">40804000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE0LTMtMS0xLTM3MzU2_73cf7255-f7a4-465c-8e87-c042ef493ab6"
      unitRef="usd">-14428000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE0LTUtMS0xLTM3MzU2_976ad470-46a0-4177-ab88-73b5863330bc"
      unitRef="usd">-37683000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE1LTEtMS0xLTM3MzU2_9b84ecc4-fe9d-430b-b9df-c38bb08e47e4"
      unitRef="usd">11900000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE1LTMtMS0xLTM3MzU2_fd167fd1-32d3-482f-8402-6c84d1fefb73"
      unitRef="usd">-16771000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE1LTUtMS0xLTM3MzU2_1adabc37-199c-4d47-a56d-5a559648c74e"
      unitRef="usd">-6724000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE2LTEtMS0xLTM3MzU2_859f77f2-b5ca-468b-a144-a67f92f8247e"
      unitRef="usd">28904000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE2LTMtMS0xLTM3MzU2_a7b14da8-abb6-4854-afdd-7a4e93ba84aa"
      unitRef="usd">2343000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE2LTUtMS0xLTM3MzU2_87053293-f5ec-4ef5-9a21-243814065065"
      unitRef="usd">-30959000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE4LTEtMS0xLTM3MzU2_81abfcda-6b1d-4510-b882-309f1e05fabe"
      unitRef="usd">197979000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE4LTMtMS0xLTM3MzU2_77fccaa0-cbe7-43bd-b4a1-1ff8987a4c1d"
      unitRef="usd">136235000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjQvZnJhZzphYmM0ZmFiYzZjNTM0NDgyYjM4MDhkZGYyMGViODM0My90YWJsZToxYjMxNDg0ZWUwZTc0NjI1YmQ1MWEwM2I4NDY3YjdhNS90YWJsZXJhbmdlOjFiMzE0ODRlZTBlNzQ2MjViZDUxYTAzYjg0NjdiN2E1XzE4LTUtMS0xLTM3MzU2_a39f36cf-0406-42e3-9e65-25701ab93609"
      unitRef="usd">19242000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUtMS0xLTEtMzczNTY_8ec24312-e0b6-42fa-8b70-c1a8bbdd52e0"
      unitRef="usd">513448000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUtMy0xLTEtMzczNTY_0c875370-750d-4077-9ae8-35bcbc96ccd0"
      unitRef="usd">470166000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzctMC0xLTEtMzczNTYvdGV4dHJlZ2lvbjpjYjI4NDVhZjI1MWY0ZTg0ODljZjlkMmIzMDk2MDM1MV81Mg_3909b1b3-082d-4b90-85b6-97185fc67148"
      unitRef="usd">4735000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzctMC0xLTEtMzczNTYvdGV4dHJlZ2lvbjpjYjI4NDVhZjI1MWY0ZTg0ODljZjlkMmIzMDk2MDM1MV81OQ_bad69b84-f389-45f3-9526-95750f72cb46"
      unitRef="usd">6439000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzctMS0xLTEtMzczNTY_3f0d8ab8-af77-4ced-a2d4-1ea243ae4c28"
      unitRef="usd">231831000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzctMy0xLTEtMzczNTY_496a4ec8-116e-4104-8974-02640afeb603"
      unitRef="usd">225532000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzgtMS0xLTEtMzczNTY_14d73a76-6678-4227-b7a4-37ceb2583aaa"
      unitRef="usd">317386000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzgtMy0xLTEtMzczNTY_b658d75e-6724-4313-8878-468708dba80a"
      unitRef="usd">310117000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzExLTEtMS0xLTM3MzU2_12558d2c-9bb6-4771-bd50-e93c0f656dcd"
      unitRef="usd">91051000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzExLTMtMS0xLTM3MzU2_3b293bc1-363e-4542-8f14-52f8f30fa987"
      unitRef="usd">69282000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzktMS0xLTEtNDE0MDk_e9b7a374-f6e7-4971-ad50-744701af0253"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzktMy0xLTEtNDE0MDk_98342178-0c49-4f24-a713-0724b82c8c99"
      unitRef="usd">162105000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzEzLTEtMS0xLTM3MzU2_08207cc8-7839-4109-9d83-7fb3c7e6a25f"
      unitRef="usd">1153716000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzEzLTMtMS0xLTM3MzU2_a379eed7-07d0-40ab-89c2-3fbcc4d64d96"
      unitRef="usd">1237202000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE0LTEtMS0xLTM3MzU2_43450ba0-f3b0-451e-ba47-4ced4c795b42"
      unitRef="usd">311703000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE0LTMtMS0xLTM3MzU2_4f4f7e8d-fdcf-4efb-b571-8e68c6ddd1b1"
      unitRef="usd">287529000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE1LTEtMS0xLTM3MzU2_3925339a-3cb8-43ae-87eb-2250742d1887"
      unitRef="usd">84543000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE1LTMtMS0xLTM3MzU2_49969103-4dee-4e58-bfd0-3c838c8f6608"
      unitRef="usd">83635000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE2LTEtMS0xLTM3MzU2_529300f0-74ed-41dd-aceb-c6d3fd52e336"
      unitRef="usd">1145573000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE2LTMtMS0xLTM3MzU2_2102893d-3ef5-462d-a1b2-e82c7eb88be4"
      unitRef="usd">989436000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE3LTEtMS0xLTM3MzU2_4d31c30e-ae58-4b08-ab55-29e98d1d8a9c"
      unitRef="usd">1013458000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE3LTMtMS0xLTM3MzU2_5f5272a5-f441-41fd-a425-327f5eb97dbe"
      unitRef="usd">932367000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE4LTEtMS0xLTM3MzU2_3652021b-885a-45b0-a2c9-2b12e881c88c"
      unitRef="usd">56950000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE4LTMtMS0xLTM3MzU2_a908c16f-441f-4cf7-b612-dcb34d740392"
      unitRef="usd">73690000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE5LTEtMS0xLTM3MzU2_c90d6740-d0b2-4fdc-bb39-3f5548df61c0"
      unitRef="usd">16440000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzE5LTMtMS0xLTM3MzU2_dbb1436d-0fad-4319-92b4-243a9789b59d"
      unitRef="usd">11277000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzIxLTEtMS0xLTM3MzU2_93b0ffb6-3d9a-4bf0-b749-fc9ec40e68a1"
      unitRef="usd">3782383000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzIxLTMtMS0xLTM3MzU2_1b09c6ea-ce9f-4525-9789-925729aa2b42"
      unitRef="usd">3615136000</us-gaap:Assets>
    <us-gaap:SecuredDebtCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI0LTEtMS0xLTM3MzU2_d69fee85-a8b7-4757-a8a9-64292dedc187"
      unitRef="usd">45000000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI0LTMtMS0xLTM3MzU2_c08dde1f-fd3c-468a-8501-f63e1f806a6b"
      unitRef="usd">33750000</us-gaap:SecuredDebtCurrent>
    <iart:SecuredLongTermDebtSecuritizationProgramCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI1LTEtMS0xLTM3MzU2_c2e75448-7977-4518-a408-16aafe3b4880"
      unitRef="usd">0</iart:SecuredLongTermDebtSecuritizationProgramCurrent>
    <iart:SecuredLongTermDebtSecuritizationProgramCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI1LTMtMS0xLTM3MzU2_fdb257a5-8f65-47f7-8a48-4da97853586e"
      unitRef="usd">112500000</iart:SecuredLongTermDebtSecuritizationProgramCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI2LTEtMS0xLTM3MzU2_936a9a68-3a79-4667-912f-35e4b1922aeb"
      unitRef="usd">14775000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI2LTMtMS0xLTM3MzU2_13cfdc05-90f0-4e5c-b6d4-fba5553314c1"
      unitRef="usd">12818000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI3LTEtMS0xLTM3MzU2_1c27b9db-48eb-427e-99b7-131d8a1e45aa"
      unitRef="usd">61837000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI3LTMtMS0xLTM3MzU2_32721898-cc01-4983-a7ed-530ce5b40a2d"
      unitRef="usd">54608000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI4LTEtMS0xLTM3MzU2_9abb5f57-1e01-4770-a722-fa423dc5c389"
      unitRef="usd">5295000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI4LTMtMS0xLTM3MzU2_2661c774-8524-4645-b2e5-86edaaa1eb9f"
      unitRef="usd">5275000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI5LTEtMS0xLTM3MzU2_5d22e686-e82c-41b8-bdbe-79a8295f5c14"
      unitRef="usd">92656000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI5LTMtMS0xLTM3MzU2_51a6e2e4-5b67-4493-9bca-dd37cd38717c"
      unitRef="usd">76117000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzMxLTEtMS0xLTM3MzU2_2cdc2a78-c46d-4575-be74-e775500eee19"
      unitRef="usd">120458000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzMxLTMtMS0xLTM3MzU2_79a8d48e-f72d-4ffe-9b0c-80ef56ef119d"
      unitRef="usd">94194000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI4LTEtMS0xLTQxNTA3_00cecc05-1339-4afe-a3eb-ee039dc01ba9"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzI4LTMtMS0xLTQxNTA3_7385e369-9db2-41da-8c3b-6ca9ccd8024d"
      unitRef="usd">11751000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM0LTEtMS0xLTM3MzU2_e44930fe-1405-4c63-a62e-7c7885fd412d"
      unitRef="usd">340021000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM0LTMtMS0xLTM3MzU2_1ee34024-8df1-417e-a841-317f1dcb7902"
      unitRef="usd">401013000</us-gaap:LiabilitiesCurrent>
    <us-gaap:SecuredLongTermDebt
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM1LTEtMS0xLTM3MzU2_c1f81e34-5e4f-46c0-af51-73deb5ea4588"
      unitRef="usd">824257000</us-gaap:SecuredLongTermDebt>
    <us-gaap:SecuredLongTermDebt
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM1LTMtMS0xLTM3MzU2_7b861e2f-2bf4-4153-bcef-6f0259e866a7"
      unitRef="usd">933387000</us-gaap:SecuredLongTermDebt>
    <iart:SecuredLongTermDebtSecuritizationProgramNoncurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM2LTEtMS0xLTM3MzU2_4d9c8d2a-1987-46ee-9dc8-2421d1f7e5d9"
      unitRef="usd">112500000</iart:SecuredLongTermDebtSecuritizationProgramNoncurrent>
    <iart:SecuredLongTermDebtSecuritizationProgramNoncurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM2LTMtMS0xLTM3MzU2_6c37ba17-ed68-4740-b02c-ec46e0788970"
      unitRef="usd">0</iart:SecuredLongTermDebtSecuritizationProgramNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM3LTEtMS0xLTM3MzU2_a9a0a035-0f46-4989-8ae6-6f82c9b00af7"
      unitRef="usd">564426000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM3LTMtMS0xLTM3MzU2_8f10e064-013a-4983-86c4-bb72d18f7409"
      unitRef="usd">474834000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM4LTEtMS0xLTM3MzU2_3117f6f3-3d4e-4b2a-99df-487718a2ace4"
      unitRef="usd">90329000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM4LTMtMS0xLTM3MzU2_4d4ca4b8-fdbd-4d91-b486-2543a042067f"
      unitRef="usd">88118000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM5LTEtMS0xLTM3MzU2_85c12459-e43d-4cc2-a105-02b9ee299e96"
      unitRef="usd">45788000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzM5LTMtMS0xLTM3MzU2_40e8ed41-3224-4aac-8938-fb8a3b46ff87"
      unitRef="usd">16190000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQwLTEtMS0xLTM3MzU2_cac8dea6-f695-4872-91dc-e0e4c375f625"
      unitRef="usd">120258000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQwLTMtMS0xLTM3MzU2_cb738170-73ab-4df7-b576-10690c888851"
      unitRef="usd">186727000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQyLTEtMS0xLTM3MzU2_e9a10b87-72ae-4665-87b5-b28282b29e6e"
      unitRef="usd">2097579000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQyLTMtMS0xLTM3MzU2_980f02e0-d5dd-4fb0-82aa-ffab1da48a79"
      unitRef="usd">2100269000</us-gaap:Liabilities>
    <us-gaap:PreferredStockNoParValue
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTAtMS0xLTM3MzU2L3RleHRyZWdpb246MDQyN2VhMzc3MzFhNDBiYTg2ZTU3NGRhNGZkOWEwMDFfMTA5OTUxMTYyNzg1Nw_cc472a1c-9daa-4b9a-9b6f-6d74349b988e"
      unitRef="usdPerShare">0</us-gaap:PreferredStockNoParValue>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTAtMS0xLTM3MzU2L3RleHRyZWdpb246MDQyN2VhMzc3MzFhNDBiYTg2ZTU3NGRhNGZkOWEwMDFfMzU_2d9af216-19ad-4007-b513-2361e4ea0f27"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTAtMS0xLTM3MzU2L3RleHRyZWdpb246MDQyN2VhMzc3MzFhNDBiYTg2ZTU3NGRhNGZkOWEwMDFfMzU_6291fdff-232b-4f7f-bc94-9f7f2156d12c"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTAtMS0xLTM3MzU2L3RleHRyZWdpb246MDQyN2VhMzc3MzFhNDBiYTg2ZTU3NGRhNGZkOWEwMDFfMTA5OTUxMTYyNzg2Ng_77d20694-4b81-481d-86a5-8472761783f1"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTEtMS0xLTM3MzU2_ec112ea9-1b9d-45d5-ba39-870f83f75110"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ1LTMtMS0xLTM3MzU2_6dbd83e5-4cd6-4e33-8ddb-d17cad8ee8ea"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMTg_85a20c07-4b6d-4cb7-b013-460faabb0481"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMTg_8c27d7c7-ef35-4fb6-be16-7f101fe50035"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMzI_750a2483-6da9-44d4-bbdb-b3d044e227d1"
      unitRef="shares">240000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMzI_fd73301a-d407-464c-9da3-71e65337b255"
      unitRef="shares">240000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMTA5OTUxMTYyNzkyNA_cc63f8fa-82a8-4252-9fe1-6652ff18eac8"
      unitRef="shares">89600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTAtMS0xLTM3MzU2L3RleHRyZWdpb246ZDE1ZTUxNGQ3MjNkNGQ2ZjhkNWU0MjgyMzQ2ZmQ0NjJfMTA5OTUxMTYyNzkxOQ_6d0c9520-a6fb-44e9-a740-8ce2639a5d82"
      unitRef="shares">89251000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTEtMS0xLTM3MzU2_0c64c673-7ea0-4b9d-91ef-0063ea3b501b"
      unitRef="usd">896000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ2LTMtMS0xLTM3MzU2_e62c3ab3-01a6-4203-be2b-7a552f67ec96"
      unitRef="usd">893000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ3LTEtMS0xLTM3MzU2_189bdc0a-9813-4723-b128-89710e42e2d5"
      unitRef="usd">1264943000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ3LTMtMS0xLTM3MzU2_0b21e6fa-1b48-44b2-a7dd-e272fc452dd9"
      unitRef="usd">1290909000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:TreasuryStockShares
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ4LTAtMS0xLTM3MzU2L3RleHRyZWdpb246OGE4MDE1NTdkYjBkNGZmOGIwNTYzMDJmNzg4MzJmODBfMTY0OTI2NzQ0MTc1Mg_e7fbe764-dbae-49d3-ab81-ea0c0f15fdf2"
      unitRef="shares">4899000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ4LTAtMS0xLTM3MzU2L3RleHRyZWdpb246OGE4MDE1NTdkYjBkNGZmOGIwNTYzMDJmNzg4MzJmODBfMTA5OTUxMTYyNzg1OA_962d25ab-67c0-4517-9a70-e1ebc340aabc"
      unitRef="shares">4914000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ4LTEtMS0xLTM3MzU2_5f656c23-08a5-4744-8ce9-69cb3977142b"
      unitRef="usd">234448000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ4LTMtMS0xLTM3MzU2_ac626f76-caf8-4286-acc9-691966a7849c"
      unitRef="usd">235141000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ5LTEtMS0xLTM3MzU2_73e171c5-2ab8-4125-9e63-06d3ce9fe6e0"
      unitRef="usd">-45155000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzQ5LTMtMS0xLTM3MzU2_ec1010bf-7314-4107-b4ea-c3aa84924e5c"
      unitRef="usd">-74059000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUwLTEtMS0xLTM3MzU2_c8c066f2-e161-442d-b3df-f699034a8cee"
      unitRef="usd">698568000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUwLTMtMS0xLTM3MzU2_bcd1c057-0ced-42a9-a92a-97d43a3435cf"
      unitRef="usd">532265000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUxLTEtMS0xLTM3MzU2_a359b799-d5cd-444c-897b-5ffd43c9645e"
      unitRef="usd">1684804000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUxLTMtMS0xLTM3MzU2_97ae194d-f0d5-4807-a97a-4a5a815c1774"
      unitRef="usd">1514867000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUyLTEtMS0xLTM3MzU2_df309297-57cb-4724-bcdc-7bf0f9cdad51"
      unitRef="usd">3782383000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMjcvZnJhZzplYzZiNGRlY2E3NzY0MjZkOGRjMGRjN2I0N2FjZTViZC90YWJsZToyNzMyOGRmZGMwOGI0MmI5YTFmZGJjMWY2NDE2MTFlMi90YWJsZXJhbmdlOjI3MzI4ZGZkYzA4YjQyYjlhMWZkYmMxZjY0MTYxMWUyXzUyLTMtMS0xLTM3MzU2_49f778b1-4e47-49ab-b7a4-3b04488b9d78"
      unitRef="usd">3615136000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQtMS0xLTEtMzczNTY_f888343f-bf0b-46d1-939e-15440894165b"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQtMy0xLTEtMzczNTY_983a433d-d99d-4d6c-a377-b10f7762a48b"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQtNS0xLTEtMzczNTY_f2cec6f3-aa34-4524-9174-1fe4739f419c"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzctMS0xLTEtMzczNTY_ccda1c94-8e4f-479e-b573-7b959f0e438e"
      unitRef="usd">119836000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzctMy0xLTEtMzczNTY_3e69fcb0-e55d-4fd0-9db9-3b0a2ccda35f"
      unitRef="usd">116031000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzctNS0xLTEtMzczNTY_fbc557fd-fd53-44a0-b156-782a87dffeee"
      unitRef="usd">109462000</us-gaap:OtherDepreciationAndAmortization>
    <iart:NoncashOrPartNoncashInProcessResearchAndDevelopment
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzgtMS0xLTEtMzczNTY_1751d3ac-0e35-4287-9afa-475c4a25c016"
      unitRef="usd">0</iart:NoncashOrPartNoncashInProcessResearchAndDevelopment>
    <iart:NoncashOrPartNoncashInProcessResearchAndDevelopment
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzgtMy0xLTEtMzczNTY_f1b44bcb-e74e-45a3-8593-5ee9e0091576"
      unitRef="usd">519000</iart:NoncashOrPartNoncashInProcessResearchAndDevelopment>
    <iart:NoncashOrPartNoncashInProcessResearchAndDevelopment
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzgtNS0xLTEtMzczNTY_67e16233-889f-4140-b829-bff24414f055"
      unitRef="usd">64916000</iart:NoncashOrPartNoncashInProcessResearchAndDevelopment>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzktMS0xLTEtMzczNTY_d8936fd4-c175-4aec-b53f-a3adb5d77ae5"
      unitRef="usd">2754000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzktMy0xLTEtMzczNTY_3ea1518b-e98d-4cf6-809d-960502403d91"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzktNS0xLTEtMzczNTY_eb35d031-e4f6-4792-b687-e657eeef2284"
      unitRef="usd">5764000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEwLTEtMS0xLTM3MzU2_8fe877df-4b44-4634-9146-36e0b441d244"
      unitRef="usd">-2755000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEwLTMtMS0xLTM3MzU2_c87c21cf-0e76-4811-abd8-76c70483a090"
      unitRef="usd">-64138000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEwLTUtMS0xLTM3MzU2_affbb454-b7cf-4e4d-ab0b-e884c2636e8d"
      unitRef="usd">-19046000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEyLTEtMS0xLTM3MzU2_3b5a7ffc-6c01-44c6-8abf-95b176b3e626"
      unitRef="usd">36210000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEyLTMtMS0xLTM3MzU2_f1732159-5ee6-4117-8d02-e19b80ab3483"
      unitRef="usd">19590000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEyLTUtMS0xLTM3MzU2_0c1d8434-1135-4f7b-b9d4-c9be28616d62"
      unitRef="usd">21255000</us-gaap:ShareBasedCompensation>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEzLTEtMS0xLTM3MzU2_bcd19e0d-8c1e-447e-aaa9-8d8a5e7b8d31"
      unitRef="usd">7030000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEzLTMtMS0xLTM3MzU2_9ffaadfb-039e-4357-a405-46f6e512cb95"
      unitRef="usd">12076000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzEzLTUtMS0xLTM3MzU2_3e1d4166-6205-433c-8be2-90e206bbace4"
      unitRef="usd">5390000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:NoncashLeaseExpense
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTEtMS0xLTM3MzU2_dbbe6f1f-a8a0-4de5-a996-1f64ffe90148"
      unitRef="usd">3834000</iart:NoncashLeaseExpense>
    <iart:NoncashLeaseExpense
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTMtMS0xLTM3MzU2_a6f49798-5160-482a-82c8-f34a1b421d62"
      unitRef="usd">2955000</iart:NoncashLeaseExpense>
    <iart:NoncashLeaseExpense
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTUtMS0xLTM3MzU2_4319b926-bd9c-4e89-b085-331183b0a76b"
      unitRef="usd">5060000</iart:NoncashLeaseExpense>
    <us-gaap:AccretionExpense
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE1LTEtMS0xLTM3MzU2_44e51f75-b208-4e68-a942-363b704b8980"
      unitRef="usd">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE1LTMtMS0xLTM3MzU2_ac4175c8-755b-4d33-834d-95048dfb011c"
      unitRef="usd">15415000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE1LTUtMS0xLTM3MzU2_ab326c72-1295-45c9-9c07-795fb2ee9086"
      unitRef="usd">0</us-gaap:AccretionExpense>
    <iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE3LTEtMS0xLTM3MzU2_260a0cc6-ccf9-44ae-a406-ff9317bc2803"
      unitRef="usd">-2240000</iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress>
    <iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE3LTMtMS0xLTM3MzU2_e533bf6b-a3a8-4f1f-be75-260ae0260209"
      unitRef="usd">-7855000</iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress>
    <iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE3LTUtMS0xLTM3MzU2_935798c5-f6b0-461b-87b5-2cb2b75bfc08"
      unitRef="usd">-1821000</iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTEtMS0xLTQyMjMw_a35f7f4c-2f11-4b1f-87db-84989610c3a6"
      unitRef="usd">41798000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTMtMS0xLTQyMjMw_01d830e8-84c9-4553-a00d-0def3bc869e2"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzE0LTUtMS0xLTQyMjMw_3fa0157b-bdf5-4686-997d-313902775846"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzIwLTEtMS0xLTM3MzU2_fd019560-f330-4feb-82c7-b84febf824d4"
      unitRef="usd">-2162000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzIwLTMtMS0xLTM3MzU2_aec1ae41-be91-4834-ae4a-e6ed4ac814bb"
      unitRef="usd">951000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzIwLTUtMS0xLTM3MzU2_b73f7965-93f4-4b4d-94d9-9c311c3e243b"
      unitRef="usd">1119000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI0LTEtMS0xLTM3MzU2_2804b0ff-4b1e-4dc6-8710-a943ee1b7dc7"
      unitRef="usd">-7265000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI0LTMtMS0xLTM3MzU2_3e579710-cdb8-463c-9810-738f0475d44f"
      unitRef="usd">-52105000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI0LTUtMS0xLTM3MzU2_af8f486c-4303-403b-bb98-3575fbd940d9"
      unitRef="usd">9428000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI1LTEtMS0xLTM3MzU2_12829639-4811-4c1f-a757-69ca03f0f6df"
      unitRef="usd">-5374000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI1LTMtMS0xLTM3MzU2_f5d1d726-752e-43b0-928c-1429e9bbed6c"
      unitRef="usd">48348000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI1LTUtMS0xLTM3MzU2_3b1988a9-15ef-4ef7-8deb-78edd1930f31"
      unitRef="usd">43308000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI2LTEtMS0xLTM3MzU2_1dd2aa24-7993-407b-9cc1-8ae8cd9a3170"
      unitRef="usd">21143000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI2LTMtMS0xLTM3MzU2_165caa1e-c375-4844-a634-df61774fbd23"
      unitRef="usd">-1632000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI2LTUtMS0xLTM3MzU2_64e7ed61-fcc1-4d80-a09f-2d41f821d245"
      unitRef="usd">-13071000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTEtMS0xLTM3MzU2_1fad2381-0cde-4b2b-9f18-18711b62c4a1"
      unitRef="usd">-7875000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTMtMS0xLTM3MzU2_86dced81-7f5c-4fca-8d98-758e87361cdf"
      unitRef="usd">-13735000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTUtMS0xLTM3MzU2_30398341-6c0c-4d94-a70e-931a2424d4f1"
      unitRef="usd">-13156000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI4LTEtMS0xLTM3MzU2_78ef13e2-0152-49ae-b414-4b15e1de93d5"
      unitRef="usd">32874000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI4LTMtMS0xLTM3MzU2_414fc71c-204a-4169-b9a5-ea04c16a4494"
      unitRef="usd">-57512000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI4LTUtMS0xLTM3MzU2_94ac4112-fd72-49aa-bbd8-65fe09ea6e4e"
      unitRef="usd">14666000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI5LTEtMS0xLTM3MzU2_ae9fffad-652c-47ed-8c18-a8cc5d900af0"
      unitRef="usd">28000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI5LTMtMS0xLTM3MzU2_9eaad2be-2acb-4af6-b56c-8c93b96dedd2"
      unitRef="usd">-37000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI5LTUtMS0xLTM3MzU2_3517bce7-357d-4ab2-a4b5-74381ee169a5"
      unitRef="usd">-607000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMwLTEtMS0xLTM3MzU2_4f532016-ef78-4910-a35e-89bc12196959"
      unitRef="usd">-14110000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMwLTMtMS0xLTM3MzU2_6f8a9e81-1c34-4b0f-8222-b58bd2aa6f60"
      unitRef="usd">-2889000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMwLTUtMS0xLTM3MzU2_43d4f6d6-2fb9-4cb3-93bb-c28371b35d15"
      unitRef="usd">-2059000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMzLTEtMS0xLTM3MzU2_e3906864-8864-48fb-8b42-d88afe68fdd1"
      unitRef="usd">312427000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMzLTMtMS0xLTM3MzU2_2c418b7f-b704-456d-a4be-d570205990b9"
      unitRef="usd">203832000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzMzLTUtMS0xLTM3MzU2_0f7e9554-21a0-420c-a8d8-904e9f48edc8"
      unitRef="usd">231433000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM3LTEtMS0xLTM3MzU2_64eb7250-27eb-43e7-896f-f6c79631427f"
      unitRef="usd">48022000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM3LTMtMS0xLTM3MzU2_a37a70a2-35ef-4e8e-b6b1-4b7b70ac2038"
      unitRef="usd">38890000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM3LTUtMS0xLTM3MzU2_066d321d-b718-4f79-bae5-2b2979f480ea"
      unitRef="usd">69537000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTEtMS0xLTQyMjQ3_eafa5a29-5a4b-4bfb-8a2e-53b197b59e15"
      unitRef="usd">190468000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTMtMS0xLTQyMjQ3_c6bff5cc-4f59-4750-98a6-68c71c45c552"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzI3LTUtMS0xLTQyMjQ3_8f83d456-beb0-482e-a06e-f8b325d057ce"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM4LTEtMS0xLTM3MzU2_e988eb35-ef97-4368-a2b4-88b462c3c069"
      unitRef="usd">58000</iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets>
    <iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM4LTMtMS0xLTM3MzU2_8599a30a-4d59-4406-93cf-43d9de23b65a"
      unitRef="usd">25000000</iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets>
    <iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM4LTUtMS0xLTM3MzU2_ff47d17f-866e-4c2f-aa80-6b78e9341735"
      unitRef="usd">64995000</iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM5LTEtMS0xLTM3MzU2_4ff9f547-120b-43c8-b13a-7f768d2a71df"
      unitRef="usd">0</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM5LTMtMS0xLTM3MzU2_1acb459a-4c05-4ce0-bba7-8086fe9cfe8a"
      unitRef="usd">0</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzM5LTUtMS0xLTM3MzU2_3378ab70-c59a-4105-8d67-05dfd7e4d5c2"
      unitRef="usd">752000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <iart:PaymentsForProceedsFromBusinessAcquisitions
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQwLTEtMS0xLTM3MzU2_1a303352-a026-4696-ab10-d86834c4b803"
      unitRef="usd">303910000</iart:PaymentsForProceedsFromBusinessAcquisitions>
    <iart:PaymentsForProceedsFromBusinessAcquisitions
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQwLTMtMS0xLTM3MzU2_2e6af553-ae60-4068-99c2-ac679e9af7bf"
      unitRef="usd">0</iart:PaymentsForProceedsFromBusinessAcquisitions>
    <iart:PaymentsForProceedsFromBusinessAcquisitions
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQwLTUtMS0xLTM3MzU2_810a4f33-4efb-4a34-8317-c0a1d97b9fc2"
      unitRef="usd">30509000</iart:PaymentsForProceedsFromBusinessAcquisitions>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQxLTEtMS0xLTM3MzU2_370fd887-d8c2-4902-938d-6dbfb78cbf7e"
      unitRef="usd">3000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQxLTMtMS0xLTM3MzU2_28337c7d-89f7-4e31-b7ba-5d4332333c12"
      unitRef="usd">3657000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQxLTUtMS0xLTM3MzU2_d3491c08-8022-4657-ae7b-ea7ab4e07a87"
      unitRef="usd">37000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQzLTEtMS0xLTM3MzU2_868a941e-689b-472b-a315-172cda85b336"
      unitRef="usd">-76000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQzLTMtMS0xLTM3MzU2_9d0892b6-72aa-4e86-99e7-0d2ca278abe8"
      unitRef="usd">7840000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQzLTUtMS0xLTM3MzU2_3e58eae7-fc37-4685-9420-522f4354fc0f"
      unitRef="usd">-1584000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQ4LTEtMS0xLTM3MzU2_45d338cc-3542-4692-a2cf-47856b5b6dd2"
      unitRef="usd">-161443000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQ4LTMtMS0xLTM3MzU2_a6d8ee26-86bf-4644-a08d-f11adc6b4e80"
      unitRef="usd">-68073000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzQ4LTUtMS0xLTM3MzU2_27e91324-cf93-437b-b841-87f47a502b2a"
      unitRef="usd">-162668000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUwLTEtMS0xLTM3MzU2_14ea74d0-a53e-41d4-b80b-c6bed4c089aa"
      unitRef="usd">25500000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUwLTMtMS0xLTM3MzU2_85d5bf20-a6e2-49a1-94ad-1b2c3d6b0c1c"
      unitRef="usd">171500000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUwLTUtMS0xLTM3MzU2_b3abc141-c538-456b-9782-7d29fa723249"
      unitRef="usd">236900000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUxLTEtMS0xLTM3MzU2_30cb29ad-1eb4-4d11-9560-a6cf54a9f8c9"
      unitRef="usd">125500000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUxLTMtMS0xLTM3MzU2_e27e496a-8e56-458f-9a4d-5cf21229f50d"
      unitRef="usd">441000000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUxLTUtMS0xLTM3MzU2_c4832df0-25ba-493e-9ce2-f1ff592a1447"
      unitRef="usd">246100000</us-gaap:RepaymentsOfSecuredDebt>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTEtMS0xLTM3MzU2_3a0c4101-f6bd-49c5-8d73-2e81012d7474"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTEtMS0xLTM3MzU2_c461d108-586d-4a5d-8c21-ef8715664456"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTMtMS0xLTM3MzU2_507b7c88-9be6-4e3b-84af-26297927aaa3"
      unitRef="usd">104248000</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTMtMS0xLTM3MzU2_6d3f2d46-f990-438d-91bb-ed0b3c2c33f7"
      unitRef="usd">104248000</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTUtMS0xLTM3MzU2_4f066461-ac85-48c4-8458-cf2a2b0e0f78"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUyLTUtMS0xLTM3MzU2_bea2b371-8b61-4cb5-8f14-5d4a7bf0286b"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTEtMS0xLTM3MzU2_166b3830-67ed-4665-92c3-78e03eec91d3"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTEtMS0xLTM3MzU2_17c8e849-8d4d-4dba-a4eb-272c6dbe06a6"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTMtMS0xLTM3MzU2_5dfa4074-1f3a-42ae-8c9a-3633c3ad62de"
      unitRef="usd">575000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTMtMS0xLTM3MzU2_6029a50c-5b61-4eac-86dc-ea9e1c5f024f"
      unitRef="usd">575000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTUtMS0xLTM3MzU2_9e228351-2326-4677-8df0-d7bd682eb617"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzUzLTUtMS0xLTM3MzU2_d78e00e4-7d58-4350-ad56-7f92b254cd14"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU0LTEtMS0xLTM3MzU2_bf9f370b-6382-41f0-a37a-7115e0ffdbb4"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU0LTMtMS0xLTM3MzU2_6bc66c33-4b30-4cbf-be79-af5cbfd3be99"
      unitRef="usd">44563000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU0LTUtMS0xLTM3MzU2_351825b7-4e3e-471c-8d95-d4d07b6686aa"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU1LTEtMS0xLTM3MzU2_9fed3099-e366-4c70-a848-67c1600ab33e"
      unitRef="usd">249000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU1LTMtMS0xLTM3MzU2_4ee6e8b4-d024-40cb-882f-23d140ff0c8f"
      unitRef="usd">24347000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU1LTUtMS0xLTM3MzU2_7f397074-d876-4ae9-91c6-ee26ec1bf8ad"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU2LTEtMS0xLTM3MzU2_f924b014-b861-4e17-9da0-557b15eeddc3"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU2LTMtMS0xLTM3MzU2_586279f8-2c2e-4ae5-b58a-185af0aa1620"
      unitRef="usd">100000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU2LTUtMS0xLTM3MzU2_f6ea0694-5f97-4727-bf0f-9cc3f156904d"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU3LTEtMS0xLTM3MzU2_d337260d-7764-4a2f-a5ea-594227bd5ddb"
      unitRef="usd">6824000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU3LTMtMS0xLTM3MzU2_22c713a7-c3f5-4b5c-a465-f84edd0d3da0"
      unitRef="usd">5232000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzU3LTUtMS0xLTM3MzU2_520a0714-adeb-4526-96fe-08d2596e381b"
      unitRef="usd">6948000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYyLTEtMS0xLTM3MzU2_fcd99898-63e8-4f92-9cd2-e1c90d172c49"
      unitRef="usd">4801000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYyLTMtMS0xLTM3MzU2_c215ad86-bac9-4cb8-b222-4d6ba2217e72"
      unitRef="usd">5075000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYyLTUtMS0xLTM3MzU2_348808a9-cc97-4596-9daa-ecd05a3f665b"
      unitRef="usd">6514000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYzLTEtMS0xLTM3MzU2_ebad72c6-31a3-4ae4-8b7d-ce47e1a80662"
      unitRef="usd">-98226000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYzLTMtMS0xLTM3MzU2_ab548311-471d-4a46-9f3d-7f1140140625"
      unitRef="usd">121625000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzYzLTUtMS0xLTM3MzU2_9042878f-9e4e-451b-b146-e1ccb4fe0279"
      unitRef="usd">-8766000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY0LTEtMS0xLTM3MzU2_63b3552d-0d51-472c-b0f4-9114636b17b9"
      unitRef="usd">-9476000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY0LTMtMS0xLTM3MzU2_53e3a390-79d8-4b29-a2b9-600b8599ba39"
      unitRef="usd">13871000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY0LTUtMS0xLTM3MzU2_686ef01f-2f13-4201-8d44-6005fb7c9a78"
      unitRef="usd">74000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY1LTEtMS0xLTM3MzU2_d7a86f15-b8d8-4842-8468-bfbd77eca720"
      unitRef="usd">43282000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY1LTMtMS0xLTM3MzU2_9fb8662a-3c3b-4756-842f-61e104182bd1"
      unitRef="usd">271255000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY1LTUtMS0xLTM3MzU2_afdbd88a-4f33-431a-9353-98e6939e1b9f"
      unitRef="usd">60073000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY2LTEtMS0xLTM3MzU2_fdc6d1ac-ee29-44a4-a823-a2162ce94656"
      unitRef="usd">470166000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie55084e91d494776891870a81ff5cb91_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY2LTMtMS0xLTM3MzU2_bac33024-4905-4057-885f-bbd23f52bfb1"
      unitRef="usd">198911000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifcaf1fbc6c2145ac92ae58dce7c7f40b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY2LTUtMS0xLTM3MzU2_ef354199-8f88-4417-a26f-5634809d4db5"
      unitRef="usd">138838000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY3LTEtMS0xLTM3MzU2_4b97860d-cf86-4f70-a8db-f5cb1df8f379"
      unitRef="usd">513448000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY3LTMtMS0xLTM3MzU2_0e632e56-579b-46e8-84dd-2305a76efe21"
      unitRef="usd">470166000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie55084e91d494776891870a81ff5cb91_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzAvZnJhZzozZDlhODk0MjlhN2Q0MjZlYjc2MDQ2MjRhYjIxZTdhNi90YWJsZTo4ZWIwMzZjMjAzNTM0NmI1YmVkNzQwODUwMjc3MDIyOC90YWJsZXJhbmdlOjhlYjAzNmMyMDM1MzQ2YjViZWQ3NDA4NTAyNzcwMjI4XzY3LTUtMS0xLTM3MzU2_df63376a-2cc7-40e5-82b8-0a1debb5076a"
      unitRef="usd">198911000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SharesIssued
      contextRef="ibca422d8af654309ab3549894c22e2d0_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTEtMS0xLTM3MzU2_65cc19fd-9ae3-426f-97ca-eed0f5bd2653"
      unitRef="shares">88044000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ibca422d8af654309ab3549894c22e2d0_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTMtMS0xLTM3MzU2_dcf48d65-10b2-408a-81fa-8e0a0c79dbb7"
      unitRef="usd">880000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="ia653c210464848738937121e1560643c_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTUtMS0xLTM3MzU2_e2af6e4e-cf9b-4fb7-97cb-d48a356412b0"
      unitRef="shares">2881000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="ia653c210464848738937121e1560643c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTctMS0xLTM3MzU2_7ac329e0-c78b-4f2a-b23a-2a6c3bbef66b"
      unitRef="usd">-120615000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3bfd63f1146a4c15a4a961a4884d8f8e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTktMS0xLTM3MzU2_c09f71af-41ed-439f-bb9d-f985fad099a5"
      unitRef="usd">1192601000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1aef4bf54744c0c98c1b03a1df9ec4d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTExLTEtMS0zNzM1Ng_88343575-e5a0-49cd-9f63-3bc788586c36"
      unitRef="usd">-45443000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b92cad52f3d4933bd002cc96a643e01_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTEzLTEtMS0zNzM1Ng_8be1f9e2-aeae-4311-a1d8-cecb6f5c4c86"
      unitRef="usd">348373000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifcaf1fbc6c2145ac92ae58dce7c7f40b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUwLTE1LTEtMS0zNzM1Ng_de16e5d8-8e9f-4fb0-9471-72b359c2ae91"
      unitRef="usd">1375796000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="iea229e31f5ee46999defcde318bf2e01_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUxLTEzLTEtMS0zNzM1Ng_ab93450c-d2af-4482-8321-8e0773bc7df2"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUxLTE1LTEtMS0zNzM1Ng_9e9418e9-f617-43f4-8581-598d0814d5e1"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3184ef53b5bf48b89f52d96b36d83cd8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUyLTExLTEtMS0zNzM1Ng_22fe3eaa-30c0-4b08-ab6f-7210b2b25bc2"
      unitRef="usd">-30959000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUyLTE1LTEtMS0zNzM1Ng_cb1269d6-b4e2-4279-8678-cd7d12672096"
      unitRef="usd">-30959000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if7d6cd85315a4099a0e9a723e15cc57d_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUzLTEtMS0xLTM3MzU2_061b3d46-b55f-4396-a184-2d78bb592a87"
      unitRef="shares">17000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i54fe101f812943a4bb6c8e21f03e6abe_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUzLTktMS0xLTM3MzU2_ad4b4eb2-62cd-42d7-b59f-2cc4ed3d2ef5"
      unitRef="usd">716000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzUzLTE1LTEtMS0zNzM1Ng_ef0fbea6-d142-42a8-a443-51a70e24e182"
      unitRef="usd">716000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if7d6cd85315a4099a0e9a723e15cc57d_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTEtMS0xLTM3MzU2_e6829f2e-bee4-4d2b-bcf0-acc97ac36ed3"
      unitRef="shares">674000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if7d6cd85315a4099a0e9a723e15cc57d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTMtMS0xLTM3MzU2_eb662e7a-7859-4a5f-b899-00f39047cb24"
      unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i57de76fda3e440858f132dfbe6b7a489_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTUtMS0xLTM3MzU2_3294c3f3-b05b-488e-b2c5-a2d8c99cd231"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i57de76fda3e440858f132dfbe6b7a489_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTctMS0xLTM3MzU2_7d988132-ab6d-40f5-87ce-b0afc301f2e2"
      unitRef="usd">672000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i54fe101f812943a4bb6c8e21f03e6abe_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTktMS0xLTM3MzU2_a6620066-1dbb-4ba1-bdd9-fafa08da3435"
      unitRef="usd">-961000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU0LTE1LTEtMS0zNzM1Ng_d8b9db49-492c-4353-828f-e23d0626b295"
      unitRef="usd">-282000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i54fe101f812943a4bb6c8e21f03e6abe_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU1LTktMS0xLTM3MzU2_c74c2a99-f5a7-47ed-be7f-06b02d85c515"
      unitRef="usd">21264000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU1LTE1LTEtMS0zNzM1Ng_2c28804b-2eb9-466a-b27b-42b9fd6c826a"
      unitRef="usd">21264000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesIssued
      contextRef="i72b41bb28dd74cab856e1fb68a9457e4_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTEtMS0xLTM3MzU2_2830735f-308a-4597-ab3e-5c92f67b361c"
      unitRef="shares">88735000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i72b41bb28dd74cab856e1fb68a9457e4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTMtMS0xLTM3MzU2_301e4187-d676-4d2c-bc79-b39712e00572"
      unitRef="usd">887000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="idfd8af4c329c447fa3829f444aa543e6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTUtMS0xLTM3MzU2_d739743d-f752-409e-9b4d-f744c3563bbf"
      unitRef="shares">2865000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="idfd8af4c329c447fa3829f444aa543e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTctMS0xLTM3MzU2_5c851744-277e-43b2-aa85-239835a7a5a8"
      unitRef="usd">-119943000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i008a1ec620f549bb9fe080a50c5507b5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTktMS0xLTM3MzU2_8eac9f01-21c7-4e3d-9b9f-95dd4f71230d"
      unitRef="usd">1213620000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ide0d9f6801174af69063a55bae4f6ea4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTExLTEtMS0zNzM1Ng_4622cf17-a4ae-441b-a37b-9b506327b2d2"
      unitRef="usd">-76402000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2ecb901e8b3f401a8bb8305e200e9cfd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTEzLTEtMS0zNzM1Ng_bb0dcb9f-7d1d-47de-b3e4-c50a62fa7a83"
      unitRef="usd">398574000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie55084e91d494776891870a81ff5cb91_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU2LTE1LTEtMS0zNzM1Ng_bb4e74b9-f6d9-4941-ae5d-4aeb308ed8a5"
      unitRef="usd">1416736000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i26020eaabf34449c9314e52e2b46ced3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU3LTEzLTEtMS0zNzM1Ng_3f148150-f6f5-4b6f-add5-1228da0be42b"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU3LTE1LTEtMS0zNzM1Ng_8f503c08-a5e7-4cf7-9c03-b38538754545"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iec381aeaa645411985794e468f533624_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU4LTExLTEtMS0zNzM1Ng_4edd6a3b-e54f-4eef-9402-287018f0475e"
      unitRef="usd">2343000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU4LTE1LTEtMS0zNzM1Ng_d6a030f8-ccf5-45b9-929c-4b30efcbaaf8"
      unitRef="usd">2343000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i82c6bb6b0f504d638356e1bbc6647d3c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU5LTEtMS0xLTM3MzU2_b5679ad2-1892-4528-8f23-d0571cf6b14d"
      unitRef="shares">13000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU5LTktMS0xLTM3MzU2_58bbf1c0-ac37-45fb-a8d3-a796612ff867"
      unitRef="usd">694000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzU5LTE1LTEtMS0zNzM1Ng_9bddbc26-d4cc-4d3c-b7d8-d2ce4cbf1da8"
      unitRef="usd">694000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i82c6bb6b0f504d638356e1bbc6647d3c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTEtMS0xLTM3MzU2_127c80e8-9112-4ac2-b8f1-70f6c560af46"
      unitRef="shares">503000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i82c6bb6b0f504d638356e1bbc6647d3c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTMtMS0xLTM3MzU2_bf6f8d81-ed19-48fc-8a27-2da8741a24b9"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5fd48636569448e0af0d30413ae28c64_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTUtMS0xLTM3MzU2_f1cfb465-780c-41ec-bca8-2d023f5a24d2"
      unitRef="shares">11000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5fd48636569448e0af0d30413ae28c64_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTctMS0xLTM3MzU2_c87fa215-78dc-4176-b7ef-c411c9b46ae8"
      unitRef="usd">526000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTktMS0xLTM3MzU2_9b34a920-7765-4bc8-82c3-cec8e2df1697"
      unitRef="usd">-1066000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYwLTE1LTEtMS0zNzM1Ng_d97f5170-c370-48e7-842d-89dc8c0891e7"
      unitRef="usd">-538000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i82c6bb6b0f504d638356e1bbc6647d3c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYxLTMtMS0xLTM3MzU2_e81c06a2-b229-40d3-b9d1-a4c71afdf6b1"
      unitRef="usd">4000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYxLTktMS0xLTM3MzU2_aa54c568-e1aa-48ad-9288-43b14a24783b"
      unitRef="usd">19397000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYxLTE1LTEtMS0zNzM1Ng_1b857aae-7514-483a-8acf-380e9f2de0ef"
      unitRef="usd">19401000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYyLTktMS0xLTM3MzU2_47f8c2f5-869a-48dd-87c4-6200c2961c7f"
      unitRef="usd">42539000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYyLTE1LTEtMS0zNzM1Ng_187ec05b-660b-4abb-9217-b7bb0984e032"
      unitRef="usd">42539000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i5fd48636569448e0af0d30413ae28c64_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYzLTUtMS0xLTM3MzU2_82c0ebfd-ec7b-40fc-896a-40c237b0a95e"
      unitRef="shares">2060000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i5fd48636569448e0af0d30413ae28c64_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYzLTctMS0xLTM3MzU2_be842321-469a-4992-9e5a-2c10ab883ba1"
      unitRef="usd">115724000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia06b0af59bc84f0b8df7a015df2dc5a1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYzLTktMS0xLTM3MzU2_de868514-72d5-48a3-8cd7-4c2b2edce465"
      unitRef="usd">-15724000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzYzLTE1LTEtMS0zNzM1Ng_72fe714d-3e44-43b2-a758-de5bde07dd50"
      unitRef="usd">100000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquity
      contextRef="ib45c219279874482b251ea345021653d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY0LTEzLTEtMS0zNzM1Ng_344ec762-f0c3-4801-a776-e89956cac527"
      unitRef="usd">-200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6646ef2e0b7149db85eb6904dd2a2fd7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY0LTE1LTEtMS0zNzM1Ng_a28bf0c6-a22d-4cf0-bafb-da38563cfa0e"
      unitRef="usd">-200000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="if738d2f8a6a346b78585e76bc617302c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTEtMS0xLTM3MzU2_3073240e-e124-46c4-8db3-0654213693d6"
      unitRef="shares">89251000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="if738d2f8a6a346b78585e76bc617302c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTMtMS0xLTM3MzU2_b7797835-e6dd-472f-bf4e-02e2cc4858a4"
      unitRef="usd">893000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i8fb5aab0b91c486f93ba0865f67d73e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTUtMS0xLTM3MzU2_dabfa40d-70f2-4bde-b92e-044f68eeeff6"
      unitRef="shares">4914000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i8fb5aab0b91c486f93ba0865f67d73e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTctMS0xLTM3MzU2_ec722d99-ca28-4142-91d5-63c601e4f31e"
      unitRef="usd">-235141000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ife0f354f47024885b393073798c5bcb4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTktMS0xLTM3MzU2_a7253357-d9b8-463e-a84c-b5b9607ec1bc"
      unitRef="usd">1290908000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9b2f27cba47049e49b27de743dc66104_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTExLTEtMS0zNzM1Ng_1a760dba-2863-41bd-9525-c6c0827781d6"
      unitRef="usd">-74059000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f9e723c32e3484daf7f94702722ed89_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTEzLTEtMS0zNzM1Ng_9aedf45c-37ef-4f86-9724-7bf8e46b04af"
      unitRef="usd">532266000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzY1LTE1LTEtMS0zNzM1Ng_ce54ad35-6745-4af9-b52a-c21c42af2b0b"
      unitRef="usd">1514867000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ifcfb8e89af374d30815fb2d4a02f9b08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzE4LTEzLTEtMS00MjY1MA_43934f63-ed74-4aa3-b354-c3dfd3ada726"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzE4LTE1LTEtMS00NDkxOQ_36d26d9b-39f0-4900-bc67-0f35d8f25860"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3dfb0dc7e5f246bb8a7849e9e7d24e92_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzE5LTExLTEtMS00MjY1MA_bb15d308-03b5-4211-88d8-780d15928413"
      unitRef="usd">28904000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzE5LTE1LTEtMS00NDkxOQ_21fbcc3b-19f9-4ee1-8fa0-a0dbcb89258f"
      unitRef="usd">28904000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="iba3867d19dfa4492be95296631dd23cc_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIxLTEtMS0xLTQyNjUw_dfc89619-a845-4e09-811c-f97c32a548e9"
      unitRef="shares">18000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i6f824b4c3df84987af91c402bc76a408_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIxLTktMS0xLTQyNjUw_7ff6b0ed-6ce0-497a-b63b-04678f38c87f"
      unitRef="usd">1127000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIxLTE1LTEtMS00NDkyMg_fe5a0fae-499a-4ca2-adb8-370ebb6e6e39"
      unitRef="usd">1127000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iba3867d19dfa4492be95296631dd23cc_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTEtMS0xLTQyNjUw_de1508de-4de2-4f3f-bea8-5f8333559f86"
      unitRef="shares">331000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iba3867d19dfa4492be95296631dd23cc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTMtMS0xLTQyNjUw_b6c7decb-d736-4b07-b2ae-6b700b8afc64"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if6c5aeb396884c44b182cf5d1e5128cf_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTUtMS0xLTQyNjUw_fb1e4734-bf4e-4132-9a8d-c2322887bcfd"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if6c5aeb396884c44b182cf5d1e5128cf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTctMS0xLTQyNjUw_e5cf5114-9f4c-41ef-92ac-1a54ef88e6a9"
      unitRef="usd">693000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6f824b4c3df84987af91c402bc76a408_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTktMS0xLTQyNjUw_8488fe9c-0284-4e10-ae96-1890c515bce8"
      unitRef="usd">201000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIyLTE1LTEtMS00NDkyMg_3204cffe-be65-4d47-bcdd-28b9605eb1a0"
      unitRef="usd">895000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iba3867d19dfa4492be95296631dd23cc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIzLTMtMS0xLTQyNjUw_5a61c08e-89a1-4014-8383-45b4319420be"
      unitRef="usd">2000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6f824b4c3df84987af91c402bc76a408_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIzLTktMS0xLTQyNjUw_3ce940ed-1415-49bf-8145-4688f6b6d6dc"
      unitRef="usd">35981000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzIzLTE1LTEtMS00NDkyMg_2bd8c389-3b4b-4d37-a8c7-b991ec913e20"
      unitRef="usd">35983000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="i7f7a013d5ebd4d9cad2eddbf41dc58f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI0LTktMS0xLTQyNjUw_c0337502-9b06-410a-b485-a32f2368c82d"
      unitRef="usd">-63274000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic716df195898449a87cdc08a6bad6057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI0LTEzLTEtMS00MjY1MA_aaf801af-908c-4e8f-9b1f-02e571a1f6b7"
      unitRef="usd">-2773000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i11696c20228346ddb295ad994c1d9416_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI0LTE1LTEtMS00NDkyNQ_05acf55e-1841-42c8-877b-20f903da23bb"
      unitRef="usd">-66047000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ie62db310d8e24fc493ae78bec1200f60_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTEtMS0xLTQ0OTI1_17aad2a9-d20c-4a36-b3d2-a26f407df552"
      unitRef="shares">89600000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ie62db310d8e24fc493ae78bec1200f60_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTMtMS0xLTQ0OTI1_57bc6673-baa3-4882-ae75-d690a1d141a9"
      unitRef="usd">896000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="ib92542029c1c4bd08191f3e3b185049c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTUtMS0xLTQ0OTI1_9e8b4d6d-7f69-4731-8a88-54c14c3f3ee8"
      unitRef="shares">4899000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="ib92542029c1c4bd08191f3e3b185049c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTctMS0xLTQ0OTI1_85311e9f-a592-4c31-bdd7-2f1809d6dd84"
      unitRef="usd">-234448000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2d0e311baee24ad7a5bd71c8891f1b7c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTktMS0xLTQ0OTI1_377a92f8-1075-4e02-a537-581661e0715d"
      unitRef="usd">1264943000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i62b5cd28862f4322bda15977250be066_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTExLTEtMS00NDkyNQ_2315d62f-0195-44bb-8e47-1242690a52d1"
      unitRef="usd">-45155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3e9517845c414b658fb2157d69d73d89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTEzLTEtMS00NDkyNQ_934d9b88-8838-45c0-9623-66f32de2b772"
      unitRef="usd">698568000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzMvZnJhZzo3N2QxZThmMjRiN2Q0MzVjODcwODhjYzVlZjlhZTdkOC90YWJsZTpjN2UyYmJkZWRjNDA0ZjViYWJkY2Y5MjM5ZmEzNjE3NC90YWJsZXJhbmdlOmM3ZTJiYmRlZGM0MDRmNWJhYmRjZjkyMzlmYTM2MTc0XzI1LTE1LTEtMS00NDkyNQ_cc035a9b-5c71-433a-b998-5adb5fa5bd4e"
      unitRef="usd">1684804000</us-gaap:StockholdersEquity>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xMzkvZnJhZzo1MjI2ODhjZjVkN2U0M2Y3YmUxY2U1MzlkMzliMThlOS90ZXh0cmVnaW9uOjUyMjY4OGNmNWQ3ZTQzZjdiZTFjZTUzOWQzOWIxOGU5XzU0NA_1d20ea41-6cc5-4e5e-83b7-87b3a08d8efa">BUSINESSIntegra LifeSciences Holdings Corporation (the &#x201c;Company&#x201d;) was incorporated in Delaware in 1989. The Company is a worldwide leader in medical technology. The Company was founded with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care. The Company sells its products directly through various sales forces and through a variety of other distribution channels.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTYw_4cdb33ad-9eea-4779-a85c-4e5c2824e47a">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BASIS OF PRESENTATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. See Note&#160;4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of new subsidiaries included in the consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;USE OF ESTIMATES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the Company continues to navigate the novel coronavirus ("COVID-19") pandemic and recent variants of the virus&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as well as the adverse impacts to global economic conditions, supply chain and the operations, there may be impact to future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#x2019;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RECLASSIFICATIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts from the prior year's financial statements have been reclassified in order to conform to the current year's presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#x2019;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued&#160;ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. Provision for doubtful accounts net of recoveries, associated with accounts receivable, included in selling, general and administrative expense, was recoveries of $1.1 million for the year ended December&#160;31, 2021, and charges of $3.6 million, and $2.1 million for the years ended December 31, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INVENTORIES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, $52.8&#160;million of inventories, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program. No such amounts were capitalized at December&#160;31, 2021 or 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PROPERTY, PLANT AND EQUIPMENT &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal-Use Software.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment balances and corresponding lives were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and production equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical instrument kits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information systems and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures, and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, $37.9&#160;million of property, plant and equipment, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense associated with property, plant and equipmen&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;t was $39.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, $42.1 million, and $42.6 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company wrote-off certain construction in progress of $6.7&#160;million related to a manufacturing project that the Company decided to discontinue. The Company determined that the carrying amounts of these assets were not recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CAPITALIZED INTEREST&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended December&#160;31, 2021 and 2020, respectively, the Company capitalized $1.2 million and $2.3 million of interest expense into property, plant and equipment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ACQUISITIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Results of operations of acquired companies are included in the Company&#x2019;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, Business Combinations (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired in recorded as goodwill. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction costs and costs to restructure the acquired company are expensed as incurred.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determi&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#x2019;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired IPR&amp;amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#x2019;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;amp;D acquired outside of a business combination is expensed immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;issuance, or validity and litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition. Refer to Note 4, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; and Divestitures&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Other Intangibles&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two reportable segments with three underlying reporting units. Refer to Note 16, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment and Geographic Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on reportable segments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;over their expected useful lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;LONG-LIVED ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INTEGRA FOUNDATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements. The Company contributed $1.2 million, $0.8 million and $0.3 million to the Integra Foundation during the years ended December&#160;31, 2021, 2020 and 2019, respectively. These contributions were recorded in selling, general, and administrative expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DERIVATIVES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes. From time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are recognized at the fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into foreign currency forward and foreign currency swap contracts that are not designated as a hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into other income, net on the consolidated financial statements. Refer to Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;FOREIGN CURRENCY &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries. Foreign currency transaction net gains of less than $0.1&#160;million, and net losses of $1.6 million and $0.3 million are reported in other income, net in the statements of operations, for the year ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to indefinitely reinvest substantially all of its foreign earnings. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash. One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;REVENUE RECOGNITION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI0Mzcw_c9172610-6a8d-4dac-b8b3-a0c0563d676b"&gt;one&lt;/span&gt; to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. Refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue From Contracts With Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RESEARCH AND DEVELOPMENT &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EMPLOYEE TERMINATION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation-Nonretirement Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ASC Topic 420 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;One-time Employee Termination Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred restructuring costs of $3.4&#160;million and $4.9&#160;million in cost of goods sold, $0.5&#160;million and $1.2&#160;million in selling, general and administrative and $0.3&#160;million and $0.3&#160;million in research and development related to employee terminations associated with a future plant closure in the consolidated statement of operations for the years ended December 31, 2021 and 2020, respectively. Restructuring costs of $10.2&#160;million were included in a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ccrued expenses and other current liabilities &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $6.4&#160;million were included in other liabilities in the consolidated balance sheet for the year ended December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;STOCK-BASED COMPENSATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations. Refer to Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PENSION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a deferred compensation plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CONCENTRATION OF CREDIT RISK &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None of the Company's customers accounted for 10% or more of the consolidated net sales during the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU&#160;2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption was permitted. The Company adopted this guidance during the year ended December 31, 2020. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued&#160;ASU 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under this guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The Company adopted ASU 2019-12 as of January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting.&#160;This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform.&#160;This ASU is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022.&#160;In January 2021, the FASB also issued ASU 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform- Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which clarified certain optional expedients and exceptions to entities that are affected because of the reference rate reform. The amendments in this ASU affect the guidance in ASU 2020-04 and are effective in the same timeframe as ASU 2020-04. The Company currently has contracts that are indexed to LIBOR and are continuing to monitor this activity and evaluate the associated risk. The Company is continuing to evaluate the scope of impacted contracts and the potential impact. The Company is also monitoring the developments regarding alternative rates and may amend certain contracts to accommodate those rates if the contract does not already specify a replacement rate. While the notional value of agreements potentially indexed to LIBOR is material, the Company does not expect a material impact consolidated financial statements and related disclosures associated with this transition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity's Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years using either the modified retrospective or full retrospective method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As detailed in Note 5,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, on February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes are subject to the guidance included in ASU 2020-06. The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ADJUSTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CONSOLIDATED BALANCE SHEET CLASSIFICATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;AMOUNT&lt;br/&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity issuance costs reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount amortization and equity costs reclassification, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2020, the Company made an irrevocable election under the indenture to require the principal portion of its 2025 Notes to be settled in cash and any excess in shares. Following the irrevocable notice, only the amounts settled in excess of the principal will be considered in diluted earnings per share under the &#x201c;if-converted&#x201d; method. Upon adoption of ASU 2020-06, the Company&#x2019;s 2025 Notes were reflected entirely as a liability since the embedded conversion feature will no longer be separately presented within stockholders&#x2019; equity. Additionally, from January 1, 2021, the Company is no longer incurring non-cash interest expense for the amortization of debt discount, therefore the interest expense for the 2025 Notes, which is included in the interest expense on the consolidated statements of operations and comprehensive loss, is lower as compared to the fiscal year of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASU 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which updates various codification topics by clarifying or improving disclosure requirements to align with the regulations of the U.S. Securities and Exchange Commission (the "SEC") . The ASU has been effective for the Company for annual and interim periods beginning after January 1, 2021. The Company adopted this standard on the January 1, 2021. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the FASB issued ASU 2021-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which provides guidance to clarify and reduce diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU No. 2021-04 are effective for all entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, including interim periods within those fiscal years. The amendment currently has no impact to the Company as the effect will largely depend on the terms of written call options or financings issued or modified in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for interest during the years ended December&#160;31, 2021, 2020 and 2019 was $43.2 million (net of $1.2 million that was capitalized into construction in progress), $47.3 million (net of $2.3 million that was capitalized into construction in progress) and $48.9 million (net of $3.1 million that was capitalized into construction in progress), respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for income taxes, net of refunds, for the years ended December&#160;31, 2021, 2020 and 2019&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was $49.5 million, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$29.8 million and $16.2 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;NON-CASH INVESTING AND FINANCING ACTIVITIES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment purchases included in liabilities at December&#160;31, 2021, 2020 and 2019 were $4.7 million, $1.6 million and $11.0 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, the Company achieved its final developmental milestone which triggered a $5.0&#160;million obligation to be paid to former shareholders of Rebound Therapeutics Corporation ("Rebound"). The Company recorded $5.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The remaining obligation was included in accrued liabilities at December 31, 2021 in the consolidated balance sheets. The milestone is expected to be fully paid during the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $20.0&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $20.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $5.0&#160;million obligation to be paid to former shareholders of Rebound. In addition, the Company recorded $5.0&#160;million as in-process research and development expense in the consolidated statements of operations. The obligation was included in accrued liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTA2_97bb00fd-a286-4abb-b0b4-4e28b1a01cac">BASIS OF PRESENTATION These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTc5_0534de93-61f4-49e3-b3af-1bee80d92ecf">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. See Note&#160;4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of new subsidiaries included in the consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTQw_29ec2f41-8622-4f07-8fd9-86e555fca8e2">USE OF ESTIMATES The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTY1_cb95a8fb-48ea-445d-a9a4-45883f8a7aeb">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RECLASSIFICATIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts from the prior year's financial statements have been reclassified in order to conform to the current year's presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMDM1_93cea070-305a-4fbf-9983-7546d424736f">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTc2_28e9b016-2846-447a-b58d-d8d1ba118f4b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#x2019;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued&#160;ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQ0MzE_97a8a068-e134-4e58-ad38-215091d67918"
      unitRef="usd">-1100000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQ0MzU_d2a042c1-b339-4b6e-b853-128c853a478e"
      unitRef="usd">3600000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQ0NDM_7dbfe249-10ae-49e3-9cae-496cfec8f36e"
      unitRef="usd">2100000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTg4_1441a030-39b7-43c2-a17c-a514320ebaed">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INVENTORIES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, $52.8&#160;million of inventories, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. &lt;/span&gt;&lt;/div&gt;The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTk4_d8582cc6-c5b4-4a87-9530-59910212bf44">Inventories consisted of the following: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzMtMS0xLTEtMzczNTY_77e6d644-4ddd-4053-9775-06f9dc44f212"
      unitRef="usd">162528000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzMtMy0xLTEtMzczNTY_0c2db2ab-e63b-4d95-92cb-c319095fe9b2"
      unitRef="usd">180301000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzQtMS0xLTEtMzczNTY_f45bbdd5-d584-469a-947b-19a395fc3e37"
      unitRef="usd">65323000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzQtMy0xLTEtMzczNTY_8a88b8c1-36f1-4765-8dcf-3b1f2a6bcd7e"
      unitRef="usd">53336000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzUtMS0xLTEtMzczNTY_ce9ec70e-911a-4b95-bd42-a5a289724ee0"
      unitRef="usd">89535000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzUtMy0xLTEtMzczNTY_3406df04-df53-4e7e-9b2a-0a243833a482"
      unitRef="usd">76480000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryNet
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzctMS0xLTEtMzczNTY_77921d7a-703f-48ef-8c5b-7f1ca3f20a2b"
      unitRef="usd">317386000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo5YTI4MGNmYmY4ZWU0YjRlOTRlNDI2MWRhOTFkMDY5NS90YWJsZXJhbmdlOjlhMjgwY2ZiZjhlZTRiNGU5NGU0MjYxZGE5MWQwNjk1XzctMy0xLTEtMzczNTY_39ac32ea-0fd9-45cf-9222-b0d30006fd45"
      unitRef="usd">310117000</us-gaap:InventoryNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i000ed083c92e4b89800da97c60ed285f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NTU3Mzk_a3f7d88b-1916-4328-ac62-c718d50fcd87"
      unitRef="usd">52800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <iart:InventoryCapitalizedExpenses
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzYzNjA_0028a1c0-00cc-47f7-a65f-6024d98ecf44"
      unitRef="usd">0</iart:InventoryCapitalizedExpenses>
    <iart:InventoryCapitalizedExpenses
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzYzNjA_abadf78c-3970-4575-9db3-d03ebb03637d"
      unitRef="usd">0</iart:InventoryCapitalizedExpenses>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTYy_52addee0-9b18-42f1-aaec-ebb08e3ef73a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PROPERTY, PLANT AND EQUIPMENT &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal-Use Software.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMDM2_7c0dd4f1-1f0f-4c3f-b66c-2e6bb7f544ea">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment balances and corresponding lives were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and production equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical instrument kits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information systems and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures, and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ida04a0f98d5547f9ac6673309e068708_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzMtMS0xLTEtMzczNTY_c5764f35-8625-4647-9c4b-5ae23f2a0416"
      unitRef="usd">1512000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7a45995162b643ef92059397e2a71385_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzMtMy0xLTEtMzczNTY_33044212-eddd-4fbd-8f5e-b98d4457f947"
      unitRef="usd">1541000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i74b70ea531614678a00a01b323481165_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzQtMS0xLTEtMzczNTY_a5c2de09-8277-41e3-9812-21011fad967e"
      unitRef="usd">19032000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic6c7328c66304f0eb5f22d8ed0526940_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzQtMy0xLTEtMzczNTY_92900b82-15e3-4162-981d-eeea5e4d7712"
      unitRef="usd">17345000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia5208743b3814ba9b6d40074565c4081_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzQtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjozZWNhYjJlMzE4ZmI0ODVkOGQ5M2E2NjcyNmYzNTIwNF80_c988427f-833a-4e40-b15c-6ec2692d3234">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i602a6eef7e324d61a157d45723a03358_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzQtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjozZWNhYjJlMzE4ZmI0ODVkOGQ5M2E2NjcyNmYzNTIwNF83_fec9b9f4-a4ca-482c-8d8e-38c068fdc2bd">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2b9b9c6b33494f24b03f4851071485a9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzUtMS0xLTEtMzczNTY_af2adbb7-fed9-4c10-a423-82e2779fc904"
      unitRef="usd">155495000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i963fa8e01c224aa0a64f3cb763df2e2b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzUtMy0xLTEtMzczNTY_001bacdd-7d4e-47aa-8cdc-f85b12dcae4d"
      unitRef="usd">144852000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic02808dda943426e93e0d648a5cde64b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzUtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpkY2U0MjMxOTIyY2U0ZjcxOGM0YjVjYTQ4Y2ViY2FmZV80_cc8c8244-dd3c-49d0-af1f-495dcfd0a610">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iefe78e2246e94ba3af3242006d2dc451_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzUtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpkY2U0MjMxOTIyY2U0ZjcxOGM0YjVjYTQ4Y2ViY2FmZV83_32975ffb-208c-4bd6-ba5f-68b4fa3df618">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9f2cb2e9bd3545d28c0f0abacf55b9d9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzYtMS0xLTEtMzczNTY_b4743c7b-f7b3-40b2-858e-8de2b250ed4a"
      unitRef="usd">183270000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i48bbc77d02174676af9eed39f9be47a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzYtMy0xLTEtMzczNTY_7746f9c0-20e1-4c87-b35c-2bfab1b93225"
      unitRef="usd">166973000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id648da5e33794a8d9bd7e7832d8f94cd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzYtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo5YzdlOTZjNTQ5MmU0M2Q3OWYyM2FiYjg3MGQyZTM4Nl80_41c7a64a-ef5e-4132-b1e6-f9da5b7e1280">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i41401778e13647b0a2ee5fcf8f706a6a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzYtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo5YzdlOTZjNTQ5MmU0M2Q3OWYyM2FiYjg3MGQyZTM4Nl83_20899f22-87da-4663-8c7b-90088252b1c3">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i602ca3405d8741a38048a4535e86e784_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzctMS0xLTEtMzczNTY_e9c047e5-5a1e-4909-8aa2-d21802743d37"
      unitRef="usd">2791000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia2a65e2f514d443397027c1f3e979693_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzctMy0xLTEtMzczNTY_fe7e1582-b890-45bc-8fcf-b7e69998874a"
      unitRef="usd">1164000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia3295f6c4fa84b5f99c2eb43117653cf_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzctNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjowMWQwNjg3MzIzZTg0MzRhYWQxYTYyN2Q2ZTQ5Yzk4NV80_08cc670a-58d6-4f9c-b1cd-478e72692e47">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i06b3b7586a5a4a83bcf6af176544c1e7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzctNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjowMWQwNjg3MzIzZTg0MzRhYWQxYTYyN2Q2ZTQ5Yzk4NV83_ee543dae-1112-41b0-ac0c-99fb7db2f998">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i01e4b5df061143a995961c4cc0610f5e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzgtMS0xLTEtMzczNTY_4e3249ee-3378-4aa8-bf16-c721116a1bbe"
      unitRef="usd">148706000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie167866deb594d9bad75e4138245a4e7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzgtMy0xLTEtMzczNTY_93c22ef0-5f18-46f7-b84e-3bdb26b2529f"
      unitRef="usd">143770000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i203bb570980f4213ae16c7f18573158d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzgtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpmNGFjNTIzYzFmMTA0NzBjOTUxZTQxNDBkNzBiMzJkY180_c48de2a6-3f95-41a5-87c8-24e9dc78791c">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iabf661f62ecd41f38efb53c5c7fab30f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzgtNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpmNGFjNTIzYzFmMTA0NzBjOTUxZTQxNDBkNzBiMzJkY183_a5519e42-01e6-41aa-b74e-2de88b7bc701">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7fd943aa50cb4e70b0f976a5852b32cd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzktMS0xLTEtMzczNTY_dc8aa945-7728-4429-8b4b-f93c699862e5"
      unitRef="usd">20921000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6f2a0560d0be447492d3aa5f43a5fb1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzktMy0xLTEtMzczNTY_cf160116-b96c-42fa-ad4f-80cfc190a81a"
      unitRef="usd">20843000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie8a2b6b9e3dc4ed2bb93554da43c0487_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzktNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjplZWY3ZmRlODFmNzM0MjY2YmMwMWQzNjExYmJhYjAyMl80_3f4c729c-180c-43dd-92dc-da81726dc04e">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6de32faeb0b247e4a9b3584e095721c3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzktNS0xLTEtMzczNTYvdGV4dHJlZ2lvbjplZWY3ZmRlODFmNzM0MjY2YmMwMWQzNjExYmJhYjAyMl83_8bdf92b2-4811-4de8-9fea-5351139b6050">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9bbd97850f3e4065b4b66bb87c2cce30_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzEwLTEtMS0xLTM3MzU2_54442127-7936-45eb-b9d6-cf5001f3ab5e"
      unitRef="usd">94850000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icb95fbf7a7c24b6d88311032f03ec584_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzEwLTMtMS0xLTM3MzU2_ac7fc644-cf5e-4dad-8385-8515260aa48b"
      unitRef="usd">73890000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzExLTEtMS0xLTM3MzU2_9d4c2904-4e21-4651-b251-91239ace80d5"
      unitRef="usd">626577000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzExLTMtMS0xLTM3MzU2_d036db57-f4fe-424f-92e7-eb6aac2a8ad5"
      unitRef="usd">570378000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzEyLTEtMS0xLTM3MzU2_69f67149-6c02-4ac0-99a4-0647191a9d05"
      unitRef="usd">314874000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzEyLTMtMS0xLTM3MzU2_eaadfcf3-758f-4d16-90df-4fd325d75249"
      unitRef="usd">282849000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzE0LTEtMS0xLTM3MzU2_3054a650-5238-4847-a995-37bc6c2ec5e4"
      unitRef="usd">311703000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTpkMDIzNmY0ZjYzYTE0YjUyYTM4NjU5YjgyNDUxMGQ1Ny90YWJsZXJhbmdlOmQwMjM2ZjRmNjNhMTRiNTJhMzg2NTliODI0NTEwZDU3XzE0LTMtMS0xLTM3MzU2_09450388-6482-449e-a541-cc20da7f4e40"
      unitRef="usd">287529000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i000ed083c92e4b89800da97c60ed285f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzMDk5Mzg_3d7c6d67-3e0b-47e2-9310-577380844dcc"
      unitRef="usd">37900000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:Depreciation
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzc1MjY_eeab0a47-165a-4549-ad9b-452fdbfe86f7"
      unitRef="usd">39400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzc1MzA_de3b33c7-2071-4b35-acd9-0674359b58f4"
      unitRef="usd">42100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzc1Mzg_4f742b04-f85a-4c94-a446-ac828f95eaf9"
      unitRef="usd">42600000</us-gaap:Depreciation>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="id6840528edb44a95a4b09018fdca6246_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzc2ODQ_71942b0c-eb6e-4e33-84a1-68631cb6adc0"
      unitRef="usd">6700000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:InterestCapitalizationPolicyPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTU1_3a890c66-e52f-40d2-921c-fdd7626b25ff">CAPITALIZED INTERESTThe interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings.</us-gaap:InterestCapitalizationPolicyPolicyTextBlock>
    <us-gaap:InterestCostsCapitalizedAdjustment
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzg0MjU_e9dcbf97-20e7-41b7-a7fd-dab91e4e14d0"
      unitRef="usd">1200000</us-gaap:InterestCostsCapitalizedAdjustment>
    <us-gaap:InterestCostsCapitalizedAdjustment
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0Xzg0MzI_97bb5228-3397-4279-9f7b-abd31a48c166"
      unitRef="usd">2300000</us-gaap:InterestCostsCapitalizedAdjustment>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTQ4_0bb1f77e-9b19-4bd2-a0be-74ef21af9085">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ACQUISITIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Results of operations of acquired companies are included in the Company&#x2019;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, Business Combinations (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired in recorded as goodwill. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction costs and costs to restructure the acquired company are expensed as incurred.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determi&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#x2019;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired IPR&amp;amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#x2019;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;amp;D acquired outside of a business combination is expensed immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;issuance, or validity and litigation.&lt;/span&gt;&lt;/div&gt;If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMDAy_30afa16a-4669-47cf-8a3a-d163fb04fe37">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Other Intangibles&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two reportable segments with three underlying reporting units. Refer to Note 16, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment and Geographic Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on reportable segments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;over their expected useful lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzExNTM0_434efcda-f467-4b1a-a818-ba9a08f799c2"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportingUnits
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzExNTYy_68cba0ce-409d-4a04-8f0f-5ea68c6637a5"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTI2_66f9646a-0501-4a95-a073-dbdc75e5750d">LONG-LIVED ASSETS Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <iart:FoundationPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTI3_9ccef8e5-c36e-41ff-a05a-a840ad7d3880">INTEGRA FOUNDATION The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements.</iart:FoundationPolicyTextBlock>
    <iart:CharitableContributions
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzE1ODQ2_e073a4e0-c5db-4b05-bba6-e3cb0bf4c085"
      unitRef="usd">1200000</iart:CharitableContributions>
    <iart:CharitableContributions
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzE1ODU4_422d8a20-4cc8-48b3-adb4-494de432154c"
      unitRef="usd">800000</iart:CharitableContributions>
    <iart:CharitableContributions
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzE1ODY1_a62c4b6e-c509-4ea8-82cf-de9c1331bbb6"
      unitRef="usd">300000</iart:CharitableContributions>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTQy_3a9b46b2-8a3e-4da0-80a0-b53194fea364">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DERIVATIVES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes. From time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are recognized at the fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes.&lt;/span&gt;&lt;/div&gt;The Company entered into foreign currency forward and foreign currency swap contracts that are not designated as a hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into other income, net on the consolidated financial statements.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMTA5_ee67d622-67e2-4199-9aa6-721221fdcc18">FOREIGN CURRENCY All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzM4NDgyOTA3OTU5NDE_160105cf-76ec-42dd-b214-4daacbc2d384"
      unitRef="usd">100000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzE5Nzgw_700d92be-a8a8-43b8-9867-ea3aab82e06b"
      unitRef="usd">-1600000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzE5Nzg3_d91af5d9-3db6-48e0-86df-21a19ff60bef"
      unitRef="usd">-300000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTk0_bf3d0cad-0bcb-4732-ad84-8ee73b6cb3e9">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. &lt;/span&gt;&lt;/div&gt;The Company continues to indefinitely reinvest substantially all of its foreign earnings. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTE5_03469f04-1d75-45d2-9285-26396ae4962a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;REVENUE RECOGNITION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI0Mzcw_c9172610-6a8d-4dac-b8b3-a0c0563d676b"&gt;one&lt;/span&gt; to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.&lt;/span&gt;&lt;/div&gt;Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contract Asset and Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.&lt;/span&gt;&lt;/div&gt;Shipping and Handling FeesThe Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod
      contextRef="id4434b0da63d4acb99529de55c3df6cc_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI0Mzc2_de205f3c-fbf1-44ed-bbd1-ae6e2cd055b6">P3M</iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTAw_cd9d0057-8f4c-49ad-8ed0-04d210199271">RESEARCH AND DEVELOPMENT Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTMw_925b8e82-25ae-40d1-ba75-66d093470246">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EMPLOYEE TERMINATION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation-Nonretirement Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ASC Topic 420 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;One-time Employee Termination Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met.</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="ib53b8c510bfb4f04a342d01490fff519_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjU4NjU_743bdaf7-4082-4051-9df8-edbafc290598"
      unitRef="usd">3400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id37cda7e161149dab639b5833e0cdaae_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzNDUzNjg_0ebee418-3b99-497e-a654-b725c6768e50"
      unitRef="usd">4900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic3178f6269054097bd491b98b26e7a45_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjU5MTE_60063ddf-02be-4852-b6e1-0ccf554d5a63"
      unitRef="usd">500000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if89798fbac704337b50567a4cce07285_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzNDUzNjk_c7818ef5-b08f-45e0-a1a4-1c12ec8de7f1"
      unitRef="usd">1200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ife4b1f164ed2413f96ccef0da637494a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjU5Mjg_d1b52e0a-e2ec-47a7-8090-97ed0f05c6cc"
      unitRef="usd">300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia8d6853b6a2340eea65ce878ccdc9506_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzNDUzNzA_02129b0e-7f6c-4b40-9f4f-2984d21920d6"
      unitRef="usd">300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjU5NzY_71eead55-4d7e-4f9c-97dd-d813774945a3"
      unitRef="usd">10200000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI3ODY2_7da61cb7-f2b8-4b15-8b63-e5ae67a47750"
      unitRef="usd">6400000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTkw_b1fb048d-c588-46b3-b5b3-3e1cc7629bff">STOCK-BASED COMPENSATION Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyOTIw_6a2c3d2b-c747-40e0-8930-cf0afd8051f1">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PENSION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a deferred compensation plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.&lt;/span&gt;&lt;/div&gt;This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices.</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage
      contextRef="i1ea7e387c13b48c89387b2d3d857caaa_D20190501-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMwNDc3_c744feaf-f76b-4064-b5f4-05a5be2a1b95"
      unitRef="number">0.75</iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage
      contextRef="i1ea7e387c13b48c89387b2d3d857caaa_D20190501-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMwNTEx_136ca1b2-9dcb-408b-bbe7-659e67993590"
      unitRef="number">1</iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMDE2_6b358ea9-3062-4eb6-9e7f-b5c21ff5cba2">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CONCENTRATION OF CREDIT RISK &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. &lt;/span&gt;&lt;/div&gt;The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems.</us-gaap:ConcentrationRiskCreditRisk>
    <iart:ConcentrationRiskNumberofCustomersOverBenchmark
      contextRef="if754557c7cc244208d000f3659321df2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODQ3_25954917-4197-4cf9-bd21-ab3874f5fd1e"
      unitRef="customer">0</iart:ConcentrationRiskNumberofCustomersOverBenchmark>
    <iart:ConcentrationRiskNumberofCustomersOverBenchmark
      contextRef="id3e5a63582034b89b1c34575b648c5cd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODQ3_26bd112c-9866-43b0-b5e0-e04db44f53be"
      unitRef="customer">0</iart:ConcentrationRiskNumberofCustomersOverBenchmark>
    <iart:ConcentrationRiskNumberofCustomersOverBenchmark
      contextRef="idb9fd4579c41462aa90ba45e8a15a748_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODQ3_d2bdcd70-ad05-4d05-997d-e1160da7de16"
      unitRef="customer">0</iart:ConcentrationRiskNumberofCustomersOverBenchmark>
    <iart:ConcentrationRiskThresholdPercentage
      contextRef="idb9fd4579c41462aa90ba45e8a15a748_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODkz_4797d054-1587-4323-8440-83787291e270"
      unitRef="number">0.10</iart:ConcentrationRiskThresholdPercentage>
    <iart:ConcentrationRiskThresholdPercentage
      contextRef="if754557c7cc244208d000f3659321df2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODkz_b287d215-7490-4314-ac6b-0fa89d57c808"
      unitRef="number">0.10</iart:ConcentrationRiskThresholdPercentage>
    <iart:ConcentrationRiskThresholdPercentage
      contextRef="id3e5a63582034b89b1c34575b648c5cd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzMxODkz_c4a19951-f52d-4a90-831a-b910e5c89062"
      unitRef="number">0.10</iart:ConcentrationRiskThresholdPercentage>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzMTEy_eed8e847-cf35-44a6-b81d-fb4d32e82266">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU&#160;2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption was permitted. The Company adopted this guidance during the year ended December 31, 2020. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued&#160;ASU 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under this guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The Company adopted ASU 2019-12 as of January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting.&#160;This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform.&#160;This ASU is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022.&#160;In January 2021, the FASB also issued ASU 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform- Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which clarified certain optional expedients and exceptions to entities that are affected because of the reference rate reform. The amendments in this ASU affect the guidance in ASU 2020-04 and are effective in the same timeframe as ASU 2020-04. The Company currently has contracts that are indexed to LIBOR and are continuing to monitor this activity and evaluate the associated risk. The Company is continuing to evaluate the scope of impacted contracts and the potential impact. The Company is also monitoring the developments regarding alternative rates and may amend certain contracts to accommodate those rates if the contract does not already specify a replacement rate. While the notional value of agreements potentially indexed to LIBOR is material, the Company does not expect a material impact consolidated financial statements and related disclosures associated with this transition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity's Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years using either the modified retrospective or full retrospective method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As detailed in Note 5,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, on February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes are subject to the guidance included in ASU 2020-06. The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ADJUSTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CONSOLIDATED BALANCE SHEET CLASSIFICATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;AMOUNT&lt;br/&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity issuance costs reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount amortization and equity costs reclassification, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2020, the Company made an irrevocable election under the indenture to require the principal portion of its 2025 Notes to be settled in cash and any excess in shares. Following the irrevocable notice, only the amounts settled in excess of the principal will be considered in diluted earnings per share under the &#x201c;if-converted&#x201d; method. Upon adoption of ASU 2020-06, the Company&#x2019;s 2025 Notes were reflected entirely as a liability since the embedded conversion feature will no longer be separately presented within stockholders&#x2019; equity. Additionally, from January 1, 2021, the Company is no longer incurring non-cash interest expense for the amortization of debt discount, therefore the interest expense for the 2025 Notes, which is included in the interest expense on the consolidated statements of operations and comprehensive loss, is lower as compared to the fiscal year of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASU 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which updates various codification topics by clarifying or improving disclosure requirements to align with the regulations of the U.S. Securities and Exchange Commission (the "SEC") . The ASU has been effective for the Company for annual and interim periods beginning after January 1, 2021. The Company adopted this standard on the January 1, 2021. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the FASB issued ASU 2021-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which provides guidance to clarify and reduce diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU No. 2021-04 are effective for all entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, including interim periods within those fiscal years. The amendment currently has no impact to the Company as the effect will largely depend on the terms of written call options or financings issued or modified in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="ib12b7654fd6c486c84790834f7e43479_I20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzMTE0NDE_97b5ec8a-3e5e-4ea6-a3d2-a8c0d0b2107b"
      unitRef="usd">575000000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzMTE0MzM_cfe99d15-58bc-4eec-8471-313100452a79"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzIxOTkwMjMzMTE0Mzg_7baa3e65-b3af-4b2a-8f74-a23293701952">The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ADJUSTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CONSOLIDATED BALANCE SHEET CLASSIFICATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;AMOUNT&lt;br/&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity issuance costs reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount amortization and equity costs reclassification, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i11696c20228346ddb295ad994c1d9416_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo2MWJhODcyZjZkNzM0MzU3YWJjNzgwZDU3ZTgzYTNmZS90YWJsZXJhbmdlOjYxYmE4NzJmNmQ3MzQzNTdhYmM3ODBkNTdlODNhM2ZlXzEtNC0xLTEtNDk3OTA_6de08de5-de42-4f52-9eb3-843fa50364dd"
      unitRef="usd">-20600000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i9e9d178090794fc6a66c5ddbb2103c9c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo2MWJhODcyZjZkNzM0MzU3YWJjNzgwZDU3ZTgzYTNmZS90YWJsZXJhbmdlOjYxYmE4NzJmNmQ3MzQzNTdhYmM3ODBkNTdlODNhM2ZlXzItNC0xLTEtNDk3OTA_86f247ae-d92c-40d5-8edc-38bd7156323b"
      unitRef="usd">89100000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ie48f6bf8baeb442bbdf792d72242d8ed_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo2MWJhODcyZjZkNzM0MzU3YWJjNzgwZDU3ZTgzYTNmZS90YWJsZXJhbmdlOjYxYmE4NzJmNmQ3MzQzNTdhYmM3ODBkNTdlODNhM2ZlXzMtNC0xLTEtNDk3OTA_9f2202e2-a4f7-4ef9-a8f5-48b160d8c355"
      unitRef="usd">-2500000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i11696c20228346ddb295ad994c1d9416_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo2MWJhODcyZjZkNzM0MzU3YWJjNzgwZDU3ZTgzYTNmZS90YWJsZXJhbmdlOjYxYmE4NzJmNmQ3MzQzNTdhYmM3ODBkNTdlODNhM2ZlXzQtNC0xLTEtNDk3OTA_3c50feb1-c15c-405a-98ef-71df9d46e677"
      unitRef="usd">-2800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i11696c20228346ddb295ad994c1d9416_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90YWJsZTo2MWJhODcyZjZkNzM0MzU3YWJjNzgwZDU3ZTgzYTNmZS90YWJsZXJhbmdlOjYxYmE4NzJmNmQ3MzQzNTdhYmM3ODBkNTdlODNhM2ZlXzUtNC0xLTEtNDk3OTA_2cb46ffb-a233-4dd0-b3ea-8ba1ffd0f8c9"
      unitRef="usd">-63300000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:InterestPaid
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQxOTI1_003392ee-8fc1-4ec7-ad57-fcdbae675d81"
      unitRef="usd">43200000</us-gaap:InterestPaid>
    <us-gaap:InterestPaidCapitalized
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQxOTM2_ad5a6c96-8dee-4bf9-b938-b2d0a79f01ee"
      unitRef="usd">1200000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaid
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQxOTky_e96b8b6e-96c5-4e5d-aec6-2a2a6443e82c"
      unitRef="usd">47300000</us-gaap:InterestPaid>
    <us-gaap:InterestPaidCapitalized
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMDAz_fd0b3354-dc57-4f80-bf77-26d85e7e5519"
      unitRef="usd">2300000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaid
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMDYy_785e82c0-d8f6-4805-96ce-3d66c0abc668"
      unitRef="usd">48900000</us-gaap:InterestPaid>
    <us-gaap:InterestPaidCapitalized
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMDcz_740209f4-b200-4e17-8d56-16da8a9252c1"
      unitRef="usd">3100000</us-gaap:InterestPaidCapitalized>
    <us-gaap:IncomeTaxesPaid
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMjI1_fb914b44-4cf2-4ef9-a557-c1f180660e1d"
      unitRef="usd">49500000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMjI5_bdad9694-4f28-4c66-ae96-11a25f948e1a"
      unitRef="usd">29800000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMjM2_9ce689e5-f1c6-4ac6-aabc-7d91db868ea8"
      unitRef="usd">16200000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMzc5_7758fa3b-d6da-49c1-84d5-8cde9bdca6e0"
      unitRef="usd">4700000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMzgz_d07b7b17-29e1-4a32-82ca-d12c4a31ff63"
      unitRef="usd">1600000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyMzkw_5442bb67-c661-44fe-bd88-67350edbe841"
      unitRef="usd">11000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="iac4630e900f848359896b56b725b4778_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjYzMzQ_c6fcab54-efa2-4173-bc25-33db8e2e2260"
      unitRef="usd">5000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="iac4630e900f848359896b56b725b4778_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQzOTgwNDY1NjY0MjA_c6fcab54-efa2-4173-bc25-33db8e2e2260"
      unitRef="usd">5000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i4078e47ac87f401e97eecd937cf9b64e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI3NDg3NzkxNTcxNTM_2b0b637a-0eda-4a9a-b695-885135b93f25"
      unitRef="usd">20000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4078e47ac87f401e97eecd937cf9b64e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzI3NDg3NzkxNTcyMzk_ba9ad83a-4377-4f55-9233-b18cb7ed9960"
      unitRef="usd">20000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i30fd64c1cb164ae0b2a907a07c1f841d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyNTAw_0ae7e097-f2b8-4579-ac6e-ddd47d3b6742"
      unitRef="usd">5000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i4207bdf79e8b43329423b675db80c712_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDIvZnJhZzplZDkwOTVmMWU5ODI0YjgzYjgyMGYwODhhZTY2NTNlNC90ZXh0cmVnaW9uOmVkOTA5NWYxZTk4MjRiODNiODIwZjA4OGFlNjY1M2U0XzQyNjMx_17293a9d-fb84-4c90-9eec-e40cc1c0bdf5"
      unitRef="usd">5000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzUwOTk_2843883d-20c9-4052-bb4f-633fe99ddb33">REVENUES FROM CONTRACTS WITH CUSTOMERS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Summary of Accounting Policies on Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contract Asset and Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transferred to trade receivable of contract asset included&lt;br/&gt;&#160;&#160;&#160;&#160;&#160;in beginning of the year contract asset &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, net of transferred to trade receivables on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of revenue included in beginning of year contract liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, net of revenue recognized on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, the short-term portion of the contract liability of $5.3 million and the long-term portion of $6.7 million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company is expected to recognize revenue of approximately $5.3 million in 2022, $2.9 million in 2023, $1.8 million in 2024, $0.9 million in 2025, $0.6 million in 2026, and $0.4 million thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Shipping and Handling Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Taxes Collected from Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2021, 2020 and 2019 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neurosurgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wound Reconstruction and Care&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Extremity Orthopedics&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private Label&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total  Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. Acquisitions and Divestitures, for details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior period amounts were reclassified between categories within the Codman Specialty Surgical segment to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 16, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment and Geographical Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of revenues based on the location of the customer.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzE3NDg_5b074aa8-941a-418b-9232-b5288eed0136">P90D</iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzUxMDA_b41d6198-64c9-4e3f-8b1d-78f00b78e542">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transferred to trade receivable of contract asset included&lt;br/&gt;&#160;&#160;&#160;&#160;&#160;in beginning of the year contract asset &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, net of transferred to trade receivables on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of revenue included in beginning of year contract liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, net of revenue recognized on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzMtNS0xLTEtMzczNTY_86d270f8-c85b-49d9-ba52-433141a55aa0"
      unitRef="usd">7430000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetReclassifiedToReceivable
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzQtNS0xLTEtMzczNTY_00189cf1-8ce4-4cc1-9e1b-13d499ad61aa"
      unitRef="usd">7430000</us-gaap:ContractWithCustomerAssetReclassifiedToReceivable>
    <iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzUtNS0xLTEtMzczNTY_51a89de8-1a74-44e8-ad51-03e7db8ba591"
      unitRef="usd">11412000</iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzYtNS0xLTEtMzczNTY_34f7e2b7-d5d9-4ae8-831f-dacc4b682025"
      unitRef="usd">11412000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzktNS0xLTEtMzczNTY_371b8950-ad75-4c15-abd5-019ed0cbb147"
      unitRef="usd">11961000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzEwLTUtMS0xLTM3MzU2_16384958-4f55-4366-b18d-537c452a7385"
      unitRef="usd">5164000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <iart:ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzExLTUtMS0xLTM3MzU2_e504c4bd-ab47-4e29-9680-5c445bdb86da"
      unitRef="usd">5175000</iart:ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation>
    <iart:ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzEzLTUtMS0xLTM3MzU2_df52c561-384e-4069-881f-353a74db4bfc"
      unitRef="usd">-26000</iart:ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTozYmRlMjljMzgzODM0ZTRhOTNkOWIxYTUzMmE0MDJlMi90YWJsZXJhbmdlOjNiZGUyOWMzODM4MzRlNGE5M2Q5YjFhNTMyYTQwMmUyXzE0LTUtMS0xLTM3MzU2_306fea43-5394-4fe8-aa18-5e2e8fe8e82b"
      unitRef="usd">11946000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMwMjU_7c1ba207-e366-4406-9097-b52145684cfd"
      unitRef="usd">5300000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMwNjY_74e8c788-f9d2-4b97-8f9e-0a57df338bab"
      unitRef="usd">6700000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i7337997e50724c52ad9348740bdd50dd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMyNzA_9e8b2891-394b-4ffe-9ad1-9573de9571f0"
      unitRef="usd">5300000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i90fd6ad1a4554b1490ef3ec1f9cc90a8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMyODA_ea086335-7a77-4999-bbb5-57e7fc24c37f"
      unitRef="usd">2900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i0fc4597fa28c4d28b01a34ea89b827b8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMyOTA_13e3479a-fc39-4db6-8000-356f7122f0d6"
      unitRef="usd">1800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i4a2a15098f6f43029cb4a63d99daaad7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMzMDA_fd157981-72e7-4e30-8a2f-11062184fadc"
      unitRef="usd">900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="id4a31a62be1b454f97664e2f38331c1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMzMTA_ec21a3b1-32f0-4de1-8b20-589a5e4ed52a"
      unitRef="usd">600000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i13ba3f3fdc0e466ca5971c734c60c60f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzMzMjQ_4a686769-95c9-41b7-a401-09cbc9aa690f"
      unitRef="usd">400000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ExtendedProductWarrantyPolicy
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzUwOTc_9fcdc379-7b7a-4128-9c8b-432c444df6ba">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ExtendedProductWarrantyPolicy>
    <iart:RevenueProductWarrantyPeriod
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzQwMzg_07a115a1-f109-4cc2-be54-45cc97273115">P2Y</iart:RevenueProductWarrantyPeriod>
    <us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzUwOTQ_58d3ed7e-c3bb-47c5-946f-9e5f1a83d65c">Taxes Collected from CustomersThe Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90ZXh0cmVnaW9uOjg0NTA3MDA0NTViNTQwMzRhNjNhODUxY2IzZmNkN2RlXzUwOTg_4d85a405-bbd7-42d1-843e-b1b0c00362ed">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2021, 2020 and 2019 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neurosurgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wound Reconstruction and Care&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Extremity Orthopedics&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private Label&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total  Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. Acquisitions and Divestitures, for details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb65637da52f4b90bf607fb7b60c210d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzItNC0xLTEtMzczNTY_2571b91e-62b1-469f-b721-879de390cae7"
      unitRef="usd">802959000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b4a664e6d9b4e52b3a3790429c82944_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzItNS0xLTEtMzczNTY_1feb81c1-d9bc-47ab-ae6e-14df2a51f689"
      unitRef="usd">716339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ff06dcd1f9e4d58b2040d6ef14e3b3f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzItNi0xLTEtMzczNTY_0a3fcde8-f8f2-4f39-aeda-f2c566fd9170"
      unitRef="usd">767793000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bb8e06d1a9b412091aa582f72d27809_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzMtNC0xLTEtMzczNTY_0f42cc1f-7466-4a7d-9edb-f4232e7ce693"
      unitRef="usd">222273000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8d2e95c76ae4a789dd053d9ce02580f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzMtNS0xLTEtMzczNTY_0182b383-28d1-422c-8feb-59c120efb8ff"
      unitRef="usd">178492000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3046a6eaecf24960a1993adec9143348_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzMtNi0xLTEtMzczNTY_f9446999-6305-47c7-8321-a39ce58a4811"
      unitRef="usd">228413000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzQtNC0xLTEtMzczNTY_199abfcd-df98-420a-a9c0-6e40eb3c0fdf"
      unitRef="usd">1025232000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb66154030084b3e8586a701e0a6bdb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzQtNS0xLTEtMzczNTY_799ad5da-5f5d-4dd4-b24c-81feeafaf643"
      unitRef="usd">894831000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69a65713dfe64c33a00c72d8483e68a9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzQtNi0xLTEtMzczNTY_e6fe47cc-f8cd-433c-92cb-7bd920ba5cbf"
      unitRef="usd">996206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb4f933be6cc44ff9ddec8c3d27cbf1c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzYtNC0xLTEtMzczNTY_db0aa00c-72a2-4e6a-acd1-540b8efb66fe"
      unitRef="usd">392463000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic811b1a099e24c99825ca52914fcf541_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzYtNS0xLTEtMzczNTY_129d7243-b50a-47c2-8218-e5e69a2d8db4"
      unitRef="usd">293038000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ba7171afa8d4132b7dbe3ab5a4a60f8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzYtNi0xLTEtMzczNTY_b185fcf3-10c9-48a2-acd0-a29e9849c1e5"
      unitRef="usd">322739000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if358055a698b49a2858282451967cd20_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzctNC0xLTEtMzczNTY_ac5f15b6-36cf-49a6-941d-9bf5f6023a52"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66173391a20f4c668d46a6f1ce9e6d20_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzctNS0xLTEtMzczNTY_dadac0a4-538d-47b6-b0f9-9cda99294b4f"
      unitRef="usd">78316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c4278b9686c4d53aea7074968344102_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzctNi0xLTEtMzczNTY_fd6a9d02-c870-43ac-85c1-2b773d3daf12"
      unitRef="usd">90082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a552626ffa247e6bf4b04926eff831f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzgtNC0xLTEtMzczNTY_6f9d6492-1adf-47a7-94e3-2b69aa77978e"
      unitRef="usd">124753000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5734c3cfbd64dd99f45e59662837d44_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzgtNS0xLTEtMzczNTY_25959353-ef5d-47b9-8b85-372a06e9ee02"
      unitRef="usd">105683000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ideb8306c92f54514bfe2a9e21c1ef069_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzgtNi0xLTEtMzczNTY_b4858ebe-64bc-48df-9461-61112ac630fd"
      unitRef="usd">108530000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d1799cdfeb443c297cec0ede24b319e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzktNC0xLTEtMzczNTY_472a9267-eeba-4561-8b2c-7c6abade5407"
      unitRef="usd">517216000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b76730b7e7f49afa097d63b1fb0577c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzktNS0xLTEtMzczNTY_f06e2d6e-93e0-4934-bea0-1e1154ec1715"
      unitRef="usd">477037000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie57e505f7452456591a3ff162137393e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzktNi0xLTEtMzczNTY_fcdf3635-1dcd-4a22-bfe1-94a65b989b9c"
      unitRef="usd">521351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzEwLTQtMS0xLTM3MzU2_c5bc1051-1564-4975-9009-144b19df8ef7"
      unitRef="usd">1542448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzEwLTUtMS0xLTM3MzU2_137b1592-a396-4834-a27b-479b8634ad32"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNDgvZnJhZzo4NDUwNzAwNDU1YjU0MDM0YTYzYTg1MWNiM2ZjZDdkZS90YWJsZTphNTdkNjkwN2RhOTI0YzY5YjhhMDFjNjA3Y2FlMzBmYi90YWJsZXJhbmdlOmE1N2Q2OTA3ZGE5MjRjNjliOGEwMWM2MDdjYWUzMGZiXzEwLTYtMS0xLTM3MzU2_adab5b16-828f-424f-8197-cf2c584385ce"
      unitRef="usd">1517557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzg5ODg_129e0886-5a50-4d2a-a52d-2b2041034378">ACQUISITIONS AND DIVESTITURES&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sale of Extremity Orthopedics Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2021, the Company completed the sale of its Extremity Orthopedics business to Smith &amp;amp; Nephew USD Limited ("Smith &amp;amp; Nephew"). The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. The Company received an aggregate purchase price of $240.0&#160;million from Smith &amp;amp; Nephew and concurrently paid $41.5&#160;million to the Consortium of Focused Orthopedists, LLC ("CFO") effectively terminating the licensing agreement between Integra and CFO relating to the development of shoulder arthroplasty products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities divested consisted of the following as of December 31, 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.111%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset - operating leases and Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The divestiture does not represent a strategic shift that will have a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the Extremity Orthopedics business to the Company's Tissue Technologies reporting unit. In connection with the sale, the Company recognized a gain of $41.8&#160;million that is presented in Gain from the sale of business in the consolidated statement of operations for the year ended December&#160;31, 2021. The Company finalized the net working capital and paid an additional $1.3&#160;million to Smith &amp;amp; Nephew as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also entered into a transition services agreement with Smit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;h &amp;amp; Nephew which requires the Company to provide certain services on behalf&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of Smith &amp;amp; Nephew for the duration of the period subsequent to the sale of the business as defined in the agreement. The Company recognized a payable due to Smith &amp;amp; Nephew of $9.1 million as of December&#160;31, 2021, included in the consolidated balance sheet within accrued expenses and other current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ACell, Inc. Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On January 20, 2021, the Company acquired ACell, Inc. (the "ACell Acquisition") for an acquisition purchase price of $306.9&#160;million plus contingent considerations of up to $100&#160;million, that may be payable upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. The final working capital adjustments of $1.3&#160;million was finalized and paid as of June 30, 2021. ACell was a privately-held company that offered a portfolio of regenerative products for complex wound management, including developing and commercializing products based on MatriStem Urinary Bladder Matrix, a technology platform derived from porcine urinary bladder extracellular matrix.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Acquired and Liabilities Assumed at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACell Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination are recognized at their fair values as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13-14 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use asset - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;408,780&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;101,842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;306,938&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the developed technology acquired was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#x2019;s life cycle, and competitive trends impacting the asset and each cash flow stream.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company used a discount rate of 8.5% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company allocated goodwill related to the ACell acquisition to the Tissue Technologies segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected synergies of the combined company and assembled workforce. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the acquisition, the Company is required to make payments to the former shareholders of ACell up to $100&#160;million based on the achievement of certain revenue-based performance milestones in 2022, 2023, and 2025. T&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he Company used iterations of the Monte Carlo simulation to calculate the&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $23.9 million at the acquisition date. The estimated fair value as of December&#160;31, 2021 was $21.8 million. This amount is included in other liabilities at December&#160;31, 2021 in the consolidated balance sheets of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the acquisition date fair value of contingent consideration obligations using a Monte Carlo simulation, as well as significant unobservable inputs, reflecting the Company&#x2019;s assessment of the assumptions market participants would use to value these liabilities. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resultant most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligations is revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities result from identifiable intangible assets&#x2019; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pro Forma Results (unaudited)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pro forma revenues for the year ended December 31, 2021 and 2020 were $1,547.0&#160;million and $1,466.8&#160;million, respectively. Pro forma net income and earnings per share are not presented for this acquisition as they are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Arkis BioSciences Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of $30.6 million (the "Arkis Acquisition") plus contingent consideration of up to $25.5 million, that may be payable based on the successful completion of certain development and commercial milestones. The contingent consideration had an acquisition date fair value of $13.1 million. Arkis was a privately-held company that marketed the CerebroFlo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; external ventricular drainage (EVD) catheter with Endexo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Acquired and Liabilities Assumed at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Arkis Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CerebroFlo developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Enabling technology license&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired   &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the intangible assets was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each asset (including net revenues, cost of sales, R&amp;amp;D costs, selling and marketing costs, and working capital/contributory asset charges), the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#x2019;s life cycle, and competitive trends impacting the asset and each cash flow stream.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company used a discount rate of 14.5% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company allocated goodwill related to the Arkis Acquisition to the Codman Specialty Surgical segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. One of the key factors that contributes to the recognition of goodwill, and a driver for the Company's acquisition of Arkis, is the planned expansion of the Endexo technology with the existing products within the Codman Specialty Surgical segment. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level&#160;3 measurement as defined using the fair value concepts in ASC 820. The resultant probability-weighted cash flows are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation is revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent consideration obligations may result from changes in discount periods and rates, changes in the timing and amount of revenue estimates and changes in probability assumptions with respect to the likelihood of achieving the various contingent payment obligations. Adverse changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the acquisition, the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10 million and commercial sales milestones of $15.5 million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated the fair value as of December&#160;31, 2021 was $15.1&#160;million. The Company recorded $3.7&#160;million in accrued expenses and other current liabilities and $11.4&#160;million in other liabilities at December&#160;31, 2021 in the consolidated balance sheets of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities result from identifiable intangible assets&#x2019; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pro forma results are not presented for this acquisition as they are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Rebound Therapeutics Corporation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (&#x201c;Rebound&#x201d;), developers of a single-use medical device known as the Aurora&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Surgiscope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System ("Aurora") which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the &#x201c;Rebound transaction&#x201d;). Under the terms of the Rebound transaction, the Company made an upfront payment of $67.1 million and are committed to pay up to $35.0 million of contingent development milestones upon achievement of certain regulatory milestones.&#160;The acquisition of Rebound was primarily concentrated in one single identifiable asset and thus, for accounting purposes, the Company has concluded that the acquired assets do not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a $59.9 million IPR&amp;amp;D expense. The balance of approximately $7.2 million, which included $2.1 million of cash and cash equivalents and a net deferred tax asset of $4.2 million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carry forward. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $5.0 million obligation to be paid to former shareholders of Rebound. The Company recorded $5.0 million as IPR&amp;amp;D expense in the consolidated statements of operations. The obligation was included in accrued expenses and other current liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $20.0&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $20.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, the Company achieved its final developmental milestone which triggered a $5.0&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $5.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The remaining obligation was included in accrued expenses and other current liabilities at December 31, 2021 in the consolidated balance sheets. The milestone is expected to be fully paid during the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Integrated Shoulder Collaboration, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2019, the Company entered into a licensing agreement with Integrated Shoulder Collaboration, Inc ("ISC"). Under the terms of the agreement, the Company paid ISC $1.7 million for the exclusive, worldwide license to commercialize its short stem and stemless shoulder system. A patent related to short stem and stemless shoulder systems was issued to ISC during the first quarter of 2019. ISC is eligible to receive royalties on sales of the short stem and stemless shoulder system. The Company has the option to acquire ISC at a date four years subsequent to the first commercial sale, which becomes mandatory upon the achievement of a certain sales thresholds of the short stem and stemless shoulder system, for an amount not to exceed $80.0 million. The transaction was accounted for as an asset acquisition as the Company concluded that it acquired primarily one asset. The total upfront payment of $1.7 million was expensed as a component of research and development expense and the future milestone and option payments will be recorded if the corresponding events become probable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the sale of the Company's Extremity Orthopedic business, on January 4, 2021 the Company paid $41.5&#160;million to CFO pursuant to the terms of certain agreements between the Company and CFO relating to the sale of shares of ISC effectively terminating our licensing agreement with ISC.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i3269a9a9d0024d43b9f980a0524d7c42_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE0NjM_7b5f530d-8bb3-458a-9c62-176383c43e87"
      unitRef="usd">240000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination
      contextRef="i170068c51ed94ca9bf2387c3ce7260fc_D20210104-20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE0Nzk_98bcaecf-dd25-4553-8adb-76cea545da19"
      unitRef="usd">41500000</iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1ODk_3a971ad8-efa2-4574-bc9a-0d224108247b">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities divested consisted of the following as of December 31, 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.111%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset - operating leases and Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzAtMS0xLTEtNDM0NDI_c44693c9-81d6-4771-b936-6b52f8161cdc"
      unitRef="usd">713000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <iart:DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzEtMS0xLTEtNDM0NDI_fdcaa91c-568a-4959-b4e9-9c512ed8624e"
      unitRef="usd">3186000</iart:DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzItMS0xLTEtNDM0NDI_f531553f-fe46-4143-a330-5026be7399fb"
      unitRef="usd">6589000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzMtMS0xLTEtNDM0NDI_337ae867-61d8-4ec5-b6a7-e66b670316bb"
      unitRef="usd">13332000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzQtMS0xLTEtNDM0NDI_224cacec-2f03-4a59-8af6-d775f6e10b6b"
      unitRef="usd">37893000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzUtMS0xLTEtNDM0NDI_bba39d76-2d7e-4b9d-b5d9-fa9c8c285497"
      unitRef="usd">47546000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzYtMS0xLTEtNDM0NDI_e460ac55-1443-41bc-b86d-e3a3cf069bf7"
      unitRef="usd">52845000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzctMS0xLTEtNDUwMDY_80296521-9d33-4762-8276-20d6087e14a1"
      unitRef="usd">162104000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzktMS0xLTEtNDM0NDY_20c11f4e-fae2-4cff-b980-62d2b7e12d90"
      unitRef="usd">336000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzEwLTEtMS0xLTQzNDQ2_41eef76e-7950-496d-86ad-9f5cf7346928"
      unitRef="usd">539000</iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzExLTEtMS0xLTQzNDQ2_4ce1e6aa-8735-4c21-87d7-eaebe064f370"
      unitRef="usd">1767000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzEyLTEtMS0xLTQzNDQ2_ec7d762c-8041-4d19-95c4-d6c8da3b2db1"
      unitRef="usd">3440000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities>
    <iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzEzLTEtMS0xLTQzNDQ2_212a464d-fee2-46ec-975a-a3c7d4a16c49"
      unitRef="usd">5669000</iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i53b2addcbddb44aa9a3b86029bb50420_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpkZmZiODM3NjA5MjE0ZTdiOTVkZDA2Mjc5MGZjOTYwNS90YWJsZXJhbmdlOmRmZmI4Mzc2MDkyMTRlN2I5NWRkMDYyNzkwZmM5NjA1XzE0LTEtMS0xLTQ1MDA2_e915a22a-2fb1-44cf-af17-4492c3ac9574"
      unitRef="usd">11751000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i96bd4fb9f9f845cfb6e003e78b8a9bc7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE0OTQ_2a63aef2-c160-461f-99c6-ad2d38d7f7fc"
      unitRef="usd">41800000</us-gaap:GainLossOnSaleOfBusiness>
    <iart:NetWorkingCapital
      contextRef="i40a2c7932fe4499294fbfb9e9cb7437f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzEwOTk1MTE2NTExMjc_53247a32-b4c6-436e-9791-47266939fb23"
      unitRef="usd">1300000</iart:NetWorkingCapital>
    <iart:DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable
      contextRef="i40a2c7932fe4499294fbfb9e9cb7437f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzEwOTk1MTE2Mzg4NzM_241d5363-0304-40fb-831b-55d7450c374f"
      unitRef="usd">9100000</iart:DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ica517bcfa6884ebc90de2aca64243203_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1MjM_df213957-f782-4ad9-8a72-2c72501e0839"
      unitRef="usd">306900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1Mzk_70772615-e4bd-4e2d-9b58-bf8a41b696fc"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <iart:BusinessCombinationWorkingCapitalAdjustment
      contextRef="ia2e483bc15a0412aa43477e358585f01_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1NTM_99a4e64d-70f3-49a4-a6a5-e879fbe6c96b"
      unitRef="usd">1300000</iart:BusinessCombinationWorkingCapitalAdjustment>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1OTA_d2221786-6134-4835-8de7-0d2b03b250a0">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13-14 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use asset - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;408,780&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;101,842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;306,938&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CerebroFlo developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Enabling technology license&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired   &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzItMS0xLTEtNDM1MjQ_2ef3e386-6fea-4742-bfe1-6d1eb4cd3eb3"
      unitRef="usd">2726000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzMtMS0xLTEtNDM1MjQ_b94fd32f-2e20-4675-a518-7d5f22c0b9c0"
      unitRef="usd">16469000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzQtMS0xLTEtNDM1MjQ_6d7155fa-60cf-4fcc-8654-193bcda1f523"
      unitRef="usd">18299000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzUtMS0xLTEtNDM1MjQ_213d5661-2c72-44c0-9f0b-1317f8528ee3"
      unitRef="usd">1498000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzYtMS0xLTEtNDQ5Mzg_0b46f608-ff48-4504-9f10-a26070548948"
      unitRef="usd">38992000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzctMS0xLTEtNDM1MjQ_6f3b6ea4-6c61-479a-9291-1beba20bf6df"
      unitRef="usd">13769000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzgtMS0xLTEtNDM1MjQ_7c8144a4-9557-44db-8471-4f86b809157c"
      unitRef="usd">245000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i39d90578eea04bf1b29ed35663a1802d_D20210120-20210120"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzgtMy0xLTEtNDM1MjQvdGV4dHJlZ2lvbjphNmVlNTc0MGViZmU0MTA3YWM1YTc3NzRiMTkyNzNkMF8xMDk5NTExNjI3Nzk0_518c8df4-00a3-4b9b-88da-0b0ba69ba61a">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i688db6d6eb2f458d8870fc231b4592c5_D20210120-20210120"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzgtMy0xLTEtNDM1MjQvdGV4dHJlZ2lvbjphNmVlNTc0MGViZmU0MTA3YWM1YTc3NzRiMTkyNzNkMF8xMDk5NTExNjI3Nzk4_44429b56-995b-4f20-a80f-62b1a7269f54">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzktMS0xLTEtNDM1MjQ_d78a7e74-5e04-46c5-899a-8509165dbebe"
      unitRef="usd">94147000</us-gaap:Goodwill>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzEwLTEtMS0xLTQzNTI0_870a3ee9-8f9a-4977-bede-78325cb9d0b1"
      unitRef="usd">9259000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzExLTEtMS0xLTQzNTI0_303d63f7-6281-416a-9fb7-e118b89f0add"
      unitRef="usd">7465000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzEyLTEtMS0xLTQzNTI0_c0068d36-7acc-4b66-b7bf-23a69d73337e"
      unitRef="usd">148000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzEzLTEtMS0xLTQ0OTM4_7e1be7ed-d81e-4cb1-b856-be8caffbe066"
      unitRef="usd">408780000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzE2LTEtMS0xLTQzNTI0_df435661-737b-4b47-ad35-6b3eec5e5b23"
      unitRef="usd">718000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzE3LTEtMS0xLTQzNTI0_67a4873e-f229-4c8b-9eec-1e04bdef9bbc"
      unitRef="usd">5966000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzE4LTEtMS0xLTQzNTI0_094b8a65-3d03-408c-b180-6c1fc002182c"
      unitRef="usd">1673000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzE5LTEtMS0xLTQ0OTM4_87841a79-c6f2-408d-9ace-d10d9a4d48f5"
      unitRef="usd">8357000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzIwLTEtMS0xLTQzNTI0_f8cacef0-2881-4ab8-83c5-84a6762515cc"
      unitRef="usd">276000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzIxLTEtMS0xLTQzNTI0_01275e66-1988-4d33-8664-659b83dfccc3"
      unitRef="usd">7585000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzIyLTEtMS0xLTQzNTI0_673bca51-8c1b-47b0-a08c-71c72b6943b8"
      unitRef="usd">61724000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzIzLTEtMS0xLTQzNTI0_4e7ed25d-4413-47dd-a16b-89b378adf01a"
      unitRef="usd">23900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzI0LTEtMS0xLTQ0OTM4_e948dca1-4bab-413f-9296-db025d122448"
      unitRef="usd">101842000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ib985a5fa452f42faa4085adbfafaedf0_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTpiZjdlMTQ0OTVmZjQ0OTRjYjU5YmRhNTVmY2NjODBhZC90YWJsZXJhbmdlOmJmN2UxNDQ5NWZmNDQ5NGNiNTliZGE1NWZjY2M4MGFkXzI2LTEtMS0xLTQ0OTM4_8b3d9ac8-0675-4eb1-8af1-5c7a759d163e"
      unitRef="usd">306938000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate
      contextRef="i5f23076f31b3452e8dd0574aff2fb161_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzUzMDE_617ad910-d0b6-4acd-af39-92e6bc8a1809"
      unitRef="number">0.085</iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i5f23076f31b3452e8dd0574aff2fb161_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIxOTkwMjMyNzE1NzU_cc6d27af-cd96-4901-a76d-ae0c2779a203"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i5f23076f31b3452e8dd0574aff2fb161_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzEwOTk1MTE2NDc3NTE_3c1b4f70-3da2-429d-ac53-21092928ec34"
      unitRef="usd">23900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5f23076f31b3452e8dd0574aff2fb161_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzEwOTk1MTE2NDM2NTE_125e90a6-de74-4cd0-81c3-3240027ca90c"
      unitRef="usd">21800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:Revenues
      contextRef="i9a53bd10b62342d88e6811d75c05b920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQzOTgwNDY1MzA2NTY_9235bd8d-987a-4c4b-888b-6fb8c6cfd9db"
      unitRef="usd">1547000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie3b4a6c5eb0b434dba966ae4580828dd_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQzOTgwNDY1MzA2NzQ_da36eb33-3789-404c-a1ff-b74c95186d3c"
      unitRef="usd">1466800000</us-gaap:Revenues>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if70040a00764430ebf4558b0c9e06708_D20190729-20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzE1NA_3d68dbed-7bc3-4218-9778-8a24c68a5c85"
      unitRef="usd">30600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzIyMg_c39c2a0e-99b3-4f9d-bb3e-a79a33fe2f7e"
      unitRef="usd">25500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzM5OA_f8b6b965-db47-4d4f-a003-72ab3e6ddf35"
      unitRef="usd">13100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzItMS0xLTEtMzczNTY_4dd2a403-705d-4819-8df1-ec4069bc5c28"
      unitRef="usd">90000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzMtMS0xLTEtMzczNTY_149b5aca-5077-40ab-ba08-8175381e0fc2"
      unitRef="usd">751000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzQtMS0xLTEtMzczNTY_ea3ae3e4-4d71-418f-8661-aa1b93f3e074"
      unitRef="usd">457000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzUtMS0xLTEtMzczNTY_ccb9a7d2-7049-4d40-b90e-d0e8f438fed7"
      unitRef="usd">1697000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic5615952a2a84ce48747f6e0a5b12e88_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzctMS0xLTEtMzczNTY_5042c153-4e2c-440e-a0a3-367d75c43b5c"
      unitRef="usd">20100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i71e837488c6d40d2bae9b77a42432999_D20190729-20190729"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzctMi0xLTEtMzczNTY_2f787416-0849-4fc1-b449-bc463ba90fa7">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4506a521f784464fab88c8e0a8d34c01_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzgtMS0xLTEtMzczNTY_a6cce117-0a40-4645-8916-3ff686542150"
      unitRef="usd">1980000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i42a7d4331e424eb9b52d2c8d7ac98fcd_D20190729-20190729"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzgtMi0xLTEtMzczNTY_db52cd2d-075e-4063-9cc2-d9a9a26a3a3c">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzktMS0xLTEtMzczNTY_1f0e961a-7491-4ca2-b324-2485c523c8b2"
      unitRef="usd">27153000</us-gaap:Goodwill>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzEwLTEtMS0xLTM3MzU2_4e1ca378-a110-4c10-8559-5605d49b67a8"
      unitRef="usd">52228000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzEyLTEtMS0xLTM3MzU2_bac8cf7e-3ea1-45ca-8769-e6868fba52f1"
      unitRef="usd">2926000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzEzLTEtMS0xLTM3MzU2_f04a7e1a-6038-4f20-a000-53d73a3bc06f"
      unitRef="usd">13100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzE0LTEtMS0xLTM3MzU2_6806da9d-b90f-4f93-b3de-ac3b26076b45"
      unitRef="usd">5603000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90YWJsZTo3MmY2ZDc0YzcwMzc0ZjhmYTI2Y2ZhOTgyODE1ZTgyMS90YWJsZXJhbmdlOjcyZjZkNzRjNzAzNzRmOGZhMjZjZmE5ODI4MTVlODIxXzE1LTEtMS0xLTM3MzU2_78c7f83b-447c-43a4-bc2d-8326b403f3d8"
      unitRef="usd">30599000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <iart:AcquiredFinitelivedIntangibleAssetsDiscountRate
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzE5MzY_77d9d7fa-976d-4523-9341-094b818cbb20"
      unitRef="number">0.145</iart:AcquiredFinitelivedIntangibleAssetsDiscountRate>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQ0NDA_b1442790-f565-4461-8109-7b611271dfeb"
      unitRef="usd">25500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4bcd02ade40d4716b1746fdd3cb2430d_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQ1MDA_8229cd8c-50eb-43f8-aaef-12a394380577"
      unitRef="usd">10000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib8d9df81e2784a7f822f5902f3423b63_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQ1Mzk_cc328d7a-6bbf-4893-be3d-adf19a96ac05"
      unitRef="usd">15500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i38aa67cd6e6c4cee8eea6791cadd135b_I20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzEwOTk1MTE2NDc3NTk_3004bb67-4640-42c5-87a9-63e843f68c82"
      unitRef="usd">13100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i5f6f1a1544924074a1d3d7fb36a12a6d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQzOTgwNDY1MzA3OTM_e0019327-3093-461b-b406-af209553779f"
      unitRef="usd">15100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ieaad07293f494ff6889330b346414a47_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQzOTgwNDY1MzA4MjU_0a377810-d8e9-43c3-8382-d39c1a85e802"
      unitRef="usd">3700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i318b6e50656b461a91847e56aab39040_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQzOTgwNDY1MzA4NDU_22c5fda1-9124-4fef-87c0-ce84b9a3e3c4"
      unitRef="usd">11400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="i051d23eceb014bb58273d6270a8f1c00_D20190909-20190909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzU5MDg_b1ee8538-bb5f-45a2-8350-613c85cf59fb"
      unitRef="usd">67100000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <iart:AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet
      contextRef="i051d23eceb014bb58273d6270a8f1c00_D20190909-20190909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzU5NTA_ae4a2df4-78ea-44da-94e7-8d819e909088"
      unitRef="usd">35000000.0</iart:AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet>
    <iart:AssetAcquisitionNumberOfAssetsAcquired
      contextRef="i4878a7d091a8419aa9f27c3d38684f89_I20190909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzYxMDY_7b02536d-d802-44c5-99a3-218fca1301cb"
      unitRef="asset">1</iart:AssetAcquisitionNumberOfAssetsAcquired>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="i4528a498ca614d9ea547555427227000_D20190909-20190909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzYzNDQ_827e79c7-768e-48b0-afd4-debc22a30284"
      unitRef="usd">59900000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i051d23eceb014bb58273d6270a8f1c00_D20190909-20190909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzYzOTk_42d897d2-76de-4556-84c4-dc71a91a02e0"
      unitRef="usd">7200000</iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet>
    <iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i49e912b1fd87487785c228195b43bd1c_D20190909-20190909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzY0MjY_46fa401a-e91b-4d59-97c3-dd1d0b3d7691"
      unitRef="usd">2100000</iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet>
    <iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i33224855ef3047999b2cae3d50de0f11_D20190909-20190909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzY0OTg_08a77297-0257-4703-994c-dc594f951f9e"
      unitRef="usd">4200000</iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i30fd64c1cb164ae0b2a907a07c1f841d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzY3NjI_cc670ee6-939a-4679-b9d1-6135d540b811"
      unitRef="usd">5000000.0</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ia442774231c74a88babc4cf70ca6a7b9_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzY4NTE_320bd504-6bd0-421b-9249-0c072e69a9b0"
      unitRef="usd">5000000.0</us-gaap:ResearchAndDevelopmentInProcess>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i4078e47ac87f401e97eecd937cf9b64e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzcyMjQ_2b0b637a-0eda-4a9a-b695-885135b93f25"
      unitRef="usd">20000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4078e47ac87f401e97eecd937cf9b64e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzczMDk_ba9ad83a-4377-4f55-9233-b18cb7ed9960"
      unitRef="usd">20000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="iac4630e900f848359896b56b725b4778_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQ5NDc4MDIzNDMyODI_c6fcab54-efa2-4173-bc25-33db8e2e2260"
      unitRef="usd">5000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="iac4630e900f848359896b56b725b4778_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzQ5NDc4MDIzNDMzMDU_c6fcab54-efa2-4173-bc25-33db8e2e2260"
      unitRef="usd">5000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i75ac54230bc045c6acdd9a962aabc8fa_D20190104-20190104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzc2NzI_f3c4a2bb-1183-4a6e-a5dd-6bed6cf70865"
      unitRef="usd">1700000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <iart:AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet
      contextRef="i75ac54230bc045c6acdd9a962aabc8fa_D20190104-20190104"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzgwNDE_b2ff49d4-89a8-418d-9997-21e162824e63">P4Y</iart:AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet>
    <iart:AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet
      contextRef="i75ac54230bc045c6acdd9a962aabc8fa_D20190104-20190104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzgyMzc_b23dfdcd-fadc-489b-bf8c-16933e63b882"
      unitRef="usd">80000000.0</iart:AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet>
    <iart:AssetAcquisitionNumberOfAssetsAcquired
      contextRef="i085349bc37c3476aa14e6828a4112638_I20190104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzgzNTk_14eea5a5-285a-413b-8f68-5b5e50e5155b"
      unitRef="asset">1</iart:AssetAcquisitionNumberOfAssetsAcquired>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1a85f0f4e699490aacc709f96ed3737a_D20190104-20190104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzgzOTg_5063f700-f144-4658-b002-4a29a3f8faf6"
      unitRef="usd">1700000</us-gaap:ResearchAndDevelopmentExpense>
    <iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination
      contextRef="ib718aecc355a42c295a29f73509ea5eb_D20210104-20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTQvZnJhZzplZmE0N2QxZDVkNDg0NjkzYTNhNDhiZmNiZjJkZDg0Yi90ZXh0cmVnaW9uOmVmYTQ3ZDFkNWQ0ODQ2OTNhM2E0OGJmY2JmMmRkODRiXzg2OTM_6f2f4a12-6969-49aa-8cf7-27a942995daa"
      unitRef="usd">41500000</iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzEwNjIy_d5c7a0aa-741f-43fd-a248-200f21e0c40d">DEBT&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amendment to the Sixth Amended and Restated Senior Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February&#160;3, 2025. The Company continues to have the aggregate principal amount of up to approximately $2.2 billion available to it through the following facilities: (i) a $877.5 million Term Loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60&#160;million sublimit for the issuance of standby letters of credit and a $60&#160;million sublimit for swingline loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 14, 2020, the Company entered into an amendment (the "July 2020 Amendment") to the February 2020 Amendment of the Senior Credit Facility to increase financial flexibility through June 30, 2021, in light of the unprecedented impact and uncertainty of the COVID-19 pandemic on the global economy. The July 2020 amendment did not increase the Company&#x2019;s total indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the July 2020 amendment, the Company&#x2019;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Consolidated Total Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Execution of July 2020 Amendment through June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021 through June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2022 through June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023 and the last day of each fiscal quarter thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the Senior Credit Facility bear interest, at the Company&#x2019;s option, at a rate equal to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt"&gt;the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from 1.00% to 2.25%), or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;the highest of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the prime lending rate of Bank of America, N.A. or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the one-month Eurodollar Rate plus 1.00% &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable rates are based on the Company&#x2019;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&#160;consolidated EBITDA (as defined by the July 2020 amendment), for the period of four consecutive fiscal quarters ending on such date).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will pay an annual commitment fee (ranging from&#160;0.15%&#160;to&#160;0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#x2019;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at December&#160;31, 2021, the Company was in compliance with all such covenants. In connection with the February 2020 Amendment, the Company capitalized $4.6&#160;million of financing costs in connection with modification &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of the Senior Credit Facility and wrote off $1.2&#160;million of previously capitalized financing costs during the first quarter of 2020. In connection with the July 2020 amendment, the Company expensed $3.3&#160;million of incremental financing costs in connection with the modification of the Senior Credit Facility during the third quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 and 2020, there was&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $31.3 million and $97.5 million, respectively, outstanding under the revolving portion of the Senior Credit Facility at weighted average interest rates of 1.4% and 1.5%, respectively. At December&#160;31, 2021 and 2020, there was $843.8 million and $877.5&#160;million, respectively, outstanding, under the Term Loan component of the Senior Credit Facility at weighted average interest rate of 1.4% and 1.5%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively. At December&#160;31, 2021 and 2020, there was $45.0 million and $33.8&#160;million, respectively, of the Term Loan component of the Senior Credit Facility was classified as current on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of outstanding borrowings of the Senior Credit Facility's revolving credit and Term Loan components at December&#160;31, 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; were $31.0 million and $838.4 million, re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;spectively. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Letters of credit outstanding as of December&#160;31, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; totaled $1.6 million. Ther&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e were no amounts drawn as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year-ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Repayment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $11.0 million in 2022, $10.3 million in 2023, $9.4 million in 2024, and $0.9 million in 2025. Interest is calculated on the term loan portion of the Senior Credit Facility based on LIBOR plus the spread paid by the Company. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $104.5&#160;million. The effective interest rate implicit in the liability component was 4.2%. In connection with this offering, the Company capitalized $13.2&#160;million of financing fees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of December&#160;31, 2021, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#x2019;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#x2019;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#x201c;hedge participants&#x201d;). The cost of the call transactions was $104.2&#160;million for the 2025 Notes. The Company received $44.5&#160;million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the carrying amount of the liability component was $485.9&#160;million, the remaining unamortized discount was $89.1&#160;million, and the principal amount outstanding was $575.0&#160;million. On January 1, 2021, the Company adopted ASU 2020-06 using the modified retrospective method. See Note 2, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further details. At December&#160;31, 2021, the carrying amount of the liability was $575.0&#160;million. The fair value of the 2025 Notes at December&#160;31, 2021 was $640.5&#160;million. Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the adoption of ASU 2020-06, the Company recognized only cash interest related to the contractual interest coupon of $2.9&#160;million on the 2025 Notes for the year ended December&#160;31, 2021. Prior to the adoption, during the year ended December 31, 2020, the Company recognized cash interest of $2.6&#160;million and amortization of the discount on the liability component of $15.4&#160;million for a total interest charge of $18.0&#160;million on the 2025 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securitization Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#x201c;SPE&#x201d;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of December&#160;31, 2021, the Company was in compliance with the covenants and none of the termination events had occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company&#x2019;s total indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At both December&#160;31, 2021 and 2020, the Company&#160;had $112.5&#160;million, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 1.1% and 1.3%, respectively. The fair value of the outstanding borrowing of the Securitization Facility at December&#160;31, 2021 was $111.8 million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="icc245d39ae2c4b37a89f9ea473650099_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzUwNA_61ea5eb6-5525-419b-a2b7-a692347686ea"
      unitRef="usd">2200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if9075dc4f5594e0a9117a256577a5b6b_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU2MQ_aacbc8cb-85c4-48d2-b503-f886d9a09fc9"
      unitRef="usd">877500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i57c63b69e03f47ecbb9a8c336b5343f0_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU5NQ_e806e3e8-f0bd-4fe3-930f-9ad6a137faa0"
      unitRef="usd">1300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iad88d8e54f1a4e9a85100c26cb3cdf36_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjQ2NDg_1e5b698d-d957-480b-916a-a6567a6083e9"
      unitRef="usd">60000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1ab723a0be194e20ace108b34163128f_I20200203"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjQ2MTk_ea7b345c-7e63-4c81-88ee-7a0319c39bc9"
      unitRef="usd">60000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzEwNjQ5_940d4722-3faa-4818-834f-91511dc34fec">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the July 2020 amendment, the Company&#x2019;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Consolidated Total Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Execution of July 2020 Amendment through June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021 through June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2022 through June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023 and the last day of each fiscal quarter thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="i6c66ebe266dc49ae8c7b140c34de1997_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZToxZTA2ZDY1YTNhZDM0MzJhOGJhOTAwMjllOWY2NWRkNi90YWJsZXJhbmdlOjFlMDZkNjVhM2FkMzQzMmE4YmE5MDAyOWU5ZjY1ZGQ2XzMtMi0xLTEtMzczNTYvdGV4dHJlZ2lvbjo2NzU3MzNhMjU0Yjg0NDg0YmRmNDMxYjM5YThjMWRhMl80_f3eedb67-33aa-4e65-ac76-e32929ad4716"
      unitRef="number">5.50</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="iee59fc6ad5d745fd93819ab6849f2abd_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZToxZTA2ZDY1YTNhZDM0MzJhOGJhOTAwMjllOWY2NWRkNi90YWJsZXJhbmdlOjFlMDZkNjVhM2FkMzQzMmE4YmE5MDAyOWU5ZjY1ZGQ2XzQtMi0xLTEtMzczNTYvdGV4dHJlZ2lvbjpiZjNkZTcxYjdmNTM0N2Q5YjNkODk0MDU1N2U5MWU1NV80_8d589744-809b-4023-8ea2-8646573ba4fb"
      unitRef="number">5.00</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="i501b6a51ff0140a7b9405a6883ce1ffb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZToxZTA2ZDY1YTNhZDM0MzJhOGJhOTAwMjllOWY2NWRkNi90YWJsZXJhbmdlOjFlMDZkNjVhM2FkMzQzMmE4YmE5MDAyOWU5ZjY1ZGQ2XzUtMi0xLTEtMzczNTYvdGV4dHJlZ2lvbjo5OWIwYTkxZmUwNWE0Y2NhODI4MDViMmJiN2Y5NDcxNF80_53d85020-c02a-4c42-9975-061fbc79d0c5"
      unitRef="number">4.50</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="i7ce7dfab586d445cbad7c5ae7a2d0d70_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZToxZTA2ZDY1YTNhZDM0MzJhOGJhOTAwMjllOWY2NWRkNi90YWJsZXJhbmdlOjFlMDZkNjVhM2FkMzQzMmE4YmE5MDAyOWU5ZjY1ZGQ2XzYtMi0xLTEtMzczNTYvdGV4dHJlZ2lvbjo5Mjc3NzJhMDVlMTE0YTE0YTg2YTA4ZWM4MGU1ZTU5Zl80_b87204bc-d097-4a3a-bed5-7b9306db1ed7"
      unitRef="number">4.00</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie42c1e0337854c7dbbf20f4ae06610e9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzE1NTU_89ac6004-d40f-4623-95ac-4f4d4221e829"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i90140523e867471889b8f2498da45de1_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzE1NjE_7c2edce1-af82-413f-9b18-ad92e169319b"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i06c53d99c8f942b598357ebec22df68a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzE2OTc_bbeadd09-4e65-4950-9900-58346295454f"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib08f50e95c0845a09194c11c67ff0227_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzE3ODY_95e566ee-dfd7-4026-b532-e60a580bef6e"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i1b5855752106436d8e5833d80860bf2d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzIyMzI_41efb433-8508-4452-95d0-679ca6cfb70a"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i8815454edf87440f8ab1bc7d9bea226c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzIyMzg_30b323e9-0d0c-406c-ab8d-0f88cce49725"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="icc245d39ae2c4b37a89f9ea473650099_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzI3OTc_e3f6d92c-dc22-4675-8a56-3d021a8e5d5f"
      unitRef="usd">4600000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i7b35bf05794c4f92b13ccc87a4d842ce_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzI4OTY_c1e4dee3-8aea-4904-b8de-b54b0e0bbaf6"
      unitRef="usd">1200000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i22d3d9561a884d1f8123cf11213b6e4c_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMwNDE_facbddc4-e2b6-47d8-ab78-cc5e460d31e2"
      unitRef="usd">3300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:LineOfCredit
      contextRef="i04d1b0160d1340fd8ab66ecf51fa7a66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMxOTk_0356f09a-6f10-4c24-b5c2-d58f127a7f85"
      unitRef="usd">31300000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i67999afc0f43421ba112b03ab3776e83_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMyMDY_02f955be-1726-4cfa-b8dd-3e287fcabdc1"
      unitRef="usd">97500000</us-gaap:LineOfCredit>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i04d1b0160d1340fd8ab66ecf51fa7a66_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMzMzI_80a0136d-2fe9-4353-aaeb-fe5d75e38149"
      unitRef="number">0.014</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i67999afc0f43421ba112b03ab3776e83_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMzMzk_35b00c7d-e0c6-446d-b763-04a8c6f1676a"
      unitRef="number">0.015</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:LineOfCredit
      contextRef="if7bb504d057d4468ac3701ee85921300_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzMzODE_e8691d1c-a8af-40e5-929c-2f87a3f9a0c4"
      unitRef="usd">843800000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ia4de4ab17ca14d19958b42305fcb9dba_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjU0MzQ_1258868d-b5b0-4e36-8296-e48d64258671"
      unitRef="usd">877500000</us-gaap:LineOfCredit>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="if7bb504d057d4468ac3701ee85921300_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzM1MDk_29fb5970-5864-42e3-882c-dc9b36f64081"
      unitRef="number">0.014</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="ia4de4ab17ca14d19958b42305fcb9dba_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzM1MTY_4f38072f-978a-4e4b-b088-5dcf0fcf636c"
      unitRef="number">0.015</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:SecuredDebtCurrent
      contextRef="if7bb504d057d4468ac3701ee85921300_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzM1NDE_d3377200-750b-45e9-8dee-e19fb1f41a06"
      unitRef="usd">45000000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="ia4de4ab17ca14d19958b42305fcb9dba_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzIxOTkwMjMyNzQxMTQ_dbb3daa2-c0d5-4201-820e-15f47fc2787a"
      unitRef="usd">33800000</us-gaap:SecuredDebtCurrent>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="iefe0207dab024691b9422a6871c2701c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzM4NzI_4d2f8d24-ef39-4f90-937c-a39f08c0c286"
      unitRef="usd">31000000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i010dd7bd40794db0b97bdb8b4817314b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzM4Nzk_e4e32807-713c-4acb-9eb0-c29e0094aabf"
      unitRef="usd">838400000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i75b71a62404445ecac16c98d28a6c859_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQ0NzM_b92fdd6c-93a9-4084-aa19-b1656e06a996"
      unitRef="usd">1600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i11503d83ecb041bba066af755cc2923f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQ0NzM_f6e352ac-9730-4ef3-8a50-93cf2794a04f"
      unitRef="usd">1600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCredit
      contextRef="i75b71a62404445ecac16c98d28a6c859_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQ1MjU_d45f7208-9347-49c6-a19d-8c231a9980d9"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzEwNjI2_17ef076f-0a21-4bf7-aafc-da3e1a0b58f0">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year-ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Repayment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZTpmYzc4YTVmMGYyODg0MGQ1YjMyMTg4MGY3MDg1ZjlmNi90YWJsZXJhbmdlOmZjNzhhNWYwZjI4ODQwZDViMzIxODgwZjcwODVmOWY2XzQtMS0xLTEtMzczNTY_299ae5e8-ee3f-4063-b805-392c3f6e858d"
      unitRef="usd">45000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZTpmYzc4YTVmMGYyODg0MGQ1YjMyMTg4MGY3MDg1ZjlmNi90YWJsZXJhbmdlOmZjNzhhNWYwZjI4ODQwZDViMzIxODgwZjcwODVmOWY2XzUtMS0xLTEtMzczNTY_fb2034af-0b27-4f12-bd95-7bc6bad59028"
      unitRef="usd">61875000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZTpmYzc4YTVmMGYyODg0MGQ1YjMyMTg4MGY3MDg1ZjlmNi90YWJsZXJhbmdlOmZjNzhhNWYwZjI4ODQwZDViMzIxODgwZjcwODVmOWY2XzYtMS0xLTEtMzczNTY_9a916dfc-4a9f-486b-9c86-0c13245691fa"
      unitRef="usd">67500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZTpmYzc4YTVmMGYyODg0MGQ1YjMyMTg4MGY3MDg1ZjlmNi90YWJsZXJhbmdlOmZjNzhhNWYwZjI4ODQwZDViMzIxODgwZjcwODVmOWY2XzctMS0xLTEtMzczNTY_5af60b85-c081-4fa7-b825-2032cd4131c0"
      unitRef="usd">669375000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebt
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90YWJsZTpmYzc4YTVmMGYyODg0MGQ1YjMyMTg4MGY3MDg1ZjlmNi90YWJsZXJhbmdlOmZjNzhhNWYwZjI4ODQwZDViMzIxODgwZjcwODVmOWY2XzktMS0xLTEtMzczNTY_3a423731-b00f-4ed4-bc51-e1fad2d3b829"
      unitRef="usd">843750000</us-gaap:LongTermDebt>
    <iart:InterestPaymentsYearOne
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1Mjg0NDQ_35a6ee43-9267-49b5-aa07-10ad85392ac9"
      unitRef="usd">11000000</iart:InterestPaymentsYearOne>
    <iart:InterestPaymentsYearTwo
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1Mjg0ODg_03272980-91fa-4aff-9167-ed1688f27947"
      unitRef="usd">10300000</iart:InterestPaymentsYearTwo>
    <iart:InterestPaymentsYearThree
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1Mjg0OTc_0b0dd0a2-d065-44b0-82c1-070d7e760e07"
      unitRef="usd">9400000</iart:InterestPaymentsYearThree>
    <iart:InterestPaymentsYearFour
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1Mjg1MDg_75b73dcd-ff0b-4db1-ac80-066cf0a24162"
      unitRef="usd">900000</iart:InterestPaymentsYearFour>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQ4MzM_c19238bc-49d3-42c7-b395-df684ab5089b"
      unitRef="usd">575000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQ4NzA_441aa1a3-9754-4146-bafa-148e9b09dc3a"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzUwMDQ_4196a897-429c-41aa-86aa-fdf1889d3f24"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzUyMzU_0e54740a-cf97-48fc-ae90-7ca2c4b7a020"
      unitRef="usd">104500000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU0MTg_d887304d-4377-4047-b208-7ccdab29faa5"
      unitRef="number">0.042</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU0ODA_d3c399df-6dd8-424a-a60a-3f6f6b975103"
      unitRef="usd">13200000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="if5c8f0f3fcc54d7fa864f05e7721631f_D20200204-20200204"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU4ODQ_d1793d3c-d610-4831-99c6-f3a60d057b3e"
      unitRef="number">13.5739</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzU5OTA_8c91fd92-bad2-47ef-86cb-d70728095023"
      unitRef="usdPerShare">73.67</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod
      contextRef="if5c8f0f3fcc54d7fa864f05e7721631f_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzYxMzg_f2ae3b5f-e0af-4500-8e38-a4ef4aae108d"
      unitRef="number">1.30</iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod>
    <iart:DebtInstrumentMaximumAverageConversionValueOfNotes
      contextRef="if5c8f0f3fcc54d7fa864f05e7721631f_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzYyODc_f1a25a46-c3aa-478f-bfcf-8b8580875a64"
      unitRef="number">0.98</iart:DebtInstrumentMaximumAverageConversionValueOfNotes>
    <iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount
      contextRef="i9c7ea572f6ff408eb1c3e8b78cead270_I20201209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzcyNjg_0e0cf28f-e9eb-481d-8e71-3360fe149ba0"
      unitRef="usd">1000</iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="if5c8f0f3fcc54d7fa864f05e7721631f_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzczOTY_2c6d742f-55d1-4493-b9a9-99df4f92b8db"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="ia5fd639d6b434c4285a6fe944615d341_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzgwNjg_63d192af-4755-484d-b839-5998afa8411b"
      unitRef="usd">104200000</iart:PaymentsForOptionIndexToIssuersEquity>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="ia5fd639d6b434c4285a6fe944615d341_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzgxMTI_9b8b6bf5-3421-4e30-a17f-988b982acfc7"
      unitRef="usd">44500000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="i396d7f2eb0c64059b81baf2f22ba97ec_D20200204-20200204"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzg0NjA_7395f90c-b360-44b6-98b1-353661e1d7d3"
      unitRef="usdPerShare">73.67</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="iae4f699d31404c7da2387e7912c12f8b_I20200204"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzg2MDg_c7412e2b-cd84-4b8e-abd4-e6747aff73e6"
      unitRef="usdPerShare">113.34</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="if6851222fe6b4433adf09a9809463a04_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjM1NTM_91569140-768f-47cc-959d-7bfe18a2983c"
      unitRef="usd">485900000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="if6851222fe6b4433adf09a9809463a04_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjM1MTk_f925168d-75e6-48f8-8f27-34162e24584a"
      unitRef="usd">89100000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if6851222fe6b4433adf09a9809463a04_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjM0ODk_a8f0499f-a853-4d27-8708-2de56a01ee03"
      unitRef="usd">575000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i55dda325db55443a874b0f8c37dd8b20_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjM4Mjg_207824f8-4304-4779-8f32-c1624dfcb078"
      unitRef="usd">575000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i55dda325db55443a874b0f8c37dd8b20_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjQ0Njg_52c0e045-0c3f-4589-92ec-fa433839c712"
      unitRef="usd">640500000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i532960b507734253829e73f26a86f856_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjQzOTM_a203cc63-747d-4d37-9603-3076e4687e96"
      unitRef="usd">2900000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ic8b32770839e412698beb581305b9b06_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzg3OTg_f561720d-0321-4e17-b996-2cebb564b2bc"
      unitRef="usd">2600000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i532960b507734253829e73f26a86f856_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzg4NjQ_0c623f49-928f-4d5b-926d-77c5fb1b1c83"
      unitRef="usd">15400000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpenseDebt
      contextRef="i532960b507734253829e73f26a86f856_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzg4OTg_044100c1-5af6-4fea-b39b-ddd2cce96bcd"
      unitRef="usd">18000000</us-gaap:InterestExpenseDebt>
    <iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0Xzk2NTU_5af4d022-3f34-494b-a937-dce86f7d3197"
      unitRef="usd">150000000</iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit>
    <iart:SecuredLongTermDebtSecuritizationProgram
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjE4NzE_246b82df-80b7-4c6c-9d45-5e99bc58ef39"
      unitRef="usd">112500000</iart:SecuredLongTermDebtSecuritizationProgram>
    <iart:SecuredLongTermDebtSecuritizationProgram
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjE4NzE_df81d523-f27e-4deb-9a29-b00784c53cac"
      unitRef="usd">112500000</iart:SecuredLongTermDebtSecuritizationProgram>
    <iart:DebtWeightedAverageInterestRateFromSecuritization
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjE5MTM_d198d351-53ea-4244-9eee-9832574c091d"
      unitRef="number">0.011</iart:DebtWeightedAverageInterestRateFromSecuritization>
    <iart:DebtWeightedAverageInterestRateFromSecuritization
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzQzOTgwNDY1MjE4OTY_a7802aa4-9960-40b5-afc0-1fe0ecd93e31"
      unitRef="number">0.013</iart:DebtWeightedAverageInterestRateFromSecuritization>
    <iart:SecuritizationFacilityFairValueOfAmountOutstanding
      contextRef="i07286d7fc74242cca19b206f52c0f370_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNTcvZnJhZzpmZmExNzRkM2U0ZjI0NzUyODMzNjAwZDRhNDRlYmZkNC90ZXh0cmVnaW9uOmZmYTE3NGQzZTRmMjQ3NTI4MzM2MDBkNGE0NGViZmQ0XzEwNjE4_5be9cf01-84a6-4321-8a81-eb80cb5a6337"
      unitRef="usd">111800000</iart:SecuritizationFacilityFairValueOfAmountOutstanding>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzEwODY4_4e6b0cf4-b9b6-4475-8b38-c118deb45d7b">DERIVATIVE INSTRUMENTS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following interest rate swaps as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 27, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11,502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,775,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,875,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (&#x201c;AOCL&#x201d;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax. Those amounts are subsequently reclassified to earnings from AOCL as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company entered into foreign currency forward contracts, with a notional amount of $9.7&#160;million, to mitigate the foreign exchange risk related to certain intercompany loans denominated in Canadian Dollar ("CAD") and intercompany receivables denominated in Japanese Yen ("JPY"). The contracts are not designated as hedging instruments. The Company subsequently settled its foreign currency forward contracts associated with the intercompany receivables denominated in JPY during the first quarter of 2021. The Company recognized a $0.2&#160;million loss from the change in fair value of the contracts, which was included in other income, net in the consolidated statement of operations as of December 31, 2021 and 2020, respectively. The fair value of the foreign currency forward contracts denominated in CAD was $0.2&#160;million as of December 31, 2021. The fair value of the foreign currency forward contracts was $0.2&#160;million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional of $7.3&#160;million to mitigate the risk from fluctuations in foreign currency exchange rates associated with certain intercompany loan denominated in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Japanese Yen ("JPY"). In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The change in fair value of the foreign currency swap was $0.6&#160;million as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of the Company&#x2019;s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross-Currency Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 2, 2017, the Company entered into cross currency swap agreements to convert a notional amount of $300.0 million equivalent to 291.2 million of Swiss Francs ("CHF") denominated intercompany loans into U.S. dollars. The CHF- denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6&#160;million equivalent to 420.1 million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF 5.8&#160;million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 4, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,335)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,283)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,262)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 21, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 22, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,843)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 4, 2021 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $50.0&#160;million. The gain recorded by the Company upon the settlement of the swap was not material for the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 2, 2020 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $33.3&#160;million. As a result of the settlement, the Company recorded a loss of $0.3&#160;million in other income, net in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the years ended December&#160;31, 2021 and 2020, the Company recorded a &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;gain of $23.8&#160;million and loss of $21.7&#160;million, respectively, in other income, net related to change in fair value related to the foreign currency rate tran&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;slation to offset the gains or losses recognized on the intercompany loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021 and 2020, the Company reco&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rded a gain of $24.3 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; a loss of $17.1 million, respectively, in AOCL related to change in fair value of the cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021 and 2020, the Company reco&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rded gains of $9.1 million an&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d $5.8 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated loss that is expected to be reclassified to other income, net from AOCL as of December&#160;31, 2021 within the next twelve months is $3.4 million. As of December&#160;31, 2021, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;foreign currency on foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,884)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.57%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.19%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 16, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 16, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(792)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,794)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2021, in accordance with the termination date, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $52&#160;million equivalent to 44.9&#160;million Euros. As a result of the settlement, the Company recorded a gain of $0.1 million in AOCL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2020, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $167.5&#160;million and 128.3&#160;million Pound Sterling respectively as a result of an intra-entity transfer of certain intellectual property rights to a subsidiary. The original settlement date was September 30, 2025. As a result of the settlement, the Company recorded a loss of $7.8&#160;million in AOCL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recorded as unrealized gains or losses in AOCL. For the year ended December&#160;31, 2021 and 2020, the Company recorded a gain of $16.5 million and a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; loss of $14.9 million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021 and 2020, the Company recorded a gain of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$6.5 million an&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d $7.6 million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated gain that is expected to be reclassified to interest income from AOCL as of December&#160;31, 2021 within the next twelve months is $5.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Counterparty Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#x2019;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#x2019;s credit ratings from any credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Location on Balance Sheet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;At December 31, 2021 and 2020, the total notional amounts related to the Company&#x2019;s interest rate swaps were $1.8&#160;billion and $1.9&#160;billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statement of operations during the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;Beginning of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&lt;br/&gt;Gain (Loss)&lt;br/&gt;Recognized&#160;in&lt;br/&gt;AOCL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&#160;Gain&#160;(Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;AOCL into&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;End of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in&lt;br/&gt;Statements&#160;of&lt;br/&gt;Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzEwODY1_bd6dd51b-684a-4c4a-af51-7241d1bafea0">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following interest rate swaps as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 27, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11,502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,775,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,875,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 4, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,335)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,283)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,262)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 21, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 22, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,843)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2021 and 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,884)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.57%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.19%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 16, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 16, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(792)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,794)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i241736141ce5441cbaf9b7d07be1bd2b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzUtMi0xLTEtMzczNTY_e0b66806-a8dc-4a04-9315-32d8b7e7ece0"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i27e95c8600d24f1788cde97b1a748f0c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzUtNC0xLTEtMzczNTY_c34fc688-b79c-477d-aee1-c2c3d0b81b0a"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i241736141ce5441cbaf9b7d07be1bd2b_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzUtMTItMS0xLTM3MzU2_3b4b65bb-4f40-4645-a9c0-8fd94df5224f"
      unitRef="number">0.01971</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i241736141ce5441cbaf9b7d07be1bd2b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzUtMTQtMS0xLTM3MzU2_2425c11c-51c5-4b91-810a-1db2f02c1fde"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i27e95c8600d24f1788cde97b1a748f0c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzUtMTYtMS0xLTM3MzU2_e51b455f-9efa-41c0-943c-dd88618b7775"
      unitRef="usd">-929000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3e368b5fda0a476a8edcda24877e2d60_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzYtMi0xLTEtMzczNTY_a36dfd00-13db-4e3b-963f-7e24a3fb7060"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8bf07d7a40de4c22bd5f4ec2b7dc0864_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzYtNC0xLTEtMzczNTY_e492ef84-772b-4f53-a404-ccb46c4ea68a"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i3e368b5fda0a476a8edcda24877e2d60_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzYtMTItMS0xLTM3MzU2_874dade9-28f5-4c46-b9d4-5cdee47a1fe6"
      unitRef="number">0.02201</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i3e368b5fda0a476a8edcda24877e2d60_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzYtMTQtMS0xLTM3MzU2_3cc7af1e-e2cd-424a-abe7-e2e82fa2e5cd"
      unitRef="usd">-5268000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8bf07d7a40de4c22bd5f4ec2b7dc0864_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzYtMTYtMS0xLTM3MzU2_a8e3fe28-2128-43af-b87b-877ce49155c6"
      unitRef="usd">-12557000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie632a54071064dd984a1daee5e94ea29_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzctMi0xLTEtMzczNTY_5085b0b5-6bce-42df-a3f6-0e4df722de6a"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia4f1a07697994a528de8da81d3b4a80d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzctNC0xLTEtMzczNTY_6f41c71e-8c25-4580-b540-272342bf0a28"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ie632a54071064dd984a1daee5e94ea29_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzctMTItMS0xLTM3MzU2_aa034975-f57f-4831-b967-1fff89c66f06"
      unitRef="number">0.02423</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ie632a54071064dd984a1daee5e94ea29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzctMTQtMS0xLTM3MzU2_884232de-a541-4908-b7d4-aff48beddd12"
      unitRef="usd">-5520000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ia4f1a07697994a528de8da81d3b4a80d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzctMTYtMS0xLTM3MzU2_0c090207-c327-4854-ab42-b43ae1e511ca"
      unitRef="usd">-11502000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia0b97ff90e2648d49fb6e83da054fb38_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzgtMi0xLTEtMzczNTY_51c5bf56-7a72-492d-aa45-e5fb26680bdd"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4cbba29541b0414aa84fce8d3ab05e46_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzgtNC0xLTEtMzczNTY_f87f1199-7df5-45bb-b8d1-83cc8aca4b05"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ia0b97ff90e2648d49fb6e83da054fb38_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzgtMTItMS0xLTM3MzU2_3056af4f-af78-47ba-a5f4-f3d2312437b9"
      unitRef="number">0.02313</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ia0b97ff90e2648d49fb6e83da054fb38_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzgtMTQtMS0xLTM3MzU2_06f09fbd-2307-45f9-b5e9-ee6480a0679d"
      unitRef="usd">-7421000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i4cbba29541b0414aa84fce8d3ab05e46_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzgtMTYtMS0xLTM3MzU2_b1159d67-585b-4c8a-b6a0-de3fb76ed0fc"
      unitRef="usd">-16243000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i288f3609bde4438a81832109716cd5a9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzktMi0xLTEtMzczNTY_59e57f71-036c-4320-b8c3-c7a81c8b1146"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i26217e69841f4b5f865e6ddc9b644f61_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzktNC0xLTEtMzczNTY_91facb86-1329-44dd-a920-1975950384a2"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i288f3609bde4438a81832109716cd5a9_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzktMTItMS0xLTM3MzU2_0cac479d-42db-4903-8304-8b512ad84bac"
      unitRef="number">0.03220</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i288f3609bde4438a81832109716cd5a9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzktMTQtMS0xLTM3MzU2_3d2e327d-5700-44ca-a3f2-0c88c49132d3"
      unitRef="usd">-5512000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i26217e69841f4b5f865e6ddc9b644f61_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzktMTYtMS0xLTM3MzU2_69139604-5248-4327-9512-ca4961c0c632"
      unitRef="usd">-9836000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibca66931d2494db380dd96d37d92bc88_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEwLTItMS0xLTM3MzU2_c67699e3-4035-4cbd-b981-490fdf1d61b3"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i65c0189ffb9a4e769aae035799d3163d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEwLTQtMS0xLTM3MzU2_ff373fdf-eace-43a8-a5eb-905d219d74a7"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ibca66931d2494db380dd96d37d92bc88_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEwLTEyLTEtMS0zNzM1Ng_751c1999-3124-47d4-8a9c-b1f0db26170f"
      unitRef="number">0.03199</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ibca66931d2494db380dd96d37d92bc88_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEwLTE0LTEtMS0zNzM1Ng_b31b791a-431b-4247-b137-9828a85d5206"
      unitRef="usd">-5464000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i65c0189ffb9a4e769aae035799d3163d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEwLTE2LTEtMS0zNzM1Ng_a5549887-257a-4588-b405-7795982dd4fe"
      unitRef="usd">-9826000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6bb1e3365e494ce89a0cf4822b064c93_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzExLTItMS0xLTM3MzU2_aead0392-f1d9-44ff-b381-818c4e8073a9"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iac02b3f863ad479ab79142979d7cade1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzExLTQtMS0xLTM3MzU2_7fb3c49b-0420-438f-bab7-a87966875b67"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i6bb1e3365e494ce89a0cf4822b064c93_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzExLTEyLTEtMS0zNzM1Ng_8a7ae308-8549-45da-bdd1-e6cb883dec35"
      unitRef="number">0.03209</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i6bb1e3365e494ce89a0cf4822b064c93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzExLTE0LTEtMS0zNzM1Ng_cf1f60e3-2892-4e01-b455-cdc27d501b3b"
      unitRef="usd">-5494000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="iac02b3f863ad479ab79142979d7cade1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzExLTE2LTEtMS0zNzM1Ng_83261388-32cd-4fa6-af52-25a259c06e43"
      unitRef="usd">-9783000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic4a132dddf0e4b05ab2279482233be48_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEyLTItMS0xLTM3MzU2_df0a1e73-d14b-427f-b8dd-293f17a96a5c"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i35359b024a1d4f2a98e87757bfa30a29_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEyLTQtMS0xLTM3MzU2_3401b294-19cd-485f-8447-3cfa8e64d20c"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ic4a132dddf0e4b05ab2279482233be48_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEyLTEyLTEtMS0zNzM1Ng_7cfa2c26-00c9-4edc-8b0b-547abb3d3a8d"
      unitRef="number">0.02885</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ic4a132dddf0e4b05ab2279482233be48_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEyLTE0LTEtMS0zNzM1Ng_45bd28a7-6cce-4385-91bf-942f2dd6937d"
      unitRef="usd">-6886000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i35359b024a1d4f2a98e87757bfa30a29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEyLTE2LTEtMS0zNzM1Ng_51b7bb3f-5568-4ec7-ae7e-f39deb98217e"
      unitRef="usd">-10407000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i65d7dee7ffe74d79a4e2144db55b55e0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEzLTItMS0xLTM3MzU2_51f73e36-f47a-4788-bc10-9e4c4150b44a"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i532ebca746b94440a3ce52a9b1e41c55_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEzLTQtMS0xLTM3MzU2_5a4dec90-1f60-4061-87f2-1adcd363f3db"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i65d7dee7ffe74d79a4e2144db55b55e0_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEzLTEyLTEtMS0zNzM1Ng_f00ceb3c-533c-4275-b72a-c83829440d41"
      unitRef="number">0.02867</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i65d7dee7ffe74d79a4e2144db55b55e0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEzLTE0LTEtMS0zNzM1Ng_0364c3a5-03ef-418a-b650-a09bf3ff3316"
      unitRef="usd">-6764000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i532ebca746b94440a3ce52a9b1e41c55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzEzLTE2LTEtMS0zNzM1Ng_fee6171b-4e24-4a85-8dae-37df87bc7cd9"
      unitRef="usd">-10431000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7b86f7b9c3c848fba14945777a7f742f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE0LTItMS0xLTM3MzU2_6a37999e-69e3-4864-b586-43d975c55a27"
      unitRef="usd">575000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i378a39326c7c47a4b12de5edfddb468f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE0LTQtMS0xLTM3MzU2_0bb0d2c4-d22c-4496-a4bd-94c27ec9d5b2"
      unitRef="usd">575000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i7b86f7b9c3c848fba14945777a7f742f_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE0LTEyLTEtMS0zNzM1Ng_0d2a04d8-39b0-44e1-af31-5eca66886e6d"
      unitRef="number">0.01415</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i7b86f7b9c3c848fba14945777a7f742f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE0LTE0LTEtMS0zNzM1Ng_5df4b70e-5025-4425-b661-f9f6548b3058"
      unitRef="usd">3552000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i378a39326c7c47a4b12de5edfddb468f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE0LTE2LTEtMS0zNzM1Ng_1afa089e-2f7f-4bcf-8fef-98a8c6fc5dc1"
      unitRef="usd">-1907000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id11bfa4243b44471878dc05e0b04c5ae_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE1LTItMS0xLTM3MzU2_e2000f5e-78e3-454f-911b-48ac2c9fcd57"
      unitRef="usd">125000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i53695045753f4b0cb6d43100ea2c5b50_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE1LTQtMS0xLTM3MzU2_df270fa8-dcc5-4f12-bd49-981c3974779e"
      unitRef="usd">125000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="id11bfa4243b44471878dc05e0b04c5ae_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE1LTEyLTEtMS0zNzM1Ng_5a13cbc0-1c9e-45d5-a3cd-0ae8f42d3c0d"
      unitRef="number">0.01404</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id11bfa4243b44471878dc05e0b04c5ae_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE1LTE0LTEtMS0zNzM1Ng_3ee3882b-2983-4a1f-87ba-2fa2269ea5af"
      unitRef="usd">821000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i53695045753f4b0cb6d43100ea2c5b50_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzE1LTE2LTEtMS0zNzM1Ng_90790828-035a-4e35-aadc-d5f215c070f3"
      unitRef="usd">-348000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia0dbe85e1e664ae9ac6dc86a82263629_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzIxLTItMS0xLTM3MzU2_78889731-5842-444f-818f-1408285ad65a"
      unitRef="usd">1775000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibcde00d2f9ee499c9b3f5bddea1dac4b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzIxLTQtMS0xLTM3MzU2_2733d85f-af4c-4bed-b36a-93507e4035f3"
      unitRef="usd">1875000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ia0dbe85e1e664ae9ac6dc86a82263629_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzIxLTE0LTEtMS0zNzM1Ng_897de309-182a-4b46-9e6d-c1bb0e592f80"
      unitRef="usd">-43957000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ibcde00d2f9ee499c9b3f5bddea1dac4b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTozNWI0MTcwOGY1YWQ0ZmUyOWM4NTk3NjFjYWMxZDEyZi90YWJsZXJhbmdlOjM1YjQxNzA4ZjVhZDRmZTI5Yzg1OTc2MWNhYzFkMTJmXzIxLTE2LTEtMS0zNzM1Ng_8f50f048-4d52-4282-a066-5b97e063720a"
      unitRef="usd">-93769000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9f291ee98dcc4db0b65295c7cc02b534_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIzOTk_d46f6b29-7ba5-476e-a24b-0497317222cb"
      unitRef="usd">9700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ibe5ea43d4f06427e8b8278ecc9d21984_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzI2NjU_361fa52e-742f-4e12-ba32-854f8a1d9a9c"
      unitRef="usd">-200000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia6f9c05623734f95b308753dab91e2d1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjIwMzA_0854c042-6286-4adf-bca9-bc35a4094a31"
      unitRef="usd">200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9f291ee98dcc4db0b65295c7cc02b534_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNzMxNTE_3a314fcf-a9b1-4467-b4db-4c71720d5cc7"
      unitRef="usd">200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i834a7d0bdde0493b82362279698dc772_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNjkyMTI_2e5fa22b-e76b-4218-81ef-f57ecf72da55"
      unitRef="usd">7300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3f34947eecd043ce89085543035baf6c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNzM2MDc_4157f266-1d99-48bd-85c6-78794fbd606a"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3a00f578e1734e96abe9db9dd7e4d84d_I20171002"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzM0Nzc_c1637001-a97b-4bc3-ac04-b42adaf86698"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie6c4104f081f4a0c97cc34bfa934b8de_I20171002"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzM0OTQ_abda9aec-2cf6-4e35-9735-a97d5eaf96a2"
      unitRef="chf">291200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0ed96b4baeca485d88d732479d36ee6f_I20201221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzM4MzU_8534a01e-b5ee-49bf-a616-bf43b48644f1"
      unitRef="usd">471600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0ed96b4baeca485d88d732479d36ee6f_I20201221"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzM4NTI_f4aec9e1-dd55-41a6-af6c-9087f6b53ad8"
      unitRef="chf">420100000</us-gaap:DerivativeNotionalAmount>
    <iart:IntercompanyLoanQuarterlyPayment
      contextRef="ie482bef356cf4e048602c1345e6faad1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNjkyMjY_3b641047-fb7c-465f-bf3d-57e85aca7c2c"
      unitRef="chf">5800000</iart:IntercompanyLoanQuarterlyPayment>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ic9225e7f823044678109956680d2a97a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEyLTYtMS0xLTM3MzU2_ba0938c2-6447-4dda-8e51-56e5671c4436"
      unitRef="number">0.0185</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic9225e7f823044678109956680d2a97a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEyLTktMS0xLTQ4MzYz_6b0b0e6c-5ab1-4bdf-8ac4-4dacbb59653f"
      unitRef="chf">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i076d006aea244c84af07364f0b1ad64a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEyLTktMS0xLTM3MzU2_c84d49b9-4d80-4866-919e-6a0f16b2bed7"
      unitRef="chf">48533000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="icb8fbe23f0de4b438088a04ce4c7f7cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEyLTEyLTEtMS00ODM2OQ_e6ccca84-4ad2-4405-bb1d-cacdddc7f4f3"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i1efb9a3c67d04590a34d8a19cd9e854a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEyLTExLTEtMS0zNzM1Ng_99ccb576-bea7-48b6-9793-783da882c59f"
      unitRef="usd">-4335000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i13f31b37f3ea4d8e97eec66b802e9e49_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEzLTYtMS0xLTM3MzU2_5da507cf-1bd8-4c9b-a444-8d2188a96486"
      unitRef="number">0.0446</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i13f31b37f3ea4d8e97eec66b802e9e49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEzLTktMS0xLTQ4MzYz_662ee8d6-2b24-41ce-a533-6026cf51e34b"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6e5cde6835114b3da99ea43fe6947ed4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzEzLTktMS0xLTM3MzU2_8289311f-9165-4464-87c2-216762254f5e"
      unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i2fa44250f8ea494f9ec6201defd7694d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE1LTYtMS0xLTM3MzU2_bb8b7501-6468-4071-a4df-2a675cff64f2"
      unitRef="number">0.0195</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2fa44250f8ea494f9ec6201defd7694d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE1LTktMS0xLTQ4MzYz_901e3634-71a9-49cf-a218-f22c4b7528cf"
      unitRef="chf">145598000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie0b9cf3906af44e588a43a37c9259020_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE1LTktMS0xLTM3MzU2_3bcc1d2a-e138-44cd-9b1d-b49a0a5af6b7"
      unitRef="chf">145598000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i9abdd3860253449b9af0cf34bcbdeb85_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE1LTEyLTEtMS00ODM2OQ_3b97d49b-301d-4e1b-98d6-198d269631ab"
      unitRef="usd">-8283000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id1d386cad6144838b3a92904df7a317c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE1LTExLTEtMS0zNzM1Ng_118c9c08-d36c-4035-adb9-95b95f432abd"
      unitRef="usd">-11262000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i5437d75eac6144cf88ae812aecc743aa_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE2LTYtMS0xLTM3MzU2_f8d7a69a-a97a-424b-ab96-08eba4fa9619"
      unitRef="number">0.0452</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5437d75eac6144cf88ae812aecc743aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE2LTktMS0xLTQ4MzYz_66552b1b-a046-4b5b-a4f0-bca6a6dfbcfb"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic4d2a0894b2040ba81435a39df496070_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE2LTktMS0xLTM3MzU2_bd0a1f8e-72f6-4f57-8e12-fc67651599c7"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i0453195fa23e46d483cf46bd3e3de52a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE4LTYtMS0xLTM3MzU2_3705da48-a1d1-4758-87e7-5b2c9c2014e2"
      unitRef="number">0.0300</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0453195fa23e46d483cf46bd3e3de52a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE4LTktMS0xLTQ4MzYz_40ea1ff0-9808-4e85-aa4b-4a6fa3433f1c"
      unitRef="chf">397137000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i73b0d274622045248510c3e54280fccf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE4LTktMS0xLTM3MzU2_83e75309-738e-4a94-be7c-0cc5e1f50ea4"
      unitRef="chf">420137000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ib2f46deba383407cb210dce486f3dcac_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE4LTEyLTEtMS00ODM2OQ_897d0ba8-cd36-4f11-b691-a0d104ad84dc"
      unitRef="usd">41000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8d35df157fe74d6e891907bc9031cca0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE4LTExLTEtMS0zNzM1Ng_f4c31747-dcdf-4f0a-8880-315a7f11031d"
      unitRef="usd">-7843000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ie3f4cc639f144ce6ac3a87548c3b6c9c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE5LTYtMS0xLTM3MzU2_09eedb1a-942a-4d92-b843-2114341f733c"
      unitRef="number">0.0398</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie3f4cc639f144ce6ac3a87548c3b6c9c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE5LTktMS0xLTQ4MzYz_94ea616b-070f-4af9-888d-b97082d4165f"
      unitRef="usd">445821000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1a6242204a744c64a6389b0800b02769_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzE5LTktMS0xLTM3MzU2_aa11db4d-9a57-47be-a26b-2d05a9ca1c57"
      unitRef="usd">471640000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i89d5d03c36334d73b8492d6c04b74983_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzIxLTEyLTEtMS00OTgzMg_2e995f82-020b-4f22-b701-aa4df4d1d7b4"
      unitRef="usd">-8242000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i33ff7b9d006640f8938113069f4a6eff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTo0M2M2ZjU2MDMxNzg0YzM2OGZhNjg2M2RhMTVmZjIwNi90YWJsZXJhbmdlOjQzYzZmNTYwMzE3ODRjMzY4ZmE2ODYzZGExNWZmMjA2XzIxLTExLTEtMS0zNzM1Ng_e8881bd3-e749-4a7a-b1ac-8b99c45c9116"
      unitRef="usd">-23441000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iee2b883defbc4b8f8ed1e8efbff9af9c_I20211004"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNjkyMzk_b4e4eba2-5904-4032-9089-330e1baf46a6"
      unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib025dac64fea4558b2d30ed1bec0b8c1_I20201002"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQ5MDA_a126d978-e5ca-40cc-ad61-0379a4cd9e88"
      unitRef="usd">33300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives
      contextRef="i4eeb4577960a4674b83a36fbcf56c4c1_D20201002-20201002"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQ5NjY_68614cf9-8658-4d96-8e7e-f2d6069534aa"
      unitRef="usd">-300000</us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i2a2aaff04d024dc4990e2909b24f4dd5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNzMxNzk_4005b58c-480c-4656-b2a0-fdb88a339609"
      unitRef="usd">23800000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ic969b2640c664168980604c5a20744f1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjMzODk_1b1f3c87-672e-4a81-9bab-1f605eacfb92"
      unitRef="usd">-21700000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie482bef356cf4e048602c1345e6faad1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzYxMDU_077722b3-3bb2-4c61-be0b-bb30bb9d9be3"
      unitRef="usd">24300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iabd46125a80f417e9a4465bdf1807227_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzYxMjI_b3af56f8-5adf-474e-815d-7417feaf321f"
      unitRef="usd">-17100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie482bef356cf4e048602c1345e6faad1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzYyNzA_40fcfe83-b97a-4251-b8d7-a532bb5e2987"
      unitRef="usd">9100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="iabd46125a80f417e9a4465bdf1807227_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzYyNzc_26565113-40ae-4d8c-825b-a20a3a18fa8a"
      unitRef="usd">5800000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i524b9ebd90024ddabb8d0282eaf6a29c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzY1NzA_c53d9399-fe47-445b-a097-03ffc3310c4c"
      unitRef="usd">-3400000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i541aa942c51c4c4399d51d31e700938e_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzMtNi0xLTEtMzczNTY_6d9251e1-0d73-4743-9467-130f0d8fec95"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i541aa942c51c4c4399d51d31e700938e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzMtOS0xLTEtMzczNTY_f1861f0b-487c-437b-b64c-10f8e3fb01c2"
      unitRef="eur">44859000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i940998b020714fa3b0888d72a26c1945_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzMtMTEtMS0xLTM3MzU2_e4d22ece-4feb-48fd-9a0e-4b71e18af574"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i3776583b04954a0e9da05addfc5f9705_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzMtMTItMS0xLTQ4NzA2_ffa942e6-1232-403d-a646-e50dd1c0f914"
      unitRef="usd">-1884000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="iccec1d91d0fd4f61b8eb3700cf25c835_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzQtNi0xLTEtMzczNTY_ceaf87f9-eef6-456e-84b9-cfcc061a6014"
      unitRef="number">0.0301</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iccec1d91d0fd4f61b8eb3700cf25c835_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzQtOS0xLTEtMzczNTY_855ddc65-2a1e-4636-986c-3a8e05a31d87"
      unitRef="usd">52000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ic25827b0d5bf448aa78483cc9a09b5a7_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzYtNi0xLTEtMzczNTY_3a80fb89-d2c5-48be-bbda-3badaf06277a"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic25827b0d5bf448aa78483cc9a09b5a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzYtOS0xLTEtMzczNTY_1699aea4-89ea-4f49-8ea3-6d6fe35d4186"
      unitRef="eur">51760000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i08c28720b7cf47028c76c53cbd46b11c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzYtMTEtMS0xLTM3MzU2_9ba8b1d3-d488-40e1-a754-fd4bea5e22a6"
      unitRef="usd">2503000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i368c248f3bd642508bc5c82fd4f9c3f2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzYtMTItMS0xLTQ4NzA5_d5ef1cb1-3076-42da-99eb-aca5d0b24f0d"
      unitRef="usd">-450000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ib09607d878144ab899b3843daa56b605_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzctNi0xLTEtMzczNTY_a2e566e5-3898-47c8-9424-fad319f74a0d"
      unitRef="number">0.0257</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib09607d878144ab899b3843daa56b605_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzctOS0xLTEtMzczNTY_df2f33b0-e9fa-42be-a510-ee6e91167d7b"
      unitRef="usd">60000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ibc153a66697e473287846740951f472d_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzktNi0xLTEtMzczNTY_9538be5b-ec2b-4dbd-9c97-019e5195c124"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibc153a66697e473287846740951f472d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzktOS0xLTEtMzczNTY_7622fff8-dffe-482b-8bf4-37c6e5e427c5"
      unitRef="eur">38820000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i3f8cf8b1ba584f49b4fa0e0a794f40bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzktMTEtMS0xLTM3MzU2_a100b61a-2278-4ac7-911c-0a5d36357b12"
      unitRef="usd">2147000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id738386e38c0494ba6b7c0a2fb112f20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzktMTItMS0xLTQ4NzEy_f66f5c45-e488-4265-92ff-c8de6d1cc18b"
      unitRef="usd">92000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ic4c8e8a8213441a18c7cff8f5e3e651e_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzEwLTYtMS0xLTM3MzU2_4fc6db18-d452-43a6-ba6a-439cf43030ae"
      unitRef="number">0.0219</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic4c8e8a8213441a18c7cff8f5e3e651e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzEwLTktMS0xLTM3MzU2_ff6eb176-28a3-42be-8c00-06d3ab2bb2d0"
      unitRef="usd">45000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ic6e1dd1f4bbe4812bf8b694608c2ed2c_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE4LTYtMS0xLTM3MzU2_4fc205a6-d364-4286-8a11-bb51f0cfed38"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic6e1dd1f4bbe4812bf8b694608c2ed2c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE4LTktMS0xLTM3MzU2_df9ddc09-582d-4657-8077-9559fb303180"
      unitRef="chf">222300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ida4c9a65c572483cbd1edbbbd8df7265_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE4LTExLTEtMS0zNzM1Ng_56883040-e564-4cfb-8ede-0c92e606b2dd"
      unitRef="usd">-792000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i594ae760b6c148209383a55f5e4e67d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE4LTEyLTEtMS00ODcxNQ_62f2d1f7-134c-4e32-b4c3-60f407d4950b"
      unitRef="usd">-3794000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i2fecaa5319254b9986b2fe9d8c2e1da4_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE5LTYtMS0xLTM3MzU2_dea076c8-9e2d-4d6f-8735-1f24e5b09594"
      unitRef="number">0.0110</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2fecaa5319254b9986b2fe9d8c2e1da4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzE5LTktMS0xLTM3MzU2_1936134e-a1f5-423f-ade9-cc71631a9407"
      unitRef="usd">250000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i76c7948c2adf40bebaa47f086f3b7c41_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzIxLTExLTEtMS0zNzM1Ng_b48d1015-8cd1-41bf-9172-9205657c7ce0"
      unitRef="usd">3858000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if753e7c4eee5471c9486881f13aa71b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplMzFjNDQ5Mzk4ZTI0ZTU1YWFhOTZhNmM5ODRkYjU1ZS90YWJsZXJhbmdlOmUzMWM0NDkzOThlMjRlNTVhYWE5NmE2Yzk4NGRiNTVlXzIxLTEyLTEtMS00ODcxNg_c7883e74-11a1-48a4-802b-f0d0caff2cf2"
      unitRef="usd">-6036000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id9b1f400a73c4c5fbdc2fc6cd85ecbbd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjM5NDQ_ff6c90c6-e81a-4ea6-bd2a-2306faacdae3"
      unitRef="usd">52000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id9b1f400a73c4c5fbdc2fc6cd85ecbbd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjM5NTc_7b87da03-44a3-483a-a8cb-a2062394d760"
      unitRef="eur">44900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="idd1fc1828d5040fbb20eb4d17854f200_D20210930-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjM5NzE_a21b2df2-1d39-476b-b84d-119ec2428581"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if753e7c4eee5471c9486881f13aa71b7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzc2NTg_c2d9a74f-289a-4745-9325-b6a1160ca2f1"
      unitRef="usd">167500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if753e7c4eee5471c9486881f13aa71b7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzc2NjU_07bb4989-1867-4dd6-abf7-a2f2cc47b10b"
      unitRef="gbp">128300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives
      contextRef="ifbeddf97b3b040cdb135d37c167dfb01_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzc5MDg_65b31e22-e04b-492b-8f44-4b296c640e48"
      unitRef="usd">-7800000</us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie589d17f3ce64923a38138283f3f843d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzg1ODI_892358b0-9e21-4781-a503-b4575738e7c6"
      unitRef="usd">16500000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ifbeddf97b3b040cdb135d37c167dfb01_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzg1OTk_5fcb4ba0-bd80-4c1a-ac72-3a9f0fa0ce9d"
      unitRef="usd">-14900000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie589d17f3ce64923a38138283f3f843d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzg3NTI_6d2a5df6-7391-4d91-aaf7-365b9ed82e04"
      unitRef="usd">6500000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ifbeddf97b3b040cdb135d37c167dfb01_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzg3NTk_4e1a8a56-449e-4703-9553-afced8fb8d55"
      unitRef="usd">7600000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i76c7948c2adf40bebaa47f086f3b7c41_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzkwNDc_69401c9e-4f98-47e4-a90b-8c9207b2a96a"
      unitRef="usd">5100000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzEwODgx_96bdaafe-2816-4618-96d9-a88b95bef99f">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Location on Balance Sheet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;At December 31, 2021 and 2020, the total notional amounts related to the Company&#x2019;s interest rate swaps were $1.8&#160;billion and $1.9&#160;billion, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i62a55cb1537d47889d076d3c8f830a02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzctMS0xLTEtMzczNTY_55b122e4-9327-407c-b7ad-f7eae7092df8"
      unitRef="usd">4900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5007bda63f4a4e2b85d809ab3472888b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzctMy0xLTEtMzczNTY_695b24c0-6030-4ed8-9332-3f65743cba7c"
      unitRef="usd">7623000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id8d483b000704749b5f5f0eb38c92300_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzktMS0xLTEtMzczNTY_0df3be9b-1415-48ab-883d-5b7f4b242314"
      unitRef="usd">5120000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if52dea29077a4f65adb78386228ccf13_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzktMy0xLTEtMzczNTY_ff8b42c3-2b4b-46b5-b392-2e98283e0ba0"
      unitRef="usd">5297000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i95418fcfcff14dcbb2439d47adcad59b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzEyLTEtMS0xLTM3MzU2_e4eaf613-d295-444f-9a4d-67799bced2da"
      unitRef="usd">4373000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i97de46c1ab694e2aa2d5f857600a53fe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzEyLTMtMS0xLTM3MzU2_a175407f-3400-48e2-a53d-95920891a6ee"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifac5dfc2c36d4dc3a7782ef005ce490b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzE1LTEtMS0xLTM3MzU2_a3c5fbbf-7e76-410d-856c-afdc30ee5b55"
      unitRef="usd">2104000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id92cc86da652405da37174ac4bd32ab4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzE1LTMtMS0xLTM3MzU2_ea2cc5c8-f655-4abf-b2a8-773cdd33ec9d"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i447e91e51b6c484fb722708a563e3022_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzE2LTEtMS0xLTM3MzU2_03fafd98-b316-430f-8ce0-614ebcd43484"
      unitRef="usd">16497000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i935a17c2069e4de2b906355e2084c604_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzE2LTMtMS0xLTM3MzU2_148ac80a-2cbe-4b27-bb06-7b2d9fbabb37"
      unitRef="usd">12920000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i694c78ee7c7447a6b3c35d7312afaff3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzIxLTEtMS0xLTM3MzU2_2068b310-f98e-4ec6-ace8-cf8165d18cf5"
      unitRef="usd">18187000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7d737f4d7da848479653a6d886df97b1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzIxLTMtMS0xLTM3MzU2_da77c636-6419-4ecb-943a-2951382888a9"
      unitRef="usd">22033000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5f58fb0074304c0eb75e1ee30a90496f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzIyLTEtMS0xLTM3MzU2_57a11a50-54aa-4b97-8205-40a69b466729"
      unitRef="usd">8283000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie4202a3390bb4daa9e7d55f6fbb4c9b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzIyLTMtMS0xLTM3MzU2_cb2662ed-bcdf-41d2-996b-32560c4a3db0"
      unitRef="usd">4335000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2b3a469b84e14fa487772842b4758f1f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI0LTEtMS0xLTM3MzU2_29d482fa-8816-4342-84d4-0c22ad5e94cd"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i244b53fa225146a8acddf34d0b484d40_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI0LTMtMS0xLTM3MzU2_d10d2cbc-ac7f-46a9-8a75-46369a169f52"
      unitRef="usd">1884000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="icef0348bbd6a498895aa0b839af063db_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI3LTEtMS0xLTM3MzU2_34f66bff-f128-4128-8dae-b8ed4febccc0"
      unitRef="usd">30143000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic1948e2d317241c495c217c582f1fd94_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI3LTMtMS0xLTM3MzU2_fa8fc8eb-aa1f-4e1d-bd03-76b42b2b2d99"
      unitRef="usd">71736000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i0816d77ecc2a4d5ab1a7fdecd924c086_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI4LTEtMS0xLTM3MzU2_3aeab5b2-019d-41cb-b64a-54533843f1a0"
      unitRef="usd">4859000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib93f9ad9f3ac454ab3e4579cba214ea5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzI4LTMtMS0xLTM3MzU2_d3a1b200-0b83-4229-b067-ea3579c54ded"
      unitRef="usd">26728000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ifb37d7988ff2469883e023d54943ceeb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzMwLTEtMS0xLTM3MzU2_2a5befb2-19d8-470f-9a89-3bb755cfaefd"
      unitRef="usd">3366000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if15b603d0fdf4013bb65d3fbdef4991b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzMwLTMtMS0xLTM3MzU2_1af344f2-d923-40b6-ba6c-fdd343427e74"
      unitRef="usd">9449000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i447e91e51b6c484fb722708a563e3022_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzMxLTEtMS0xLTM3MzU2_8a5d5f38-6559-432e-9cb5-1076b9673d24"
      unitRef="usd">64838000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i935a17c2069e4de2b906355e2084c604_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTphMmY1N2I5OGM5OTc0OGU5YTI4NDM2NmNlMmZkYThjYi90YWJsZXJhbmdlOmEyZjU3Yjk4Yzk5NzQ4ZTlhMjg0MzY2Y2UyZmRhOGNiXzMxLTMtMS0xLTM3MzU2_00649f72-6b31-44ce-be0b-af3e2c68d9f1"
      unitRef="usd">136165000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i75b27d98cb6b453489a1a735b29fb883_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzQzOTgwNDY1MjY0Nzk_1e50f928-7c90-4b48-974d-3e11acffcaa4"
      unitRef="usd">1800000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3a049fa208ff4ab2bb36343f0be21bd6_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzIxOTkwMjMyNjkyNjg_2af7da7e-d86e-4366-9ea7-1d0493b84702"
      unitRef="usd">1900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90ZXh0cmVnaW9uOjZjNTVmZDdjOTc3YjRkZGZiYzhlZmIwYTNhODRlNTMyXzEwODUw_d812b32a-c6f1-4bd0-a34c-7d5dbe8cfa71">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statement of operations during the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;Beginning of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&lt;br/&gt;Gain (Loss)&lt;br/&gt;Recognized&#160;in&lt;br/&gt;AOCL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&#160;Gain&#160;(Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;AOCL into&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;End of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in&lt;br/&gt;Statements&#160;of&lt;br/&gt;Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="if4857792c8c74e459972027dfdcb6655_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzQtMS0xLTEtMzczNTY_0c2fc227-728a-4cbe-83f1-2cb57ac057a4"
      unitRef="usd">-93769000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i138a2424e4fc4b28a990586217f205b5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzQtMy0xLTEtMzczNTY_29cafc7e-bc17-44a2-8b7e-916441510d29"
      unitRef="usd">27402000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i138a2424e4fc4b28a990586217f205b5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzQtNS0xLTEtMzczNTY_0499fcbc-c83e-4d5b-9ce6-dd6a9beef9bf"
      unitRef="usd">-22411000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i1531f368d10d4c27aa41a904bfae834d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzQtNy0xLTEtMzczNTY_54cef86f-01f8-4e73-b854-8e0f58328a27"
      unitRef="usd">-43956000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i29855f0ec5bb4f3b88df4733138e0e6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzUtMS0xLTEtMzczNTY_7303d984-739d-4511-b8ed-a936957d62e9"
      unitRef="usd">-1073000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6cd187ce19574cadad3a77fa3939be9c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzUtMy0xLTEtMzczNTY_77b51ae4-b5ba-4ba9-b000-e5c07a38c644"
      unitRef="usd">24275000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6cd187ce19574cadad3a77fa3939be9c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzUtNS0xLTEtMzczNTY_915ca4cd-e817-4fbd-8cb7-417665109e49"
      unitRef="usd">32890000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i08216cb065b9461b8fe2a96e91b1fc10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzUtNy0xLTEtMzczNTY_d046e7e1-e8a0-44fb-adca-891f14ca53de"
      unitRef="usd">-9688000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idba5aafc495241d195d5376e3caaf972_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzctMS0xLTEtMzczNTY_21178a92-1d1f-4447-adb7-da9797b39448"
      unitRef="usd">-12291000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib65c4a4a4cb943548bc313bbe81dab81_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzctMy0xLTEtMzczNTY_c84e0f50-eff1-4051-a8a7-5f2f6eb79fcf"
      unitRef="usd">16515000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib65c4a4a4cb943548bc313bbe81dab81_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzctNS0xLTEtMzczNTY_0e461f99-538f-4ea7-96c8-2fea6fa097c3"
      unitRef="usd">6545000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i5e6ebae6a0544329b7878caaf61f7c19_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzctNy0xLTEtMzczNTY_d7bcafef-f777-4a3b-b9c4-0c8c0e1a2223"
      unitRef="usd">-2321000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia7221c7b217944b9952cb1447ba40473_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzgtMS0xLTEtMzczNTY_55aba98a-5e91-4df8-b6af-04717b0a5ac1"
      unitRef="usd">-107133000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ida54b96ca0584539ae3b3b157470910b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzgtMy0xLTEtMzczNTY_7193510f-7471-4200-949d-6827186050d5"
      unitRef="usd">68192000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ida54b96ca0584539ae3b3b157470910b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzgtNS0xLTEtMzczNTY_b8c2b259-916b-4a28-81b9-f71321883f89"
      unitRef="usd">17024000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i2e2ac390bcfd4e6183936c3252ad179f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzgtNy0xLTEtMzczNTY_605e91a9-3103-4e36-9ac7-fe4fec989468"
      unitRef="usd">-55965000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i554f5b5c47644e348d9ce91db90fc9b3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzExLTEtMS0xLTM3MzU2_a11597d2-562d-477f-ad3e-a866b1061cfb"
      unitRef="usd">-45145000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6cdda7c780084113bb71a011c3ec558b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzExLTMtMS0xLTM3MzU2_1296be7c-a82d-46ea-8a0d-297a8bb72746"
      unitRef="usd">-64778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6cdda7c780084113bb71a011c3ec558b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzExLTUtMS0xLTM3MzU2_6d360278-85c4-4756-8325-26aacefadcaa"
      unitRef="usd">-16154000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="if4857792c8c74e459972027dfdcb6655_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzExLTctMS0xLTM3MzU2_6ce7f7d2-648f-4952-ab27-115bc5a189f6"
      unitRef="usd">-93769000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8882f763c98a4445ad3da17239380121_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzEyLTEtMS0xLTM3MzU2_ee369e23-7d13-466c-8eea-02a4eedaa715"
      unitRef="usd">177000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia478304e872e441bae733c20fd924acd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzEyLTMtMS0xLTM3MzU2_91b2de7c-a8c6-4907-8ccd-c0388827e5f6"
      unitRef="usd">-17147000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ia478304e872e441bae733c20fd924acd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzEyLTUtMS0xLTM3MzU2_ec0cad9f-0474-4fc0-b9ca-8f0ec909b110"
      unitRef="usd">-15897000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i29855f0ec5bb4f3b88df4733138e0e6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzEyLTctMS0xLTM3MzU2_53410e9c-3bab-4537-90b4-4f21d729d50c"
      unitRef="usd">-1073000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d649a29e36c49c1acac597e1b567b30_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE0LTEtMS0xLTM3MzU2_6151940c-012c-4253-81f2-7fbda54cfffc"
      unitRef="usd">10229000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iff47d977eef64f639713c2bdfe4ec819_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE0LTMtMS0xLTM3MzU2_93cf49a1-d38a-4beb-9a32-15716a4f755b"
      unitRef="usd">-14911000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="iff47d977eef64f639713c2bdfe4ec819_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE0LTUtMS0xLTM3MzU2_cec3fad3-d60c-42ce-a7ef-f89c1ae8c789"
      unitRef="usd">7609000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="idba5aafc495241d195d5376e3caaf972_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE0LTctMS0xLTM3MzU2_460e657f-0343-49ef-acc9-ebfefd916cbf"
      unitRef="usd">-12291000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c7bf1b9701f467ca31a33bccb2a8bd6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE1LTEtMS0xLTM3MzU2_4f8ff734-c91e-48b4-8edc-2475ec7a674f"
      unitRef="usd">-34739000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i751fe1d8d73549729e2da93079a949e7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE1LTMtMS0xLTM3MzU2_2f7a5446-a4e3-4480-8923-41e83c80680f"
      unitRef="usd">-96836000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i751fe1d8d73549729e2da93079a949e7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE1LTUtMS0xLTM3MzU2_0cc54d4f-9b80-4888-8415-010d3fa9f84f"
      unitRef="usd">-24442000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="ia7221c7b217944b9952cb1447ba40473_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjAvZnJhZzo2YzU1ZmQ3Yzk3N2I0ZGRmYmM4ZWZiMGEzYTg0ZTUzMi90YWJsZTplNDBlMWRhZDEzY2Y0MWI5YTRjYjQ5MDg2YjJmMWE1Ny90YWJsZXJhbmdlOmU0MGUxZGFkMTNjZjQxYjlhNGNiNDkwODZiMmYxYTU3XzE1LTctMS0xLTM3MzU2_6d93a48c-bcf1-4f3f-8c22-efccff50048e"
      unitRef="usd">-107133000</us-gaap:StockholdersEquity>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYxNjg_88228a30-ac02-4dc4-8985-086f7f66da16">GOODWILL AND OTHER INTANGIBLE ASSETS &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests goodwill for impairment by either performing a qualitative evaluation or a quantitative test. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The qualitative evaluation is an assessment of factors including reporting unit specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of a reporting unit is less than its carrying amount, including goodwill. The Company may elect to bypass the qualitative assessment for its&#160;three&#160;reporting units and perform a quantitative test. The assumptions used in evaluating goodwill for impairment are subject to change and are tracked against historical results by management. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quantitative test estimates the fair value of the three reporting units using a discounted cash flow model, which incorporates significant estimates and assumptions made by management which, by their nature, are characterized by uncertainty. Inputs used to fair value the Company's reporting units are considered inputs of the fair value hierarchy. For Level 3 measurements, significant increases or decreases in long-term growth rates or discount rates in isolation or in combination could result in a significantly lower or higher fair value measurement. The key assumptions impacting the valuation included the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The reporting unit's financial projections, which are based on management's assessment of regional and macroeconomic variables, industry trends and market opportunities, and the Company's strategic objectives and future growth plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The projected terminal value for the reporting unit, which represents the present value of projected cash flows beyond the last period in the discounted cash flow analysis. The terminal value reflects the Company's assumptions related to long-term growth rates and profitability, which are based on several factors, including local and macroeconomic variables, market opportunities, and future growth plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The discount rate used to measure the present value of the projected future cash flows is set using a weighted-average cost of capital method that considers market and industry data as well as the Company's specific risk factors that are likely to be considered by a market participant. The weighted-average cost of capital is the Company's estimate of the overall after-tax rate of return required by equity and debt holders of a business enterprise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company elected to perform a qualitative analysis for its three reporting units. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill in 2021 and 2020 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;954,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ACell Acquisition &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company's identifiable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;Prior period amounts were reclassified as it relates to All Other within this table to conform to the current period presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, $13.3 million of Intangible assets, net were presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase in the Company's identifiable intangible assets at December 31, 2021 as compared to the year ended December 31, 2020, was primarily driven from intangible assets acquired in conjunction with the ACell Acquisition. See Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets with Indefinite Lives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company elected to perform a qualitative analysis for its intangible asset with indefinite lives. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense (including amounts reported in cost of product revenues) for the years ended December&#160;31, 2021, 2020 and 2019 was $83.3 million, $74.5 million and $72.8 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Annual amortization expense is expected to approximate $79.1 million in 2022, $78.4 million in 2023, $77.7 million in 2024, $77.7 million in 2025, $77.6 million in 2026 and $585.8 million thereafter. Amortization of product technology based intangible assets totaled $66.5 million, $46.7 million and $45.8 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively, and is presented by the Company within cost of goods sold.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU0Ng_aa2be0ea-6abb-4f61-bc3e-8b7204b94618"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:NumberOfReportingUnits
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzc5Mg_aa2be0ea-6abb-4f61-bc3e-8b7204b94618"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:NumberOfReportingUnits
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzgyNDYzMzcyMzAyMjc_7f66ff31-a0aa-4b1c-bfda-e5c57884761f"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYxNzQ_f33d5d00-7eb0-458b-b993-445402d2a5e7">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill in 2021 and 2020 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;954,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ACell Acquisition &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i6130dbfd55434e3ba87710002f62993d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzUtMS0xLTEtMzczNTY_5f8396d5-a517-4dbd-abf3-b7692fc63cf0"
      unitRef="usd">653500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib7ac68eceebd454197e37a04d780f9b2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzUtMy0xLTEtMzczNTY_44b03d46-369c-4e0d-93cd-f747db5437f5"
      unitRef="usd">300780000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie55084e91d494776891870a81ff5cb91_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzUtNS0xLTEtMzczNTY_d7b7770b-9d3c-469b-9490-b6d84648118c"
      unitRef="usd">954280000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="icb66154030084b3e8586a701e0a6bdb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzYtMS0xLTEtMzczNTY_0b209991-7d30-43e7-8c59-f2450dd61f98"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i1b76730b7e7f49afa097d63b1fb0577c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzYtMy0xLTEtMzczNTY_2291c7ef-93b6-4dd2-b115-a6d4bdb8b1cc"
      unitRef="usd">-47546000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzYtNS0xLTEtMzczNTY_1e9b7666-c50a-4b1f-b9c3-1fb1a4a1da3e"
      unitRef="usd">-47546000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="icb66154030084b3e8586a701e0a6bdb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzctMS0xLTEtMzczNTY_a742e006-f8f7-46ec-aea1-0465dc9c48af"
      unitRef="usd">18475000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i1b76730b7e7f49afa097d63b1fb0577c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzctMy0xLTEtMzczNTY_924cbf2b-5586-4f70-8447-fa76a92462dd"
      unitRef="usd">7158000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzctNS0xLTEtMzczNTY_1439c424-6bbc-4916-881a-334aecd3d403"
      unitRef="usd">25633000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i4abb8a070bc94419b02bdf48d4701704_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzgtMS0xLTEtMzczNTY_5c934099-ad54-4829-a846-824784daf904"
      unitRef="usd">671975000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i75ce8d6ec8224485834914549b9bdc7c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzgtMy0xLTEtMzczNTY_000ce99f-c112-4d57-b94d-7cc6c07b4a15"
      unitRef="usd">260392000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzgtNS0xLTEtMzczNTY_279141a6-3978-46be-bf94-c07f35711834"
      unitRef="usd">932367000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzktMS0xLTEtNDkxMDc_8f49396d-6003-4f04-a47a-2190e22132f4"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4d1799cdfeb443c297cec0ede24b319e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzktMy0xLTEtNDkxMTQ_78b99c40-2254-4289-9d8a-13c4f65514b1"
      unitRef="usd">94147000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzgtNS0xLTEtNDk4NTk_3800c9af-1960-4203-9b31-223003ffb24d"
      unitRef="usd">94147000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzktMS0xLTEtMzczNTY_9bad5037-c765-4964-a0e3-3a7ea1f2d26c"
      unitRef="usd">-8547000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4d1799cdfeb443c297cec0ede24b319e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzktMy0xLTEtMzczNTY_83c9bf95-8f17-49d4-a8d5-1ac3e05feb49"
      unitRef="usd">-4509000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzktNS0xLTEtMzczNTY_6cea4c75-ef94-4905-8ef4-f2ca6e359a83"
      unitRef="usd">-13056000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i2cb20ffbdee24ca9b4586a5cf126dba1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzExLTEtMS0xLTM3MzU2_c2d190ec-7195-4bf9-9859-10342b242745"
      unitRef="usd">663428000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7778b95afae64e8cb2f805b44e496258_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzExLTMtMS0xLTM3MzU2_d720bddb-f90e-47f0-85cd-14261bdcae1c"
      unitRef="usd">350030000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTo1ZjcwZTZmZWVmNDU0MGNmOTdhMTlmYTMxZDI5NzZmZi90YWJsZXJhbmdlOjVmNzBlNmZlZWY0NTQwY2Y5N2ExOWZhMzFkMjk3NmZmXzExLTUtMS0xLTM3MzU2_560c88d0-c9a4-4830-9223-2d60122d0f42"
      unitRef="usd">1013458000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYxNzM_51f10330-1473-4f8b-aa73-525e5bebdf9b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company's identifiable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;Prior period amounts were reclassified as it relates to All Other within this table to conform to the current period presentation&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYxNzc_1a3783d2-5ab4-48cd-b973-b5e0dc1c0ccc">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company's identifiable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;Prior period amounts were reclassified as it relates to All Other within this table to conform to the current period presentation&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i93d465a35e4d4eabb157247c1091f1d7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzQtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpiN2MzNGE0ZmFhNTA0YzBiOGY0ODBmMDkwZDUxOTczY180_1a7aa786-91eb-4cf1-b0df-f49fdcc578da">P18Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i565486756b7249efbbaa382505163bde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzQtMy0xLTEtMzczNTY_a7c822bd-e082-40dc-b64b-60e0fd4f0356"
      unitRef="usd">1132954000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i565486756b7249efbbaa382505163bde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzQtNS0xLTEtMzczNTY_89d87988-aaa3-45b7-93ef-e0b1c807af50"
      unitRef="usd">307013000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i565486756b7249efbbaa382505163bde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzQtNy0xLTEtMzczNTY_e79bf7d0-1a25-46c9-967b-5e0790759d47"
      unitRef="usd">825941000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i1252007ac54246de9abeebe0a6b2d8f2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzUtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo3Y2IzMzVjYTE2YTU0ZjAyYmM0NjNlNzYxM2YzY2VmNF80_35abb41a-8880-4080-88da-d71fbaa55351">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="icc306b5f7a374a95bf6db9885328d885_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzUtMy0xLTEtMzczNTY_3a7de71f-ee52-486d-9802-9c5ead9658e7"
      unitRef="usd">211344000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icc306b5f7a374a95bf6db9885328d885_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzUtNS0xLTEtMzczNTY_7a0b0a95-afe7-48de-9b61-ce4fd5098e7e"
      unitRef="usd">142755000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="icc306b5f7a374a95bf6db9885328d885_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzUtNy0xLTEtMzczNTY_142422f2-e706-4dad-bfb6-be7fd211ca3c"
      unitRef="usd">68589000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iae5ad95d43134ec6a2a3f3e3a0aaf4f7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzYtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo2NjY4ZjlkMDc3Mjk0NWU3YjYyOWI1ZDRlYjY0Y2U3MF80_6057f23b-2563-4de2-867e-e1fa11d1e22f">P28Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i10c021d4850a4d869790819bbad3ae43_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzYtMy0xLTEtMzczNTY_14e08198-be08-4716-a253-1a283d081cc8"
      unitRef="usd">98367000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i10c021d4850a4d869790819bbad3ae43_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzYtNS0xLTEtMzczNTY_0350c842-44b9-420e-ab23-827e0400e595"
      unitRef="usd">31468000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i10c021d4850a4d869790819bbad3ae43_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzYtNy0xLTEtMzczNTY_adb273d2-83c7-429c-862a-02c6b47af1fe"
      unitRef="usd">66899000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i62f8ee36cb1e4ac58c021879c749533b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzctMy0xLTEtMzczNTY_9d2608d0-d7ca-42c7-96d0-33d3bdc91539"
      unitRef="usd">167758000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i62f8ee36cb1e4ac58c021879c749533b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzctNy0xLTEtMzczNTY_af1741c2-b7b2-4a4b-8505-d7d088440e6c"
      unitRef="usd">167758000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3234077932f2438296d701e72d5ffac3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzgtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpjN2YyYzc1NzViYTQ0OThkODgzOWQ3NGZlNDBlMDU3MF80_1bf2987a-2930-42d9-baad-657a227cc279">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i0de13c4843ae43a09d39c8eb3d4b8fe4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzgtMy0xLTEtMzczNTY_ff56a1a5-1f13-4ebb-bb30-c1a0f72133e0"
      unitRef="usd">30211000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0de13c4843ae43a09d39c8eb3d4b8fe4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzgtNS0xLTEtMzczNTY_096f5061-2569-4c80-b53c-fe193db3c069"
      unitRef="usd">16192000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i0de13c4843ae43a09d39c8eb3d4b8fe4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzgtNy0xLTEtMzczNTY_dfb0dedd-6ddd-47f3-82b2-1426902495d1"
      unitRef="usd">14019000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9bbe1d90175a46fe8dfa0043b4527186_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzktMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjpiNDQ5OWMzZGQ3NGM0N2M3YThmYTQ2MThhOTlhMTJiZF80_e3a36ed8-4510-46c4-8d4b-4c907f3e332b">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="ic0bcf683f0a14720a1b91832c115533e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzktMy0xLTEtMzczNTY_751d1944-9c8a-400a-9d04-59df3a76e742"
      unitRef="usd">6258000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic0bcf683f0a14720a1b91832c115533e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzktNS0xLTEtMzczNTY_7c4120be-2a4c-40c7-815e-9429f86591e6"
      unitRef="usd">3891000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="ic0bcf683f0a14720a1b91832c115533e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzktNy0xLTEtMzczNTY_b689b213-d246-4df6-9558-2a3cfda3715f"
      unitRef="usd">2367000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzEwLTMtMS0xLTM3MzU2_bc6751de-357f-4458-a990-4b76954a0990"
      unitRef="usd">1646892000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzEwLTUtMS0xLTM3MzU2_878254f7-61b0-4375-8cf0-46e9cc438d52"
      unitRef="usd">501319000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTphMGQwZjFkZjI2N2E0YzhjYmRiOGYwMjY0OGFhMDllMC90YWJsZXJhbmdlOmEwZDBmMWRmMjY3YTRjOGNiZGI4ZjAyNjQ4YWEwOWUwXzEwLTctMS0xLTM3MzU2_e84d46a9-fe04-4458-820a-d54a46739917"
      unitRef="usd">1145573000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iaeb0d8ccf2a044b79a58dfc3b65f8e15_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzQtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjphMzU4ZjQ2MTlhMGY0MDU0OWZkOGE4Y2UwZjY4OTY2MF80_94ee8fa5-f4b6-4b57-93a6-2c7e78588058">P19Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i3edc297cbc6e43909b926332dfc8a2d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzQtMy0xLTEtMzczNTY_3a64f3d0-7f09-4947-9f03-05bbbd555be7"
      unitRef="usd">896478000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3edc297cbc6e43909b926332dfc8a2d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzQtNS0xLTEtMzczNTY_b05530d7-0a86-4066-9ef4-d4f42329215c"
      unitRef="usd">248088000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i3edc297cbc6e43909b926332dfc8a2d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzQtNy0xLTEtMzczNTY_5ae93963-b9c3-47ba-ad4a-bd88d403a983"
      unitRef="usd">648390000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9e32de5cf50a4cab9682cd23ec61237e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzUtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjoxNWZmMWI0OGU3MzI0YjVlYTBkOGMxMzM1NjhkNDU4NF80_45da6ad3-1bee-4151-8d1b-cf9da0f59b6d">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i04c114db065b4f4eb88c5a3d48995ddb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzUtMy0xLTEtMzczNTY_2165eb54-631a-4875-b0d5-7c83b877bb16"
      unitRef="usd">213270000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i04c114db065b4f4eb88c5a3d48995ddb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzUtNS0xLTEtMzczNTY_2a0a3e1a-aefe-49f2-9f9b-17f548260dd3"
      unitRef="usd">132838000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i04c114db065b4f4eb88c5a3d48995ddb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzUtNy0xLTEtMzczNTY_f39bb4f2-9095-4501-bd27-d10f340822b2"
      unitRef="usd">80432000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="idd79a69fcf5a4ee1bc04e02cbd130619_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzYtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo2OTZmZTkxOTRmZTA0NGVhYWE1YWUzNzJjNDQzYjBmOV80_0ff3f617-95e1-461b-a768-6d364ff31ef2">P28Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i13a5de5444e140fc92fa01a15959c201_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzYtMy0xLTEtMzczNTY_30e8499f-6d1f-47ce-a9f6-9a7381758353"
      unitRef="usd">104209000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i13a5de5444e140fc92fa01a15959c201_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzYtNS0xLTEtMzczNTY_9c4c1822-086b-4713-9140-a8810e57e1e8"
      unitRef="usd">31767000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i13a5de5444e140fc92fa01a15959c201_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzYtNy0xLTEtMzczNTY_128a238d-533d-4864-9c82-cad3ad937d72"
      unitRef="usd">72442000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i33f5557b4fd84457a5a5e3d5dcc1d9a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzctMy0xLTEtMzczNTY_d243d4e9-48d7-47b1-97af-09e26e335990"
      unitRef="usd">170226000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i33f5557b4fd84457a5a5e3d5dcc1d9a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzctNy0xLTEtMzczNTY_eb33f410-b46e-486f-8547-1ba0a3f9d563"
      unitRef="usd">170226000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4475ac8a68ef47fb85a8578399b0bf14_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzgtMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjo5YTgxNDQ2Y2I5OWI0OTEwYjZiZDI5NmI3NTBiZjNhN180_8ea7662e-3119-4bc6-aa3c-d4af9640acb7">P27Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i737468523a6841bf8124822271ebf871_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzgtMy0xLTEtMzczNTY_1a8a0fed-e2ad-4e7c-89c4-93ad452f460f"
      unitRef="usd">30211000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i737468523a6841bf8124822271ebf871_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzgtNS0xLTEtMzczNTY_00d05006-c7e0-4f31-a9f6-d26b0d4f242d"
      unitRef="usd">15203000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i737468523a6841bf8124822271ebf871_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzgtNy0xLTEtMzczNTY_83578b67-d1cb-4548-885d-d35622542a88"
      unitRef="usd">15008000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3a37880f41f64981a5fef9ddf9b77d0c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzktMS0xLTEtMzczNTYvdGV4dHJlZ2lvbjozNmI4MGFlN2JlZTQ0YzEyYjlmZDgxNzk5YjZmOTVkNF80_12f7b4c4-2397-42de-9583-6903fe360b74">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i7c4b331f18ed42aba33f65f03aa1c992_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzktMy0xLTEtMzczNTY_fac4b537-8e7e-407e-94f7-2e9a2943e0f4"
      unitRef="usd">6693000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7c4b331f18ed42aba33f65f03aa1c992_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzktNS0xLTEtMzczNTY_2261223f-dc43-4945-b8b8-32859738b6c9"
      unitRef="usd">3755000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i7c4b331f18ed42aba33f65f03aa1c992_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzktNy0xLTEtMzczNTY_5180a54e-dc63-498c-ada1-7de8e6f14e21"
      unitRef="usd">2938000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzEwLTMtMS0xLTM3MzU2_309e06dd-f57d-43e2-8cc4-cd0fe24961da"
      unitRef="usd">1421087000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzEwLTUtMS0xLTM3MzU2_041f3fd5-24ed-41ef-9ec2-618460e635d7"
      unitRef="usd">431651000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90YWJsZTplYzNlMWZiZTFlZmI0YTMzODZhNjNkNzgyZDYwNWI5Ni90YWJsZXJhbmdlOmVjM2UxZmJlMWVmYjRhMzM4NmE2M2Q3ODJkNjA1Yjk2XzEwLTctMS0xLTM3MzU2_3bd6aae3-ab6e-4606-931e-12e655e771bd"
      unitRef="usd">989436000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i000ed083c92e4b89800da97c60ed285f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzMzOTc_8e8aa8e4-868c-4aed-8033-6b117d493fad"
      unitRef="usd">13300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:AdjustmentForAmortization
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU3MjQ_f1dc22e2-f720-4fe6-b17c-40f3ec17e3fa"
      unitRef="usd">83300000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU3MzY_dc686007-4c0d-4cc5-90ec-22c2de86b71b"
      unitRef="usd">74500000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU3NTI_75cfb68a-ff9d-4644-9f7e-3890fa27a4e1"
      unitRef="usd">72800000</us-gaap:AdjustmentForAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU4MzQ_5f10bb2d-4c37-4a9a-83ad-6c2cae883948"
      unitRef="usd">79100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU4NTM_b670e67f-9f4e-49cf-bc68-ce57cce0da9e"
      unitRef="usd">78400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU4NzI_2836dbf6-842f-4b5f-ad6e-ecc2d9236a48"
      unitRef="usd">77700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU4OTE_f1998acf-358b-43c6-905b-25fd555d9a1b"
      unitRef="usd">77700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU5MDk_9a9226bf-328c-4d04-ac8f-9943a121d7cc"
      unitRef="usd">77600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzU5MzA_f4281911-0142-4dd9-9672-4fc167b450dc"
      unitRef="usd">585800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYwMjE_192a8a66-090b-42a2-b679-a9b7cbba31ef"
      unitRef="usd">66500000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYwMzQ_faa85584-631e-4025-b6b5-0d4c4ebe4515"
      unitRef="usd">46700000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjMvZnJhZzowN2JhZGVjZjg5NDg0NzRhODUyMGI5MzRiYzQxNzFmMy90ZXh0cmVnaW9uOjA3YmFkZWNmODk0ODQ3NGE4NTIwYjkzNGJjNDE3MWYzXzYwNTA_8d1ea1c5-008a-493b-accb-e3af7248c8d8"
      unitRef="usd">45800000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:TreasuryStockTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzE1NzU_307275d1-c67e-435c-bb1b-95da3d2acafc">TREASURY STOCK&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, there were 4.9 million shares of treasury stock outstanding with a cost of $234.4 million and $235.1 million, respectively, at a weighted average cost per share of $47.86.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 7, 2020, the Board of Directors authorized the Company to repurchase up to $225&#160;million of the Company&#x2019;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2022. The price and timing of any future purchases under the share repurchase program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price, and such repurchases may be discontinued at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For the year ended December 31, 2021, there were no repurchases of the Company&#x2019;s common stock as part of the share repurchase authorization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On January 12, 2022, the Company entered into a $125.0&#160;million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;accelerated share repurchase ("2022 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;ASR") and received 1.5&#160;million shares of Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. The remaining 20% of the expected total shares is expected to settle in the first half of 2022, upon which additional shares of common stock may be delivered to the Company or, under certain circumstances, the Company may be required to make a cash payment or may elect to deliver shares of our common stock to the 2022 ASR counterparty in each case pursuant to the terms of the 2022 ASR agreement between the Company and the 2022 ASR counterparty. The total number of shares to be delivered or the amount of such payment, as well as the final average price per share, will be based on the volume-weighted average price, less a discount, of the Company's common stock during the term of the transaction. As a result of this transaction, $100&#160;million remains available under the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$225&#160;million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; repurchase authorization&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;During the twelve months ended December 31, 2020, the Company repurchased 2.1&#160;million shares of Integra&#x2019;s common stock as part of the previous share repurchase authorization. The Company utilized $100.0&#160;million of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included $7.6&#160;million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a $92.4&#160;million accelerated share repurchase ("2020 ASR") to complete the remaining $100.0&#160;million of share repurchase. The Company received 1.3&#160;million shares at inception of the 2020 ASR, which represented approximately 80% of the expected total shares. Upon settlement of the 2020 ASR in June 2020, the Company received an additional 0.6&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the transaction.</us-gaap:TreasuryStockTextBlock>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzUx_65c8802a-917a-4f12-84db-7af5ad72afd3"
      unitRef="shares">4900000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzUx_ce2755c1-182e-4cd3-be2a-dfb1ad9b0928"
      unitRef="shares">4900000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzEzMA_fe6df185-95a0-4f36-96bb-2c5bdbe4c03f"
      unitRef="usd">234400000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzE0Ng_fb1756b0-5306-479b-b1a1-84f7f8ab0b72"
      unitRef="usd">235100000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzE5OQ_bbe1f20b-98a4-43f4-93a4-e11ea0103a39"
      unitRef="usdPerShare">47.86</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzE5OQ_ce0ec6cf-24ef-45c5-aa91-d1754e9f5f77"
      unitRef="usdPerShare">47.86</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i1b58cefefc354ae79f2cb3074a62ea26_I20201207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzMxMQ_d1ec5efb-7b3b-47ff-8bd5-a85aeecc23fe"
      unitRef="usd">225000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="ia20712ff79044b74a597c82e1faea48d_I20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzU0OTc1NTgxNDY5ODc_6c5e1b97-0892-4595-af44-db88e4fbcadb"
      unitRef="usd">125000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <iart:AcceleratedShareRepurchasesSharesReceivedAtInception
      contextRef="ia20712ff79044b74a597c82e1faea48d_I20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzU0OTc1NTgxNDY5OTE_d0315985-fefe-4192-add2-2b790fca185e"
      unitRef="shares">1500000</iart:AcceleratedShareRepurchasesSharesReceivedAtInception>
    <iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased
      contextRef="i538c9dcc0e144b5ca4a9c2183db495d7_D20220112-20220112"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzIxOTkwMjMyNjM2ODI_5d9e78a5-f64a-47a2-bb83-8e1a6e377e10"
      unitRef="number">0.80</iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased>
    <iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased
      contextRef="i899fa5b890ff487689edae2dc21aefef_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzIxOTkwMjMyNjM2ODc_976cdac1-1916-415d-9c52-095e69cc9170"
      unitRef="number">0.20</iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ia20712ff79044b74a597c82e1faea48d_I20220112"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzIxOTkwMjMyNjM2Njg_d22c6797-8873-4c6c-bd68-c1632d6be106"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i1b58cefefc354ae79f2cb3074a62ea26_I20201207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzgyNDYzMzcyMTY5NDE_d1ec5efb-7b3b-47ff-8bd5-a85aeecc23fe"
      unitRef="usd">225000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzc2OQ_08336461-93c0-4ef7-8c39-d5e07e2f2ac1"
      unitRef="shares">2100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i7a682151366145e6904be6c9c0346121_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzg4Mg_2ae19489-633f-4e2b-9982-e8d07711572a"
      unitRef="usd">100000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i1eedec01832141fbb14f413eb354531d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzEwMTE_51a8175e-ffef-4982-8658-470eabdae438"
      unitRef="usd">7600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="i9c54334459e24015b6e27d3a60186407_I20200205"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzExNjA_341d5e94-e761-4e00-b125-199eb47c9bea"
      unitRef="usd">-92400000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i9c54334459e24015b6e27d3a60186407_I20200205"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzEyMjY_f3cb3b0e-b75c-4edb-ba9e-38d24511dce0"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i05515ce3d5484989bc6dd472a4eedeed_D20200205-20200205"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzEyNzE_c6fe67e6-487d-449a-987c-c0e07be87319"
      unitRef="shares">1300000</us-gaap:StockRepurchasedDuringPeriodShares>
    <iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased
      contextRef="i05515ce3d5484989bc6dd472a4eedeed_D20200205-20200205"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzEzMzg_72d4ae56-34a0-4c65-9a4e-b4c2c1cb0a9c"
      unitRef="number">0.80</iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i8c6a1769495943b9b5d9b5d31e294c90_D20200601-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjYvZnJhZzo5MzRmOWNkZTZlNGU0ZWVjOGI1Y2MwOTRiZjc1MmM3MS90ZXh0cmVnaW9uOjkzNGY5Y2RlNmU0ZTRlZWM4YjVjYzA5NGJmNzUyYzcxXzE0NDc_93249434-adbc-4fc0-9ffb-271c221510e9"
      unitRef="shares">600000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYzMjU_afb59530-38cb-4aef-ac2c-1922760b7143">STOCK-BASED COMPENSATION&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated tax benefit related to stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect on net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EMPLOYEE STOCK PURCHASE PLAN &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purpose of the Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;) is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan. Under the ESPP, a total of 3.0 million shares of common stock are reserved for issuance. These shares will be made available either from the Company&#x2019;s authorized but unissued shares of common stock or from shares of common stock reacquired by the Company as treasury stock. At December&#160;31, 2021, 2.0 million shares remain available for purchase under the ESPP. During the years ended December&#160;31, 2021, 2020 and 2019, the Company issued 16,948 shares, 18,284 shares and 12,531 shares under the ESPP for $1.1 million, $1.1 million and $0.7 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EQUITY AWARD PLANS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the &#x201c;2003 Plan&#x201d;). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2010 and May 2017, the stockholders of the Company approved amendments to the 2003 Plan to increase by 3.5 million and 1.7 million, respectively, the number of shares of common stock that may be issued under the 2003 Plan. The Company has reserved 4.0 million shares under each of the 2000 Plan and the 2001 Plan, and 14.7 million shares under the 2003 Plan. The Plans permit the Company to grant incentive and non-qualified stock options, stock appreciation rights, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;restricted stock, contract stock, performance stock, or dividend equivalent rights to designated directors, officers, employees and associates of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options issued under the 2003 Plan became exercisable over specified periods, generally within four years from the date of grant for officers and employees, and within one year from the date of the grant for members of the Board of Directors. The awards generally expire eight years from the grant date for employees and from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIyNDc_dac495da-8c41-4f99-8dc2-4cfbd78ca20b"&gt;six&lt;/span&gt; to ten years for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in control provisions within their grant agreements. Restricted stock issued under the 2003 Plan vests ratably over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the 2003 Plan is subject to service and performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company values stock option grants using the binomial distribution model. Management believes that the binomial distribution model is preferable to the Black-Scholes model because it is a more flexible model that gives consideration to the impact of non-transferability and vesting provisions in valuing employee stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the value of stock options granted, the Company considered that it has never paid cash dividends and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield. Expected volatilities are based on the historical volatility of the Company&#x2019;s stock price. The expected life of stock options is estimated based on historical data on exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock options granted. The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected life of the options. The Company accounts for forfeitures as they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used in the calculation of fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.51%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of option from grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stock option activity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Contractual Term in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$34,560&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $5.0 million, $3.2 million and $3.0 million in expense related to stock options during the years ended December 31, 2021, 2020 and 2019, respectively. The intrinsic value of options exercised for the years ended December&#160;31, 2021, 2020 and 2019 were $11.1 million, $8.7 million and $14.6 million, respectively. Cash received from option exercises and employee stock purchase plan was $6.8 million, $5.2 million and $6.9 million, for the years ended December 31, 2021, 2020 and 2019, respectively. The realized tax benefit from options exercised w&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ere $2.2 mi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;llion, $1.7 million and $3.0 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, there was approximately $2.9 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately two years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Awards of Restricted Stock, Performance Stock and Contract Stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Stock and Contract  Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments for performance achievement related to award target&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested but not released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $31.2 million, $16.4 million and $18.1 million in expense related to such awards during the years ended December 31, 2021, 2020 and 2019, respectively. The total fair market value of shares vested and released in 2021, 2020 and 2019 was $15.7 million, $17.3 million and $21.1 million, respectively. Vested awards include shares that have been fully earned but had not been delivered as of December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance stock awards have performance features associated with them. Performance stock, restricted stock and contract stock awards generally have requisite service periods of three years. The fair value of these awards is being expensed on a straight-line basis over the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, there was approximately $21.1 million of total unrecognized compensation costs related to unvested restricted stock, performance stock and contract stock awards. These costs are expected to be recognized over a weighted-average period of approximately two years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, there were approximately 0.5 million vested Restricted Units and 0.1 million vested performance share units held by various employees for which the related shares have not yet been issued. The final determination of the number of shares to be issued is made by the Company's Compensation Committee of the Board of Directors which is contingent upon achieving certain revenue and organic revenue growth performance metric.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, there were approximately 3.5 million shares available for grant under the 2003 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalized into inventory, share based compensation costs of $0.5 million, $0.4 million and $0.3 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively. Such share-based compensation was recognized as cost of goods sold when related inventory was sold.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYzNjQ_f7c2443c-f7ac-452a-beab-e55dd688785b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated tax benefit related to stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect on net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib53b8c510bfb4f04a342d01490fff519_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzMtMS0xLTEtMzczNTY_7c5cb7c3-da89-4420-87b3-0037b2c2921c"
      unitRef="usd">470000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id37cda7e161149dab639b5833e0cdaae_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzMtMy0xLTEtMzczNTY_6e782c1c-eeee-475a-92c5-148559797172"
      unitRef="usd">344000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1323b59618784a1fab24844213313e44_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzMtNS0xLTEtMzczNTY_60d7e77e-8b8e-4c9c-bee8-2099e5936cad"
      unitRef="usd">317000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ife4b1f164ed2413f96ccef0da637494a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzQtMS0xLTEtMzczNTY_3aecf8ed-ba40-47b9-9a1e-0f9ebcf87b64"
      unitRef="usd">1644000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia8d6853b6a2340eea65ce878ccdc9506_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzQtMy0xLTEtMzczNTY_e0170670-d2aa-4323-ac16-b20496b57dbf"
      unitRef="usd">1471000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4ef4bd774a64465bb9beb6cfda1cdbc9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzQtNS0xLTEtMzczNTY_644c6f2e-0986-4c46-b25c-963a45ac8c79"
      unitRef="usd">1785000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic3178f6269054097bd491b98b26e7a45_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzUtMS0xLTEtMzczNTY_cdde56e5-9104-4be2-b47f-3a156987ac11"
      unitRef="usd">34096000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if89798fbac704337b50567a4cce07285_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzUtMy0xLTEtMzczNTY_4fd0cae4-0732-40dc-b18f-48a87029fe1d"
      unitRef="usd">17776000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i93981c800579497aaf2dd345c9d2a500_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzUtNS0xLTEtMzczNTY_d005f0b2-2e41-43f1-9a14-4359200d2ec3"
      unitRef="usd">19153000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzYtMS0xLTEtMzczNTY_c82389ef-8edd-452a-bd4e-e60d77eaf47e"
      unitRef="usd">36210000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzYtMy0xLTEtMzczNTY_729ae8bb-576b-4017-815a-9f3654285a79"
      unitRef="usd">19591000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzYtNS0xLTEtMzczNTY_705b8619-4890-4b82-b53e-da3043c7cc6a"
      unitRef="usd">21255000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzctMS0xLTEtMzczNTY_4197a312-bbfc-4555-91df-7da5bdd6e3ad"
      unitRef="usd">13804000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzctMy0xLTEtMzczNTY_05161b9c-a937-49a1-9060-0e6232cfa47b"
      unitRef="usd">6221000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzctNS0xLTEtMzczNTY_a8ca20ab-d722-44ca-bbce-ba20eac36abe"
      unitRef="usd">9420000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzgtMS0xLTEtMzczNTY_6b46e5dd-2bec-478c-99e3-3bf7542dd9c9"
      unitRef="usd">22406000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzgtMy0xLTEtMzczNTY_5062af9a-72fb-4549-8b0a-718fba23c2b8"
      unitRef="usd">13370000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpkMTJjYjZhOWY5ZWQ0OTQwOTQ4M2NlNjVhZWMzMDc5NS90YWJsZXJhbmdlOmQxMmNiNmE5ZjllZDQ5NDA5NDgzY2U2NWFlYzMwNzk1XzgtNS0xLTEtMzczNTY_8e930c15-b887-4394-a951-65702c4ea650"
      unitRef="usd">11835000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i53a14816cfaa497fba679e918c9d17fd_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzUyMQ_7aa4289f-0826-46e7-9e4a-d4567beb6b00"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i53a14816cfaa497fba679e918c9d17fd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzc2Ng_2e56548c-0efe-4e72-b212-22868cc73d53"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ib3145669c89f4e22a4ae2186bc7b0142_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzg3OQ_ba0ee556-ed3d-461f-b222-f0abc20485a2"
      unitRef="shares">16948</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="if60cbed693984bf4ac9378ff4177b4cb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzg5MA_e3c6cf71-cd4b-4c0a-8cfc-b29fb9f907a3"
      unitRef="shares">18284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i07b2805613624db19aac4968ce38ff27_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzkwNA_2d1125a6-af55-4eab-ac2c-d1c3cd375664"
      unitRef="shares">12531</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <iart:EmployeeStockPurchasePlanProceeds
      contextRef="ib3145669c89f4e22a4ae2186bc7b0142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzkzMw_3cb353da-be13-4ef4-9deb-8aaae1678abc"
      unitRef="usd">1100000</iart:EmployeeStockPurchasePlanProceeds>
    <iart:EmployeeStockPurchasePlanProceeds
      contextRef="if60cbed693984bf4ac9378ff4177b4cb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzkzNw_38c2ad53-d704-4a8f-a233-620d0e0d5851"
      unitRef="usd">1100000</iart:EmployeeStockPurchasePlanProceeds>
    <iart:EmployeeStockPurchasePlanProceeds
      contextRef="i07b2805613624db19aac4968ce38ff27_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzk0NA_e586267a-8a31-47d6-b0f6-3f25f90c2ef9"
      unitRef="usd">700000</iart:EmployeeStockPurchasePlanProceeds>
    <iart:IncreaseInAuthorizedShares
      contextRef="i2b897ca4831342edaea566ae6b0cdc36_D20100501-20100531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzE0NTU_2898fd81-b850-471a-8f5d-6ced140bf37d"
      unitRef="shares">3500000</iart:IncreaseInAuthorizedShares>
    <iart:IncreaseInAuthorizedShares
      contextRef="i26a65d8304ba448f91360ee062277da9_D20170501-20170531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzE0NjI_2c6b108c-0c41-4f3b-8834-639ecbcd1603"
      unitRef="shares">1700000</iart:IncreaseInAuthorizedShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i584d7e4f3e034bb6aa9b60e07b8d05fe_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzE1ODI_961704fc-bb2a-4bac-b0a9-f6de1a7273d6"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ib73b40adb8374cff8a251fef052acd84_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzE1ODI_c4527e86-7f84-4faf-8dcf-b1efd32ff6f0"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i13bb28aa1adf4576aeb1ec00d3e26d97_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzE2NDM_48dc8246-8614-49fd-a12e-ee715c66e1b6"
      unitRef="shares">14700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i5fff9ccde2f5438e83ff62797cae4f8d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIwMzk_c3cf52a8-42d2-40e5-87ad-0f1821a1fc7b">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i734854acf1ee4be8bf15f1abd93bfd07_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIxMDQ_b925a4e7-1998-490f-9ce2-37a868d86985">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i0e555d1eb8964644b65afbac50ffd7a1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIyMDE_33347a51-9fcc-4a3d-a596-ca549d9b4a99">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ie513c0771de143ca92523d08ff0e8443_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIyNTM_f520770a-81f6-412f-9f00-7ff402db1ad2">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i929f1fd93be942479d2f584793b7dda6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzIzOTA_f91ae07e-abe3-40d7-8ff8-c44744cd4d21">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzI5NTQ_4d1c0744-011b-4e85-917b-7a64546c4c83"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYzNDA_1c1e95c2-6cef-417e-84d9-fa3bc06e6f1c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used in the calculation of fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.51%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of option from grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzItMS0xLTEtMzczNTY_66d759b3-229b-4d38-abec-fbbdd326213c"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzItMy0xLTEtMzczNTY_adc3e527-8e62-4834-8dc6-6f5a333fa813"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzItNS0xLTEtMzczNTY_ac2d89ea-ff38-4e96-8096-1406c9bf7afd"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzMtMS0xLTEtMzczNTY_d02beb4e-2ae9-418f-946a-7e1172d18880"
      unitRef="number">0.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzMtMy0xLTEtMzczNTY_17d3ea95-2a80-451e-a2dd-9193924d237e"
      unitRef="number">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzMtNS0xLTEtMzczNTY_b41e74d4-bba2-4fe1-91c1-cb3467e8ef0d"
      unitRef="number">0.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzQtMS0xLTEtMzczNTY_85ec7db5-ba43-4a73-9920-ff71c95a7160"
      unitRef="number">0.0130</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzQtMy0xLTEtMzczNTY_33454038-17a6-4e45-8022-e02b6a6dd320"
      unitRef="number">0.0089</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzQtNS0xLTEtMzczNTY_e0fe0e9a-2f37-4968-93fe-f6c6672667f2"
      unitRef="number">0.0251</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzUtMS0xLTEtMzczNTY_36b59b59-9f1a-4fcb-ba98-941942fcb330">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzUtMy0xLTEtMzczNTY_07c9ab79-56c2-4d3e-b66c-84a3e225a0e4">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzUtNS0xLTEtMzczNTY_5c752401-149e-4273-b5cb-7bc06b52dd9f">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzYtMS0xLTEtMzczNTY_cd3a72d9-afe5-4c98-9ee2-3fc1f4827f49"
      unitRef="usdPerShare">22.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzYtMy0xLTEtMzczNTY_e0153bc7-ba2f-4000-b49b-85cac6861da2"
      unitRef="usdPerShare">13.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo5NWUzZGY1ZjI2ZjQ0ODllODkyMDA2YTZjNjY3NWEwMy90YWJsZXJhbmdlOjk1ZTNkZjVmMjZmNDQ4OWU4OTIwMDZhNmM2Njc1YTAzXzYtNS0xLTEtMzczNTY_6c7d6a5f-b338-4411-89d5-bfc7a18cb215"
      unitRef="usdPerShare">18.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYzNTQ_9ee567bd-1dbf-4558-b09e-1a1a1a900e52">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stock option activity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Contractual Term in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$34,560&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzQtMS0xLTEtMzczNTY_48b9a9e3-9045-4cfb-bdf3-2f559e02fa94"
      unitRef="shares">1346000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzQtMy0xLTEtMzczNTY_b3034a4d-e777-4211-96a2-2ea130b0e4aa"
      unitRef="usdPerShare">39.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzQtNS0xLTEtMzczNTY_5b01a3da-c320-499f-87df-5484b3b0259f">P4Y4M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzQtNy0xLTEtMzczNTY_1f4a266f-7c29-4862-8989-92f829e45ad1"
      unitRef="usd">34560000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzYtMS0xLTEtMzczNTY_e6b4bd86-495a-4e50-8be7-d6eb01f36c66"
      unitRef="shares">150000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzYtMy0xLTEtMzczNTY_971743bd-79b0-4151-a43b-f578c2749c22"
      unitRef="usdPerShare">68.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzctMS0xLTEtMzczNTY_22273745-9594-4ea0-bcb7-c7843b03bfb2"
      unitRef="shares">230000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzctMy0xLTEtMzczNTY_2d297079-2e5f-49ac-9ac5-41d63e55cf07"
      unitRef="usdPerShare">24.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzgtMS0xLTEtMzczNTY_eb31f589-7ed2-4ee0-96ed-295797c5712d"
      unitRef="shares">41000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzgtMy0xLTEtMzczNTY_9db94a40-a2e4-44ec-9f88-0d6fc5097c6f"
      unitRef="usdPerShare">51.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzktMS0xLTEtMzczNTY_870e3fec-c8fa-4ddc-9c6c-b7f2caf22477"
      unitRef="shares">1225000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzktMy0xLTEtMzczNTY_a4034bd4-a47e-4db3-89ae-32fd66309d28"
      unitRef="usdPerShare">45.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzktNS0xLTEtMzczNTY_88c96466-fac9-4f1a-8b78-5dd3bee0ef7b">P4Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzktNy0xLTEtMzczNTY_d1c11bb8-740d-4dfd-b8ce-8aee0b30bffb"
      unitRef="usd">26970000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzExLTEtMS0xLTM3MzU2_fdcb1eef-3bcc-450f-87e1-7ce14b61cac6"
      unitRef="shares">858000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzExLTMtMS0xLTM3MzU2_d3d89f22-3920-42ae-a076-909ef69a4168"
      unitRef="usdPerShare">41.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzExLTUtMS0xLTM3MzU2_0aed848c-8287-4f4e-a39e-034c35939074">P3Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTo3YmZjOWQ0MWNlMmI0Njg5OTllNGNmMWFhZTMwMjc5My90YWJsZXJhbmdlOjdiZmM5ZDQxY2UyYjQ2ODk5OWU0Y2YxYWFlMzAyNzkzXzExLTctMS0xLTM3MzU2_cbf3798f-929d-4992-bd02-9ae1856d0348"
      unitRef="usd">22242000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5fff9ccde2f5438e83ff62797cae4f8d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM2OTk_b07743d6-4d60-4765-951c-eaeb195a054e"
      unitRef="usd">5000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8cc999d233cf40bc8ec03bb79a5c46af_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM3MTE_dccfbb73-efb4-4c42-9762-2b44e09fe3b0"
      unitRef="usd">3200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0213557267b54d06b2a34a0a8ebac7d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM3MjY_565ad3bf-18a4-4877-885a-0d6130e8651d"
      unitRef="usd">3000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM5MTg_5e47205e-a6c5-4850-8168-2382907b0436"
      unitRef="usd">11100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM5MjI_d0fdac1d-4c77-41e8-8aef-1474b4528e5d"
      unitRef="usd">8700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzM5Mjk_94e32496-a5e1-4d51-a896-9c5ddd735243"
      unitRef="usd">14600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQwMjA_35ff3a7d-1150-485c-a153-0cbf4998344a"
      unitRef="usd">6800000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQwMjQ_b0e4ff5c-ae24-4d5a-af83-cdead32fdd38"
      unitRef="usd">5200000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQwMzE_23fd3b3d-d533-43a0-a9e5-05b68b7a1dee"
      unitRef="usd">6900000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQxNTA_b48617d5-1338-4ad6-b35e-15c78e82b625"
      unitRef="usd">2200000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQxNjI_d8068f41-a094-4661-9de6-016d29d3c62a"
      unitRef="usd">1700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQxNzc_75dbf1f7-8f6b-4dc9-8f37-60a1370f87a8"
      unitRef="usd">3000000.0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i805f26cc2af34805ae2b1843c1cf9841_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQyODQ_a2980bb3-8b94-4a31-bb1c-94ba3e19aaab"
      unitRef="usd">2900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i5fff9ccde2f5438e83ff62797cae4f8d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ0NjE_91ffc288-dc6a-4f48-951f-b85a57814b0e">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYzMjc_1276cfd9-f7b5-4c8f-b58c-f1d1762c0895">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Stock and Contract  Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments for performance achievement related to award target&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested but not released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iaa6e6cac04eb43cfbe239e917800016c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzYtMS0xLTEtMzczNTY_b7403fc2-3e2b-4b12-9315-71f6f3e045b5"
      unitRef="shares">472000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iaa6e6cac04eb43cfbe239e917800016c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzYtMy0xLTEtMzczNTY_38e8c193-9ff6-4281-ba65-1ca58651dd5b"
      unitRef="usdPerShare">50.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0d007eaff7044bccb12fab7314f2acbc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzYtNS0xLTEtMzczNTY_6303f880-ee44-40c8-969f-3cc23f588c19"
      unitRef="shares">197000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0d007eaff7044bccb12fab7314f2acbc_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzYtNy0xLTEtMzczNTY_4c3f89f5-27ce-45ac-a634-3d3302f900c7"
      unitRef="usdPerShare">47.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzktMS0xLTEtMzczNTY_711ea3ae-43db-45c3-a710-d586954444cd"
      unitRef="shares">242000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzktMy0xLTEtMzczNTY_b0466a9c-3d49-42d7-9ed7-b561d369ed2e"
      unitRef="usdPerShare">68.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzktNS0xLTEtMzczNTY_2dacbaf6-7e0c-4fd6-b8ea-4d8329b8d310"
      unitRef="shares">223000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzktNy0xLTEtMzczNTY_30508e19-9ef9-4a36-8bf7-afac58157c11"
      unitRef="usdPerShare">67.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares
      contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEwLTUtMS0xLTM3MzU2_68d4df7e-188b-43f4-bce8-7a345dedd6ec"
      unitRef="shares">96000</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue
      contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEwLTctMS0xLTM3MzU2_27dcb95b-cd90-48d2-b354-514a753a2209"
      unitRef="usdPerShare">58.18</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzExLTEtMS0xLTM3MzU2_be57339f-911a-47dd-a2d1-69bf3abe66f2"
      unitRef="shares">78000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzExLTMtMS0xLTM3MzU2_fb53f29e-ceb9-4481-87d9-fdf1c0eb3f38"
      unitRef="usdPerShare">54.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzExLTUtMS0xLTM3MzU2_f14e7e1d-6335-45a6-b085-6080f265f2d2"
      unitRef="shares">152000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzExLTctMS0xLTM3MzU2_431b57b5-dd5b-4815-9bfe-e1ab28b9f7f9"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEzLTEtMS0xLTM3MzU2_8198e67b-0195-491a-b625-21c4b58e1f92"
      unitRef="shares">214000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEzLTMtMS0xLTM3MzU2_b966d9cb-d5dc-42b5-8715-9a5bac7321b8"
      unitRef="usdPerShare">51.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEzLTUtMS0xLTM3MzU2_23d3a1a9-a02d-4a5a-8bf7-0bc29af15d4c"
      unitRef="shares">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzEzLTctMS0xLTM3MzU2_4f46a5f2-29cc-438b-a5c0-4e5f0233df58"
      unitRef="usdPerShare">67.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod
      contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE0LTEtMS0xLTM3MzU2_a0907ddd-bd26-41e7-aeca-663f15bab75b"
      unitRef="shares">0</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue
      contextRef="i46632fd80c2a4ae3ad6124af51e8fb49_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE0LTMtMS0xLTM3MzU2_519eafa5-fa2d-4c8d-8d65-88fe61301b46"
      unitRef="usdPerShare">0</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod
      contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE0LTUtMS0xLTM3MzU2_611f5254-35cf-4df8-9794-2837286682c1"
      unitRef="shares">289000</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue
      contextRef="i2996160eb8934409898d8d620fe2717d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE0LTctMS0xLTM3MzU2_78f73fb7-f381-44a8-948e-b03028fdcb5f"
      unitRef="usdPerShare">58.06</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i06246f5086ac4c68bca11471e51b6e0f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE1LTEtMS0xLTM3MzU2_ad0ada23-c535-4c97-af03-08f200f60726"
      unitRef="shares">422000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i06246f5086ac4c68bca11471e51b6e0f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE1LTMtMS0xLTM3MzU2_23f95b7f-ea4e-4d41-85a4-e30080ec9ca3"
      unitRef="usdPerShare">58.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id6371ddc8cc744adb4b34059dd3546dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE1LTUtMS0xLTM3MzU2_08bc936e-1a14-4cba-bca7-7faa5c80f5ea"
      unitRef="shares">55000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id6371ddc8cc744adb4b34059dd3546dd_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90YWJsZTpmYWYwN2EyMjZhYTk0OWUwOTA2NDUzYTE4ZWQxZDc2OC90YWJsZXJhbmdlOmZhZjA3YTIyNmFhOTQ5ZTA5MDY0NTNhMThlZDFkNzY4XzE1LTctMS0xLTM3MzU2_619a94a8-4e64-4702-90fb-2281f4eb3e62"
      unitRef="usdPerShare">70.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i59a4575819974e84b2e3ab5b22160dbf_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ2OTI_045b704f-0c36-4bd8-8e2d-137ade22f022"
      unitRef="usd">31200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1f25d0f4a8ff400f889dcdf76cc14f18_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ2OTY_14132d8c-4250-4356-82e2-1d7d6a9d0e93"
      unitRef="usd">16400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i57f8fa208ea049e1801ad47d1e48dd52_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ3MDM_6aa7be55-bc77-48a0-8d33-0551fcdb0901"
      unitRef="usd">18100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i59a4575819974e84b2e3ab5b22160dbf_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ4ODQ_b8451d6b-d3d5-432f-ad95-ee4fe2488e7b"
      unitRef="usd">15700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i1f25d0f4a8ff400f889dcdf76cc14f18_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ4ODg_611e3f27-5bfb-4bf4-905d-5d6685f8b59c"
      unitRef="usd">17300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i57f8fa208ea049e1801ad47d1e48dd52_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzQ4OTU_b8cd1d9a-f2da-47e8-8cb0-810fa8493d44"
      unitRef="usd">21100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i59a4575819974e84b2e3ab5b22160dbf_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzUxODc_e7abb608-abf7-49d8-a2eb-a78b9454602c">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iece74e9f340746efb7bf12abd5b3f771_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzUzMzg_185d24e4-6da3-41d5-b3a5-4451326437e6"
      unitRef="usd">21100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i59a4575819974e84b2e3ab5b22160dbf_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzU1NTU_9ad3f96a-ed50-42eb-9623-340e8ef9f48f">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod
      contextRef="ic049e8c605994794a6b0cffa137659b4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzU2MDg_f495c5b5-ca23-4f5e-bb34-a2540b2d9896"
      unitRef="shares">500000</iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod>
    <iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod
      contextRef="i37884f7fb85845bfb78ca42534df7c4c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzU2Mzk_b3beb6d0-bac5-4f35-9ee6-a55c48d21e8b"
      unitRef="shares">100000</iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYwNDM_7e64f551-7d01-43ee-ba91-248bf47820e6"
      unitRef="shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYxNjQ_5def35e0-ed39-404e-9788-116ca6f643e8"
      unitRef="usd">500000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYxNjg_3c818830-d94a-43ca-8b14-3db563f386d9"
      unitRef="usd">400000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNjkvZnJhZzplZWNhZjliZmJkNjc0Y2RmYTI2ZDE0YmRmYzcwNGQxYi90ZXh0cmVnaW9uOmVlY2FmOWJmYmQ2NzRjZGZhMjZkMTRiZGZjNzA0ZDFiXzYxNzU_58d5aaef-8220-484c-bc33-f8976edc0f5e"
      unitRef="usd">300000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxNzM_4038e6a0-8f63-408a-884c-65d1d89d2f6e">RETIREMENT BENEFIT PLANS&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DEFINED BENEFIT PLANS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various defined benefit plans which covers certain employees in France, Japan, Germany and Switzerland. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit pension plans for the years ended December&#160;31, 2021 and 2020 included the following (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net period benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,904&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,007&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2021 and 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest crediting rate for cash balance plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2021 and 2020, the discount rates were prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities. The expected returns on plan assets represent the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rates of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2021 and 2020 and a reconciliation of the funded status at December&#160;31, 2021 and 2020, respectively (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Projected Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plans transferred in&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected benefit obligations, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65,184&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets at fair value, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plan assets at fair value, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,914&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation Of Funded Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unfunded benefit obligations are included in other liabilities in the consolidated balance sheets at December&#160;31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the periods ended December&#160;31, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company had a net gain of $7.0 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $4.6 million, respectively, recognized within accumulated other comprehensive loss that has not been recognized as a component of net periodic benefit cost. The gain recognized during the period ended December 31, 2021, is primarily attributed to a change in the discount rate used to estimate the projected benefit obligation for defined benefit plans which cover certain employees in Switzerland. The combined accumulated benefit obligations for the defined benefit plans was $60.3 million and $61.5 million as of December&#160;31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrecognized gains and losses are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses is determined by using a 10% corridor of the greater of the market value of assets or the accumulated benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior service costs/benefits for the pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net plan assets of the pension plans are invested in common trusts. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts is valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk profile.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The benefit plans in France and Germany had no assets at December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, no plan assets are expected to be returned to the Company in the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is the summary of expected future benefit payments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Next five years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, contributions expected to be paid to the plan in 2022 is $2.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DEFINED CONTRIBUTION PLANS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has various defined contribution savings plans that cover substantially all employees in the United States, Belgium, Canada, France, Japan, Netherlands, the U.K. and Puerto Rico. The Company matches a certain percentage of each employee&#x2019;s contributions as per the provisions of the plans. Total contributions by the Company to the plans were $8.8 million, $6.7 million and $8.6 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DEFERRED COMPENSATION PLAN&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2020, employees participating in the Company's deferred compensation plan began to defer their compensation. This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at December&#160;31, 2021 and 2020 was $3.8 million and $2.0 million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxNjQ_8420b162-9c93-4887-b8d8-aa333b2f4291">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit pension plans for the years ended December&#160;31, 2021 and 2020 included the following (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net period benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,904&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,007&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzItMS0xLTEtMzczNTY_6d8b2316-a7b6-4ea6-8262-5e32efcd3dd9"
      unitRef="usd">2741000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzItMy0xLTEtMzczNTY_37b4bba2-5d98-40b5-904b-38ace921d6f2"
      unitRef="usd">4029000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzMtMS0xLTEtMzczNTY_4de5dddd-e25f-4718-9011-d68be97c54c8"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzMtMy0xLTEtMzczNTY_56926161-0efd-4384-94b1-96ce8d10b611"
      unitRef="usd">219000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzQtMS0xLTEtMzczNTY_4c2c36eb-e471-4026-9064-c08db2dba5f5"
      unitRef="usd">893000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzQtMy0xLTEtMzczNTY_4cd4d949-75c4-4d36-9776-3daf05d48369"
      unitRef="usd">652000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzUtMS0xLTEtMzczNTY_4d08339f-773b-464d-a861-40b447a562a0"
      unitRef="usd">-281000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzUtMy0xLTEtMzczNTY_4b8d4719-20c8-48ba-bd5f-e2a2dad05037"
      unitRef="usd">-274000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzYtMS0xLTEtMzczNTY_6a12ac8d-a4bd-4182-a1b3-f78dc9396084"
      unitRef="usd">-186000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzYtMy0xLTEtMzczNTY_f48a3d71-8761-4d66-95a5-12cb4674b997"
      unitRef="usd">-787000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzctMS0xLTEtMzczNTY_152c8321-05a7-48e7-bdd9-86cc9f43285f"
      unitRef="usd">-51000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzctMy0xLTEtMzczNTY_888193cb-2f01-4697-885f-851a1027821e"
      unitRef="usd">102000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzgtMS0xLTEtMzczNTY_639efd13-8a1c-45f9-a735-b5c31cd37fa5"
      unitRef="usd">1904000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTpjY2NhNTVhYmQ4MzI0M2UyYmQwMTk1NDhiNjA0MDUwMC90YWJsZXJhbmdlOmNjY2E1NWFiZDgzMjQzZTJiZDAxOTU0OGI2MDQwNTAwXzgtMy0xLTEtMzczNTY_ec6b1f1e-2dc6-477e-8a01-159e0edd340e"
      unitRef="usd">4007000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxNzk_43b29962-eed8-46dc-8ddf-5068de42a62b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2021 and 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest crediting rate for cash balance plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzItMS0xLTEtMzczNTY_41de272c-94e2-4827-88c7-4d067eebd40e"
      unitRef="number">0.0037</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzItMy0xLTEtMzczNTY_e2b10280-a368-4547-84a5-ded2726d835f"
      unitRef="number">0.0034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzMtMS0xLTEtMzczNTY_42e9ccdd-89c3-4d5a-a634-3e7ffaa14886"
      unitRef="number">0.0359</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzMtMy0xLTEtMzczNTY_2b6d607e-2f2c-4469-8e43-d14145a744da"
      unitRef="number">0.0204</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzQtMS0xLTEtMzczNTY_15dfa699-fe87-4a1c-921b-fb6d6a2985de"
      unitRef="number">0.0210</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzQtMy0xLTEtMzczNTY_4ab646c1-f63f-46af-902d-72b73a44b172"
      unitRef="number">0.0214</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzUtMS0xLTEtMzczNTY_23844d1b-c0b8-45fe-b5d8-de13645f2dd1"
      unitRef="number">0.0100</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTowZmY4MjhmOTA0NzI0ZTY3OTRkMWY1MjE2ZGYzYmVhZS90YWJsZXJhbmdlOjBmZjgyOGY5MDQ3MjRlNjc5NGQxZjUyMTZkZjNiZWFlXzUtMy0xLTEtMzczNTY_4d0641ba-8314-46c2-b1fa-d5d8f3232738"
      unitRef="number">0.0100</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxNTY_faad234c-ce44-40ac-b4f2-40402de8d9c2">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2021 and 2020 and a reconciliation of the funded status at December&#160;31, 2021 and 2020, respectively (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Projected Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plans transferred in&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected benefit obligations, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65,184&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets at fair value, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plan assets at fair value, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,914&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzMtMS0xLTEtMzczNTY_b0410ea6-1901-454c-bc01-8e5d506550a9"
      unitRef="usd">72869000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ie55084e91d494776891870a81ff5cb91_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzMtMy0xLTEtMzczNTY_35ce51d3-a13f-48c5-b431-32ce11add3a8"
      unitRef="usd">66972000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzQtMS0xLTEtMzczNTY_02d0f3a4-842b-4bc0-8489-f4f102a1910c"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzQtMy0xLTEtMzczNTY_f9721f15-4a4c-4cc8-935f-70c485fce0ba"
      unitRef="usd">219000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzUtMS0xLTEtMzczNTY_229e805a-4422-417c-a279-df60edfe795c"
      unitRef="usd">2741000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzUtMy0xLTEtMzczNTY_19c510fc-6f06-416f-a96c-26722ea2cd0d"
      unitRef="usd">4029000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzYtMS0xLTEtMzczNTY_ee1c7a16-e666-49c0-b337-84292dc83d1f"
      unitRef="usd">-5044000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzYtMy0xLTEtMzczNTY_0d5fefae-7978-4cb3-afa5-8df1c9a52ea6"
      unitRef="usd">-3347000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzctMS0xLTEtMzczNTY_3acdc652-49a6-4d4f-854e-57fc84234692"
      unitRef="usd">-586000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzctMy0xLTEtMzczNTY_b3da136d-9550-4f79-a257-5a05a1bf5fdb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzgtMS0xLTEtMzczNTY_a461a8e9-877d-4029-9c99-9dfcd4b46ac4"
      unitRef="usd">655000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzgtMy0xLTEtMzczNTY_51020d14-9a7a-4e0d-9f38-6148771f70a7"
      unitRef="usd">77000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzktMS0xLTEtMzczNTY_4701c040-4ec1-4d91-a8c8-7e435747fef0"
      unitRef="usd">917000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzktMy0xLTEtMzczNTY_7b56318f-0c49-47ca-b5f8-55ca8036493e"
      unitRef="usd">883000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <iart:DefinedBenefitPlanBenefitObligationPremiumsPaid
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEwLTEtMS0xLTM3MzU2_30cab794-5453-4330-80e1-5307ab2b057f"
      unitRef="usd">373000</iart:DefinedBenefitPlanBenefitObligationPremiumsPaid>
    <iart:DefinedBenefitPlanBenefitObligationPremiumsPaid
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEwLTMtMS0xLTM3MzU2_3690e41f-cb77-4130-87f9-d8cd8f2d8bf9"
      unitRef="usd">388000</iart:DefinedBenefitPlanBenefitObligationPremiumsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEyLTEtMS0xLTM3MzU2_ab392dc0-4e8b-4842-9c2a-a5cc962cd299"
      unitRef="usd">2128000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEyLTMtMS0xLTM3MzU2_6d8931e2-e44a-4666-a710-441ae85a40a4"
      unitRef="usd">1537000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEzLTEtMS0xLTM3MzU2_b929de93-4626-4c07-b1a0-2331cba11698"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzEzLTMtMS0xLTM3MzU2_9186d355-cb39-4f68-b7e1-abd8a5dcde85"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzE0LTEtMS0xLTM3MzU2_3ee51a03-672c-4d2f-9f81-03d1c0fff09e"
      unitRef="usd">-2657000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzE0LTMtMS0xLTM3MzU2_eff1c0f5-d282-424e-9b05-364cb676ee78"
      unitRef="usd">6115000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzE1LTEtMS0xLTM3MzU2_032bca28-032f-49c3-ba95-df8a4bd44211"
      unitRef="usd">65184000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzE1LTMtMS0xLTM3MzU2_57861116-940e-4b46-b6ac-78e4242095d5"
      unitRef="usd">72869000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIwLTEtMS0xLTM3MzU2_5ee73708-a682-4706-8290-6e379cb7cae5"
      unitRef="usd">37825000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie55084e91d494776891870a81ff5cb91_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIwLTMtMS0xLTM3MzU2_9d8e5dfd-0ab0-4e4b-b7ad-f5f21b1f5af9"
      unitRef="usd">30770000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIxLTEtMS0xLTM3MzU2_da94d519-3413-492e-ab72-7d72700e8d23"
      unitRef="usd">3371000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIxLTMtMS0xLTM3MzU2_9fab21d1-0b71-4353-a3a8-33218eaf0ffb"
      unitRef="usd">2882000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIyLTEtMS0xLTM3MzU2_19987742-8b47-4574-8e00-aa2e47d40b1f"
      unitRef="usd">2254000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIyLTMtMS0xLTM3MzU2_3e3a6e29-4eab-4171-898d-0ba5f8cbb258"
      unitRef="usd">2274000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIzLTEtMS0xLTM3MzU2_e327e637-bd52-4837-bd67-b561cc462d6d"
      unitRef="usd">917000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzIzLTMtMS0xLTM3MzU2_7b527125-ac88-40ca-b7b2-39fbca62ab15"
      unitRef="usd">883000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI0LTEtMS0xLTM3MzU2_7d3c3418-16a1-4132-9f66-c98029c8d722"
      unitRef="usd">633000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI0LTMtMS0xLTM3MzU2_72800c4a-4ce0-4e7f-b2ef-1695460189ed"
      unitRef="usd">56000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI1LTEtMS0xLTM3MzU2_a9dab49d-c717-4e45-b28c-c6f188478679"
      unitRef="usd">2128000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI1LTMtMS0xLTM3MzU2_683adbb4-8dbc-4a44-8ec0-7ec4924fd29b"
      unitRef="usd">1537000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <iart:DefinedBenefitPlanPlanAssetsPremiumsPaid
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI2LTEtMS0xLTM3MzU2_feded5d4-27c3-4da6-b261-231a6ff17afe"
      unitRef="usd">373000</iart:DefinedBenefitPlanPlanAssetsPremiumsPaid>
    <iart:DefinedBenefitPlanPlanAssetsPremiumsPaid
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI2LTMtMS0xLTM3MzU2_8aa8be52-08a7-4626-be87-2e7dfacc1d21"
      unitRef="usd">388000</iart:DefinedBenefitPlanPlanAssetsPremiumsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI4LTEtMS0xLTM3MzU2_9426ef33-5ea1-4861-9822-c8afc4c53365"
      unitRef="usd">-1319000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI4LTMtMS0xLTM3MzU2_6b0679f0-6653-4eb4-84a5-5e849966c9f9"
      unitRef="usd">2997000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI5LTEtMS0xLTM3MzU2_1fc3e0f1-73c5-4eab-8cbb-80fe8a5a7242"
      unitRef="usd">39914000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTphYjc4MmZhYmYzNDE0MTRiODZjZjkzZjdhMmRjZjUzZC90YWJsZXJhbmdlOmFiNzgyZmFiZjM0MTQxNGI4NmNmOTNmN2EyZGNmNTNkXzI5LTMtMS0xLTM3MzU2_db6fe0ba-2820-4d56-95d4-83bc1f5c9c41"
      unitRef="usd">37825000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfNetFundedStatusTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxOTc_ff098dbe-3da2-4a8d-881e-267f79ab9cef">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation Of Funded Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetFundedStatusTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzMtMS0xLTEtMzczNTY_e9586315-250f-4247-9057-418c7fd4473f"
      unitRef="usd">39914000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzMtMy0xLTEtMzczNTY_ec9e15a4-119a-4df1-bf19-aa4c5a6c26b2"
      unitRef="usd">37825000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzQtMS0xLTEtMzczNTY_6cf5a94b-1f95-40d2-b8c2-ed0e5562b56e"
      unitRef="usd">65184000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzQtMy0xLTEtMzczNTY_774ab3f1-bc7e-4966-9460-09a4b11c60cd"
      unitRef="usd">72869000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzUtMS0xLTEtMzczNTY_8a04bc5b-3e90-4cea-bffa-3a4bf5aa1b29"
      unitRef="usd">-25270000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZToyYmRiZjY2M2U4OWU0OGFlYjM4OTM3OTBjYTkzOGQ4MC90YWJsZXJhbmdlOjJiZGJmNjYzZTg5ZTQ4YWViMzg5Mzc5MGNhOTM4ZDgwXzUtMy0xLTEtMzczNTY_fc49679e-5471-47d9-8710-b92810bea61e"
      unitRef="usd">-35044000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzIwOTM_7b12505f-39c0-43c4-a5e3-79e6e03f5a74"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzIxMTQ_53de050a-38d9-4795-aaee-7f479040d84a"
      unitRef="usd">4600000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzI1ODI_54a55294-3b90-48ef-a0af-6d1e523a8b33"
      unitRef="usd">60300000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzI1ODk_0c7cc28f-4116-47ec-845d-22be8d0a85ea"
      unitRef="usd">61500000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4e17b5e38d9b4e68968d4ad4b693c479_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzM4MTU_d9d981c5-76a7-4583-8055-0ccad8dc77e2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzM4NDM_40da5ca5-9b87-479d-81ba-c35ed05499ff"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUxOTE_3fc62f17-1bde-445d-bbf8-9b69f6ded7fe">&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is the summary of expected future benefit payments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Next five years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzItMS0xLTEtMzczNTY_b9c064f2-1e95-4252-8eb6-e47c018947bc"
      unitRef="usd">1934000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzMtMS0xLTEtMzczNTY_6cc366c5-19a5-4812-86c0-21aa4bdb1195"
      unitRef="usd">1796000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzQtMS0xLTEtMzczNTY_cc5d6d6e-a056-43bd-b049-52f8e6088293"
      unitRef="usd">1831000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzUtMS0xLTEtMzczNTY_29d6ad2b-f3b4-4e60-9375-335f6be5f575"
      unitRef="usd">2073000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzYtMS0xLTEtMzczNTY_631dfb53-cdfd-46ac-a79f-a56c201fbd03"
      unitRef="usd">2003000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90YWJsZTo2MzI1MTc1N2NhZjY0M2IyYjAwN2QwNzY5ZjNiZGNiMy90YWJsZXJhbmdlOjYzMjUxNzU3Y2FmNjQzYjJiMDA3ZDA3NjlmM2JkY2IzXzctMS0xLTEtMzczNTY_bc769601-3cce-4773-b75a-aaf0ec474909"
      unitRef="usd">10395000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzQwODQ_0ea7b409-105d-450b-8121-98d4f207c377"
      unitRef="usd">2300000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzQ0NzY_a9aa1041-34f4-4bf4-bcc0-957641681cbf"
      unitRef="usd">8800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzQ0ODA_81b06179-67af-4188-aac3-28e369a91cfe"
      unitRef="usd">6700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzQ0ODc_5e633bc4-192f-4226-bef8-a61a7e7aa551"
      unitRef="usd">8600000</us-gaap:DefinedContributionPlanCostRecognized>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage
      contextRef="i1ea7e387c13b48c89387b2d3d857caaa_D20190501-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzIxOTkwMjMyNjE1MDA_e5db4015-492d-4902-ac98-2fd247f85689"
      unitRef="number">0.75</iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage
      contextRef="i1ea7e387c13b48c89387b2d3d857caaa_D20190501-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzIxOTkwMjMyNjE1MDU_079c6c91-89a7-498c-8675-d85bea875407"
      unitRef="number">1</iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzUwNDI_45af244f-b87d-4600-8b62-0f25726f0f78"
      unitRef="usd">3800000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzIvZnJhZzo1YTczZmUzZWZiZTE0OTdhOTI4MzU1MGY5ZjRmZDk0Yi90ZXh0cmVnaW9uOjVhNzNmZTNlZmJlMTQ5N2E5MjgzNTUwZjlmNGZkOTRiXzc2OTY1ODEzOTk4ODY_d3195190-f6c0-4586-8075-7cb2afc9f42e"
      unitRef="usd">2000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0Njg_32ac3c15-05ac-41eb-b1c4-3ff6475e5f7a">LEASES AND RELATED PARTY LEASES&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of December&#160;31, 2021. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease expense for the year ended December&#160;31, 2021 and December 31, 2020, was $20.3 million and $19.7 million, respectively, which includes $0.3 million, in related party operating lease expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to operating leases at December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under operating leases at December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Third Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no future minimum lease payments under finance leases at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is 50% owned by a corporation whose stockholders are trusts, whose beneficiaries include family members of the Company&#x2019;s principal stockholder and former director. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <iart:LesseeOperatingLeaseNumberOfRenewalOptions
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzUxMw_66df436a-510f-4b99-ba4f-792d98eaff65"
      unitRef="renewal_option">1</iart:LesseeOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:OperatingLeaseExpense
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzEyNzA_8030a8e2-eb86-4b7f-bb23-da7815ce592c"
      unitRef="usd">20300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzQ5NDc4MDIzMjc1NTc_17a7c1ee-95bf-4bca-8690-3857483addf0"
      unitRef="usd">19700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i2ce740a3a7a74ecfb0d0952de3f48b37_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzEzMTA_a187e438-29e6-41bc-8950-a38addf66c4f"
      unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i362b521165e0418c9733b648915a160b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzEzMTA_dd8a7c99-29c3-4c4c-828b-1f0010c74b3a"
      unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <iart:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0NjE_eee7df72-58f5-4e7d-a92f-505e40f45eac">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to operating leases at December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iart:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzMtNS0xLTEtMzczNTY_9cd6570c-9ba9-41fa-a26f-29d1fa3c864b"
      unitRef="usd">84543000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzMtNy0xLTEtMzczNTY_3d7266a8-8d62-4f3a-832a-ba51be2bab6c"
      unitRef="usd">83635000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzUtNS0xLTEtMzczNTY_65a394cc-f5e9-44b6-b917-110e41d0ff43"
      unitRef="usd">14775000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzUtNy0xLTEtMzczNTY_c411430e-83a3-491f-ad84-dde5bf6bdd1e"
      unitRef="usd">12818000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzYtNS0xLTEtMzczNTY_716e2b7c-5908-4f3a-a78e-269b9b8fb974"
      unitRef="usd">90329000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzYtNy0xLTEtMzczNTY_32958cf2-e52d-4f22-a183-a12ececf5ac1"
      unitRef="usd">88118000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzctNS0xLTEtMzczNTY_a93a8adf-9e52-4cf2-9163-e4434937fec5"
      unitRef="usd">105104000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzctNy0xLTEtMzczNTY_352dbd68-dee0-4865-8989-c8b7fa5c42ce"
      unitRef="usd">100936000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i2c98fd68510e48b4a3b8d493e99cff78_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzExLTUtMS0xLTM3MzU2_dd5fe1e5-33ed-4bed-9cb3-2c85cfe4deb9">P10Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i7f1da00ed5194d3681b3dfc0e0e27e6d_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzExLTctMS0xLTM3MzU2_e8ef1825-19a7-46be-aa86-e6ce7b9d814e">P11Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i7de60faccb404da8a7dddec7331da235_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzEyLTUtMS0xLTM3MzU2_213ce30d-f44c-4fea-be60-a6333d6f7309">P2Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i2c2fbe33ab9a467d8b4133eedd8f7209_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzEyLTctMS0xLTM3MzU2_7eab9b78-4b7f-4b5a-b90b-76a5b7f12b35">P2Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i2c98fd68510e48b4a3b8d493e99cff78_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzE1LTUtMS0xLTM3MzU2_215d4feb-01f3-41f7-ab64-3d2a17e1788d"
      unitRef="number">0.051</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i7f1da00ed5194d3681b3dfc0e0e27e6d_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzE1LTctMS0xLTM3MzU2_e7247112-c1f9-4f38-8eaf-429d97cf1ee0"
      unitRef="number">0.046</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i7de60faccb404da8a7dddec7331da235_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzE2LTUtMS0xLTM3MzU2_916060dc-e124-4c0c-b717-14098475a71e"
      unitRef="number">0.026</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i2c2fbe33ab9a467d8b4133eedd8f7209_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTo5Yzc5ODc3ODgzNTI0ZjJiYjNkN2E1ZGY1Y2U4N2UzYS90YWJsZXJhbmdlOjljNzk4Nzc4ODM1MjRmMmJiM2Q3YTVkZjVjZTg3ZTNhXzE2LTctMS0xLTM3MzU2_cc8e5b64-1e52-4937-8299-9bf7a2b7967c"
      unitRef="number">0.023</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <iart:CashFlowLesseeTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0NjM_e44ba1e7-67d4-4a2d-9b8f-30f2fac2404e">&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iart:CashFlowLesseeTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZToyMDdkZjJhMDUyNTk0MTdhOTI5ZDhiYjMwNmVmMjU4NC90YWJsZXJhbmdlOjIwN2RmMmEwNTI1OTQxN2E5MjlkOGJiMzA2ZWYyNTg0XzMtMS0xLTEtMzczNTY_99491b89-df6d-4cf7-92f9-7334c6a2b92d"
      unitRef="usd">15077000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZToyMDdkZjJhMDUyNTk0MTdhOTI5ZDhiYjMwNmVmMjU4NC90YWJsZXJhbmdlOjIwN2RmMmEwNTI1OTQxN2E5MjlkOGJiMzA2ZWYyNTg0XzMtMy0xLTEtMzczNTY_a60cd722-c40f-467e-9c23-bbba359dcaeb"
      unitRef="usd">15226000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZToyMDdkZjJhMDUyNTk0MTdhOTI5ZDhiYjMwNmVmMjU4NC90YWJsZXJhbmdlOjIwN2RmMmEwNTI1OTQxN2E5MjlkOGJiMzA2ZWYyNTg0XzYtMS0xLTEtMzczNTY_328d19b1-35fe-4507-b8da-3b18475788d5"
      unitRef="usd">12610000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZToyMDdkZjJhMDUyNTk0MTdhOTI5ZDhiYjMwNmVmMjU4NC90YWJsZXJhbmdlOjIwN2RmMmEwNTI1OTQxN2E5MjlkOGJiMzA2ZWYyNTg0XzYtMy0xLTEtMzczNTY_f88bcee9-2c2b-4c0e-b78b-80fe8d469a45"
      unitRef="usd">6027000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0NTg_51809715-d958-48c8-939a-067e913cc8a6">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under operating leases at December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Third Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzItMS0xLTEtMzczNTY_608e3e88-cf37-43f9-92ad-b76029186587"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzItMy0xLTEtMzczNTY_db71280e-9101-463a-a61a-fa267f19da0b"
      unitRef="usd">17678000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzItNS0xLTEtMzczNTY_a19185db-ab0e-45ba-94db-cabd1969ac15"
      unitRef="usd">17974000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzMtMS0xLTEtMzczNTY_c7f3c0b4-9142-4a7d-820c-164ae24fa6ea"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzMtMy0xLTEtMzczNTY_271c7e31-f48f-4cad-9297-10a324c5a8ac"
      unitRef="usd">14611000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzMtNS0xLTEtMzczNTY_1f1b3ee0-5507-4780-9c36-d77e676ce6ec"
      unitRef="usd">14907000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzQtMS0xLTEtMzczNTY_05f72bd8-bac1-4e08-9bdb-f06ab82d35a9"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzQtMy0xLTEtMzczNTY_3bd7a9a5-f859-46d7-96cd-7f10d2220240"
      unitRef="usd">12784000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzQtNS0xLTEtMzczNTY_fec90e81-5b32-4d77-82a6-0611bf3789d5"
      unitRef="usd">13080000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzUtMS0xLTEtMzczNTY_34c3c342-cb36-4267-bed8-66eba6a2559e"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzUtMy0xLTEtMzczNTY_01adf3c8-ea70-47b3-9edf-4945478c9c67"
      unitRef="usd">11289000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzUtNS0xLTEtMzczNTY_80218fa7-d830-4ef5-9714-e5dc41747381"
      unitRef="usd">11585000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzYtMS0xLTEtMzczNTY_29e6673f-6f89-4637-b48a-ab3e36b5ded5"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzYtMy0xLTEtMzczNTY_ef744d26-6a93-4a5f-9503-daf925b66a14"
      unitRef="usd">9889000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzYtNS0xLTEtMzczNTY_1a35ec1e-af22-41b7-b205-d28bc682c578"
      unitRef="usd">10185000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzctMS0xLTEtMzczNTY_e3d8d266-36af-4e60-b84d-2403e007e870"
      unitRef="usd">838000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzctMy0xLTEtMzczNTY_ea5aa00c-cba6-4eae-855a-006b369bd5ad"
      unitRef="usd">67992000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzctNS0xLTEtMzczNTY_9bf30c38-3b02-41c5-a491-2319f5ff0313"
      unitRef="usd">68830000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i50839ea5a7cc493fb5a6e6e76650da66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzgtMS0xLTEtMzczNTY_8a40813f-387a-40ce-8f52-21e05bfb256a"
      unitRef="usd">2318000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i9d34d4dd5abb4dddbd1fe34dc24470c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzgtMy0xLTEtMzczNTY_a36d06b9-ffe1-4c71-87ea-589e22ab655c"
      unitRef="usd">134243000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzgtNS0xLTEtMzczNTY_f7910ec7-8a2e-4f0c-b17e-d12e572e77e5"
      unitRef="usd">136561000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzktNS0xLTEtMzczNTY_e9adef51-6a0f-46b1-9e1b-43c5b4d06894"
      unitRef="usd">31457000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzEwLTUtMS0xLTM3MzU2_0127fc51-d4f8-4ff0-8d6a-3c0d1d30b35f"
      unitRef="usd">105104000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzExLTUtMS0xLTM3MzU2_65a394cc-f5e9-44b6-b917-110e41d0ff43"
      unitRef="usd">14775000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90YWJsZTpjZjJmODgxYWY5ODA0Y2EzODU5ZjVlMjQ5NzkxMTliNS90YWJsZXJhbmdlOmNmMmY4ODFhZjk4MDRjYTM4NTlmNWUyNDk3OTExOWI1XzEyLTUtMS0xLTM3MzU2_716e2b7c-5908-4f3a-a78e-269b9b8fb974"
      unitRef="usd">90329000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzE2NDk_c45cf51e-fdfa-46de-873d-b59e654f64ac"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector
      contextRef="i2ce740a3a7a74ecfb0d0952de3f48b37_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzE4NDE_97629ea4-603a-41cf-b8ed-0e5ae998103e"
      unitRef="number">0.50</iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector>
    <iart:AnnualRateOfLeaseAgreement
      contextRef="i2ce740a3a7a74ecfb0d0952de3f48b37_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzIwNzg_06d16f84-23ac-445c-abac-cdf3475e380f"
      unitRef="usd">300000</iart:AnnualRateOfLeaseAgreement>
    <iart:OptionToExtendLeaseYears
      contextRef="i029daea7b92e41a4bc3613610fa420e9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzIxMzk_b8071a61-7561-4c3a-9f16-ea30825b5322">P5Y</iart:OptionToExtendLeaseYears>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="i029daea7b92e41a4bc3613610fa420e9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0NjU_b03004f0-ea88-4342-a829-c076b27704d0">November 1, 2029 through October 31, 2034</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <iart:OptionToExtendLeaseYears
      contextRef="ifaf346d6a89a4e7ea791875504218b91_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzIzMTA_70477d97-68f2-4ca9-87b3-a41c1d79698a">P5Y</iart:OptionToExtendLeaseYears>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="ifaf346d6a89a4e7ea791875504218b91_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzUvZnJhZzpiYmM1MjM5YTdmZmE0NzdhYTUxYmRjYTRjNzVhYTlmOC90ZXh0cmVnaW9uOmJiYzUyMzlhN2ZmYTQ3N2FhNTFiZGNhNGM3NWFhOWY4XzI0NTM_685880a0-1459-4397-a35f-e22f7efa5843">November 1, 2034 through October 31, 2039</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxMTY_43bb4d0c-7a13-40c7-805b-ae5fdf00aede">INCOME TAXES &lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (Loss) before income taxes consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. Federal statutory rate to the Company&#x2019;s effective tax rate is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) in income taxes resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Excess tax benefits from stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intercompany profit in inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible facilitative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Research and development credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;Fair market value step up on intra-entity transfer of intellectual property&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Gain from sale of business - book to tax differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Swiss tax holiday&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible R&amp;amp;D expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our effective tax rate was 21.2% and (43.2)% of income before income taxes for the years ended December&#160;31, 2021 and December&#160;31, 2020, respectively. In 2021, the Company's higher effective tax rate was driven in part by an $8.5&#160;million income tax expense for nondeductible goodwill related to the sale of the Extremity Orthopedics business, offset by a $3.1&#160;million income tax benefit related to excess tax benefits from stock compensation. In 2020, the Company&#x2019;s lower worldwide effective tax rate was primarily driven by an $59.2&#160;million income tax benefit on an intra-entity transfer of certain intellectual property, substantially completed during the fourth quarter in 2020. Excluding this transaction, the effective worldwide tax rate for 2020 was 20.2%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain, the Company&#x2019;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow model based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Co&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;mpany recorded a $59.2&#160;million deferred tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in Switzerland related to the amortizable tax basis in the transferred intellectual property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2021, the Company&#x2019;s foreign operations generated a $63.6&#160;million increase in income tax expense when compared to the same period in 2020, because of the intra-entity transfer of certain intellectual property in 2020, geographic and business mix of taxable earnings and losses, among other factors. The 2021 foreign effective tax rate is 15.2%, compared to (57.1)% in 2020. The Company&#x2019;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above for 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2020, the Company&#x2019;s foreign operations generated a $48.2&#160;million decrease in income tax expense when compared to the same period in 2019 due to the intra-entity transfer of certain intellectual property, geographic and business mix of taxable earnings and losses, among other factors. The 2020 foreign effective tax rate is (57.1)%, compared to 3.5% in 2019.  The Company&#x2019;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above for 2020. During 2019, the Company finalized negotiations related to tax holidays in Switzerland, on a federal, cantonal, and communal level. The Company received a federal tax credit in Switzerland of $12.1 million ($0.14 per share), which may be used over a seven-year period, ending in 2024. The Company also received a reduction in its rate for the cantonal and communal level taxes during the third quarter of 2019, pursuant to tax reform in Switzerland. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate.  Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation.  The current U.S. administration has proposed tax reform which, if enacted, may increase the Company&#x2019;s U.S. federal income tax liability.  Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing (BEPS) project begun by the Organization for Economic Cooperation and Development (OECD).  The OECD recently finalized major reform of the international tax system with respect to implementing a global minimum tax rate.  Such changes in U.S. and Non-U.S. jurisdictions could have an adverse effect on the Company&#x2019;s effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,830)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,046)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Inventory related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalization of research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Unrealized foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Charitable contributions carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred tax assets after valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intangible and fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, the Company had net operating loss carryforwards of $71.7 million for federal income tax purposes, $26.6 million for foreign income tax purposes and $39.0 million for state income tax purposes to offset future taxable income. The majority of the federal net operating loss carryforwards expire through 2037, while $4.1 million have an indefinite carry forward period. For foreign net operating loss carryforwards, the remaining $26.6 million have an indefinite carry forward period. The state net operating loss carryforwards expire through 2036. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation allowance relates to deferred tax assets for certain items that will be deductible for income tax purposes under very limited circumstances and for which the Company believes it will not satisfy the more likely than not threshold for realization of the associated tax benefit. In the event that the Company determines that it would be able to realize more or less than the recorded amount of net deferred tax assets, an adjustment to the deferred tax asset valuation allowance would be recorded in the period such a determination is made. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s valuation allowance decreased by less than $0.1 million, increased by less than $0.1&#160;million and increased by $2.9&#160;million at December 31, 2021, 2020 and 2019, respectively. The 2021 and 2020 valuation allowance primarily remained unchanged from the prior period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost.&#160;Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;The Company will repatriate foreign earnings when there is no need for reinvestment overseas and no material tax cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans. As such, the Company has determined the tax impact of repatriating these earnings would not be material as of December&#160;31, 2021. The Company does not anticipate the need to repatriate earnings from foreign subsidiaries as a result of the impact of the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prior years' tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately $0.7 million of the balance at December&#160;31, 2021 relates to uncertain tax positions that, if recognized, would affect the annual effective tax rate. There are no amounts within the balance of uncertain tax positions at December&#160;31, 2021 related to tax positions for which it is reasonably possible that the amounts could be reduced during the twelve months following December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes interest and penalties relating to uncertain tax positions in income tax expense. The Company recognized a minimal benefit for the years ended December&#160;31, 2021, 2020 and 2019. The Company had minimal interest and penalties accrued for the years ended December 31, 2021 and 2020 and 2019. &lt;/span&gt;&lt;/div&gt;The Company files Federal income tax returns, as well as multiple state, local and foreign jurisdiction tax returns. The Company is no longer subject to examinations of its U.S. consolidated Federal income tax returns by the IRS through fiscal year 2017. All significant state and local matters have been concluded through fiscal 2015. All significant foreign matters have been settled through fiscal 2012.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxMTM_8d91baa1-38da-45bc-887f-4325a0ceb4fd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (Loss) before income taxes consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzMtMS0xLTEtMzczNTY_35c7ed79-2b99-4f79-9809-f8c13cd20274"
      unitRef="usd">91150000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzMtMy0xLTEtMzczNTY_d63af452-8f72-4aab-a2e1-87df4325d2c3"
      unitRef="usd">15082000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzMtNS0xLTEtMzczNTY_bc056967-e0df-411f-8819-07551bc8c034"
      unitRef="usd">-38359000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzQtMS0xLTEtMzczNTY_e051f771-fad6-4cb6-9473-7e26b248101b"
      unitRef="usd">123527000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzQtMy0xLTEtMzczNTY_a00c208c-c041-4747-b346-b92a698dca10"
      unitRef="usd">78438000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzQtNS0xLTEtMzczNTY_0c1cec06-cc37-4795-8ba8-a52fc677ec08"
      unitRef="usd">98463000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzUtMS0xLTEtMzczNTY_b3ba4dff-4c0b-466c-bb58-e3d0fc9011b3"
      unitRef="usd">214677000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzUtMy0xLTEtMzczNTY_ab6ff5fa-ffe7-4ac3-89e0-5f4af1ef6e66"
      unitRef="usd">93520000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo2MDk2NmI2YmNmMDI0YjZjOWE2MmNiYWY2OWFiODljMS90YWJsZXJhbmdlOjYwOTY2YjZiY2YwMjRiNmM5YTYyY2JhZjY5YWI4OWMxXzUtNS0xLTEtMzczNTY_4c2afbc0-644c-4970-a2d0-a496320de0d0"
      unitRef="usd">60104000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxMjI_a24c6336-2bfc-4381-9e76-a0f17c7c2d81">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. Federal statutory rate to the Company&#x2019;s effective tax rate is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) in income taxes resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Excess tax benefits from stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intercompany profit in inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible facilitative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Research and development credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;Fair market value step up on intra-entity transfer of intellectual property&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Gain from sale of business - book to tax differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Swiss tax holiday&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible R&amp;amp;D expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzItMS0xLTEtMzczNTY_14676916-bef7-4d30-8d54-8296c3fbbb6e"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzItMy0xLTEtMzczNTY_9921b66c-573a-4d90-be31-3f98870e90f1"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzItNS0xLTEtMzczNTY_5e724ca2-28e4-48d5-919d-0866c7410df3"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzQtMS0xLTEtMzczNTY_b5a146d1-db61-4756-b840-133d90e4ff6e"
      unitRef="number">0.019</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzQtMy0xLTEtMzczNTY_32950df1-aac6-4bad-b1e9-2663e38d6224"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzQtNS0xLTEtMzczNTY_333b266d-7b61-4fde-ac87-6096a9e52d57"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzUtMS0xLTEtMzczNTY_4894ac8d-a575-4d39-8eec-34ce8cc3b226"
      unitRef="number">-0.040</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzUtMy0xLTEtMzczNTY_8b2a2b39-f683-4536-b11e-60fa729c0450"
      unitRef="number">-0.079</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzUtNS0xLTEtMzczNTY_d4e79543-f737-459c-8250-2c99401c5739"
      unitRef="number">-0.200</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzctMS0xLTEtMzczNTY_a1285a49-5e9f-4907-af80-87ebd4a9fc5d"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzctMy0xLTEtMzczNTY_e806b442-d671-4afc-abd0-72c78fd31f4c"
      unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzctNS0xLTEtMzczNTY_d3df3321-d3ed-46f2-ada0-8dbc30f5f9dc"
      unitRef="number">-0.056</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzktMS0xLTEtMzczNTY_1010ea50-6f78-4030-8a3d-f459677b8672"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzktMy0xLTEtMzczNTY_b8689606-6311-43de-997c-b698e1813d8e"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzktNS0xLTEtMzczNTY_d6833f4a-e9f4-45ed-a8da-35f6c118ee05"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzExLTEtMS0xLTM3MzU2_d3c830fe-3367-40b1-9928-1d1c3b1a5161"
      unitRef="number">0.002</iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent>
    <iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzExLTMtMS0xLTM3MzU2_4b601d16-edba-4150-94d9-b8f10ef0ef1a"
      unitRef="number">-0.012</iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent>
    <iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzExLTUtMS0xLTM3MzU2_96d498ee-bdd1-440a-a217-b6f13b8de233"
      unitRef="number">-0.012</iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzEyLTEtMS0xLTM3MzU2_029fa61c-0bda-40fc-a410-bda0d59648ad"
      unitRef="number">0.002</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzEyLTMtMS0xLTM3MzU2_6860656a-bd84-442e-bd61-b0833f60adc5"
      unitRef="number">0.014</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzEyLTUtMS0xLTM3MzU2_a648054a-48e5-487c-a916-d25953560d5f"
      unitRef="number">0.008</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE1LTEtMS0xLTM3MzU2_a0f434d8-2087-4236-b346-932bac60a3c7"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE1LTMtMS0xLTM3MzU2_bf7878ec-dfd1-4788-b161-6792e29a2546"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE1LTUtMS0xLTM3MzU2_dad8f424-c9da-4f9c-973e-ad8018acfb64"
      unitRef="number">0.029</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE2LTEtMS0xLTM3MzU2_dfd1ec65-e6aa-4527-85ab-a0383c5f5f4c"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE2LTMtMS0xLTM3MzU2_fb1d50fb-32ca-41fb-ac08-368bff89d872"
      unitRef="number">-0.023</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE2LTUtMS0xLTM3MzU2_c621fc9e-7037-4872-9c6b-9996cec70970"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE3LTEtMS0xLTM3MzU2_42b9f4e8-9985-4561-83e3-d785996b9f38"
      unitRef="number">0.007</iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent>
    <iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE3LTMtMS0xLTM3MzU2_1ce6d155-4121-468b-8465-749e3b77227d"
      unitRef="number">0.025</iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent>
    <iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE3LTUtMS0xLTM3MzU2_3cc1b81d-9052-4f08-9664-e811072d43df"
      unitRef="number">0.076</iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE4LTEtMS0xLTM3MzU2_aa042fed-ef05-4dda-b5b8-c8c0f7b18d3a"
      unitRef="number">0.009</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE4LTMtMS0xLTM3MzU2_2f97baf5-d2aa-4c05-aa2f-a5b084bb5041"
      unitRef="number">0.024</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzE4LTUtMS0xLTM3MzU2_814abd89-2cf7-456d-8c6b-c33181002268"
      unitRef="number">0.030</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTEtMS0xLTM3MzU2_a6b7b0fe-b969-4b73-9357-c2416ed97da7"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent>
    <iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTMtMS0xLTM3MzU2_233b4dca-598d-4bb8-8a71-b5a5ed4d708e"
      unitRef="number">-0.633</iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent>
    <iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTUtMS0xLTM3MzU2_a7a4ccc1-2fa6-4fd8-a939-490378151228"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent>
    <iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTEtMS0xLTM3MzU2_6dfa80dd-0ee7-4636-a412-d1d4f8cbb693"
      unitRef="number">0.039</iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent>
    <iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTMtMS0xLTM3MzU2_7eb2adc0-dedf-40fc-ad3c-a10b871ca884"
      unitRef="number">0.028</iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent>
    <iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTUtMS0xLTM3MzU2_27cde1e5-e1a7-4d90-8118-6aceb834692e"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTEtMS0xLTc1MTM5_5b42e400-17ec-476b-b6d5-536f767b4a2e"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTMtMS0xLTc1MTM5_d4b1a2a3-0971-451f-b577-e036ae411cc5"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI1LTUtMS0xLTc1MTM5_0b773980-fcb8-46db-a7f1-cf3a6e8d954b"
      unitRef="number">0.157</us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTEtMS0xLTc1MTAz_8eaadfe9-9a0c-4d40-a591-771826ca192b"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTMtMS0xLTc1MTAz_a8148e32-6c4e-4b7f-92fa-f0f501c733bd"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTUtMS0xLTc1MTAz_98d02698-b08b-42f7-9c6d-4a3e877b8031"
      unitRef="number">0.227</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTEtMS0xLTgxMTc3_edadd873-c22f-4fc4-8e3d-d0ca17ccfd22"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTMtMS0xLTgxMTc3_e097c55f-98a0-473d-aaf4-bcc31e17790b"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI0LTUtMS0xLTgxMTc3_2b3a4ed3-6008-40e4-8fbd-17eb57acd818"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI2LTEtMS0xLTM3MzU2_be9350c5-d2b9-4f3f-9921-dad070f84498"
      unitRef="number">0.212</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI2LTMtMS0xLTM3MzU2_90cf8f42-aceb-455b-8415-d768dd6ad60f"
      unitRef="number">-0.432</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo0MzA2NjQxNDY4MzE0ZjI1YmFkODM3MDQwNzVjNjY1OC90YWJsZXJhbmdlOjQzMDY2NDE0NjgzMTRmMjViYWQ4MzcwNDA3NWM2NjU4XzI2LTUtMS0xLTM3MzU2_15db1ca8-db4e-4cff-889e-b9860b57d880"
      unitRef="number">0.165</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzExOTI_be9350c5-d2b9-4f3f-9921-dad070f84498"
      unitRef="number">0.212</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzEwOTk1MTE2MzUxNDM_90cf8f42-aceb-455b-8415-d768dd6ad60f"
      unitRef="number">-0.432</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="i9f63720b3c7e46459c42a7742e5a8136_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxOTI_275b2caf-7f39-44f2-97b2-245205bf2cf5"
      unitRef="usd">8500000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxMjA_1182778a-9b8e-4f67-ac66-5329824de8f3"
      unitRef="usd">-3100000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <iart:EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzEzOTg_6873cfc0-d8bb-4e69-8ef4-1d96adf50afc"
      unitRef="usd">59200000</iart:EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount>
    <iart:EffectiveWorldwideIncomeTaxRateReconciliationPercent
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzE2MTQ_88c7da12-9e78-481b-8bfb-d227bdf856c2"
      unitRef="number">0.202</iart:EffectiveWorldwideIncomeTaxRateReconciliationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount
      contextRef="ie99f5f90e3c34fc2b03a2184dd276704_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzIxODI_483a4688-0811-4661-b8a9-6bea405a5d14"
      unitRef="usd">59200000</iart:EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzIzNTk_f62ae358-6067-4979-9ebf-96d641338cbc"
      unitRef="usd">63600000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzI2MjY_784c390b-758f-49a8-bdc0-fb6670b608f3"
      unitRef="number">0.152</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzI2NDI_bede2a8c-3821-4458-b318-5c47e98188b0"
      unitRef="number">-0.571</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxMzQ_3cad3aa0-00c4-4034-b230-1f20b824a980"
      unitRef="usd">-48200000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxNDk_57981524-e278-4d08-8ec1-d9b38277f037"
      unitRef="number">-0.571</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxNTg_aa321a46-5118-4de5-a0d6-a966db3d114a"
      unitRef="number">0.035</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign
      contextRef="i8271de19ce8942b7a5a6ac1978cb2a0c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM0NDA_d93675a1-a8c9-4f86-874b-de9cddfa808d"
      unitRef="usd">12100000</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <iart:EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare
      contextRef="i8271de19ce8942b7a5a6ac1978cb2a0c_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM0NDQ_7d9bab9d-bbd9-4118-92b7-67df719b08ca"
      unitRef="usdPerShare">0.14</iart:EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxMjY_f1d47847-d39c-4243-bb54-f48da0182a5c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,830)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,046)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzQtMS0xLTEtMzczNTY_87169bfe-b056-4a16-b9cb-82cf7e2ead16"
      unitRef="usd">31938000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzQtMy0xLTEtMzczNTY_44393a8a-512a-4f85-8025-fafe238b4245"
      unitRef="usd">6184000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzQtNS0xLTEtMzczNTY_b698bc18-5a69-4884-8b3e-a57dcdc281fc"
      unitRef="usd">14597000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzUtMS0xLTEtMzczNTY_ab5ad3f5-c65e-4597-b566-0f4d2b2f8db1"
      unitRef="usd">11377000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzUtMy0xLTEtMzczNTY_953ae68f-6655-4624-993a-b47dd22aa69e"
      unitRef="usd">5029000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzUtNS0xLTEtMzczNTY_f528a3f5-5e8d-435f-923b-44557c5fd236"
      unitRef="usd">3447000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzYtMS0xLTEtMzczNTY_3b2cfacb-0242-48af-9296-46fe5e6394d5"
      unitRef="usd">5042000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzYtMy0xLTEtMzczNTY_53765d78-3b02-456c-be8b-db340994b8a2"
      unitRef="usd">12553000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzYtNS0xLTEtMzczNTY_a802175a-be88-45a2-9526-aeeb8e15caa8"
      unitRef="usd">10905000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzctMS0xLTEtMzczNTY_b31214ac-a10e-4646-aec6-1bb48e5e3dc0"
      unitRef="usd">48357000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzctMy0xLTEtMzczNTY_631f6fd1-4449-40e9-8dc5-94482de2d80a"
      unitRef="usd">23766000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzctNS0xLTEtMzczNTY_f77e7c62-3ca7-4577-9643-75eb40cdd339"
      unitRef="usd">28949000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzktMS0xLTEtMzczNTY_dee731fb-b26d-4a00-9f72-50d6588577bf"
      unitRef="usd">-12830000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzktMy0xLTEtMzczNTY_41a3cce0-d01a-4897-aaab-7f187819c072"
      unitRef="usd">-5079000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzktNS0xLTEtMzczNTY_1fb8a160-a399-4f7f-8d5f-2aac7c44fe96"
      unitRef="usd">-10889000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEwLTEtMS0xLTM3MzU2_8620c218-3910-4d95-99dc-b1d129d80df9"
      unitRef="usd">-3688000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEwLTMtMS0xLTM3MzU2_9942bf63-a773-4b2a-b440-50a0d6f3b9f9"
      unitRef="usd">-1760000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEwLTUtMS0xLTM3MzU2_298fcbb9-e05c-4d88-be79-e82788beff52"
      unitRef="usd">-666000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzExLTEtMS0xLTM3MzU2_4c61f859-b808-4371-a19f-8bd0c6c4e3f9"
      unitRef="usd">13763000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzExLTMtMS0xLTM3MzU2_8515b8d3-7f68-4fdc-9b29-b9d9ceb9cdbd"
      unitRef="usd">-57299000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzExLTUtMS0xLTM3MzU2_6ec8be21-7a0a-4dd5-beae-6e2625208b3e"
      unitRef="usd">-7491000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEyLTEtMS0xLTM3MzU2_aec6c7b0-f088-4822-ab7d-041080e6583d"
      unitRef="usd">-2755000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEyLTMtMS0xLTM3MzU2_cd378069-d29c-4f2b-93c4-74887b63abaa"
      unitRef="usd">-64138000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEyLTUtMS0xLTM3MzU2_5c25e8ab-dbff-4166-a07c-c47b8d89b360"
      unitRef="usd">-19046000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEzLTEtMS0xLTM3MzU2_8b77e489-be22-4e56-bbdf-a9f31f3a284c"
      unitRef="usd">45602000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEzLTMtMS0xLTM3MzU2_4b28a226-a0e9-4036-95e5-69977b1e88d2"
      unitRef="usd">-40372000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZToxYjBmZGE5YzJhNjY0NzY2ODY3MGJiNWNmN2U1ZmFiNC90YWJsZXJhbmdlOjFiMGZkYTljMmE2NjQ3NjY4NjcwYmI1Y2Y3ZTVmYWI0XzEzLTUtMS0xLTM3MzU2_469deec7-73fb-43b5-9eef-20d056440d10"
      unitRef="usd">9903000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxNTI_be7d32f3-d82f-4e2f-b788-f6332e732839">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Inventory related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalization of research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Unrealized foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Charitable contributions carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred tax assets after valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intangible and fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzQtMS0xLTEtMzczNTY_2c041977-c8bb-4ba1-9dd9-8f99b3180f32"
      unitRef="usd">2029000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzQtMy0xLTEtMzczNTY_a6add4ae-bbaf-4fbb-817d-97482be7c5bb"
      unitRef="usd">2207000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzUtMS0xLTEtMzczNTY_d733f411-9290-405c-9112-6cbfce57e1c3"
      unitRef="usd">31841000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzUtMy0xLTEtMzczNTY_0e86d4da-9f08-4f5e-893b-b575dc47bb3f"
      unitRef="usd">47034000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzYtMS0xLTEtMzczNTY_4aeb5cdb-2c68-421f-91f0-733989bbe58d"
      unitRef="usd">13319000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzYtMy0xLTEtMzczNTY_645eaa93-7027-4b69-a0a9-53de49ce5f2a"
      unitRef="usd">18319000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzctMS0xLTEtMzczNTY_d3d54c73-1fdd-41cc-9521-cd0ca783c76b"
      unitRef="usd">3042000</iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation>
    <iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzctMy0xLTEtMzczNTY_f528c82f-a8a6-4ddf-bba4-60afcb916ee8"
      unitRef="usd">3403000</iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzgtMS0xLTEtMzczNTY_eb7d077f-4411-41f3-a0ba-c7d3484fe4ea"
      unitRef="usd">7415000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzgtMy0xLTEtMzczNTY_d3916078-1d5c-4e39-8a9c-27002d357494"
      unitRef="usd">4883000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzktMS0xLTEtMzczNTY_33493d58-5535-4f3b-b87b-c05c0f98f386"
      unitRef="usd">13955000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzktMy0xLTEtMzczNTY_8bbc4f4f-ef67-4ba7-8c89-2144d65ad7bb"
      unitRef="usd">6160000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEwLTEtMS0xLTM3MzU2_e2bbe36e-2bd6-4891-96e6-162c49ac6f3b"
      unitRef="usd">1742000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEwLTMtMS0xLTM3MzU2_d782fcd6-0de9-45ca-a5a6-e9631a866482"
      unitRef="usd">1665000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzExLTEtMS0xLTM3MzU2_eff9bb71-7c2d-4cd4-928b-20bd95d177c6"
      unitRef="usd">26198000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzExLTMtMS0xLTM3MzU2_9e079787-7be2-46e6-abba-9857cec3687f"
      unitRef="usd">29335000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEyLTEtMS0xLTM3MzU2_a3e357dc-a8b5-489a-a430-2ee7d3f8e6f5"
      unitRef="usd">36770000</iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment>
    <iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEyLTMtMS0xLTM3MzU2_b2bd38e0-3158-4e1f-a4a1-875683c307f4"
      unitRef="usd">13044000</iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEzLTEtMS0xLTM3MzU2_ff4a3864-e68c-43a0-a2df-604567e64090"
      unitRef="usd">12849000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzEzLTMtMS0xLTM3MzU2_606d2f58-f9c5-4009-bfe9-480c4f4e24cb"
      unitRef="usd">23798000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE0LTEtMS0xLTM3MzU2_667375c9-2a45-4078-a057-e1c8c480310d"
      unitRef="usd">206000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE0LTMtMS0xLTM3MzU2_036ec9bc-e360-4d6f-9a87-2daf5c777677"
      unitRef="usd">203000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <iart:DeferredTaxAssetsLeasesAndOther
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE2LTEtMS0xLTM3MzU2_4d6a2ae2-1934-4a06-a462-fb4974ff32c0"
      unitRef="usd">41371000</iart:DeferredTaxAssetsLeasesAndOther>
    <iart:DeferredTaxAssetsLeasesAndOther
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE2LTMtMS0xLTM3MzU2_98fe4b3e-cf9c-4a8c-9a8c-d2cb86ad6c7c"
      unitRef="usd">23205000</iart:DeferredTaxAssetsLeasesAndOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE3LTEtMS0xLTM3MzU2_d047c773-00e9-4989-80df-3d78ef3f32d4"
      unitRef="usd">190737000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE3LTMtMS0xLTM3MzU2_85afa55f-0009-45be-9946-08c2fd4c6442"
      unitRef="usd">173256000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE4LTEtMS0xLTM3MzU2_a5368bba-97f6-4bd8-9723-fec4072b26af"
      unitRef="usd">9767000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE4LTMtMS0xLTM3MzU2_bb8ff0b0-6aea-4a19-803c-c9715d89f50e"
      unitRef="usd">9897000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE5LTEtMS0xLTM3MzU2_0a544ee0-9dcd-44e2-9433-9844a7759dfc"
      unitRef="usd">180970000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzE5LTMtMS0xLTM3MzU2_d7915431-49de-4e1f-952c-8ce066ac39dd"
      unitRef="usd">163359000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIxLTEtMS0xLTM3MzU2_e18e649a-62f2-424b-a927-e968fa53ca7b"
      unitRef="usd">152150000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIxLTMtMS0xLTM3MzU2_6598bfeb-e9dd-4615-8985-c1c8bc203b58"
      unitRef="usd">90274000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <iart:DeferredTaxLiabilitiesLeasesAndOther
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIyLTEtMS0xLTM3MzU2_b05c6207-6b48-4d73-a886-c7f1e6187269"
      unitRef="usd">17658000</iart:DeferredTaxLiabilitiesLeasesAndOther>
    <iart:DeferredTaxLiabilitiesLeasesAndOther
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIyLTMtMS0xLTM3MzU2_781e99ae-bcbb-4627-94c0-a26042ea3d37"
      unitRef="usd">15585000</iart:DeferredTaxLiabilitiesLeasesAndOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIzLTEtMS0xLTM3MzU2_4c0cf4a0-6b9d-4da1-b66d-ab901e712a2b"
      unitRef="usd">169808000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzIzLTMtMS0xLTM3MzU2_f3fb9fe6-523b-428d-9d79-306cf13e8046"
      unitRef="usd">105859000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzI1LTEtMS0xLTM3MzU2_c4ea30de-501d-437b-8cdf-36a6eea1ad83"
      unitRef="usd">11162000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTpmZDBiNWQ5ZDc1ZTg0Zjc0OTM2ZTVjNDNiNzcyNzc3NS90YWJsZXJhbmdlOmZkMGI1ZDlkNzVlODRmNzQ5MzZlNWM0M2I3NzI3Nzc1XzI1LTMtMS0xLTM3MzU2_ebe5a005-afb7-45a7-89fb-93df5a8c1f66"
      unitRef="usd">57500000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ife5918aed5c1487692805e84f2c59330_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzQxNjY_32782cb9-3200-4ee1-816e-112035dd4d9f"
      unitRef="usd">71700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ia2d92855590d44b3b95dd1dc07dd512a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzQyMDI_49d3628a-d82e-41da-aa09-0b3eb8dd7fac"
      unitRef="usd">26600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i1ea077a5d12f4d53afbcafb365160302_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzQyNDE_8306283a-8e47-465a-9acf-c6917e179d76"
      unitRef="usd">39000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="ife5918aed5c1487692805e84f2c59330_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzQzOTM_274f5ef4-c24d-4393-9eba-270293408c23"
      unitRef="usd">4100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="ia2d92855590d44b3b95dd1dc07dd512a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzQ1MzM_470e9cd2-22bb-4b4c-99f2-65a8c38cc04b"
      unitRef="usd">26600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzUyNTk_07019501-9e46-4cfd-b4d3-3a821a309af7"
      unitRef="usd">-100000</us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease>
    <us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxNjQ_529cef39-2544-416e-8738-72984e1bf8a2"
      unitRef="usd">-100000</us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease>
    <us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzM4NDgyOTA3MTAxNzg_4e5e8674-008c-4362-a620-436855d9796a"
      unitRef="usd">2900000</us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease>
    <us-gaap:ForeignEarningsRepatriated
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzU5NDc_a56a9b88-5c22-4540-aebd-02fa04683a64"
      unitRef="usd">0</us-gaap:ForeignEarningsRepatriated>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzcxMjg_7e18b207-b4d5-4042-b16a-c1bef71a24f3">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prior years' tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzMtMS0xLTEtMzczNTY_bce6b9db-1aed-4bbe-aa60-4c4a243b3e33"
      unitRef="usd">702000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie55084e91d494776891870a81ff5cb91_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzMtMy0xLTEtMzczNTY_62ee925c-e3a6-4879-93fd-e2e29eeaeade"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ifcaf1fbc6c2145ac92ae58dce7c7f40b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzMtNS0xLTEtMzczNTY_ed3f4874-d6f5-4dd8-9b3d-589f5827b6d4"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzUtMS0xLTEtMzczNTY_bb41b188-b9c7-4435-ae58-c16f7f2bbaed"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzUtMy0xLTEtMzczNTY_0b97f7d5-86a4-420f-9509-b2ec0c1b0e4d"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzUtNS0xLTEtMzczNTY_20df087a-7d5c-4f3c-9d43-afd9d1c6235d"
      unitRef="usd">53000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzYtMS0xLTEtMzczNTY_dfefb418-9d11-4be5-b323-5e6f3c236a40"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzYtMy0xLTEtMzczNTY_12bd5510-9838-4036-ab6c-80abb98c1cf8"
      unitRef="usd">26000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzYtNS0xLTEtMzczNTY_ea847c0f-a292-4eed-af66-0d5cd96d6980"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <iart:UnrecognizedTaxBenefitsReductionsResultingFromOther
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzExLTEtMS0xLTM3MzU2_f399efd7-4aa7-4f18-a62c-2b2c2fc2c953"
      unitRef="usd">26000</iart:UnrecognizedTaxBenefitsReductionsResultingFromOther>
    <iart:UnrecognizedTaxBenefitsReductionsResultingFromOther
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzExLTMtMS0xLTM3MzU2_e039b985-68ac-443d-b9a1-7616d27a9cdb"
      unitRef="usd">0</iart:UnrecognizedTaxBenefitsReductionsResultingFromOther>
    <iart:UnrecognizedTaxBenefitsReductionsResultingFromOther
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzExLTUtMS0xLTM3MzU2_3f92a18b-b643-4a0a-bf09-4f78999dc962"
      unitRef="usd">53000</iart:UnrecognizedTaxBenefitsReductionsResultingFromOther>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzEyLTEtMS0xLTM3MzU2_3b3fb66e-4cf8-40c8-9b5e-f0469e02ae7f"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzEyLTMtMS0xLTM3MzU2_e9f1b78b-893f-41dc-a492-4174286ff450"
      unitRef="usd">702000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie55084e91d494776891870a81ff5cb91_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90YWJsZTo5ZmM3YjlkNTI4OGE0ZTFmOWFmZmJjNzMzNWEzYWIzMS90YWJsZXJhbmdlOjlmYzdiOWQ1Mjg4YTRlMWY5YWZmYmM3MzM1YTNhYjMxXzEyLTUtMS0xLTM3MzU2_8c0e82f8-33ef-4056-8283-731c2e235911"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzYwODM_ef290dd6-1cae-4e35-80c5-64f9bf43f8ae"
      unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xNzgvZnJhZzo0ZjU5Mzk2ZmU3YTU0OWE5OGFkZjNjZmVhMWFjZDRlNS90ZXh0cmVnaW9uOjRmNTkzOTZmZTdhNTQ5YTk4YWRmM2NmZWExYWNkNGU1XzYyMTc_823af604-74d3-4fa0-b436-589949052810"
      unitRef="usd">0</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90ZXh0cmVnaW9uOjUxMDg4ZGE5ZGZlNTQ3ZWY5YWY3NTAyMTBhOTU4NWUxXzcwMQ_5486ee29-a9d7-41ca-9f1d-735787e9e9bb">NET INCOME PER SHARE&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per share was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Dollars in thousands, except per share amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Basic net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Diluted net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock of approximately 0.1 million and 0.3 million shares at December&#160;31, 2021, and 2020 that are issuable through exercise of dilutive securities, respectively, and were not included in the computation of diluted net income per share because their effect would have been anti-dilutive. &lt;/span&gt;&lt;/div&gt;Performance Shares and Restricted Units that entitle the holders to approximately 0.5 million shares of common stock are included in the basic and diluted weighted average shares outstanding calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90ZXh0cmVnaW9uOjUxMDg4ZGE5ZGZlNTQ3ZWY5YWY3NTAyMTBhOTU4NWUxXzcwMA_e8bfc570-b01c-4975-ac5b-173268aad7c2">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per share was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Dollars in thousands, except per share amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Basic net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Diluted net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzQtMS0xLTEtMzczNTY_65468cf4-dd35-4218-a5e9-2d0f7a7d7121"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzQtMy0xLTEtMzczNTY_bf2afda1-fa9e-40ac-ad64-f2b61249170f"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzQtNS0xLTEtMzczNTY_4bec1973-aa6f-4f25-b842-f1852aac9e73"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzYtMS0xLTEtMzczNTY_75a86537-18dc-42ba-af53-749d6a579505"
      unitRef="shares">84698000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzYtMy0xLTEtMzczNTY_1e98e3fb-9af3-48db-8395-2fe2da4ea616"
      unitRef="shares">84650000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzYtNS0xLTEtMzczNTY_765ddf45-3463-485d-bf11-e753346d3963"
      unitRef="shares">85637000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzgtMS0xLTEtMzczNTY_e3a44300-e647-4c1a-8f2e-002c5e9701b6"
      unitRef="usdPerShare">2.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzgtMy0xLTEtMzczNTY_d1d14dec-d77e-4408-9313-1b951ed91a0d"
      unitRef="usdPerShare">1.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzgtNS0xLTEtMzczNTY_9c6c951e-1aa9-46aa-bef3-296f613af9a7"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzExLTEtMS0xLTM3MzU2_74b5bd5c-7ea0-4c84-99b4-7c1c75f17883"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzExLTMtMS0xLTM3MzU2_823e03b2-2997-42aa-931a-f574f84fec50"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzExLTUtMS0xLTM3MzU2_286290ce-5973-4385-9d30-dabb77f7e142"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzEzLTEtMS0xLTM3MzU2_b1adc263-d1c0-4b21-b46f-556384c916d6"
      unitRef="shares">84698000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzEzLTMtMS0xLTM3MzU2_0fe40724-a228-4123-a8c1-5c0a145b848a"
      unitRef="shares">84650000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzEzLTUtMS0xLTM3MzU2_2c4f324c-b8bc-4df7-857b-ed3afd08b480"
      unitRef="shares">85637000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE3LTEtMS0xLTM3MzU2_95cec570-8ec0-4a79-9424-311ddbbe6f62"
      unitRef="shares">787000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE3LTMtMS0xLTM3MzU2_3865d4a5-84b1-4e3f-bb53-5b6c859f8c78"
      unitRef="shares">577000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE3LTUtMS0xLTM3MzU2_757cc7bf-afde-4477-9afc-d1cc776452ee"
      unitRef="shares">857000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE4LTEtMS0xLTM3MzU2_519a8ecd-9a28-4abe-827c-c5478d1655cf"
      unitRef="shares">85485000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE4LTMtMS0xLTM3MzU2_1251cb81-b6d1-4815-837b-04d70d4e6e62"
      unitRef="shares">85228000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE4LTUtMS0xLTM3MzU2_00a170ef-07cc-4863-9d80-7c36eae47d33"
      unitRef="shares">86494000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE5LTEtMS0xLTM3MzU2_bf5fcabb-3bc7-44c1-a924-fd19a833100a"
      unitRef="usdPerShare">1.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE5LTMtMS0xLTM3MzU2_26ab4b20-afd5-4c2b-b428-77aae77ab934"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90YWJsZTo1YTZjZjRiNWY3Y2Q0YTJiYmJhMTBmZWNkNzZiMzk3ZC90YWJsZXJhbmdlOjVhNmNmNGI1ZjdjZDRhMmJiYmExMGZlY2Q3NmIzOTdkXzE5LTUtMS0xLTM3MzU2_ad4d5e65-b277-4cf2-bcb7-866f4881ecf2"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90ZXh0cmVnaW9uOjUxMDg4ZGE5ZGZlNTQ3ZWY5YWY3NTAyMTBhOTU4NWUxXzExNw_08faa078-40bb-4371-88bd-08152c9349a6"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90ZXh0cmVnaW9uOjUxMDg4ZGE5ZGZlNTQ3ZWY5YWY3NTAyMTBhOTU4NWUxXzEzMg_a066107e-f883-46f2-9294-24b345ba04cb"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <iart:AdditionalEPSShares
      contextRef="i0a62d727286a47e8bee85dd137b2d0b4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODQvZnJhZzo1MTA4OGRhOWRmZTU0N2VmOWFmNzUwMjEwYTk1ODVlMS90ZXh0cmVnaW9uOjUxMDg4ZGE5ZGZlNTQ3ZWY5YWY3NTAyMTBhOTU4NWUxXzQ0NQ_a05b51ce-e689-4f57-a706-3b3fd048132c"
      unitRef="shares">500000</iart:AdditionalEPSShares>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90ZXh0cmVnaW9uOjQyNGFjNjIxOGM3NjQyOTU4ZDQ4MDBiMmUwYTVkMGI2XzM1NQ_d54650e8-c48b-49b9-b5ff-7e9cabb0b7f1">ACCUMULATED OTHER COMPREHENSIVE LOSS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive loss by component between December&#160;31, 2021 and 2020 are presented in the table below, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Benefit Pension Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amounts reclassified from accumulated other comprehensive income, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2021, the Company reclassified a gain of $25.3 million and a loss of $12.2&#160;million from accumulated other comprehensive loss to other income, net and interest income, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90ZXh0cmVnaW9uOjQyNGFjNjIxOGM3NjQyOTU4ZDQ4MDBiMmUwYTVkMGI2XzM0Nw_68c2081c-b0f8-4435-bf36-ed2110b074b3">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive loss by component between December&#160;31, 2021 and 2020 are presented in the table below, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Benefit Pension Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amounts reclassified from accumulated other comprehensive income, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="ibbb8ffeeace8408783309370a8cc931b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzItMi0xLTEtMzczNTY_e3efe9a5-6640-46e0-b970-4a4d0aa09b13"
      unitRef="usd">-82249000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2866d8b778aa44fe895f36a6d30cbdf5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzItNC0xLTEtMzczNTY_cff16c86-0633-4ee2-af00-128767f19403"
      unitRef="usd">-5105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie8713e0cf33449019cc4cf84a4e3d77b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzItNi0xLTEtMzczNTY_96e86918-5dd7-4671-8827-7b5143dc1a02"
      unitRef="usd">13295000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9b2f27cba47049e49b27de743dc66104_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzItOC0xLTEtMzczNTY_bc86e0f0-0509-45fa-b7b5-e748ab377aaf"
      unitRef="usd">-74059000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i76189f48f3644d178eedea04bdbe9155_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzMtMi0xLTEtMzczNTY_0ca48089-c0f7-45be-8e6b-c104824c8c26"
      unitRef="usd">52359000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i33b0eb0c48144061a9b7a61f90a00974_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzMtNC0xLTEtMzczNTY_6b70b45f-bc16-457f-a9e0-42638fe46cb8"
      unitRef="usd">6998000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i6e53f5024f5b49708d10aea5ff725429_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzMtNi0xLTEtMzczNTY_77fb0b45-2d85-442f-a051-8e0f8927a1f2"
      unitRef="usd">-17362000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzMtOC0xLTEtMzczNTY_034be5d5-f574-4e4b-9742-91a60fd14e2e"
      unitRef="usd">41995000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i76189f48f3644d178eedea04bdbe9155_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzQtMi0xLTEtMzczNTY_b8a6d654-d4ec-4afc-93ab-a5f4ea4ff387"
      unitRef="usd">13091000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i33b0eb0c48144061a9b7a61f90a00974_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzQtNC0xLTEtMzczNTY_6205cf39-bac3-48a9-87d3-76d236eaf262"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i6e53f5024f5b49708d10aea5ff725429_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzQtNi0xLTEtMzczNTY_ca980151-9fd2-4752-b9b6-45b058569f8d"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzQtOC0xLTEtMzczNTY_47c07a3f-56e2-4b6e-9fe4-177e48116d50"
      unitRef="usd">13091000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i76189f48f3644d178eedea04bdbe9155_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzYtMi0xLTEtMzczNTY_63ce014a-eaf7-4c6f-9fa7-7cd64e47f6c8"
      unitRef="usd">39268000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i33b0eb0c48144061a9b7a61f90a00974_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzYtNC0xLTEtMzczNTY_9c59be9d-6e80-42b4-9d79-52cbc64cfbe4"
      unitRef="usd">6998000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6e53f5024f5b49708d10aea5ff725429_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzYtNi0xLTEtMzczNTY_1a04dc82-c045-4960-87a8-87fe412051e7"
      unitRef="usd">-17362000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzYtOC0xLTEtMzczNTY_fcf24b54-3006-44fb-9266-77198cc40c3d"
      unitRef="usd">28904000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ia04c800bf5404c7b9232f7d4bc6754c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzctMi0xLTEtMzczNTY_ff3e7591-cb01-420a-8289-8ceb73e18271"
      unitRef="usd">-42981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia77c775b70934877bc93a2298d93cb4c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzctNC0xLTEtMzczNTY_00a9fd89-510f-4a56-abfb-9e65ed9f352a"
      unitRef="usd">1893000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i16240e1f2c9948f4bb47909f3308fa08_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzctNi0xLTEtMzczNTY_2f5bf876-0479-4cc9-9df2-ec89a0ef9594"
      unitRef="usd">-4067000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i62b5cd28862f4322bda15977250be066_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90YWJsZTpiMzk4OGNiMzdmYTA0ZjZiOTM0NDExMTMwZGEyNWE5YS90YWJsZXJhbmdlOmIzOTg4Y2IzN2ZhMDRmNmI5MzQ0MTExMzBkYTI1YTlhXzctOC0xLTEtMzczNTY_833f03c9-8d16-43a3-8b0d-616e30e4d7bf"
      unitRef="usd">-45155000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ia65ff802a8ad4a8eadd83dd25409c85b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90ZXh0cmVnaW9uOjQyNGFjNjIxOGM3NjQyOTU4ZDQ4MDBiMmUwYTVkMGI2XzIzNQ_9dc5a1a7-17be-4c7a-8b25-20e2a35e726d"
      unitRef="usd">25300000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ia068e43763f9429bac4588f20427197f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xODcvZnJhZzo0MjRhYzYyMThjNzY0Mjk1OGQ0ODAwYjJlMGE1ZDBiNi90ZXh0cmVnaW9uOjQyNGFjNjIxOGM3NjQyOTU4ZDQ4MDBiMmUwYTVkMGI2XzI0Mg_da0207c4-1de6-45cc-8bf8-b7f18328d585"
      unitRef="usd">-12200000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzIwNjI_34fb49fb-3662-40a1-a079-d98b445432df">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the fair value of contingent consideration during the twelve-month period ended December&#160;31, 2021 and 2020 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2021 and 2020 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Arkis &lt;br/&gt;&#160;(See Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ACell Inc.&lt;br/&gt;&#160;(See Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additiions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers from long-term to current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.074%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Arkis &lt;br/&gt;(See Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers from long-term to current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derma Sciences&lt;/span&gt;The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences")&#160;related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3 million related to the aforementioned contingent liabilities. One contingent milestone remains which relates to net sales of Medihoney&#x2122; products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0 million. The estimated fair value as of December&#160;31, 2021 and 2020 was $0.2 million.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzIwNTU_95df60d1-fc0a-4663-b7c2-17f44593fa4a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2021 and 2020 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Arkis &lt;br/&gt;&#160;(See Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ACell Inc.&lt;br/&gt;&#160;(See Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additiions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers from long-term to current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.074%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Arkis &lt;br/&gt;(See Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers from long-term to current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2eab101e6425464cb1a382b10930b341_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzMtMi0xLTEtNDM4ODI_d8cf0b7b-dae9-425b-8699-cc88f1d29a15"
      unitRef="usd">3415000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic91d4b47894f4d7a96fcbf0bd64e0b77_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzMtNC0xLTEtNDM4ODk_6c72b651-a2b8-45cf-93c3-d37c03c8b716"
      unitRef="usd">11746000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4a23d3b6fbf04e0390ce17338efbe5ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzMtOC0xLTEtNDM4OTU_43c62385-6429-46a2-b1b0-c4d8b145ea26"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1a9425a324d94f60bb5d946be181483a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzMtMTEtMS0xLTQzOTAx_d553a668-ee31-4de4-8664-b697ddec51b4"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="iebd7836a15ac4b8b944cca235159afc0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzQtMTEtMS0xLTQzOTAx_2f7bebf4-369b-4537-b986-89ad1b0ccd0f"
      unitRef="usd">23900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i2a46fda6cf2140edb1e670f70f41e243_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzUtMi0xLTEtNDM4ODI_ba5a737c-7067-48d4-ae99-7955888ea871"
      unitRef="usd">276000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i6aa77aab677c460cabbffe02b9267bf8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzUtNC0xLTEtNDM4ODk_b677848a-e2f5-4b0d-bb1a-3d70d6bdd92c"
      unitRef="usd">-276000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i2a46fda6cf2140edb1e670f70f41e243_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzYtMi0xLTEtNDM4ODI_601c8fb5-9fff-4fe1-a9cc-3dfb1494a967"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i6aa77aab677c460cabbffe02b9267bf8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzYtNC0xLTEtNDM4ODk_448a600d-4d2b-48c5-84c7-37c089e0861b"
      unitRef="usd">-62000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="iebd7836a15ac4b8b944cca235159afc0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzYtMTEtMS0xLTQzOTAx_f72f1289-5b74-44ca-9c0a-f48a4a45cad3"
      unitRef="usd">-2100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if1f3f919472d407284a8f3f85a6ed4d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzctMi0xLTEtNDQ5MzU_c7615139-04c1-4101-8f03-79bfb361da04"
      unitRef="usd">3691000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6e801d197ed5482db7634fd855e8728f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzctNC0xLTEtNDQ5MzU_564042a6-1f7b-493b-984a-e4c7533d6fbd"
      unitRef="usd">11408000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4252807040ee4349abee84d30b8c631b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzctOC0xLTEtNDQ5MzU_8ec2fbc1-b093-43d6-a9a6-769bd04a769f"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i25ef1e32c9ce4449a3b9050b6a0eb0a9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTpiYzY0ZDRmZDAxNDk0MmRiYTM3N2QzMWY5NTlkNDMzNC90YWJsZXJhbmdlOmJjNjRkNGZkMDE0OTQyZGJhMzc3ZDMxZjk1OWQ0MzM0XzctMTEtMS0xLTQ0OTM1_56b1592a-343f-4b37-8c3a-13b6f1911acc"
      unitRef="usd">21800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ie6092d39074b47158db64e1a12d8002f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzItMi0xLTEtMzczNTY_0f469275-f440-45b7-98a9-a13297f3b181"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic89e76baba8646799816d81431077940_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzItNC0xLTEtMzczNTY_b5acd348-398f-4edd-a0b7-0e002a3d98d9"
      unitRef="usd">14210000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i35e2f5b0e8cc4bb789f0d6856afb0e8d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzItNi0xLTEtMzczNTY_34a07c7d-b8a0-43f9-8d5a-72d6966a6e56"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i65e3f0df348d4cdbadb7cd4bfc901932_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzMtMi0xLTEtMzczNTY_6b1094c7-0a53-48a4-bf31-4a059927daca"
      unitRef="usd">3415000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i4c75bb71571a44fa91621f994d3c6236_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzMtNC0xLTEtMzczNTY_df8c6afe-6c3a-48ef-b4fe-8c789a49e210"
      unitRef="usd">-3415000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i0d8d2300006048a5856f3014db3d9faf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzMtNi0xLTEtMzczNTY_8b4f89e3-f719-4e16-84d3-26c214bf550c"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i65e3f0df348d4cdbadb7cd4bfc901932_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzQtMi0xLTEtMzczNTY_85fbeba3-9390-47b8-9ef7-85009ee264ea"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i4c75bb71571a44fa91621f994d3c6236_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzQtNC0xLTEtMzczNTY_f39c9b98-fd1b-4aad-9893-3e05c28f7e84"
      unitRef="usd">951000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i0d8d2300006048a5856f3014db3d9faf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzQtNi0xLTEtMzczNTY_deed83cf-084c-4656-9a96-d9199db208a8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2eab101e6425464cb1a382b10930b341_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzUtMi0xLTEtMzczNTY_4a8a0fe2-4ec0-41c3-aa45-cf9b9c504095"
      unitRef="usd">3415000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic91d4b47894f4d7a96fcbf0bd64e0b77_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzUtNC0xLTEtMzczNTY_2a459a89-7545-4e64-a9c5-067923961153"
      unitRef="usd">11746000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4a23d3b6fbf04e0390ce17338efbe5ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90YWJsZTo5NDJhM2Q4MGQ3ODk0ZWE4YTA4ZWI0MTM5Zjk0NTFiYS90YWJsZXJhbmdlOjk0MmEzZDgwZDc4OTRlYThhMDhlYjQxMzlmOTQ1MWJhXzUtNi0xLTEtMzczNTY_6ecc3f98-7232-4b40-8c05-0bf9f7d2ff8a"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ia320d69e30b449ea850f977af47c941a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzI3NDg3NzkwNzE5Nzk_15c0de68-24d8-4ad3-95c8-3f59bafd5bed"
      unitRef="usd">33300000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
      contextRef="ia320d69e30b449ea850f977af47c941a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzI3NDg3NzkwNzIyNjY_0f2de039-4d0a-4119-bf4d-93d60042af44"
      unitRef="usd">3000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifd2d3085810d47938abea6521730980b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzI3NDg3NzkwNzIzMTg_46bd7396-235f-47c9-adb2-5dbd0be94b42"
      unitRef="usd">200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i19abaf1be5a54d1cad2b918f942e1949_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTAvZnJhZzplNDU2YTIwZmEwMmE0OTEzOGFjYjdjNjZiNmI4ZDJjZC90ZXh0cmVnaW9uOmU0NTZhMjBmYTAyYTQ5MTM4YWNiN2M2NmI2YjhkMmNkXzI3NDg3NzkwNzIzMTg_aafa0d93-9606-435b-ae5c-a13188b96a76"
      unitRef="usd">200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90ZXh0cmVnaW9uOmU2YWQ3MDZhOTExNjRiNzc4ZTQ0MTczZWU3NWVjNTUxXzIxNjY_8af69fc9-cbcc-42d5-bc89-912d2fba4b7a">SEGMENT AND GEOGRAPHIC INFORMATION&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company internally manages&#160;two&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;two&#160;reportable segments and their activities are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Tissue Technologies segment includes such offerings as skin and wound repair, plastics &amp;amp; surgical reconstruction products, bone grafts, and nerve and tendon repair products. In conjunction with the sale of the Extremity Orthopedics business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,914)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,757)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,028)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(453,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of the World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes long-lived assets in Puerto Rico.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90ZXh0cmVnaW9uOmU2YWQ3MDZhOTExNjRiNzc4ZTQ0MTczZWU3NWVjNTUxXzgw_72f1f5f2-4664-4fc4-a780-a6474a7d8d94"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90ZXh0cmVnaW9uOmU2YWQ3MDZhOTExNjRiNzc4ZTQ0MTczZWU3NWVjNTUxXzE5NQ_aa87322a-cd41-4728-836c-2b29f7c68809"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <iart:SegmentReportingInformationNumberOfProductsOffered
      contextRef="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90ZXh0cmVnaW9uOmU2YWQ3MDZhOTExNjRiNzc4ZTQ0MTczZWU3NWVjNTUxXzY0NA_03310bcf-4de5-4e81-ad85-4852beb6734b"
      unitRef="product">40000</iart:SegmentReportingInformationNumberOfProductsOffered>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90ZXh0cmVnaW9uOmU2YWQ3MDZhOTExNjRiNzc4ZTQ0MTczZWU3NWVjNTUxXzIxNTY_17358ea8-3f98-48fd-bdcd-594c1ddff6c9">Net sales and profit by reportable segment for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,914)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,757)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,028)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(453,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of the World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes long-lived assets in Puerto Rico.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzQtMS0xLTEtMzczNTY_14eacba5-a6ad-4e01-bf65-a438b3982fe5"
      unitRef="usd">1025232000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb66154030084b3e8586a701e0a6bdb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzQtMy0xLTEtMzczNTY_d597fe1e-a250-44e6-81a7-ae18429b537f"
      unitRef="usd">894831000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69a65713dfe64c33a00c72d8483e68a9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzQtNS0xLTEtMzczNTY_752481ca-d497-43cd-9711-2af5c55fb26e"
      unitRef="usd">996206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d1799cdfeb443c297cec0ede24b319e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzUtMS0xLTEtMzczNTY_1556bb2b-2de5-4255-a817-4acfd7785e20"
      unitRef="usd">517216000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b76730b7e7f49afa097d63b1fb0577c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzUtMy0xLTEtMzczNTY_bf613354-6e36-4215-902e-1cc9d0cdb61a"
      unitRef="usd">477037000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie57e505f7452456591a3ff162137393e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzUtNS0xLTEtMzczNTY_a7893160-02cf-40f0-ad6c-1cbc425659af"
      unitRef="usd">521351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzYtMS0xLTEtMzczNTY_538301cd-0de4-4aac-bdb1-677969fa9f03"
      unitRef="usd">1542448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzYtMy0xLTEtMzczNTY_efb537e7-3c7c-4857-9034-0aae3a9e224f"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzYtNS0xLTEtMzczNTY_2ead1a5c-c517-4d86-8043-7107fb329198"
      unitRef="usd">1517557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6f756bb0be9d4f989bfa36dadc8b61d1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzgtMS0xLTEtMzczNTY_01070e39-f338-4cfd-8b35-57edaae1544e"
      unitRef="usd">439471000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9d6343e390534664acd42ec3984442ea_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzgtMy0xLTEtMzczNTY_e3220c93-ba5e-430a-9336-9ad893250752"
      unitRef="usd">356657000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i98fc4020b8994f4587d792aaefced1fa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzgtNS0xLTEtMzczNTY_041fa4ad-1c76-4ba2-871d-b95395745556"
      unitRef="usd">395019000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5b128710253a40d3b28600e3c705fdb6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzktMS0xLTEtMzczNTY_ba3b56ee-239a-4c19-b389-53d58cc91ff4"
      unitRef="usd">228199000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieda682a36ee340289bb7f3a9602fabce_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzktMy0xLTEtMzczNTY_919acb3e-4186-4182-a365-1da284f336a5"
      unitRef="usd">159630000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icabd362120ba4ad89874c966b42f3fb2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzktNS0xLTEtMzczNTY_6a19e3e5-7135-4f54-8efd-a85d3fc0be9b"
      unitRef="usd">144638000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iee33c44f27cc4e77b072623b9ba9c96b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEwLTEtMS0xLTM3MzU2_0e217adb-4de1-4b35-b31e-86d4306dced5"
      unitRef="usd">667670000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i24453718685347bdbc8c3364e2bc9dd1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEwLTMtMS0xLTM3MzU2_03647c4c-b68d-460b-9ac9-8ec6775dabc7"
      unitRef="usd">516287000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8ec4766ff8b74bb2bbaa2ea51f38c98c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEwLTUtMS0xLTM3MzU2_b396b87a-4268-4c4d-ae97-fac5bf9528c4"
      unitRef="usd">539657000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzExLTEtMS0xLTM3MzU2_eca76822-0eca-4b6b-a08d-61c3c46b3e35"
      unitRef="usd">16914000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzExLTMtMS0xLTM3MzU2_40f64fc3-d866-4cbf-a8c3-0fdd683ec05e"
      unitRef="usd">27757000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzExLTUtMS0xLTM3MzU2_62969d95-7a44-4afb-b5dc-919842e7544e"
      unitRef="usd">27028000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i33ba2e9dbfa94793bdffd7e52faa2682_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEyLTEtMS0xLTM3MzU2_d14ae12c-d767-4252-808d-7eedd7e1e899"
      unitRef="usd">-453526000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i53e08de3817440699e14abb26fa3b8c1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEyLTMtMS0xLTM3MzU2_2275c075-89e0-405e-bb1d-9c864abaa193"
      unitRef="usd">-337160000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9f1d90d19e9e4cdaa2643ef6b865abb2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEyLTUtMS0xLTM3MzU2_1a909308-92e2-43f5-83c9-e66405b74957"
      unitRef="usd">-418869000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEzLTEtMS0xLTM3MzU2_67111ea7-a825-4ca4-a87a-eb78e873f825"
      unitRef="usd">197230000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEzLTMtMS0xLTM3MzU2_6c20e9ec-8a84-4021-8ffd-b25146d2c116"
      unitRef="usd">151370000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTpkNDJkOWYwMTA3OGE0YjBmOGIxMmIwMzE0M2YyMGM1Ny90YWJsZXJhbmdlOmQ0MmQ5ZjAxMDc4YTRiMGY4YjEyYjAzMTQzZjIwYzU3XzEzLTUtMS0xLTM3MzU2_d6b89124-7260-40b4-b01b-7315f60ca40b"
      unitRef="usd">93760000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97aab3d9bc7649968f7bd24913cb99f3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzMtMS0xLTEtMzczNTY_93438cb5-5dc0-4f0e-adbe-bf5060184278"
      unitRef="usd">1089526000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if42f2680503f44fb8c7e794fb7e10a6d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzMtMy0xLTEtMzczNTY_e24d9978-5f09-4515-b687-e6fe1b709d86"
      unitRef="usd">191327000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3109fd420bc7439cae7cd959e1de8c73_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzMtNS0xLTEtMzczNTY_926d99db-5064-41c8-a302-bbb4ecc4ad09"
      unitRef="usd">182034000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ef83b8d6d124777b62a31b4e2684492_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzMtNy0xLTEtMzczNTY_dd737352-7445-45d8-8631-ab991c651084"
      unitRef="usd">79561000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzMtOS0xLTEtMzczNTY_8377477f-907a-4a9d-a0ec-ebdf26589e4c"
      unitRef="usd">1542448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b32cebb922d4397bba7d163b3b0f280_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzQtMS0xLTEtMzczNTY_514ff98e-d616-4bc5-8260-9039dee04dfa"
      unitRef="usd">971975000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ef8247221b044978061dddd77b93c53_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzQtMy0xLTEtMzczNTY_412461d2-9db1-429f-b1be-f84bb35a59a4"
      unitRef="usd">172689000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4eed1f8c5f0645c891b92ba3cda138e1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzQtNS0xLTEtMzczNTY_f3a28cb9-b338-4755-9ab1-0e766d4bbf9a"
      unitRef="usd">157174000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i922bc66b09174c569548f8ce0a89a406_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzQtNy0xLTEtMzczNTY_09b3491f-333f-4437-ab0f-b46178e68a90"
      unitRef="usd">70030000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i488c668ed69943629b8567d269181e0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzQtOS0xLTEtMzczNTY_f3c126c6-10c7-4438-adcb-4d0a616eecc8"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic33aa545fd0d4f1ea1f097ae92801f2e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzUtMS0xLTEtMzczNTY_504ee94c-765b-4dca-848c-26e66cf44dcb"
      unitRef="usd">1077379000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1119ac444814938a3b945328c7b101a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzUtMy0xLTEtMzczNTY_eb21fab9-6e71-4a3c-831b-c3d58957d84f"
      unitRef="usd">197468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56f905190bdc42abbc8fb75b81e146e4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzUtNS0xLTEtMzczNTY_8efb3985-b163-457b-b029-7e51241724f1"
      unitRef="usd">157391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i785fadf198a94822ad3bd70f37b63804_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzUtNy0xLTEtMzczNTY_605644ff-1cbe-46fd-91cf-dce425d0aba1"
      unitRef="usd">85319000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife4c17ea55d147088caf92a3f2764b7e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzUtOS0xLTEtMzczNTY_8b23fc62-8f72-4eca-b934-d412a9fe0dbf"
      unitRef="usd">1517557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NoncurrentAssets
      contextRef="i50142c614bbf430787c2956bba7a20e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzctMS0xLTEtMzczNTY_46c5e675-d46d-4b1a-a41a-c92c2d0899bf"
      unitRef="usd">339535000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i256baa22e9624220a6984e22db834aba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzctMy0xLTEtMzczNTY_d1908551-bb65-460c-b852-93f2caf55f57"
      unitRef="usd">55026000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i019eb6b80cbd43b781098b4683f8f8ce_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzctNS0xLTEtMzczNTY_c31b240c-843b-4d4a-94b9-911a976f9779"
      unitRef="usd">11289000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i4e860ddce78e406f83a26966f4ed71d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzctNy0xLTEtMzczNTY_4917c2c6-fd29-4681-a9d6-5706618fe725"
      unitRef="usd">6836000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="iee25a280ce1a41fe94147173b06ec1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzctOS0xLTEtMzczNTY_1c4b5cbb-593a-4727-9dbf-1dc14b3599cf"
      unitRef="usd">412686000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i475c2989d2c1426fa24528e14601b247_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzgtMS0xLTEtMzczNTY_73b96997-6459-42a1-bdf6-942ab8449777"
      unitRef="usd">324893000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i50cdb7226ffa49d2a639d7b8ce77fa33_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzgtMy0xLTEtMzczNTY_8104dd93-d894-4719-bdd3-793e50b011cf"
      unitRef="usd">38812000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i438e0780f85c42f9b797ba9e48948fd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzgtNS0xLTEtMzczNTY_675a7428-0fcf-4271-a5ca-def1953b81b5"
      unitRef="usd">13121000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="id1639642b327422bb89bec9a0b6728a6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzgtNy0xLTEtMzczNTY_e19d926d-7910-43b4-8636-c0e30539eb56"
      unitRef="usd">5577000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="if319a53d6ce443d0adc847fb824d705d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8xOTMvZnJhZzplNmFkNzA2YTkxMTY0Yjc3OGU0NDE3M2VlNzVlYzU1MS90YWJsZTo0ZGE4YTcwNWE0ZDg0NDUwOTljNzk4NzJiYTJjNjhiYy90YWJsZXJhbmdlOjRkYThhNzA1YTRkODQ0NTA5OWM3OTg3MmJhMmM2OGJjXzgtOS0xLTEtMzczNTY_17ceecc5-1bc9-4170-b55f-5e6af7a100a0"
      unitRef="usd">382403000</us-gaap:NoncurrentAssets>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i37632302c2864aada6356f5aeb73834f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90ZXh0cmVnaW9uOjBiYzk1NWZkNDMwNTQyYjc5ZTRiZWUxN2U3MTY2YWJiXzYxMw_80a2e951-7bec-4865-9557-ea94d853fb68">&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II &#x2014; VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged to Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;The above amount primarily relates to amounts acquired through the acquisition of Arkis and a charge recorded in 2019 to valuation allowance related to the non-deductibility of executive compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;The above amount primarily relates to amounts acquired through the acquisition of ACell.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Deduction primarily relates to a decrease to the allowance for doubtful accounts as a result of collections in the period and accounts written off during the year, net of recoveries.&lt;/span&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i901487c914b2405ba16f79b4bc6b4d8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzQtMS0xLTEtMzczNTY_d9e4db43-69df-4b84-a72f-de16df1b860c"
      unitRef="usd">6439000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i6bf12c9378fe4261a4675d758ca41164_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzQtMy0xLTEtMzczNTY_959288d5-c4ff-4cfd-8d04-0501cffa5ceb"
      unitRef="usd">-1059000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i6bf12c9378fe4261a4675d758ca41164_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzQtNS0xLTEtMzczNTY_9101228e-1783-442f-80b5-3a0adbc56502"
      unitRef="usd">341000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i6bf12c9378fe4261a4675d758ca41164_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzQtNy0xLTEtMzczNTY_fa131e9d-1443-4637-b764-7cc5f43ae937"
      unitRef="usd">986000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i4861d0427af7477a92dde072e3da72c3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzQtOS0xLTEtMzczNTY_ed95cfdb-9f47-45b0-bbba-47e3cb28e64f"
      unitRef="usd">4735000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ie8831947c0944fa381c1aca73be705ae_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzUtMS0xLTEtMzczNTY_f3db07e5-0482-496b-badd-866604a2e001"
      unitRef="usd">13825000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i3324aa5df4cc4aa9956ed23a488056f5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzUtMy0xLTEtMzczNTY_48dc3a5e-4f71-406a-b866-dfc3b732d316"
      unitRef="usd">1444000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i3324aa5df4cc4aa9956ed23a488056f5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzUtNS0xLTEtMzczNTY_7c18ff5d-c1d9-41a8-b295-0a2c5d928be8"
      unitRef="usd">89000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i3324aa5df4cc4aa9956ed23a488056f5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzUtNy0xLTEtMzczNTY_070b5871-24fd-4eee-a3eb-d34953cdcebe"
      unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i719d426fe5474f3c937a1a2698a52f36_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzUtOS0xLTEtMzczNTY_04fe87a7-e34e-40a9-8da0-dbb1e522e506"
      unitRef="usd">15258000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i095295915bc84f77b7412b41247d7e72_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzctMS0xLTEtMzczNTY_51e3dc4c-0fa5-470c-a84c-f2afb86ba73c"
      unitRef="usd">4303000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ifb8809409b6e47a485116299cbd2d2b2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzctMy0xLTEtMzczNTY_26660ecd-112d-4648-b711-3841fffc8669"
      unitRef="usd">3635000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ifb8809409b6e47a485116299cbd2d2b2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzctNS0xLTEtMzczNTY_fe733034-9d1c-468f-a4e8-615a55e2a30d"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ifb8809409b6e47a485116299cbd2d2b2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzctNy0xLTEtMzczNTY_a15f6b6c-ed42-4c60-a4f0-bfd53247cd82"
      unitRef="usd">1499000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i901487c914b2405ba16f79b4bc6b4d8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzctOS0xLTEtMzczNTY_c22e50fe-04ac-4a12-965f-21dbb6d0e316"
      unitRef="usd">6439000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8ca3471c88c14eedbaed1fb2d38b42a4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzgtMS0xLTEtMzczNTY_64891a00-24f7-4bf1-9cb8-808c799b86fb"
      unitRef="usd">12069000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i380c1d6ae64a4d0bb857dc194834acae_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzgtMy0xLTEtMzczNTY_170fece5-210f-47fe-bd34-320552f70885"
      unitRef="usd">1617000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i380c1d6ae64a4d0bb857dc194834acae_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzgtNS0xLTEtMzczNTY_7d0e4a7d-a198-41e2-b340-afb223599455"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i380c1d6ae64a4d0bb857dc194834acae_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzgtNy0xLTEtMzczNTY_bb6cd40d-2cb1-49f3-8e75-e519d6cdf6c3"
      unitRef="usd">-139000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ie8831947c0944fa381c1aca73be705ae_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzgtOS0xLTEtMzczNTY_611074e9-bdb5-48c5-a790-1fcf6189202e"
      unitRef="usd">13825000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ied8b91f481774dfe8fc8d278e1b3b31d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzEwLTEtMS0xLTM3MzU2_6bc66128-7dfd-43d7-bb89-d9263bba6f72"
      unitRef="usd">3719000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i72bcc06055074e33b93d370ce18fa181_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzEwLTMtMS0xLTM3MzU2_34b09898-c0d1-4153-a1f0-7af001082edb"
      unitRef="usd">2126000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i72bcc06055074e33b93d370ce18fa181_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzEwLTUtMS0xLTM3MzU2_878b711c-1403-4cb0-9be1-04ded74157a2"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i72bcc06055074e33b93d370ce18fa181_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzEwLTctMS0xLTM3MzU2_9a2e858a-465b-4c65-b726-d73b4f7301b6"
      unitRef="usd">1542000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i095295915bc84f77b7412b41247d7e72_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzEwLTktMS0xLTM3MzU2_d85cc081-b944-4412-8903-5db35f9b4872"
      unitRef="usd">4303000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id0e72938928e4ed1ad56b0e288505382_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzExLTEtMS0xLTM3MzU2_80fca608-87ca-45ab-8fb7-6de136f0ee93"
      unitRef="usd">6973000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ife0647d5414a46d1b2593bedad7c330f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzExLTMtMS0xLTM3MzU2_1747d21c-bc72-47cb-85c1-1715a2f171b6"
      unitRef="usd">3848000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ife0647d5414a46d1b2593bedad7c330f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzExLTUtMS0xLTM3MzU2_e2f3b9e4-e802-4676-b407-452824b428df"
      unitRef="usd">1291000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ife0647d5414a46d1b2593bedad7c330f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzExLTctMS0xLTM3MzU2_c7d52df5-03fb-4f17-bd16-1307510b77a3"
      unitRef="usd">43000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8ca3471c88c14eedbaed1fb2d38b42a4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3MmJmNTA2MTU2ZjQzZTY4Njk0MTJhNjY1ZjU0NDE4L3NlYzoxNzJiZjUwNjE1NmY0M2U2ODY5NDEyYTY2NWY1NDQxOF8yMDIvZnJhZzowYmM5NTVmZDQzMDU0MmI3OWU0YmVlMTdlNzE2NmFiYi90YWJsZTowYjFjZGQzNzkyYWU0MzBkYTU1Y2YyOTVjM2Q1ZDgwMi90YWJsZXJhbmdlOjBiMWNkZDM3OTJhZTQzMGRhNTVjZjI5NWMzZDVkODAyXzExLTktMS0xLTM3MzU2_565f750e-4724-483f-aeb4-66d0ae3c3d18"
      unitRef="usd">12069000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>114
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MBH,>?:Y?(=*R*87J?' )C*V1*4YIEHP$NLPBC%.WP&0K, D*O&_$BI=S)'Y
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M= -91*&VGL/$*5&7@)<"%ENIT3,OC()W9Z1LD+ XBJR)M,TH36/?.AMX@\/
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M"N^RE*6;[!DR_B!]9'E9E:TTXW4FJB.HB@?M!-BJ9\C&GNR=R@+:8FWO&@J
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M&?GA61DVT75IE&]<A$IIV:0O40QPOW4N'C>28'K;5_\"4$L#!!0    ( ,:
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MWAU/,!4M^L=U:-Y\S+KV'5MWXFD$1Z_:QV7$TT#E"3@-0 [OW?.;++K\Z#Y
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MG*8%^O71"UFF-J*"4>"\%IPG%B,>2YE+D1"%$1PHB$[L%4<72 MT?$ _'U9
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M,>''@CE?A\_U-]2BG ?87/J-KY8"4\0G?O..1$"TY[3..O(MV27<Q-"F=C@
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M*!J9(N=]GIFA7NV,_>XV2A7B/DMS]_ID4Q3;EV=G+MZH3+J^V:H<;U;&9K+
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MF3IP7=',]C2+]L67T+U_DQ;RL LNE"VDKE.Q:8LR--<TH"3JSG?UG@&)EAF
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M=(,W:2QCGNDY\C&"E;3Z)-XJ]B$HAH,'A?<T9:R R^>#WBB,Q\<B^=%@M<=
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M;,2<W$<)V0/G6,E*6>/<0WK6KSJ*:/ML;&"Z<TD S+'-&/A IR[(.Z!A Q3
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M?7)D#RS[UQCUTD0.4MMJ2T2LSE3*$<LME,E[:9#1!3DL:=69>:W31-]+_(V
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M42+P9OTJCYZH\C[)#[O@^TBRMV=-E"[GDW:M^A%&IHW'-YUB$I:G4HZ[#QL
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MUV<!A..B@^K)Y[17J"KX&HOB9!B[0M7ADH(R"9TE$'<>A=Q]_A!@1WU5DMR
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M>/4BKZLTR<2'@I7U=LN+A]<BS>]?GC@GS86/R7I3X87S5R]V?"UN1?5Y]Z&
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M:S_:[P:)6]WZQ8[7J]8TA#C_[6$.7([#?K,Z[53:+#IJ[_&A;O6"DB34J#8
M[6.F8:U?\S5YK&GCJ4?B^=_Q.)AVF!AMZW\<G&U>?XNP^S2+#)*S];OSM8X0
M706O!2LK8L;$IK.?'/:3[\'F4[V_\:-3:A,?./>BB &'K:8X6?'4J2XZOMX;
M%:9(\K;KQW5!*7^[$6KF3FXY9>5-BB^I.>S0Y^9![N8UUT7PA*W'<K4NG8X@
MKI\GS'@ X)NK6]<YW72:*8>-I+0&6?VC;X!ZV9ZYV]#MF904V?:4I&OG0V8.
M=@1J9/V/Q/)K#Z4?!G%Q25GD+:5'ET! V>WXYGU/)YW/WE,&._DFF41 W-$P
M&$8B/)O@/AB/VU1#,(Q4$Z,FB6(QG@1GH3C/_EG;RE5E/.CK:$6F"^J(N#OJ
M."K;#28V<U7MI)>SL1@AFTV!4""1NX()670R14)*@K-$/ M'T?-V_4>5*^ER
M7)APSAK'N$:Z W_31/SB8H*FI=0TF&;Y]KG/HNG9<SIZ..[H9S=!)1%K"& [
M%:.1F R;.F5?;HK##1P2Z(R#9 NBIYT)XX'T5--'#^=&WS$Y.7CAF@PQ]@66
MV'1NSND\FK@9HM<:6-R;CR@1A*/NR.HXG 1Q7]BHEZ_Z+'DS>3EUD>9UU@[+
MN3E< (V 5PKP7/-<0)K"&Y9&J&1<?HM^&#1-.P[<$]$W!\:H[HRN!\^4;!H!
M/Z[)VL\7RSV$]LUN=W%G9\;!YQJ:*EE48H(F<%2-^NF-:UVH?/=@RUC9JZ8K
MQOA&>Q::X+;=>1-WD%+0MR^"D1/ZWDBM)=8QXG/;WO3_?.0WI:_NL/Q_RE_?
MB.9.^O]7OON*?NA/?_.P,^#U@G8RR^="5Z[B&G;4Z-?UQ&=\KWGY@KK .QIC
M@=_:=N9?A,3KA4[==[9&R3Z<V-LH7AZ5CQDW8_2.I0N:,JAFKMZ8<]_0V6G4
M3RBU=5^S^I^2_F3YJC4[;I:ZJI0Z/ CTG&L>9I%74OZH5]S/44(A/TV5J>@K
MDT%^*6HW#B[-7!:HMIMG<U.N$:I=[2T5*?S0QZR#MNL.YYO/2;W/6Z[-_>J
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M52*58,>L8BM8KVI-=D0J6 'L6@]L]K4'$0E9*(W_BIQE"!F:BK6WO7@2.I'
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MQEE5N&4F.,*1"'"^5,JV#\2@^QAU^5]02P,$%     @ QH!85%NR+^0+$
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M^TZBM2 '5M=*OG&JKBC>222B&B>$*]=D5C@8]NN.+3/?OEO[$'TG[%ZC*4C
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MX\FB7O8S_P-IV9)NFGYJ5#MO3'X@IO8C;%^:-.K \)M^,-UX:,5PSD )*6[
MPA#[E(_;&/PXPGU5]:8PUK]D3D&VFC^].HF9Y40@MS_C#,/;:A?F"[$]W)GL
MXG<R&;[:V<,BV1[C[_??[2>3Y$<Q#?1@?O2O'OXFV\/7X[&X[3F36U.BT3H/
MD)]N/Z[A-$>5O-H3&_BS^078:4_1?]@BW1[,G=R!O! ;>\DF"N108FR4870Q
MGTS-V>OE-I+A9#S>%#?QX#84P >N#@HR0[OR44'R3>A!'E>$&:]E<N_U)&9R
M9[S?9S*9#/>1GF\CU#-<';=L>T"F;V70<[Q9)PCBW1DFDW$;[[]A0:3>1OA9
M,>&2)W103O\/+KS>G?3K)PGQ5'%7X3[:)O=3_MC%9[1VU\0Q=!YNU"YL)CY>
M._NW_:5]&N^J*_%XX[^2=HYM&?M>#M7QUJO=0;QI= _>U.'F.C,>]^"P+ @G
M0LL"^)X;X[L'-M#_*^/X;U!+ P04    " #&@%A41DU=HX,'  #X$   &0
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M;"]W;W)K<VAE971S+W-H965T,C4N>&ULM59K;]LV%/TK%UHQI(!B/>U8G6/
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M&C/0 F9"44Q,K,X>Z<)0J.!2YRAA3G&U!U#MHU$M[.',4:62;VRXYZ(HF%3
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M/#":B18;V]270M,3P0YS>I.A-!OH^TH(O9L8@NZ5-_X'4$L#!!0    ( ,:
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M#-YR R*J!*<!FM;\4Q<5O(1F YRDWQJ'!D(*4 (UR0@'+[<$I<9#AV@")UT
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M60&:88$&D%5YLF+.PFF9%3,D7#L"$G]5,;7"YLLM [WY/L'T]M?Q5;?W700
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MS$#*KE3[IKIWG50D[G.1([RCQ<,!J[1YNA)O*(.4;#F$H/ZQ-;VO/;L/D>?
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ME%25VJTNA1-#C::CP63(=^5<C7X=7=]R4]3)H?)9:8V@*D0 V[AIM.Y<RNW
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M6[^(X$KT-F*T6[@NL*\XZVC=MW'^":Q?#J#1"3PYNQZ_O9V</:7BM=QFS <
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MQN+Y),7"O9PA>TZXCHOSTX,O3!_)LN]$)/6Q"O]7=M9L3)VF#,_(8:;F65Y
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M!JPO!"ZPVXDQT/^+<_8/4$L#!!0    ( ,: 6%24OXN,+P8  !H/   9
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MFUB[,7+F;C]WTN NY9937%ZYL@3X/I;2+#=6P>HZ?/PO4$L#!!0    ( ,:
M6%078M"6'P8  ,\0   9    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;*58
M6V_B.!3^*T?L12!%)5<2.FTEVJ':2ML.:CL[6JWVP00#WDGLK.V4=G[]'MLA
M0 >85OM"[,3G_IW/-F<K(;^J):4:GLN"J_/.4NOJM-]7^9*61)V(BG+\,A>R
M)!JG<M%7E:1D9H7*HA_Z_J!?$L8[%V?VW41>G(E:%XS3B015ER61+Y>T$*OS
M3M!9O[AGBZ4V+_H79Q59T >J/U<3B;-^JV7&2LH5$QPDG9]W1L'I96;6VP5_
M,+I26V,PD4R%^&HF-[/SCF\<H@7-M=% \/%$KVA1&$7HQK^-SDYKT@ANC]?:
MKVWL&,N4*'HEBB]LII?GG:P#,SHG=:'OQ>HWVL23&'VY*)3]A95;&^/BO%9:
ME(TP>E R[I[DN<G#ED#F'Q (&X'0^NT,62\_$DTNSJ18@32K49L9V%"M-#K'
MN"G*@Y;XE:&<OK@?/][<CV_'=X]P.;X;7]\\PN3WT=T#=!_)M*"J=];7:,8L
M[N>-RDNG,CR@,@CA5G"]5##F,SK;5=!'_UHGP[63E^%1C1]I?@)1X$'HA\$1
M?5$;=&3U18>"III)BM#2<$DYG3.MX*_15&F)(/G[B(&X-1!; _$! P_8.[.Z
MH"#F<(>=-:&2B1G+U^;@2BBM]J7VJ%[3H:>J(CD][V +*BJ?:.?"&*C6!J:-
M@=P8 &Q:T$N*YLJ*\)=??\K"(/V@#&Q1\ZQ=735=5A6$;Z1>*)$*J"DB8 EH
M.:6R+0,0/C,#'QC/B]JL,3)S46"?,[Z +BE%S=$)QO&+J!4*J-XI_(E:#RJU
M"A\P+I93&P/\#*&7Q@$^8\\/AW##-<707800^#Z$P1#&SQ6V.:J45->20Q,+
M$*4HNM#-AE$/NH,D[,&H%%*S;\22 M:GPLPA2VW;[.:2SIA&B3 +S&\:]^">
MYF+!V3<T@BBIB62D@$*@ 05!-H T2]%SK0L++ 5) -W 1X.;^NQ4!R,*O*$?
MN\C\%([@+FEQE[P9=U\L(:&WHR<JD5]AI)!Y*Q.V@L_J=6,Z^!U7_[A3X-7:
M &D,D"T#*RP2U,J@0B#<GI#]*^#;2%UC;A>Q!E4&1YL46Z!CISZ1HL94VXJ)
M?URU7^L0TX(MB//@?2CV$#G*8 CWB.+E%)-E+!T Z$>F<H-MD$13\$^B%'XQ
MCQ@?/T!B=)(,<55XXIO%]T8>[>38GQB*PR3V$VZOBN*BP+=K [-V WP+3E,!
M:][$F1.UQ,T)[2"$71,')[X1=H\CT!JTT!J\&5IK%ONTE6Z3R(D)=&0#W0>N
MHP;V<]LNXFP&,5Z]M)7-EX0C[)!?-HC8AX0UIK;6;U7DG6QG!@2+FPN>LX*U
M-&+)K[;22A-=HUG]9KS]#[*\<D'=<)BT2=A7G\FQ%'GX<L$X-TG&6$PJD);2
MT,L&0QP,!MXP#0]0[PY;.ZYV3#UJ6[B[P--ASY(E=!//CY%.NY$7Q6G/888@
M9<X<;7:3;- #NU.%']Q7M<6JR.$)"J<H.2ZK0KQ08YEKR::U+<4P2"'+(HR7
MEJPN%52$S=!::C: *,MZ;78J\F*/ -W0"T)\WPV\)&H\4H!G :[F5&*SF:*L
M'5H_Q_,Y9M,D"_&#1,CQL(9K>?X"]+D!FFE/9=0/$E0[\((@^5$9, U;!1@D
M7I#%FTJ\"PV;7FQR[,:(RCEATM'I_KI'J9>%B1GX7IKZKI#%(4+SHA2->UD6
MKBLB=RJB\&.8Q.8WC?<736VJ]GV](U.X9-#;'-5<15]7[6"]WU&JP(N"80]=
M'0[38UG;+5,T](9!O$G<$;9-6[9-W\RVUXY5'BRK[./5HZKV\^J/D72_RW"?
M7OD!UVTZ[):\E:OO$W*YAY0;;#?(_LP;[MS'WW@$3! \OE%HV>-8AK,VP]F;
M,]SNV6M')XX:]F;[J-JW[&+:7*R *;ME-)=AXP5=>S&OL='HYG#>. /=5YL#
MUBETIT@\>> DLI-T.#"3V$ZRR)8SL<=H/XW,9. F?H0GTV?$->Y S>:'$KX7
M#?<CN+]UR2RI7-BKM )[$'+WS?9M>UL?N4OJ9KF[ZM\2B:RCH*!S%/5/4CQV
M2G=]=A,M*GMEG0J-%V [7%(RH](LP.]S(?1Z8@RT_V%<_ =02P,$%     @
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M)*%V&^C[4BF[G3@'S6_7^!]02P,$%     @ QH!85 "4%M5Q!   5PT  !D
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M^YN')Y@\7,/MS>/M;#+]>'<%=P\?'F?WDZ>[QP<X>I*+6MGCL[%#A]YL7.S
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MDQ0'ENFO\?V+TYMP=5YHAQ?Q(*[QRT<9KX#[2ZW=_L4[&+ZE+OX%4$L#!!0
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M=8)LB-).,.,C(?1;P][WY=>US3]02P,$%     @ QH!85.B6H+-7 P  & H
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M/ >H]Q>,R?=!OD#U*\GX?U!+ P04    " #&@%A42>P8LYP#  "G"P  &0
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M\IEAL@FI69Z82'P0> V:1'PM'J4Q6V]O9UA:_T-UND<WJ_M'UJ?[^PIRO=9
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M%;F\T"+-WX1-A-8BSC_.& 6_S #X?BJ$7EV8EVOK%\*]_P%02P,$%     @
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M.E195-4SJXF1,]>GQM)0UW/#C+XS4-D#M#^1TFPFMO757R[]/U!+ P04
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M[B/\8K(]^^U$B\J>MXW0>'KM,,?K$J0IP/=;(?1I8HYP=P$G?P%02P,$%
M  @ QH!85#!!:PG !0  G20  !D   !X;"]W;W)K<VAE971S+W-H965T-3<N
M>&ULO9IK;^(X%(;_BH5VI8ZTA?B6RX@B=7K1(+4SH]+I?ECM!Q=<B"87-C&E
M*^V/7R?0.-2.Z0@S_5!R\7E[?/SVP1PR7.?%CW+!N0 O:9*59[V%$,N/@T$Y
M7?"4E?U\R3-YYRDO4B;D:3$?E,N"LUD=E"8#Y'G^(&5QUAL-ZVO?BM$P7XDD
MSOBW I2K-&7%OY]XDJ_/>K#W>N$NGB]$=6$P&B[9G$^X^+[\5LBS0:,RBU.>
ME7&>@8(_G?7.X<<+&E4!]8B'F*_+UC&HIO*8YS^JD_'LK.=5&?&$3T4EP>3+
M,[_@25(IR3S^V8KVFK]9!;:/7]6OZ\G+R3RRDE_DR9_Q3"S.>F$/S/@36R7B
M+E]_YML)T4IOFB=E_1NLMV.]'IBN2I&GVV"901IGFU?VLBU$*T#JF /0-@"]
M-P!O W ]T4UF];0NF6"C89&O05&-EFK505V;.EK.)LZJ99R(0MZ-99P875[=
MC1_.[\</5V#\97)_]_WVZLO]!)Q,I%]FJX2#_ F,,\$+7@IPQP0'DS5;@DM>
MQ,^L6H'R SBYY(+%B3PZ!1>L7(!K:0[PF<_F<3:7URYY&<\S&3L#K&RNC[-2
M%"OI""&'?)]<@I/?/@P'0LZIRFPPW>;_:9,_ZLJ?3_L PS\ \A TA%^\/]S;
M#1_(2C;E1$TY4:V'._5>ZP+^NI'WP%CPM/S;HHP;95PKDP[E+WEE>Y: \S1?
M9<)4J8U 4 M4_[[/(Q@$U*M_AH/G=E4,0T-MZ$Z>I,F36/.\*D6<UFM]S>("
M/+!DQ4W);E3\5@:G!$<TT',UC(QPX$>=J=(F56I-%9ZF>286M?ENQI^^WH&;
MG&7@/[/A&P_?LF*Z "BH3 ,#R]+Z31Z^8],$C7)PJ&D"S0EOZQ]H]8>>9[-*
MV&076K.[CE]D.7>*;<K0+@+[40!_M]0J:K*)G!@WVENPR&!8U&U7Z"E6>\<P
MK(0<3Q]Y 2#>>!;<%RR3@ ?04C?8>@N!COT+%4\A.M3!6X7VBF#-H-LW Z0M
MC3YT-U/%9V@']#O=O$<%]>4"V>P,%8BA&Q)O9=KU.Z7(#PWE,Z 8(KH+[=UL
M%8OA46#<[6UD*Z)",W3-9JC@# ^F,]3Q#&F'MPV<UH;N9JI #9V0>H\*ZA.$
MK=Y6K(9N8 UU6I]2BDSE,U ;R@*BSO(AQ6WTB[F-;5M5Q6WDFMNHM0\^F-M(
MYS;JX#;2N:T/W<U4<1LYX?8>%=3'T.IMI+B-W' ;&;@=$ 0-Y3-QVT<$=Y=/
M<1L=A=M?IR*OK>W5U@[?M25!"MO(-;:1PC8Z&-M(QW;'!S&D4]O^.0PI:",G
MT-ZC@OL(67VMF(W<,!L9F0V1H7BFG7:(_<[B885L?!1D=]K:MAO!BMC8-;&Q
M(C8^F-A8)W97?T$'MMW6N-4'<<+K/2JX#Z/(YFNL>(W=\!J;]MG$)X;JF5H>
M(;+X6N$:_UI<VW8B6.$:N\8U5KC&!^,:OQO7^&=QC16NL1-<[U&1N/;LOE:\
MQFYXC4V\)I')UR9>!V'W-H0H7I,C;['#G]B'$ 5LXAK81 &;' QLH@-;[]UM
MNZPZL?>T^8A"-G&"[#TJJ!^&U&9MTNI1.VI2&Y#MAZ%O*)]IB^T1K[LU0A2S
MR9%;(V^];=N,$ 5MXAK:1$&;' QM8FB-='G[IUO81&&;.,'V'A7I;3^P>EMA
MF[C!-C%@VP],VQ%B:HUX!,/.\E'%;7ID;M/-=W?OXC95W*:NN4T5M^G!W*8Z
MMVG'CH3JW-:'[F:JN$V=<'N/"NP3:.4V5=RF;KA-=6[C3=OO;?5,V(XLU*:M
M+Q>/3.VWSK91FRIJ4]?4IHK:]&!J4P.U48>S#=36ANYFJJA-G5![CXITMD>L
MSE;4IFZH375JAZ:6GV'<*2:A7KI!Z]F1ZL&=6U;,XZP$"7^2D5X_D"XO-L_"
M;$Y$OJP?)WG,A<C3^G#!V8P7U0!Y_RG/Q>M)]81*\T32Z']02P,$%     @
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M.W\#QI0'CWXR'>(WX&1,A1^$\FHVX2"(P.V*;6,_6L2#GI!!)DWUYBJ@\WU
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M]]_Y)AR1 B!8 $ "@%X"< $ "P"N^@1= /2J "( I"K $ "C*L 4 +,JP!(
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MD1K50U37<_JTMB(^ ,/4<3%,U"Z)VL?EST_F[9FS#^;'3I_U+5:C ^"@#/L
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MJ&@>$S7^8ZXOJ/,-8_)UH1W4?RB&_P%02P,$%     @ QH!85,^+JF@8!
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M45B$>@"\GW/@5-SH#T[E9]C1?U!+ P04    " #&@%A4L^UG_] #  "'#0
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M&@#_KSE7[QT]0?7V&O\/4$L#!!0    ( ,: 6%2U?<TM<0<  #PH   9
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MZZOI: @&=[>3T?OIU?W-W7MP]AYSCG7:7X&S(9&8IN(5> ,^3H?@[+=7X#=
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M*_9O%O:0K\Q:P9$^XX:)XA/9),2&B>)?P$2QS430Q43MG8^;,L(7Q6=H0E7
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M; !]SZ4TQXZ=H*D$Q_\"4$L#!!0    ( ,: 6%21>YW1?P0  * 1   9
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MJL\F^X/0Z9DJ3+,8V?WUB::HBKYKBD*G;S!%O@:[;P?[1V#KB/%4JG;=2N1
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M[4Z9!\YDO,=;LB3JQWXA])U398EI2IBDG %!-G>#>W@[0[X)R!5_4W*01]?
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M<8[!(?2] _!=W_MT.X>]7_85"ERSY!^9V19I87GVXYANA=E!M5_GN%_ ]G?
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MJ;M707NKT^D^N,E K'5BSC:P_?=G.R$%&M+NZ?8+V/$\SSPS'H\]W''Q3>8
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MI6_%WI-'0<FV#LHS#_E^Y.6$%8/QL'ZV$.,A+U7&"KH00)9Y3L3W3S3CI]$
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M6&E9C_3:T&)EA]Q<:!R9=IGC+0C2..#WA1!Z8Y@ [;TZ^@M02P,$%     @
MQH!85(,Z(QY-!0  7!<  !D   !X;"]W;W)K<VAE971S+W-H965T.#,N>&UL
MG5AI;]LX$/TKA(%=N$!KB_218Y, B95V VP/)-T#6.P'6AK;0B32):DX^?<[
ME!3);BBR*1#$NMX,YY$S\\BSG53W>@-@R&.1"WT^V!BS/1V/=;*!@NN1W(+
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M%9.6VP=W ](-&<RH0%L-;4G;AW-$4Y5)VY:148/Q\()X*(\KRN,3ZPCZC4A
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MA&_!#]\$4,!4=8:N;K0\E,?0M=1PJ"TO]YQMN#(&\'XKI7Z_,2?;^C\9\_\
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MC:H%028DHT6P4D#C-'^2Y\*(@P#//1+@%0&>T9T3&95](DF[R=D6N-ZMT/3
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M50LUPTA]M"#7&]3[)6-R-]$$Y6=0^S=02P,$%     @ QH!85.PU_XF9!
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MM\B=&Y[^+_/B"HJ)7%.N@.'*N+::-R:R+,9ZL=%BZR;C4F@S9]UR8VY"E-;
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M6%UOHS@4_2M6- ^MM"W8!@.C-%*:=#I]:!HEF=UG!YP$#>"L<9KI:'_\FH]
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M$-,$S+?,#VDD/\!\)]:A3Z..,GL5MG>U307-VFW-"[=5"?!)4!/9"*.&\)I
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M%LJAH33G;&4C*/G=%OS0"7X0@05G*I+@CH4T? ]@Z&"KB-%;Q+>H%W%&@QN
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( ,: 6%1%'D-^[@   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,: 6%297)PC$ 8  )PG   3
M      "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ QH!8
M5/),JC=F!@  JQD  !@              ("!#0@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( ,: 6%2P'D+$(P(  'D%   8
M      " @:D.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M" #&@%A4V"^>,*(%  "*%0  &               @($"$0  >&PO=V]R:W-H
M965T<R]S:&5E=#,N>&UL4$L! A0#%     @ QH!85$,Y>Q: !   _ X  !@
M             ("!VA8  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4
M Q0    ( ,: 6%0@7,F0? <  .\>   8              " @9 ;  !X;"]W
M;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " #&@%A4X!(<#AD#  !K
M"0  &               @(%"(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL
M4$L! A0#%     @ QH!85)ZJW$D "@  .BL  !@              ("!D28
M 'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( ,: 6%0AYBI+
M-@@   TJ   8              " @<<P  !X;"]W;W)K<VAE971S+W-H965T
M."YX;6Q02P$"% ,4    " #&@%A4 CZ"XK<#  #G!P  &
M@($S.0  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ QH!8
M5&.W)SZE*@  PH0  !D              ("!(#T  'AL+W=O<FMS:&5E=',O
M<VAE970Q,"YX;6Q02P$"% ,4    " #&@%A46QI0*Z,+  "8'@  &0
M        @('\9P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0
M   ( ,: 6%3':EGY8!4  +]+   9              " @=9S  !X;"]W;W)K
M<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ QH!85'T'?GJ\$0  JS<
M !D              ("!;8D  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q0
M2P$"% ,4    " #&@%A4XTA1P$$3   O10  &0              @(%@FP
M>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( ,: 6%18):CE
M70P  (,C   9              " @=BN  !X;"]W;W)K<VAE971S+W-H965T
M,34N>&UL4$L! A0#%     @ QH!85.7NO\DZ!0  :0P  !D
M ("!;+L  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #&
M@%A4%5N0YE\-  !')0  &0              @('=P   >&PO=V]R:W-H965T
M<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( ,: 6%2(N55*YPL  !XA   9
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M970R,BYX;6Q02P$"% ,4    " #&@%A44.;1B[ &  #6$   &0
M    @('Z^0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    (
M ,: 6%1&35VC@P<  /@0   9              " @>$  0!X;"]W;W)K<VAE
M971S+W-H965T,C0N>&UL4$L! A0#%     @ QH!85/M20-D4!   \0D  !D
M             ("!FP@! 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"
M% ,4    " #&@%A49)X$?UXV  "EP@  &0              @('F# $ >&PO
M=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( ,: 6%1/1Y[SD 4
M !X,   9              " @7M# 0!X;"]W;W)K<VAE971S+W-H965T,C<N
M>&UL4$L! A0#%     @ QH!85-B?AO%"!0  + P  !D              ("!
M0DD! 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " #&@%A4
M+3!S6CH%  #"#0  &0              @(&[3@$ >&PO=V]R:W-H965T<R]S
M:&5E=#(Y+GAM;%!+ 0(4 Q0    ( ,: 6%1W6?MGC ,   8(   9
M      " @2Q4 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%
M  @ QH!85-?)%*2@"   -QL  !D              ("![U<! 'AL+W=O<FMS
M:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " #&@%A4QE"GO=<%  #1$0
M&0              @('&8 $ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+
M 0(4 Q0    ( ,: 6%24OXN,+P8  !H/   9              " @=1F 0!X
M;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ QH!85!=BT)8?
M!@  SQ   !D              ("!.FT! 'AL+W=O<FMS:&5E=',O<VAE970S
M-"YX;6Q02P$"% ,4    " #&@%A4_Y=.)VX$   D"P  &0
M@(&0<P$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( ,:
M6%1USK5S( @  "$4   9              " @35X 0!X;"]W;W)K<VAE971S
M+W-H965T,S8N>&UL4$L! A0#%     @ QH!85.6ET <E P  +@<  !D
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M=#0Q+GAM;%!+ 0(4 Q0    ( ,: 6%34_&5EI@(  'H&   9
M  " @469 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @
MQH!85%VXI34B!@  TR(  !D              ("!(IP! 'AL+W=O<FMS:&5E
M=',O<VAE970T,RYX;6Q02P$"% ,4    " #&@%A4QL1D?9$#   D#   &0
M            @(%[H@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4
M Q0    ( ,: 6%07%,&:V (  !L'   9              " @4.F 0!X;"]W
M;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ QH!85(D6IQ*@ P
MNA4  !D              ("!4JD! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX
M;6Q02P$"% ,4    " #&@%A4Z):@LU<#   8"@  &0              @($I
MK0$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( ,: 6%3K
M&M_*300  #$1   9              " @;>P 0!X;"]W;W)K<VAE971S+W-H
M965T-#@N>&UL4$L! A0#%     @ QH!85$GL&+.< P  IPL  !D
M     ("!.[4! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,: 6%0A4)IK)0H  %(X   9              "
M@37/ 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ QH!8
M5%[#NI.[ @  Q0@  !D              ("!D=D! 'AL+W=O<FMS:&5E=',O
M<VAE970U-2YX;6Q02P$"% ,4    " #&@%A4E"\&ST "  ",!0  &0
M        @(&#W $ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0
M   ( ,: 6%0P06L)P 4  )TD   9              " @?K> 0!X;"]W;W)K
M<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ QH!85,*"-?ZI!@  ,2,
M !D              ("!\>0! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q0
M2P$"% ,4    " #&@%A4/FMEO?T%   \)   &0              @('1ZP$
M>&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( ,: 6%2WS68;
MI 8  (PK   9              " @07R 0!X;"]W;W)K<VAE971S+W-H965T
M-C N>&UL4$L! A0#%     @ QH!85&L49EPW!@  &B8  !D
M ("!X/@! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " #&
M@%A4M%FU-O8%  #Y'@  &0              @(%._P$ >&PO=V]R:W-H965T
M<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( ,: 6%2%Y5FAPP,  %P,   9
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M970V-RYX;6Q02P$"% ,4    " #&@%A4M7W-+7$'   \*   &0
M    @(&6' ( >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    (
M ,: 6%1(\]38- ,  !4*   9              " @3XD @!X;"]W;W)K<VAE
M971S+W-H965T-CDN>&UL4$L! A0#%     @ QH!85)%[G=%_!   H!$  !D
M             ("!J2<" 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"
M% ,4    " #&@%A4"F8SQ<0$   *%@  &0              @(%?+ ( >&PO
M=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( ,: 6%1:^)!"/P,
M ! )   9              " @5HQ @!X;"]W;W)K<VAE971S+W-H965T-S(N
M>&UL4$L! A0#%     @ QH!85&5%WD79 @  X <  !D              ("!
MT#0" 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"% ,4    " #&@%A4
M+6!A;LD$  #<$@  &0              @('@-P( >&PO=V]R:W-H965T<R]S
M:&5E=#<T+GAM;%!+ 0(4 Q0    ( ,: 6%1G1H#1A0(  )@&   9
M      " @> \ @!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%
M  @ QH!85$3%40@8!   E T  !D              ("!G#\" 'AL+W=O<FMS
M:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " #&@%A4A=#1*H,"   ]!@
M&0              @('K0P( >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+
M 0(4 Q0    ( ,: 6%3(ZPV@'@0  "0.   9              " @:5& @!X
M;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ QH!85*Y]PK=P
M P  S0L  !D              ("!^DH" 'AL+W=O<FMS:&5E=',O<VAE970W
M.2YX;6Q02P$"% ,4    " #&@%A4*%$X*[4"  "3!@  &0
M@(&A3@( >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( ,:
M6%1C^347-00  (L1   9              " @8U1 @!X;"]W;W)K<VAE971S
M+W-H965T.#$N>&UL4$L! A0#%     @ QH!85%233?O% @  8P<  !D
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M=#@V+GAM;%!+ 0(4 Q0    ( ,: 6%1?2'R5  ,  #@)   9
M  " @0EM @!X;"]W;W)K<VAE971S+W-H965T.#<N>&UL4$L! A0#%     @
MQH!85-W24Q:^ P  $PT  !D              ("!0' " 'AL+W=O<FMS:&5E
M=',O<VAE970X."YX;6Q02P$"% ,4    " #&@%A45:2XN\ "   8!P  &0
M            @($U= ( >&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4
M Q0    ( ,: 6%3FD)N8'@4  #T8   9              " @2QW @!X;"]W
M;W)K<VAE971S+W-H965T.3 N>&UL4$L! A0#%     @ QH!85*:/90S= @
M$@D  !D              ("!@7P" 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX
M;6Q02P$"% ,4    " #&@%A4[#7_B9D$  "<$P  &0              @(&5
M?P( >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;%!+ 0(4 Q0    ( ,: 6%1Q
M+WS=V (  &<'   9              " @66$ @!X;"]W;W)K<VAE971S+W-H
M965T.3,N>&UL4$L! A0#%     @ QH!85'SC@$^! @  ZP4  !D
M     ("!=(<" 'AL+W=O<FMS:&5E=',O<VAE970Y-"YX;6Q02P$"% ,4
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M  #O%P  #0              @ $YEP( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( ,: 6%27BKL<P    !,"   +              "  >&: @!?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( ,: 6%1HMS2DO08  !M    /              "
M <J; @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #&@%A4M"E^S,("   *
M.0  &@              @ &TH@( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " #&@%A4C,4FGTX"   G-P  $P              @ &N
LI0( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     :0!I -8<   MJ (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>485</ContextCount>
  <ElementCount>691</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>153</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/BUSINESS</Role>
      <ShortName>BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2115104 - Disclosure - ACQUISITIONS AND DIVESTITURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURES</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2122105 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2127106 - Disclosure - DERIVATIVE INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTS</Role>
      <ShortName>DERIVATIVE INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2135107 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2140108 - Disclosure - TREASURY STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/TREASURYSTOCK</Role>
      <ShortName>TREASURY STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2142109 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2149110 - Disclosure - RETIREMENT BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANS</Role>
      <ShortName>RETIREMENT BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2157111 - Disclosure - LEASES AND RELATED PARTY LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASES</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2163112 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2171113 - Disclosure - NET INCOME PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARE</Role>
      <ShortName>NET INCOME PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2175114 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2179115 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2183116 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2188117 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/ACQUISITIONSANDDIVESTITURES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2323304 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBT</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2328305 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2336306 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2343307 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2350308 - Disclosure - RETIREMENT BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANS</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2358309 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/LEASESANDRELATEDPARTYLEASES</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2364310 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXES</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2372311 - Disclosure - NET INCOME PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARETables</Role>
      <ShortName>NET INCOME PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/NETINCOMEPERSHARE</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2376312 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2380313 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2384314 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - ACQUISITIONS AND DIVESTITURES (Business Acquisition, Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES (Business Acquisition, Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - ACQUISITIONS AND DIVESTITURES (Asset Acquisition, Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES (Asset Acquisition, Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2424414 - Disclosure - DEBT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTNarrativeDetails</Role>
      <ShortName>DEBT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBTTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2425415 - Disclosure - DEBT (Maximum Total Leverage Ratio Table) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails</Role>
      <ShortName>DEBT (Maximum Total Leverage Ratio Table) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBTTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2426416 - Disclosure - DEBT (Schedule of Debt Maturity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTScheduleofDebtMaturityDetails</Role>
      <ShortName>DEBT (Schedule of Debt Maturity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBTTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2429417 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2430418 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2431419 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2432420 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2433421 - Disclosure - DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2434422 - Disclosure - DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2437423 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2438424 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2439425 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2441426 - Disclosure - TREASURY STOCK - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/TREASURYSTOCKNarrativeDetails</Role>
      <ShortName>TREASURY STOCK - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2444427 - Disclosure - STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2445428 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2446429 - Disclosure - STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2447430 - Disclosure - STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2448431 - Disclosure - STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2451432 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2452433 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2453434 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2454435 - Disclosure - RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2455436 - Disclosure - RETIREMENT BENEFIT PLANS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2456437 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2459438 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2460439 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2461440 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2462441 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2465442 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2466443 - Disclosure - INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2467444 - Disclosure - INCOME TAXES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2468445 - Disclosure - INCOME TAXES (Schedule of Provision for Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Provision for Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2469446 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2470447 - Disclosure - INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2473448 - Disclosure - NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails</Role>
      <ShortName>NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/NETINCOMEPERSHARETables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2474449 - Disclosure - NET INCOME PER SHARE (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails</Role>
      <ShortName>NET INCOME PER SHARE (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/NETINCOMEPERSHARETables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2477450 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2478451 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2481452 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>2482453 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>2485454 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>2486455 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>2487456 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="iart-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>2489457 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS</ParentRole>
      <Position>97</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="iart-20211231.htm">iart-20211231.htm</File>
    <File>iart-20211231.xsd</File>
    <File>iart-20211231_cal.xml</File>
    <File>iart-20211231_def.xml</File>
    <File>iart-20211231_lab.xml</File>
    <File>iart-20211231_pre.xml</File>
    <File>iart-20211231xexx211.htm</File>
    <File>iart-20211231xexx231.htm</File>
    <File>iart-20211231xexx311.htm</File>
    <File>iart-20211231xexx312.htm</File>
    <File>iart-20211231xexx321.htm</File>
    <File>iart-20211231xexx322.htm</File>
    <File>iart-20211231xexx44.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>iart-20211231_g1.jpg</File>
    <File>iart-20211231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="1515">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>120
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "iart-20211231.htm": {
   "axisCustom": 1,
   "axisStandard": 43,
   "contextCount": 485,
   "dts": {
    "calculationLink": {
     "local": [
      "iart-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "iart-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "iart-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "iart-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iart-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "iart-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 969,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 15,
    "http://integralife.com/20211231": 1,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 20
   },
   "keyCustom": 94,
   "keyStandard": 597,
   "memberCustom": 71,
   "memberStandard": 81,
   "nsprefix": "iart",
   "nsuri": "http://integralife.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://integralife.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115104 - Disclosure - ACQUISITIONS AND DIVESTITURES",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURES",
     "shortName": "ACQUISITIONS AND DIVESTITURES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122105 - Disclosure - DEBT",
     "role": "http://integralife.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127106 - Disclosure - DERIVATIVE INSTRUMENTS",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTS",
     "shortName": "DERIVATIVE INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135107 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140108 - Disclosure - TREASURY STOCK",
     "role": "http://integralife.com/role/TREASURYSTOCK",
     "shortName": "TREASURY STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142109 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149110 - Disclosure - RETIREMENT BENEFIT PLANS",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANS",
     "shortName": "RETIREMENT BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157111 - Disclosure - LEASES AND RELATED PARTY LEASES",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASES",
     "shortName": "LEASES AND RELATED PARTY LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://integralife.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163112 - Disclosure - INCOME TAXES",
     "role": "http://integralife.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2171113 - Disclosure - NET INCOME PER SHARE",
     "role": "http://integralife.com/role/NETINCOMEPERSHARE",
     "shortName": "NET INCOME PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2175114 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2179115 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2183116 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2188117 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "role": "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables",
     "shortName": "ACQUISITIONS AND DIVESTITURES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323304 - Disclosure - DEBT (Tables)",
     "role": "http://integralife.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328305 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables",
     "shortName": "DERIVATIVE INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336306 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343307 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350308 - Disclosure - RETIREMENT BENEFIT PLANS (Tables)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSTables",
     "shortName": "RETIREMENT BENEFIT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358309 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables",
     "shortName": "LEASES AND RELATED PARTY LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364310 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://integralife.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2372311 - Disclosure - NET INCOME PER SHARE (Tables)",
     "role": "http://integralife.com/role/NETINCOMEPERSHARETables",
     "shortName": "NET INCOME PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2376312 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2380313 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2384314 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxLiabilitiesNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i11696c20228346ddb295ad994c1d9416_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxLiabilitiesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i7337997e50724c52ad9348740bdd50dd_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i7337997e50724c52ad9348740bdd50dd_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "if319a53d6ce443d0adc847fb824d705d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "if319a53d6ce443d0adc847fb824d705d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ieb65637da52f4b90bf607fb7b60c210d_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfBusiness",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i3269a9a9d0024d43b9f980a0524d7c42_I20210104",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i53b2addcbddb44aa9a3b86029bb50420_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details)",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i53b2addcbddb44aa9a3b86029bb50420_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - ACQUISITIONS AND DIVESTITURES (Business Acquisition, Narrative) (Details)",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES (Business Acquisition, Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ica517bcfa6884ebc90de2aca64243203_D20210120-20210120",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ib985a5fa452f42faa4085adbfafaedf0_I20210120",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentInProcess",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - ACQUISITIONS AND DIVESTITURES (Asset Acquisition, Narrative) (Details)",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES (Asset Acquisition, Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ib718aecc355a42c295a29f73509ea5eb_D20210104-20210104",
      "decimals": "-5",
      "lang": "en-US",
      "name": "iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SecuredDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424414 - Disclosure - DEBT (Narrative) (Details)",
     "role": "http://integralife.com/role/DEBTNarrativeDetails",
     "shortName": "DEBT (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "iart:InterestPaymentsYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i6c66ebe266dc49ae8c7b140c34de1997_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:DebtInstrumentCovenantMaximumLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425415 - Disclosure - DEBT (Maximum Total Leverage Ratio Table) (Details)",
     "role": "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
     "shortName": "DEBT (Maximum Total Leverage Ratio Table) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i6c66ebe266dc49ae8c7b140c34de1997_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:DebtInstrumentCovenantMaximumLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426416 - Disclosure - DEBT (Schedule of Debt Maturity) (Details)",
     "role": "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails",
     "shortName": "DEBT (Schedule of Debt Maturity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ia0dbe85e1e664ae9ac6dc86a82263629_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429417 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i241736141ce5441cbaf9b7d07be1bd2b_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430418 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i9f291ee98dcc4db0b65295c7cc02b534_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i0ed96b4baeca485d88d732479d36ee6f_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431419 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "icb8fbe23f0de4b438088a04ce4c7f7cc_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i0ed96b4baeca485d88d732479d36ee6f_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432420 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i940998b020714fa3b0888d72a26c1945_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i0ed96b4baeca485d88d732479d36ee6f_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433421 - Disclosure - DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i447e91e51b6c484fb722708a563e3022_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "if319a53d6ce443d0adc847fb824d705d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434422 - Disclosure - DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ida54b96ca0584539ae3b3b157470910b_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437423 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "if319a53d6ce443d0adc847fb824d705d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438424 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i488c668ed69943629b8567d269181e0c_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillTransfers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439425 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441426 - Disclosure - TREASURY STOCK - Narrative (Details)",
     "role": "http://integralife.com/role/TREASURYSTOCKNarrativeDetails",
     "shortName": "TREASURY STOCK - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444427 - Disclosure - STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445428 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "STOCK-BASED COMPENSATION (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446429 - Disclosure - STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "if319a53d6ce443d0adc847fb824d705d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447430 - Disclosure - STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iaa6e6cac04eb43cfbe239e917800016c_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448431 - Disclosure - STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iaa6e6cac04eb43cfbe239e917800016c_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451432 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452433 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "if319a53d6ce443d0adc847fb824d705d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453434 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454435 - Disclosure - RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFundedStatusOfPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455436 - Disclosure - RETIREMENT BENEFIT PLANS (Narrative) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456437 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "renewal_option",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459438 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "renewal_option",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460439 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i2c98fd68510e48b4a3b8d493e99cff78_I20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ibca422d8af654309ab3549894c22e2d0_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ibca422d8af654309ab3549894c22e2d0_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:CashFlowLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461440 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:CashFlowLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462441 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465442 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails",
     "shortName": "INCOME TAXES (Schedule of Income Before Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466443 - Disclosure - INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails",
     "shortName": "INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467444 - Disclosure - INCOME TAXES (Narrative) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468445 - Disclosure - INCOME TAXES (Schedule of Provision for Income Taxes) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails",
     "shortName": "INCOME TAXES (Schedule of Provision for Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469446 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "if319a53d6ce443d0adc847fb824d705d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470447 - Disclosure - INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails",
     "shortName": "INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ifcaf1fbc6c2145ac92ae58dce7c7f40b_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473448 - Disclosure - NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)",
     "role": "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails",
     "shortName": "NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474449 - Disclosure - NET INCOME PER SHARE (Narrative) (Details)",
     "role": "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails",
     "shortName": "NET INCOME PER SHARE (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BUSINESS",
     "role": "http://integralife.com/role/BUSINESS",
     "shortName": "BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "if319a53d6ce443d0adc847fb824d705d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2477450 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2478451 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ia65ff802a8ad4a8eadd83dd25409c85b_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i2eab101e6425464cb1a382b10930b341_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2481452 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ie6092d39074b47158db64e1a12d8002f_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ia320d69e30b449ea850f977af47c941a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2482453 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ia320d69e30b449ea850f977af47c941a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2485454 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ifc5c0e4c8dc94d87aa7a82a466be543e_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "iart:SegmentReportingInformationNumberOfProductsOffered",
      "reportCount": 1,
      "unique": true,
      "unitRef": "product",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2486455 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee33c44f27cc4e77b072623b9ba9c96b_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i37632302c2864aada6356f5aeb73834f_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2487456 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "iee25a280ce1a41fe94147173b06ec1d5_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "i901487c914b2405ba16f79b4bc6b4d8e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2489457 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "role": "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "iart-20211231.htm",
      "contextRef": "ied8b91f481774dfe8fc8d278e1b3b31d_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 153,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States (Includes long-lived assets in Puerto Rico)"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Smaller Reporting Company"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "iart_ACellIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ACell, Inc.",
        "label": "ACell, Inc. [Member]",
        "terseLabel": "ACell, Inc."
       }
      }
     },
     "localname": "ACellIncMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ACellMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ACell",
        "label": "ACell [Member]",
        "terseLabel": "ACell"
       }
      }
     },
     "localname": "ACellMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased",
        "label": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased",
        "terseLabel": "Accelerated share repurchases, percentage of expected total repurchased"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_AcceleratedShareRepurchasesSharesReceivedAtInception": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases. Shares Received at Inception",
        "label": "Accelerated Share Repurchases. Shares Received at Inception",
        "terseLabel": "Accelerated share repurchases, shares received at inception"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSharesReceivedAtInception",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_AccruedExpensesAndOtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses and other current liabilities.",
        "label": "Accrued Expenses And Other Current Liabilities [Member]",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AccumulatedOtherComprehensiveIncomeLossRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossRollForward",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_AcquiredFinitelivedIntangibleAssetsDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired Finite-lived Intangible Assets, Discount Rate",
        "label": "Acquired Finite-lived Intangible Assets, Discount Rate",
        "terseLabel": "Acquired intangible assets, discount rate"
       }
      }
     },
     "localname": "AcquiredFinitelivedIntangibleAssetsDiscountRate",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_AdditionalEPSShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the basic and diluted calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares",
        "label": "Additional EPS Shares",
        "terseLabel": "Additional EPS shares (in shares)"
       }
      }
     },
     "localname": "AdditionalEPSShares",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_AllOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Other [Member]",
        "label": "All Other [Member]",
        "terseLabel": "All other"
       }
      }
     },
     "localname": "AllOtherMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees",
        "label": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees",
        "terseLabel": "Amortization of debt issuance costs and expenses associated with debt refinancing"
       }
      }
     },
     "localname": "AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AnnualRateOfLeaseAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rate of lease agreement.",
        "label": "Annual Rate Of Lease Agreement",
        "terseLabel": "Annual rate of lease agreement"
       }
      }
     },
     "localname": "AnnualRateOfLeaseAgreement",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ArkisBioSciencesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arkis BioSciences Inc. [Member]",
        "label": "Arkis BioSciences Inc. [Member]",
        "terseLabel": "Arkis"
       }
      }
     },
     "localname": "ArkisBioSciencesInc.Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Assets Acquired And Liabilities Assumed, Net",
        "label": "Asset Acquisition, Assets Acquired And Liabilities Assumed, Net",
        "terseLabel": "Remaining net assets acquired"
       }
      }
     },
     "localname": "AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Development Milestone Payment",
        "label": "Asset Acquisition, Development Milestone Payment To Be Paid",
        "terseLabel": "Development milestone payment, to be paid"
       }
      }
     },
     "localname": "AssetAcquisitionDevelopmentMilestonePaymentToBePaid",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Maximum Contingent Development Milestone Payments",
        "label": "Asset Acquisition, Maximum Contingent Development Milestone Payments, If Circumstances Met",
        "terseLabel": "Contingent development milestone payments commitment (up to)"
       }
      }
     },
     "localname": "AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met",
        "label": "Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met",
        "terseLabel": "Maximum future purchase price, if circumstances met (not to exceed)"
       }
      }
     },
     "localname": "AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AssetAcquisitionNumberOfAssetsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Number Of Assets Acquired",
        "label": "Asset Acquisition, Number Of Assets Acquired",
        "terseLabel": "Number of assets acquired"
       }
      }
     },
     "localname": "AssetAcquisitionNumberOfAssetsAcquired",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met",
        "label": "Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met",
        "terseLabel": "Option to acquire, period subsequent to first commercial sale"
       }
      }
     },
     "localname": "AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://integralife.com/20211231",
     "xbrltype": "stringItemType"
    },
    "iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Intangible Asset Acquired, Discount Rate",
        "label": "Business Combination, Intangible Asset Acquired, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "BusinessCombinationIntangibleAssetAcquiredDiscountRate",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Current Portion of Lease Liability, Operating Leases",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Current Portion of Lease Liability, Operating Leases",
        "terseLabel": "Current portion of lease liability - operating leases"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability, Operating Leases",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability, Operating Leases",
        "terseLabel": "Lease liability - operating leases"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Asset, Operating Leases",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Asset, Operating Leases",
        "terseLabel": "Right of use asset - operating leases"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationWorkingCapitalAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Working Capital Adjustment",
        "label": "Business Combination, Working Capital Adjustment",
        "terseLabel": "Working capital adjustment"
       }
      }
     },
     "localname": "BusinessCombinationWorkingCapitalAdjustment",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Abstract]",
        "label": "Cash Flow, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_CashFlowLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Table Text Block]",
        "label": "Cash Flow, Lessee [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowLesseeTableTextBlock",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_CertainPurchasersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain Purchasers [Member]",
        "label": "Certain Purchasers [Member]",
        "terseLabel": "Certain Purchasers"
       }
      }
     },
     "localname": "CertainPurchasersMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ChangeInContractWithCustomerAssetRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract With Customer, Asset [Roll Forward]",
        "label": "Change In Contract With Customer, Asset [Roll Forward]",
        "terseLabel": "Contract Asset"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerAssetRollForward",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_ChangeInContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract With Customer, Liability [Roll Forward]",
        "label": "Change In Contract With Customer, Liability [Roll Forward]",
        "terseLabel": "Contract Liability"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityRollForward",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_CharitableContributions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charitable contributions",
        "label": "Charitable contributions",
        "terseLabel": "Contributions to Integra Foundation"
       }
      }
     },
     "localname": "CharitableContributions",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CodmanSpecialtySurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Codman Specialty Surgical [Member]",
        "label": "Codman Specialty Surgical [Member]",
        "terseLabel": "Codman Specialty Surgical"
       }
      }
     },
     "localname": "CodmanSpecialtySurgicalMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CompletedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Completed technology.",
        "label": "Completed Technology [Member]",
        "terseLabel": "Completed technology"
       }
      }
     },
     "localname": "CompletedTechnologyMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ConcentrationRiskNumberofCustomersOverBenchmark": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Number of Customers Over Benchmark",
        "label": "Concentration Risk, Number of Customers Over Benchmark",
        "terseLabel": "Concentration risk, number of customers over benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskNumberofCustomersOverBenchmark",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_ConcentrationRiskThresholdPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Threshold Percentage",
        "label": "Concentration Risk, Threshold Percentage",
        "terseLabel": "Concentration risk, threshold percentage"
       }
      }
     },
     "localname": "ConcentrationRiskThresholdPercentage",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_ConsortiumofFocusedOrthopedistsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consortium of Focused Orthopedists, LLC [Member]",
        "label": "Consortium of Focused Orthopedists, LLC [Member]",
        "terseLabel": "Consortium of Focused Orthopedists, LLC"
       }
      }
     },
     "localname": "ConsortiumofFocusedOrthopedistsLLCMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ContingentConsiderationLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration Liability [Member]",
        "label": "Contingent Consideration Liability [Member]",
        "terseLabel": "Contingent Consideration Liability"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset, Net Of Reclassified To Receivable",
        "label": "Contract With Customer, Asset, Net Of Reclassified To Receivable",
        "terseLabel": "Contract asset, net of transferred to trade receivables on contracts during the period"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetOfReclassifiedToReceivable",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Increase From Foreign Currency Translation",
        "label": "Contract With Customer, Liability, Increase From Foreign Currency Translation",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation",
        "label": "Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation",
        "terseLabel": "Contract liability, net of revenue recognized on contracts during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.",
        "label": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CrossCurrencyInterestRateContractFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Four [Member]",
        "label": "Cross Currency Interest Rate Contract Four [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap Four"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractFourMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract One [Member]",
        "label": "Cross Currency Interest Rate Contract One [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap One"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractOneMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Three [Member]",
        "label": "Cross Currency Interest Rate Contract Three [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap Three"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractThreeMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Two [Member]",
        "label": "Cross Currency Interest Rate Contract Two [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap Two"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractTwoMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateSwapContractOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Swap, Contract One",
        "label": "Cross Currency Interest Rate Swap, Contract One [Member]",
        "terseLabel": "Cross Currency Interest Rate Swap, Contract One"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateSwapContractOneMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateSwapContractThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Swap, Contract Three",
        "label": "Cross Currency Interest Rate Swap, Contract Three [Member]",
        "terseLabel": "Cross Currency Interest Rate Swap, Contract Three"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateSwapContractThreeMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateSwapContractTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Swap, Contract Two",
        "label": "Cross Currency Interest Rate Swap, Contract Two [Member]",
        "terseLabel": "Cross Currency Interest Rate Swap, Contract Two"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateSwapContractTwoMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification",
        "label": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification",
        "label": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 1 [Member]",
        "label": "Debt Covenant Period 1 [Member]",
        "terseLabel": "Execution of July 2020 Amendment through June 30, 2021"
       }
      }
     },
     "localname": "DebtCovenantPeriod1Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 2 [Member]",
        "label": "Debt Covenant Period 2 [Member]",
        "terseLabel": "September 30, 2021 through June 30, 2022"
       }
      }
     },
     "localname": "DebtCovenantPeriod2Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 3 [Member]",
        "label": "Debt Covenant Period 3 [Member]",
        "terseLabel": "September 30, 2022 through June 30, 2023"
       }
      }
     },
     "localname": "DebtCovenantPeriod3Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 4 [Member]",
        "label": "Debt Covenant Period 4 [Member]",
        "terseLabel": "September 30, 2023 and the last day of each fiscal quarter thereafter"
       }
      }
     },
     "localname": "DebtCovenantPeriod4Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Axis]",
        "terseLabel": "Debt Covenant Period [Axis]"
       }
      }
     },
     "localname": "DebtCovenantPeriodAxis",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_DebtCovenantPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Domain]",
        "terseLabel": "Debt Covenant Period [Domain]"
       }
      }
     },
     "localname": "DebtCovenantPeriodDomain",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount",
        "label": "Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount",
        "terseLabel": "Combination settlement for debt conversion, minimum settled in cash per principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DebtInstrumentCovenantMaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Maximum Leverage Ratio",
        "label": "Debt Instrument, Covenant, Maximum Leverage Ratio",
        "terseLabel": "Debt Instrument, Covenant, Maximum Leverage Ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaximumLeverageRatio",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "iart_DebtInstrumentMaximumAverageConversionValueOfNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Average Conversion Value Of Notes",
        "label": "Debt Instrument, Maximum Average Conversion Value Of Notes",
        "terseLabel": "Maximum average conversion value of notes"
       }
      }
     },
     "localname": "DebtInstrumentMaximumAverageConversionValueOfNotes",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period",
        "label": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period",
        "terseLabel": "Maximum selling price of the company's common stock of the conversion price"
       }
      }
     },
     "localname": "DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DebtWeightedAverageInterestRateFromSecuritization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt, Weighted Average Interest Rate, From Securitization",
        "label": "Debt, Weighted Average Interest Rate, From Securitization",
        "terseLabel": "Security facility, weighted average interest rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRateFromSecuritization",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DeferredTaxAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset [Member]",
        "label": "Deferred Tax Asset [Member]",
        "terseLabel": "Deferred Tax Asset"
       }
      }
     },
     "localname": "DeferredTaxAssetMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DeferredTaxAssetsLeasesAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Leases And Other",
        "label": "Deferred Tax Assets, Leases And Other",
        "terseLabel": "Leases and Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeasesAndOther",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation",
        "terseLabel": "Accrued vacation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development",
        "terseLabel": "Capitalization of research and development expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxLiabilitiesLeasesAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Leases And Other",
        "label": "Deferred Tax Liabilities, Leases And Other",
        "negatedLabel": "Leases and Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasesAndOther",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DefinedBenefitPlanBenefitObligationPremiumsPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Premiums Paid",
        "label": "Defined Benefit Plan, Benefit Obligation, Premiums Paid",
        "negatedTerseLabel": "Premiums paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationPremiumsPaid",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage",
        "label": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage",
        "terseLabel": "Defer payment and taxation, base salary, percentage (up to)"
       }
      }
     },
     "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage",
        "label": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage",
        "terseLabel": "Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)"
       }
      }
     },
     "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DefinedBenefitPlanPlanAssetsPremiumsPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Premiums Paid",
        "label": "Defined Benefit Plan, Plan Assets, Premiums Paid",
        "negatedLabel": "Premiums paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsPremiumsPaid",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.",
        "label": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DermaSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derma Sciences [Member]",
        "label": "Derma Sciences [Member]",
        "terseLabel": "Derma Sciences"
       }
      }
     },
     "localname": "DermaSciencesMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DirectorsandCertainExecutiveOfficersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors and Certain Executive Officers [Member]",
        "label": "Directors and Certain Executive Officers [Member]",
        "terseLabel": "Directors and Certain Executive Officers"
       }
      }
     },
     "localname": "DirectorsandCertainExecutiveOfficersMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Lease Liability, Current",
        "label": "Disposal Group, Including Discontinued Operation, Lease Liability, Current",
        "terseLabel": "Current portion of lease liability - operating leases"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Lease Liability, Noncurrent",
        "label": "Disposal Group, Including Discontinued Operation, Lease Liability, Noncurrent",
        "terseLabel": "Lease liability - operating leases"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination",
        "label": "Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination",
        "terseLabel": "Sale of Extremity Orthopedics business, payment for terminating license agreement"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Right of Use Asset Operating Leases and Other Assets",
        "label": "Disposal Group, Including Discontinued Operation, Right of Use Asset Operating Leases and Other Assets",
        "terseLabel": "Right of use asset-operating leases and Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Transitional Supply Agreement, Payable",
        "label": "Disposal Group, Including Discontinued Operation, Transitional Supply Agreement, Payable",
        "terseLabel": "Transitional supply agreement, payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Foreign Income Tax Rate Reconciliation, Continuing Operations",
        "label": "Effective Foreign Income Tax Rate Reconciliation, Continuing Operations",
        "terseLabel": "Effective foreign income tax rate"
       }
      }
     },
     "localname": "EffectiveForeignIncomeTaxRateReconciliationContinuingOperations",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 16.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent",
        "terseLabel": "Gain from sale of business - book to tax differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent",
        "negatedTerseLabel": "Intercompany profit in inventory"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "terseLabel": "Deferred income tax benefit, transfer intra-entity intellectual property, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "terseLabel": "Income tax benefit, transfer intra-entity intellectual property, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent",
        "terseLabel": "Nondeductible executive compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent",
        "terseLabel": "Nondeductible facilitative costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Per Share",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Per Share",
        "terseLabel": "Federal tax credit (in dollars per share)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Global Intangible Low-Taxed Income, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Global Intangible Low-Taxed Income, Percent",
        "terseLabel": "Global intangible low-taxed income (\"GILTI\")"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent",
        "terseLabel": "Fair market value step up on intra-entity transfer of intellectual property"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Worldwide Income Tax Rate Reconciliation, Percent",
        "label": "Effective Worldwide Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective worldwide tax rate"
       }
      }
     },
     "localname": "EffectiveWorldwideIncomeTaxRateReconciliationPercent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee [Member]",
        "label": "Employee [Member]",
        "terseLabel": "Employee"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_EmployeeStockPurchasePlanProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds received from employees in connection with the employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan Proceeds",
        "terseLabel": "ESPP proceeds received"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanProceeds",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ExtremityOrthopedicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extremity Orthopedics [Member]",
        "label": "Extremity Orthopedics [Member]",
        "terseLabel": "Extremity Orthopedics"
       }
      }
     },
     "localname": "ExtremityOrthopedicsMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/INCOMETAXESNarrativeDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current",
        "terseLabel": "Transfers from long-term to current portion"
       }
      }
     },
     "localname": "FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_FiveYearLeasePeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Year Lease Period Two",
        "label": "Five Year Lease Period Two [Member]",
        "terseLabel": "Five Year Option Lease From November 1, 2034 Through October 31, 2039"
       }
      }
     },
     "localname": "FiveYearLeasePeriodTwoMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FiveYearOptionLeasePeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Year Option Lease Period One",
        "label": "Five Year Option Lease Period One [Member]",
        "terseLabel": "Five Year Option Lease From November 1, 2029 Through October 31, 2034"
       }
      }
     },
     "localname": "FiveYearOptionLeasePeriodOneMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FoundationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foundation [Policy Text Block].",
        "label": "Foundation [Policy Text Block]",
        "terseLabel": "Integra Foundation"
       }
      }
     },
     "localname": "FoundationPolicyTextBlock",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_FranceAndGermanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "France and Germany [Member]",
        "label": "France and Germany [Member]",
        "terseLabel": "France and Germany"
       }
      }
     },
     "localname": "FranceAndGermanyMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress",
        "label": "Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress",
        "negatedLabel": "Loss on disposal of property and equipment and construction in-progress"
       }
      }
     },
     "localname": "GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_IncomeTaxLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax [Line Items]",
        "label": "Income Tax [Line Items]",
        "terseLabel": "Income Tax [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxLineItems",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_IncomeTaxTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax [Table]",
        "label": "Income Tax [Table]",
        "terseLabel": "Income Tax [Table]"
       }
      }
     },
     "localname": "IncomeTaxTable",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_IncreaseInAuthorizedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in the number of authorized shares under the Plan.",
        "label": "Increase In Authorized Shares",
        "terseLabel": "Increase in authorized shares (in shares)"
       }
      }
     },
     "localname": "IncreaseInAuthorizedShares",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_InformationSystemsandHardwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information Systems and Hardware [Member]",
        "label": "Information Systems and Hardware [Member]",
        "terseLabel": "Information systems and hardware"
       }
      }
     },
     "localname": "InformationSystemsandHardwareMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments [Member]",
        "label": "Instruments [Member]",
        "terseLabel": "Instruments"
       }
      }
     },
     "localname": "InstrumentsMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_IntegratedShoulderCollaborationInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Integrated Shoulder Collaboration, Inc. [Member]",
        "label": "Integrated Shoulder Collaboration, Inc. [Member]",
        "terseLabel": "ISC"
       }
      }
     },
     "localname": "IntegratedShoulderCollaborationInc.Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_IntercompanyLoanQuarterlyPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intercompany Loan, Quarterly Payment",
        "label": "Intercompany Loan, Quarterly Payment",
        "terseLabel": "Intercompany loan, quarterly payment"
       }
      }
     },
     "localname": "IntercompanyLoanQuarterlyPayment",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Year Four",
        "label": "Interest Payments, Year Four",
        "terseLabel": "Interest payments, year four"
       }
      }
     },
     "localname": "InterestPaymentsYearFour",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Year One",
        "label": "Interest Payments, Year One",
        "terseLabel": "Interest payments, year one"
       }
      }
     },
     "localname": "InterestPaymentsYearOne",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Year Three",
        "label": "Interest Payments, Year Three",
        "terseLabel": "Interest payments, year three"
       }
      }
     },
     "localname": "InterestPaymentsYearThree",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Year Two",
        "label": "Interest Payments, Year Two",
        "terseLabel": "Interest payments, year two"
       }
      }
     },
     "localname": "InterestPaymentsYearTwo",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche1Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche2Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 3"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche3Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 1",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche1Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 2",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche2Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember182018Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember182018Tranche1Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember182018Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember182018Tranche2Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedMarch272017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated March 27, 2017 [Member]",
        "label": "Interest Rate Swap Designated March 27, 2017 [Member]",
        "terseLabel": "Interest Rate Swap Designated March 27, 2017"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedMarch272017Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche1Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche2Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 3"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche3Member",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InventoryCapitalizedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Capitalized Expenses",
        "label": "Inventory, Capitalized Expenses",
        "terseLabel": "Inventory, capitalized expenses"
       }
      }
     },
     "localname": "InventoryCapitalizedExpenses",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_LesseeOperatingLeaseNumberOfRenewalOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Number Of Renewal Options",
        "label": "Lessee, Operating Lease, Number Of Renewal Options",
        "terseLabel": "Number of renewal options (or more)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNumberOfRenewalOptions",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_MilestonePaymentOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment One [Member]",
        "label": "Milestone Payment One [Member]",
        "terseLabel": "Milestone Payment One"
       }
      }
     },
     "localname": "MilestonePaymentOneMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_MilestonePaymentTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment Two [Member]",
        "label": "Milestone Payment Two [Member]",
        "terseLabel": "Milestone Payment Two"
       }
      }
     },
     "localname": "MilestonePaymentTwoMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_NetWorkingCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Working Capital",
        "label": "Net Working Capital",
        "terseLabel": "Net working capital"
       }
      }
     },
     "localname": "NetWorkingCapital",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_NeurosurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neurosurgery [Member]",
        "label": "Neurosurgery [Member]",
        "terseLabel": "Neurosurgery"
       }
      }
     },
     "localname": "NeurosurgeryMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_NoncashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Lease Expense",
        "label": "Noncash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "NoncashLeaseExpense",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_NoncashOrPartNoncashInProcessResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Or Part Noncash, In Process Research And Development",
        "label": "Noncash Or Part Noncash, In Process Research And Development",
        "terseLabel": "Non-cash in-process research and development expense"
       }
      }
     },
     "localname": "NoncashOrPartNoncashInProcessResearchAndDevelopment",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_OneMonthEurodollarRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Month Eurodollar Rate [Member]",
        "label": "One Month Eurodollar Rate [Member]",
        "terseLabel": "One-Month Eurodollar Rate"
       }
      }
     },
     "localname": "OneMonthEurodollarRateMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_OneMonthUSDLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Month USD LIBOR [Member]",
        "label": "One Month USD LIBOR [Member]",
        "terseLabel": "1-month USD LIBOR Loan"
       }
      }
     },
     "localname": "OneMonthUSDLIBORMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_OptionToExtendLeaseYears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option to extend lease, years.",
        "label": "Option To Extend Lease, Years",
        "terseLabel": "Option to extend lease, years"
       }
      }
     },
     "localname": "OptionToExtendLeaseYears",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_PaymentsForOptionIndexToIssuersEquity": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Options Indexed to Issuer's Equity",
        "label": "Payments For Option Index To Issuers Equity",
        "negatedLabel": "Purchase of option hedge on convertible notes",
        "verboseLabel": "Cost of call transactions"
       }
      }
     },
     "localname": "PaymentsForOptionIndexToIssuersEquity",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PaymentsForProceedsFromBusinessAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For (Proceeds From) Business Acquisitions",
        "label": "Payments For (Proceeds From) Business Acquisitions",
        "negatedTerseLabel": "Cash paid for business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsForProceedsFromBusinessAcquisitions",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire In Process Research And Development And Intangible Assets",
        "label": "Payments To Acquire In Process Research And Development And Intangible Assets",
        "negatedLabel": "Acquired in-process research and development and intangibles"
       }
      }
     },
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director",
        "label": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director",
        "terseLabel": "Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director"
       }
      }
     },
     "localname": "PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_PerformanceSharesandRestrictedUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Shares and Restricted Units",
        "label": "Performance Shares and Restricted Units [Member]",
        "terseLabel": "Performance Shares and Restricted Units"
       }
      }
     },
     "localname": "PerformanceSharesandRestrictedUnitsMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_PerformanceStockandContractStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Stock and Contract Stock [Member]",
        "label": "Performance Stock and Contract Stock [Member]",
        "terseLabel": "Performance Stock and Contract Stock Awards"
       }
      }
     },
     "localname": "PerformanceStockandContractStockMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_PrivateLabelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Label [Member]",
        "label": "Private Label [Member]",
        "terseLabel": "Private Label"
       }
      }
     },
     "localname": "PrivateLabelMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ReboundTherapeuticsCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rebound Therapeutics Corporation [Member]",
        "label": "Rebound Therapeutics Corporation [Member]",
        "terseLabel": "Rebound"
       }
      }
     },
     "localname": "ReboundTherapeuticsCorporationMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RegenerativeSkinAndWoundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regenerative Skin And Wound [Member]",
        "label": "Regenerative Skin And Wound [Member]",
        "terseLabel": "Wound Reconstruction and Care"
       }
      }
     },
     "localname": "RegenerativeSkinAndWoundMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RelatedPartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Parties [Member]",
        "label": "Related Parties [Member]",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "RelatedPartiesMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RestOfWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from rest of the world.",
        "label": "Rest Of World [Member]",
        "terseLabel": "Rest of the World"
       }
      }
     },
     "localname": "RestOfWorldMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RestrictedStockPerformanceStockAndContractStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock, performance stock and contract stock member",
        "label": "Restricted Stock, Performance Stock, And Contract Stock [Member]",
        "terseLabel": "Restricted Stock, Performance Stock and Contract Stock"
       }
      }
     },
     "localname": "RestrictedStockPerformanceStockAndContractStockMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Return Policy, Issue of Credit, Number of Days from Shipment",
        "label": "Return Policy, Issue Of Credit, Number Of Days From Shipment",
        "terseLabel": "Number of days from shipment to issue a credit on returned goods"
       }
      }
     },
     "localname": "ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period",
        "label": "Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period",
        "terseLabel": "Manufacturing period for products shipped with no alternative use and right of payment for performance"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RevenueProductWarrantyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Product Warranty Period",
        "label": "Revenue, Product Warranty Period",
        "terseLabel": "Product warranty period (up to)"
       }
      }
     },
     "localname": "RevenueProductWarrantyPeriod",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "label": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "ROU assets obtained in exchange for lease liabilities:"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_ScheduleOfAssetAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule Of Asset Acquisition [Table]",
        "label": "Schedule Of Asset Acquisition [Line Items]",
        "terseLabel": "Schedule Of Asset Acquisition [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAssetAcquisitionLineItems",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_ScheduleOfAssetAcquisitionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Asset Acquisition [Table]",
        "label": "Schedule Of Asset Acquisition [Table]",
        "terseLabel": "Schedule Of Asset Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfAssetAcquisitionTable",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_SecuredLongTermDebtSecuritizationProgram": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Long-Term Debt, Securitization Program",
        "label": "Secured Long-Term Debt, Securitization Program",
        "terseLabel": "Secured long-term debt, securitization program"
       }
      }
     },
     "localname": "SecuredLongTermDebtSecuritizationProgram",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SecuredLongTermDebtSecuritizationProgramCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Long-Term Debt, Securitization Program, Current",
        "label": "Secured Long-Term Debt, Securitization Program, Current",
        "terseLabel": "Current portion of borrowings under securitization facility"
       }
      }
     },
     "localname": "SecuredLongTermDebtSecuritizationProgramCurrent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SecuredLongTermDebtSecuritizationProgramNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Long-Term Debt, Securitization Program, Noncurrent",
        "label": "Secured Long-Term Debt, Securitization Program, Noncurrent",
        "terseLabel": "Long-term borrowings under securitization facility"
       }
      }
     },
     "localname": "SecuredLongTermDebtSecuritizationProgramNoncurrent",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SecuritizationFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securitization Facility, Fair Value Of Amount Outstanding",
        "label": "Securitization Facility, Fair Value Of Amount Outstanding",
        "terseLabel": "Securitization facility, fair value of amount outstanding"
       }
      }
     },
     "localname": "SecuritizationFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SegmentReportingInformationNumberOfProductsOffered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of products sold by a segment",
        "label": "Segment Reporting Information, Number Of Products Offered",
        "terseLabel": "Number of products offered (more than)"
       }
      }
     },
     "localname": "SegmentReportingInformationNumberOfProductsOffered",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_SeniorCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Credit Facility.",
        "label": "Senior Credit Facility [Member]",
        "terseLabel": "Senior Credit Facility"
       }
      }
     },
     "localname": "SeniorCreditFacilityMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested But Not Issued In Period",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested But Not Issued In Period",
        "terseLabel": "Vested but not issued (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares",
        "terseLabel": "Adjustments for performance achievement related to award target (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value",
        "terseLabel": "Adjustments for performance achievement related to award target (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period",
        "negatedLabel": "Vested but not released (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested but not released (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iart_SmithNephewUSDLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smith &amp; Nephew USD Limited [Member]",
        "label": "Smith &amp; Nephew USD Limited [Member]",
        "terseLabel": "Smith &amp; Nephew USD Limited"
       }
      }
     },
     "localname": "SmithNephewUSDLimitedMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_SupplierRelationShipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Relation Ships [Member]",
        "label": "Supplier Relation Ships [Member]",
        "terseLabel": "Supplier relationships"
       }
      }
     },
     "localname": "SupplierRelationShipsMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SurgicalInstrumentKitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Instrument Kits [Member]",
        "label": "Surgical Instrument Kits [Member]",
        "terseLabel": "Surgical instrument kits"
       }
      }
     },
     "localname": "SurgicalInstrumentKitsMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SwinglineLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swingline Loan [Member]",
        "label": "Swingline Loan [Member]",
        "terseLabel": "Swingline Loan"
       }
      }
     },
     "localname": "SwinglineLoanMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ThirdPartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Parties [Member]",
        "label": "Third Parties [Member]",
        "verboseLabel": "Third Parties"
       }
      }
     },
     "localname": "ThirdPartiesMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TissueTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tissue Technologies [Member]",
        "label": "Tissue Technologies [Member]",
        "terseLabel": "Tissue Technologies"
       }
      }
     },
     "localname": "TissueTechnologiesMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TrademarksBrandNamesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks Brand Names.",
        "label": "Trademarks Brand Names [Member]",
        "terseLabel": "Trademarks/brand names"
       }
      }
     },
     "localname": "TrademarksBrandNamesMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit",
        "label": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit",
        "terseLabel": "Securitization facility, outstanding borrowings, maximum limit"
       }
      }
     },
     "localname": "TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_TwoThousandOnePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand One Plan [Member]",
        "label": "Two Thousand One Plan [Member]",
        "terseLabel": "2001 Plan"
       }
      }
     },
     "localname": "TwoThousandOnePlanMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TwoThousandPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Plan [Member]",
        "label": "Two Thousand Plan [Member]",
        "terseLabel": "2000 Plan"
       }
      }
     },
     "localname": "TwoThousandPlanMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TwoThousandThreePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand three Plan [Member]",
        "label": "Two Thousand Three Plan [Member]",
        "terseLabel": "2003 Plan"
       }
      }
     },
     "localname": "TwoThousandThreePlanMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty Five Senior Convertible Notes [Member]",
        "label": "Two Thousand Twenty Five Senior Convertible Notes [Member]",
        "terseLabel": "2025 Notes"
       }
      }
     },
     "localname": "TwoThousandTwentyFiveSeniorConvertibleNotesMember",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increases During Period [Abstract]",
        "label": "Unrecognized Tax Benefits, Increases During Period [Abstract]",
        "terseLabel": "Gross increases:"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_UnrecognizedTaxBenefitsReductionsResultingFromOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Reductions Resulting From Other",
        "label": "Unrecognized Tax Benefits, Reductions Resulting From Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromOther",
     "nsuri": "http://integralife.com/20211231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r504",
      "r787",
      "r788",
      "r790",
      "r900",
      "r915"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An affiliate is a party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the entity.",
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Affiliated Entity"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Asia Pacific.",
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r160",
      "r225",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r245",
      "r249",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r353",
      "r355",
      "r356",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r160",
      "r225",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r245",
      "r249",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r353",
      "r355",
      "r356",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r78",
      "r80",
      "r157",
      "r158",
      "r364",
      "r402",
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r173",
      "r181",
      "r187",
      "r275",
      "r588",
      "r589",
      "r590",
      "r632",
      "r633",
      "r726",
      "r729",
      "r731",
      "r732",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r173",
      "r181",
      "r187",
      "r275",
      "r588",
      "r589",
      "r590",
      "r632",
      "r633",
      "r726",
      "r729",
      "r731",
      "r732",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r173",
      "r181",
      "r187",
      "r275",
      "r588",
      "r589",
      "r590",
      "r632",
      "r633",
      "r726",
      "r729",
      "r731",
      "r732",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r363",
      "r401",
      "r539",
      "r543",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r806",
      "r862",
      "r865",
      "r901",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r363",
      "r401",
      "r539",
      "r543",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r806",
      "r862",
      "r865",
      "r901",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProFormaMember": {
     "auth_ref": [
      "r187",
      "r335",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported based on historical fact adjusted for potential activity. Includes, but is not limited to, information expected to be reported in future period for effect on historical fact. Excludes forecast information.",
        "label": "Pro Forma [Member]",
        "terseLabel": "Pro Forma"
       }
      }
     },
     "localname": "ProFormaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r252",
      "r440",
      "r444",
      "r810",
      "r861",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r252",
      "r440",
      "r444",
      "r810",
      "r861",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r363",
      "r401",
      "r476",
      "r539",
      "r543",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r806",
      "r862",
      "r865",
      "r901",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r363",
      "r401",
      "r476",
      "r539",
      "r543",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r806",
      "r862",
      "r865",
      "r901",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r79",
      "r80",
      "r157",
      "r158",
      "r364",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r182",
      "r540",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r182",
      "r187",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r168",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r253",
      "r254",
      "r440",
      "r445",
      "r864",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r914",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r253",
      "r254",
      "r440",
      "r445",
      "r864",
      "r886",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r914",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r182",
      "r187",
      "r335",
      "r540",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r258",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r166",
      "r167",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt",
        "terseLabel": "Accelerated share repurchase program, receipt (payment)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r174",
      "r175",
      "r176",
      "r177",
      "r269",
      "r270",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r342",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r632",
      "r633",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r786",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r28",
      "r58"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable, trade"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r25",
      "r40",
      "r259",
      "r260"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, net of allowances of $4,735 and $6,439"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionExpense": {
     "auth_ref": [
      "r319",
      "r320",
      "r322"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion Expense",
        "terseLabel": "Accretion of bond issuance discount"
       }
      }
     },
     "localname": "AccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r85",
      "r90",
      "r99",
      "r100",
      "r101",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Pension Items"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r56",
      "r312"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r90",
      "r99",
      "r100",
      "r101",
      "r102",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Gains and Losses on Derivatives"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r43",
      "r87",
      "r89",
      "r90",
      "r851",
      "r873",
      "r877"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r99",
      "r100",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r86",
      "r90",
      "r99",
      "r100",
      "r101",
      "r170",
      "r171",
      "r172",
      "r681",
      "r868",
      "r869",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r82",
      "r90",
      "r99",
      "r100",
      "r101",
      "r681",
      "r757",
      "r758",
      "r759",
      "r760",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Items"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted Average Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r41",
      "r591",
      "r793"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r588",
      "r589",
      "r590",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r137",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Share repurchase and equity component of the convertible note issuance, net"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r545",
      "r547",
      "r594",
      "r595"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r547",
      "r579",
      "r593"
     ],
     "calculation": {
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "netLabel": "Share-based compensation expense recognized",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Net effect on net income"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r47",
      "r265",
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r118",
      "r137",
      "r383",
      "r767"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r111",
      "r137",
      "r383",
      "r769"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Incremental financing cost expense"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r137",
      "r291",
      "r300"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization",
        "verboseLabel": "Intangible asset amortization"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Shares excluded from computation as their effect would be antidilutive (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "auth_ref": [
      "r669",
      "r670",
      "r671",
      "r672"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Consideration Transferred",
        "terseLabel": "Upfront payment"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r152",
      "r233",
      "r240",
      "r247",
      "r271",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r677",
      "r683",
      "r744",
      "r791",
      "r793",
      "r830",
      "r848"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r26",
      "r27",
      "r75",
      "r152",
      "r271",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r677",
      "r683",
      "r744",
      "r791",
      "r793"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r17",
      "r20",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Total assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r17",
      "r20",
      "r309",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r549",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]",
        "verboseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r693",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis Of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and building improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Leased facilities"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r536",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r536",
      "r541",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]",
        "verboseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r659",
      "r660",
      "r662"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase price of business combination"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r136",
      "r666"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent consideration and others"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh": {
     "auth_ref": [
      "r667"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any change recognized during the period in the high-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High",
        "terseLabel": "Maximum undiscounted payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r658",
      "r661",
      "r664"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent consideration, liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": {
     "auth_ref": [
      "r651",
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability",
        "terseLabel": "Contingent consideration, fair value"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaids expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r651",
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 8.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r651",
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other long-term liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r651",
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r22",
      "r169",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "BUSINESS"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/BUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CallOptionMember": {
     "auth_ref": [
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.",
        "label": "Call Option [Member]",
        "terseLabel": "Call Option"
       }
      }
     },
     "localname": "CallOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r142",
      "r143",
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Property and equipment purchases included in liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r23",
      "r53",
      "r139"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r30",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash And Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r133",
      "r139",
      "r145"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r133",
      "r755"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging",
        "verboseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant strike price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r331",
      "r332",
      "r333",
      "r336",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r170",
      "r171",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized shares (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r39",
      "r793"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock; $0.01 par value; 240,000 authorized shares; 89,600 and 89,251 issued at December\u00a031, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r94",
      "r96",
      "r97",
      "r108",
      "r838",
      "r857"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r107",
      "r121",
      "r837",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r214",
      "r215",
      "r256",
      "r742",
      "r743",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r214",
      "r215",
      "r256",
      "r742",
      "r743",
      "r878",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r214",
      "r215",
      "r256",
      "r742",
      "r743",
      "r878",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r210",
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration Of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r214",
      "r215",
      "r256",
      "r742",
      "r743",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r147",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles Of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Changes in Contract Assets and Contract Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r417",
      "r419",
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Contract asset, End of Period",
        "periodStartLabel": "Contract asset, Beginning of period"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.",
        "label": "Contract with Customer, Asset, Reclassified to Receivable",
        "negatedTerseLabel": "Transferred to trade receivable of contract asset included in beginning of the year contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetReclassifiedToReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r417",
      "r418",
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Contract liability, End of Period",
        "periodStartLabel": "Contract liability, Beginning of Period"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r417",
      "r418",
      "r441"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Contract liabilities",
        "verboseLabel": "Short-term portion of contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r417",
      "r418",
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Long-term portion of contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedLabel": "Recognition of revenue included in beginning of year contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r35",
      "r833",
      "r850"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt",
        "terseLabel": "Convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r358",
      "r360",
      "r361",
      "r363",
      "r373",
      "r374",
      "r375",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r393",
      "r394",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Long-term convertible securities"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r249",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r114",
      "r810"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of product technology"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r325",
      "r326",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Employee Termination Benefits"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r477",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap",
        "verboseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r153",
      "r626",
      "r636"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r153",
      "r626"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r153",
      "r626",
      "r636",
      "r638"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r153",
      "r626",
      "r636"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r213",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r150",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r377",
      "r384",
      "r385",
      "r387",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r151",
      "r160",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r393",
      "r394",
      "r395",
      "r396",
      "r770",
      "r831",
      "r833",
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rates available to the company at its option"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Debt proceeds, classified as equity at time of offering"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r362",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "verboseLabel": "Initial conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r64",
      "r362",
      "r404",
      "r405",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "verboseLabel": "Initial conversion rate"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r360",
      "r393",
      "r394",
      "r768",
      "r770",
      "r771"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Convertible notes, aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r375",
      "r393",
      "r394",
      "r741"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r63",
      "r391",
      "r768",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r63",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt, interest rate",
        "verboseLabel": "Convertible notes, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r65",
      "r151",
      "r160",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r393",
      "r394",
      "r395",
      "r396",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r65",
      "r151",
      "r160",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r386",
      "r393",
      "r394",
      "r395",
      "r396",
      "r404",
      "r406",
      "r407",
      "r408",
      "r767",
      "r768",
      "r770",
      "r771",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r373",
      "r767",
      "r771"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate on debt"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Deferred compensation plan, fair value of assets"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r153",
      "r627",
      "r636"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r769"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Capitalized incremental financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r153",
      "r627",
      "r636"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r602",
      "r603"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r137",
      "r153",
      "r627",
      "r636",
      "r637",
      "r638"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred",
        "verboseLabel": "Deferred income tax (benefit) provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r36",
      "r37",
      "r617",
      "r832",
      "r846"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r602",
      "r603"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities",
        "verboseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r153",
      "r627",
      "r636"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.",
        "label": "Deferred Tax Assets, Charitable Contribution Carryforwards",
        "terseLabel": "Charitable contributions carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsCharitableContributionCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r618"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory related items"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r620"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r620"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets after valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r623",
      "r624",
      "r625"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "verboseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses",
        "terseLabel": "Accrued bonus"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.",
        "label": "Deferred Tax Assets, Unrealized Currency Losses",
        "terseLabel": "Unrealized foreign exchange loss"
       }
      }
     },
     "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r619"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Intangible and fixed assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": {
     "auth_ref": [
      "r90",
      "r497"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax",
        "terseLabel": "Gain (loss) recognized within accumulated other comprehensive loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r467",
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Actuarial (gain) loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r453",
      "r492",
      "r521",
      "r527",
      "r528"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Recognized actuarial losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r453",
      "r493",
      "r522",
      "r527",
      "r528"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Amortization of prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount": {
     "auth_ref": [
      "r510"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of defined benefit plan asset expected to be returned to employer within one year or operating cycle, if longer, following current fiscal year.",
        "label": "Defined Benefit Plan, Plan Assets, Expected to be Returned to Employer, Amount",
        "terseLabel": "Plan assets expected to be returned next twelve months"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r501",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate",
        "terseLabel": "Interest crediting rate for cash balance plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r455"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Projected benefit obligations, end of year",
        "periodStartLabel": "Projected benefit obligations, beginning of year",
        "terseLabel": "Benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r462",
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefit payment"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Employee contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation": {
     "auth_ref": [
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in benefit obligation of defined benefit plan from business combination.",
        "label": "Defined Benefit Plan, Benefit Obligation, Business Combination",
        "terseLabel": "Plans transferred in"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change In Projected Benefit Obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change In Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r469",
      "r477",
      "r479",
      "r525",
      "r527",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "netLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Next five years"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r487",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Contributions expected to be paid to plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r453",
      "r491",
      "r520",
      "r527",
      "r528"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r466",
      "r477",
      "r479",
      "r480",
      "r527"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Plan assets at fair value, end of year",
        "periodStartLabel": "Plan assets at fair value, beginning of year",
        "terseLabel": "Benefit plans, assets",
        "verboseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effect of foreign currency exchange rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r452",
      "r475",
      "r527"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "negatedTotalLabel": "Unfunded benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]",
        "terseLabel": "Reconciliation Of Funded Status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlanAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r453",
      "r458",
      "r490",
      "r519",
      "r527",
      "r528"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost",
        "verboseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r488",
      "r517",
      "r527",
      "r528"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net period benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "terseLabel": "Plan amendments"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r471",
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r470"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Employee contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effect of foreign currency exchange rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r454",
      "r495",
      "r524"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r456",
      "r489",
      "r518",
      "r527",
      "r528"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "negatedTerseLabel": "Plan settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedLabel": "Plan settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r534"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Total contributions made"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r137",
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]",
        "verboseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r77",
      "r80",
      "r81",
      "r696",
      "r805"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Total derivatives designated as hedges \u2014 Assets",
        "verboseLabel": "Derivative fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r77",
      "r80",
      "r81",
      "r696",
      "r805"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Total derivatives designated as hedges \u2014 Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r741"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair Value Asset (Liability)",
        "verboseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Fixed Rate",
        "verboseLabel": "Fixed Interest Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r80",
      "r694",
      "r697",
      "r703",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]",
        "verboseLabel": "Derivative, by Nature [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r721",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r691",
      "r694",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r691",
      "r694",
      "r703",
      "r708",
      "r709",
      "r713",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r686",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "netLabel": "Notional Amount",
        "terseLabel": "Aggregate Notional Amount",
        "verboseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r685",
      "r687",
      "r688",
      "r691",
      "r692",
      "r699",
      "r703",
      "r710",
      "r712",
      "r716",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r159",
      "r685",
      "r687",
      "r691",
      "r692",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "CerebroFlo developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r440",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r308",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Aggregate purchase price received"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r309",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r536",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/INCOMETAXESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r109",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r188",
      "r190",
      "r195",
      "r196",
      "r197",
      "r201",
      "r202",
      "r732",
      "r733",
      "r839",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "netLabel": "Basic net income per common share (in dollars per share)",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "Basic net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r109",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r190",
      "r195",
      "r196",
      "r197",
      "r201",
      "r202",
      "r732",
      "r733",
      "r839",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "netLabel": "Diluted net income per common share (in dollars per share)",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "verboseLabel": "Diluted net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r755"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r605"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails",
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Increase (decrease) in income taxes resulting from:"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r155",
      "r605",
      "r640"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r605",
      "r640"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "auth_ref": [
      "r605",
      "r640"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent",
        "terseLabel": "Nondeductible meals and entertainment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment": {
     "auth_ref": [
      "r605",
      "r640"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent",
        "terseLabel": "Nondeductible R&amp;D expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r605",
      "r640"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r605",
      "r640"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Return to provision"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r596",
      "r605"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent",
        "terseLabel": "Excess tax benefits from stock compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r605",
      "r640"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r605",
      "r640"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "Research and development credit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays": {
     "auth_ref": [
      "r605",
      "r640"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income exempt from income tax because of a tax holiday.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Holiday, Percent",
        "negatedTerseLabel": "Swiss tax holiday"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxHolidays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Capitalized share-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation costs related to unvested awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for cost recognition, in years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Total estimated tax benefit related to stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Tax benefit realized from stock options exercised"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r99",
      "r100",
      "r101",
      "r170",
      "r171",
      "r172",
      "r175",
      "r184",
      "r186",
      "r207",
      "r275",
      "r403",
      "r409",
      "r588",
      "r589",
      "r590",
      "r632",
      "r633",
      "r731",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r762",
      "r868",
      "r869",
      "r870",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar Rate"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtendedProductWarrantyPolicy": {
     "auth_ref": [
      "r334",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.",
        "label": "Extended Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "ExtendedProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r375",
      "r393",
      "r394",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r527",
      "r735",
      "r796",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r739",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r375",
      "r393",
      "r394",
      "r477",
      "r479",
      "r484",
      "r527",
      "r735",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r375",
      "r393",
      "r394",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r527",
      "r735",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r736",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r736",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Contingent Consideration"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r737"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "verboseLabel": "Change in fair value of contingent consideration liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r738"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Additions from acquisition of ACell"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r736"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, End of Period",
        "periodStartLabel": "Balance, Beginning of Period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r375",
      "r393",
      "r394",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r527",
      "r796",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r693",
      "r699",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Overnight Federal Funds Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r783"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "terseLabel": "Future minimum lease payments, finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted Average Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r299"
     ],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Expected annual amortization expense, thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Expected annual amortization expense, 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Expected annual amortization expense, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Expected annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Expected annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Expected annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r292",
      "r295",
      "r299",
      "r303",
      "r811",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r292",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r753",
      "r754"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "terseLabel": "Foreign currency transaction gain (loss)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignEarningsRepatriated": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign earnings repatriated from subsidiaries outside the country of domicile.",
        "label": "Foreign Earnings Repatriated",
        "terseLabel": "Tax impact of repatriating foreign earnings"
       }
      }
     },
     "localname": "ForeignEarningsRepatriated",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Currency Forward Contract"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r535",
      "r537",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture, fixtures, and office equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r694"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "terseLabel": "Gain (loss) recognized in other income"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives": {
     "auth_ref": [
      "r694",
      "r700"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of foreign currency derivatives and nonderivative instruments designated as fair value hedging instruments which were recognized in earnings, net of offsets by the gain (loss) on the hedged item to the extent that the fair value hedge was determined to be effective.",
        "label": "Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives",
        "negatedTerseLabel": "Loss recorded, settlement of derivative"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyFairValueHedgeDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r137",
      "r682"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain from the sale of business",
        "terseLabel": "Gain from sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r283",
      "r284",
      "r793",
      "r829"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 9.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "ACell Acquisition"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r288",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill And Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Transfer to assets held for sale"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r691",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r137",
      "r304"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Non-cash impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r137",
      "r307"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Write off of construction in progress"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "IPR&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r154",
      "r639"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r105",
      "r233",
      "r239",
      "r243",
      "r246",
      "r249",
      "r828",
      "r835",
      "r841",
      "r859"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r154",
      "r639"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r536",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/INCOMETAXESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r16",
      "r18",
      "r19",
      "r20",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r314",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r155",
      "r606",
      "r615",
      "r622",
      "r634",
      "r641",
      "r645",
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r607"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Penalties and interest accrued"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r185",
      "r186",
      "r231",
      "r604",
      "r635",
      "r643",
      "r860"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision (benefit) for income taxes",
        "totalLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r98",
      "r600",
      "r601",
      "r615",
      "r616",
      "r621",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Amount",
        "terseLabel": "Tax expense related to sale of business"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Effective income tax rate reconciliation, foreign income tax rate differential, increase (decrease), amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "negatedTerseLabel": "Excess tax benefits from stock compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsForeign": {
     "auth_ref": [
      "r605"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount",
        "terseLabel": "Federal tax credit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r134",
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r136",
      "r807"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r197"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options and restricted stock (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r294",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r294",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r290",
      "r297"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "verboseLabel": "Intangible asset"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCapitalizationPolicyPolicyTextBlock": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for interest capitalization.",
        "label": "Interest Capitalization, Policy [Policy Text Block]",
        "terseLabel": "Capitalized Interest"
       }
      }
     },
     "localname": "InterestCapitalizationPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestCostsCapitalizedAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest costs capitalized disclosed as an adjusting item to interest costs incurred.",
        "label": "Interest Costs Capitalized Adjustment",
        "terseLabel": "Interest expense capitalized into property, plant, and equipment"
       }
      }
     },
     "localname": "InterestCostsCapitalizedAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r103",
      "r227",
      "r765",
      "r769",
      "r840"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r118",
      "r381",
      "r392",
      "r395",
      "r396"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r120",
      "r382",
      "r395",
      "r396"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Cash interest"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about interest income have been included.",
        "label": "Interest Income [Member]",
        "terseLabel": "Interest income",
        "verboseLabel": "Interest Income"
       }
      }
     },
     "localname": "InterestIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidCapitalized": {
     "auth_ref": [
      "r126",
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.",
        "label": "Interest Paid, Capitalized, Investing Activities",
        "terseLabel": "Interest paid, capitalized into construction in progress"
       }
      }
     },
     "localname": "InterestPaidCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r717"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Gain (loss) estimated to be reclassified to earnings during next twelve months"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "netLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "verboseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r24",
      "r73",
      "r793"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r29",
      "r74",
      "r148",
      "r206",
      "r280",
      "r281",
      "r282",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "verboseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "verboseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r117",
      "r226"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Maturities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r783"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r783"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r783"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r783"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r783"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r783"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r783"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r783"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee, Operating Lease, Option to Extend",
        "terseLabel": "Period for extended lease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES AND RELATED PARTY LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r60",
      "r152",
      "r241",
      "r271",
      "r343",
      "r344",
      "r345",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r678",
      "r683",
      "r684",
      "r744",
      "r791",
      "r792"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r46",
      "r152",
      "r271",
      "r744",
      "r793",
      "r834",
      "r853"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r62",
      "r152",
      "r271",
      "r343",
      "r344",
      "r345",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r678",
      "r683",
      "r684",
      "r744",
      "r791",
      "r792",
      "r793"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r17",
      "r20",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Total liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r15",
      "r17",
      "r20",
      "r309",
      "r315"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Enabling technology license"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r35",
      "r833",
      "r847"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Line of credit facility outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of credit, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r741"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Line of credit facility, fair value of amount outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates an ownership position in, or purchase of, a security.",
        "label": "Long [Member]",
        "terseLabel": "Long"
       }
      }
     },
     "localname": "LongMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r35",
      "r374",
      "r389",
      "r393",
      "r394",
      "r833",
      "r850"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Principal Repayment"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r160",
      "r340",
      "r379"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r160",
      "r340",
      "r379"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r160",
      "r340",
      "r379"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r160",
      "r340",
      "r379"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r65",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and production equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r21",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "ACQUISITIONS AND DIVESTITURES"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r133",
      "r135",
      "r138"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r20",
      "r92",
      "r95",
      "r101",
      "r106",
      "r138",
      "r152",
      "r174",
      "r179",
      "r180",
      "r181",
      "r182",
      "r185",
      "r186",
      "r194",
      "r233",
      "r239",
      "r243",
      "r246",
      "r249",
      "r271",
      "r343",
      "r344",
      "r345",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r733",
      "r744",
      "r836",
      "r855"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging",
        "verboseLabel": "Net Investment Hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r181",
      "r187",
      "r201",
      "r269",
      "r270",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r342",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r630",
      "r631",
      "r632",
      "r633",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r786",
      "r812",
      "r813",
      "r814",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Total long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r90",
      "r102"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive gain (loss)"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r233",
      "r239",
      "r243",
      "r246",
      "r249"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r775"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r774"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r774"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "netLabel": "Less: Current lease liabilities",
        "terseLabel": "Current portion of lease liability - operating leases",
        "verboseLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r774"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "netLabel": "Long-term lease liabilities",
        "terseLabel": "Lease liability - operating leases",
        "verboseLabel": "Non-current lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r776",
      "r779"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r773"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right of use asset - operating leases",
        "verboseLabel": "ROU assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r782",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r781",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r623"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityEquityAxis": {
     "auth_ref": [
      "r399",
      "r718",
      "r719",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of options indexed to an issuer's equity.",
        "label": "Option Indexed to Issuer's Equity [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityEquityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityStrikePrice1": {
     "auth_ref": [
      "r398",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.",
        "label": "Option Indexed to Issuer's Equity, Strike Price",
        "verboseLabel": "Initial strike price (in dollars per share)"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityStrikePrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r693",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax [Abstract]",
        "terseLabel": "Unrealized gain (loss) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r675",
      "r676",
      "r680"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent",
        "terseLabel": "Change in foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r675",
      "r676",
      "r680"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive gain (loss), before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, before tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent",
        "totalLabel": "Unrealized gain (loss) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r83",
      "r87",
      "r695",
      "r701",
      "r715"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "netLabel": "Gain (loss) recorded in AOCL, change in fair value",
        "terseLabel": "Unrealized derivative gain (loss) arising during period",
        "verboseLabel": "Amount\u00a0of Gain (Loss) Recognized\u00a0in AOCL"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r87",
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "verboseLabel": "Amount\u00a0of\u00a0Gain\u00a0(Loss) Reclassified from AOCL into Earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r87",
      "r91",
      "r702"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Less: Reclassification adjustments for gain (loss) included in net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gain (loss) recorded, net investment hedge, change in fair value"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r93",
      "r96",
      "r675",
      "r676",
      "r680"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive gain (loss), net of tax",
        "verboseLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r84",
      "r87",
      "r496"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Defined benefit pension plan - net gain (loss) arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r88",
      "r99",
      "r107",
      "r604",
      "r642",
      "r644",
      "r756",
      "r759",
      "r762",
      "r837",
      "r856"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTerseLabel": "Income tax (expense) benefit related to items in other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r115",
      "r137",
      "r310"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpenseMember": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other expense.",
        "label": "Other Expense [Member]",
        "terseLabel": "Other Income, Net"
       }
      }
     },
     "localname": "OtherExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r693",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other liabilities",
        "verboseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "terseLabel": "Payment for contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Payments for (Proceeds from) Derivative Instrument, Investing Activities",
        "negatedTerseLabel": "Net proceeds (payments) on swaps designated as net investment hedges"
       }
      }
     },
     "localname": "PaymentsForProceedsFromDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Cash taxes paid in net equity settlement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r125",
      "r663"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "terseLabel": "Upfront payment, intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r476",
      "r478",
      "r484",
      "r503",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r527",
      "r529",
      "r532",
      "r534",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "RETIREMENT BENEFIT PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r511",
      "r530",
      "r531",
      "r534",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r549",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockNoParValue": {
     "auth_ref": [
      "r38",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, No Par Value",
        "terseLabel": "Preferred Stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, authorized shares (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred Stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r38",
      "r793"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred Stock; no par value; 15,000 authorized shares; none outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r26",
      "r51",
      "r52"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "verboseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Collection of Notes Receivable",
        "terseLabel": "Proceeds from note receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from convertible notes issuance",
        "verboseLabel": "Net proceeds from offering of convertible senior notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of Extremity Orthopedics Business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from borrowings of long-term indebtedness"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r127",
      "r583"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Cash received from option exercises and employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds from sale of stock purchase warrants",
        "verboseLabel": "Proceeds from warrant transactions"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sales of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r127",
      "r583"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercised stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r56",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment by Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r55",
      "r311"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r31",
      "r32",
      "r313",
      "r793",
      "r842",
      "r854"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r54",
      "r313",
      "r889",
      "r890"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant And Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r31",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment Balances and Corresponding Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r31",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": {
     "auth_ref": [
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by property that could be leased or is available for lease.",
        "label": "Property Subject to or Available for Operating Lease [Axis]",
        "terseLabel": "Property Subject to or Available for Operating Lease [Axis]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": {
     "auth_ref": [
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A descriptive title of whether the property is subject to or available for operating lease.",
        "label": "Property Subject to or Available for Operating Lease [Domain]",
        "terseLabel": "Property Subject to or Available for Operating Lease [Domain]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r110",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r90",
      "r102"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "terseLabel": "Less: Amounts reclassified from accumulated other comprehensive income, net",
        "verboseLabel": "Gain (loss) reclassified from AOCL"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Uncertain Tax Benefits [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r504",
      "r787",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r504",
      "r787",
      "r790",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedLabel": "Payments on debt"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r598",
      "r809",
      "r903"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r598"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research And Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process",
        "terseLabel": "In-process research and development",
        "verboseLabel": "IPR&amp;D expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r137",
      "r321",
      "r325",
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring costs incurred"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r34",
      "r322",
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring reserve, current"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "auth_ref": [
      "r76",
      "r322",
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Noncurrent",
        "terseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r42",
      "r409",
      "r591",
      "r793",
      "r852",
      "r872",
      "r877"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r170",
      "r171",
      "r172",
      "r175",
      "r184",
      "r186",
      "r275",
      "r588",
      "r589",
      "r590",
      "r632",
      "r633",
      "r731",
      "r868",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r507",
      "r513",
      "r514",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r535",
      "r537",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r507",
      "r513",
      "r514",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r535",
      "r537",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r224",
      "r225",
      "r238",
      "r244",
      "r245",
      "r252",
      "r253",
      "r256",
      "r439",
      "r440",
      "r810"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "netLabel": "Total revenue",
        "terseLabel": "Total revenue, net",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r149",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "verboseLabel": "Revenue Recognition and Shipping and Handling Fees"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r429",
      "r430",
      "r443",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUES FROM CONTRACTS WITH CUSTOMERS"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Performance obligations expected to be satisfied"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Performance obligations expected to be satisfied, expected timing"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for election to exclude from measurement of transaction price tax assessed by governmental authority that are both imposed on and concurrent with specific revenue-producing transaction, and collected from customer. Includes, but is not limited to, sales, use, value-added and excise tax.",
        "label": "Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block]",
        "terseLabel": "Taxes Collected from Customers"
       }
      }
     },
     "localname": "RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r104",
      "r152",
      "r224",
      "r225",
      "r238",
      "r244",
      "r245",
      "r252",
      "r253",
      "r256",
      "r271",
      "r343",
      "r344",
      "r345",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r744",
      "r841"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r780",
      "r784"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r214",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Sales Revenue, Net"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r90",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Assumptions Used"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r513",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Benefit Obligations and Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary Of Employee Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r65",
      "r160",
      "r393",
      "r395",
      "r404",
      "r406",
      "r407",
      "r408",
      "r767",
      "r768",
      "r771",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Maximum Leverage Ratios"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r511",
      "r512",
      "r515",
      "r516",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r694",
      "r703",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Summary of Fair Value in Balance Sheet for Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r685",
      "r687",
      "r688",
      "r691",
      "r692",
      "r699",
      "r703",
      "r710",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r16",
      "r18",
      "r19",
      "r20",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Major Classes of Assets and Liabilities Held For Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Basic And Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r547",
      "r578",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r292",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Components of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income (Loss) Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r302",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Components of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r29",
      "r48",
      "r49",
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Contractual Repayments of Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Periodic Benefit Costs"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetFundedStatusTableTextBlock": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.",
        "label": "Schedule of Net Funded Status [Table Text Block]",
        "terseLabel": "Schedule of Funded Status"
       }
      }
     },
     "localname": "ScheduleOfNetFundedStatusTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r178",
      "r181",
      "r204",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of Impact on Statement of Operations"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r56",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r233",
      "r236",
      "r242",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r233",
      "r236",
      "r242",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Net Sales and Profit, by Segment",
        "verboseLabel": "Schedule of Geographic Revenue, by Area"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r562",
      "r567",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "verboseLabel": "Summary Of Restricted Stock, Performance Stock, and Contract Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r549",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation, Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r555",
      "r567",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Summary Of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Summary Of Weighted-Average Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r614",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Uncertain Tax Benefits Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtCurrent": {
     "auth_ref": [
      "r33",
      "r831",
      "r849"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt, Current",
        "terseLabel": "Current portion of borrowings under senior credit facility",
        "verboseLabel": "Term loan component of senior credit facility, classified as current"
       }
      }
     },
     "localname": "SecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredLongTermDebt": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.",
        "label": "Secured Long-term Debt, Noncurrent",
        "terseLabel": "Long-term borrowings under senior credit facility"
       }
      }
     },
     "localname": "SecuredLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r220",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r256",
      "r324",
      "r329",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r220",
      "r222",
      "r223",
      "r233",
      "r237",
      "r243",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r255",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT AND GEOGRAPHIC INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment Net Sales"
       }
      }
     },
     "localname": "SegmentReportingInformationOperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Profit"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Requisite service periods of performance stock, restricted stock and contract stock awards, in years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Cancellations (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancellations (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of year (in shares)",
        "periodStartLabel": "Unvested at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested at end of year (in dollars per share)",
        "periodStartLabel": "Unvested at beginning of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Released (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Common stock reserved for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for purchase (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercisable at end of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value, options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited or Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r557",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of year (in shares)",
        "periodStartLabel": "Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)",
        "periodStartLabel": "Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r546",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r549",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r573",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life of option from grant date"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Contractual Term in Years, Exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Contractual Term in Years, Outstanding at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance, End of Period (in shares)",
        "periodStartLabel": "Balance, Beginning of Period (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates the sale of a borrowed security or written option.",
        "label": "Short [Member]",
        "terseLabel": "Short"
       }
      }
     },
     "localname": "ShortMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r146",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Amount of unrecorded benefit reasonably possible to be recognized (less than)"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r337",
      "r339",
      "r674",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r8",
      "r220",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r256",
      "r288",
      "r316",
      "r324",
      "r329",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r68",
      "r99",
      "r100",
      "r101",
      "r170",
      "r171",
      "r172",
      "r175",
      "r184",
      "r186",
      "r207",
      "r275",
      "r403",
      "r409",
      "r588",
      "r589",
      "r590",
      "r632",
      "r633",
      "r731",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r762",
      "r868",
      "r869",
      "r870",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r207",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r38",
      "r39",
      "r403",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock through employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r38",
      "r39",
      "r403",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r38",
      "r39",
      "r403",
      "r409",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r38",
      "r39",
      "r403",
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock through employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r38",
      "r39",
      "r409",
      "r548",
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "verboseLabel": "Stock repurchase program, authorized amount (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining amount under share repurchase"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r38",
      "r39",
      "r403",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Accelerated shares repurchased (in shares)",
        "terseLabel": "Stock repurchased during period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r38",
      "r39",
      "r403",
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Accelerated shares repurchased",
        "terseLabel": "Accelerated shares repurchased, amount"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r39",
      "r44",
      "r45",
      "r152",
      "r267",
      "r271",
      "r744",
      "r793"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, End of Period",
        "periodStartLabel": "Balance, Beginning of Period",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r763",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r763",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r763",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SwissFederalTaxAdministrationFTAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Switzerland.",
        "label": "Swiss Federal Tax Administration (FTA) [Member]",
        "terseLabel": "Switzerland"
       }
      }
     },
     "localname": "SwissFederalTaxAdministrationFTAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Trade Accounts Receivable And Allowances For Doubtful Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Codman trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury stock, average cost per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock outstanding (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r69",
      "r411",
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "terseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r67",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r67",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Balance, End of Period, Treasury Stock (in shares)",
        "negatedPeriodStartLabel": "Balance, Beginning of Period, Treasury Stock (in shares)",
        "terseLabel": "Treasury stock, at cost; shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockTextBlock": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock [Text Block]",
        "terseLabel": "TREASURY STOCK"
       }
      }
     },
     "localname": "TreasuryStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCK"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r67",
      "r411",
      "r414"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 4,899 and 4,914 shares at December\u00a031, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r599",
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance, end of year",
        "periodStartLabel": "Balance, beginning of year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r607"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Penalties and interest expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r611"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Prior years' tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r613"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r208",
      "r209",
      "r211",
      "r212",
      "r216",
      "r217",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use Of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "Deferred tax assets valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r161",
      "r167"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Period",
        "periodStartLabel": "Balance at Beginning of Period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to Costs and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)",
        "terseLabel": "Valuation allowance, period increase (decrease)"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Leased vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r189",
      "r197"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average common shares for diluted earnings per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding (See Note 13):"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r188",
      "r197"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average common shares outstanding - Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Previously capitalized financing costs, written-off"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e12803-110250"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/subtopic&trid=2208821"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "32",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123355311&loc=SL82860478-203043"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(t)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90198-114008"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "210-10-S99-1(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r904": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r905": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r906": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r907": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r908": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r909": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r910": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r911": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r912": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r913": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r914": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r915": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r916": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r917": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r918": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r919": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r920": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r921": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r922": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r923": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r924": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r925": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r926": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r927": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r928": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r929": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r930": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r931": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r932": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r933": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r934": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r935": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r936": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r937": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r938": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>121
<FILENAME>0000917520-22-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000917520-22-000010-xbrl.zip
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M"#5A]CY8JY)H^!A4[+[&^'D^D^==GOXL3&P<;(KC>,7-T_W38[Z,Y6.<?HY
M7=$5 <$E4>=BAEO/D)J,<LFFP*;M0!I=]W5%MY!9G\P$H* 8G=5>@P\1E4*E
MR1H+48+Y&VP[>"/(W#D93YJZEN,N?GTD#M+LU<H"],7T9I^#;<7/WBJHBLG5
MUC).S+$S/H':,G':)&CKDS24(8P!+-DH_BPF\@64"N"\>+@2U/=@DJ5EOIZT
MW;C>)\)VQM/QT<G1NAR9;O-B\],Z7AGTS#6P-5"\QA81@0O&HK+6]6D:]@:A
M_EO$QC=7('8O260H4<J>K(4$U0 I6R$ZK8*6?[ 'D?67>6.,"SZ<34H/+7WR
MMF)DI;,Q@*C00[69@K>EMO7&6V;I;QZJ-4Z9*A-5+ 436#">DV55/$1TN; '
MZH%J[IA]OR$V;%XA<^40621<6".NH<4JUMTHY8LI&5P?7,,; WBPY9<-1#69
M#"<JUH$K$A2JJI P5^<HE6VSY3N8#\=3GI]^>&!/;#E$HAQ"D6L&\,%C3<S%
MIIJ((6 /5EIU'*HU9I+%;A=T;&U(@+&(> 51T=:46!/DT@.%W#%;?D-LV+Q"
M!@U*!S'GVGH(I- PNYIKK$%Y]-A3ZES)@@[4^=KD3D8+RI480*.-2J('<-9Q
M]*)]8$ML^=ETZ,G\^3CCY)$HZ?E).^2_Q[V)RM&@=VRJTU  K$UMW6!N15DI
M))^VQ9)O"J@UYMRM2:[Z#!4CD*LI9<,$5NO0]G+IP\*&CMCQ&^7"YE6Q\F0I
MN.BQ;203+>4J_GIC#4#6''I G!N"=XC'+Q-'LRB:4I77&BRFY)+7&7*6-U1U
MO$TV_-'T;.=H.?WIZ6+)1PN<EO_">7F-\[Y4&;+V(7I?F%P"B?.P!,>@;30@
MDL\=7NC2)[S6V+=!62(75(JJ@FE-X+3/H>KH@M4N#I%YIRFQ>?V,5+W7U1O.
M!<1CCUQ)/$$G'$*RJJ\>X0;"\V^3/Z&6MJE+ZW)/8AX4J9J">(G1&;(FERVQ
M[Q<'/SB93\?+DSG+@0_&;]IO?0G2?36HG%=%$0,$2*8TW*J@YRKI'M2G=QNI
M-:X]C&C(4V);,G Q1,DZ!P7!9@6Q#\%61VSZS9)A\]I8_'9K*C(I,A 8,)%U
M$5@E%XS.M@?,N2E\ASC]HY9]5%*(3E7+H+PC(-\:4H5L<F;;@_7.7T28N[-5
M3B<W1^W15$Y]+HSIBR7/E,1BUX "CL!48K1:*Q%\93F[V(/VBEW':ITSYQ&4
M,Y$+@:ACAT J*1UKR>@-^+-N[5K=8+?V+]5',ACJ)EJBGX@*7PW:.6COQN%H
MM0R>SY.R9Q]>7./BLXO7[2)_N."<CV?SY7CZ_#_MK4]?]_(Q5[G\1VV#2Z!0
M(8$.H R3B1"2;\NYH#C5AY*UO^VS]=+@M8E*D<6"WA9 4:FM(5]AYUI+-]^+
MCGS?EH="SE+,3BNJ!%4!6C!%:4BJUNITZ@%@?[+0^O'L4TN3[\X6R[W:UB%O
M9:A2;,@% ^LV,90*DK>)7+26E;R/W*-M3#H&YT:V,,E6AUB]\4DY4"E0@:0I
M13*>VVKG;9/.ISR9B+/PD*<\Q\FJ/<*1&$MQ5,^Z8+TYELMNI^36F$**E3 '
M!=8&<LIYP5CB1!5,=-LFN=V >B-271E(5^U;%A*TK4D<(ZXKIRF(J]N'XLTO
M@OH)+QCG^5! OL>O>#);!:7G"&^C+&.4 %4<*X_&@F)&[S+'$',N.3GEMTV6
M-PGP1B18L_A8-H:L+4',,<GO9(HMT86,N))@+39[!7#[I7/Y!YU&REUMW,X.
M_>K\P_2D ?Z'-,'Y->37+\X.U.# R8"'G V 4;'("%7K7;)&E]JG/O]W9],L
M9YQU0GHR7KR\<WJ'I_GP".<O/[*;S==](E(V/>%=7EO#V$_<P"=RAB>+I6B#
M^1\.WA(E_HZK^?Q!/YW4NAB&+R9LL>S$R+MHE&W-S$AG"RXX\J)$W/F"GW[8
MA8&PG3-*A5)M73I2:V7H#6)2)#$B1]0. \1SHZ3/C=+ KIZRJ]GC*[+KX\T5
MOR91J VUPO1:?-O!+[=$O(H6:F"P\OO9])C\0%=)=8]I^;[H_(/RLOW7L_W#
MV4DK*MM_+1^=/I  ]"E/Q[,&[2N>+\>TZEMX[;4NRHP4K&%^#!FJ3ZE8#0IR
M*!*'Q,!!9#YK4R-U'ZS'L^GS)<^/&FB?G+R\@*4=L"ZI_X88DC@5':)**B2H
MV:/WV95") ZSS:G#>Z5>O87^N;-VU1[Z#?U59]*3Z?()YTO]37LR+\X0JR<1
M<&22B(BHU)!,"<; JG/?-X[J[:,V&?WV+(-Q5A_1&B8OEHN>XHT9O%6<).R-
M$*U+,7ERGH)Q!"'TH!?M[<6"E[>S(+$8?X3Q$R8!K>P?\AR/^60YSHN[L_GQ
M;'[]"*VQ'8<*L?7=R#%44)I38,XEV9!KDK"/NRN1W49H?3)DE;BTD'4F[0%9
MD9' *:!J2ZTCZ-+=[=X[C= :]W4'H\+*DG$DL-8D,)9\<(6BRD&;'@6V'8)J
M\R%E:(UO1"$Z%0QD9U#T(L0 BDIQJFQ\E<M2XH[RYUB>9QV>\!&.VY8*XH.L
MEBE-,^_19/Q\A5N;!,E++OOC(SFDE2HLQXN*J[++IQ>C?,:"?U[/A?]19NTZ
M36F:"Y2O]YO>L?2# >R.14Y-WV/1",X!M4HGKI9%V:><D\*-^TQ;QSH[L.[6
M6-4,+H6*)F8H)I+2:($Q)HHFT,"Z=;,.!M:)YX0&M5,I5E_!MLW="%II;DH%
M$4L86+=FUKF!=:T('*U&;X@U@8.V=%DB75-MM%9G30/KULPZ/[#NUEA;0EMM
M+5DQ>)]1S*W.P4+V2G[JP+HULRX,K+LU9O+.VU#0F0J4%%6O0J5 0CJC55\Z
MQ?P\GY63O-R;/^7YJW'^L/G&+I_,V[9TSWE^NJZ)MG?UA'=.%N,I+Q;GZ\\^
MW,KN[JP(=9X*6\8X69Y>M W;DE*CR\%!\\K$1/J2"+CU^$ ;D@+QUZ)) #VH
M"QI(M.GR'U6K\B4771-#<9&, E4\5PULR=8>9$D'$FTZ):N)(@N--(HFTD:P
M1731U&"*:=4"/3!GUX_LU_+X?8G)5JYDRK$83BX'CPP88BI%.5M29HF/XWGS
MLVY;LX%#&S9F5H%'S\BY&DA>H4[)8N&<-%C;JUK6@4,;LF4UNY8*$'64$Y08
M$ -&@^ ]L0/+@RWKK84A[[4#996*0)9C:Z$=E&:%G@KU:7U==Y'=B-[W";T+
MVI;*'K*UJ%06W[,5M[&/F :]WU=M7 AJLI;8YPQ0JWB%G&.V$E=DJKH/G6&^
M!-G]\6)QPON<#Z>SR>SY>#V=\_["F#_AYZNE]*TF]NG+<:MO_;W5$VVE_H]:
MDT:5$AO(*47C,CHCOF'-U8'>,OW_K7!I,VDSPJ"#QHJQ@+:&0B&V2&U'#J_J
MMD4:WPB7-A1Q6!>5<^A3)$AHQ"\U;8L'G7S(Q:C!QGT=E^Z_6<[Y2(9I;[X\
MG!US&>>MS*!)=!.L31J-JI"]%\WDT8N3Q(G]!8\&^]8G'FW$MJ4,)D1*/OH,
MQ5EDB9(#R&L+H%6?"N<''FW0KD5TSGCC:\76 -U3!5*0C.=:H]5]V,ZDTSSZ
M>3Y^);?U&(FW,U_G6AF6S96*AU)2JN#8)>]-M*'THKYAX,\F.YLP1:M\3D:B
M>Z>!*AN4V%]GS57Y;<L*;C%_-F._H.B04BZUK8JWV:20.2LN;("L3MLV$_3%
M_.FE4=$4?+"* K<&\5A1I5"\)5U)N1#RMVY4>JGIV;7EH*X&< :<=Q(#VUJU
M-]H&F\[F;+]E3=]+]6N-3RA_BE(&"EA*-46%2B N04+4L\I\ ;6SW8@^ZH)Z
M!R>MJ/WI(?-RU;FXK!9SXZ0U&IFT$D5>W#F5%\>S!4X>SF<GQPNYQ.2DC*?/
M5\U(Y(ZF)USVCOEL>??BZZ+**S_(I7NZ>ZGER>4.2Y<./'LAMUOOG+:&:[NS
MY:>?8OWLO52TW[B[CN9'.BCEVZX'7!)D3%1;?RP)4#@8K^K[N4@8#<S\)IAY
M)0_Z;NLAQ/-C&8K373SB2Q/YTT7K+71R-*L/9OFDW=+%&"V6B\>/[]Z("P97
ML=8?'?H5BMU9,EA*IK+:ATETO*7HE4E$3H%1W6]N,XA/!Q3[^GKY)$\%:O,O
M:@27*WE6RG*(%$7+YS[L\3DP<]/,W'QH"PI-#LF:R@ IF22<%E9SRA3 AHTO
M91W8VUWV7L_>F.ATH%S1QPA,.:G"!C-Z,&"->K<#KJCRBU^ZRLR+:/S33;AN
MW^7)1)AW$UKE_7-]UEM[?^C7='!.T:&K"&VILJF(H.2-0A4K<JGJ(@P?L/M<
M$/K!4WU%[T[#$"UE[5"!-@*'A1#8NBA_JM+G<'@[P/&7</B170<<-I6D7(C,
M @=5329QL<Y[BSHJ4WJ@XJY_>_AO5WF*X2ODBV<2Y>EBB3&HFL4#(W#)9-<#
M>JP5Q+]%QIO;1O6FZ>&JL2KX*GRP8E\YMC6O ;!64TE[W7V/O1/*?&UY '26
MBE;D3=O/-D;V4>L27%:.4B\*<9O O(N?GF:>HCS]>UGZ>3Y[T'KK;)]FO^E@
MFVWKOI(=DR)QP0IA\FWENHLJ&I'C'LPC?XM<V<S.G4$I4*A$U0-8Q22^@(ND
M<F+E@[I8+!),&EW\TC6N7!'$^<OQXLYX]C2/>9JY)6/^<?U3TV%DTM6FIB\=
M^C53TQ&QK<WP[#-DYN;^^Y!TQE*T=736_'W \:HV_&-HOB;GY+QVR1DT& 6:
MUA@\5,\*'6EQL.(W",V5O_F!A'U+?CQ^Q>715 !XWK8G6O6>7]PYW<$7L_DJ
ME?E1!O-LZU8N[^I13I^,GQ]>1W.(:R%,T!QM@!BS+Z"*(>1$(> J1YE2^I:5
M\]8P9_,F YSRZ(RN(0)XJ$C"N"AZ*18+^2QO-[!KC>QZ/,[M.M/GMY_/>>7B
M]D4C@<%0P%K-HH.8$CE33(XE8$ZQGNWW.FBDWG*F [J(<E$&"XN]@Z ]Z0"^
MEF(SB=%39=!%?_[-=U>SL<_E=EOQECS+V93LAQN]KNYA9SSAQ7(VY9_QM#W<
MWO0:MK2_%O5#L:12HV8CI@I#C<94EY2I=K6!DAW8L7YV[+^>]80=KOJJ43N
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MT?IL40;4UI12JF(@Y9",":D9(VN)88B+KB>S'H?T0@?$:'W&R#KK4NM7A[I
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M$&P,C-X&1J]/1[.MD+.WJ;:$$WO,%F-P$+,EG].@HP=&=R>F[XH9T.@-M$
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MU'U1L.H;$%6BT,:YIC[7/B2QZ$4)A@-+[?<\I8$*=3(IL.A=C6D'P-BO6"%
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M@3D!92!E"URH5$<B>5!.8$M$F8I"1#%5]!)A&W$\,-$$OB(?YRDKIMF%8HH
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M^9@-=F'UC'%8<'^0X+J'!?+87>T]*'&D%W31"$:NCQD/(+._BP+_3:A< B8
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M;!U,M2RKY!Q"9)(IPVFW.@JK##]<-<GB@DE^02<F'57>% H3  QA&:S<-#%
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M1RKBV+L][1W(Z@S?@Z2CVO[<K*2D[F-2U VI0Q@F<S3J0;]3@DS%P:BP#H-
MQ2);X[EL^U7U]I]K==C(!H*]W9Y3/EZL/RFPJZ1:@XN1:F2"!,/'=0:1Y.BL
MYJ>+H:%=54Y8=\:9KP6KJN]1\H/<KZLP%OJBU34DU((=B) (,6^ F/R9RLAZ
M0&>1Y[8=FMBI^FKT^S.I>5NGCA.\V1SE)!;@U+,B)!(? ;_CU]I[C-15B(VS
M):B]V<(XB?G&(&W$.EA9._VPOZOM[YT! K."WWSP+I*0P&Q?YQ=R;$&D"@(7
MD;S1GVN&QE>#G$*6">5:T%]*0J%0SN/QS&":TSHQ(:'9IKN\VV2Z17G=+.Y]
M6Y%;@[O,%[*A0E;!@5TP3 ^H=:415E G4<5)R%E">G!5SH6 PXP(F:;"ZA]R
M@9D+V.('@2HA1KT)U7MG-NTMKYJ,$^1P&@.5_:)@,Q#C_H#'5!R&2X?Y3#W,
MLT8B!/;F)B-C.E^Y-P?ZF>%P($9"97ED5=I+K97/<65I[*G*]FJ!?VHQW \:
M*+MU>>P\)Y2Q>-F?J6%$EOEH(!LZ-7O'-B-"U&VVI#9>(JH;OU9KJU2FS4+4
MY6K&6:?7:9_M_ZZUCP^T@\['SH>34RPDU7K]LW:_\_[S2S"-3LB@44WRY725
M6:<V)(-+F6M6"VI,!L/]RD2<(>8&5;Q*>D%OM*3(R\I!JO+;:A%;8<O\2 QI
MTX,"/9VUU%'(GD5D_-P6K:1:;EJ]T6HLSHOYOHB58Z(Y:F:W=@#4XQ-^X FH
M3'$ )/9\A;_.2 P>S-U@5=Q=-\N3S4%4/)/(1J1 1@68B&BI+U%P;M22(\M#
M3C#'1F;).(WF==6X'H&Y22RJ7!B4X((GRX>8^Z[R^YZ29$,6?</$G(RW%&+'
M])^WJRNE/6OBT+(4F.?>_]T=$U:UJ[]YJTO37%9^>U5=_14K&SE E85$4ZXB
M(1M>SG50T0[S7([G."@F%T")F,=>58-HKW; P-YY#:3'DB$1^)SH1Z^<U B4
MND#.N64COFYA9WNHQ;+)'3.G:@Y0.VVQ(S'PL99J^;!+B1LMU<QQUE.ERA*6
M6?NIG(A2I^[A4PWA?ZMX""?\0HR5'Z4DEOM5$ ,_6723-3:]A#U*5BQ*U;EL
MA"% RF!&;VB5<Z):7[#9["#XDD9\)8S<FU50(T/%AY1V-=]LEG$B(5'.>=.G
M&>R>NMI6>N H3Z>R48AL.Z-R9&:M0S'MNIROC9KOO"O;=%8)9 TOW9S(:4Z7
MNJD[-N,TB+3(MU4#[,IQ/DM[K6P*&8ZYH5C>#9%ZZ%MMULDF21<H,NY(H7DZ
MNEY1)<#*&565='/69"1]C TA?;[:Z1Z<]8'CS$M^,BLIAQM4D[E&(&2^U#$#
MU2!>N:4KXIAW8-3U!=-=%6+ 8715(QFT#')I8#<'P=3%4Q.EXJFLZAJOYAM1
M [74>5L-7^V31AI6#EG9V%N7#!?N;D)%9=54E,8  .SS5JEFG(T9ZMQ;&GQ.
M&GR7I&P*DOD360DRXPAI[]VG(Z"])*L=.6E^I08>R+3C!9=/;9C+^7Y $^@N
ME8:$4M)EB2HZDB;5C! <#]J(19[-6R"]RCI1_M*$<F&_ G%F5(- G[=!>&'C
M-JV71XD8$[U6:_94&%>U<U8Q7>H63:$$-I4=KFAIN3="R<K83Z=--U64HG%7
M"1^\(6K;5U8&H.S<I]:*IF0&RC,J3RG.VLGS(?4&!-XTH0$[U&N/#E@_- 8(
MUZX'VN%\\4=53KG80;]J9=P8^$<Z#JA_RW(? ,P'A^=83(AYI/E0.;8QWI12
MM$?J&FJETR*Y/1]M2YA/)QP)_WH1BV,<[KF\-!W@J!**90][F:-$E(=YS J@
MLZF@INDL%.566A:L],^2IC*J2<78P!U?89BP8?%MEK@E<=&6G\KV6RTL1AFP
M4C4Q1&6Z:C@E*^EP/W5Y."J?34Z [_MC1MR2(^TS'-_$Q9 8 Y.=ND'0U^@(
M@G=2WJR%>[73.]E'>T7F@"M=DF9/P6IA 2)<MI)/LEBH7MG8FCU38EX%)BO/
MCBK3C^,TE[G7N/OYKI%TNVGR#;D&=;*7@Z$JLJP"UFE.E=SD9"\J?0/V"I9)
M3LY..=(.W;, J&PR#&4H%HFZ&6A59*FTHSOTB5\Q3<[=V#2Y-71S=&[X[/J+
M$W"[\Z65:\E19QX&,KQO'&K.SI@;-JK$>W,&AW3Q)MFR(;AJ.A9H21HJOI1G
MI)P0E0YRHV?OK"MGE<-0^7*OYE(\I*U[70_6I2BEG+=1-Z+%XRTT&)OS-I.!
M5 H:O"N]WJ+INJV3L](DADU.HW1.VLC;F=E#N$LPI*C/IZIH!'Y!32":8Y_G
M)G+\>%P*32B9;46ZQ6NSH3DV'0?;]@X;.U0SE%OS0Y1G+2QVM24-&A:'RRKT
M:/K 09(5K"0AN:R=Z)R'@UK7@T%9M7>N:[?O5;@M94!U/:HI1]T(^*@K^S)3
M%3G>8XI(+B?'JR;.Y'D;YLJ70F-U^31C0TK(4=F&'-C/$]>(KYSDFP/N0R"8
M6';1K:=#U6%&-=1&?D-C"F4GG:9;JNK,LH :BA!S:2,D19%<T+^JOBSSL^BJ
M!#G2T JL!LOS]%LRKD,F^\@OGMDM_Z0Z=O]H+:4!V(B@-IY*MC<D=O61I>@Y
MHHY$JAU.G1-1#B:RH#!.+B9%Y<.AB3+8":G1#T:V15:S$W&I:MP0.L.E0ERG
MWTUH:%(\:?9M4?T+J?M2PELXP*RN!&PZ]$D?Q8F"M7/K6F0J9"]EB'+6HL2C
MEZN!V9.02E_'LWF,  9B!6IZUD*EQL( MKM9\7+1.N<2:TB!=EKF-T3A9(35
MKY(8SGMM;3^5'9YK!UN(?#NJ,F?4R( &=\;1X:-$1,V,T7%5<-^HIF\0LI(3
MLW8C-]IF4^:R]/<IR=GL *'*^JFU=U%M:6FOB#H8JA(RI:!^2*G .I!2-5?I
M[N31NA^X8G#4IXH:2QU)J:SUB%G>VK.J_DWM?%5-R3$B$ %:1U.TV*I1EC(H
MKUI9D5MQEN5/2,WNZ($%6\V'JNT*YEJMM"76IH>I[^$E_L'X1VJQ Q8+#I]8
M$L4IB?-6TV I[=<(T/D@>Y[@"LTQK)A5=W/\(R[!T57'EGCQI[*U6ECDAVG^
MDCI!K1S^E$U"WIY+J0Q1HAI' D!HO]KI?#Q [V2$;9J0IQ"I=#(NKK> >%1
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MV'#T=A\_VGE-ZB><75Z,0+]@M:'JKD!RGAZU\5&&EHG:X:M<F2I"219XIOG
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ME,DVE71!;ZM47*1S#GZKI%<>[VH#0IP($8>8K/0ZD,G)!9?!'#I%"EI Q8F
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MT)N7]>*@*Q=EQ\<T/H#3R;J8M+F<\?JGV^"2</FIBOP(:L@3NE<<G0$F6_H
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MRNU?UK0M*8YCNB<'*4W13^>M$<O2UQI&33 4^PU><O+WJ#0U^-J:+#@]P49
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M+A@R@[4=M[G:UM(X;$*'GCZ]/#9*IFX+=&VMK>C +XG!AHO#=3DNR$K+A+P
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MP$D]>@M?SCT6U3'NI/SBP5]VNMAXK"\$P:R>MOWE+G?KQ2^H4B\WVG%CQ^<
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M\W0$E1^(R[5L,F!!44WBBR88;25^B*@-3[N034\6MGVX5V#36A7]VD#^.!7
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M-KHX=R>$E5+E"7VOS_F1L(I>E5NO^0)@N94X(+DT(60N"%2,;^1_7>C)-57
M$/1KFJ2.U"KH/.4EL^I*'-$Z7 &K):*,0#&+LQ@6O)C?0+K 0Q8-2*_M&'$P
MP\8-D5IOO@Q(QX/JE&:2(K.?\QW?Y,E.]1M;!1^-"H7<J(M\VDAIUJTD99<M
M6Z(-+T;53HL2:'%[O4TD-"D<#%R]^19Y^I3&5*%E4M97]*"=N;21RJ0X1R:V
M*>"+EUQEB T+I@W>;9K&$<Q&Z*LFY+P9'GTFEIY%]=')"$MS+0^H./"2$PQ
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M3[Y"$#AW")GDJOD 0H7YL/S-:;EMU:(J OKPJ-GZ4K09S5BPB^E@>>H@;VK
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M#./'^,>F*;.']_ (#T-K7E<NM65Y]Q4/ YICR:5 VGMR4CBLHDS)9DT_,SF
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M%[,B&52L*5Q"2%EA0QCI[)%#QSU.,$*SF* HG.-'PK0C;"55\H<4 JLRDTQ
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M-9$/CJ\_K@4<WP@Z499 O"T:)T^(ZJT8J2N>&%6%8,[XDEWC&^UTHTV%A+P
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M8/B4W?4RCD;XF!E;MI0W<Q'AZNCB13JN,AOI34H9&RC+I&";J+.]T]L !CS
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M-S/L3\M[+ :KE)/6E\N8']*0A/0*+0GVQA6+6AK!>OU51W7)L!@TQ^Y-B6
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MH&D2(]3)IDCP3O1Z=H]<,1.LG^VX/7=9HH? 4J%GRFVL"3YH%G-W^$&A0VH
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MB*.AY+?2/Q#J=T4UGL)TCZ3\N"QQ08Q<T3?9%THU>J_Q%D.RFUPFRSR<,]T
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MJ91M)K<BK<8>>!9-/NB]8U4<-N>#EGK>M\K\/;)>WW\6NDYA[.UG08NFYFK
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M;#5XEV&0Q8\K[5_="Z=]$.YL/]0>W9@%OUI;A]VG[*;V@RP#7NM.J]-;9HW
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ME5+P(2J*&^FF3)?IR[UV7?1PK=1;<([^M"JF.=$\ONSL:J\7[S<2)6GX#5-
M[!PHW[?[,_)F&G^$9N%XC%(K[!ZJ]_C+?-WK2.^<K)5RB:UPYLWFRBIN2#O_
M(%3>IV+E$=SLON^$I=K=:_7\.8-=E.!<+N'2O+B$4>SL\?)TE2U?OWD9$2$3
M3!=.2X+>G/=XDQL[BR_@/Y581K?A'H/#?0SN];:E-#>=)4!)8$&Z4PYD_4E;
M[:Q\*NJN#NH@T$]IWC9KJ*64IOJUSI<.F#97"5ZUYL+RXF-P;JJLB*?1K.#P
ML['\R.C4L^BYM)QFOPFP2_L(P]$C,:3LR4O1?6%@2#QJ\>+U*[P8Z:W79-O:
M8#@:83,8P:!B4A1XG+X9X]QX XK9&*M).O24.S[S,L9QPCNL\8H#1#H[?+ 9
MQV%)7YM?KIHOBZK<AM#-&HF:*ATCF:?#5WR 9F2!4:YH([SW'^HF@>DE,/<7
M)S ?T(I\_\4*9#V7J_OY^^/3]V>'G_]Z<A1\/CM]^^7H/#@[_N?QIR_'_>#P
MT]O@]//QV>'YR>FG_@^B@WIZ3BQ5@:J!X])2'H(B=D,&:'_Z<414Q&[,?@C3
M 9V,W+9NQW1TS";1O\!:KCU.B=[QB6,Q_X2B:\4)MPX.6IW=@\?P;>UU6KV=
MO1]/806.4OM^%%8/Y=O:_3F#[6WXMC9\6ZNVB1N^K0W?UH9OZW[5-EZ&?\.V
M];/FO]PE5^UP>_\@['66L/OVAG%K(\X/G?C!7CL\V.LMJ3"O/<,&=S1Y=K0:
M[7"GL^'56/9MVNN$N_N/;$"Y1,P:RWOZ#\LD"CY'0RQB>V846^W]3KC]8-J6
M#<?6K]ZFWE[8WGO";5I["P#+=3&8_ <BP9Z9(; 'CM1N>V,'+/DN;8.FWMZ8
M 3]M@3GW="99K UYUH8-Z+&AJ5ZW$W:[CV0N?7I2H U_UN;$_.(3L[/7#O=W
M5_;$?!^-UG(B.Z3R AY>.@0O!N2A_4^IYK+5;X5!%& [3(%U,*(=L734F'M$
M^<VM49SEQ,R#:#FLWXFXY3<".K ?H5:R*R!$"L5U* 88@DTIN: <H85<PT+X
M=QV-O) Z&VIS]] 6H8_3"FN%^-V#>'8=QW._-70_SIO@O0K5S\O8&>8HMV4Q
M7(-C@,4"!N3GC^()/E9I 62M_UQZG1T5Q4@U80B>; 4?"+J(!:^P?D-:KD2:
MI1?<;QGK99Q^RT@B!&).(FL*<"+Y"9$8::$+C5G:0G+_]"*>PHK%V8R@<HR=
M-(A(*A-B)"5UR9TQV0!^1XJ&< K\A8ETAIX6N,]8"9*FU#\2?CF Q:).E30.
MY^U$!  'Y"L61]2E; TJ&-Z"Q,#[A_8HU:@?VFXWR?L32-R++ZMEFW?K:GOO
MWO^9K^[3&^$[]MR J+C1M]IP.BX+Q@\=SE+"6;FY>QQH+ +'3O&(1].('+1Z
MC6V$;]FD<ZHSM<WEC91>I/F :I^04<&A).$6W(,;UI4Y]Z =:0_L&ZJ(!24&
M2FEDZ:".3O]Y\G:K?1# ^H-.1%P?\X2@AAC#S3"\3+ 8YK;>WUS#4L0#W#(<
M:EG!B6=]D\/;L';F*D^K"2K0ODA[<'0)]T\8_"W"G3^*LF@$_\6'@BL2*V0R
M&24%:B550VYK79HPT\@QQ1R\D*M[_4K<*"USK7-UIYY&6#RF^WL4%_&')/L:
MG!Q]#C[F63(SY6"&&L[IGUSB%8"72SK6)U#AV[Q>O!_:=[?]XJ'*=+F@MQ].
M_O'EY.W)^?\2T/;H\//)^>&'X.RX?_KE[.CXOGC;U6*1!)WP%07B*)KB;Y:0
M)>=Q)7QT_AH_V@ZQ1)<F/>1)<Y_T_?9.O8Z/BLKV=W9KI>]U"I<_:H\31#&7
MVE,@2&F.I$PSI7[:WB=@:E&]L92WB-%DN1P](A/0G628E9<QEB"OI6 >(54#
M;L!'TIN$G.['L%RT1JLQY7O[1UAK.M0)TS_B?U?)%=PSV4PDA;@L_#;D/9!8
MVW"<*R#WMBWS*0OMP@KG!91$H>-O$9'&R +N/\ %G@9M,,8CN""%02>9(_2X
M3, _*(:7<#9NJ;'%VQ&I5,E/\NJ[+F.P4VJ3[71[#J<K\J(L7B_T\W#XT564
MI"0Y:/10=6K-!_!O63B=A?Y>:J2).D*;V&?,#I&-2F9.:R@VXSK8S"GZJA6T
M)5RF34Z95%FBXUAEK!2PJSNV!L]R6\>%=6##')^-)LHDX9>8QY*38R:T*6-R
MRY@.UI>'\8E5\[LTO[ZO&E[6 IG]UL'>[J,*9'9:.]V?4G.RL_VXNIN["F3V
M?\Y@#S8%,FM2(+.IC]G4QVSJ8S;U,?Z,/\4SMJ\-B\/@QB$'P5#\%3NMF^*9
MYUEML-/NA-T'([\WI3,;85Y"8>YL[X3[.YTE%>:U!\Z:VZ8J.?+),94[;IHU
MQVJ^:N^VPVYW9]/%?GFW:'<_W-Y[FAUZ/B8H*857:HB^1DM4&-T]_?#,JFY>
M'>R'G<[N@_M%+I%UM>8[U.ZTP]W.(^MQ-W;#?4IN!?<UMOUEF&;9A>8A; 74
MR'.S'@["[MX#M,/&=OC5V@$\CKTG+)AZ%O:# :&]4@[CUX3[791"WA3L;,H/
M'K<RW9VPL_]] 81-M<[FN#R7X]+9:X>=WO=QU:QQK<X2]MJTX(_@LY,3.C4Y
MH<.&2-UJKLSM37/,A$U3J?+Q+3JWW6*)V]#UID6(F#74NQ-!2X@,@^T0;+>E
M#:>F.]3:-YMKG$RVC^EF'HUPJ173I\.[94J!Q?+!)&IXO>Z!TP7ECA;L,JGF
M!NR"E\>9:<F6J0=H["(Z_R[>. .3GZL7\/JEV](%IP9)@+O$_&Z1NMR7U5O0
M(1B1I993V55T9011@(TIU*;92"5-9Z%PJ$&KK9MWYHI<&L7GG(4$3C!W<]4^
M-75H=%+.$>-']IT2HL^TP]++G@-(-0UF,89OH**#*F$N_3(:Q[,;.,_Y\&LP
MB4;Q_#8@I3XUFM!7^*>FN^_,%K;].DZ)]%[F-3)E2=+09Z..YL_NMM/5Y<XC
MVCYHT#MWZ(]YS;#MM!>'-Q&RUZH*.A[T-U.N]8-.HS/1^YQ&DC#W/(EXWKJ8
M[A)&_MEL=YT"JH5G$Y?XW#W6JAN;#F+F55?98X*GCL^ ?\I@&&6,K>U,B6@K
M.,E,@V6[1"7W4Z:R(UN4!?.JL/)J&MW@$$KM+32X<7Z(VS.D:M-2&D+2<$49
MP)K3525U8.1[FS(O!'C&5,2+%:5YL=:E#6Q"?9%$YXE)=![.)S+64%V]M65H
M=]I*U(UK&B78AS+39% TH2:7>+!VMG><TDXJ,TRY)8"V?K1J ']P>$3W!#5D
MDX:E^%@J](NEIQ?VDVLZK:GI5GK\;498?#!]B]DE:)!1,BR-ZFDHWZ,9X)/P
MWMJV][E<M%C:B(785<%UK64UQ1)XMT; OZ]A/EI3/<.5J4@32?$U;%"%O1%Y
MF>%?IK9(&R7"$V P$UFH>'B9P=9?W+C7]7K?F+>+8.!4BXGTO=S9KY40-^U=
M&$QR+KGE,AI2I%P"RM<";H^S(=2_@I7 1VQ"FL3I* P^'KX)?H?GH%+&?W^,
M)]/+!!Y^_ND-[>%G&/PPIL\__8UK?SH]1ZS@BLR'W%")6!"BX642DWLPPAJ>
M?(H[C&7U"2AR> R,A"8I1P9% Q:AO(3+#)L?87TU3.F,"V17I3?SX_7R*U',
MKSTG]YU)-R]=H_;F&3V/R^1+R6V-V:RCKF$-N( '..=T9K'?U@U;LW0CP/&R
M-X)0<( ADZ=TJARZ$CS@_3A#)^8(3*9D%KSCX\X59%K$R'TTS6<U2VRN06K7
ML9HU=<%]Q^C<)MRN$',8:.[%LUD:BQ(_IUYAE;'JK-7V<M=YJ+G_3'5Y_"TN
MA@F;KV) 3ODF4GUC%V20%P4US<%2-NS/^\A56 W%<F<[Y2FJYV0*"K:$A1C^
M4/G<YFU\V6OW6CM^P7+2M(U)65;,XS(&D<HHH,G5M+0[G_(9<W=(TV0*041B
M(5U'18%4/1[!#NU^>Z]=[\MI9.#[1$ $MB:KM>/8!=>LU@KUQY_)D&A#YM=X
M% ]F=EFQ-+.LMQL_G/ .XM.1@X,^\T=P>%'$;,PI.]"]=HI7?WN[/GW<>Q"U
MRTBTX:R@(EWQ_5;D8#WT?GO *H<+ES2L[S\_CO?SK_'HXI?Y9;]*1?7CF*8>
M],*?W1]RX8XNZA@YF/WT,=TZ CG ?-C@/XY<Y@6Q $&O4\L8UD>O/D?@J)V<
MA,$)_"G89Q<Q*8-W8$4'[>VMO[\FY1XA\]6P*DM'*3U,@H6CI>>H@@6JBSZC
M+=Y=OBTNDBMR7<'D*6=%Q:NXGGL^O^.7HE#LS=\*_HB)KP!Y <!(D ZOX-9S
M !NWTI((B)60@2X)9M=Q>H6MV[/9)5AW<!-@ ]BR&H^388(W"S,&1 G;C);2
MC7Q"\D3-Y#"E O^>J0%''6CC8E)JQ.-=/"BJ""X4LD%(<,WM];<JG?N[+&KS
MM;MIM^K*7W?;7XX-3\&/L [Z&+T K:IF4? YC;(UN+U/,QNFVM,H%1ZUWW-L
M:@_']2W%F_("=$<UN\P+>/C(<RE)+YAUJ::<B.G4#'I-F/*/_ON_]COMO3>4
M7IU@-IGL2@IT@M-Q44039%S#Z,GB-R'["0650*M0?+/*DI+P%: _V&-))ISZ
MA?_EASL_U]GP7<=]Z"GE8-8#%J.#/P--S"[KPE_#!VF$GAGG'..K)*_*AD6X
M_3&AC?1AB,#_*:M>O-WM+D3,WD+3A)\FY#K02/B*)Z^+(X>1T)%>HP^.;A L
M"\\9?9WFV$7KYURCG7L)YHJ$!1?-@7K3OKL7WH%Y>LA%S5P!+^]S9HC@"\T'
M^2X=B(42]C,]MR</W8$J^UN4D571[M#B=OS8%]W*%(JEC"J%X6J.[U,:CM%P
M&*?$)SR:W\97+W ^3Q8KOITXKW_VXK6?!)N+YZBB]B2Z)LD$!HBG;@=NFC0\
M7XG$# 5P7"?UVM_^D_X(4RB2(<&TA+S:6J+Z4+T24+&BF=RYZQ%P$3@?2&34
M<)8E13DS#)@L?=4T5V9F#<?:IV$4SYT_$A /,%N?PA(ZT E=K+P(91+#N)BA
M'3Y,BF$U 4</EJWT95T>5F 05YXUB;Z".A *!HY_(1TS?I,3^4@BRB]WAHB&
MO3=,&94N(K-!QP4J(0)1Q1',=H@R"\*+,2ACO7L>@/E]9$)7+N&U27=*.*OQ
M=;R!O$4V9RECG^7^:HHNMLG>LAJ:A0A=S _O)NY4!#\%0QE#L$/"5O##0^,>
M>>WCF=15S@H*J/OKD)D:V6_'(82UP_#GFF)WV%5QX?3;3O348Q$W3J/SA5""
M>X%O1)0.F9T]%6BM.%^E03RE.EQXB2VE#MS82C\NA>Y'(A;FTETU865E%'1:
M[45WSPFH#G N[F5)&3/^#I/*0V=4LR0ET[PIJ@X/]L A)JN2C\<QS9ZN!!M8
MSC2&%'^+A]4L;K;PW'R*N"N<@<%A[+5V_4'02_4"T6<41BW/OYZ"/=F_JHS1
M5!3MH6^F>2EC=N?0"L .,^&=7M-FU>VP@TZK6R/+O=,4V@[8ZD#6=@Q%Q;(Z
M]C9?L /UQ_G[YQ@P.XU"M,!(V?XQ1DHK^((6@TVYUE^!N_&W*HL;CX ,/<I<
M8V.[+@ RD5&,MPIYE%6I)^_6&^P'W%=KH*=,NF-_V6+AYYJDZ]-^/.7=+7O_
M$V+@XZH@Q!F(+Y@P/Q=6]B311@H<O$T0)X30+%BUX<UJS/%6B?@CYLXS<*<(
M_A+=/W1%1C)7JJJ?\S;*A'+8F%U0A"'<,(LS\&DR269ES=*WKZ!,R'5,3@^8
M_F!!PS#&%:+MC$84A.0,89;W&J,Z Q*.0P._B-T+@F.I%(W#KXYBA/BQ<UC/
MFV0*VF&KGEVPJ6V1X\#-+?P2T9D8H!VA(X5>>!I?H=\ES2_H]>MW4@1GQ[#)
MLUC ,:LQR[O.R@#<UO@J9GDE@=/R<NNZS<&D%F?(*"/HI_)8Z/AH.;A@KF!O
M@!%KKA#SBF4<,Q,Z'1P^CW*(]+<2>&#E[DH]R/P$S[[(;%A#"W''$@T\* 0Z
MU#@W)3N9.IVK#HQ=?6U;5?$7#/0XA/U#4_(B&0;3-)))^O4<H"O0E,73!'?*
MH1.KL9"K-(%?C&@US1[ 0E;&W ;3"E'69/TXF].$R$GQ=?1%PO]05E;A=MJ7
M8#UA-J?C\=;OTG.BCSTG@D.$A5VPJ*S&E.\ZO:.<[CEIM8;5;&-R.=MOO&X;
M+G3/60/7DL;,P=:M^%+2$/0F1(60:Q.5(+J#%"_#K^AU@)#B%[ 3GM8#YN;
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M)[%<.;4O+3H3!/V$E;72P<1E#ND.G;B\=*+F0XK_, 6;<RH*IVX2;E&4L*%
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M=$!\#N[02%D%,-Y?.913PDQ"G)E;21;*OS#HQ=K_-9[4IL14*SB<,<>D#^I
MG<:5GNH[8WTI!6CM]I'!^@V/>_!O9*:4Y$:. :BX'%+N 4TV<)S&6VDRCIDC
MV:&=B6U45Y)Q)9TE)\<[9XJF&+.D)J!"41%JJHF,1'31E8%F@@OL?I$,RZ2D
M?INFLUXBFHR2/3@)K/YWYX#SS*FVDRDQK)\"4ODUKKEU:#<F(%R&0KAA]K2^
M9<.#U?H=@^I/;(BBB+4&&-4R7?VR\/@$&NLLMI0=,AFJR30.PM2A^*#T3SQ!
MOQHCMJ1/S:]-1!1UI'EX3IQ!IG6>Q\HP)P1>TU.X:G,A:9O%CG-O!%BT*;ZR
M85;.4^'/SG\)J(T6.* %IB<C:6<.@T,X$EZ<SJH3\+KDF,1<8$%&-8P8QB>Q
M;[,J;(RPKDX*YZET3-@*D<_@UBUN<(\X>X( />/6-1_"D[K0$I-L3;9H@5@)
MP& SE1R5_!!_!,;"-:^DC>FP\-RQM%3+[0N"<:?$5U4\CMM-6#N!^S-VLMTW
MUM,2_Y]#. RSE%?-.;/BQ[(?J/Y;2;VHU\(;\Z'/5,-/P4.[:HR.K%M-AFER
M3BJ+^ (-8_PID23"1H0V+ 4#CK@N_\^E2:+(!@P8::WVFP"H_?BF,71<!F2)
MR!AJS]2=RVB^^19\;TO'YLR4P#B1.@4(HD4F81UD*):41RH$QAAJ$C2V#?$1
M]G3.$M;D(W@IAW;U=7 )9&28HD_@K-4 W"=6+-03FB5M<.,L&/$X(YY"T\).
M;,*%XTJCA?4TV@Z=FKO5F. =175-\#!*!8AX4[?P+)&8F0N1;8K7-\/-(N.[
M6+BKU_&8C(!:O9!&4!556^N0'-D6Z@WXL\/^4;"_W0N#W_5+1S9Y40:OY//7
MMNQ5.\O*Q-WGDYN9:A-<C<\+[$?7J88+8U0)080=)F^+)"@-JY_&!NSTF#U0
M;RFI]] J6J%,O1(,BH^=T<Q"?7 4P]/@=6EP"\M:#F.I757[9ZI%2<$K>#ZV
M@F%%]4;,)U+)-%VMBOA)7-H/+*S:9+PQX[VSR7A_[QJ:\MQZ$7GB(OYFKHJ(
M3.YO/C;IZI_S2X5KF@<9R# V-7+1C6*NVZB?ZX,R6$[Q=M9807\2_UBJ#Y>P
M01U\A$G!)1 5:1Z4"8<XV4\3SVT@^6I+)IUP3259..B_$QX1XY"84A%[NI96
M<9Y#NK(LR7*AJT.N*-7SQ'677(+&Y%72%N4.H-$KK7=VQ7"-.*:?5[,O41)&
M/1H#*G3,LE!!/Q-L<^SV0C=/#^G^$V9)RB%B<$!@F_9+E" J9%N5FUOAL2XT
ME<,!R;\IWW.,"PK.48$L5XBF2MDH=6:O.6[2NE&1Q:,F5"<OI:XY2:B1Q$@"
M+S:5K-D[2G[B*6-%'OD$2V)A4 A "I*,B&H 6':1Y# EQ\R!>THDW=C;\\-N
M6LL:>E[DOUG0-'9=NBDU,HCFOR\LAT,'T\O$I.B=2%\521SSP.U/%;3L!1(:
M=F A[X3=&F9T)<P9"9,3#3;N$O.<>H@O\L@-+60-^66![D5R@0U0TANC6%;$
M3;BW$RM;L)2&51:7#8*Q&#]OCQ-7'L&_+2Z6XT2("%1?/,D,E_9<A05EGT<<
MH;4N99TB@&WLDLA-Q?Y]F.%K)Y US<=,%?'&Q@A^*Z=&R5'G'DU9\+G: FOZ
M6Z9 QVMPT5(FV>CB<12=63;5>,S#V[5&PP$'48S4Z@A39N#R"E*U@:U2,<40
M5F?H7SG,YY0H<*2BY!P4K$9H'!^Y+V7A:4&,"TCQQ^'-,(UM$+=&<C,.TO@"
MPS)\U0SQG^Z=IR$8<_N9:#2&K$7[>68-KB%/A\,B#84D7FL*D$)96;/I]34C
MR!E>2[*N9(-HI)R9^G3I]!DH@<X#\+S;.*FWE#*'AAWQQUGKQ.@"MYJKKKBJ
MRB83..M!P?V?6YOPY,KM4(_CR>>S_XXFTS=OU1"69'S-%"8%D: URI4%2-T9
M2__+DM$PHWB,7XD%UE\7*K"\"B>@04TV8Q(_SRVUX[GD!T<IO"AC,)>(755O
M&%.5HBWJUNT=M[S8D7@6?%FUHW"C LWZ2KK].!:UO+!TWS9_ALA)V\(:!;?0
M:<8D5"ZXT0T#4:T$J77,4<"\$3]'2D2T1U8_9^6"-^EYB_RSU@KZ0B=HX/6N
MRG5O*46^JS'HAC7I]Z@A><3.1>AJ9C^_X0R.4H2XF%0=;OY+X_ZVSHWS(IP%
M"$U^@ S1,- ]I&!(J'!!29]BEL3P"8BRQBV$FQ/5BZ]L&&P8TZL#M,0*1KU&
MI<95*#WHK@@-N*XGD00_CB9-=P-]__;+P=7M\!SLA,&P 2-2M-C<79S[_WFO
M;> 86G1RJ 9I%)=#D$8\XX,<J<OGCI/=0/]@J9$C]\L('=DQ<[/<5K5H8 \<
MS0%QN4RFN#D$JLVBB3@*YABF8.5P[>=1XT]M%R@<*KP_*2_C4>T[G"*Q,&#.
M58H-1HG9:,0@F2Q.380598QA2J9-@=?[0)B3\>YR1F_',Q^(8U>;!)R^O/@"
M6O[[Y2$*%&\>-P-TSPL%35&K<#C@:2A=2.7-1<(7QCJYXQ>AG:<SSIPWY,7X
MG-PQ+$HDHQZ6F#R>#4J<(Y'*K3]T:EJUB !AS+BJ6[C"4H!%1;RV,QO]D8ZK
MH[Y">T?8(^K<%@8<OI F1NTX;+M=#4HPR;G&*1K -W,3M[C7<K ?[B;_6DTW
M;%[-T.Z]Q3.0UJ^T?<ED$H\2ZNCVB(/2%-U<J0/VMHIMN&8QWNZN_375H&C]
MX17&* X_7,&=8SA*H9@DT]T=X9X2J' N'#>LR9:)J8"X0^#H9=)-E51&60W1
MMT71=4)[HBFE>S Z.O/$14[X47^GY>)BA7!AJX)6W.)6R05C6Z<D%;1E/J!+
MK4$WE(Q.R$AY#V&WN-)1P5NW/4N$7V$;*:R.H-+I9W3>"6XM%]4TPK#P"DNN
M=N AX FLG73SH8S@3$+#:^U[B>HU>L_)00HZ"B, 8.=ALU%'$]I:>O=.$YRV
M+4BCBACR@YW,(#HH<_=1IA>/>T5FB&*VQ=J>5T@%8DT_"[U BYO];7#L%,_=
M[-DU7QCJV]?SX*W@LP::&8EE$2?6E;V%0GBQ4>+9"M>71.$BH)>D>1&0J6S,
MG@%10W57AFBS":>Q'!4<)(]O$VPCQFU*5F1%GPLSZ'+G(1X(5_JGR\'R7C3@
M:LSTSHR+#Y#A0$ES=L"YCMQ\ARK)N/13YBY YKUS:^ ]YJ3&/+(>-+KH(8AX
ME@O)$H#,%\M6&=95H+$(^B"KT/HDZX'"4^/"."=8\V(? [X)F&'4DS,""]&/
M&?ZY;(C-XZRPW,4BJ-U[T$EC<FX5GVK[B\Z#6<V/Z<;SG3&[YO62<%P3NZCU
MM9%8&QS.8F1RS; R8(Q2K&P!O$M*W'K;W  5KC/\#?XP$^"WK0'R*\!E%>.[
MYHB(7]SS@;.,6%+NWXE[RU8B^-YEI3FE<-6)<6'7E2*1SHV3@-P0C'APJ^X&
M;O63+]<3-R)LSUMP2/?.FERY)G4=<VBR'O?F6\$$T (,H)5S=Z'<=\V*_RYM
M[W;1Q3O3S:A3]^VX('HGZAJ03'2H8_1OZ&X(\N&P8HX(_UHPM?+13&#^!J]&
M>!7#W5&#3]0GW! Q',080:+B5;UNV+/T;TH>:VVY,,W&Z#B9&I<[PWK!C2Z,
M$ [57L&?834+?X@/Y=<L^$EB_&9K.C1T43;%I19V9< _EMP-U@*D%)/X$OZA
M<D\I$FOD=O,R,)I Y4I34NJ**L)"'[R-+=67 Z:6BZ4I5)NBD4B_OG/]47XX
M)X:5W#?3B'Z9E(M6CAM2L+PUKOHZQWP^:\42_LTEP+@C?,Y8,5R?^/^R]ZW=
M:2/9VG]%*S-G)GD/8-U!R9E>B]A.VAE?TL;IC/.EEY *(P<D1@+;Y->_>]=%
M%Q 8;,S-=<YTMVV$5*JJ_=2^/MOGB7Z\$GE:+YR#!+;*7!C+Z7OH">9^CG\F
MD[K?+'T/MTAN7(P/-,3VE"016C,/5TYLKT*&C"@V'&(S\M% ^+H%O0TJXF$N
M(7,J(86ZJFB(\HX5#Y8IK]G3T#S"[J@\_7'.C2ME]PJ2U*]$& M ;DY8]D0V
M)>0AH/P\S3#_5TK:&>12CCD;2]%PF[$8:;0G$W/L[-SS1CT>^IE(8"V9+YK=
M26E2B5\VL)Q';;+<CF-,[DOLV-B1=,4E-9FCE,)U+TK1OZ>9&Y5<53E/.: E
MK1AHPW@&7(81;<[=@!3\M!A;$'JPSL)9*@MSH$:)X%:D)QP-,M'(40Z!TJ9%
M&?$PH[[R:&8C4S5BENE'V4[\F)U3F-W"@C]9N2A]0JX0CU?8\2I?42Y.!3TA
M$Y2\65[^)*<N.\=3<B!ZQP%L<3S&Z*D<>?1J&M"/!Q&]>&HHG%JSAF1Y"SPW
M)B525\X84DC7*CD,*'B,AMTH%H>NH(FI*=_2P(+X6X6G.41)@:9826N\80IA
MYS*:@=!G1WX'PX_EE*QX[^D/E#X6/[>+=Z-Q\NQ5\%L4RT1DD?^!JF[T9Z96
MHM<*BT,YIPOUZ^-A ??-BNLJQ0*SE$FE37!@]&Z\$5>.#[53/"W+=-I24F<D
MK*8Y.DAADVEJF-9&&>%+IY 5P^4R9,6LY5-6\/J*J*NNB+<9C@=T.&7?8)):
MSCTM@D["61?E91K?O9#C*N*_=&\SC*#T?2GQ-*-)8J+IYY RH[./.AT\<OG%
MV1WX>P3HNBBNR'=.Q4+95RA6^*SR//=&N6@7I_P"%9R3_J"D(A"!X'VB06M*
M<!?1_Z;EZB1K3IX?=X'6H+A12[9Z(3\,<&(H2/*%ULR@3X ;J$7P&.ILY,PO
M% I%2A GU]@9?_O\(%,1\N8 G2L8$0H5H$E:]\2=T\6.,WSW%/A(Z,Z9EP :
MS92*"B5&XCJ=4%@S]RW76&'KL(@C(TH4B8*TFIQNR X#U@D8+6>#Y*PC0_<G
M;^07"1C*""=A8]^[L3]Q8E9F'9=<6:7$1/?PK&X0%J( J S& ]H)N2,4;L&6
MA$Q5DU_L%">=$8:F!0W<A$@E:H1;^Q?&L$M+I_J13WKY/,J\3_RS@ MZ-QH7
M#D$U30K'.(!FQ,C^ D$JF02P==U9FX0>C'2IF3J"[!=#UJ@7\_5X=)<^)ZVD
M%M9(6O53X>G0V7#8B<@*Z7@'CS1#IL)H5>(X:D<\8VM<R3^/*T:P!5RVYV*!
MW)1T@PX/9BC<4VTZW^1Q'V"N%5"=BZ3I0'FJ -1*./,9S]NCIZV@NJ>,]51S
M9,GO/D^]HHH$BSQ1+8V@_CGH@F7O(]-IVK6XP\E="$WVSA1S2H%!DS+H,*A"
M>.<R U(\$G-HBUI.^DG*I<8K4V]'</B#22 2NC-V'Z$E\^XPG&H&NPJRU!'N
MC.0(@<X.JJAA4EA\1^9T.*WD:Q39XYC745#KE4]CT5!EQ9C\/I28GA+#T/#H
M]'<]6GR01%F3A"FVO-+^(=2B*.D80M/@X/>>>R_NL1?G^@5;Y!P;+<\EITU6
M\L2J;!G@#:I\05)M/'67,@=5A2T5]X# ] U[*2-G=G.P9_Q \!WDMBZ;XV(;
M#>%4+7'53DA4/WC(/:9-T(@0_6*HP<4U79K@1]]0U&VQ/339J^*?PE[.CYS2
M$Q-:980J2BH*XN]>WFK,S$^69DY/L/0\BRA_H,O2= ,_<./%^OUN1UO?_0NP
MT@KSQ6@^.UG_*<J=F:M\%Z8KS9*%V0(!IRR;N'G8/JJ47Y/;9")U[BT'T7<3
M.S6] =O&U,+B%*74=8E$YU.PN!>0]3UG;L#QDSMHF'T&(RH>0R*(#?/#TTSF
MA%SHB9' "S+"6WILDP<W;;1;\$&D19T*]G#+T$,\D;LCB@YR["SJ]G+$>ABN
M$\X,YEXNN)+;::5U6K:;9\QGC<9O8N(.!4F<I2):>ZP#59[3@1GFHCTR>[E1
MC_<=*")U\34.,V;!C-Z(GOIX$GL]+$NEC,2LZSGV!\(1YWD0'NLIRL"4T\Z5
M-T)G<R=(?KB:C>T)RKM!3],H3,O7'(EXE=D3ELR>6'6O)D%%+ KI"*6OS[-1
M%DKL!!24E%Z@O(F[Y2OBJ-I6?@]1V\H+(W,=W?)QPP]*-[K'G+)RXN-<E5QV
M9XI4V1BS#ZC5TQ9X0AU":7,06H:"PCC%E\'?#[/4Z0BH\EX<1DY-[+BB4F\B
ML8&:%:Q[$R/]Y&ZG7.5+GOH_E^I0$L_$PY0>G6QL^Z/QIR9.0=GG[6GH;#"&
MB8>"6DSZ&!F)Q^DRXHRWR? >'>(E4SBGERCK]9LC@D_I<+BO5V@[09SK7):#
M;W%=1KQ0/CR/GHLI6_+$*_'"1>K-9DT\LXP/&CD59A]G!Z<OR+UXA?.JU):D
M0?O'TCL2?"/Z]CRE!?V/[(@M,429<*61>W:.TX%XPI/)%:,P*FI%47[9<S=$
M+63ZVW14Q='PH+.X*7-K4#Z.L% _4B#J@ =QMQQ=N7O";;G,NF>WW0O)^DZS
M<M#90T,!(CF$9E2QZ!8U\X:N2+3BLXM+([3YU.W#[1#Q][Q]""C.,WUX[1]5
M@FGAN?:A$Q,T2<.0LE@AVC,ED[()]@/>$8\_1?178(V*4@9ND462% ^P9(2=
M^@*\]%NM58/]_-\1K?_*&^1M=);2KH0@7*Y'/Z7M*4-Z3@&2$KHCZ!VH.SFD
MN1OHUD+N<E93)Q1=;(*,A7AI(RX^'?C%FJ)<A((P!%]VE*!>C1$H/G#:4B%S
M,:69X3%;)ZKM_R1DD":G%%8@C8B7+B4#3^K'SE,LT-?*,Y]5 $A<#&I1TV1Z
M/07OV;0+9$<\QH^U5X55.R(>Z;=A*QJL,X=6S&7L\C8=*7%2^?&$MDJ8;@B2
M:T9"Y[944I@3:LQ]_*1/1)?;&6M:4UKHNV(/9,$AT)Q@=F%J:,^'"88/\5#<
MO=VHYW.?+$ER?J;"2] S@?K'LGU&FV!R3S .H9G0*Z8G*<>6(PXSL;T[.5')
M&GN*1[ WX<=&&@1VRQ=G5[!XR5 %=@'** N]/6E%\9U,TMB!,1[T^?X#%!D%
M63< T%1 Y:)$X]@&1IP]HC@H#^/\+IB1VQ_THC%AK'V8_XF5)^)O'+S8Q9.<
MDODN!SSJAIF$Q9INW/J8M<:3@ZB!S_N 3_;!SBM47)C3JDYFI[ OI4D:&:&$
ML%)$.AR+!:<ICRFQ(_<O%/IK,RT%/=$%/TX63J8WY;[F?- Y",$@H@X.&";-
M4*S0[.S! '8L/KS"O7]4,M/&]!GI*)L'Y ]3.H0D62!98!A_/4P#C>#$][*.
M2SC"B1D<<SV1$G%R/@@VW4][1,D"4;C%M"-Z+\ZBS6X .TE01& P.2$]YI_A
MP02L:6-Y+J7.5CY'PD)A&<P"QE(+,F.=%W;C*.RX=Q%+Y(3'(Q SQ;]$2-+8
M%&^FP-4BG":%1=E%X^'[_(<%6Y\%J4IN+G)0Q/Q6J)(%QQVK#Z J"5.C;VYB
M<D-90!@!=$JE(%ZXDK8=$HV-N:HXW2JRIOP^SZYGIT1Q"9DED#.7<]' 4LKS
M2IX/-\H5HN=2C^CX<0ZQT;,KVGOQQA4\OD0UM*FB/FXS\;7+2 IY)^<]/:N^
MDI#&XSX*5^9NO.7"134B9):P#'J$!VY6#OB;#WJNX-VDJ=AIHDIV',$OGV*6
M[_@%3(VPHGP&[4B0,;4 HWZ1&&X#&M6?//;- XA,O+.4[R"<\K"+<>3R1HI!
MQW!$E2;D_DI'- &>C&>?^C 2MX?G+F]CA./#>D\J29QJJB*2&MD=6+-+A<]$
M&H:F;H%R;LM"HI28SAQ?,Z>52$WS=,8%!4-6UD 99+B*F&,03JDOBG2X2%AV
MEX;$\I/'%C'/D)N:FME]*S,&3*VW-L^.C^*47QLYG5/7"_-6\+Q_$J.5"=.!
M!\<HR;E1YFRQ/)4&34N="ED4HA053C@VD5):>&Y:7BW2FGGO.MC\,>GBT^]2
MCPB_@:C^Y;8ZHR?ESZ#9^+L"=(M"0$J35]C-W!@JD)?F-2JQ?<8!MF6&W^[R
MK&PTZ10>QVN8QI5<(*H3/&3V9"Z;CU,0T;V<K[+(#2?3F#+5RA]E!*]40"?S
MZC(KMRBNV)(2ARNH^5B21/&]:"\(D87>CD)?M+V"?<KZ.2K<1PE/;S9QVS;Q
M/P!%_QT%("&4*47D%%+=%Z<@97G/1KHG>VH^:F8;A$UV;@Y%<U/\T@1X,W[W
MR5NEK NY9E5IO'&R8TP)IKF,/XH?#G2G\/*--$LU?9?"\(K. "$365/D8M.\
M?%9B+H]FLCLSSZ_*WJ^F?$O80&C)$/>BYXO-*]RR$')5F#PWR]_."#$5]"3>
M4+ZM."U6P:U/:QSHTWB;F9Y(<N,Y;Z*"(:T+X'<*]B02<\7C+(4-UBDY09DA
ME7H=J?6,BQ>/6+^PO!N']4'-?#F'Q6NGHO6GE)A#9T&UK' C !F)O>YXBH":
MMJ*<O"7OM #*6LH_(IAS9_4$XB^:ZU:0+73Z:?:&TXTO:2?5*"Y>*KD0"M%\
M6T;S5R&DG0B#>KA'TTXLXA#)4RK?DSBOCU.@8P+.2W]3L18G V7R$0',3.LN
M<#H7^>XG[Y!3\%/UFRJ3A&JDY:A 'XD=LBLY>FJ8N04Q5=.+ZT5_+]OSS$V>
MRA%6UF %=\\=).2]^.$#.@![[OA]$-+9IU_Z4'PB[C:8\"$>;OPA]'GL8[X1
M':=65^NX%X<Q_..+!_-M6J/;]&#H3W]65VNJ9L[\6*UI,S^;=UM-KSEU^TFW
MG?^991@O,]CZHK>%Q<.M\J\WQAMQG5C&, K)\E<>T#6+9WUE@"DHX<U[5=$&
MP[*[.U.7ZH,'O'AZ8T[N)+:)7AQ>ICP]:GF +!7"#4WU3+:%1]=@@7MP$*"H
M,<#DAU[@*V*6=VOE$$@76*OG386<:S'7ZO;)A><1DI.+DJGLD<[4P;6FB9S2
M9NA$'N6=$3-G5'_\I1?>7*I2,B^42&6K)D:M&76F)$W.RLIF C^E,[+=,_$_
M3P*U"5F8B5NO<VN9<FLMNK4VJ]OL H8?S_5V/@G42V9A1X3+J%G.DL)5ON3[
M(C]/5]_W<X/H-759]-WO#2*5Y,=F\9)'7FC'KC!)>X[0JI'G*,T[*3Z:^C3E
M94_%YT55W]W<($_4;O=T@T@%]K%9/!'%O:RJBI8DBVQ7FC0H,FYH]/.5*;1:
M;5F\W6]U1>JS<G^\,-P>T)#C3D>IFVD6->:CC1+E;3\(1\D[1;=X_>P@"FAB
M13@KPV@JUY3FG$6"M"^-<G=IZEU$^>(P'9+FB]/ZP%SE@J_\7:UI"KQIC_(*
MI4GX;W,9^>_2ZJ6PD/#"VH'2.JB9B2T5FK8NR+-FI-Y&67Y30%/R=)JM\G>]
M9HBA[44BT7?&L<?X->(X\#&1572TYLEH=_D.#K-28M/?\> 5I-*3-Z35>0DM
M7LU2%J9H1+.42IKXB^QC;J%@O"2->$;>\17- \/:OY1D<NIQN*Y9^U5:*"3*
MV*>N973ABJ;^CT@>$NPIHG$V39^KBH*2+ TCGZC%\P#3S(RR;+\ASP.$71.*
MBFB>H%&@AL&\]HD63WS6@R3?559D'Z8IC 0SZ6G+ I9%GN8E8NG(,(@9G8O/
M!9VS)]+78-48 >S6>5E36R4#2Q91M(:1][/*$M .<Z;\;KSLHU5_@T&/)<*5
M$T,S/LW<%.2]&;SK?7HM;V3**?[#@#%J%1/L!2%5KLQJFI*55SO,>*SB<N*$
MUJP+Q$/2P2O1(/?-K)&7(%.,7;&_\P,).6<^E;X &W&P0L.,;9'2ETXV[^*O
MFRPU)II#!3>F(, ^%Q_PAAFL>B#W">\'#^<7GGZ%3RC))!S,]+#D+:.%U--5
M2@)*U520=L$LA;=@[.0<38IT2(S+@J0_T6, Z_EIX1>%Z=DKQVKY"OG-<W@#
MR]B>TG*^8OW8?H+/)?%8>> )=O]E%:A-'S8._-S,Z,E;H$3YN/"[,0ES0:G8
M*V[KB M;HWX?:[!@\[5RA VYQ?C*"?[WD=:0H_5BM(:QV+PNW[$Y0GT0^C!"
MPC56/C.];P/_7V\"K:ZW.Y9J:Y;=,0UB-VS'U'37MJV.99I:XR^[_F;9S3Z9
M9KJNW3Z#^?CJ^(R9)/5F;6-;O7QL?WQKGE^=7#6O3OX\5IKG1PK\X53\?G32
M.CR]:'V[/&XIS8\7WZZ4L^;EOX^OE,N3UK_W (8X(T*N>8E@/LXU,2ER'>1X
MQ02_3#DC.V<Q*/0[R351XW79"Q1-TQN5%FQ?19P]EEEM68L!5JB0ELLDM&<$
MK?9).V"G'&QE;1'$+,SJND!MIAQ7'*/?9W7W2&V2MK*?U0>@PVCS&2>4X#XO
M[>.P&[ML2:'[Q+?.H=@ZQV+K9,U):63Q$O??;DS!8X(F&,.GJ-&9.5\40ZK"
M8D^=*3*_1X1NCG"5B%!ECL3E.V9QG,CH?7)#G3\B]A:3;"<%8<*'Y5HQ^P1M
M$-9Z!%[X>!1'(*,?P6@+8$ #]-;"[ZW[ +LT8$T[_'8(*. 'L*P^%DH@ZS6M
M<D?!'Q-XRS/R@!H,V  )NYG["X#"1694%[GIF]B<T.WE[D!'=4B;0< ]1F[(
MZ:M3M"EY;4Y+B_H ;^@@&BBWF0>)$>%S(ML>97M@Q(LA&4YR64;8'@,[0-V!
MYN7RYC]@><'$C)#?F_6621@(PMS<B)Y-&<M1.K1.;X3>HI2:OS#]$_,=1F$'
M5!9.8<EO$7"8+/3E*VTC,Z/!DZC]1BTK3TTVM6=$VP]A\?%RWKY[6R!!Q'L'
MPQ%W>GW/& V#WECP#*;4O3B?Z!'CO\[NXI,]E(I=KM?31%<F1CDWLU(])5H,
MBWZ!?O8U;@%B]2<WF5,_'.L%Q+H#N9Q_D6X0042W!WA8WIPHMZ.F=HC8&.E.
MR2U6J@9,"6-ZTL[<[V[V);8RE'(2W?/8M3.KO9\6BC'UNKL<0BL3PC?U G3;
M':0>WWRSLP*]&74VYMM'M2>^R]TYPK>TS$QQ,4S<?KXG#Y/JR0;F]K89I5DW
M0N4D!RV;-$ I,ROK3I8O_%9>Q##=![G/MX"XAR-]")@G>@4R_G)D__*IY-Z@
M,X^% M TF.@PF/6& /R?4"]R7<TJ>>4IAZQ,UK)6;1,Q,43U'J&$AYD4SNV-
MQSKT%=@R<-7)?T?4/5"9<^;ESKJ4>U"0U(VF>]&)!FI%/:L/LR7Z>7'JK44.
M.OYV,RY-XYN%_F,3@%KH8"=KRO,UY7594[Z*FO)R(P7)8D8)6B'([8OB+3HG
M4D+#*5HV1H< ,,V:(>P(G"YI6:?Y8JGYO..O6;XK#E$?IR8:_G"<4ODDF]0&
ME*HR[5!++7G:4B/G#9NVRKHDNX+;!QFS#FVT(]Z:_I 1&&'^A](=#U"!I0E)
MH#"HQ5P6<3PH)4V(4XY-040Z\SF4EA+#,)2X?CB+,H$=8VGO@,F7 BFDOK,'
MFOX"\OEW*Y?_0AD1X7_A2#A(:J!(%8BC?9+>>>KF[-GM'#D0<KZ,BMF2O&<S
M4[MS#52&61NXX@BCD!3F,W6)Y,ADYSA"RGP@Q?$(K8@9!!.WVAWZJ:55^O9P
MPQ*+-*I%N:2KQ:RK).?R@B6CA.7,0:2<GGR\N*PB-3:2I:5,[FQGC/*[GMXT
MN7<'LYS!F?T:S>PRGKF7<.O,:BA.@_2ESTZ0U:T(,9DW,FVIP#B.4\DIOB,,
M@SK5JYQK+7OC?&8 37D;%HA@RD8SCXA)><OG6+#54H4[&L%*^\F['6=> 62N
MJ4QE6Y9Z13-JEN:\ $>*T7@!0A>M9N_.8/6:KC[MMG*P>S78>J.Q*X,U:[JU
MV& 7) S:,+])8R%ZD]^9#P>]9 MDO"_!#;-3LW ><5]TDQZ1KW@FC@A:!LSM
M>C2/J&7_I^(X[6'ZRB?BBM)?RCV!@3;*Y5SP"KWBV3A.2VX^H?/^3W3>%Z;C
ML9+2%?&0+4-9)A\I'_G"C]P)V6VR]*"WIUDHZMU2LKLBNHU^X/L]\M)S,*.@
MM=J':[K*M]81<\XHIY$;+@#HKX:)8;%Y-%2U @_8"!?#BZS2\[;Y)H5]!O>B
M('G5#/0):O47W>/[-GM?W'"$Y1O4GZHUY-P]9>=Q;[0NT779*427G[;[/#>+
MO:SD05IZRMY:%=UNO-O$N;LFRJ ]T1'WE#UFP7FTGJ(CKH9 YD56Z7G;?(M/
MZF?IB*]U]KZ,>D)!=.3$+35Q(5$,E2J'IH35Y95#4S=VGY7K)97#5[T_0#FT
M='5QY7"%!ZYT($H39E$4DP[$[3ZEI0-1.A"WPX'X-!WQ=:-KS="6U1&E _'U
M[(^W]8JI:]*!N/4ZXJNV9.J6]!]N\T%]X0TCJB&JS]!R7NOD9>[#A;I-RHDK
M<Q]:$E27SMRIZ?H>D/I+]^$+N@\U7;H/MUXU?-4&S)-40^D]W"W5\+5.WK-5
MP]<[<<]5#5\UJ!HUS5FVOZWT&KZ>_0&JH6F;TFNX]:KAJS9@I-?P\4-ZD_M\
MY[V&FYR\G?8:;G;B=MYKN,GI,VJZNJQJ^"Q,W>3+2J_ADU1#9PG54'H-I==P
M _,HDPZW^Y3.D@X;.^HWW(K9XWK.RU;>[N_L,?WZ91->7PQ?-SF%>JW1L-:)
MKKNG)6Y\?VQ42[0KC88M'8A;KR6^:EOF:5JB]"#NF);XZF?O65JBG+WG:(D;
MQ]<-:XEV7?H2MWI_;%A+K"\39I:^1.E+7/\\6C(%<4=.:LW:T52ZC0>:N8[S
MLJET^S9STH_X_#.J9FK2C[C=^V.CB:H5R](W=_)*7Z*T91:=1UUF(^[&:?TL
M+?&USEXN'?%ED^KV;>*D&W$52J)J2C?B5N^/31Z]#7U9"O4M<B32I8*)QC:\
M*W;X//8]WO"&MV0U8!A^-,(&K[AB'V:VPWE\AVR;COOW96V'E<S,5L.,5JD_
MQZVYB@EZ AYOVBTE[_%Z[B'14Z+GS,"E:50<J[YT?MLF89,J*@>T&?MOCS6$
MMP>%?O!V<8/>CI)AT!FO>NI1 YH_]SKM6-HE"5$"T:8S=H=$2>[=0:+<PU\4
MGS>Y);[B)HKG)EVETXONE2XV0T[P;U%'$489._RX9:;5%+BW,HR&;D\)1==@
MEW8-3I28].A-AY$RA*L.HSZ\^_@??P/EL_XAF3V>OVNU!GM,.^CUL,VJ&_K*
M?3#L*G]OU*T:/X#[_$.2-J:=/]*/;@*#@2]$HQC^&29#N"UL$04V41S=PT_P
MKL,97Z\H+NB;JM)VDR!1!E& +^AUW? &)[;X+O :T:CG*UT7QA3 2WLX"^DE
MY&% 0E@/& E.RRCLLJ;3 R$:^2TR4Q%?U]Z)8MKH%N85!^N3]E!ICW&)-$4L
M %T@^%\X@LW^"]Z$3E(ME?14< +_7V\"K:ZW.Y9J:Y;=,0UB-VS'U'37MJV.
M99I:XZ^Z\699:=/T6>)&A3>=3(86,'4]V&SDO?CA@Q\D@YX[?A^$= +HESX4
MGV@-IL""/I!]_(&U17><6EVM_\^;U+SA#WZ\WWJ]UC!7W\6]X=0<RU[HMD_O
MXEYV^+Z,;3NU9<M[>9Y<'9\IC=H"7H$M>RMZQ_<!@&G@+?">GT[.F^>')\U3
MI775A'<^/K]J*<WS(Z7U[>O74_I[\_):.6I>-:=;F>[!L?8I"-W0"^#$ 2@?
MDCY!3,:C I&J,_VADG@ M2/$@P'Q@DZ 4#6&JP'13^"2"IQ4-P2^'+/#!F\3
MDP$@(/X8$P:#7^/ (_=PR[@;C1)R&$4#$B?*Z>E7."/@]!H R*-+U5<Z "_T
M7*%W5S2+H6B0\+O6E"=#I/ULB&1N7XF0FT)(6)--PJ.S__!X^'OS_/-Q2SDY
MIZ!X=-)J?KX\YC#Y_>3J=Z5Y>'CQ#4 2_W!Q+GX].?],OY#!*WSU\/2B]>WR
MN+5"(-T0:IY'0\4=#& .<=QE&,0'Q+]EZK4ZBO8@2@)4!=]3M1[4;2[1;++S
M7^1OK&9?<=M@F8V&L[]2!DR;F!RS49R._+^7@&<GA>=NG G3#:FV8^+^K+H=
M>,/W;N_>'2=O#HJ;!O;'Q,1/SAF;F=_^KQW#5TM&^WJ49J>F:O75'PF-6KUA
MO$JEV6F^@F/AXOSJ\N*4:<I?+R\.CX]6#.QKU9 7?WL*<,=W;F_D"I/^*$B\
M7I2,8O3.A,,8UIHJT%_CR --&339F:?#5DW"7$S_3I2^&X1#^$?QLQ?V\B\\
M2%\8%'1W2!5YYA9C_BOX_"[PT1QPDRBD\.@F<!LP,0C[1A!VHKC/9C8F_QT%
M,?MFFXB'4A\0=3X=/W#/4=,;<EL@4:A9X"'8^A4VGB3!'Y-1'V:6^E5PI.QR
MPOQA 7,A#6&Z%+!"@LA/<K8-_[1%O%$,YS!AKYH^_##J]X,D@0&G+KD8C"-V
M%;Z,,*;@[9*1URV\(HS6];Q1?\1<?'BA!_<;A2#XW.>';PJ+!\<>&E\5^+K7
M&U&'&WXRB.'W8 #V&7F  5+_7=3I@&T5\Q41GV>6'/^\@HX^4&'B""Z"IZ'=
MIKAH:^&PZ6STQK!\7H OA]-ZX\;TP>G"9/N@EA>"&7NBHH01O,H03FVE"T^Y
M)[U>MCWP6K0!\;TKB@<;7.R6*(1QE&X9D#W7ZP;D#D?%'&L)'1@?@1*U;YE3
M$QZ.#\@FDFV4;(.A+C=6 MA!MR/_AET1*H3+.;^]%R5PZI*0=((A\\OBS'2#
M 8X$U+0DP/'->/V:<I8]O0MSG[XZ+N0B(O6( "TQ&W/TU=U!I&9N!=OC(AQ<
MHG]",]RJ9KUMOZO 7F-^9,^-XX!.^1"]K23%\8HR"D%!H_.6C& ?WM%MG_G,
M\8.!BT<RB)- _A<43NXJ3MWR(0!9YC_&G9,3F=QP%MA(BSCX1P/J6 <IR<_1
M,]\*1X031#@>+CA>&LY8+#Z1%Q**MF62LBN[?TFE)(.7]"2Z9'XW6,H3- <Q
MK,0U%.4"]$LE\_VQ*W'G[L;<S$6&LPF83V S,VS&DXTDJ)(&@-OPMNQ48'H-
M_=T'2,%(6B F+$5/G+!L2\?IA%$HAP^8KG!)#W\./9UW.5C):1 %K(+-K#F&
MR<YC&#2(1RU;KT<?'R2+ZUC9&<Z\LKW ;0>]8#C&092^&_<##^!/;@8T)6[A
MA,WM Q_V8!3#@4@P/HDJ#BAD=  42F\ S&+0-,;X"1E0S0<N&87TD1P_>NR[
M^/!O88#7M(8T*@B/;_9A7WBN\A8WNJY^^-QL?J4_:A_>U93OA*J -R'L&(8S
M;>*YHX2>D'C"!R'ZH6%S]((^2!<]Q"M++'C?'6.8%B?E#F\#[^V3(:"3@II@
M.B$UI=E+(JJ%TG,7E2@\H\-Q#E/Q+T6,AS7LC(:(AT(7134Z&='#6T2!XR#Y
MR=XM!4T<%;QHU,>]FV[CW*NS+4=G%;[D!WQ$,;L/.U=N8L*NC?H#V!SIDM$]
M$ $."?TW!\_X8'Q_&"QJ;[N"KO-C_9%8(U)^#./1M?".J>05SU%"F$QY  8P
M.A?%%WYN,_PH"U^OXTPIGX>I8X,>+?H'BD\W5%E7/L6 6O=1_/.EQSYWI&]U
M53/> 1HF(Q&0XL89&!QT3[?P%(ABE."+^,8%>'!3H<2+KP R_7O8S)E)ER+,
MX47K(D.8>2I2;J5+M)W%0>8>3H-%<S+V0>!FZ;JE^2Z+GLNS]40TP-J$P.$$
M^OJ0[9BY,4G,3O') (_G$(V_FR#!3!1 PA$H$U[^!.L$<9^>YO0L$!Z$(!9A
MT/MN )HI6)S$A=OC612$)7D>V[B&2ZJDA]F1\ZH4T"M<5&:WA%'^X%T. ]Y.
MJY:EFF5>G7S'P<8#99/Z:$:QT/= (XC1^4)5S)D&%'Z;VLI]EQY/5$^CDHF.
M&5 74!U)M<LQ*%$_T5$TC*:_4%GN?9\>R6_H.QS);UC&4\(VFE:K-UX@E&_7
M5.UU)CLY'_<_;G-Q]?OQI7)R_NGB\JQY=7)Q_N2(C564)VO[0_$+CK\L)KPX
M%.FJ4<B\E(#RB@'E</\!)<OJ42Z//S<OCS#Q!]#E^.3SN?+EV^5)Z^CD$(&F
MI5S]WKQ2OEX>_WE\?@40U/IZS#Y8'H*V'7 6U%JLU6DM:][C=!Z^-B]A'4].
MGJZQ;VC@)^>'%Y=?+R[I :A\O(:=^^GX\OC\\'A/C(]"D!F@HT?S:&,T<FD2
MK87!R/@G&=*_7E)C-G9S@0-T@<!7C_\["H;C"ES! M2M8>3][$8]-#S.:"27
M>0-/T.L2*U]',1@B"7/2LN_FO=XL8HK&2*00]BGZ&4F8L('"^8>.6);FJV)(
M.08C(HKA;\=IJ.F"A9+8<P^C>$"=CLIG-"K0HB#B!EHM]ZW#W'/$!7I-#&ZL
M7-R'<$\>R3T$P,4TAX\TTDMM%/8Y?68NN("_SID:\2"CEM[R,A<T3@K?OX+Y
M3UR/.Z/Q$_'Z8#H+QX-'V'33VYHU]%CP6%N3N1]@#95/A/MH6QC%] A-BH#K
MQ%SYW.6 NR$F'72%8_I%>7D1-3\#.H>#.'H8Y_+ <>N@.[U)2U:4,T+HXJ*G
M+9N+A*:+;V5-#N:PB^22+NG1HJ8S=\SL8<U@S,45Y7Z37DWJ*9JS!NA\?!A0
MVYR_22?HD5S(.N?+Q) %[C7J\ ]A_ZN*[XYAJW2&W(] ,*#<X8G_">"&,B9N
MC#=F+JM<UCTO2YN72? J,U^=562^-AH;SGQ=A2'D:&]6?4=SY7>LK_J.,,VK
MO^4"I7S3UNR6J8E_/EE-UM32.AT8CE>%5XSAT'S/TOO&V^#0:]0,1WN2_:W7
M-/T%[&^K9M=?I_VM6?MO?Q__Y_>3CR>\9+&DEE%I'?Y^?/3M]'CW'7T*_-];
M]YUR%'DCGG)"E1W,FZ&Y>1.5@>^?[0K<Q!LJN8#NQK?81(5H*Y?<LHMSBZ9Q
M5D]:FL5$T[;G5+VR=)Q%-]ZN^'X=O6:KJS][K)KF;/3H256PDMW6Z;S,;@-8
M9N/SL1"!FOOO::P6KX(QN:4:#'GH!NU@^&'C U2Z,>G\Z\W?%E#,-+!31(II
M)^>F&'*7$LV/^,KR(YI9?L2G(.XK;^=E6WR".>BZ?>6K&_^LT#?^ I^1<47Y
M>MB\^*B<'/T-1,S];4.F.3.E@H?W812>CV@R(@UNPYQ>XMP%1MTV=$/5/;UA
MFZ[KN[8!DVBYI%TW&H;9^>L(8^TJ_'\5?]!T0WNCA&X?AN^3X'T3<U*B&.?I
MQ'_#U&3?^'/</HKN3O7+NVOC;.3?'M_]^.S<7MP>&V?]+_WSJZ9^=O5-_W'[
MQZ\?5]?F^>U/]>SJ2_?\]EK[<?M-/3\Z-D^-\][UK^CA_->7 /YV?WY[K)WW
MK]4S_9M^<71MP37CZZMK_?S[M79^],?#Q:?&P]G1]=V/\$OWQZ_(O/YU_.O'
M]Q/M_/,QW-]3S[Z?6!???_S\<0O/T[\99T=_C'_ ]\Y:CGK]_4ORXRJRKG]=
M=L]U&,/G8^WLZD:]OKU6KZ^.U8LKS[R^.K\]__ZE=_;+,]/O_.=+M]WW>Q>W
MO5MXCO'C]L^?UU??'BZ.+H/SV\ONV=4?UOFO;O=,/].N^]]^G?^Z>?C/K^;P
M[%!].+TZ'I[_NKX_NSJY\S__:?J_?^G]T'MW[=O(O/C\Y>?YYS_@^D_]']^/
MU?.K&^/B^_G/LUMXY^_'O\Z._)]P/^.LUQB?7?VTSHY.?IW=?M//CIKF7[KC
M.[YEN]6&9CM5LV$ZU8;O@?!:OF>U-974&V";ZD;C_PX*N^*Q#2HA:!40]"X/
M!=R3L7IU7QXE+[V.GZK:C)64VL$.+JFNO?GM$%-N>X'OI@G\3,L&=>%"5"ZQ
MR@%T.H]I0F0Q/4W)N,.0.YWJY[JJ.5+F]V*#?*+KN%_O5-W#=S(D,N_1@IIS
MD1ECP#'IDC#!D.-)2&N*)$:_VJWR:>\ #5[*E("V1PM:GP"TCVZ/%B^VNH0,
M)RO>4[CB0(4=>210[<$6V#^@@I>R)%#MSX(:ZGS-"UG#/_6B>VD3O^(-LG<P
MAB]E2QC;HP4UYL-85O":3P7F2<4B,WP1A-LW08!YT_;PG7"M]O"U]O*EA+:P
MAZ\F%:#]6,?]4X#@I>I2 =JC!;5I&2ACY2QH0F7)DA*6]F+!]P^6X*4:\V%I
MHIA+8_F[\W?N DT12R_=K?*#)?/T]5H9-"@MGE:\3*%"V:1-KI.^>^LD >P%
M91ULZ3>_B<VFG)RD1'Y_IDR4:!?\@<WG.F/,TN4)N](3^8HWS+Z=>/2ES%F[
M<U-'WI/KL+:'<Z+9ZRD1[?F6U<G0>G.L O 5MQW=<09V2KH8459.OY+2T\)7
MQ[2P)BQPJPBZ.?RKX'JG''2Y[V4D\!.=%0+!OLEIA+V\FEY:^P,W#IE2CPP)
MPV@GBYS64Q-17BFF&)LD2]BVNKEC!I#%1A,I18/@8K%5#7WFE^1FQ+A!E%;U
MW[6-%9 ]L8F4IM94<[%V3\M]9AE/N^O<DNAZ35VPTGKWVA665ROI->VI%L8*
MW[R<L>/1HTLJ<_/TGNYP.'A_<'!_?U^#8=9NHKN#9NQUL<_+ ?%OW/@ CCSW
MP-'JEJX>P&@US3$TW=),%7#*:!SXMEF''WWRH*E:K3L$W9J&[5(^)Z6)O/"L
MQ8DO.IQC"K\WC- (T"U4_Y$R!T -38 V&=[C.7^(O0@"^.%S'(T&2JO6K%W6
M3FN,Q(@QB"NG08>TO !)B)*4T(ER;Y_D.8O@SI=YLB(.KD@4I<TB+SI$"EQ:
MC2C:8'P"!4%I5/_-,1C^\L4-1VX\5C3V#N:L8J)RY=!^0=UP8Q;Y1E'JK?M.
M I4$*@I4*OM1I]O.K!\$;CRLTM\=0WT@#P\ZAZNOHZ%R,:"H,055+>PP0GT5
MNL.\%)44GW*@P9JO<9HVWB@D&;43P"\W%ETO6GWDU?J'VQ]\@$D;=&'>OK6.
M ,+Z 35GW.PKM*4*O?Y_^95OL^Y0^-P47.F-W5X.915W.'31CD*<;0ZPJ#J
MS2O,DG?3T!B70:,^&QG_8%3@O?$D-FIJ]8_4XU,D#,\FTE#91+ZK2;#<+%BV
M)5CN,5@F3T)+#7_6&AE:(KT 0\LV@\L<T&";TIY+$>^,Q#>$<H2Z_0A JE1!
M^SWJX08I:FIXE^8AMG,$7*H55,344<ST*UU]!+O*P(H33$XCU;]3I,K3%99[
MJ%6IV&T4JW0)5/L+5$\S/XV&H5OF@=]0=;! P?S4"]8G194D(<,2.U08F@RI
MSH@_C*,P\"H4@"K9'Y3_1'V"MF8RC"EG&&< ;C5;E86LT*+!FZE FL[,Q2>K
M8O]<S#Q-3>RZ-$^W ,4,B6(2Q0HH9NFF76_4 <4L0]7S()9US&1LW@!!07M4
M-%)32W0Y9:M%W-8 1E]Z11&ROHQ"PEL\4:M-LYYO/2[D5QN!<<E RY*@M5'0
M,B5H2=": "W+-BWGP#?K=;61 ZU'+<-4YWI<<?KJ N!%0Z6E";7LZOA$^1A$
MB;B<6HL4'..:<AVX81@DRED41G?1Z*>;3 .9HMO/Q+ %U2Z*7KHJX6L+X,N2
M\"7AZQ'XTE\0OO0\?(%EB9MC'="EOVKHFID4M\ZV(@OW&-A$NI.ESNXULIFV
M(4LDQ\F\)IG7M!KUP);J@50/"NI!757KAF,<^(9F-VQC=>9-N;=%7'I$XKXK
M= 6J&N ?%/'MRG1P+,T]8J=U?4V>&?%4C3UU=W6$O<"ONL0OB5\3^&6:\&^*
M7Z#JY?#K8Q#2_*&+#L""<DJPS>03<8LCU-?16&F-0\"21$!7'J$^D7;,P,)<
M)T1ECV59F8_4SDN(>EF(:LBD3(E24R@%.%574<MR+-O)1[YF!NU=S\, NL]R
M+;&ZE,0)K"$#D@DP8C!TYF:*RGJPAS[1>HIJ])*%@J\4=V1^H\2=8GHC6G>J
M:CHBO1%^GT@&GP4_TPGA#2;E3\\'/W>'HR3O$\[0Z:53M*<2A&QIS6T<L@Q9
MOR(A:PJR5!M_MNT#\F!4-1>+U#7UIVIHIFK7A@^P_LT^2UI&3+DDM"+=5PYQ
M83NPM$/"VNMY.>N-MVD78,6YIU*S"<! <QQC011BV_89Z=<E>=<\YXBJ;NHZ
MXU#VZX$:J1U)J!%0TV@X#4VO.DX53#35-ABP3& (Q1EJBH&LKPATT%[2=8HW
MC27PIKUBO*%U'C@&J0!M&)4\B4H2E80"9&'UF6JIJ@'"?3!6[;KMD(<[XUZ[
M]]8*46CF 3PX2T"4]Q(0!=J0+.+8-$3Y$J(D1!7=2FBC:6H=;+2_C ?M@?I7
M?"ZXNOZ 5S#WTAKP*@4,QJNHV8N#UG,\W]EC67&;+:VVU8./+AU$$GS26)H.
M&HEA:,APTC"= _Y"PI%=AB8?QSWW/IG C8I".AWB8?HK#]P+E0>K_Q=&C\F,
MXZ70HSF(@YZ")%#X3 D=+P$=&W;X2.;=S>DG#1KVTM&'_)?V -^-0M^-VQ0-
M'N")NBK*3O&3<DTDPXXETALGD25C]&#*R>).G^7AY6>)<L(K[Z6?9Y-@9$HZ
M28E0Q80@T&'TAJ$AGX>M-TS3)P\F5V1.X!GA<!23&<F%]927K4@?N5PRXV$P
M#-IN^+.BG->:F(*=*,,8]@(A2IY[C4(+/%VM6>K_8.\6NK6P&J5%PB"*%=;7
MQ1\1')2U*-F:N:*,Q[JD5ML&>-LL75%>T=HFA-.L+4>X^0-<"0^EI0DS3<#;
MIR!.ADIK-!CT:*(1305*$>^E,&TML)1J7<[:2=1>B5EG2DXAJ4E-I%8[FF49
MC<:!#Q_H-A: F*;0I$K0XP@%']L+H(23,&'P@=5M,_Q"+%5PT5 80(@QNQ2=
M8D:KVL &!DAQQ%L8I VN"GG5.O,..=)VVRCB2$*@/44<0?FJ"<I7@1M')/'B
M8"!"3BWBC6)0+4CRO[+"87.2B+T+9#AH;Z7QR?G"%M4%T->KJ54-\X4;/S5-
MU52+I<R<$BQL.(M\%E9&H?Z;KE N$MKN"@[KB08=#9:&.V6-@)(0A$D[BB.D
M6HV\P!WRTH;EVW.4*@_/;<]Q'MWQF+1,)'Y!$)*9Q!*$)F+22"-?U[2)F'09
M]!AET'/FPE.8U&*@:-=PAPV?F2N:-%<VC4_;EE-<Y*#2BPQ7>O&&$L V6"BJ
MU5, 4[6_>HA>_12\9D.:609I+,.%4^O5=P_3^/B?5-LN-:F%D$IF]TD@RC0I
MP]8-N'<#_F?9QH%7;]BF31[N-/5>A(YX,!KC1?TP Z",,Z-#(])A];@_Z$5C
M0I2C("9@UL4,6BXZ\!T"O[S-/+T@YEB$$$W1Z#B+!K.?BS19)C&E#5(;[_[?
M=J&-9!>=(PV,752;6"W)+BK915\;NR@]T672[:L[N84)X5 3PDBY9AHBKJ*I
MQK,/\.+YG1W?4Z=V35GCZ2D=$"4@(%,T)#),\"PTJO +J+8L(J,YCHV5?2#P
M*,*L@1WO2$R)H@  _AC!DG4"9*#*?TQ9B-^ZH,[SE/UA-XY&-]V<$LU*E^M+
M:._F2G)1#<ZH(.%GL_ C\S4D_)1$B'6#18@-QBCU7TU3'1$BIFPL93B3JPN*
M15V0Z%*"C4-L'F=='&LFD\-6VF0<1K)EKH/]@!395$E"RAQ(,<LAQ5D3I,Q4
M7R2D;"^DV#+V(5&E#%54!YD-3);)EC14L)\$IJ1.$88K*6GOE%$DB+GKG$'I
M^>4O,_+5!:!@2OO;PC7G44TQ#*.JZ76ST7B7BZN.;F!W\<)DB2XOA2XR1TVB
M2VFBK%I,E%7UNH 75IE7H&B:ASBB/+G(J:TNVK)Q9;FNVOJ!9.5^EZT>W#X
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M':F1SO96T,3A5M(W4C1:W@M)=,W$AIL^&6"/S'"H7%*J-A(37_DZ:O<"+U_
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MZ&A:M4%L'^:7N*9)W+IE>)@?:58L_=D*B13NK17NE5L94KC7+]R3Q@9Q==,
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M8@25R[:YQ53DXH>*HM(W9G-!W7P=0P'U TB&*:B#15HDW0#6.0XLV1R@G=2
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M"*YGFU8%)%5B9:!)W "S.$!:4 Q:4YH6VN'$S0G7J*)R'M>E8*2MD'YX<5*
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MPY1J8":QEJ'!0@B(:N\0MD:7JI7-!WI3UD>C0"\V2E.QERG:)54\4*%!^]R
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MPG1O#HRY3@CLN,OAL&ZK4,?)'E?8XD%KC>;9:KI*UU-TITUA=OK^.*_43KU
MA<8:I#$R+S6\)\80!E+K[ &1%K1S&)0)RGEM*):H'HR%&6V'"Z0X-M<W>%$
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M"YGD@F(*A'2)8Y"QE(9<EM:2<;_%F]W6;/T[H;5HA":A/*,16 @B*,O (\*
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M4ORTP%N!M]6LIE;@[<'AC4S!6XA$1@%XIB-XISPYC Q7!"GJF# >!&ER040
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MP]JZ9$VJ9FMG_J,H\8HJ<8':IR"E1:#6*R)#(D9HHSDW5BL?/-96.ALD%JI
M[<I![4R7/6N3QL0F9+#VB$<-OSF2$*91*&))DDZMK=.F4K,AH8*UST&+"9%&
M>M!4JAF70)6H$388PST)AA-9M'CUM/A:9'?WC\]86)^$B(AH3A"G7B.ME$,4
M)X-9L)0Y!Y1)-C&?K0GS*&K\K')?U5PE_-VV<S689F,S^GCB8J_!2#/'%\E]
MLE]'70KK!YMI5#C1PS!+IM]MM\*SZ_8Y][QYE#0X1G#0D?+DN6$V*NVB)Q3C
M)'$%8W<Z9EY=O4[@+\"U1. B$Q5?ZD ]41;<<VM0H!C(AV42.18HLE0FCE4
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M#3RQMJ-PB[PC>-V'K8KGJG^!!QI#M;MY#=NN >@\S&U.6<-;[>FK7QG8>@\
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M:-[OU_ +#]\;UI,^_?UJ3D<;F'??OJP'?]T6H4L[/>8;(ZR#YZ^.D$U:JGQ
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MC?<V__RZ]_8/L4.WZ.ZQ/X<QPO>VSW;?:/S9&ZTY50GE*DV(1XZ1(\(C&3W
M. V9FZVMB^F<&O2C920QM1)\"!49Y4$22X0*X'=19C%C0I=E],R6$?N<HC?.
M)(XL][",-/5( QE 3'LL=0J>NK"VSO'T.JJ[@DZE;[V8/9BY.9&EQN=-E),Z
M6&->.L:XX8ERAUGB6A"L"/QC37$?5PUE9HM]VD1M<$ZA%'-U%$\P0 9EX$U&
M\"=-\@:#O2%"-+DIU3Z?L3(;R9+5$1-/*;<6V[Q'Y9V2+"18"Z[XCRNHS-.-
M23"!U1L" GH7$5?6(NV#1TD+1VCP%GQ(4&;.FUHL:V]Q%97Y 7G)TW(@/:8:
MZQ"LX8Q3&0V+.$BNK? A2NX*\U\%-?XQ\S_]>DASI;.=[WL'V^?Y]T_'_OO>
MVQT8SY_'AP=_\$/Z9^N0OCGY]&=V(+WVFG*.0F ><1/ H">2X#<1? J ZP0#
M!BSD0,84E8Y@%V %<6>93>!(4HQE %#AHL0AGMLR8I\9-4JDY$"@&I:1"Q(Y
MFZL/:,>3!4X@B<ZIC _G0#[!S<@=ZX_@Q5S\I!,FBP-=GCTI>Y$W\L]$O:/1
MN, $%X%JCQ.V,!E)"&="<297#G$.9YQ)QQ5G7CF4E&.(8T>1%CHB'<"!H +'
MP&UNC,>:5-V[[OP*;V"\>&7FVCFO5 "-55PJ:9.),3"3C(O@EK#B3*Z@,I]/
MUR'G,AF/@0%$@KC7"CDF/*(N64><892*W-!7-HUZSHWDRF[D./<<',=@161,
M&6YU %.MP"]@-.ADN _%"U@%-;YE&TD<7L U#SX=[Q[\(79.P".@?["]OP[/
M=^B;%HR#P1C./^5QM<&9Y,0K*[E%,>=K<L(H<B1*E PL!*<BH1J<2;:0,\D)
MQT2!/TF8Y,IA2V,4R2>=%)96VK*,GMDR8I_!AS3 [X$-JF 1EY(AG6FBP5AK
M*J@CGCVL,_D$=R/WA[VZBFZKTQ_TAE7E@J^MLA]Y,^N4F'K+.!9!*TXLTYAK
MRP4344LP5+RXD*N&,[/=;R(P3JZB0,(2L#@F)[9:2U&@1&,*[F7(W8MI4YEE
MG158Q0V,%Z_*EEHI(DV"\)"+WQD%PO<DL6B4D:8XD*NHRE,.9(I $(4&RJA-
MKG7J/-+ \Q#P1FF,T0#2.1K4))(_8U4N>Y%CE6;4B"0]3U9S)Y(QGD;'&2%*
M"N;O5=JK\/YE*?$MO/^L[K0$_/YB&^;G"]ZY^'!T^-<?W^%YSW?I'_03^ .'
M%U_Y;MZ+Q-I[J;!%0@>)>#(>W$<?$ ?O3^5TUI@/_O&%W$<L'7-*:&F%Y58S
MYY.T*:\ASCV)JBRC9[:,V.<8!? ^&Q$!<2).'$;68X_ IW0J. I0HN?D1+_H
MK<CM3KV ,\_JG_<'\:0^(7ED>R&7:"P;D3?V"",1S%-(6!+"F35&&$D\]QY>
MP$G$XD6N&MQ\F?$B>3[I8&)$C"F-N+4:N40D\@HD1Z0ESN5#D5PW%5Y6#]55
MW+MX\<H<B51:RA"=,#P89X,2D1.F*0?Z &RA^)&KI\S3IR*9IS0FC$3*%==E
M4N!1<M!M![9?.BJH25F965,]ZZR"LA$Y/G>"F7-"8:-QXI0P"UKN%2P.H1@!
M5Z.X *N@QK>D(Y[LOGUSO'NP?7%X\>9DYV #[U[\?KQW\/$[4']XQM^_PM^M
MG8O_?#TD.:N5YQPB*Q%+1H +8 72RFM$>33!*ZT,\8MFM5J7I"1)TN@#)XGI
MF)Q@7L!2LH[A$I!X;LN(?;9"$!,Y13CO8L,RLL@I,"4T1*V=<EYALK:NRC[D
M!!*_&?8Z52_89B/!$LY-89N5*]E-J>7C/7-;7\1NADK!@"MI!?8.2"=V.!DE
MK="".D9]*"[EJN'.UQF7,GAMK>$"*46!A7)JD';<H03T5!JCP8R(G,/0-+3L
M3#YC79:Y0J>0.& 7.5<\UV0 S4Z@WR(Y<E,+^:++CZG+4QZE3Z".A$CDC/2Y
MAY=%-O"$-/;)$X.M)K;29<WOG=FZPKI<MB;'42)MJ9/.1!8\CX$Z9Y@0/%C.
M/.:Z["FMA!;?X@FT/_UUR#Z=?&CO;;XYV;W8P3O'A_3P9"?O-5W /'P_//G/
MT>'QQOE.SFQEB7M%C4?@70($L! 0(+E' 71?41E [G%1AU*&R !+HL..<A6Y
M-8X)S2,V0E'B65E&SVP9L<_:A62HHR@7S$0<W$AD4K1(,$$(,TYBD4_;EKW)
M22A^W:TR6BMSBEH=5/4LC_U2J/7FPY'.!:.TP(E%CJ4 QT-*Y[3R% PUP\6!
M7#6<V3JK,*;"FAVV<_&1?A:\JH*MD#),(BZB _X9)/))8$P2LTZ R3&Y.,=S
MWL9X\<KLG0%/,2D+V@MZ'+1FA&!@#IA%+T9IZL6#7#%EWKFNS-:KY"7G67LC
M&'X;D&9:("V(H!);R[5;6U>LJ<US5N:?O<:2 N?5'*A72JPXXSGH#FS[/O'Q
M&XO_/W.LC)$*2\%%B\1RDJ+AA"NBF,,R>A)*A?K5P\KO,\3'!.ZIP1SQ2,%)
MDH(@1^&' ;D9ZZ/&0:RM2RJ;0JF'[@"RDI&X@@ W(D!BQ%C!@O21<Q:P#5YS
ME9RF/"@L0F%+JX@ 4VPI8":#$PHEGH M49Z0H5&AZ*2UGEIM,P((A9M,Z1>)
M #][C9<0+WH7^_W?&AO>#T^&;3N( 13]M >Z6:6WWR=J]*Q ]>^/P*LFA+(Y
M(1/XO1WS+P"T&R==F*.+ZO4;0;C@[Q+Q]WR&@4F3I"+<(.DQ1=QZC(RQ'&$)
M4C?$FH !?QGA3:UF#V/^8U%/=36@=XD!J1>+$\MB7P4G5A,GIGA:M#8DGQA2
M0B?$ Y'(X "_I<"H"$I0;M;6J:9-S<U+PXE'CG6M-$4;*VRS<9I5MLH/O4P,
M;38Z<28[]([TO7ZJWQBL@= =NG:LU\<] 'GEYNYGVP#?;VI6VT:M4HAP-Q:S
MLTRS@V?H*<."6RDP$I1IQ(%AH'SN%C'EO/0T>A%YIJ>DJ?"R$O*6H41/HUUZ
M@= "H8\<8RT0NG0(G6+NV'"!F=9(<@T>/C<16<$)\I[B8%7*G00S<U=-06>9
M^XN%T.7$7_\YL/#8EWE\UU/])G.A3VSO2ZLSGC$)>CQZ)<^2O ZRQ\/^H)7.
M?SUZT(P>&X/&9O3QQ,5>@Y%F(P- L_$_B]31P#@&K)G/97Z<-AK#0C3*2WB9
M:G'300DQ#2J;K?YIMV_;;T$FI]L=WQYF*<"K^6ZMSC"&/0"=980-Y!,%GT__
M/<+^Y,^._<L,]T[^_+IWL"'@NM\_'7SE.\<? #QV,X"<?3K>X'MOW[3S.&$<
M^+\7V]_W#KYFX+G8V?PJ &P^LP 2"E(A%K%#7$6*#"/ S)1B&FO.@_= Q=2K
MFT $UF([KXQNR@TP;G$*&V>V#Q^+?7@A N#$4PN2C.WS!KR^MM'OQT&_<13;
M(<NO 8L@@H@Z>9T=#SOU"CQK#8X:@Z-8O9OOFG_?^C[HQ9/6X+RQUQL<P2A"
MR_<;;MB'==[OOVKLQ]C8[0YB@S<;8]1[("VKKOA;:P!*[>^B=QXFJ-_*CU87
M[-EL?8L !-6YRP<>Z@\']NIZLO*3!+7)T&,C?C^-G7Z$E=;OYM=@_55KZ4>K
M=IX ;@P&_:JGJK5H$6AF2C+*,/542VYML)()F82-#I2<\?DGWW^(T1,36[!V
M/M9ZLG-\^#E&Z[ %!Y=(81$7W" ;#""MH"FX%+5,"O#5O)K=AFF,H/4Q46 Q
M"L"U]E+J&*0QG$EJG!92!2H-T21B7ZTS/%YG=^$"99W=99U=;'P.D3G&O(*)
M501QQP2R/AB$I>),&"=TXFOKG+Z:/:P\7F?U*?]%Y)TB]T1%*T0@7&&0ODV&
M6I:HDMRIF.5-S$C>Q!1Y+TO>7S[SI#AUF.=>GX KWN36WUR"T#75R8@(DJCD
M/5ON;"SOBF-E]E2=36K$3@"3.'8":G(W\@1&_D"U/K(@FPT@)Z<1+O<-N-NK
MQ@-2A4>WMIO#'K@?U3RE[A#89>/_AK8W #<)N&?M)>7W7G=/8-3GC;,>T$S4
M3:GA@538FKQ>GG[*9'9\^BE_?Q%E"U)S+"B@J^/<&F&YPZ!;N;F[E93+&EP)
MOC.X;L.(6[W,S??2NV[GRSN09J@Y^$'W]UC[8>!MI:*)-V@BC.6/SXJ8K(D^
M)[=%Q"-C2'-+D-22$>^D#1ZOK<M7-V6ZCK6Q%^M<IT&W81NP;(<)/E8O/E@R
MQZ!ML-#LX-IJRS((]7?"E8/\JG%P[3.P6$]@78>K[WO;ZYWG*]L34*U!?^1'
MU>PX^V!GL1<;G>X 1N6[W\#==NWX1#R"&QTP-5>_?W3 ]Z=X\Y22P>5 VP>O
M[6DUI%&^0Q<&=U[_/(#;_=[N^J\O3G_^.-\[^$@^,ZL-!MZ((G!BQ'&@R%#B
M40I!R:K@7THU%E;1GXV,0QH#MV18)0[\AE!0%9>D9LD0;CD)?*T1 99.<SF"
MWC"NK;_>>+]]L/%N^]/69F-[]V#KP];^P4S@[DDL[Q\:J[R81Q-5.[W5BKIU
MLM8S7K1&*Q5F&G[ =WV]9,?HTV_"1T;1N 9<H]5N#5HQ1UE:[8"ZP]ISKJ[2
M@6\- 4SZW33(Q8?AF_WQY>!IPNB3^6(Q_U)C4G7;.IXSNN6KQG6U@<^<@+WR
M<-?+,%!J]>![E7,?JJC)):T9HV:^V7CU],'"#EKM:^_#V/I#UQ^ \]^R[?9Y
MODM.4XK5-WO1AO/JFBW Q?QX%4^"QWO5^.LH=@ E 6)==1EXI&&OEP-;0(Y:
M*0>SV_5W[?ANS:MYGIJ3;N=R1!-/ P/NC_E'+?H\?1F1OUR?LA'<_PVP?#C(
M#U/)R75[O>X9_-9_52WWR<6QWGAS9P(XHGZ9[4Q2O^O<9_)I'C4\<0FZ,#_]
MUU>CV@A9/4N ^&9(_H)WCC]^SC4673+9F8PJ%V!7R*H4_G_VOKRIC23;]ZLH
M_-Z]TQU!,;5D+=G]GB-HP#W,,^ &W'W=_Q"Y%<@6DD8E&<.G?^><S*Q%"XMM
M;,"Z,=<-2%65E7GVY7<"+22/##,1TXARL!FO]BWNZTI^]=#!F@:^@ :N]TYY
M+F4:QT6 PW@"%N<\X&4N R%U$@E6J"C+7KR,-Q?K,WJME$ M['ST%?XPNCE1
M,.]./JQ]]IO+$8 ,D_TAR<7*VF4_W+FC.?8'.PVEC,H\-P&7$<=)\'$@0FF"
MG)DRCD3)PR*=-\> '%@<9[%,5<:24 %UJ#B6!8?[A+#O\^;8H[6N[ND\;&W_
M\7;O>.]D[_#@^!F8CT>FF@VL-SCR.5;Z36"6"@T;1:H>S3XPZQ9,.&<(_/?_
M*N(H_[5"4V')_81W-UNFA'V"S8/U-/C!5=>)%4I91]4;=^WOXP+K9!^N!;\]
MT0(,16LG;AUO]XHPW>AY;N^UV;WWD_O\Y\W>EO.'QZ)O/7'[XNW[XXN#73=2
MWENGY5BWN=XGE&B#OI#>2(;/08#IGA25-?7@HOX$S&CXYZ,8H&'J7'-\^7K+
M[0O"LF +S"?EHD9DO,XFZAQN!K(405G11[?F<'U'_TU,N\XOKS\DQWZ"9P?'
M<38:Z4L0VIM+DZ/?/01W,H&+G0F!)F_E3'K\"?8?]0O&U]#VKTFC(=8K.C&G
M?^AUO9F^^3TS*W-:;L$7G3?6VQ+%W8C%%@EA/+)T\@N%D(";?KWLZ^FYKPMK
M7>AD4-A<(F0U&LRFJR]I"2>%6?O)=Y)-KX(HG-NRUK_G$[^>,3A&@02O[4,@
M2ECN+V)P*:ZJ%__LRF00OW.[^'@V8+FNP;#%[T=;O==[KW:/M_=V#[9WCWO_
M.GR]LW?P^W%O^_#HS>'1%FJBE8KHL;S)P>$)+/WD$!9]<'SX>F]GZV1WI_=J
M[V#K8'MOZW7O^ 3^L+][<'+<^ZFV,WY>>"V[^)?_1T[^^7(992R-A8@L,N!F
M9)E*8I:5AI<Z-QF.G 0KDK.%0%/*%.>)4BK/4R;!.5%I#)Z1BED>:L7C53&7
MVRVB[G,X^%22946>2,%B6*(HA4K*-,QTJI+T,=M,-[+M-KWE&0XSQD1(7SLS
M *,?C0J:MO462.@+(ZK9I-:4RY4BV@?VBOI&<--:PV(5S05:$GAA.;.A(=#Y
M0]5O@EJD_T&S&7SXI#^:@>H?30U%@L #-$/\HX_!&+ E#,9R]M$)Z6V+R6#4
MJ_K4YT9V2!UWDE;S7P5UR 9TSN@"WFT,GPIU#J[K!-,MO7(RNH#U?S1 ":TE
MHX)KW8<4>%713&BR:)SEY,V/0?^#&?3/08W;73KOFX^X8M7L_D@"-5B#9[/7
M.I6QN,+;5IW\0[LHB8[-QIDTK',P<N5<$W.&+SZ:7&TX?7P!NHLV%^@(7F4T
M-/7=-\@LT]H:;/ (K-ZJ GM8S9?P/JBMZ5BUVW;*;,RH8$R)ZKQ7#D:7O:E1
MY\/^?V9H*.[BAOJLG(WO53/X4^OM?9Z#3 $Q&1J]L<)<\E;;E:70FA*!1@T^
M9V+&V+>(61DXPI$U]00%%:QU(<CN@)<?3EN&+Y*/-4%:) H6'"RO\J=(=#BP
M>1FT%\?NM)#0[5>]H=U=]K*];%AA-L94KZ7_Y80&M GZ$E<&%*R-_T542[X/
MW\#W4%/A36_X!%>,]7_VV;C6R9FWX)M+9Y7+5/F$U(H34*M$1G,T>(S53+YW
M+%"!G*-P*USR?J;/:!5T+F 5 CUZ/P0O(U:YLAFSL@2"(0XDN]'GPB9]$*44
MNO6"977JZ]$(VB4IOT=IS ^1WA?.O>693('0^UA5[IR6FEO@K00(%DU7.=>-
M,IJ8:O#9]GYK#B)10,-(*% _4KI47F&"%0Q%&V_J.)K.LT/.J'VN^SE;S0L,
ME[U/_:I @HWCM>.8HJXUF+^UC9UU[[71<CC19YU,YWQAU;BY0,OTU:H3LH<U
M7(@/IL-!-<?2SE1M%G8.?XM=Z"5;(L"J551L5N+4$KNR M<+\Q[6_38BP?]U
M>CZJVA?U*%I(]<)V-S9J=]NI0[?QM"%UX&'0+^$N5VI@K$YQ8J4E2^"R@3D3
M@PVG213^V%9IP/G#T45?U<IM;*9]"E5,^M4')]PZ5@ONH7V=$=D)BT</,KF5
MC0<J=#M;'_K\GN$R2>OXS!":&+A>8-:S*UJ9WSI_#Z3 U@V0WYU^@:5VMM*]
MPY(3Z:[3!29@I42+3B/2YB^)M<#O9CQM<RE< <>J<<E]4SUD%<%W%VY;GAWW
MWAS]M[@8_[KC[5Q@K^M%2Y<$1-^G'4%M@L*")U\[2P+%F38E?L4$ [(7YXD*
M#*M)*XP&YW-Y;HC\.J&09CWG]L9B0'E:NLB1':4TV[)P5CEI,6^\WJ+$G9F(
MO-"EU685[4C4<GF%2X&]:QG,[H%5^VF+/$1.?S 5G]I<(*;325_.J&W'6UOM
MX"/NI!7KF.2=$?:Z%2).>@SG^:Q:\23/;Z++:YN]X]%%K24N1I.NR&UKJ?X0
M3L\Q%TG,QNBVUX]\F4Y;$;8ELY?7>EX88/"4Q DF?)O?8(?U#!/A=7H?KW.V
M'\AMGV8F.W.CY\^0 G ;O<H,!F2RPDX!PWXP4^MYT(=T(GB$H#E1O'2%#9IN
M9D Y>/2>T M#A60%C#TDD+6=':$%S\M)X'^P62^6Z0;Z_LW*H2W;X3Y##;L)
M#* :DJ+-IB05WFW^L?,&1#5:R3D;R-;:5 JH$7E< LUM++)3<X!=QO)&CM,O
M&OW4LD]$O439U*>I0%C"*B;6Q4-R.>^/\7 F B@&\V'6#ZC9< !6#GHJX"@N
MO12=($?=L%1X?K\Z-WKN.Z0-_*/A:9?G?4MK:(,!?]C""O1KAF90Q_5]5X_W
M%:VKCN1IUPB"^2.L#G57:_7->A:#O]:3)@*G+W^!+?_=]<M]!.A"S<W=% J:
MHHW L4'VNJZ%1-Y"_F5E?+WW=DR&IS+],7%C8V!9EOA(!ACQR2W+PK<A.>PR
M0<:VB)&_??.%Y 58K"'K1PCD6X&[&N .HX/1)\<639<!&H@V4=.OB%U;XFNC
MT1$-B[:TQ69OKTYL@81%R8,66FL_YVJ.P"2'OV+[FX1OCNJPQ)VVP[K99'"Z
MW=]<IF&Q' @Y;K5G />JCZ]_<6%TGWKR/H-1E@5CGQ2#[<Q,$XUQXM:&WSH]
M8[>=K]5\F"&MK HC/W4N&H&.GP]"("E-K!E8QR-\'**E<-I12VN9../\5H*C
MA]DG6Y%1S13ZMDBZK<B=DY16I9&CL_#N[>BBO\[7YSDK9 /H;$IB 4N(!^ =
MVL#B!BQM(*Z0UT"Q#4C)@[<D2:DMD0WD_H$?1L);P6FAFP9J"YY8W7(O1_S6
M((%K87?01_&7$;_WP>KRI81C,6V/M'QZE(LO@V^X@6\&>]?7%"BC//3417XW
M%W..*W.,S\ ;6YZ9N3W3XH1X+4%;&70](I*FGH[^=#;M5 ;8/,*\=K3>KPUR
M>0_"2OEI*Z^-KLZ"9AMZ%=96MG"BPR9RU/4O00$,EUZVT0G9M*L7EKB(Q!#P
MC.4^XG+5XZ,$\W4<F[TW/B)-PNIR-!N =C4=I[A:'?-=;=YTK(Y+- ULPH2,
MX:6;L*P$]LB4UNNXJ3W\6U#R%_2-/ZZ.]CMUL3_"'7V<M2\H"BA<T IL;W[+
M LG?G:#9&NJ]V@BU76(_?/_*]?[.UM5I$H(&B3(1L"SC <M5&10B$8&.LJ24
M(2M-DL^G^U61:VZB4I32@#H2/&&YC@LIF6"%+LQS+9C\_?!PYZ^]UZ][6P<[
MO<.3?^T>83O.UL'O>[^]WNUM'1_OGAP_9#OIM\S&=0OV;!!M>>:H96"T<V%>
M[9FJ6RW1+MC[O64'H&72RHJ*%L N&>1TDX]]<^E,C'[= -JKW0B?W,92_=X
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M=*&V8+\_:8]!PE71W(O-WE9K?!?"A5]2FJC?FJ%'O>NWH1Q4N/.49G'(#C9
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M6WA;\>:35&PKAGC<9L:00H3C0A'D DWMJGV,7SE9BWR[4C6T  86-50ME)8
M$"Y73$YN8[%6/0$88WDN1@AWO!K5K31V_ 0H9JJ*LF!&M5%? ]S58&6(OU8K
M$IS7]$!/WZAW;E4BU'4E^=O:RS9[-!WZLH\#/E;<@119"\:3TK98V4TSGYK
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MWH85U1@N!6@[L\2P;WPWM\TU6AQ%JVG;%NUT83:5S896TY'Z$-CR$M7BD9[
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MCSKA2%2',)6[GUS%\>]NTOB:N.Y 7.B2G$H@)UTD0%=)CH45:1IP;/.54:'
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M%RK-I,Y"%D><\9LFGCVEFAB[,HV:EW;K%P(EPF^]>'D\N[A B L$&VH:;-^
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M'LX44;RJ]DZ>^YU$^OWHH@6(I%K.!B60LIO744U[</3G!/\K+%KX6.#4A!6
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MF[[(=<"-E@'\.8E-KDS&DQ<OXSC>B/,OEIY?$0)N#2'^?"'$5:%CPU.59\(
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MPEFL=,YS9PQ8MI199AASTBDRVC-[*#/XDSL.?M@*!_F4XNM?K?GBS]UV^#0
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M0SI^0J-@NY\T0R5?$])04+UJ436CS)8Z*!)(<QIB?KAV(;/%ZHE>(!#U_C'
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M.4P1F/T89Y)SAH/-N1#*8J<#EAE6$9>(QAG5J/IP&S_PV'9HC,,@R!J[ECB
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M^4%YS1X5)HIJ8U5]33.=&.69%RQX(4A9S%UQY<]48>Q'(65]#BD)UU889Y#
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MIF-:%ZG28"S;&<LW%64OMV)1O;+RZCBL _10'QX?0S\&L?)HKRRY%\MM?#-
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M+G,A\[FQ,7$0Y\)9XS,G3,@,]=AG2PJ(KE'N!Z'<EVM1KG[B&/3[&%"M56\
MRJ7_'=$OC6W^]9\ZK[_[3+XVX)G1[K0JHYA;ASS6&>*&&62#%PB4&\/26Q)\
M%E'N%G3MM[0-,!G?/QD:_2SWBD;!!_W:<)0A8LFNK0VF%W>)0PR^W:RJF,_N
M'A5'K#:+L^^]5$43L+!UZXT=-CUZ\<\2R5"$K5=L\7@67\5]V,[@%2+JT:ID
M-K<>K_+<]$@1NI4E]WJ<A]UAK^OC;E<ONN;#HOVZI1'7O\8KBE,R15;V 30Y
M37#\]ZPU+$[Z3A0Z37+P2R\F[X@!H_&>%4UN3AT)F+%,">XR;VU.<1Y3CTM)
M<- +M\:OC.^:QO,_8CG73V>@JOU!YV_32[5^XL"0$9HC^DSA_ Y;YV2_\?E0
M:>,DQAQYCG/$)1C 6AB'>,X]IY0$176,]EN J/\5I6*UF=;1%!&4!24SGA&E
MM%4YY5IYPX4/9#W3#S33)[N'F:/!@^F'3*YBQB^6(VV)0L9K&F*: *)M"AF?
M#_S]KU\W:Z S7@JH/QU4UUM:5J!^#-< 3(,M<E_:-:-/>R+(DYD'@F,5VF(>
MBIOBF:YR]SN6#>^DP+6W9?F2'.A6/^G%=$KH+(8@]H_'Q<.KZV*^@=ZW,#I@
M%%O^I=L[W2ST[&K8BJ43S&OM5*XYM4(K)K)@@Z/4YU*9-;8^"+;2@X8[M$"?
M/=@DQ588UP(CK3%&0C%0J5IPP?.-UWB1]^6_7LABID]R,<=L-&%TYJ]7G@%<
M>. /-. +F2KV)*>J"Q>VX>[C.?/F%F!IL<H%F!;"8<6%P9IH[@AQ,LMS3&FV
M!LL' 4L&;3G4(@@I0T ^]UG<<Y/("D91D-@(A6W(95AJ<OP$$?N->?.YG\IG
MQZKVO@I<GW6]7!^P^TMEXI?)N(IO <9^,;\69R*FGA%)2O('C*/9XYWQC,W0
M'1='DE,JN50?L,CCU4\Q\OVA/8GN@72D(!5Q&P!,%K%:1>-C*?IN]"=]@]_*
M:*W0"S%8OUN[22:-EUU:0:Q+*ZQ+*]RQM,*UJ3=F4G4X)4).E1'><DXX5Y3A
MP /\EZB@U;,MQ?"+701^NW_L-7:VIQRCI6VVX"3%KYNCHXAG*=]J!,F4#C0^
M,X6I?@LS>X/]6LDITQ&T$D]__1D.G$TFHT@IUL[,13I:UND,TRF1=KM98'X>
M9OS"Q42LQM2(%4J(3  ;DYS)>/Q7,>855A+;G/K5F=JBXYIO1JU^&V)2W0@;
M@*\OF:SM7=0O]PXY";GEC"$EL$*<"XJT\!C)3#LC76XS;*)E2Q9X#8OI'G1O
M,^U*D6@U!Y^KC'.<*V.)=9G78&E3*MUZVA]PVH\.&;:,LJ 1]M@!1Y<.&:L\
M@HE0S@6NLU@H#F^Q!1P=X'(1D_V?&W#8S>J>,G?-.$=)!&!;[6=.;&<N337P
M4V1P;"S?L&W&X6S%)(:]E+4]*;"8B'I@0*V;6(T"_C,J!5"49I[.^CBR+3YO
M?=I*]S9]$VS5T-\L,L8G!39;VZ,LAK&\61/FP3=X6G?8GSA$&'<;.S%34529
MXQ.%Z?#^N#9'F?^(;"XHEE14 $F)0UO-E!:@2.,$G4V*=O30K=J2PY)+SC5/
MO\:9LY3\ZW+%_-BWRY4TGXMVIZR;_38-77C3[0_Z[WK=6/AVG4%@(7"QZ(D-
M+)=>TUC;G-)80UD@X+02,0^"9( \>)''"!%Y7?VDO!+:""UQ\ NAFY:FXF2K
M*VCW(J?9TK#4'X4@5Y_5C\ONO-=-7L_5<B]GE@F;8Y%I[GBNJ27,.:<RP[WB
MU(6DGW&EGS%FU]7B_*?7'(!^SN/A]D+RDT>M3/T1Q7\M^$L$GQ\TOAPZ$K@/
M 8B:"09QC3D"A1V0%=SB@*TMLS//9P2;$_PS4*H1MEO3*#B['JXMKKP,?Z\[
MK#Y.$;V*1%+JF=="PBI7W)-< 2=T.3!#PJP,W)42F542J1F^6B*WV]W>H'F9
M%O=!_K;J?4+BM2PNEL5Z*J@!',QZ[S@*U$K$,Z^ /68*.2<"E]@S$FC<9IA/
M(34GBRD?1UD%\0: G+(J3H+RU?@W(<*#XV;/_XSUP;>7T:J$_J.4,;U4'O=)
MZK"58 ##VK<8^ND) [O1@^$H97"Y(+G)C)37E1Y<9"ZN5_N2U?[]H'%ZB&,B
M&ZP-DCG!B /_!:7C*/)"Y81F)LL5V(IL8<:X41G!SFI@+S.MM<D=SCGCE%@#
M,VHQ,T"X,QD4NVD%\/4LWV"6+^H[7PXQS;40-B"24<!TEYO(+SQB@:HLUI+T
MCFR\UE?EC=R,6T5G5?IUL/6'@Y3.;9E%?Q;U[[48#F;C7$A.%<A<;J[! U:,
MI;D5B,PEAHL,]I^R;=M%T_;*EL6]X)?L9H)O+_<.%3:8,.D1S8-&G F&C D6
MY6"G92(P17B*/N4+=H(C9*R8H^!6H+&>U=5F]?00+$.,7>91P Z@@L/\VDPR
MA+E1#I2$S*2)L[K 93P-$5NUE<C+:JF),VL%K',P83TT41G'P#0(00D-%@->
M<G!HK4%N)Q8'8!4$)37QQ"&C3(XX#@)IJAVL?949EFN#'=]XK3C;4O='% P8
MQ=Q8DCE# -2U%LK&ZG4B=U9[:]9$X6%R>'[&]<L/AX0*I:2"]0^0@'A@$BFJ
M)0I<><GA1YF19=FFITS!*ZC#Y@1W&">FGJHK=1?VL#IYN!VRK-7,"GA"ZCNG
MAU3G5N@L1ME*CCB-OB^5/+_:,IE+CA6Y/_)P.R!9S^I*L]KX<LASIG!&<Z0S
M%5,+<8LL5@H)[W*<NUPRZ9:0A\>+6MUX_?R(RZ?@AJ67_<VPUXN9?]=Z;8E@
M1J>F9V F4(Q1)K!%7(#!HGP(*!# (9)S8K#<>,W%%156'XV]K.?ZQILIT:5U
M7C^I7^Q??OA>;WPX]-8R;PQ%#GL!:@83X# X(")RGN6.9L!>-UZS1:SU:@J3
MWY*R1,!P+=/O%TEUXU_%G%;!$U-A%M:TTB9Y_SC$O?N?P*$=HP]RT^S5OIG6
M,/&S24>2'1]ZOW(8_Z<_'SL2E^>"^>@O#TUXFO[R\ZA75L&9D ? D<P;BRD'
M*\UJ3JF1*B,@WYBXVQC#U4"_A:GZ.\[40;Z=HGH.QK.U1J$E&H?OQ]@[#Z:Q
MIQR%G&G$<XV19AG8STSG6#D<4\DGQ_H]:AQ,L/>9]1QGFGN+K88_+&@=13)&
M^)*L46M)>$A).#T,8#I3H,4H(\PA;IQ%.H!%[:@.&&MNC,W!CF9J@;$SZ7U_
M3(8\R8X!PON3(-XO(,N'HB1K$<PV+$JQUGPLXUN4H$]'4?)6]SQN\H;6.,ZP
MTH"@LT[#8-;_/U7J;"+0H&I(LW,V'!1G<&)QZ"[HD$)W7M2Z-A[13?>6SP:U
M:HIB(DT8)1/+QAI;UDBK,D?U EP0)K5TW)UN=E+*[%:-5JII0HT=-\$8[+EC
M:%1U4=FL7CB+A;$[@^J+=!8G-G:B<56 >@K1BV=OJE8!TPC-V"08QQ[,0.NB
M.)E3_554[DI/2U?!PP$UTDQ5/9YXS60+H).M&.<W[!@?&4&(V^?=^,]9K^E@
M,&*;FO$T8\P\-0I!G!JPGX".O)^K1#1)1XH35=>8@D^31:0 W16#<#)A,V(D
MY9AS,)&<<40Z#4I,&>G 0KVQ^B@&M=(@$XJBT!PO6"-\@.?6#ZVFN??2 2,P
MP VPXL@8HI$E4LB I=%:7I%+;4$Q+"(P\XH%9S$GUH(U*TV>">% R5"6W]A1
MOIZYJV<NEX$):F#F,A9]XGD,V8L) YC+*9 N@V.N +(@0G6I:D]ZK/>8RCT4
M"OS!D>*:<QW3+#)O?@\>78;>\\_:=P>ABYLQAYZ+/*-8@93Q#''M) *T\$@Y
M&&# "H6]WGC=Z<Z+6'$2HU_S/7/>N5*=/5(MK'I11!G(Q$'^OMLYB@9\='0U
M(F%YV96Q]N@AR4*.,YDC;"A!W.89Z(G<(6]8( 9;H7+\<U3&>@-71*G]_^Q]
M:U,;2;+V7U'P[IZ8B:#8NE_L#2(X!L^R86#&X)W%7XBZ@FPA<20Q&'[]F]7=
M ET!"3 ">F,6@[K575V=^>0],Q<A@LIL+XO1:(N[V;)*',ZS1EWU->P]UKBJ
MFWWZN?.J",9KN"S[GGM@E5XSU#S!P"K@]T<?6$7T&M7ZB0=6+=^DIL-HNZ@<
M+C\ Z,:XG_(-#K#ZO=ML^^99T6ZK0H5IHZKF'A*U'$VNS;UZ*F\6W7)Z9?//
MSCE<*?0>ER3NWJ9Y!FF]BL;B3S7&99X]PHV7L%-_&]^FN1YQ^-&Z^:I+]6SS
M1&$B%99J[$$SXR1%PPE71#&'9?0DB!G.D\EYU$-:\(UV?(U^H"=?8^)V>Q=N
M?W 16W_%G=Q<ZYZ53>R%ZM-E]_.ST\,KSP\/_G.Z\]LAG'N,=W[[@QQ^V[G<
M.3CF\!G;V3R&];5.)[J?GW[]MGMU<@)KN8![\;W-/^ >_VGNY,#QYC%\YB_V
M-O]SFKNG%\-J]D>ZGQ]18VP44:,86<Z!E PYC05BAGJ69-1"AYQ$L(JG=+^J
M^B@\@%<R-,_),V]FH,U3#:N99X]>&UQ/>\0:KA\"UUG)/[CHU"C]>"C]90*E
MDZ.8<9L0=E0AG@A%+I@\9L)+9X,PF.J5=4E6M9J5M_P0%OEI*/TRE6I>*]6U
M4OT"4/JD&V.-TX^'TX<3.&VL(3*DG!%C0)O6TB'CM438$T:YD(8D"SBM5D6M
M3?]\G!:U-EUKT\N/TQ\[Y]T:IA\/IOT$3 N;)'9:((\U 77:*N0T%0B4;.H#
M)XQX## MS2I[5?KT8PQTG%=/K?SP-Y,(&J%SGH., V:_7SSCM4'G(^].C;JW
MH&X-IH\'IM\GP)193IEB!#F<![;%P)'S@J (NFZ@@;EB8)OF;%5-F3:SF-+[
M2&SS(!Q^A?,Y/YZ#>C)4;GZ3LU+6<>5D^$9KGIR5B7SX\41XN%UNKN?+!KQY
M#$6W\P/XLC]GO=!BL"%&ANX.ZIY_KQX[*V-[[7N:S&\P>W2HN\(QK/N/(R:L
MC)$S9*C,27U.(&NQ0@3;H 4SU/K</>?6^J!F.^>'T-7E>/WW]FR_]=</DN((
MM&=%C<8HNSD0MRG!;T (,1"I=9%+K.#UX]OZKI6OGRW+Z[^_R^S-$\"!/\(.
MAX M10'GJ7/<8:2I)P@K'%14$D<,!&!NJ0FKWC]?G;M.\,EHX/[F^!LG 0(:
MYE'.HF?!!Y12;DH0'$'6 R1@*7T"TN!$TMRGW]Q% B)WZZUTA=Q:WK;\>:LH
M@IM01N[7EN]:%?FT_;][GV\&1_>*H6B@ZS2O1ZY<5^-M]&[OZ5]0:='+H#EH
MS'MS0P]+<[%(_6T6S>1S)^$\M'JUT>[<*$(GM@>GQ?S<N</]S43LP2/G>HI7
M4):6J^1'ZN*K/@#56YO8X_NJF,U>D16==W[01I^M5A3T,K:MN.*[HJVUO\<0
MIP^==F&=9'NGVI/=3O]5E"[N#;U$OGK3E>:Z$7>SUSN?LP+01IZD,8$1CO,P
M=TN9!F%D"$@FFK2[GG_ YQJH"/07!P5DM7"8*ASRYT>>&-APY\$<" QQZA5R
MS B41P!SZP36><JW4-/:U(PVW[;'Q]T\J*,8DEIE4%=C67)?[OZ\(S>?B#"&
MNV?M][/$JN?XE.2P>[5QQ#FQEE@P$97@"'0TB9P%:X%P'8W#)GA6C&^:TDVK
M,0OX"OS/@-_X)6/%2O%K<63EUW(VS,TGY82P4ULX.H!$-LZ/ ?$:1)0BHQ#H
M#K2^&_F<!?>"C?=J"ONI%/;E8F?SCR-.C+3:*, : Z@#Y(:TA!\I)*(UO(Q$
M^2P*.XO=8FS<:79]E:50\;2)RDERK<NLF=DNJ(O=7F[R6 PCA3]:S5A,WLO$
M&4-N:W%VWO4GI;[9A3]#C*>E7F>][W3#S9"@@2)[719V0ZDEY0[IMGDL*D!?
MQ\<8JHX'DYV7XO^=5UTDBTOG8=+5E3LIQ6*XP+S]W1:CXFD#A(:)>(B9/\">
M7E[78^\E>.ZMXC$^#%3 6L3.H/C+G:LO1S@*KCBVR*=,]CIY9*/!2'F;1SXI
M"^\F^UWX74U-2Y*+0"AENXW1OJ/-/-_*-_L#^^2ZH<>0JIYIZV=@Y-0VEM,1
M<FOP.#5(%B0#ZSX^"EHKAGE G*D\\IJ#5I:KL97WP3IJDK4B3Z6:',[S]QE3
M=)J]:X1YG+EECP<[]=RR.2ED;W/C*##/8/<3DB%HD*7<(BL!8UB223K0W@AF
M "KL/O.;;N;DI)@%VRNP5,>TRAS'ZA4J:58,>F5WRT;'P4H+!\[XI,.;)D=^
M2*D%O.V4+:7RT=X)'.\-;)L\QC:/[NUW_/<;7U83^*=9#+G-5^GE_<Y8O3HR
M$KUHAG1:>5+F;!TMO$XXL>2]X$$EJR5/6$2E*)&,I&J&%3 AFL:-_/XZP/4#
M?,X;1MYP@XPO.01_%(@R#)@0!9F'V&A&D,E=,A(#-LR]=AV+!?\)Q:8X4ROB
MR0KMWT@NWIHPFJ>HG(U?+DZ:_N2FP5?N'S:-QHI^6OG[MP(Z"-S]O(Q' 7:Z
M "G]GI?YIDE)[!UL'&EO2 J&@J4=*.(J)K"(O$-!844U-@)3@'+%UJ2:)*1,
M004Q39K2%70!#I6F4=% KNA,4;AQFUU_?IK=O3[VWC5^(;\VFB7!^5:GZ*1W
M347C0WF'D.[:.PX632M:T$5_*H -V>)%@&B4Z';LC^;I^>E^!$G7/BZH;2]]
M*):_GU=?F#)CY+A93'C[O1C;_I;UT,,?>:QSHC8R)Q**.(_@$!@C'9E&EL?$
MK8T$Y_)3,FVJ\X!P)F!I:(;>6;'-[QN_T&OB&\Q4Z'=MN"'"6W!R"DR"KEO8
M_D5K0K#PP>B&TT'4+A]M5BW];XBPZG=:NL?>,OW!-?U1(I8*RR7RS%J 1IV0
M2Q[PT6FAL5;"2KZR;B8[:5^3WX">ALAP5+W-W\ROO=D^MV77M"&%M](I.5U3
MN6/.&0!C/N==-[:*B=0WC7+^/MH&J5*1\<U7K.MU6N?]V5^9:(KR7%EFB,JQ
M+1KZ>=*]:?9Q')'K1OL=V03+?6=;%_:RM_*/49,!K(.Q75R>#9@>P-O>/=CZ
M[?-&X]/VQZW]#]M;NQ^V]AO_VONTN;W[VW[CP][GW_<^;QQL[^W.M).6Y4EV
M]PY@Z0=[L.C=_;U/VYL;!UN;C8_;NQN['[8W/C7V#^"#G:W=@_W&+Q4/Q/#K
MQ&.5BU__I^O"NYU"&6,<5$*5UR(FJJT(CG/"N:8,1Q[A)]'1:/-2VX9=-Y$?
M$SJ56+.54,O.WA!3T9NXTKV:[=S;%BQ/$'CLU^&,@VPJ@IPJV&AXVGP1]&#O
M\[%?>"$B<U/DTIGL.]VSHNUP%I7M7HE[8#1XL&V+S(B9??=R?D-[\ B] AI#
ML_QV_-$L^O(63J-J_,"@!_*P.=TNGL_F4\Y;_8G#HZV,X<Q6)TO\V#U]RDR)
M9^^ N]>^::1EIH7'"RPH"*+:TX_%'.S]\[.SUF!H\?: 2@;[WNDV81NROG/<
MC<59C7)20]E;<3P@#^IX_R)KY,,WSB_L [QC9]O?5QN[:QMKJ_GKH(O ZXZK
MC>,.",?V0"VKOO4__T]3HM[W1M)"Q@,@UY'_;LX0\=:!K1%;9<)PMBG@(6*K
M"5*@H-1I%S\K,"-[5DXZ'2#'LY/+7M$ NA?[_7);&D5C^LMA(3[)@$7$I2#_
MW@@_Y=-"%1^\<\_S1F5M=)P!\MUAY2X_1[[]_LW:<M=J>^O22B+8OV;=LKM6
MHXRG5)&B'/9TL7KF C(*1]-\BB\8@N5EVAU@N8M!=^YYW+K&JVB%HDFFQ+&.
MCG@6M5/:1[!.%1ZT]<7F_KKNT,;=[-O'3K<8+W.];SO-=FFM%3NPW?X SP]V
MV'7UW3S9'&_/E> O=[\='^&(/0A=L-=,=(AK$L!>4P0Q)G&*A!MG<ZAI:K>@
M5^'W_5>G%:KFZIDWAG(*3L 2*#/9\NF9I[LY&-L=0:7RXT%XN&#MTM\+%RC8
M?#27L3G(<+#/Y_>8[F_['$,\+9"U\&K4L;6"1Z[V<DLM+X/B-"$A D&<&X:<
ML0;E: I/ACH=7 ['SO9IP&L?!^/5,F&UD+7>=W,27!8EY^TBN700J%UMG)]5
MZ;&%H.K&*L/2-A*H+;821T!\;3!9?[E%A6R4%F@6V)T;2O]U5"87= _TTBGS
M7 MJ+\IX8.U@M_7BN(.F4"<ST9]4;'1QTKEV(P[3>W,RQ.CA' N?3SY(I91V
M*W=.'CQ1KOFT++>^K,1S=\@[&4!I@+M>CJ7\EGO5[O0KSV3WFLQ?!7I-C=S&
M(JMR.!=W7+.8JE[ZC%DCID$FR O;A8_Z(P=6\UN!+8'G*>]I4VJVFH-)Z"7=
ME3&& 3)VIT8G\M]9KZ/X_4D,0,%G-E?I 9NT^[WB 'E?D:CO]*X5F,F5SIT"
M(U*0S 3I...>4RVLS"4&7!(1&"=3^X//K#(85!> AK)7T%96#W\<=+9S<FNW
M5^:^U-'IZ1A[?)'U$,D",32[C)40H(?P@)QF!@ECM 5AQPEQ9<K+7>'IP9R:
M679'%PPN0(HY<Q<>BUX&PO?W*NWK8[=SNEUQZU[ZLV2V.I-A%JW\V#G8/C).
M.^F20(SGCO.1862)2LAH[8RFUB>O5M;YG=E1&4ZNT^\2O(B";J8!WDRBFD2B
M9CN7/>01127R%9&S0AL\JRXUN-$DXJT.ICM-7\3UI7ME?&KTNI6(G+QJ!=&-
M$Y ;.?;7[S:_QRI,4EA[16#E.L%Q^*+E0PZP?.2;BT/QC"@R,Z!E)1H=]I)C
M 2^9.)MHHM19HZ*_0\&=""</(7$,8UB\7SS)FX\F'V.XWI%B1B2#/7)@\^4B
M/PF<Y, $%$Q*$DE0868T>30OI=UOHM!LG1>O_"9+I9=/ROZ@3$6@,@S&FA44
MVRFFHTUEKMOH;BJ#+$IZCY3 \"%[,*]!?*_[.2MJ6S_ DFKV8A5,'B!\=;3W
MILF/Y@)#KSBAD3KD@^:(.QV1=8&C*!57H%@J%F6N,6=K;$J9Z20PCY"D!Q($
M+;M[.9LX7[6#>=:0\,K-[*M$[3$'X:Q$X+F&B$LM"*4T1="9.&,V) Q&L\:&
M2V8QO^^TKZ$\H.RPV.VT?3U?^KXEO#MD]V#GR)#<J)!CI*3."K;WR @3D'(I
M$FVIT<R#OJ3%E"+>L0'396'G*9CMF6K.X55E]U;.!![,T'PV0AEU9WVY6=IF
MM;*:8.Y#,#L'WX^2H8)(#10BHLSU!QKE;@^@;Q,)4,V%YG9E79LU<A>]#/39
MR5#$4(3HYU!,70#ZN)2"]S:_'UF=,#<F(:L%0SP D6B%-:(A"FDQB3$GE=^C
M&'2ML==N_-NVB\#D==AY)"(9P"@!H-G8_U)(,(1E-<"W\ QV0ADJZ\9^MS.8
M!-PXC:!AAK7&?BP=G@VZ>NWV^]F">F95^'31O7]^6B@N()/W0<. I_-9X=WP
M!9CEY_Z]D\MW;NK$ETKS6"U4LW3>+2<#Q[YMMD"OGZ60D'LJ)/-BA1 A6$9%
M<$( 5EBMN,-)>Z9"T([B>P^!K+'B 5C!=[X='U&L-.4@2S@#&YXK94"J,(H\
M"!4>DG=P_)Y8<3 ZV7K2LVQGD=GR$% UJ;ZFG[OIYP^<7<2">APQ%PC[/-E&
M:(,,C1[@"W0 S8Q7A*ZL2SZM$GB,?H!]^YUNE0$R4MO6:?>:H8B)7)S$=B."
M57=:A<WNHKGK=B_9PPS858TJKT:<5Q/+.QD+X95VR\,E*;>*<>Q3TY*'%@2$
M6\YM)Z\B=+4QE XV2+T-56X/_#TDYD?U -C=#HC#JZ)>JG59AMMO"EMCV5.H
M\H9F5AZ,[+P^!P3H67F3N8" 42.Q$U@IQJE@FIJH6*+2:IFTD'.'  8UK5L_
MSF*[5UBW6S\R"965T]U! Z(:(>Z!$/#[SI&EF'DO&5)<!=!&F4+PRAAB6,G(
MI58QCRRG=YFY@X940YPX<#-=YDX2HQ,PQT84-WX?#E@/*'IUN(AARD4:HWZ9
M*;0^2N9STJ[7CE$%BCDSD1,JC7;1"4T8%LXX+"O?>D6[]S"V:]I]H.N3 >T>
M)2&)HC@@S(I %E'(&2,1]=$Y(;FCSF=ZG1S4/M9()V?7#NWZ $^O?3*=V07^
MSXV"P]2RES(A#?PUOW?C:?/\M":A&20$:__C"'M)6>)9%<J^O2!<[M4:D%)>
M)$<<\3I7=8LI+1HGP^868*L_(BE/0'FXNR[T&21E316SJ"(#"^:<8.P)RH,1
M$$_1YAY=#H40J/<@!9W/57CZSA9=$Y+PA30NG+,#WXR.CR_C66_5LC=OU([4
MR<X8L#ML-V>Y U.#I->W)(39LKU145I>9LU4'91&-NNZ=6;9JVO&5J[\"H@!
M=DRC+$B?=EU8T" E,'1.L^7EB\!Q,S1MMSGHR=!I%7T2<DY?&V7]Z+S;B[E_
M0K-(@;!EP4N9>7:6@\OP2,7JJCRS_=^W!HEEJ]5BFMD2R84.W?.SOK^$JYYV
M<LN%;'OE/O.%07&]DLNQ N>UPB77S9I/Z[+<3=OKQ9MR?+ACL?1VI]^P?]EF
MJWA:6&L/MJB7RG3%V9TEBC3B,I&Q6872!SL"AFR13)(+@K+"6;0B'=SRU%Y6
M?3I@U\YG['F5&G+3J[/HOWK]2@=]+]QESF1N%:DEL(Y9ERNMV1O7W4AWT$ZW
M6V1J7C>?G]5FM2ISRA5'Q9/EXMSF:;.RZIZ^A?!X:<)!3C%(L=OI]@:""'X9
M?'K=B 9H;J-X[U6A[G;[KUB&F#_EU=<":[K ^DYW#[[D 3X\8$H12XPC;KA#
MUH#Y%GP$G4$%1DSN-"[P+9WF2^J;154;U[50OXQCU/4A *G1NJ:9G8"!R@"G
M>M> Y>%K;5OVUPA%W=J@[B?^5209-#;:XQG<U;&R$URRA1^DT,'&OUTA9]&2
M:=;2"W8_SB&/;K-W70E65BY<-YPYS^2;4\.*LH7!?6)YY0'3WU4*. Q-V9G:
M+(='@&TQT@1O=$>&Z@>G[$[CQ(;![H07HF'<5=>W ^^#ZFF;-B%CX?V%DC(+
M"5I\,[NJ-P8'@"ZO6R9/)\A2D,'CEVZ%R5SY(NOPVMM !]YP6,'00GG)0I,+
M ($,FY,%V$@AP'AEWL!ZR(T-8VC'WDM1%^_*H8%5GLP**&3RGO#<E.=DLO[I
M+>_W2YD]/"]IE&I^[W:.N[:VJ^_A5MSBNU=;1Y1+IVE(2&.G$/?2(Q.X0"(:
MX[S0,3$SUTRL!.+,"A:DCYRS@&WPFJL$-^%!81'N2GFIW_.3O.>0-# 992A1
M%1$'%$/&4I/G8"G-O6#>^IR)2*<$F.Y*A)FM#9?"/0OHVQ3B1@E1.0Q4]2<9
M[>4Y=R.XQ;"&313M_EFMJ^I+,]RH,QLGH\_TEFL)1^A-[!SL' 5B=&""(,&B
MS1T9.3(Q1F0THT)QCPW)7IHI659_+Z3.G 6D"X%._<(?"6!R(:E5&E-KX36;
MG&F/\SBMY#$"]L/1!\,B;#Z\\,EQ2G]?'?06 !6_=3DK V(JQ-RE.SY>KD3N
M/I>+.+P"8J;>6V(<Q3+ER'UB:D:NQ#2Y=KW,P2JO\R7V4M55^N91:PDWG0"W
M\KKXD7#1^(0)TMQ*Q'.H25M-4'2 _DY8R5BVK0E9F^R*-6);]X9)K@<2J1MS
M8E=ASI5.HC(?SUX'G@9QR]3J7.04O=B:'"!8Y4>,SQ$<=I2->-O*A33;9^?]
MJG%,)G17=+8I%M%QH.B7[JWJVF !V2+ ,:@\&03"FE5KFIRC%N&$D2XTV90%
MX[;,N: #+AIBNI,F(&#7G\"B!B=5R[KNMSGXH$@TR8L=6MP@IEQX"[/I?QV>
M6VW$9IDVU^P"R[<*'R"85=5?-[UF.\5911&7K1(>RR<>NLWP"N A<Z>5G+A=
M%$# 4U99*E5Z2EY3,U>,%_U4!G[,D0U;J[NAW=4-3<WNAI877, 04=0E@241
M,G$6I9:@@5$KI4B"<Z*/ (E7ZAYJ=0^U63W4[NM+(;08[_T<.R'7JFG ([-T
MQ\H^E6248>I!=>#6!A!'P!'"1J>89CQ-#1:/9U9VFW\5>'*37]G;:(=_Q7"<
M\U$R,A;0E3,+6IT>F,T'</__;77\]^=6"KYM5$I!AQY>?2$@N-GAU7>V2[?Q
MU]\^GQZ>[O"O?WYM[ORV=75X<(R_'GRYVFF.*07?OG[;/?C/Z=?-\&WOP+/#
M;Y^_?_WM:_/PZJ3U]73[XO!@]V0/%(K=@YW+K!3 6O@1C])AGSARQH%2P)5
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M2"]]CS9C#Y90^I$W;3_6FS1EDZZG*==;-&N+#H82UNM-FK%)'PN?]$@\XDF
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MS)!FF"/M!*$V: [DN[+.UNB4]-ZZ9J!&BL=H.[X03M0.Q"4"E?%>0H%&1E5
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M"PJ6&BM>BDMQ,:2H78K+!"OC@0+,)/?,"H193(B38HZIP,ABXQ)+B3$B<Z!
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MS'%#:KV:NF91%ZSY2&I)N,_A9"ETSDV12$<54:)!@KD@&+=V91W?15P9_SI
M0%WX!< (<*X=^_G#3%1 &H6"6$!9KP__#(1&!V1" 8Z]UR 6LNB< N3 =5TX
M8+O=)CQ_9\J>.-LJQ$;O),*NV7XC 3$W_LK4O I('AK^Q+:/8:'5AMX<+J]]
MPZT]X,INA,VX@K^R& ?6[18L7'Y[8^_#I[7&QTHB7T;;[35B.W]U4/I;OE9&
M*O4UWSVSZ$QX&+RWX0V?-"I2\;_W/^M-% K,G)A%+;4V)<P#ICQX;@R.U&#C
M*$\\!%%@%@&L(FBJ%W%"W-U U0T:;;=[_>YY)O\>F,R_=V/?_J@!ZDXM]RH;
MV]^/X&4+)[1'7&/X(85$CEJ,4@ SQ#(&XL9D"WAM5A/H 5IEJEY$KGDC@1XD
M"&$I.9'::"PQ]\)2K#A/E5P;T,BD?^4^<JTFEH6DV=7>P?'%[N8A 8*YVMO\
M?D0<2<QKA:2BN=Q+$V2<=8@DB7.?M.0,!6(A:[-JO2IB6<TJTUGT^8VT+E>G
M2[IN;!5(WN]46)U/NX'IX>,%@)>Z2^-:3G2SFM[OVO8T./U9J-EKE88*++*3
M$JB&Q5K'I4C&_N-V(6 J639A@HQ+\UN=-]42.%U3 I9YUNDU\SGOBBV#/7]_
MT0S]DT&VU= 7*XT WWS%.I"IY_W97YE(_GXF3>$CHF9LBX9^GESGV9S9XX@<
M"/3OR"98[CO;NK"7O95_C&I(H R-[>+R;(":N@';NP=;OWW>:'S:_KBU_V%[
M:_?#UG[C7WN?-K=W?]MO?-C[_/O>YXV#[;W=F6KALCS)[MX!+/U@#Q:]N[_W
M:7MSXV!KL_%Q>W=C]\/VQJ?&_@%\L+.U>[#?^*7B@1A^G7BL<O'K_W1=>+=3
M*&.,@TIXCYA'ISEQ+(%A#F(H$2-!90=!F+P3MI1>Q1TWLL0(B6&JI:%4"K <
MHXZYD!EC;;&,<)65%ZIX/XH^NY2*;*5D+Z+/1JZIBXF!Q9TX4$H>E. )XR+*
M9&T@<^NS>UGJY1WKQI/8[A4*2I: 66WY8'LG'UN=B\+X'N@R_QNSG/L<?<OV
M>LW4] 7I;K3#0:W'S-)C#G_L;'XYPDHI2AU#S#F*N)<$N8@=<HYAYTPP+@*S
M4C[%+&\,Z;C/J4PLZ#FR+G!)J+ :)TY4-):#GN]"(AK#EJC%->R:?'\.^7[;
M/G+,)B&31L+FRD_%(])$!*3@C:9H$Z,DS\Q2:Y-QRL9LK3O[+NY4M"N_YC0W
MS&MP,;UR25?9&L\LZ&I;_($@<+E[M7'$<?(I:I9KE')7? $R3 >%K&#4.1&I
MT6IEW=R" 8WG-8?#SQ9<-14^-A7Z([!TI""$(8YM1#QHCS3-W=4IMLP2G:RV
M*^MBBL?P%DDT+=+A6^<9P6X->?1&8Q[C7J%F579=>H-",R7X$^PWV[I5K#5>
M@5S+H1-X\N9IL1^%XM@_L;"O(.1^Y,TO=\D5L8Y*'RL_FGP7J=LY+94%6VSX
M#/F8P^35VVK#-C3Z%['U5VR<PEI/>OG&\W"_H-R9Z(+!.7@0K .H U.;@K(C
M+9U97CM;6QTNP9^JG1YT_G=(-XUA\[S;;!_OPHH(W2F>X=XY>6\0&TB64%ZP
M8)@Q*$6N$.<9%K!1"+.4/&,$>U[4Y?.9V%#$U&>2V*CF%3JQ3(PI";J1/QOW
MK5[ 92>('&"ATP!]KPWOMU>F@HP&\4.S-_ -Y2AB^6DOCB>,].#*WI[#@?RE
M3K<)2%"FY\#'O8+#NL#"%;$72\G+[7C FQ>B.Q=7?-?LP^W\?7QW@!;;[;^
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MFD=G\&A03#,M(],><\.=E4YY;&ERP)B)XMD!\SI._N1L.!PGW[H\2E(FX;E
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M59>FT_Y'=NF*3^!!M#,8@<4^B3Y/1_LL8\A5&VXS^@[[%@&:M(9G!?S:'21
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M3=D0Z-UOIZTP/)SNBKMRX\0RXLM;K(,.CH:WWS)W'NZY+"9B>&:(KOP\O#@
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M"=TQF(AQ^T+>:E6Z26]&W5">E8#^?NCY21B[6_P^H7B?,L5[FITN-\O-C7O
M'OQRN2[N,ECSH9:LB8BMW\ B<^AJ/([_(K\\YXC-,.WOF/A%H=C**>VBTM[!
MR#U]4&52D^M[3AQ\."DR5&P.!N"CO;F+35O5%&HO4R(GNUIORBNBQB',)1#.
M6XH7]N.)!2C)VRZZ@TF8?KRV-EX6&)8!^.&=J.6/!N:G).IYGO$"I/([J7*)
M7J?/(Y;F#E+Y/>*3]\D4>:-,4>Z4^3FQK,#RN3AW*7UW$;WGK5<WORQZA^SM
M+SM)NZ16".^(8"IPI;4)6,G O$Z:88OI@G)6EASH5:1I.]SMP+/HCFB\WQ6-
MIL>-]Y_%7G.'U[=V:;U3;^]V]H_WFH='>ZW9-&W;9]!&MG=TS.%]HG[^)]]O
MM@]WCP[P[OD>W:.?S_8['P\;[^NMO\_])%G[]G#WW)_7FWM?A7"$TLASN@:%
M.%8>.64#2BK:J+"A(>FU#5XS]\W6_GA)V>]2?>Y5:*' 6+F\6)FXY9$Z+8+&
MQCK&%=5:N]MS)E9:^,Q:>'9="Z41CG*/D<0,(QZ#!GUD%+$DA>+,.ZO\VH:J
M27I;'HTGU\*5(Q^OA!/7X["X/(%<$>/E^.8BHPC/))B/2I?O-  OSX('';AF
M#MJC,%?<.)%$PM&Q?"*!85SQZ.6TX,=S/!J'Q%PT#A%.1,YU[)#6+"#A5.)@
MVV$*^=J&J!'ZX*I'WX&&QZIZ=->0V:M7Z"1HB)8:K)3E0-YL<$HS+2G5WB?"
M*DJ^M H]0\E3THY3SQ!U.967= (Y9BBBT>0\$!$[B[-"4Z.67J%? !_Z#E=?
M]E65,EW00Q9.*B*^G$1\=9W$A2R<5.MY2X>'=Q/%*WNX)_>C_.4W=%RI\CDP
M<F?N3-H3;1^Z47-^<OL0_>4'.WA>?7%?(SC1R<-_B?#@'3A&S 2N;/ V".,J
M?W<YZ?%%:9_+0K^11YLD82A0 PXOYPD9RP.22AGC? PTV+QPQ-0]0]9+7^:W
MTNBK&JU"Y-(3ZZ3AD5I+@TA:*(FQ%2S%QW-X4^M;#.@\]GN5,M];F7>O*[,E
M2G"L$F(@$(CK2!',7D!&&(JU(5;&F(^@E%L3EUZ=7P"]>Y%>Q^*6IBK78^E<
MCU>T-/4J#'NR7H3DJ6<R %5G5BE-8\)8^,@-KJCZLEIW,D?5+<LE[5Q"*BJ)
M.,$!:2$]L@GF%<<H7,Y72FL$\Z6W[155__G%9D.]US)8*2C'(EBFB.+6<Q<8
MM8Y75'TIE7F&JD<+LRB\1DD*\+LMJ+6C5B.EF ^!L>AS,OR*JC\S55\&%G3S
M";1F;VC;/T@F,G<.[;YKF7<^__S2JKO?N_\OQKQPKJ(A41 G/=<\.46IPCE/
M.HL,T^I,P++:&#I'&#%+P V-1H[E+$P,)Z1]Q$@2'IT/G,'\YJ)!-;ZPS0_W
M29CPG%N=*N"K@&\V!,Z$)<I3+$WD(5)GL&1"1(HU]Q(_(J^N@.^AP#=#K@G7
MUFML$?4NYJJ-"CF')5*.!I.<=8ZI7,^T9A:VC?.9@&]IB??T*U-M%"7\/L,V
MIRL3PV#H0V^4,]G]3*Z@E6CET@K$R_7$[IP+Y$/+NE:[E7.J5\LEJR:5WSME
MQI9\Z^JF]_U1_&Y"D/8#9;/:W+ITB+GBR\S5YM95%\MJ<^OJ;&Y]\)K:"L<\
M;NKBBPEK2,.]TC$JKSA75CKFF0B*$6J338DM*)X[Y;9G56AC<:&-G6]S,5V*
MI7:,8)2,CHA'+Y'U42.?-)$B$.V36-L@ND;T@V.ZR[<+H$*I%XI2"A!))1Y4
ML)IKKHP4S,J@M2P+)Y,%!5\KE'HDE)H)P :KE)=,(LF)R2CED.',(FI$67]=
M:VO6-BBM8;;\QPI> !.OTI"\AJP%(@F=',:*,\P]CDZ)2&)DV!K,C4P5U5MB
M$)T_FB64)<0*C 2W%G%G%-(4"\2QE<9Q*14%$-4UJA^,H54NDN75ZLA!:RUC
M!CO'@[4FJB!$D@G^],;)BAHMMU;/4"/OJ)0T!N1\2(B30)$QTB%&A<2>6Q8<
M+@]<,K'T6OT"F-%/+.N4?[>Z(79!NV\*MST77:KR"2Z'$#[32L\=Q-4LC[!6
MW/Y>+( Z9CG0/LTCX<ERK92BFE/'%9!^\LC<OCKY\;,$ ,]'<$W@FB:+=%D;
ME7&*- \<84^I#2(:[A=W\J,B]DNLTIP[P9*E5! NK;8^A,1XP(YG@< 5L5]N
MO9Z->1(<J'<>6:^ V$MKD+8*W'7)I+%$FB3HV@:I:?W@XYD5L7_9^[7&J0:K
M+5DK+'[5EJSEVDY5;<FJMF2MV):L.S'E5Y'RP,>$&=?.!6FYT=H(:['3S-B$
M)0N+2F)2,>7'8,ILS@-F/$GI4D*)4(UX_J&#C<CI&'B*SGN/US88KA&^_+L#
MJDPF/Z_6Q.0<=8$113GQW A/B?)"TT12,(LZ<5FI]2.I]8P#G*Q.7D>'K"7@
M $<2D N8(24=IX[FLY=F;4.1FF)RZ=7Z!7"]:M//:X@B8DUD4"IZ3RT/PCIB
M50),"R97HM.RXD9+#*)\GAO9:)UP%&%B G C[Y"3W"+!!6.:LT1LN3U "[/T
M4<1J;>"GM=H9EHP-)C'KN>#6L<B%,MY92GBTHJ)&RZW5LVL#S!)',4;9:T6<
M4H,<E@I%R_*L"AYB6-N@LJ:H7GJU?@'4J"H9NH11_VKEH*+MK\; )\=44$;K
ME"B7\"^+F+(@N.$,I+X*:2ZQ@=\]G=_48X6+"6@[L':-N,*YC(HVB#FGA/#)
MQ@0&GM68?'#HHZ+M2ZS51#B)6< I)(X)S+X4@2478N+&$%?1]N76ZMD\<C8Q
MSA-%P5"@[=A)Y*ST*(7 \L8]%15?VS USI??&7\!S.@AB]>/"QP+2=%\E_1@
M=U@SFJ22&\O$3=GD'I;;=*7Q^8F2&U?X_!CX/)\, R8NB,0TDD(8Q!F-R'@G
M$,%*.B,5"Q3P6?*:9@\.JRQ<NU9H&;J"E&=/&UQ!RB-!R@SEPUARDQ1%TC&"
M./<1N8@= B88J9<ZF$36-@B3-2(??$!SR3%E22GCKT,+@S/=+7=E5V+']@]:
MW2OC^-ODDTE:W=^N;5LT)]?/QB&S^&V,8EW_<.<@_=[.0?+]K8/DET?9[_C#
M2'39YFM[0-=I'KWF82S>]CK0EK/"M^U@T$JMDO9.80QH;ZY#4B8@O;*_/;/A
M:2;2W+U0 .@.X6$^[SA.[=[IH$Q>ZC-S'O8*%XM6M[PA%*>MX6%K_.W4:\-7
MH5$%H6-5[$ O#@?KUS=8WBHR\JXB,YZ(H]%@V$IG*R]%=,FD:'-8;$4?.R[V
M"T9J1>;DI<1D2UHK9WI8NE;=7NXN_&([ *L@5F7'QR(RO!3%TL%2OPU 9F:W
M"P^*4_BD^)_[I*H2CJI@M'?2<<&X-I98Q>!3DYS6MR74T[<;_/JD&YME+^YF
MX,V*&OC]OP^Q[_S5M5_,J'&T?U1O_M79WPI'8.3!:'\\WG^_W]H[/VSO=W9.
M]YKUP\;6QW:]N7OV]_F?YXWFP6E]:X_L'NWA^OGQ5W#D<#)4(^4-1MQQC8SB
M ;%(B/4I>6MS?9/UV[@_H$\[3W86K?M( +,8.((%AI<2MXXZQR3C+&$7*7'A
MMHP<E00\4 )VOC6:QZ>[1[MGT ?X_\%7:I,*5D44M(S@ $J)3+0*D0 SQ)SF
M"N<S=^NWA><F$E #X!ADZP)3T3Z;L1:3.^NC#DR7'_^=Q:'5'95+L-?LR03:
M.!V?,)M'Y--6&!Y.O8PK-TXL$+Z\Q3K@>:/A[;=<L40^9F1[>F>)YC:]0XS.
M#-F5GX<7I2!.[ &0Z7ZTQ\"FH;EO;/O4G@W6?KUND<'XSHSB\@S 7)RO'("=
M>G/[_<?-XL/.N^U/;W>VZV^W/Q7_:7S8VJF__U2\;7S\H_%QL[G3J-]*0Y:E
M)_5&$YK>;$"CZY\:'W:V-IO;6\6[G?IF_>W.YH?B4Q,^V-VN-S\5_YKH0 R_
MS'5KW/B-?[L^S.T-DC&C06,<BXJ#-\1SAH/(DV=&Y%@.8SR(H(E,%U[Y1!-G
M,%E)1AFFGFK)K0T6G'"9A(U.,<UX^KJ5K3*&_]"E>;X.QY_\80RC]C6W>Z<[
M&/9'>3_%X+UM=3_T!H.=[J<AT(?\62.]:W5MU[=L^X_8+T&[ZV,3&O5[N^>/
M7QU ;Y\VMCZ??H7IHHY1B[Q,X$.[@)%EW",%,^FB]LDJ&/P(=NPDRWY_%-?N
M3LKEC1S\F:"O><WI. $KDB6EY)[@V(-!*7KIJO?3NA2GF;6 "T=GNBJ024DW
M#N&6BQT]DRL3U\AZ/Z:W^=6@"V54H'S<8"J?^>V]DSC>*@1O'/7S=_/-9]'V
MP:4"GR5<<.VQ29PCW&_NZ#P1>GVBRK\??Z;NXF6LS01FR@#"I>4M@RO0D#;X
M _'-])??I@&(5K=\7GG3;]?[?%/RI]SC\>6)X3)FG5":;==DL6ORXHE96R_-
MVDRL:'R-LG7*Y*V7\3JY]=KW'DOH.I?FIQ[[_6N"J<4WEJSSGQR#9V@LN.KR
M9QOTY(U=*3'@ZT;?K4$_6%>^Y_+QXZQ#Z#LM0VQE*.KGN 6 =F\$3PIWV=#Y
MG1Z.V>7S]/'F1?+?;3N3IC% M[KC?S<;;S^4[/'W"&C;S5:KE\H/]L!PW6,(
M[K!E=*5&:QP@& _29$0R+RW^E9GI+^7?'Z/O'73AD6$ZIN7'Y9!6 S<>N/&_
M>>3&OUT?OFG@.A2IW^M<C%X.'_;*O[9M/\OD?73QI8WG]]5V.]<72\4K5]8/
M/3_Q;\<J>.$W#JXI<.."H5\;JR?:'M5IA=".SS- 63Z*[6M.R$7 _R$'%^ZT
M7OK<IQJJ1E:-_&XC%WER1-TIX]GC8$&5=:IZQDH_8Z''"^F=CA<^CB8^.*O6
MS^3EN',=KF?M\R/7X7K6OOWK/B=8N!9*&>JU5SQR88P"-J9""MY)*;YS\#Q'
ML^&WN5658<\?'_;: .>#[?^.7LL.QG9]Z_?V[I>/A_M;VWG?(=[]LB/VFA^/
M]H[^%+M;!W3OZ/\ZNU^@'6>S.Q@_X]WWG[_MOW]WO-NL'T&_ONT=M0_K[^NM
M^M;Q:6,+WMG9^[;7_,S^/O]SLGMQ>[A[[L_KS;VOV-/D*55(46T1]RXBS1)!
MU#NAK,?P(Y]9834EYU?%?WF:!#P7VK!(,E9ATBIATCT@B3!M*:<\KPIS!U)M
M#!9:4J(2Q<*)&Y=VO[?5NDROF_>&]>-A[ [*95[?Z\0<!,ID,W/-DFI.EWQ_
MCX!8\3(R-';K-[NA:;]5:+90-#N[CF;4>)N\BLAYHA#GEB+MX$]#).=$Y)3;
MN9"@JG%,GS6G6 5IKQ[2[D.S%H!IM_"M>X/;'*SEO5D5L"T8V.JS-(T;DW*U
M *]91#P(AXR/$H4@K7$@^L:ELD(J)Z2B:16FK0*F"482DSH7PN">*FLYR95'
M7;)1,QYN/UQ;N8[/@TDS9$MP'Y.6"6&2-.)1,>2TX$A'G(1F8*6H6MO@K&;$
M?!:35<:DE5M>NV\@+Y^=Z@[BP]87OU?28@6BFDN1GFIEP)P:+43"T0OG>&).
MZY"X8@R(:\11VBH.N%1@_GDN#J@89L%HCA3+B60%(65^?60-DT:H(&DTN1P5
M5O,Y]N^.Y0]*6_-S6/[LR:A6)6XF?2!:^4A@NKFWP09FE4J6&08>AO%5W.P%
M:?\,E5/*"6(C1TZX7#O>YH2S&*,H/%:6:2\Y!_>2UZAZWC+3%0:\< RHPDM/
MH?^SX25#A+?<!Q1UCILG%Y#V#GXC2DI!L(D<K#^C-6UPI?\KIO_WX?%84R*]
MPU(XPR5Q.D5JC8R&.)(\P5509MDT><:2!\QE5)& )EN,.*@RLL%;I U)!"!=
ML!!S#DJIY],<O @>?_^0Q%*'(<:U75NET:SE$YZ/L>E[Y?=\5KGLJV<\_S.J
M$&D5(KV=6@5GA;4IURVDG 1PL8)@2D;FX5.C:!4B72IJY>="I,![E;:&(IB\
M!-2**Z!6X"0%:Y11CAG.]=H&H35J'K(&O\3<ZF4J\7WJ;$GAN87_/+A'3'#M
M/,MI^\%M#M9I4L5(7Y#ZSWA67O.\L(T1V'^".!8$66T5$HDF&9TRR2=0?UD3
MI(J15AA0Q4A77/_GMN!%+DDR!@FF<[UB4'TCO48T12N3Q49YMK8!ZL\K]5\U
M];\/CQ<1T-Y&:;'@G%'CE%8Z<WB0#N6)J4*DRZ;(LR%2Y;Q-,:&DE$+<,H><
M\1QAKSV.Q%)*09%IC=$72N-?6(CT8MO:.$JZT #I?;<C/ZRRQ=,EE'JLO<IW
M[_]R5_2XCT&PBE+BE:-$&<Z=,8)Z1SA7SG+,%:L".TME$ [F CM"6&>-MDA$
M YY=2!HY:1."R2/*82NLST4\L*H1]I#=;_?5D6<N^5-AW>O NOO$L*T @),>
MN*_F@AD;F6..",45-@2[*O[U@E!R=H\@,4P0G!!,-J!D+D]ON E(:JJ(EEC@
M(,#_U35B%G6VMD+*"BF7J>,KA915E/ I4'(V2NBTIXX*DU,..,0MU4@39U!2
MA%&B-4LZGZ-0-4QYA9(52KY E+S7N;%(K6<&.Y\"CY)H9ICTC IJ [C3J0JF
M+AO>S;!"X'W@-%N#&,$,\<@D,M8KE")/T1MMN-1K&T+4S WU+U^LZ[PL6\E6
M-)LO?DC.SBLR<D-MU&7)'%FU\K6U\M%SA:[R!NZ%).U=A3W"U3.6\QFO;>_V
M Y+VWG6;Q]+U^>X>V4U=?$$[6 1/P@G/E>3 V+D.Q@.)#\[@Y(TK%RR)J9RN
M)7&ZML<.5QEHVF6[YY_I5TN(,"I0)"0-B"N5D TL(JNE= 1+XI-;V^"B1F[8
MC+;*>U@J4'JIH"1]"%9YI3'6G.0-M8I83(AGT0NAQP%S/ V8WV<[1;7&N,3
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M6ZRP\X9S8AS.Y4:Y#AP\+X7Y[<F>JT7NQP;B@_GMB=XPCHU!-@B.N*;PF^:
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MF<;8&YL0,1*#2H.M-@#+H.$,['9*#IS )53IU[ 6M_!M?S>,P8I@TWVV*B_
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MK+?,KVU(71-Z/H?6\UGQU[!'I]FW(79L_WCP:WE2K%2IGPL,/+#WJQ48L%$
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MS&]<RS6V85*/1MVQ<&5=+14R7\VORK]O?QOV8Z<U/"L:_>%A[R2&EA\4;C0
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M+"P#NF/B' 6G=>3)>1O<TGM"Q0J^1H5\I@8U!2';<R*9Y>>_+65*F[N^9^?
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M\6_KVY\^%2_);W]OM(MYFT?]WL]VB(T(CU:,1SSO"7]Q8LKYB,3>T5&O/\S
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M\B5E70S>.(K]@N'RF,R+[V04R.1SX<\%?,Q<+,/'^ .]T7 PA$]EB_I<Z]@
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M*/J<(TR(0SSJW$5:.:2LY()+S[UF2^]G8[7_?>[H/6G'3EAIC/>W\;.7HT_
M^>ULKP&8E"W=>X7JUC@ J.KU<W>#\P^>3+EWSRIJ2P8Y@H^7);I%*_CB)IUV
MFL-" &#G;>;/;CMQ2Q#?ME&TE"]<IK.76&X<]09#-(8K$,,IMH>C<=50KZP
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M;^'/,>R"I 3)5]EZ#\^AOK8=3GYVOU8SP7>^YQ, T_%D)!#&GQ])&CC#F8<
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M<#<:V%Y?V],$5!>B#)+*YL886H/&[!FB.C)IK"$^Y8D2*VJ.K5$B]T1%*T0
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M:&A4(Q*(9XY8023)&EH)$1:O_6(:@%-.^X(P3XTP6Y<1ACN) 4TDBL%9Q(G
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MFK=X8WW_9'MGC6WMK-5P1I5P%-10I%)N&\@3148YBB@7% N7J$]B:55?J]2
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M28TQ)4WMYXA2#RQ0)G"D#4")_0FY3G(5ID_U"F*^# ^7:LSFX+6_K/Q\] >
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M5\WV0JUS05_UVO"H?]*KN0CZ4*Q]&\.SH5T(8MNI]>((N.9KO6;AVO$@#C/
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M#=0*]S6^4,63B(DC#R8%6/V&(1.=151A:AC/>7K ZN?K\RE"SXGUR/[(AQN
M^D),;:"(6%)4;;(N-5BP=C^LU]Y=0KI?D6&I3 UBUT*+<,=S2,4%D-[KI2[2
M.&M\X0I'XP-%E.98'<<],B91)+/9P[3WF+M?R<=;DU=&O1(T[X%Q<KUV;F,5
MMLI*VB9Y"JY)C@!\U(%Y*23'=9L&6=QXL.6 UVHPOUVX\<B.:CF,ON8B/!+&
ML"A9PN0[KQ-)8('FO P1EJ73[D(;H>;; S_NPH) !THM)C\,@L0?73&47.RT
MXP^XI3UY8Z\_J@UA!,-T6MS8!<B 5K_'3OX.DYIO@*6+PZ-^IVRUK IT7G<V
M/P5#Z_NV'4U&ZF(/J&>T7MOI%9?AC;U1.<S+G0EQ% ==F-?)%.0^]<?P%IB&
M0L3"#$Y*$)7]@I=W<F*LHF,E9/EL6H>:[8)=/LK=N6&OIIZIVH9,,4517&@Z
M-S!_Y[5+>MZM\Q>VRPZ4[% ;CG/=W?,!E8^WAZ 7A/AB:'VR;/_W_VA*U&_7
MIB?+"#_(\9DP6:>7UNHN H4IR2BHSIYJR:T-5C(AD[#1*:893U^VLD#!\!^Z
M2;(,8<+@TZR(F<_]D\-(IQ4Y_RB6<J=7#F!K,I!*H;E>Y'PZA7N_8(6)$; 2
M)G*)N$\!.1X88A9HQ#)L;%)K&_AO%)IZ1KB'D@S7VDNI8Y#&<+ 1C=-"JD#!
M"- D8E^0#)Z2S+P+MR*9IR"9!F]N?3W=;6VR1FOS9_/;QR^"&A\3,X@*SL&B
MEQ%I8'*DJ-$\$I>TI=>33^D,G&HM6=Y=(:.[V4[<@ZUH!1CQH$(!*=EDJ&6)
M*LF=BIEXB)D0#S&_UF0KFGDTFCG[^H5',&REX@CCHNREI,A*BO,GL$*"449:
MT'+7;\K7<$XS%Y[EVH53.<-#04YYJ>L@[H?'8&:T?X Z5.J\^;;)#7#G=2+P
M> !K-@ 1/#&H@"+'O;)"+>A/@WZW5!R "@;GVO0+T! V"P?[[9SUPT*K/![T
M?[2S+G6NA%THN]"O@FL'\=B.!J5F&>T@6Z?#<A*GMNUP[(;MT(89SXIO%A[Q
MM&8'616)W:S8];/>=F'/%.O2[@$GCHJ5F4B<"$^ PF9!9>OU@"1*'7NB0&<U
M%/3L4I>=]N*D/3J"<< #H/2U;:=0(7U_.%HO!]^X]#MTK50A+X@CZ[BCLJS5
M5->=#BFWG+7M;$^5#V>"Z_3]%2]V;O,H]DK=\[Q7Q<C;P[+A&"9]N:2^E6K_
MQ;Q>E%$^'UAN]7Q&8(2]&*>:?SEQA0;=!P-D"-A5=.ZZ>2BF?E ,XO*\Y6VT
MJ?K]J5=8+_O9D!RNU_8NMP\@#0L;2^-^.G\P_,XXQ*DOSOK_';>'[>(.(+(!
MT&_)[(6^#V9165H]FZ"Q%]K%,\<=N&N]!O2:9VZ>-,^MDE!<RJ-IPU5?6!?G
M\S89UO R010]?$)-=V[G^5VYE-N3'NU=,,]5^5(DQD!G<= _%RWXU8F63] /
M_\4*:4%=U$AX2A$7'".8_X P319SJ9F5?&VCUY^3)J/,P><T;_\&_4K!<6[T
M]F,)?[8W:OOV<6;!3&<%DQ5(<\Z9MP,\FZ74N#.:VN(7Q%I0]NZ?.UN(F!J\
M/ "(^?6KLB8/*Q-ENU<*LBO29P+PG*XK 4+@N%^RVIO"PP%"\;>3=A@=32,M
M+CTXD5?XXA'KAOT.(-*-CUP29![8/PZ>28Z] R*8F:)+?Q\-IOTYME\C<J"\
M?4=%GLPWMG-B3X=K_[HJOT%4S\SB\DS 7,AK,0$[S=;V^[W-VH>==]O[;W>V
MFV^W]VO_V?VPM=-\OP_TM/?'[MYF:V>W>:/2LBPC:>ZVH.NM7>AT<W_WP\[6
M9FM[J_9NI[G9?+NS^:&VWX(?&MO-UG[M'Q,>B.&?<\,J.[_Q;S> M;V&,F8X
MJ,31%)CT5A%)0^ 4!\=4T&#N&)] <36Z% 7%&S<S*K,D&'6$264X5X(Z277@
MT5FJ.6.Y>-B_K\1S+$"27)4=^_XHAG$G[J9<]]OWO_9RY>^6_?E[Z<P;[O4[
MG7>E3[>5-986O/UW4$J^OSK)X7\VOGW]HB+1+A]S=SSDZK><(D>D19ZXF!2Q
ME"<0T!'DZW'FB<$XKJVJ:E^X/7N^W6E?\?JZ"-TM-HRRKI45K/SQW!,+5L_$
MS7W))SPLM.SL!<\&T_#-;4T?0J].4/']VADJU>ES051$7L%,=>SQ,+Z9?OAM
M>J"AW2O&6SSTV]579K">";HJ7EA>GN"X,>M:L SEDY,0DQ=/4'Z]0/F90++R
MFC#KE-(;+^-U<N.UOVN6D'7)U+V:_?MK@$]59_G-ER\W^XNC,;],($'$W+W7
MQ"&7PO5IPFWUK8[+'(#*.JQM][)5?]F[<B6B\I:3LPJ!UUL93F#$Q6Y0?PQ-
MA9LS#5Z*>+_#6;+E7O"L32QJP+=)D7DETG:^J1<UL;B:V$>96&+N T>WP>J7
M,TO_V+F$:/^\RWRMV+'/ZW']=]O)OOSZ)147%-I3D&X/26GS0@\35:>!_LXG
M>X,U_4(.^O3%8;?!#KYUOC=;.WSW_38^;+WK[GY^USWL_O=;\ZQQUOR\?7;P
M>>>L,7O0YUNG>W 6VKN?/Q(PI_E!:Z_3^'P@#CX?=@^Z^3!/@QRTFD<'WQH_
M_SJ;'O+9'C7._%FS=?#%^9C3G#A$; R(.Q>1M1(C[CF8WLRQR-C:AL*+.CZY
M0N<?*\Q9IK'=Y6RW$%CS:$C@ABLEM2%:8:M)2L([0S+F7!.!4&'.8V'.Z57,
MD31&0X5'D5F)N%8&&98"BC12$Z.--L2U#:D>7%RUPIP*<YY*S_$VD>2\])1P
M8;VA-@H=?%1>)8Y=@3FZPIRGPISFC)X3 TN -!P%F03B(1=#=2P@D4LG:JJ<
MS$7=EPMS7D,.SJ*@^7G4X3W+T-RVCD'5QNOP.\PG=GT['@QR-%3V/92G0"81
M%?>K:+.ZV:>?,Z[J!MDV#>(=[A4!.#"A[P;][F3%RCA?N/N/Z8+],@:K$I&W
M$9&?YET!CA-'M$;.>(4X9P)E'09Y(I-*U#D;0^8M30G];8G$9)5V?L&,_]!S
M(!7C+SGCS]CCV!F55!!(2\L1ISC7;\0&.1H]]L3AR"O&?PV,_] S/(_&^!6#
MWXG!9XU?BD/"6ED$3.X13\PC$SA#-@43B)>4"6!PP9:(MU^#[3MOIOQ1'&?*
M1LKP_RW 3%G=VGPK8Z84*U;I*H\$90=S1DI(,8&=H@' "$'<18$<+#\240*L
M408:#%Z8KE*5Y%Q>MG]>(^5&MJ_8^V[L/6.*$.J"$ 0CHYE&'#.)K),>:6R=
M,]H3GW1.OE-Q]LOE[.>U0BJ!_K@</[<Q9S57'B=DJ:$Y/VD LT1*A,%4"48"
MO.NE%.BO81^E*K7[1*9'4:?SI@.#928SP* K.#4IVUFASQW09_OG7 6)Q(R)
M*2@$ZP=_); LK*0>40>KFCSU1K!K%8ZJPN[2LO!S6!'WY^!*KU@09\]6,,#,
M@,D@D-36Y^W,@)RQ!"E)9*#*&A]<M:NQJCQ^IRJ%BS(H*C']9,S\Z2HSL[Q@
M1#OD)&<@J[%%+F$# EMI8TSP1M)K=S"JXMF/?;8K]L*=3W5=+09YJXHOK[FF
M["(F:+GA_!DJ]U61U@O!ZM,YDXHYEIR4,2>RS3Y<GT.M140)<VDBIC:JM)!0
MZX4SR6I4V*[@LH++Z@#NZL+EK)UJ$G$*5%MM6,KUF#RR/+O"B>)4RY2XP LY
M@5O!9067%5Q69X=7#"YG/ ':XZ@I*):,18!++"325#.D&/$T4B8,(2]+NWRQ
M14F/CP?]G^V<_+=SMUH#]S0!YTH,W,"DK2,[^IRS4.\4.8"W4RJ3U\,M>]#9
MJLC ]?D\#TYVMQI?8J(&AR 1\19,P,@$@H422/)D7.(L:1MS,8J_*3<ZS8M9
M>I@NEQBXFA'Z<HFHJUDRS\-FBXI(]5H[U2Y6NCY),6Z+=2T++_5ZXYS??+K2
M12,#:+M(.ITSI,.?1R?0G>:[N72RP*;M!-#0&[TM:A_L]&Z*9AGN13OL]P F
M3O_H#X>Y]-5FD41TFHHV%UR:W%WE,9^GWM-&RW_1E-DD,4<JU]_AR6+D.)/Y
MF+CA!@NJ";XVC_DD86M9SV!2U6I*P'-)7"_(\U>T7>0RO_K(146R]BAG@1V<
M+WN^J5CWBQIATU[YB\I;8>QSL8CQ>4F!T4GL_,BEP7JCHVE&V7SMAC3L+Z#(
MQN5$\N?,E$^ACX#7AZ,B#^]Q[-E.KC5?KD0Q63?#3/M*'=RB3L(P7LU8?\&U
MN3Q&NY>9?IK.MUC4O!9%Z']VJ5_*_#E;!.1*<96K[\@%O*=-WS :Z_U@/"E$
M<=,;SRNY7)1HN7C?'1+?KPY%7)]]_-?9Q"]/?FIWH$/OYNMD#^)H/"AJ:0 \
MQ$Y1YJ";MPB/.Y/JC_5)69))Q<&B0,$WX-!A:)>RYE(S5U>\+"W2Z8-H&.2:
M!M\*D=8'$K33"GI%386<,OK3^OYZ40\DJZ@%N-S<V5S^*9/'SM[^><G)U,[2
MH3Q##[2@UFN;,)CAA8@J!W.IS J(&"#"85D/T\78RZ\O2H^$V5:A03'?X'0R
MYAL:QM&H<VTS='V>*J_)CUVL,%'4)8$E$1)TDRBU!%%-K90B"<Z)_D(T7[LK
MUN6DVL^4JY^P]=HC9[B?ED7Y(P[VCT O6I8$]KM;'Z<J VFT-L$JW3O:!5%_
M""I#D_Y96*?-LT\GC6_;)Z &D-VM/SN-.97AT\_&UE=^^'Y;'+X_[(#*P X+
MZ_2 0;]!1?C]:+?UB3<_?P+KU)\T/GX17$M0]PRR)D>1@=:+3"(![%&AM(HF
M&N=FJQ0XY:2T4?N8-+?1:H.Y=D;@$(ET7,_FNV]NMVH[S;>[C>W:']M[M?W_
M;.YMS]F 5PC\6CC[]6NO=I,[10T7C- H@3F$HT)K*W(C3B<=G["8PBS1_6Z'
M;;_9"UOM7 UEN2HI/ LA;GZ)VB4O%"BLF'C$C1+(>N$0F!U4:E@ Y>G+**10
M+'XA94*Y_$6UVHD,.\YR,)-([<1>*9%054AXY44'5JJSBZV0\*S;%[.ILO_N
M,/2-APVJ4@XKM(K7U7.H@TGBX_'H$D!/G!-5I8='+TCP,B;N&2HYO(B)NUNE
MAD6=7(.I>WHC&$9<]BMDAW=A^[PI:M#FNZ::XW7:XOT23TYF9F%$=^\@_]?;
MR2>*M7X*:KY>I#;/J?4AQUQ?: C+RPQ"67A*&Z"AG8*$/O2'P]OM7S]W@,I]
MO2B3 !5RT#K\=OAMKPUML@/Z$1^T_ML^Z/[WJ-'ZO7N8=_W.#MN-L^_L\.UL
M@,J?1\TN_/=^!_H?\L[B$8P3GMW^V7A_V(&V6+.[<[;;"M__.OLXEZ!&"BZU
M3QR%P 3B-!\H%=$@&G!25@5%*%G;(-+4L1)+=)[]B8+R*DQ:IK$]9[Z="I,>
M#Y-FLNJX1&T*E@ 1F8@XMA[9(#E*U$E"N2$*I[QWQ.K:+"K,N,*D"I-6+E-0
MA4F/ADFS>7^XBYX8Q7*YL81XH@(YS2E*1 MJK3=1L;4-@>NP<DL$22_(>7(]
M^WTNON0@)>B2_1IAE-TNL&'A)1G6^N/1<&2+&N6O+#'0C;A4SLQCFW#3==DL
MEZ4YSCL)NZG8#1_N7JQ*X>*JH&MQT#6?@U0)JZ5@"A$=/)AXSB*;!$.*FR"M
M4$9@L;:A>5T:7246>=%LOG"KJ&+SYV/SV5RDT>C(DD/&)H:X#@YI9@2B*=)@
M>;22R)+-!:[8_$6S^<(-C8K-GXW-9PT1)44(B0O$N,QL+@)RB1 4E6#P4V!&
M@B&B15VR^3-++[Y PG/MXMZP5WO9&*FVPUZJFV<:Y;M8FXK^*I)] K9+<@1N
M-?#TZYQU%)GEG&&,HN0*@=RT2"<:$8:%$]$H3!RH370=/UAIJCS-%00],00]
MT-ZK(.AQ(&C&<@L$U'28=124BHASK)%AA"'BC" Q&&)Q6-L@Z^+![ID*@BH(
M>F((>J M6D'0HT#0K%5IO/09;!"QUB NK44N)H:HD4D2!DMF54Z#(<P20=#$
MIIR^:TJIH@"89X@&K=JX11LOW!'P=^'<6W]S_.]^ =V_$*Y5&P\AO%7;"K]'
MY/5M'>(KK&1=-\355;*JR.L55;FNJ>6CN!,N5S@&[1@C[C5'QCB.E"=>B424
MUFQAH=?+MV-7@=(+!:4J]'J50&DFO;.F+&+F*%A^1B%.P1 TC%B4A.))\Q1]
M3N^\H-CK"I0J4*IBKRM0F@.EF23*H-U2@WU$(D=@<Z8%,H%A%*QS2B45":>+
M"KY>?,S#P_Q3JV!:OZ0V7KR;X/81\[5)M<%:X6.OXN>K^/G7('[.Y@QU1VSP
M5#(4B =#W5&"')<)"2&9YMX0&6050/\J^+P*H'])?#YC^V(P$K"B'%E*->*P
M>,AJ3Y#PV!(NG.;:5A'TKX+/JPCZE\3GL^:DYXE1[I'3SB,>DD):*(=B8#8%
MK!W7N JA?WH6+2O7Y/3O1:+<7-AD&/UXT,Z5 *H-\A6Q?$MQ0->I6&9:VQ_U
M_?=:_WA2UZ07:KGXQ*#MLV4\S!<K>_<I[=V=GA_$;NR-;.=MX8\H)>/F"-;$
MC8LTU*W^-. OAC_L:;YY<S#(58;RQ^6I5;<B<I'-V;E&^%BD9-<QV[E6&60X
MJ,.,D!"<BS+EJO5*+Y-0K)3?%3!R*^9^!N:>,6Z9EB)P*Y#FCN1"=PDY)Q@2
M3GHM3-)>Z;4-H2KF?MG,O7#+MF+N9V#N&8M6">6]<@F!_9I/$"F5LT#X[+#V
M"M95T!BS1;M,S/WBS=E?;+3EBG;3@C!Q<JCE(A[\7M;'9(8>5BA\U0'NJ;;B
M)M'\<QZ\RGFW0*CC<T:*(,:"?1( X+*3WKJ(-%4>><&5#D0*X5/AO.-Z4?F*
M'[UD]J(]0!5&+,DV7H413X,1,[8.H8)XIPER,H"MHPE8/4PYA'E0./ H8W9D
M $90NJ@CU15&O#2,>*HMP HCG@8C9DPFC"U1.":$P70"C) ,F: Q4I[):"-7
M@>4\6K+.#5\5C'A!L8O7)]FZX03MO=)L51']JP31SY=F:T)S58J)NR&NF ^C
M3")YZQQBSBO$0;HB:RA'*623CC&@ )O3W+S$(,H*A5XX"CUVIJT*A>Z+0C.V
M(976<4=Q=I4+Q#UUR'&JD5+61OC+&<:+9%O+Y"NO4*A"H65(ME6AT'U1:,;Z
MM($'$:5 CJJ<=311Y+Q32$N90)20"+\4^;:621<JS,M_%3NZ\&]H_]B8=JXY
M[@*-^XU_PX_3KG3MX&N[A\HFWD@@^<DOV?Z55W'EVW@X:J?3IV<TFAGM[<1\
M+$,"4\T>'P_Z/X$G1K%S6GO:W2<QRX*;O5%[&@Z[?QX-N_W3=\8AAG>#?A>Z
M?SP>%=FF=M,LQVX61<O/&5:N*,,>_G6$???/GOULQKO?/OUL;'WEA^^WQ2$P
M6[/UD1U^/A 'P,30[U-@WJ/=UB?>_/SI9SY.W#SY@G6R%BN-. ;[@S-%D-8N
M(*R)H!XDOK$RL]O\Z>$:T%LG+WL.$7W:38:*%!9-"F>-KU\LEI)@%5'2FB$N
M 7D--1Q1[A@7SF+N728%=C,I3#;P[:BV%7W,7MP2DQFIUS)3UPMBR6M:&QW!
M77!WK3T<CC-PPB\ SU^/:O%G'/CV,-X0[E[/\<C'T>>?.Z=EBR<1&NKU"]=7
ML>3P =HK @NFRW[>W UYYFHN>CL>YG[$]J 6RY#[D_ZX$VI']D>^'C.QC]IH
MVJOUVKFP.<?\3.CMWKAXY8JB_K]GAE%R VA)0 V"$1HE9U$X*K2VPDDP&W32
M<6T#V*EPS/=\K.U/* $69^\B?/P3P,*P7/H([8^*58^UHWXGQ %<Z#](PF K
M:5!4@8"Q7$4-"Z9%"(0I1P-V_,O.WPN6MAV,WFR"-I#?93O;?^SO3U[S:H'A
M(VY^!& 03A ?493:()Z$0E9AB9AC*6"N":.^4,E^"0S @OZR2E'P_PS+NJ)<
M1":<*;>>S(8+77,@'Q;(CSLEN2; ^PD7!Z"C_-8"9#)=3IF\UZ^E\0!NRC[R
MWK -]#>A]6$MC"-@##0&KP22S)TZ?Q[:RM_+W)6GQ9LOQRZMSV/ #$9<0H0)
MTW&ZKO*)D./^L*"\-\6[ 5Y^.VF'T='4YKGTX 1#\,4CU@W[>;)N?.02N'A@
MO3AX)FQY!X)E!C0O_9T[7' 84=0E@24!%1' 1FII.*%62I$$YT1_(5JM39\Z
M.D\D<@S4@=P@VN_()ACD&]LYL:?#M7]=16( W9FY7YYIF]O>*:9MI]G:?K^W
M6?NP\VY[_^W.=O/M]G[M/[L?MG::[_=K;W?W_MC=VVSM[#9O)+9E&4ESMP5=
M;^U"IYO[NQ]VMC9;VUNU=SO-S>;;G<T/M?T6_-#8;K;V:_^8\%$,_YP;5MGY
MC7^[ :SM-?1T6\%+:.$'>HZ9('Q]*N F5N("#*:K>G'6>@?Q* + _8AE4J9F
M?Q1;\([?.P# SR[/_%2>X<:WO:.#LP.0/T??FF?PW#>07^\_XMVMS9.#;__M
M--YOD\.MW]O-]JP\^WC:?/_N6_/;SL_=]PW6A.]9?AUN?>0-N+_1_02R\,_O
MC?<[]*^S!@%Y%@27 D>-/-=@\QAGD!,I(15-WH7!3B52JA8%\6WF0 -*@R7.
MR*A8X 9+2RTESFI!(W$^P/T1E(3CS&B#,>A"FV_??FI\^E 0]V[K/]M[0.^-
M/_:V_[/=W-_Y<[OV87=_?\Y'<(6.KU7"?MF-C4>FJ'U_%,.X$W?3IO?C[KB0
MDKM9CEY#:SD!6*L(<W^]!(?!R);:4S"H/7(X@:7-F4 N,8EB@$G&#BNPL&8)
M:#5-A[='^>S",.MR]H(^:OV)HG6)0FH=((Z:.RU^[?= )(%N-CK)-M;UMN.%
MZ9BU1FAHF,78N=I8.-^@B4[_I%[8=UE3LS_?W"@0[S>IY6O.]; B; 4FMV./
MA_'-],-OH3T\[MC3-^U>,47%0[]=?6'6.F:C1_(+R\L7"LDZ+I622?#*Y,V3
MR^O%I1E/9WD--!NB^(V7\3JYYS6F[]?JWW66T'5N9-79JK,"TULU^XN KCO&
M;3W.;I:^U6;65@:-P;#$L?X86@K#6V1TN$.R@[^9C-(4>)[IN#Z0[;UM3](.
M9.TA6_E9( S:/PJ3^#7/S%9,\%NH_1Y[\&E4^R,+4IB=G5'LON9Y>=<?P-=>
M[>UX,(@]?_KJ)Z35']G.E?$_4?CK^:#/#?2GC@SXW78*-]U-.Q!XQE?PA"$D
M#SLSL/KQ);<?_W('G_SC#KFUG7,ZI1BMCYICK31CV#"%K?;>,.**'8EK#U$-
M89SP:<[\SF[SR7;)]O^.VZ/353D,<3_#NPQ'.<ZA)GSW?1/^#=V#UB8^_';8
MWFTU<G]^-EJ-D\/WVZ?-S]OB8'\F'*4(-?G*#^C.69,>'C6V]KK-[HYHG'V$
M<<&S9[]_/VCMD(-6Y^BOLYU1HSU; S>F:*Q 4G*,N(P8.:-R"A@>L+78.)+/
M0M ZY?/UW_[Y:"RRY-%R%=2]/JBC6LJ@G5+:6LY3U$8D)JT,#'L7DJB@;LF@
MKOGV*M3YE(CT6B(L&4,\1HILPA@1JI54B1B. >I$G>#Y?=X*Z2JD6VFDNP/0
M1:T(B]@GQC@WF!CON4\:-(+(@E)_H]-5^/:D^#:CRAD9=0XP1"($!:I<$>E(
M%5).$,Z")Q;37+^I3LVB:LI5*%>AW#(-_"[ZG'$T4>6=Y0IS$SE\5R&JS"DY
M3)17^MR2X=WNC#[G0)>+.&&$!3:(BV21 ZQ#L(;:.I9/=:6U#<7K^)K2Y<NG
MT"TH*5KQ;DJNS\%<?&_W0NR-WB SOT'[K,R[>\T>^E?;[M7^D7?2YQ;LJ5.B
MO*2L)_-HJ"31)G$-)BWG@2@=8X@6<Q=<-$2(.Z=.V_7MWR/ 7]R+OF.'PW:"
M62E2;C?C:#>U[,^K:2+_L(.8CRA4B+DHQ&S,.?NPMUQC;9#'"31$D1.H1>F0
M!W&G*??:4PD6,*VS:Q#S?HE/5C3_T<MF=L8<C@Y[K@GG6!)KG+*2)(,MQD;Q
MBME7D-EGW5W2*>Q *T+.$PG,KA*R)F+$J60Z12Z]TVL;LFX>GG2CXO4EMG-D
M%"P)3'D2CAN%=2#81BM24E1P:F[![#<8/!77+P'7SXAXI9++;(]HT )Q3H'K
ML2 @YW'2ABI+\NERHNI,SM?POKU15''\$DOW16=!KOC\^?E\UOF!&7=1!(&2
M4!SQR!T"Q8TB0ZS$*1 >:5S;X 3$^Z)R(:]0FL++<5HS$6XHW_^&XDL.DDL.
MD6?B[@]Q.'Q3*T_I#VN#<S:+H3SK^:NC!N51[^)8P./%?]T*85]@+8TG<);,
M FM.Z+#9]^TRXG/T!XRH'RJP?1JP_3CG-W':RB %1X%'CW@NKV&8=0B4:!XM
M3XGEP[J$U;&93R.R\JG#*KY_-+_)@OD^M7_&@,[BH%^Q_!U9?LY[0K'PB1D$
MI,X0U]8@K0)#2@::LT0GFO/(_]__HRFAOU4\_W)Y?@'NDXKGEY3G9\2\MT9C
M(@@R*5#$E:#(&9=]IPX++:1).E0\_PIX?N$>E$J_7RK&GW6F<.6QLBPA(2,P
MOI,1("!R1)2*H.L1&01>0OW^U4>, ,?4?,E"Z+C@H6N](TL41')C%-$+1]3%
MAY?\34:6*9#^T1_D?E5X^KAX>C#G+Y',1TRX16 GY13',@&>6H64#Y)'KI+T
M>FV#F3J5CUZ$:U7WJ%XK4BP^-J5"BN5!BEDWB_'"@ 0(2$:=0U,<1R8H@P3U
MSDONDXM\L4$J%5 L,U L26!+!1E+!!DSR@4!M3%X39''7"!N)$9:60U_@<E&
M*!8DJL5%N%1PL<QP\:Q1,15(+ ](S'ITDD^4.\$1PU@BSI-#ADJ)E")&>\^Q
M9V%M@^JZP8]>XG-5 V>6,\$1>?8$1Y/\E@Q6,O3'.5OF=%8>@*TOY@SI@V=G
MN27.71347%!$8^R2X/!).4,932IPL&R4X%[>4*ZA.F'Z/%+$S_FQ4F)1"4.0
M=Z 6<(HMTE0;I'W6&B+15)&U#4[K1L_O"]SWA.E#&6@UCMI7(/J*0?0N&*J4
M5THXA0WC6BGG#;.4&AT,\X[[FS&T@LZGA,Y9QQ[&UJ0 6"D(3HA;(9%U60N/
M4L1@$A,T5WRN:S-?;>M!N4@J^*S@\X7#YUUT4"(IQY$DZHWA.G'GN#(8^(_E
MPHA85SKHL@'IC Y*DW!)*XDP+!SBWAMD0J(H>FTLCLD(PT$'K6,Y7[6Z4D$K
M#*TP].$;3=0)'ZC6DB;.*'7!$F&4H@*[B&5EQR\;ALYZ@S5C"3- 3AUR*@1F
M&=(.!R2)C Q''I1+@*&B3L3B4G\^%XB^U%+=[_J#H@[2:;2#6NSE@IHWU>#-
MM^6=&=L[O7J8TI:Q@/U4^Y^[V*!2I*0QM=H&;G6$1=(L!"HX-EX+=^?"WD\4
M#OS\U5R?NA@9P,/'+R9X88E5B"@706-2%KB="EB;2"T345&9]W[$W]5YSN59
M;%G!ZZ[$@J6./.\V)L.I 93@0NM$,:>*&'6;*O W2(V*:AZ+:G#CZY=@,<7*
M<T1"S$<^O >J21KE6HF:41V$%FL;A*[/!Q64\#,EG5L=V"XH:]2?7+MT?+N@
MO'8NN!*'H_,+EPN"K]^F)/<M:\P:O+9*]43%4]03[;9'76"6X68OO"WF]6OL
M^78<;K6''I9M/%B>8H^MS0FG''>:6Y\HJ$ GA]WMDT9W&^^VML]V@0,.O@7@
M@L,VJ$M _?_]=OAVAE.Z\/X6J%3??L\J&;SCHP!5C!]\;K:;M$'A.7KP[>A[
MH]O\#IP"_=KY E/IN$D.,2DIXM@29#$8I\%HQ[D %3FDV?*B*G*"C6"$I<@I
M%P9600:;0//2U&$W6QWR[6ZCL=,JR^1N-K=R,=W63O/]=O/MSO9]ZHK^^OU7
M^\L!KC53/E'#N97:,8QSRGAM:,@-K*VH%K73FRD'#B*AYD&?S'K1*/JC'G3D
MZVF]!F\:)P"X\0 XH%X+[6$I4."9>@%2PPAXU_M:*U32LJ!9I^T!WZ"S7P>V
M=ZFX^$07NZJ8'5EXZ.L@EK<=6U#5^J>V,VJ7)=&&((S*>NJ3SAT/^F'LX4VC
M(PO(."HZ,%ROM:#-\LG3W$K!N^4]E]_6M6%2U#S_/(SEJ\N;3P!L:[W^J!"\
MA7CMC8IYR0].ZJ&7QTN&%V4Y9V!X)8FA=6F"VL/:<.R^@93)R_'#PG#'PQIH
M'.WNL%[KV),AV*GE,L-*@*63#97AM#@I6#3MGAWD8J?CP?"\BORD\?\WK+GQ
M$%X_A*9 IG7&94G[HO&B1&JIPD SA8H"BQ2[QYW^:8S#2Z37'Y3OSZ(TCMKG
MWT_:HZ.IB,R=S_T\IY9)A_,7H$_KVATPMW\YKCI89=UB&"=';7\$Q/HCUUZ-
ML$1Q-.H S4*O+XUPO;8SF8CC=B^S%3P)RV._%B0&K8VAD<EX<W77V"X$/Q#E
M_P)*@52'08%55[;;[H&4*8)@8#X*#>&D/<Q)7D+L]@I#IIZOV G5QI]YX/E'
MN*/]HQW&M@,-]@?3Q;%?@=:_PFOJ>79@HL:=45' %KH(BD;;=H"C [P>7@(&
M;)[%?F]F_1(L+XA!V\GP$=H9!M9K_^F?1'BLGKD1Z.<8E)IV-G1GN>__#2=O
M+1BZ?SS!'ICEBV;AX:+5<H7M\*B6.OV3LM N\'4V>$&?&DP8,=-9!R8KG@\!
M1FR+OI^O#8S&7Q;@+XUC0<<$43DLD*K0)Z^,%@@7J+5<F)"1KJ!O9\_79V+>
M9!@N"!OX,G-A*!:@N*.X#H^#)@H6 CQ8@JV=I"DJWQ\*.G1VF#7=DFK2N-.9
MW#4%@K*)O#9E5>0BG=BY),I@<$'T$S8L>3+T"QHO00/>W3MOJAPWT'6GE@ G
MSMD@T[B+%\-I%Q*O%TO+K<"*W*.9&3LMQS:=VZ)GPQ'P;N=BHN_WLFN6QF8!
MU0?Z+-K*\W?> )!N?SS*LY))'(1I)]]M+\A^.%H1.BY:?-,>P>O\+RF[[!F8
MHOT2&MX4HCK?!:K@=.Y&L#R75)?5F(9;LW.( &3=H@!JP42V/0 QW!D74LA?
MS,%5]2T4^EE9(/PD=GY$U(5;CZ;T\G=^LHMZXX542)U"?$)#OJAQGFEYRFM9
M/I2@#Y@]5;) F@###E.<B.&B#S [%[V&KL33RUTL>P56W*S"_H@FW3N8R#]S
MCSY,I#]P8"/:;,B%W=Y>S(P'_?O= L-_ZO4=+.6/#'8[O>,Q] *ZX^&I8K9?
MM>'7^O3%B) D#@0ECRWB4C+DE*>(J 1VGV')<CMK2!&C!">.!<$=!_O0.&:H
M<ICDHD(QZ%G#;S49>3/[F2]1RE3N@:[3R\3ORJCFX=0BRIZ$*[^7]X-(^  :
M5:?&:MV21$L+)5WR?0]OR=3M0LZD?J=0H_YQN?KV/]_<$CNSLV?6^7/]I!>.
MQO.MD7*#P^?"W\?#^&;ZX3=0Y8\[]O1-NU=,8?'0;U=?*>9S#!0O+"__-JFC
MCO$Z+D/))C'QDS?_N@0[->O:W*^R^]/7B]?KTHBJKPOO*\'K8F4ZNP03>TU4
MQI2507+'%1W5[<F%K0NJ;M7LY)S.](9S(5$XS6=F<@# /'-L[[['=9ZA"/M!
MWH?=OB**:G-G=!Y0FYZJU2Q.?Y.Y4OMP[GW:B^7.$"@#F_Y_Q^V)YZ.?WBQB
MXGYQZ_442LUU%'K;5YK[+U6W'4(G/L]2;0Z^@Y;T;S?XUV0/[Q_[,=::_5&L
M\7_6'F<M5F)B/O3]9.^D5WMW[J+;'P'5%@KI*YZ:+3#2;6W?MV/6VQ<[$3?(
MU$5,V7,BXN;;V.G4=GI^O6*UA[':?4\!_SKB[!;3>O^$D@OIX4J0^OY1?S!"
MV9%WKTQS3[)<+V2J/_1[7Q\\TX\ZGRO!7]6Z+TPH5Y._9/1\G=WST&RISV.2
MF[OESBC\R?^UO7$.R;B]37[GQ$._>FY5ZJK?;GIO?Y3FSL-_IL,RMQOW':*?
M:;2.8!(EIX)+[AVQ3%/XR3#L&"<W%U6_8=.N<;$-\KD].IK;H!M>W:$;7MW/
M.W>Y%&VMR"&;>V[N30_9')P=X,.MO>[AUN;/YA;TJ;O7/F@U6)-^/&M\AG>V
M.M^;6XVSYMO90S;_A3;WOC??'WYO;.5W?3P]?/_?H\:99X=;C9^'.?;Z\T?<
M.&O@R\6%H2V^N[7S)6B?L%,.!1L-@O5W2$MCD/=:)Q*HL42L;; Z)XLJ2/;H
M)=F?&R5?,T2^3'STA@3NN-*&)QZ4-3)Y!VR3\R(#\Z@*'U\,/DXS8I3X^/V+
M](HZ*0BRU.E\P"0APSQ#@2F/F==.$;FV04A=<;D2*>D6G;SRF=NH=-E*E[V"
MU=Q2%IB3"0 :T)D9["-1C.F87!0V/#-65W!\)SC>O0S'K4]?./.2,BT0F"J@
MKDI+D2,.(\^#=H2+:"G ,67XE2FK=P[UJ-3:2JTEUH#!9QGE 11;B9T3\$&Z
M2#3AFMDE4FN7L5[>BD!H(Z?4V,\P^O$,^OSS2Q""62DUBI$1Q$/D8/)+CIPT
M*L Z"^+XP@KFO2J=]JG3/3\#O&P6)PHR\S[J7L**%3.\W=Q-6*HJ.5FMTE.N
MTK*T45'+:E'+K[;07^1ZWD%]CBXHS:0EPGKNM#.<>V\I$T08FSR^<VV2^^K1
M-ZC1?XP'_L@.X[#R$"].G_XXKT_3I%QTB2,FC4-<,(6<T1)I8P-QV/N 4_9)
MU U^L%MB)8#C;FV\@@B/UOF)VR+-5&<:CI./$DR3:!R718>>N]3MBT9L:KE,
MP4J?*.$X!D>B5#C!_SF)E+-;(W;;#D;7PO7)+>#Z'*#/R2+GA,LQ6BV@B5%_
MDAFN N8[ ?.GN= &9X553'FDL%2(Z\"1C<8@98306D>K<QT0JA:U;[>,GHP7
MR?%WR@)LK5+6.JF4YQ)[ZUQ*$5-GJ,Q9Q.Y>;K+B_27D_=EM^[S>FFN+(DT"
M\9PVV#EB$0L*!^E",-1?S_MWKC6YC&R_+&V\2/BYG\F_$M3R$)._6L_E6\]J
M^V+VF/=YDJ1;9FKJ7*0?NLUYQ\H[^NRVV2-YT][;=B\7"=XI<]J%G=ZV'>0L
M0<-JIWHA2MS!G $G,?$Z.8$,0!;B*1)DC?>@Q"5'N.'62+6PC>KE\ZP]& Z6
M#7SO7-1F=:)NGM<D?0;(JZ#M3M V:Y]RL$TE!JN4!^H0UUX@S;U".:I<FXBU
M)&YM0\Y7+;AS79LE K07JE/NQ6&T W]49K[-B0#[QYGS*G6QVDQ_W9OI=Y&*
M"]A-?WZI6.VS+] :F-UG3XHFD@NY"Z<X O*PR.2,M@ED*;=<>!O8V@:MDVNV
MV2NQN71B<[^L1%*O?8V].+"=LGI7Z+9[N7*$S663'I9%:?7B!*YF@KC(SXB?
M/1?$BE==?=SS(JM:='7A/KQ$$DN&&*YHX%A1S:V&7[2P,@8>^,TE5ZMSTBLE
MG?TE7]U'T3C[],4K201A!F'N">)93=,),Z2,2XY)$BSF.8^$-&2Q1TJ6O>IU
MA;\5_CX5_LJH,0G$J!@$US0X)1E/00L1-:!QJO#WQ>#OA4.QQ%\A.>;42D22
M<H@;YI !\8LB]THP%F1RH<A3P;&N '@)VZ@$024(%I<$@PJJL<(<Q\@9-];%
MJ'E@V&DO&7'/+ @JK+\3UN_.8+V.GB8':K;#AB$.X(ZL >A7TKB N85_TR,D
MP7AY0/^P%!D5%%=0?(NX)A$3B8QZXR/G ,7,&2RPDQ9'AZVI=/(7@].7=BS@
MW@8!I=P18:A%C+.$N&,*:<\L(CD_%3&$6)^CT$E=/_QDX$O'ZGN$LOZKJ%2W
M,2F7-U=]?J;B_)6">A-NYW1=Y=)VTS+';P:Y!E#[1[RH:)?1X-*#DXG'%X]8
M!W,\'MW\R%SJ\$5CVBVK(;Y#7%VM,'CY[Z/SVD/']FM$;A#M=V03=/>-[9S8
MT^':OZZ6)&SWT,PL+L\$S*5)+R9@I]G:?K^W6?NP\VY[_^W.=O/M]G[M/[L?
MMG::[_=K;W?W_MC=VVSM[#9OK,.X+"-I BSNUUJ[T.GF_NZ'G:W-UO96[=U.
M<[/Y=F?S0VV_!3\TMINM_=H_S@M__G-N6&7G-XKZ+]=1Q@(J4,XP82EH.*=*
M,^43-9Q;J1W#F,=(M:$A<LKGJI5J*XEDF 0))H_35OM ,.4^:69")#>]YY=5
M3C=6J$*F7A=*/T)I/L%N?NF]2_.)=2W,JG3VL<I./DIGZ3K%BZ^E2,4Z5K=K
M]A?[] \MA'?Y5B)6L[36LQ0;O.6ZK'8-2[R(FF0/J(OXG--2&@R7JB->+M;V
MS+7:GG->[EW[;P588:%UZ!91O^PN%MW+J&AVI^)QKV]Z[E)[JIJ=>PWY1A9=
MT('>TD^-KT'"XGL;)'%O] :9>0OG<4IT/KRLUFW4A(6?UWN5NP)W&_M+<?I'
MB0T-S(#-Y+@B0@<G>226T* QID4@#C%+X?2_?%YYA;W\?6CSOT<-^I$WWG]D
MNUO?\>'G;7[0VN2'GW>@?PUQ"/ULMMZU#_9GO/RY_]WML\.MKR>'6Y[OMO8Z
M!ZVCH\;64>?@V\>?C;-.=[?UD30^__?HK[.=\\C'QID_:[8.ON#$I:%*H,0Y
M1EPXA8RV!EG"J%&).:+)HD\I+X<3O\+#"@]O64!+FZBDL\YJR:4R1A,9-.&,
M8*4,QTN$AR]S$_3IX'$:F#B%1R>L#XQKQ(Q.B,<0D,6 D3B"(+0L&!W,V@;A
M=4H6E1VU0L<*'9]]T'= 1R9RECJ'H_:>.Z>T23A(+:1-^<?PS.A8 >#= '!&
M/V3<8N550$Y;T ]9,D@'89&B01HIK8QB,26K5@;]GN@DYW,Z'ZJ,S\L!K5)$
M!F":6$[_ZX.SP2D?N$O> *0R6F05P-.L G]3Z^IILKY6BNBB<+@Q9Z?+7,\\
MY]C!5C"4<P8@EW(!+(N% 0,^6&\76^EZ&0/J7B0@W"7/2#X/!3H6$8I8SI,U
M1%*2C.&A*"TI;X$(SY(0NH*&Q4'#K(T:DO:@;$<D<W0NUS$AQ^&K]J"+6VXB
MV*8W0<.+R!?](E'A#J" @PZ@@</_) ;)(,#V2@P3'AP+)MFTQ&K"B\LW^H0P
M,*,A:&!Z;2)#21&#>"02Y4-SB$I/">B,0F"_Z,*8RX(&3Y3[^3EMLIRTJS3'
M?)4%>DF!>&'VVA)E@:ZP^)=8_''.6M,BN>@L0X89C+AR&IF8%-("8Q,CE3S:
M%YS[N0*$Q9EK58[DU8" 6:LL,>.-,QJE0!SBU@9DM&&(12P\U4E%S=<VC'AP
M0JF*_9>6_1=FF"V1/E#!PMU@848S"#$&S7Q"6'./N!02&6LD"H88$QS%VNH7
MI!FL@&%UJP3HKV#3[Z;TK0^).7[,K%&O,\9DD3/S4L0LC=:!#(V24\$E]XY8
MIFG>,&/8,4Z*)"6/*%VK^+PG$J>?Y@QM;K7%*5+$HP=#FWB&K.4"^02ZMQ>8
M8R,6NRVZ",Y;Y:RM%>Q6L#L)BS8DY ,BVO#$@P(M-GF7L N21^R4JF#WQ<#N
MK'.# L8:JPU2 L"6@^3-M>T$PE(9RHPD1+ B7ZOBBZI/7N%NA;L5[A9.94M9
MR#G8 &P!:9G!/A+%F([)16'#,^-N!:UW@];90+_H/4M&(T49J+6.8Z0]!FAU
MR205:$K:/EEZU!7 U:NY\N:RXCU2_K*BQ3?M$8S*_S(Y73DKP(K]<D/^#0PM
M#O)=-Z;WF!O'+U*6R:L9R^1-"<N>(S/?#=G+?IGUK'44:V_[7>CQ:<T.A^-N
M##?'.+1[16!ZJ+G3VM4YK==V>GZ]]H^UJS^O_;/DE\%%JJ+V:%BS%^F*"C_8
M[^W^5N$9'!WED(M1['2B'XUMIW8\Z!\#<9_6+K70B*%]U._%TWPUC/UHN%Z[
M,@SO@:[SS:"=%DU>&M#E, V7FP5ZR?2>[VL/K@1[](IG [PV]S%_OM3OFK-#
M> -\L+D;;IJ4J5PDN )SU>_"(\=PU?JCJUT\LC )G4&T 09A@=O_YPZBR3**
M@S218<>YB58+G(Q2-G'E#2?V5V7PQ*R,^L.>9K'TKC^XR#IU)>G4N?29Y(_I
M?=V$7OXH9O%V-H!<44%U^-<1]MT_>_:S&>]VX?VMPZ/&M]^[(*3@'1\%""E^
M\+G9;M(&A>?HP;>C[XUN\_M?9SNLN?65-<^^GS3/M@7\^X4(CT.4&E$>-.(V
M,&2$UX@E89Q-0;@8UC886V=S4J<&B-')9'&)#0J"A+DO5 JX=I5Q+]'Y>FVW
M=X4'H+$X',$3T%S7MH$'3X[:_FC2^# WWHL@AV#E"O8\9[C_^W\TU_2W<[ZK
MQ9\^QH)]/' I-%6SW<Q[0Z"WU.X5;%!V].L@%AVMN3@ZB;'\]9QC>V$&3TIV
M.>Z/\M@ ![KV9[L[[@);A/9PRM[')=V>OQ/Z_:Q\]/MX"&,>#F%8#A@EO_\&
MAMH<#')X69%_Z6T1:;;3@P'OY4^[:7<\RM@Q_!4W%KK@?P!O*A[\-0_NG$+_
MO^!$0];F$0_8(DZ(02[Q@ P#"9FKHR2>:U"MSRM^4Q8L*1/X!^:VD#$7$N/J
MIDXI^28[.Z2@\6PRU$[@MKN0:0HT,*R%)CAP99BV+EHI*%@CV&CL;K!$'D"=
MYP16T=4MZ.JLT?KZA4L7%#,24282R@"";' 4B> "=M& B4'O9'\28T$FD&QK
M"AZ(MX$Z0W0RG$9B^$TYX:M5?\I5MS99' S(<8DEXDPX9*/P.:\+T=H9:95<
MV\#K\S7:;X:7>;/D(ISXW#PIE7M%71)8$B$39Z!82)!:U$HIDN"<Z"_$L+6[
M&C4Y#?,S9:0F<KWV[RL9V&?.P"O)P"2GGFJ90[VL9#!R8:-33#.>KI775[EA
M/W[-,G<O%@=K>U^W0)GH]+-?I@6O^;W3]]^?G:P;%V3=??>]>;8)I/W]9Z-U
M@ ^^>;;[OFB;->B?G>;9G]#^)]+8GR-K>O#Y(VML'1X!*_QL?MMK-\\\/VQ]
MA#[ZL\//GUCS\Y_?FJU//X&L?V;!J&V2)@%L>><]XC0(Y+PVR! ::'*6.V5G
M<VH;K;!WR47ELX\L:TY48XN)4#P*X]= 3'I[#/,_&HS!#-_??I\3BM<VFUNU
M]]N[[_<V__C/SMO:3O/=[EYCDC5]-@/_9<J_UL3]=2>N=MIIXQVCP0:>N)7<
MT%S]R$<7A$HJR;4[.0">R=J_;$MF>WG0LYW.*6C)/?LU#B<^JIN$S;!D@MD,
M$_?AK@O) XLXRVRPB* &[::2V[+O:,)^5VU&F .?I<P)&.+#V#L7,/C5<>+7
MDR^Y?GD2B2(N)4<\>8ZLTA@!H2IN5=#!@'XZ.NG?X)C\VND[,)<&YU->FZSV
ML%! R]^'A?$UB,-Q9U2HK-DGXR:*0FG_Y5_\43NF6O:_V(R5Q6+___:^M:FM
M(VOWKZ@X==Y*JM1,7U;?[+>H<H(GQU,#Q E.!G])]=7(%A*CBS'^]6?UEH2-
M!(XP B3HJ;$CZ[)W[^Y^GE[W-2P[Z<1]2(-&#JX[;3-WVDNY_QJE%Z,%YXZ$
M" QE5FZ($2H0[KG-.BACJ/W67KMNDTTL:>["0M1R@X3K-PR#CB^VP]3MGVU?
MVQ_C;TVN4P,U*?ZV9^)J(^SEJJ/,/!A1EQA3KB[\!?<_A,O3Q6!;EKF8G!\1
MK]WZ_325@M"C\];O8YQG1,1L-8L)LT0L#UL_='YL*&,_C0=%6GJ7!N<7A-&>
M6H^&J=O%M6[E<;?;*L,HS')A*2JFV-[7/R\[I7FCA?NB\5ZT0MDHPW&)$D42
MZ@R'1:?VW<EAG_X[[C0AH^U6' \F'%=4[]D=VL4$E7SY9'B*FDZWE;OC3IR>
MB<WSQ/2QT]BJ\<C$K3QPO<:TU$>ZZA=/V]?W*,.;?6,X:C2CSW,#:;[S0V<Z
M-Z]Z0Y1R)BBX>FI.^OAXHV.<\VL)<_HP\Q: ( --$$P,%J+1SFEGN,,C M5#
ME/R7)\PF]WA>"'[5FW!DIY&[&B+]=3JI!SGCI,;E-,*G1Z-'=/_%7U0(1GU
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MD3\!&N'@2 3>+U>[4';@^R[5!]:O[._=!1)T#IH(.NY(5NY^VRQ)[!9\&?)
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M98LZQ@^VD1<,B^Z/1ZP/[Y5J+/Z9QN7M5&^.&'<V2A UB> ^J\SUM)6V(O/
M$O(6S/EJ+ :9QMN3-S2%RZSIV*[;]!V'6MKJF.LY#R(QTZM*-18;R;.@&>;+
M$/5Y1><1BS[U\,J+Z^%M@R]4GR&3CB,8^5")10-]GF5$ W"3#7+"L9^%(Y%C
M'=5POJJFSPXGX01U+==S6/$H]V$57$H9S2GU>J6\Y4= +!:<NE*+Q5C2! ?I
M((P0?I *22$16LC#*KR;0Q@Y)*3G+$GKJ6Q/IU3S4KC9HJXQLS 5J*FZ\XYI
MO_)5:5OK^A.N/1TLJ<.&=@A==!1ZQ'*G*+58A"9-[CAY IG;D$B01H)$AKK,
MMC9U.UR$L:'T-"7R<3!H?>OV>HU^:S#^ E/>'S?ZC]V'7KLQ&N4O.Y4)1N@3
MJ%]7X\F9(4@6?6% R08JX6#/C%K/<"%G04Y@0K]!_:8>=^3D8=HI>A&R)KSD
MX;$P6+$:OE5JL4!H/HZ>^*DRBP])&>TP8RO#FC466#7;GC[:MOYJF.9A!: $
M8K&(W"FU6 0KGXBD)=$'Y!!.#_X:4G26I226-NW%TK:XG85_J];*[>KPV9@:
MJ%>[>(]_9L!?/ _NL )5%KM8JNZ56LP%G4^J-O0PN>(4_<4E49K(AJ@@-_ T
M)6L\!":^#']G=>ARRL-V'Z$5IU2J\:L087]>_.Y4)[OD]BZ&(5Q22E6IQ:RS
M;6; %Z>='<UFX:$Q:K>PZ'"[/V)EH_,6ODCN+%XA6 $A5M$" 5TR2"0*ZN09
M4:PVF@B$\!RCU.OQPV<:4T[Q[)(\M2-_L5"=E3UM+Y:FO:)TY-G:]P<5D. N
M3"V7D=U^PS^+ED,[($:QEE246@'>!Q2@I1'20!@1EXP*$B6#!'2<IJF1S,&R
MU?'R 1-S^EJIQ8R3=$Z?^'DV8P%^H_C(']4;/.D-;&I_L2SA?MX;C9CE-THM
M]VZ[M;A#Q)<!9A)!?1:(!$XQ)3A@$]308-D4SO8K#U\L K=*/18)S24"#"/A
M*$F(\\S[!-Y\99?J5$M_L?C]NB'\US$T^(M-8J3T!OO,"@KRP@GL\T$%Y5#$
MB*7J3JG'*ZOFD2I.'KN9&!)(-A1RH?NP5:PD^(K7-0S*3;#O3E,6A^UQ=\B*
MZS^T^^U.=_S<:^1^B"BEL_C(=E^-7T#= "(!),) G3PC"M:E$X 0'MFN*_6D
MHAO)3#G%(UORU&XE&8&2,6S=T!ZH!9B]INT6=17OB42H8J^K2CVAVF :AW>3
MF$*\)$!,&.:SRDQB4\2V?0$4"2R#S0<L(%]U#-5\YG/!\GX.*R[[TR&6*$QO
M*B=1$<H(DI8L7FR/7M-' @)YAM19\I(XSJ. AA7,XJ8N&U:,P#+/90)8!T8J
MEJFZ4H]%0_/)%"<# Z"A#$4H8:*$M)QTN$K,2=V>=GQ+1[M>]?R#"DD*:+$H
M*$H]H8QJEBCH* L<&>'8SKS>,*1TB=Q<P,3\O%;J":4HT_AYXO["+*6+OG \
MX0:Z[EE=L01,4'-/0,3"7["SK3'QD1[;>K&F;$F@"CRP^C\$)6+!N5'J"84F
M\^P)(6WK+2&DCNT' 7TD2B#FLX8DL@WC1-4'9J>TL2K(L-W#-_B>&\/Q[_S+
MG'(C@B!T$%S?5N-UB7A'EKD2P",,8/##F3/X92%G038<L<?@KAZ/O&=PZ10=
M!X)I+KD9%X$H5JSW2CWF],EBX:FGN AF?^0OER:["*&:T1M#D=?N#\;I KB$
M,G!34>J%E_$EB:+?N8\4H> L(.E,"R_['%LX!'C$@H%UF/<4C,UEH;-0I#*K
MXV-AU< 6[5$LR<>-U!>P09W@-I4U8[\$]YL#+_#!Y&5_$L2BA,F3Q46)4[6V
MTAGVT( GC#*R)HW_ZI* N,"?>)*BUNTW!T_M<>.?N2WU: ^A97Y3K\;K/O+>
MA'4_S6DN9';'^PG-;#C[QJ.ET2D_19LZ,H?1>BXPQ_2!PD9#^=]C]:UH*8$R
MD,6Z[UI1A$MFMS8,@B<<5_B)83M--T0B/_A]93B P,1@#9TAU6Q+,TRCA!6U
M!P(QWV\4)18<2^?[&B,RFQ<&VD9Z\NPO>5@601 S\%918I&H;0:>N(LZ<>D\
M._8/PP4$H, .JX4S((N9>:<HL5A2^FI<HR* ZZR%DSG=HE,*QK8.\[+_$U;[
M8!!S_EY18E&G=,Z'*)D:/C]"E2$"+Y9&'9@*"V8KB+"X!]^,\R,1"L)M15%B
M4:1T05AC99(0XCUORB *_?:8S]MS>SCZTABV<W(WWD]XV,0H4,R" A@ATP *
M86!.>>H+'3W3>@L/H+>U>CP:E\2&4SR(QF;T074-#3:,EF'Z'M59Z3FT'IZI
M,YJK3D'CM31XL2:L*THL[)/,48:/;8 !QJ"@'3.( "EA6,]JD$U7R1-*-APQ
M-^&8$@O@)'/SQ,\KC6;SY>F%N9I9\0N\4S)L?VGW1]VO[=Y@E/_EPRPXXGWM
MNAI_LB ",ZC,L065(-@SJS937/ QQ'S0Q/O@33WIS:-LMIWBOI@YXY$D=4WS
M%T@P8/+FU,$;WPZ=4\ME91)QI^G9;L'CY/'PBW7QK7*=\+9>'AG9RH[?D$08
M362+J'#__1GI^NM9ER<RN/236$7AB@7B3KE.>&(OCT"<^&8-4_+4';,"I8U^
M"Q]\[O8?V_UF-W=44P1!O$'?5^-/U$2@L9CU%KPS7W 6"NW)V7"$N_%=I1YW
M#@AY=(K;L&"2US6O,?G9L&8P2/C+-?2@>&^0TU4Z.^DHJ(6Z]JZJ7,<,-+%(
M7))(R>T--62+G _K_+933V(2\+3D=EL$HICY>'6L*/-/.Y%UU'[$J8&)>6P/
M'H>-YR_=9K??&0R?"A5MRX BW&GOZM7XDV(!1,:Q#4P2 7IF4C@3Q0JZY8(E
MWG;QD93B##O%O3=CMLL6[BH(5:PTKY7K4MP\\;-)%A.H-U)!VO'VLV-/#6^R
M&M*E[7BX!D9TAOFKA^5Z 81B@;A1KF,GGUP"03W"2.#WK!D19+(B&S)(0,=9
M8I)4+[YX.J0_J.73R>I)_9?M/%(;Q& Y-[2&0]6#BDMN;&)9N56N2^S=L!6P
MYUT#_"@DC *R(8$@#2<J)\TO[=9+K]WM?FWT7MB$P53^]M+H=3N_@^G::#8'
M+_D?$\T-3FREW57C#QV&H$FW"Y_6X!GG-PA(B.',P]BD%US3!:&*U^Z]<KTO
M1__7U^<O5V_N)W6Y-.#0C]_PSY9E<]K95_ -Y9>=&.<-U?'^Z-N6IKIS=A\E
M*%A[0=2)RPK-?;Z8JB9^8:D+^ODBL:UEF";NF)\O/,>'SV\3QS0^+=F%%B3O
M\X7N<\]$^-N$^R?@!SHQO OB^H#.\-A]]D?']I>?+WA#PZ.+"^(Q(/R;A6T!
M%YU5%WY!X!=7J0,;O]KCN>V'15V>Z&)"G>C0.+E\9"F-BXPMURATS[G$O]Q/
MNKU0#2O'..+OOH:/6[6HQNBL7M<JM<K8@4F=TYIXH&6AR3 30)-.%ZKSW7T
MZO0^#,C-8*N@APPC"KD1EGGXG:K.>.[0]"4HZ)$](,/"$EI>;!UJ#M6/MQ#Q
MA?6F#>:3NKZ%Q^8GC6GI[65@V=:SK='5%!;G!%4B%LHB$&08<7 2XF<CPYI%
MW,I]'\D<8*Z[[FN>.YA.831ZJO26 77P*0B^0:N%.KGD%W;D3;T86#,LZSI8
M@0T+\[UY(,"V?!<^K^/R825XD&(-C8A9^KH^+)(CBLV2H\DQ;T.87XMRQ\OH
MNV$!T=]LW]+%JR.KEPPKXL5RJ&;/+./?+-E_D^6-D@NXX"_7-U' .XZ]8)Q*
M97PI6++:7.MK8>L++_'K:&!$ZGQP,(# BFR_4<W'?@D"G3ISQT$FQ=)I-*EI
MPK#$2V6WE0Q+ T.1J-O]A3WMV!H[N#C>W%Z"A>%Z;J_7S-@<<_>78;3IUO1
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MJ)PC5FRZ)B\$0]KS 5MMFKU8JM:J9ZO6;SY\2QUS%0Q/G)XA["BK%^W9,7Z
M;NFI$YIAU"2UE$%\GPP3%"2,.)CKS$0,00<9QM/0-,"M!U'+3<P_9MQDV*!%
MP<@P]B#3<. \PZ?@0]=B&L7%B#A5'6T.0VG!EF_:2^&:+ 5+UF7:T'6F/56S
M_3QB89QT79S8]CA64>X@38LZ"W6D&92[,X3&0%)3&80S8F6/7^&750=S5:AE
MV Z89F"#LFR#ONUEF@/% <DP_O:;Y] %GJ/"R+R6,5!1#QE&-*2>[UC/MFF
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M4^ T96A"F_4#T&U58VZ)+14$4Z_9[/(BUJ/QJ1_!47Y],1V.T< .N,>A<(E
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M8@/I6.3:*P)4>B++64P+5!&4C6)6V)1YFQ/%ZZ#M4Z?^'A-Q/>GN@H>/YR?
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MG[IDCEK(TM[M]K6%/?OO8^Y#]?*+6!]]YE(O;<Q\O5^?,+PTG: 9S]D0-*!
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MXK#GWNTD_+VY8#OT#AY.+&H#XUCGWJVE@A43TS:17X>1@(=PE*+19"H(^-D
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M<1D3,=24E#*32/ 47P]-@\XL&+!U4JTJ+^P(6'N(%*A0(-[>FOL&.8-(B<I
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MGK$I]\.2=110A1WS?(CET=N%1931>M8Q$24C%)"<.","B;PDVCB5 [0J =^
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M=/$5'D"190\^TUE7D!FR %UM ]N8.GWP'N[!80^&;&5;,TTUN)7N@;5R/KL
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M,3<0LV%)UFD1O#1@RXNYC8:2_5VV[#R/:@?$Z]-0D,,7F:P--3()B)4,CJM
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M(:9()UIWXGX*557-.-)'_@VXL8I\O/DG?0V3+TA__#O,\CK%1'%?9'UW*76
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MRK.APWY"'KK)RTE*LRO<1LYU5OPYKK$2'E%B+'6J(CE>RO"ZZ)H/S0.7Q9%
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M9_(OA&5MPIA; (W5K'!8#@PAW6-I(OC @?CJQ^_AOZ>SWVI+U&6C!T>GW&+
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M3,2XA_#[CZV^;NGPJ(#GVR2\;.-0)$>&H6[8@* 4_<ZS.@-3<R&49#:D1N[
M4$L8JPG,H6V9@ZC\6'J]+.&O.^%[(0S1BB"S0G)4B5QWR2V8' 1BT8FLCC;I
M!S=A'+Z?RZA,V$PYV%DCAR@CV2J(G\N8Y/I =F-(3Y<UM9U6TF!5A^D1LP=9
M^KIT8VGZJ; XJEQ<EID6(VHU>DC@;4)PHD@6R#)G^4 AC*-A[R.M:XZ<O'T4
MW("TMPIO5AT0C/28I<_ E;7+A!IGA87"A/62P$G3IJCZ'C!'Z/,TU_(V+VA'
M%;7L%/SS^7X]R8X[98I,D)BKS:!X &><@3KL5IMH4@QMNIMLA?2+00.IJ\'I
M\PGGE[/SFD6]@/8G:6;^Z?.?*W#"6@P6.9C"JK^%9-\*6C<+SI"/'KPUN@F7
M'H3UBT\#JFWH"MX-9'_@K$QGWVJVW>+/)(;?R,.=A71Y\S3E5J4HDH4D2Z'3
M5 7PP4B0QJ2L9?2H-QS2+0'RG3[_@@DUDLX:3,F\B7*1Q;F&Y5-&Q @,A0$5
M=(:@0P&/T6J>2"JY30^#+8!>,+F&5%6#<N+U"I?SHV6Q*@H!/M8,WN 31)D1
MM+?:NVB-MVT2!&^B>-D1L9WUT:![_ ;[NZ!I&LHZAB#4[OK9HN@]A-O %-Y
ME55";DH GDU]HE(1O#((AC&OE5).-NJ ?@01FU::[B/3 36\,')._YZ>?IU>
MS<,DGY*^%KU-5O=0<"DQ=)Y@H5W:RZZ$"$YQ;7CV&DNW%B+;OS&^%;"/Z*?#
MRVW &,@FK!N(N PB.)5 "+>HA6<UN&@@B>Q5LE%*P?MJ\IDI<4=I-=R.'R<W
M264P9N_ID$DATQHS+Q %UX!HF8O:RZ1C7Q7>^L*ST.+N,AO06*K#,T_/+ZO=
M^&Z2:Q7^5;A8W!D+^QVMK3E]$90S&9Q+GLQ )4N0C*4!1U#?"^%EFM+#:&1
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M2-QO*@U$$Y47J![S$O:AB,PR%DC6QOK,A4JNV737@TZE:47_YJDT;8C7=27
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MICKS=;5E0YY%D[?U?S(\Q[T'216=$ZMM*_?5M\N7X*?P___?_P%02P,$%
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MWR2U\3[)K]J0'1*H6%M40G/ U2]CN8UO(^1O-E$ 1VUY&7_ZV#9OR74^O%B
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M!/X+RVXB^97YZ+PC>GT?O<>P7OUWK+A5=Y>G_HZZ6"CCG7PO+X>"L!,JUS$
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M40@2D*T]YM=MQUTXW+7OQ&!G=AJWG.\=V]2',VI[Y' CPO,PH:-0,+*K=J=
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MF")7\*)+WD$AF.H&EED7P6Z%TH"1M9KB,SMAWS';;QO&"IV<IQM 'E1E-]R
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M-./49&K<PK'0>ANL&N)S2F176E9;'#3E>57Y64H*\&AU?9>/?.H#09<"?)O
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M@(7J\Q>7?_[=;ZWPWXW_D;>>T N Z%;]V*O]L-Z>657^.30W#2)E$'W?VCP
MH/LQIKIA)[&!.$D!7KTA#[&0NZ>/+P5IUMSU_MP<-EQCE./U-?.8X8["5LMS
MVI1MJS8@^DALJU_:^D92E(J\"DJ+5 JWA2'&H/.5A7/'^H626 C<\:<C+CD\
M24T"HJM#;9Z?DY1NNX2ZC5KB%IN[F+QTY@F\-J06I($B3\&#$Q_B/[_\XBBM
M9'Q)/?# ,X[DJ]POJ&G<D&[*_+H<)00N_XX6=4[BHB^V7!FSL$\L0.YT^[BM
M@/'[/Z\Q# I$%M0!LI"F.7M#U\QMY\&MH_?E6HK.J8U_G?I^G':\)C@SVDN0
MD44SXX4T$TPY@'>>T"<YZ;1B'^]U4;]TZE[?]]KXPMAAL22Q#Y'%NTK3+O5P
M_/Z*5G%WYL3NNM;BT'.]**4WBG^ZC4'4T) MQ\^A9P(_#3-!=\B8?;;VP801
M$<.>,J66ZP_?*0:$G,;*^W\XOWFU6-I?:ZL6)3ZPY0MB;TFY&=*#:>@)W'Q$
M%-D@**SN0\7S)[1T]QS,Y<VGG8^LH?NAJUORZ,0%]0[R^\[=4Y<FY%RD[-P>
MJ*Z2$9]-M8BE[Q=_1ISA-3#1];&Y:(W6FY0?6(L*:AH[3+LP97V$YP'-'>"'
M6YQG9D849TE^FR\>B@;N!?3#$51E,PTY64SMB!/0,+'M\C&?#@5O7P**&H17
MUVPQ?"]1,QJ@ )^=DNCQE4?O"$^.VV;;WC!D"2L[VZ%L+MA?SF3J42\DW<;H
M[;+25.R3ZNA]WIC<-227Q+SE^ FMM '/#KPX/T)# 9P6A"^_B<1>,NZ17V2N
M E6["4N-.O:6ST1LKTEM6V@1XF\A8ZFV5WEA^\>VH'*3#.K .J,6L95]!,5S
M]&2@>SG>Z82'@WU_G9W+T.-ZV*Q?XS*VX^BTE=L%BT>:UGRI-#"RWAGRG'&)
MWE[77>_.383+$J)"S<%Q4_78+D1+G0!R$\RW0P'VA]67BET"X0&B597.8 &4
MHI=.TT#(MX@;VMJ3P:QZF[3?\,BP;87>[-61L?BO['>-QNMZZ/ONBP\I1:I^
MUEU5[-"TC!_?>]2A'0$12XU6"MMG9B2W3K/(/=9%A2R4AJ(7LS?:STP7Q*(I
M %?)=M,T1H/YG)E; 6Q,/"SMQZU$1H6/KT'1XH>&T. 4T_>&LV7XR@ K;L7#
MWGAN(9Y0UQI0,PH4BUYT6U857#<%D4\6YSY$;#*SF4WXAOO="-FW]EUY3@%F
M4J?HJQ#GH-Y1L_5&2S?:%KD"TLZO;+=6Q*]I!8.QN@CRV(*/N/<A7TB3I/ C
M]'!;B_B_7R(]F&+^R3R[I[[[L+!S8R073_,$!L*H(UXIW/"(U<><B"TPI7E3
M4^W#X0/T2$H]U:#YVOM47A!OL](WN^7TE5,3*M-3?4/#G4]%P'4I4:Q .\9!
MG UV?[]^,_TH-]1P^"*X\^JK1E-5<=;Z12LK=J'(=1^AD%V"8N#N&ARC(CPZ
MK6]NA;/++5$"N^5--6T2SY]:J%.C '3W2$B/01?8+,E-\98K4UJ%<XM"FDOL
M?C?<70<K>,M7]3R4R@YVE&=C9N7,Q[3@DF3EN=ML^,FY:9QD[.SD;ND/HL?\
M[3MGO>NCQC"TXUM9)A[S*#3J'5&) @1Y^\.R;R%F-=]R<PP/.6N)RZJ4+S\+
MBH[;?>-+$T/3*PL;;,+VJ.N-C^V@Q4;F88%\7!I<;4UF:GAQLA=8=@651;X.
M;^2!VS*_R4Z# I,PB8[LUV/R@Y+CF-JW+)D^U5S2]V._=GM?C*@[7D*4&;ZL
MB3T17F@K\\K&HS+3YD91YZO['5+TKQA6!R%]S]P8A6Y F;5%]NS(RHG&IXT2
ML4_GUY)%[%L:\EV>!QI>Y@Z)UELIZ:PH[6U8:JD*U<6*^06,$ 4?C.T(EA*J
M] ^V3>H%:GD<M?5"'LCJ1^?ADSJ25SS<]=F0;WF#0L&^#22XS-#GP?1Z$(__
M]*0<QYCHX]8GMM3(6N_<?S:8EG@T;#!J8&7P-&Q9_#1O:;7ELI.>0D:-46[1
MSX#*\450G09D>NQS_N5,5=?/TOA#%(Y/<C,4O&%*4+$C7TE=@C.NA9(^H(Q;
M:SO':FF7! Z]?PI&N-ZS6EFJNQ"VBWUO9%!PKFD8$A&/W#_B*A?4B%343UN=
M('\HWU2:-AB8J2U/NUQHG#=L:QW<U/;KR.NGF7RZ_T/>>\8U&7WIHD%4% M%
M.DA4JH"@=&E1D28" D+H$9%>0F^&1$&*5 $!12721&JD=T*OTGOO(#VAA$#:
MC3-S[OUP[F_F/_?,^<VY,Q_V^^E->?=:ZUG/L_?:ZV74.,N5B@8A%D)!%5XP
M';Q- ";'JO9 !D77AHOAG"&.<SG>?*HZTKQR56\F"<#QR/F0'OVY-+JH"!*5
MQER$#539RCQ![8/,&Y=O1J9S#6SA57X*9T0>7&W\S]:P_ZWT,2H.L5"(*$,3
M;T"N[!!ILOO S[%/ FI";MHZB"455\IW[)FP*I%&7JAS<)UVM)%%BS$2H3YW
MG)]_<RW;$9S2KOVLAU&/-(U;4?!#M:'C(.Q[#4I$RW$E\$\W4Q_G!&RK+KS_
MPLG+:$3-6XT&J3FT(I8;Y,]#-WH;!"\<SX(/G^P<!,4-$2471^-^PZM-X;LQ
MR(*&[A/HOF7?H[>]K+F+07([*7,V#+,M_2,X"H"+[//QH]$D28*C6I'/N>74
M'N<:O NL2UR#0IWJU5A7NW5J2T>B#8P?JK$\__C_6B9V9>>K'ZZ7)T1D/OTH
M]V>ZHM/;K4SY7L.GB=K5^_-)2OF^UD;YY2/2^"-1+YZ0/Z]SB[3UAU>&Q<WN
MTPW@K+>L8KAF-ON]^@K5FF9=-)S]!#YN\;L8C:>SCCE,U6R.38?WW,)L;5@$
MZ>3,=_V8%1M$?@X,&0Q/1U4N\HH5)B[=$>V.1M8#2=4!J#:'4QG,5]NF0ZDZ
MY66'L<AC6PJ@HJ>+S& TJC+U/^JCC8*D#..,*@[XEDMO*Z53A0&!_+( ?/CC
M&KL&J[I\)/-:=-(P9)QXCU@=W336#$[F9F+G;)O,(07UVY5KZ'S?"GGVD"?\
M&A6K&[:>5'WZ*\BUC T_:#AME"D[^LA7-+#9;H+J=T6_KTF+A$=(S^]<8GX.
MWP=]#B*I07[HN2</LL<'_]QUH(W\SL/UY5GR?12_@ZJ8BR?-3P?:026!0JH3
M;XC\1@2Q=]TXWD8 L85/#M 7MA 3-26ELC=35A(G LFL?]ZLH7NI=JMB()DM
M7219R;:,UVW@S @#5.UD/H@0C3,\I0LY0._PT*\CZL(2#K;)SMBGPB@SO!:!
M$]^Q%)?H(8/"74T1O%C=8%#4D_9$[?C+B+T3TNQ4>S%E6W$!22/2$^0RQU=/
M :2E-'* HWD>JU@@ZJOBS&(9,!J14D=< YG;#NA*8VS-'L=DUXFB9\-R;U7'
MG<9*.O$ WUCTZ\F@XWT597P 1J\-P@HA\YO=6=U6Q,FTSXN?4VZ*_U7-^[GW
M=4H+!8 78CV:B(5><_XPF=OD['SV@/^4D^,<W9\"T:U+S@[;.T,<-K'"F=SZ
M3+YY<0_HGB2@?^#M_TRW^)_C^IR5'8DT;]"$=-^#S<.F@N+Z2H&,I?0['9>3
M9([1]1O'_ %Q5.EA@PYON$J3^#!<_XO;L.#WM76_AK$3FF-ZT2'I'=EYS5+M
MU]K^KJ[+')KIT;=NX&C?&NI#JFR5E)-6W7$!;KPLX&,^COFQ+L@:S$T4^+ZU
MP45-2WNT\B241=^JJ?-_"H*D)0K@S!\DHS?JU]:42E*126(B]*>9AA>3?,>L
MN\8C#=VC?+7GKY9.,C.O:>5+K>S%@#!J\V\1;"]J4O0&Q.NX<_NBV=;5:OR7
M-.2GVNGNL)U7V119D?+ZRH1%[-!1^<,5?.+"?3>4$FW^ALK]82KE\7$4C0$9
MT >L:,*2IP>0][060CD;26\S&KZ(+XM-G]_A*M(NJU\]WCN6#N H"#\'\?=L
MV-+# ]\2)V&&>-&EO;>G2QL-=S%]E8OYDW(<RR,N<_-]].YFDHUT5AJ_LV(#
MQ^]!ACI:(6%P7GSMHG8,0QN7^!>4([OJ<7+EV);TJX68QKLG)J\6PRYL7D"%
M@9P8\#>@P42/RU/AS20SZ/E-<[B.[*F6A/2D.6C^Y;#:UZ/?(6_.Q):?"AHN
MJ3"7I\=&_2 4VI"==^$Y/<O^QO6@UU=/4ER1)Z!&8BPU- [GIQ1QBO@8@O 6
MT@:+#H.65;UZ67'\1VF+NX&&-+/U4>@L<_5EJ4[6-:-3ULMJ"@-&#EU/).R^
MC<_!ZI]XY8AK_4#:.9AL[9M_*(%C0=A%<[;*^#G!/]-^J'+/PS_VS@&T?*S6
M,^#G3C+5_2*.VS[/C=V^H,0H /X)]>W9&$=C;,)KCNX[;E3+2C[Z=S2XNGPG
ML&.[4N4EJ>O^*5>ZI0SI>WVY0_\(4-5B^+:Z2&!N4U%@?*G"[>X_NV@[1%Q@
MY787MK^E06[P"TE"M89926-WIKDQJ_AN9Z?_9,K/38:SM)"!XQ9HA!FD+0[@
M0!8<%&?;TAIWY:LOCS<U%]Z\0.=XXV[?A:ZFL[ZHM53T,]#"6V0YP<+,"7F^
M/#^A?48[W]^[D\3X;5RV6_G3YS? N4_C:PTW5Q FS05! GN&\WT@#&]##-*R
M^22\I  S/&4>2 $T40!\AT.1PJA6O8'@_^P>9_]]^J>)-*#RS1VX=$:/5KJ@
M]K:7^I50QR]C'MK9; ,$$Q.>;'M$N77B]\CT),)#(#U,>1@.-.GL"5C2J:P)
MDY2=HFJ 6X=-\[<2F\X&F"C)P+W&O0A:,/LJTG<567Q(FQ_]X(\<3WCO-9I/
MK@-GWU\%G'UG=/;XODP+>+^#S5Y/^G?>2W!S_00%$.IZO$FV/^J@6]&^W;VQ
M:'8\7R^!52;OL&>P/J\]IY]L\T;9N7A([/R7E_$4 +NQRH]?,-&<H"+";^M]
M52J7*,IHD&,UV$L".H?FY$C1"V=4ZW[_UWA2WM2/S[RY+C:(^E'SFM12->DI
MOT>.,G8><A4&CL=7>$(NHW_^="X>/?QTY!Q4N-^)]J@73:@I3^A>S(SW+4D]
M=!@UM++_9A85L@_,V91T3.%]Y;JM8<<;5C,K9Q!G6,FL005DJTWGJ'PSW7S!
M1)\UB=\YX8_<.1!Q5 6;UT (\6_^H6\^,5:;+I1'!A-[CBS!GT_F>=PMQ=;B
M*M(=QB,'*0!),OA4):YS.W?PZ<"3HFBCCRM,4^FE=;'D6=OWE7SP%Z? P 1T
MYA]PCME7IR$G_80:9[O/Q(Z(=(-0+?V"K[;L=FD;F>EZK.UB?I)(Q1]-,Z<D
M438*0#]%/\4[YM"JYYF^V:=05ANM(?&CG2?<BMSF4=,]89,LC.JO$HP/C9YI
MJ30WC)!2$ N?L)/27..MH5K9!KQWF&_+J=>]XLPR/."A/B"V0^#M#0!L'',-
M9X0-W[F6F^>0?/Z*C,G[<L5?@Y-MT2MN36(S-D[!GNKN]U$#$I-[N/N8^<9>
MR3&MXJ4K@:SK^C51O*:-'+%*'SXUK2>O$">6ZLV?#.V4*<O.]?7-<9MKFXP)
M6[\_H\$LW&A$^P:P8RS:W[XJ+_9J8[1M*'I5Y^!A]^W]>A3W-G%P4(/5[*,M
MEX&'@;&O;\UV,Q5#'JS_HX=.A/&)+6;0:&_%;Q+@X6T?2UFLKX69U8/2)H5U
M>>\71F$/%F)',0Q_E?[9FYCY&)<]F?YW8-46L[&G.8_K/B-UJC>?M*ZPA\;Z
MGRUQ/\_H"5(51AF*]A5_#M)S#/T2YS-X6HA<GUANMSV\I[]:R'UR9!5-=H'?
M(7)C-1H1W);^7FVG KB00M/X-?.9GRM,'[H;DWQN8+HUE6.\9$@\\('Y4E P
MP@EZ!AU>!TV?WF*[D5+Y84TQZO:%CL^7HP[X@JY>O?N0D_6$JD'.T5  P1K^
ME3@MA?#W=;+#_OF+*T*_G7_134LG"=&X\0$#U!\</'/=;9*GP\&O+T>+OQB]
MK+&[20&L%)ZHD/56)C'W<ZZ.-<]E2P0"(X\H !D\$#BZ(V?V6HP/-GCJ!\G6
MSVC8T"J,^^JHW)=W<6SM[F#%JO+&:*_))K.)5C5\8S,GO9 @NM(0[@GGJRJ*
MZ%M7^CXHPZ)O_. ?+<,QEH@HJ*M^W#.(AQ:Z/@=7-.^/+H-:Y7'*>;;<&9FB
M4I^*:A?DVG7,<:_Q78MHKC\%H+(ZN:#K*PZ_C<19>)3$-!3Y'W5.K#NGKGQ^
M<L]P5/>*@,?S'*X/WFM%J:66PS/;[[Z^RKX^2!*#2>&CLF&6^-<9^$S5*G8S
M]7I[UJ."SYS"FQSGF^2MO][M/\LT52EZ@"1?8"> @2QX=C.\7KY%Z1P>X9N?
M&1!K4I[YZ]KC:F5F]<N ZP+0)R0.U-K3 ]%D2$QN:'+7'T).'L)O"5Z;LLP7
MV=)>LH5&/<N(%.U2_/=D\_]?C?^C\ED#A!H%13 OO3!$::F_[YQ.34Z,+>'6
MFS;3.YDB!R!>-+^_\N.<H8;OJ$ZJ#A!&=OC@=P@Z3L-FG0F.*KS "=SEJM:H
M:W*?3JZK/AEB1-16- !;+Z]OWG^>3K<W>@S.Q"-G<_(UYO!>"0@'>\:OX]7:
M\_#\10B\X7T:^X.UR ',;/ATN4S_3-0Z: B=:BMNY(LP:%?JZ_SCK0,BR.EI
M8@\J?U, AL9_,NIRM2I] XN-_\I; XY_*SB,[CAK6!K/$TI0,] _3CNL^HFZ
M?SZK:9E^E<8H%Q3R1!I]7 AY6E1J.3!N%.6Y:*>_CX386!04ETE*_IKJ=M=(
M1ZDG&4D'C#I628[%%VAE]5?#':;W<E 4@%5-CW;5WG=3/M?N^6SWH]>/QLPU
MJT[>.D#V?FX= =>18VB-A32I-%-]ZWNZA_P4 .;\*4I\:ZV\!O$)NT[;(I.%
M_:3FA(7@N2R!2/O]0-.BFEJ)8 A-G1:6 FA3U<;L1.FM)LG)Z5ZH+#'\*AU+
MT^[NKO"5AS;$4F([G2"T!2GG1:^95D[4R=G?BMK13UF]?C'V)M%S^:NW1?!$
M)]TA:E&H^<ZEA93@G4,)ALD.1WN&WSO171XW:245?>SD>=(:K[X!'ZHIQ']]
MOK";EEN8"DK=-/QVOTK'-(>: 8NBEQ%VB$G:%F"I50+*GFO3ZD;RW12S FR<
M3.EQ\KW^Y'#"]P1W25TIJV(UUL?_GW9Z^#*ZHPO2D\(N\-V(-!.F/4"3Z:6H
MJ<)BB!B0L\DKC7]H<SYQZ<)(O\]B%:M-Z4B]3E6GR:L.#$-\K2OH]7X<>$B<
M",JS,)F?FC&9-^T<Z(=Z,,6:6.IRFIJ<*6 XRQ0/&;:%95/!G9/JUA!_/UP_
MAI@Z%EN1!L2_M^6\ZW2)T:3\ 1WCK$WR1FCBGA!!>W]\XZMHAV%+^;O?YA\5
MM/V 5EO]/FL5)SQ;X3;&1[_RAC9K0+K]&/O%-BU'7YP7G6J_QY8YD!G.[8R\
M //(]8>VIKJV)Q8Z2G&(N^982-[=563E^Z!QEE&#-1Q2^LA)2_?JQN9GC$&4
M7K*&MO5/#03;*J%E3\+#<%S"U7,L42S"O>=T7,TF,&4 "FD-Y-I\MU?=*V_^
M7$>-Q3C,^A\\.'%>*,*%^"5>F%#B<SKFXYV:C9H6^X:(@/4<L?:.*VM.?F-9
M]0[TVW8FJ%K >T!EE>^(4(;4L5.=N>D_'PZ4L]YT*'C?2.2^Q^/>I-D$B/L3
MUGYZ7;>;^XMC1E5EE5KR[9?N&R)W.VWY@B_<"%88/[@)J81@U/JG7NK%H4O.
M%27^G"EOKUV@3G=QT>5WI5VNE3YE[]*FI8 6Y 5L9_^JBH"MQ6'N&J-9QVQ*
MYO2N'T1JQU^/N^>^M>VXT68E$<2WE2><@;ZNLOV?W;_IOTE?J /DU/C2.E%X
M;W*\S8HO5D]\?ZPKO>1F\*^JCQ%+?,J^I><[E&ZCVH7^GUK<H+]5X5_PS78-
M&-3;.S\4;QJ/03^PBICL1@)>!]-]=7>_X*.$C7NW=3+?6C>^99HSFD&:>C*/
M.Q@E1ZT@GN#-$TF&MT]'QNM-Y\FS9AI'B+M%F<W)(+OANF:5@%C$U?GUN>I:
M19L 'QYM"N .!T.V[Y]@:2,K5O5S<)O(I)3;IT5L"@>7U%C %V?^L>T"(Q]+
M'>E:]?CBV@R)XQCY'[,?OB: ;1&,SIE/HWKB/L]XD#N/BDQGLU[^]I/RU-K3
MK:IZG9NJQ>UUKTNZ^W!C^)FQ4G<YSVQS?29.FA0C@YKJ::\%]PW#[OSH!)4=
M*:/]T(EL_HXF08]"JB@ ^@K(=AQ!W&F^7*^-P_NU3.J\9NEMV4)X?MM7_L.S
MV#79"\\"/^BIR9RN8X87BZ(PX4U<B' 8R(87F>U8'+'TGDYH]-.1O4V"R;Z6
M(%IS 7XY((M<&66<R4X!O"T?#!!'K9370CYACWG$?B!',&Y'*Y7DQZ=HN4'8
M7+(.G)LH-PAGPHNTM)"!O\)UAKPGB%76T7"!3T=VU&]<2="2J59C)5W2_>K8
M](B^RR%A4KR3[))KX".X^=RU8G=ZM.+T5T:D2.?_2L=&%0\JS+Y#--TG2A$\
M\:*]=]BBEF-$SEL*F3Q?K(F'N@-ZFG4#89U:MGVF$,S>4G]S#&+!KU4'W-P@
M/+PZ=-3+YG6NM_:#>V"8,8_DKYM)87];S*$VGC10O3\X!=$D=XB:AC:&& RI
M%:5@+ZE%4 #VD+O3U_=]"&(KB(L@'\P3X,M&\MNF.DNQRV/7J'K-$X?HI@!.
M>+=^;!62[54ZQP3%Z\_M%1(I@ 4*H 48>B23M&72=QW!M"FR'EUW/0^FC#5.
M3]_RE>.R0F7UX<9]*R]6:/(;AAF .I6=9=%>T8E/]">(:_I_^C*F5MW231E7
MS0]S19%#,GS6LMPD<]Z@^JWO5ZI>>3*H6GHD#?;(3X:RZ#_7_(=JZ!4+S$C)
M)^B:^;M%D:5U&M U,[%ORTHDAA/6;YJS7(9)G]]#7B":F!M4*IOVIG5;U*JK
M]KV1O%,-<9+%BN<:23NE+Q!,\4\??'AP,/W#4P54"*3#%Q$:T^Y09U7<KGRD
MS+D*52AHH*HFK7N=@ZE/55@I$!R?^L(FNOEY<\^.8$,0L&LS4%Y)-=U*)F72
MCP*0.K7)H#KT) 6P=!37T1\,9\<F(_D]S?VC=",/+EQ@T@0?QR\D!B><-Y ,
M,.S:L@Q%2#S/$?'R7BL8+CW2V+Z;\/%Y9BG5)4J%__>!:5W_\OI.P )P,J4U
MC6D(9EN@DSWOO[:S7>8_U.W\UN-6V9/)>_EG:7(B;(N/ZV,!RI*1HKT@!^#4
M02.H!(=:- =R.5]S]%.1JG.^?MN ^@GI2!OCKA@3X?,F)RY!NU(A;QBT_WG!
M XN88L =X1$$2>)+C-];HKY'GD8A?DYSJ&-[+,WE;OBG1S&BKUP-UH'"+^]J
M 9[1E>GK)-L&"R:H/X^AL;.3IZ<ST&'L2[E;$%_2Q1/)::IK]/;/P\/O=/^W
M_2$*9"JH5FXC2L([D._(%Z#T%?44P"55 TNEN1CM;?3DFYF'5RD B6Z$' GN
M4:VR*]6G,?@<H*^3YK_S(L#6)U9^I+3V>MYW3RWE-Z@D^$T*H,F1&AO(<+A@
MXA,HITY!+U0H17I*]YO,; GORA,6_C>![2:!=F]4"C*JXMX@RQ#!(.K]9RF
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MO7=D7KP>@8$HI<>PX3OE,5YW/V?++*H=75=76UT>:VH;7U,LUGH9F?3H9R,
M< E2K+&#78!,ES9SA64N<LI<4MRY/J:L_63$QF1W^WAWHL-9LD1EK$64]QTC
M VL/>1Q=!FZ>#P65'3=1 )?QPXUW\9EM<+$1FW(,+N_4M;!I4"!AC<.H->';
M!J%#_7< GUW@6X@BN?WT'+H%@9>@Z[AS32M2T5+VX&'RT<ZR9?%[ 5?9Q4\T
M[7X]0J1#)SV\*#LQ"X73^6N='@I M^(CS=S?%T6AG7H08<#2^0B5Z^A0HM%/
M"_]^M0.^T>T=5<<*@(6PJ/3G;F3*]^N<0<Z]Z(5D),; $M2,/-O 0KP-#0<Q
MH<2SJRR%"&[S>N!AEGY__,>N6A6S .2]#AKSH88TJO50%$"W8H,(8N(VXA!F
M9$B^R$ !""_C(12 E1SPU%09X(.LH-N97@!.(%LJ_*SNU-35C,K83?[X4_/J
MT?*SD:L/!!A+WGR/3[;33SMO#L#')E%E8 YF/9QHDSU!5,-#L*!%>%R12L]U
M>ZNA5$7C?G7W!ZY5F\]4%+$)*N[X),)#B /5L\PAW/X)RXOST0VB6@O*]UW*
M=("JI:]SRS)^3:=73^1-1$L/?VMU/Z9_2,?Z!UB1LA._-#^UC'/"@MZLD9+(
M]\UGG!EOE]1488Y:"I.Z[_JO+HEA6NAX/FC^T?S.,-BKJ%\Y>H@7WQ'\EV;5
M&>[8[G]J5GTC^ )?\!68#]:&? F\ +Q(-&K A <3A98AD5QA":M0-R5EAU*S
M'W/ 'I?D1,>S;/2,N)?WL_!J2R!N&#UU\@1T I9$+6U:R%*8]> C^9>1^[*1
M!WK"XTQ3]XRY/Q18:0,TN@$<RRQ(S".)4 6-8- +2_96-M^!HL)EQ:WI7O4%
MX0/^?3?;BO>7?*;RV1X=GM=0-AF@ZT%60'>^+""GM7'5I&0?--V,58?XEZ6(
MPG)E23+#+8+VQTU9$ZUGS'5O-$5^YYRUO_'V=!'R"8TQH@!"57@Q4")+/LX#
MRY:4/37A1!;!LGX>S0GU)56GCXBUNBVX6XA^,.>\(<R_8'.X^4;%GOH4S4ZI
M:_%4HO<''R\>/,XT4UY?!I:@9;HU53\CJG*/*'AKL=9%P@)"9+[6"#E/]",P
MXNT)= \Q187Y+0PI2Y"R254/_\H5I%3?W*47%,!Y_\E*'O"$V5R4_9(EUY[N
MR!W7O3("WFIN;<J_-5Z/.[@@.B?,X.)9W@LR)QO8>?*%S$+8'6S,>"P%8#?/
MO9EV<3SSCHA#PFR=>U??,@L8L'*S_:P7G6&:!3V (-2(/E-'1[CI#VXW0P?7
M"=;HU.,334>D20(<I"+-E_(FUG>*.?(6;ITST-/U@B3+(3'/\CG_MJ](1K.C
M%VFQ>Q.+@[TIN(LED!U#<AC6C6FW?:9BMU[2>7L/+\!.9 &V <M9&D3P"*Q(
MDPN<W_]<Y%SGKX@KV\XWP_0D!4X,'%9H+(3I_8H *^#/F\#]8M<X4E0X!:"3
M\(QN'%+*L/,VFSR$.%<.Y=%:W&/&"ST==,NIK(YJE6V>>_&AA:=?GE[79@K?
MGW=WQXKN;_>:X@&B_FL?H9;^=PBVAEL.%4^[Q MS'+8K"I['@FF^0/GVWO$I
MB^Y<MW99&1)/><;6^V*@JIH=$"!X)P=.FG&=_KH>;2^S?PW19-7 L1%8-L>&
MMUP 12"9;PYT5@ QH7@7[9R'P>JM)Q^70\H*7G-X7N09H,N#MT$PS_3.P&=.
M97.%0JE<^7#6YI&MI;;&Z$TFRZDP,5:RL:VM@&9WPL/%X 2IDQ8"E#R7C&!"
M+V0 +\*L@6^)?C]4,?M8OA2=^A*3/1^IZ\OW9#>JPF:C+\?WLVY0 +\86L.P
MQT2V^26W<NBB'B.>#<3D[Z15Y*WLV;/MA^L#Z_DYOB1?XX^TI:OI9 C<1"QD
MS>^G0">CR+54--\(^,Z0![(!3OOVXWI"6@U,\4+M#0R\UYUMH7A-L>09RY,Y
M-Z4,CMWI5=C<E_&Q:LB4#9G^\P+B#9!%XXUW#'L;A!GFS_+9&W)I,JA(6[WQ
MINW]Q8C[4V\G->8NQ2,SZLR+$,WW%G7T#/:G(-L$+3=?F@0"8P6(![RB1V2.
MPM6-JUS"0SI41/2"$2PJHOZ9[6;+7;G^*:K#_+5Q-,QZI:4%+F?37J'X .J/
MXU?<A6EW)28SR?2E"WNQ:';0HA4^J@4NBK=>SM4[%4Q:,H>4EF^L7XAV?_P5
MF#3J112(?8!#32GB/F"0VSF8'X1V*^F1J\C,2<G6#.D#H9K/I24<'SS[)I3<
M 6<36)A!THB%[VA6L@!\*NTFWBL?#\9YX'L7(1S^0L;LLC7?UD(\W[2;7G_6
MR<?MVQW1]&D1;M.N"Z>2B^ F>*>5(.D7PK8V2*YI21')Z&]O'&=6^2M^%&Q@
M%&F2)B#V*+RU-L6/SA&RU E8H0JFA7(N^#<;YR)\R *R'<+@SX9)UV.V^-,Z
M)0*:_9#&B$(D32RX<V AKN 69"G5N/8M*8%'*6_(<OY@$[S.LDZ4J[N/J+J.
MN#V?VW(572C/X=R/NPR23+U!K;'\#[I512\'*S ]N/1?I2,1Y HU+]N3;\OD
MA-?Q+73R S<2M?(M?PQ^^ZE4%; 5;&4%FN1-.A: /Z7>]K1!@"%BOGP\@IDS
M.W6X98LW_H)-JRLS^9!F8ZTL":/";P<$=V7K2IC%:*S6$ED;[/^D<=C.F_8M
M&VL_T>I9+R%:CJ<OR-Q)*JZKC;WY=^7SJHC(&":T\ENN]+<,"[)0'!:U=IJP
M&F5_>"1_H,67;70A78-&'9"=$;FO9_*/4%*1AD*X]#1["KY&^$@YK\V3+#Q"
MG@Y:19U6Z:KDU#NK(Z4+;,URQ-SLNOB>;/_6EN))>#WL4-2RP-Y$G?<X)/LA
MZ.+&B:F/\YN$GM@[B\_,3!D(/SF6JP$^,MO/,A5&^=03ZK*&M&L#^?TGHM44
MI+/-\LM>?H&6F%4$R5!33B8IX4L'7 +$5+YEX.UZ594WD6405EFI6I"I;"S>
M<9:=[\.S2!)7 20<?F98A0W/K8W9C7.KJ+&C7@;4Z]]L:FV:?$W0XT_0$ZS(
M/T6&>7(%Z)Z7=]BZLT+HVMLWEQ"8(6LM%=W,_VK'W*:MN<,Z)0K],GO2,$;5
ML UO3G[]:[4L_YY1]'JIHWGVVC*T)<BF&<Y?RCXE6.\R5NF^*_(D[:'!?6,#
MVC/WS]).U7")Y(Y\Y,^ALRO7*Q74-[ HF2#[()R1DREFI'BXDK/5Q;&*WV-B
M@B4UD.H@IY-[3U4RPZY_-O&*'D\=WX$0V<)QLJ RO^TMJNXUCK(;QM<NXA-V
M64(O:;U^-4%X+,]3_"S#:%.] V"G"HE,(EUOKE[JO7LO7R)602O@^/ U:2O]
MQ,HK18GW9A-,PFAC>L5B$-70X2MUS+^(3B\*KE:8&T#!1QW+&PYA01I.IWF>
M?_Q]^$;JU5B,VV_^(]M+?N_O'$\5?%N6)S*<L+ZW5%L!.98G@/9NL_:,*QL5
M]D7J:7/-G<'&S+?T7W=HN/'++I:@B@YY5FGK6E"B=JLSB[?#,];Y]#$>NNP,
M?8]@D 8RF[H2@!'26T%/+LLNKO8R=]8MV(?Q+( /M"'5$(RZ7B25-I:!7B N
MM_")6OH;+ZT_^II+ :1!U]0O;#^6;%4\[(<Q],">-AXL.KX<P_K"$R!KZ&O;
M51I,/6;>$"-$+9GG-"]2&-6NU_ ?_H(BLBVB& I:']HBD^3PX,-1M2#[2UC5
M+E)A[L'!_E%Y(4+H]0S6*QJY1:0R<(D[IY#7 44=!Z*D**KB4TF!'&^@F_\J
MOB'QI;^*3\IL1@05(^VI%?V&;CH=A_KC&WD*TW@?6WC;\+2^.A$"]"%?Z\AI
M5DHTQ-4J$D&81PUZU"10#V]3&-^)(BA.5KX[UEJ6.#_WM[.S;[-:W$YWB\NO
M\)=GJFE,M6ZX13,L=9XV1Q)_$?@.T(MQ1/8H;;S'8H02")NYN!=7!N1UU(\R
M;RT=7GZ%_@PP=D_4NJ:^'3 9ID_:#?Y%YL1#ENB(K*]QRQAHFQZCO[8Q!M0,
M#/,LG(NZ^CU=<&0MUBC)_<*YWPG\MMTA7%F*M&SW0=D&CQ)JI&Z5JD]_B$\(
M/_LJD(=9Y=WP3]H5(%[<.,4GGPJ:RG4/6;/KVT;04ZFO7<(D=^+*).19=^:+
M6<N2(<6(9@Z[6$V[\"8S206%I%?6-A=NA'3>P*&>9;P!J5  ]H5L^PQXB?EV
M[2ZQW80AO4O"6E."3.A=[Z*8:-[P_3PJ37:E)^A39^@#O%N.#>=G.-VT)*K*
M']_\._YM[M2UA//GZ91PJ(%-8=JNOV\WYPKO8)A87Y(++8ORK1DMMV2VMCWS
M5?K@.[,&Q['= SJ75'PI^2*519^3PE  S>C0!@#^RI(>/7X.%,&66CV0+'PX
M8I)A'M5NF^RZB^)J+2&>/'H0G>;I<6JN!H#[DB>L&+&H[6O4SS,@IA1;5%A'
MZFP7$&R.^3G^>6--?GK6[R)EY0%)ABL/A3UE4\#JMZNUMNVH?QY/Y!O97@IO
M(7/A$Y>N!*ZP1FE6#O&QG]%]:W*2Y4->.]B9:EC\H0'ED=3<XA)]HJIXKLD3
M $!: 8"A@("&TN\]!%-R%SC5K3ISWE\7$<'+E3"WI5?+63W$NS83''N!#F9;
M?98V:>5JTLDJ@?EO=_E=T$(R+^<(F9[HCD%$%OP8E%BK&A(_G."KTGKY<<^6
M>Y:VW2)9B['BZ3O&6N>CEU_$F'X_JQ'EF/9,YIP*X.0-3SP9H%O1VP%A04OV
M.Q#"2W(_B$D&=693A1'#,R=>5H*I_S:B5G[QI?:T1NKF LW^13G! ?=[G--5
MMM-'2Y'"M!T(-X88LA(I387!#)_9J'(1"IPU=?H08ZX=K6E/[K]],UFSKJ[B
MR(.Q;YS&]+T!#=^:'P40\@[.^2.*'X0)AFGRBCQ<I0!LRK]5G0_*VCY0FFWR
M:H)*^ 6%-9S^.&$Z(;NU'<CNS,=]N>Z!? + RY$O<A.D\"LP&WP*]F!),(+,
M-DKFUY'<.'T\*.W'^%!Z:4G#UD7RINW[YW=G'K_Z0'.N"CA]T!H8OJU!M>4K
MC'V'CN'#,1\@8,[Q5A]YMYU![E78Q9TTI6+Z$F&'+'H3-\ ":1O^6?\!4&*6
M^+<!6' JO!'-PH^'YFR=FCN-^9V>_T9"T9LU9 I7J O(UJ*2A%)?SFBNJ'A$
MGD#)%^>I/R*- 6V;$V0FB+>Q.<$PCVS8 \SJZE!_]L2?Z=WR ('/*\93OZ/Y
MZ9LNP&#%XA<Y:(^84U\:BG25P]K.J=I\N"HIM??VA!Y ["&%^>CQP!Y1_T(?
MOK8]319CN1[LP\#BKX6Z]O2CU!=%]^1GC25RQ*-[C[/?-EW6ZT9[>X,P9A(,
MU#Q$#W+H?TL!<)>1KCT;DY8X,R^!:S%[_(J@H.;%LPF,OA'_-(]GX3R ^2(G
MB37CC9(03HY4K\1-@)G@O]4)9>+3QI]B3J=;/%10]CQ,EF5+%AV\74"/A\#>
MKS:_K:I[8>8$):+%.'HA@@)@@CDN2$3P,F%E2S$HJU'(\P&81O9TP7SS-8F$
MGZ:9FB'IMJ\<NNB[&\<WU5AHL.A@]$(9E<M/8OG4,.@6Q!GB8VSV6B[B7&';
M[T#WX&&]2 VC@!77OB8; Y-5%FN]WW0R6\"*RITDN6WK;+R710T&%%%GNACT
M:,U$YLO.=5B7MYJ1(4_T.U=;3Q-8WQM7PN0-H&ME9>S0N5CA(?EE;J-_.M-P
M^Y#FA(J]Y^A(E75_0UH9[Y@!D\-K+T!9_%LZP&;1[++CB8XO);9-3ICM'OQ^
MX!+ZTH/1HMCE)VJ8(=CJ8BW>$6/3K,*#KF$?GP,.NAQ.?WGC*<X?=C8&*0\,
M^)@64NC]:[K#C;LGAF^F;=IIV8LWBX T"_HOU1;:'E_:6C%W&5.44V!USUQ9
M<,B\J_,Z7\RERC]7X-?QE:V55M)8XYP"R/V$ ^/:Y/W%KKX-?L]M!+,.O!31
MI*X$I0 NR&W[+7.R=O?F/N3]P@AL6]?\N4PFI8!"X8_'%QO$;+X6/[\;Y=#6
M==I%);"N1+UY&+#QYZ+H,N]^0N1A))H\BS_GW<!0L7^(2^3IG %:DW6\C*8<
MW8-2=,- N]_[Q^OA]R.3,FUPO\6@HLE4!KV@V/P/5-#1UXQ2I8KO-WYDVS%X
MTSE&2*9PB1I *H>/T+Z\#2MC.H'R_I[MI'Y%)A5'\U_@#08B,QAGJP+ O_;"
MTAI53N?[9X"$]*Z,76)\.!M\_G(!K;NF2.XP/[AYOA3:5!L7A^:N4UPT8=.3
M,*B!E-=<_\']ZF0-MK#P[DITM%OC'J0L53T)^GU#MD(VOD"VPCV+L?V[2'OD
MF9\ =P" GN373'P/;M66S"O+R4*TCJ%6T" ^+))-_NU BZIHQE%N ;HY+6J-
M2E7^J0=N+;#_?SJ9_K\X:.W?BG_W7U%+N,^2GWDYG[;IK-]Y](6_;]A!EYPA
M=U( Y=>)7+:_0IKA(E?R'=*ON?C^^0V;MMU6RI&G+9&&EQ/J(;<13=9H6Q#>
M$3K)]PP]7/B4+(CA#(+J7I#BQ^11 -D/Y/EW(Z#T=:4M''L02)/I<*/=O>CY
M:L/9E'[[?42(?7@K!T/!HGGD<68>"=P+EP5=%1E+#, ICMH<FZ]"LXTRT.G&
MJ<B4>F^%;I&B&#]</FO_G-['T;PMW<UU/F-?*N_[%/QO^4%UX1.)6V0C"L 9
MA)09&I-X?W/2-XYTU+$DJA"EG6H0^+G\U)(".+\+ ^_#'F+9&_=+*( L\^FM
MBORO=_<GFNYUN,,Z53[MI8&DG3=0>'ZZ5@0>#,(\ ])*=3*/6[R.X851 .S?
M:",:*8"*9HD>UGVB4<AIGZ$5TH@;94*8SX[S$D!M%Y>MKD/1>B.DJ8Q(T9,"
MTHO_[-*G_^+E5/@6\B70,F)[+Y27";-?=27?*<&JYECT[&N$6!](A+B)*@(M
M%,_=<37'O1_T3GHQ\.?TUKUG\.V$'CXYLD+Q>.<1L:.C"@U-,P[B<T E@(EN
M""/_@)#3AH</?9)6R*[E>)/D;F#9G!KP>(9^IX.U"V_%H&@21_X</#H&;ES*
MWN.'OP^UVK)68P'?'ODW,\'UWUO.;OMRLP]TM$QY[];MNQC<'+-;_P/JS,OA
M=>17T_)L*_V::IQFY[OZ*<&QS*B07;T&RU;LF#/1)#"Z<]@%A=)?+BM1/&?$
MN_(!Q'6TS#8OHO192Z"7;X\"P//%-98/U=TL@CVLJXQW*S>]FI*CB.K!>8L,
MU9SN?CB'NXLTA+B.2V"T%[/13?WOX-<Q]47S$FK%D9.?GPE]N<&9\(B.TUZL
M8S;.;%/T%!TNF9UB._(KRKN< K@V2@:])0:U3K:6*O45W=L1VJ4 0AW0#.V+
MU*>N\O]'Y.N_:^BDG:UYNQS/IKEB4!0M^;>@=(;+AX6&2*(2936J! 'B;=%3
M!VUIG)6AUH-K2(*>YA0 4J)WD/&3HS$FJFW BVDG&*:"!E,!;@$Q.0A3Q?2T
M@*X5+-G5878:!\N9JSHF!<4&%?V:=?;?,)C'?M.!/P,?(NG7D)">VV.)=0FK
M*7G#V$%B?]=!-'"TV.M'Q6P@:']B +,SGNAKH\P/_%G8O?KR8XM(R9%AO.5C
MSXLVQI":EEL-&1_+BI>,S&9\6/3-/O^;6]'V_@G*8T[SLTZ#>:=U<+=O=P\M
MR!8C/<^?^]VOV5"YBB=#0T%L1(FE*%];9$M->=&/=Y</+O<(Z3XDU%^0Z1VT
M\+F1PW[1Y5"13X@MJP8X'%HX QXK[C\;WWNYF_<^4XAH+N=9IJ:S7O$&X 1X
M$Y*)H0TR,;Q85-7SODCZDH/@28];,LL^_WVE?6SQ.K\]I[+SV-:)(>O#P4(%
MR;D[J.H)4FJ,FL%7)_%<4!TURAH'_K,1Y[\P@A'#J=H@TC_+OQ+7A2WKJ>PI
MJXYL\TWL2+SL40G!):'[999\AF V6$/_K:6]2)\?A*D&E$] G)ZD/0S.6>2&
M_E!JH3=VKYRJ[*6SR+A)4OI':WCAV\QPLJ9:4!<?M,G#;LD15)..D*( QHK"
MBHF<;-.<W,  [%%C8>3)MFK=Y.%SUN_4Y%J@\V]G6"CK+"GSN8C*-A]T>63\
MV2Z?NMV?3,&JU^]C6O?X?'S%G/,O<7>5IK"*BEY&9: 74H"7$8O6Y+%4G9D!
ML3$X9V6*40KL]4>%.''QUO/,FD6*Q,\\D2=C: W00@SR$OJ7"B,^JBV1/THN
M C4V='W>N\DM9PU2D*#)0/)B/;9@2"9YW<^D*X,H4@"5/I#7)2=(FHYJY$B)
MPH'>7,**5<D@J7MO)2B>BDI'-,3O_[M>HQ)PO&..,9:8DL!!J<HPR\1,C]'1
ML\G)%I %O@&M_+!.2!1SI0!H-A7&#])]G._$C'S0X_G0>^EC@IQ!0?35"S?V
M+RB]&#]<A+P%80SW0IB(]*2J.K\LL^G"BB\!OC6%"9G,#9;=8AV<_#%%?56@
MV>5H\.8<QQI;KODY\5PM6!DBE1 7M;0MLWSYT2$BE:1'4T@ZL]PW//JZW7?L
MG"/>SK6T$SEG08:0:TB17\KB0GZBKME%"A>%?/VW_/!VB?BA+1G3IA )6.F<
M\E#300"37HN<WO_I'+T-^KN+$0Z7@K*0&\UDOFBM(9H5\^8W6D8?INP $"L=
M\ D4ROD 1;XRC8UOP-_'<K?,65MG;\E.Q:7$LN\P<AP@$27+9%I(1A)QNNVC
M<BPT(OP810&\?3V?>]JN;8BD?6)E3"@C49T,]4WYP7_4PO$_#PP4'U!)Y6RG
MU]'[<0@*H%TTCO.S]=WDTU&39H*7ECIN;MP)5Z/X*\!*BA.19Y"D:PY)%C=N
M&"_QK?]6SQ"04<=-YG7%@,CA4&+F/ 6 C40O0O#"B*9Y;O],G4%O-$=0OL'H
M;D9)63A!Y$AI,LL]HC:5,5.L\=6'\P&WJI9;[S]/C?:0GD;,QYU\2UBLF[OG
MF<R6H4U(H #XIGYF-#RA1G_&WR4@HA&!R0IV?Q@&7*SG;E6HC"O:W1EP,E#H
MX'PW+9(7^NKD6Q%XS0YP3J6:MVD):3;X=Y^D10,^"SF$PJEXU1P\3@$D;FU"
M)U-:*0!&)6L,5&=$1=@?JH-)B5Y+L [X83)3V'I7..G=8X6N6\3!T)>T7Z]-
M?P?L_?Q7_0)]CP*P0^$E["/(@L1 S%S\4O\Y!P6Y8*(^%7!L6G+-=>ZF=FN(
M\(G_;N.XG7"'*$[+UMDN3'NX%"G:1@% ^Z=.AW%\I"\R$&YMYZN9N1=M?@VY
MV":^G+/L^9:GN>Z45Q=-)V!SX\7! ]Y!-1A5]IZMH,Y'#+X6MX#5B"N#</A#
M-#"[Z0OSI=8NE_.3_3[SQZK%?PHSCO!6[F>=P6<N(3KRJ=80C%FLEVOFLNQH
MNN\2,N\L]BF)HWG;_+?D*X7?3(_.WC?LM^RF.;3]FW=9,?U$YCA<*+:R76_J
M->[#4)W^DJ6AQ3!,#I5E9ED^\B5S>& 6<E,S'%,TD<G! \MH6*-BWTD*F?X$
M"VE%GJ, 7E  +%MS+&/0LBM.W/D<-O6EB3UI J]_CC97&G4G2-YODIDB]\V!
MQF#Z!!H\J'4J+-W##V6%YYK63\,]NEPRPRW@=7.GJA)D!L"9B2Y1F=M-^_9^
M=I@?*9[X,-^_I]6L\GVY(H3=8E+5Y^>,] &_J/VKI;N]?0-#]SL(Z@T#_X+&
M*V0EF!8T!$(+LU^^L&-\JD?O )YJGI;:9C\_-[MVP?RKVV0TKA<FA+E&IA<B
M6,*'T0R96/!;\D4\G<6 79KVJQKRJ+9+%V=+3*(5'S:MUMV!]O!EY D*IXFO
M)CSU7U]Z-X9@;V#!0YK@K.87!>*>#1^9N-DY?\"^BWMIT>W^O-.KC.&CUP3I
M]K]0&F-$5)V>\P*2WBFU%_O!U%$V86Z&Q?(W7\RE"CJO4*5GYT-9UT E]COV
MBY!IN44;?$O31IY&5D>0>%K/3_,"J8LVS^U.C#[97*U;JU?XYV5^T5ZJDNN?
M8A['@4E?8);+/9\6/]>!7@Z9-8FR:G])N25_2W[]BNAW^94S.K!EJN-0_3$8
MB8_"36'#(V$2RX775#$40$39%V$95Q5E!<YT\UJM>]6?!>.G1=<>-+UM$:MN
MW*7!E;. U^,ZH)'S[&A7(/ZV1$3#!1@('Q. J6WAI1UJV\%EYS2M65A4F7MN
M^]9( 247^2[P/SM3RI-&=7&%R /DI,TB.*KA$HR_DOIC,4I>/MAK)F7528EF
MU14$I>%'O1_!EGW:$GP"GPCCF51V"ULG@&%Z^*-%ABG%Q:(43'\SEU7M@J7N
M$@BO!;5_6E_".6I[[G?4:NB[% /6]RZ8B2EX]/^A9Q=+8(@B1+/4@HZSP?PJ
ME95/Z'FA";5\=OV+D6.H^R34$1JO@;9%1H#YN-&_)&X:O.:\Y="Q.=H36[C]
MZTB$ A S)R3UU9T#ND;F:)QDI<P-@3@<,B+)RJ!RW=)F[/;@2RI!2SQ-'<BK
MN>4RY-I! )!AHWG[3HI=I6,Y6094#\GZ>UB>9J#YF+G (U]SVSTODQ]IK9KY
M>+N@H"#G+%/PE:#)'^19)!W"/NJ2)7=3 V]-0Z1\O'WUKW)-8]6WWX8T'R>
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M69N'JT>!TSUMEI^\]_5_#+6(WEX(_EOTB-HZP)>=0LB\6((\!3#X; B-.7]
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M5H1&JMS&SH?"^?P-^M98Q[U?FTO'BKZ*;W[;5N=2O"L2_-BUZ9MGECW(ERA
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M)[]79I \2@_]>BD\N'MD_8&^9GUFF_H&N)"39@76H$;,4>M6('"HP$DB^2W
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MN !=7QQQ#4/;])L-"<:0<61-RNK')= T;K*CR2SN$QGI:3EID1CZPI*AY$#
MY;VQ5 I,Y%R8( <= /(^PF<XPF81_#)W)RU:I4*!+:1I<ZHJN]R^M:;#3=Z
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MM'#=[U*)UF;L8>_>!_9Y0DB3Z& B>[:AIQV920ZEH9J5VGW+ (V=BHQ!ZU(
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M?)_;T_14YLZLD,_(=<'[%^:YXE'>"2T">-A3\<FX9MU"?.*$%GW>/43BKO*
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MS;_Z4_38+F=G$?2+7OBQ[Y\!74V!L*S?MH!2 O5!;1H4@#,P'EFCD.35++\
MQ*2E:-TH'?R\X6>XZ":\N>HJ>H/AXD/3!4>C!E>!X)@.-R&V&FB;=CYPMH;,
MZ(O^);%H.!.ARUKIX5N\Z2W>T:,R8V??=+M;_\KQR]2K=AK.#TS]_%>@]?%G
MF7LX6U(&U'&/QSTS!&KR;?+YL'SAD()"H$=%4E^_T<ZT9[+;ZIN>OU.=TB\
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MT@:D/.R@ (1!KC]9_+"!<NX]YC4-8_+C2<P5+QO'N&UH1"[_Z!!\PW9+YG
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M "_) D,0X?49@P3LN26K1(^D\/"MI(IWHY8+@?X*.:*O+CQD97[ZOKQ;QQU
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M7]^B?CX2K32[V-$4*D9>GP%1K6_A-$&.I<\L*]^[(NN!DW;?UV8M/C:F+O0
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M-,C8\OU2TI+>544!:=7,C"+I629][0L:OH;;Q0#J&(_X"J=O#$+$K["7DN'
M"OK8#B@EICHOT<?_G7+1*<^N^VM0:'7>Q\J+/=0O/]9S= :< W;()SG5%YPR
M7@^BD]+%69-6[-0BT/A\,J5!\+3*=83]]09+N%Z'CSWMP%SJF0T9OQ$/R?#]
MF' 5TY*"5G:[UW;X3/Z]K/?$3NG+)EBU]5RVJ'#=Y]6<^R8OI%D]?4,2K4]V
M7N Y<'S884QI2K;_YN33AO+A/?KCNJI&5U\F%B%/4,&-(X09V=H.D&^1Y8/O
M8 Y['S*5]K7"=HXO^Y!G#ND^P;FTDQ>[>G@[9<7XY-+&RO+&ADVA!L"??<>6
MW/=1G#'>#A<W:;5ODP)S7A)5F& 9KTJK=/7>+^PKPACN3U4D4[Z]7VI$7L9A
M#&<_VN<D;++=;T0BWXMG?*%0$-^2KZR50)T)W63R-+Q0Q,U$ XC_(?2-%N,L
MASU[_.R#:0G_^_NW/)H?4]0Z#QK&*6Z!;^)&29?!&,HNJ%K=)*Q"=D=$N9!P
MZCV@;'0@)JW_3,1-G#.=.&9/J_ TFQ4KR$*QU'"'P+R%=@]3D_#GZTJ5CYC5
M&%?CV1C,72^;UA^>::>C"76/)UDHXA_E-#+]LA1(''A&+(&1R4,XJJ8ET98A
MSCO@M:1,6;]]P?1OMSUQT_+ZAW$<^O>JVX54WC+(;IL\I>Y;^)N"1H9 BW%\
M?SPOCZ<V'B]M>NB*5<X &2%=HW'9/<!ZR,7(.D"%T,LF)O5;+9$X4\SH8]P]
MS.0#3&8$][ 36?M$&U3JV$EKWXI]4/I')3&DM_3=?]V*-%WDX?[T-Z\"ST0-
M/IV!E-@^>F<]%WP48,N/H8T@73R%%(*_H3 6[I0E@^\(S$NF?=49VV=V$=1_
MF+H$K#+3 R3/ <&\=<N'?Y!?_+=H,:>K_D>)1F1%G0#+&-S<8]B/9OR(7IT0
M[B2/M207]VP4DTXR*R7K0%46Q#$I:6R2.=\ ZXJS(VV]<ZU!A'9J+=2?76*S
MV7D7)51J7/#OLD3V+K-,^RHOAE,'7_CW<P"PQ,U$GLP\?FM;XKK4(JJM%3U[
MI46T4L6Y]5QP7)TG4,!^9F+ILTJM@.SYS@":*Z _L>U7R6=JO[=4O=EU>P7^
MD83F0!]!&N'.S6JM3T:,Z5:W2S-CB#TXU^5^8!20P1O,N+$2'&]5$86]62=U
M?YW+F1_W.2'']T;4'.(C;/$CBM=V/Z5U:Y!R_C&P2N4.OYY+,4HF.5'QM4+O
M],WG@8M*5[\@$$5G@S<'^+_8'Y5[X'7 ?;HZDHGU!)\.Q2<5<UVEM&#[QH#.
M+?9#,UJAK&:OKG]Y166A'+]GG[Y^$2GH%5BDN,^7P8=YX]Y]/-3"Z:^%+LF)
MQI8$KF^!-A&'@DT<VDGAT*V>WYI:EC 70C;B%=E2PDDC2,PXO!H1U63J+JJ3
M+;"L/]SJ:\_VQI[?GGHW\NK&XSC*QRB+?252(OI5R:)TG[= \Q^$) B!KNTA
MP!6Z@AW9E:+=4K+(Z]_]D#'35&.SFW5,XWJ4K"G^QUU1]O::!3=T8I7ML6P]
MV%#'V:OCQW&9H09KX<=_3X";!EN 1?6_X&T/EXK-_"(%IQV*B'](IM*^&EIF
M+PTU7D.D,'9P1I( +JB]+-G<9T=_5O^!4GBJ:4S@.2!HI&Y-\'J]KIVOIG@C
M_QD5,:+I$OGX/P?8HL)3Q8:"4Y<&VVO</-B\*APC[3[S!>^.;R;QE!3[RI6W
MTQ9[//C.J*7Q].Y%\DKZ1_VN-C=-/G C[JYMCQ46J*M[ZP2W:K"8W0[Y5]=-
M^\]N_Q:QCOH.@3.B)#+*8F?/ <Y#E^#_%#Q9RO5/N<.&_I7]H Z%M>I"KI'D
MB7%-1C=-G8_@=XR>A/Z,,I7F5>67W#G:! J*GH@N&82^Q$5C]FPP!#PDP\L@
ML[7?$:#+==M_+79Z.96@.B&3ED%IUE#>%+:S)Y;G?R>2=&1T4Z0ON)4*A(:*
M+LY)??;0<1:J(RSMG>IB@-]4^+J%%XO07!/21J<ZEH?Q2Z#260/XCMS=WDG/
M"]#JCDE#M"A<67<:GGJ;'Z-R#HB%*D?%+GMAB\6:MS@_&VJ\R6C]CPQ-?"F-
MH<)%[3F^DH"*AQWNF2=-^D<8D(9&GPD15V!*D_PVR;R0896Y1XIV@2G;KOOC
M2$?8#)?Z/DN"=H/SQ^E-;>3!R PXZ4#Z7M6.Q^"S3FCW[)R6'Y5GQX: D9"W
MMW)2Z\JUH%!PZ/A9Y-\DQ\0\ZBZ#=TA,S";HEL$U?UFFJ7!TJ=C@M;HU,9"S
MY@V/]X/B@]N9;&M1&>:K/C8))]F;R45_DDA/" :=I7P^P@_ELJHC&H&:Q,F#
MURC9J;-W?VL&Q+?^RZ.+6D!D%$*2QCY!?_-5L)78NJJ(+DGR"*3RPIFO/7NT
M%?WUW9G $Y!JYC-2Q&84X6^FUA^DB0'\,])X:DD7W/>UBBCZY8Q:%.LA=T$L
M?C9DZK3B0FO#9\;0$]>M.DG!,Y(MN^RN\0E\O<4=\P2#"[U[5L-:0# :AB)6
MD%Q\LL,:YB,E:M.!10310_D1Y/?D!KZ46C>]#,[1[61=>-,Y0*K(Q- Z6L/V
M4V/C7R^V=__><,HA.G+X'(/=4ABSI>G IE? R4&M82,E9JFRX$@FM][F'[=J
M*@2A<T!8"1Z" PZ\UW-$?Y=K?',9G_F 3Q!)L\!Y&HY\? Y8G$>%\3GO2W88
M<!NX=>8VUT0Z*MKD:3KG/PV^'W<!MO"W@FG,68VQ318JN7_"9F\SZ*LX@VML
M/H,R<88\57\3Y TX;OVGX\K_A[&* OP1B7F*"(=ABF"N\>P6G:^'S#=3*,UJ
M>M$3Z$=QH"&:)S^HW5J^("9_X-A)=#J8Z1=C!(ZE=5OKT6ZY3]Y3:ZMJK\AH
M\C-O:UWI,'X0\J2?V**_);[1"TP\ ?^!]Q#YVWYU;YZ.?%M(>KE\:'- 2#V%
MTTYTAY8V-4[?VKFU$JQU*AMOO)$"?CEV,Q%?,CC:#%,TB9>Q .9M](T\V7'*
MBCJ(-_D/7<TE[+.E$>$%<L/X>C5[[#'KQ+BJGQYIM,R>\B3Z\,[D.0!A:5C8
M+_[$U?A/_-?NR6QH'YAW%^EP#HA3DH_\[DR?[AD,-PJ#K2X-]S!)*'\$O""-
MB ?T<NG3L^Z\\#"]>YQM$UV5-6HPP"LA2:?+K.D?V+>?X(RX#=WV]^N0LQ$;
M$JO6D_NC/  T#)%PRX]9O1T[)EV&O1$*$D4#<0+('9>$F7- 6\GD:_[8)91:
MB&CB5PJQ@]FU?.X&O#O/9]!\$M&T_71<;)3RBK7X0H)U3BUX==X<WI.N\VFB
M3^JP=7S:E9TP' 0\W!Y5UV !5?FK_\N,@#5B7W)),QH3^E.I-I*@$7PU+6O=
M=]#'ST/XYR.;=ORO;MH?B@XWKB1<-.$7[M44V5D/$Q8J:HY/@BU6H&I220/(
MRKE,YF'$+?!U?ZRPV"?6L7[;YR;%ATDWEGTAN0)7DCWSI?9QV39)>"OH2 -R
MQW5_SWJ_IG2DF_A=,L769;#>&_^H)^KB3TK:9FU*+S;;?F8;5_#PG.BG8L2%
M0MWEY IH<#,;*F@3:IKN(,GQP0M,.QSH=QKF[F0&MJ^:0T'U#<IVS ,UXF=?
M=T&7/%%H:]9@4Z%C%:6$OP&0KU[^1YP_M8* TR5VB?BB[HEZR 0J\LZT0R&9
M"W(=\:V8"7J-!TZMYU35@7;E"8Q>:#Z"R.#4O?9:HY]#-KB&S66K]+LK$3 1
MYM'OX=>_P)KWP)$+%S%A:QV27$YGES*_']-[GM&K3>O\=+;_9*M.5B5W$1NB
M/Q>NEN/\%DOX[X\LQLWJ#8NARZLC+XW'"7V\]5;U+>NI>^27W2?B8K<6]&HW
M6,]J<7SV;0I0E]'2,]'@<P &%5E$MH#E.ZA_O3<R:!4QNPM<JT*=3"-Z(&;[
MYF_ X^YA6!(*OG/@>> )\P0A@4DE$VOC;P:O-*%F+/+OW)'473@YM'Q&?)R%
M%(>B/,C3EG<.:!GP 5)*YL%B,QDN.6LKK7Z\4;YVL@%.MC\'/!9:*C<I0TV7
M>/5)(6N:2T>:FU-TX7K@=D?]SS^"7V+U"#PIN/@13J%B.)__K '.=='-L<.B
M"N4X<L3%44U7#ZQGT;8>)![D(8L-^@>%]_T(+ _1?"$P)[S[^[/\J+#:V-)2
MM^WDT6WC*AT/!;/PVU_N)'.$YN\_9P=\]*2N :$1'V".#(R00&*,VBWHV F?
M2T1GBIHB9W4VO]3=*;&8A"IHOX?,<SZTY;TA!^1+H-U>7/(YH JYC5I$\5B>
M!NRS?64YN0SWY?IT8'#]'.!I_PFV*$.Q;@(*(TVA,$^!%TE=7NLS#B6N)?[1
MG9D"P'U1#"G2'1N]E3M?"QVY;RI^$)->3B7D5A*GA?7_Z[9I0;#%H7,(JON2
M;7N18'H5K2663#TA_] G3C>:#UX$Y%C_8@VETN1?%?&(>7?_!L_:#@4^@*!&
M3%63]I?_V2+4,)8UJ>(AX#%%S!S]%4XAT,82 .9W^2JM<$63YL95U^FB/_$S
M)]AW.&,, IN+4T6C.'$7)%G\&SM3W_MF\HZGZ577*8DAO*YHXU=OCC(IU3QE
MDEOQBMJ#N0[.ZK8"R[5"BH\'.?0*M7UT!DHS7N1;!F?M/?U,WVFH8WK]^NJT
MU@U'@0L46R:@=G8DQDKU3FO%C(U_^R*R<_ R[C76/DK5YN3)+/NO-U>YG%0N
M:)O9'J13@AT):OND^'W0SS.#2!5@\-7<K*WDP@!['S;? >:8PM96ZK%KEQ6I
M+ES^1A^UCYI1QA)Q6G@!7%:W!BYT^7(5/<BH&N_67#:ZN\?S?:&'^Y11;<C\
M&?W4[XFN-ZY318=:)%IJ-)Z!%=;JT4*U,9,;FYF;/[\N)S7HZD,[<*4?.Z ;
MKDEU%WOKK5H61I+ 6HOUP44C-/(VD"PR7W;SGA?XT"DWRS$9&"S,:7 R=!:M
M%ZR8&YJ;FS^SN^9Y&9&$7/S.5\;7!OL K(B(D^3'N(<1E(O]_1XUC7L3C?5'
MERI29Y[=='[K$*NY/NLP84;E]O(^-947'^:10<Q,2B1L,9-QP?_'@4$93MZP
M>71G=U??=^HAMQ=E8^$S0N\UQZPNP"(M /\X"A=W#B#1N7[#I6(W2+P$05SY
M/IU&N8..CQM0V[[ZI53?XKV+*\&8]X&@*E(G$/,43$&:YY0HO!-&MM2J>=N'
M]IQQGPK;RJUGPL5826;V=H+:?>4W,*TZ'( 3I;_7/"[PF:V?YX#RVO;0)7=N
M%P-G-]$OKW;$EP]+CSGN#Z9<">!0V'SV \'UQ:'%;@2XV,A+'VHTN@O1PTPN
M^;TGW/G1D%N##,J_5'.S09$VP";_Q/XW-6"(>@A5?0[8Z5\$3H4^&#IFX-;[
M(69SHR'(\E%Y%?[1^V]7=MMO7'S:G^EU>(5R(' ^[OO5W/QV'ZIHP>8.5S%/
MAH8>376"ENPAD,#BA?V*T\( T0:A30_W17]B()I#QVX:L(ILTF!-\S/N-CMF
M"D6Z=^D>D[<:#&;QV+H(K#9.L[(V#&*X)*RB3C\>0Y]M09-HX$$C*C#-[^(U
MB\\?>:NBM$:BXU^2C.15V[_X-YXI1$T$EXN&T\U=EY0MTIT(<^1_0QQSIH+[
MQ_8>LMF3+@[R'L Q3^,!K7@]?QB:_@0[ 5^.A7:)=M:D]A3+Q0M<\GD'^FUF
M'9HW(GV_1P6TMD=@S,>>C (=&4(C?HY"@/MK'R0(&DM=7S8#5=\-.C-D\!2+
ME':&]&W/:3UOGVB9WP?M7,3D_RV^FN+OCMY9>WNK'I?[8T-<%1ZEG^8RX,8T
M.Z>[>MIQVH^OR[$J(*EXWWZKEI)5SQ<'YFD2Q<L39)'[?C'53M[!#/H G7N%
MOI]FPV(9U1U]52X^-5BD0<0GDNCZT>SAJK8D5H-..XRNSFI-RPP$^O@P!K/*
M\%KEU^&HRC6&QO5BOG ^IB-P#)S!&\;J[[OO0\]@4ZW;+_HV)O/5*VGI8DKA
M;77 N\NRS?_""*3_(I%0?YL_@L#"CP82Q%'3P$ZY\NX6O'8$_N4H37WM[.H4
MQ:0X^Y=0[E7\D=JX7K)@YNTX#9#613(6W%559^W^\AP=W6[2-C;CG']HIBR]
M_0KC_\/_1U#;8]V5/1P\M IDBU<GW',/A7%!#-'P4\?L3:9V!H$_W+L?#@>E
MDH#+$W6;I$<(36^7OEB]I1EHX31\>BH04_)8MI @K8/0+(UK5V_$.R31P9AB
M\S<5BI(&<=*'#.+U),D,V"=2TA HUD*ET@E;T)]*0Q9UYJG_ST,UD4\9GGKX
MY_$LZ%A&M/F:O)NYE )K=#$N]\4\3PU'Y3MBQ$CE<3RC3B&;!G%.+;0HV%6N
MT?G%V:^EH@\;%-;]Y0Z*#HH")SE9E4VZ2T62-%.G)PD[@W/J_3VP:;X5VN,#
M I(YKN,A36C>IDE:E2W+K'LO?U_7<AE.B:EC*>_[Y:)Z>;N4-(>%B*6@P8M;
M; W-82NI/KM?;\VU^W!MN_H]K%-X/=7E>CR*Y2&650%G[RS.*2W /=R)Y7EE
M51.OEB'55<LWU)2V/PK;JWWE$-2#TN FES1.8L#][D>NLAL7Y*GGX[W.@D !
M>";2I,7D-G@?I;__.N7/O/,:D0LT^BC-V*C*]O#F-H<^!U>ET"8--5Z^?8_2
MBSM?O.A#MUG-K2P](S./6&2JM=U$:E!14RVX1^V6?_7;WU)5Z\^=H9MIL"8_
MHR2\Q*>M4D25C\$96U8]/!3.[BT9#[SB#6;W?[UMX]2P4S$WB^0:!09P7_!M
MD#--49'^9"WK:9(OI-/F,N TZ>!?GI!@%/>+K%42_ET!_A^JB,<+7*R"UV[#
M>%MN(MIA-"YWY_WEVP[=D?6A?_2,GW)0TP]G?8#\T*24^KB:\@*1#ULL0V*,
M6(F9!'X/#*HU\+UMM](*ERS7ES3)[S/:S?&8P5N?:AN*W*\+TD.5E:M*?_TR
M_[*2X*F#F*BC#+>><(X"+QJ0Z=LY0!)9OJ^BEX8X49(D&!R= X"-=9]_Y$X)
MK22^%1:UO#_J0?I(9JD41-?CGJ[=[O8^,Y"D<PWX1;4)2:(X6.]95M3F[,.4
M-__-YZ6EE R!T+^UHH[C9]D?)W:<3>3?"8<PNRN&2##QG%BD2:*NA9^:FF#L
M7L5.4SP+G]T;(3^L@+0KVLK'$!%=<M;^#C)>2QF*J%^#\Z*K8;:9M#&\<[RN
M?Z3FK%/01?U7YG*%"%;EGJO'3MB[IVPBU;(@[?SJ&= 14&8=84!,);.$<P 7
MT@7.@+NT992J>L]LW*;/<O9IB^VCM%Z[WR9L-*V*E*I;1WQ_Z\J)02@PG7O3
MU9(?>*5'=VDC&*VV4KTEJXX47)][M*[-5 _495.FF,9R:\G+)(UG+:0QA_1Z
M*-0I?2ZQVRFJR5_58SW^F];7"\N# ^%%"4H84N&B)(>+S8TQ'W&=$@GQU\?*
MN@.?+G]MZKS6%?:F5?T._Q\>Y?SMC', %0ECAL3?!4.<<*U+>H[W,5;WKF^7
M5%6!JZQ%?MU<Z,A.X'S5Q6C"][EF422[H^Y.:)SRPNKG>J-5R&]0A<[K6<'5
MZ_'%*FHICW?FS25VX#>&P>;0.13&8) >PH031<.CP/00G4+_Q)]0?J?LKF]%
MV#0OD<HN?!*SB&^22$]Q,4!QD!M%8(['<J1@NW%P#XFR23:UBYBER.KH,7?Q
M' &FY/UZJDNO[.,QW^Z\ REK?;AK0"G6GCH4.]I0J>?<[UBREQNSFK3$)OC"
M;4_9LAINB3U4\\AJYL*61*./4[J(-H/H&/E^-(]J6$ESY_APG>O)DX@,'4K&
M<GQVPUO_W]3IDX41)3O.FB7IKQ,KAXM.K'\K59W>1GOOC+L=T IEU=S[WS\C
MY W>?<?FNYXM0Q&!F N8Q&MI=Z&ZFPWS=6XF:SIL=M].LTKP\U-:*BX._OLA
M^QE.!BI*FK=@/9H@^<(79\V/Z_MO"O& ^D+3G]]--O& G_X)%CVYU'*)O/(4
M$-ISP/M[6*]]ZKC26W1^RWI:V]C??(I5U7.A<1V_1D,W65WW4DF0Y:;V+?.J
M99["7-:#<9(XXM,9C!X='$<KOB<.)2+))B^Z;.#_+\^2?M""-!$]&-V^!QOD
M@.V%@GN CWMJB2EDO04\!YS0G-6&2Z#,SP&U0.R!R&;+15CO:XP[,4(,>10(
MDL5R(-=BD">MI?F+]NG]^Y6M*YTW**TJ!))4H$314]N(PD$\B#Z;)  \RH$F
MQ26<51M@D#W$6V0=M=C,5V5 $ %.K4*$'3U675",[LGM%#5EE1&O:J^H1A[8
MJHURX@.1<BUW_*' V3T2G;TC.L-8+]X4P]>:<;>:6#)?ECSQY^GW*:4RD=G=
MVV&T9>VY]8LQJ>< <X/5PV:<-=Z>U$>B)<;*H$)/P,PRSE5)&/307I_SB7]&
M[H>2CNP38,!* -]4]1LDQMVON^ U1'!Y\/VAB]0F/3H-.W[T]6-&K5R%?)+P
M_8#+ L]0GR:66@;/ >$<N#OG@$=^:$<2DR\?P:6%A?B=P/CB;_FQOVD0"??V
M\\.]@_0H?\(8L^)UFBI'W=@6?K,'UU1F=5^G_>[E]N9!2/+<FX >ZBPR#FF3
MZ A/<'IX)QP#]A,N&.V+"W%'J][=2,V,9*I*8;R!?U#UX0?=CM.NY96H+GF]
MSL<)HE/G %L$3@38+CE[KT,*%SB(?]BNIE![=4U]XCOC[]]1CS(?OC-[D.VK
MU8?W8WI+&7,.F#$FT7[]1NK^6R=7172?NA4J,4I0PF(&<G&I?:@=.;_5(?8'
M^:]'8NNA9E[=-[W DG#F:5BK[E\W:_ 52  FI<UB(@V-H!B@G_Q ,/6QQ6KO
M$;Y"6AGY;WXI./C,_.?NI[K+(064?Y&X'-9'QG@[%/YZ,?)HRQEL!QU#\D(Y
M2 .\S.7[*1UI)1*_Q>46\Y+$L#"7)OQ#"=I9(;/@52W!-X#5#]R3W4B,Z8#2
MTAJ)5@]_NY>G:43K'$##D_^K0/O41UGS=?!GIF!J65L2G1MFJX,3UK'W#L7*
MWNZ7*8W1:I]_,E"Z4?9P[7+B8.V7K^S4C'T?/XNU/Q?YWH*AHD!6PPDL_5K$
M'* =BF\]%4P6+W&<X9'%_K[KI>5^Z(\-/HD!3S#SO;=ZT"]BA^T7/-Z^QR+^
MAK;<V#0&_\V:W,24*+=:73_V/5XU96>T!B@GNPJK A)8P4^(I20 KO'GW\J!
M],N2'*XV@D-[8M5<:444KK;?9W1>;WF(5;@K?K*UK89NO%1S4- B'WFXFQUZ
M[&0T;.-*2O'9S6KGY^![E9(*./N#%$4N%IT-QOPCICL8]S (<P[0&3T>Y+3$
M.?0>1=.MT;C[ &=]Q$03!9Y?<2Q"3"!-7 _CL8NCNX+DSFZ1!@_%F&6T'E52
MM#'ENRUD6<*?]QGD:94 +'!?,978&6*="M\YX#(X5JR%%R*,R2QM$[>QEGLA
MVX&Q2W@OV-GZ_(V:J3?]1XYWR8@*H"-XNK'M'% !WU[+Q=$9/+,?\@Z2MYS>
M8_5%W5LMO?V%NY0[68#W J$9@'B,D"%6D+BVP-=A]GP?,MDQ6VX3QSL7=G\/
MZ%YDUM[_>$L 0WGP585^C&)Q!-9J0V)=;_B\<!UGOPC_ &<L.=*KZ?_;J_".
M!F]JWV'.C)[[BSO"'&;+SC?^-%&3:/#[["1F.$X\OV/GY60;]":&VX8?,U?+
MKL1;[_!J;V?E17[/GABX;42;\VE0\;=S *L\B>9O'3]I#-^V(5YFFB"ZGQ^J
MXIY-N(_969VJ'Q4[LCZQJ*IX<B#JYJ#)=%&4@R'NEA7W<SJ^,N0'@OT^%XG.
M8)F!W7^T]<2&9AQBL'A8H)7S1%?'T;6FCPMV]YA)YDWA\P<?.\/'NX8H:O%@
MY[_W.P8$]GMHAK>$^\C7F,$(,J^B5X/(-E7FR/N%U?!R!83//[.]4OX<0P_]
MX)_?I@2*@\@&9+M:N,65Y&PR7G_]JG31O&3M(4$LAO;3M@:$D=QY,YSL,B*4
MK]J@?6_&]J>2^&1D1"C:4MQ//T1>Z7[L#<FW=*\2A%=CTX4/L$5^2W]I 7M\
M._*:C. (]#I!!A>Z%/\AI>]ES?!:N?H5)N*(G9.=GSUUNDA,2&]\ 8 ,5(M+
M6Y>]$=-%Z.:28JG964O7'19#S>]&,I8@VF]7 0"R]6WL#Y*TX3&P;>J@<T 6
M;\O%<T#HV^\39(T^?0_]9"8N\\7$[0GCG0ELGYVVA,U K6:.(U!ME3M]N3D8
MOU_#7H^36EI?-DO0D;'L-#5,?OD< E!UHER.Q\DGDIZX6YP#RML.R<;]:BOI
M?PA>) NWUF;?BAE2>V#W5^Y/IYF2S?9S.:\OS SK\'W@WZ3WXF.1V2+K/6HF
M@D+:]F$ $!/[!(_E:=1,*Y#P&N7ZP'%\XRD5'\8BQ3T*52VY/8NIP;J&8?8B
M98^"'U],M//C]9FOKH"?),A]N;H\H%9]QN&&;E;J;R_,;G_AR);(4U>E*Q"B
MT=#&[I[,WS6?YC\;8QN%JR31 ?'B_H-+#B&+P"B^JSNO9279(,)CG+AGK=>2
MS;^C6+),]$N'=2[PA HFS>+K%#CE"=P4BP/@MC?3G1C4$NMDA_FU!RJJ[JY<
MW8(3<SOF#[^J-.W#[\#P/.N4NWLT."U=#'OX]E$PLW[%B'>&FA1K24:.Z!6V
M=6 8XWU:U3"G27:\$@[9::.&XT<WNW;-<$,Y]O4+'21DZ<4I*>RV=4QN1CYO
M]5UA_JA#3?6R\?&_CAO\UW'K^8=KSRX9Z+H)[*0V7,@W_\UQJW;$ V_\:-=8
MYK4KCI.2'/S(L\SQ?7MH&W0>?I%]N7:[?TE<0N')3'(&S;CWXC<V^6M%=TT7
M#S:ME8-)64C>K=/^#DC^YM?*$M;=<2N4:BYNZQ"8UR3U6ZT^\0<S])B]_V !
M& Z_%2Q]N,T^W#]MH+;<[/N]]DJ<^KIK:&EE.PCU:I0%Q@*\24HZ+151$N8K
M0-L717[78 $QSOS??C(PMOOT\L&O5M/ Q)DRGWC6JJ]QDZLVX?IK&Q;&^<+-
M5S9-8EBGOQ?[AXO+L((7](C#PU DVFI@YZCA_8)=27UC($/N WT]5I1^S(OR
M5J.J_#K#IZC-:QN^GE96VA_;K_<K<U/86"\/QMQS%17,2VM9&*]S;M 1VHO?
MC1_#>XH>J5%B4 I+3:#R?K2+!Y2HXWR9<-9?988H29K!Z<LL;Q>%ERU,\BB/
MN<[GM0A#&B0. @.;^0R7D=%R+=?%W1PK#D[UKSN>>,":M(RW@8\/8L'F#9.(
MU*5=QU2'3<O:,AX EM4D/544O]=^#J [>,W<?K"X/&CQ>*1(<$^W%R8&:V@J
MG04!(W'+'5:3D44H=@D+'7S5,@8A3Q@YA/KJ.+&8?)S5></U\IX;A\*.X>3Z
MVD^X*:Q5F@Q9.4KYVZ;+U2.RD1*R#!%*JVT9FJ.":7I>8?)OKD*?2S4#3L?O
MXUNUB0V8_*@C%(^_H\%$5=!6L.[C\1NZ1;I%?BB>#GU*4>'=R[*$@<D9.$87
MAA-QF]S^7C"+D^Q*M )#E)O23J3?VJ6H?YH5OQ570B.0K)Z@:$^U:GD(E4'S
ME=Z):]4ZB5[2W9'8PO?O'ZLA(@X'GY,0'Z!K6K,DZA7HD*&I#$]@=Z>28%YN
MWOSL)F<P0=3#S<O]1H+P\G/:AC+TYW>7^4LL$9V<SM/P;PM_D^X)_[_,(LF'
M,9+$"?E&XZ\1%.4F$%>_+^]X7E)22SMY+Z(#KGZB_"CG&C7(?D;ABMD>@46>
M1,M./ABG7-']U]QDW7E<AA*SG4KN6"4@G=.%Y\J$J8=Z^@RU3S. ]"TB!+-]
MZJZ]#TKY44VF/ZQ<.;'E4JF;F[;]O"$F5UE9[YMJ4)C>)Q\3B"$%Y?>"\:F=
M2^,%)2F'0))6XU;%EOO7P<K.<)NVZ!,4^?^H:Q<<_1&=@2EQ37JP$E?V2<[D
MHA_Z)R _T%4;RTBKA%\=QP*I@UEYY16N&VV28W!U<'V7L,0S>'J?M;E$8E[:
M*>DYI!K?/3G3P&I=%/*3FS9N9M[MQ;/)7<26$<C*ULZS#_3BWZ9,A4X0C(GI
M362]C='/H$;#VE\X.Q;9."=SV@_\2@$Z1EW_(CK?-] /Q>Q1"3FH.?\\PB5V
MD9]]L!?=PHX9FYR!%B[N7;.R[+!SY=*MSZ[[$H^.Z67*YD4&I!PC*OZ&6B)9
M5'2^P5H5;/<=0WQB=;4R2KS[DYO+$OLSW&X?C.UX'$I .DX_OU/U2,6XXVXB
MNX&\! U<TK(;G\WD,>J:$]N,G5]0-5>]1$NOISUMB'FO:/.5G+<!!ZT[X \K
M=;\F:9(F?Y4=OHMQF$L$?<Y,:=QH^4!DO]N^6+3L_$*D"^2A(W.D:VD.B4^&
M+::=V7>%D=D")0YF'W"EIC8YL..CP96BZJ5/+Y/,G_&J4UW3*@DN)S\@3$;-
MEY#[Q-(6-:TE\K[<M&&N'44/+Y;AU;[[J8 8;JD4:]/1Y=U=IBI;]T?$_JUH
M;['20DE^*\;_Q 23,3^1$I"_^=1:P\?N#X?;KMH W9/-_AXUYX^)J#NJKK$8
MQ,[R?GY;RXUPTN227YR$!/^;?M8_"-GMJU[IUW,=-*F'2H+S[DC^DAI?=U2@
MZ6+R3JA*A+$WGTV=;BH42_!F/$$RLPO^/M:?=3YC.0<X@Z>6EQBV4W[,6N)&
M'[DJ!RUIY!XQT6SO?N 0J9#4Y)M_):?8I8BH:[F \P&^!N($'A/N8>*^YR%B
M5>1%NE5C.]JX69KO9<M)/]!AYE:\+E&LS*3:2*(U?MVB1AZ0G6MJ2N0K=/EX
MBOZHSSVN//JDC53ZGL9ZXQ1_XIL5T+)$AFIG\[:;TZB65^,K!Z:'*_LA<9Y>
M<:)P,83EAP/<>,&X4I7+[510M =H!B]S/#G8,\NAGVD<]>:=9YBVQ<#T].EL
ML#)? ;BJN\UU1QXKAS/&2V],6D!+]N\\RYS<,<,>!'S:&-*T2PWZ>E5>3+N;
MXL/%MAH*?M8V$HKON@QL:G!1(@TO1Y!(T/'137M.NM,2 AL18!)RU)P=3%-8
MC<!T5FL^I&^$T7GS $DT?/@;UOY['<F8>8@=+HPQVJ"R[C2GBHJ:43ZX?-7N
M2XP]]K:_F=($C%D6.%5$HLG()9@-+8X>_TWWP22);AX_+L)1'?P^,1!#2E$Q
ML5X3LMJYTK$L$'4ZI[IL=!78DK\#%B=.C96(6YW-7*M./H$I!R:)H07. 7X2
M&M!2EHGAC0#=T@FM/Y3"9JW7^=\QN(@>@4BTN>B=.\N@[8>8VF63!C-XGG^C
M!9X%=&"IR;Q#X^$J4/R>^(=&($"OXV/QW#'B]P^BO,! \HMP+*&I1)X-$22S
M?3Q"JE$#WOW9).[N"+6W&YW9./7^A^/H^W\0$F '2,WT1Y=23\ 9[5"IW[,&
MO/7A77S10=3OG.)8X:[M(K,C'MK#3LZ=Y*_YL[T^L(+?R35#-T[SDJ9$A$[$
M[A-<<H-#R'+M*3$#B/8E3;,%KJY65:RC&-"DZ:0VTMY.P*S+^[50I'=V*>2=
MDD-3^BC/%3:F/)$@#?G-,\FTH:,W_@$O1;MBH*/E>&J\*D&@&D>/46Z#TE<J
M?\<LI%R,#/[^Y'>!?,_]93'\%WQY:5>4Z*EOB8Y)6J&JI1^TF!C.:!@5XZNN
MP6)F_[\D']B_:?29EW>_^>=J)"BR%&73]_W$J/.TYCYB_&9*8:H)H'PK[/2/
MJ^!+G4QMC8:F(,&R;.[$!!B3#L%Y[-_\AI1PDMU,R\MWW\M[J#DX3GX2PI3^
MIJWOIGVTVQ=5PO_:\Q)=.D7BYAO &87^OW')=0IC<_AX*Y+C0:7MGQN. +AZ
MXFFJS_\74SG_M]XLI^Q48C2@ .B(S:VADN6#HWI[]C-?%A%BIGN&"<4TEW<P
M<GQRVPWR%["#<)P+LCCE/%Q?UX*.#P/M7("?)85B94KX2P#04YUC$'#)*Q7'
MQ^@)*UW5KV)'ZB[8P)V#9PCQPRKW?I.RT\C4=-7=YQP0O8U$&N#]"5,EDG1@
M8J(1([Q1O@_:C!QL=A@J-@WAT;J%3%OEM;<]"Y1>]5/N$VE)"92EN[RZV_X'
MJ[K9&:!G/IWYPP]$MD6CZ_^#\[&;KFG$DVCOV$-?P_$?R95+WI6_WK@EZ.\0
M1$FROPW>G$BG?/KZM2'16J9LUZ+?-K7TII;VKOFX3WTUZ+3E66N/^DCAL+H"
MZ_SU6>UTZ<3 LF+P==QN=VM-?493?[A5]P7X5U)+Z!RI>@"WMBP3",5;WWEU
M&%-DQ6MK< )K"CX+=OWUNG2UI<[9(4$GQRO9S^T7C).4BFE?QT</!-R3N*4?
M2S^N^D,OX/@]F$0UT:>D30K<9^Z^(F$YD+(B;EI2F8D)/=A0A*T4[BX4C.W[
MQ;I#;(/^6*E-I7Q &Q_<0<_A4[NS,ECT5$),=>]Y7T!6'S0A:%)>O'CWT]AD
MH]5<4Z07UKJ[4+)Y#/QT3ZR?-;Y#ESVV8,U(?U=O'KF5-2U^;69HU%NNH;WW
M<_RQ2VW>NJY[1!K]G1=39K&!P_GCF78_O!\^#W'+IHUBU<JUVTK5'W&(]2<)
M\C1OO0P=<!;**W;DD-GU]#;+*\_:GI?A7]WL4PX6E:A?9<OX.LQQNS2^%+B8
M"L.8Z-EBI2:8VZ$WV"U0[=$;)_TN^3Y=<=M0YY(#CZK$E.ALOB]N+V>13E >
MB-8021PG:K#/'GZL;&VK,7Z+V6)^ML;(%&BCSD/[\?*-=Q2LA%%0,[0-5DLV
M&^2+05YBD9ZSK#N="Q/ECW7C)V9TGWY*=X]IW04 %KG?4EZX2[V6;M[ZM!O%
M'GKB<FPM2#(81-BLC:TTJ8O)%DQ.\)PA#FW ?K8GFU$'>],&V%8,<"<>0_39
MHW:QL7T8UC+Z6JX[.$_Q-YM3JP(U]14:L]96!85C3H(N8T3A@^Q<"PEIR_P&
MH'J^&>NM?+UYM>__T_[D8*&_Y:MAB_DD/F)TE;D,#_?,%I)1\M;\57BCMX6%
M]*I#??<3C)E*^'-U]!N#:/+#FLC%J@DURKBM5CBU^ZMC-U>OAP7^L9=31WH]
M^F8^>HA]!6XI:K3^?.D)3VJYN4]/GBV?K0%CDZ:&,1]Q3;_ZAH;ZS_VROTIU
M[S7*Z4H))!@(I!+OA?FS^<QY!$15R1MN$H,DQ5$)J!6O4OY8Y>&VQOZB]69E
M9,\8+G??H(./LRFXT#^[DS-WHKS49>2T5MZXQOPW@)9:P_0IJ\F+?W#J4FA4
MPLR$;N\#S7I@'](A7_]NU'O6A&$!"$O.K&?BF'A)YNX+;ELQV./U5V),;3Q%
M_3#&XYS1HZ-1]$Q3.7Y@RTSTQ[7R <4Y\F$Y].O?:F=\/_86F0#5. &OD"X_
MQ*"6:B,0/L1+7?/%;A(EWZ+6=9PT+U9AM$VD"_K"J0B-)@BN>*\E,$XTO_4<
M,+V'WL%^Q0#)?'[:1_?D4%XW7RM_JO@]K/@C/X>@Z)!DW]V[UZ\X'AI%G:IH
M7;3W<>VKRMJYX\=Z.POE&^\)O[9\4\]8SZDX(VGDP+$>VDW&[&LX.KS1P#Y#
M9T/P8/2E<IXYBX*Y3,B?M:\"7.$3BIOY@'>:&L%)N?]87CMW!A</7$([VM5B
MJ[PN <C?9B8U_^@<$!18]O%6#>R#G%>FQP#TQ;"U(IQNL7P\N$1+J%$(7^&A
M)YYHZ2/5NO8L1D:1WP$1;+J-GSO+)M$RDR%8?ASY"N=& .8Z5_I[M?K*7UJT
MU)'#9SQ6;U/!0TUII1^Y?J01J+Q6MTHFPQF99!J'R5X6R+R+R_7Q[T?7C:P]
M&ETL<TUJ;.SMB-$"=+\UD:-P,/Y42;UV)EK*P<N63+$Z%=1&;SD?N-52>M:<
MME-=)95L;^&?%%7DK.,WVZ_A%O^,6 ETV;'%MN+F"_SSC0[%B]F)7#IEDO6O
MQ$TR"C>:5BIYM[O+ $&3VT1R=R_BW$M)O7+(2R19?_<.I;S87.V\MG. EKTT
ME3GGHZMTV?RW'[]K#!5NI:2"1SME,WY$B[XH1+]:YG13.*A)MYC.1QT>TRHF
M!?KD6IQX-OB!]-36SQ*Q1&*+C,&,UL\61AQL4?42OAW)0. L3WN&F(:.OMEO
M7^E,,GM3Q&W_\W2JYD"?'E*KP3J>LGITUX2-[VH)JU]1H]OFK+OO]&!4ITF'
MB8_+WHFXG#;9TG85V\B\@O8L S6U_149G45T31MP\@\__%U_,+G;/;EE?CQH
M!'+44)B^")V'M;(!'?EPAO#R&GCQ_(]S@"M!_;-K(D]1@[+G=[?$-ROQ8@%?
M5*]LJ[H>Z&(5B)F[,!>#&5 ;E.8]HWN1S:66CVS@VR-W[3)J+[J5K!9=%+#U
M>*K]V_6,;^2H,9CA26U%Y3M12V6%Y,LW(WUSM+^)_ CY2=YB6$0?Y/% @-!H
M_^)Q2K.D1NW"\2F?:YN_FG,_LT2J) B)/DTFCX/@C2_[7Y6HX3^[_5-=FD#[
M?W*J6:<T^">7\4GZ?^)23O_RSA3OL?N;=7?;L(UY6QM=K!^MMG06EWCIOAP[
M5L30<[QC(6/2)V+HD=!@_\#S_>>L[8EN]%XG(KPAHA45:3$9+JO1N1OM/;'[
M1NH&=U$,<[NP&?>1RYKK7CQ.#+A]O#;M#&22P>GC'F^DU@P3J-6>Y&?>]4R_
MZB>I OIY3,COJ)>I:.K*8R0(+T@VV:!6"*- 1)VE2IQ;\FB79&21CF\"BC"9
MJ#GX7I;A]FK)%*'"LV7@'#!)2AJ>I&,IN?)C\TV?)[UOJL_F)IM''[)#D3>B
M&9(ID@&75FND,]I*2C348.WS^3]9N:FXI57T8X.TM8]'ZD27;+;YC[D"2=,N
M2W^4GT7WM)KXR0YL\=Y.P%U'SW-;,YRD%KIPIL^D-^:X9\5%'_TXGM>]FEU<
MJR"RQ%T5UZK!^@NWMN0&?\_Z'7R41JQGI#S(@S4%!2XC1A4163T*?E*_RS_]
MM/?.>)RPWB"QL\/24#.B%9KA6'<EFT[LM:VI<3XOHF@[>:<E\O9T=>D6MH5K
M=&;SP#1*<-%/+!BPZ]I+\-LWVNK4*-DYL9A:VPT]["?M'V$WCI?*FAXN60ZR
M@*L[5P;XF0\*\)_B-7C"GB)VXZ] :/KK A[>'7 #LS=LT;KC"_<$"7ND></Y
M<P"7?^2R'%#US\_5VNSPZ7. RN1)ZC1P%2R'U6"A2+1(??UVY*5.B^DF>_W9
MY!'5RX7N):8$R\_;,KV2LZNG)CZVEA,6$%_A]S9!Y9LN)AJQOC_"#(<H="V[
M:*X_=@MC,32[_Y>VFMD4?=^[K:VE^CB0*&H4]55#M2\F=6JEIS6KMEJ5PUW=
M_M3^>!MET5%7&V0NUY-K0>9<<1]Z[V7A=/9#.U 7('[V2^XTKNRIO-7/IZ.6
MYC&/3[1X>+BNB_PLY%'_ZU$V!231J:,9XB?.W,.A-W7<%\\!G#UL5 U>M;KC
M.>MRBN< HQUB]ZG7VU(=6B#G.B)CT-^=.G6TVL=9/*<6_*<)WM==E/QG'./9
M+)]O@OV;WV-P8X#'7L/^>5_[C="/&N)0#E('#&-F\ %<P>(;R#,6O;1'V=:'
MG ;]ALQ>/Y /3K8I['H3VR UK2XPN46]_?=RYQ+.&F\SK=G"ND_U=.M5VNJP
M++>E"^,;F@Z[I?O2%$[]B&;HG<PW<<IBKXVLCLX!7]T.K=4" RJ/N!M5VE^.
M)ZZF.)[YD:I4*Z*$$"FJ;__#^[8 %]\QXQY:I9QA#!H3\RZ1&_";LU[0+U._
M<-3?>.V'(G<B&$X^Y^,)[*[J&+X9&<GW<C4M0F-?:=4:?4MKY.*[SPH^T"MR
M$SI^7* X[6;=M ^0N"=5N(TI\]P]DP15$/#<_K_:PME4QG/=)1##?"[0(6!5
M2BC0?H]";TF2<\OL3./]\P\?"2?L\=V[Z ^0$3GM];L4_=<H^ \DL8=DGM/J
MWX_-Q_N%$T0D5'@6=3BU;2ZO7#H!?<#0=X3N%G*H&7%#.J0@%]0<<9/[LYW(
M*H.X4A6=9=77>]83$I=&9:9,(Z6UM8?OFZ@GACT%#'C*XN6O8N38*5QP:29%
MYX $A,;X*3)!J]4A7<.2.="[>0HJ.4E(66(Q!%4-<""@CGU:6_,M22?.\EEJ
M;HTN?5@Y)G!_-73/5_6B-YNOX51G-?78B:S -?&F%XR^/[#YH$<O;#.-7Y%/
MG8K_L ]7=E,]6_( /^SR\MQ84O22*$KN!2UQ;+5YX$FNG8FMGZWB7,]J6K)M
M@K-0*6+1G<Q&ED\ZSP%7<?<>Q;3D+HFN;R^YA26SVA[V_?2JD+FR'23";&4J
MHIG.H],H4(I*4.9G%Q;J]H6FDBD8 .G BAELUPM:JLEVYYN%Z/$[*SWD9HL;
M82?B8WA5>C]+7&4X4PN4!V8EA6(0Z-\9&!@Z+Q1M?=/.6K*] :+D@_@RF][-
M1'4QWE>A5RUGXA@F[?@UI_**SQ.3FL317G$F/)+Y>*[Q4EF=_[ U6TOS [(M
M"NS\Z^.$_XNT?XK7FLS[IXN,MS*D_ZXDW!O4?^?2^K^D4W=)MR%JHR11"'!"
M1?Y']Q_GL_&BF5_*!2_:&;"?T1%UK+BB?2WT1#8F?NEV.3K# BCY=/AUYHP5
M0Q+&G]Q9^Y0K#&_:D!Y%:!1.='"[EUB4;4[0&WDN[O&<J=OBD9%NF_ZM],.0
M\KCV+FWO[>I31*0Y7>=BLE+"R8;[&B_2EY0"-,(T?DBFX\:PPNLM)@Y2R7-S
M87:B>VWGE;^!,5YU<'J*D$!$.9P#MB94:3N?,8YYBI[N>AC%?B7>I%'H6]\3
M^M$@ER6K?#$1U]VWO% "2A(8K51]UBOKS6*H<3/L8DU,)F#3A6L+5X7SZYO5
M>D'>G+^V. D-:6Y\C1'X;.1$=;ZF\9%TH?G#L:$)B F+C&]39K@!IIC:]U._
ME-@O3YT]'8U EHT"4?[!#!V=^3 YYY$9M@3-9\OJ]5_C6+4*93.68&Q3.,T>
MO8#;\]TTG#%-$5,PFZ05M7NXB.!E8=^>!8T?"494=]S+W??XH)EO05L+7#A@
MVKZ]AK6D;9B!18+ER5,++V"#:%%+_,&NVKZN*#KU=31Q]V:)<'ZMHSP6M'0F
MZM( YB$XRM-.-"C::U*I]G(].P?4*0<; /6KU^)V1"OOL3DH"J23]SMB#\JP
M",D.?P,S[BL\0%3?*?Z#[[.&)$=Z:Y.$EDKO#BA$L!\W]>7+'W0Z7R\=ME99
M*#E^):+KZBRQ.LNY"^PK=IY12>GV..4_5B4EU;LZ\Z0'V5H%G<AB#?,6BD]U
M3'1?UJ1E:]E1R@_>0;PX*JHRM,QU8PQUVR5/M=0_W4)J^#GR; ?969WQ+N5F
MO54D/M1,Z-D%+VAM*@>[9/@D/7PZ9-O0KX6O!^Z//NN#VSJ-[;XPJ9$?=4XI
MFYO5$V_N;"PNUV7^[)^A_U"8^]UE*L:1Y,TN2[F.*"VD[=,)<6^'WF.M67 %
MG,#.O@1J-:D9(;AQ$AX-V=H;R\ZUF!5><,RH7#S-3_ 0>OGFTC'KF2)>%M:J
M!V6 CGE93*U#A2*>3)::,&9OT6&5*SHHR^7Y),RX]YG+%S/3)Q?U6/<#D!=6
MZR;6]((43^)0"CLGEF,G&!6-Z'9\!61_^^04>%A/5#($AYP#*,@:L9"/"^FX
M?$7)/5:RND2"";AD77H.Z.B:*[A^F?/AGZZ6X8;)63X*X.+B'OU6BUY^!^PR
MRDF>2H[X4 M6/<MT2?/E*^WZE3>#OY69XP<.)0 #=R>3!'YHX1N)@^"&M7&T
M?QHU2*>6>JUV 6G)E\T"2B!P$QO5KD$@UR3#2#?\7V-W5T)X/I\ ;9N]1B_0
MU&@'+(<=';-NF>Y78XX+=!.JK, .J;#(/>,2VNC4-+T 93)C>O9_X?1M!HLD
MF.?B[FBF&4U4BP.U1W>Z[!N:ZW3];7F@CIXLWJIZ"IVU=O0YI0.THJM\,2B,
M^3D@!$ACFZ ,O&;CWW<F9R=W1O_]JSK@VI,1E@^%OZ7CYG%++?(X/)FGD' A
MR]IVE1CJB"H$U6PRE<T\8Z'-XC7_JUFL@S?>Q;<NA@X$RX%;IVND\CGU19N:
MQW&;))U,-5&UUJ<+?L')2 R0^=BK&\5( &(0[5ZNO+<GJA ,&T\S$'X%UH)-
M-](_-J:'U"TN7M570$3 7/9PDI+O6KASSAS;Z56;W(M"0@KF16>=W_ J715,
MXWYWJ74H0O;4<O_A,C :*KLU4(AK[$B=_+#W)4%P3&(!)CE-R2V"%P($@NZ!
ML^S5N-!.U<8\\H98"RT""KT.:9&/VC*QJO/I:]P]!_1"[Q20AE$U?AV(&:3)
M(<%M*9KX>$+^\,9HMII&6#D'((?F_1P%?\#%#YM=30U1@%[$$ 87:'*CT# J
MQJQ75/+G:6"2HY'5,9=[(ZWWW>J.$$-=J6V1X[@0P>Z!V[9@@O]$<TFZKTZ-
M[.QF4.IFK-R)XJJA>)2%[]NRC,,7:158UEP-UJ:7R5W2B4'D57WR[Q5Y_;?M
M M=6N?VK$=YYZL)2Y_^#+;CL-L*P:7!QZ HD6,^P-#"A44FXJT?TF(MTF1G/
M+P?/=3D'7*^.MD=!$3G^0;[7/XR7>RGP1-HS4K92"&ZW S/. 97PG\V6V,^X
M:32*:OT'ZM5DZ0CU%Z$7S@SFCL_-U1F_.70M6KZF%@ =:6 &T0LIF'CT;C0Z
M^.J<A3,G?;J9W*=+XA4*8T*]+W54[!)T!!)T$ .01[])B+!GM 8+A<C/H--F
M56:UQK"#<X"K^9)#5=P"V39ZYK*B1/>9CV[\9ROK_]^H]O\IY;X$W^'"Z#XE
M9JI);=FPCK$.3MV>=Y5:L;9$#K"\7:1,NL'M_;R]0+9]<I.=P$J'->/C;&$Z
M![29YEB<9M[!I#L\X'\P8F/N:1=-66@$Z=P:_LD12&A&K"Y(H$_M%=\7(-Y9
MM)ZJ918YGAP#B^OD/V2GVP^3<3B2S]<5WX_(GH=,/C@'1!R#MV>'ZY$^=QAV
M]JR=%%E;)W70S6XVG=FI_UM[WQG5!->E&U]45$"4*C4H($H'I9>H2!,!D0Y"
ME(X!0N\0!2E2%024EE>JU- [A!YZ[[WWDE #I%S\?MP[<V?6_;[YULSXKCO^
M>/YD/3GKK)6]GO/LG'WV?I1WI4?O$$PH];:XDX1?\JEC3*\=L=&Q*UP0/]AJ
M_1H%5>L\S,5;MO#)KFWO?9P^*Q\H5.[FUO,M9GFEJ$1E-*/L)?"-AP[J.\Q"
M>SD]RW"=[N4KHV<%3;<Z'[@2 ;)^M>2RK.EO/Z<J\+^,+E(V*CM2YC/T^;PZ
M@KCVP@6BK'#?J&PKRK!LIBVYHA?H;5".1D>-U.>U["7EHK[.R^QO^ 3)C6;P
M?,6LMFR&.[=#,N/*BMZ4PM.B3HF *IFJT\,6!Q&\QSRL?W:N"YOGZI!ZXJ6
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M<LV&[R\^S MNO6)#]^;X*JOO UIUBB=Z(3W](=4$)'M5 ,/(CRS-Z6H@#-9
M#C,I1B/FST.:UN4,)&",^2*K$Y&OMFDDQK8[\:CI>0>3A$2X*5MX%^5L#%AE
M8/M 1GBFH^=*GLW6@AY;(.?$YSOOLK-) 0  R42N[CZ_0[QVEY!3R_",NORX
M,YB38+GISLPL6,*NP *B'SYW0\;6(_^=P]__N_%7&3;_;_9UHG*NC4!\C.&1
M.[;M-#;.IA"KVW+]6/3)O0Z4);\3)])>4&V9F2+OG:PF.$>[D3  O%""G)";
MI\N:]]'0EAVJLTWJF2J-Z?!?[I#],!>QT24UVH$)NHX2JY?4('"X^.]OKQT=
M%J_YP"YA>(ML&K3CT,MIHW$PO=UUER&<=DI9W1UW4BVL_F*X9E/5<&7I\$.O
MP+**R+)YW#.O'')!F0;26I/1/?PSQP^)=W-'PEVM"/F9+T78,DF=AP>--,<#
M:.@FA-U)LA"RF-56LV(^2&I1.W<4PEY! S9]*(N7K85L5(#\G'SOMOJH<&=V
M$8:2/_GMWG?>,RCO?[ JGA,F7,?:Z ,5SNJHZ](IBMZF'>U>B].)B&OU!16B
MS4AZ[D+B&)1NX%!31("S%^'1:"0VLY5^1J"&:D9Y+W,J7%R)X'^:#)%<6%#)
MFE%F28M2X.U"<7[<4,[0/48%$BB7F;E4=54F3>)'TF*GA^AJ<JJQ<%T()TX#
M-7-_)5%53)ZP29[\97"V![H-:G#6'?ZBF?(Q\Q/W?0N9 %OK*JK)-RM-[6.N
MM*<')N,GSFF?U57[)M9RVK]$#E;K# GFU;S1>/)CZ_Z0[E.3S[WW1<]_38W;
M_^AMO%('\YMW;];D^6@NZ/C0S<!.+$M.$;0Z8/+[1( N#Z4%0]XS;@_J^ZJI
ME\'7I[BFQX@ .8((V;K;S<- ]7J+JF?</E$\$\4Q[O&@FERDAFI^4;RI)H[G
M1.N,JK:PH]_H<6DP$= I3@3L?E8<OT,$)&N<GTAW(DU8QY;72!P6JC[;,B:S
MJY^M)--#'RL64MHXKEOSPETEF-8R,B+E*Z,)^HL;C_)#0GS;R2:*Z00HGLUZ
M/@5GBKP%7G\"]TA6[],)H'V6J,&?]HV<3G"2<KHU9S?B[=M[.6S_?+UZ]MO3
MX,+R$_5=I@#6Y ,Q<X=T-Y.X8!&6[J7;<XY+K'7#<7*BB]%#_:^*8J9[OK9V
MM(0+J%2-BDAY,3%YA79VMNM<8?-[P%'<ULR=\J/=@N,=8"D:7 -&/R<"QK)G
MCP3Q25M; FSET%N;'>6G^ Y$%R<[CPT3%\^UI$1FNIEZBF$,#'<#=40#OH4-
MKQ-V3^DV&WSH84!)\9A;E*M:,ZB:L,D+%A8 S]B![H<KXPT0K=)/%@0@FF?"
M_L<FNR"Q?N^JDU.@3^,)F$.V7.,M <@YNWKB>2ZJX*_ U[]:^?ZG*NM/>'\\
M%U<U_&?P L(O#A5_*3?:/:BI8*LVD).AIHC!9&S#6#I**H97XK:\K]DFX78I
MNB=Q5#?JRJ*Q?X[$ 4DE8I81=V[2_'I@#2#@G%B8*39\WCV? VU7*Q;M9O5#
M_R%/=-LU13+R(,['9XB8-2W=+@UTSH5FZ<=J[B$S'538 8/N''WY;7I.KW*?
M$M7BG0)?;E-'W@AW3^?:M$6TZ$&(US[?A+I97ET>AS=T$?EQU%? TD]F9,+7
M/=AG7:BO$F\O?KHHTMDO#WN]Q"P39_;UWO*)$:=:HB<_HMJK[+1LTG+?UR79
M=-_[56%EN.++M*JZT")#CBI.,UJ3IN=1^#IPC**.B&AH)LJ'QR/\&!8T4JY!
M)W+M3^Z(=ZX(3YK='&G]H;+@D(Y&*9IF2*^KC*JJ/&U_8<^O#JC_ SG1_K_-
MHGYQT4V,!T*FM'H-F><4%V?K83\@YNO?IW5:EP'-F$!NC/YY>)SMTOM2MY^%
M9M%63[?,MP%6&%MX9H-S+D%O(R;RG)E8R@UVTJD<3&VK;[U4F!4YT2*57BYX
M(N*A^!Y'G>/]#!/Q;1Y_K=5616^$_^5 SP@O-%GWMK:"/2E7%MN%=C;RT5VW
MK4MG=.O 0H'Z:J,_ADTJ,)?3RW:-AVAVQ.*D' (X_KCS.$:^OKX=]$ (Q-3*
MK%!4(\ G=C:^#N3?\TV20GX[8&#5PL0@0'Y2)R<P(TH#-.7[A_  PK4!G-1W
M?53FVBE?D8'^Y'=.D_#+@/8EO/K=TK449/(RU]UE+M?>P46:F/,LD);]E]_'
M_$^\[_G?0&$#YEBX%N#O2Z$4FV4.X+73X9SQZ0:VMBBQ6Z GDOY#-ZXLZ;30
M:D2'?4E-??)%4\=R__C,Q[<EOGQ+'M.SV51.X> S?X:V*^%3>TJR788S-V3V
M*(PNK4>)OP:8(R@1:_Y'*'QT#>C,S/O&4 U['HI9C#_#5N#%S<"XYU4D2S'*
M#!/J'1M"E63D?H^!?D#6.A)LPA$$FYJ%E6NI\K(^K?N*%6\/7!%6:T\QN8R=
M(@\\];MPD7+M.N6"U8H[S%R?<,I$!'C A/%>H+N17<53W^<V]IOF8F>,P4N.
M@FHC SG?)SJ-Z.#>Y4?S<;O.;]8@\5FY"(-6^TULI 88<E4?+B,^S2)"RY+7
M,=U8=+L-E*YLQ"7XGUT=_,]"1[0R^R/2B>'D\4DDHE0U;X/P0K#5UR[,1R:'
ML3!+-G@B4?(\L\3_;#'P -8@UML"NV& ,\#DP7&:DC+U/I=;M=G/U#9$+[X2
MW"4W>WW=#5ET8T84FO"BLZ"H1=>3+T[GE'.3"+AX4" N^36[(UQF=JXZ^?#\
M _OS!>T%ZI%7FS!BK1/ZD:T30Q(#>?RZ*_TVTX^G7N [/UZ0Z.T*?H)+3Z,]
M3J?1W0^TC=?M$A(^7[0NB6HM+NIG5XX\OX;!QGXM:QLD_?3?<K&A7R^^_[.=
MP]_VMP_$T: (5U<S"5-@\H6*P?A9-<QN4*I3FG'%M;AG'A#]28:]L:4LPF4)
MY@>!IXXAF_6+.:\W4=1!KE]<"=6R&>)A,I('T]S9Z_"NW; :EFQO&8S.]^^;
MKF*,QHBTGJ-1U_*K94H<FH$O06TR$%&D%?+GB"ST\S8B ") 41XNS02!4C:K
MLE(@KI#=&IW7:%:;EEXFN=(]].8JB36X5491K:+_\.HV__9*:57IY^_Q#)_2
M/E4E"A<ER_UQA6WO"F(MF67AFD0^TT23,B)$!GXB&WGX'%?\L)/[=?:>BEXM
M'(:505E/A%KOVQEKX9</\P.OCJQP.DOHY!ODKE=%6^]A]ME]EA%IF5)6O7?2
M!+(E)>_''I.YW'"6BLDZ[',*^"]^D_%W8;G)B!RG[XS$O]F 5:N-B$ +$7%
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M+G1=^AS\QHRU9"O<(WTCWCN#+$>EPH!A>\I%5P&0Q?I!^QK^7%'](L\E1_@
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MY^M-&)A G@W,FYF9-_-PL''P_,,?^GM@ZZ8-]UC*F!AV 8Q;&9BV,M"K  @
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M];2$8%QT8(A#F0I7IMW.:S.1)] !FE8; EN)&)6V4 1X#+37V_^!QCM"![9
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M%QLUDQY!_8JF\B9<E0XD"N)HC!)T0/CE_\Z(!9N%FR-"CK3 -'Y%LU8LGU5
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M=G$OA;4L;5935XTFKL$8(HDJU+SQ[WCR^GLWZ>Y,*+:>1J2YXQ6GL)")(3H
MAL]J-%?BG6LLU"HZT&,[H[G=.9P.O$.0O1HD7Z"?<.'^'>\5_2ZMM'+1F X\
M?$$'J.UTH'DWB@MU@QJ#'K)#TP%WZ/QFQS$O5]KQ7'_$BJXF+!@]=,Z<UDL'
M6A\N:/,8P J1M_Z\;X5\ 4-T2O131UJY"6YE#UIA8O[M(IC<1KEF(#Y)D>G
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MX#!+(I*V&9=F5E#Q%'&\+O1<3N>56'SO?6'I:GYCL0DA%(6Q"-+]P2*[31.
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M]^12U9?OT8#.;9H*J0"_ ZLWLCB_CVO1^;.2MU"B$N9QR30=,*&V8+M*/4(
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MF=IBCJ0 ES@!W@$T']0F01;B50$1(#E7F92Q$$/Z3Z::IKK_Q-REO,/F4'Y
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MH5V9H>MF]:]3"5,K4OC H6!&;;R?H(X&K^*F8.C]<3 EV5P0B!B%@A/IOX(
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M^KB9+;H9V"S! HAN?K]#])8V',T5!'7@.*JCN?O."<+37%D($A)H>T&S[:T
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M5O%1L3-"4:_,O%8OZ5QT,+*<U(%ZV6&-H;Q@>I[.M#Y=[8^VP%4N^K78H U
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M*#SJ-/QZ4:#T^4= =8*%NL36P;@\3Q^^?(QVVA#N(,:.IX'V$45,??P;T9+
MA^?80D-%6X^6UA"!*D\"2KM(MS'MY'.#ZR*+A=&&PPL+?6-F[IMK+#T!%X:H
MW:;+]K:E<O3KNN?S%L#D4&'OB,DP+\+ 9.4#\^T9]4+=1?F;-R0^5B]Q:8NF
M0ZDQIE-A3CJHB,=0C5QP2+;ILX9S*0S&]\L@[:=N6P>2([BQH;X&Z<L#Z /L
MK%.SKW,PP:0DT6KJ0U79O?KHK'N#$=>JR&0+C I0'>/])2C+J9,E4Q$,K%[2
MM7IZ(VT<;P:.13F^?W3G<'+)(\XR>LEQRS,50ZMI!]LYNKMG9O4]-VS'!MZH
MOY%:6)]D,&]V\02O-NV5(YVF;9YP%R6JFBNRY>>KW%T\+'$F):ML-@6?GV/-
MA)5!%AFHR76LKM[_C+=^[O7,SMRIVG.>05/IY@]E^;_'=8(#?%DOLU=22U_7
MV]<'JKC.9QY2PV4UX:BSK0@"Z+3D*5HC0G^_A%IQC\ C'B4SA3Z4!B4%@7_4
MK])CNUW@2KNG?L 8!;KPUD75EKP:4%0N$X%!PQ\Y#Q(D4#031%=G,*%G6;1,
M=9NO7AU0D[Z8=;=DN!,ES"\G5&DME/1FBM+U[5!%F>R)8=CM&%(N(XM\('!F
MRVXEOLU61[0Z#IH'C5.FMF17Q2T-V:Z>*0LXY_=;/,\I72Z3EKK>8_U57KUR
M[/.DTHA%9(SN;$$8KXT35\-LL;J[H_AHN\<[A!;Z;HXM*JO:?'/I.EHO('#T
MY'UY"YF3L@[1&LBK6\+6#%D59_F%'SD^OE6FKE[N0LK#!86;6RXSON,W-[AU
M]=BK!*N2G!1/JZ*RM6D%M&)37:W'@_R\3WMXU/J*[11KG%/C.C@V V=M'.!-
M*4>)^AP\-=N;F]!>]G".=M!I&7S+YB..'$U9-W0CU0F!"51?4:\7IX%!\OPB
M$=<NZCA%/*(D'^N7X4%[7D&_R(NW]3,2J..2V'ASI)2<)[(Q49HLN.9>XLDP
M\9:B5SDI-B4[IIA*I=A9YFNN%^XO:5VU4[VR]W8/N::.TCLI<QTUVE$O5>]1
MP30P))>9,9.01>7*9*P\!=]8,9#[\*8IU1!62S<1EYZ@U9?0WE?$%[1Q5M5S
M3<910<:A9NOAP!O(1N,E#)_\BZW8]C*G&;WA+:$6#QH/-]'7J(Z:'HB;!OQF
M'VO[P);8QMK91U?GHIBW.4;P/KG7+O(6T0B6Y/ U6!VNRG%;8[:S19BYWD<]
MXYNL##@\I*';[!S2W5J87K13-.B;;C-45)7L-&%'855\J.,WI6#/UTH)-JI.
MD0>B-HZS<N]0ICH3 3H96Y[0AW:W5CMU%N.ALZ.+(S?N7%J5+>5"B=9A/.OO
M&M/@7":Q7E[3[X-NEF+-<VK"1LQNM7^F(.]H!],KV4+9"A,7I^I'.2$<H\,Z
ME1NVT0J!E_WJQ61W"(%E:(R'=<#5<!:]H\+]ZXXE8B4%B[AL1W-,?,2QJ\^L
M;=PS%-6O7$9>?%$V>'9T+E53B1&=/A3PMSR%_@\9HXLX@<\B4-G V"LH4^?+
M:$?AEFXV&0)3Q2E<;\TI;G$";R3;#5RW9BO?!P,Y:<.BB7";1_7"2L<;5>=5
M :WX/P=!NO/X%"(P_6K)>/M(%1'H$MU--TZ%?W_FE\M .&BLM0LZ^QIVG,-7
MB4'["USB']FWTP"N@RPK4K="Y%H4:Y331!><GI,YX'!G_DVTVD/IDM+YZ0<C
MALPI&1_-)4[O]86TZ>UHWM$O;PU)\CEXXFI'X5$?,[36@S<M.]1Y6?&!1>^L
MNX;/;FVU3>HKG_%]=,Z*0E6*=QJ7XEN=Z:QI[AGP^4ZT@3J_%6O+&HM7GP6W
M8*?KN_DD!26&V__(>U_DGM7(=1$]6+D@(=AZ<VA#\-NM:!?< -]E)^6\"'4B
MH!Z'OSP1BPOF_=IGCPB\K3[_)AAW$^_\M[;KL'M19>*5A60>"7>X\=__Y#?9
M.+2N:N0)28?H0VW/'#H_FJFAN)DQ_^;U\-W[[V\LT$1SOP3F<\D^T@BWR05?
MH/E;2>#[]K8;:F^';E"?H!Q"!'9N$P'Y%U6Q0>!I&Y4Y$M<%,Y@$@I(H<F4,
M?P%TAQ0HL'$8^E^R4P.')E:%5,))]B.7&;V(P!N;C1M(=? #$F4\4@-X/P1R
M\[JWU<""P07<D:JL=3EU*0*W[->SO ]R]O^,+B[_K#7Z[4%F1>LW'D'00%L2
M5)QA2]VD&G<6=@UB3@3.!"._-B%9N$2*RT@&L.&_^H;U#^L[ZZV0^^'"<NI$
MQRY+URZ)"?Y=[W.D_[INAW4C E=5^DAASWO6F^+?X[I]#RQ"RK#_P_C2B%CC
M"0<O]WMN=A2\\H)<C8S:/.%JY/$8-\(INTDX_@@3>(< (EQ$7IEXI<0B8LU;
MH-GWJ'L>6F5W-56MIE9@H8M#2\D#\>U=#1"J%<9 2M%O?B "2!+[:)=M8^-:
M6,<\$1A7QW60+_:1Y(K_M)[)UP>;>$&X0!)\LA,1@$T0@4G2-X'ZF'32OAW0
M@2<"I)TZ)&4)H[&+!^&H8"^]])#KX ^)?P5*9R\8%1$ D[9.7\$-NBQM@LJ.
M< LI\_T#\-]R&H&8 ,]MPE!G"?>VK$DQGS#KKL6XB/P!/JQ. $<RHN0K<P0B
M\/5!;-<6C@='B"!0(#_)Y1CO@KYT\+ZIU/X..,8<&0S;/&] !,8P,$R9'/(Q
M$8"3E%,=NQO41RI=N+!Q,W>T,TD0OX=.!&A*T!J$ &HXEI00?ATZ.H"";^R!
M,<>)P*6](M@TS$DF,WC+^#L,X!\$O$<X08"1XML!XUG0700N8M7RN:91L@M6
M"'?C?8E[.NIUO8/@J*F,C%/$6D\R_J7W>8,KT4T3?"_"JLWMY#@42 +]D5.!
M7X?3K!_!?V=*?S;5NO]<2\W2)[3!CJ_.QC-#^>S7K[A^K(*"+\SAD:9_H(SV
M?67\NX6-')[E ?1%OH\KQK4EU ZGOV3,U45+$@&[SS^2*_P3D+MO;G]7WQ_S
M;@,?W_S\6XD<8VFPD&N@<*T[#C3T!SB?,R[Z;^MCWKIST/\_E#\2\5,RN6^D
M?Z.17LO'QQ/.+EXN&(;<G;QS=T@U\5A'NN#='\GXI;G\!:RT_MM6*.H3X$'X
MI,5KQ+"! >36Y'DMLX.AJ%<68N0I>U&&<[CS< Y89SD8CP_Y^O1]%GQBX4Z3
M)4/FO?N+2K>NH@U:<#W=BWOP3@+[_?/CZV5Y]6T*96%#UWD>Z2QEU&@:KGW[
M]RD$!HT(\+PAG$!H^/H2>AHT^'EL%RV(.TA2V!Y\.Y&2\/7V"DGS]G>T'R /
M01_L(!Z4,33.,#FIS*I$2LRM>087$($C/$WPS8L=)(W>_]J.A=#>2 0ZGL+&
M!7'^6 URDE8F_J05"5Z^2B(0<&*J8X_)DB36?-C7)@U/T7-X:A*0L<](3":X
M(!^Y,6F,H28"IPD]U20P&!C)@MJ/!*_!)G[#;! "!HG VK+QUT?<;Z#N)+4N
MDXK!;4$";\3RLAT.$TOX^CL/N! %WB" OOJSL-^;\C&,IIP,27.N,"R6Z4\]
M);X5 E::E0C(G24"/LAUNA49.AS)3KYJ=?Q=[LZW M+<Y_6/>2TLPPA/J5_@
M5"N\D.*>\-"D&?0),K5O'/N\?N6UM S#,^7)YQ;O=>#!I'%%HPYF#C2:KH@"
M-XG3O\W'>%M\+4W%Y+Z6IIKXUV&D $FBM]IXE_+W\:=0V_,'G#_(T-(4-E>/
M1#$1%/#IOB0XJ#\%VE>,C*-$X#OY?B?$/\>]2)C5.&P.!R9M")8'E=R0WXOW
M>QENNXH3H.I$@ PV#1J"@'9)NR%IYXK[B\'V?V;USG\TJYE%R!HXBV&;R*7Y
MVS*1K]\+QH%:2%39?.[ZGZ X./]'"^S?E56M5=#[$EP8"?IJ.L%7P '^'0F5
MX&UOE/*'<>1) Y4<JS63C3>%]P;U[:DO>B^(;K*!_1HT/V7<2+W C<BZ+ABP
M"Y*LUUD^^S"W\$)?:$)QL!KRJ3M<^>LIAR0&\DN><NP/G/T6^_[ V>"?K\7_
M_L#9/UP_WXS$_8&S^P-G]P?.[@^<W1\X^W<(IOL#9W]</]]XQ/V!L_L#9W^A
M#H7[ V=_AWM_X.S/&%'W!\[^47KS\XU(W!\XJ[D_</87N?NZ/W#V_V'>'SC[
M4T;3_8&S_]/ZV7Z-WA\X^W]CZO[ V?T#OOT#OOT#OOT#OOT#OK^(>?^ [V<,
MIOL'?+_"#]+[!WS[!WR_Q@$?'2\^A3T%XYXM=5G;\"(F\+8?74P_4AQ6[$*W
M2_CZ"J*-(+JG\./+>M6).Z]92@RUIZ&)SF.%0<E.6,N;1 "^!,?BQJ94MMM)
M01<\ -[9139F=!D[M7(TM3O)S72LO%8DP')A:QNP,-"P5!".E!,2@;%9(L"2
MKL26O\S6\>'_!T>%WY-2>-6 ,-@+GMO[^AY#'-.%+W@'Z]CJP!/LT)G.FJT<
M-9^PL>#?$2\">[@(VL!_?7>2@+-^S>#8E/=/(^3%L [RGK^GO4KR<V3C,QNF
MQ4N"N:2"(S>'('HC6-+TLR3<<>[W@"-^1]7M-^$ZVT<MOWSX'=R4WY-T9S[E
MA:Q_W,[%WS/XX/<D]4F=GXDPF?5JA7_+X>_%\Y,3$FD]T*+&5 (D(BM)8GWV
MD^GW)R4$/C30X,\Z'%:7O*$/;L_4_+6Y^2<1TBV6 YVB];2O&[U+ I+QBW/S
MKR1$WU!O%Z(_'+!W=6Q*_6<1R, [C,J="CN:A>F1=C7MY@U6@@>XTIW1(_TQ
M>%J[!SD"P[-L89J"1U=5U'+ GB#\&<LE(Q;/P8;?B, <*3_H3G(&#;G!-W;
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M4*/3(M#4=6)2!'^/DCW#R1?!YA3.W(RGUP^?]J.[PE=K!WZPQFI]4GCP"PY
MB_3'*'<V4^?SSM<=5%TOHW>XZ5U+H$=K^T&9)@W!]7JBA*?6>Y&)C6,W;T7X
M^<B1S8%X-[[,^HA!+;&&.@MR?+TX\0G!0Y"0IOC<6&']T;"+?17OS.[R+D5F
MU_L=QI9.^5GOU,*&2I0P85-,J,",9.M$6O0-JH@;?3%6D0%?6JB 0.!$H&:D
MQ&9*@W'ACE_%B<F$,6J(IU(?5'>2,6ZZ/ ]5G'AN^()DY >*1W9KC%^<:FK:
MY2 87_2YC4G*%754[)U2E%'1>/F[M9P<UR77-IJ2RPF^'REH?-B#IN1!=I#6
M1CTPJ7*A'5T:VEJTVC.,MWMAV;QH#Y!'UT<";-$V<Y[&PW5J9:;OB$#MP4D7
M5'RIRL!O9%&2C3ITSV!C[MO9'9CSRJDR56PH\: 7EH$]6GVZZ;SVZ29:I_;<
MWTX-RV8MRO+5E3T*F<#:'NUN9RY,\'2P84^K-EWW6QE2N7)YH-]'3@7_8@L/
M;C N2F^0-;[Z0;]-;+M?;665GIZ=!?)$0B8B>;9R:8IGA7H"X4]K;ND=JU>,
MA)4LQU], ,4YG1<H%),BBY1?53U-[A]!@8\5H::C]NX?8]Q\S3OX<'-)YUPX
MM7/[YX&58Y$IL@%.++!Z66,-?)[<:8S?6(T4/,)NL^<<W,K6HLDEFH_?VX15
M'PBXUT/0N[PFS]&:3AA\(67QP?3>%((<$C&!8^I^6(+LR_DL#UFLSXSJM23+
M3[07LAFM4$0H3JS1+GKT!O<,?QY2A[0>.^7RV\4KV]-'=OFF8NOM6'$6&)L,
MC)&&[^C9@OB)E.C1=7FS=6X5VE(Z?A>R6(2RZ#+'J?Q^YXY![D&,WZB-H=%P
M[0!]!VW37OTP>6;@SM!)'XE6Q'!!G2-$6ZFR&RJ=82-%2)_-Z[35$<E3#F^N
M4K[I\/JM#YG$DJ^?UQ'L=B1J+HA NX"D+\+:M)T9PC$$J;O0.J\'FJ_WFAWP
M5I:48)Z>K"@@4"V-C_ V3=@2@:>F1;>SQ\;4; 5Z !TE9L-W5?[<,8L.B?[L
M$2LP5% ]F '*FF*(T3T^I]=I5S7,'OJ8S+YTFK;)RN1*))UFU!;0EH]'V"67
MY2488[0FV\@5*J,EIOIF?0IM*GRRJS-]J+@P3[F21&\3CI!*8VZ.,4*=&*E*
MNZB7CUK;_M1=)& ]7 >B+^1;(X,D7LD7&ONM=O +2M*$Y5)3VD0A#+*52010
M-^UV3V\3@>U3):1TSK'SH+[Q,+DJ:BS0.8ROSINIO\+I7&S:4%J*V]O:ZT4%
MAY\)Q0&27&SH\,&E"$,,#[JG#LE>(2V7GGPJ*;ZO7MM5_"I%\;*CM@0W?34;
MO2?'XV/:WE00TC8$JT70Z,QO:WX>EGTL?C0_W.SYU%TWT]Y\GHQM=@"12 0L
MAIDKP%A#W+WN[&<*)G?5'I^_E!37%4AI(M-(OB3/D4.*9):/*X31'35RK'TR
M/$<S)@4TF9;U>O1K.RQH0I,H[U5 J^'/PHNZH0Z8)E.4>(W-I#1>;NI60&Y*
M(;V^4-8CDR9)V;RT"M;MQT0@IATC2P0,2/&\^ZE-"FG_\X<U4Y+XSVM#$D)>
M^ A"ZK;;NS9';JPWU7*<[(=Z/ 1/;:]=?8)_0:<Y>_#A%.4KV\USY6.^8X64
M@03I^0$F*7""^;O!2$&1UFSWSKD4&ON/]O9U/9%TC%DHC=HA[<=RC)C[3:KO
M@QL'LT^_[K_\*5K&NGW9XP7WEN@&//#A)$H#Q\"EE4?:?/KUVOQ;G2CD*;[T
M+PD?EYV.<.M[1[Y\];^3Q)]L.I3VZ%BA71,>-FY6Q92'VH:_;;-UL_C4ZD43
M5F#1=[.<^^8A6N@)8SW,U/9CDJ6H%0[*:$W8'1\UT*TV>1IC9L.Q?)++O+J#
MJQ3'-[NAQ]%?2=4>DW%XPU!0)*>/H_A(^EFIJ-!>LQ4+(G"BU?N"=^\H/Z9D
MXFZGJ"<MRU!SFEKKYQK>YN?MAXR4 :<%N,<"[![$-&9*=%B*3\1#9CD@\"I<
MB#-JWEX5=UT#33=.Y[\U%B@.HI=CMHX5]W")/+=SO4(24COE3N&C]8R^X8:C
M)&4:Q&ZP9++Q.<JI:8=E-M_6W<52X/&+!'Y-%OE/Z#P)"\V(R)TUW181FYF^
M#)-[EIDS1?'>#]XNWFZXG7A&>]CHA:QT/1$HH0PO-#YN/01ET0@R8E7_D-/U
MMOA5_AW'I%?7)*LW$908.)KO#B9_LAFJD%5C9>?.K78LO$5,M?9=]41<N'=:
M90N[W;8#QC^W4%Q*XPE4VATF+;VH?>NY(E>^Y$/UTYHQ P_(D:<0ES$DQ[TQ
M-0X/3GJOG_+.BJDK;CEW\$K!>0DS$_!31TDV>H6I2#Y!'2G1YQ)=SHNB?7KX
MY=7.?&.=C.O-O;-A>[+E')7HVY-B"*RH#H:K=I02>S&!=<'!6NKQ[)"DWM[=
M^^F>]#>$PEHB[:L/ (QUA/[14SW9./?DQ2'1X,&(8U;V8\V6!P"9V?M41RCO
MLGHZ.GKVE4>$@F@)9R$V=0Y0I6X7(K R<FC0]N2<$J38J+Z4S&Q4@6)+HLF1
MV9+QR\+H^7PT1ZHGNK5!S_HSQDGQJ?,:]8-<!9NG,:YU/:\NFT8>/:J!*Y@+
MC$X\>C.+U_:ZTP7PG"TVPVUM.CRN=)(A*76U7!3?6[*)OV%L$ 6V #^>NN+[
MW)L+DDMV+ED(#K]>*'G@DN?E:8<Q!P*CZ(:MU\$,W %T>OV*IHS*).PXQNTW
M-.63CQ\*NK=LIAA[%R%*JK6O:&R/I'#3'#@(B0V&"F9@!.N9AL[E/^SW>/XJ
MT: SGY(2\#L\[G?X='A2\/;[W>Z=Z/CG*MDY.U;3Q2JO@T,WH<5^7;":#<^X
M.YI*GBK_D)\D?XJJFX)IH-.JV&GDR\<S);XL:MR/@I/,XG?M)BEB">>+[)A'
M8H-'UY>'/E>/U1TA[YC;6T7H8I+?:4RN>-15#ST,N#:M\:X%OMYR[",EJ1P8
MDRN*PEZQ0ED9T78^7#$]IE\#CF4YVL)U6GO4[+(.;Z\=[BKRL2@I0L=C8^-V
M=^B;I]YIS\#*4S!MPZA@F.>Z[ NZK6-$H S\'+J$PDZ,OD:S&J'5%V/%HXIR
M/O+VKR85;\=(EUSH& 'E>#':$=Z =U36$:S=WLR8C=J]%UER05D+=[O&KL^"
MXS[$/1-FI+S,YC75LX$0YZGW9-%Y4IN9+NFX7C*]-;_'D>82N+V5U_.:Z=8K
M]P_1 Y"%/A<I.!7N9"<.E*N0.3AB??S+%6;>#EZ&W6<9'P]+GQA]A],O2[@U
M(",P$253O*WWND;<XARO(0.B&0Z%=V<\0!ZO4)P8.ZF'@36*16:4F^09#:.H
M>(Y QOT@R\KNN>F3(+^+4"U\G&>:H8IYME6,>W_W52K%CV?UV=^GY"_TQ/?$
M5[)Y20T&W+!);^4;>;B\N<*S_J4CELY8,$OE8MJ4U<4'>ATNGXK6&.>W); K
M1X8G(NHCJ'/]9_5U%C]M[XA9W'5^:,M:=?^&MSV,+L=Y[$2%KDMZG6W2 V0%
M^E FM/1*XCW%.E4OZ7'LB:%\45GPG>ZU-^B(L-QE5ZO+EPKS>Q17W%E]6YU*
M7WEL4H:RI$[@;PD>*<&=K3H7[(DXMM16W*I1' '-8&+^[1:$ (*:N+2Y>(H:
M=M=K[!3XE7B[CQ0B^I3%'+T*)?I4@K3L-XF "U7Y]G1 ]*,1ME07QC%]CK!Q
M)-401K!N>\^VI%U[-OZA$W_0VF5"HL^1D=S;M<AC#V4TWVFD)>BW"=X)@#:^
M[^5<G^9K.FWYQ7/#T!":>%%T2D_C.%RZ;RQG#V[J_X+CSIF\'$<!QC+])$TE
MQD;7O_GV_R_PRT\HIG(2Q(#1KBXI0_AOJN(4<_1E'HHLD)_@UV^**[Q D6<0
M23GM :(*V29TKDR)><!]933-)T]+]MQE_OQH\\LG1 36$J/=)W*3L@5>H.$C
MHSU)!$(3SV%:)U<X<3*BJM=87!.DHB[V'T[^*'&:WR%SVK<T7P)P@J-/J*'!
MRW-8Q470B<*P0QOUHW1HBC,"MU@9:07*\PV_ !JC2B;U@!LCM[W-4MEY\EE_
MK"O$^$[H,,:MEH-_P,7/-?<U>W#6(=F761] /J)]A.Z>,8C_MBZ:O7[H8;]>
M0'^"K4@93$B-/.Z,16BD)*\C59/U=LMY\A:8N:>[+<P22=$@8D<38N88?>$6
M&#*7C#C?R_\(-C'!8MXQ.(,%;U_&;]<5$&2GV3U<$%D/DNABP'8"<HM[V F[
MP9RTTN',YO*6T&*A>XT.F^#GGH(KG*A<NU!C*E$8W>#[M/3U$=U'I_FNGVK)
MX$FZ]\%IV-53.UU3'L2!$\7G3F-N3[#2'8:JH-R>+&^-<)S-"U?7UW)PS']'
MM3/H;9OD*'ZH<7GC;A4'Q*D!7*C=M *>#'KBS(J@A:@K1+1V\Z_YZJ:[\&L6
M1]*-WI\I,]=2>'C"V( $_!S4NV<U%_P0]OA$@ZU(Y%N'1U%<9Y5Y(E_![QGK
M=BD!C.B!E:*CZ:FXNQCM26E#%JQ68?>LN%#.*_[I7:<&SFL^]JIL%E4-;WSD
M=(E X#P1R#2<1&!WB,#G'N2#L8.8F,FC$:BUR3$_Y_+T@4VMH)M2(ET1,K43
M%D=N9YAS62E$*[(YSRU>)6E*&C0\4'MEZ+R+QA%,6IW!>>J%+(OHXYAI+J9;
M=;(M&=L("XP*FO(F)FY"NQ^!NPR;D!\09*],2XT2R?-)->>]8TNC3N.TXQ03
MO_(NB2[ FQ8G#WIO&5;AD *51VUG6_8)4FR7-;Q&Q%_L%9ZBB"H56PYUXZ:_
M4"6'UG[JS4?HA!^6T1+WWP+181XN=@XOI.T)7;2XDR@>K4MO>1\WQ?[D[NG$
M,5=->8Z#6 LHJ,^;#RI<$EN'JFPO?S/B]9X:TL[QH"7J3#K6V,5GT77<4<DA
MD15?RE/5N5*HC:)\8E=U9E?]6,^]$FJ:]U.LS>V;MY15!YNN[2"RSR?1A<',
MV9D:].Q6)-$GC9F&L_5F&N%S(T5E\+-F+U3-/J<G5S^TUQB122R"39Z+F80-
M=FP']<KQ6+'0SCVM $T>_DWOK1@OB[[;_?)2 %X17/,$6.55'1\8<+Y)V4:Y
MO8RJRCA5@EI[+*.;NT2Q8B@ES7B7QO.RMB,8L/D,-7=SS\$Q#CQZ)+(K@L5V
MT'5PQWNRK]%$/*QOB#QT-:8D76+!L(B!; .^S&0E"Z^^H_[$S+<]W;'&[,K;
MB)A$[^<CT(>802>4D>WQ==@1:[V=H-6*/B2RY]!V/E_!/;Y0^F%XEN#(DE&J
M$@"]C)Z:?!ZTXI(Z;W0"XS4AH*W9]V+7PE9ON\LTO%M&*.]B:M[;]R]XR&?8
M;UQ> )6<#'&A7)Y)U5$^BTP<N%D0-OT;?UOQ!8;\I@R"RR:>@:P#*ATV@8%-
M/',Q<^D1T'H>>/C,V8]GJIPPITR=Z%82T*Y6 C/A3"6V[X7H<^(XN2@KO?1)
M1,2AL1IEI?A\ KT&8V'WE:B&LM]"GS,G7G'T"B"5TC4*R&G_89+I6HP1 :56
MXVO:'? 2IL=;B%-0QO!6A6X[T83>/I.7PSK5/6IY_#[%?121U'3M/A)@"N\!
M[3$J'.@MQ',2[+\5E:5H>7RA)-[@/&KQTD-C 5^+FZR/A$MDZ0!<40I6""/>
MP"&'J9NT"QT5Z$[O[-\3MDW5^7( D1=P?5B5DIJ%EQ3L"NCY%D!D@VWI&%!=
M<<EE$7%ZJWZT.FNHD%!]DO_JX9RA_W<*MAXQ!":HM1<1 9.L-?P)XWB7/=T?
MK^E>G= 8U]HRCEK7'4!S?AW[Z=6\X?MW/R1AN'EPY(12!9HCWS35JA/_AK#M
M7%(29&^X+GU0\\5IFFA)[B/SHAJ/$\6Z$/'M:[4>G[2!E2/%0A)V.[H*-%+K
M5 L&#:^G][R^B-\M4+-UHLZ.ND[-"/G,%GA+DN+8J^"M+-#0\&0:_+[ [?K1
M!YH!+SPEN"-AU7&2."<#B:#@ZUZ&2@BQ@>FX+O7/A?@LJUV=K;5##]S@!V#F
M,!;UR4)"6Z_,;V=+"GIRP?T6JM#4@Y[BH_>E>4/WM#^-,F+L)F%L5GO/5WW?
M?%E$635>=A1@D$[##]O[K#Y<MBL[>KE#\R:FJ6F4$^/[CGKMF/6.5$YM*.?K
MJCL<P2E'4N8/JH]'/.4XA['S$A@+W H)X[62/_[DB5G,J<9-$ZW\F%#_4+C>
M=') _;V)6V^L^A*01L8WL"[B&7K/U:X(B![.<M_;%L$)H&XW$B[V)_7P5XAF
M*/&''YLM*X*\>>SPPLT$ -CV]LB-6K'VD/!:0]-:(\:B#_KE.8>Z&GJ.ZNHI
MT&N9+A5?(N7E#[3)LKW[00Q%6<K%,?5KMB<NW!5S[:R=DZW+?$0YK^0NVE!?
M<KM99%VF1[4A48VY0)A#C7M+]%+=?9O[G$_J!QV-6L0]*EEM4WN29O2>2]U*
M55Z+'[#[N$HX KWP 5,TI>K<.=NC5FQ<N*A=[U.\O;03KD$6H0!'R-LD8P;1
M]^N:."YW%^:<.5N$$@P:$7#&JM8<1F>0S7#U^4S)C!^=G@OM))RW&65%R>5/
M&(H]L!49T:T;56.3U^#U.53'8_B2,F([H7?@K"%8^_4UQ1SM!PN,0]B2N9YF
MCSA/G=KH=-I1DBUORL7B,PNOV]S!)Q?J%LX_NJB$.PD;C)%/?9[7M'II\V%)
ML=.8:)OWX$!Q+)Q=E+'8W"VP>_1"RRL"ZIR]5^US4( 3!PC_MHH;8JP0HMQ3
MH>G ^/C"3/U[108$R[:6VY5JLNI3X\X-[B-;6XVI[J(C7]8-#:_-JEG$M9;G
M2_+7KZO)+D50^N8H.^.S[J8S,=HL>5IO]M@6B=??O] ;^D'07;I\<Q.+>T+R
MRYT(D7_$DVR^/AE.(G"FZC5AB0C,#R#X$'=00;C@/3<L@@BD&"%/HDT)OSDC
MEY9AFT_A.1A+4AH9#-]:-=Z[0^M!2@YC-!:2_M+KB+]BD;=L:?CM!0P\=1&X
M7]<PH'>GY+WP^^':&K^8UZF/_4_#KH[+7<2 [J)R8TSEDB<3VCPD+<_G?0FJ
M97^[ROKVD:=VMTO$I :5E9Q@<>"8=B'6X#+X9<BLU+W\T!G599O%/$G"F3 /
MQWKI6BDKYM'^]_W-!)YF"S;I0$10!IN(NZ6 R[,<U]7-<F/?F/$QNE$(CTIE
M[%TT;7_1,6/PIP]W\2V\T?*ME\%!Z5>[\]!-045\#K)51??14V"1Q;=>"J?#
M*Y?,DU6>U'_,8;W8G2UT>,'?0&NNQIC2R.!4@NJQ:,>[I]XJ@7T>TM4QSC3F
MLIZ0[&ULN:J1?<=VQPK#43@_F9<7($-S?[),K84(P"HQKY@B1/E@3T''*Z33
MYF\)C.=[;8PHM9P?37TB6TT]T#NN77;R"!4/X"+Z?((('+'B8"QYX)QU.+NK
M"BVO+MX7KH:[KM=7^+$H1VRVT36*LU21]>6K+%M9>5'(%T-^E??):J(WXM]7
M(;1=QW:]N4WL7?)&AX]I96B]6UUYTZ5[ULL;YCO[8M%;$#*P0KN!T5"*/18Q
M45[*CJ\FZ!#0&3*ZW*Y@M@H^!T@K8XIN,YL=SQ%N_/C2TL9IG)+'N:#D08S=
MU9*>;$[ZH=I2K44O-9X///'^]4:,W5!=Z^*]HF=N49Q?RI_>O;U<[0<F-[S\
M*4.Y,MHZ.#0I>N1<CO>7MD7"5+2NN>Z]W=S7EN?;2@H<K-[MS*@K[;SB2&OV
M1!,!92P7%<N !JSHY>[0X4A@=-<,U^#Q_#[$LL9#T'\J2B2!HDC(:Z?9S2[K
M,@_'"-^C"ISKF==N-T00K8??I>UXE'C:V&(+NJOO9=Z;NJ5EVR8I*5*LK::W
M9VR[7$2J:BIZ>OXC[NG\_=<?#!3L[O@AB= ^ CN R,1%1+<CG]+)OPGF6]5X
M]2^_6/6WKF\OFK4L?1=-&RIT2"IF%]S#_NGFM_<I(O!Q,AWO&4MX3FX4?!XQ
MW;/WX)_1>.-_O3OLSWO]CYKW^G-D _^P]=U-X+JE;\U[SXB-Y*TY(#@ANB-V
MTFZ7H9\(E, VWWJ13%=[U7+\AY^C?XD7T.YV*[0VHFL^1>J>D+>)D[9"VQ*3
M3]6E\T/(Y-FB-9@9=V=(>41'(VB3UP:&N9A !)XB>KYMS(-(;A5^.A/YC.NH
M3?FJ.^03A4/T+<>BB!8ZS%UO$J_)M_5)I:[S&.XZ")6-NT<$KJ25$ &_!20F
M'F_\IA*QE8O [1F[DX+$_;K=L2_>-V&U!>@@_)'X,0)U&A&8)'E6@.44W1ZC
M*!+'1/+]^H%%/ ,LQP4VUXVMPYX$M1.FUOT)C/!0\/P=DD90AN)$X(0*C@_,
M#.O,R"$"XV5VA'-([?D4O$T6$9"+'05]SB.X[8">_4 .>$(74T<(N&Y'! [V
MP-"B>T@ET)*A\>YF%8K0$+2!+,4E?4]+UP_"Z=L[3P3T%HE 1^I.T#8_^#6^
M:8;R.VHBOI>,-Z)+96] F^ E6 '.OX=;6P6?_XX8D>^D8K/E'0SN+T-N+'A-
MX$/HYF .NPK?TY+RO52,LS8U"45]1 "NOD:WK .3QD8T+\BQ08H9!'D"MMXJ
M]"5HO"0C N'=B#H8DVIR;.U0#Q]-((MS/0CGBKPE\\?OHB/^2X$0V'^I3YL(
M[.OOGZ>_O\[+OM/1]RYF%8631AMDSR<R][-'3CQ_>);;RUL/?_^;SDC?:FR#
M=5]C_TJ-_:^<ZII=D#>?[EVNB3 3U3I.VL<?P(%#7[7\^SX1WXF_<5_\O]R>
MU',.XS99[C(B&"CZ<D#BRQXT"38ONM?P^QY6WSDS$X$QG92T_W]I_>]><_ON
M^:O9Q^N@B;'@589"(^9^;F#\6=XS(K!<2 1^D/BK;[HE_=)Z1EQ#(7RAZG2!
MRUPQ=4.94EDS>BTW5=;8-H>-WSAK?W10YD3+'9&0"HE2OJJMMQQ?,NFE<;27
M"&@[.#;T[ R'A"4F%*YA0  IDSDQ*;@'6,,QE#Q_4A"GW!E2X7DH@PCX.)*$
MO;/%N.NVEZ!"@($_P.+VQ/=6] E0P4I2.$71??<MB8UO8!G#-%7^[U^^A.7V
M(>=JL6.[?Q5.!EA&(6QN QN[&_2W(X2GU$HM7;O/<O&-.?E9N>9S$YC[;XG
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M#_#@&-\V[64PN]>1@^1$]=+NG0\M9D>%,8'7KW\9ZF>@$W #_(T$?OT,+T0
M*>/<%(G3MT$=? XG(4)7\(?E4]9T*9)_>B\3?T6-W7+_DW:[52A[3<6Q<PYB
M1E)<@EA/*9QZ.B:D/@VL^5C3./(1+-F:D*W5:5ZQ\-J$!\ (($$KC2IL[>RU
MO!2F9!__<AN,7:59[1=W%Q<7FOX-ODB1UHD@J;H7J1&,4 L?PCUR*)M]2G7/
MQ[\[DT8&.P4- 1)1I\60VQ5D>T+O>M_H9;NZJ\L*C7'R@V&7@PO2E4Y_GX]4
M/U9]X=K),%'W'VV^?HSTC;E%&0/Q4Z06MC5$9NH.)P[#\D2<E7_0-^7ZA=!V
M7I!-^LN @>^$O"?+$QIRL7:.7*')IDU?W5P:6@N939IY-9YPLM^:WT9%:D26
MMMD=?2..!^'M,,_?MEC<W$:]P?;USM'O&YB/2D_.>E;T>_]LIO-W<,0XSMF9
M$$)B<8?%U'OET$8H)U_%>KW;?5/=VOBS\L_[9Q)% >$Q*4$EP!IW^!NP*XCZ
MK>X.CC8;?$COWX*\GK_*'@?;"_&2:YPU%I(&-P<VMH"+-/$/G! QRR1'5/)*
M?,\J(7N-_!<8*SUI./DBW^M3'.>3"8G[=S-R?HJN(_9TSD5J-'Z6D:D^6'!K
M:FU*FEG4./BN?,_!?U"-\63A2&=6P9 E$.N&))T:KUM_P^=\^>IQ;)WF8,94
M]X6ML?$-J_JCE;1<#;DB$]3W%3ZB8I\>F*5-S._[=HB9(H=9*UULE/Y62;3R
M?QL;[S?&,)4Q\*VO)D60Q]7&6(NAZ=-#/VW!*EDDLQ>GV>=[J?1<#YD!#$^3
M,O\=5TBL@U!9V./$%WML1"],>J3/>7@R1+=S,)R5;^)<KQ8#@T]PL^0=RY2,
M03HW6THGA;VM-LX;UK,D.AUTVIQO85=O[K+=S)61P'LH2AICF#RP%OR 6H (
M$.T:S:9E%.S P#D#R=G9U)8PYY3;!07[?K<THA$/B1;X8HO3VHYZM3 "O_U4
MZ1@*MSQ1%Z'AE]''74'S)K+R=4E4<X*3R6>&A3?6R.._/G 2%]D37UV37^/H
M"6:%Z,ADB162H\C%A5;:D>?B3&0%;M&*"!_<.1A%&9I/03P(R9C^[J9#B6H9
M[9FVA46SJE7907^!I^]TFE[PI!(/G[QD!/PU3SI1>H#_"?L.PZDOHUF(5KM'
MX NA-2,/FR9\I/E<TERLKTP&^P\8A^^O**N%.-;U][)8];X8C5MBTO!-@UB0
MWKB/L*16#&0&B^SB^1F^6OM\D:/!':ED?_S$8>@6Q/++LY=W^;4RLTJTUC;.
MRBN5J(='&A+!R^I*2!7SW;3%$!,_73ZL<^I^8[-Z*X#!<^<_Y#C;D"NPS@C5
ME>R:#-;WU9XMX".O@8T7@Y9JPQBM7XP%*^[]4W]G,QR@75"N29QX2S,!G8AI
MC.4S$'V9$%WZ>5!T9P-0 JR\#D^"/7%D_K5(1/8MW:QO[\A'WHJ;J-)8O/$L
M7TXR_YV?TDW)L!6*[4QZCY%%#ZCN&'>Q B(W<=A:".RD@'15ZG*\ZW=Y]6UH
MP#TA#9W5G:CAF(E(C=Y2A!AQF"3;L;.)L2)&X9$]X=.QNYF$]K6V/Y6)3I+<
M(4-?+IR/6WORL$)==O03V8!X"@/OO.I@DW]&8H57H)#G!H'DUI']A(\W"DXG
M1%'A>!9 !+<.Q(B@MUP%HJ,P;X(Y( HUGD<4I5J2X/#N>ZGM@<:/YE\P4P5<
MB^*TI&:&.\,1-U9&4_G<D!VO9(EH2]-2+^7RQF]62!.U!-XKCA5J19T<J$C5
MKL\H_A47Z?=*[]60OK^!MZ3]6WT"4XXK%3#@[^#N10O#>'-BXHKF,\)Z4@<,
M_*Y)T:J?7ID3U-IIKO?\YAD J('[MT;C2E[QO03K%ED>AME?"ELWG-R5@=1
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MNBJZ7KQ'AB,T'^L82V$-E;"(N$IZ9*98#F/B>I&R>T4)^ Z0L#O7)>(^<G&
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MZ>:OZ@B=?YW.L#F@M&!NZO53!@IUXW4!_<)#+9?BZ,+9C*#0#;[C! H+V9S
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M^,=\ L'D'AZCC1_M]),:35:HIMC^&GK5VM^J[%@<IK8LV$^Q22')X*0( 6>
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M7<;JI!6O:RY;A1@/)F[''\FW!?/TC>*+[T,S;KK=;4_J[[&5&FSYYA5MI33
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MKAF\&_@87S;V![N*,/Z_"0!02P,$%     @ QX!85"W8@VI4Y $  _P3 !4
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MZTZ['K5.:BK'86>E#R1J&KM*@X[6@+R [G6-YD"I/@.U\J"C/5#J@TKH#QH
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M)WB&!WCZ<Z+G"1H$YX$91,K<"=(2UM9&[/8?"G8EN<WX?T.L+&<!Z(X^<BZ
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M-7S*%YFX8+WO]?T@2D@80%EP!R*7AS )?!=2ZL1IC @/7*.*&;TEF1HY-HJ
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M+0K@^Q:''V9@#<6F5)PJ\%VC83%)Y55FT6Y^R[@JC)L:\RK3LY=5\SI2]%M
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M&3C08MFB0]4"JG:]KI<(-*YKU@)T>_Y;&\_L89C>?\WO'_.5K")^+Z:3R^S
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MGL!L/(3EU9(U_5ROJ/B3^A0W\6.;:HT^(V+SF<*01P@B#V-(?,Z@[R 2AF'
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M2>Q0G\ H]03_4$Q@[%%/_#-R0DH09J%61\:S(TV-=FIA@906_B[%!:V\=:T
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MMJ2#Q)@:6U5;%KJW97G8;44-=Y7#9D9SY^@<;]>[P^N;DYN[HMH9KH3:X<U
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MG,9A'"0A3 (?0^31#.),1)#SR&-IE,4)QD9!'",K,#4.;F0%M;"@D1:4XLY
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MG^[X6G4WG<=!@GD:$.AQ2J5]%B4P$T01I,=H$(;(\[2X<7S1I\:J98*NJMC
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M1WM0JS\[N'#76+3!8*(OBL&ASD1?F)&.B*;WXIB=/+W![/6>8XTISWBG8F^
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MT!,9@2CC/LQ2@6&2Q#R*,)?&JF]"A</$F!H57EW_W]]OOMW<W]Q^^0:NOGP
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M3(J?/,X@TYM,R)*H2',N5)%QI^NC,QV-C=&-CU*3[6*38-_Q_N<<I)8W.3T
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M!!$3.:0%BR%33% NLEA*)Y?%D[V,C9RV0H)*2L?KR9- 6MY27@M/:'OC )D
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MB!?\=F06&M3 M-:*#RKY;\!& ["K MCH<',YXXN[K]05$/;K0.4CR+!>55=
M=>1J=4U;'OY77R5;K.?B\;MN]$6N5U->WBV6+XNZB\9A/161WL:)&"+&,XB*
ME&JS+HZ@*/(<:[[+LYQ8NV39]#@V@FMD=G!%LL*UF\R"H!68N1IQP:Z\8$?@
MRX[]GE Z.'KU#>E OE_70^OF$>8"4Z>3F%5#P_F-N>BUYTKF]&*X/*6WJX]2
MMTAG)M1LK0?P=>_A29HD$8^2#*:<$H@RA"#!B$*5Q&D69RE2S"G50 \RC8W.
M&V%!V4H+]!@ZEM+H8ZCLC-F!!R#P"F&?IY2N0#M0&ZT.7WJC/*66< ^>IO22
M7*/+4FH)I$^24MNF_9CZ?FX21.A&C7?Q_?S+<L%E64Z*C B5)@@F<6(RO&,!
M:812F##!59%)253FYLIQNJ/Q>6X8\4S$_4LMH!N9GD'3CA^O1R@PY6T$O $M
M2HV0-V:'WP&6,WEU8]$K'YWI:E"*Z5;WD#4N/.U'!'>FT.%R-64S^5ZR-L0[
MYA@)JCBDQ%1ZX(I"1F@"!4$BR5*"*'&Z_CC9R]C,JATA@9'2C0-. VE' 5?#
M$Y@!#I$)$-_>"4&O$_]T3X/.^TYE#Z=]]\.>-Z%M*H^=JI/EYA__<ZKMCB7_
M_MIX]?"TX#++,,PD3_663&20)I2:L"&18(Q5X<8&3KV/C25V,NYL)*W<Q3_?
M_LW3G<IM-"SO0T-A'/I*]"IXW6]!?6#J]R+428)A[T)]P#FZ#O5JQ(_6]G)G
M3HA*A(AQ"M,H)Q EJ8 ,B1RJ/$MXQ'-&L'1)Y+#7NA,M#9"VX?,F*[$;]^Q#
M%J,TQ4@RJ)B2$)$TAT649Y"Q/,TB@=.$.]6+](=LH-CUZR&SHV-O( +3[7'.
MX],9C?ICW)-(],JH^ST,RI@GE3MDQ-,/O7VPZ%UU1?NDWVE_]SJAF$:T0!@B
ME!<02<P@E1$V]6HTLT:Q%(F3Z1=8WK%1S%9$H+^@<BHV'@_*V#D_S!+X=A&D
MIP;<CLY&-(R!"?)4%.G-]6&D.Q_&1NMQQI%V#,]H(TE/R?RGC27M&("0T:1=
MW?JM59NT]9_T3D!^G3Y]7SVH7\M:F E2 I,(YS#'VF1'3&2P$"J%*DFCE# N
M1.%4HZ2SM[&M$Y5X)L?ONI1U8@$ =ZJ(S(P*CG<2W6CK'1$K!!>09%PO[BQ)
M(8L8@QBEF<PC0B,<N5WT](;W,/<]7Q]^]<K@T VKW>K9&U2!U[YM@9-*4+WL
M&5'A0D$M;+W6];=F68'2ZXK3W>.@ZX65\H=L;_>29YZH.INP7AD>5M_E\LNB
M7"WE:EH?WU394+\L9E/^.E&YR&22I9!4-\8IBB"ITOIC@67!(F*9[LZUX[$Q
M>)M^N<DIZ,@JUG#;$4P($ -S38N?L9@KH<&^U'7JY1M0"PY^:_X;)-N]*WS]
MYKFR[7S8'%B.D!SEQW)]_[J<RIL4*%N.7&BSV)2:58OE[W0IRHG"-!98()A@
M&9DR)!*RG!001XCA@FFKL\!.D3#V?8^-O,PIX(ZUJ<4%?%=>ORS -H-@QV>!
MH U,:2=21=WL%(TSHH,[*YB],P4[ !8D:[!-_V^20=@!F'/9A%V:\(AL>?Q]
M\?A]L2[U@O@PEX8B&Y<2Q!,5:=5ABH6)X&,8%B22D.9YK!07.656)<0[>QD;
M0^G>XLH$< B\.(M@-^GTADM@>M$B@E9&H(6LX/$)4#F+DT-02A]X#12(XHF;
M6_3))3PZ(T[.OCQ<E,DE^?<B2RX^[.N:6*[,:>2"3TU%CK]/5]\__#%=/2S;
M(,-M^<N'Y5=IJACQU7JIB;@Q)G=*SL4Y50D5,(E-RB<N$:0QSR%7B1)899EF
M3C=_QKY$&QO1?GA^F2U>I:DCMGQNLV;Z;6I['#\[,_%M1B4PS5=*@:U6X'>M
M%C!Z 5/QKPVUWBE!K/]Y7[EA=LW]H]^SVV=OX@WL*]HWK,<.IKWWX+U[/ZBY
M=#_7G*=[-").XB@IF$IR/<(LA0@G A94_Y0+HC?KBJ,T*QPW[!W=C8V86]D
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M[F:TK",88I9E!4(((I0PB(A@D(I8P9QF44*R1!8X<J*/KM[&QB ;"4$EHE>
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MSSWEZ="UF#\]RN6S2<WY5[I:+ZN001/#_5K[EJDOR^F<3U_H['[^#TF7CQI
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MQ?YQ7,@L90BJ--.&G$@P9&F1P*Q(F& 8Y3ARJIQP.,38/!9&PDZJ0:].#&\
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M6GU4KPL$!2:E5KJJ(JS#MMH::0M7A5?TAHVL>-TNS?RY):@MLG>!D'5P681
M>""GA3>DW1P7KHB==%U8/VPXYX6K?J_<%\XW]^Q+^BJMM?5I3PN5)3$1!41Y
M1"$B*H(DDUROHH2S/*<)QZE3V] WAQF;^V"7TUT5Y5;SY<^R+NJVW/YF;A1P
M-"Z/@&QG2UX.76">/LB$;V7TV*SR) 9^>TF^/=2PK1Y/JGO0B?'TU0/'K[5N
MUCH$YFJS?ERNJO#/)%4)*82"@IC\]"C6E,)9 IDV$R/,J,B04Q<8[Q*.C8VT
M6D_+!2C72_[?8%4G<-0-!69EN:FR,G^;+>J^]^7?!HI6.SJ]=F3VKI,6F <]
MQ)P=1)#M%!U!]-BY.1A'@-A1*?]GQ("= ]E;F-?9@?HM'#=*2;[>M@.^I[],
M^6?C35WPV7Q62?>VS#>_N"R-PZ*U>:7^,!?K*<(9SQ&F4'!3N5DR 3%!$4Q8
MR@K$8TR)4VRS=PG'MG#48H(U_=7VIV^LV'HIX1V-W%8-_W-KMVJ\ZXP%7C6V
MNK7=XHW3M2I^_UJ_VAO;%+\ OS7Z_&WR]G*R^_PGH-'9WP(2;#J\+B#^I1QT
M 0D&\OX"$FZ@?@N(2576-SU>+<1'^4/.E\_F-6Y>_+OE?,9?IBS-44HS!?,T
MK6K[84BRB,$<4T%BK) 0A<N28#'FV$B^%1EHF4%':#=&MP';CJ,]0QB8=;?H
MT=?HM02K6;,2&?S5_#=(6K$#9EZIT6;<0<G. 8A]^G*YU5N,U_5R4<Y$Y799
M+DS_DK(^=HNG>91SF>8<)EF"(>),,Y.*]/HL4IYF&94IB2\,W#HZ^-@HZDX_
MZ%$O&N!Y->.O^F$8&[15Y^(0K>.38<=<H2 .3&%O!U.]DAQT1 \:#'46K] 1
M3L<%>.^PI;/06,0BG7]&/V:[6RU_S$K]S$_+U<>FN-M54]MMBBE-4Q7E$"%!
M#9-ED.6H@!%.&$99A",J7)CLU&"C8ZY65A]U[TZB;$=1OK +3$FM2&;K*F<_
M3,#<ZV)WV^VK*?NQ*NG\N-O:F99L,/)*0R<'')1V;%3?IQFK>WJ>*9M\4;-1
M7,E'/=W;K:4>2<X>%M<;S5T+_E(1&>65NW(AJK_-:^>E^*]-N:Y\EU)_?V9+
M>F?J?^K?K.N*#56UF.6=WI0NUE.5*(1-NZ DCQ1$*5>0I9JWF)0JBPO!"NIT
ML#2L^&.CONM'XSD"LXKZC+Z -PJ#]4Y'0+=*NIZ%#_MR6)ZQCW;*0Y_=5Q4-
M7FG>^B'K]FP3T&  6A! !X5J^]S! >R F !606'<EF8WO:I_WX'#E,FO ?$8
M*/ N$^DW &%8%88-;'B7Z3D(F'@?*7HV-%TNQ<_9?-XM_H)9*@1*,>0JSB J
M2 9I0B,HA"J$7@4S6C@Y&=X88VS+4BNB;4T5:RSM%H@+$0K,XJ[@N/?//*Z^
MW]:9;XPS;-?,XXH>-,P\<6G?DX_NF<NM^G.QVB8A[4Y9RIM??+X1L\7#U5-E
MK=_)U9K.%OH?[I<WO^B3"1LUISARO5DMRNZ[GM.4X8)CF)!<FA8A"-((,XB%
M$CG'$5&IX[%)6(''1D*O]34.S3_U6U4I4YW.M@I?1%+!WP+;\YSQS&WPPZ##
M:=TI^VIF38>21F'0: QV*AN+ME6Z/L>OU0[&RT--DN?3I\!"#WQT-<P4')Y[
M#31NSR96=+8RI<AE)T'V#TG+S4J*6Y-<JXUL+<0'6L[*/Q=+9J);C=7\>?&\
M6;_6[</+MMM6U62UZ3D<YRK*$U) CD4"$<D*2 F*(:4BD0)%*8F=W#[!)1[;
M:F84KDK^2Q.5NI6X:5_<KWET^&FW6[U&-9F!EZ\+Y]&]9]90V/KMK!5<ZF'[
M;PTU"0==N@8;N-_"<[^JA'GY;F)==]T0$"]BE<H$QAE7$-$"0Y(S 7.BUQ J
MI"+(:>OS]C!CH_C[;S=7W__\]I_@^_WM]?]UH_(C0-KQ[^7P!";-5D!020C^
M"A+?=1H%K_1V9*A!.>FTNOM$<N;J7G5DN7FFIII=-D.=W3#%$N6%DOK+QR9@
M-,D)Q!@54"J.8LFYRF.K'((SXXSM^V\E-<=Y="MKDS+FGCUV#N73W. 1N\#D
ML(7M\Z*3@05<RL*?@\JIS*P/R 8J)7#_:%ZVW5NWUG]?[(IV'KR#FX6H2JK+
MJMS OWFK1GL.LC,%:8_>/F1-VG,Z[)6E/7MY/X.J6^%J(2JV?ES.]?UE72A\
M&A=YQE,3@D\+O1$O,(94Y1CF/!-)3"*E>#)=FT8S=J;5N0&=2'8[;,!7ONJA
M,^]4IC.GXF5'[O___\-)7/P?("OYW<RPL_#;&60^00W,OE_VD+PYC9JS568+
MA5?[[.R@@UIJMA#LVVS6]X7+':T.[W<G\.54,:$2P7(H$U.O)*4",BP)C&0F
M<XSB3$1.A^%]A!B;W5?)YS^W\P![.^X)C6A@/K+/T*RCJ3I:O%/RY3$P!\^O
M/!!D="F4QZ#JDR5Y]%G]V+#J3T;Y^C]FZ\=K_4P][&KG,*N"E-;3*$8LRQ""
M@A "$8D(I'F40HSR7- \)IE=3P"70<?&=JW,71O,C?RLH.9%E,4Y95"JJ#!U
M"")(-;P0)Y*B0@F%<NI69M4WV,/46/VN=Q=KJ"?V"3PW89UZ:\?W)\'1SK6:
M KOUQC>L@=>7[>O[4\L+6H$GNY.<21-[ZW$5<8'(ZZIA-?"@JX0+%/NK@M.]
M/;??LBRE?%WC:SM$6^SKXT::-C2?]/HTS;&*F1!(TU3!]8I ]6*@)P.JK,BP
M4KF,,NZR(K@*,+;50>N>.VZY72&WW(('!#+TEKP271NX^Z7^.ARU7@(FJ_*@
M37,IHX/'77M/]/SNXEV%&'97WQ.B@UU^W^<$*C58'BMAU?0CO/FE-UFS4I:?
M%WJ[-5N*_Y"SA\>U%%?:(*(/LOW]G4E#GQ8$H33&"*)(QA EIE5NCCDL,D%8
MEN.48:>^W\.*/S9V;64%C;"@E194XDZV?Q?5<9-8SN=T50+];M4G +[K%OI]
M5^R(?;QO0.!EP:;B87FFY.&VD>X6!'-L5,,P 6=>KP&+(@:9PV$K)OI585SE
M%(-,CW.MQ3!2].X><[2 >!L=7-6XIWF2"J$0Q(5I*YGJ-XL0Q2!!N4IS162>
MR[9/P[W]NF@[OA6?O>[7<#_ PK;-Y;!OVN",O-WRXA7(T;1NV.+KIZ% 7[!\
M=Y2Q&WSHEC).D+S14\;M_AZA6]]-W*@47Y:+!_UQ/WV4;%W]TVP]^U=%LG>K
MY<.*/DUI3'(LB( QYPE$"B>0QCR#),J*E$M>8)I9!W+9CCHVH[N1&\RUX+4C
M5FC1)Z!\)3QXKJ5W"%BRGH;3S!4,W-#V;(.KD1D:H<''"M?7<H.[<+@ZA(6%
MP'>@(#%/.+O%A+GB=3)"S/IAP\6+N>KW*GK,^>9+G-F50^FC+/EJ5IG%]R8_
M8$H41[@PW698%D.$<0IQ+"0LHB+7?V$%QDYEOD^,-38^;]VKC5.U(R[XJQ+8
M,0OK%,PNONJ+P1O(+=T#MY[^YY.(!' UOSW>.WB53RK^M@/Y]"T](\2>GN?+
M%RF_R]4/O45^>T.^2W_]I+5I]]2WJHI7:W;BTRR6>6Q::J.<"\TY:0XQB3!,
MLP0K:NB'.@5.>)-L;.1TOVLC %:2SJOH[4X[@64M-I"MH]<Q[LS;C-HQV[O,
MTX!^V#=; &R]IDO5.%PGW;(&'J/3?*/K-V3-FW3#QK'Y!O4@N,W[ 'U=EJO9
M#VJB[+[,%O+S6CZ5TPB+@A<JT:\WU[8A*@J]X4<4DIQ2*9$BD7+J1/C&&&-C
MW)V(X"\C)*BD=+0!W\+2UM]X$4+!78MNX/3P(!Y5W[.S\'"<@?V"1Q4]= $>
MO_2RHOH=^_!J(:JL\5MU9[K=-5Z(7>9QGG.4%3&"*.8%1*H@$$<JAHDJ>)RA
MC*F<]"FM;R_"V(CBPY_?/W^]^?Z]7PE]!^CMB",LH(%Y95M.O[N+-.E'E?S&
M<.IJ$"AAO#^"00KL.XCQ+F7VW6$Z5FR_QY-ZFCBS\GE9TOGOJ^7F^?.B*<ZD
M_]7$3\\6&RF:N*OEXK,>>O$PTYOF^JQE2E&N\@BED"5,0I3%"N("2UA0EDL>
M2\DCIXK\%\@R-B;<R0=H<\"XD(Z]D"Z9&DO+:AC 0UM@C1:@4F,"MHJ KB9@
MJXJY8CL[M38>K;7+(?5KU5T@S[#6W^7 '5B)'A[9TRU(5Z:DG:EN5VU>=Y:+
MP"GA>J\(59Z8+B:J, VG]<SE::P(U4P:Y4YNOF,CC8T1O][<@\]?KV__N %W
M-]_ ][]??;MQ],P=!=72T^8#JL!<ULIH @[K*,5 EMU9,/PZNHZ.-JSCZIS2
M!XZHLS?TXX>:9&Z5 T--4X5SQ0F"6%$%3?D@2'"20\DH%TF,8T&82UF+'C(X
M<<I@E2YJ PL\RGG=C5[K<CP0U]MTV'%.8)!'9UGY-J<NP,\K@?618U!JNP"H
M?=*[Y%$>:B1>\7]N9JMM"/+ULERW]#ME#(F,QES;3&FL=YR(0LI0 A6CDD0X
MEH+0WE433PP\-F-J6RVP.O*< -ID(W M\RZ7Q4N&B_7<V!%B",0#L^!>:<96
MZ,DV!\3(O3/8 I5KM, J7 ''4X._7TE'"TA.%GFTN;]GM?&Z<X^)2_Y#FF)S
MTY3E+$VB FH33D 4(0P9BC.8% 5%3!:%5$Z^LH,1QD91;9LN(Z%CS>X#\.RH
MY2)( G-(%PWP5RV>SQ+8QU3W6[+Z8)1A2TP?4_*@)/31"WOVCWRN741"_I+B
M?OFY+#?;"F/W^I%-)?@LT=9)03F44ND-&D\C2#.>06VJB%C&,DNXDW%B-^S8
MOOM::M"(;;+P:\'_5]D4SIL (WS/>OZ64V%'&/X!#LPBWK!U[V/H!)7?_H-V
M0P_;-] )CH-^?VYW]ZQB(!],K-TW6=5$6CQ\7JCEZJF-G5>SM6FG><7*JE[,
M%/%$4*+)BA6I,+$,"I)<;ZRBA+&<BB@I(J=@=Z?1QT9AC?"@EM2Q(( 3['8\
M%0S,P'35XK@5''0DGS3P-GU=P5^M AY9JQ=P?G/@G208-H6]#S@'&>B]'N(K
M@=RT;^=K*3YMUIN5;'_1%(0QU6#N?RZG!6="*,)@P3@QZ>02XCPA,(\80P62
M:8H= S;[B#$VCM/O:WII%KD5_):1",%!#>TJ?S/#O%4"U%KL?EOKT12FTIJ$
M3#AW03)P^KF5*.^<C.X"U_G4=*>G];3TUG0AV,L7N3;$<:NN5U+,UHWKA A-
M<%&60IY%QN]4)!#+1!MV<9(+Q2.*J5MUJ1.#C8WC&EE!(ZR)F:S%=33I3N%K
M:<%Y0BVTP78,L  N*QM(_)IBIP8<UO*R4/W T+*YQXT_RM5Z^L=L,7O:/#4O
MLU2H(!+G,%.9*6:A<DASB2&+%8M(@0LFK3Q8!T\>&S,TPMGQP"%.IS_ZB[0/
M_(4W<GG\GH]J>^KCU3=U/MRR*6G0^6@/GSK(%WI4F?9S/'Y!WST-6W]>Z.U1
M5>;B>KGX(?4^BLWE-5VM7K9M<F_5_:.L'40F!6ZY,,6G25ZDJ:0,QKG22[OD
M A)4""@+)5-*$THH=MO8])9E;-^W4<64F^%2BG("N.GF.%,S;8C3LNEZ ^@:
MK&=/50KJ4BEIFD2Z;HCZSYWMKFB0&0F^-=*3L5-C CJ*Z+\TJC3MR\UTU*J
MK2X^-T<7 ^IYA]1?GH&W21<#=[A7NOR1X4N8&Q<&+3*",3;-&E$!D8D_HCE1
M$,<XR],"R2)V\B YCC\V<G5W';D";L>. 6$,S(B]RI=[]1+UQ.[=BI</[A?J
M"= EI<LO]P1]F2UDNS6<XD2J%,<)I(QRB 2.(48$06T6%GF!,YS&3IDFW8>/
MC9*,;%73E]I;H2BO6\XO-^O2;)R=;;M72%K244]\0G/-MB9C"](9'UB/_H6'
MBGON5=@98."^A(>J'?8@?..:2_H-WJJ;7_S1%,LQ+;UN%]>T?#3_,T;0#SHW
MC/%-:KMI9OS*YA=7"_'Z'SI73F66TRS-&,P98Q E&EZ<, (YY1%/L<HH<3K9
M#R#CV-BD5M%\*K)1$JQ,>[WZYQ(L%X!K#:IL_.H'N=.E3Y-#OQ-NQU;O/(V!
M26\W@ZU^=8-$/7-&Z$GU)^C(/@$[M>I?FLG=_[<;BWGNV4 QR$P$Z*_H5\YW
M:+\8!.BWNS.&&:IO.-A<__;A=[G0INA<#W0EGF:+F0G,,&5TS#'EHI33B*5I
MD48"YISD$'&"(2-I 9,D1BQ/.<I8XA8'9C/LV!: 1NH)>*CEKLB OI+<-2K,
M"GW+PT3OF(8^5FSA_+T#YVNA02.US]@O%Y0\!WU9#3UPM)<+'(=A7DYW]Z,H
M$Q"K]%/7>H?\0XK]D@P?7OZ@_[5<71M?_M6O63G%:<1Y5B0PBT0&$<H*R&+.
M8)00P;,(X<BM_(SC^&,CK9WX<&[D/ZQR OXR<CM&W+O.BAV'!<0Z,)E=#K,S
ME?4$RRNGN<HP*+GU!&B?Y?H^IA_=?9,_Y&(COTD3[*_)]4ZNJMA9K?$MF\\>
MJB#:-GSL?J;Y]N%6?=?_6BK*=_73BSC/!4("TB*C$,F809Q'":01%JJ@.4]B
MIU-@/V*-C1P;K<PVK]$+=!0#.\TZ,9NU<F83V56O7P5\3Y-M1Z[#3V%@SAUP
M]IS)V2_87CG;DVB#4KE?./<9WO/3^Q'_W6JV7-7M]K[)-C2%UZW[Q']MRK4Y
M%.H4@)RF29HEL>9T09DI.8V0WI2S A*1(JY4'*'$Z?S958#QD?EKH1V=KL[X
MV[%N2%2#\^MK>2=5[ U=->>48"<_^.MN.9_Q%Q"D*%E?"+VRIK,0@_)C7XCV
MF;#W<_IRGE1RM9*B*KQ1E=@HKS;KQ^7*M.^8"HJ88BB&)$I,(VPF(>980:ST
M)A_A!!7$:2M_>KBQ\=E6VKK"S 30K:AUR9ZRJN13_^A8ON<,\+;4Y@O.P$1V
M@&0M*]@)ZY.L;$#Q3$TGAQR8B&S4/Z0=J[MZGG&<:X=\K!OR)SI;_8/.-V:C
MOWFJ6X?L=4+^QW*NGV960W.6,R5)K$%#!621,'&!HH 82PRC1 J4(Q;GL5M:
MU6"BCXW\MANV'ULQ'<]6AIMUR_.94<YEZ#.>3LNGKMK=OD^ O8 W6T,9Y2?
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M3/^_=&KO[C3ZV"CE?D6%!+01%ZRV\DX ;?5RW2,YS8;E#BD4QN'W1S6PWSK
M;I6IJILTH>K&=IXT%=X]!JGW L[OWLA)@F%W1GW .=@7]7I(WXKN:K:0HJEA
M>J=?M:8U0-L9X.87?S05&DWSWNOJI[*Y^);-9P^-DS66",4)AHK$"40HPA +
MHJ#D%!4B25-<<+?Z[QZD&ALQUOU)C>V@FNX+O.V^(!MUP$KKXUI&Q<L,VI'F
MX/,2F$P;?4 C(S :3;9_VXD\.6R8T6FR 'XW?2QKCY3/(O<>L?9<$M^'9 ,7
MT/<(YF&Y?9\/[\?CWV2Y7LWX6HK*!F[SDYCFXY02F.$X-?E)%+(8Y;# 6&*6
M13S*G6+:WAQE;#R[$[+9FU6=ZAU9]6T\[5CR8I0"L]X!0/X#2$Y"X)6,WAYI
M4'(YJ>P^69R^N$_1E%W5ICJC6O_0_EM3H5Z/*5<_JLQK;4>N-G1>7M/GV9K.
M9_^2POQ6#_FH?_O1%$Y=UGW[6%84&=%;V10AS1THY5"S"8%$4ISGE)",6MET
M(84<&_5L!=ZFJJP:N:OZ"6(GN3;Y*JV=JF@$FNG3K#:6^0MO"N[JY-4Z3JJ?
MM[]H])R 5E.@E0&MKGJGO=,6M.I6EW04'L%LN]1,>?]9'ZIFROO.OF/-E+#3
M<KIF2J"Q!ZR9$A:]US53 H_5,^Y\VS_;Q!N93J?&V50U7)C&A!581@2B.)-Z
MU2\4Q&E"(%>QB&*)]>_Q=&$2_*2PVS.<&,V*"$A-!-TQP_% FW5N6EB;5G:S
M1ES C;R.D>@G8+;;2%P*W4 1Z8V454]C UHK*+@^"9I[5/IY./Q&II\8;]CH
M]/.*'T2H6]SBH;YV=?XV4S->=QO]-2NG5%',$IG .$$Y1)P*R%C,H"R*-&,B
M2DF6]*Z>?3C>V+8 KZNO@=<"@[^,R.X9_R<!MW3=^H,QM"5^"8*75:\^CDNX
MVM1OC/E^E:>/ W"RKO2)V]R#]:XV8J;G[*M^1:8X5TF2BQ06!,<092J&6- 4
MHE0F)$N+ A'KX+S.<\=&&HUHP,AF'X'7!>HT"5R@?NCC;!O-G>+IWM"S=_Q<
M]UF#Q<N]H4 W/NZM7[M_9-?+'W)UQ<KUBO+U-$U8G#'3[$)*O6;':0:9J9)<
MH"P2%.>%8E89IP=/'MN'5@FGUY!&/,N5^!"P\Y];;Q@"?W#6"#A]=&]JV_NS
M>_VTP3Z\-Y7H?GIO7]"SFW:=^6.L\S9P"?,\BQC7ZURN&$1%(2 F4D#"*$6Q
MW@E+NVJ"QX<8W>=8BP5,$?G&8?Y&[N9BIA>(IGBI6^KF";#C/%$820Z36!MH
M*"XD)(;W$">2*$9%BN.IGFZV' ;N[E#A *_2 ^=+NJCREJJ.Q@;TMS&> -[8
M=5( 6@*G[,T3T-MM6"Z#,S"+MCF7=::E]QB[X[K[[>U].,RP+;N/JGG0B?OX
ME3US 8PGY&K1>F'+:2$ICDF&(,F-]Q-I*L!($"AB1ADVB4!23=?+-9W;L<'^
M $[4NQTF(!.8,6JW9G4VZ78>>11&NV_[$G""VT<M(C?G$'&/Z3^BMM]0_OU!
MAHW@/Z+B0>#^L>OZ?<YU;.4V;?">_C*Q5M^DD5JO995;0O_CWY?SF: OY33A
M7,9$9C#/E()(&P*0(1)I3 6F".7:"E/M,<>]O<7E*$:/\X_[ :RR[S]G95GU
M]GNL!77C!->YL*.,$- .E$382M[F+IMS92,\>"U]?>#<*# Q!0FY5Z.B)X)>
MR<E5AD&YJR= ^]36]S$]#1E:FM-A\Y^;?VYF/^C<'/OL%]O+2):2I(AA')FM
M9<P3TP4C@EPE&5$2I2QV2W"T&75TNTTM;1624?W0D=O1YK%"W-(0\HUC:.O(
M($??@'"8&H=.</FUJJQ&'M;4<@'CP/YRNKD?-;W*RJSKI$U5DM,T8@(2&IMJ
M"SPS'3,BR%3&DXP5",56-<M.C#$VVMEF"I=&Q@F@ZVK;]7] 69?O^VVV:'X\
MGCUBCR_)H@1C"I522&]C%84$,08SR3$7$5<JY:UA6U?7_;ZFJW58L%^;L/O#
MAD/^ YV;J >3T?,P6RQ,!8>E:BH]3_8SN+U.0Q+%B.DW6J^W*8>H$"ED65Y
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MA_H"S7%9G0$L:89(SC',*=:K9I)I-LF$A+'2?$(R&6?*J0;]T9'&MF"^KC4
MEIMUN::+RFWJ)\7Z%<QV=.(%O,!,LI]N78L9..WZ+2S")5^_&NW]4K#?4OID
M(O:;-_0CC$^SQ6RM6>B'%)\7^KMXF+&YK!OS7#T9$[/NV]:$(_ZGI*O[G\LI
MI7&<LBR&/#&58F6:0YKC L:YQ+E4*";2:<?=2XJQ$8V1KNH@21>+#9T#VI&\
MK24Y ?J]3-W(IM\4V1%1<. #DU0M/ZP4 #L-ZGYE$["=DJXR$V#T %H1?R1V
M$8Y>":Z?)(.2WT5@[1/C90_K1YI_E^+!'+W)<O:PV'6=481FF@\S38BY_H/D
M9F.,!22""$V)<<[CV(45WQYF;+372 DZ8O;JZ7,$5#L>NQRJP$35 R5G$CH-
M@E>6.3+4H#1R6MU]GCAS=<^.!<8$,[4"A#;)#,'4<>I4@Y8BCJ!4#$.4,:+-
M(\0ABG!:"*8M@$0Z=2UX<YBQ$4$E)33E9D152K^5T[$X_MN0VM' Y4 %IH$N
M1MOB(JN5OD2:GTV&ZH)7=23K]<IC_?R3T/BMH?_V4,/6T3^I[D$M_=-7]R.'
MJ]OKSU?K]6K&-FNJC9)[D_6J)_FK7-\J4P)W.9]_6JY^TI68:K+@*,,21D@J
MB%1"S3EP#$64(L+S0F;**>#88>RQT<A'N9K]H$UQZ'*]JK)QR@GXG<X6;33'
M7T9^T"C@:&>X3(L=ZP0".S 5&:E!5VRPKK+C:QJ251,4DY]JB;4S(?5 S2M+
MN8P_*'7U &:?S_H\PF>M[:OU-5VM7K2]55>4R'F:,E-AFX@LA8AC @F)&<0B
M1FFA:('<_$56HXZ-V+:%HJL%7OJMM;V/N!US><<Q,&>=J+5-UZ"5VG=]#R>4
M!BBQO3_R"$IL'P'#KL3VL9M[9G'(YY7D=4^!:4;B6%!"8"91IG=B1$+*A/Y#
M%%DF*-*_=:KRT7WXV/BE*UOK;W9,ONA"9\<@?0$)3!1=L3SF/KRAK-^4ANX
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M1U; FE.PY5;:2\\>3TY$W[-&7_"^R]EB%^_# (V0AX@VL 4^-#PIPCL?$MK
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M9*ZU&[S-G1W7O<N,!*9$#QW%._-Y=[H2>+_NX3X1]]\MW(MTPW<']PGJF]W
MO0[0HXSCS=/S?/DB9=4OZDY_+H]Z-&/*WJV67$I13O-4)K1@>N-=57/D6:[W
MX8G>EA.D1!+)@D3VU1S/#C<Z%OY^=P>>&^&:,O^V[EA+@$^SJG_8 E-E*VO=
M!PZTTM:Q JV\7@%T*/3H%<B!ZCW>[;]]P) 5D(TJ5<4GS6D+<RBD%Y>?IO:^
MZ3?17E"W+P3/[428D!Y?52*M\3Q9+/+\4X:K&6FMT:O2D?9W];2_]4M6K0FW
MJAKB<3G7-Y<W_]R8\MQMC"O!49;2G,.$912B0O,USE(!$4H530C/N')RF5J-
M.C;&W@IM0I6Z8O\O4 MN$^%ZP218&LF^H0UM /M U=VP=4')K]%J-?*P!JD+
M& ?&IM/-?4E*/[CN-OJQ:GM4FZ=U%]*C#%E.D>(*F4,>07,,D4IC35LH@1C'
MLHA3KJ?(J8Q#3SG&1F1&@ZIR@?[B>*<1L5[<5\O-P^/)!;Y_E^*^LVC+>\'G
M)C@3&K!K%4"M0[.AW_4\/F4#>XR4O1!,SX393Y:!*?0BP Y)];+']6V1]&DV
MEZMK3>@/R]7+E%,J>1IGL(A9 5&L$DCB*($QYS0K.(\EL2IO<>3Y8Z/%IO%/
M)2-HA73MB?0:P=/4Y0&7T%MN)TAZ-$%Z4_$+&R"]?N; S8_>5.BP\=';E_7-
M-U_(6W6]DF*V_D1-W4_]?#I;_8/.-Z;RZ]-RHZVSS;I<TX707#(E1+&$\PBR
M3#"(I""0\ES_-2<%BO.,,>IT>NLJP-@^?"-_90M5&@#5J##1/\U6X(?1POR:
M5GJ Y4X1U]QUQWFR,WQ"HA^87EK@:^'!IRWP1G[PCQ;X6@5P:P%\CRSX?NAY
M3HYW%&+@G/E^$!VFTO=\3L_J7:ME65YO5BNYX"_=,/>V_613.*) !,4D8K#(
M"8*HT#_A6$4PPD)@13+.D5.I:<MQQT:"E=BPE?MUT@?X_I,^.Q;RLD0_XYAG
M$=&[<XKU'S(I("'"A/.+",DT%Q$G;M55 ^ _3,'5>@9X.P-E,,SMUI4 . 9>
M3BJ)P9%7>-M"V'\E%4>D_)94LQQ[V,IJ;H <%%ASO+W'Z?3'6?F\+.G\]]5R
M\_QYP><;L^+H?^5UE0(IMD4*F@/R;[**>KI?MD*8)- F*'X:$<DE$A&4A!*(
M!$/:HHY-IWN92XE3E-+"^BC;KVQC6V>^T[89U'HEG\SN\G:U?EP^:ZN EX U
M&0<3\-P$N:CE"JQ;=18/;=FH7OT//<^ZQ?GZ^\UE8*YM%0.59B9)M-$-=)7;
ME7^9;*.6&@5-@_8M)W=T?+_I=#CM?[]I'2@T8/CI=0L/"#,!)V,)/ \Y7.!!
M&*Q>12D$&N*"D.(/Y\/?/NR'OVTWHYW:$-]FY7]_TBM-UPR9_C_JWK6Y<1Q)
M&_TK^'2V.T*8Y04DP?=\<KFJ>GU.=;E.E6<F-OJ# E>;L[+H(25W>7_] 7B1
M*.L&4"#%CIBIMBV1R'Q )A*)S"=YFLC(DS%$GE3+O6!8;1D3#AGU_3 B)&*)
M50!M<(FGY@1H&8%40EY"VC#\/!N>/$YI]H8^H[P\7;D3V^OH/0/5,Z%5W]VX
M.4YF'F.>W"<Y#RKU^,G/8TS"P:3H40:^M%G>1U%DKV15D8NW-!WE;R1;:E+X
MNV4GX>:S6C"7+".+;Z)0^Z1GG=2QI<H72<A2AE.=^((@0C2%V L]Z"=(]RX2
MD8A1OQYZCB2<VJI4\Y_HS>E6P0X33JG^7&:/R\J])26X)>43^+S(_P3_);AN
MD*K,X$;U4M]F2W38MPF?JV?!<"6[Y@P/O6$].*4SH)4:MT6J8VP':MWG2LHK
M=?1S#/+Q1G^N![JL:81FJBMOR4NV(@M-TG'#_[4N5WK\N8\"D<2,PH1( E&(
M.4PY":#P-9M2X(O KEG-^2&G9M_?MY4 ;"NUWHCDNAY'F6Q] JU3'5<UCX[X
M]SI[,8\T6DR)F55V"_3 9G:#<24MZ(@+MO*Z[V!Q'IM!FEJ<&/8J?2[.PW"L
M]87!E?TLT\9][E !_2Y(N2X$O]=T0NM")S@JMSLK_[[,:2F*5[T*WRU?UJO=
M3L9;=R;V8JH\6 '#0%>A<)] &E'=DY.1. X$Q6:E@T,*.37KU^U97'-Q/^I=
MN?JQS'CCI]I9N$&FULPF7GO"!K:BVQC);(?&K551;S4V2H)*RQGHZ@DJ1=]U
M A_4OQUR1IS:[D$$'=7:#PGU^_5AT+%Z'-S?+VN2HT_K(N?Y8D$*'7MI$ENP
MY#3E80R9+Q*(A(A@RCP$A8>I3V6<TL@W/H8_-=+4;+N2%5;"@JVTIZ.GEL@:
M''6[PFM@TZK$! >A.I\89(F9Q7FR*^Q&.AV^ $.[8UX37$X>VIZ\P7A'L"9Z
M[!RH&EW0SR%O"\<_*Q&K$J+[.J;]Z:<H6%8*/H_BB"(NE3M-> !1C!)($Z06
M4B_B@?3","56&;%G1YR:.=T0(]1\"*V833ED_M(CI'L>=3/'URF6 YO:71CK
MBL5&7+"1UYT':@R-4W?R_*BC^H;&(+QW],PO[&=V;A@KA+YCVY8U"#&)I+(M
MC$411"2@D$@4P21)A$PI\Y-8V%B9]P-,S:ALY-,;<)HO.<C:.FRN$V76M@'&
M/43-+,@E. UL,+80.6]U>TQKI[9@;Y!17_UC*KY_TX]^K\=VK'L KHM$MB>D
M'P6KO!4_##P_>2C4@_XD@L8UEC@)D7K/8<)8"E&:,H@Y]2'U&$E2X0N2Q,8;
MM7XR3,T\[!?<=(^;6TV '\Z 5@8TV@!#KNY+9LM@\S?\'(QU;F$+?Y]M8\]Y
ML-A0#C\?(VTU!YP7NZWH98B>W*3VO/5XV]?+=-_9V%YXJQY+U-^7Q:9GQ0/Y
MV7"GEW=+M0J24I1=@HT-UY:'4!KY80QQ[!.(*/%ABOT LMBG4A>*1MP\DMA'
M@JDM3[]5M759*[)A?^7^$V"PY@P-Z\ K3E?\JI%RJT!5;5&KL$L#9,TOUQ]^
MBZ5FZ&D8::$99CKLUIA+H#RYPO2Z\7CKRR5Z[ZPN%]VH9WY#MLQ6XHNF3U5K
MFWJBLDT_I ]OOY-_Y<7M@I3ES<^LG",>\2AD6&U[8A\B/^*0XDBJ?T3(PA2'
M,@RLTA;,QY[:>E*+#BO9P5;XMJ<9?0.5_*!20+UI2@5+4DV;B3%,.A@&[J%S
M"5PB;9\68(^9V]-^B_''/<2W!V;O;+['+>R9X6[4XLOU OQY01[GRO'U?))$
M,/(# 9$74HA1$L+(BV7BAS@.I%%1P=Z=IV:@-L(!+9TY#=PN7*<-RT4@#!V+
M-=/?BO/MH*Z]V=YV[S8:S]M!);H,;X>_<"$]=\VGJTN7\J7.,*^6+<;]A"72
MAXR'1!,T,O4RBA"&2'H<)9X7Q$:[5*/1IO:"-NS06R%[>0FG 3;S"YS!-O K
M;8U8?UKM4T@,0Z=]<,3KT&B?4OXH??;)B_H9C]_SU^K6=TN=P5?7.RX6^9_Z
MS+&\6?+O0F?KB?)[OEA\S@M=[#BG"><HBI4-21(,U89%F11&)(PB02@20>IY
M5B:EAPQ3,S0_/MV"-GEZ!OP >ND,M'KI'AD;S<!6M:IRI%4._*'5 XU^EA:J
MSRR:V:V!YV9@:S;>M%B;P0N =6H<^\@QJLF\ *CWAO226_4X5:BV657#ZS+3
M8WT4KV*15V5BOV<+4:Z4%6^JR!_R#^K'C,_C*$","0YY0A)=M<(A]4.I?#;,
M(T[]()+FAPH]!)B:8>V(#)Y;F5OBKQE8Y8#J7S.;KEA]YL7@K&%@M(?>RVGI
M04?\&>ABO]%@0]7QD(,/^K?!H;<X9QAX"D8Z9K"="D<G"Q> =_)@H<]]QSM7
MN$#KG6.%2^[3SW7_F)7D\;$0C]7C>"^_JQ&7:U'5;\T1)L@7!,$D8C%$H1]#
M$F &)9,^PR(-9&!%/W5JL,FM&3NRZE3*1MJFN,W2N3Z)LYD7[0J]@=> _L!9
MN[\FB#CU<T\..*I#:Z+Z>\_5Z)J>'.A::LVOI^^L28L>U'T^YL\D6\XC$L28
MR1 2CT8024XAP1Z#RK;$/$1QXOE6/?U.C#4U([(C:DT\IH4%?]3B6MJ04R";
MF1!'T UL07JC9D^H?1X/MR3:)\8;ESC[O.)[9-D&E_38WS[\F3\\Y>N2+/G#
MG^K^;Y^S5_%#++.\4".^BF*E#QN_YBM=#MSD=.,D#*) DS $:G>+0TC3-($^
M3QB.0Q'Y'C/>W5H//S43HUL+@DH^BQV4/>@&6]=!H1S8Y"C902L\J*4'6GQ0
MRP\Z"M1@]\G&MD?=8M<Z*/HC[5D'F 6[W6MO$$_N7>WO.M[.M;?&._O6_G?I
MRT*F/%<UCV]?Q6I.J>2">C%D7LH@BL((8JG\2\KBD',/ASBU.DGJWGQJUKZ5
M+=,].I?"FBFL QLFB60>]A1L)(2(( K3-*+0\S!*/9&F')'Y*E^1Q<"P;888
MT+#H,4#F#CPS=[LO) ,O=ANQ9N#K"11Z<*3MJ^N8#:TSP,B\9_NJ[3.<'?C.
MI1R]/\1CS6+_DA>:2>MN63$ZZG7XPUOSX9;3BC I4>(3A5WJ0>2'&*8T"=0[
MK4QDRFC@(=F/B==*CJE9S2XCF9H<H%O#U">TWXI<9JM9Q21>*]&70-=NHKPP
M2-/8XS#Q8@D1]@@DA%"( RH"Z:LM3"SMNI&-,%7C="?K3M9O(G\LR,M3QMH@
M8C55-X4@X\R3F9T? ?N!EX0NZ(V88*,$Z&C1?55&HC'NA>E 9,5VLER)DK@7
M8,>)A_O=;N26*@V)R&_JB[H,IZZ\F4LO21B+0IC*E.JM00!I( D4.$GBR,.Q
M$+9FUJF T[.^E7R"@U^R)2BK+O"_CM0LY? ,&AK@J\W*T';Y\C8H]VW?DUI)
MG;!6JUEY_]K@?\X+*;+5NC@10QRO"<K)*9E&QY/#(OXUVIN<A-=9+Y/3H_1,
M51!2%(7@GX5F$5[<+5G^+![(SX9=IJG!G(>8> (I7YHP'$ D$PP)2@0,XQ!+
MP67JAU;=2,R&G=J6IY'6,DG!#&'#= 7GN V=N- (#!J)02UR5:/=" U^:<0^
MOBC:)S%8X>0VG<%LZ'$3&ZS@V$MQL+NZGR'Z(LI2B*;GSO+QBZ[X;EF+WQHK
M6'Y<BQNIWO3_%J30T?"YB+C 41+ B.I627$80I(2 D.1I"&F'@\"H]:]%TDQ
M-3/U\"347EY+:&>I^DV!F>$:'-B![5@M_PQL- "5"EN"][<VY5GG#\Y !3_0
MBE2';>XLVT5 .C5T_209U>Y=!-9[,WC9S>RL8EFL-*<G7[/5??%#%*\9$W71
M*$.,,X(AHB&#*$P)Q$SXD#*11#&*8D:->#>/#3 U6];(6,65&S&M*D6/ GG:
M;+F 9V"+U ,98V-S3OU3=D1=V[$A97-XW[$?1V\^BFDXIUK[UI_]GCT7PZ?E
M2EN*-5UD[/,B)ZLYD;$O>.1!22G2KS2&&(4!3+@O,:612+%1%N?!NT_M5:X%
M!+6$H!+1G)AA'[O3+_#%B S\]MJ 8<72<%3IWDP-^W<<C:WAJ#)=QH;C7[)_
M13\V.5F:="HO7G+=UYI_>/NN=T!BIR=G&"11D"8)#")?+<1>XL.4I!BFB$0)
M"3E)L%&"C-6H4WNE-X*#KN0Z=KJ1W?P5-\?^_*L_"*)#ATK.@PG^<'HLV NI
MWG;$?*31[(NU\EV[8W]QGTQN43Q_R<GR,V'5/J/)80W\.$4\$9!IVA@4QPRF
M22PA)5@2'*72#XWB'B?&F)JMT5("+29HY;3)$CX,XVE#X@B<@<W&/BZ]TJ@/
M V23*WTQ4&,E1/< S#+C^204I].:#U\Z8N[R2=EW$Y1/?[4O9Y:RF'=EN1:\
MR_=9G8B5AX_.YHCY41CB"%(J.$1A%$,2^@'$88RH1Q+*$J/BE0MDF)JUO&N[
MD^02L/SY.5\V_8]D7H!7458A3/59V3GC)OJ0L<[BW7Q4@C^SU=.36/#JRA7Y
MJ?[4/X^AQ^2:Q9<'GK*!;7@M)JCEG]6)!^7L< +"]IRXC3)O4PU<<H'UQM,Q
M0YB]'"/SAO4&:I]-K/^M+C"VW\6+>HZ?]*WWAYTGH1_%TDLA041"E& )221C
M&&-.&</()T$R7^KR9\$?+$WLR9&-7L^T?CWWQA_N5;UA3"Q$O35K+&2Q5>-"
MTWAZ*A"+XE"&*>0ZT(!\X:FIB!#$*/!H@'#J(VR]S%T^!V/FG%=+6!=O7G.Z
MO]2<[D.B;[$..<-TZ&6G@K,C[2Y%?KL0.5Y5C-!QOXB<'G;\-<,(AH-+A-F5
MEQ;)?!6KS^LE%UR37*[+*BM]&X+C<8Q9D'I0R C73-(I$^JG,$YX2C5'6L^B
MF)/C3LX@=5+\:ZE!+7;?2HK3J!O:(/=8#FV(WM42[4 Y4D6$$58#54"<'OM*
M%0]&@!RO<#"[?.2*AMI&UC[V)AU>>574\QF%7L)#Y>+2"!)! ^@A*A(O\I5=
MBZQLF4OI)F?Q:I\WJX2\0D7#P1DTM(O7FI<QH@>7U3/L!""VU0P3J%PXA?TT
M"A<.2OC7J%LX!:ZSLH63@_1F1FOY+SX*NOJJ8%H7A1IP3F6$ B$1E)Y0MIQ+
M'U(A-,5B&@24"\*EE2T_.M+4[/*7?/D(5_IH@W4(74JAQ,U6F2F1T7F S4RM
M$]@&-IM=XALMY QLQ73*AG8:"==<:$=&&YL)[;32!WC0SES0SU#\0SQE;+&A
M?O(IYR+VL?+O1*+VJF$(J0P(Y!Z+.<&444W/8FX==F\_.9,@JJ7^M1'2S@*\
M0\[LM>^/Q\#O>BN8PY/>TSH[?:O?#3'JJWQ8O??O[Y%O7=@VZ4NV%'?JQW).
M(A9R'"IP1.2I+5H40NRK%Q?SA.IV223P[<)->T-,[>7=2 C^T#*"2LB^[9&V
M0)I&L2^!9_"HM14R_=L@[2D_3.^C[3#7:7BTI^;1+D?[W^RY*I_L\=&0[WH(
MIT3*&":<Q[J)-X)$$A^*D*0>XG$:)T:5+C:#3LX('.J28] 9IQ<3LM&L&/H!
MCK$>VJ(,!+.]+V&!FUL/PV3@<?T."RCVO!&;:WLDY?[0NVK!]99;Y\#I'<N/
M9J/]O]6XWPI-L?5\VP8E1)QPH9ZK--15RC(0$.M$"B%(G)*04.ISXVQ=R\&G
M9M(:L4#%>U2W,J!Y4>1_9LO'$N@#@V(3M:CU =(^W]=VADZ;M:%Q']J\U9*#
M*D149;_6X8Y=\4$C_PS<GHF!7 ZW15KQ@+"/E&_L&GZ[7.2>^)U,4K:]YWC9
MRSVUW4EK[GN/RPAX'LC/NOGW[1-10^G3TMM\N2HRNM9CWI*B>)-UY[MR+KP8
MQ6D0P2@,.$2IQV"*XQA2'@=,IC$)L!7M11\A)K>P;$36$?"-S"5@':G[4?=8
MS8V9ASPTX@,O*1M:'\WC4RN@#-=V!KHZ@!TEW'/\](%P$,8?*T&NPO_3!ZIC
M;$"][M67F9X5.I;]4=3_O5M6(Q&V^F>V>KI=EZO\610;+HYY+)C/>$2@3$2D
M4](0I"Q,((X(]CGU4$*LFB-9CC\YR]@("Q:-A-;'@;838&8#!X1U8//72@Y^
M:67_52=-;(#6-3.@5:##$>22%KX7=HZ9X^UD&)E<OA= ^_SS_6[3S]!]6)?9
M4I3E;?Y,LV7=%$JP_'&9_:_@=UQYFYG,M*6M+6_5U%*9XILE_[)]M=5G:EO#
M&_>T_N8<)PE+XA##0.H#%$QU7H1'8!R%./%\+TY]9-.88C!)K8SG:%TNFM-H
M0"H9[8SG<)-J9F8G,54#&^161]!1<@:V:H*NGHW#"EI-JZAN1U?0*+O9BC<7
MN+/>@T^)4SL_G+2CK@B#@_Y^[1A^P.OPP=^O5^5*O3/9\O&?(GM\6BF97T5!
M'L6GGZ)@62F^%1D3W_/%HMD S#%B 2,QAEZ 0N61:R9AP6/HRR2BB'B18%:)
M-^.K,#6GWB6)>0>-&6CQ  T@H$4$5)" /S0HNN98W\0V(6'\)\\PX6'2S]/0
MYP-7>Y1N:%GYTBZS-ZXVD]/(1N^OQE\C9?WB:7)-QW^!)$X94O2AMSC"H1$F
MG 2>H)!)$:O='V.01CZ!/(Z)"!,2XL@J(&8OPM26SR'Y49QPHIR:3L,U;=!)
M&F--VC*B5$)/D1#% ,TQ^%!.B3$%.A0#F S94$SNU/,D-G_6[SV[S=?+5=$R
MH.$8^8PB93"I3D.,$Q]2+CV8\"B404AQ% 961ZV'1IF:=>S7Z.0@?H;'H9>B
M,O1Y9R-??=ZY7CWEA5O>.",@W)Y:'AQIW&/)4\KNG3N>_+*S>+L.[RMCHU83
M]5.9\8KM?\<?++_KG^ZE<OQT(Y2RLDC_I3R_>13($&%E)@+-Q8F2U(>ICK0G
M- D1T4U(0ZOB0[?B3<W(;%71"1M;76: D?()O#0=%0!?"[!^40X:84^9>*VW
MH]IM$\6*9$M0U$U,&[?@1115)T7MVSUG"_7(Y$M-6;=^ :O<LDC=\>/1.UP_
MTJ1?)4;?>0IVE.OZ=<KGKO33L]YJN/$)M9:#1N8=H#]T./X2$:\=@W< KT'@
MW<4H8ZXQMT_ZQ[OEPY-X)]>1BS='T)WE**8(>:D'/2(Q1,)',.4>A\II91'Q
MI$B1$47]U369VLKU._F9/:^?=;9Z5C+MC^B%IUZOQEAA7#P<0RY&(T_YE->M
M&@J=''1@!3MVCYVN8A-:YAS.ZP161!?:_ 463X>3YF:==2E0WYQ[NOJH+/<B
M+]>%: ^AYF'@RR01 >11@""*='TY9C&DOL?2!"<D\*WX50\/,[7%3$L)MF*:
M',K9@&H8_[D8JJ$#0/8H]4AH/P6"XY3U@T.-G)1^2MW]M/.3W^YG"+X5^8LH
M5F_?U%RO;I;\T[_7V4M]YO>@[E@U"HS2.)8TD= G3.I6*QRFF 60BIC$J2\B
M1JR\:(,QIV8B6I%GH!*ZRI?;B*TS [3@5FT9;2; S((XAG5@<U+5 G[)7JL*
MFN5CMLE*=-;"L0<N3BV,R;BCFAL+(-[;'IM+'54![I>PSR.,1)!X'F34(Q E
ML=K.2QI!/V""1MCW/9*V3/RF#LK948W>F5T6_H&-D6[#"UXWY RDE?3"TKX#
M@)NZ+FY O&+AW@&JBP'+]([C,VQ5WH%QKUN$=QR(LS5W)R[M9X Z&<?W4OE9
M+WE)%K\5^?KE;LD6:YW=I+VO:H.V%KSI@JWV>TU%?R IBA,:PY3HAG0D2F$:
M2 XCY(<H\;#RDCP;+^E">:;F076K"S;)0DHC2ZMUZ2R96;01L1_:VC7"@TKZ
M&=C(#[H*@(T&LVX9B$,F!L?(.K63E\HTJ@UU!.![^^KJMGW9C)ONH5_SY0_Q
MJ!W+)GDF(G[B48&@E%ZLF>DEI'XJ88S], G2,(V2T([-^,A(4[.7&T&KO6:^
M>A*%+8'Q,4S-;* 3I :V;AL9*^9BV(@Y0%+263 <<Q@?&VUD#N,S2N]S&)^[
MH ?5F&9")N531>7[Z:=.=11S%,:<I3B!D@3*U_)9"FF(.-2=+CFCL8@3HSCU
ML0&F9@STPUVE!"VJFGM12VE!3W4(Q--FP 4T [_]C72@$@]\<@**!2_7A>",
MQ+UE!Y(=L]8)!$ZR9QVZ;CR&K!-2[[!@G?I>#SMVFY<KY5H)F2VSE;A9\KLE
M;WZIPJ!WZE&HXZ#U!E<Y7V7YZ6?C?/V6Y_S/;+&8)S)A,9(>Q'[J0Q3+"%*)
M0R@BBB*)L% 6T=CTN9%I:M92:V5A!AQ-C($Y'1_NP?VO<@7N)6A5 DHGL%4*
MU/']K5HM[T"E&-AH!EK5QI\U"WL__NR-M$2XGL6_.5I>W )^<D5R--1XBYA;
M;';6/<>W[A<1N-<;WF;5;;:M,HX#YC,?)G&D5CXJ):0TB"'W/$%I&,0TM>IQ
MOS_$U!:R2D(=LLN?]0Y76*96'L#0;.M_&3(#KSDU*(UT VSUCROO=(]_8)A1
M-_?'U7R_JS_QS=YDANJ!?B _-1?,4C-;5PN<^L-M(7BV*C_GA<@>E_, QU$4
MAT(YMY$._GD4IC).84(0HCR*&,)&K.&V T_-#C3%B+JV&K!*4FOR0C/ S<S#
M$# .;#0^22G82JU>C36M#G^_Z^CJK@ZSZH-:C1EH])B!FV>=XNZ4N] *0=>D
MA6:#C\U6: 7) 9I"N^M[YLLI*Z@/G9>\,HO?E*]4B%56U#P98JD<I56YS=+;
M-JYF ??3@*4P]7D*41@DD*1> 'D8TQ@E@DC?ZB"CKR!3LVW?/SW<??_T^Z>O
M#^##IZ^?/M\]@&]?;K[^L,RBZSLM9A9O#+ 'MH#?-_*"5F#PQR -Q2\%RVT2
M7E]AQLW,NQ"RO72]2^_7<]-6\0'I[>)/P1_RBKJB*'6NX.KMQZK(_J<F O+G
MGA>'1* 0"D]32J"0PS16DQ>H_5P2A1$2"9J_BH+FQILYPZ%MWLBN ,.]F'=J
M8YTIYZZLI 0O%2^8[BK.\\6"%*6NYZZ9=BQKMXUGPW!3. #"0V\5*Y%!(S-8
MY36;3O$?):CEGH%:\IJ-S>$>TA(KMSM+T\''W6]:0K*W"[6]OB>U6-,$[5ZV
MI5T5*6F954QG']XZOSUHXM*Y2$D@6>A!W<(*HDCXD/I)#&60>HBE/$A2JT8D
MM@),S9]KY==UGINZT:X*,UTNT?F#\D*T'K8\FK;S9&;DAD1_8&/G'GA[AK">
MZ+GE![,58EQVL)X0[7&#];V/G5GD(IM_;$ZA;I;+-5E\%[IOW5P*3R0L19!@
M+"'RXQ"F:<2@"#"->>!Q+S'*=CXVP-3,6BLCJ(4$M91F-NLHB*=MD@MH!K8Y
MEJ@8&Y1SJA\P&*5@?WO,7_]375K9BG\C_2.L?ZP,Q-&;CF( SJG4ON!GOV?W
M I>ZG1L32U)DN8Z ,5*V::")3"A#$88QT:\PI[S.) E(Z"<D" (_,>+U.S[$
MU%[B5CJSU_8$=*=?7#> #/SJMH(Y/$$[K_>IA5Y=W5GDR^:8OK/ G[C]*&_P
M>?7:=]C@FSV+)+N)^?4O@BL7X.T'68BO^>I@BG[9ON]Q1#EG$A)?[U2X0A8S
MZL$H#*,H]9.$!U9EW)<(,S7+\+Y,IE6G:L[[!K1&.L5\=:1JQI+P^*)I--O(
MC#4Y0SL8%\[+$/RD#I!U6^9YB4#CUG\Z@&ZO,-3%/2?3JZSSP3Q"F(0X$3#V
MTT"7/OF01#&#'J&QP!$-J">OW+"L\X&511^]:UGOOH\#S[&9,9_.S UL[@=N
M8O;%X"F80B>S Y,S]79F79&O30DW /PC-#8[-&J_=:GIC2@YBZD(&0P]22"*
M P+3F*20!U[,DY#R)/%MUH\I=Z?LTY72JH7DY/H]NF[(.&#WQ&NT.CS=E]!)
M$\$JM4)WWRC$D\ZW>!5U#MJ7O"P?R,]Y+"GR0LP@\IB "*, 8LD8#&)*N?"1
M%Y&H92MZL$Q;/SZLT2.Z2U?T,,(&NTF[U!FLOS3EJ[\"6F>B@$(LM!SZ@#Y;
MB>=2D\56%>^Z,=%63[!0*O9(@3\Q1X:I#PX@'S,Y?D?4-N/U%RWMKU6"J^-D
M^?/(N,^</S'F^&GTYP$XF%-O<)E]L/^C\C.8FK0F6N2%3'#.$\APRB&B"864
M$ XI%B1E I,T,@KZ[=]Z>B&\6CKSX/X[J,X']?L#,'B8K!;,<3#_L+X7!_'?
MW7:TX/UA=;I!^R/?Z)DJKJ;HJYJTC_DSR9;S4*0B3&4 .8\]Y1,D":0>\2&)
ML52O:,2$$%8)X#NWG]K;J*4#6CSP1RV@+2WJ+GAFZW1_2 9^/RW0L$^W/JBT
MVR3JW2'&38T^J-Y>PO/A;_6@:= LR^^ZF-XMU1LCRI6N%_JL!/PAV+I0&_7_
MK8O&.4H$QRF#:>3INE3"($XHAVD2ABF6E'!I5-G1;_BIO?B-=&] $M;T;_BS
M;8),FB;(6:,1T%Q!%C7_]G-SVFX,C_C0Z[Z2_4"3Z5;^JL)M!K0*8%>'04&W
MX%08%/R1Z!/<3X(=34)O#$\R(MC?=3SR@]X:[_ <]+]+CQ2LF@WM-Y$_%N3E
M*6-DT7@V 8MQD*0QY%%*(4HB"3'V XB%]&08!S%+C=S"DZ-,;9'H2FCI()Y&
M\_P>S@E& YMU.WCL\K/.J7]YBM;1$<;+TCJGY$ZBUMDO]_ BO]<=.;4-T2U]
M=*..?V:KI]MUN<J?1?&MR/F:K<H?3]G+B^#ZHZ_YS4*]>OHLZ57\O=2\*]^U
M;;J739OOSWGQ;=O9\W>R7"L/:]7I"SWW.8UBB3F,8JQVF$3M,#$.8R@"*F@J
M4>C[1K&>JVDP-3.U(Z*NPU,R5KS5+XWVH*S5!W\J_<$R!V2+ %B7-7=KH4'0
M"4M-?[SZ#EL@+'RQJSQ6!C[TU!^6@>UUHW[MX[4  *TF:"&8@18$T*!0?_XU
M!QT@@$*B8M^JL-"<7 T:FHH"=/"8@=UGLX9DZD^2Q<9@ZD_42'N+R3]9=EN5
M:\[JR=W.500;;\-T3=QW]EQ7%:1?&/^[*(6ZZ$D-_%%)O\BKOD<M7W#L192F
MGH0QYQRB$,60)G$ .4G#D% _922VB>J?'&UJ_E$K;.7F\*VX=@359D";G0 X
M@V]PCZ&#7$=2=P3-5H@X/2TX/>*HAP=&RK\_2S"[J&^7LR)[K4Q9:_YT^[0F
M>)&B&#$?IS D"8((L1@200*(&8\I$TQXU(I*X-1@4S,E6UFW;DZ_D\.3$/,T
MBKPT1##VA(8884AH*&'D2ZHLME"_"#OB&5<@CT,VLY5V=LGI[$F,S2RU*]P&
M/V'I\5SVZ!!W'@S'K>%.##AR3[CSJN\W@S.XIL_9KWG?HX>"+&MZ!;+XL7YY
M6;S=/!:BXM=2?FG%..(G$DL>"V7.0Q^B($:01&D$/2SC" 6>'R7FX3BGHDW-
M^'<E!F4E,B"MS#,=-]-2VYQ9.IU(DT/D:TW/T.;/NGW<SES6^H&;[5Q^N_)<
MVIQ-7VM.QSJW'GMN+8^UAX#_])&WTQ%'/ X? JG=H_)!1NC)T)8]+C.9,=V(
MFC'-RZPC/?DB8YDHM\2N4L01QB&#?N)'$-$HA3A%$>0)29,HPC&BH9VG;S;P
M]'S^'W___?>;[_\-[C^#'W>_?;W[?'=[\_4!W-S>WO_]Z\/=U]_ M_LO=[=W
MGRPY=PTGPFP[X![<@5?&CL!@*S%H11Z(6]<.)K>\:F9#C\NF9@7''H>:W=5]
MP\=5Q/N[T)N3.B;=QJKOZ2)[K(RF#BXQ78F5/:NOW,L?ZJ^E#F.KS^H@MC^/
MXICXTM-%G,J,(40P) A)&$KL!1$36!"KZ) KP::VF>CH ?*-(F45DV9-E1D5
MH*PTR71Y^/:32DO;J+6C^34-<(\_:^.<GNLZ_T:I[GDDV*HU ZUBH-9,)U5T
M=9LY.ZT<"F['@79'PHT<DW<+Z7[XWO']>Q41R&PI>,.TKHL3U%]$T9Q8WBSY
M _E9R?$A7Z[+EJ9=UP.*94D:(9C> CZ*N?"#Q.,T@BGQ$428(9@RY,$(A1%7
MEC^1L44<R:%D4[/\E2:;+"M]LK9JE)D!JM79MM(&0CT)52^[JCDJZ^@WT[E9
MC8;@E_6+6B\,B=?=3[U)Y.E*$SIXW+U2"S1Z :W8#-0SW&:NZ'26A\T,5_I5
M?]L606_G=*ODM>;2JBKB.G,Z6L'$Z'-K6U'A'O\SQ18.!QRS#L,]3N]*- 88
MP+YZXW;]O%Y4YTUU'[':0[B7-SRONA(T!Y\D#(F,*8-QBC%$ 2408^K!@,94
MDI1[.#':H9D/.;45>"LUJ,5N/7+MJ;>B]RCX,)R T\OE,+ .O XZ0M2J1L0.
MI(L+1@R'&ZUZQ$[];BF)Y97] DI?Q>I6^:S?BOPUX\HVOOV]U#UYFP#\\O%&
M]SFLV05#G>42\QA23]DB)'T.*5$_D12E.$Z)VCMP&P8P\Z&M#-,(+&%*\MK3
M?VEDU^RQ>2LW(!O![8(_%G-A%MX9!N&!;90&5TL-OG7 _45+#K+EKV C/+@Y
M#[-UA,8>,:<Q&(OA1XVRV,/R/H[2XP[]#-KG=;',5NM"IW9_SG[JGUJNZT"$
M%(51"KV0(7V(QV :< RCD#')T]BG<6H3\SX^U-0\J8VD,R ;06=U^$)*W2!.
M_'N=57FI=@;K!-9F!LH-@@,;I(V0%6*MF -P@9]'PZFQ.3'<J,;EO-KOC8G!
M%2ZK,^Z6RFPQ499S1#!)D$"0<IQ Q)#V?B(!4403GXH8A\RHR8GA>%,S(W=+
M^%)+!HHCQ1HNBC2V>*>QX#'R0XB)%T+$$P1QQ#",(T+\V \2SJ1=VH5#Q$=J
MZ/GM^_]%GE_^[X\NRV"V")N>$SI#;?#COR.E,-D2--(.70VS!\L(]3#;,2=0
M$;,'@%E-S/YE?:MBJ+I7N2JJZ'/=KS'$H>=3Z4,?$4_M7<,8IJ'ZA].8*!/#
M1.QCNV*8O3&F9JR['1R_Y,M'J 9]!EIPL)6\[-<O\Q#$9I;D0N &MAZ.,.M1
ML7$4%<>%&OOCC%R?<531_;*,XU_M9Q@^D4(?X9??1/%#=\#^0,J,W="RJOF8
M1Q$-4IHFD$240Q1("HF,8BBC((U1(@7UF)VO<7*\Z7D:E7A@*?1:67$\;UJ%
M_Q\[ZW :9S,[X0R[@2U&*Z>.HX-*TAFH@?RCE=:AG3!"Q:G%.#WBJ+;#2/GW
M5L3LHKZ.QOOSQ .-//0YXDXSW?K;V^2A.?.DG\;*-_'B5$(4)Q[$3/V3$N(%
M3'#A<V[GF[@0:VKNC-:C!"M=#R!%45318%NGQ<ETF?HY8T_"P(;N<)I%^ULW
MK?)0VR67KI)+8!U[5TY$&]DA<PGGO@_G].[]S/0[5LZO:QTHO)?5<E#>KU?E
MBBQU 5*U-,Q)$$9Q*$(8^;K92N03;8@%Q $+D] 30LC(QAI;C3XUHUM[,K]D
MR]H/+ U3%WLBGR(N$N5Q>X(H!]SW8D@"WX?2#[&@/O9#SS+8-QCVXSCD_WS/
M=*V\\N>\G0N0;Q4 $(PZ569KX&#P#[S4[9$OUY)7]0$U]!WA&W??W0+7"S6G
MZYB=!*,N5[W >;\J];N)FYC#QVRQ5D//HY"EG <AQ-S3/;T2 @E/,&22QA$)
M!94>OBS:T(PT/;/6"%;9*IXO%J0HMZ$&2[-U#%XLDSC!E,$T\77R) \@#CT.
M1<*H CR-*";SI5@-#^VF.=IJ)%C?!7"Z:\:@D/>+Z_1X2J\0T6FD'"Z0\PZ&
M04,X[5A7#=Z\4_A<V.;]UWL6^]?DW$U^KQ=*GC 2P20($N5O^D('?"D,0B\0
M:>R)./1L//V=NT_-DV^$*WM2=.TB9_:J]\9CZ$,>8RCL"^H/J>RV;GYGA''+
MXP\IMU<%?_!+_8H>JS#? _E9]U=5/[1_:]@3NY49RF-KX@;EI^>71?XFQ#\(
MJR-V."*!$(RHW;S^)Y01I(2I'3X/21(3F@2QT9;>L5Q3,Q$WC!6:HN>UD<^N
MM,W59)VV+5><@N'CJW586RG3]**ONJN"S0>-:K.=>K4JSZ55;P9:!<$_KCJ)
M=M6)5YC,\6H31YU4Z\)$Q]"?*TMT-=RH18F.,7I?DNCZ]J[.,G^(XC5C:OAR
M-?<#CT9,>I!031I 6 0)5MMIY3_C$"<8*0_ZLB/*SFA36Q<;T=1.NK1,;ST-
M:L"1D'&H7+QJ_Q%3I/8?V%=N21Q&F&/,J&7"B3-81Z(2&PC8OB>T/<&ZRL%K
MB]WM*>P<'*X>P&3@,]/NB%<^"CV@_/D3SD,7]>P<NTU_^YW\S)[7STW$^C9?
MJA]*9?7_019K<2^_YBM1S@/D2\)1" ,4,&6E?0%3R:IBA0@''DF5=;%J'6LW
M_M3L=B-SY_2LE5IM<938^CQGJ06W;%]J.2M&&YHAL1[</NUDQ^J./S7N[>G9
M5@-0J:#;!7T='G?+OK'#X3]BXUC'\V#?.;8?BF=;QUK>=MS>L?UTWFL>V_,V
M_=S]+4/E#WW820I>_OV%DY7X]'.E-AN:R^I+IEPI1KP4,<&@D$$$$8\Y3--(
M]X1,TUBF(N38JF36<-RI+24=2M:-W* 6'/RQ%1UHV2TCZZ8S8>;4#H#OP,N'
M*;2?ENK=J$FA'0;L+?%RZOJ:CCVJ$VP)R'MWV/;R'H[Q.5J4&_ZO=;FJ#B&4
M5:U8Q95$WP5;D+*L"'KUMYHR=2_U$*-8PL"7J:8$D)!&)%9;\H3'OMJ#)Y&1
M?7,NV=0LH!%ST QL59S595.MEN"]FA;.G],9-W#'KS6/ UM:YU-XG@)AX+FT
M</&O-:<C.?_CO9YV>X(A8#^Y6W ZX'C[B"%PVMEA##) O[W'G7H;EA5=;GWD
M\56L/OULFH#\EN?\SVRQF ?2]Q 6""8)81 E-("8X! FQ!=I0B6*L55RCLF@
M4UMSMS(#TIP=+H5EI-P(;)\0DD8AA5+G1B!.$@4VYU &G :14IIYOMU)A&NX
M1^+:> ?X %";;>-<PS>P9]'!K3WDUBQNOVQD!JW0QW--K;=N-A@YW;<9#3SJ
MILT&BO<[-JMK^QE\?8)=B">]_WL5=U5JLAKE7CZ0GW,<Q9SC*( >#2A$4<(@
M"93%CSW,:*A+\45J0RIY8BPK\SX"B^2.J$W*=F7AM<^V(C_MK,\ID,V,CB/H
MAM[%[*!6BPE^^9*7Y:^UU5'@*8F5K[M:%1E=KS1QA.[2\HT4I_BIK.V/ 5Q.
MS<ZI\4:U-@:*OS<R)I?TM2UUR]9_9JNG6^7!JCL77S)"LT6V>IO'A(5$8 F]
MT/.4%RDPI)1QF%(A2!)$@M)@_E*YPC]6RDTVM3$GQK1Y5=Z//.1;TW0;7K1R
MZMKMQVRY;!K?G&EUTP-['Z?$2V0 22B)SAGR8,J4C\FC6+,M49ZD48/]IR6_
M"O+MN./B_JGBW1P <5,S[PC#P0U] ]V?2E#02CH#&UE=FG(#2!P;\U,CCFS.
M#93?-^@F%_4FX5P5:[9:%\HV::JXXE7<K@N]>L^#V$>(X@@R+H3>J7H0<R)@
MHG:PU ])RF); LYC8TTM&K C:L6_J62= 59+:\T*>11B,ROB"+B!;<@N9M];
MS&[/8-:'"/(<&JY)((^.-S8!Y#G%#Y _GKVD=PYSE3A=.YC*MVPM4B;TMG8>
M12SP<4PA$=H;I+Z F%*N+$C":(*]) EBRRSF4^--S8!L:@[4WG+CCU@W*3@'
M<DS\0(J$JD?7EQ"%3$"2<.5R!T&$TXB),*366<VN8!ZIP'T4H,WLM$/P!K;5
M&]2:/;TND^D(6VWNG68ZF^#B.M?YY)AC9SN; ' @W]GHLGX6O&JX]54I4*\'
MG7NW+1R21)=E$QA++U'6!<4PY6&HC+G::?H\P@Q1&Q-^;L"IV?"Z8=U6X.X;
M8F=>SD)M9E]< CBP@3F%W0#='$R1<6IBS@XZJHTQA>"]D3&^KI^5:3GH.J1S
MU8^%$ W!@0@"#_$@ACA$6'=W4)ZB##$,2.CY(H@B*:W27L^..#4[L^%P[$@\
M ZW,/4DDSN-N9G.<HCFPT;D42&NS8PR.4[MS?M11#8\Q".\MC_F%EYF>#OWE
M=\'RQV7VO\JGXLK893(CF\/89FQ^L^0=(Z@^6S\+_JW0+>=6;[KH3'<O_=0V
M<9KS1/JIC!,8>[$FO$A3F/J>A 'V1<)B$G [9IM1I)Z:"6P%G8$7+6I5D[_I
MD]4C$V><J;>SH).9T+&L<$?A&=BJ#+HZ-SDLK9'FU<QW?<5&\1G8/B*5\G5+
MM8W^[FWZ*-,UR+HPK.1765M&F8QCZ],X@_=D66N:J-S+.M5T<^3_0'Y^)RNA
M!5XR)4LE?M78XT'\7'U0(/_/7$KD<2D2R 33?=62!)(D#=1*)CR*>(I$@*Q(
MV2X09FHK4K<[S4:;;KA,*P1V-;*D>;MDZLR6GK$F9. 5I<]<-'V#@-8'5 JY
MI)YS@*M;IKI+!!J7V,X!='L\>"[NV:,ZKK+[G=W+?97=_Y W*T&==/)C34OE
MRNJV2KE:29Y%P3*R^$$6XD[>9@5;/VL*9*;#+:MY$J8)H]*#@JI)1I&RS=0G
M'$J/DD"])FD:2N,2.>?B3<U&UPKI?$-2JS0#=:X1*#=:Z4]E5I2KBIRWU@Z4
M2CV+.BKW\WS:?%]_]@8VZ)5NNU&:9BX?\G8KL"FJVNJH/]UJ";2:,W GP8ZF
MX'?3S>) <VM1*'?5.1ZI6NYJ<VU7/#?85)RLH',_ZGAE=(,AME-+-]PHE^6]
MG" 1;/)LZE8[K%B317FS6.1_:@D^Y\7'?$U7<KUHRO?+.1<Q2D,BU**/ HB\
MB$",$(.^"%+?HU(FN%>JC#L1I[;PM_*I=;\6L%^VA\,YM$L0N<[,C)53LN%?
M/4:_VNA81? :)?4Q3:V1WL>)[%4[Z>J/K>I Y@6X57?)5D#7G[A/3G$_)X/D
MLS@4\RHI,.YA/I8U,\!(/?F?%M53*'C;%%/P+L]L(].F@"Q-PACQ-(&,A1(B
MW;(F10F!"2<<L2BE-+"JTK,;WLK4CU"XIZO,1+6K!\IEW/9;L21^LIL",VL^
M'+!#Q].TO)!J@<$W\J8W >"F*-171'W>MK'41*KE7%MQARQ0O5!S2P9E)\*X
MG%"]X-FCANIWE^N?L]_N92%M>EGS5&!,]/$Z$1%$E&"(.4_5),?,HTPB/[G:
M0?MQL:?F.C>2=E.E+3N.CS3=XQ^NNYG$O^;I^NVA-,T!FJJ/.U^3/5X_(?I?
M]GS]_'0,><!N,'J?$YY;L5C<+5F;$8]]S^->#(.$: 9#%$+*J8!Q@-.8!V%(
M+9H;[=Y[:NM$)=U,'[+^S2::OHN7R3%';Q2&/J/8 M"'>^\=$C:' KT1&2NB
M;_!H6 ;?#ZI\.G*^>\F(8>^#LN[&K ]_I3=[=$TG)WB5JG^ WJ.U3@0')$D0
ME"P(=29JK--Y*)21AY"4?A(ES)(_VFSDR=FNK>"@+D39);(Y&4"\<!(2Q--(
M\$1S+'&(/"9U2_L4\DCWM(]CS_>Y74GF(-,P3G'F@PX0#86T89!F"/2&7GKN
M;^^.4"H-4#MEC9!K8F[#T<>FYK8#Y0 YM^4-^A)\LD*04GP4]7_OEG?+5_6@
MY(5R@><R1!%.8@8Y#PA$L3Y:E(D/B1]ZB'L<$^'/E^)1BVEFC4Z.9_0.;9IT
M;T<=[E7J"&=+,'D*5S/;<SE68U%*UO*!7UI)?P79$IA@UX-)T@ 3QQ22IT8<
MF3O20/E]TDB3B]PQNE6;;4UZD! FXU!*Z/M$LTO@&*82,1AZB9^RB$0DP6X(
MW=HA;=Z)*_"YD?I0>X?+[<41L]@&=1K$ 4-^ (-8(-TE(8&IB# ,,/4\B0@C
ML>^"RJT_YB,RN36(.V9QVV!M9L9=H3>P%3_&X=:D8M1'>2,D5)C -3B_VV;
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M.J75NWD*[R78 06TJ( *%O#A#72  97^H L-4-B &IQ9\_$./LU^6H :(=!
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M>\JGOP94_P';QZ;1U?TJ,.14N&_9Y5S2\9MR#07VP;9;@PWFI%V-WS*:>U'
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M4SJV^9*,(8[31*U%F$$4<@9I)!/(,*9>(%(FP\#&BS<:=6JK3RMI?5Y(F]]
MUA'<SF$WP][,/W>.Z,!K22MDA>7FEZ[( ^0=6('DU,\V&WE4M]H*C/=>M-W%
M_4S3W9(5^N1-6;_JOW?+IK1\^7A+7K(566R.3WBL25^K5H^!!U$B!<18()C$
MG*(@B4+J&[&RVP\]-2-5;V8J"E&RI1A9; \S+4^X+";!S% - ^W@GF\M+/BE
M%5L?'H*-Y* 1?9 #*'O$G)HNB^%'M5_VL+PW8CWN,#(U:]T#XVZII*@V$F5U
MLO6@WO&&//8?RE_4\=XZ(?N?(GM\4K_?O"HU'L5OZOZKC\J!_$RRXA]DL19S
M+TT0I3R&::@=.2D]F 8B@(R$)$DC+$-DUR1R*II-S0Y_%PM!6L)MKDM$BU)3
MO];DV[;<VU-!>6C&UVL^%0,O(0Y88IN.1AUXZFPPL%( ;7G$:XRV).(ST.($
M&J! A1304 &-%:C F@#-[%#S/PUJ6N?:_37H;(>:5&<4N(,)V..P0/GO158E
MH^B>&U5FBI9@'D4R3"21,$0)@BA,0HA)%,#(4_^J38Y,$_.^4T<&F=H:NB-<
MU=NM)E\ G_/UDE>S:Q%0/H:L0>3> 5X#KRY;"6O>^%9$!_A81-0=X#12R-P:
M+[N(^!D@3H:\CUT[7DS[C/0[0>MSW^VW86H["CWD52\B9;/79;84FHKNMR(O
MR[D?Q41X+(6QSBA1YC"!.! ,$D*D1*E/F;#J*'INP*F9QE9>;15)+3&@C<AV
M>XNS4)NY_"X!'-A6=K%KA 5;:6>@DM>=,VR*C%,?]>R@H[J.IA"\]^B,K^N=
MTG:@VN.W/.=_9HO%S7*/L&3.$B_4Y;&0(<X@BA7V%'DI3!/D<Q2)./:(77<Q
M:QF,7J11B^@ZU#XZUBPSW8FW#CY;)[!9SH>9;1H&XVO7V[7R5Z"_IU=R:+]Z
MH^<Z4<U2BK%SU/J!=" ]K>>-ALE,PX'GXR;CH&V2X<<L04BHO:@7J[THEASB
MD(=0DH3%012%,C8BF;M AJGY8Z8I.%BGX/AXDX)CT^"EYVP9[&^'GX/!S^=Z
MPC]09MJA>7";F7;A?$PL,ZW'O#A/43N!Z*4I:H=N/:D4M1.ZVZ:HG;I5/S?]
MBW+Y[^6M6A2SU6?"])+XUO0E_I 71?YG?5ZK/EF]S:DFD(ITETJ<!!"%E$),
MP@22E' 6$>:1Q(H U6;PJ2U*;5MOV@H*6".IG5]N-0%F+OE0L Z\SFBQ=?>>
M6G#02K[MH+X1'MR>@]K:$>^#F5,?W$J 4=WO/M"\][Q[W:.?16O=^<]Y(93]
M;-E_M-4L%]62W#8*F,<\X22(.40)4?8L8BDD4<2A[_E$%P<GE%GUY3(?>FK6
MK)$8L):<:K65V<Z>6<!O9LV& 75@6]8*/0,MLAO:KX[@W0XE[DR9/6!.#9G%
M\*.:,7M8WANQ'G=PTMLU;'N[QLC#C,:0)#J_+.+*$:/ZA,8G.")>%(O4O*W(
MT6&F9II^J+FM=S)-W];@8#?7\*(6I:'Y?MX)<(,'-@^T) W==',-[;?<3B"[
M9C=7 ^@N[>8:6NR*CU]]S6ZNX8F][?EO]TS^%8_ZF?@N7C3AS/+Q;BGSXKEZ
M1+3+>:<L1SF7(HX148;2BWUE+3E.((VY)CZ.(B*]U$-FQ,<V@T[/BE8R@XW0
MH",U^*/:>U6"&QH'JPDP<_1<PSJPC76 J'WNIP5$;M,R308>-V/2 HJ]9$:;
M:WLFV>1EU8#S8_ZL?,*YB#%)8Q1!@D-E@G <0J+VES"-"!=1% 8>LF)JV;W]
MU(Q-*QWXHY;/TJ:\P\[,>O1'9& [80Z&??;+09W=YKKL#C%N9LM!]?;R6 Y_
MJ\?.ZX:Q8BUXTRUGPTE:[_-6G1/CQ@.6R$/2DP1&+-)Y<EX =9T/C-((Q4DD
M(XFY\7[,<O"IO?*-^&W#K[HR,J_906L5NG62%AL0VTDQV,$-"/7 MJ1%N15]
M2UK<Q)=6.PWO>^SW;.&VV 4."/M(>T.[A_QOCO:*/7$[N8.TO>=X^\J>VN[L
M-OO>PQ5YWTU9KI_KZA;-&'A+%DRW*%:>YE?1;'\SUGS_-B]758?W];(Z^9T+
M'RN7D(8PB"(,4<PX3 ,40J%\R!A[!*4INXS4[Q+QIK;NM+(!W3;T4DJ_B^;-
MS$V]WFP,'G(\1 '840Y4;*@=]71+=M JN+E.JS@#FVG]?FI:'9 #ND!_8-+
MBT2\,IF@"WC/DPPZ&:6?\:_S1.^ENN5+7I+%;T6^?KE;LL5:T[94 RV5(&HU
M:N@/\N;<:#6GG@@Q8A021!*(?$0@#J(4>IY(O<0/41!;T07T%V5J1KW6!#R)
M!0<R+X!2QM*V7S M9G9\'+"'MMF-\*"2ONIY7LL/N@J C0:S)O]]UNXVW%GF
MR_%T:H4O$&=4BWLY;.^MJX,[]@B]M+5'M_DSS99-M_>=7/RF2(GO^%PTY0+1
M2$+"A4[@\3U(8IG .,)2".*EB><91V#ZR3 UV]G#(;YD!@S"+</C.K"9;!4
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M.>NI_Q,B. T))!&E$*=<6I @Y3!&21C0E/E^0O4/Q@\/-#73T8@*?B2W=[^
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M9C!I/F/9@WB;@$EG!??]$LYF\^\C'ER4E&GBN9*E)CDC^<@#8\DS(W@R9O?
M])$';P:*YI.4VPNS"2R<7/C)Y-WE8CR%!5J\* +S)F%T'2V1 OUIEZPE@E,T
M?$HDTT-![R,/W@P+#6<J=Q5F$U@XN(#Y&6Y_O\QG?R[/]V<77_ST^\@8I45
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M\O,)@H:M<WD5!&TC^B8P]#N,S\Z1\CW\4'^V[I=_E!_T@;B6&@\Y!Y<P'&;
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M8XE2T6J#+S(=JJ#J&:*&S4=7@E1?2F@ 3V4B6)''[^/E^?[E8CF[@/F#-1+
MXJX=*-%.E@'47!-'4R0L&<C,X'^U2G WH&[85'8EA/6NE@:@=G#Q93+[#G ,
MDV[TZ@/)C8P&%X%J0GV4I8NW*DU!/$F $E1,&6DKS4CZ$6G#)L K@:Q?A32
M,+3+\\M'&4F"66LU(ZS$QI)KC_99 6%:<)E##! J74-YBJ1A<^/U-L8>%-
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M9^*LIT2)I)BA@<5<[8[F"VEMINW=J]P*[DMI#=A*=)/7!VQ[\;\NQW.X4Z6
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M]&&)IIII@5Z$DG6VTV?):@116^C[*>CL+/P&D'2/A_>S"S^>EFK.C")B).B
M_H/0FCAI-4HK,:TT\T:%*@AZE)Q&D+.[NN\GD':6?0, NG4H^RM<!)B7EEN)
MEP,%:4NYID!G$)V_2++12@3G&=>BCC=_GY1A@=.#>N^[YCO)N@&PG):LS>7\
M^VT6K'7)"L:(EAQW\> 8<2 T[N(F"1>M 5MGMWJ$F&'+K?L'S*[R;@ R>REU
M]Z_]Y+,?I\/INL'?FIF8;.:1*\(Y+2=%N=PX\)0 3Q:=0I-XI7ZSSY(U;+EU
M_S#J3P<M "K&RXO+[KB\:^=8!#6'<Y@NNANI96K.FC$9RWDC\T1IF=#"4DF<
M-I:X*(-"D8&'.AO9QB0.>[)6 6A5=-, Z(YAB;*!=.#GT_'T;''%A4<9E<NC
MHLP/DU0 \3)F8IQABJHD&:0J"'N<GF$/GOJ'4P]2'Q [B_ERM+]:#HC^U:G6
MZACL*.^E65>0UL4@D7KMD@,"$E3I7*=)\&B%F;=!>96LAXU&5> #;R%HL4Y6
MWD+/IA0UTNER^U"_BN@;A])ZO5&E?.0,%UA&IU#R:-9MWV,T(89$L]OHBD<O
M8!HR_J^#@1< ; N%- ZQFV&%:TN<30+%I"4TVTBD\0I%EVBYC <I!2KB9L,A
M^[%<]ZAK%W;;(.,EEFT7-37@;%UO !]Q\S_$;Q<CD922)@="A:+%70S$,^.)
M1X%EK:5SJ4XYW4-:&NE6T6,>?#LQ-P"4A^5$#T^;CF>3R8?9_$\_3Z-,#6!X
MFPD/&=#2<TN"$)'D #P&'5-*=0+"%Q+:2,)\2US\< I#?TIJ (-=??ZBNYZ.
MM!L6(*!@F+,&(Q-D  UY)!9_P3'JR:S24)K;5+0V4[-'==^W8-O*OIFZJX>R
M&=$(- >7B+(Y(Q^!$@O@B3!:@??*9UZG%/ A+:V-RZR(I-WTT R>[AP8K);'
MB$L0PAM7;EGB%QO1X=1>8GRCE?4)M%)UKF$_0DQK8R[K(6I73>QZ:>MSS\BZ
M,Y)^A/L^F*PE48H7=I(DSN.71%/.$N.)).IL='?(:&U"93TT;2_]!ERDIXX"
M"B_(V%$^]=\^S^:=WI;+^3A<+DMP<SK[W.EA9#4X58)6R3,M<3(C-E!-E M>
MVY23MW5VQ!T);VTZ93UXOJ:&MP;T5YB'66\I"A3ERO%\?SD?3\_6YK:S\P<7
M7R:S[P#=FSZOVQ^4AL^+D9?<&VH#$0H$.A60R]PP_%%+CQ)049A:U:%;$=S:
M],K*'F!EC39@BY]@\Q]^<@E/<CFBH*E#^1%&3;D5T'7KD);P#(%1ADQ62IQL
M16YKPRU?';0]:K-=R*Y6YA/M$:33U@H=2+8)RJFS(TY%=).8S,8%FZBI4P"[
M!;'#-F9I *Z]:;)=L'8K\@D.7>*>^V#0VRFE,(E:9(Z7PQK'O<O* *]31/)R
M6H?MS=( 5/O28P-(O3DE+%/$'J\0[#@-]SD]AM54'3B!^==QA)5HCB'.SJ;=
MIW12&AF3HXI&$>?*Z&;F(K&4!Z)C1"^?.V%5I?*[RIP-W/?E-9=!4R!Y(XOF
M7AU<Z7MWMZ<LU\BLP2W-1\F09V:(1R@3ZWQ&1\R!C742LGU0OQGX_RF.EUY=
MV0T O)/F3=/&1_RT$0TH-RH=2;P<C(@8,>)-F7B3C,S"8<!;IXGPCVG;#)S_
M/"=6_2FJG1YQSS&VVC,8YS27&4'4X6J2R2=B$T:R"M#+2E1E ^K5 ?@"S^"?
MXGRK7S4U!+_;-04"71, )XBVRA)IA":.6D9TCJ I4.ZASD[]\GJ.?XICKJV%
MWVLKDE[+.;3/W'E< %PXC J]1'$8E([QF87@LQ6RXF[Y\G(.]D]Q(+6C(AJ!
MTV,U!-8D*023Y<J++F4I!EW)F$B6RG,OD]*\3C.5;:LYV#_%\="NJNBGG*,O
M8.W%.+N<EIF()TL_32B<Q6]?4NF]5_H"+4KP\G&\6(Z009IE4"3JB-%YQ@C&
M6Y1="LZJ<C\B5)H7LB&!FP'PG^*HIX;*>HLW^VW>]>ZWD\-/!R<G=\G<K"/7
M]=_VT6;K<4)ZZIUU-#_ST_%_=U3MSZ:+V62<5M"=IL^W*#[*ZQ;+?G)=F7W3
M*4Y9I[5*C%@)Z&0;0TGPS!(F7= L9<&A3B%6+^3O:L>NYKR_AT6<C[^L'__.
M+\:+,FK[AHI35-J[21D\01ECCDI.N*5E"GP"XD%)HFD$F02/F=8Y&7PYK<,6
M<K\^/N^;O,K:;=3ZG?SVZZ][Q_]Y].'D\)=/AQ\.]_<^G>[M[Q_]]NGT\-,O
MGX\^'NX?'FQE&S?\Y#XLYS9,]&17;S;*SPC9>+O]?59:Z&P0#MT)7;DMY3,X
MW'\5152Z&%.=M?\T33M'G..SZ3B/HY\N'S[D9EU$H75P@+2)LBZDUAC\<$]D
M&8/"M8V,5BK@V8B^82U=3XAY$(/VKYH>:Q^',%I7S-<S7M=/>#TC]CA3]8V9
M-8(:%B-A-DDBA<*MC@9.M#::1:9=M)5:)U4S9NNM_=X#OJ^^WJP8'IP1QB="
M<T3. \K V@#$) 7>>*53J%,/OAE]S1JSER#F@2_6OVH:..V\X]?>Y\4B+]KX
M3(PH[6FS-<0[B\%[EBXIK82 .IFVYZ@:]DI>)7#UIH8&(/5;F71XL%B.+S 6
M6HPHI(#A3R"TS)J3*202@C(H)2L$[FZ&\CHC3^[2,>R]NTJPV4'4#0#E\WP\
MFU]714W\8M$YBW<;>-P*?4?42RJ$#80%66Y]68=!->J>>RL"D\SI5&?;>RFE
MPU[+JP2VJNIJ ([KR1#WQ_;<,\:!"9Z9P5V]NZC%;"3.4$MT$ H95E*%.K7*
M&Y$W[(6[6IMC[XII &VG<Y\ N>HN#JX%M\!U!<A?F,"*NU'BSDN!8  C(V[]
M'"TZ"$4$C=)!R"JJC1KC;7'6N0%YP]Z-JX2V_A73 -H.IU]1HK/Y@W ELPCH
M(TB2J2P'<H&20%/I0BJT1S>"1U'G.N93% U[=:T2IGH1?P,P^CR??8'Y\GNY
M1+?$-5+,\9>R[=_G2WCPC@E-K Z!2,K*4 $().H4O4PZ:58GS[PIA<->.:OF
MH5503P.P.YSB9\%BN:XX7Q_)/9Y_H2'K8*(@UNO2Z4]KXHT'XC1P[V+R.M69
M]OT"(H>]1%;-QM514@/XNSJ&W9]=A/&TXVOM?HZB9&4Q><*M5>@'Y$Q"RH:@
M<Q T-=QI7:<^Z&F:!KZ<52O]VH\.&D#3+[-9^G,\F:"!QC7CIV>E<FEOL8"'
M,0TDQ3**A3#E+)&@.7'>2T*=QF42I!&P47?9%Z-K<QH'O@U5"6V5=-0 ^@XO
MOOCQO)M,-W\_7GR9+?SD*'^<3<\^CK]"6O%X/97X<>8?B$#:'(-)1!M>%J#'
M8$A$0Y063FH!+$"=@[@*S Q\@:K6YCRPU@<$?CE('WU H3Y^N!*I5M:H3 PZ
MOZ5[3;DB9B2)5B2&>X?EZMY5JH<G\\\_8N K43TCJD=Q-F -W\-\_+5K)/[
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MN0^]*Z5QD*V=<NVDX!$EQ03'C3?@XO/4*:*5D\HX4&*S,7B]P&S($+L.!EX
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M(&T":?<&H"&C7,E&%'<B*4&686J4&Y&#%SE RC[6;>OHLCX(4,.^WV7A7@.
M-=!&;X![QCF_6_U(OUSD"RRL=@!E<(0=BI-#!!\P@;>6B]KX'P<V)Q_P\2YK
M7!I ;6H]=)!2/-YL=MN+=A%2MBEI 3G70OS,#3%&LO-U-"A:+[EJ4Y7W#<*Z
M?%^>)H&84B4'(^P/7,?59(\H]\L7R1W__-?##<+9.G+1WM0XTI%_MN2?I4EU
M>!S]Q&B-:%3(,(2Z+A\PID';Y,KI G+[U.7=:A<8/&3S JW(J&6&XNO^"</J
MN$#AP)<@T$5G%8M-\/9-TKJ\C)L&;-.JI;<P[?6G[17/GK??<;U8Y;?7<8/_
M?;T-$5ZL/G[$=5J$R_I4_DA:';T-Y-L=<(&"7#LCQDV]$JI\9\Z3&?AD,#EI
M\^SZ/GV(=UH=]H;@W;70+]=7UVM\ZN+R$9Z]+B6F&"DD,36E+QQ<3!H\8\AU
M=,7F?!!N#R1HIMU,L]WC-558MUG*;C7IA?6)V!$:(D<+"HT E\CL7#(^*Y-C
MX*?,479DS;3N:,84Y1!]S.T![SUA/_^"O0M>WN!E'6%63X+E=M[K.UQ_W$V%
MO2"3$MZK7+<22E".>7 Y22C6N3H#UF;)!CG":>F::7-0>W\XH_HZG2'^T\\_
MOKM/XK!AX-O_;HJIWE\3,-%X[I\P7GTI9[J=MNRU#$QQ RA9!.65!=(B_2.8
M4J30DL=&=6./TG-T^=R]G_J.9/<C_?6_+ZSU'+4KM:"<#,,%#B%D#=R;DHTM
MS*0V@TF>(&CFRJ/CL?!5N=H$@N_8)VRK:0Y:$W#GOY[*/SQ&3%LO49A#7V(&
M:TH=*%,(%%E&<$4Y6:OA4;>9&]W&2WPY5.O/?[FDGWI]<[-RB]MH&-(Q9B"(
M2'FH4(Q"?*% V,0%&8KAILTRJV_3UJ7O&(.0A[YC8G5TD'%]X>C70+GES>+>
M\FJU?%_CI<KEUH:_\%=R\IBY@D"Q/BC#!01F.? 80TF%:^W:W*>.I73>P4E-
MP== 51V?:%.LP'GTYTQURIUD:<T3@&*$J.P" ]3>@:I3U)QP DJRGBF=O0R-
MNN::1<5?W.I-97!242K++$@*T4 ECA#+]JG *NV\90+;'>D/B.GR1!N#@<>B
MX6,$WL$1=I^%F\%,@MFH&0-I;!TO( 0X5)I.8CJ=0Y!<ZC8WA5_3,C]BCE+O
MLW 9+>ONT'*G6<4EASSJ4$L3Z]T4\Q!J RO],2LIA1*PS7BTIRCJ"3GC-?TL
M< X4^]R7R&]QN5BM7]!7%U>_A+3=J;SO=S;*1!$1!,9ZGRD8>(41L!21;')>
MN&&%[D]_HR<\'*K U?32G!L4-?A^M0K+!RPDF[W2*D*1F8R%*1*+91*L2MEX
MEYD-P]JZ'O_Y\V<WTX)A BG.#H0_5^\^K*XW89G?_4EB^?P+I00[D*^6?^#Z
MJM:__+:ZPOV0A*0I!\/,(#%FB#LZDZ,DP$<?,1'$@TS#GM-'?WJ>KH2&\&DJ
M^P["EOMN<GL<1T:!O2D&,G<4QW&EP#/NP6L400F6*+1K$K!\34M/WNCX(/=(
M67>'EIUQU>G_4;H$I5*N9%W6QBE-K%MQBJ <T<8V%\6/43-O,'.LAI\%S 'B
M[@ R;S%=TU>K+>U'PN9(AXPNP-&KVN' :KC/2$#2!NYS]K'-U=)7I/0$ED.T
M^_ B]RA1=X"5-_C'ZO*/Q?+]H\&[L(H;;15@9(%<KZU]"W4]9!$6C5'%Q385
M_L^2->\1-3F&IE-!!WAZ>T5Q6_S\"J_JSWQ=;GC:!VJ,&Q%+ 98%24G467M8
M!U7'))T/SDLMVKBA9ZB:-WZ>WB--I8"Y<["W?Y))T-]@S25W]#L?9:A)A4-9
M)\$*08<Z!872*9>\*M:F;[X?/?7#YVF^G1P'D\BN T?RK[!>U/#_3;BZF5G-
M?/#)8@1I@K@9:Q]9[=<LQ=M$<1WF-NOG'E+24\)]?(9TE)P[P\E^5E4.09$O
MJTT<Q 'WIDY "Z"S5TPEPZ-HCY0><J/C=/L,4 X0= =0^?EZO<IU??5ZOZ?*
M)A^S"70<TDFH/"H@B@L(+Q6W4B7MVZ1%#RGI!R:':'8UH9@[@,DO6!MR+G^Y
M7N;-SZ5@JO4@;_\,GZI\]CM=9?+:H*C+[NKM)LG'Y:))7-;PH+6TK,VTK@'$
MS9L>30RFJ94Q=U3[>HF_KI97'[X8R1U&K":!6%N;%SB%:+4!QZ>2@5PVLUDY
M$<2P@2#/?67>\&4B>$PKR[F7VX3E^YOSN62F$"41742D_(QB]!#<-EHG-TFG
M,W.#UG@/6UZS_^R\F<]4 >WADNQ!_?LDK="1F R#[)R[J<L(V5,"6'0PAA=T
MPW8W# ? [(MF#E/90Z4?(+^9U?[K8EG[@/?;<ZU![\@_Q5P+_Q(/0#EYQ;[G
MDDXQC\-6)@Q2_+U/SZSZ0Q2WFD**<ZO_I@U\1[BR=#C55@,ZFBRE8\K3::4"
M)$TRH33-Z(?E \>H_^ZGYXD6)U/_P5+L(=$(B_6_PN4U_OCY]I?_:T'A[CI]
M^/RJ-FEO_:(-"6V.&DR,Y!=UK?V7S(/44I"X(@K6:.7P(/KFF237ZCJL@4YZ
M0MJO&&J]^;;1Z6O^=@&Y\CS(+!B(VF>B<GUR4AC ""'I%);1BS;5**/(G'G5
M:P.</ 7%R976$R)?+C]=7VVV$A/[^R*5E',\0;!6T6&0.$3I:L<32]K6S?2E
MT>7*TT1U@K;IH? 4Z([42Q<CY6I#W=6^H8[^FZU)!I>U*RF 91)!24X'0Q61
MC,:A<]8;9$W0]1@U\\S$;'5X'BWO#AS30Q[VY:PF&YN$AFS)L)0H'$*Q"%RQ
M%#CJR'V;(.QQ>N9U1\?K^1O .4#H'4#G3GGRG8*P$*7V' 5PZ; .RJ&D1#(!
M22HER"_+F-JLXWR4G+Z <XB>'Q9L'BWT#I!S,\+PY3+C7W7.T<O-YII^]L__
M?;VX^GSSSYNNK4(VY$($;5R@_)8Q.MA%/=U]%G3"1VX'W1*,AM(P^N89N=OJ
M,&N@D\Z1=L<BA1<RJA @B507W102G"#!I<@$B]8QU:A2;QA]\WJQ%L@8 ;X#
MU=0!^%Z$R\L;SO;7?E)&03D$,*=K&ZJ6X)7A((1FCI<8R\-]&U.=C0\HZ1=0
MAVK[X3%YC.@[@,Y][_[J=@QA,%P&RF@A\+HC1%H-D14&0<?B<RK.R3:U7D\0
M-,\D\-/,"#A,ZAV IQ*^KX2^+:^_>3GX<;5>KVJU[(OPB?[FZO-%$5DDJ0V0
MJ6%= ^\@:FXA"\%5(4FB:H.H,53VU$!^("P>IH"M=-0!_N[+Z\>P66S>$BTA
MOU[>K8?A%\H*RP.CD&$[AI<7#4XK 8PLN!24/L4VN>)0"GOJ#IT&=TUTTP'F
M'K.G.@A_<57Y_ 7KG/Q4E?<>+Y1CSH:Z7DO7"BRC&?@0"TCEI1(YH$J-KD2'
M$]E3U7T[CS>%ACH WT^[S_ZR6-;Y]2]6FZO-/]:KS>;"9294KJL6=.2@5&UI
M(0I(:F@H&O$AA%;CG)X@J:?JMZE<VA32[P!&_[5>7)&)E#JC\X: K;@H/=KS
M=:&,H-BV;IBVK/8QB (QF@R8*5NBO-L5T::$_]NT]508,0VP)M9'!PC[X>-J
M?;7X/UNMO"XW!E,#S6HR%QJ#4<9',*YNW&!T[ =A$$(Q7I7H"LMML/4<53V]
M&$Z#JLETT &>[I[I%UY(+^JN7&XD18PJTZ&=B149*&(,Q;MBVYQU=ZGHZ5)^
M^KAIE(P[P$>5QW_AXOV'*\P__(%KBNU>+NG'X^:J9AD7/'-RD#Q!$75J$CH%
MW@L$0\Z3%2=$B.TF%SY#6$_76M/E?5-IH@-@W1E$\N)Z785ZP9,7*A+=3@;B
M(&0),=7W>:,4-\P5"OV:8.EK6N991=<2/D?*NX_RJ$<2T-OZK]>%SN7KY=7K
MZZNZA*SNZ+FP*%)BUD"2M6G89,I'33:@?0DQQ2!E:C,P?BRE,RV3._5MP63*
MZL"!/1A8<H>3&]8NO,HN,>W J2A!64Z_8HY#0,O#ML (V\P\^Q9E,VV-:PJV
M*94Q=\OM_EC?;[+]_S"L7R_Q(K+(LV$:4JR3:9T7$"Q9"6=!2<<RYH=/AT]T
MVS[Q@9DVN+7 Q61R[!$+[_Y<75@AZ?^3 HYUMA8S&;RL0[>XQ"2=B"X.&]_Z
MQ >&8>$LKJ\GDV.76"#EXD62T90LMSM6/$5RS((/&NEL<*B9(5@K>3@:ZB>&
MX>$L;ITGE&6/B/AE=;V^0)YK_;($H55M2/:4#*IZR^"0&Z>42U^678X&1/W"
M,#R<Q67Q=)+L("J]+QB*NW$7 *F@;#847>NZB%D57W>#T<G'.(7<,:E:Y'>"
ME_HO% U#T%E=#$\B_.Y =/>6Z>U576Q[YYVW3L07VM;]WKR.2G(>HE4:LO):
M,4N^5+=;&3J,QF% .ZL;Y48*ZN*2YSYO=[HE7H3U^O-M1O>ZO/N -Q6G+U8?
M/ZV6]49+Y< D&@:8 F5YO%8=^%3HM\X)Q:*@6.\$:!Q%]#!XGMU5]2E4V+6K
MO!W^=<<8F1>6J6 HU=26,L\8()HZ[;UN )<A%LI(3^PM'R%S&"+/ZO:[G9JZ
MP^!=<]O^<D.*>U/5QR_J@FJC, /%^+R^$=59[R'5!;%>92.=*^[$_O$!B</J
M-<_J(KR->CH_JV]9^WV]2,C)I#AZLAL0/&I0%!"3-4D/18F(5G/ZJU,LTGR&
MQ&'(.ZM;\3;JF15YVV3]/E^[HONW>$G_\OLM0Z]+K4M=+=]>K=*_MV'& XY_
MNE[7?Q?7BU6^,$:7E+F@%-^&&B=+"(:1%?I<>&'.*3MLBN6T= T#Y/E<Q\^H
MM;GOZ1YE?5?$\87'W<OH=E/8A17<,^/JFDL*@560''P*$1+CUIK,#5?Z<% ^
M^^UAP#N?N__&TN\+7&1"<;'<:NLM7EU=;D?O_+):;PL_;IG=32&\^3?RR^6+
ML/E =D56MDR+3^%R=V]EK!4F^E)[[VI-43'@,=01M<X')5,HYA#/."6-P\!Z
M/@\3G6BSN[3F#6;\N.T'WAX%=UM-*#JVO#B*76J7L3>4K=E8((<LO"K.JI.$
MED\2. RA9_%4TE(U<[O1_<L/6=>=]O8'S>T7/F$IT3,P.EF2FB;YU7(E$:.Q
M3J)B..QA;=#GAD'G+-Y(&LFXBS3X]_4J(>;-+R3!?7/)Z_)?8;T.Q.Q%E%*[
MP"/)1U)R)5P&EU""*XQB5%Z$]FV:9)^G:QBXSNI=9$)%= &LY^9LO+U:+_Z-
MN_R].&VC#UBOR2,YVD#R<ER#M1H5IJSCPQ7P)QA_<Y?"86 [JU>.)LKI G8O
M+L-F<VLWK]=O:M?!SW_1N;[8X"Y5WQO5[F\W_$+GXH15GJ 2*6>2#($,3H#U
MB?DDA&"-)IL<1.XP0)[5(T=[M?6!SOL#]'Y;+=.^H0&M"+8^U(A:V,FDA5"G
M]$DA0@DDV&#:/&\\2=*P(0!G]9PQC?B[RR__N0PW;9V8?UILTC9AK@.'=#("
M,F>4OB3AZ_RJL&V5\=EF[76;?MIODC8,5V?\6'&L.KK#UVWKRX53LC8#:TIJ
MZEN+B )BU@%$0">\9[F$-FUN3Q T#$MG\<XPI>@[0-"^3N'GOS[A<K-UMS__
ME2ZO=WTMMTWH%X473=&D@:SKPW&F?T26*.!DV9)1H,5&"T2'4C@,8V?QI-!4
M.1V [OYT@\K6W@'_OL:/B^N/%\RD1/)*P 6)CLYY4]<7*8C<1.N*XU:T:6S[
M)FG#8'86CP%MU-$!OAZQFPLT!8O*$DQ(!I22D2+'@N!<5M;9J(IO4[?Y"#'#
M,'16U_7'BGSNJ_EWE+)NZ+.K]6;/"OUB_Z>W@Z,6X?*'S0:O-KLGWI>4J&RN
M;L3X<7%U$;(7VD@$83R)4!L'Y'])HC$9AM9DYQ_,B'[B[GX:>H8![7PN]V?0
MTMS W U5J%L"WNVV!&S_:+'WV+^O5^_7X>.%#)G+) 4XQ10H(Q(X+AA01E.R
M\8\$:$] ;^@7AX'K+"[WVTEZ;OA\8Z1+?<6XS^2%3IZYZ"SH4E-@$3*X6AWO
MM#*<F8PIJ$$X&OWI88 ZBPO\$\A^;F3=)WW0^ UGR+\F+'6C);%74A6B8R"+
MRUI2?HQQV.DX_MO#L'46=_&GD/YDX/I__N=7 B?N_[W]J^W?U/_J#9;_J_[O
M/]^\O/WY"[(4\K:7BX+_(ZT^WOSTGW[^\=WN3'^WN@J7=15;-:MM<?MVM/M/
M>!46EYO[?&P6'S]=XK>0-?R'_\\OY#]D;/>->^"9DA7\ZPJ7&?/_??S%84WR
M+E=U==X/D9 9TM6%"-:@" *24K68IMXCY%S 6(J*>$Q!FW:SMK^F9]KKT9O1
M_\%+-,(8\,'55#8B^%AI$D67(DRQZA3]*5MBYI]8?R0&GK\4'2_P#NX.[K-P
ML[!4!9>4"Y!9[1?,O,[;3!)0>J>E8<+K4U3_#5XG=:(WF0/4^RQ<1LNZ.[3\
M%C[N]](89FT(IH!.]496D0$Y9A,D0RE"5JSHU&:+SU,4]82<\9I^%C@'BGW^
M 'JY6*T?;/>X641DN0TI:0;&U(D@EN*UX*T'GYD0/MCB[-! ^:EO](2'0Q6X
MFEZ:<X/BINK^#UR&Y=5-%]+66)S1UM:"KA0"'<K2UVV025"*J"/S5AK_L.SD
MF:3\ZY_?TPJ3PX^5J038'P;VQJ%R"$H*R-$ERN"T!N\P :)BQ):D"&W81+:G
MOC"/4YA,;\_CX  A]H<$OO-IWI=@;';D(EUMM$D.'(\6(L]".^=RTL-[]Q[]
M1%=8.$1WSZ/A$$'V!X?]&GJG+<M*!O!>Q<H*HV.ST#DGG=,ZV>BU/1 .8@0<
M)C\B3@:'0P39'QSD/N(QQ5A)9#M3?)UP(^E7@E)Z7T3*G&?Y\!YG,!SD"#A,
M7FQS,C@<(LC^X*!V7"#ZJ$H=1>RU J4S_4K1;RTK'H-CP>"PI\$G/S'/PJB3
MP>$0079W._'EU8%1W*0E(U0+3Y(1C(X[1;%VEK&VP@5EY"F*CF\)ZFF/W=2W
M6H=)O0=?<K=%_,88=N\5]YXJ+HP)"8N)P%)@%$"A!Q?(1=91USEZ"MDS&^Q<
MAGVSI[N+ _7[7#_^1,+N^ WO;?J ^?H25]MJPU_#57W+_'SDV]WS/W2J-[L1
MI+=]JTM<Q+JOG(+41(E+1D=!*D:(QM!?&)XT;_<J,?U;W=VRFYU4%[AY@Y]V
M_=ROR^VLB9?+WTBT[_[$RS_PU]7RZL/F(F4O8\X,4(LJ#"OIB/;DM-%XBN"4
MRJG-P^519,_OQX[$U5<[,DZFQ ZBJU',[I<!1!(E#SI#T-K7 2EU_H]AP+P2
M5B/20=%F1O8AU,Y_+3PG/@]1V5G"<KN3@*6BL]8"V/;9OVQW=L4$TAEC>)3.
MIS8YP6'TSI\RS [-T6H[1W!N%R0PR237M7\\FEJ2@K5_O-9KEYA9*"(XU6AI
MZ"'DSK\\>VYHCE9:9\B\,-%'%<G'BR)C3?])4+Q82$YHJ[E1/+4_I>??E=T0
M1Z-$?#@\MI65[3+9-R__]<.[E__Z^>5O;]^]^>>O/__V[NUAV>MC/VB:C/6;
M)$Z6I:X7?X0ZY?S+5<;FAV7^7YC?UW;5.@!]ZS<> 55VB0>+ 4RNAYBQ];T%
M$SB=2B!0N-+(OQ]!]/%WLZ,__8Y4]2/]C']?!)2<H2A0[[#)"DN=XLUJ9YTQ
M2B=9;.Q&8+=4SYWMG@:?7]\&GTC/W5[W/>*!MI?L!U[T/?WCFCG,Q\CMP&WR
MD#5F5T>LU@>N+"(ADD<H=+;ZQ.F ]:V><69SF_OKU]JG_@@17TQ'!2E27:H6
M/&5'9"P"0DX>BBY!1!U\Q#9;HX92>+[N< SNOMH1WD)_':0/W^#KY7*[-:O^
M^G6Y;5+^?;59W+1O[=JVOK ?E0I%L@R1TB7*G@JG[(G.@&*-$!@C:U4_/C$C
M<U\A=HGRIFCHWQC^$1;+5ZO-4V+ =5FM/]:YJE\$X*V69//$NS+D#6)QX(M'
M"$SGN!URTRA#F)R5N2\NNS2(QH@XI]#XR_ORO9V+?X9/7R2W.>JE_-B/-@NS
M#V>]@V \6V9=K*TEB:"HD$7P.@MP3*D4#?I@6[7.=G"'<5,UY8QG3!4-VM5&
M&R8+1(L"<A$A*I^9]*V:WNX1<KZA]1@4/7W3,%X;'00-SQX,/W[>2>\-7FX5
MN?FP^+1M$"G)&F^" UMX((G1KWPN"0HRHYAPQ=IT.KO[)KV]0/, B RYV)I6
M7QV@\A$V=N7%(@F;<YV?$5A=N&UJ:7A1(#-7G*40?:,WHB=)Z@5;[?"P:J&<
M#E!6MRG]<KGZ<\?0OMH\AU@8(^^??0'E$@,G0@'C';<IHO<%FR#L47+F1==$
MJGXX:/QHN7< GAWQ/^%F\?YFC]?6L&)1-GL7@6NU39 TQ+KQIC:V>:Y#8;+-
MP?@X/;U<!!U_\$T@[RY1L[,GZ5$7# &R5DA\2 ;>60TBY908&IU\FP7B3U'4
MA>,Y2MO?!- !HN\ 0GL&,/^PV?%T9P?FKKW6^:(YRR!=O<8W6Q&1H9%[U9I'
M1)=;A>??)*XW8!V"@J^"\FE5T@'*_A76B^JSZUW0UO0\YW6I402!EM==1P&(
MH01TZ*,@N145VD#J(26]7.4>?Z0=)>/.,+(/"PG2(E$<&*VMXR(,IW!.<8A!
MJ%Q,1I;;!,]?TS*OGSE.M\\ Y0!!S]W6^'IYTVORS[<_O7KYX^LW.X^H8M)!
M49C/2])D.E[4'CX$I"S VI*,U\/ZHQ__^?WH_Q"5K::57P?>XK&;BC>+S;^W
MUJ$8CPF%!AN)(3H=/= Q6>K.=S3*F9ACFST!SU$U=TEYVUO#@V3?%8Y>D%'4
M^_MW]%_N;,P*+HLOM72/+$'E^GAOT(-D9&44@0DTK>^EOZ:JOQO"PW3_)*B.
M5,3<Y]/7[Y[[</Y7(NJ#L()QNW.ZPA#Y=?%U\.1O51UAY()6D)6WJ WCA0V;
MTS[BH[W@YU@UKTX@\WZQ]!.F+3M<5M;J]HST ??SL%BD\+!8!D+5V""&2+$!
M.N \)>Z-T,;Z(V'UW/=[N28\#<(FT\29@6T_;2L;$Y2T%H2T"92CI,2Y)$#F
M$E6Q6F-I K8Q,\U.D,#/"+9#-'%F8-O/\LHZV5)X!KF-,'QT$-$JD+5!T68I
MTL,;@6G -F9BV@EB^!G!=H@F^@7;ZW2UJAPRXM ]\-TU14(=',BR?92D&"'X
MP"$;773(UFAYK&-[YO-S=XZ>%FI3Z>&\D+9WW,G+HBD1A^)3==RV=DSPNI_1
ML"19TI:7!D@;<X(VW"\W/](.T<-Y(6WOM04EXK&N_O0AU]WK)8.K6XNBT;8P
M7[)SPZ9/'_3Y04AKN&QN?J0=HH=^D78;(+A'W';1A3(=X<![IVM1F(7 ; #N
M6;:HD!4_;-S]8=\?A+6&>^AF"M6.U<29@4W<LH@J<#10.(6D2CH!KHY85-Q2
MZ*HR_4>Q!=C&'*$-%]-U +9#-'$&8-,$$?; GK2-+F3#*?5!"D@U0PH3C )*
MKT/*.44Y<!3S8=\?=H'+OCNT':N*,T/;WJ"X0F&8=Z"5I$2[" &A8(;$0_;,
M*V7PV.3@N>\/0]MW\UXPF2JZ>MM\=3O@6(G@K),>LJ 46F4*/+T+@?@P14L,
M,8?64V=>C1H9?H(KCBE?Q ^3=%=@^6U551 N;[;/7A16T'OEP#I%T:,KY&)E
MM'2^2]0JI<Q8FR*LIRCJY0'S0%4_"9TCY#X>/_X&/TN\FA@]ORS^PGS7OUY(
M(X1R*D(II&<5BX7H2H)8BI?9<F.D: R@KXCJY8ER:@P=)_V#W= ?N(ZKR1W1
MG4W8=ZP$KRY8P*!(($"'/)F&LAZ<S935!HO..1ND:3TTZ2G:>GF.G!Q84^AB
M0GR=8(K#;V&]WK(Y]:2&KWYPLVD,S[/0P<0%)]%S*Q@@9HJHDR#T\!IYI:2-
M"TYK=[I*S9DF+A0OBD,GP4@I0'EIP$6R(-29&UT"B:%UE>&93UP8@Z)O35P8
MHXVNPO9'ZC$#)3"YCO?1EKR^8G7I56UUX\%S'XI0BIF36=>H.NB334\8I>XQ
M==!C9-\5CAZY9]$A!@HB,CA5)YI82<>[,PQD]"0D4Z03K2\-SJH.>I3NQ]1!
MCU%$%\'\+ZLU+MXO?_XK?0C+]TB__3.L\_ZI0'%?9(Q0WSOK-N!"H6/AH%-V
M27I95&P3QC]'52^P.E;[JT:*Z,!7O;BFCR[3YWISNZ]&XTDPJ15I.M;U\%%
M9,R"+$45;@-#WF9JU=>T]'*U,#& CA1Z#[!9KS:;/1MW[TCVDMJQ%8CXE)@&
MG6N# %E"O3%QP!/ZJ'6F7+I-/#Z0P%ZN&*8&6 /U=("Z_438;6!@6/:ND%2\
M9D0[3Y$DI274H0"NY.1M:0.MNU3TXJ".#\ /EFU'N-A93O(Y"LI<(:FZH"R2
M+'R6M:$[>D3&E4FE*3)Z"*H/U^<3P#A N!U X^V'U7KO[:SV@L5,9ZRLM5N<
M,?"I:!!$FKV9*.V:X.(.$7V XA!=/IQ@?*!@.\!$W;NT[RF3D:--",PY11Y3
M('@9-1@KE50^&5O:Q+I?:)CW")D0$0>*M0- '#BJD8648^0URTO$I4$.3@J2
M75%,"Y8X8JN-P\U&K9YL/,_4EX43ZZL#5#X]XE&%*#.S")I+!/*O2(PD T4K
M$:QA.I<V+SW?UZC547@8/&IUC'(Z0-GC(S\5<]EDX: .G 65%(G&.D&_U8Y2
M1E^PT=27LQJU.DK5@T:MCI%[!^#Y#:]>+O_ S56UN/N<>"%*D"06[72L)5<>
M?!T2P3"4H(IU)K4I=7N:IGDCK38PFD@#'6#IB<&B FVL?:F4JRJRB&*)"V<*
MN!1S,$)ES=KLD3AB;._))D\=$T1-(.\N4;,S*NZM]#E%B#8F4"@CN( ";%2%
M^QB%:?1>?U9C>T=I>^C8WC&B[P!"OZV6^<N,H]TYK%04Q1A(N4[A=V1B/G)+
M#I2.9Q>+":7-5=$CQ/0&G$.T_/#4.E+D':!FT&1AGXS@)8..E26# 7P.%KCQ
M663EDF]6D3?-L.?6P="TJ)I:)5V@[.LB9.$=2EXG*Q0F:T5,@1"]!ZU8D#SI
M)%SK:Z=7?;8=37.G=)BDNP++@_87$0(WSG*22ZB90*U.$2:#B85SK147K/4>
MLM[;CD:I>FC;T1BY=U%BMK\S>[U\]$J-DLW?UW@5_KK0%!GZ)#DD'FOW9F'@
M5?1 461@ CGWK,W)-I3"7A[FIT%8$[UTY;$>[8GY8;/!JPM;W;>,#I#5_0R2
M'+JWB!0<".ZUQB0:[3<80ETOCRI3>[*)]#&K5_O2GIY6'S^%Y>=7J[#\?Z_I
M3W%]^?GW\+D:#SEIKYS-&:0V=5B[('8D.BA",(7%>V8>A%//S01XYDN]7!T=
M!Y7IA=J!'_KB7W>UO?O:N5LSJ/D$?I'AYB);[8(6=?LXIT2%O"XX;Q5P:>C_
M?-3*MNG$'4]K+T'ZU&=A$UT=T?[]OJ:>[R8#Y>NK#[A^04:VQ@^XW&R/?+(Y
MK,S??3W"VY=.+"21-Y@NPV:S*(MTH^-E?D>10=#!BR B,)U)!H'"@YA" ;3)
M,B&\-JK-*3HI&[W,5YP&RO-I>/8A!_>*DA]C]=WJQSN,8O[I>KU8OO\-_[KB
M8KMSI4:]%SQ8)^O,HA)S <4=KP,F$4Q]Y&(V6&':9+;3T-_+$,=IX#R#3CN(
M'9XSXJ]>9X=9<AU9&5*B4\K%&E<S!D%Q"<51)%6L"0';9-?3\]++Z,CV#OL$
MNIX,[2>8^/ V?<!\?8FK<J\9Y69"V&UH-O4XB'%?;38KX@CF.Q@DH92TJ;8'
M1.2Z=AYY"B0D QUD<,R:'$N;C;<=#9)(T1+?28 Q+-5!Z22-0K\J1C,OI>*Z
MD0O^;@9)C$'1MP9)C-%&!R'!@?6H)M9&=Q/!L5H'5K!.W9!T%&"*D3GM%6M]
MT3EY/?G)AD^,@L@T]>1C]-4!*I\N0(Q*NARC XW>@JIWNZZ.@+$V(#.!F RJ
M"?"^KWKR47@87$\^1CD=H.SQNN;H%6KN'22G&:B,[&;:*PM<%6.R-[%-2'%6
M]>2C5#VHGGR,W#L SQ-5BEBT06/K,Z8P-U7Q7A<*)61Q0EE31&Y3\7)$#?#)
MFKZ/.?@FD'>7J-G;DT'E17)@,B=[LMI2EJWHMX$97IP/K+3I03BK&N!1VAY:
M SQ&]!U :$CIH$1KC*TOF4G4C;S90V ^T!DO I-<1O]P7UYGU9RGKQ$>A8(#
MJCG'J*0+E#TSZ"QIQ7.L')B<Z_!7!!_J42UXR"(445+K0;P'#A@\6<_PU#G>
M0;+O"D>/+7(PI61FZZP/7F?Z\ 0Q.P]>5--SO(CTGT7KA^I^U*+U$8J8>Y_*
MDP.CZI7UGK?72]SY70P!17UE%EIJ4,(C!&LDY&"S+$$Z51[XJB=JIL9]MQ<4
M':OLU6DD?Q:@>O?G:K^;U)=@BB+!2<E!H:N'.66MN203T'./#RNJC@'5[7=[
MR>9.#JK#)'\>H")\["W&1:>C5QJ*MO+F@346)Z'PP-!3Q%#RL)U/8[_<2^QT
M>F =*/T.(JNA@Q,SC\D6IL I66KELP!O=!6@$E%E"B)LHQFI$\ZUG&FY^@'8
M:ZF>#E!W;U:?3BZ$9!-H1V2K6@OBN8YU)J=%XR3GO,W @]%S+4\VYN"8O.]@
MV7:$B_UPMMHA;6)=RY@H4Q'"0Q3,@S/(*"I,.MHV-P3=SK4<I<]OS+4<(=P.
MH'%GV%Y4R5E>(B@9$%3*$D**%,))$T+=L2A,;@*+D3,,3S;5<HPFGYYA.$:L
M'0#B[CS.X%%SIS,1;.OZ16?H5T0_V8>(.K&<.QET>K*QED= XE#!=H")1U>8
M)1:9DP**T,0"\@!>N@#1Q5@*\SRGO^GT@&ENEP^3=%=@^7KQ8>:^Y* R^%CG
MN>I H73($9A#4ZP6(K ^UTZ>=G7I&(6/6#LY1OI= >G!. 1IZZAQ+& =DA<N
MJAZFP0#*NIW5%,5BZY>) \90G'9SZ200.D+N7>'GR469EN?"62ATGD?B*'M%
M<3^9A8W:.J])5J)-@/-MVGJY]9O<+4VAB_-L8/FZLV=SDA:68=\]01/+ 0+H
MH(W%(N>.,P.),C90BBP@%(SU$EHZEG4*[+MO8_$FU(PE0_:LCKA6#J(L&5S.
M1:,U%EWKA?-GWL8R!D7?:F,9HXVN#N)Q8]5-B%Z9!$$[2HU+((G140 Z26M=
ME5IJ<X']/;2QC(+(1&L11NBK U0^73Z/00F;N /K'0>5*-AU*2-D"G"-X<XE
M;)-??%]M+*/P,+B-98QR.D#9,W/534;R^]* MASI1 @6O"@!2A283.):-%HO
M=N1D^QD:6D8I??AD^S$:Z !+3]3=6UZ$"IFX8$76PD,%L>91Q;- V;J4K-%N
MS'/H:CGF')Q WEVB9F=40DFELW.04MVVICT#Q[T!5A<^,%NBCVTVB)]55\LH
M;0_M:ADC^@X@-*B%(ILD@T\@47C*:E0"KY&!R<JYH&56N57;P;EVM8Q"P2%=
M+2-4T@7*GJFN]RFD$.EL=EP74))IH-\I8$R@,L7IX-L4)YQ/5\O4*=]!LN\*
M1X]4#0;OE/%)@I,4/RJ/D=QYL6 5"XD%%S)CC7%T5ETMHW0_IJMEC"*ZK17_
MNJ]".QND(?L31@=0P6_W0ICZVJH#\X8'^>#2:FR5^#EULXQ2\J#Z\.,DWCV0
MOO12Q,"--A02H(GDS:,VX(WQQ)MS,24OBXC3 .D<.EC: >DPB?</I#N]$S(2
M'^@U&-24PD2>(-B8B3&?8]$A6)XG@M)9=*TT!-.!4N\>3K^LKM?[GHA$B7"B
M.("[[;!^@Q1FLEH-F:PD5YP<3N28OGRTES:"DX+I0)EW$($/;:\)F) SRD@I
M=7&4L0@-GI, C8LFE92CMVUNH*;L?CI!7>E$L&NIG@Y0=Z^C(VLIA:OCTU1=
M+H*I%N$2*\H:D0.3'DN;2_%^NY^.N1\X6+8=X6+?-\@$XSX1\US%.DLF0(BV
M;BZ-P5OFM-1M;I*Z[7X:I<_GNY_&"+<#:-QITY$F6JN< 1E*=7;$0_ J@(B>
MR8 JV(?MW=]W]],H33[=_31&K!T XFZ33DK9%DX1>Y;.@@I!0Q < 8-AV44?
ML;2Y*NRU^^D82!PJV XP\5@MM*;HB[C@1'BJ0ZE+;:HP @RY3-19>AE:UZ:]
MZK/[:9I7B,,DW158'NF_T0%S\@*$<N0+LR56MF9@LT9NG/&RS1%S5MU/HQ0^
MIOMIA/2[6*+Z=!^.+C)EE2!%5<C$=.4D%V#::X]&NJS:C-D^G_ZG:4!TA-S[
M<D5/]=S0L:TYDZ3H4M<KEFQ)8+4\W6F;>;+>Z?_T/TWLF*;0Q3GU/]TRO+K#
M\)U"XA\__Q@NPS+AVP^(5Z]6-UN-INZ&.HZ*9KU1$PJG@TXI9:5(1FH0:"CV
M8UI#]%Z!2Y+S(KRRK'6 <_).J5L-WFUE>TQI/WY^_$+WMH#^3H'832AMDG(J
M;3>-!O(#%#F#+RENM\ 7PGM0V3019SN>>@DWVV+[_V?OS9:<2I:TT2=RLYB'
MRX2"?;!# 099W:>O9#%X@'HG$BUE4L7_],=#RGE"PPJM4/9?%Q2CY,/G'NX1
M/MSW_IU@I(.8Y(DB6Y\P&92KH01(7! DG18)=/(E"L533&VV9.U1PMX,I;V@
M9;-J^&U4UR4 +R^WI!0E&4ZRR*8.-Z"X/M(_AV(4LT%R3/>?M?\W5L-OI>U-
MJ^&W$7T'$-JD])K[;+R)G@037>TL"A!M9I"06\$<TR6VNA\\UFKXK5"P0S7\
M-BKI F7/5.6J[+E!+D$%27Y<: >.IP)DFAEYMJK<'W'=2S5\LUN@3D_-P=38
M%20?*4B1@:,T60"/MHXYE X"3QE0^&1C2HZ'_UM8OZONMRFLWT81'8#J_O#O
MJV)<)XSDUH)PW(#*="XX'0H(S9BW)08CV@S&?IR>7H"TK[[G@PM_>PCY-81F
MY)(/66RH':JZU0)R=(4,CF?P& P8LL.@F$\1VX1D0Q8;CE-]OP_$6JBGL^>Y
M[9:[2H.&D;=GD=7EKJ*VJT0.1D4CF,P4E[9^O!M\JDVS9Y@C"NH&5GT')_,S
MXS@4R<ZS M946W56U 4)AA#'#0]%2M>HB?)E#<C9"@^;#\C90CD=H.SQ?</2
M!\M4<B"5YK5LT(+G+H*(P5JF(TFNC9<\JCW/6ZEZHSW/V\B]BU/XF>D^UI=2
M)_B 9O7"LD[N<(Y^5IR+6J%$I]H4>N\Y7ZE9C-<&2 -IH LT/19:K%RUC-FY
M0'%O4=*"JO6OOM@,D1OOG70E^#8/5$]1-&YK2:=QV2#JZ^!,?+3FXW(#1<)@
MM9&@A:?47 D&0=@$P7@E(R/V?)N:@*=I&O=T'$;G&P!I!P5T *5/"_P1IOG-
M/S]PML1:[/#Q_!LNU@GY^<ERB>?+*V]=FWZRCF!SG4NKZBI;62@ 8"648K(/
ML4U4OSF-_4%M%U3<;Z%JHZ(N#M05)W=8B")*S!RA,%NG++ $CL(/B)3P,)=<
MX8T<V -2Q@W&&H%I/X&//8?@)*7%!3YE"N^G(4[/5@5:E[P1_:+$6.JB-DI7
ME.%52 R2XH'+XDB ]Y80/3&+8,LO'O=6;&#H-)=\!\?@BIF'7&0K7<K<0$J*
M(D[N;)WVP@%EYLDH*]"U.?(>IV?<H+ZE1]I/]!T Z%:><YW\O+]N#4 FI569
M@^ Z@_*9W&O0 71@+C"/2/ENXTO]1\@:MS&PTQQQ.$5VA<I'VTI6<<#$>,%K
M*S\4@62\1AH(P6B@WQ>:U[:W1@^?FU#7R\7]WF#8KN%G>\WTC[8K'_]K(HT2
M/I.DF%24>N<@P+'"('HTK(B2BQVEK>R:PE[>V@^,NMTTU!7R[K5D(B7"7&H-
M.=12*D,!:="\AJ%%U27P&DV;>]F]6F$/T+;8#EE[:."8VA;?E(+I_(FVO)MZ
MX]O/:+B<S[X0-;CZ._/R\0<NUB\M0W<S-B&N69-C>U%VT?MHBD^>@\=4ZE 3
M 3[E#$EDR[-1/MX?LGG\O8_;USV\^O5N1F#!:]T^E@3<K99=A_S<,A5+9*"S
M9*!DG4I'1QCPH*)(6FM;6H<4K7GL)11NB_W]:ZD.@J$.@IXG6K"T3<S5RY=H
MO:QC""AJHZ07BN%"N2(2BC:]'SWV2O:*GLUZ)[=199> O%ID(CC#6"]@DHL4
M P8)H9@,0J7B-0\IR39GWU'U3FZE[8TW"6TA^@X@M$FC'I9@%9H"K-1AQT:0
MQ()+8%@PAID8V]U7'6OOY%8HV*%W<AN5=(&R9QJO3$3T&!T)I\XXI308G T<
M5'&L&)*6=VTF _?;.WDDI^A@:NVB-.+YCILZ;3N$"$)@J@69"D)4&GR45OL8
M-8K672)'U4VYE?:WZJ;<0A%=P.J)ECXM4&GF(]C *$7CAI(U31Y<.VXQ)VM:
M >KX^BFWT?AF_93;"/]H^BG1DUVAD< 3_: P* IG10!75%'>45!K>1-$O8!^
MRCT@UD(]73BNZU#BS?]<3,]_O9Y__S&?K2ZAJH,//JA<4Z:LA:"X049PO'BP
M7G =!//9M"D;?):L7EY[N@[;AE-L!ZG%/1ZN#-K8'+2B7%[F5!_!$"*7'HJP
M(K/ A+)M+D >)6?<PW5 =<^'EGT' #I)Z>+[Q5G-M]<5EL3. K_A;+DRO6J=
MEQ[<9>40,]F<C,28UQZ\"P&$<3K5/BIIVH!J8Q+'!=H <)@?0C<=@.X)K[^R
MR!@T1J1H-+%Z=U1$'>F6$.J*:)981M1MXKAGB.IE<5+7Y^I02NT7GY<FS06W
M=?DF$$<D)!)+7<PI0)20G3&13+#-A?"S9(WK_ 93_F:@VD$37<!JG1Y==C5<
M-U%YHQ)*R-R9.GG+@%,^0:;L/)2<([(VDSX?):=+&.VB[B>N0G:7?0< 6D4!
M'^:S^;K\J+Z,5'G=Y2E*(X03&HRV%-)ZBCA\('.3W.K@3<S:MRG^WX2Z<6]!
MVL%K<,UT@+8KD[D3:3+FDM*. M@ZC$,YKBB>M0$TU\(S4YL^VV0!CU$S[GU'
M>V>UL^0[0,^.0XBRDX%[98#5:?8JBP0N80#N' 8MM#?I@'6+P\PC.\"RLZXS
M@P- H0/ /SW.1GM$40?-,&L+R8[$%HP6A$#A;):8*-QH68_T0N:3;86'C>>3
M;:.<#E#V^)RL(+-2K!  HM=T-A0-(9H"5CMI9<XYI4:/7\<TGVPK56\TGVP;
MN7?QJO7,=*RLLHQD8%!J3*JRT>!*M) TXS8569+R33!T?//)]@'20!KH DW/
M.O+W-XU>Y*"E5@I,MI1E.X/@D/+MX*U(7"<=4YOS;S/Z-D*9Z><P["^&VTW5
M'9RF)Q]?OSLY/U],X\5Y%='I_--*:62D'\MI^.?S_.SL[7SQ=UCDB2C9%^$<
M"&M7+SD&?.U6M<EE995-"=MLD]N"R([CNATQ<O])K)'".L#BE_-Y^O>W^1GI
M:+E^2YPX6Z)S%.QJOEIO)!%\9D@,R2@#"<KF-E5R#VD9%UG-U/Z@-F0O'>R,
MHA]D.?-,#GTQ3-'<4\_%U1#O]+5>'S18Y@O\C.DL+)?3,KU\OIEE$NY$ZAQE
M'8;#9=VASDO=H4XBT#&Z'%F.&=M$AH.R,6XP>2@$CZ?Y+B+2K=E_P'@ACUY9
M-PF=Y=E!J#,)*,;7X)U3(',JB8<D4VS3ES$8"^/>CG<+^$$TW@78'SFM>#+)
M^9R!L^R)AZ AH!1@)>,R,>,Y;Y-J[1@Q-"N:&3%BV$8'>T8,;V:YV1B2?WW\
M^,=_OGO__N3#'Q]/_Y\WG]]].#WY\*]WK]Z_.?GRY<WIE[LL;#8]Y+>?.<30
MC^T('VA6Q[_F\_SW].R,#LYW1/3LZY1 MQY\^LB$@I(-9\I:J T70#EX &^X
M(\34D;J2%QW;E(]O1>:^_FFC+SLE!;RB?_7OB9..)8P*@O5D-T93L%'+,H1(
M*5FOBO%MIE]N1^>XF5 [G-WW; VUU^G@I=\YCM4MVDY3DS;\Y$-XO\>8&,4'
M)J>2R'6-7ZD#\842X")/$#$&2JP1<V@S..2@/O!+^H;YX@P_EJNOO3$9*XTM
M9(C ]&J[3>35>!(D'KE&J:-O-"WN&:*.R;MM@Z '<=M >NGAXO":E7=DQ&4Z
MFY[C>\J#'HAP9?HW;&J-J'4RH%A:'0X6B+,(:*.PKBBK0YL+[1T)'O<"9PQH
MMM-G5[!]NS&+25!RID(&X70$%2,#)R5"#%Y:4PK3KLW8M1V('??Z90RXMM'C
MD0:+'\)BL7H+VV/8YM;?<8@ \GG&Q@DE:[NZH1/:F*1 !<IU?%(% L=@!?<F
MXPM(IQ\)65;/^B&SJ!294 H%UQM50M$97$@\9V:$96V*OYX@Z*A"R"V0LT$(
MN;4^.CB'G_':KW[]&?Y[OGA=[\O7<VU<S.O-VR$P4#P;"C$H4%;)I.*5"E*T
M>0G<@LB1V\V' ,7\,!KJ&WPWC'T(WZ]&E6B5<I+% 18IUB5RH0K4AY@HI) \
MY#;M 5L2.BX(FP%F<V#NK;T.P/GZ8GD^_XZ+V\5W5_N"C#=".PJ1 Z^UFH)%
M"EZS!&E1&VV4P-+FLOH9HKH%W?Y@N%^-/9!F.@#9O5K.VQN)*(0YR7FZWF]P
M$[R0#=,O?LR7X>Q?B_G%CR5]Q-E%KI,XZ>_,9^?3V07FFQ'U*S.G],[$8"7P
M(CTH[RC9LJ4 ,\4%M%()W>;D/@Q_X]X-M3CT.\1%!]:R%8.WG(T(0G,M&=!A
M%^F4TQI<BA)*EE:6+&04V 3^.Q+<51M^%]B[7X]^ "",O7[TR_?I^;</^.,;
M_OW7ES_>3^F7F*].N5*4Y]J!XXYDATY!4#Z E3:5F$(JYMY-Z!.K1I_YDI&K
MR0^AX7D#<??F)E_?+7>KEE>("Y<*'4R(MG:"<(B:?BA*(YU93$K6:$'D\X2-
M>V?>XA@?4A-] ^MJ[D%$IIVQD+FHQ7360C!<@<7 +7I> F^3&/V6M([<V;Y
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M*?!"!#!,,8;)EZ+;#"#9D>!Q1SF-#LRM=7:4T'P[OUA,R-A8M#)#XCZ#4LZ
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M3R\HCER0 ,]_U2?.E3$YIHIBDE,28"EVSYJ\L'8>,J4'S@F?I=YH:B-]P2W
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M.U\K$!<_IPF?L/=;.<UG3/.OL_IDN7X^6E&Z;KS)41:4)$>94UWH;AVY'*[
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MJEUMW$ 2N<[WC5(*OBT*M@1 LV.E 0!VE%Q'NO\XNPU@@S%[3\XPA4PRR;Q
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MRNCK#"3>OUT]QMJXS:DOQ9SV!DTO5K3+K<ASY_8I+K[S22G:HR(]297JV/U
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M>37Q,IS=Z/9&84YC82%Y$#PJ4,E$B(4A2(,.O<:<8F<KXS9AZZA;EL:TH>'
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M Z/X8&M>]X;4_PZ#NYHZ(HI641=PCCM0W)(V5?&0%#=*LZRRT<=J:T<]'O,
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M)JPNQ>K.]H0/RO^+?V]^ 3%",SR_:"]P]]EP@W2+V:P].4V>/+G/G"FR,BF
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M>VRM-N!9/,_R<W?+\]*X&PG*J-$D4+#221!<E8F&"6\XFHPA^%="UTES=<1
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M!$:B0EB()CIE5."Z,R?E$$K[G<UR$A[+T8!P"J?B.??MXJ\4%N7?_?A2=2L
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M<H1390Q[[">\AMD=OKV?$6[U8%A+\,T@Z\59<RNZ#CMO47$=.>.01,REQ"R
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M0RAZ,<]'U' #4U">\9*T(HP[14O*WI?-T*5=DR%#E#L9HU*"D9:\5?DSP.Y
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M+*I'B='-$Z!W^>+V$+2/LB='DGP#!FK)S"7:[DW\L!P\)Z5@1DF+M[TC95.
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M2)W"NUY#1ZL[_#2\9^:%<0%=;)C9Y>,K3S\XRE:9W1K%B:5)>"5 982/R"Z
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M%_R*'P W6]O)'\"VF8;3>Q#;2>V33G70'(K603ZAEF#$'4'9<O*H*;,M- *
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M^J%SVNFC>LVK/;9XM:T+'G/>6UB.C,,&0FL1FKL9<^:NXQN1B"SHH7OQ0-&
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MY(0>T/FTE%3!ARRVN2F]6(ZL41 %." +!*J+?")#C,ZI5!J=&/NOI AB7RL
MU@%QK@CG*F%WF%/H/GT&[2SMJH4Y#C 0ZX RF13 ZE)6V[$4$42P;F@#$>QZ
MU$+5ZH0D$+T^]4F;!Z(G6&Q3'X%2%Q0!2A<D0- !D:@3XI&=H-(G_I@+.\(*
M%:L3\D"'ZQ+'O+_H;:'W1!'&E#_&0XV&;]_4=^J'$H4DH-\II^;O!/4$#^P,
M%L,UO47AX , 7:QN-GCC":#\X)).MX?.*<?<MU7P1D>:UQ0/-J$=YH8ZF1P
M[#)@%\TG!%0AOG7#)Y;5'I%WU'9P]294?R?2?I]15P<0W!:KS9P<@.P39/.Q
M6=,&NR-*VS4 (.75 6V@BEW ZZ7A=4),,PN=G *?!5>I5@>@<X[.?#&,TUB:
MPI$6'%V<9'U;:&,H9&A>0 FZY6+"$5:SM3.N<6 "VG2B@3UT$[B&>M<QGTQ1
MS<:UT4VWM0CHO/2"^E*H:51AC@6B(1O!+8_,>.[ T(,#<K1P8BZ!.LJVSV#L
M80&H-E]FMJX6,.N ,A F+*?U7&+NDX=UX'HG/:"UV+'W5!%@]3FKV2CA ZOO
M8>"V:&E@X'8YK4!GT5( G4OI_(C-@Z-/WB<(3HL5)!4""'U.Z*-UBC>RCI%-
M:%BY)!4TK-;%%]*WW!()TK?6X[8WQGPTQG03M82W!>DQQ>O4&E,. P2KP#V)
ME984&F$.Z)-+ <BN0/94XN^4V2H60QU;\')]J11 [ IB(<?;%7F@(;8FLFV[
M;5$DJ2)IXFSW"L %<!WSR4)PYZ:"M9)(Q@JZ$MQ0*U,#^%W!;T=CEJ">)ST&
MT6W!^E@I -@5P%ZD!J$V5AJ=?RO#))NB53J+!Y@"MBNPS5=#M)L?0?/,%:4@
MREV3WAYFYK.;SEEX^V9[[_ V_<2S"3@?"&9Z[!M?SM;]M(?#M 4 W#6?+ 9\
M.NE\(TOSW(2$V\*%@H3;]= =FR]X,$<PY#2X)1KD-*S'L3$>F\#81!":>)#2
M4+Q,,T6 W57L1ICR+=3SNL!LP<Q:)8#75;S.+:W4>_NF7M\YE S(A?65W'/+
MC-\>VC@EG+#X?A-=_@&P%IN)0]B(QJ]9Z'X@M!;A$J?\#!1?D'OJ"QLLH+,V
MNC:1;OI#R_OC!V*'?\"+ZQ/_VIO_>[\.F:;/OPT5C0>,F/\#>G=\9#ZF=N5G
M;]>]O1USAT@H:L<#FK:MJ.D=.9S00(_SJ\^?F/N^^G *'BB[;OWR4^;\YMO%
ME67NH^.C@34QMSFU</YS+*<7B/"(E >2X-LR'IKSFYA-<*(>WR6DO/SDJ9X:
MM.*V*TQ.7?F$1",OPY$BS>D/AP%5$<-)D_)4I?2DPQ#+D3$O]YTU[0D[Z?VR
MXMSJ@[JW>Y :GM=H^8WS9_+2HNE7Y5'9SJZWO;>\N.K57E56]QKUQJO.?,G8
MQKZW7]U;Z[(0AV0U>'ROB0_3W!R0!);;7\'J11LF6A2O!LQV7PZH7><N7^H&
M!MR*5@4&W)9Q>DEB*>9F#=N0E*<9/)AM0BS@@%*0Z; NO;-EFC9N/L$8L1M*
MP?:1KV3X](=ZS8#=?T"A2Z+'V; %M,%6@ML)(^,I_3C/# '!$/<ZY9'%\$*L
MX((V$"NL1:V:S;S029I,AC9.;GJ0D.[ HB/&#%AVY >XO?P&V!8=XT[0-X(A
M-V<QN-?$)_3.#K4JV/6L<%6@*VPYJ>E$-NBP=4 1H/0%2@DCOA82*M/")0%,
M7\!T+HO\8:,2#)GDD$GNHENFV/XIY"VZ>F%7R0O*S&/ 5I(NB ;U[P*0E>A3
M!9,@BM8!1KY>PK/OM3UTCGW*J$Y@H+9X70#7A6[YZ*&/..1$HMYTP]T.5UK&
M(>$:^@I<D B"@$7[$TFJ(;V[>"$@O?N92[I?;^96!,L;6F5T08*T>NU%Q*>F
M-)FM%08(0_WJF$\,K.WAD*:CL0E$ 0XH I0NH)1R3I30&*596IH:8@%6EX0!
M6N=:H)AKP4?HS(9,LW!@MF H;&7FADRPE=GS])^ V, 5IBA"JK9C'LG9A)>^
M UKTR3V&OM4YAUQ)T])7Q+SPN3;U9YXDD*Z #ZP67F^@CT0J CU7RX'-)WK[
MZ41ONV37B8<"\H-K=0&^_\,5MP#='-UIJPI:5 YHTS(F#(7D,._E.;%V2YS'
MU:W.JUN(: N7",!=Y)5K,A Q#U!_3"2.2&SL@EUWW9$'!@H6K8M.P@%+4$LF
M0L5R1&0"\[F=4 ;F<Z]B=CI0 +RZH KPNK3[#TL5JQFN$+X6K@A$ @LH;7?0
M*7U89P"6@7-&&JA:UX46ZM;")8&Z=3&F\/IW1HZ_@.C/N4U-__W7ARSM1&D2
MVO&#'UF$ #:F<4K0Y=^ 9UO3+-V=Y?]KVYK*0 2)^6^L0W;\7U!+ P04
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M67;<VV_<'LB7^P+<H_9I1/. .UV<*0PAI\*/HZQ)63J1E=N]"Z7+&,1BI)"
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MK?QFEX]<A*L_P[4\OB!X\5]02P,$%     @ QX!85*.JDI :"   -2@  !@
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ME[A@+!3&(JYR\<[83'3:C;\0R*YQ:8RM%.]5"I]B!7F,+OYL-"EW2,T6>\D
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MU_>^BY3GVET-PQQK]3;/5[A\KP%+B-S.R3LA,^*YUB_-$MB6D:1"FO<*J"2
M>"9(I1BR"&2]; *OK?<);X<$M>&& R1=<8X,0).<87)KII;&J(2/*R;!;$GH
M=V<Y>L$)?4/0^^YH]R1!3M&2T *-Q33B2.EFV2*))>Z4Z.)L$R]IOH!F[7K#
MH%.K928))-QPI!? =TDZ_T62CN5(IJSN&#%:H:B9X*BIW9:**642J5)@CT(0
MR[864\X)JF$P2%D4%$@(E&BME.44MR(<1X.).229KH:S5ER5NO*B@+I+E8^H
M;>^5_C^&:WA0K6I>-[$H3>@F@DC(!*2%@7!:E! V?T8)*PM.JY#EQIY1&FT)
M&PFE1!;J8].];KDQY5N6&G;6XNV):MBQ^T%/'ZH4GJ14TCC>GK=L<]YR5+(O
MZ]@]=_BLU+6]9V7_:#6PA[WG53_;[,#V@N?%#\TZ!H@:#(2[1**<MH)6H[#E
M=N@7&^+M]@!-]\>(UV!__29@#LHS7#*[^^HV^6\\KW<0R165%?$[9N?QO[/\
MCH\Z_5%IGCLGMYTT#^2IJ[-M'03- 5.W_4AOB3B7E(*SA#2 ?$L0ORQ87QAR
MQF+(%'J+#\#RH,^)?9 =LVGM;;Y/?-,_.),]NA8H1'TO$DK@5+O;NRCXQ%RS
M*;J?5&B$]%VI?95_N5O8/NN;#G/G,OD;4$L#!!0    ( ,> 6%2J3&5\C00
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M="TR,#(Q,3(S,2YH=&U02P$"% ,4    " #'@%A4JMW-S=\B   G?P$ $0
M            @ $[]@0 :6%R="TR,#(Q,3(S,2YX<V102P$"% ,4    " #'
M@%A4?$])S",X  !"6 ( %0              @ %)&04 :6%R="TR,#(Q,3(S
M,5]C86PN>&UL4$L! A0#%     @ QX!85.M(G;[^P0  Q;$( !4
M     ( !GU$% &EA<G0M,C R,3$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( ,>
M6%1&8)Z:@#$! .S( 0 4              "  = 3!@!I87)T+3(P,C$Q,C,Q
M7V<Q+FIP9U!+ 0(4 Q0    ( ,> 6%3&'<!FR,X  '#T 0 4
M  "  8)%!P!I87)T+3(P,C$Q,C,Q7V<R+FIP9U!+ 0(4 Q0    ( ,> 6%0M
MV(-J5.0!  /\$P 5              "  7P4" !I87)T+3(P,C$Q,C,Q7VQA
M8BYX;6Q02P$"% ,4    " #'@%A4'73MVI B 0#O>@T %0
M@ $#^0D :6%R="TR,#(Q,3(S,5]P<F4N>&UL4$L! A0#%     @ QX!85/SM
M:NY_"@  4O8  !@              ( !QAL+ &EA<G0M,C R,3$R,S%X97AX
M,C$Q+FAT;5!+ 0(4 Q0    ( ,> 6%1+^C!&B0,  *P.   8
M  "  7LF"P!I87)T+3(P,C$Q,C,Q>&5X>#(S,2YH=&U02P$"% ,4    " #'
M@%A4EO:^=A@(  ![*   &               @ $Z*@L :6%R="TR,#(Q,3(S
M,7AE>'@S,3$N:'1M4$L! A0#%     @ QX!85*.JDI :"   -2@  !@
M         ( !B#(+ &EA<G0M,C R,3$R,S%X97AX,S$R+FAT;5!+ 0(4 Q0
M   ( ,> 6%0,E"OE@P0  ,X1   8              "  =@Z"P!I87)T+3(P
M,C$Q,C,Q>&5X>#,R,2YH=&U02P$"% ,4    " #'@%A4JDQE?(T$  #_$0
M&               @ &1/PL :6%R="TR,#(Q,3(S,7AE>'@S,C(N:'1M4$L!
M A0#%     @ QX!85'I"EZ3,"P  RS@  !<              ( !5$0+ &EA
K<G0M,C R,3$R,S%X97AX-#0N:'1M4$L%!@     /  \ ]P,  %50"P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
